PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Lau, DKY; Kong, APH; Chan, MSW				Lau, Dustin Kai-Yan; Kong, Anthony Pak-Hin; Chan, Michael Siu-Wai			Sentence types and complexity of spontaneous discourse productions by Cantonese-speakers with traumatic brain injury- a preliminary report	CLINICAL LINGUISTICS & PHONETICS			English	Article; Early Access						Syntax; sentence complexity; traumatic brain injury; Chinese	CLOSED-HEAD-INJURY; VERBAL IMPAIRMENT; WORKING-MEMORY; APHASIA; NARRATIVES; LANGUAGE; ADULTS	Previous investigations on sentence production in English-speaking individuals with traumatic brain injury (TBI) have yielded mixed conclusions based on their findings. While some studies found comparable sentence complexity between speakers with TBI and control speakers, others reported more syntactic and lexical errors, reduced sentence complexity, and erroneous word order transpositions in the sentence production of speakers with TBI. These contradictory findings could possibly be due to the use of language measures that were less sensitive to subtle syntactic impairments among speakers with TBI. In this preliminary report, the language samples obtained from 11 Cantonese-speaking participants with mild-moderate TBI in Guangzhou, with a mean age of 37.6 and mean years of education of 10 years, and nine control speakers with a similar age range and education background were analyzed using in-depth linguistic-oriented frameworks adopted from pervious works in Cantonese. The results indicated that the TBI group produced more errors, different varieties of sentence types, and lower syntactic complexity in their sentence production compared with the control group. The findings suggested that the more refined and linguistic-oriented measures used in the present study were more sensitive in identifying the subtle syntactic impairments produced by the participants with TBI.	[Lau, Dustin Kai-Yan] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, AG522,Core A, Hong Kong, Peoples R China; [Kong, Anthony Pak-Hin] Univ Cent Florida, Sch Commun Sci & Disorders, Orlando, FL 32816 USA; [Chan, Michael Siu-Wai] Ruttonjee Hosp, Speech Therapy Dept, Hong Kong, Peoples R China		Lau, DKY (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, AG522,Core A, Hong Kong, Peoples R China.	dustin.lau@polyu.edu.hk		Lau, Dustin Kai-Yan/0000-0002-7088-7511; Kong, Anthony Pak Hin/0000-0002-6211-0358	Departmental GRF of Hong Kong Polytechnic UniversityHong Kong Polytechnic University [4-ZZFP]	This work was supported by the Departmental GRF of Hong Kong Polytechnic University [4-ZZFP].	Alexander MP, 2006, J INT NEUROPSYCH SOC, V12, P236, DOI 10.1017/S1355617706060309; BEESON PM, 1993, BRAIN LANG, V45, P253, DOI 10.1006/brln.1993.1045; Bock J. Kathryn, 1994, HDB PSYCHOLINGUISTIC, P945; Bussmann Hadumod, 1996, ROUTLEDGE DICT LANGU; Caspari I, 1998, BRAIN COGNITION, V37, P205, DOI 10.1006/brcg.1997.0970; Cheung Hung-Nin, 2007, XIANGGANG YUEYU YUFA; Chow W., 2016, FRONTIERS PSYCHOL C, DOI [10.3389/conf.fpsyg.2016.68.00018, DOI 10.3389/CONF.FPSYG.2016.68.00018]; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COX MK, 1993, EDUC PSYCHOL MEAS, V53, P951, DOI 10.1177/0013164493053004008; Crosson B., 2012, COGNITION ACQUIRED L, P167; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Frankel T, 2007, APHASIOLOGY, V21, P814, DOI 10.1080/02687030701192448; Frazier L., 1987, MODULARITY KNOWLEDGE, P291; Garrett Merril F., 1984, BIOL PERSPECTIVES LA, P172; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Halliday M. K., 1976, COHESION ENGLISH; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Henderson A, 2017, SEMIN SPEECH LANG, V38, P40, DOI 10.1055/s-0036-1597257; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Kertesz A., 1982, W APHASIA BATTERY TE; Kong, 2016, ANAL NEUROGENIC DISO; Kong A.P.H., 2014, FRONTIERS PSYCHOL C, DOI [10.3389/conf.fpsyg.2014.64.00028, DOI 10.3389/CONF.FPSYG.2014.64.00028]; Kong A.P.H., 2016, MAIN CONCEPT ANAL MC; Kong APH, 2020, INT J SPEECH-LANG PA, V22, P37, DOI 10.1080/17549507.2019.1581256; Kong APH, 2019, BEHAV RES METHODS, V51, P1131, DOI 10.3758/s13428-018-1043-6; Kong APH, 2015, J NONVERBAL BEHAV, V39, P93, DOI 10.1007/s10919-014-0200-6; Kong APH, 2009, CLIN LINGUIST PHONET, V23, P255, DOI 10.1080/02699200802673234; Lai CCT, 2017, LANG SPEECH, V60, P633, DOI 10.1177/0023830916688028; Lapointe S. G., 1989, LINGUISTIC STRUCTURE, P107; Law S.P., 2001, J PSYCHOL CHINESE SO, V2, P211; Law SP, 2015, APHASIOLOGY, V29, P81, DOI 10.1080/02687038.2014.951598; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; Matthews Stephen, 2011, CANTONESE COMPREHENS; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Peach R.K., 1986, ANN M AM SPEECH LANG; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Renkema Jan, 2004, INTRO DISCOURSE STUD; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Tang Sze-Wing, 2015, YUEYU YUFA JIANGYI; Tang Sze-Wing, 2010, XINGSHI HANYU JUFAXU; WOLFOLK WB, 1992, B PSYCHONOMIC SOC, V30, P226; YIU EML, 1992, J NEUROLINGUIST, V7, P379, DOI 10.1016/0911-6044(92)90025-R; Zhu D.X., 1981, YUFA JIANYI	46	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.												10.1080/02699206.2021.1984582		OCT 2021	17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	WE1HV	WOS:000705379600001	34612132				2022-02-06	
J	Riadh, O; Naoufel, O; Ben Rejeb, MR; Le Gall, D				Riadh, Ouerchefani; Naoufel, Ouerchefani; Ben Rejeb, Mohamed Riadh; Le Gall, Didier			Impaired social perception from eyes and face visual cues: evidence from prefrontal cortex damage	SOCIAL NEUROSCIENCE			English	Article						Social perceptual processes; Prefrontal cortex; Reading Mind in the Eyes Task; Facial Affect Recognition; Voxel-based Lesion Mapping	FACIAL EMOTION RECOGNITION; TRAUMATIC BRAIN-INJURY; VOXEL-BASED LESION; FRONTAL-LOBE INJURY; NEURAL BASIS; HUNTINGTONS-DISEASE; ASPERGER-SYNDROME; SEX-DIFFERENCES; WORKING-MEMORY; HUMAN AMYGDALA	Despite the key role that decoding of social-perceptual cues from faces plays in interpersonal communication, it is only recently that the potential of prefrontal cortex damage to disrupt this ability has been recognized. In fact, few studies to date had assessed whether the ability to identify the state of mind of others from the whole or part of the face is disrupted after prefrontal cortex damage and whether these two abilities are associated and share overlapped neural systems. In the present study, 30 patients with focal prefrontal lesions and 30 matched control subjects were assessed on their ability to recognize six basic emotions from facial expressions of the whole face and to identify states of mind of others from photographs of only the eyes using the "Reading the Mind in the Eyes Task". Results showed that frontal patients were significantly impaired compared with control subjects on both tasks. Moreover, regression analyses showed that these two abilities are associated and reciprocally predictive of one another. Finally, using voxel-based lesion analysis; we identified a partially common bilaterally distributed prefrontal network in the decoding of both emotional cues from both the whole face and eyes centered within the dorsomedial and ventral regions with extension to the lateral frontal pole.	[Riadh, Ouerchefani] Univ Tunis El Manar, High Inst Human Sci, Dept Psychol, 26 Blvd Darghouth Pacha, Tunis, Tunisia; [Riadh, Ouerchefani; Le Gall, Didier] Univ Angers, Univ Nantes, SFR CONFLUENCES, LPPL, F-49000 Angers, France; [Naoufel, Ouerchefani] Foch Hosp, Dept Neurosurg, Paris, France; [Ben Rejeb, Mohamed Riadh] Univ Tunis I, Fac Human & Social Sci Tunisia, Dept Psychol, Tunis, Tunisia		Riadh, O (corresponding author), Univ Tunis El Manar, High Inst Human Sci, Tunis, Tunisia.; Riadh, O (corresponding author), Univ Angers, Univ Nantes, Angers, France.	werchefani.riadh@laposte.net					Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Asgharpour Mania, 2015, Iran J Psychiatry, V10, P13; Baddeley A., 2002, PRINCIPLES FRONTAL L, P246, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0016; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Barrett LF, 2009, EMOTION, V9, P649, DOI 10.1037/a0016821; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Ben Jemaa S., 2008, TUNISIE MED, V86, P793; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bloom P, 2017, TRENDS COGN SCI, V21, P60, DOI 10.1016/j.tics.2016.12.003; Boucher J, 2012, AUTISM, V16, P226, DOI 10.1177/1362361311430403; Boucher O, 2015, NEUROPSYCHOLOGIA, V71, P1, DOI 10.1016/j.neuropsychologia.2015.03.008; Bramson B, 2020, J NEUROSCI, V40, P2925, DOI 10.1523/JNEUROSCI.2048-19.2020; Buades-Rotger M, 2021, J COGNITIVE NEUROSCI, V33, P1069, DOI 10.1162/jocn_a_01706; Buitelaar JK, 1999, J CHILD PSYCHOL PSYC, V40, P869, DOI 10.1017/S0021963099004321; Burgess P.W., 2004, CLIN NEUROPSYCHOLOGY, P185; Burgess P.W., 2003, HDB CLIN NEUROPSYCHO, P322; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Channon S, 2004, ACTA PSYCHOL, V115, P235, DOI 10.1016/j.actpsy.2003.12.008; Chawarska K, 2014, J AM ACAD CHILD PSY, V53, P1317, DOI 10.1016/j.jaac.2014.09.015; Clark US, 2010, NEUROPSYCHOLOGIA, V48, P1901, DOI 10.1016/j.neuropsychologia.2010.03.006; Daffner KR, 2000, J NEUROL NEUROSUR PS, V68, P18, DOI 10.1136/jnnp.68.1.18; Dal Monte O, 2014, CORTEX, V58, P9, DOI 10.1016/j.cortex.2014.05.002; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Davison A. C., 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.1017/CBO9780511802843]; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ekman P., 1976, PICTURES FACIAL AFFE; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fernandez G, 1998, J NEUROSCI, V18, P1841; Filkowski Megan M, 2016, Neurosci Neuroecon, V5, P65, DOI 10.2147/NAN.S87718; Filkowski MM, 2016, COGN AFFECT BEHAV NE, V16, P325, DOI 10.3758/s13415-015-0393-0; Fischer A.H., 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; FOSTER JK, 1994, COGNITIVE NEUROPSYCH, V11, P133, DOI 10.1080/02643299408251971; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Funahashi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050049; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gambarota F, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02392; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Gilaie-Dotan S, 2015, P NATL ACAD SCI USA, V112, pE361, DOI 10.1073/pnas.1414974112; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Gray JM, 1997, BRAIN, V120, P2029, DOI 10.1093/brain/120.11.2029; Grossmann T, 2017, PERSPECT PSYCHOL SCI, V12, P107, DOI 10.1177/1745691616654457; Guarnera M, 2017, J GENET PSYCHOL, V178, P309, DOI 10.1080/00221325.2017.1361377; Guarnera M, 2015, EUR J PSYCHOL, V11, P183, DOI 10.5964/ejop.v11i2.890; Hagiya K, 2015, PSYCHIAT CLIN NEUROS, V69, P773, DOI 10.1111/pcn.12329; Happe F, 2017, ANNU REV PSYCHOL, V68, P243, DOI 10.1146/annurev-psych-010416-044046; Hareli S, 2013, COGNITION EMOTION, V27, P1395, DOI 10.1080/02699931.2013.791615; Hareli S, 2012, COGNITION EMOTION, V26, P385, DOI 10.1080/02699931.2012.665029; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hennenlotter A, 2004, BRAIN, V127, P1446, DOI 10.1093/brain/awh165; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; Holt RJ, 2014, PSYCHOL MED, V44, P3215, DOI 10.1017/S0033291714000233; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hutcherson CA, 2011, J PERS SOC PSYCHOL, V100, P719, DOI 10.1037/a0022408; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Jack RE, 2015, CURR BIOL, V25, pR621, DOI 10.1016/j.cub.2015.05.052; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kanske P, 2018, INTERDISCIPL SCI REV, V43, P115, DOI 10.1080/03080188.2018.1453243; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Kim YT, 2011, PSYCHIAT RES, V186, P80, DOI 10.1016/j.psychres.2010.06.027; Kimberg DY, 2007, J COGNITIVE NEUROSCI, V19, P1067, DOI 10.1162/jocn.2007.19.7.1067; Kipps CM, 2007, J COGNITIVE NEUROSCI, V19, P1206, DOI 10.1162/jocn.2007.19.7.1206; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Koster-Hale J, 2017, NEUROIMAGE, V161, P9, DOI 10.1016/j.neuroimage.2017.08.026; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Marco-Garcia S, 2019, REV NEUROLOGIA, V69, P207, DOI 10.33588/rn.6905.2019047; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; Martins Ana Teresa, 2011, Psychol. Neurosci., V4, P377, DOI 10.3922/j.psns.2011.3.011; Mattavelli G, 2019, J NEUROPSYCHOL, V13, P1, DOI 10.1111/jnp.12130; Maurage P, 2011, PSYCHIAT RES, V190, P375, DOI 10.1016/j.psychres.2011.06.015; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; Meinhardt-Injac B, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00025; Meyer ML, 2020, SOC COGN AFFECT NEUR, V15, P63, DOI 10.1093/scan/nsaa022; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mitchell RLC, 2015, NEUROPSYCHOLOGIA, V70, P1, DOI 10.1016/j.neuropsychologia.2015.02.018; Moor BG, 2012, SOC COGN AFFECT NEUR, V7, P44, DOI 10.1093/scan/nsr020; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Ouerchefani R, 2021, J NEUROPSYCHOL, V15, P533, DOI 10.1111/jnp.12241; Papagno C, 2016, NEUROPSYCHOLOGIA, V84, P29, DOI 10.1016/j.neuropsychologia.2016.01.036; Pelphrey KA, 2006, CURR DIR PSYCHOL SCI, V15, P136, DOI 10.1111/j.0963-7214.2006.00423.x; Petroni A, 2011, NEUROSCI LETT, V505, P41, DOI 10.1016/j.neulet.2011.09.062; Phillips LH, 2002, J GERONTOL B-PSYCHOL, V57, pP526, DOI 10.1093/geronb/57.6.P526; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Plant EA, 2000, PSYCHOL WOMEN QUART, V24, P81, DOI 10.1111/j.1471-6402.2000.tb01024.x; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Preckel K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37163-9; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Richell RA, 2005, PERS INDIV DIFFER, V38, P1735, DOI 10.1016/j.paid.2004.11.017; Ritchie SJ, 2018, CEREB CORTEX, V28, P2959, DOI 10.1093/cercor/bhy109; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Sabbagh MA, 2004, J COGNITIVE NEUROSCI, V16, P415, DOI 10.1162/089892904322926755; Sasson N, 2007, NEUROPSYCHOLOGIA, V45, P2580, DOI 10.1016/j.neuropsychologia.2007.03.009; Sato W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00151; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Schroeder U, 2004, HUM BRAIN MAPP, V23, P181, DOI 10.1002/hbm.20057; Schurz M, 2021, PSYCHOL BULL, V147, P293, DOI 10.1037/bul0000303; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Schyns PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005625; Seo E, 2020, PSYCHIAT INVEST, V17, P835, DOI 10.30773/pi.2019.0281; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shields S.A., 2002, SPEAKING HEART GENDE; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P518, DOI 10.1016/j.neuropsychologia.2005.07.003; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Suardi A, 2016, COGN AFFECT BEHAV NE, V16, P383, DOI 10.3758/s13415-016-0414-7; Tager-Flusberg H, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P173; Talairach J., 1988, COPLANAR STEREOTAXIC; Tao IF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196503; TEASDALE G, 1974, LANCET, V2, P81; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Thieben MJ, 2002, BRAIN, V125, P1815, DOI 10.1093/brain/awf179; Thye MD, 2018, NEUROSCIENCE, V374, P172, DOI 10.1016/j.neuroscience.2018.01.045; Titchener E. B., 1909, EXPT PSYCHOL THOUGHT; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tsuchida A, 2012, CEREB CORTEX, V22, P2904, DOI 10.1093/cercor/bhr370; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Wang K, 2003, NEUROPSYCHOLOGIA, V41, P527, DOI 10.1016/S0028-3932(02)00171-9; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Willis ML, 2010, NEUROPSYCHOLOGIA, V48, P2182, DOI 10.1016/j.neuropsychologia.2010.04.010; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wolf RC, 2016, CORTEX, V82, P255, DOI 10.1016/j.cortex.2016.06.017; Wolf RC, 2014, BRAIN, V137, P1772, DOI 10.1093/brain/awu063; Wood RL, 2004, NEUROPSYCHOL REHABIL, V14, P329, DOI 10.1080/09602010343000255; Xiao RQ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01330; Yang CQ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0618-3; Yang DYJ, 2015, NEUROSCI BIOBEHAV R, V51, P263, DOI 10.1016/j.neubiorev.2015.01.020; Zakil J, 2017, TRENDS COGN SCI, V21, P59, DOI 10.1016/j.tics.2016.12.004; Zebrowitz LA, 2006, SOC COGNITION, V24, P657, DOI 10.1521/soco.2006.24.5.657	189	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.	NOV 2	2021	16	6					607	626		10.1080/17470919.2021.1983458		OCT 2021	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	XO8MB	WOS:000702703700001	34544320				2022-02-06	
J	Sakai, M; Ihori, N; Nishikawa, T				Sakai, Mariko; Ihori, Nami; Nishikawa, Takashi			Pitch accent disorder observed in a Japanese patient due to traumatic head injury	APHASIOLOGY			English	Article; Early Access						Pitch accent disorder; prosody; foreign accent syndrome; lexical pitch accent encoding	APHASIA; STRESS	Background Suprasegmental features are often affected by brain damage, and are typically accompanied by motor speech disorders such as dysarthria, apraxia of speech (AOS), and foreign accent syndrome (FAS). However, there is no report of a selective pitch accent disorder without motor speech impairments or FAS. Aims We describe a female Japanese patient who developed a selective pitch accent disorder without motor speech impairments or FAS, with accompanying mild Wernicke's aphasia due to head injury, in order to investigate the mechanism of pitch accent disorder based on speech production models. Methods & Procedures We analysed her spontaneous speech, confrontation naming, repetition, reading aloud, and the error patterns in her pitch accents in two sessions. Additionally, we gave her a reading aloud test of homonyms with different accent patterns and an auditory discrimination task of pitch accents. Outcomes & Results The patient exhibited a significant recovery from aphasia, and paraphasia was observed to almost disappear, although the pitch accent errors remained in all speech modalities. While she was able to auditorily distinguish between correct and incorrect pitch accents, she was unaware of her own abnormally accented speech. The results of the analysis of the error patterns in her pitch accents revealed that they, even if incorrect for the selected words, did not actually deviate from the correct patterns in the Osaka dialect, her native dialect. Conclusions Our observations suggest that the process of pitch accent production may be independent of that of phoneme production. Moreover, it may be that her accent abnormalities were not produced randomly during the process of articulation, but instead may have been due to a problem in selecting pitch accent patterns from the repertoire of Osaka accent patterns allocated to the corresponding words. This suggests that the patient's pitch accent disorder was a problem in a higher level of linguistic processing, i.e., lexical pitch accent encoding, rather than the motor control of speech production.	[Sakai, Mariko] Yukoukai Gen Hosp, Dept Rehabil, 25-1 Nishitoyokawa Cho, Ibaraki, Osaka 5670058, Japan; [Sakai, Mariko] Osaka Prefecture Univ, Dept Clin Rehabil, Grad Sch Comprehens Rehabil, Habikino, Osaka, Japan; [Ihori, Nami] Kawasaki Cooperat Hosp, Dept Rehabil, Kawasaki, Kanagawa, Japan; [Nishikawa, Takashi] Naragakuen Univ, Fac Hlth Sci, Dept Rehabil, Nara, Ikoma County, Japan		Sakai, M (corresponding author), Yukoukai Gen Hosp, Dept Rehabil, 25-1 Nishitoyokawa Cho, Ibaraki, Osaka 5670058, Japan.	rehabili@yukoukai.com					Aichert I, 2004, APHASIOLOGY, V18, P1201, DOI 10.1080/02687030444000516; Cappa SF, 1997, COGNITION, V65, P1, DOI 10.1016/S0010-0277(97)00024-3; Clements George N., 1985, PHONOLOGY YB, V2, P225, DOI [DOI 10.1017/S0952675700000440, 10.1017/S0952675700000440.]; Cruttenden A., 1986, INTONATION; Crystal D., 2005, HOW LANGUAGE WORKS; Goldsmith John A., 1990, AUTOSEGMENTAL METRIC; Hauser K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00317; Hasegawa T., 1977, STANDARD LANGUAGE TE; Kori S., 2018, ASAKURA NIHONGO KOZA, P109; Laganaro M, 2002, BRAIN LANG, V81, P601, DOI 10.1006/brln.2001.2550; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Liang J, 2004, BRAIN LANG, V91, P282, DOI 10.1016/j.bandl.2004.03.006; Moen I., 1996, BRAIN DAM B, P159; MONRADKROHN GH, 1947, BRAIN, V70, P405, DOI 10.1093/brain/70.4.405; Mori E, 1982, Rinsho Shinkeigaku, V22, P329; Nakano A., 1996, JAPANESE J NEUROPSYC, V12, P244; Nishida K., 2011, JAPANESE J HIGHER BR, V31, P205, DOI [10.2496/hbfr.31.205, DOI 10.2496/HBFR.31.205]; Sakurai Y, 2015, NEUROCASE, V21, P289, DOI 10.1080/13554794.2014.892622; Sugitoh M., 1998, NIHONGO ONSEINO KENK; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361	20	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology												10.1080/02687038.2021.1978382		OCT 2021	15	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	UZ4PQ	WOS:000702189500001					2022-02-06	
J	Alhamidi, S; Alshahwan, M; Tumala, R				Alhamidi, Sami; Alshahwan, Majid; Tumala, Regie			Knowledge and Perception of Registered Nurses Regarding the Scope of Practice of Speech-Language Pathologists	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						interprofessional collaboration; knowledge; perception; registered nurse; Saudi Arabia; speech-language pathologist	CARE	Objective: To assess the knowledge and perception of registered nurses regarding the scope of practice of speech-language pathologists (SLP) in Saudi Arabia. Background: Interdisciplinary collaboration is vital between the SLP and nurses due to the complex care needed by patients with speech problems. Methods: A total of 294 registered nurses were surveyed utilizing the Knowledge and Perception of Speech-Language Pathologists questionnaire. Descriptive statistics and tests for differences and relationships were performed. Results: The findings revealed that nursing respondents had an overall good understanding of the value and scope of practice of the SLP. However, they frequently and wrongly responded to scenarios concerning patients who suffered from Alzheimer's dementia, laryngeal cancer, traumatic brain injury, and stroke. Conclusions: It is vital for nurses to understand the value, role, and scope of practice of the SLP. Further educational nursing interventions and training are necessary for effective interprofessional collaboration and teamwork.	[Alhamidi, Sami] King Saud Univ, Coll Nursing, Postgrad & Res Ctr, Dept Maternal & Child Hlth, Riyadh 12372, Saudi Arabia; [Alshahwan, Majid] King Saud Univ, Coll Appl Med Sci, Dept Rehabil, Speech & Hearing Program, Riyadh 12372, Saudi Arabia; [Tumala, Regie] King Saud Univ, Coll Nursing, Med Surg Nursing Dept, Riyadh 12372, Saudi Arabia		Tumala, R (corresponding author), King Saud Univ, Coll Nursing, Med Surg Nursing Dept, Riyadh 12372, Saudi Arabia.	salhamidi@ksu.edu.sa; mialshahwan@ksu.edu.sa; rtumala@ksu.edu.sa		TUMALA, REGIE BUENAFE/0000-0002-0558-1751	Deanship of Scientific Research through the Research Center of the College of Nursing at King Saud University, Riyadh City, Kingdom of Saudi Arabia	The authors cordially express their sincere appreciation for the support provided by the Deanship of Scientific Research through the Research Center of the College of Nursing at King Saud University, Riyadh City, Kingdom of Saudi Arabia.	Alanazi AA, 2017, INT J HEALTH SCI-IJH, V11, P43; American Speech-Language-Hearing Association, 2019, SUPPL DEM RES LIST S; Braun-Janzen C, 2009, CAN J SPEECH-LANG PA, V33, P5; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Dey R, 2017, CLIN EPIDEMIOL GLOB, V5, P48, DOI 10.1016/j.cegh.2016.12.005; Dondorf K., 2016, J NURS ED PRACT, V6, P17, DOI DOI 10.5430/JNEP.V6N4P17; Ghassemi Akhtar E, 2017, Iran J Nurs Midwifery Res, V22, P497, DOI 10.4103/ijnmr.IJNMR_4_17; Guo R, 2008, J MED LIBR ASSOC, V96, P138, DOI 10.3163/1536-5050.96.2.138; Gurevich N, 2020, J INTERPROF CARE, V34, P572, DOI 10.1080/13561820.2019.1657815; Hines S, 2011, INT J EVID-BASED HEA, V9, P148, DOI 10.1111/j.1744-1609.2011.00211.x; Hsiao PY, 2020, TEACH LEARN NURS, V15, P128, DOI 10.1016/j.teln.2020.01.004; Janes TL, 2021, AUST J RURAL HEALTH, V29, P61, DOI 10.1111/ajr.12680; Khoja MA, 2018, INT J HEALTH CARE Q, V31, P896, DOI 10.1108/IJHCQA-06-2017-0106; King E.E, 2017, MERGE, V1, P1; Mahmoud H.N., 2019, J LANG TEACH RES, V10, P1298, DOI [10.17507/jltr.1006.19, DOI 10.17507/JLTR.1006.19]; McMillan L.R., 2016, IJTLHE, V28, P125; Peranich L., 2010, J NURSE PRACTITIONER, V6, P36, DOI [https://doi.org/10.1016/j.nurpra.2009.08.021, DOI 10.1016/J.NURPRA.2009.08.021]; Porter KL, 2020, AM J SPEECH-LANG PAT, V29, P2049, DOI 10.1044/2020_AJSLP-20-00049; Potter NL, 2013, CLIN SIMUL NURS, V9, pE461, DOI 10.1016/j.ecns.2012.08.001; Puhlman J, 2019, J COMMUN DISORD, V82, DOI 10.1016/j.jcomdis.2019.105936; Robbertse A, 2020, S AFR J COMMUN DISOR, V67, DOI 10.4102/sajcd.v67i1.686; Sullivan A., 2003, JSLPA, V27, P98; Willoughby KA, 2016, EUR J OPER RES, V252, P657, DOI 10.1016/j.ejor.2016.01.029; World Health Organization, 2010, HLTH WORKF FRAM ACT; Zikria M., 2021, IRAN REHABI J, V19, P165, DOI [10.32598/irj.19.2.1335.1, DOI 10.32598/IRJ.19.2.1335.1]	25	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	OCT	2021	18	19							10534	10.3390/ijerph181910534			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	WH9EH	WOS:000707971400001	34639834	gold, Green Published			2022-02-06	
J	Ali, M; Dreher, N; Hannah, T; Li, A; Asghar, N; Spiera, Z; Marayati, NF; Durbin, J; Gometz, A; Lovell, M; Choudhri, T				Ali, Muhammad; Dreher, Nickolas; Hannah, Theodore; Li, Adam; Asghar, Nek; Spiera, Zachary; Marayati, Naoum Fares; Durbin, John; Gometz, Alex; Lovell, Mark; Choudhri, Tanvir			Concussion Incidence and Recovery Among Youth Athletes With ADHD Taking Stimulant-Based Therapy	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						ADHD; concussion; ImPACT; stimulants	DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; METHYLPHENIDATE; IMPACT; ASSOCIATION; PERFORMANCE; MEDICATION; LINE	Background: Attention deficit hyperactivity disorder (ADHD) may affect concussion risk and recovery in youth athletes. Purpose: To evaluate the association between incidence of concussion and postinjury recovery of symptoms and neurocognitive dysfunction among youth athletes with ADHD and differential stimulant use. Study Design: Cohort study; Level of evidence, 3. Methods: From 2009 to 2019, the authors administered the Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) to youth athletes at the beginning of each season. Throughout the season, athletes with concussions were examined and readministered the ImPACT both postinjury and again 7 days after the postinjury administration. These athletes (N = 7453) were divided into those with ADHD on stimulant-based therapy (ADHD+meds; n = 167), those with ADHD not on stimulant-based therapy (ADHD-only; n = 354), and those with no ADHD (non-ADHD; n = 6932). Recovery of neurocognitive dysfunction at postinjury and follow-up was calculated using the ImPACT symptom score, verbal memory, visual memory, visual motor skills, and reaction time (calculated as standardized deviations from baseline). Univariate results were confirmed with multivariate analysis. Results: The ADHD+meds cohort had a lower incidence of concussion (37.3 concussions per 100 patient-years) compared with the ADHD-only group (57.0 concussions per 100 patient-years) (odds ratio [OR], 0.51 [95% CI, 0.37-0.71]; P < .0001) and non-ADHD group (52.8 concussions per 100 patient-years) (OR, 0.50 [95% CI, 0.37-0.67]; P < .0001). At postinjury, ImPACT scores were elevated from baseline to a similar extent in the ADHD+meds cohort compared with the other 2 groups. By follow-up, however, deviations from baseline were lower among the ADHD+meds group compared with the non-ADHD group in verbal memory (OR, 0.46 [95% CI, 0.28-0.76]; P = .002), visual memory (OR, 0.27 [95% CI, 0.10-0.66]; P = .005), and visual motor skills (OR, 0.58 [95% CI, 0.33-0.99]; P = .048). The deviation at follow-up was also lower among the ADHD+meds group compared with the ADHD-only group in visual memory (OR, 0.56 [95% CI, 0.33-0.96]; P = .04) and visual motor skills (OR, 0.42 [95% CI, 0.22-0.81]; P = .01). Conclusion: Stimulant use among youth athletes with ADHD was independently associated with reduced incidence for concussion and lower deviation from baseline in verbal memory, visual memory, and visual motor skills at 7 days postconcussion, suggesting lower neurocognitive impairment at follow-up in this group versus their peers.	[Ali, Muhammad; Dreher, Nickolas; Hannah, Theodore; Li, Adam; Asghar, Nek; Spiera, Zachary; Marayati, Naoum Fares; Durbin, John; Gometz, Alex; Lovell, Mark; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ali, Muhammad; Dreher, Nickolas; Hannah, Theodore; Li, Adam; Asghar, Nek; Spiera, Zachary; Marayati, Naoum Fares; Durbin, John; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, Neurosurg Dept, New York, NY 10021 USA; [Gometz, Alex] Concuss Management New York, New York, NY USA; [Lovell, Mark] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA		Ali, M (corresponding author), Icahn Sch Med Mt Sinai, Neurosurg Dept, New York, NY 10021 USA.	muhammad.ali@icahn.mssm.edu		Hannah, Theodore/0000-0001-6527-9725			[Anonymous], 2020, GET FACTS TBI; [Anonymous], 2011, PRINC EP PUBL HLTH P, V3; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Dalsgaard S, 2014, EUR PSYCHIAT, V29, P259, DOI 10.1016/j.eurpsy.2013.06.004; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gobbo MA, 2014, EUR NEUROPSYCHOPHARM, V24, P1425, DOI 10.1016/j.euroneuro.2014.06.006; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Hanson CL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2503; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kroshus E, 2019, J CLIN SPORT PSYCHOL, V13, P390, DOI 10.1123/jcsp.2018-0004; Liao YT, 2018, EUR CHILD ADOLES PSY, V27, P279, DOI 10.1007/s00787-017-1042-7; Lichtenstein P, 2013, NEW ENGL J MED, V368, P776, DOI 10.1056/NEJMc1215531; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merikangas KR, 2013, JAMA PEDIATR, V167, P141, DOI 10.1001/jamapediatrics.2013.431; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nikolas MA, 2016, J CHILD PSYCHOL PSYC, V57, P141, DOI 10.1111/jcpp.12491; Pope CN, 2016, J DEV BEHAV PEDIATR, V37, P702, DOI 10.1097/DBP.0000000000000353; Salinas CM, 2016, APPL NEUROPSYCH-CHIL, V5, P264, DOI 10.1080/21622965.2015.1052814; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179; Williams LM, 2008, BIOL PSYCHIAT, V63, P917, DOI 10.1016/j.biopsych.2007.11.022	27	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2021	9	10							23259671211032564	10.1177/23259671211032564			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	WF4ZM	WOS:000706314300001	34646894	gold, Green Published			2022-02-06	
J	Amoo, M; O'Cearbhaill, RM; McHugh, P; Henry, J; O'Byrne, K; Ben Husien, M; Javadpour, M				Amoo, Michael; O'Cearbhaill, Roisin M.; McHugh, Paul; Henry, Jack; O'Byrne, Kevin; Ben Husien, Mohammed; Javadpour, Mohsen			Derivation of a Clinical Score for Prediction of Recurrence Following Evacuation of Chronic Subdural Hematoma: A Retrospective Cohort Study at a National Referral Centre	WORLD NEUROSURGERY			English	Article						Chronic subdural hematoma; Computed tomography; cSDH; Subdural hematoma; Traumatic brain injury	MIDDLE MENINGEAL ARTERY; INDEPENDENT PREDICTORS; POSTOPERATIVE RECURRENCE; EMBOLIZATION; SURGERY; EPIDEMIOLOGY; MANAGEMENT; VOLUME; MODEL	BACKGROUND: Chronic subdural hematoma (cSDH) is a common pathology, and recurrence is a common complication, which may be predicted by certain patient and radiologic factors. Empiric radiologic surveillance has been shown to convey no benefit. -METHODS: A retrospective review of a prospectively collated database was performed. Preoperative and postoperative noncontrast computed tomography scans were reviewed. Radiologic appearance, preoperative hematoma volume, patient age, presence of bilateral hematomas, maximal hematoma thickness, and therapeutic coagulopathy were assessed as predictors. Receiver operating characteristic curve analysis, logistic regression, and LASSO regression were used to select potential predictors. A multivariate model was then fitted, and a score was derived. -RESULTS: A total of 142 patients were included. Maximal hematoma thickness >12 mm (P = 0.02) and age >65 years (P = 0.01) were found to correlate with the likelihood of recurrence. Bilateral hematomas and a hyperdense or mixed density appearance were also identified on LASSO regression. Bilateral hematomas (P = 0.19), hyperdense or mixed density (P = 0.66), maximum thickness >12 mm (P = 0.01), and age >65 years (P = 0.02) were included in the multivariate model. A 6-point score was derived. A score of >3 had a sensitivity of 89% (95% confidence interval [CI] 78%-97%) and specificity of 26% (95% CI, 17%-34%) for predicting recurrence, with recurrence significantly more likely in patients with a score of 4-6 versus those with a score of 0-3 (P = 0.02). -CONCLUSIONS: Certain radiologic findings may predict the recurrence of cSDH following evacuation. The score derived may be useful in identifying patients who might benefit from routine postoperative surveillance imaging.	[Amoo, Michael; McHugh, Paul; Henry, Jack; O'Byrne, Kevin; Ben Husien, Mohammed; Javadpour, Mohsen] Beaumont Hosp, Natl Neurosurg Ctr, Dublin, Ireland; [O'Cearbhaill, Roisin M.] Beaumont Hosp, Dept Neuroradiol, Dublin, Ireland; [Amoo, Michael; O'Cearbhaill, Roisin M.; Ben Husien, Mohammed; Javadpour, Mohsen] Royal Coll Surgeons Ireland, Dublin, Ireland; [Henry, Jack] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Javadpour, Mohsen] Trinity Coll Dublin, Dept Acad Neurol, Dublin, Ireland		Amoo, M (corresponding author), Beaumont Hosp, Natl Neurosurg Ctr, Dublin, Ireland.; Amoo, M (corresponding author), Royal Coll Surgeons Ireland, Dublin, Ireland.	michaelamoo@rcsi.ie		McHugh, Paul/0000-0003-2162-0762; Henry, Jack/0000-0001-5662-198X; Amoo, Michael/0000-0001-6886-6714			Ambrosino R, 1995, Proc Annu Symp Comput Appl Med Care, P304; Catanese L, 2020, NEUROLOGY, V95, pE480, DOI 10.1212/WNL.0000000000009826; Catapano JS, J NEUROSURG, V26, P1; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Desai VR, 2017, NEUROSURG CLIN N AM, V28, P279, DOI 10.1016/j.nec.2016.11.010; Fontanarosa Joel B, 2011, BMC Proc, V5 Suppl 9, pS69, DOI 10.1186/1753-6561-5-S9-S69; Frechon P, 2020, CLIN NEUROL NEUROSUR, V191, DOI 10.1016/j.clineuro.2020.105682; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Haldrup M, 2020, ACTA NEUROCHIR, V162, P777, DOI 10.1007/s00701-020-04266-0; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Jack A, 2015, CAN J NEUROL SCI, V42, P34, DOI 10.1017/cjn.2014.122; Joyce E, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20518; Jung YG, 2015, J KOREAN NEUROSURG S, V57, P266, DOI 10.3340/jkns.2015.57.4.266; Kan P, 2021, NEUROSURGERY, V88, P268, DOI 10.1093/neuros/nyaa379; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Lu HJ, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3255-x; Miah IP, 2021, NEURORADIOLOGY, V63, P27, DOI 10.1007/s00234-020-02558-x; Miah IP, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2945-4; Motoie R, 2018, WORLD NEUROSURG, V118, pE87, DOI 10.1016/j.wneu.2018.06.124; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Nathan S, 2017, NEUROLOGY, V88, P1889, DOI 10.1212/WNL.0000000000003918; Ng S, 2020, J NEUROINTERV SURG, V12, P695, DOI 10.1136/neurintsurg-2019-015421; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; Portet S, 2020, INFECT DIS MODEL, V5, P111, DOI 10.1016/j.idm.2019.12.010; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schucht P, 2019, NEW ENGL J MED, V380, P1186, DOI 10.1056/NEJMc1812507; Shen J, 2019, INJURY, V50, P1634, DOI 10.1016/j.injury.2019.08.019; Simon N, 2011, J STAT SOFTW, V39, P1; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Stanisic M, 2017, NEUROSURGERY, V81, P752, DOI 10.1093/neuros/nyx090; Stanisic M, 2013, ACTA NEUROCHIR, V155, P323, DOI 10.1007/s00701-012-1565-0; Takei J, 2021, WORLD NEUROSURG, V151, pE407, DOI 10.1016/j.wneu.2021.04.052; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Tugcu B, 2014, J NEUROL SURG PART A, V75, P37, DOI 10.1055/s-0032-1330961; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Won SY, 2021, NEUROSURG REV, V44, P961, DOI 10.1007/s10143-020-01271-w; Yadav YR, 2020, J NEUROL SURG PART A, V81, P330, DOI 10.1055/s-0039-1698388; Yajima H, 2020, CLIN NEUROL NEUROSUR, V197, DOI 10.1016/j.clineuro.2020.106097; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217; Yan KX, 2017, NEUROL RES, V39, P803, DOI 10.1080/01616412.2017.1321709; Yang WY, 2017, NEUROSURG CLIN N AM, V28, P205, DOI 10.1016/j.nec.2016.11.002; You WD, 2018, ACTA NEUROCHIR, V160, P893, DOI 10.1007/s00701-018-3513-0; Zhang ZZ, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.08.22	46	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2021	154						E743	E753		10.1016/j.wneu.2021.07.126			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WD5UC	WOS:000705004300030	34343685	hybrid			2022-02-06	
J	Ashford, S; Meeran, RAM; Clark, T; Ruiz, MM; Hoffman, K; Playford, D; Pandyan, A				Ashford, Stephen; Mohammed Meeran, Rasheed A.; Clark, Teresa; Montesinos Ruiz, Macarena; Hoffman, Karen; Playford, Diane; Pandyan, Anand			A consensus process to agree best practice for managing physical wellbeing in people with a prolonged disorder of consciousness	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Consciousness disorders; Consciousness; Consensus	NOMINAL GROUP TECHNIQUE; TRAUMATIC BRAIN-INJURY; CONTRACTURES; SPASTICITY; ADULTS; PRESSURE	BACKGROUND: Current practice for physical wellbeing of people in a Prolonged Disorder of Consciousness (PDOC) is variable. A scoping literature review identified no agreed standard of care for physical management of those in a PDOC. This study addressed this deficit using a consensus process applied using nominal group technique. AIM: The aims of this project were to promote best practice for physical management in PDOC, by identifying consensus for: 1) a pathway of care; and 2) current best practice recommendations. DESIGN: A consensus process using nominal group technique. SETTING: Representation from national, purposively selected, rehabilitation services assessing and managing people in a PDOC in the UK. POPULATION: The population to whom the consensus process relates are people in a PDOC, requiring physical management. METHODS: An initial meeting with selected clinical experts from national centres was conducted to set terms of reference. A consensus meeting using nominal group technique (N.=33) then followed. Experts were initially asked to review systematic review findings reproduced as statements. Following systematic refinement, they were then asked to vote on the importance and relevance of statements. RESULTS: Following the nominal group process, 25 initial recommendations were refined to 19, which expressed the principles of physical management for people with a Prolonged Disorder of Consciousness. Statements are grouped into "acute-care" (6-recommendations), "post acute care" (10-recommendations) and "long-term care" (3-recommendations). Across the participants, agreement with the final recommendation statements ranged from 100-61% (N.=33-20), 15 of the statements were supported by 85% or more experts (N.=29). In addition, a clinical pathway of care, incorporating the recommendation principles was produced (agreement from 28 experts, 83%). CONCLUSIONS: The recommendations provide a basis for standardising current practice. They provide a standard against which care, and effectiveness can be evaluated. An accessible guideline document is planned for publication to enable implementation into practice, supported by online resources. CLINICAL REHABILITATION IMPACT: Recommendations have been produced under the headings of "acute care," "postacute care" and "long-term care." In addition, a pathway for provision of care interventions has been identified for the physical management of people in a prolonged disorder of consciousness.	[Ashford, Stephen] London North West Univ Healthcare NHS Trust, Reg Hyperacute Rehabil Unit, London, England; [Ashford, Stephen] Kings Coll London, Dept Palliat Care Policy & Rehabil, London, England; [Ashford, Stephen] Univ Coll London Hosp, Ctr Nursing Midwifery & Allied Hlth Res, London, England; [Ashford, Stephen] UCL, Inst Neurol, London, England; [Mohammed Meeran, Rasheed A.] Holy Cross Hosp, Haslemere, England; [Clark, Teresa; Montesinos Ruiz, Macarena] Royal Hosp Neurodisabil, London, England; [Hoffman, Karen] Royal London NHS Trust, London, England; [Playford, Diane] Univ Warwick, Warwick, England; [Pandyan, Anand] Keele Univ, Sch Allied Hlth Profess, Keele, Staffs, England		Ashford, S (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Hyperacute Rehabil Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.	stephen.ashford@nhs.net		Clark, Teresa/0000-0002-4349-1482	"Holy Cross Hospital"; "Brain Injury is Big,"	This work was supported by "Holy Cross Hospital" and "Brain Injury is Big," who provided an unrestricted grant administered by Holy Cross Hospital to support the Guideline Development Group meetings and wider consultation group meetings.	Allison R, 2018, ARCH PHYS MED REHAB, V99, P433, DOI 10.1016/j.apmr.2017.07.016; Bennett G, 2004, AGE AGEING, V33, P230, DOI 10.1093/ageing/afh086; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; Burke D, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e31827624a7; Carney O, 1996, J ADV NURS, V23, P1024, DOI 10.1046/j.1365-2648.1996.09623.x; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Department of Health, 2005, NAT SERV FRAM LONG T; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; GALLAGHER M, 1993, FAM PRACT, V10, P76, DOI 10.1093/fampra/10.1.76; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT., 2018, PRACTICE GUIDELINE U; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Harvey LA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub3; Harvey N, 2012, INT J NURS PRACT, V18, P188, DOI 10.1111/j.1440-172X.2012.02017.x; Hough A., 2001, PHYSIOTHERAPY RESP C; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Justice J, 1990, Am Pharm, VNS30, P43; Katalinic OM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub2; Kwah LK, 2012, J PHYSIOTHER, V58, P41, DOI 10.1016/S1836-9553(12)70071-1; Malhotra S, 2011, CLIN REHABIL, V25, P184, DOI 10.1177/0269215510381620; Mentimeter homepage, MENT; Morgan CL, 2003, CLIN REHABIL, V17, P871, DOI 10.1191/0269215503cr691oa; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; Moseley AM, 2008, CLIN REHABIL, V22, P406, DOI 10.1177/0269215507083795; Moseley Anne M., 1993, Physiotherapy Theory and Practice, V9, P215, DOI 10.3109/09593989309036493; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Hoang PD, 2014, DISABIL REHABIL, V36, P1588, DOI 10.3109/09638288.2013.854841; Pingel J, 2017, J PHYSIOL-LONDON, V595, P1027, DOI 10.1113/JP272767; Potter M., 2004, NZ J PHYSIOTHERAPY, V32, P126; Prabhu RKR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009331.pub2; Riberholt CG, 2013, DAN MED J, V60; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Royal College of Physicians, 2020, PROL DIS CONSC FOLL; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Singer B, 2001, DISABIL REHABIL, V23, P829, DOI 10.1080/09638280110067180; Turner-Stokes L, 2003, REH FOLL ACQ BRAIN I; Wade DT, 2019, CLIN REHABIL, V33, P1571, DOI 10.1177/0269215519852987; Wenger N K, 1982, Adv Cardiol, V31, P138	42	0	0	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	OCT	2021	57	5					701	709		10.23736/S1973-9087.21.06624-7			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	WX0UR	WOS:000718320700005	33565740				2022-02-06	
J	Assonov, D				Assonov, Dmytro			TWO-STEP RESILIENCE-ORIENTED INTERVENTION FOR VETERANS WITH TRAUMATIC BRAIN INJURY: A PILOT RANDOMIZED CONTROLLED TRIAL	CLINICAL NEUROPSYCHIATRY			English	Article						resilience; veterans; traumatic brain injury; rehabilitation	MONTREAL COGNITIVE ASSESSMENT; NEUROBEHAVIORAL SYMPTOM INVENTORY; PSYCHOLOGICAL RESILIENCE; POSTTRAUMATIC-STRESS; HOSPITAL ANXIETY; NEGATIVE AFFECT; NORMATIVE DATA; DEPRESSION; PTSD; REHABILITATION	Objective: The present randomized parallel two-arm pilot study aimed to compare the efficacy of two-step resilience-oriented intervention with treatment as usual in veterans with mild to moderate traumatic brain injury. Method: Two-step Resilience-Oriented Intervention (TROI) is a brief psychological intervention that targets cognitive (step 1) and emotional (step 2) factors of resilience and consists of six 1-hour sessions. Overall, 70 Ukrainian veterans serviced in Anti-Terrorist Operation / Joint Forces Operation were randomly assigned to an intervention group (TROI group) or a control group that underwent treatment as usual (TAU group). For pre- (T1) and post-treatment (T2) assessment the Connor-Davidson Resilience Scale (CD-RISC), Hospital Anxiety and Depression Scale (HADS), Montreal Cognitive Assessment Scale (MoCA), Neurobehavioral Symptom Inventory (NSI), Posttraumatic Stress Disorder Checklist 5 (PCL-5), Chaban Quality of Life Scale (CQLS), Positive and Negative Affect Scale (PANAS) were used. Results: Multivariable linear regression with the treatment group, gender, baseline cognitive performance level and TBI severity as the independent variables revealed statistically significant improvements in the TROI group in resilience (CD-RISC), cognitive performance (MoCA), postconcussive symptoms (NSI), posttraumatic symptoms (PCL-5), positive affect (PANAS) and quality of life (CQLS) comparing to such in TAU group. We found no statistically significant differences between groups in depression, anxiety (HADS) and negative affect (PANAS) outcomes. Additionally, Wilcoxon signed-rank test revealed that participants who completed two-step resilience-oriented intervention had significantly improved scores for all outcomes compared to the baseline (p < 0.05). Conclusions: In summary, we can tentatively conclude that adding TROI to the standard treatment measures may improve the resilience and sustainable symptoms in veterans with TBI when compared with standard treatment Targeting cognitive and emotional factors like problem-solving, decision-making, positive thinking can promote resilience in veterans with TBI and be useful in facilitating recovery from injury. Results of this pilot study are promising, but the intervention needs to be studied in a larger trial.	[Assonov, Dmytro] Bogomolets Natl Med Univ, Dept Med Psychol Psychosomat Med & Psychotherapy, Kiev, Ukraine		Assonov, D (corresponding author), Bogomolets Natl Med Univ, Dept Med Psychol Psychosomat Med & Psychotherapy, Kiev, Ukraine.	assonov.dm@gmail.com		Assonov, Dmytro/0000-0002-6803-6961			Armenta CN, 2017, EMOT REV, V9, P183, DOI 10.1177/1754073916669596; Assonov D., 2021, UKRAINIAN SCI MED YO, V124, P15, DOI [10.32345/ USMYJ.2(124).2021.15-26, DOI 10.32345/USMYJ.2(124).2021.15-26]; Assonov D., 2020, PSYCHIAT NEUROLOGY M, DOI [10.26565/2312-5675-2020-14-07, DOI 10.26565/2312-5675-2020-14-07]; Assonov D., 2019, PSYCHOSOMATIC MED GE, V4; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Benavides AM, 2021, J HEAD TRAUMA REHAB, V36, P397, DOI 10.1097/HTR.0000000000000647; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boxley L, 2016, J REHABIL RES DEV, V53, P873, DOI 10.1682/JRRD.2015.05.0088; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bumberger A, 2021, ARCH ORTHOP TRAUM SU, DOI 10.1007/s00402-021-03967-0; Chaban Khaustova, 2016, INDIAN J SOCIAL PSYC, V4, P473; Church D, 2016, EXPLORE-NY, V12, P355, DOI 10.1016/j.explore.2016.06.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Elliott TR, 2019, REHABIL PSYCHOL, V64, P383, DOI 10.1037/rep0000282; Elliott TR, 2017, J CLIN PSYCHOL, V73, P1160, DOI 10.1002/jclp.22414; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Farber F, 2018, DTSCH ARZTEBL INT, V115, P621, DOI 10.3238/arztebl.2018.0621; Flaherty JM, 2018, J CLIN PSYCHOL, V74, P1281, DOI 10.1002/jclp.22595; GaIatzer-Levy IR, 2018, CLIN PSYCHOL REV, V63, P41, DOI 10.1016/j.cpr.2018.05.008; George E, 2016, PROG NEUROBIOL, V141, P25, DOI 10.1016/j.pneurobio.2016.04.002; Helmreich I., 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd012527, DOI 10.1002/14651858.CD012527, 10.1002/14651858.CD012527]; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Horn SR, 2018, HARVARD REV PSYCHIAT, V26, P158, DOI 10.1097/HRP.0000000000000194; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kaminska M, 2018, J CLIN SLEEP MED, V14, P819, DOI 10.5664/jcsm.7114; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Klimanska M, 2020, PSYCHOL J, V6, P119, DOI [10.31108/1.2020.6.4.10, DOI 10.31108/1.2020.6.4.10]; Korte KJ, 2016, J ANXIETY DISORD, V38, P95, DOI 10.1016/j.janxdis.2016.01.006; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Lee JH, 2013, J COUNS DEV, V91, P269, DOI 10.1002/j.1556-6676.2013.00095.x; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; McCarron KK, 2019, PSYCHIATR REHABIL J, V42, P296, DOI 10.1037/prj0000361; McGeary DD, 2021, CONT CLIN TRIAL COMM, V21, DOI 10.1016/j.conctc.2021.100699; Merritt VC, 2021, J NEUROTRAUM, DOI 10.1089/neu.2020.7516; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nalder E, 2019, DISABIL REHABIL, V41, P2708, DOI 10.1080/09638288.2018.1474495; Nasreddine ZS, 2016, CAN J NEUROL SCI, V43, P665, DOI 10.1017/cjn.2016.273; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Page P, 2014, INT J SPORTS PHYS TH, V9, P726; Parsons S, 2016, J EXP PSYCHOPATHOL, V7, P296, DOI 10.5127/jep.053415; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Rabinowitz AR, 2018, APPL NEUROPSYCH-ADUL, V25, P295, DOI 10.1080/23279095.2018.1458514; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Saper RB, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1321-5; Sarkar M, 2013, MEAS PHYS EDUC EXERC, V17, P264, DOI 10.1080/1091367X.2013.805141; Skandsen T, 2021, ARCH PHYS MED REHAB, V102, P1102, DOI 10.1016/j.apmr.2020.10.106; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Soendergaard PL, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3794-5; Stainton A, 2019, EARLY INTERV PSYCHIA, V13, P725, DOI 10.1111/eip.12726; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Stienen MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00734; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Teare MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-264; Treichler EBH, 2020, INT PSYCHOGERIATR, V32, P173, DOI 10.1017/S1041610219002096; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; Vos L, 2019, BRAIN INJURY, V33, P1615, DOI 10.1080/02699052.2019.1658132; Vranceanu AM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20807; Waldron-Perrine B, 2019, NEUROL-CLIN PRACT, V9, P101, DOI 10.1212/CPJ.0000000000000604; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wong GKC, 2017, J CLIN NEUROSCI, V46, P41, DOI 10.1016/j.jocn.2017.08.039; Wu CY, 2019, OCCUP THER INT, DOI 10.1155/2019/2517658; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	0	0	0	0	GIOVANNI FIORITI EDITORE	ROME	VIA ARCHIMEDE 179, ROME, 00197, ITALY	1724-4935	2385-0787		CLIN NEUROPSYCHIATR	Clin. Neuropsychiatr.	OCT	2021	18	5					247	259		10.36131/cnfioritieditore20210503			13	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YJ0KT	WOS:000744228900003	34984068				2022-02-06	
J	Bae, M; Hwang, D; Ko, MK; Jin, Y; Shin, WJ; Park, W; Chae, S; Lee, HJ; Jang, J; Yi, HG; Lee, DS; Cho, DW				Bae, Mihyeon; Hwang, Do Won; Ko, Min Kyung; Jin, Yeona; Shin, Woo Jung; Park, Wonbin; Chae, Suhun; Lee, Hong Jun; Jang, Jinah; Yi, Hee-Gyeong; Lee, Dong Soo; Cho, Dong-Woo			Neural stem cell delivery using brain-derived tissue-specific bioink for recovering from traumatic brain injury	BIOFABRICATION			English	Article						neural stem cell delivery; traumatic brain injury; regeneration; brain decellularized extracellular matrix; 3D cell-printing	TRANSPLANTATION; PATHOPHYSIOLOGY	Traumatic brain injury is one of the leading causes of accidental death and disability. The loss of parts in a severely injured brain induces edema, neuronal apoptosis, and neuroinflammation. Recently, stem cell transplantation demonstrated regenerative efficacy in an injured brain. However, the efficacy of current stem cell therapy needs improvement to resolve issues such as low survival of implanted stem cells and low efficacy of differentiation into respective cells. We developed brain-derived decellularized extracellular matrix (BdECM) bioink that is printable and has native brain-like stiffness. This study aimed to fabricate injured cavity-fit scaffold with BdECM bioink and assessed the utility of BdECM bioink for stem cell delivery to a traumatically injured brain. Our BdECM bioink had shear thinning property for three-dimensional (3D)-cell-printing and physical properties and fiber structures comparable to those of the native brain, which is important for tissue integration after implantation. The human neural stem cells (NSCs) (F3 cells) laden with BdECM bioink were found to be fully differentiated to neurons; the levels of markers for mature differentiated neurons were higher than those observed with collagen bioink in vitro. Moreover, the BdECM bioink demonstrated potential in defect-fit carrier fabrication with 3D cell-printing, based on the rheological properties and shape fidelity of the material. As F3 cell-laden BdECM bioink was transplanted into the motor cortex of a rat brain, high efficacy of differentiation into mature neurons was observed in the transplanted NSCs; notably increased level of MAP2, a marker of neuronal differentiation, was observed. Furthermore, the transplanted-cell bioink suppressed reactive astrogliosis and microglial activation that may impede regeneration of the injured brain. The brain-specific material reported here is favorable for NSC differentiation and suppression of neuroinflammation and is expected to successfully support regeneration of a traumatically injured brain.	[Bae, Mihyeon; Park, Wonbin; Chae, Suhun; Jang, Jinah; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang 37673, Gyeonsangbuk Do, South Korea; [Hwang, Do Won; Ko, Min Kyung; Jin, Yeona; Lee, Dong Soo] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul Natl Univ Hosp, Seoul 03080, South Korea; [Hwang, Do Won; Ko, Min Kyung; Shin, Woo Jung] THERABEST Co Ltd, Seocho Daero 40 Gil, Seoul 06657, South Korea; [Jang, Jinah] Pohang Univ Sci & Technol POSTECH, Dept Convergence IT Engn, Pohang 37673, Gyeonsangbuk Do, South Korea; [Lee, Hong Jun] Chungbuk Natl Univ, Coll Med, Cheongju, Chungbuk, South Korea; [Lee, Hong Jun] Chungbuk Natl Univ, Med Res Inst, Cheongju, Chungbuk, South Korea; [Lee, Hong Jun] Res Inst eBiogen Inc, Seoul, South Korea; [Yi, Hee-Gyeong] Chonnam Natl Univ, Dept Rural & Biosyst Engn, Coll Agr & Life Sci, Gwangju 61186, South Korea; [Lee, Dong Soo] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Lee, Dong Soo] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Lee, Dong Soo] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Cho, Dong-Woo] Yonsei Univ, Inst Convergence Res & Educ Adv Technol, 50 Yonsei Ro, Seoul 03722, South Korea		Cho, DW (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang 37673, Gyeonsangbuk Do, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul Natl Univ Hosp, Seoul 03080, South Korea.; Yi, HG (corresponding author), Chonnam Natl Univ, Dept Rural & Biosyst Engn, Coll Agr & Life Sci, Gwangju 61186, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.; Cho, DW (corresponding author), Yonsei Univ, Inst Convergence Res & Educ Adv Technol, 50 Yonsei Ro, Seoul 03722, South Korea.	hgyi@jnu.ac.kr; dsl@snu.ac.kr; dwcho@postech.ac.kr			National Research Foundation of Korea government [NRF-2019R1A 3A3005437, NRF-2018H1A2A1062091, NRF-2020R1A2C2101069, NRF-2019R1C1C1009606]; Korea Health Technology R&D Project - Ministry of Health & Welfare, Republic of Korea [HI14C1277]; Commercializations Promotion Agency for R&D Outcomes (COMPA) - Korea government (MSIT) [2021C100]	This study was supported by National Research Foundation of Korea government (NRF-2019R1A 3A3005437), (NRF-2018H1A2A1062091), (NRF-2020R1A2C2101069), (NRF-2019R1C1C1009606), a grant of the Korea Health Technology R&D Project, funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277), and supported by the Commercializations Promotion Agency for R&D Outcomes (COMPA) grant funded by the Korea government (MSIT) (No. 2021C100).	Adak A, 2020, ACS BIOMATER SCI ENG, V6, P2287, DOI 10.1021/acsbiomaterials.9b01829; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Alvarado-Velez M, 2021, BIOMATERIALS, V266, DOI 10.1016/j.biomaterials.2020.120419; Amer MH, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0028-x; Bianchi F, 2018, STEM CELL RES, V32, P126, DOI 10.1016/j.scr.2018.09.006; Bonsack B, 2020, CNS NEUROSCI THER, V26, P603, DOI 10.1111/cns.13378; Che LB, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201904450; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Donega V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112339; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Georges A, 2020, TRAUMATIC BRAIN INJU; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021; Hwang DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105129; Iwashita M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38395-5; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jiang JP, 2020, BIOMATER SCI-UK, V8, P6362, DOI 10.1039/d0bm01116a; Jin Y, 2018, NAT BIOMED ENG, V2, P522, DOI 10.1038/s41551-018-0260-8; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kim BS, 2020, CHEM REV, V120, P10941, DOI 10.1021/acs.chemrev.9b00808; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Lantoine J, 2016, BIOMATERIALS, V89, P14, DOI 10.1016/j.biomaterials.2016.02.041; Lee DH, 2009, CHILD NERV SYST, V25, P1547, DOI 10.1007/s00381-009-0973-9; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; MacLean FL, 2018, APL BIOENG, V2, DOI 10.1063/1.5023709; Papadimitriou L, 2020, MATER TODAY BIO, V6, DOI 10.1016/j.mtbio.2020.100043; Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935; Stukel JM, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa9a4b; Sultan MT, 2021, BIOMATERIALS, V266, DOI 10.1016/j.biomaterials.2020.120413; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wang YC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7848901; Wang ZG, 2017, EXP THER MED, V13, P3613, DOI 10.3892/etm.2017.4423; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu Y, 2017, CELL TRANSPLANT, V26, P1224, DOI 10.1177/0963689717714090; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Yao SL, 2013, PROG NAT SCI-MATER, V23, P103, DOI 10.1016/j.pnsc.2013.02.009; Yi HG, 2019, NAT BIOMED ENG, V3, P509, DOI 10.1038/s41551-019-0363-x; Yu Y, 2019, ACS BIOMATER SCI ENG, V5, P3475, DOI 10.1021/acsbiomaterials.9b00225; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhou YX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00301	49	0	0	9	9	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1758-5082	1758-5090		BIOFABRICATION	Biofabrication	OCT	2021	13	4							044110	10.1088/1758-5090/ac293f			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	WB6PK	WOS:000703692300001	34551404				2022-02-06	
J	Baghdadi, S; Shah, AS; Lawrence, JTR				Baghdadi, Soroush; Shah, Apurva S.; Lawrence, John Todd R.			Open reduction of radial neck fractures in children: injury severity predicts the radiographic and clinical outcomes	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Pediatric fractures; radial neck; proximal radial; elbow fracture; open reduction; outcome	PERCUTANEOUS REDUCTION; EXPERIENCE; MANAGEMENT	Background: Radial neck fractures are the third most common elbow fracture in children. Open reduction may be required if closed or mini-open techniques are not successful in reducing the fracture. Previous reports on open reduction have noted poor outcomes and complications with this treatment approach. However, it is unknown whether it is the open procedure itself or the severity of the initial injury that leads to the poor results. The purpose of this study was to evaluate the correlation between intraoperative findings at the time of open reduction of radial neck fractures and the clinical and radiographic outcomes. Methods: Data from patients who underwent open reduction for an acute radial neck fracture between January 2009 and December 2018 were abstracted and reviewed. Patients undergoing open treatment for a nonunion or malunion and those with inadequate follow-up were excluded. Demographic data, injury characteristics, treatment strategies, intraoperative findings, and clinical and radiographic outcomes were assessed. Results: Twenty-two patients met the inclusion criteria. Of these patients, 14 were girls. The mean age was 9.7 +/- 3 years, and the mean follow-up period was 15.8 months. Fifteen patients had a Judet grade IV displacement. Fair or poor outcomes were observed in 12 patients (55%). Ten reoperations were recorded during the study period. Age, weight, and associated injuries were not predictive of poor outcomes. Intraoperative findings of soft-tissue stripping and radial head comminution were the only significant predictors of fair or poor clinical outcomes (P < .001) and subsequent radiographic changes including fragmentation and collapse of the radial head and arthritic changes (P < .001). The quality of reduction and the choice of hardware were not significantly associated with either clinical or radiographic outcomes. Conclusion: Our findings support the notion that the outcomes of open reduction of radial neck fractures are most closely correlated with the injury severity, with the intraoperative findings of complete soft-tissue stripping or comminution of the radial head fragment being significant predictors of poor clinical and radiographic outcomes. The choice of hardware and the quality of reduction achieved at the time of surgery have less significance than injury severity. Level of evidence: Level III; Retrospective Cohort Comparison; Prognosis Study (c) 2021 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.	[Baghdadi, Soroush; Shah, Apurva S.; Lawrence, John Todd R.] Childrens Hosp Philadelphia, Div Orthopaed, Philadelphia, PA 19104 USA		Lawrence, JTR (corresponding author), Childrens Hosp Philadelphia, Div Orthoped, Dept Orthopaed Surg, 3401 Civ Ctr Blvd,Second Floor,Wood Bldg, Philadelphia, PA 19104 USA.	lawrencej@email.chop.edu		Baghdadi, Soroush/0000-0002-3401-2355			Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Basmajian HG, 2014, J PEDIATR ORTHOP B, V23, P369, DOI 10.1097/BPB.0000000000000057; BERNSTEIN SM, 1993, J PEDIATR ORTHOPED, V13, P85, DOI 10.1097/01241398-199301000-00017; Cornwall Roger, 2013, J Bone Joint Surg Am, V95, pe157, DOI 10.2106/JBJS.M.01063; De Mattos CB, 2016, J PEDIATR ORTHOPED, V36, P6, DOI 10.1097/BPO.0000000000000387; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Erickson M, 2010, ROCKWOOD WILKINS FRA, V7th, P405; Falciglia F, 2014, J PEDIATR ORTHOPED, V34, P756, DOI 10.1097/BPO.0000000000000299; FLYNN JC, 1974, J BONE JOINT SURG AM, VA 56, P263, DOI 10.2106/00004623-197456020-00004; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; Gutierrez-de la Iglesia D, 2017, J PEDIATR ORTHOPED, V37, P159, DOI 10.1097/BPO.0000000000000617; Guyonnet C, 2018, J PEDIATR ORTHOP B, V27, P296, DOI 10.1097/BPB.0000000000000502; Kaiser M, 2016, ACTA ORTHOP, V87, P529, DOI 10.1080/17453674.2016.1203700; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66, DOI 10.1302/0301-620X.71B1.2915009; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Neher CG, 2003, J PEDIATR ORTHOPED, V23, P626, DOI 10.1097/01241398-200309000-00009; Nicholson LT, 2019, J AM ACAD ORTHOP SUR, V27, pE876, DOI 10.5435/JAAOS-D-18-00204; Pring Maya E, 2012, J Pediatr Orthop, V32 Suppl 1, pS14, DOI 10.1097/BPO.0b013e31824b251d; Radomisli TE, 1998, CLIN ORTHOP RELAT R, P30; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Shabtai L, 2016, J PEDIATR ORTHOPED, V36, pS63, DOI 10.1097/BPO.0000000000000763; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	22	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746	1532-6500		J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	OCT	2021	30	10					2418	2427		10.1016/j.jse.2021.04.037			10	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	WJ9IV	WOS:000709350900031	34020001				2022-02-06	
J	Bal, E; Hanalioglu, S; Apaydin, AS; Bal, C; Senat, A; Ocal, BG; Bahadir, B; Turkoglu, OF				Bal, Ercan; Hanalioglu, Sahin; Apaydin, Aydin Sinan; Bal, Ceylan; Senat, Almila; Ocal, Berrak Gumuskaya; Bahadir, Burak; Turkoglu, Omer Faruk			Anti-inflammatory and antioxidative effects of genistein in a model of spinal cord injury in rats	ASIAN BIOMEDICINE			English	Article						antioxidants; genistein; oxidative stress; spinal cord injuries; sulfhydryl compounds	NITRIC-OXIDE SYNTHASE; NAD(P)H OXIDASE; TRAUMATIC BRAIN; SOY ISOFLAVONE; HOMEOSTASIS; IMPAIRMENT; THERAPIES; ISCHEMIA; CATALASE; RECOVERY	Background: Neurological damage from spinal cord injury (SCI) is a result of primary mechanical injury and secondary damage from oxidative stress and neuroinflammation. Although genistein has been shown to have potent antioxidant and anti-inflammatory effects in studies of brain injury, its effect on secondary damage in SCI has remained unknown. Objective: To determine effects of genistein in a model of SCI in rats. Methods: We divided 21 rats evenly into 3 groups, a control group, in which only a laminectomy was performed; a trauma group in which SCI was induced; and a genistein group in which genistein was administered subcutaneously after SCI. The rats were assessed using a Basso-Beattie and Bresnahan functional score at the 12th hour and on the 1st, 3rd, 5th, and 7th days. Biochemical analyses were conducted at the same time points to determine the serum levels of catalase, ischemia-modified albumin (IMA), disulfide (SS), total thiol (TT), native thiol (NT), disulfide/ total thiol (SS/TT), and native thiol/total thiol (NT/TT). Total oxidant and antioxidant capacity, and oxidative stress index were determined in spinal cord tissue obtained on the 7th day together with immunohistochemistry for cyclooxygenase-2 levels. Result: Catalase activity on the 7th day was significantly (P = 0.001) higher in the genistein-treated rats than in other groups, and IMA levels became stable earlier (3rd day) in the genistein group. SS values were significantly (P = 0.004) lower in the genistein group. NT/TT ratio were significantly (P = 0.049) higher in the genistein-treated rats on the 7th day. Conclusion: Genistein has antioxidant, anti-inflammatory, and protective effects in a model of SCI in rats and warrants further study.	[Bal, Ercan] Ankara Yildirim Beyazit Univ, Sch Med, Dept Neurosurg, TR-06760 Ankara, Turkey; [Bal, Ercan; Apaydin, Aydin Sinan; Bahadir, Burak; Turkoglu, Omer Faruk] Ankara City Hosp, Dept Neurosurg, TR-06800 Ankara, Turkey; [Hanalioglu, Sahin] Ankara Hacettepei, Dept Neurosurg, Sch Med, TR-06230 Ankara, Turkey; [Bal, Ceylan; Senat, Almila] Ankara Yildinm Beyazit Univ, Sch Med, Dept Neurosurg, TR-06760 Ankara, Turkey; [Ocal, Berrak Gumuskaya] Ankara Yildirim Beyazit Univ, Sch Med, Dept Pathol, TR-06760 Ankara, Turkey		Bal, E (corresponding author), Ankara City Hosp, Dept Neurosurg, TR-06800 Ankara, Turkey.	ebal@ybu.edu.tr	; Gumuskaya, Berrak/K-9692-2015	SENAT, Almila/0000-0002-5806-562X; Hanalioglu, Sahin/0000-0003-4988-4938; Gumuskaya, Berrak/0000-0003-0599-8968	Ankara Yildirim Beyazit University Scientific Research Project Fund [4887]	This work was supported by Ankara Yildirim Beyazit University Scientific Research Project Fund (Grant No. 4887).	Albayar AA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00027; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bar-Or D, 2001, AM HEART J, V141, P985, DOI 10.1067/mhj.2001.114800; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bhattarai G, 2017, J BIOMED MATER RES A, V105, P2510, DOI 10.1002/jbm.a.36109; David L, 2020, MAT SCI ENG C-MATER, V110, DOI 10.1016/j.msec.2020.110709; du Sert NP, 2020, EXP PHYSIOL, V105, P1459, DOI 10.1113/EP088870; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Erel O, 2020, TURK J MED SCI, V50, P1728, DOI 10.3906/sag-2003-64; Erel O, 2014, CLIN BIOCHEM, V47, P326, DOI 10.1016/j.clinbiochem.2014.09.026; Giden R, 2018, CLIN LAB, V64, P163, DOI 10.7754/Clin.Lab.2017.170816; Goorbandi RG, 2020, BIOMATER RES, V24, DOI 10.1186/s40824-020-00187-2; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Gunduztepe Y, 2020, J CLIN NEUROSCI, V75, P188, DOI 10.1016/j.jocn.2019.12.026; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hua Y, 2019, NEUROIMMUNOMODULAT, V26, P84, DOI 10.1159/000495466; Khodamoradi M, 2016, EUR J PHARMACOL, V786, P1, DOI 10.1016/j.ejphar.2016.05.028; Kim DH, 2020, FOOD CHEM, V305, DOI 10.1016/j.foodchem.2019.125462; Kong GG, 2017, J NEUROTRAUM, V34, P2645, DOI 10.1089/neu.2017.5192; Lee YS, 2004, FREE RADICAL BIO MED, V36, P330, DOI 10.1016/j.freeradbiomed.2003.11.006; Liu J, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyou S, 2008, NUTR NEUROSCI, V11, P155, DOI 10.1179/147683008X301559; Milosevic VL, 2018, HISTOL HISTOPATHOL, V33, P843, DOI 10.14670/HH-11-984; Mirahmadi SMS, 2018, CYTOKINE, V104, P151, DOI 10.1016/j.cyto.2017.10.008; Mizushina Y, 2013, INT J ONCOL, V43, P1117, DOI 10.3892/ijo.2013.2032; Morse LR, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02304-0; Oliveira PWC, 2020, CURR PHARM DESIGN, V26, P3711, DOI 10.2174/1381612826666200331084338; On-ong-arj P, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5407052; Oran I, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/5692583; Radwan TAM, 2021, J NEUROSURG ANESTH, V33, P254, DOI 10.1097/ANA.0000000000000647; Ray SK, 2020, NEURAL REGEN RES, V15, P1601, DOI 10.4103/1673-5374.276322; Saghazadeh A, 2017, BIOMED PHARMACOTHER, V92, P128, DOI 10.1016/j.biopha.2017.05.048; Semeniuk M, 2020, ARCH TOXICOL, V94, P1625, DOI 10.1007/s00204-020-02708-3; Singh E, 2020, MOL BIOL REP, V47, P3133, DOI 10.1007/s11033-020-05354-1; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Swaroop S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1214-5; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Wu WD, 2017, ONCOTARGET, V8, P87658, DOI 10.18632/oncotarget.21142; Ydens E, 2017, MOL NEUROBIOL, V54, P1482, DOI 10.1007/s12035-016-9757-x; Yu LQ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920738; Zeng H, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1658-2	43	0	0	2	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1905-7415	1875-855X		ASIAN BIOMED	Asian Biomed.	OCT	2021	15	5					233	243		10.2478/abm-2021-0029			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WX0NU	WOS:000718302700005					2022-02-06	
J	Moreno, JLB; Munoz, RC; Matos, YR; Balboa, IV; Puertolas, OC; Ortega, JA				Ballve Moreno, Jose Luis; Carrillo Munoz, Ricard; Rando Matos, Yolanda; Villar Balboa, Ivan; Cunillera Puertolas, Oriol; Almeda Ortega, Jesus			Responses to the Dix-Hallpike test in primary care: A comparison between subjective and objective benign paroxysmal positional vertigo	ATENCION PRIMARIA			English	Article						Benign paroxysmal; positional vertigo; Primary care; Pathologic nystagmus	CANALITH REPOSITIONING PROCEDURE; DIAGNOSIS; MANEUVER	Patients who experience both vertigo and nystagmus in the Dix-Hallpike test (DHT) are diagnosed with objective benign paroxysmal positional vertigo (BPPV). This test provokes only vertigo in between 11% and 48% of patients, who are diagnosed with subjective BPPV. Detection of nystagmus has important diagnostic and prognostic implications. To compare the characteristics of patients diagnosed with objective and subjective BPPV in primary care. Cross-sectional descriptive study. Two urban primary care centers. Adults (>= 18 years) diagnosed with objective or subjective BPPV between November 2012 and January 2015. DHT results (vertigo or vertigo plus nystagmus; dependent variable: nistagmus as response to DHT), age, sex, time since onset, previous vertigo episodes, self-reported vertigo severity (Likert scale, 0-10), comorbidities (recent viral infection, traumatic brain injury, headache, anxiety/depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, altered thyroid function, osteoporosis, cervical spondylosis, neck pain). In total, 134 patients (76.1% women) with a mean age of 52 years were included; 59.71% had subjective BPPV. Objective BPPV was significantly associated with hypertension, antihypertensive therapy, and cervical spondylosis in the bivariate analysis and with cervical spondylosis (OR = 3.94, p = 0.021) and antihypertensive therapy (OR 3.02, p = 0.028) in the multivariate analysis. Patients with subjective BPPV were more likely to be taking benzodiazepines [OR 0.24, p = 0.023]. The prevalence of subjective BPPV was higher than expected. Cervical spondylosis and hypertensive therapy were associated with objective BPPV, while benzodiazepines were associated with subjective BPPV. (C) 2021 The Authors. Published by Elsevier Espana, S.L.U.	[Ballve Moreno, Jose Luis; Rando Matos, Yolanda] Inst Catala Salut, Equip Atencio Primaria Florida Nord, Barcelona, Spain; [Carrillo Munoz, Ricard; Villar Balboa, Ivan] Inst Catala Salut, Equip Atencio Primaria Florida Sud, Barcelona, Spain; [Cunillera Puertolas, Oriol; Almeda Ortega, Jesus] Inst Univ Invest Atencio Primaria Jordi Gol IDIA, Unitat Suport Recerca Metropolitana Sud, Barcelona, Spain		Moreno, JLB (corresponding author), Inst Catala Salut, Equip Atencio Primaria Florida Nord, Barcelona, Spain.	ballvejl@gmail.com		Cunillera, Oriol/0000-0003-2891-099X	CarlosIII Institute of Health, Ministry of Economy and Competitiveness (Spain) [PI13/01396]; cycleXIV (2013) research grant from the Spanish Primary CareNetwork (REAP); European Union ERDF fundsEuropean Commission; JordiGol Institute for Research in Primary Care (IDIAP Jordi Gol) [2014/005E]; IDIAP Jordi Gol	This project received a research grant from the CarlosIII Institute of Health, Ministry of Economy and Competitiveness (Spain), awarded on the 2013 call under theHealth Strategy Action 2013-2016, within the NationalResearch Program oriented to Societal Challenges, withinthe Technical, Scientific and Innovation Research NationalPlan 2013-2016, with reference PI13/01396, co-funded withEuropean Union ERDF funds. It was also funded by the cycleXIV (2013) research grant from the Spanish Primary CareNetwork (REAP) and a predoctoral grant from the JordiGol Institute for Research in Primary Care (IDIAP Jordi Gol) (2014/005E). IDIAP Jordi Gol also funded the translation ofthis article into English.	Alvarenga GA, 2011, BRAZ J OTORHINOLAR, V77, P799, DOI 10.1590/S1808-86942011000600018; Balatsouras DG, 2012, OTOLARYNG HEAD NECK, V146, P98, DOI 10.1177/0194599811425158; Moreno JLB, 2019, BRIT J GEN PRACT, V69, pE52, DOI 10.3399/bjgp18X700253; Moreno JLB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-179; Benecke H, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00136; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, P403, DOI 10.1177/0194599816689660; Brandt T, 2006, ACTA OTO-LARYNGOL, V126, P160, DOI 10.1080/00016480500280140; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; De Stefano A, 2014, AURIS NASUS LARYNX, V41, P31, DOI 10.1016/j.anl.2013.07.007; Dieterich M, 2016, J NEUROL, V263, pS82, DOI 10.1007/s00415-015-7905-2; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Froehling DA, 2000, MAYO CLIN PROC, V75, P695; GonzalezAguado R, 2018, BRAZ J OTORHINOLAR; Grill E, 2016, J NEUROL, V263, pS36, DOI 10.1007/s00415-015-7913-2; Haynes DS, 2002, LARYNGOSCOPE, V112, P796, DOI 10.1097/00005537-200205000-00006; Kerber KA, 2015, ANN NY ACAD SCI, V1343, P106, DOI 10.1111/nyas.12721; Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Li YC, 2015, PAIN PHYSICIAN, V18, pE583; MIZUKOSHI K, 1988, ACTA OTO-LARYNGOL, P67; NORRE ME, 1995, AM J OTOL, V16, P806; Peng BG, 2018, WORLD NEUROSURG, V109, P347, DOI 10.1016/j.wneu.2017.10.063; Tan J, 2015, EUR ARCH OTO-RHINO-L, V272, P3247, DOI 10.1007/s00405-014-3399-2; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; WEIDER DJ, 1994, AM J OTOL, V15, P321	24	0	0	1	1	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	0212-6567	1578-1275		ATEN PRIM	Aten. Prim.	OCT	2021	53	8							102023	10.1016/j.aprim.2021.102023			7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UZ3US	WOS:000702134200001	34000460	Green Published, gold			2022-02-06	
J	Basto-Mancipe, Z; Montoya-Gonzalez, S				Basto-Mancipe, Zaira; Montoya-Gonzalez, Santiago			Sports injuries and illnesses during the ASCUN National University Games 2018	IATREIA			Spanish	Article						Athletes; Athletic Injuries; Epidemiologic Surveillance; Sports	EPIDEMIOLOGY; FOOTBALL; SURVEILLANCE; CONCUSSIONS; COLLEGE	Introduction: Sports injuries and medical inquiries are common during sports events, to know their behavior allows the planning of responsible actions for caring and contributes to the creation of new strategies for care and prevention of injuries in athletes. There is no knowledge about injuries that occur in sports events held in Colombia. Objective: To describe the injuries and illnesses that required medical attention during the 2018 National University Games. Materials and methods: Descriptive study that included 4592 athletes. Medical consultation in different sports venues were recorded, reporting characteristics of the injuries such as anatomical location, compromised tissue, severity and the sport in which the injury was presented. Results: It was found that 11.1% of the records of care were due to sports injury, 3.9% due to general illness, soccer was the sport with the highest number of injuries, muscle injury was the most common and thigh was the site anatomical most frequently compromised. Conclusion: Most of the consultations were due to acute sports injuries, located in the lower limb, the muscle injury being the most common and mainly affecting team sports.	[Basto-Mancipe, Zaira] Univ Antioquia, Bienestar Univ, Actividad Fis & Deporte, Medellin, Colombia; [Montoya-Gonzalez, Santiago] Univ CES, Medellin, Colombia		Basto-Mancipe, Z (corresponding author), Univ Antioquia, Bienestar Univ, Actividad Fis & Deporte, Medellin, Colombia.	zaira.basto@udea.edu.co					Alonso JM, 2010, BRIT J SPORT MED, V44, P1100, DOI 10.1136/bjsm.2010.078030; Asperti AM, 2017, ACTA ORTOP BRAS, V25, P93, DOI 10.1590/1413-785220172502165651; Bahr R., 2012, IOC MANUAL SPORTS IN, V1st ed.; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Bromley SJ, 2018, BRIT J SPORT MED, V52, P8, DOI 10.1136/bjsports-2016-097313; Carr PC, 2019, CLIN SPORT MED, V38, P597, DOI 10.1016/j.csm.2019.06.001; Chomiak J, 2000, AM J SPORT MED, V28, pS58; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hammami N, 2018, SCI SPORT, V33, P73, DOI 10.1016/j.scispo.2017.04.014; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hess MC, 2020, J ATHL TRAINING, V55, P195, DOI 10.4085/1062-6050-269-18; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jae-Ok K, 2016, CLIN J SPORT MED, V26, P239, DOI 10.1097/JSM.0000000000000244; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Llinas PJ, 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2015-000072, DOI 10.1136/BMJSEM-2015-000072]; Nabhan D, 2016, BRIT J SPORT MED, V50, P688, DOI 10.1136/bjsports-2015-095835; Neira Tolosa NA, 2015, LINEAMIENTOS POLITIC; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Ramirez CA, MEMORIAS DEPORTE UNI; Rejeb A, 2017, EUR J SPORT SCI, V17, P495, DOI 10.1080/17461391.2016.1275820; Roos KG, 2017, AM J SPORT MED, V45, P201, DOI 10.1177/0363546516660980; Rose MS, 2008, MED SCI SPORT EXER, V40, P444, DOI [10.1249/MSS.0b013e31815ce61a, 10.1249/mss.0b013e31815ce61a]; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Swedler DI, 2015, J ATHL TRAINING, V50, P419, DOI 10.4085/1062-6050-49.3.73; Valle X, 2017, SPORTS MED, V47, P1241, DOI 10.1007/s40279-016-0647-1	30	0	0	1	1	UNIV ANTIOQUIA, FAC MED	MEDELLIN	CRA 51 D N 62-69, MEDELLIN, 00000, COLOMBIA	0121-0793	2011-7965		IATREIA	Iatreia	OCT	2021	34	4					307	315		10.17533/udea.iatreia.91			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WC7SH	WOS:000704453600003					2022-02-06	
J	Becker, BE				Becker, Bruce E.			Case report: The physiology of a preventable tragedy-Near death in a hot tub	CLINICAL CASE REPORTS			English	Article						anoxia; aquatic immersion; hot tubs; hyperthermia; pediatric; traumatic brain injury	WATER IMMERSION; HYPERTHERMIA; CHILDREN; EXERCISE	Hyperthermia in children is a known risk within enclosed vehicles. Exposure to an overheated hot tub poses a real risk in children due to unique pediatric physiology. Medical and aquatic professionals should understand the risk and mitigation strategies.	[Becker, Bruce E.] Univ Washington, Sch Med, Bend, OR USA		Becker, BE (corresponding author), Univ Washington, Sch Med, Bend, OR USA.	beckerb2@uw.edu					ARBORELIUS M, 1972, AEROSPACE MED, V43, P592; Bain AR, 2020, J PHYSIOL-LONDON, V598, P943, DOI 10.1113/JP278889; Bain AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00092; BARTLETT AA, 1983, AM J PHYS, V51, P127, DOI 10.1119/1.13466; Becker BE, 2009, PM&R, V1, P859, DOI 10.1016/j.pmrj.2009.05.017; BONDEPETERSEN F, 1992, AVIAT SPACE ENVIR MD, V63, P346; Carter HH, 2014, AM J PHYSIOL-REG I, V306, pR636, DOI 10.1152/ajpregu.00516.2013; CDC, 2018, MOD AQ HLTH COD; Denny SA, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0850; Duzinski SV, 2014, INJURY PREV, V20, P220, DOI 10.1136/injuryprev-2013-040910; EPSTEIN M, 1976, J APPL PHYSIOL, V41, P230; Falk B, 1998, SPORTS MED, V25, P221, DOI 10.2165/00007256-199825040-00002; Fischer M, 2020, J PHYSIOL-LONDON, V598, P2053, DOI 10.1113/JP279745; HART LE, 1980, CAN MED ASSOC J, V122, P1144; Hickey RW, 2000, PEDIATRICS, V106, P118, DOI 10.1542/peds.106.1.118; Hildenbrand K., 2010, INT J AQUAT RES ED, V4, P127; KINNEY EL, 1987, AM HEART J, V113, P345, DOI 10.1016/0002-8703(87)90276-6; Kiyatkin EA, 2007, PROG BRAIN RES, V162, P219, DOI 10.1016/S0079-6123(06)62012-8; LOLLGEN H, 1981, KLIN WOCHENSCHR, V59, P623, DOI 10.1007/BF02593853; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Pugh CJA, 2015, MED SCI SPORT EXER, V47, P299, DOI 10.1249/MSS.0000000000000422; Sanders, 2009, INT J AQUATIC RES ED, V3, P24, DOI DOI 10.25035/ijare.03.01.04; Topjian AA, 2012, NEUROCRIT CARE, V17, P441, DOI 10.1007/s12028-012-9747-4; TsuzukiHayakawa K, 1995, EUR J APPL PHYSIOL O, V72, P12, DOI 10.1007/BF00964108; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1376-4	25	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2050-0904			CLIN CASE REP	Clin. Case Rep.	OCT	2021	9	10							e4951	10.1002/ccr3.4951			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XG4NP	WOS:000724731500062	34745615	gold, Green Published			2022-02-06	
J	Binder, H; Majdan, M; Leitgeb, J; Payr, S; Breuer, R; Hajdu, S; Tiefenboeck, TM				Binder, Harald; Majdan, Marek; Leitgeb, Johannes; Payr, Stephan; Breuer, Robert; Hajdu, Stefan; Tiefenboeck, Thomas M.			Management and Outcome of Traumatic Intracerebral Hemorrhage in 79 Infants and Children from a Single Level 1 Trauma Center	CHILDREN-BASEL			English	Article						traumatic brain injury; intracerebral hemorrhage; infants; children and adolescent; prognostic factors; outcome	SPONTANEOUS INTRACRANIAL HEMORRHAGE; EARLY DECOMPRESSIVE CRANIECTOMY; SEVERE HEAD-INJURY; BRAIN-INJURY; SUBDURAL-HEMATOMA; ETIOLOGY; HYPERTENSION; MORTALITY; LESIONS; STROKE	Objective: Traumatic brain injury is a leading form of pediatric trauma and a frequent cause of mortality and acquired neurological impairment in children. The aim of this study was to present the severity and outcomes of traumatic intracerebral bleeding in children and adolescence. Methods: Seventy-nine infants and children with intracerebral bleedings were treated between 1992 and 2020 at a single level 1 trauma center. Data regarding accident, treatment and outcomes were collected retrospectively. The Glasgow Outcome Scale was used to classify the outcome at hospital discharge and at follow-up visits. CT scans of the brain were classified according to the Rotterdam score. Results: In total, 41 (52%) patients with intracerebral bleedings were treated surgically, and 38 (48%) patients were treated conservatively; in 15% of the included patients, delayed surgery was necessary. Patients presenting multiple trauma (p < 0.04), higher ISS (p < 0.01), poor initial neurological status (p < 0.001) and a higher Rotterdamscore (p = 0.038) were significantly more often treated surgically. Eighty-three percent of patients were able to leave the hospital, and out of these patients, about 60% showed good recovery at the latest follow-up visit. Overall, 11 patients (14%) died. Conclusion: The findings in this study verified intracerebral bleeding as a rare but serious condition. Patients presenting with multiple traumas, higher initial ISS, poor initial neurological status and a higher Rotterdamscore were more likely treated by surgery. Trial registration: (researchregistry 2686).</p>	[Binder, Harald; Leitgeb, Johannes; Payr, Stephan; Breuer, Robert; Hajdu, Stefan; Tiefenboeck, Thomas M.] Med Univ Vienna, Dept Trauma Surg, A-1090 Vienna, Austria; [Majdan, Marek; Leitgeb, Johannes] Trnava Univ, Inst Global Hlth & Epidemiol, Dept Publ Hlth, Trnava 91701, Slovakia		Tiefenboeck, TM (corresponding author), Med Univ Vienna, Dept Trauma Surg, A-1090 Vienna, Austria.	harald.binder@meduniwien.ac.at; mmajdan@truni.sk; johannes.leitgeb@meduniwien.ac.at; stephan.payr@meduniwien.ac.at; robert.breuer@meduniwien.ac.at; stefan.hajdu@meduniwien.ac.at; thomas.tiefenboeck@meduniwien.ac.at		Tiefenboeck, Thomas/0000-0002-8698-8341			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Al-Jarallah A, 2000, J CHILD NEUROL, V15, P284, DOI 10.1177/088307380001500503; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; [Anonymous], 2018, SCHADEL HIRN TRAUMA; Beuriat PA, 2015, J NEUROSURG SCI, V59, P405; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ferrete-Araujo AM, 2015, MED INTENSIVA, V39, P422, DOI 10.1016/j.medin.2014.10.008; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Ghajar J., 2006, NEUROSURGERY, V58, pI, DOI DOI 10.1093/NEUROSURGERY/58.SUPPL_3.S2-VI; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; Jordan LC, 2009, STROKE, V40, P1666, DOI 10.1161/STROKEAHA.108.541383; Jordan LC, 2009, STROKE, V40, P400, DOI 10.1161/STROKEAHA.108.518761; KANG JK, 1989, CHILD NERV SYST, V5, P303, DOI 10.1007/BF00274518; Karibe H, 2016, NEUROL MED-CHIR, V56, P264, DOI 10.2176/nmc.ra.2015-0308; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Kumar R, 2009, PEDIATR NEUROSURG, V45, P37, DOI 10.1159/000202622; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lin Chih-Lung, 1999, Kaohsiung Journal of Medical Sciences, V15, P146; Lo WD, 2008, ARCH NEUROL-CHICAGO, V65, P1629, DOI 10.1001/archneurol.2008.502; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mandera M, 1999, CHILD NERV SYST, V15, P267, DOI 10.1007/s003810050389; Manfiotto M, 2019, WORLD NEUROSURG, V129, pE56, DOI 10.1016/j.wneu.2019.04.215; Meyer-Heim AD, 2003, BRAIN DEV-JPN, V25, P416, DOI 10.1016/S0387-7604(03)00029-9; Mhanna MJ, 2015, J NEUROSURG-PEDIATR, V16, P508, DOI 10.3171/2014.10.PEDS14117; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Singounas E G, 1992, J Neurosurg Sci, V36, P201; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Sorokina E G, 2020, Zh Nevrol Psikhiatr Im S S Korsakova, V120, P72, DOI 10.17116/jnevro202012004172; Sorokina E G, 2000, Membr Cell Biol, V13, P389; Sorokina E.G., 2021, BRAIN BIOMARKERS CHI, V131, P103; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Wolf H, 2014, J NEUROSURG, V120, P447, DOI 10.3171/2013.10.JNS13726; Wu E, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.587587; Zahuranec DB, 2014, NEUROLOGY, V82, P2180, DOI 10.1212/WNL.0000000000000519; Zakhary MM, 2009, ACAD RADIOL, V16, P572, DOI 10.1016/j.acra.2009.01.007	49	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	OCT	2021	8	10							854	10.3390/children8100854			15	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WV3SF	WOS:000717159200001	34682119	Green Published, gold			2022-02-06	
J	Butler, S; Dimovitz, C; Muller, A; Daramola, T; Becirovic, S; Mancano, L; Ong, A				Butler, Susan; Dimovitz, Cynthia; Muller, Alison; Daramola, Temilolaoluwa; Becirovic, Sahin; Mancano, Louis; Ong, Adrian			Documentation of Cognitive Rest After Concussion by Pediatric Primary Care Providers	JNP-JOURNAL FOR NURSE PRACTITIONERS			English	Article						ambulatory concussion management; concussion tool; pediatric	RECOMMENDATIONS; KNOWLEDGE; SCHOOL; RETURN	Pediatric primary care providers manage the initial assessment of children with concussions and guide ongoing care for cognitive and physical rest until all acute symptoms resolve. The goal of this study was to identify if there were gaps in provider documentation for cognitive rest and if the use of a concussion tool improved discharge instructions. A retrospective chart review was completed on patients 5 to 18 years old who presented to our ambulatory pediatric practices with a concussion. The results showed that although few providers adopted a concussion tool in their practice, those who did were more likely to incorporate vital recommendations in documentation. (c) 2021 Elsevier Inc. All rights reserved.	[Butler, Susan; Dimovitz, Cynthia] Tower Hlth Syst, Reading Hosp, Childrens Hlth Ctr, W Reading, PA 19611 USA; [Muller, Alison; Daramola, Temilolaoluwa; Becirovic, Sahin; Ong, Adrian] Tower Hlth Syst, Trauma Serv & Neuro Crit Care, Reading Hosp, W Reading, PA USA; [Mancano, Louis] Tower Hlth Syst, Reading Ambulatory Practices, Reading Hosp, W Reading, PA USA		Butler, S (corresponding author), Tower Hlth Syst, Reading Hosp, Childrens Hlth Ctr, W Reading, PA 19611 USA.	Susan.butler@towerhealth.org					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, HEADS UP HLTH CAR PR; Grady MF, 2017, PEDIATR ANN, V46, pE93, DOI 10.3928/19382359-20170220-04; Keenan RP, 2020, ADV EMERG NURS J, V42, P63, DOI 10.1097/TME.0000000000000280; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1555-4155	1878-058X		JNP-J NURSE PRACT	JNP-J. Nurse Pract.	OCT	2021	17	9					1078	1080		10.1016/j.nurpra.2021.06.015			3	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	XN3QN	WOS:000729423000010					2022-02-06	
J	Caffey, AL; Dalecki, M				Caffey, Abigail L.; Dalecki, Marc			Evidence of residual cognitive deficits in young adults with a concussion history from adolescence	BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Stroop; Sustained attention; Youth	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; EXECUTIVE FUNCTION; PHYSICAL-ACTIVITY; STROOP TASK; ATTENTION; MATURATION; IMPACTS; ABNORMALITIES; ACTIVATION	The present study investigated executive function and sustained attention of non-athlete, young adults (ages 18-23) with a history of concussion beyond ten months post incident. Cognitive functioning was examined in 24 non-athletic, college students with a concussion history (mean age 21 yrs.; mean time and range post-injury: 4 years, 10-90 months) and 24 non-athletic controls with no history (NH) of concussion. Computerized versions of two cognitive assessment techniques were utilized to examine executive functioning (Stroop) and sustained attention capacity (D2). Primary dependent variables were response time, error score, and sustained attention score. Relationships between dependent variables and concussion metrics were also analyzed. ANOVA's revealed a significantly higher error rate in concussion history (CH) participants when performing the Stroop task (p < 0.05), including a trend for greater errors in the incongruent task condition (p < 0.05). Group measures did not differ in the sustained attention test (all p > 0.05). Nevertheless, there was a significant relationship between D2 error rate and time since concussion (p < 0.01), showing that D2 error rate was greater for participants with more time since concussion sustainment. Our findings indicate the potential for prolonged cognitive dysfunction linked to decision-making, but not to processing speed, in young adult non-athletes with a CH averaging four years post-injury. These findings may provide evidence of residual cognitive deficits in young adults with a concussion history over time.	[Caffey, Abigail L.; Dalecki, Marc] Louisiana State Univ, Sch Kinesiol, 71 Huey P Long Field House, Baton Rouge, LA 70803 USA		Dalecki, M (corresponding author), Louisiana State Univ, Sch Kinesiol, 71 Huey P Long Field House, Baton Rouge, LA 70803 USA.	mdalecki@lsu.edu			LSU Discover Undergraduate Research Grant Spring 2019	LSU Discover Undergraduate Research Grant Spring 2019 and Summer 2019 (AC).	Alosco ML, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00440; Alsalaheen B, 2017, SPORTS HEALTH, V9, P324, DOI 10.1177/1941738117713974; Arata W., 2019, J SPORT EXERCISE PSY; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Brickenkamp R., 2002, TEST D2 AUFMERKSAMKE; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Ceschi A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00313; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Dalecki M, 2019, EUR J SPORT SCI, V19, P1257, DOI 10.1080/17461391.2019.1584249; Dalecki M, 2019, CHILD NEUROPSYCHOL, V25, P1098, DOI 10.1080/09297049.2019.1578342; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Dalecki M, 2012, J APPL PHYSIOL, V113, P1075, DOI 10.1152/japplphysiol.00825.2012; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Gevers W, 2015, J SLEEP RES, V24, P666, DOI 10.1111/jsr.12320; Goenarjo R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041406; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Grandjean J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041513; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Johnson B.D., 2014, CONCUSSIONS ATHLETIC, P331, DOI [10.1007/978-1-4939-0295-8_19, DOI 10.1007/978-1-4939-0295-8_19]; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Manly T., 1997, METHODOL FRONTAL EXE, P135; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mavaddat N, 2000, BRAIN, V123, P2109, DOI 10.1093/brain/123.10.2109; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAvinue LP, 2012, ATTEN PERCEPT PSYCHO, V74, P1570, DOI 10.3758/s13414-012-0352-6; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNabb C, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120960; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Oyegbile TO, 2020, BEHAV SLEEP MED, V18, P241, DOI 10.1080/15402002.2019.1578223; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Piantella S, 2020, ARCH CLIN NEUROPSYCH, V35, P482, DOI 10.1093/arclin/acaa012; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; Telama R, 2006, PEDIATR EXERC SCI, V18, P76, DOI 10.1123/pes.18.1.76; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Wallace J, 2020, AM J SPORT MED, V48, P2774, DOI 10.1177/0363546520946753	60	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2021	1768								147570	10.1016/j.brainres.2021.147570			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UE2BT	WOS:000687700200008	34216582				2022-02-06	
J	Cao, M; Halperin, JM; Li, XB				Cao, Meng; Halperin, Jeffery M.; Li, Xiaobo			Abnormal Functional Network Topology and Its Dynamics during Sustained Attention Processing Significantly Implicate Post-TBI Attention Deficits in Children	BRAIN SCIENCES			English	Article						pediatric; traumatic brain injury (TBI); attention deficits; functional MRI (fMRI); graph theory; dynamic functional connectivity	TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; RESPONSE-INHIBITION; PRELIMINARY FMRI; BOTTOM-UP; TOP-DOWN; CONNECTIVITY; SCHIZOPHRENIA; ADOLESCENTS	Traumatic brain injury (TBI) is highly prevalent in children. Attention deficits are among the most common and persistent post-TBI cognitive and behavioral sequalae that can contribute to adverse outcomes. This study investigated the topological properties of the functional brain network for sustained attention processing and their dynamics in 42 children with severe post-TBI attention deficits (TBI-A) and 47 matched healthy controls. Functional MRI data during a block-designed sustained attention task was collected for each subject, with each full task block further divided into the pre-, early, late-, and post-stimulation stages. The task-related functional brain network was constructed using the graph theoretic technique. Then, the sliding-window-based method was utilized to assess the dynamics of the topological properties in each stimulation stage. Relative to the controls, the TBI-A group had significantly reduced nodal efficiency and/or degree of left postcentral, inferior parietal, inferior temporal, and fusiform gyri and their decreased stability during the early and late-stimulation stages. The left postcentral inferior parietal network anomalies were found to be significantly associated with elevated inattentive symptoms in children with TBI-A. These results suggest that abnormal functional network characteristics and their dynamics associated with the left parietal lobe may significantly link to the onset of the severe post-TBI attention deficits in children.	[Cao, Meng; Li, Xiaobo] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Halperin, Jeffery M.] CUNY, Dept Psychol, Queens Coll, New York, NY 11367 USA		Li, XB (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	meng.cao@njit.edu; jeffrey.halperin@gmail.com; xli.aecom@gmail.com		Cao, Meng/0000-0002-2982-0841	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH109791, R15MH117368]; New Jersey Commission on Brain Injury Research [CBIR17PIL012]	FundingThis research was funded by the National Institute of Mental Health (R03MH109791, R15MH117368), and the New Jersey Commission on Brain Injury Research (CBIR17PIL012).	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Braun U, 2015, P NATL ACAD SCI USA, V112, P11678, DOI 10.1073/pnas.1422487112; Brooks BL, 2020, BRAIN INJURY, V34, P895, DOI 10.1080/02699052.2020.1753240; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Cao M, 2021, BRAIN CONNECT, V11, P651, DOI 10.1089/brain.2020.0866; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Conners C.K., 2008, CONNERS 3; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ho TC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00040; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Hou WS, 2019, BRAIN CONNECT, V9, P475, DOI 10.1089/brain.2018.0629; Hutchison RM, 2015, J NEUROSCI, V35, P6849, DOI 10.1523/JNEUROSCI.4638-14.2015; Jolly AE, 2020, BRAIN, V143, P1158, DOI 10.1093/brain/awaa067; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Katsuki F, 2014, NEUROSCIENTIST, V20, P509, DOI 10.1177/1073858413514136; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kramer ME, 2009, J PEDIATR REHAB MED, V2, P255, DOI 10.3233/PRM-2009-0091; Kuceyeski AF, 2019, HUM BRAIN MAPP, V40, P4441, DOI 10.1002/hbm.24713; Kucyi A, 2017, CEREB CORTEX, V27, P1831, DOI 10.1093/cercor/bhw029; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Le Fur C, 2020, ANN PHYS REHABIL MED, V63, P270, DOI 10.1016/j.rehab.2019.09.003; Lee CU, 2002, ARCH GEN PSYCHIAT, V59, P775, DOI 10.1001/archpsyc.59.9.775; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Li XB, 2012, J AM ACAD CHILD PSY, V51, P1197, DOI 10.1016/j.jaac.2012.08.013; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Narad ME, 2020, J HEAD TRAUMA REHAB, V35, pE271, DOI 10.1097/HTR.0000000000000550; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Percival D. B., 2000, WAVELET METHODS TIME, V4; Perlman SB, 2013, J AM ACAD CHILD PSY, V52, P1314, DOI 10.1016/j.jaac.2013.09.004; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rabner J, 2016, AM J ADDICTION, V25, P91, DOI 10.1111/ajad.12338; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Silverstein SM, 2010, PSYCHOL MED, V40, P1159, DOI 10.1017/S0033291709991735; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Stephens JA, 2017, J NEUROTRAUM, V34, P3117, DOI 10.1089/neu.2017.5081; Strakowski SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1734, DOI 10.1038/sj.npp.1300492; Strazzer S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/104282; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2015, J PEDIATR REHAB MED, V8, P321, DOI 10.3233/PRM-150350; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Tuerk C, 2020, HUM BRAIN MAPP, V41, P561, DOI 10.1002/hbm.24822; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; Venkalesan UM, 2019, NEUROPSYCHOLOGY, V33, P893, DOI 10.1037/neu0000553; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang JJ, 2017, SOC COGN AFFECT NEUR, V12, P1983, DOI 10.1093/scan/nsx100; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wechsler D., 2011, WECHSLER ABBREVIATED; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wu ZY, 2018, CNS NEUROSCI THER, V24, P539, DOI 10.1111/cns.12811; Xia SG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00162	86	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2021	11	10							1348	10.3390/brainsci11101348			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WT1DU	WOS:000715612800001	34679412	Green Published, Green Submitted, gold			2022-02-06	
J	Carrick, FR; Azzolino, SF; Hunfalvay, M; Pagnacco, G; Oggero, E; D'Arcy, RCN; Abdulrahman, M; Sugaya, K				Carrick, Frederick Robert; Azzolino, Sergio F.; Hunfalvay, Melissa; Pagnacco, Guido; Oggero, Elena; D'Arcy, Ryan C. N.; Abdulrahman, Mahera; Sugaya, Kiminobu			The Pupillary Light Reflex as a Biomarker of Concussion	LIFE-BASEL			English	Article						pupil light reflex; concussion; gender difference; brain function; pupillometry	GANGLION-CELLS; QUANTITATIVE PUPILLOMETRY; NORMATIVE DATA; MONKEY; LUMINANCE; SIZE	The size of our pupils changes continuously in response to variations in ambient light levels, a process known as the pupillary light reflex (PLR). The PLR is not a simple reflex as its function is modulated by cognitive brain function and any long-term changes in brain function secondary to injury should cause a change in the parameters of the PLR. We performed a retrospective clinical review of the PLR of our patients using the BrightLamp Reflex iPhone app. The PLR variables of latency, maximum pupil diameter (MaxPD), minimum pupil diameter (MinPD), maximum constriction velocity (MCV), and the 75% recovery time (75% PRT) were associated with significant differences between subjects who had suffered a concussion and those that had not. There were also significant differences in PLR metrics over the life span and between genders and those subjects with and without symptoms. The differences in PLR metrics are modulated not only by concussion history but also by gender and whether or not the person has symptoms associated with a head injury. A concussive injury to the brain is associated with changes in the PLR that persist over the life span, representing biomarkers that might be used in clinical diagnosis, treatment, and decision making.	[Carrick, Frederick Robert; Sugaya, Kiminobu] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Carrick, Frederick Robert; Sugaya, Kiminobu] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Carrick, Frederick Robert] MGH Inst Hlth Profess, Boston, MA 02129 USA; [Carrick, Frederick Robert] Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge CB2 1TN, England; [Carrick, Frederick Robert; Azzolino, Sergio F.; Hunfalvay, Melissa; Pagnacco, Guido; Oggero, Elena] Carrick Inst, Cape Canaveral, FL 32920 USA; [Pagnacco, Guido; Oggero, Elena] Univ Wyoming, Dept Elect & Comp Engn, Laramie, WY 82071 USA; [D'Arcy, Ryan C. N.] BrainNET, Hlth & Technol Dist, Vancouver, BC V3V 0C6, Canada; [D'Arcy, Ryan C. N.] HealthTech Connex, Ctr Neurol Studies, Vancouver, BC V3V 0C6, Canada; [D'Arcy, Ryan C. N.] Univ British Columbia, DM Ctr Brain Hlth, Dept Radiol, Vancouver, BC V6T 1Z4, Canada; [Abdulrahman, Mahera] Dubai Hlth Author, Hlth Regulat Sect, Hlth Informat & Smart Hlth Dept, Dubai 7272, U Arab Emirates		Carrick, FR (corresponding author), Univ Cent Florida, Coll Med, Orlando, FL 32816 USA.; Carrick, FR (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.; Carrick, FR (corresponding author), MGH Inst Hlth Profess, Boston, MA 02129 USA.; Carrick, FR (corresponding author), Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge CB2 1TN, England.; Carrick, FR (corresponding author), Carrick Inst, Cape Canaveral, FL 32920 USA.	drfrcarrick@post.harvard.edu; sergio@azzolino.com; melissa@righteye.com; guido@vestibtech.com; Elena@vestibtech.com; ryan@healthtechconnex.com; marad@dha.gov.ae; ksugaya@ucf.edu		Abdulrahman, Mahera/0000-0001-6271-3776; Carrick, Frederick/0000-0002-2818-6551; Sugaya, Kiminobu/0000-0002-2788-5457	Carrick Institute	The Carrick Institute funded this research.	Alosco ML, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-021-00872-x; ASCHER K W, 1962, Trans Am Ophthalmol Soc, V60, P53; Avuluru VS, 2020, NEUROPHYSIOL CLIN, V50, P320, DOI 10.1016/j.neucli.2020.09.004; Behar-Cohen F, 2020, M S-MED SCI, V36, P594, DOI 10.1051/medsci/2020094; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496; Bouffard Marc A, 2019, Continuum (Minneap Minn), V25, P1194, DOI 10.1212/CON.0000000000000771; Boulter JHH, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.685313; Clarke RJ, 2003, J NEUROPHYSIOL, V89, P3168, DOI 10.1152/jn.01130.2002; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Ebitz RB, 2017, J NEUROSCI, V37, P5008, DOI 10.1523/JNEUROSCI.2433-16.2017; ETTINGER ER, 1991, INVEST OPHTH VIS SCI, V32, P501; Fan XF, 2011, IEEE T BIO-MED ENG, V58, P36, DOI 10.1109/TBME.2010.2080678; Favre E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2796-8; Ferrario E, 1998, NEUROLOGY, V50, P642, DOI 10.1212/WNL.50.3.642; Gamlin P D, 1995, J Am Optom Assoc, V66, P415; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; GREGORY R, 1974, NATURE, V252, P637, DOI 10.1038/252637a0; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Horn AK, 2008, J COMP NEUROL, V507, P1317, DOI 10.1002/cne.21598; Hu XF, 2020, VISION RES, V170, P35, DOI 10.1016/j.visres.2020.03.008; India State-Level Disease Burden Initiative Neurological Disorders Collaborators, 2021, LANCET GLOB HEALTH, V9, pE1129, DOI [10.1016/S2214-109X(21)00164-9, DOI 10.1016/S2214-109X(21)00164-9]; Joshi S, 2020, TRENDS COGN SCI, V24, P466, DOI 10.1016/j.tics.2020.03.005; June D, 2020, NEUROIMAGE, V221, DOI 10.1016/j.neuroimage.2020.117182; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P164, DOI 10.1037/h0026952; Kataoka N, 2020, SCIENCE, V367, P1105, DOI 10.1126/science.aaz4639; Kebapci A, 2020, INTENS CRIT CARE NUR, V58, DOI 10.1016/j.iccn.2020.102801; Kelbsch C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00129; Kono Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70234-4; Kurniawan IT, 2021, J NEUROSCI, V41, P6328, DOI 10.1523/JNEUROSCI.3027-20.2021; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lobato-Rincon LL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00221; LOWENSTEIN O, 1950, ARCH NEURO PSYCHIATR, V64, P313, DOI 10.1001/archneurpsyc.1950.02310270002001; Master CL, 2020, JAMA OPHTHALMOL, V138, P1135, DOI 10.1001/jamaophthalmol.2020.3466; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; May PJ, 2018, INVEST OPHTH VIS SCI, V59, P1486, DOI 10.1167/iovs.17-23737; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mitsuoka K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.619; MORRISON JH, 1982, BRAIN RES BULL, V9, P309, DOI 10.1016/0361-9230(82)90144-7; Moss Heather E, 2019, Continuum (Minneap Minn), V25, P1310, DOI 10.1212/CON.0000000000000785; Pfeiffer RL, 2020, EXP EYE RES, V199, DOI 10.1016/j.exer.2020.108196; Rickmann A, 2017, NEURO-OPHTHALMOLOGY, V41, P12, DOI 10.1080/01658107.2016.1226345; STEIGER HJ, 1979, BRAIN RES, V160, P1, DOI 10.1016/0006-8993(79)90596-1; Szabadi E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01069; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Vazey EM, 2018, P NATL ACAD SCI USA, V115, pE9439, DOI 10.1073/pnas.1803716115; Wang Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197739; Zhang FR, 2019, P NATL ACAD SCI USA, V116, P7951, DOI 10.1073/pnas.1816360116	49	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-1729		LIFE-BASEL	Life-Basel	OCT	2021	11	10							1104	10.3390/life11101104			24	Biology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Microbiology	WT1AP	WOS:000715604500001	34685475	gold, Green Published			2022-02-06	
J	Carvajal, FJ; Cerpa, W				Carvajal, Francisco J.; Cerpa, Waldo			Regulation of Phosphorylated State of NMDA Receptor by STEP61 Phosphatase after Mild-Traumatic Brain Injury: Role of Oxidative Stress	ANTIOXIDANTS			English	Article						mild traumatic brain injury; & nbsp;STEP61???????; SOD2(+/-) mice; & nbsp;oxidative stress; synaptic transmission; & nbsp;hippocampus; NMDARs; & nbsp;behavioral performance	D-ASPARTATE RECEPTORS; AMYLOID-BETA PLAQUES; SYNAPTIC PLASTICITY; CREB SHUTOFF; MOUSE MODEL; CELL-DEATH; TRAFFICKING; ACCUMULATION; MICE; RAT	Traumatic Brain Injury (TBI) mediates neuronal death through several events involving many molecular pathways, including the glutamate-mediated excitotoxicity for excessive stimulation of N-methyl-D-aspartate receptors (NMDARs), producing activation of death signaling pathways. However, the contribution of NMDARs (distribution and signaling-associated to the distribution) remains incompletely understood. We propose a critical role of STEP61 (Striatal-Enriched protein tyrosine phosphatase) in TBI; this phosphatase regulates the dephosphorylated state of the GluN2B subunit through two pathways: by direct dephosphorylation of tyrosine-1472 and indirectly via dephosphorylation and inactivation of Fyn kinase. We previously demonstrated oxidative stress's contribution to NMDAR signaling and distribution using SOD2(+/-) mice such a model. We performed TBI protocol using a controlled frontal impact device using C57BL/6 mice and SOD2(+/-) animals. After TBI, we found alterations in cognitive performance, NMDAR-dependent synaptic function (decreased synaptic form of NMDARs and decreased synaptic current NMDAR-dependent), and increased STEP61 activity. These changes are reduced partially with the STEP61-inhibitor TC-2153 treatment in mice subjected to TBI protocol. This study contributes with evidence about the role of STEP61 in the neuropathological progression after TBI and also the alteration in their activity, such as an early biomarker of synaptic damage in traumatic lesions.</p>	[Carvajal, Francisco J.; Cerpa, Waldo] Pontificia Univ Catolica Chile, Lab Func & Patol Neuronal, Ctr Envejecimiento & Regenerac CARE, Dept Biol Celular & Mol,Fac Ciencias Biol, Santiago 8331150, Chile; [Carvajal, Francisco J.; Cerpa, Waldo] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas 6200000, Chile		Cerpa, W (corresponding author), Pontificia Univ Catolica Chile, Lab Func & Patol Neuronal, Ctr Envejecimiento & Regenerac CARE, Dept Biol Celular & Mol,Fac Ciencias Biol, Santiago 8331150, Chile.; Cerpa, W (corresponding author), Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas 6200000, Chile.	francisco.carvajalc@outlook.cl; wcerpa@bio.puc.cl		Cerpa, Waldo/0000-0001-7344-0144	CONICYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21161392]	FundingThis work was supported by FONDECYT N 1190620, Research Team Project in Science and Technology (ACT1411) and BMBF 20150065 (PCI), Center for Excellence in Science and Technology (AFB 170005, PFB 12/2007), Sociedad Quimica y Minera de Chile (SQM) for special grant The role of lithium in human health and disease to WC.	AIZENMAN E, 1995, NEUROSCI LETT, V189, P57, DOI 10.1016/0304-3940(95)11442-Y; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Basen-Engquist K, 2001, HEALTH EDUC BEHAV, V28, P166, DOI 10.1177/109019810102800204; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Cahill-Smith S, 2014, BRIT J CLIN PHARMACO, V78, P441, DOI 10.1111/bcp.12357; Cardoso S, 2017, EXPERT REV NEUROTHER, V17, P77, DOI 10.1080/14737175.2016.1205488; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Carty NC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.63; Carvajal FJ, 2018, BBA-MOL BASIS DIS, V1864, P2010, DOI 10.1016/j.bbadis.2018.03.019; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Carvajal FJ, 2013, J ALZHEIMERS DIS, V36, P99, DOI 10.3233/JAD-130230; Cases S, 2018, MOL CELL NEUROSCI, V86, P41, DOI 10.1016/j.mcn.2017.11.003; Castonguay D, 2018, CURR BIOL, V28, P1079, DOI 10.1016/j.cub.2018.02.047; Cenini G, 2016, CURR ALZHEIMER RES, V13, P164, DOI 10.2174/1567205012666150921103213; Cerpa W, 2015, P NATL ACAD SCI USA, V112, P4797, DOI 10.1073/pnas.1417053112; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; Deb I, 2011, J NEUROCHEM, V116, P1097, DOI 10.1111/j.1471-4159.2010.07165.x; DeWalt GJ, 2018, NEUROSCI LETT, V664, P160, DOI 10.1016/j.neulet.2017.11.016; Dosemeci A, 2006, BIOCHEM BIOPH RES CO, V339, P687, DOI 10.1016/j.bbrc.2005.11.069; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Fan J, 2012, NEUROBIOL DIS, V45, P999, DOI 10.1016/j.nbd.2011.12.019; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ghosh N, 2011, FREE RADICAL RES, V45, P888, DOI 10.3109/10715762.2011.574290; Gladding CM, 2012, HUM MOL GENET, V21, P3739, DOI 10.1093/hmg/dds154; Gladding CM, 2011, MOL CELL NEUROSCI, V48, P308, DOI 10.1016/j.mcn.2011.05.001; Goebel SM, 2005, MOL BRAIN RES, V142, P65, DOI 10.1016/j.molbrainres.2005.09.012; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Huang YH, 2008, J BIOL CHEM, V283, P2751, DOI 10.1074/jbc.M706578200; Inata Y, 2018, FASEB J, V32, P728, DOI 10.1096/fj.201700576R; Inestrosa NC, 2013, J ALZHEIMERS DIS, V33, P941, DOI 10.3233/JAD-2012-120397; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jang SS, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0148-4; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan Barry D, 2014, Continuum (Minneap Minn), V20, P1588, DOI 10.1212/01.CON.0000458972.94013.e1; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Li R, 2014, J NEUROCHEM, V128, P315, DOI 10.1111/jnc.12463; Lira M, 2021, BIOL RES, V54, DOI 10.1186/s40659-021-00329-3; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meyer DA, 2014, J NEUROSCI, V34, P8259, DOI 10.1523/JNEUROSCI.4368-13.2014; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mira RG, 2021, CELL MOL NEUROBIOL, V41, P1413, DOI 10.1007/s10571-020-00924-0; Mira RG, 2020, BIOCHEM BIOPH RES CO, V528, P514, DOI 10.1016/j.bbrc.2020.05.160; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Patel R, 2016, BRAIN RES, V1639, P174, DOI 10.1016/j.brainres.2016.02.046; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paula-Lima AC, 2014, ANTIOXID REDOX SIGN, V21, P892, DOI 10.1089/ars.2013.5796; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Saavedra A, 2019, MOL NEUROBIOL, V56, P1475, DOI 10.1007/s12035-018-1170-1; Schumann J, 2009, J NEUROCHEM, V108, P697, DOI 10.1111/j.1471-4159.2008.05794.x; Serrano FG, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-61; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Tassin TC, 2015, J BIOL CHEM, V290, P16319, DOI 10.1074/jbc.M115.654897; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wolf MS, 2019, NEUROBIOL DIS, V122, P9, DOI 10.1016/j.nbd.2018.04.018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu F, 2006, BRAIN RES, V1121, P22, DOI 10.1016/j.brainres.2006.08.129; Xu J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001923; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yousuf MA, 2016, J NEUROCHEM, V138, P317, DOI 10.1111/jnc.13620; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013	105	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	OCT	2021	10	10							1575	10.3390/antiox10101575			23	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	WO0HX	WOS:000712145400001	34679709	gold, Green Published			2022-02-06	
J	Chen, B; Shi, QX; Nie, C; Zhao, ZP; Luo, L; Zhao, QJ; Si, SY; Xu, BX; Wang, T; Gao, LY; Gu, JW				Chen, Bing; Shi, Quan-xing; Nie, Chuang; Zhao, Zhi-ping; Luo, Ling; Zhao, Quan-jun; Si, Shao-yan; Xu, Bing-xin; Wang, Tao; Gao, Ling-yu; Gu, Jian-wen			Establishment and Evaluation of a Novel High-Efficiency Model of Graded Traumatic Brain Injury in Mice	WORLD NEUROSURGERY			English	Article						Injury severity; Mice model; Neurologic impairment; Traumatic brain injury	RAT MODEL; DEFICITS	BACKGROUND: Although previous studies have made significant contributions to establishing animal traumatic brain injury (TBI) models for simulation of human TBI, the accuracy, controllability, and modeling efficiency of animal TBI models need to be further improved. This study established a novel high-efficiency graded mouse TBI model induced by shock wave. METHODS: A total of 125 mice were randomly divided into sham, 0.7 mm, 0.6 mm, and 0.5 mm groups according to the depth of the cross groove of the aluminum sheets. The stability and repeatability of apparatus were evaluated, and the integrity of the blood-brain barrier, cerebral edema, neuropathologic immunohistochemistry, apoptosis-related protein, and behavioral tests of neurologic function were used to validate this new model. RESULTS: The results showed that 4 mice were injured simultaneously in 1 experiment. They received the same intensity of shock waves. Moreover, the mortality rates caused by 3 different aluminum sheets were consistent with the mortality rates of mild TBI, moderate TBI, and severe TBI. Compared with the sham group, mice in different injured groups significantly increased brain water content, blood-brain barrier permeability, and neuronal apoptosis. And the mice in all injured groups showed poor motor ability, balancing, spatial learning, and memory abilities. CONCLUSIONS: The novel TBI apparatus has advantages in its small size, simple operation, high repeatability, high efficiency, and graded severity. Our TBI apparatus provides a novel tool to investigate the neuropathologic changes and underlying mechanisms of TBI with various levels of severities.	[Chen, Bing] Univ Chinese Acad Sci, Savaid Med Coll, Beijing, Peoples R China; [Shi, Quan-xing; Nie, Chuang; Luo, Ling; Zhao, Quan-jun; Si, Shao-yan; Xu, Bing-xin; Wang, Tao; Gu, Jian-wen] Peoples Liberat Army Strateg Support Force Med Ct, Beijing, Peoples R China; [Zhao, Zhi-ping] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Gao, Ling-yu] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China		Gu, JW (corresponding author), Peoples Liberat Army Strateg Support Force Med Ct, Beijing, Peoples R China.	gujianwen196606@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31770386]; Scientific Research Projects of Strategic Support Force Characteristic Medical Center in 2019 [19ZX26, 19ZX11]	This work was funded by the National Natural Science Foundation of China (31770386) and Scientific Research Projects of Strategic Support Force Characteristic Medical Center in 2019 (19ZX26, 19ZX11) .	Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Chollat C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00407; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hayman E, 2018, J NEUROTRAUM, V35, P2136, DOI 10.1089/neu.2017.5435; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Lu C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070853; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Ma Y, 2014, NEUROCHEM RES, V39, P1809, DOI 10.1007/s11064-014-1395-y; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Phipps HW, 2016, METHODS MOL BIOL, V1462, P61, DOI 10.1007/978-1-4939-3816-2_5; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Shi QX, 2020, BRAIN RES BULL, V157, P149, DOI 10.1016/j.brainresbull.2020.02.002; Tao LY, 2019, AM J TRANSL RES, V11, P1510; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Toklu HZ, 2018, BEHAV BRAIN RES, V340, P14, DOI 10.1016/j.bbr.2017.04.025; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wang C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31141-x; Wang H, 2018, NEUROPATHOLOGY, V38, P484, DOI 10.1111/neup.12509; Wang HX, 2016, J NEUROPATH EXP NEUR, V75, P183, DOI 10.1093/jnen/nlv019; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Zhang JH, 2018, EXP THER MED, V16, P93, DOI 10.3892/etm.2018.6146; Zhao RG, 2019, EXP THER MED, V18, P3397, DOI 10.3892/etm.2019.7939; Zhou Y, 2018, CHINESE MED J-PEKING, V131, P2447, DOI 10.4103/0366-6999.243558	31	0	0	6	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2021	154						E7	E18		10.1016/j.wneu.2021.05.012			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WK0KL	WOS:000709423800003	33992827				2022-02-06	
J	Chen, YH; Chen, YC; Hwang, LL; Yang, LY; Lu, DY				Chen, Yu-Hsin; Chen, Yen-Chou; Hwang, Ling-Ling; Yang, Liang-Yo; Lu, Dah-Yuu			Deficiency in Androgen Receptor Aggravates Traumatic Brain Injury-Induced Pathophysiology and Motor Deficits in Mice	MOLECULES			English	Article						traumatic brain injury; controlled cortical impact; androgen receptor; ARKO mice; motor activity	ALPHA-II-SPECTRIN; CONTROLLED CORTICAL IMPACT; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; RAT MODEL; SIGNALING PATHWAY; PROTECTIVE ROLE; CELL-DEATH; BECLIN 1; AUTOPHAGY	Androgens have been shown to have a beneficial effect on brain injury and lower reactive astrocyte expression after TBI. Androgen receptors (ARs) are known to mediate the neuroprotective effects of androgens. However, whether ARs play a crucial role in TBI remains unknown. In this study, we investigated the role of ARs in TBI pathophysiology, using AR knockout (ARKO) mice. We used the controlled cortical impact model to produce primary and mechanical brain injuries and assessed motor function and brain-lesion volume. In addition, the AR knockout effects on necrosis and autophagy were evaluated after TBI. AR knockout significantly increased TBI-induced expression of the necrosis marker alpha-II-spectrin breakdown product 150 and astrogliosis marker glial fibrillary acidic protein. In addition, the TBI-induced astrogliosis increase in ARKO mice lasted for three weeks after a TBI. The autophagy marker Beclin-1 was also enhanced in ARKO mice compared with wild-type mice after TBI. Our results also indicated that ARKO mice showed a more unsatisfactory performance than wild-type mice in a motor function test following TBI. Further, they were observed to have more severe lesions than wild-type mice after injury. These findings strongly suggest that ARs play a role in TBI.	[Chen, Yu-Hsin; Chen, Yen-Chou; Hwang, Ling-Ling] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan; [Yang, Liang-Yo] China Med Univ, Coll Med, Sch Med, Dept Physiol, Taichung 40402, Taiwan; [Yang, Liang-Yo] China Med Univ Hosp, Dept Med Res, Lab Neural Repair, Taichung 40447, Taiwan; [Lu, Dah-Yuu] China Med Univ, Sch Med, Dept Pharmacol, Taichung 404333, Taiwan; [Lu, Dah-Yuu] Asia Univ, Dept Photon & Commun Engn, Taichung 404333, Taiwan		Yang, LY (corresponding author), China Med Univ, Coll Med, Sch Med, Dept Physiol, Taichung 40402, Taiwan.; Yang, LY (corresponding author), China Med Univ Hosp, Dept Med Res, Lab Neural Repair, Taichung 40447, Taiwan.; Lu, DY (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, Taichung 404333, Taiwan.; Lu, DY (corresponding author), Asia Univ, Dept Photon & Commun Engn, Taichung 404333, Taiwan.	amytokimo@hotmail.com; yc3270@tmu.edu.tw; llhwang@tmu.edu.tw; yangly@cmu.edu.tw; dahyuu@mail.cmu.edu.tw		Lu, Dah-Yuu/0000-0002-4463-5919	National Science CouncilMinistry of Science and Technology, Taiwan; Ministry of Science and Technology [NSC 102-2314-B-038-024, NSC 103-2314-B-038-038, MOST 104-2314B-039-058]; China Medical University Hospital [DMR109-65, DMR109-68]	This study was supported by the grants from the National Science Council and Ministry of Science and Technology (NSC 102-2314-B-038-024, NSC 103-2314-B-038-038 and MOST 104-2314B-039-058), was supported in part by grants from China Medical University Hospital (DMR109-65 and DMR109-68).	Abou-El-Hassan H, 2017, METHODS MOL BIOL, V1598, P65, DOI 10.1007/978-1-4939-6952-4_4; Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Balduini W, 2009, AUTOPHAGY, V5, P221, DOI 10.4161/auto.5.2.7363; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Bekker M, 2021, NEUROBIOL AGING, V100, P91, DOI 10.1016/j.neurobiolaging.2020.12.013; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Bianchi VE, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa120; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Brattas PL, 2021, AUTOPHAGY, V17, P1316, DOI 10.1080/15548627.2020.1760014; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Bsat S, 2021, J INTEGR NEUROSCI, V20, P489, DOI 10.31083/j.jin2002052; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cardali S, 2006, J Neurosurg Sci, V50, P25; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Ceccariglia S, 2020, AUTOPHAGY, V16, P28, DOI 10.1080/15548627.2019.1630223; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DeDominicis KE, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00490; Delgado RE, 2018, MIL MED, V183, P379, DOI 10.1093/milmed/usx156; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Frye CA, 2008, NEUROPSYCHOPHARMACOL, V33, P1049, DOI 10.1038/sj.npp.1301498; Ganau Mario, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010019; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gibson DA, 2018, MOL CELL ENDOCRINOL, V465, P1, DOI 10.1016/j.mce.2018.02.013; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Hartman RE, 2016, ACTA NEUROCHIR SUPPL, V121, P71, DOI 10.1007/978-3-319-18497-5_12; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Huo DS, 2016, J TOXICOL ENV HEAL A, V79, P856, DOI 10.1080/15287394.2016.1193114; Huppenbauer CB, 2005, J NEUROSCI, V25, P4004, DOI 10.1523/JNEUROSCI.5279-04.2005; Hussain R, 2013, BRAIN, V136, P132, DOI 10.1093/brain/aws284; Izzo G, 2016, INT J SURG, V28, pS103, DOI 10.1016/j.ijsu.2015.05.056; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Jones KJ, 1999, J NEUROBIOL, V40, P560, DOI 10.1002/(SICI)1097-4695(19990915)40:4<560::AID-NEU11>3.0.CO;2-I; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Korley F, 2021, J NEUROTRAUM, V38, P1953, DOI 10.1089/neu.2020.7072; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liu X, 2018, REJUV RES, V21, P405, DOI 10.1089/rej.2017.1999; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Mehta Tejas, 2020, Open Access J Neurol Neurosurg, V12, P86; Mhaouty-Kodja S, 2018, MOL CELL ENDOCRINOL, V465, P103, DOI 10.1016/j.mce.2017.08.001; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Ortiz-Rodriguez A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072479; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Raghu VK, 2021, PEDIATR CRIT CARE ME, V22, P906, DOI 10.1097/PCC.0000000000002776; Rana K, 2014, ASIAN J ANDROL, V16, P169, DOI 10.4103/1008-682X.122590; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shu XD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1813-9; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Swift-Gallant A, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12578; Toman E, 2016, J ROY ARMY MED CORPS, V162, P103, DOI 10.1136/jramc-2015-000517; Tran M, 2021, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.612757; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang CQ, 2017, NEUROSCIENCE, V343, P30, DOI 10.1016/j.neuroscience.2016.11.029; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang YB, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122698; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168; Xiao L, 2002, HORM BEHAV, V42, P327, DOI 10.1006/hbeh.2002.1822; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Young WJ, 1998, ENDOCRINE, V9, P79, DOI 10.1385/ENDO:9:1:79; Zhang Y, 2004, J NEUROSCI, V24, P5315, DOI 10.1523/JNEUROSCI.0913-04.2004; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	94	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1420-3049		MOLECULES	Molecules	OCT	2021	26	20							6250	10.3390/molecules26206250			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	WS3KA	WOS:000715082700001	34684832	Green Published, gold			2022-02-06	
J	Chilton, G; Vaudreuil, R; Freeman, EK; McLaughlan, N; Herman, J; Cozza, SJ				Chilton, Gioia; Vaudreuil, Rebecca; Freeman, Elizabeth K.; McLaughlan, Nathaniel; Herman, Jessica; Cozza, Stephen J.			Creative Forces programming with military families: Art therapy, dance/movement therapy, and music therapy brief vignettes	JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH			English	Article						art therapy; child and family therapy; creative arts therapies; Creative Forces; United States National Endowment for the Arts Military Healing Arts Network; dance; movement therapy; military families; music therapy; posttraumatic stress disorder; PTSD; TBI; traumatic brain injury; U; S	POSTTRAUMATIC-STRESS; SERVICE MEMBERS; CHILDREN; IMPACT; DEPLOYMENT	LAY SUMMARY Creative arts therapists (art therapists, dance/movement therapists, and music therapists) administer assessments and interventions that support the holistic well-being of military families affected by traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). Through participation in the Creative Forces: United States National Endowment for the Arts Military Healing Arts Network, military families discovered strengths, inspired connections, and improved understanding of their relationships. Creative arts therapies (CATs) motivated engagement, which ultimately boosted family resilience. CATs are an integral part of interdisciplinary care to address behavioural and rehabilitative conditions of military families impacted by TBI and PTSD. Future research should examine the efficacy of creative arts therapies in improving resilience in military families. Creative arts therapists (art therapists, dance/movement therapists, and music therapists) administer assessments and interventions that support the holistic well-being of military families affected by traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). Clinical examples illustrate methods used by creative arts therapists to address the neurological, physiological, and psychosocial needs of service members and their families. Creative arts therapists describe areas of need, identify common goals, and present creative arts therapy interventions used with military families. Three vignettes detail the application of creative arts therapy interventions with families, couples, and parent/child dyads. Art therapy, dance/movement therapy, and music therapy interventions were applied in discipline-specific sessions to promote familial bonding. As a result of these sessions, families were better able to identify challenges and discover strengths, improve intra-familial interactions, and create deeper mutual understanding and connectedness, all of which strengthened family resilience and encouraged motivation in other areas of rehabilitation. Creative arts therapies are an integral part of interdisciplinary care to address behavioural and rehabilitative conditions of military families impacted by TBI and PTSD. Future research should examine the efficacy of creative arts therapies in improving resilience in military families.	[Chilton, Gioia] Intrepid Spirit Ctr, Ft Belvoir Partnership Creat Forces Natl Endowmen, Ft Belvoir, VA USA; [Vaudreuil, Rebecca; Freeman, Elizabeth K.; McLaughlan, Nathaniel] Henry M Jackson Fdn Adv Mil Med Inc, Support Creat Forces Natl Endowment Arts Mil Heal, Bethesda, MD USA; [Herman, Jessica] Henry M Jackson Fdn Adv Mil Med Inc, Support Creat Forces Natl Endowment Arts Mil Heal, Ft Belvoir, VA USA; [Cozza, Stephen J.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA		Chilton, G (corresponding author), Ft Belvoir Community Hosp, Intrepid Spirit Ctr, 5980 9th St, Ft Belvoir, VA 22060 USA.	gioia.c.chilton.civ@mail.mil					American Music Therapy Association, 2014, MUS THER MIL POP; Amighi JK., 1999, MEANING MOVEMENT; Bradt J, 2019, ART PSYCHOTHER, V62, P19, DOI 10.1016/j.aip.2018.11.004; Bronson H, 2018, MUSIC THER PERSPECT, V36, P195, DOI 10.1093/mtp/miy006; Bruscia K. E., 1987, IMPROVISATIONAL MODE; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Campbell M, 2016, ART THER, V33, P169, DOI 10.1080/07421656.2016.1226643; Cozza SJ., 2018, BATTLE PLAN SUPPORTI, P265; Creech SK, 2014, PROF PSYCHOL-RES PR, V45, P452, DOI 10.1037/a0035055; Fairbank JA, 2018, J DEV BEHAV PEDIATR, V39, P683, DOI 10.1097/DBP.0000000000000606; Fraser K, 2017, OCCUP THER MENT HEAL, V33, P199, DOI 10.1080/0164212X.2016.1265475; Friedlander ML, 2018, PSYCHOTHERAPY, V55, P356, DOI 10.1037/pst0000161; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gottman JM, 2011, AM PSYCHOL, V66, P52, DOI 10.1037/a0021706; Gray AE., 2017, WHAT DO CHILDREN THE, P102; Gray AE., 2015, CREATIVE INTERVENTIO, P169; Hass-Cohen N., 2016, ART THERAPY TRAUMA N, P100; Herman J., 2021, ANIMAL STRENGT UNPUB; Hibben J., 1992, MUSIC THER, V11, P28, DOI [10.1093/mt/11.1.28, DOI 10.1093/MT/11.1.28]; Howie P., 2017, ART THERAPY MILITARY, P53; Kaimal, 2018, INT J ART THERAPY, V23, P70, DOI [10.1080/17454832.2017.1388263, DOI 10.1080/17454832.2017.1388263]; Kaimal G, 2019, ART PSYCHOTHER, V62, P28, DOI 10.1016/j.aip.2018.10.003; Kerr C, 2008, FAM THER COUNSEL, P1; King JL, 2019, ART THER, V36, P149, DOI 10.1080/07421656.2019.1649549; King N, 2016, NURS EDUC TODAY, V47, P29, DOI 10.1016/j.nedt.2016.04.018; Lacson FC, 2020, BODY MOV DANCE PSYCH, V15, P4, DOI 10.1080/17432979.2019.1699859; Levy FJ., 2005, DANCE MOVEMENT THERA, V2nd rev.; Lowe KN, 2012, J FAM STUD, V18, P17, DOI 10.5172/jfs.2012.2003; National Academies of Sciences Engineering and Medicine, 2019, STRENGTH MIL FAM REA; Potash JS, 2020, ART THER, V37, P105, DOI 10.1080/07421656.2020.1754047; Ridder HM., 2016, MUSIC THERAPY FAMILI; Sobol B., 2013, USING ART THERAPY DI, P245; Spooner H, 2019, ART PSYCHOTHER, V62, P12, DOI 10.1016/j.aip.2018.11.012; Suozzi J.M., 2004, TRAUMATOLOGY, V10, P17, DOI [DOI 10.1177/153476560401000103, 10.1177/153476560401000103]; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Thaut MH., 1989, MUSIC THER PERSP, V7, P55, DOI [10.1093/mtp/7.1.55, DOI 10.1093/MTP/7.1.55]; Vaudreuil R, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00119; Vaudreuil R, 2019, DISABIL REHABIL, V41, P2333, DOI 10.1080/09638288.2018.1462412; Walker M.S., 2018, INT J ART THERAPY, V23, P180, DOI [10.1080/17454832.2018.1473453, DOI 10.1080/17454832.2018.1473453]; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317	40	0	0	0	0	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA		2368-7924		J MIL VETERAN FAM HL	J. Mil. Veteran Fam. Hlth.	OCT 1	2021	7	3					104	113		10.3138/jmvfh-2021-0031			10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	XQ1BX	WOS:000731289600013					2022-02-06	
J	Cong, PF; Wang, T; Tong, CC; Liu, Y; Shi, L; Mao, S; Shi, XY; Jin, HX; Liu, YN; Hou, MX				Cong, Peifang; Wang, Teng; Tong, Changci; Liu, Ying; Shi, Lin; Mao, Shun; Shi, Xiuyun; Jin, Hongxu; Liu, Yunen; Hou, Mingxiao			Resveratrol ameliorates thoracic blast exposure-induced inflammation, endoplasmic reticulum stress and apoptosis in the brain through the Nrf2/Keap1 and NF-kappa B signaling pathway	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Blast thoracic exposure; Brain injury; Resveratrol; ER stress; Nrf2/Keap1 signaling pathway	UNFOLDED PROTEIN RESPONSE; IMPAIRED AUTOPHAGY; INJURY; CELL; MITOCHONDRIAL; HOMEOSTASIS; INHIBITION; ACTIVATION	Blast injuries include the various types of internal and external trauma caused by the impact force of high-speed blast waves with multiple mechanisms involved. Thoracic blast exposure could induce neurotrauma as well, but effective therapies are lacking. Resveratrol is a polyphenol flavonoid secreted by plants and has been shown to provide cardiovascular protection and play anti-inflammatory, antioxidation and anti-cancer roles. However, the effects of resveratrol on thoracic blast exposure-induced brain injury have not been investigated. To explore this, a mouse model of thoracic blast exposureinduced brain injury was established. Sixty C57BL/6 wild type mice were randomly divided equally into four groups (one control group, one model group, and model groups with 25 or 50 mg/kg resveratrol injected intraperitoneally). As traumatic brain injury often accompanied by mental symptoms, cognitive dysfunction and anxious behavior were evaluated by Y maze, elevated plus maze and open field test. We also examined the mice for histopathological changes by hematoxylin-eosin staining; the expressions of inflammatory-related factors by ELISA; endoplasmic reticulum stress in brain tissue via the generation of reactive oxygen species (ROS) and the expressions of inositol-requiring enzyme-alpha (IRE-alpha) and C/EBP homologous protein (CHOP); apoptosis by measuring levels of Bax, p53 and Bcl-2. In addition, proteins of related pathways were also studied by western blotting. We found that resveratrol significantly reduced the levels of inflammatory-related factors, including interleukin (IL)-1 beta, IL-4, and high mobility group box protein 1(HMGB1), and increased the level of anti-inflammatory-related factor, IL-10, under thoracic blast exposure (P < 0.05). Cognitive dysfunction and anxious behavior were also ameliorated by resveratrol. In brain tissue, resveratrol significantly attenuated thoracic blast exposure-induced generation of ROS and expressions of IRE-alpha and CHOP, lowered the expressions of Bax and p53, and maintained Bcl-2 expression (P < 0.05). Additionally, resveratrol significantly ameliorated thoracic blast exposure-induced increases of Kelch-like ECH-associated protein 1 (Keap1) and nuclear factor (NF)-kappa B and the decrease in nuclear factor erythroid 2-related factor 2(Nrf2) expression in the brain (P < 0.05). Our results indicate that resveratrol has a protective effect on thoracic blast exposure-induced brain injury that is likely mediated through the Nrf2/Keap1 and NF-kappa B signaling pathways. (C) 2021 Elsevier Ltd. All rights reserved.	[Cong, Peifang; Hou, Mingxiao] Northeastern Univ, Coll Med & Biol Informat Engn, 195 Chuangxin Rd, Shenyang 110016, Liaoning, Peoples R China; [Liu, Yunen; Hou, Mingxiao] Shenyang Med Coll, 146 Huanghe North St, Shenyang 110034, Liaoning, Peoples R China; [Hou, Mingxiao] Vet Gen Hosp Liaoning Prov, Affiliated Hosp 2, Shenyang Med Coll, 20 Beijiu Rd, Shenyang 110001, Liaoning, Peoples R China; [Wang, Teng] Jining 1 Peoples Hosp Shandong Prov, 6 Jiankang Rd, Jining 272011, Shandong, Peoples R China; [Tong, Changci; Liu, Ying; Shi, Lin; Mao, Shun; Shi, Xiuyun; Jin, Hongxu; Liu, Yunen] Gen Hosp Northern Theatre Command, Emergency Med Dept, Lab Rescue Ctr Severe Wound & Trauma PLA, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China		Hou, MX (corresponding author), Northeastern Univ, Coll Med & Biol Informat Engn, 195 Chuangxin Rd, Shenyang 110016, Liaoning, Peoples R China.; Hou, MX (corresponding author), Shenyang Med Coll, 146 Huanghe North St, Shenyang 110034, Liaoning, Peoples R China.; Hou, MX (corresponding author), Vet Gen Hosp Liaoning Prov, Affiliated Hosp 2, Shenyang Med Coll, 20 Beijiu Rd, Shenyang 110001, Liaoning, Peoples R China.	cszx_cpf@163.com; 19819090637@163.com; cszx_tcc@163.com; cszx_ly@163.com; cszx_sl@163.com; shunmore@163.com; cszx_sxy@163.com; cszx_jhx@163.com; cszx_lye@163.com; houmingxiao188@163.com		Tong, Changci/0000-0003-2999-7011	Science and Technology of Liaoning Province [2019010205]; PLA fundation of China [AWS14L008]	We would like to acknowledge funding support by the grants of Science and Technology of Liaoning Province (No.2019010205), and PLA fundation of China (No. AWS14L008). We also thank Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.	Ali I, 2017, J VET SCI, V18, P1, DOI 10.4142/jvs.2017.18.1.1; Amen OM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00977; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Bonsack F, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00228; Brewer JW, 2014, CELL MOL LIFE SCI, V71, P1067, DOI 10.1007/s00018-013-1490-2; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cong PF, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8460290; Connelly C, 2017, INJURY, V48, P64, DOI 10.1016/j.injury.2016.08.025; Dai YY, 2018, CHEM-BIOL INTERACT, V284, P32, DOI 10.1016/j.cbi.2018.02.017; de Lesquen H, 2016, INJURY, V47, P1939, DOI 10.1016/j.injury.2016.06.008; Domazetovic V, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.06.024; Dyck GJB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040904; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Flores-Santibanez F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121563; Folbergrova J, 2018, MOL NEUROBIOL, V55, P7512, DOI 10.1007/s12035-018-0924-0; Garcia-Gonzalez P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02541; Ghosh K, 2017, TOXICOL IN VITRO, V44, P330, DOI 10.1016/j.tiv.2017.07.025; He JQ, 2017, FASEB J, V31, P2893, DOI 10.1096/fj.201601353R; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hwang YJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03242; Inyang E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59888-2; Jiang T, 2014, KIDNEY INT, V85, P333, DOI 10.1038/ki.2013.343; Kerr NA, 2021, J NEUROTRAUM, V38, P646, DOI 10.1089/neu.2020.7257; Kovuru N, 2020, MITOCHONDRION, V50, P115, DOI 10.1016/j.mito.2019.10.009; Kubra KT, 2020, CELL SIGNAL, V73, DOI 10.1016/j.cellsig.2020.109699; Kumar S, 2021, CURR MED CHEM, V28, P3773, DOI 10.2174/0929867327999200918100746; Lang YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133215; Langer V, 2019, J CLIN INVEST, V129, P4691, DOI 10.1172/JCI124884; Li HG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092155; Liu YN, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4848560; Malaguarnera M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030188; Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003; Mohammed-Ali Z, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/428508; Pearce AP, 2017, INJURY, V48, P1900, DOI 10.1016/j.injury.2017.07.019; Gomes BAQ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8152373; Recalde MD, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147079; Ren XY, 2020, EXP CELL RES, V391, DOI 10.1016/j.yexcr.2020.111988; Sedy J, 2015, J NEUROTRAUM, V32, P1135, DOI 10.1089/neu.2014.3609; Shi ZH, 2018, MED SCI MONITOR, V24, P1097, DOI 10.12659/MSM.909042; Shih YT, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-017-0403-3; Sivandzade F, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.017; Strom J, 2016, FASEB J, V30, P66, DOI 10.1096/fj.14-268904; Thoudam T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1851420; Tong CC, 2018, EXP BIOL MED, V243, P934, DOI 10.1177/1535370218784539; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tsokos M, 2003, AM J RESP CRIT CARE, V168, P549, DOI 10.1164/rccm.200304-528OC; Wang WC, 2017, BIOL PHARM BULL, V40, P583, DOI 10.1248/bpb.b16-00756; Wu YL, 2018, FREE RADICAL BIO MED, V115, P309, DOI 10.1016/j.freeradbiomed.2017.12.011; Xiang Q, 2016, INJURY, V47, P1647, DOI 10.1016/j.injury.2016.06.006; Yang FL, 2012, INJURY, V43, P367, DOI 10.1016/j.injury.2011.11.013; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Zachari M, 2019, DEV CELL, V50, P627, DOI 10.1016/j.devcel.2019.06.016; Zhang Y, 2019, ANN NY ACAD SCI, V1457, P166, DOI 10.1111/nyas.14196; Zhao Y, 2018, ENVIRON POLLUT, V242, P1871, DOI 10.1016/j.envpol.2018.07.080; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	59	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2021	52	10					2795	2802		10.1016/j.injury.2021.08.019			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	WT4SO	WOS:000715855800020	34454721				2022-02-06	
J	Crocker, KL; Ahern-Djamali, S; Boekhoff-Falk, G				Crocker, Kassi L.; Ahern-Djamali, Shawn; Boekhoff-Falk, Grace			Stimulating and Analyzing Adult Neurogenesis in the Drosophila Central Brain	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							IMPACT	The molecular and cellular mechanisms underlying neurogenesis in response to disease or injury are not well understood. However, understanding these mechanisms is crucial for developing neural regenerative therapies. Drosophila melanogaster is a leading model for studies of neural development but historically has not been exploited to investigate adult brain regeneration. This is primarily because the adult brain exhibits very low mitotic activity. Nonetheless, penetrating traumatic brain injury (PTBI) to the adult Drosophila central brain triggers the generation of new neurons and new glia. The powerful genetic tools available in Drosophila combined with the simple but rigorous injury protocol described here now make adult Drosophila brain a robust model for neural regeneration research. Provided here are detailed instructions for (1) penetrating injuries to the adult central brain and (2) dissection, immunohistochemistry, and imaging post-injury. These protocols yield highly reproducible results and will facilitate additional studies to dissect mechanisms underlying neural regeneration.	[Crocker, Kassi L.; Boekhoff-Falk, Grace] Univ Wisconsin, Genet Grad Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Crocker, Kassi L.] Univ Wisconsin, Sci & Med Grad Res Scholars Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Crocker, Kassi L.; Ahern-Djamali, Shawn; Boekhoff-Falk, Grace] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA		Boekhoff-Falk, G (corresponding author), Univ Wisconsin, Genet Grad Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Boekhoff-Falk, G (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	grace.boekhoff@wisc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P40OD018537, T32 GM007133, NS090190, NS102698]; University of Wisconsin Graduate School; UW-Madison Women in Science and Engineering Leadership Institute (WISELI)	We are grateful to Stacey Rimkus and Becky Katzenberger for technical assistance and to Eduardo Moreno for sharing the perma-twin stocks. We would like to thank Barry Ganetzky and David Wassarman for lively discussions that undoubtedly improved science and Kent Mok, Cayla Guerra, and Bailey Spiegelberg for their contributions to the laboratory. The FasII antibodies were developed by Corey Goodman and obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. Most of the Drosophila strains used in this study were obtained from the Bloomington Drosophila Stock Center (BDSC; NIH P40OD018537). This work was supported by NIH T32 GM007133 (KLC); NIH NS090190 (GBF); NIH NS102698 (GBF); the University of Wisconsin Graduate School (GBF); and the UW-Madison Women in Science and Engineering Leadership Institute (WISELI) (GBF).	Arain U, 2021, JOVE-J VIS EXP, DOI 10.3791/61273; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bonini NM, 2017, GENETICS, V205, P1, DOI 10.1534/genetics.116.187864; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Brace EJ, 2017, EXP NEUROL, V287, P310, DOI 10.1016/j.expneurol.2016.03.014; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Crocker KL, 2021, GENETICS, V219, DOI 10.1093/genetics/iyab092; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; Hao Y, 2017, CURR OPIN GENET DEV, V44, P84, DOI 10.1016/j.gde.2017.01.009; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Kelly SM, 2017, JOVE-J VIS EXP, DOI 10.3791/56174; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Meinertzhagen IA, 2010, ACTA ZOOL-STOCKHOLM, V91, P64, DOI 10.1111/j.1463-6395.2009.00425.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Plavicki J, 2012, P NATL ACAD SCI USA, V109, P1578, DOI 10.1073/pnas.1016741109; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Thurman D., 1999, REP C TRAUM BRAIN IN; Tito AJ, 2016, JOVE-J VIS EXP, DOI 10.3791/55128; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9	21	0	0	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	OCT	2021		176							e63182	10.3791/63182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WS2ZG	WOS:000715054700017	34694294	Bronze			2022-02-06	
J	Cuenca, CM; Clarke, EE; Dengler, BA; Borgman, MA; Schauer, SG				Cuenca, Camaren M.; Clarke, Emily E.; Dengler, Bradley A.; Borgman, Matthew A.; Schauer, Steven G.			An Analysis of Intracranial Hemorrhage in Wartime Pediatric Casualties	WORLD NEUROSURGERY			English	Article						Hemorrhage; Intracranial; Military; Pediatric; Trauma	TRAUMATIC BRAIN-INJURY; MILITARY; IRAQ; AFGHANISTAN; CHILDREN; TBI	BACKGROUND: Children make up a significant cohort of patients treated at combat support hospitals. Where traumatic head injury, including intracranial hemorrhage (ICH), is well studied in military adults, such research is lacking regarding pediatric patients. We seek to describe the incidence and outcomes of ICH within this population. METHODS: This is a secondary analysis of a previously published dataset from the Department of Defense Trauma Registry for all pediatric casualties in Iraq and Afghanistan from January 2007 to January 2016. Within our dataset, we searched for casualties with an ICH. RESULTS: Of the 3439 pediatric encounters in our data set, we identified 495 (14%) casualties that had at least 1 type of ICH. Most were between 5 and 12 years of age, male (74%), and injured by an explosive (42%). Of the casualties with ICHs, 82 had epidural (16.6%), 237 had subdural (47.9%), 153 had subarachnoid (30.9%), 157 had parenchymal bleeds (31.7%), and 239 had ICHs not otherwise specified (48.3%). In the hospital setting, the epidural group was more frequently treated with skull decompression (41%) and craniotomy with skull elevation (28%). The subdural group was more frequently treated with a cra iectomy (17%) and the parenchymal group had more frequent intracranial pressure monitoring (18%). In our dataset, 22 received ketamine prehospital (4.4%) and most were discharged alive from the hospital (79%). CONCLUSIONS: Within our dataset, we identified 495 cases of ICH in pediatric patients. Most survived to hospital discharge despite less than half undergoing a decompression procedure.	[Cuenca, Camaren M.; Schauer, Steven G.] US Army Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA; [Borgman, Matthew A.; Schauer, Steven G.] Brooke Army Med Ctr, Jbsa Ft Sam Houston, TX USA; [Cuenca, Camaren M.; Clarke, Emily E.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Dengler, Bradley A.] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Borgman, Matthew A.; Schauer, Steven G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Cuenca, CM (corresponding author), US Army Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA.; Cuenca, CM (corresponding author), Univ Notre Dame, Notre Dame, IN 46556 USA.	camarencuenca1@gmail.com		Cuenca, Camaren/0000-0002-2528-4148; Clarke, Emily/0000-0001-5615-2845			Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Arul GS, 2012, ANN ROY COLL SURG, V94, P52, DOI 10.1308/003588412X13171221499027; BAJEC J, 1993, INJURY, V24, P517, DOI 10.1016/0020-1383(93)90026-3; Beitler AL, 2006, MIL MED, V171, P189, DOI 10.7205/MILMED.171.3.189; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Caceres JA, 2012, EMERG MED CLIN N AM, V30, P771, DOI 10.1016/j.emc.2012.06.003; Er E, 2017, AM J EMERG MED, V35, P82, DOI 10.1016/j.ajem.2016.10.008; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Faul M, 2010, TRAUMATIC BRAIN INJU; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hargrave JM, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000452; Heit JJ, 2017, J STROKE, V19, P11, DOI 10.5853/jos.2016.00563; Heltemes KJ, 2011, MIL MED, V176, P132, DOI 10.7205/MILMED-D-09-00238; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maddry JK, 2019, MIL MED, V185; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Pannell Dylan, 2015, Can J Surg, V58, pS141; Robinson John B, 2016, US Army Med Dep J, P87; Schauer Stephen G, 2017, US Army Med Dep J, P92; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P608, DOI 10.1080/10903127.2018.1428839; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P624, DOI 10.1080/10903127.2018.1439130; Schauer SG, 2018, AM J EMERG MED, V36, P1540, DOI 10.1016/j.ajem.2018.01.014; Schauer SG, 2019, AM J EMERG MED, V37, P94, DOI 10.1016/j.ajem.2018.04.068; Sharma RK, 2010, INDIAN J PLAST SURG, V43, pS43, DOI 10.4103/0970-0358.70719; Smith Erik B, 2019, Anesthesiol Clin, V37, P119, DOI 10.1016/j.anclin.2018.10.002; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Talbott JF, 2014, AM J NEURORADIOL, V35, P1930, DOI 10.3174/ajnr.A4001; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Walker PF, 2020, BMC EMERG MED, V20, DOI 10.1186/s12873-020-00335-w; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	33	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2021	154						E729	E733		10.1016/j.wneu.2021.07.128			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WD5UC	WOS:000705004300028	34343690				2022-02-06	
J	Demirci, H; Kuzucu, P; Seymen, CM; Gulbahar, O; Ozisik, P; Emmez, H				Demirci, Harun; Kuzucu, Pelin; Seymen, Cemile Merve; Gulbahar, Ozlem; Ozisik, Pinar; Emmez, Hakan			The effect of antiepileptic drugs on re-myelinization of axons: Phenytoin, levetiracetam, carbamazepine, and valproic acid, used following traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Neurotrauma; Antiepileptics; Traumatic brain injury	NG2 PROTEOGLYCAN; EPIDEMIOLOGY; CELLS	Objective: Traumatic brain injury is a major health and socioeconomic problem and the first cause of young death worldwide. For this reason, the prevention of post-traumatic brain injury and the research of new methods for it are important today. In this study, we aimed to determine whether the use of antiepileptic drugs contributed to axonal healing after traumatic brain injury. Methods: Thirty-six Long-Evans rats, each weighing 300-350 g, were used in this study. A total of 6 groups, including the sham, control, and 4 study groups, were determined. A 1.5 mm-sized trauma was created in the biparietal area with a blunt-tipped dissector. Carbamazepine phenytoin valproic acid and levetiracetam (phenytoin: 30 mg/kg, valproic acid: 60 mg/kg, levetiracetam: 80 mg/kg, and carbamazepine: 36 mg/kg) were intraperitoneally administered to the study groups, and the control group intraperitoneally received a physiological saline solution (15 ml/kg) twice daily for 3 days. After 72 h, hemispheres of the sacrificed subjects were taken for examination in biochemistry and histology. Glutathione, malondialdehyde, and NG2 levels in the samples were determined. Results: No significant difference was found in biochemical measurements. Histopathological examination revealed that the NG2 expression was more intense in the group treated with phenytoin and levetiracetam (phenytoin was partly higher) and the amount of edema decreased. The NG2 expression increased and the edema decreased, though lower in the group treated with carbamazepine and valproic acid, compared with phenytoin and levetiracetam. An increase in the NG2 expression and edema intensity were determined in the control and sham groups. Conclusion: Antiepileptic drug selection after traumatic brain injury is an important medical matter. Although the patient-oriented selection is essential, the study suggests that the choice of phenytoin, levetiracetam carbamazepine, and valproic acid will, respectively, have an accelerating effect for axonal healing.	[Demirci, Harun; Ozisik, Pinar] Ankara Yildirim Beyazit Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Kuzucu, Pelin] Univ Hlth Sci, Gulhane Fac Med, Dept Neurosurg, Gen Dr Tevfik Saglam Cd 1, TR-06300 Ankara, Turkey; [Seymen, Cemile Merve] Gazi Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey; [Gulbahar, Ozlem] Gazi Univ, Fac Med, Dept Clin Biochem, Ankara, Turkey; [Emmez, Hakan] Gazi Univ, Fac Med, Dept Neurosurg, Ankara, Turkey		Kuzucu, P (corresponding author), Univ Hlth Sci, Gulhane Fac Med, Dept Neurosurg, Gen Dr Tevfik Saglam Cd 1, TR-06300 Ankara, Turkey.	drharundemirci@gmail.com; drpelinkuzucu@gmail.com; cmerveseymen@gmail.com; ozengin@edu.tr; pinar.akdemir.oz@gmail.com; hakanemmez@gmail.com					Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Borowicz Kinga K, 2011, Front Endocrinol (Lausanne), V2, P50, DOI 10.3389/fendo.2011.00050; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Grewal AK, 2013, KOREAN J PHYSIOL PHA, V17, P485, DOI 10.4196/kjpp.2013.17.6.485; Kaptanoglu E, 2005, ACTA NEUROCHIR, V147, P405, DOI 10.1007/s00701-004-0447-5; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Miyazaki I, 2016, J NEUROCHEM, V136, P194, DOI 10.1111/jnc.13405; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rosenberg SS, 2007, CELL MOL LIFE SCI, V64, P3059, DOI 10.1007/s00018-007-7265-x; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Suda S, 2013, EUR J PHARMACOL, V707, P26, DOI 10.1016/j.ejphar.2013.03.020; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029	20	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2021	209								106911	10.1016/j.clineuro.2021.106911			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WD4TM	WOS:000704935100025	34509750				2022-02-06	
J	Farraj, Y; Buxboim, A; Cohen, JE; Kan-Tor, Y; Hagege, SG; Weiss, D; Goldman, V; Beatus, T				Farraj, Yousef; Buxboim, Amnon; Cohen, Jose E.; Kan-Tor, Yoav; Hagege, Shira glasner; Weiss, D. O. R.; Goldman, Vladimir; Beatus, Tsevi			Measuring pupil size and light response through closed eyelids	BIOMEDICAL OPTICS EXPRESS			English	Article							GLASGOW COMA SCALE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; DILATED PUPILS; PROGNOSIS; HEMATOMA; CRANIOTOMY; PREDICTION; REACTIVITY; SCORE	Monitoring pupillary size and light-reactivity is a key component of the neurologic assessment in comatose patients after stroke or brain trauma. Currently, pupillary evaluation is performed manually at a frequency often too low to ensure timely alert for irreversible brain damage. We present a novel method for monitoring pupillary size and reactivity through closed eyelids. Our method is based on side illuminating in near-IR through the temple and imaging through the closed eyelid. Successfully tested in a clinical trial, this technology can be implemented as an automated device for continuous pupillary monitoring, which may save staff resources and provide earlier alert to potential brain damage in comatose patients. (c) 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Farraj, Yousef] Hebrew Univ Jerusalem, Inst Chem, Casali Ctr Appl Chem, IL-9190401 Jerusalem, Israel; [Buxboim, Amnon; Kan-Tor, Yoav; Beatus, Tsevi] Hebrew Univ Jerusalem, Benin Sch Comp Sci & Engn, IL-9190401 Jerusalem, Israel; [Buxboim, Amnon; Kan-Tor, Yoav] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Dev & Cell Biol, IL-9190401 Jerusalem, Israel; [Buxboim, Amnon; Kan-Tor, Yoav; Beatus, Tsevi] Hebrew Univ Jerusalem, Fac Sci, Alexander Grass Bioengn, IL-9190401 Jerusalem, Israel; [Cohen, Jose E.] Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, IL-9112001 Jerusalem, Israel; [Hagege, Shira glasner; Weiss, D. O. R.] Hebrew Univ Jerusalem, Sch Business Adm, IL-9190501 Jerusalem, Israel; [Goldman, Vladimir] Hadassah Hebrew Univ, Med Ctr, Dept Orthoped Surg, IL-9112001 Jerusalem, Israel; [Beatus, Tsevi] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, IL-9190401 Jerusalem, Israel		Beatus, T (corresponding author), Hebrew Univ Jerusalem, Benin Sch Comp Sci & Engn, IL-9190401 Jerusalem, Israel.; Beatus, T (corresponding author), Hebrew Univ Jerusalem, Fac Sci, Alexander Grass Bioengn, IL-9190401 Jerusalem, Israel.; Beatus, T (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, IL-9190401 Jerusalem, Israel.	tsevi.beatus@mail.huji.ac.il		Beatus, Tsevi/0000-0002-9875-2766	Kamin Grant of the Israel Innovation Authority [59008/59009]; Azrieli Foundation Faculty Fellowship; Alexander Grass Bioengineering Center of the Hebrew University of Jerusalem	Kamin Grant of the Israel Innovation Authority (59008/59009) ; Azrieli Foundation Faculty Fellowship; Alexander Grass Bioengineering Center of the Hebrew University of Jerusalem.	Ando K, 1996, BIOL PSYCHIAT, V39, P22, DOI 10.1016/0006-3223(95)00109-3; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Kerr RG, 2016, AM J CRIT CARE, V25, P213, DOI 10.4037/ajcc2016554; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Lee Ho-Sun, 2006, Korean J Ophthalmol, V20, P79; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Osuobeni EP., 1997, CLIN EXP OPTOM, V80, P35, DOI [10.1111/j.1444-0938.1997.tb04845.x, DOI 10.1111/J.1444-0938.1997.TB04845.X]; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; VANGEMERT MJC, 1989, IEEE T BIO-MED ENG, V36, P1146, DOI 10.1109/10.42108; Voke J., 1999, OPTOM TODAY, V9, P22; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd	30	0	0	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	OCT 1	2021	12	10					6485	6495		10.1364/BOE.435508			11	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	WB9FR	WOS:000703871700003	34745751	gold, Green Published			2022-02-06	
J	Forrester, MB				Forrester, Mathias B.			Rodeo-Related Injuries Among Adolescents Treated at Emergency Departments	JOURNAL OF EMERGENCY MEDICINE			English	Article						rodeo; bull; horse; injury; emergency department		Background: Rodeo is an extreme sport involving powerful forces created by large animals. Objective: The objective of this study was to characterize rodeo-related injuries among adolescents treated at United States emergency departments (EDs). Methods: Cases were rodeo-related injuries among patients ages 13-19 years reported to the National Electronic Injury Surveillance System during 2000-2019. The distribution of the national injury estimates was determined for selected variables. Results: A total of 408 adolescent rodeo-related injuries were identified, resulting in a national estimate of 17,363 injuries. Bulls were involved in 58.4% of the injuries and horses in 28.8%. The patients were 84.7% male and 15.3% female. The most frequently reported mechanisms of injury were: fell or thrown from an animal (41.4%), stepped on by an animal (22.4%), other contact with an animal (7.4%), contact with infrastructure (6.6%), and kicked by an animal (5.9%). The most common diagnoses were contusion or abrasion (29.5%), fracture (22.8%), strain or sprain (15.0%), laceration (8.1%), and concussion (8.0%). The affected body part was 26.9% head and neck, 25.9% upper extremity, 24.6% lower extremity, and 21.6% trunk. Conclusion: Most of the injuries involved bulls. The majority of patients were male. Most of the injuries resulted from falling or being thrown by an animal or stepped on by an animal. The most frequently reported injuries were contusion or abrasion, fracture, strain or sprain, laceration, and concussion. The injuries most often affected the head and neck followed by the upper extremity and lower extremity. (C) 2021 Elsevier Inc. All rights reserved.	[Forrester, Mathias B.] 4600 Monterey Oaks Blvd F2335, Austin, TX 78749 USA		Forrester, MB (corresponding author), 4600 Monterey Oaks Blvd F2335, Austin, TX 78749 USA.						Acton AS, 2020, AM J EMERG MED, V38, P1062, DOI 10.1016/j.ajem.2019.158366; Boham M, 2014, J ATHL TRAINING, V49, P274, DOI 10.4085/1062-6050-48.6.06; Brandenburg MA, 1998, ANN EMERG MED, V32, P118, DOI 10.1016/S0196-0644(98)70123-4; Brandenburg MA, 2007, INT SPORTMED J, V8, P78; Butterwick DJ, 2011, CLIN J SPORT MED, V21, P243, DOI 10.1097/JSM.0b013e318218acdd; Butterwick DJ, 2002, CLIN J SPORT MED, V12, P30, DOI 10.1097/00042752-200201000-00009; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P796; Cuenca AG, 2009, J PEDIATR SURG, V44, P148, DOI 10.1016/j.jpedsurg.2008.10.025; Elder AJS, 2020, CLIN J SPORT MED, V30, P591, DOI 10.1097/JSM.0000000000000654; Fox S, 2015, J AGRIC SAF HEALTH, V21, P3, DOI 10.13031/jash.21.10221; Livingston R, 2012, AUSTRALAS MED J, V5, P362, DOI 10.4066/AMJ.2012.1280; Moneim MS, 2003, AM J SPORT MED, V31, P728, DOI 10.1177/03635465030310051601; Professional Rodeo Cowboys Association, AB PRCA; Short SS, 2018, J PEDIATR SURG, V53, P545, DOI 10.1016/j.jpedsurg.2017.03.043; Sinclair AJ, 2009, CLIN J SPORT MED, V19, P383, DOI 10.1097/JSM.0b013e3181b625e4; Stoneback JW, 2018, RES SPORTS MED, V26, P114, DOI 10.1080/15438627.2018.1439034; United States Consumer Product Safety Commission, 2019, NEISS COD MAN; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; Yetman AT, 2004, J TRAUMA, V56, P697, DOI 10.1097/01.TA.0000028973.98526.15	20	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	OCT	2021	61	4					387	394		10.1016/j.jemermed.2021.03.023			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	YJ0YO	WOS:000744265200018	34088544				2022-02-06	
J	Gallagher, VT; Murthy, P; Stocks, J; Vesci, B; Mjaanes, J; Chen, YF; Breiter, HC; LaBella, C; Herrold, AA; Reilly, JL				Gallagher, Virginia T.; Murthy, Prianka; Stocks, Jane; Vesci, Brian; Mjaanes, Jeffrey; Chen, Yufen; Breiter, Hans C.; LaBella, Cynthia; Herrold, Amy A.; Reilly, James L.			Eye Movements Detect Differential Change after Participation in Male Collegiate Collision versus Non-Collision Sports	NEUROTRAUMA REPORTS			English	Article						collision sports; eye tracking; oculomotor; repetitive head trauma; subconcussive	CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT EXPOSURE; TIMELINE FOLLOWBACK; NEUROLOGIC FUNCTION; CLINICAL MEASURES; INVENTORY-II; BRAIN-INJURY; FOOTBALL; CONCUSSION; DEPRESSION	Although neuroimaging studies of collision (COLL) sport athletes demonstrate alterations in brain structure and function from pre- to post-season, reliable tools to detect behavioral/cognitive change relevant to functional networks associated with participation in collision sports are lacking. This study evaluated the use of eye-movement testing to detect change in cognitive and sensorimotor processing among male club collegiate athletes after one season of participation in collision sports of variable exposure. We predicted that COLL (High Dose [hockey], n = 8; Low Dose [rugby], n = 9) would demonstrate longer reaction times (antisaccade and memory-guided saccade [MGS] latencies), increased inhibitory errors (antisaccade error rate), and poorer spatial working memory (MGS spatial accuracy) at post-season, relative to pre-season, whereas non-collision collegiate athletes (NON-COLL; n = 17) would remain stable. We also predicted that whereas eye-movement performance would detect pre- to post-season change, ImPACT (Immediate Post-Concussion Assessment and Cognitive Test) performance would remain stable. Our data showed that NON-COLL had shorter (improved performance) post- versus pre-season antisaccade and MGS latencies, whereas COLL groups showed stable, longer, or attenuated reduction in latency (ps <= 0.001). Groups did not differ in antisaccade error rate. On the MGS task, NON-COLL demonstrated improved spatial accuracy over time, whereas COLL groups showed reduced spatial accuracy (p < 0.05, uncorrected). No differential change was observed on ImPACT. This study provides preliminary evidence for eye-movement testing as a sensitive marker of subtle changes in attentional control and working memory resulting from participation in sports with varying levels of subconcussive exposure.</p>	[Gallagher, Virginia T.] UVA Hlth, Dept Neurol, 1221 Lee St,4th Floor, Charlottesville, VA 22903 USA; [Murthy, Prianka; Stocks, Jane; Breiter, Hans C.; Herrold, Amy A.; Reilly, James L.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Vesci, Brian; Mjaanes, Jeffrey] Northwestern Univ, Dept Sports Med, Evanston, IL USA; [Chen, Yufen] Northwestern Univ, Ctr Translat Imaging, Evanston, IL USA; [LaBella, Cynthia] Ann & Robert H Lurie Childrens Hosp Chicago, Div Orthoped & Sports Med, Chicago, IL 60611 USA		Gallagher, VT (corresponding author), UVA Hlth, Dept Neurol, 1221 Lee St,4th Floor, Charlottesville, VA 22903 USA.	va.t.gallagher@gmail.com			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS106840]; Warren Wright Adolescent Center at Northwestern University	Research reported in this article was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number F31NS106840. The content is solely the responsibility of the authors and does not necessar-ily represent the official views of the National Institutes of Health. Funding for the Eyelink1000 Plus system came from the Warren Wright Adolescent Center at Northwestern University.<	Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Gallagher VT, 2020, NEUROTRAUMA REP, V1, P169, DOI 10.1089/neur.2020.0051; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; HEDBERG AG, 1972, PROF PSYCHOL, V3, P389, DOI 10.1037/h0020743; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hollingshead A.A., 1975, UNPUB; IBM Corp, 2019, IBM SPSS STAT WINDOW; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Landry AP, 2018, J NEUROTRAUM, V35, pA190; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lunn J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160508; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Pedersen ER, 2012, PSYCHOL ADDICT BEHAV, V26, P672, DOI 10.1037/a0027945; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Reilly JL, 2008, BIOL PSYCHIAT, V63, P776, DOI 10.1016/j.biopsych.2007.11.009; Reilly JL, 2014, SCHIZOPHRENIA BULL, V40, P1011, DOI 10.1093/schbul/sbt132; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Robinson SM, 2014, PSYCHOL ADDICT BEHAV, V28, P154, DOI 10.1037/a0030992; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	57	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	OCT 1	2021	2	1					440	452		10.1089/neur.2021.0030			13	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WD3EW	WOS:000704829400001	34901940	Green Published, gold			2022-02-06	
J	Gong, YT; Wu, MY; Gao, F; Shi, MY; Gu, HP; Gao, R; Dang, BQ; Chen, G				Gong, Yating; Wu, Muyao; Gao, Fan; Shi, Mengying; Gu, Haiping; Gao, Rong; Dang, Bao-Qi; Chen, Gang			Inhibition of the p-SPAK/p-NKCC1 signaling pathway protects the blood-brain barrier and reduces neuronal apoptosis in a rat model of surgical brain injury	MOLECULAR MEDICINE REPORTS			English	Article						surgical brain injury; STE20; SPS1-related proline; alanine-rich kinase; Na+-K+-Cl- cotransporter 1; blood-brain barrier; brain edema; neuroprotection	SUBARACHNOID HEMORRHAGE; CEREBRAL EDEMA; KINASE; SPAK; NKCC1; OUTCOMES	Surgical brain injury (SBI) can disrupt the function of the blood-brain barrier (BBB), leading to brain edema and neurological dysfunction. Thus, protecting the BBB and mitigating cerebral edema are key factors in improving the neurological function and prognosis of patients with SBI. The inhibition of WNK lysine deficient protein kinase/STE20/SPS1-related proline/alanine-rich kinase (SPAK) signaling ameliorates cerebral edema, and this signaling pathway regulates the phosphorylation of the downstream Na+-K+-Cl- cotransporter 1 (NKCC1). Therefore, the purpose of the present study was to investigate the role of SPAK in SBI-induced cerebral edema and to determine whether the SPAK/NKCC1 signaling pathway was involved in SBI via regulating phosphorylation. An SBI model was established in male Sprague-Dawley rats, and the effects of SPAK on the regulation of the NKCC1 signaling pathway on BBB permeability and nerve cell apoptosis by western blotting analysis, immunofluorescence staining, TUNEL staining, Fluoro-Jade C staining, and brain edema and nervous system scores. The results demonstrated that, compared with those in the sham group, phosphorylated (p)-SPAK and p-NKCC1 protein expression levels were significantly increased in the SBI model group. After inhibiting p-SPAK, the expression level of p-NKCC1, neuronal apoptosis and BBB permeability were significantly reduced in SBI model rats. Taken together, these findings suggested that SBI-induced increases in p-SPAK and p-NKCC1 expression exacerbated post-traumatic neural and BBB damage, which may be mediated via the ion-transport-induced regulation of cell edema.	[Gong, Yating; Wu, Muyao; Gao, Fan; Dang, Bao-Qi] Nanjing Univ Chinese Med, Dept Rehabil, Zhangjiagang Tradit Chinese Med Hosp, 77 Changan Southern Rd, Suzhou 215600, Jiangsu, Peoples R China; [Shi, Mengying] Nanjing Univ Chinese Med, Dept Anesthesiol, Zhangjiagang Tradit Chinese Med Hosp, Suzhou 215600, Jiangsu, Peoples R China; [Gu, Haiping] Nanjing Univ Chinese Med, Dept Neurol, Zhangjiagang Tradit Chinese Med Hosp, Suzhou 215600, Jiangsu, Peoples R China; [Gao, Rong] Nanjing Univ Chinese Med, Dept Neurosurg, Zhangjiagang Tradit Chinese Med Hosp, 77 Changan Southern Rd, Suzhou 215600, Jiangsu, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China		Dang, BQ (corresponding author), Nanjing Univ Chinese Med, Dept Rehabil, Zhangjiagang Tradit Chinese Med Hosp, 77 Changan Southern Rd, Suzhou 215600, Jiangsu, Peoples R China.; Gao, R (corresponding author), Nanjing Univ Chinese Med, Dept Neurosurg, Zhangjiagang Tradit Chinese Med Hosp, 77 Changan Southern Rd, Suzhou 215600, Jiangsu, Peoples R China.	714866001@qq.com; zhenjiangdbq@163.com			Zhangjiagang Science and Technology Project [ZKS1914]; Zhangjiagang Health Youth Science and Technology Project [ZJGQNKJ202030]	This work was supported by the Zhangjiagang Science and Technology Project (grant no. ZKS1914) and the Zhangjiagang Health Youth Science and Technology Project (grant no. ZJGQNKJ202030).	Akyol O, 2018, EXP NEUROL, V307, P82, DOI 10.1016/j.expneurol.2018.06.002; AlAmri MA, 2017, CHEMMEDCHEM, V12, P639, DOI 10.1002/cmdc.201700077; Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Bankstahl M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0123-18.2018; Begum G, 2015, STROKE, V46, P1956, DOI 10.1161/STROKEAHA.115.008939; Benggon M, 2016, ACTA NEUROCHIR SUPPL, V121, P299, DOI 10.1007/978-3-319-18497-5_52; Campisi M, 2018, BIOMATERIALS, V180, P117, DOI 10.1016/j.biomaterials.2018.07.014; Cao-Pham AH, 2018, NEW PHYTOL, V220, P35, DOI 10.1111/nph.15276; Chen JH, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/6848943; Delpire E, 2010, J PHYSIOL-LONDON, V588, P3365, DOI 10.1113/jphysiol.2010.190769; Eroglu H, 2001, J MICROENCAPSUL, V18, P603; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; Gagnon KB, 2010, J BIOL CHEM, V285, P14115, DOI 10.1074/jbc.M110.112672; Gong YT, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.12032; Gong YT, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.641993; Haas BR, 2011, AM J PHYSIOL-CELL PH, V301, pC1150, DOI 10.1152/ajpcell.00203.2011; Huang HC, 2019, AGING DIS, V10, P626, DOI 10.14336/AD.2018.0928; Ke KF, 2014, J MOL NEUROSCI, V54, P171, DOI 10.1007/s12031-014-0271-1; Kikuchi E, 2015, J AM SOC NEPHROL, V26, P1525, DOI 10.1681/ASN.2014060560; Kim CH, 2017, NEUROBIOL DIS, V107, P66, DOI 10.1016/j.nbd.2017.03.001; Klug NR, 2021, AM J PHYSIOL-CELL PH, V320, pC619, DOI 10.1152/ajpcell.00177.2019; Lee HA, 2003, EXP PHYSIOL, V88, P569, DOI 10.1113/eph8802558; Lee YC, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-03168-z; LeVine SM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0564-9; Lin GM, 2015, WORLD J CARDIOL, V7, P306, DOI 10.4330/wjc.v7.i6.306; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Luo LX, 2020, MOL CANCER THER, V19, P1550, DOI 10.1158/1535-7163.MCT-19-0910; Luo WD, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1221-6; Lykke K, 2019, J CEREBR BLOOD F MET, V39, P497, DOI 10.1177/0271678X17736715; Matchett G, 2006, J NEUROSCI METH, V158, P234, DOI 10.1016/j.jneumeth.2006.06.003; McBride DW, 2016, ACTA NEUROCHIR SUPPL, V121, P317, DOI 10.1007/978-3-319-18497-5_55; Ocak PE, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113203; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Taherian M, 2020, NEUROCHEM RES, V45, P1156, DOI 10.1007/s11064-020-02997-1; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Tian Y, 2015, BRAIN RES, V1622, P174, DOI 10.1016/j.brainres.2015.06.007; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; Watanabe M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00371; Wu BJ QC, 2017, CHINESE ASS LAB ANIM; Wu DG, 2020, EXP NEUROL, V332, DOI 10.1016/j.expneurol.2020.113386; Wu MY, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146553; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Yang SS, 2015, PROG NEURO-PSYCHOPH, V61, P30, DOI 10.1016/j.pnpbp.2015.03.007; Zakhary G, 2020, J NEUROSCI RES, V98, P155, DOI 10.1002/jnr.24489; Zhang J, 2015, MOL NEUROBIOL, V52, P1527, DOI 10.1007/s12035-014-8939-7; Zhang JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13851-6; Zhang JW, 2017, EXPERT OPIN THER TAR, V21, P795, DOI 10.1080/14728222.2017.1351949; Zhang JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35986; Zhang MK, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0358-z; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2; Zhao HS, 2017, J CEREBR BLOOD F MET, V37, P550, DOI 10.1177/0271678X16631561; Zhao YQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081196	52	0	0	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2021	24	4							717	10.3892/mmr.2021.12356			11	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	UF3LM	WOS:000688478100001	34396440				2022-02-06	
J	Goss, AL; Creutzfeldt, CJ				Goss, Adeline L.; Creutzfeldt, Claire J.			Neuropalliative Care in the Inpatient Setting	SEMINARS IN NEUROLOGY			English	Article						palliative care; critical care; stroke; traumatic brain injury	SURROGATE DECISION-MAKERS; OF-LIFE CARE; TRAUMATIC BRAIN-INJURY; BREAKING BAD-NEWS; PALLIATIVE CARE; ADVANCE DIRECTIVES; UNIT PATIENTS; HIGH-QUALITY; PROGNOSTIC INFORMATION; DISABILITY PARADOX	The palliative care needs of inpatients with neurologic illness are varied, depending on diagnosis, acuity of illness, available treatment options, prognosis, and goals of care. Inpatient neurologists ought to be proficient at providing primary palliative care and effective at determining when palliative care consultants are needed. In the acute setting, palliative care should be integrated with lifesaving treatments using a framework of determining goals of care, thoughtfully prognosticating, and engaging in shared decision-making. This framework remains important when aggressive treatments are not desired or not available, or when patients are admitted to the hospital for conditions related to advanced stages of chronic neurologic disease. Because prognostic uncertainty characterizes much of neurology, inpatient neurologists must develop communication strategies that account for uncertainty while supporting shared decision-making and allowing patients and families to preserve hope. In this article, we illustrate the approach to palliative care in inpatient neurology.	[Goss, Adeline L.] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave Box 0114, San Francisco, CA 94143 USA; [Creutzfeldt, Claire J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA		Goss, AL (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave Box 0114, San Francisco, CA 94143 USA.	adeline.goss@ucsf.edu		Goss, Adeline/0000-0002-8427-6180			Adelman EE., 2012, SURROGATE DECISION M, V18, P655; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Alonso A, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-016-0166-5; Anderson WG, 2015, ANN AM THORAC SOC, V12, P142, DOI 10.1513/AnnalsATS.201407-325OC; Anderson WG, 2009, J CRIT CARE, V24, P249, DOI 10.1016/j.jcrc.2007.12.010; Arbour C, 2014, PAIN MANAG NURS, V15, P506, DOI 10.1016/j.pmn.2012.03.004; Ariesen MJ, 2005, J NEUROL NEUROSUR PS, V76, P839, DOI 10.1136/jnnp.2004.048223; Armstrong J, 2004, J CANCER EDUC, V19, P88, DOI 10.1207/s15430154jce1902_7; Aslakson R, 2014, J PALLIAT MED, V17, P219, DOI 10.1089/jpm.2013.0409; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Back A., 2009, MASTERING COMMUNICAT; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Bar B, 2020, NEUROCRIT CARE, V32, P302, DOI 10.1007/s12028-019-00838-w; Barclay JS, 2007, J PALLIAT MED, V10, P958, DOI 10.1089/jpm.2007.9929; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Benejam B, 2009, J NEUROL, V256, P1126, DOI 10.1007/s00415-009-5083-9; Berger JT, 2008, ANN INTERN MED, V149, P48, DOI 10.7326/0003-4819-149-1-200807010-00010; Boersma I, 2014, NEUROLOGY, V83, P561, DOI 10.1212/WNL.0000000000000674; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Brinkman-Stoppelenburg A, 2014, PALLIATIVE MED, V28, P1000, DOI 10.1177/0269216314526272; Center to Advance Palliative Care, 2019, AM CAR SER ILLN 2019; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Childers JW, 2017, J ONCOL PRACT, V13, P700, DOI 10.1200/JOP.2016.018796; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Creutzfeldt CJ, 2019, NEUROPALLIATIVE CARE; Creutzfeldt CJ, 2020, JAMA-J AM MED ASSOC, V323, P115, DOI 10.1001/jama.2019.19652; Creutzfeldt CJ, 2015, STROKE, V46, P2714, DOI 10.1161/STROKEAHA.115.008224; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Creutzfeldt CJ, 2015, CRIT CARE MED, V43, P1677, DOI 10.1097/CCM.0000000000001018; Creutzfeldt CJ, 2012, STROKE, V43, P3405, DOI 10.1161/STROKEAHA.112.673376; Creutzfeldt CJ, 2012, J GEN INTERN MED, V27, P853, DOI 10.1007/s11606-011-1966-4; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Damschroder LJ, 2005, SOC SCI MED, V61, P267, DOI 10.1016/j.socscimed.2004.11.060; Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169; de Groot J, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0057-1; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Epstein RM, 2011, ANN FAM MED, V9, P454, DOI 10.1370/afm.1301; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; Ferrell BR, 2018, J PALLIAT MED, V21, P1684, DOI 10.1089/jpm.2018.0431; Frick S, 2003, CRIT CARE MED, V31, P456, DOI 10.1097/01.CCM.0000049945.69373.7C; Fried TR, 2003, ARCH INTERN MED, V163, P2073, DOI 10.1001/archinte.163.17.2073; Goss A., 2020, PHYS DISCLOSE PROGNO; Halpern J, 2008, J GEN INTERN MED, V23, P1708, DOI 10.1007/s11606-008-0719-5; Hashim MJ, 2017, AM FAM PHYSICIAN, V95, P29; Hawley ST, 2017, PATIENT EDUC COUNS, V100, P18, DOI 10.1016/j.pec.2016.07.008; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Henry C, 2009, LONDON J PRIM CARE, V2, P96, DOI 10.1080/17571472.2009.11493261; Heyland DK, 2003, J CRIT CARE, V18, P3, DOI 10.1053/jcrc.2003.YJCRC2; Hickman SE, 2005, HASTINGS CENT REP, V35, pS26, DOI 10.1353/hcr.2005.0093; Holloway RG, 2005, JAMA-J AM MED ASSOC, V294, P725; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Holloway RG, 2010, J PALLIAT MED, V13, P407, DOI 10.1089/jpm.2009.0278; Johnson PD, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011317; Johnson SK, 2011, AM J RESP CRIT CARE, V183, P915, DOI 10.1164/rccm.201008-1214OC; Josephson SA, 2017, NEUROLOGY, V89, P730, DOI 10.1212/WNL.0000000000004230; Kapoor A, 2017, STROKE, V48, P1688, DOI 10.1161/STROKEAHA.117.016728; Kehayia E, 1997, STROKE, V28, P1867, DOI 10.1161/01.STR.28.10.1867; Kesselring A, 2007, AM J TRANSPLANT, V7, P211, DOI 10.1111/j.1600-6143.2006.01594.x; Knies AK, 2016, SEMIN NEUROL, V36, P631, DOI 10.1055/s-0036-1592358; Kon AA, 2016, AM J RESP CRIT CARE, V193, P1334, DOI 10.1164/rccm.201602-0269ED; Kruser JM, 2015, J AM GERIATR SOC, V63, P1805, DOI 10.1111/jgs.13615; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; LeClaire MM, 2005, CHEST, V128, P1728, DOI 10.1378/chest.128.3.1728; Luengo-Fernandez R, 2013, NEUROLOGY, V81, P1588, DOI 10.1212/WNL.0b013e3182a9f45f; Man-Son-Hing Malcolm, 2002, Health Expect, V5, P246, DOI 10.1046/j.1369-6513.2002.00188.x; Messinger-Rapport BJ, 2009, CLEV CLIN J MED, V76, P276, DOI 10.3949/ccjm.76a.07002; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Musa I, 2015, AGE AGEING, V44, P371, DOI 10.1093/ageing/afv041; NAKAO MA, 1983, AM J MED, V74, P1061, DOI 10.1016/0002-9343(83)90819-7; Nelson JE, 2010, CRIT CARE MED, V38, P1765, DOI 10.1097/CCM.0b013e3181e8ad23; Ohnishi M, 2002, FAM PRACT, V19, P7, DOI 10.1093/fampra/19.1.7; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Penrod JD, 2012, CRIT CARE MED, V40, P1105, DOI 10.1097/CCM.0b013e3182374a50; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Porensky EK, 2016, PATIENT EDUC COUNS, V99, P68, DOI 10.1016/j.pec.2015.07.022; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rabow MW, 1999, WESTERN J MED, V171, P260; Rao JK, 2014, AM J PREV MED, V46, P65, DOI 10.1016/j.amepre.2013.09.008; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Reid M., 2013, J INTENSIVE CARE SOC, V14, P324; Reimer WJMSO, 1999, QUAL HEALTH CARE, V8, P30, DOI 10.1136/qshc.8.1.30; Rijkenberg S, 2015, J CRIT CARE, V30, P167, DOI 10.1016/j.jcrc.2014.09.007; Robinson MT, 2016, NEUROLOGY, V86, P2056, DOI 10.1212/WNL.0000000000002625; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; Sharma K, 2017, HAND CLINIC, V140, P379, DOI 10.1016/B978-0-444-63600-3.00021-0; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Siminoff Laura A, 2002, Prog Transplant, V12, P52; Sleeman KE, 2013, PALLIATIVE MED, V27, P840, DOI 10.1177/0269216313490436; Snell K, 2009, AGE AGEING, V38, P617, DOI 10.1093/ageing/afp123; Stacey D, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001431.PUB4; Sudore RL, 2017, J PAIN SYMPTOM MANAG, V53, P821, DOI 10.1016/j.jpainsymman.2016.12.331; Taylor BL, 2019, NEUROLOGY, V92, pE1975, DOI 10.1212/WNL.0000000000007364; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Thomson R, 2005, CLIN MED, V5, P465, DOI 10.7861/clinmedicine.5-5-465; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Weil AG, 2011, CAN J NEUROL SCI, V38, P434, DOI 10.1017/S0317167100011835; Weissman DE, 2004, JAMA-J AM MED ASSOC, V292, P1738, DOI 10.1001/jama.292.14.1738; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; White DB, 2018, NEW ENGL J MED, V378, P2365, DOI 10.1056/NEJMoa1802637; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wittenberg E, 2015, TXB PALLIATIVE CARE; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Yadav KN, 2017, HEALTH AFFAIR, V36, P1244, DOI 10.1377/hlthaff.2017.0175; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008	114	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	OCT	2021	41	05					619	630		10.1055/s-0041-1731071			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WD2YT	WOS:000704813500013	34619785				2022-02-06	
J	Greenham, M; Gordon, AL; Cooper, A; Hearps, S; Ditchfield, M; Coleman, L; Hunt, RW; Mackay, MT; Monagle, P; Anderson, V				Greenham, Mardee; Gordon, Anne L.; Cooper, Anna; Hearps, Stephen; Ditchfield, Michael; Coleman, Lee; Hunt, Rod W.; Mackay, Mark T.; Monagle, Paul; Anderson, Vicki			Fatigue Following Pediatric Arterial Ischemic Stroke Prevalence and Associated Factors	STROKE			English	Article						child; fatigue; ischemic stroke; prevalence; quality of life	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SICKLE-CELL-DISEASE; MULTIDIMENSIONAL FATIGUE; POSTSTROKE FATIGUE; CHILDREN; RELIABILITY; SCALE; IMPACT; PARTICIPATION	Background and Purpose: The aims of this study were to assess the prevalence of multidimensional fatigue symptoms 5 years after pediatric arterial ischemic stroke and identify factors associated with fatigue. Methods: Thirty-one children (19 males) with pediatric arterial ischemic stroke, participating in a larger prospective, longitudinal study, were recruited to this study at 5 years poststroke. Parent- and self-rated PedsQL Multidimensional Fatigue Scale scores were compared with published normative data. Associations between parent-rated PedsQL Multidimensional Fatigue Scale, demographics, stroke characteristics, and concurrent outcomes were examined. Results: Parent-rated total, general and cognitive fatigue were significantly poorer than population norms, with more than half of all parents reporting fatigue symptoms in their children. One-third of children also reported experiencing fatigue symptoms, but their ratings did not differ significantly from normative expectations, as such, all further analyses were on parent ratings of fatigue. Older age at stroke and larger lesion size predicted greater general fatigue; older age, female sex, and higher social risk predicted more sleep/rest fatigue. No significant predictors of cognitive fatigue were identified and only older age at stroke predicted total fatigue. Greater fatigue was associated with poorer adaptive functioning, motor skills, participation, quality of life, and behavior problems but not attention. Conclusions: Fatigue is a common problem following pediatric arterial ischemic stroke and is associated with the functional difficulties often seen in this population. This study highlights the importance of long-term monitoring following pediatric arterial ischemic stroke and the need for effective interventions to treat fatigue in children.	[Greenham, Mardee; Gordon, Anne L.; Cooper, Anna; Hearps, Stephen; Ditchfield, Michael; Coleman, Lee; Hunt, Rod W.; Mackay, Mark T.; Monagle, Paul; Anderson, Vicki] Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic, Australia		Greenham, M (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic, Australia.	mardee.greenham@mcri.edu.au; anne.Gordon@gstt.nhs.uk; anna.cooper@mcri.edu.au; stephen.hearps@mcri.edu.au; Michael.Ditchfield@monashhealth.org; Lee.Coleman@rch.org.au; rod.hunt@monash.edu; mark.mackay@rch.org.au; paul.monagle@rch.org.au; vicki.anderson@rch.org.au		Mackay, Mark/0000-0002-3787-1112; Hearps, Stephen/0000-0003-2984-1172; Hunt, Rodney/0000-0002-2446-1739; Ditchfield, Michael/0000-0003-1707-3671	Murdoch Children's Research Institute; NHMRCNational Health and Medical Research Council of Australia; Stroke Foundation (Australia)	This study received funding support from the Murdoch Children's Research Institute (postgraduate research scholarship [Dr Greenham]), NHMRC (senior practitioner fellowship [Dr Anderson]), and the Stroke Foundation (Australia).	Aarnes R, 2020, NEUROPSYCHOL REHABIL, V30, P1449, DOI 10.1080/09602011.2019.1589530; Berrin SJ, 2007, J PEDIATR PSYCHOL, V32, P330, DOI 10.1093/jpepsy/jsl017; Bruininks RH, 2005, BRUININKS OSERETSKY; Brunton LK, 2018, PEDIATR PHYS THER, V30, P135, DOI 10.1097/PEP.0000000000000490; Camara-Costa H, 2020, J HEAD TRAUMA REHAB, V35, P104, DOI 10.1097/HTR.0000000000000502; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coster W, 2010, PARTICIPATION ENV ME; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Crichton A, 2015, PEDIATRICS, V135, pE1015, DOI 10.1542/peds.2014-2440; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Dampier C, 2010, PEDIATR BLOOD CANCER, V55, P485, DOI 10.1002/pbc.22497; Dunbar M, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-013201; Duncan F, 2012, INT J STROKE, V7, P157, DOI 10.1111/j.1747-4949.2011.00741.x; Eddy L, 2007, J SPEC PEDIATR NURS, V12, P105, DOI 10.1111/j.1744-6155.2007.00099.x; Ezekiel L, 2019, ARCH PHYS MED REHAB, V100, P945, DOI 10.1016/j.apmr.2018.06.017; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gordon AL, 2015, INT J STROKE, V10, P1068, DOI 10.1111/ijs.12489; Greenham M, 2018, DEV NEUROPSYCHOL, V43, P312, DOI 10.1080/87565641.2018.1440557; Greenham M, 2016, STROKE, V47, P1159, DOI 10.1161/STROKEAHA.115.011622; Hinds PS, 2013, PEDIATR BLOOD CANCER, V60, P402, DOI 10.1002/pbc.24233; Holland AA, 2014, CHILD NEUROPSYCHOL, V20, P71, DOI 10.1080/09297049.2012.748888; HOLM S, 1979, SCAND J STAT, V6, P65; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kwok T, 2011, DISABIL REHABIL, V33, P1990, DOI 10.3109/09638288.2011.553709; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Levine J, 2009, PHYS MED REH CLIN N, V20, P347, DOI 10.1016/j.pmr.2008.12.006; Looman WS, 2010, CLEFT PALATE-CRAN J, V47, P273, DOI [10.1597/09-009.1, 10.5555/09-009.1]; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; Macartney G, 2014, ONCOL NURS FORUM, V41, P390, DOI 10.1188/14.ONF.390-398; Maher C, 2015, DEV MED CHILD NEUROL, V57, P742, DOI 10.1111/dmcn.12736; Manly T., 2016, TEST EVERYDAY ATTENT; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Naess H, 2005, CEREBROVASC DIS, V20, P245, DOI 10.1159/000087706; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Parks NE, 2012, CAN J NEUROL SCI, V39, P619, DOI 10.1017/S0317167100015353; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Nunes MDR, 2017, EUR J ONCOL NURS, V29, P39, DOI 10.1016/j.ejon.2017.05.001; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sumpter R, 2011, BRAIN INJURY, V25, P1288, DOI 10.3109/02699052.2011.613090; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; ter Wolbeek M, 2008, PEDIATRICS, V121, pE449, DOI 10.1542/peds.2007-1093; van de Port IGL, 2007, CEREBROVASC DIS, V23, P40, DOI 10.1159/000095757; van Markus-Doornbosch F, 2016, BRAIN INJURY, V30, P1533, DOI 10.1080/02699052.2016.1197968; van Markus-Doornbosch F, 2020, DEV NEUROREHABIL, V23, P328, DOI 10.1080/17518423.2019.1692948; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Viner RM, 2008, ARCH PEDIAT ADOL MED, V162, P469, DOI 10.1001/archpedi.162.5.469; Whitsett SF, 2008, J PEDIATR ONCOL NURS, V25, P86, DOI 10.1177/1043454208315546; Wilkinson J, 2018, NEUROPSYCHOL REV, V28, P73, DOI 10.1007/s11065-018-9370-z; Wrightson JG, 2020, DEV MED CHILD NEUROL, V62, P234, DOI 10.1111/dmcn.14273	62	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	OCT	2021	52	10					3286	3295		10.1161/STROKEAHA.120.033000			10	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	UY1YZ	WOS:000701327900045	34176311				2022-02-06	
J	Herrera, ML; Bandin, S; Champarini, LG; Herenu, CB; Bellini, MJ				Herrera, Macarena Lorena; Bandin, Sandra; Champarini, Leandro Gabriel; Herenu, Claudia Beatriz; Bellini, Maria Jose			Intramuscular insulin-like growth factor-1 gene therapy modulates reactive microglia after traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						IGF-1; Neuroinflammation; Neuroprotection; Traumatic brain injury; Astrocytes; Microglia	INCREASES HIPPOCAMPAL NEUROGENESIS; ANIMAL-MODELS; IGF-1; RATS; NEUROPROTECTION; TARGETS; MEMORY; DAMAGE; MOUSE	Reactive gliosis is a key feature and an important pathophysiological mechanism underlying chronic neurodegeneration following traumatic brain injury (TBI). In this study, we have explored the effects of intramuscular IGF-1 gene therapy on reactive gliosis and functional outcome after an injury of the cerebral cortex. Young adult male rats were intramuscularly injected with a recombinant adenoviral construct harboring the cDNA of human IGF-1 (RAd-IGF1), with a control vector expressing green fluorescent protein (RAd-GFP) or PBS as control. Three weeks after the intramuscular injections of adenoviral vectors, animals were subjected to a unilateral penetrating brain injury. The data revealed that RAd-IGF1 gene therapy significantly increased serum IGF1 levels and improved working memory performance after one week of TBI as compared to PBS or RAd-GFP lesioned animals. At the same time, when we analyzed the effects of therapy on glial scar formation, the treatment with RAd-IGF1 did not modify the number of glial fibrillary acidic protein (GFAP) positive cells, but we observed a decrease in vimentin immunoreactive astrocytes at 7 days post-lesion in the injured hemisphere compared to RAd-GFP group. Moreover, IGF-1 gene therapy reduced the number of Iba1+ cells with reactive phenotype and the number of MHCII + cells in the injured hemisphere. These results suggest that intramuscular IGF-1 gene therapy may represent a new approach to prevent traumatic brain injury outcomes in rats.	[Herrera, Macarena Lorena; Champarini, Leandro Gabriel; Herenu, Claudia Beatriz] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Farmacol, Cordoba, Argentina; [Herrera, Macarena Lorena; Champarini, Leandro Gabriel; Herenu, Claudia Beatriz] Consejo Nacl Invest Cient & Tecn, Inst Farmacol Expt Cordoba IFEC, Cordoba, Argentina; [Herrera, Macarena Lorena; Bellini, Maria Jose] Univ Nacl La Plata, Fac Ciencias Med, Buenos Aires, DF, Argentina; [Herrera, Macarena Lorena; Bellini, Maria Jose] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Argentina; [Bandin, Sandra] CSIC, Inst Cajal, Madrid 28002, Spain		Bellini, MJ (corresponding author), Univ Nacl La Plata, Fac Ciencias Med, Buenos Aires, DF, Argentina.	mariajosebellini@med.unlp.edu.ar			CONICET, ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0618]; Plan Argentina Inovadora from Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion [PICT-2018-02446]	This research was funded by grant PIP 0618 from CONICET, Argentina to MJB and by grant PICT-2018-02446 Plan Argentina Inovadora from Agencia Nacional de Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion to CBH.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Bake S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091427; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Occhieppo VB, 2017, EUR J NEUROSCI, V45, P1586, DOI 10.1111/ejn.13594; Bellini MJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-21; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Bryan Miles R, 2017, Adv Neurobiol, V18, P113, DOI 10.1007/978-3-319-60189-2_6; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Crupi R, 2013, PHARMACOL RES, V70, P80, DOI 10.1016/j.phrs.2012.12.009; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/endo.143.4.8750; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Falomir-Lockhart E, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00048; Fernandez AM, 2017, DIABETES, V66, P64, DOI 10.2337/db16-0861; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Hatton WJ, 1999, J COMP NEUROL, V409, P169; Herenu CB, 2007, GENE THER, V14, P237, DOI 10.1038/sj.gt.3302870; Herenu CB, 2009, NEUROSCIENCE, V163, P442, DOI 10.1016/j.neuroscience.2009.06.024; Herrera ML, 2020, ASN NEURO, V12, DOI 10.1177/1759091420925977; Herrera ML, 2020, EUR J NEUROSCI, V52, P2827, DOI 10.1111/ejn.14703; Labandeira-Garcia JL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00365; Larpthaveesarp A, 2015, BRAIN SCI, V5, P165, DOI 10.3390/brainsci5020165; Lawton T, 2019, RESTOR NEUROL NEUROS, V37, P71, DOI 10.3233/RNN-180856; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Herrera ML, 2019, BEHAV BRAIN RES, V372, DOI 10.1016/j.bbr.2019.112050; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Mazucanti CH, 2015, CURR TOP MED CHEM, V15, P2116, DOI 10.2174/1568026615666150610125715; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Palermo L, 2020, APPL NEUROPSYCH-ADUL, V27, P158, DOI 10.1080/23279095.2018.1501374; Pardo J, 2018, J GERONTOL A-BIOL, V73, P459, DOI 10.1093/gerona/glx125; Pardo J, 2016, EUR J NEUROSCI, V44, P2120, DOI 10.1111/ejn.13278; Paxinos G., 2004, RAT BRAIN STEREOTAXI, P209; Rashno M, 2019, LIFE SCI, V228, P285, DOI 10.1016/j.lfs.2019.05.007; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Sama DM, 2018, RESTOR NEUROL NEUROS, V36, P559, DOI 10.3233/RNN-180831; Santi A, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0196-5; Santi A, 2018, CEREB CORTEX, V28, P2007, DOI 10.1093/cercor/bhx106; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Sebastian V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00038; Serhan A, 2020, NEUROSCIENCE, V426, P101, DOI 10.1016/j.neuroscience.2019.11.035; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song Q, 2015, MOL MED REP, V12, P7203, DOI 10.3892/mmr.2015.4407; Stein Angelica Miki, 2018, Dement. neuropsychol., V12, P114, DOI 10.1590/1980-57642018dn12-020003; Stein D.G., 2015, RECENT DEV CLIN TRIA, V1st, DOI [10.1016/B978-0-444-52892-6.00028-3, DOI 10.1016/B978-0-444-52892-6.00028-3]; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uriarte M, 2017, NEUROREPORT, V28, P307, DOI 10.1097/WNR.0000000000000755; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7	61	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2021	175						196	204		10.1016/j.brainresbull.2021.07.023			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD0FU	WOS:000686894000003	34339780				2022-02-06	
J	Ho, MH; Yen, CH; Hsieh, TH; Kao, TJ; Chiu, JY; Chiang, YH; Hoffer, BJ; Chang, WC; Chou, SY				Ho, Man-Hau; Yen, Chia-Hung; Hsieh, Tsung-Hsun; Kao, Tzu-Jen; Chiu, Jing-Yuan; Chiang, Yung-Hsiao; Hoffer, Barry J.; Chang, Wen-Chang; Chou, Szu-Yi			CCL5 via GPX1 activation protects hippocampal memory function after mild traumatic brain injury	REDOX BIOLOGY			English	Article						CCL5; Reactive oxygen species (ROS); NADPH oxidase; Traumatic brain injury; Glutathione peroxidase-1 (GPX1)	ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; MOUSE MODEL; RANTES; CELLS; EXPRESSION; PROFILES; DEFICITS; TISSUE	Traumatic brain injury (TBI) is a prevalent head injury worldwide which increases the risk of neurodegenerative diseases. Increased reactive oxygen species (ROS) and inflammatory chemokines after TBI induces secondary effects which damage neurons. Targeting NADPH oxidase or increasing redox systems are ways to reduce ROS and damage. Earlier studies show that C-C motif chemokine ligand 5 (CCL5) has neurotrophic functions such as promoting neurite outgrowth as well as reducing apoptosis. Although CCL5 levels in blood are associated with severity in TBI patients, the function of CCL5 after brain injury is unclear. In the current study, we induced mild brain injury in C57BL/6 (wildtype, WT) mice and CCL5 knockout (CCL5-KO) mice using a weight-drop model. Cognitive and memory functions in mice were analyzed by Novel-object-recognition and Barnes Maze tests. The memory performance of both WT and KO mice were impaired after mild injury. Cognition and memory function in WT mice quickly recovered after 7 days but recovery took more than 14 days in CCL5-KO mice. FJC, NeuN and Hypoxyprobe staining revealed large numbers of neurons damaged by oxidative stress in CCL5-KO mice after mTBI. NADPH oxidase activity show increased ROS generation together with reduced glutathione peroxidase-1 (GPX1) and glutathione (GSH) activity in CCL5-KO mice; this was opposite to that seen in WT mice. CCL5 increased GPX1 expression and reduced intracellular ROS levels which subsequently increased cell survival both in primary neuron cultures and in an overexpression model using SHSY5Y cell. Memory impairment in CCL5-KO mice induced by TBI could be rescued by i.p. injection of the GSH precursor - N-acetylcysteine (NAC) or intranasal delivery of recombinant CCL5 into mice after injury. We conclude that CCL5 is an important molecule for GPX1 antioxidant activation during post-injury day 1-3, and protects hippocampal neurons from ROS as well as improves memory function after trauma.	[Ho, Man-Hau; Kao, Tzu-Jen; Hoffer, Barry J.; Chou, Szu-Yi] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Ho, Man-Hau; Kao, Tzu-Jen; Hoffer, Barry J.; Chou, Szu-Yi] Natl Hlth Res, Taipei, Taiwan; [Ho, Man-Hau; Kao, Tzu-Jen; Chiu, Jing-Yuan; Hoffer, Barry J.; Chou, Szu-Yi] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Ho, Man-Hau; Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan; [Ho, Man-Hau; Yen, Chia-Hung] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung 91201, Taiwan; [Hsieh, Tsung-Hsun; Chang, Wen-Chang] Chang Gung Univ, Sch Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun; Chang, Wen-Chang] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan; [Chiang, Yung-Hsiao; Hoffer, Barry J.] Taipei Med Univ, Neurosci Res Ctr, Taipei 11031, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Hoffer, Barry J.] NIH, Scientist Emeritus, Bldg 10, Bethesda, MD 20892 USA		Chou, SY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, PhD Program Neural Regenerat Med, 250 Wu Xing St, Taipei 110, Taiwan.	sichou@tmu.edu.tw		Chou, Szu-Yi/0000-0002-4387-749X	Ministry of Science and Technology [MOST 105-2628-B-038-005-MY3, MOST 108-2320-B-038-025, MOST 109-2320-B-038-016, MOST 108-2321-B-038-008]; Sunny Brain Tumor and Brain Disease Research and Development Fund	This work was supported by grants from Ministry of Science and Technology (MOST 105-2628-B-038-005-MY3; MOST 108-2320-B-038-025; MOST 109-2320-B-038-016) and Sunny Brain Tumor and Brain Disease Research and Development Fund to S.Y. Chou. Ministry of Science and Technology (MOST 108-2321-B-038-008) to YH Chiang, WC Chang and B Hoffer.	Ajoy R, 2021, MOL PSYCHIATR, V26, P6451, DOI 10.1038/s41380-021-01103-3; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Cha B, 2011, J PHYSIOL PHARMACOL, V62, P167; Cha JH, 2016, NUTR RES PRACT, V10, P26, DOI 10.4162/nrp.2016.10.1.26; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Darcet F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00136; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Friedman-Levi Y, 2021, EXP NEUROL, V338, DOI 10.1016/j.expneurol.2021.113604; Gawel K, 2019, N-S ARCH PHARMACOL, V392, P1, DOI 10.1007/s00210-018-1589-y; Ghiam MK, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.635483; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Ignatov A, 2006, BRIT J PHARMACOL, V149, P490, DOI 10.1038/sj.bjp.0706909; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Kester MI, 2012, CLIN CHEM LAB MED, V50, P61, DOI [10.1515/CCLM.2011.731, 10.1515/cclm.2011.731]; Kim HY, 2015, HYPERTENS RES, V38, P666, DOI 10.1038/hr.2015.62; Laffer B, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00430; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Liraz-Zaltsman S, 2021, J NEUROTRAUM, V38, P2003, DOI 10.1089/neu.2020.7015; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Moye LS, 2019, CEPHALALGIA, V39, P77, DOI 10.1177/0333102418777507; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Noto T, 2006, J VET MED SCI, V68, P803, DOI 10.1292/jvms.68.803; Qiu L, 2009, IMMUNOLOGY, V128, pe325, DOI 10.1111/j.1365-2567.2008.02966.x; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Shemer A, 2020, IMMUNITY, V53, P1033, DOI 10.1016/j.immuni.2020.09.018; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Tokami H, 2013, BRAIN RES, V1517, P122, DOI 10.1016/j.brainres.2013.04.022; Tripathy D, 2010, NEUROBIOL AGING, V31, P8, DOI 10.1016/j.neurobiolaging.2008.03.009; Tweedie D, 2020, ELIFE, V9, DOI 10.7554/eLife.55827; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	44	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	OCT	2021	46								102067	10.1016/j.redox.2021.102067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC1TD	WOS:000704045500001	34315111	Green Published, gold			2022-02-06	
J	Ishijima, T; Nakajima, K				Ishijima, Takashi; Nakajima, Kazuyuki			Inflammatory cytokines TNF alpha, IL-1 beta, and IL-6 are induced in endotoxin- stimulated microglia through different signaling cascades	SCIENCE PROGRESS			English	Article						Microglia; lipopolysaccharide; inflammatory cytokines; tumor necrosis factor alpha; interleukin 1beta; interleukin 6	NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; INTERLEUKIN-6 IL-6; CEREBRAL-ISCHEMIA; ACTIVATION; NEUROTOXICITY; ASTROCYTES; INHIBITOR	By using an animal model in which inflammatory cytokines are induced in lipopolysaccharide (LPS)-injected rat brain, we investigated the induction of tumor necrosis factor alpha (TNF alpha), interleukin-1beta (IL-1 beta), and IL-6. Immunoblotting and immunohistochemistry revealed that all three cytokines were transiently induced in the cerebral cortex at about 12 h after LPS injection. To clarify which glial cell type induced the cytokines, we examined the respective abilities of astrocytes and microglia in vitro. Primary microglia largely induced TNF alpha, IL-1 beta and IL-6 in response to LPS, but primary astrocytes induced only limited levels of TNF alpha. Thus, we used specific inhibitors to focus on microglia in surveying signaling molecules involved in the induction of TNF alpha, IL-1 beta, and IL-6. The experiments using mitogen-activated protein kinases (MAPK) inhibitors revealed that c-Jun N-terminal kinase (JNK)/p38, external signal regulated kinase (ERK)/JNK, and ERK/JNK/p38 are necessary for the induction of TNF alpha, IL-1 beta, and IL-6, respectively. The experiments using protein kinase C (PKC) inhibitor clarified that PKC alpha is required for the induction of all these cytokines in LPS-stimulated microglia. Furthermore, LPS-dependent IL-1 beta/IL-6 induction was suppressed by pretreatment with a nitric oxide (NO) scavenger, suggesting that NO is involved in the signaling cascade of IL-1 beta/IL-6 induction. Thus, an inducible NO synthase induced in the LPS-injected cerebral cortex might be related to the induction of IL-1 beta/IL-6 through the production of NO in vivo. Taken together, these results demonstrated that microglia induce different kinds of inflammatory cytokine through specific combinations of MAPKs and by the presence or absence of NO.	[Ishijima, Takashi; Nakajima, Kazuyuki] Soka Univ, Fac Sci & Engn, Glycan & Life Syst Integrat Ctr, Dept Sci & Engn Sustainable Innovat, 1-236 Tangi Machi, Hachioji, Tokyo 1928577, Japan		Nakajima, K (corresponding author), Soka Univ, Fac Sci & Engn, Glycan & Life Syst Integrat Ctr, Dept Sci & Engn Sustainable Innovat, 1-236 Tangi Machi, Hachioji, Tokyo 1928577, Japan.	nakajima@soka.ac.jp					Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BARRACHINA D, 1994, EUR J PHARMACOL, V262, P181, DOI 10.1016/0014-2999(94)90044-2; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bowyer JF, 2020, NEUROTOXICOLOGY, V77, P181, DOI 10.1016/j.neuro.2020.01.014; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; Choi S, 2014, NEUROSCIENCE, V257, P11, DOI 10.1016/j.neuroscience.2013.10.058; Conroy SM, 2004, J NEUROIMMUNOL, V155, P43, DOI 10.1016/j.jneuroim.2004.06.014; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; DIJKSTRA J, 1985, BIOCHIM BIOPHYS ACTA, V845, P34, DOI 10.1016/0167-4889(85)90051-5; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; GALANOS C, 1993, MEDIAT INFLAMM, V2, pS11, DOI 10.1155/S0962935193000687; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; Giannoudis PV, 2003, INJURY, V34, P397, DOI 10.1016/S0020-1383(02)00416-3; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hong J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70390-7; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; IANARO A, 1994, IMMUNOLOGY, V82, P370; Ivetic A, 2018, CELL TISSUE RES, V371, P437, DOI 10.1007/s00441-017-2774-x; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Long-Smith CM, 2010, J NEUROIMMUNOL, V226, P20, DOI 10.1016/j.jneuroim.2010.05.030; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maeda S, 2009, BRAIN RES, V1305, P1, DOI 10.1016/j.brainres.2009.09.025; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Matsuda S, 1996, NEUROSCI LETT, V204, P109, DOI 10.1016/0304-3940(96)12340-5; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Nakajima K, 2006, NEUROSCI LETT, V401, P199, DOI 10.1016/j.neulet.2006.03.014; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oshiro S, 2008, BBA-MOL BASIS DIS, V1782, P109, DOI 10.1016/j.bbadis.2007.12.002; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; PATTERSON PH, 1995, CURR OPIN NEUROBIOL, V5, P642, DOI 10.1016/0959-4388(95)80070-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfeiffer S, 1997, FREE RADICAL BIO MED, V22, P787, DOI 10.1016/S0891-5849(96)00407-8; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Quest AFG, 1996, ENZYME PROTEIN, V49, P231, DOI 10.1159/000468635; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Slowik A, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12482; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Stojkovska I, 2015, EXP BIOL MED, V240, P1387, DOI 10.1177/1535370215576313; Strniskova M, 2002, GEN PHYSIOL BIOPHYS, V21, P231; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Thier M, 1999, J NEUROSCI RES, V55, P411; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Yamamoto S, 2010, J NEUROCHEM, V115, P1057, DOI 10.1111/j.1471-4159.2010.06996.x; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	65	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0036-8504	2047-7163		SCI PROGRESS-UK	Sci. Prog.	OCT	2021	104	4							00368504211054985	10.1177/00368504211054985			21	Education, Scientific Disciplines; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Science & Technology - Other Topics	XJ4CD	WOS:000726737300001	34821182	gold			2022-02-06	
J	Jiang, HY; Li, HX; Cao, Y; Zhang, RL; Zhou, L; Zhou, Y; Zeng, XF; Wu, J; Wu, DW; Wu, DY; Guo, XB; Li, XW; Wu, HY; Li, P				Jiang, Hongyan; Li, Hengxi; Cao, Yan; Zhang, Ruilin; Zhou, Lei; Zhou, Ying; Zeng, Xiaofeng; Wu, Jia; Wu, Douwei; Wu, Deye; Guo, Xiaobing; Li, Xiaowen; Wu, Haiying; Li, Ping			Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats	BRAIN RESEARCH			English	Article						Cannabidiol; Traumatic brain injury; Blood brain barrier; Brain edema; Tight junction	SIGNALING PATHWAY; GENE-EXPRESSION; CEREBRAL EDEMA; CANNABIDIOL; ISCHEMIA; PATHOPHYSIOLOGY; HEMORRHAGE; STROKE; MODEL; AQP4	Cannabidiol is a natural herbal medicine known to protect the brain from traumatic brain injury (TBI). Here, a TBI rat model was established, with cannabidiol administered intraperitoneally at doses of 5, 10, or 20 mg/kg, 30 min before surgery and 6 h after surgery until sacrifice. Brain water content, body weight, and modified neurological severity scores were determined, and enzyme-linked immunosorbent assay, immunofluorescence staining, hematoxylin and eosin staining, Nissl staining, Evans-blue dye extravasation, and western blotting were performed. Results showed that cannabidiol decreased the number of aquaporin-4-positive and glial fibrillary acidic protein-positive cells. Cannabidiol also significantly reduced the protein levels of proinflammatory cytokines (TNF-alpha and IL-1 beta) and significantly increased the expression of tight junction proteins (claudin-5 and occludin). Moreover, cannabidiol administration significantly mitigated water content in the brain after TBI and blood-brain barrier disruption and ameliorated the neurological deficit score after TBI. Cannabidiol administration improved the integrity and permeability of the blood-brain barrier and reduced edema in the brain after TBI.	[Jiang, Hongyan; Li, Hengxi; Cao, Yan; Wu, Douwei; Guo, Xiaobing; Li, Xiaowen; Li, Ping] Kunming Med Univ, Fac Basic Med Sci, Dept Anat & Histol Embryol, Kunming 650500, Yunnan, Peoples R China; [Jiang, Hongyan] Suining Cent Hosp, Dept Pathol, Suining 629000, Peoples R China; [Zhang, Ruilin; Zeng, Xiaofeng] Kunming Med Univ, Dept Forens Med, Kunming 650500, Yunnan, Peoples R China; [Zhou, Lei] Kunming Med Univ, Biomed Engn Res Ctr, Yunnan Key Lab Stem Cell & Regenerat Med, Kunming 650500, Yunnan, Peoples R China; [Zhou, Ying] Kunming Med Univ, Dept Kunming Med Univ, Electron Microscope Lab, Kunming 650500, Yunnan, Peoples R China; [Wu, Jia] Kunming Med Univ, Dept Morphol Lab, Kunming 650500, Yunnan, Peoples R China; [Wu, Deye] Qilu Med Univ, Dept Human Anat & Histol Embryol, Zibo 255213, Shandong, Peoples R China; [Wu, Haiying] Kunming Med Univ, Affiliated Hosp 1, Dept Emergency, Kunming 650032, Yunnan, Peoples R China; [Wu, Haiying] Kunming Med Univ, Affiliated Hosp 1, Intens Care Unit, Kunming 650032, Yunnan, Peoples R China		Li, P (corresponding author), Kunming Med Univ, Fac Basic Med Sci, Dept Anat & Histol Embryol, Kunming 650500, Yunnan, Peoples R China.; Wu, HY (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Emergency, Kunming 650032, Yunnan, Peoples R China.; Wu, HY (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Intens Care Unit, Kunming 650032, Yunnan, Peoples R China.	why0209@hotmail.com; kyzplp@163.com	Zeng, Xiao/ABG-5938-2021	Jiang, Hongyan/0000-0002-8636-4766	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC)	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn).The authors wish to thank all participants for their time and patience during the experiment.	Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; [Anonymous], [No title captured], DOI 10.3389/fphar.2019.00352.s003; Arango-Davila CA, 2015, INT J NEUROSCI, V125, P936, DOI 10.3109/00207454.2014.980906; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; Batsaikhan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030502; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; Chaves YC, 2020, NEUROSCI LETT, V729, DOI 10.1016/j.neulet.2020.135020; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Gall Z, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050801; Gao W, 2018, WORLD NEUROSURG, V119, pE765, DOI 10.1016/j.wneu.2018.07.265; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Guo J, 2015, BRAIN RES, V1594, P115, DOI 10.1016/j.brainres.2014.10.046; Hajmohammadi M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01043; Hayakawa K, 2010, PHARMACEUTICALS, V3, P2197, DOI 10.3390/ph3072197; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Huang YP, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4170156; Huestis MA, 2019, CURR NEUROPHARMACOL, V17, P974, DOI 10.2174/1570159X17666190603171901; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; Kovacs GG, 2018, HAND CLINIC, V145, P13, DOI 10.1016/B978-0-12-802395-2.00003-1; Li QX, 2018, WORLD NEUROSURG, V117, pE117, DOI 10.1016/j.wneu.2018.05.202; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Mantle JL, 2018, NEUROBIOL DIS, V119, P113, DOI 10.1016/j.nbd.2018.07.030; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marmarou A, 2003, ACT NEUR S, V86, P7; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Navarria A, 2014, PHARMACOL RES, V87, P151, DOI 10.1016/j.phrs.2014.04.014; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Pazos MR, 2012, NEUROPHARMACOLOGY, V63, P776, DOI 10.1016/j.neuropharm.2012.05.034; Prieto JP, 2020, NEUROTOX RES, V38, P478, DOI 10.1007/s12640-020-00218-9; Petrosino S, 2018, J PHARMACOL EXP THER, V365, P652, DOI 10.1124/jpet.117.244368; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Song W, 2019, J TOXICOL ENV HEAL A, V82, P1045, DOI 10.1080/15287394.2019.1686215; Song YM, 2019, NEURAL REGEN RES, V14, P1796, DOI 10.4103/1673-5374.257534; Stark T, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.114004; Sun J, 2020, NEUROPSYCH DIS TREAT, V16, P1217, DOI 10.2147/NDT.S233622; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tan ZJ, 2020, ANN CLIN TRANSL NEUR, V7, P742, DOI 10.1002/acn3.51044; Tao YH, 2015, BRAIN RES, V1602, P127, DOI 10.1016/j.brainres.2015.01.025; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Vose LR, 2013, J NEUROSCI, V33, P17232, DOI 10.1523/JNEUROSCI.2713-13.2013; Wagner EJ, 2016, FRONT NEUROENDOCRIN, V40, P101, DOI 10.1016/j.yfrne.2016.01.003; Wang LX, 2013, ANN NEUROL, V73, P189, DOI 10.1002/ana.23762; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu P, 2019, J TOXICOL ENV HEAL A, V82, P1036, DOI 10.1080/15287394.2019.1684707; Wu P, 2018, J TOXICOL ENV HEAL A, V81, P1108, DOI [10.1080/15287394.2018.1503073, 10.1080/15287394.2018.1504385]; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Zhang L, 2020, BRAIN RES BULL, V157, P26, DOI 10.1016/j.brainresbull.2020.01.019; Zhang YM, 2019, J CELL BIOCHEM, V120, P17584, DOI 10.1002/jcb.29025; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	75	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2021	1768								147586	10.1016/j.brainres.2021.147586			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UE4UN	WOS:000687885400004	34289379				2022-02-06	
J	Jones, C; Smith-MacDonald, L; Bremault-Phillips, S				Jones, Chelsea; Smith-MacDonald, Lorraine; Bremault-Phillips, Suzette			Perceptions of Canadian Armed Forces Health Services health care professionals on cognitive assessment processes	JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH			English	Article						CAF; Canadian Armed Forces; cognition; cognitive assessment; concussion; implementation science; mental health; military; mTBI; TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MILITARY	LAY SUMMARY Canadian Armed Forces (CAF) Service Members (SMs) experience mild traumatic brain injuries (mTBI) which can affect cognitive functioning. Adequate cognitive functioning is needed to perform military duties safely and function in all aspects of life. A standardized process that includes cognitive screen/assessment within an mTBI rehabilitation strategy is not widely utilized within Canadian Forces Health Services (CFHS). A qualitative thematic analysis nested within an implementation science approach was used to explore the experiences of 17 CFHS health care professionals who perform cognitive screens/assessments. Perceived facilitators, barriers, and recommendations for improving cognitive assessment practices for injured CAF-SMs were identified within five themes. Development and implementation of cognitive screen/assessment policies and protocols will enable CFHS to best assess and treat cognitive dysfunction among CAF-SMs. Introduction: Canadian Armed Forces (CAF) service members (CAF-SMs) experience a higher prevalence of mild traumatic brain injuries (mTBI) compared with Canadian civilians. As cognitive dysfunction may be experienced after injury or illness, assessment of cognitive functioning is necessary to ensure CAF-SMs can safely and efficiently perform their duties post-injury. Effective treatment and rehabilitation to address cognitive dysfunction can be prescribed once reliable, valid, specific, and evidence-based cognitive screening/assessment are performed by health care professionals. To date, a standardized process that includes cognitive screen/assessment within an mTBI rehabilitation strategy is not widely utilized within Canadian Forces Health Services (CFHS). The objective of this study was to explore the experiences of CFHS health care professionals who perform cognitive screens/assessments, identifying specifically: 1) perceptions of facilitators and barriers to cognitive assessment practices and 2) recommendations for improving the practice of cognitive assessment for injured CAF-SMs. Methods: A qualitative thematic analysis, nested within an implementation science approach, was performed. Seventeen CFHS health care professionals were interviewed, with the data being transcribed, coded, and analyzed. Results: Themes focused on facilitators, barriers, and recommendations associated with: 1) education and knowledge of clinicians and staff regarding mTBI and cognitive screens/assessments, 2) multidisciplinary collaboration, 3) stigma, awareness, and attitudes of CAF-SMs, 4) availability of resources, and 5) cognitive screen/assessment tools. Discussion: Development and implementation of cognitive screen/assessment policies and protocols will enable CFHS health care professionals to best assess, treat, and rehabilitate cognitive dysfunction among CAF-SMs.	[Jones, Chelsea; Smith-MacDonald, Lorraine; Bremault-Phillips, Suzette] Univ Alberta, Heroes Mind Advocacy & Res Consortium, Edmonton, AB, Canada		Jones, C (corresponding author), Univ Alberta, Fac Rehabil Med, Heroes Mind Advocacy & Res Consortium, 8205-114 St, Edmonton, AB T6G 2G4, Canada.	cweiman@ualberta.ca					Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Bernthal EMM, 2015, J ROY ARMY MED CORPS, V161, P3, DOI 10.1136/jramc-2015-000527; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Creswell J, 1997, QUAL INQ; Department of National Defence, 2017, SURG GEN INT HLTH ST; Doneva SP, 2018, J MIL VETERAN FAM HL, V4, P121, DOI [10.3138/jmvfh.2017-0012, DOI 10.3138/JMVFH.2017-0012]; Donkervoort M, 2001, NEUROPSYCHOL REHABIL, V11, P549, DOI 10.1080/09602010143000093; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Ely, 2020, MILITARY BEHAV HLTH, V9, P119, DOI [10.1080/21635781.2020.1803163, DOI 10.1080/21635781.2020.1803163]; Fixsen D.L., 2005, IMPLEMENTATION RES S, V231; GARBER B, 2016, BMJ-BRIT MED J, V6, P1, DOI DOI 10.1136/BMJOPEN-2015-010780; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Gordon WA., 1993, ADV STROKE REHABILIT, P162; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Jones C, 2019, J MIL VETERAN FAM HL, V5, P131, DOI 10.3138/jmvfh.2018-0005; Larner AJ, 2017, COGNITIVE SCREENING, Vsecond; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Mahoney N., 2019, CAN I MIL VET HLTH R; Malloy PF, 1997, J NEUROPSYCH CLIN N, V9, P189; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Roux FE, 2003, J NEUROSURG, V99, P716, DOI 10.3171/jns.2003.99.4.0716; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42	34	0	0	0	0	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA		2368-7924		J MIL VETERAN FAM HL	J. Mil. Veteran Fam. Hlth.	OCT 1	2021	7	3					6	19		10.3138/jmvfh-2020-0066			14	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	XQ1BX	WOS:000731289600004					2022-02-06	
J	Jorda, EV; Cantallops, AE; Molina, AG				Jorda, Elia Vilageliu; Cantallops, Antonia Ensenat; Molina, Alberto Garcia			Non-pharmacological intervention in post-traumatic amnesia, a systematic review	REVISTA DE NEUROLOGIA			Spanish	Article						Agitation; Behaviour; Cognition; Post-traumatic amnesia; Traumatic brain injury; Treatment	TRAUMATIC BRAIN-INJURY; REALITY ORIENTATION PROGRAM; ACUTE-CARE; DURATION; RECOVERY; MEMORY; RECOMMENDATIONS; REHABILITATION; MANAGEMENT; COGNITION	Introduction. Survivors of traumatic brain injury may experience a transient state of confusion and global disturbance of cognitive-behavioural functioning called post-traumatic amnesia. Aim. To describe the characteristics, methodological quality and main results of studies that have analysed the impact of non-pharmacological interventions in the treatment of symptoms associated with post-traumatic amnesia. Patients and methods. Following the PRISMA guidelines, a literature search was carried out on papers published in the PubMed and Psyclnfo databases over the last 20 years (2000-2020). The methodological quality of the articles was assessed using the PEDro scale. Results. After applying the inclusion and exclusion criteria, of the 1,036 potentially interesting articles, eight met the eligibility criteria, four of which were randomised clinical trials. The interventions applied were grouped as follows: structured retraining of activities of daily living (four studies), reality orientation programme (two studies), Perceive, Recall, Plan and Perform system (one study) and therapeutic application of music (one study). Seven of the eight articles reviewed showed positive or partially positive results. Conclusions. According to the results obtained, there is evidence that non-pharmacological interventions have positive effects on reducing the cognitive-behavioural signs and symptoms associated with post-traumatic amnesia.	[Jorda, Elia Vilageliu; Cantallops, Antonia Ensenat; Molina, Alberto Garcia] Inst Univ Neurorehabil UAB, Inst Guttmann, Barcelona, Spain; [Jorda, Elia Vilageliu; Cantallops, Antonia Ensenat; Molina, Alberto Garcia] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain; [Jorda, Elia Vilageliu; Cantallops, Antonia Ensenat; Molina, Alberto Garcia] Univ Autonoma Barcelona, Barcelona, Spain; [Molina, Alberto Garcia] Univ Diego Portales, Ctr Estudios Neurociencia Humana & Neuropsiol, Fac Psicol, Santiago, Chile		Jorda, EV (corresponding author), Inst Univ Neurorehabil Guttmann UAB, Cami Can Ruti S-N, E-08916 Badalona, Spain.	eliavllageliug1@gmail.com					Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; [Anonymous], 2007, ABIKUS EV BAS REC RE; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Baker F, 2001, J MUSIC THER, V38, P170, DOI 10.1093/jmt/38.3.170; Centro Cochrane Iberoamericano, MAN COCHR REV SIST I; Chen NYC, 2019, BRAIN INJURY, V33, P1087, DOI 10.1080/02699052.2019.1610797; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; Divita C, 2017, BRAIN INJURY, V31, P1840, DOI 10.1080/02699052.2017.1346288; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Garcia-Molina A, 2015, REHABILITACION MADR, V49, P144; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jacobs B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-69; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Langhorn L, 2015, J NEUROSCI NURS, V47, pE2, DOI 10.1097/JNN.0000000000000106; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li CMF, 2019, J TRAUMA ACUTE CARE, V86, P1033, DOI 10.1097/TA.0000000000002233; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Mortimer D, 2019, ARCH PHYS MED REHAB, V100, P648, DOI 10.1016/j.apmr.2018.08.184; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Roberts CM, 2015, NEUROPSYCHOLOGY, V29, P522, DOI 10.1037/neu0000178; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shores EA, 2008, GLASGOW COMA SCALE G; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2019, NEUROPSYCHOL REHABIL, V29, P1655, DOI 10.1080/09602011.2018.1441033; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Turner-Stokes L, 2019, J HEAD TRAUMA REHAB, V34, P205, DOI 10.1097/HTR.0000000000000473; Watanabe TK, 1998, BRAIN INJURY, V12, P81; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2; Zencius AH, 1998, BRAIN INJURY, V12, P53, DOI 10.1080/026990598122854	43	0	0	1	1	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	OCT	2021	73	7					223	232		10.33588/rn.7307.2020625			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WC6HB	WOS:000704356100001	34569032				2022-02-06	
J	Kamali, A; Mahmodiyeh, B; Jamalian, SM; Kishani, A; Dalvand, M				Kamali, Alireza; Mahmodiyeh, Behnam; Jamalian, Seyed Mohammad; Kishani, Anahita; Dalvand, Mohsen			The effect of methylphenidate on the level of consciousness and weaning from the ventilator in patients with brain injury in the intensive care unit	ANAESTHESIA PAIN & INTENSIVE CARE			English	Article						Methylphenidate; Brain Injury; Intensive Care unit; Glasgow Comma Scale; APACHE II score	DOUBLE-BLIND; REHABILITATION	Introduction: Brain injury is the one of the leading cause of death and disability in the most active sections of society, especially in people under 45 y. The prevalence and severity of traumatic brain injury is rising in the Iranian population. The clinical effects of methylphenidate in improving treatment outcomes and cognitive function in this set of patients have been demonstrated in some studies. We conducted this clinical trial to assess the efficacy of methylphenidate in improving the level of consciousness and weaning from the ventilator in patients with brain injury in the intensive care unit. Methodology: This clinical trial study was performed on 90 intubated patients admitted to the intensive care unit of Valiasr Hospital in Arak, Iran. The patients were randomly divided into two groups. Patients in the intervention group (Group M) received methylphenidate 0.3 mg/kg twice daily, in addition to the routine drugs that the control group (Group C) received. All patients were compared for ventilator isolation, Glasgow Comma Scale (GCS) and APACHE II. The results were compared and analyzed in the two groups using SPSS software version 22. Results: The mean age of the patients in methylphenidate and control groups was 34.20 +/- 7.87 y and 34.53 +/- 8.31 y, respectively. There was no significant difference between the two groups in terms of age and gender (p > 0.05). The mean APACHE II score on the first and third day in Group M was 15.98 +/- 1.70 and 13.73 +/- 1.72, while in the Group C it was 16.02 +/- 1.75 and 13.87 +/- 1.84, respectively (p > 0.554) . The GCS in the Group M was significantly and rapidly normalized (p < 0.0001). The mean duration of intubation in methylphenidate and Group Cs was 7.18 +/- 0.83 and 9.8 +/- 1.04 days, respectively. This time was significantly lower in the Group M (p < 0.0001). Conclusion: The use of methylphenidate in patients with traumatic brain injury on mechanical ventilation in the intensive care unit is associated with a reduced duration of intubation and early return of the level of consciousness to normal.	[Kamali, Alireza; Mahmodiyeh, Behnam] Arak Univ Med Sci, Dept Anesthesiol & Crit Care, Arak, Iran; [Jamalian, Seyed Mohammad] Arak Univ Med Sci, Dept Forens Med & Poisoning, Arak, Iran; [Kishani, Anahita] Arak Univ Med Sci, Student Res Comm, Arak, Iran; [Dalvand, Mohsen] Arak Univ Med Sci, Dept Neurosurg, Arak, Iran		Kamali, A (corresponding author), Arak Univ Med Sci, Dept Anesthesiol & Crit Care, Arak, Iran.	alirezakamali849@gmail.com					Calil AM, 2009, REV LAT-AM ENFERM, V17, P120, DOI 10.1590/S0104-11692009000100019; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Husson I, 2004, NEUROSCIENCE, V125, P163, DOI 10.1016/j.neuroscience.2004.01.010; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kajs-Wyllie Marylyn, 2002, J Neurosci Nurs, V34, P303; Khalili HA, 2008, PROGR NEUROTHERAPEUT, V3, P189; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Volz TJ, 2008, CURR NEUROPHARMACOL, V6, P379, DOI 10.2174/157015908787386041; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632	17	0	0	0	0	ANAESTHESIA PAIN & INTENSIVE CARE	ISLAMABAD	C/O TARIQ HAYAT KHAN, ED, 60-A, NAZIM-UD-DIN RD, ISLAMABAD, 00000, PAKISTAN	1607-8322	2220-5799		ANAESTH PAIN INTENSI	Anaesth. Pain Intensive Care	OCT	2021	25	5					643	646		10.35975/apic.v25i5.1633			5	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	WG1XO	WOS:000706791400016					2022-02-06	
J	Khan, MP; Anwar, M				Khan, Muhammad Pervez; Anwar, Muhammad			Determine the Outcome of Traumatic Extradural Hematoma and to Compare the Outcome of Small and Large Size Extradural Hematoma	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Traumatic Brain Injury; Extradural Hematoma; Glasgow Outcome Score	HEAD-INJURY; MANAGEMENT; HEMORRHAGE; LESIONS; VOLUME	Objective: The aim of this study is to determine the outcome of traumatic extradural hematoma and to compare the outcome of small and large size extradural hematoma. Study Design: Descriptive case study Place and Duration: Study was conducted at the department of Neurosurgery, Saidu Teaching Hospital, Saidu Sharif, Swat for duration of two years from January 2016 to December 2017. Methods: Total one hundred and forty patients of both genders with ages 2-70 years were presented. Patients had traumatic extradural hematoma within duration first 24 hours were included and admitted through the emergency department. Detailed demographics of enrolled cases age, sex, GCS on arrival and cause of injury were recorded after taking informed written consent. CT scan of all the patients was done for diagnosis. Glasgow Outcome Score (GOS) was used for determination of outcomes. SPSS 23.0 version was used to analyze the data. Results: There were 110 (78.6%) male patients and 30 (21.4%) patients were females. Mean age of the patients was 32.78 +/- 10.43 years. RTA was the most common cause found in 84 (60%) followed by falling 29 (20.7%) and assault in 27 (19.3%). Small size hematoma volume among 100 (71.4%) cases and large size was in 40 (28.6%) patients. According to Glasgow outcome score, 24 (17.1%) cases had 1-3 score and 116 (82.9%) cases had 4-5 score. Mean GOS was 4.01 +/- 1.12. We found successful outcomes among 116 (82.9%) cases in which majority of the patients were from small size extradural hematoma. Conclusion: We concluded in this study that a significant relationship exists between the volume of extradural hematoma and both the clinical and functional outcome. Prognosis becomes increasingly worse with rising extradural hematoma size.	[Khan, Muhammad Pervez] Saidu Med Coll, Dept Neurosurg, Swat, Pakistan; [Khan, Muhammad Pervez] Saidu Teaching Hosp, Swat, Pakistan; [Anwar, Muhammad] Sir Syed Coll Med Sci, Neurosurg, Karachi, Pakistan		Khan, MP (corresponding author), Saidu Med Coll, Dept Neurosurg, Swat, Pakistan.; Khan, MP (corresponding author), Saidu Teaching Hosp, Swat, Pakistan.	doctorpk68@gmail.com					Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P198, DOI 10.4103/0974-2700.82206; Deverill J, 2007, EMERG MED AUSTRALAS, V19, P325, DOI 10.1111/J.1742-6723.2007.00969.x; Dubey A, 2004, NEUROL INDIA, V52, P443; Haque ME, 2017, J SCI FDN, V15, P52; Khairat A, 2021, STATPEARLS; Korinth M, 2002, UNFALLCHIRURG, V105, P224, DOI 10.1007/s001130100316; Lloyd DA, 2005, ANN ROY COLL SURG, V87, P323, DOI 10.1308/003588405X51191; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; Marcus EM, 2003, NONVASCULAR SYNDROME, P597; MCKISSOCK W, 1961, LANCET, V2, P221; Mezue Wilfred C, 2012, Niger J Surg, V18, P80, DOI 10.4103/1117-6806.103111; Mishra A, 2001, NEUROL INDIA, V49, P94; Rincon S, 2016, HAND CLINIC, V135, P447, DOI 10.1016/B978-0-444-53485-9.00022-2; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Sanders MJ, 2001, MOSBYS PARAMEDIC TXB, V2nd; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SKULL IT, REG INJ FOR MED TOX; Tariq Muhammad, 2021, PAK J NEUROL SURG, V25, P134; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332	20	0	0	0	0	LAHORE MEDICAL RESEARCH CENTER LLP	LAHORE	590, Karim Block, Allama Iqbal Town, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	OCT	2021	15	10					3363	3365		10.53350/pjmhs2115103363			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XO8DQ	WOS:000730409600040		Bronze			2022-02-06	
J	Kousi, C; Lampri, E; Voulgaris, S; Vougiouklakis, T; Galani, V; Mitselou, A				Kousi, Chrysavgi; Lampri, Evangeli; Voulgaris, Spyridon; Vougiouklakis, Theodoros; Galani, Vassiliki; Mitselou, Antigony			Expression of orexin-A (hypocretin-A) in the hypothalamus after traumatic brain injury: A postmortem evaluation	FORENSIC SCIENCE INTERNATIONAL			English	Article						traumatic brain injury; diffuse axonal injury; immunohistochemistry; orexin-A; beta-APP	DIFFUSE AXONAL INJURY; BETA-APP; HEAD-INJURY; NEURONS; DAMAGE; SLEEP; WAKEFULNESS; DIAGNOSIS; RECOVERY; AROUSAL	Traumatic brain injury (TBI) is one of the leading causes of mortality and morbidity. The key component of TBI pathophysiology is traumatic axonal injury (TAI), commonly referred to as diffuse axonal injury (DAI). Coma is a serious complication which can occur following traumatic brain injury (TBI). Recently, studies have shown that the central orexinergic/ hypocretinergic system exhibit prominent arousal promoting actions. Therefore, the purpose of this study is to investigate by immunohistochemistry the expression of beta-amyloid precursor protein (beta-APP) in white matter of parasagittal region, corpus callosum and brainstem and the expression of orexin-A (ORXA) in the hypothalamus after traumatic brain injury. Results: DAI was found in 26 (53.06%) cases, assessed with beta-APP immunohistochemical staining in parasagittal white matter, corpus callosum and brainstem. Orexin-A immunoreactivity in hypothalamus was completely absent in 5 (10.2%) of the cases; moderate reduction of ORXA was observed in 9 (18.4%) of the cases; and severe reduction was observed in 7 (14.3%) of the cases. A statistically significant correlation was found between beta-APP immunostaining in white matter, corpus callosum and brainstem in relation to survival time (p < 0.002, p < 0.003 and p < 0.005 respectively). A statistically positive correlation was noted between ORX-A immunoreactivity in hypothalamus to survival time (p < 0.003). An inverse correlation was noted between the expression of beta-APP in the regions of brain studied to the expression of ORX-A in the hypothalamus of the cases studied (p < 0.005). Conclusions: The present study demonstrated by immunohistochemistry that reduction of orexin-A neurons in the hypothalamus, involved in coma status and arousal, enhanced the immunoexpression of beta-APP in parasagital white matter, corpus callosum and brainstem. (C) 2021 Elsevier B.V. All rights reserved.	[Kousi, Chrysavgi; Vougiouklakis, Theodoros; Mitselou, Antigony] Univ Ioannina, Sch Med, Dept Forens Med & Toxicol Hlth Sci, Ioannina, Greece; [Lampri, Evangeli] Univ Ioannina, Sch Med, Dept Pathol Hlth Sci, Ioannina, Greece; [Voulgaris, Spyridon] Univ Ioannina, Sch Med, Dept Neurosurg Hlth Sci, Ioannina, Greece; [Galani, Vassiliki] Univ Ioannina, Dept Anat Histol Embryol, Ioannina 45100, Greece		Galani, V (corresponding author), Univ Ioannina, Sch Med, Dept Anat Histol Embryol, Univ Campus, Ioannina 45100, Greece.	vgalani@uoi.gr					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adeghate E, 2012, VITAM HORM, V89, P111, DOI 10.1016/B978-0-12-394623-2.00007-X; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Christopher JA, 2012, PHARM PAT ANAL, V1, P329, DOI [10.4155/ppa.12.27, 10.4155/PPA.12.27]; Davceva N, 2017, J FORENSIC LEG MED, V48, P35, DOI 10.1016/j.jflm.2017.04.004; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gotter AL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-90; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Iino M, 2003, INT J LEGAL MED, V117, P153, DOI 10.1007/s00414-003-0370-y; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Moreno-Balandran E, 2008, EUR J NEUROSCI, V28, P331, DOI 10.1111/j.1460-9568.2008.06334.x; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peyron C, 1998, J NEUROSCI, V18, P9996; Piper DC, 2000, EUR J NEUROSCI, V12, P726, DOI 10.1046/j.1460-9568.2000.00919.x; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Thomasy HE, 2019, J NEUROTRAUM, V36, P802, DOI 10.1089/neu.2018.5810; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Vittoz NM, 2008, EUR J NEUROSCI, V28, P1629, DOI 10.1111/j.1460-9568.2008.06453.x; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zhong YJ, 2015, MOL MED REP, V12, P4441, DOI 10.3892/mmr.2015.3898	40	0	0	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	OCT	2021	327								110961	10.1016/j.forsciint.2021.110961			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	WK2GB	WOS:000709548200011	34454377				2022-02-06	
J	Lang, J; Wang, LY; Wu, QH				Lang, Ji; Wang, Liyun; Wu, Qianhong			Theoretical study of oscillating squeezing flow through a porous medium	TRIBOLOGY INTERNATIONAL			English	Article						Porous media; Squeezing flow; Oscillation	INTERSTITIAL FLUID PRESSURIZATION; CONSTANT NORMAL FORCE; SUBARACHNOID SPACE; PARALLEL PLATES; JOURNAL BEARING; FILM FLOW; LUBRICATION; TRABECULAE; DYNAMICS; SUBJECT	In this paper, we report a theoretical study of a transient squeezing flow through a thin porous gap driven by an oscillating boundary. The process is governed by the viscous, inertial, and Darcy effects. It shows that when the squeezing depth increases, the alternating dominance of the viscous and inertial effects would increase the oscillation of the velocity profiles. The existence of the porous media effectively stabilizes the fluid field. The study presented herein, revealing the fundamental physics of an oscillating squeezing flow, has significant potential for biomedical and industrial applications, such as the cerebrospinal fluid flow under concussion and the oil film lubrication in journal bearings.	[Lang, Ji; Wu, Qianhong] Villanova Univ, Cellular Biomech & Sports Sci Lab, Villanova, PA 19085 USA; [Lang, Ji; Wu, Qianhong] Villanova Univ, Dept Mech Engn, 800 Lancaster Ave, Villanova, PA 19085 USA; [Wang, Liyun] Univ Delaware, Dept Mech Engn, Newark, DE 19716 USA		Wu, QH (corresponding author), Villanova Univ, Cellular Biomech & Sports Sci Lab, Villanova, PA 19085 USA.; Wu, QH (corresponding author), Villanova Univ, Dept Mech Engn, 800 Lancaster Ave, Villanova, PA 19085 USA.	qianhong.wu@villanova.edu			National Science Foundation CBET Fluid Dynamics Program, U.S.National Science Foundation (NSF) [1511096]	This research was performed in partial fulfillment of the requirements for the Ph.D. degree from Villanova University by Ji Lang. Mr. Ji is supported by the National Science Foundation CBET Fluid Dynamics Program, U.S. under Award #1511096.	Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; Benko N, 2020, J ANAT, V237, P275, DOI 10.1111/joa.13186; Bhattacharjee B, 2019, TRIBOL INT, V138, P415, DOI 10.1016/j.triboint.2019.06.025; Cicone T, 2019, TRIBOL INT, V138, P140, DOI 10.1016/j.triboint.2019.02.018; Darcy H, 1856, FONTAINES PUBLIQUES; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Gacka T, 2017, J FLUID MECH, V818, P5, DOI 10.1017/jfm.2017.133; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; HAMDAN MH, 1994, APPL MATH COMPUT, V62, P203, DOI 10.1016/0096-3003(94)90083-3; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13157-2; Ishizawa, 1966, B JSME, V9, P533, DOI 10.1299/jsme1958.9.533; Jackson JD., 1963, APPL SCI RES, V11, P148, DOI [10.1007/BF03184719, DOI 10.1007/BF03184719]; Karmakar T, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5025882; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Krishnan R, 2004, J ORTHOP RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002; Lang J, 2019, TRIBOL INT, V135, P259, DOI 10.1016/j.triboint.2019.02.046; Lang J, 2019, J FLUID ENG-T ASME, V141, DOI 10.1115/1.4042758; Lang J, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4999071; Laun HM, 1999, J NON-NEWTON FLUID, V81, P1, DOI 10.1016/S0377-0257(98)00083-4; LAWRENCE CJ, 1985, J FLUID MECH, V156, P479, DOI 10.1017/S0022112085002208; Leardini A, 2005, GAIT POSTURE, V21, P212, DOI 10.1016/j.gaitpost.2004.05.002; LEIDER PJ, 1974, IND ENG CHEM FUND, V13, P336, DOI 10.1021/i160052a007; Liao JJ, 2021, COMPUT METH PROG BIO, V203, DOI 10.1016/j.cmpb.2021.106053; Liao JJ, 2020, TRIBOL INT, V145, DOI 10.1016/j.triboint.2020.106185; Liao JJ, 2019, J MECH BEHAV BIOMED, V95, P153, DOI 10.1016/j.jmbbm.2019.04.008; Livesey J.L., 1960, International Journal of Mechanical Sciences, V1, P84, DOI 10.1016/0020-7403(60)90031-X; MODEST MF, 1978, J LUBRIC TECH-T ASME, V100, P323, DOI 10.1115/1.3453180; Mortazavi MM, 2018, WORLD NEUROSURG, V111, P279, DOI 10.1016/j.wneu.2017.12.041; Moss EA, 2011, J FLUID MECH, V671, P384, DOI 10.1017/S0022112010005756; Naduvinamani NB, 2001, TRIBOL INT, V34, P739, DOI 10.1016/S0301-679X(01)00064-0; Pascovici MD, 2003, TRIBOL INT, V36, P791, DOI 10.1016/S0301-679X(03)00095-1; Roemer DB, 2015, J FLUID ENG-T ASME, V137, DOI 10.1115/1.4029683; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Saboori P, 2010, IFMBE PROC, V32, P440, DOI 10.1007/978-3-642-14998-6_112; Salerno L, 2020, PHYS REV FLUIDS, V5, DOI 10.1103/PhysRevFluids.5.043102; SANGANI AS, 1982, INT J MULTIPHAS FLOW, V8, P193, DOI 10.1016/0301-9322(82)90029-5; Scheidl R, 2016, J FLUID ENG-T ASME, V138, DOI 10.1115/1.4032299; Singh A, 2021, MECCANICA, V56, P73, DOI 10.1007/s11012-020-01259-2; Sorge F, 2018, J VIB ACOUST, V140, DOI 10.1115/1.4038946; Soro N, 2019, J MECH BEHAV BIOMED, V97, P149, DOI 10.1016/j.jmbbm.2019.05.019; Stefan J., 1875, ANNELEN PHYSIK, V230, P316, DOI [10.1002/andp.18752300213, DOI 10.1002/ANDP.18752300213]; Talbert DG, 2016, J TRAUMA TREAT, V4, P3; TICHY JA, 1978, J LUBRIC TECH-T ASME, V100, P316, DOI 10.1115/1.3453179; TSAY RY, 1991, J FLUID MECH, V226, P125, DOI 10.1017/S0022112091002318; WANG CY, 1976, J APPL MECH-T ASME, V43, P579, DOI 10.1115/1.3423935; WEINBAUM S, 1985, J FLUID MECH, V156, P463, DOI 10.1017/S0022112085002191; WU H, 1970, J LUBR TECHNOL, V92, P593, DOI 10.1115/1.3451481; Wu Q, 2005, J FLUID MECH, V542, P281, DOI 10.1017/S0022112005006294; Xiang L, 2016, NONLINEAR DYNAM, V86, P1057, DOI 10.1007/s11071-016-2946-3; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; YANG SM, 1993, J TRIBOL-T ASME, V115, P632, DOI 10.1115/1.2921687; Zhang SL, 2019, TRIBOL INT, V132, P185, DOI 10.1016/j.triboint.2018.10.043; Zhou HL, 2020, TRIBOL INT, V145, DOI 10.1016/j.triboint.2020.106168; Zhu ZH, 2019, TRIBOL INT, V137, P246, DOI 10.1016/j.triboint.2019.05.003; Zhu ZH, 2017, CHEM ENG SCI, V173, P525, DOI 10.1016/j.ces.2017.08.021	55	0	0	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	OCT	2021	162								107110	10.1016/j.triboint.2021.107110			10	Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	TI1VM	WOS:000672572900001					2022-02-06	
J	Lee, HJ; Kim, H; Kim, YT; Won, K; Czosnyka, M; Kim, DJ				Lee, Hack-Jin; Kim, Hakseung; Kim, Young-Tak; Won, Kanghee; Czosnyka, Marek; Kim, Dong-Joo			Prediction of Life-Threatening Intracranial Hypertension During the Acute Phase of Traumatic Brain Injury Using Machine Learning	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Predictive models; Machine learning; Brain modeling; Monitoring; Windows; Standards; Hypertension; Clinical outcome; Intracranial hypertension; Traumatic brain injury; Neuromonitoring; Machine learning	WAVE-FORM; AUTOREGULATORY INDEXES; PRESSURE; THRESHOLDS; REACTIVITY; MANAGEMENT; CARE	Intracranial hypertension (IH) following acute phase traumatic brain injury (TBI) is associated with high mortality. Objective: This study proposes a novel parameter that may identify a potentially life-threatening IH (LTH) event and designs a machine learning model to predict LTH. Continuous recordings of intracranial pressure (ICP) and arterial blood pressure (ABP) from 273 TBI patients were used as the development dataset. The pressure-time dose (PTD) and pressure reactivity index (PRx) were calculated for each IH event, and an IH event with PRx > 0 and PTD > 5 was considered an LTH event. The association between the LTH parameters accumulated over five days and mortality was analyzed. A categorical boosting (CatBoost) model was employed to predict the occurrence of a future LTH event from the onset of IH using the ABP- and ICP-related parameters. Training and validation were performed on a total of 5,938 IH events. External performance evaluation was performed in 307 IH events included in the Cerebral Haemodynamic Autoregulatory Information System (CHARIS) database. The performance of the proposed model was evaluated through the area under the receiver operating characteristic curve (AUROC). The LTH parameters were able to distinguish between the deceased and surviving patients (AUROC > 0.7, p < 0.001). The CatBoost model predicted LTH with an AUROC = 0.7 on the external test dataset. This study demonstrated that the proposed LTH prediction model has a reasonable predictive capacity for mortality. The CatBoost model anticipates whether an IH event will develop into an LTH event. The findings of this study support the usefulness of ICP monitoring.	[Lee, Hack-Jin; Kim, Hakseung; Kim, Young-Tak; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul 02841, South Korea; [Lee, Hack-Jin] DoAI Inc, R&D Team, Seongnam Si 13449, South Korea; [Won, Kanghee] Samsung Elect, Samsung Adv Inst Technol, Multimedia Proc Lab, Suwon 16678, South Korea; [Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, PL-00665 Warsaw, Poland; [Kim, Dong-Joo] Korea Univ, Coll Med, Dept Neurol, Seoul 02841, South Korea		Kim, DJ (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul 02841, South Korea.	hjlee1109@korea.ac.kr; mkhsm@korea.ac.kr; kyt3426@korea.ac.kr; james.kh.won@gmail.com; mc141@medschl.cam.ac.uk; dongjookim@korea.ac.kr		Kim, Hakseung/0000-0001-5407-293X	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science and ICT, MSIT) [2019R1A2C1003399, 2020R1C1C1006773]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1561]; Korea University Grant	Manuscript received July 26, 2020; revised October 27, 2020, February 24, 2021, and April 9, 2021; accepted May 27, 2021. Date of publication June 1, 2021; date of current version October 5, 2021. This work was supported in part by the National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science and ICT, MSIT) under Grants 2019R1A2C1003399 and 2020R1C1C1006773, and in part by a Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea under Grant HI17C1561; and a Korea University Grant. (Corresponding author: Dong-Joo Kim.)	Andrew G., 2013, INT C MACHINE LEARNI, P1247; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Conroy Bryan, 2012, JMLR Workshop Conf Proc, V22, P246; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 2005, ACT NEUR S, V95, P341; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2012, INTENS CARE MED, V38, P925, DOI 10.1007/s00134-012-2572-6; Donnelly J, 2020, NEUROCRIT CARE, V32, P437, DOI 10.1007/s12028-019-00748-x; Dorogush AV, 2018, CATBOOST GRADIENT BO; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Gulin A., 2018, ADV NEURAL INFORM PR, P6638, DOI DOI 10.5555/3327757.3327770; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; Hassan MA, 2017, APPL ENERG, V203, P897, DOI 10.1016/j.apenergy.2017.06.104; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Huang GM, 2019, J HYDROL, V574, P1029, DOI 10.1016/j.jhydrol.2019.04.085; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jones PA, 2003, PHYSIOL MEAS, V24, P201, DOI 10.1088/0967-3334/24/1/315; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kalagara S, 2019, J NEUROSURG-SPINE, V30, P344, DOI 10.3171/2018.8.SPINE1869; Kim H, 2019, J NEUROSURG, V131, P1887, DOI 10.3171/2018.7.JNS18995; Kim H, 2018, J NEUROSURG ANESTH, V30, P347, DOI 10.1097/ANA.0000000000000462; Kim N, 2016, J CLIN MONIT COMPUT, V30, P821, DOI 10.1007/s10877-015-9779-3; Koyner JL, 2018, CRIT CARE MED, V46, P1070, DOI 10.1097/CCM.0000000000003123; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lundberg S.M, 2019, EXPLAINABLE AI TREES; Lundberg SM, 2017, ADV NEUR IN, V30; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Melville P, 2004, LECT NOTES COMPUT SC, V3077, P293; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Scalzo F, 2012, MED ENG PHYS, V34, P1058, DOI 10.1016/j.medengphy.2011.11.010; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; Tsui F.-C., 1995, P 17 INT C ENG MED B, P1045; Vellido A, 2020, NEURAL COMPUT APPL, V32, P18069, DOI 10.1007/s00521-019-04051-w; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Xie YA, 2019, AM J ROENTGENOL, V212, P44, DOI 10.2214/AJR.18.20260; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2021, J NEUROSURG ANESTH, V33, P28, DOI 10.1097/ANA.0000000000000616; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129	52	0	0	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	OCT	2021	25	10					3967	3976		10.1109/JBHI.2021.3085881			10	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	WC2SH	WOS:000704111100032	34061756				2022-02-06	
J	LeGoff, DB; Wright, R; Lazarovic, J; Kofeldt, M; Peters, A				LeGoff, Daniel B.; Wright, Roslyn; Lazarovic, Jacob; Kofeldt, Miranda; Peters, Aimee			Improving Outcomes for Work-Related Concussions A Mental Health Screening and Brief Therapy Model	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article						assessment; brief therapy; cognitive behavioral therapy; concussion; intervention; mental health; mild head injury; mild traumatic brain injury; postconcussional syndrome; return-to-work; screening; telehealth; work-related cognitive-behavioral therapy	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; SLEEP DISTURBANCE; HEAD-INJURY; DIAGNOSTIC-CRITERIA; RISK-FACTORS; SYMPTOMS; PREDICTORS; EXAGGERATION; SEVERITY	Objective: This study assessed the efficacy of a neurocognitive screening evaluation and brief therapy model to improve RTW outcomes for workers who experienced mild head injuries. Methods: Patients referred were evaluated using a neurocognitive and psychological screening battery. Work-focused cognitive behavioral therapy was provided when appropriate, addressing the role of negative emotional adjustment and functional sleep disturbance in prolonging recovery. Results: Average time to RTW was 7 weeks post-evaluation, despite workers being off an average of 10 months between injury and referral dates. Overall, 99% were released to full-duty work without restrictions or accommodations. Conclusions: This study demonstrates the favorable outcomes achieved via a structured, clinically driven program for workers who experience head-involved injuries, validating previous research on the importance of recognizing the role of psychological factors in prolonging concussion recovery.	[LeGoff, Daniel B.; Wright, Roslyn; Lazarovic, Jacob; Kofeldt, Miranda; Peters, Aimee] Ascellus Hlth Inc, 9400 4th St North,Suite 201, St Petersburg, FL USA		LeGoff, DB (corresponding author), Ascellus Hlth, 9400 4th St N Suite 201, St Petersburg, FL 33702 USA.	dlegoff@ascellus.com					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American College of Occupational and Environmental Medicine, 2017, ACOEM PRACT GUID TRA; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2006, J OCCUP ENVIRON MED, V48, P972, DOI 10.1097/01.jom.0000235915.61746.0d; Arango-Lasprilla JC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9062007; Ashendorf L, 2019, J CLIN EXP NEUROPSYC, V41, P432, DOI 10.1080/13803395.2019.1567693; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Calvillo M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01423; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ EP; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAN IN; Centers for Disease Control and Prevention, 1999, C TRAUM BRAIN INJ US; Chen J, 2020, HEALTH SERV INSIGHTS, V13, DOI 10.1177/1178632920938674; Choi Mi Suk, 2013, Korean J Audiol, V17, P13, DOI 10.7874/kja.2013.17.1.13; Chu SY, 2017, BRAIN INJURY, V31, P1674, DOI 10.1080/02699052.2017.1332783; Dadas Aaron, 2018, Concussion, V3, pCNC53, DOI 10.2217/cnc-2017-0019; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Gaudet LA, 2019, OCCUP MED-OXFORD, V69, P419, DOI 10.1093/occmed/kqz089; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2019, J CLIN EXP NEUROPSYC, V41, P497, DOI 10.1080/13803395.2019.1585518; Lilley R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-995; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Moore P., 2017, COCHRANE DB SYST REV, V2017, DOI [10.1002/14651858.CD012755, DOI 10.1002/14651858.CD012755]; Mosti C, 2016, NEUROL-CLIN PRACT, V6, P129, DOI 10.1212/CPJ.0000000000000225; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Ontario Neurotrauma Foundation, 2018, GUID CONC TRAUM BRAI, V3rd; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2020, J HEAD TRAUMA REHAB, V35, P117, DOI 10.1097/HTR.0000000000000510; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Prins A, 2016, J GEN INTERN MED, V31, P1206, DOI 10.1007/s11606-016-3703-5; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Reiley Alexander S, 2017, Arch Physiother, V7, P12, DOI 10.1186/s40945-017-0040-x; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sahyouni Ronald, 2017, J Concussion, V1, DOI 10.1177/2059700216684518; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Sheese ALN, 2014, PROG NEUROL SURG, V28, P149, DOI 10.1159/000358775; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Terry DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198128; Thastum MM, 2019, ECLINICALMEDICINE, V17, DOI 10.1016/j.eclinm.2019.11.007; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Vikane E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00639; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; Zwibel H, 2018, J AM OSTEOPATH ASSOC, V118, P655, DOI 10.7556/jaoa.2018.144	85	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	OCT	2021	63	10					E701	E714		10.1097/JOM.0000000000002350			14	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	WI7BA	WOS:000708511300008	34412089	Green Published, hybrid			2022-02-06	
J	Lele, AV; To-adithep, P; Chanthima, P; Lakireddy, V; Vavilala, MS				Lele, Abhijit V.; To-adithep, Puriwat; Chanthima, Phuriphong; Lakireddy, Viharika; Vavilala, Monica S.			Correlation Between Brain Trauma Foundation Guidelines and Published Severe Traumatic Brain Injury Research	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; severe; guidelines; evidence; publications		Four editions of the Brain Trauma Foundation's (BTF) evidence-based guidelines have been published to guide clinical management after severe traumatic brain injury (TBI) and increase TBI research. We reviewed the association between published clinical severe TBI research and BTF guideline year of publication and guideline chapter topics. Using PubMed, we searched for peer-reviewed articles on severe TBI research published between 1975 and 2019. The frequency and study design of publications on chapter topics included in all 4 BTF guideline editions was collected and the relationship with published TBI research examined using linear regression and the coefficient of determination (r (2)). A total of 845 relevant articles were identified, with an average of 19 articles published per year. There was an increase in the overall number of publications (r (2)=0.72), with the largest increase occurring between the third and the fourth guideline editions (r (2)=0.70, 31 articles/y). Across all 4 guideline editions, 54% (n=460) of publications were retrospective studies, 27.2% (n=230) prospective studies, 12% (n=101) randomized controlled trials, and 7.6% (n=64) meta-analyses/systematic reviews. Publication of retrospective study numbers increased the most (r (2)=0.61), followed by prospective observational studies and meta-analyses/systematic reviews (r (2)=0.47 each), and randomized controlled trials (r (2)=0.39). The 3 most highly published guideline chapter topic areas were ventilator-associated pneumonia (r (2)=0.70), hyperosmolar therapy (r (2)=0.47), and decompressive craniectomy (r (2)=0.41). In summary, the TBI research output increased over time and was associated with BTF guideline release. However, the increase in published TBI research was not consistent between serial editions of the BTF guidelines, and many studies did not incorporate high-quality prospective research designs.	[Lele, Abhijit V.] Univ Washington, Neurocrit Care Serv, Harborview Med Ctr, Seattle, WA 98195 USA; [Lele, Abhijit V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pediat, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [To-adithep, Puriwat; Chanthima, Phuriphong; Lakireddy, Viharika] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [To-adithep, Puriwat] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand		Lele, AV (corresponding author), Univ Washington, Neurocrit Care Serv, Harborview Med Ctr, Seattle, WA 98195 USA.	abhijit2@uw.edu			Aqueduct Critical Care	L. received research support from Aqueduct Critical Care and receives salary support from LifeCenter Northwest. The remaining authors have no conflicts of interest to disclose.	*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P561; Brain Trauma Foundation, 2016, US; Brain Trauma Foundation, 2016, GUIDELINES MANAGEMEN, V4th; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2017, TRAUMATIC BRAIN INJU; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Distiller SR., 2018, SYSTEMATIC REV LIT R; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Khormi YH, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0140-1; StataCorp, 2017, STAT IC VERS 151; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474	12	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2021	33	4					323	328		10.1097/ANA.0000000000000684			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	UR2BP	WOS:000696559100007	32149889				2022-02-06	
J	McLaughlin, D; Anderson, L; Guo, JH; McNett, M				McLaughlin, Diane; Anderson, Lisa; Guo, Jinhong; McNett, Molly			Serial Optic Nerve Sheath Diameter via Radiographic Imaging Correlation With ICP and Outcomes	NEUROLOGY-CLINICAL PRACTICE			English	Article							COMPUTED-TOMOGRAPHY; INTRACRANIAL-PRESSURE	Objective Evaluation of optic nerve sheath diameter (ONSD) is a suggested correlation of intracranial pressure (ICP) and potential predictor of outcome after neurologic injury. Studies have evaluated sonographic measurement of ONSD; however, clinical limitations to this approach persist. Evaluation of ONSD measurements via routine brain CT imaging is less studied but offers potential for detection of increased ICP in the absence of invasive monitoring. Previous studies have used cross-sectional approaches to ONSD measurements via CT scan among patients with traumatic brain injury (TBI). No studies have evaluated serial correlations between CT ONSD measurements and ICP throughout hospitalization and across diagnosis types. The objective of this study was to investigate correlations between ONSD via serial CT imaging, ICP, and outcome at discharge among patients with neurologic injury. Methods This is a retrospective cohort study of all adult patients admitted during a 12-month period with acute neurologic injury requiring ICP monitoring and critical care admission. Results N = 48. There was a strong, positive correlation between right/left ONSD across time points (r = 0.7-9, p < 0.001), suggesting a consistent bilateral response. Correlations were strongest between initial inpatient CT scan ONSD readings and ICP (r = 0.5, p < 0.05), but decreased over time. Patients with increased ICP across all diagnosis types experienced higher ONSD values on presentation to the emergency department (ED) and throughout hospitalization (range 5.7-6.4 mm, p < 0.05). Conclusions Findings contribute to the utility of CT ONSD measurements as a potential indicator of increased ICP. Measurement of ONSD during serial CT brain imaging may inform clinical decisions regarding need for more invasive monitoring after neurologic injury.	[McLaughlin, Diane] Mayo Clin, Dept Crit Care, Jacksonville, FL 32224 USA; [Anderson, Lisa] MetroHealth, Dept Neurosurg, Cleveland, OH USA; [Guo, Jinhong] Ohio State Univ, Columbus, OH 43210 USA; [McNett, Molly] Ohio State Univ, Helene Fuld Hlth Trust Natl Inst Evidence Based P, Columbus, OH 43210 USA		McLaughlin, D (corresponding author), Mayo Clin, Dept Crit Care, Jacksonville, FL 32224 USA.	mclaughlin.diane@mayo.edu					Chacko J, 2014, INDIAN J CRIT CARE M, V18, P707, DOI 10.4103/0972-5229.144007; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Frumin E, 2014, WEST J EMERG MED, V15, P217, DOI 10.5811/westjem.2013.9.16191; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Lee HC, 2018, CLIN NEUROL NEUROSUR, V167, P31, DOI 10.1016/j.clineuro.2018.02.012; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Lim TK, 2017, J TRAUMA INJ, V30, P140, DOI [10.20408/jti.2017.30.4.140, DOI 10.20408/JTI.2017.30.4.140]; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Sonmez BM, 2019, J NATL MED ASSOC, V111, P210, DOI 10.1016/j.jnma.2018.10.009; Turkin A M, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P81, DOI 10.17116/neiro201781681-88; Wang LJ, 2018, JAMA OPHTHALMOL, V136, P250, DOI 10.1001/jamaophthalmol.2017.6560	15	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	OCT	2021	11	5					E620	E626		10.1212/CPJ.0000000000001038			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WN5PV	WOS:000711820300018	34840875				2022-02-06	
J	Mei, ZR; Hong, Y; Yang, HY; Sheng, QY; Situ, B				Mei, Zhengrong; Hong, Ye; Yang, Haiyi; Sheng, Qiongyu; Situ, Bing			Huperzine A protects against traumatic brain injury through anti- oxidative effects via the Nrf2-ARE pathway	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Huperzine A; Neuroprotection; Nrf2-ARE; Oxidative stres; Traumatic brain injuries	SKELETAL-MUSCLE; STRESS; ACTIVATION; EXPRESSION; ISCHEMIA; CELLS	Objective(s): Traumatic brain injury (TBI) is a prominent health problem worldwide and it may lead to cognitive dysfunction, disability, and even death. To date, there is no effective treatment for TBI. Our previous study showed that Huperzine A (HupA) improved cognitive function in a mouse model of TBI. However, the detailed mechanism of HupA remains unaddressed. In this study, we investigated the possible mechanism of the neuroprotective effect of HupA. Materials and Methods: C57BL/6 mice were randomly divided into 3 groups as sham, injured with vehicle treatment, and injured with HupA treatment groups. The Morris water maze task was used to evaluate the impairment of special learning and memory. Brain edema was as-sessed by measuring the wet weight to dry weight ratio. Malondialdehyde (MDA) and glutathione peroxidase (GPx) levels were measured for oxidative stress. Protein expressions of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygen-ase-1(HO-1), and synaptophysin were detected by Western blot. The brain sections were stained with hematoxylin-eosin (H&E) for histology study. Results: We found that HupA therapy improved histology and cognitive functional outcomes after TBI. HupA reduced brain edema in TBI mice. furthermore, HupA inhibited ox-idative stress. HupA promoted nuclear factor erythroid 2-related factor 2 (Nrf2) nu-clear translocation and activated Nrf2 after TBI. Conclusion: HupA protects against TBI through antioxidative effects via the Nrf2-ARE pathway.	[Mei, Zhengrong; Situ, Bing] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Dept Pharm, Guangzhou 510150, Guangdong, Peoples R China; [Hong, Ye; Yang, Haiyi; Sheng, Qiongyu] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China		Situ, B (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Dept Pharm, Guangzhou 510150, Guangdong, Peoples R China.	843234573@qq.com			Project of Traditional Chinese Medicine Bureau of Guangdong Province [20212136]	This work was supported by a grant from the Project of Traditional Chinese Medicine Bureau of Guangdong Province (20212136).	[Anonymous], 2017, BIOMED CHROMATOGR, P31; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Gao F, 2021, AM J TRANSL RES, V13, P1483; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Howes MJR, 2011, DRUG AGING, V28, P439, DOI 10.2165/11591310-000000000-00000; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lei XF, 2016, MOL MED REP, V13, P412, DOI 10.3892/mmr.2015.4534; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Liu Y, 2020, J ALZHEIMERS DIS, V76, P491, DOI 10.3233/JAD-200188; Liu Y, 2015, J NEUROL SCI, V351, P88, DOI 10.1016/j.jns.2015.02.045; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mao XY, 2016, CELL MOL NEUROBIOL, V36, P915, DOI 10.1007/s10571-015-0276-5; Mei ZR, 2017, METAB BRAIN DIS, V32, P1861, DOI 10.1007/s11011-017-0075-4; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Peng L, NOVEL ASSAY DETERMIN; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005; Sarkozy M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01648; Shen J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01133; Sheng L, 2016, ACTA PHARMACOL SIN, V37, P994, DOI 10.1038/aps.2016.24; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Turkseven CH, 2017, LIFE SCI, V184, P47, DOI 10.1016/j.lfs.2017.07.012; Wang CY, 2011, NEUROPSYCHOPHARMACOL, V36, P1073, DOI 10.1038/npp.2010.245; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Whitman SA, 2013, EXP CELL RES, V319, P2673, DOI 10.1016/j.yexcr.2013.07.015; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Xu SS, 1999, ACTA PHARMACOL SIN, V20, P486; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yang MY, 2019, PHARMACOL RES, V144, P227, DOI 10.1016/j.phrs.2019.04.023; Ye JW, 1999, J PHARMACOL EXP THER, V288, P814; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhao ZB, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9436; Zhu HF, 2018, J CELL BIOCHEM, V119, P8359, DOI 10.1002/jcb.26919	39	0	0	3	3	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	OCT	2021	24	10					1455	1461		10.22038/IJBMS.2021.58169.12932			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	WC0YN	WOS:000703990500017	35096305				2022-02-06	
J	Mercier, LJ; Kowalski, K; Fung, TS; Joyce, JM; Yeates, KO; Debert, CT				Mercier, Leah J.; Kowalski, Kristina; Fung, Tak S.; Joyce, Julie M.; Yeates, Keith Owen; Debert, Chantel T.			Characterizing Physical Activity and Sedentary Behavior in Adults With Persistent Postconcussive Symptoms After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Depression; Exercise; Fatigue; Quality of life; Rehabilitation	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; INDIVIDUALS; DEPRESSION; EXERCISE; FATIGUE; ASSOCIATION; PREVALENCE; VALIDITY; SLEEP	Objective: To evaluate physical activity (PA) and sedentary behavior and their associations with symptom and quality of life outcomes in adults with persistent postconcussive symptoms (PPCS) after mild traumatic brain injury (mTBI). Design: Cross-sectional cohort study. Setting: Outpatient brain injury clinic. Participants: Consecutive sample of adults (N=180) with a diagnosis of mTBI and PPCS. Interventions: Not applicable. Main Outcome Measures: PA and sedentary behavior were assessed using the Godin Leisure-Time Exercise Questionnaire and Rapid Assessment Disuse Index, respectively. Participants were dichotomized according to whether they completed 150 minutes of moderate-to-vigorous PA per week, based on Canadian guidelines. Postinjury moderate-to-vigorous PA was also analyzed as a continuous variable. Results: Prior to injury, 85% of participants reported meeting PA guidelines, compared with 28% postinjury. Individuals meeting PA guidelines postinjury reported higher quality of life (h2p=0.130; P<.001) and lower scores on measures of functional impact of headache (h2p=0.065; P=.009), fatigue (h2p=0.080; P=.004), depression (h2p=0.085; P=.001), and anxiety (h2p=0.046; P=.031), compared with those not meeting guidelines. Sedentary behavior postinjury was negatively correlated with quality of life (rs[127]=-0.252; P=.004) and positively correlated with symptom burden (rs[167]=0.227; P=.003), fatigue (rs[127]=0.288; P=.001), depression (rs[174]=0.319; P<.001), and anxiety (rs[127]=0.180; P=.042). Conclusions: PA was significantly decreased in individuals with PPCS compared to preinjury levels. Meeting PA guidelines postinjury was associated with better clinical outcomes, suggesting that returning individuals to PA should be considered in the treatment of this patient population. Archives of Physical Medicine and Rehabilitation 2021;102:1918-25 (c) 2021 The American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.	[Mercier, Leah J.; Debert, Chantel T.] Univ Calgary, Dept Clin Neurosci, Div Phys Med & Rehabil, 1403 29 St NW, Calgary, AB T2N 2T9, Canada; [Kowalski, Kristina; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Fung, Tak S.] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Joyce, Julie M.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Yeates, Keith Owen; Debert, Chantel T.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Debert, Chantel T.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada		Mercier, LJ (corresponding author), Univ Calgary, Dept Clin Neurosci, Div Phys Med & Rehabil, 1403 29 St NW, Calgary, AB T2N 2T9, Canada.	leah.mercier@ucalgary.ca					Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; Boberska M, 2018, HEALTH PSYCHOL REV, V12, P195, DOI 10.1080/17437199.2017.1396191; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carr ECJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081472; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Christie AD, 2016, EXP GERONTOL, V77, P7, DOI 10.1016/j.exger.2016.02.001; Eyl RE, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0934-7; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Hamilton M, 2016, BRAIN INJURY, V30, P819, DOI 10.3109/02699052.2016.1146962; Hart Peter D, 2017, J Prev Med Public Health, V50, P10, DOI 10.3961/jpmph.16.080; Herring MP, 2018, EUR CHILD ADOLES PSY, V27, P1425, DOI 10.1007/s00787-018-1134-z; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120950682; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Ross R, 2020, APPL PHYSIOL NUTR ME, V45, pS57, DOI 10.1139/apnm-2020-0467; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Shuval K, 2014, BRIT J SPORT MED, V48, P250, DOI 10.1136/bjsports-2013-092901; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sikes EM, 2019, DISABIL REHABIL, V41, P1243, DOI 10.1080/09638288.2018.1424956; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thiel DM, 2017, CAN J DIABETES, V41, P58, DOI 10.1016/j.jcjd.2016.07.004; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; van Markus-Doornbosch F, 2019, EUR J PAEDIATR NEURO, V23, P53, DOI 10.1016/j.ejpn.2018.11.002; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; World Health Organization, 1993, ICD 10 CLASS MENT BE	50	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2021	102	10					1918	+		10.1016/j.apmr.2021.05.002			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WK2DU	WOS:000709542300007	34044001				2022-02-06	
J	Mizobuchi, H; Yamamoto, K; Yamashita, M; Inagawa, H; Kohchi, C; Soma, G				Mizobuchi, Haruka; Yamamoto, Kazushi; Yamashita, Masashi; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro			Prevention of streptozotocin-induced Neuro-2a cell death by C8-B4 microglia transformed with repetitive low-dose lipopolysaccharide	MOLECULAR MEDICINE REPORTS			English	Article						neuroprotection; immunomodulation; neurotrophin-4; 5; tyrosine kinase receptor B; diabetes-associated; pretreatment	DEPENDENT INSULINOTROPIC POLYPEPTIDE; TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAYS; ACTIVATION; NEUROPROTECTION; EXPRESSION; RECEPTOR; DISEASE; MODEL; BDNF	Diabetes-associated neuronal dysfunction (DAND) is one of the serious complications of diabetes, but there is currently no remedy for it. Streptozotocin [2-deoxy-2-(3-methy1-3-nitrosoureido) D-glucopyranose; STZ] is one of the most well-established diabetes inducers and has been used in vivo and in vitro DAND models. The aim of the present study was to demonstrate that C8-B4 microglia transformed by the stimulus of repetitive low-dose lipopolysaccharide (LPSx3-microglia) prevent STZ-induced Neuro-2a neuronal cell death in vitro. The ELISA results showed that neurotrophin-4/5 (NT-4/5) secretion was promoted in LPSx3-microglia and the cell viability assay with trypan blue staining revealed that the culture supernatant of LPSx3-microglia prevented STZ-induced neuronal cell death. In addition, reverse transcription-quantitative PCR showed that neurons treated with the culture supernatant of LPSx3-microglia promoted the gene expression of B-cell lymphoma-extra large and glucose-dependent insulinotropic polypeptide receptor. Furthermore, the inhibition of tyrosine kinase receptor B, a receptor of NT-4/5, suppressed the neuroprotective effect of LPSx3-microglia. Taken together, the present study demonstrated that LPSx3-microglia prevent STZ-induced neuronal death and that NT-4/5 may be involved in the neuroprotective mechanism of LPSx3-microglia.	[Mizobuchi, Haruka; Yamamoto, Kazushi; Yamashita, Masashi; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Collaborat Innovat Partnership, Control Innate Immun, 2217-16 Hayashi Cho, Takamatsu, Kagawa 7610301, Japan; [Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Macrophi Inc, Takamatsu, Kagawa 7610301, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata 9560864, Japan		Mizobuchi, H (corresponding author), Collaborat Innovat Partnership, Control Innate Immun, 2217-16 Hayashi Cho, Takamatsu, Kagawa 7610301, Japan.	mizobuchi@shizenmeneki.org		Mizobuchi, Haruka/0000-0002-6667-4820	Control of Innate Immunity, Collaborative Innovation Partnership; Council for Science from Technology and Innovation in the Cabinet Office of the Japanese Government [SIP 14533073]; National Agriculture and Food Research Organization	The present study was funded by the Control of Innate Immunity, Collaborative Innovation Partnership and supported by a grant from the Cross-ministerial Strategic Innovation Promotion Program (grant no. SIP 14533073) from the Council for Science from Technology and Innovation in the Cabinet Office of the Japanese Government and the National Agriculture and Food Research Organization.	Ajmone-Cat MA, 2003, J NEUROCHEM, V87, P1193, DOI 10.1046/j.1471-4159.2003.02087.x; Batista CRA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092293; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7; Biswas J, 2016, MOL NEUROBIOL, V53, P2794, DOI 10.1007/s12035-015-9144-z; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; Deng Isaac, 2020, Brain Behav Immun Health, V4, P100060, DOI 10.1016/j.bbih.2020.100060; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; Feldman EL, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0092-1; Grieb P, 2016, MOL NEUROBIOL, V53, P1741, DOI 10.1007/s12035-015-9132-3; Hayakawa K, 2014, J NEUROSCI RES, V92, P1647, DOI 10.1002/jnr.23448; Isaev NK, 2018, TOXICOL APPL PHARM, V348, P99, DOI 10.1016/j.taap.2018.04.024; Javed S, 2015, THER ADV CHRONIC DIS, V6, P15, DOI 10.1177/2040622314552071; Ji CH, 2016, REV NEUROSCIENCE, V27, P61, DOI 10.1515/revneuro-2015-0021; Kalwat MA., 2018, BDNF TRKB SIGNALING; Kanda N, 2005, J PHARMACOL EXP THER, V315, P796, DOI 10.1124/jpet.105.091645; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machalinska A, 2013, INVEST OPHTH VIS SCI, V54, P8292, DOI 10.1167/iovs.13-12221; Malik SZ, 2011, J NEUROTRAUM, V28, P415, DOI 10.1089/neu.2010.1487; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Mizobuchi H, 2021, NEURAL REGEN RES, V16, P1928, DOI 10.4103/1673-5374.308067; Mizobuchi H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65998-8; Naseri R, 2019, DARU, V27, P781, DOI 10.1007/s40199-019-00289-w; Ohgomori T, 2020, NEUROPHARMACOLOGY, V176, DOI 10.1016/j.neuropharm.2020.108227; Park JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171322; Pepe G, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1011-6; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; R Core Team, 2020, R LANG ENV STAT COMP; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sakharnova TA, 2012, NEUROCHEM J+, V6, P251, DOI 10.1134/S1819712412030129; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Slomiany BL., 2018, J BIOSCI MED, V6, P63; Spielman LJ, 2017, EUR J CELL BIOL, V96, P240, DOI 10.1016/j.ejcb.2017.03.004; Sun P, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00145; Tuvikene J, 2016, J NEUROSCI, V36, P1290, DOI 10.1523/JNEUROSCI.3360-15.2016; Twayana KS, 2019, J CELL PHYSIOL, V234, P1889, DOI 10.1002/jcp.27064; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Ye Y., 2020, ENDOCRINES, V1, P22; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Zhan XH, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00042	46	0	0	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2021	24	4							687	10.3892/mmr.2021.12328			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	UA9KH	WOS:000685472700001	34328201				2022-02-06	
J	Moody, JF; Adluru, N; Alexander, AL; Field, AS				Moody, Jason F.; Adluru, Nagesh; Alexander, Andrew L.; Field, Aaron S.			The Connectomes: Methods of White Matter Tractography and Contributions of Resting State fMRI	SEMINARS IN ULTRASOUND CT AND MRI			English	Article							TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; COGNITIVE IMPAIRMENT; NETWORK ORGANIZATION; DIFFUSION MRI; GRAPH-THEORY; AUTISM; CHILDREN	A comprehensive mapping of the structural and functional circuitry of the brain is a major unresolved problem in contemporary neuroimaging research. Diffusion-weighted and functional MRI have provided investigators with the capability to assess structural and functional connectivity in-vivo, driven primarily by methods of white matter tractography and resting-state fMRI, respectively. These techniques have paved the way for the construction of the functional and structural connectomes, which are quantitative representations of brain architecture as neural networks, comprised of nodes and edges. The connectomes, typically depicted as matrices or graphs, possess topological properties that inherently characterize the strength, efficiency, and organization of the connections between distinct brain regions. Graph theory, a general mathematical framework for analyzing networks, can be implemented to derive metrics from the connectomes that are sensitive to changes in brain connectivity associated with age, sex, cognitive function, and disease. These quantities can be assessed at either the global (whole brain) or local levels, allowing for the identification of distinct regional connectivity hubs and associated localized brain networks, which together serve crucial roles in establishing the structural and functional architecture of the brain. As a result, structural and functional connectomes have each been employed to study the brain circuitry underlying early brain development, neuroplasticity, developmental disorders, psychopathology, epilepsy, aging, neurodegenerative disorders, and traumatic brain injury. While these studies have yielded important insights into brain structure, function, and pathology, a precise description of the innate relationship between functional and structural networks across the brain remains unachieved. To date, connectome research has merely scratched the surface of potential clinical applications and related characterizations of brain-wide connectivity. Continued advances in diffusion and functional MRI acquisition, the delineation of functional and structural networks, and the quantification of neural network properties in specific brain regions, will be invaluable to future progress in neuroimaging science. Semin Ultrasound CT MRI 42:507-522 (c) 2021 Elsevier Inc. All rights reserved.	[Moody, Jason F.; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Moody, Jason F.; Adluru, Nagesh; Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Adluru, Nagesh; Field, Aaron S.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA		Field, AS (corresponding author), Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA.	AField@uwhealth.org					Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; [Anonymous], 2016, FUNDAMENTALS BRAIN N, P89, DOI [10.1016/b978-0-12-407908-3.00003-0, DOI 10.1016/B978-0-12-407908-3.00003-0]; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Azadbakht H, 2015, CEREB CORTEX, V25, P4299, DOI 10.1093/cercor/bhu326; Balardin JB, 2015, J PSYCHIATR RES, V69, P142, DOI 10.1016/j.jpsychires.2015.08.003; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bennett SH, 2018, NEUROSCI BIOBEHAV R, V88, P51, DOI 10.1016/j.neubiorev.2018.03.001; Blanken LME, 2017, PSYCHIAT RES-NEUROIM, V263, P127, DOI 10.1016/j.pscychresns.2017.03.015; Boguna M, 2009, NAT PHYS, V5, P74, DOI [10.1038/nphys1130, 10.1038/NPHYS1130]; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Collins JA, 2017, BRAIN, V140, P457, DOI 10.1093/brain/aww313; Contreras Joey A, 2015, Curr Behav Neurosci Rep, V2, P234; Cope TE, 2018, BRAIN, V141, P550, DOI 10.1093/brain/awx347; Descoteaux M., 2015, HIGH ANGULAR RESOLUT, DOI [10.1002/047134608X.W8258, DOI 10.1002/047134608X.W8258]; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Di Martino A, 2014, NEURON, V83, P1335, DOI 10.1016/j.neuron.2014.08.050; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Ecker C, 2013, MOL PSYCHIATR, V18, P435, DOI 10.1038/mp.2012.102; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engel J, 2013, CURR OPIN NEUROL, V26, P186, DOI 10.1097/WCO.0b013e32835ee5b8; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Farahani FV, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00585; Filippi M, 2020, MOL PSYCHIATR, V25, P230, DOI 10.1038/s41380-018-0067-8; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Gao W, 2015, BRAIN STRUCT FUNCT, V220, P1173, DOI 10.1007/s00429-014-0710-3; Gilmore JH, 2018, NAT REV NEUROSCI, V19, P123, DOI 10.1038/nrn.2018.1; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Goni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058070; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haneef Z, 2012, EPILEPSY BEHAV, V25, P350, DOI 10.1016/j.yebeh.2012.07.019; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Hausman HK, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00177; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He J, 2020, COMP MULTIPLE TRACTO, DOI [10.1101/2020.09.19.304758, DOI 10.1101/2020.09.19.304758]; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Huang H, 2015, CEREB CORTEX, V25, P1389, DOI 10.1093/cercor/bht335; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Itahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094115; Jiang XY, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0467-9; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Keown CL, 2017, BIOL PSYCHIAT-COGN N, V2, P66, DOI 10.1016/j.bpsc.2016.07.008; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kupper H, 2015, NEUROPEDIATRICS, V46, P72, DOI 10.1055/s-0034-1395346; Kurtzke JF, 1992, ARCH NEUROL-CHICAGO, V49, P342, DOI [10.1001/archneur.1992.00530280020007, DOI 10.1001/ARCHNEUR.1992.00530280020007]; Lariviere S, 2020, EPILEPSIA, V61, P1221, DOI 10.1111/epi.16540; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee Jaime, 2012, PERSPECT NEUROPHYSIO, V22, P90, DOI [10.1044/nnsld22.3.90, DOI 10.1044/NNSLD22.3.90]; Lilja Y, 2014, EPILEPSY RES, V108, P481, DOI 10.1016/j.eplepsyres.2014.01.017; Liu Y, 2017, RADIOLOGY, V282, P534, DOI 10.1148/radiol.2016152843; Losnegard A, 2011, INT SYMP IMAGE SIG, P497; Luft CD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00132; Lv H, 2018, AM J NEURORADIOL, V39, P1390, DOI 10.3174/ajnr.A5527; Madole JW, 2021, BIOL PSYCHIAT, V89, P795, DOI 10.1016/j.biopsych.2020.06.010; Maier-Hein KH, 2015, ALZHEIMERS DEMENT, V11, P485, DOI 10.1016/j.jalz.2014.04.518; Mandelli ML, 2016, BRAIN, V139, P2778, DOI 10.1093/brain/aww195; Markett S, 2018, BRAIN IMAGING BEHAV, V12, P238, DOI 10.1007/s11682-017-9688-9; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mesfin FB, 2021, DIFFUSE AXONAL INJUR; Misic B, 2016, CEREB CORTEX, V26, P3285, DOI 10.1093/cercor/bhw089; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neher PF, 2017, NEUROIMAGE, V158, P417, DOI 10.1016/j.neuroimage.2017.07.028; Oghabian MA, 2010, J RES MED SCI, V15, P84; Osmanhoglu Y, 2019, NEUROIMAGE, V199, P93, DOI 10.1016/j.neuroimage.2019.05.064; Owen JP, 2016, BRAIN CONNECT, V6, P548, DOI 10.1089/brain.2016.0431; Owen JP, 2015, NEUROIMAGE, V109, P402, DOI 10.1016/j.neuroimage.2015.01.007; Pandya S, 2017, J ALZHEIMERS DIS, V55, P1639, DOI 10.3233/JAD-160090; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Payabvash S, 2019, BRAIN CONNECT, V9, P209, DOI 10.1089/brain.2018.0658; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Raizman R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65948-4; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Redcay E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00573; Reid AT, 2016, NEUROIMAGE, V125, P311, DOI 10.1016/j.neuroimage.2015.10.057; Roine U, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0058-4; Rosenthal G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04614-w; Roux AM, 2012, AM J PREV MED, V43, pS457, DOI 10.1016/j.amepre.2012.08.011; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Sadeghi M, 2017, PSYCHIAT RES-NEUROIM, V263, P48, DOI 10.1016/j.pscychresns.2017.02.004; Sarwar T, 2019, MAGN RESON MED, V81, P1368, DOI 10.1002/mrm.27471; Schilling KG, 2020, BRAIN STRUCT FUNCT, V225, P2387, DOI 10.1007/s00429-020-02129-z; Schopf V, 2012, INT J DEV NEUROSCI, V30, P11, DOI 10.1016/j.ijdevneu.2011.10.006; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shah P, 2019, BRAIN, V142, P1955, DOI 10.1093/brain/awz125; Shi Y, 2017, MOL PSYCHIATR, V22, P1230, DOI 10.1038/mp.2017.92; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smitha KA, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400917697342; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Song LM, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00561; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; St-Onge E, 2018, NEUROIMAGE, V169, P524, DOI 10.1016/j.neuroimage.2017.12.036; Staempfli P, 2006, NEUROIMAGE, V30, P110, DOI 10.1016/j.neuroimage.2005.09.027; Taylor PN, 2018, NEUROIMAGE-CLIN, V18, P202, DOI 10.1016/j.nicl.2018.01.028; Telesford QK, 2011, BRAIN CONNECT, V1, P295, DOI [10.1089/brain.2011.0055, 10.1089/brain.2011.0038]; Thomason ME, 2017, SCI REP-UK, V7, DOI 10.1038/srep39286; Tian Lin, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P716; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Turk E, 2019, J NEUROSCI, V39, P9716, DOI 10.1523/JNEUROSCI.2891-18.2019; van den Heuvel MP, 2015, CEREB CORTEX, V25, P3000, DOI 10.1093/cercor/bhu095; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Van Essen DC, 2015, WORLD PSYCHIATRY, V14, P154, DOI 10.1002/wps.20228; Vecchio F, 2017, CLIN NEUROPHYS PRACT, V2, P206, DOI 10.1016/j.cnp.2017.09.003; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang ZJ, 2015, NEUROSCIENTIST, V21, P290, DOI 10.1177/1073858414537560; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Yang S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00492; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Yeh CH, 2021, J MAGN RESON IMAGING, V53, P1666, DOI 10.1002/jmri.27188; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhan L, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/frogi.2015.00048, 10.3389/fnagi.2015.00048]; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	132	0	0	4	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0887-2171	1558-5034		SEMIN ULTRASOUND CT	Semin. Ultrasound CT MRI	OCT	2021	42	5					507	522		10.1053/j.sult.2021.07.007			16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	US9UN	WOS:000697771100008	34537118				2022-02-06	
J	Moreda, M; Beacham, PS; Reese, A; Mulkey, MA				Moreda, Melissa; Beacham, Pamela S.; Reese, Angela; Mulkey, Malissa A.			Increasing the Effectiveness of Targeted Temperature Management	CRITICAL CARE NURSE			English	Article							HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; IMPACT; RESUSCITATION; VARIABILITY; MODULATION; INDUCTION; OUTCOMES; NURSES	TOPIC Targeted temperature management and therapeutic hypothermia are essential components of the multimodal approach to caring for compromised patients after cardiac arrest and severe traumatic brain injury. PURPOSE To describe the underlying pathophysiology of fever and the importance of manipulating water temperature and of preventing and treating shivering during that process. CONTENT COVERED This article discusses nursing considerations regarding the care of patients requiring targeted temperature management that are necessary to improve patient outcomes.	[Moreda, Melissa] Duke Raleigh Hosp, Durham, NC USA; [Beacham, Pamela S.; Reese, Angela; Mulkey, Malissa A.] Univ N Carolina, Rex Hosp, Raleigh, NC USA; [Mulkey, Malissa A.] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA		Mulkey, MA (corresponding author), 35 Pearce Wood Ct, Zebulon, NC 27597 USA.	mulkeym16@gmail.com			National Institutes of Health National Research Service Award T32United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NR018407]	Malissa Mulkey is working under a postdoctoral fellowship in advanced training in self-management interventions for serious chronic conditions (National Institutes of Health National Research Service Award T32 [NR018407] ) .	Aneman A, 2018, INTENS CARE MED, V44, P940, DOI 10.1007/s00134-017-4753-9; Arvidsson L, 2017, ACTA ANAESTH SCAND, V61, P1176, DOI 10.1111/aas.12957; Badjatia N, 2007, NEUROCRIT CARE, V6, P186, DOI 10.1007/s12028-007-0011-2; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Bergan HA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1099-y; Bernard SA, 2016, CIRCULATION, V134, P797, DOI 10.1161/CIRCULATIONAHA.116.021989; Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Borgquist O, 2017, CRIT CARE MED, V45, P1337, DOI 10.1097/CCM.0000000000002367; Bougouin W, 2018, J THORAC DIS, V10, P49, DOI 10.21037/jtd.2017.12.13; Boulila C, 2016, CRIT CARE NURSE, V36, P33, DOI 10.4037/ccn2016387; Bray JE, 2017, RESUSCITATION, V113, P39, DOI 10.1016/j.resuscitation.2017.01.016; Carwell M, 2018, CRIT CARE NURS Q, V41, P102, DOI 10.1097/CNQ.0000000000000199; Constant AL, 2017, INTENS CARE MED, V43, P485, DOI 10.1007/s00134-017-4709-0; Debaty G, 2014, INTENS CARE MED, V40, P1832, DOI 10.1007/s00134-014-3519-x; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; Gebhardt K, 2013, RESUSCITATION, V84, P1062, DOI 10.1016/j.resuscitation.2013.03.038; Glover GW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1552-6; Gordon L, 2018, RESUSCITATION, V129, pE10, DOI 10.1016/j.resuscitation.2018.04.020; Greenwood JC, 2018, J THORAC DIS, V10, P10, DOI 10.21037/jtd.2017.12.26; Heap NM, 2018, THESIS U DELAWARE; Jain A, 2018, J NEUROSCI NURS, V50, P63, DOI 10.1097/JNN.0000000000000340; Kaikaew K, 2018, J THERM BIOL, V77, P137, DOI 10.1016/j.jtherbio.2018.08.016; Kim KH, 2018, RESUSCITATION, V125, P56, DOI 10.1016/j.resuscitation.2018.01.043; Kirkegaard H, 2017, JAMA-J AM MED ASSOC, V318, P341, DOI 10.1001/jama.2017.8978; Kirkegaard H, 2018, J THORAC DIS, V10, pE752, DOI 10.21037/jtd.2018.09.78; Kochanek PM, 2017, CRIT CARE MED, V45, P305, DOI 10.1097/CCM.0000000000002182; Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972; Lenhardt R, 2009, ANESTHESIOLOGY, V111, P110, DOI 10.1097/ALN.0b013e3181a979a3; May TL, 2018, RESUSCITATION, V131, P8, DOI 10.1016/j.resuscitation.2018.07.022; Nayeri A, 2017, AM J EMERG MED, V35, P889, DOI 10.1016/j.ajem.2017.01.058; Olson DM, 2013, AM J CRIT CARE, V22, P70, DOI 10.4037/ajcc2013907; Passi NN, 2019, BRIT J HOSP MED, V80, pC22, DOI 10.12968/hmed.2019.80.2.C22; Peter J, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0542-4; Presciutti M, 2012, CRIT CARE NURSE, V32, P33, DOI 10.4037/ccn2012189; Pruskowski KA, 2018, J BURN CARE RES, V39, P612, DOI 10.1093/jbcr/irx034; Scales DC, 2017, RESUSCITATION, V121, P187, DOI 10.1016/j.resuscitation.2017.10.002; Schenone AL, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012666; Schenone AL, 2016, RESUSCITATION, V108, P102, DOI 10.1016/j.resuscitation.2016.07.238; Song LJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2350974; Taccone FS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-019-2721-1; Wannemacher J, 2017, AACN ADV CRIT CARE, V28, P332, DOI 10.4037/aacnacc2017708; Wason R, 2012, INDIAN J ANAESTH, V56, P370, DOI 10.4103/0019-5049.100821; Yacono CS, 2017, JAAPA-J AM ACAD PHYS, V30, P29, DOI 10.1097/01.JAA.0000511792.75301.73	43	0	0	4	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	OCT 1	2021	41	5					59	63		10.4037/ccn2021637			5	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	WK5QW	WOS:000709781600009	34595495				2022-02-06	
J	Morrongiello, BA; Corbett, M; Bryant, L; Cox, A				Morrongiello, Barbara A.; Corbett, Michael; Bryant, Lindsay; Cox, Amanda			Understanding Infants' In-Home Injuries: Context and Correlates	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						accidents and injuries; infancy and early childhood; longitudinal research; parents	TRAUMATIC BRAIN-INJURY; YOUNG CHILDRENS RISK; UNINTENTIONAL INJURY; SEX-DIFFERENCES; PEDIATRIC INJURIES; MOTHERS; SUPERVISION; PREVENTION; BEHAVIORS; TODDLERS	Rationale Infancy is a time of elevated risk of injury. Past research has focused mostly on the type of injuries, leaving many gaps in knowledge about contextual information that could aid in injury prevention planning. Methods In this longitudinal study, a participant-event recording method was used in which mothers tracked their infants' home injuries through three motor development stages (sitting up independently, crawling, and walking). A contextual analysis elucidated where injuries occurred, their type and severity, the infant's and parent's behaviors at the time, if the infant had done the risk behavior before and been injured, the level of supervision, and the nature of any safety precautions parents implemented following these injuries. Results Injuries occurred as often in play as in nonplay areas and were due to physically-active nonplay activities more so than play activities; mothers were often doing chores. Bumps and bruises were the most common types of injuries. As infants became more mobile, supervision scores declined and injury severity scores increased. Infants had done the risk behavior leading to injury previously about 60% of the time, with higher scores associated with parents implementing fewer preventive actions in response to injury. When mothers did implement a safety precaution, greater injury severity was associated with more modifications to the environment and increased supervision; teaching about safety was infrequent. Conclusion Implications of these results for injury prevention messaging are discussed.	[Morrongiello, Barbara A.; Corbett, Michael; Bryant, Lindsay; Cox, Amanda] Univ Guelph, Psychol Dept, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada		Morrongiello, BA (corresponding author), Univ Guelph, Psychol Dept, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	bmorrong@uoguelph.ca			Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Canada Research Chair awardNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs	This research was supported by grants to the first author from the Social Sciences and Humanities Research Council. The first author was supported by a Canada Research Chair award.	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Birken Catherine S, 2004, Paediatr Child Health, V9, P323; Brussoni M, 2011, J DEV BEHAV PEDIATR, V32, P491, DOI 10.1097/DBP.0b013e31821bd1f5; Chorney JM, 2015, J PEDIATR PSYCHOL, V40, P154, DOI 10.1093/jpepsy/jsu099; Cole WG, 2016, DEV PSYCHOBIOL, V58, P341, DOI 10.1002/dev.21374; Cummings P, 2005, INJURY PREV, V11, P43, DOI 10.1136/ip.2004.006833; Curry AE, 2013, INJURY PREV, V19, P342, DOI 10.1136/injuryprev-2012-040645; Dal Santo JA, 2004, J PEDIATR PSYCHOL, V29, P273, DOI 10.1093/jpepsy/jsh029; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Gaines J, 2009, ACCIDENT ANAL PREV, V41, P1070, DOI 10.1016/j.aap.2009.06.010; GARLING A, 1993, J PEDIATR PSYCHOL, V18, P105, DOI 10.1093/jpepsy/18.1.105; Gill A. C., 2017, PEDIAT INJURY PREVEN; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.1111/j.1467-8624.1982.tb01332.x; GREAVES P, 1994, HEALTH EDUC RES, V9, P307, DOI 10.1093/her/9.3.307; Haarbauer-Krupa J, 2019, J SAFETY RES, V70, P127, DOI 10.1016/j.jsr.2019.06.003; Karazsia BT, 2011, J PSYCHOPATHOL BEHAV, V33, P386, DOI 10.1007/s10862-011-9227-8; Karazsia BT, 2010, J PEDIATR PSYCHOL, V35, P51, DOI 10.1093/jpepsy/jsp036; KOCHANSKA G, 1989, CHILD DEV, V60, P56, DOI 10.2307/1131070; Landen MG, 2003, PEDIATRICS, V111, P328, DOI 10.1542/peds.111.2.328; Longobardi C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00836; Mayes S, 2006, CHILD HEALTH CARE, V35, P269, DOI 10.1207/s15326888chc3503_5; Morrongiello B. A., 2008, HLTH PSYCHOL REV, V2, P191, DOI [10.1080/17437190902777594, DOI 10.1080/17437190902777594]; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P285, DOI 10.1093/jpepsy/jsh030; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P415, DOI 10.1093/jpepsy/jsh046; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P433, DOI 10.1093/jpepsy/jsh047; Morrongiello BA, 1998, J APPL DEV PSYCHOL, V19, P625, DOI 10.1016/S0193-3973(99)80059-8; Morrongiello BA, 2004, INJURY PREV, V10, P114, DOI 10.1136/ip.2003.003459; Morrongiello BA, 1999, J APPL DEV PSYCHOL, V20, P227, DOI 10.1016/S0193-3973(99)00015-5; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V76, P89, DOI 10.1006/jecp.2000.2572; Morrongiello BA, 2001, J PEDIATR PSYCHOL, V26, P105, DOI 10.1093/jpepsy/26.2.105; Morrongiello BA, 2008, CHILD DEV, V79, P627, DOI 10.1111/j.1467-8624.2008.01147.x; Morrongiello BA, 2006, J PEDIATR PSYCHOL, V31, P529, DOI 10.1093/jpepsy/jsj045; Morrongiello BA, 2015, J PEDIATR PSYCHOL, V40, P85, DOI 10.1093/jpepsy/jsu056; Morrongiello BA, 2014, ACCIDENT ANAL PREV, V71, P194, DOI 10.1016/j.aap.2014.04.016; Morrongiello BA, 2012, J AGROMEDICINE, V17, P149, DOI 10.1080/1059924X.2012.655127; Morrongiello BA, 2011, CAN J PUBLIC HEALTH, V102, P455, DOI 10.1007/BF03404199; Morrongiello BA, 2009, J PEDIATR PSYCHOL, V34, P1063, DOI 10.1093/jpepsy/jsp011; Morrongiello BA, 2009, SOC SCI MED, V68, P1030, DOI 10.1016/j.socscimed.2008.12.019; National Center for Injury Prevention and Control [NCIPC], 2020, WISQARS TM WEB BAS I; Nouhjah S, 2017, EMERGENCY, V5; PETERSON L, 1990, HEALTH PSYCHOL, V9, P177, DOI 10.1037/0278-6133.9.2.177; Peterson L, 2002, BEHAV THER, V33, P271, DOI 10.1016/S0005-7894(02)80029-6; PETERSON L, 1995, CHILD DEV, V66, P224, DOI 10.1111/j.1467-8624.1995.tb00867.x; Peterson L, 1999, PSYCHOL ASSESSMENT, V11, P458, DOI 10.1037/1040-3590.11.4.458; PETERSON L, 1986, J PEDIATR PSYCHOL, V11, P177, DOI 10.1093/jpepsy/11.2.177; PLESS CE, 1995, ARCH PEDIAT ADOL MED, V149, P553, DOI 10.1001/archpedi.1995.02170180083016; Pollack-Nelson Carol, 2002, Inj Control Saf Promot, V9, P121, DOI 10.1076/icsp.9.2.121.8696; Reading R, 1999, SOC SCI MED, V48, P321, DOI 10.1016/S0277-9536(98)00311-6; ROSEN BN, 1990, CLIN PSYCHOL REV, V10, P187, DOI 10.1016/0272-7358(90)90057-H; Schnitzer PG, 2015, INJURY PREV, V21, pE63, DOI 10.1136/injuryprev-2013-041128; Sleet DA, 2010, AM J LIFESTYLE MED, V4, P25, DOI 10.1177/1559827609349573; Squires J., 2009, AGES STAGES QUESTION, V3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Unni P, 2012, AM J EMERG MED, V30, P1457, DOI 10.1016/j.ajem.2011.12.001; Wang DE, 2013, INT J INJ CONTROL SA, V20, P27, DOI 10.1080/17457300.2012.656316; Xu Jiaquan, 2018, Natl Vital Stat Rep, V67, P1; Yanchar NL, 2012, PAED CHILD HEALT-CAN, V17, P511, DOI 10.1093/pch/17.9.511	58	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	OCT	2021	46	9					1025	1036		10.1093/jpepsy/jsab032			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	WK7LZ	WOS:000709906300001	34414441				2022-02-06	
J	Nazari, V; Pouladian, M; Zheng, YP; Alam, M				Nazari, Vaheh; Pouladian, Majid; Zheng, Yong-Ping; Alam, Monzurul			A Compact and Lightweight Rehabilitative Exoskeleton to Restore Grasping Functions for People with Hand Paralysis	SENSORS			English	Article						assistive device; exoskeleton; three-layered sliding spring mechanism; functional rehabilitation; hand paralysis; quadriplegia		Millions of individuals suffer from upper extremity paralysis caused by neurological disorders including stroke, traumatic brain injury, or spinal cord injury. Robotic hand exoskeletons can substitute the missing motor control and help restore the functions in daily operations. However, most of the hand exoskeletons are bulky, stationary, and cumbersome to use. We have modified a recent existing design (Tenoexo) to prototype a motorized, lightweight, fully wearable rehabilitative hand exoskeleton by combining rigid parts with a soft mechanism capable of producing various grasps needed for the execution of daily tasks. Mechanical evaluation of our exoskeleton showed that it can produce fingertip force up to 8 N and can cover 91.5 & DEG; of range of motion in just 3 s. We further tested the performance of the developed robotic exoskeleton in two quadriplegics with chronic hand paralysis and observed immediate success on independent grasping of different daily objects. The results suggested that our exoskeleton is a viable option for hand function assistance, allowing patients to regain lost finger control for everyday activities.</p>	[Nazari, Vaheh; Zheng, Yong-Ping; Alam, Monzurul] Hong Kong Polytech Univ, Fac Engn, Dept Biomed Engn, Hong Kong 999077, Peoples R China; [Pouladian, Majid] Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran		Alam, M (corresponding author), Hong Kong Polytech Univ, Fac Engn, Dept Biomed Engn, Hong Kong 999077, Peoples R China.	vaheh.nazari@polyu.edu.hk; pouladian@srbiau.ac.ir; yongping.zheng@polyu.edu.hk; md.malam@connect.polyu.hk	Zheng, Yong-Ping/M-1197-2015	Zheng, Yong-Ping/0000-0002-3407-9226; Alam, Monzurul/0000-0003-0987-1999	Hong Kong Polytechnic University (UAKB)Hong Kong Polytechnic University	This research study was supported by the Hong Kong Polytechnic University (UAKB).	Arata J, 2013, IEEE INT CONF ROBOT, P3902, DOI 10.1109/ICRA.2013.6631126; Bain GI, 2015, J HAND SURG-EUR VOL, V40, P406, DOI 10.1177/1753193414533754; Beekhuizen Kristina S, 2005, J Neurol Phys Ther, V29, P157; Bos RA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0168-z; BUCHHOLZ B, 1992, J BIOMECH, V25, P149, DOI 10.1016/0021-9290(92)90272-3; Butzer T, 2021, SOFT ROBOT, V8, P128, DOI 10.1089/soro.2019.0135; Bullock IM, 2013, IEEE T HAPTICS, V6, P296, DOI 10.1109/TOH.2013.6; Feix T, 2016, IEEE T HUM-MACH SYST, V46, P66, DOI 10.1109/THMS.2015.2470657; Gull MA, 2020, ROBOTICS, V9, DOI 10.3390/robotics9010016; Islam M.R., 2017, ADV ROBOTICS AUTOMAT, V06, DOI [10.4172/2168-9695.1000177, DOI 10.4172/2168-9695.1000177]; Kamper D.G., 2016, NEUROREHABILITATION, P311; Kang BB, 2019, SOFT ROBOT, V6, P214, DOI 10.1089/soro.2018.0006; Kang BB, 2013, INT CONF UBIQ ROBOT, P459, DOI 10.1109/URAI.2013.6677311; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Li M, 2019, FRONT NEUROROBOTICS, V13, DOI 10.3389/fnbot.2019.00034; Mateo S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-9; Mohammadi Alireza, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2120, DOI 10.1109/EMBC.2018.8512617; Nanayakkara V. K., 2017, FRONTIERS MECH ENG, V3, P5; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randazzo L, 2018, IEEE ROBOT AUTOM LET, V3, P500, DOI 10.1109/LRA.2017.2771329; Sandison M, 2020, IEEE ENG MED BIO, P4867, DOI 10.1109/EMBC44109.2020.9175332; Sarac M, 2019, IEEE T HAPTICS, V12, P400, DOI 10.1109/TOH.2019.2924881; Shahid T, 2018, BIOMIMETICS-BASEL, V3, DOI 10.3390/biomimetics3030017; Shen Y, 2020, WEARABLE ROBOTICS: SYSTEMS AND APPLICATIONS, P1, DOI 10.1016/B978-0-12-814659-0.00001-1; Tong KY, 2010, IEEE ENG MED BIO, P3406, DOI 10.1109/IEMBS.2010.5627930; Vergara M, 2014, J HAND THER, V27, P225, DOI 10.1016/j.jht.2014.04.002; Yun Y., 2020, WEARABLE TECHNOL, V1, pE8, DOI [10.1017/wtc.2020.9, DOI 10.1017/WTC.2020.9]	27	0	0	6	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	OCT	2021	21	20							6900	10.3390/s21206900			15	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	WS6CG	WOS:000715266200001	34696113	gold, Green Published			2022-02-06	
J	Obana, KK; Mueller, JD; Saltzman, BM; Bottiglieri, TS; Ahmad, CS; Parisien, RL; Trofa, DP				Obana, Kyle K.; Mueller, John D.; Saltzman, Bryan M.; Bottiglieri, Thomas S.; Ahmad, Christopher S.; Parisien, Robert L.; Trofa, David P.			Targeting Rule Implementation Decreases Concussions in High School Football: A National Concussion Surveillance Study	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; youth; high school; football; targeting; rules; loss of consciousness	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; IMPACT	Background: Concussions occur at higher rates in high school football as compared with all other high school sports. In 2014, the National Federation of State High School Associations implemented rules defining illegal contact against a defenseless player above the shoulders to reduce concussions in football players in the United States. To the best of our knowledge, rates of emergency department (ED)-diagnosed concussions of high school football players before and after the 2014 rule implementation have not been compared. Hypothesis: It was hypothesized that (1) there would be lower rates of helmet-to-helmet and helmet-to-body-part concussions after rule implementation and (2) alternative mechanisms of concussion would not differ, as these would be less influenced by rule implementation. Study Design: Cohort study; Level of evidence, 3. Methods: Data from the National Electronic Injury Surveillance System (NEISS) were analyzed for high school football players 14 to 18 years old sustaining a concussion from January 1, 2009, to December 31, 2019. Data were collected on mechanism of injury, setting, and loss of consciousness. Raw data were used to calculate national estimates based on the assigned statistical sample weight of each hospital by the NEISS. Results: A total of 4983 (national estimate = 154,221) high school football concussions were diagnosed in US EDs; 58.8% of concussions occurred during competition and 41.2% during practice. Between 2009 and 2013 the rate of concussions diagnosed in EDs rose 10.7% as compared with a 6.2% decrease between 2015 and 2019 (P = .04). Between 2009 and 2013, the rate of helmet-to-helmet concussions rose 17.6% as compared with a 5.6% decrease between 2015 and 2019 (P = .03). There were no significant changes between other mechanisms of concussion before and after the 2014 rule implementation. Conclusion: We identified a decreased trend in overall and helmet-to-helmet high school football concussions diagnosed in the ED after implementation of the targeting rule. This study adds to the growing literature regarding the importance and efficacy of rule implementation in reducing sports-related concussions.	[Obana, Kyle K.; Mueller, John D.; Saltzman, Bryan M.; Bottiglieri, Thomas S.; Ahmad, Christopher S.; Parisien, Robert L.; Trofa, David P.] Columbia Univ, Med Ctr, New York Presbyterian, New York, NY USA; [Obana, Kyle K.] Univ Hawaii, John A Burns Sch Med, Div Orthopaed Surg, Honolulu, HI 96822 USA; [Obana, Kyle K.; Mueller, John D.; Bottiglieri, Thomas S.; Ahmad, Christopher S.; Trofa, David P.] Columbia Univ, Med Ctr, Dept Orthopaed, New York Presbyterian, New York, NY USA; [Saltzman, Bryan M.] OrthoCarolina, Sports Med Ctr, Charlotte, NC USA; [Parisien, Robert L.] Boston Univ, Boston Med Ctr, Dept Orthopaed, Boston, MA 02215 USA		Trofa, DP (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian, Dept Orthopaed, 622 West 168th St,PH 11-1130, New York, NY 10032 USA.	dpt2103@cumc.columbia.edu					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bartley JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740887; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hammer E, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120903699; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kimbler DE, 2011, J NEUROSCI NURS, V43, P286, DOI 10.1097/JNN.0b013e31823858a6; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lundberg GD, 2016, CUREUS, V8, DOI 10.7759/cureus.592; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; National Federation of State High School Associations, 2015, HIGH SCH FOOTBL RUL; Pfaller AY, 2019, AM J SPORT MED, V47, P2294, DOI 10.1177/0363546519860120; Pielke R., 2020, FORBES 0128; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sondheimer E., 2014, ANGELES TIMES 0213; Stemper BD, 2020, MED SCI SPORT EXER, V52, P1629, DOI 10.1249/MSS.0000000000002283; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Trofa DP, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119845636; Trofa DP, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117741647; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165	29	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2021	9	10							23259671211031191	10.1177/23259671211031191			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	WJ9PM	WOS:000709368600001	34671687	Green Published			2022-02-06	
J	Papa, L; Johnson, B; Walter, AE; Wilkes, JR; Knollmann-Ritschel, B; Bhomia, M; Slobounov, SM				Papa, Linda; Johnson, Brian; Walter, Alexa E.; Wilkes, James R.; Knollmann-Ritschel, Barbara; Bhomia, Manish; Slobounov, Semyon M.			Decreases in Dorsal Cervical Spinal Cord White Matter Tract Integrity Are Associated with Elevated Levels of Serum MicroRNA Biomarkers in NCAA Division I Collegiate Football Players	NEUROTRAUMA REPORTS			English	Article						biomarkers; cervical spinal cord; concussion; microRNA; MRI; sports	SUBCONCUSSIVE HEAD TRAUMA; DEFAULT MODE NETWORK; BRAIN-INJURY; CONCUSSION; SEASON; PERFORMANCE; YOUTH	This prospective, controlled, observational cohort study assessed the performance of a novel panel of serum microRNA (miRNA) biomarkers relative to findings on cervical spinal cord magnetic resonance imaging (MRI) in collegiate football players. There were 44 participants included in the study: 30 non-athlete control subjects and 14 male collegiate football athletes participating in a Division I Football Bowl Subdivision of the National Collegiate Athletic Association. Diffuse tensor MRI and blood samples were acquired within the week before the athletic season began and within the week after the last game of the season. All miRNAs were significantly higher in athletes regardless of their fractional anisotropy (FA) values (p < 0.001), even those considered to be in the "normal" range of FA for white and gray matter integrity in the cervical spinal cord. miRNA biomarkers were most significantly correlated with FA of the white matter (WM) tracts of the dorsal (posterior) spinal cord; particularly, the fasciculus gracilis, fasciculus cuneatus, lateral corticospinal tract, rubrospinal tract, lateral reticulospinal tract, spinal lemniscus, and spinothalamic and -reticular tracts. Areas under the curve for miRNA biomarkers predicting lower FA of WM dorsal (posterior) cervical spinal tracts, therefore lower white matter integrity (connectivity), were miR-505* = 0.75 (0.54-0.96), miR-30d = 0.74 (0.52-0.95), and miR-92a = 0.75 (0.53-0.98). Should these findings be replicated in a larger cohort of athletes, these markers could potentially serve as measures of neuroimaging abnormalities in athletes at risk for concussion and subconcussive injuries to the cervical spinal cord.	[Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 West Underwood S-200, Orlando, FL 32806 USA; [Papa, Linda] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Johnson, Brian] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA; [Walter, Alexa E.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wilkes, James R.; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA USA; [Knollmann-Ritschel, Barbara; Bhomia, Manish] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 West Underwood S-200, Orlando, FL 32806 USA.	lpstat@aol.com			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]	This study was supported by Award Number R01NS057676 (Papa, PI) from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Centers for Disease Control and Prevention (CDC), 2017, HEADS UP CONC PREV I; Chagawa K, 2015, ASIAN SPINE J, V9, P541, DOI 10.4184/asj.2015.9.4.541; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clark AJ, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11173; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Fehlmann T, 2016, RNA BIOL, V13, P1084, DOI 10.1080/15476286.2016.1234658; Fischer I, 2016, NEURAL REGEN RES, V11, P58, DOI 10.4103/1673-5374.169634; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Johnson Brian, 2021, Neurotrauma Rep, V2, P84, DOI 10.1089/neur.2020.0035; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Leister I, 2020, NEUROREHAB NEURAL RE, V34, P95, DOI 10.1177/1545968319899920; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; NCAA, 2018, ESTIMATED PROBABILIT; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2018, J NEUROTRAUM, V35, P32, DOI 10.1089/neu.2017.4994; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Rebbeck T, 2019, J ORTHOP SPORT PHYS, V49, P819, DOI 10.2519/jospt.2019.8946; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Tsushima WT, 2019, APPL NEUROPSYCH-CHIL, V8, P223, DOI 10.1080/21622965.2018.1427095; Vedantam A, 2014, NEUROSURGERY, V74, P1, DOI 10.1227/NEU.0000000000000171; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	37	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	OCT 1	2021	2	1					476	487		10.1089/neur.2021.0036			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WT6LG	WOS:000715973500002	34901943	gold, Green Published			2022-02-06	
J	Parrington, L; King, LA; Weightman, MM; Hoppes, CW; Lester, ME; Dibble, LE; Fino, PC				Parrington, Lucy; King, Laurie A.; Weightman, Margaret M.; Hoppes, Carrie W.; Lester, Mark E.; Dibble, Leland E.; Fino, Peter C.			Between-site equivalence of turning speed assessments using inertial measurement units	GAIT & POSTURE			English	Article						Gait; Turning; IMU; Multi-site study	CENTER-OF-MASS; WALKING; HEAD; GAIT; BALANCE; BODY; KINEMATICS; SENSORS; PEOPLE; FEASIBILITY	Background: Turning is a component of gait that requires planning for movement of multiple body segments and the sophisticated integration of sensory information from the vestibular, visual, and somatosensory systems. These aspects of turning have led to growing interest to quantify turning in clinical populations to characterize deficits or identify disease progression. However, turning may be affected by environmental differences, and the degree to which turning assessments are comparable across research or clinical sites has not yet been evaluated. Research question: The aim of this study was to determine the extent to which peak turning speeds are equivalent between two sites for a variety of mobility tasks. Methods: Data were collected at two different sites using separate healthy young adult participants (n = 47 participants total), but recruited using identical inclusion and exclusion criteria. Participants at each site completed three turning tasks: a one-minute walk (1 MW) along a six-meter walkway, a modified Illinois Agility Test (mIAT), and a custom clinical turning course (CCTC). Peak yaw turning speeds were extracted from wearable inertial sensors on the head, trunk, and pelvis. Between-site differences and two one-sided tests (TOST) were used to determine equivalence between sites, based on a minimum effect size reported between individuals with mild traumatic brain injury and healthy control subjects. Results: No outcomes were different between sites, and equivalence was determined for 6/21 of the outcomes. These findings suggest that some turning tasks and outcome measures may be better suited for multi-site studies. The equivalence results are also dependent on the minimum effect size of interest; nearly all outcomes were equivalent across sites when larger minimum effect sizes of interest were used. Significance: Together, these results suggest some tasks and outcome measures may be better suited for multi-site studies and literature-based comparisons.	[Parrington, Lucy; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Weightman, Margaret M.] Allina Hlth, Courage Kenny Res Ctr, Minneapolis, MN USA; [Hoppes, Carrie W.; Lester, Mark E.] Army Baylor Univ, Doctoral Program Phys Therapy, Ft Sam Houston, TX USA; [Lester, Mark E.] Texas State Univ, Dept Phys Therapy, Round Rock, TX USA; [Dibble, Leland E.] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84112 USA; [Fino, Peter C.] Univ Utah, Dept Hlth & Kinesiol, 250 S 1850 E, Salt Lake City, UT 84112 USA		Fino, PC (corresponding author), Univ Utah, Dept Hlth & Kinesiol, 250 S 1850 E, Salt Lake City, UT 84112 USA.	peter.fino@utah.edu		Fino, Peter/0000-0002-8621-3706; Parrington, Lucy/0000-0001-8507-9974	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH1820049]	This work was supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the Congressionally Directed Medical Research Program under Award No. W81XWH1820049. Opinions, interpretations, conclusions and recom-mendations are those of the authors and are not necessarily endorsed by the Department of Defense.	Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bengevoord A, 2016, GAIT POSTURE, V43, P54, DOI 10.1016/j.gaitpost.2015.10.021; Chan E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00304; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Crenna P, 2007, GAIT POSTURE, V26, P172, DOI 10.1016/j.gaitpost.2007.04.010; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Fino P, 2014, J BIOMECH, V47, P1395, DOI 10.1016/j.jbiomech.2014.01.032; Fino PC, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.544812; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2019, J HEAD TRAUMA REHAB, V34, pE74, DOI 10.1097/HTR.0000000000000418; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2015, J BIOMECH, V48, P104, DOI 10.1016/j.jbiomech.2014.10.034; Friesen KB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73734-5; Fukuda Y, 2020, J BIOMECH, V103, DOI 10.1016/j.jbiomech.2020.109702; Genzel D, 2018, P NATL ACAD SCI USA, V115, P4264, DOI 10.1073/pnas.1712058115; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Hachana Y, 2013, J STRENGTH COND RES, V27, P2752, DOI 10.1519/JSC.0b013e3182890ac3; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Hudson TE, 2005, EXP BRAIN RES, V165, P283, DOI 10.1007/s00221-005-2313-y; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Johnson RT, 2020, GAIT POSTURE, V77, P171, DOI 10.1016/j.gaitpost.2020.01.007; King LA, 2012, J NEUROL PHYS THER, V36, P25, DOI 10.1097/NPT.0b013e31824620d1; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Leach JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22492-6; Loy BD, 2018, COMPLEMENT THER MED, V41, P169, DOI 10.1016/j.ctim.2018.09.006; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; Mellone S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0147-4; Niswander W, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20215993; Orendurff MS, 2006, GAIT POSTURE, V23, P106, DOI 10.1016/j.gaitpost.2004.12.008; Ortega-Bastidas P, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071647; Park JH, 2016, EXP GERONTOL, V85, P48, DOI 10.1016/j.exger.2016.09.018; Parrington L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18124501; Paul SS, 2017, IEEE T NEUR SYS REH, V25, P2347, DOI 10.1109/TNSRE.2017.2740945; Paul SS, 2017, JAMA OTOLARYNGOL, V143, P1008, DOI 10.1001/jamaoto.2017.1443; Prevost P, 2003, NEUROSCI LETT, V339, P243, DOI 10.1016/S0304-3940(02)01390-3; Raffegeau TE, 2020, GAIT POSTURE, V77, P6, DOI 10.1016/j.gaitpost.2020.01.006; Raya MA, 2013, J REHABIL RES DEV, V50, P951, DOI 10.1682/JRRD.2012.05.0096; Shah V, 2021, INT J NUMER METH ENG, V122, P455, DOI 10.1002/nme.6545; Shah VV, 2020, J PARKINSON DIS, V10, P1099, DOI 10.3233/JPD-201914; Shah VV, 2020, J NEUROL, V267, P1188, DOI 10.1007/s00415-020-09696-5; Solomon D, 2006, EXP BRAIN RES, V173, P475, DOI 10.1007/s00221-006-0393-y; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Stuart S, 2020, J NEUROTRAUM, V37, P139, DOI 10.1089/neu.2019.6450; Stuart S, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102557; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Verlinden VJA, 2013, GAIT POSTURE, V37, P500, DOI 10.1016/j.gaitpost.2012.09.005; Vitali RV, 2020, J BIOMECH, V106, DOI 10.1016/j.jbiomech.2020.109832; Voss S, 2020, GAIT POSTURE, V80, P206, DOI 10.1016/j.gaitpost.2020.05.010; Yamaguchi T, 2018, J BIOMECH, V74, P163, DOI 10.1016/j.jbiomech.2018.04.038; Yamaguchi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179817; Yamaguchi T, 2013, GAIT POSTURE, V38, P209, DOI 10.1016/j.gaitpost.2012.11.007; Zukowski LA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230479	54	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2021	90						245	251		10.1016/j.gaitpost.2021.09.164			7	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	WA4KF	WOS:000702854900019	34530311				2022-02-06	
J	Peng, Y; Zhao, Y; Huang, YM; Liu, XY; Zhang, H; Zhao, Z; Cheng, YW; Liu, LX				Peng, Yong; Zhao, Yang; Huang, Yameng; Liu, Xiaoyue; Zhang, Hui; Zhao, Zheng; Cheng, Yawei; Liu, Lanxiang			Neuroprotective effects of low-intensity transcranial ultrasound stimulation combined with Baicalin intervention on traumatic brain injury in animals	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Low-intensity transcranial ultrasound stimulation; Baicalin; Apparent diffusion coefficient; Fractional anisotropy; Neuroprotective effect	WHITE-MATTER; IMPACT; TIME; MODERATE; MICE	Low-intensity transcranial ultrasound stimulation (LITUS) can improve the inflammatory reaction after traumatic brain injury (TBI), and Baicalin also has a good protective effect on TBI. The purpose of this study was to observe the neuroprotective effect of LITUS combined with Baicalin intervention in the TBI rats. Sprague Dawley (SD) rats were randomly divided into 5 groups (n = 15) which were Sham control group, TBI group, LITUS group, Baicalin group, LITUS combined with Baicalin group (L-B group). The rats were scanned with 3.0 T magnetic resonance imager, and the apparent diffusion coefficient (ADC) and the fractional anisotropy (FA) of the brain injury cortical area were determined at 3 h, 1, 3, 7 and 10 d after TBI. The ADC value, FA value, neurological function score and Nissl staining were used to assess the level of brain damage of rats. The results showed that on the 10th day after TBI, the ADC values of the TBI group, the LITUS group and the Baicalin group were remarkable greater than that of the L-B group (all adjusted P < 0.05), FA values were remarkable smaller than that of the L-B group (all adjusted P < 0.05), neurological function scores were remarkable greater than that of the L-B group (all adjusted P < 0.05), and Nissl body loss rates were remarkable greater than that of the L-B group (all adjusted P < 0.001). This study indicated that compared with the LITUS group and the Baicalin group, the L-B group can more effectively reduce level of brain damage after TBI, and the method of LITUS combined with Baicalin intervention was a more effective neuroprotection for brain injury.	[Peng, Yong; Zhao, Yang; Huang, Yameng; Liu, Xiaoyue; Zhang, Hui; Zhao, Zheng; Cheng, Yawei] Yanshan Univ, Inst Elect Engn, Qinhuangdao, Hebei, Peoples R China; [Peng, Yong] Yanshan Univ, Key Lab Intelligent Rehabil & Neuromodulat Hebei, Qinhuangdao, Hebei, Peoples R China; [Liu, Lanxiang] Qinhuangdao Municipal 1 Hosp, Qinhuangdao, Hebei, Peoples R China		Peng, Y (corresponding author), Yanshan Univ, Inst Elect Engn, Qinhuangdao, Hebei, Peoples R China.	PY81@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61573305, 81871029]; Qinhuangdao City Science and Technology Support Project in Hebei Province, China [201502A261]	This research was supported by the National Natural Science Foundation of China (61573305, 81871029). This research was also supported by Qinhuangdao City Science and Technology Support Project in Hebei Province, China (201502A261).	Armstead WM, 2019, EXP NEUROL, V317, P291, DOI 10.1016/j.expneurol.2019.03.015; Cao YG, 2011, BRAIN RES BULL, V85, P396, DOI 10.1016/j.brainresbull.2011.05.002; Chen SF, 2018, MOL NEUROBIOL, V55, P7079, DOI 10.1007/s12035-018-0897-z; [董晓阳 Dong Xiaoyang], 2017, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V32, P744; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Hameroff S, 2013, BRAIN STIMUL, V6, P409, DOI 10.1016/j.brs.2012.05.002; Hanks R, 2019, BRAIN INJURY, V33, P355, DOI 10.1080/02699052.2018.1553073; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kim HJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1372946; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Kwon CS, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.05.014; Li HaiYan, 2017, Chinese Journal of Information on Traditional Chinese Medicine, V24, P35; Lin Xiao-Juan, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P221; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Lu X, 2017, EXP THER MED, V13, P2247, DOI 10.3892/etm.2017.4283; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Monti MM, 2016, BRAIN STIMUL, V9, P940, DOI 10.1016/j.brs.2016.07.008; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Pan MX, 2018, CHIN J TRAUMATOL, V21, P224, DOI 10.1016/j.cjtee.2018.04.003; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Sasso V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0616-5; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Scott LK, 2009, J NEUROS-PEDIATR, V3, P484, DOI 10.3171/2009.2.PEDS08292; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; Su WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15916-2; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZJ, 2006, BRAIN RES, V1123, P188, DOI 10.1016/j.brainres.2006.09.063; Zheng T, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00172; Zhou H, 2019, IEEE T BIO-MED ENG, V66, P3006, DOI 10.1109/TBME.2019.2899631	43	0	0	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2021	175						246	253		10.1016/j.brainresbull.2021.07.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL4ZI	WOS:000692660600003	34343642				2022-02-06	
J	Podell, JE; Miller, SS; Jaffa, MN; Pajoumand, M; Armahizer, M; Chen, HW; Tripathi, H; Schwartzbauer, GT; Chang, WTW; Parikh, GY; Hu, P; Badjatia, N				Podell, Jamie E.; Miller, Serenity S.; Jaffa, Matthew N.; Pajoumand, Mehrnaz; Armahizer, Michael; Chen, Huanwen; Tripathi, Hemantkumar; Schwartzbauer, Gary T.; Chang, Wan-Tsu W.; Parikh, Gunjan Y.; Hu, Peter; Badjatia, Neeraj			Admission Features Associated With Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: A Case-Control Study	CRITICAL CARE MEDICINE			English	Article						autonomic nervous system diseases; critical care outcomes; epidemiologic factors; matched case-control studies; sympathetic nervous system; traumatic brain injury	AUTONOMIC INSTABILITY; DYSAUTONOMIA; DIAGNOSIS; CLASSIFICATION; PROGESTERONE; MANAGEMENT; CONSENSUS; SEVERITY; DYSTONIA; CARE	OBJECTIVES: Paroxysmal sympathetic hyperactivity occurs in a subset of critically ill traumatic brain injury patients and has been associated with worse outcomes after traumatic brain injury. The goal of this study was to identify admission risk factors for the development of paroxysmal sympathetic hyperactivity in traumatic brain injury patients. DESIGN: Retrospective case-control study of age- and Glasgow Coma Scale-matched traumatic brain injury patients. SETTING: Neurotrauma ICU at the R. Adams Cowley Shock Trauma Center of the University of Maryland Medical System, January 2016 to July 2018. PATIENTS: Critically ill adult traumatic brain injury patients who underwent inpatient monitoring for at least 14 days were included. Cases were identified based on treatment for paroxysmal sympathetic hyperactivity with institutional first-line therapies and were confirmed by retrospective tabulation of established paroxysmal sympathetic hyperactivity diagnostic and severity criteria. Cases were matched 1:1 by age and Glasgow Coma Scale to nonparoxysmal sympathetic hyperactivity traumatic brain injury controls, yielding 77 patients in each group. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Admission characteristics independently predictive of paroxysmal sympathetic hyperactivity included male sex, higher admission systolic blood pressure, and initial CT evidence of diffuse axonal injury, intraventricular hemorrhage/subarachnoid hemorrhage, complete cisternal effacement, and absence of contusion. Paroxysmal sympathetic hyperactivity cases demonstrated significantly worse neurologic outcomes upon hospital discharge despite being matched for injury severity at admission. CONCLUSIONS: Several anatomical, epidemiologic, and physiologic risk factors for clinically relevant paroxysmal sympathetic hyperactivity can be identified on ICU admission. These features help characterize paroxysmal sympathetic hyperactivity as a clinical-pathophysiologic phenotype associated with worse outcomes after traumatic brain injury.	[Podell, Jamie E.; Miller, Serenity S.; Pajoumand, Mehrnaz; Tripathi, Hemantkumar; Schwartzbauer, Gary T.; Chang, Wan-Tsu W.; Parikh, Gunjan Y.; Hu, Peter; Badjatia, Neeraj] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Podell, Jamie E.; Miller, Serenity S.; Armahizer, Michael; Schwartzbauer, Gary T.; Chang, Wan-Tsu W.; Parikh, Gunjan Y.; Hu, Peter; Badjatia, Neeraj] Univ Maryland, Med Ctr, 22 S Greene St,7 Gudelsky, Baltimore, MD 21201 USA; [Podell, Jamie E.; Chen, Huanwen; Schwartzbauer, Gary T.; Chang, Wan-Tsu W.; Parikh, Gunjan Y.; Hu, Peter; Badjatia, Neeraj] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Jaffa, Matthew N.; Hu, Peter] Univ Connecticut, Sch Med, Hartford Hosp, Hartford, CT 06112 USA		Podell, JE (corresponding author), Univ Maryland, Med Ctr, 22 S Greene St,7 Gudelsky, Baltimore, MD 21201 USA.	jpodell@som.umaryland.edu					Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bassi A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00182; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Edlow BL, 2016, BRAIN CONNECT, V6, P187, DOI 10.1089/brain.2015.0378; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Francis HM, 2016, NEUROPSYCHOL REHABIL, V26, P103, DOI 10.1080/09602011.2014.1003246; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Godo S, 2017, TOHOKU J EXP MED, V243, P11, DOI 10.1620/tjem.243.11; Hagen C., 1972, RANCHO AMIGOS LEVEL; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Hinson HE, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000271; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; LEHMANN KG, 1987, J AM COLL CARDIOL, V10, P46, DOI 10.1016/S0735-1097(87)80158-4; Liu Y, 2013, CASE REP MED, V2013, DOI 10.1155/2013/358182; Lucca LF, 2019, J NEUROTRAUM, V36, P2430, DOI 10.1089/neu.2018.5963; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Macey PM, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00513; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rittenberger JC, 2011, RESUSCITATION, V82, P1036, DOI 10.1016/j.resuscitation.2011.03.034; Samuel S, 2018, BRAIN INJURY, V32, P1115, DOI 10.1080/02699052.2018.1482002; Shoemaker JK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00240; Silver JR, 2000, SPINAL CORD, V38, P229, DOI 10.1038/sj.sc.3100996; Sklerov M, 2019, CLIN AUTON RES, V29, P555, DOI 10.1007/s10286-018-0577-0; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Tang QL, 2017, PEERJ, V5, DOI 10.7717/peerj.2986; van Eijck MM, 2019, J CRIT CARE, V49, P110, DOI 10.1016/j.jcrc.2018.10.018; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738; Webb AA, 2006, BEHAV BRAIN RES, V171, P338, DOI 10.1016/j.bbr.2006.04.017; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	46	0	0	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2021	49	10					E989	E1000		10.1097/CCM.0000000000005076			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US5RL	WOS:000697486100010	34259439				2022-02-06	
J	Portanova, J; Buchanan, D; Moore, M; Thompson, H				Portanova, Jaclyn; Buchanan, Diana; Moore, Megan; Thompson, Hilaire			Factors Associated with the Development of Persistent Pain after mTBI	PAIN MANAGEMENT NURSING			English	Article							TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; HEAD-INJURY; SYMPTOMS; QUESTIONNAIRE; RELIABILITY; VALIDITY; COMORBIDITY; EXERCISE; NUMBER	Background: Persistent pain after mild traumatic brain injury (mTBI) is widely experienced, yet little is known about who is at risk for experiencing persistent pain after their injury. Aims: The purpose of this study was to 1) determine if there are factors associated with later experiencing persistent pain after mTBI and 2) examine if there are symptom patterns associated with the experience of persistent pain. Design: Secondary analysis was conducted using de-identified data from an NIH-funded longitudinal study.SettingsParticipants were enrolled in the emergency department. Participants: Participants were aged 21 to 92 and all had experienced mTBI. Methods: We examined baseline characteristics, symptoms, and injury related variables associated with the endorsement of persistent pain among those with mTBI (N = 183) from baseline to 6 months postinjury. In order to identify a persistent pain phenotype, exploratory factor analysis was used to determine which symptoms co-occur with persistent pain. Results: Persistent pain was found in 78% of those with mTBI. Those with lower overall health status at day 7 and at 1-month following injury had greater odds of developing persistent pain. Those with higher levels of general health status and physical function health status at day 7 and 1 month, and those with higher levels of overall health related status at 1 month had significantly lesser odds of persistent pain at 6 months. Factor analysis revealed that persistent pain and co-occurring symptoms (anxiety, depression, dizziness, nausea and vomiting, sleep disturbance, poor memory, poor concentration, longer to think and light sensitivity) loaded on one factor, indicating that these symptoms are associated. Conclusions: Those at increased risk for persistent pain should be screened beginning early in the recovery trajectory to reduce their risk of developing persistent pain. Identification of a phenotype offers potential for recognition of symptoms that cluster with persistent pain, improving the ability to treat patients more holistically, and develop interventions to support recovery from injury. Published by Elsevier Inc. on behalf of American Society for Pain Management Nursing.	[Portanova, Jaclyn; Buchanan, Diana; Moore, Megan; Thompson, Hilaire] Univ Washington, Seattle, WA 98195 USA; [Portanova, Jaclyn] Dept Vet Affairs, Washington, DC USA; [Portanova, Jaclyn] Linfield Univ, Mcminnville, OR USA; [Portanova, Jaclyn] Yale Univ, New Haven, CT 06520 USA		Portanova, J (corresponding author), 333 Cedar St, New Haven, CT 06510 USA.	Jportanova10@gmail.com		Thompson, Hilaire/0000-0002-5472-478X	National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [5T32NR01483304]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS077913-02]; Hester McLaws Nursing Scholarship; National Center for Advanc-ing Translational Science (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR001864]; VA Office of Academic AffiliationsUS Department of Veterans Affairs; Yale University	I acknowledge my funding sources, the National Institute of Nursing Research (5T32NR01483304) , the National Institute of Neurological Disorders and Stroke (5R01NS077913-02) and the Hester McLaws Nursing Scholarship. This project was made pos-sible by the Yale National Clinician Scholars Program and by CTSA Grant Number TL1 TR001864 from the National Center for Advanc-ing Translational Science (NCATS) , a component of the National In-stitutes of Health (NIH) . Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. This project was made possible from support provided by the VA Office of Academic Affiliations through the VA/National Clin-ician Scholars Program and Yale University. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Abbreviated Injury Scale (AIS), 2008, ASS ADV AUT MED; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Franke GH, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-016-0283-3; Green CR, 2003, PAIN MED, V4, P277, DOI 10.1046/j.1526-4637.2003.03034.x; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; KAISER HF, 1961, BRIT J STATIST PSYCH, V14, P1, DOI 10.1111/j.2044-8317.1961.tb00061.x; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Portanova J., 2019, 2019 W I NURS C; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Sherbourne C.D., 1993, MOS SOCIAL SUPPORT S; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thompson HJ, 2020, INJURY PREV, V26, P471, DOI 10.1136/injuryprev-2019-043325; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walsh D, 2006, SUPPORT CARE CANCER, V14, P831, DOI 10.1007/s00520-005-0899-z; Wren AA, 2011, PAIN, V152, P477, DOI 10.1016/j.pain.2010.11.017	37	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	OCT	2021	22	5					592	598		10.1016/j.pmn.2021.04.001			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	WG5FT	WOS:000707021100006	34011466				2022-02-06	
J	Prendergast, E; Allen, KY; Mills, MG; Moran, T; Harris, ZL; Malakooti, M; Smith, CM; Wainwright, MS; McCarthy-Kowols, M				Prendergast, Erica; Allen, Kiona Y.; Mills, Michele Grimason; Moran, Thomas; Harris, Z. Leah; Malakooti, Marcelo; Smith, Craig M.; Wainwright, Mark S.; McCarthy-Kowols, Maureen			Targeted Temperature Management Protocol in a Pediatric Intensive Care Unit: A Quality Improvement Project	CRITICAL CARE NURSE			English	Article							TRAUMATIC BRAIN-INJURY; MAGNESIUM-SULFATE; CARDIAC-ARREST; HYPOTHERMIA; CHILDREN; HYPERTHERMIA; FEVER	BACKGROUND In patients with acute neurological injury, abrupt temperature change exacerbates increased intracranial pressures and negatively affects perfusion pressure and cerebral blood flow. Critical care nurses must provide coordinated and effective interventions to maintain normothermia without precipitating shivering immediately after acute neurological injury in pediatric patients. OBJECTIVE To improve hyperthermia management in a 40-bed pediatric intensive care unit, an inter-disciplinary pediatric critical care team developed, implemented, and evaluated a targeted temperature management protocol. METHODS The project was guided by the organization's plan-do-study-act quality improvement process. Quality improvement was assessed retrospectively using electronic medical records of patients meeting eligibility criteria. Samples of pediatric patients who received temperature interventions were compared before and after protocol implementation. The protocol included environmental, pharmacological, and body surface cooling device interventions, as well as use of a bedside shivering assessment scale and step-wise interventions to prevent and control shivering. RESULTS Before implementation of the targeted temperature management protocol, 64% of patients had documented temperatures higher than 37.5 degrees C, and body surface cooling devices were used in 10% of patients. After protocol implementation, more than 80% of patients had documented temperatures higher than 37.5 degrees C, and body surface cooling devices were used in 62% of patients. Four patients (6%) before and 5 patients (31%) after protocol implementation were treated with body surface cooling without requiring use of neuromuscular blockade. CONCLUSIONS Creation and implementation of a targeted temperature management protocol increased nurses' documented use of body surface cooling to manage hyperthermia in pediatric intensive care unit patients with acute neurological injury.	[Prendergast, Erica; Mills, Michele Grimason] Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Chicago, IL 60611 USA; [Allen, Kiona Y.] Ann & Robert H Lurie Childrens Hosp Chicago, Regenstein Cardiac Care Unit, Chicago, IL 60611 USA; [Allen, Kiona Y.] Ann & Robert H Lurie Childrens Hosp Chicago, NICU Cardiac Neurodev Program, Chicago, IL 60611 USA; [Allen, Kiona Y.] Northwestern Univ, Dept Pediat, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Allen, Kiona Y.] Northwestern Univ, Div Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Moran, Thomas] Ann & Robert H Lurie Childrens Hosp Chicago, Clin Pharm Serv, Chicago, IL 60611 USA; [Harris, Z. Leah] Univ Texas Austin, Dell Med Sch, Pediat, Austin, TX 78712 USA; [Harris, Z. Leah] Dell Pediat Res Inst, Austin, TX USA; [Harris, Z. Leah] Dell Childrens Med Ctr, Austin, TX USA; [Malakooti, Marcelo] Ann & Robert H Lurie Childrens Hosp Chicago, Pediat Intens Care Unit, Chicago, IL 60611 USA; [Malakooti, Marcelo] Northwestern Univ, Feinberg Sch Med, Div Crit Care Med, Dept Pediat, Evanston, IL 60208 USA; [Smith, Craig M.] Northwestern Univ, Pediat & Neurol, Feinberg Sch Med, Evanston, IL 60208 USA; [Smith, Craig M.] Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Pediat Crit Care Med & Neurocrit Care, Chicago, IL 60611 USA; [Wainwright, Mark S.] Univ Washington, Pediat Neurol, Seattle, WA 98195 USA; [McCarthy-Kowols, Maureen] Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA		Prendergast, E (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA.	enenni@luriechildrens.org			Ann & Robert H. Lurie Children's Hospital of Chicago Prince Nurse Scholar Grant	This work was funded by an Ann & Robert H. Lurie Children's Hospital of Chicago Prince Nurse Scholar Grant. Erica Prendergast and Maureen McCarthy-Kowols were the recipients of this grant.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Armahizer MJ, 2020, CRIT CARE NURS Q, V43, P251, DOI 10.1097/CNQ.0000000000000305; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Benedetti GM, 2018, PEDIATR NEUROL, V88, P12, DOI 10.1016/j.pediatrneurol.2018.07.004; Brown JM, 2008, CHILD NERV SYST, V24, P477, DOI 10.1007/s00381-007-0517-0; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Dietmann A, 2012, CRIT CARE, V16, pA24; Duff JP, 2019, CIRCULATION, V140, pE904, DOI 10.1161/CIR.0000000000000731; Fink EL, 2012, PEDIATR CRIT CARE ME, V13, P80, DOI 10.1097/PCC.0b013e3181fe27c7; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jain A, 2018, J NEUROSCI NURS, V50, P63, DOI 10.1097/JNN.0000000000000340; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Smith CM, 2011, PEDIATR CRIT CARE ME, V12, P449, DOI 10.1097/PCC.0b013e3181f390dd; Tasker RC, 2017, PEDIATR CRIT CARE ME, V18, P355, DOI 10.1097/PCC.0000000000001098; Vaity C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0804-1; Wadhwa A, 2005, BRIT J ANAESTH, V94, P756, DOI 10.1093/bja/aei105; Wainwright Mark S, 2018, Continuum (Minneap Minn), V24, P288, DOI 10.1212/CON.0000000000000565; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1376-4; Weant KA, 2010, PHARMACOTHERAPY, V30, P830, DOI 10.1592/phco.30.8.830; Yunge M, 2019, PEDIATR CRIT CARE ME, V20, pE77, DOI 10.1097/PCC.0000000000001813; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007; Zweifler RM, 2004, STROKE, V35, P2331, DOI 10.1161/01.STR.0000141161.63181.f1	25	0	0	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	OCT 1	2021	41	5					41	51		10.4037/ccn2021554			11	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	WK5QW	WOS:000709781600007	34595494				2022-02-06	
J	Rakers, SE; Timmerman, ME; Scheenen, ME; de Koning, ME; van der Horn, HJ; van der Naalt, J; Spikman, JM				Rakers, Sandra E.; Timmerman, Marieke E.; Scheenen, Myrthe E.; de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje; Spikman, Jacoba M.			Trajectories of Fatigue, Psychological Distress, and Coping Styles After Mild Traumatic Brain Injury: A 6-Month Prospective Cohort Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Fatigue; Psychological distress; Rehabilitation; Traumatic brain injury	PREDICTORS; STRESS; SCALE	Objective: To analyze fatigue after mild traumatic brain injury (TBI) with latent class growth analysis (LCGA) to determine distinct recovery tra-jectories and investigate influencing factors, including emotional distress and coping styles. Design: An observational cohort study design with validated questionnaires assessing fatigue, anxiety, depression, posttraumatic stress, and cop-ing at 2 weeks and 3 and 6 months postinjury. Setting: Three level 1 trauma centers. Participants: Patients with mild TBI (N=456). Interventions: Not applicable. Main Outcome Measures: Fatigue was measured with the fatigue severity subscale of the Checklist Individual Strength, including 8 items (sum score, 8-56). Subsequently, 3 clinical categories were created: high (score, 40-56), moderate (score, 26-38), and low (score, 8-25). Results: From the entire mild TBI group, 4 patient clusters with distinct patterns for fatigue, emotional distress, and coping styles were found with LCGA. Clusters 1 and 2 showed favorable recovery from fatigue over time, with low emotional distress and the predominant use of active coping in cluster 1 (30%) and low emotional distress and decreasing passive coping in cluster 2 (25%). Clusters 3 and 4 showed unfavorable recovery, with persistent high fatigue and increasing passive coping together with low emotional distress in cluster 3 (27%) and high emotional distress in cluster 4 (18%). Patients with adverse trajectories were more often women and more often experiencing sleep disturbances and pain. Conclusions: The prognosis for recovery from posttraumatic fatigue is favorable for 55% of mild TBI patients. Patients at risk for chronic fatigue can be signaled in the acute phase postinjury based on the presence of high fatigue, high passive coping, and, for a subgroup of patients, high emotional distress. LCGA proved to be a highly valuable and multipurpose statistical method to map distinct courses of dis-ease-related processes over time. Archives of Physical Medicine and Rehabilitation 2021;102:1965-71 (c) 2021 The Authors. Published by Elsevier Inc. on behalf of The American Congress of Rehabilitation Medicine. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)	[Rakers, Sandra E.; Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neuropsychol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Timmerman, Marieke E.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychometr & Stat, Groningen, Netherlands; [de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Rakers, SE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neuropsychol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	s.e.rakers@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mollayeva T, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0744-z; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Perry SE, 2020, MEDICINE UK, V48, P765; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Vermunt JK, TECHNICAL GUIDE LATE; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wang YW, 2019, INT J GERIATR PSYCH, V34, P1623, DOI 10.1002/gps.5175; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	26	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2021	102	10					1965	+		10.1016/j.apmr.2021.06.004			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WK2DU	WOS:000709542300013	34217729	hybrid, Green Published			2022-02-06	
J	Ramirez, S; Mukherjee, A; Sepulveda, S; Becerra-Calixto, A; Bravo-Vasquez, N; Gherardelli, C; Chavez, M; Soto, C				Ramirez, Santiago; Mukherjee, Abhisek; Sepulveda, Sofia; Becerra-Calixto, Andrea; Bravo-Vasquez, Nicolas; Gherardelli, Camila; Chavez, Melissa; Soto, Claudio			Modeling Traumatic Brain Injury in Human Cerebral Organoids	CELLS			English	Article						cerebral organoids; traumatic brain injury; disease modeling; Alzheimer's disease; amyloid plaques; neurofibrillary tangles	PATHOPHYSIOLOGY; NEUROPATHOLOGY; ASTROCYTES; IMPACT; RISK	Traumatic brain injury (TBI) is a head injury that disrupts the normal brain structure and function. TBI has been extensively studied using various in vitro and in vivo models. Most of the studies have been done with rodent models, which may respond differently to TBI than human nerve cells. Taking advantage of the recent development of cerebral organoids (COs) derived from human induced pluripotent stem cells (iPSCs), which resemble the architecture of specific human brain regions, here, we adapted the controlled cortical impact (CCI) model to induce TBI in human COs as a novel in vitro platform. To adapt the CCI procedure into COs, we have developed a phantom brain matrix, matching the mechanical characteristics of the brain, altogether with an empty mouse skull as a platform to allow the use of the stereotactic CCI equipment on COs. After the CCI procedure, COs were histologically prepared to evaluate neurons and astrocyte populations using the microtubule-associated protein 2 (MAP2) and the glial fibrillary acidic protein (GFAP). Moreover, a marker of metabolic response, the neuron-specific enolase (NSE), and cellular death using cleaved caspase 3 were also analyzed. Our results show that human COs recapitulate the primary pathological changes of TBI, including metabolic alterations related to neuronal damage, neuronal loss, and astrogliosis. This novel approach using human COs to model TBI in vitro holds great potential and opens new alternatives for understanding brain abnormalities produced by TBI, and for the development and testing of new therapeutic approaches.	[Ramirez, Santiago; Mukherjee, Abhisek; Sepulveda, Sofia; Becerra-Calixto, Andrea; Bravo-Vasquez, Nicolas; Gherardelli, Camila; Chavez, Melissa; Soto, Claudio] Univ Texas Hlth Sci Houston, Mitchell Ctr Alzheimers Dis & Related Brain Disor, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA		Soto, C (corresponding author), Univ Texas Hlth Sci Houston, Mitchell Ctr Alzheimers Dis & Related Brain Disor, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA.	Santiago.D.Ramirez@uth.tmc.edu; Abhisek.Mukherjee@uth.tmc.edu; Sofia.E.SepulvedaContreras@uth.tmc.edu; Andrea.d.BecerraCalixto@uth.tmc.edu; Nicolas.A.BravoVasquez@uth.tmc.edu; Camila.GherardelliBrooks@uth.tmc.edu; Melissa.V.Chavez@uth.tmc.edu; Claudio.Soto@uth.tmc.edu		Ramirez arevalo, santiago/0000-0002-7335-3005; Bravo-Vasquez, Nicolas/0000-0002-7565-5138	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R0AG1061069, R01AG061901]; Department of DefenseUnited States Department of Defense; Zenith award from Alzheimers Association	This project was supported in part by grants from the NIH (R0AG1061069 and R01AG061901), a grant from Department of Defense and a Zenith award from Alzheimers Association to CS.	Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Aggarwal N., 2016, INT J ANAT RES, V4, P2216, DOI [10.16965/ijar.2016.181, DOI 10.16965/IJAR.2016.181]; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; [Anonymous], 1800, MMWR Morb Mortal Wkly Rep, V68, P237, DOI 10.15585/mmwr.mm6810a1; Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Becerra-Calixto A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00088; Becerra-Calixto A, 2017, MOL NEUROBIOL, V54, P6681, DOI 10.1007/s12035-016-0162-2; Bennett E.R., 2016, TRANSLATIONAL RES TR; Bianchi F, 2018, STEM CELL RES, V32, P126, DOI 10.1016/j.scr.2018.09.006; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brownjohn PW, 2018, STEM CELL REP, V10, P1294, DOI 10.1016/j.stemcr.2018.03.003; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cakir B, 2019, NAT METHODS, V16, P1169, DOI 10.1038/s41592-019-0586-5; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chen ZJ, 2004, J NEUROSURG, V101, P314, DOI 10.3171/jns.2004.101.2.0314; Chiaradia I, 2020, NAT NEUROSCI, V23, P1496, DOI 10.1038/s41593-020-00730-3; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzalez C, 2018, MOL PSYCHIATR, V23, P2363, DOI 10.1038/s41380-018-0229-8; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jgamadze D, 2020, CURR OPIN BIOMED ENG, V14, P52, DOI 10.1016/j.cobme.2020.05.004; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kim H, 2019, STEM CELL REP, V12, P890, DOI 10.1016/j.stemcr.2019.04.011; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Laskowitz DT., 2016, TRANSLATIONAL RES TR, P97; Lebkuechner I, 2015, J NEUROCHEM, V135, P234, DOI 10.1111/jnc.13213; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Osier N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070088; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Park DW, 2019, CHILD NERV SYST, V35, P343, DOI 10.1007/s00381-018-3955-y; Pekna Marcela, 2012, Cerebrum, V2012, P9; Pollen AA, 2019, CELL, V176, P743, DOI 10.1016/j.cell.2019.01.017; Pomfret R, 2013, ANN NEUROSCI, V20, P118, DOI 10.5214/ans.0972.7531.200309; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Shi YC, 2020, PLOS BIOL, V18, DOI [10.1371/journal.pbio.3000705, 10.1371/journal.pbio.3000705.r001, 10.1371/journal.pbio.3000705.r002, 10.1371/journal.pbio.3000705.r003, 10.1371/journal.pbio.3000705.r004, 10.1371/journal.pbio.3000705.r005, 10.1371/journal.pbio.3000705.r006]; Singh D, 2019, J BIOMECH, V92, P84, DOI 10.1016/j.jbiomech.2019.05.033; Tan X, 2016, DEV CELL, V36, P624, DOI 10.1016/j.devcel.2016.02.023; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhang SQ, 2017, EXP THER MED, V14, P1905, DOI 10.3892/etm.2017.4760	67	0	0	5	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	OCT	2021	10	10							2683	10.3390/cells10102683			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	WM8BE	WOS:000711303600001	34685663	Green Published, gold			2022-02-06	
J	Redell, JB; Maynard, ME; Hood, KN; Moore, AN; Zhao, J; Dash, PK				Redell, John B.; Maynard, Mark E.; Hood, Kimberly N.; Moore, Anthony N.; Zhao, Jing; Dash, Pramod K.			Insulin-Like Growth Factor-2 (IGF-2) Does Not Improve Memory in the Chronic Stage of Traumatic Brain Injury in Rodents	NEUROTRAUMA REPORTS			English	Article						cortical impact injury; fear extinction; novel object recognition; water maze	FACTOR-I; ENHANCEMENT; HIPPOCAMPUS; CONSOLIDATION; EXPRESSION; RECEPTOR; PATHWAY	Persistent cognitive impairment(s) can be a significant consequence of traumatic brain injury (TBI) and can markedly compromise quality of life. Unfortunately, identifying effective treatments to alleviate memory impairments in the chronic stage of TBI has proven elusive. Several studies have demonstrated that insulin-like growth factor-2 (IGF-2) can enhance memory in both normal animals and in experimental models of disease. In this study, we questioned whether IGF-2, when administered before learning, could enhance memory performance in the chronic stage of TBI. Male C57BL/6 mice (n = 7 per group) were injured using an electronic cortical impact injury device. Four months later, mice were tested for their cognitive performance in the fear memory extinction, novel object recognition (NOR), and Morris water maze tasks. Twenty minutes before each day of training, mice received a subcutaneous injection of either 30 mu g/kg of IGF-2 or an equal volume of vehicle. Memory testing was carried out 24 h after training in the absence of the drug. Uninjured sham animals treated with IGF-2 (or vehicle) were trained and tested in the fear memory extinction task as a positive control. Our data show that although IGF-2 (30 mu g/kg) improved memory extinction in uninjured mice, it was ineffective at improving fear memory extinction in the chronic stage of TBI. Similarly, IGF-2 administration to chronically injured animals did not improve TBI-related deficits in either NOR or spatial memory. Our results indicate that IGF-2, administered in the chronic stage of injury, is ineffective at enhancing memory performance and therefore may not be a beneficial treatment option for lingering cognitive impairments after a TBI.</p>	[Redell, John B.; Maynard, Mark E.; Hood, Kimberly N.; Moore, Anthony N.; Zhao, Jing; Dash, Pramod K.] Univ Texas Houston, Dept Neurobiol & Anat, McGovern Med Sch, POB 20708, Houston, TX 77225 USA		Redell, JB (corresponding author), Univ Texas Houston, Dept Neurobiol & Anat, McGovern Med Sch, POB 20708, Houston, TX 77225 USA.	john.b.redell@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS109118, NS101686]	Financial support for these studies was provided to J.B.R. and P.K.D. and through grants provided by the National Institutes of Health (NS109118, NS101686).	Agis-Balboa R, 2014, CELL MOL LIFE SCI, V71, P21, DOI 10.1007/s00018-013-1316-2; Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; COUCE ME, 1992, ENDOCRINOLOGY, V131, P1636, DOI 10.1210/en.131.4.1636; Cruz E, 2021, AUTISM RES, V14, P29, DOI 10.1002/aur.2418; DUFFY KR, 1988, METABOLISM, V37, P136, DOI 10.1016/S0026-0495(98)90007-5; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Iwamoto T, 2014, REV NEUROSCIENCE, V25, P559, DOI 10.1515/revneuro-2014-0010; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Johansson P, 2013, PSYCHONEUROENDOCRINO, V38, P1729, DOI 10.1016/j.psyneuen.2013.02.006; LOGAN A, 1994, ENDOCRINOLOGY, V135, P2255, DOI 10.1210/en.135.5.2255; Pardo M, 2019, NEUROSCI RES, V149, P1, DOI 10.1016/j.neures.2018.10.012; Pascual-Lucas M, 2014, EMBO MOL MED, V6, P1246, DOI 10.15252/emmm.201404228; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; ROSENFELD RG, 1987, BIOCHEM BIOPH RES CO, V149, P159, DOI 10.1016/0006-291X(87)91618-4; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Steinmetz AB, 2018, J NEUROSCI, V38, P1015, DOI 10.1523/JNEUROSCI.2010-17.2017; Steinmetz AB, 2016, NEUROBIOL AGING, V44, P9, DOI 10.1016/j.neurobiolaging.2016.04.006; Stern SA, 2014, LEARN MEMORY, V21, P556, DOI 10.1101/lm.029348.112; Stern SA, 2014, NEUROPSYCHOPHARMACOL, V39, P2179, DOI 10.1038/npp.2014.69; Aleman IT, 2012, ENDOCRIN METAB CLIN, V41, P395, DOI 10.1016/j.ecl.2012.04.016; Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102; Ye XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141078; Yu XW, 2020, ELIFE, V9, DOI 10.7554/eLife.54781; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	32	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	OCT 1	2021	2	1					453	460		10.1089/neur.2021.0031			8	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WL3NT	WOS:000710316700001	34901941	Green Published, gold			2022-02-06	
J	Riberholt, CG; Olsen, MH; Berg, RMG; Mehlsen, J; Moller, K				Riberholt, Christian Gunge; Olsen, Markus Harboe; Berg, Ronan M. G.; Mehlsen, Jesper; Moller, Kirsten			Dynamic cerebral autoregulation during early orthostatic exercise in patients with severe traumatic brain injury: Further exploratory analyses from a randomized clinical feasibility trial	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Dynamic cerebral autoregulation; Early mobilization; Head-up tilt test; Orthostatic intolerance; Traumatic brain injury	MOBILIZATION; REHABILITATION	In patients with severe traumatic brain injury, there is limited evidence of the clinical effect of early orthostatic exercise, although such exercise may strengthen systemic or cerebral hemodynamic responses to head-up tilt, thereby minimizing orthostatic intolerance. We measured dynamic cerebral autoregulation (dCA) and the occurrence of orthostatic intolerance after four weeks of regular orthostatic exercise by head-up tilt using a tilt table with integrated stepping using the ERIGO (R) tilt-table and comparing it to standard care. Thirty-four patients with severe traumatic brain injury admitted to a neurocritical care unit were included in this randomized clinical trial. Middle cerebral artery blood flow velocity (MCAv), non-invasive mean arterial pressure, heart rate and PaCO2 were recorded; dCA was measured by the non-invasive mean flow index (nMxa). Transition from the supine position to head-up tilt triggered a 10-16% decrease in MCAv and increased nMxa in both groups at all time points (P < 0.05), with no differences between groups. There was no difference in the number of episodes with orthostatic intolerance (5 vs 3; 1 vs 2; 1 vs 0) at baseline, two weeks and four weeks, respectively, and no association between changes in PaCO2-adjusted nMxa and the occurrence of orthostatic reactions (P = 0.35). Early orthostatic exercise does not affect dynamic cerebral autoregulation and does not protect against orthostatic intolerance in patients with severe traumatic brain injury. (C) 2021 The Author(s). Published by Elsevier Ltd.	[Riberholt, Christian Gunge] Copenhagen Univ Hosp Rigshosp, Dept Neurorehabil, Traumat Brain Injury Unit, Kettegard 30, DK-2650 Hvidovre, Denmark; [Riberholt, Christian Gunge; Olsen, Markus Harboe; Moller, Kirsten] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark; [Olsen, Markus Harboe] Copenhagen Univ Hosp Rigshosp, Dept Neuroanaesthesiol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Berg, Ronan M. G.] Univ Copenhagen, Dept Biomed Sci, Blegdamsvej 2B, DK-2200 Copenhagen N, Denmark; [Berg, Ronan M. G.] Copenhagen Univ Hosp Rigshosp, Dept Clin Physiol Nucl Med & PET, Rigshosp, Ctr Phys Act Res, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Berg, Ronan M. G.] Univ South Wales, Neurovasc Res Lab, Fac Life Sci & Educ, Pontypridd, M Glam, Wales; [Mehlsen, Jesper] Copenhagen Univ Hosp Rigshosp, Surg Pathophysiol Unit, Juliane Marie Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Moller, Kirsten] Copenhagen Univ Hosp Rigshosp, Dept Neuroanaesthesiol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark		Riberholt, CG (corresponding author), Copenhagen Univ Hosp Rigshosp, Dept Neurorehabil, Traumat Brain Injury Unit, Kettegard 30, DK-2650 Hvidovre, Denmark.; Riberholt, CG (corresponding author), Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	Christian.riberholt@regionh.dk; mols0212@regionh.dk; ronan@sund.ku.dk; jesper.mehlsen.01@re-gionh.dk; Kirsten.moller.01@regionh.dk	Mehlsen, Jesper/AAA-5848-2022; Riberholt, Christian Gunge/AAC-9574-2019	Riberholt, Christian Gunge/0000-0002-6170-1869; Berg, Ronan/0000-0002-5757-9506; Olsen, Markus Harboe/0000-0003-0981-0723	Council of Danish Victims Fund, Denmark [16-910-00043]; Research Fund of Rigshospitalet, Copenhagen University Hospital, Denmark [R114-A4672]; Danish Physical Therapy Association, Denmark [15242]	This work was supported by The Council of Danish Victims Fund, Denmark (grant number 16-910-00043) ; the Research Fund of Rigshospitalet, Copenhagen University Hospital, Denmark (grant number R114-A4672) , and the Danish Physical Therapy Associa-tion, Denmark (grant number 15242) . The funders did not influence the design of the trial or interpretation of the results.	Bartolo M, 2017, J REHABIL MED, V49, P715, DOI 10.2340/16501977-2269; Frazzitta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158030; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; Olsen MH., 2020, CLINMON CALCULATION; Riberholt CG., STAT ANAL PLAN DYNAM; Riberholt CG, 2013, DAN MED J, V60; Riberholt CG, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.626014; Riberholt CG, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3004-x; SALTIN B, 1968, CIRCULATION, V38, pVII1; Sato K, 2012, EXP PHYSIOL, V97, P1272, DOI 10.1113/expphysiol.2012.064774; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0; Verheyden B, 2008, EUR HEART J, V29, P1523, DOI 10.1093/eurheartj/ehn134; Vollman KM, 2013, CRIT CARE NURS Q, V36, P17, DOI 10.1097/CNQ.0b013e3182750767; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhang R, 1998, J APPL PHYSIOL, V85, P1113, DOI 10.1152/jappl.1998.85.3.1113	17	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2021	92						39	44		10.1016/j.jocn.2021.07.047			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UR8YN	WOS:000697027600008	34509259	hybrid			2022-02-06	
J	Robb, AS; Connor, DF; Amann, BH; Vitiello, B; Nasser, A; O'Neal, W; Schwabe, S; Ceresoli-Borroni, G; Newcorn, JH; Candler, SA; Buitelaar, JK; Findling, RL				Robb, Adelaide S.; Connor, Daniel F.; Amann, Birgit H.; Vitiello, Benedetto; Nasser, Azmi; O'Neal, Welton; Schwabe, Stefan; Ceresoli-Borroni, Gianpiera; Newcorn, Jeffrey H.; Candler, Shawn A.; Buitelaar, Jan K.; Findling, Robert L.			Closing the gap: unmet needs of individuals with impulsive aggressive behavior observed in children and adolescents	CNS SPECTRUMS			English	Article						ADHD; assessment tool; impulsive aggression; maladaptive aggression; unmet needs	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; PROACTIVE AGGRESSION; MALADAPTIVE AGGRESSION; ALZHEIMERS-DISEASE; WEIGHT-GAIN; PLACEBO; SCALE; YOUTH	Impulsive aggressive (IA, or impulsive aggression) behavior describes an aggregate set of maladaptive, aggressive behaviors occurring across multiple neuropsychiatric disorders. IA is reactive, eruptive, sudden, and unplanned; it provides information about the severity, but not the nature, of its associated primary disorder. IA in children and adolescents is of serious clinical concern for patients, families, and physicians, given the detrimental impact pediatric IA can have on development. Currently, the ability to properly identify, monitor, and treat IA behavior across clinical populations is hindered by two major roadblocks: (1) the lack of an assessment tool designed for and sensitive to the set of behaviors comprising IA, and (2) the absence of a treatment indicated for IA symptomatology. In this review, we discuss the clinical gaps in the approach to monitoring and treating IA behavior, and highlight emerging solutions that may improve clinical outcomes in patients with IA.	[Robb, Adelaide S.] Childrens Natl Med Ctr, Dept Psychiat & Behav Sci, Washington, DC 20010 USA; [Connor, Daniel F.] Univ Connecticut, Dept Psychiat, Med Sch, Farmington, CT 06107 USA; [Amann, Birgit H.] Behav Med Ctr Troy, Troy, MI USA; [Vitiello, Benedetto] Univ Turin, Dept Publ Hlth & Pediat Sci, Turin, Italy; [Nasser, Azmi; O'Neal, Welton; Schwabe, Stefan; Ceresoli-Borroni, Gianpiera; Candler, Shawn A.] Supernus Pharmaceut Inc, Rockville, MD USA; [Newcorn, Jeffrey H.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Buitelaar, Jan K.] Radboud Univ Nijmegen, Neurosci Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Findling, Robert L.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Findling, Robert L.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA		Robb, AS (corresponding author), Childrens Natl Med Ctr, Dept Psychiat & Behav Sci, Washington, DC 20010 USA.	AROBB@childrensnational.org	Vitiello, Benedetto/AAC-1758-2022		Supernus Pharmaceuticals, Inc., Rockville, MD, USA	This work was funded by Supernus Pharmaceuticals, Inc., Rockville, MD, USA. Azmi Nasser, Welton O'Neal, Stefan Schwabe, Gianpiera Ceresoli-Borroni, and Shawn A. Candler, employees of Supernus Pharmaceuticals, Inc., were involved in the design, analysis, and reporting of the literature review.	Allan ER, 1996, J CLIN PSYCHIAT, V57, P455, DOI 10.4088/JCP.v57n1003; Aman MG, 2004, J CHILD ADOL PSYCHOP, V14, P243, DOI 10.1089/1044546041649020; Aman MG, 2014, RES DEV DISABIL, V35, P1412, DOI 10.1016/j.ridd.2014.03.006; Aman MG, 2014, J AM ACAD CHILD PSY, V53, P47, DOI 10.1016/j.jaac.2013.09.022; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2017, NEUR BAS NOM NBN; [Anonymous], 2007, RISP PRESCR INF; Barratt ES, 1999, PSYCHIAT RES, V86, P163, DOI 10.1016/S0165-1781(99)00024-4; Bearss K, 2016, AUTISM, V20, P663, DOI 10.1177/1362361315601012; Bidzan L, 2012, MED SCI MONITOR, V18, pCR182, DOI 10.12659/MSM.882523; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Blair RJR, 2016, J CHILD ADOL PSYCHOP, V26, P4, DOI 10.1089/cap.2015.0088; CAMPBELL M, 1984, ARCH GEN PSYCHIAT, V41, P650; Ceresoli-Borroni G., 2017, CHILDR AD ATT DEF HY; Ceresoli-Borroni G, 2021, J ATTEN DISORD, V25, P1564, DOI 10.1177/1087054720909084; Ceresoli-Borroni G, 2019, J CHILD ADOL PSYCHOP, V29, P592, DOI 10.1089/cap.2019.0035; Ceresoli-Borroni G, 2019, J CHILD ADOL PSYCHOP, V29, P599, DOI 10.1089/cap.2018.0089; Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), 2017, GEN PREV ADHD; ClinicalTrials.gov, 2006, PIL TRIAL NEUR CORR; ClinicalTrials.gov, 2019, NEUR NK 1 ANT PATH A; Coccaro EF, 2016, J PSYCHIATR RES, V81, P127, DOI 10.1016/j.jpsychires.2016.06.011; Coccaro EF, 2012, AM J PSYCHIAT, V169, P577, DOI 10.1176/appi.ajp.2012.11081259; Connor D.F., 2002, AGGRESSION ANTISOCIA; Connor D, 2017, CAMBRIDGE ENCYCLOPEDIA OF CHILD DEVELOPMENT, P441; Connor DF, 2006, CHILD PSYCHIAT HUM D, V37, P1, DOI 10.1007/s10578-006-0015-8; Connor DF, 2019, J CHILD ADOL PSYCHOP, V29, P576, DOI 10.1089/cap.2019.0039; Connor DF, 2016, J CHILD ADOL PSYCHOP, V26, P2, DOI 10.1089/cap.2015.0204; Connor DF, 2010, J CHILD ADOL PSYCHOP, V20, P119, DOI 10.1089/cap.2009.0076; Dodge KA, 1997, J ABNORM PSYCHOL, V106, P37, DOI 10.1037/0021-843X.106.1.37; Dowson JH, 2010, ACTA PSYCHIAT SCAND, V121, P103, DOI 10.1111/j.1600-0447.2009.01460.x; Felthous AR, 2015, J AM ACAD PSYCHIATRY, V43, P456; Findling RL, 2017, J CHILD ADOL PSYCHOP, V27, P52, DOI 10.1089/cap.2016.0081; Fontenelle LE, 2005, PSYCHIAT CLIN NEUROS, V59, P30, DOI 10.1111/j.1440-1819.2005.01328.x; Gadow KD, 2016, J AM ACAD CHILD PSY, V55, P469, DOI 10.1016/j.jaac.2016.03.014; Ganguli R, 1999, J CLIN PSYCHIAT, V60, P20; GREENHILL LL, 1985, J CLIN PSYCHIAT, V46, P20; Gurnani T, 2016, J CHILD ADOL PSYCHOP, V26, P65, DOI 10.1089/cap.2015.0167; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hesselink JMK, 2017, J NEUROL, V264, P1617, DOI 10.1007/s00415-017-8391-5; Hollander E, 2010, NEUROPSYCHOPHARMACOL, V35, P990, DOI 10.1038/npp.2009.202; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P309, DOI 10.1097/CHI.0b013e31802f1454; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jurewicz M, 2010, J IMMUNOL, V184, P2939, DOI 10.4049/jimmunol.0901889; Kaat AJ, 2015, J CHILD FAM STUD, V24, P2734, DOI 10.1007/s10826-014-0075-5; Kashdan TB, 2008, J ANXIETY DISORD, V22, P925, DOI 10.1016/j.janxdis.2007.09.009; Kempes M, 2005, EUR CHILD ADOLES PSY, V14, P11, DOI 10.1007/s00787-005-0432-4; Knapp P, 2012, PEDIATRICS, V129, pE1562, DOI 10.1542/peds.2010-1360; KNOEDLER DW, 1989, AM J PSYCHIAT, V146, P1081; Krakowski MI, 2014, SCHIZOPHRENIA BULL, V40, P886, DOI 10.1093/schbul/sbt117; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Kronenberger WG, 2007, J CHILD ADOL PSYCHOP, V17, P334, DOI 10.1089/cap.2006.0012; Leclerc MP, 2018, SCHIZOPHR RES, V201, P27, DOI 10.1016/j.schres.2018.06.016; Malone RP, 1998, PSYCHOPHARMACOL BULL, V34, P41; Malone RP, 2000, ARCH GEN PSYCHIAT, V57, P649, DOI 10.1001/archpsyc.57.7.649; Mathias CW, 2007, PSYCHIAT RES, V151, P231, DOI 10.1016/j.psychres.2006.11.001; Mattes JA, 2005, J CLIN PSYCHOPHARM, V25, P575, DOI 10.1097/01.jcp.0000186739.22395.6b; Mattes JA, 2008, J CLIN PSYCHIAT, V69, P310, DOI 10.4088/JCP.v69n0218; Mosti C, 2018, J NEUROPSYCH CLIN N, V30, P220, DOI 10.1176/appi.neuropsych.17070141; Owen R, 2009, PEDIATRICS, V124, P1533, DOI 10.1542/peds.2008-3782; Pappadopulos E, 2003, J AM ACAD CHILD PSY, V42, P145, DOI 10.1097/00004583-200302000-00008; Pastor Patricia, 2015, NCHS Data Brief, P201; Perroud N, 2011, J AFFECT DISORDERS, V134, P112, DOI 10.1016/j.jad.2011.05.048; Pollock BG, 2002, AM J PSYCHIAT, V159, P460, DOI 10.1176/appi.ajp.159.3.460; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Robb AS, 2019, POSTGRAD MED, V131, P129, DOI 10.1080/00325481.2019.1574401; Romans L, 2015, NORD J PSYCHIAT, V69, P397, DOI 10.3109/08039488.2014.994033; Rosato NS, 2012, PEDIATRICS, V129, pE1577, DOI 10.1542/peds.2010-1361; Saylor KE, 2016, J CHILD ADOL PSYCHOP, V26, P19, DOI 10.1089/cap.2015.0126; Scahill L, 2015, AM J PSYCHIAT, V172, P1197, DOI 10.1176/appi.ajp.2015.15010055; Schneider LS, 2016, AM J PSYCHIAT, V173, P465, DOI 10.1176/appi.ajp.2015.15050648; Seeman P, 2002, CAN J PSYCHIAT, V47, P27, DOI 10.1177/070674370204700106; Seeman P, 1998, MOL PSYCHIATR, V3, P123, DOI 10.1038/sj.mp.4000336; Sikich L, 2008, AM J PSYCHIAT, V165, P1420, DOI 10.1176/appi.ajp.2008.08050756; Soloff PH, 2017, PSYCHIAT RES-NEUROIM, V260, P76, DOI 10.1016/j.pscychresns.2016.12.009; Stanford MS, 2001, PSYCHIAT RES, V103, P193, DOI 10.1016/S0165-1781(01)00287-6; Stocks JD, 2012, J CHILD ADOL PSYCHOP, V22, P102, DOI 10.1089/cap.2011.0087; Tsiouris JA, 2011, J INTELL DISABIL RES, V55, P636, DOI 10.1111/j.1365-2788.2011.01418.x; Tufan E, 2016, J CHILD ADOL PSYCHOP, V26, P94, DOI 10.1089/cap.2015.0004; Vitiello B, 1990, J Neuropsychiatry Clin Neurosci, V2, P189; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Wright A, 2012, J NEUROPSYCH CLIN N, V24, P16, DOI 10.1176/appi.neuropsych.10010013; Young AS, 2020, J CLIN CHILD ADOLESC, V49, P787, DOI 10.1080/15374416.2019.1622121; YUDOFSKY SC, 1990, J CLIN PSYCHIAT, V51, P22; Zanarini MC, 2004, J CLIN PSYCHIAT, V65, P903	86	0	0	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529	2165-6509		CNS SPECTRUMS	CNS Spectr.	OCT	2021	26	5					448	456	PII S1092852920001224	10.1017/S1092852920001224			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	XB4DC	WOS:000721279900008	32228725				2022-02-06	
J	Root, JM; Fong, J; Badolato, G; Madati, PJ				Root, Jeremy M.; Fong, Jeanette; Badolato, Gia; Madati, Ponda Jamil			Rest-Based Concussion Management of Pediatric Emergency Medicine Providers	PEDIATRIC EMERGENCY CARE			English	Article						concussion; management; medicine; rest; school; sports	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; PROLONGED RECOVERY; 2ND IMPACT; SYMPTOMS; MILD; ADOLESCENTS; PREDICTORS; CHILDREN	Objectives This study aimed to survey pediatric emergency medicine (PEM) providers on their management of 2 hypothetical acute concussion scenarios. We hypothesized that most providers would recommend a management strategy based on cognitive and physical rest. Methods Fifty-nine percent (46/78) of PEM providers that were surveyed completed the study. The survey consisted of 2 clinical scenarios-a female patient with a mild concussion and a male patient with a moderate concussion. Practitioners were asked questions regarding how they would hypothetically manage these patients in terms of recommendations for returning to school and returning to sports. Results Eighty-six percent of providers recommended moderate time off from school for the moderate concussion scenario compared with 67% of providers in the mild concussion scenario (P = 0.008). In regard to return to sports, all providers recommended moderate time off in both scenarios, including 78% of providers who recommended clearance by a physician in the moderate concussion scenario. Conclusions In both of our hypothetical concussion scenarios, including a very mild head injury, most PEM providers surveyed recommended a management strategy that included a moderate degree of a delay of return to school and sports. Given recent evidence suggesting that prolonged rest does not reduce the risk of prolonged concussion symptoms, recommendations of periods of cognitive rest, particularly absences from school, should be approached cautiously. Future studies should examine why providers are recommending rest-based treatment strategies and the potential benefits of active rehabilitation.	[Root, Jeremy M.; Badolato, Gia; Madati, Ponda Jamil] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Fong, Jeanette] Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA		Root, JM (corresponding author), Childrens Natl Med Ctr, Div Emergency Med, 111 Michigan Ave NW, Washington, DC 20010 USA.	JRoot@childrensnational.org		Root, Jeremy/0000-0003-2650-6889			Allen C, 1999, LANCET, V354, P1229, DOI 10.1016/S0140-6736(98)10063-6; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Bey T, 2009, WEST J EMERG MED, V10, P6; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	20	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2021	37	10					E631	E635		10.1097/PEC.0000000000001727			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	WH4QK	WOS:000707664200020	30672900				2022-02-06	
J	Said, MF; Islam, AA; Massi, MN; Prihantono; Hatta, PM; Patellongi, IJ; Cangara, H; Adhimarta, W; Nasrullah; Nasution, RA				Said, Muhammad Fadli; Islam, Andi Asadul; Massi, Muhammad Nasrum; Prihantono; Hatta, Prihantono Mochammad; Patellongi, Ilham Jaya; Cangara, Husni; Adhimarta, Willy; Nasrullah; Nasution, Rizha Anshori			Effect of erythropoietin administration on expression of mRNA brain-derived Neutrophic factor, levels of stromal cell-derived Factor-1, and neuron specific enolase in brain injury model Sprague Dawley	ANNALS OF MEDICINE AND SURGERY			English	Article						Brain injury; BDNF expression; SDF-1; Neuron-specific enolase; Experimental research	NEUROTROPHIC FACTOR; BONE-MARROW; PROGNOSTIC VALUE; NADPH OXIDASE; PROTECTS; DEATH; BCL-2	Background: Traumatic brain injury (TBI) is a complicated condition that is the primary cause of death and disability in children and young adults in developed countries. Various kinds of therapy have been carried out in the management of brain injury, one of which is the administration of erythropoietin (EPO). There are not many studies in Indonesia have proven that EPO administration is effective on parameters such as stromal cell-derived factor 1 (SDF-1), brain-derived neurotrophic factor (BDNF mRNA), and neuron-specific enolase (NSE) in brain injury patients. The purpose of this study was to see how EPO affected BDNF mRNA expression, SDF-1 serum levels, and NSE levels in experimental rats with TBI. Methods: This study was conducted using a rat head injury model. Fifteen rats were randomly assigned to one of three groups: A, B, or C. EPO was administered subcutis with a dose of 30.000 U/kg. Blood samples were taken after brain injury (H0), 12 h (H12), and 24 h (H24) after brain injury. Serum level of SDF-1 and NSE were measured using mRNA BDNF gene expression was measured with Real-Time-PCR, and ELISA. Results: This study found EPO increase BDNF mRNA expression in group C at H-12 (7,92 +/- 0.51 vs 6.45 +/- 0.33) compared to group B, and at H-24 (9.20 +/- 0.56 vs 7.22 +/- 0.19); increase SDF-1 levels in group C at H-12 (7,56 +/- 0,54) vs 4,62 +/- 0,58) compared to group B, and at H-24 (11,32 +/- 4,55 vs 2,55 +/- 0,70); decrease serum NSE levels in group C at H-12 (17,25 +/- 2,02 vs 29,65 +/- 2,33) compare to group B and at H-24 (12,14 +/- 2,61 vs 37,31 +/- 2,76); the values are significantly different with p < 0,05. Conclusion: EPO may have neuroprotective and anti-inflammatory properties in TBI by increasing mRNA BDNF expression and serum SDF-1 levels, and decrease serum NSE levels.	[Said, Muhammad Fadli] Hasanuddin Univ, Fac Med, Doctoral Program Biomed Sci, Jalan Perintis Kemerdekaan KM 11, Makassar 90245, South Sulawesi, Indonesia; [Islam, Andi Asadul; Adhimarta, Willy; Nasrullah] Hasanuddin Univ, Fac Med, Dept Neurosurg, Makassar, Indonesia; [Massi, Muhammad Nasrum; Hatta, Prihantono Mochammad] Hasanuddin Univ, Fac Med, Dept Clin Microbiol, Makassar, Indonesia; [Prihantono] Hasanuddin Univ, Fac Med, Dept Surg, Makassar, Indonesia; [Patellongi, Ilham Jaya] Hasanuddin Univ, Fac Med, Dept Physiol, Makassar, Indonesia; [Cangara, Husni] Hasanuddin Univ, Fac Med, Dept Pathol Anat, Makassar, Indonesia; [Nasution, Rizha Anshori] Pelamonia Hosp, Dept Neurosurg, Makassar, Indonesia		Said, MF (corresponding author), Hasanuddin Univ, Fac Med, Doctoral Program Biomed Sci, Jalan Perintis Kemerdekaan KM 11, Makassar 90245, South Sulawesi, Indonesia.	fadhelfed19@gmail.com; andiasadul@yahoo.com; nasrum2000@yahoo.com; prihantono.md@gmail.com; hattaram@yahoo.com; ilham_pt@yahoo.com; drhusni1977@gmail.com; willy.adhimarta@gmail.com; nasrullah.makassar@gmail.com; rizha_nst@yahoo.com	, prihantono/AAK-2259-2020	, prihantono/0000-0002-8247-0457; Hatta, Mochammad/0000-0002-8456-4203; massi, muhammad nasrum/0000-0002-3347-6529			Bathina S, 2015, ARCH MED SCI, V11, P1164, DOI 10.5114/aoms.2015.56342; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Cheng X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00590; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding SLS, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00190; Elliott E, 2005, EUR J NEUROSCI, V22, P1081, DOI 10.1111/j.1460-9568.2005.04290.x; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Haiga Y., 2019, INDONES J CLIN PATHO, V25, P135, DOI [10.24293/ijcpml.v25i2.1377, DOI 10.24293/IJCPML.V25I2.1377]; Haque A, 2016, METAB BRAIN DIS, V31, P487, DOI 10.1007/s11011-016-9801-6; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirdajova DB, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00051; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kremer KN, 2013, J BIOL CHEM, V288, P22899, DOI 10.1074/jbc.M113.449926; Laidding SR, 2021, ANN MED SURG, V64, DOI 10.1016/j.amsu.2021.102254; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mcgee SJ, 2012, GROWTH FACTORS, V30, P22, DOI 10.3109/08977194.2011.637034; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Nasution R.A, 2021, MED CLIN PRACTICA, V4, DOI [10.1016/j.mcpsp.2021.100229, DOI 10.1016/J.MCPSP.2021.100229]; Nasution RA, 2020, ANN MED SURG, V57, P109, DOI 10.1016/j.amsu.2020.07.029; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Samma L, 2019, BALI MED J, V8, pS542, DOI 10.15562/bmj.v8i3.1569; Schulz K.F., 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c332c332-c332, DOI 10.1136/BMJ.C332C332-C332]; Simon D, 2016, BRAIN INJURY, V30, P23, DOI 10.3109/02699052.2015.1077993; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Urao N, 2012, STEM CELLS, V30, P923, DOI 10.1002/stem.1048; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Wardle J, 2003, EUR J CLIN NUTR, V57, P341, DOI 10.1038/sj.ejcn.1601541; Wardoyo M.S, 2021, MED CLIN PRACTICA, V4, DOI [10.1016/j. mcpsp.2021.100235, DOI 10.1016/J.MCPSP.2021.100235]; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426	45	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	OCT	2021	70								102877	10.1016/j.amsu.2021.102877			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WH1TZ	WOS:000707470700015	34691421	Green Published, gold			2022-02-06	
J	Saksvik, SB; Smevik, H; Stenberg, J; Follestad, T; Vik, A; Haberg, A; Asarnow, RF; Kallestad, H; Skandsen, T; Olsen, A				Saksvik, Simen Berg; Smevik, Hanne; Stenberg, Jonas; Follestad, Turid; Vik, Anne; Haberg, Asta; Asarnow, Robert F.; Kallestad, Havard; Skandsen, Toril; Olsen, Alexander			Poor Sleep Quality Is Associated With Greater Negative Consequences for Cognitive Control Function and Psychological Health After Mild Traumatic Brain Injury Than After Orthopedic Injury	NEUROPSYCHOLOGY			English	Article						mild traumatic brain injury; insomnia; cognitive control; depression; anxiety	CONCUSSION; RECOVERY; METAANALYSES; DIFFICULTIES; ACTIVATIONS; MAINTENANCE; SEVERITY; SYMPTOMS; INSOMNIA; OUTCOMES	Objective: To test the hypothesis that poor sleep quality has a stronger negative effect on cognitive control function and psychological health after mild traumatic brain injury (mTBI) than after orthopedic injury. Method: Patients with mTBI (n = 197) and trauma controls with orthopedic injuries (n = 82) were included in this prospective longitudinal study. The participants (age 16-60) completed three computerized neurocognitive tests assessing response speed and accuracy at 2 weeks and 3 months after injury, as well as questionnaires and interviews assessing sleep quality and psychological distress at 2 weeks, 3 months, and 12 months after injury. Separate Linear Mixed Models (LMMs) for each of the outcome measures (response speed, response accuracy, psychological distress) were performed. Results: We observed a significant interaction effect between poor sleep quality and group (mTBI vs. trauma controls) in the response speed (p =.028) and psychological distress (p =.001) models, driven by a greater negative impact of poor sleep quality on response speed and psychological distress in the mTBI group. We found no such interaction effect for response accuracy (p =.825), and poor sleep quality was associated with worse accuracy to a similar extent for both groups. Conclusions: Our findings show that poor sleep quality has a more negative impact on cognitive control function and psychological outcome in patients with mTBI, compared to trauma controls. This indicates an increased vulnerability to poor sleep quality in patients who have suffered an mTBI.	[Saksvik, Simen Berg; Smevik, Hanne; Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway; [Saksvik, Simen Berg; Skandsen, Toril; Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Stenberg, Jonas; Vik, Anne; Haberg, Asta; Skandsen, Toril] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Kallestad, Havard] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway		Olsen, A (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway.	alexander.olsen@ntnu.no		Olsen, Alexander/0000-0001-8691-3860			Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Battistone M, 2008, APPL NEUROPSYCHOL, V15, P69, DOI 10.1080/09084280801917863; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Churchill NW, 2021, BRAIN IMAGING BEHAV, V15, P1508, DOI 10.1007/s11682-020-00349-9; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Derogatis LR, 2000, BSI 18 BRIEF SYMPTOM; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Edinger JD, 1997, SLEEP, V20, P1127; Enders CK, 2017, BEHAV RES THER, V98, P4, DOI 10.1016/j.brat.2016.11.008; Freeman D, 2020, LANCET PSYCHIAT, V7, P628, DOI 10.1016/S2215-0366(20)30136-X; Goldstein AN, 2014, ANNU REV CLIN PSYCHO, V10, P679, DOI 10.1146/annurev-clinpsy-032813-153716; Grassi L, 2018, CANCER-AM CANCER SOC, V124, P2415, DOI 10.1002/cncr.31340; Green TRF, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00894; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Hanks RA, 2019, J NEUROTRAUM, V36, P554, DOI 10.1089/neu.2018.5873; Heitz RP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00150; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Karlsen RH, 2021, J NEUROTRAUM, V38, P74, DOI 10.1089/neu.2019.6922; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Konstantopoulou G, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02836-1; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Li L, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147062; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; Lowe A, 2020, DISABIL REHABIL, V42, P1041, DOI 10.1080/09638288.2018.1516819; Ludwig R., 2020, SLEEP QUALITY CHRONI, DOI [10.1101/ 2020.09.04.20188425, DOI 10.1101/2020.09.04.20188425]; Ludwig R, 2020, PM&R, V12, P500, DOI 10.1002/pmrj.12309; Massar SAA, 2019, NEUROPSYCHOLOGIA, V123, P169, DOI 10.1016/j.neuropsychologia.2018.03.032; McTeague LM, 2016, J PSYCHIATR RES, V83, P37, DOI 10.1016/j.jpsychires.2016.08.001; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Minkel JD, 2012, EMOTION, V12, P1015, DOI 10.1037/a0026871; Mollayeva T., 2017, NEUROPSYCHIATRY-LOND, V7, P86, DOI [DOI 10.4172/Neuropsychiatry, 10.4172/Neuropsychiatry.1000184, DOI 10.4172/NEUROPSYCHIATRY.1000184]; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Olsen A, 2015, CEREB CORTEX, V25, P2170, DOI 10.1093/cercor/bhu023; Olsen A, 2013, J COGNITIVE NEUROSCI, V25, P903, DOI 10.1162/jocn_a_00358; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, V2; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Raikes AC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00468; Saksvik SB, 2020, J NEUROTRAUM, V37, P2528, DOI 10.1089/neu.2019.6898; Saksvik-Lehouillier I, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa078; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Song MK, 2013, NURS RES, V62, P45, DOI 10.1097/NNR.0b013e3182741948; Stenberg J, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.541533; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Tapp ZM, 2020, J NEUROTRAUM, V37, P1829, DOI 10.1089/neu.2020.7010; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Tubbs AS, 2020, SLEEP BIOL RHYTHMS, V18, P143, DOI 10.1007/s41105-020-00255-z; Van Someren EJW, 2021, PHYSIOL REV, V101, P995, DOI 10.1152/physrev.00046.2019; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wild CJ, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy182; World Health Organization, 1992, ICD10 WHO, V67, P227; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	75	0	0	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2021	35	7					706	717		10.1037/neu0000751			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WC4PI	WOS:000704240400004	34383539				2022-02-06	
J	Saraceno, G; Servadei, F; Di Bergamo, LT; Iaccarino, C; Rubiano, AM; Zoia, C; De Bonis, P; Raffa, G; Hawryluk, G; Grotenhuis, A; Demetriades, AK; Sala, F; Belotti, F; Zanin, L; Doglietto, F; Panciani, PP; Biroli, A; Agosti, E; Serioli, S; Rasulic, L; Bruneau, M; Germano, IM; Bosnjak, R; Thome, C; Regli, L; Vukic, M; Tessitore, E; Schaller, K; Chaurasia, B; El-Ghandour, NM; Di Ieva, A; Bongetta, D; Borghesi, I; Fazio, M; Esene, IN; Rosseau, G; El Abbadi, N; Baccanelli, M; Vajkoczy, P; Fontanella, MM				Saraceno, Giorgio; Servadei, Franco; Terzi Di Bergamo, Lodovico; Iaccarino, Corrado; Rubiano, Andres M.; Zoia, Cesare; De Bonis, Pasquale; Raffa, Giovanni; Hawryluk, Gregory; Grotenhuis, Andre; Demetriades, Andreas K.; Sala, Francesco; Belotti, Francesco; Zanin, Luca; Doglietto, Francesco; Panciani, Pier Paolo; Biroli, Antonio; Agosti, Edoardo; Serioli, Simona; Rasulic, Lukas; Bruneau, Michael; Germano, Isabelle M.; Bosnjak, Roman; Thome, Claudius; Regli, Luca; Vukic, Miroslav; Tessitore, Enrico; Schaller, Karl; Chaurasia, Bipin; El-Ghandour, Nasser M.; Di Ieva, Antonio; Bongetta, Daniele; Borghesi, Ignazio; Fazio, Marco; Esene, Ignatius N.; Rosseau, Gail; El Abbadi, Najia; Baccanelli, Matteo; Vajkoczy, Peter; Fontanella, Marco M.			Do neurosurgeons follow the guidelines? A world-based survey on severe traumatic brain injury	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; traumatic; Intracranial hypertension; Temporal bone	COMPUTED-TOMOGRAPHY; HEAD-INJURY; MRC CRASH; MANAGEMENT; TRIAL; EPIDEMIOLOGY; ADULTS	BACKGROUND: Traumatic brain injury (TBI) is going to be the third-leading cause of death worldwide, according to the WHO. Two European surveys suggested that adherence to brain trauma guidelines is poor. No study has compared compliance between low-(LMICs) and high-income (UHICs) countries. Hence, this study aimed to investigate differences in the management of severe TBI patients, comparing low-and high-income, and adherence to the BTF guidelines. METHODS: A web-based survey was spread through the Global Neuro Foundation, different neurosurgical societies, and social media. RESULTS: A total of 803 neurosurgeons participated: 70.4 from UHICs and 29.6% from LMICs. Hypertonic was administered as an early measure by the 73% and 65% of the responders in LMICs and UHICs, respectively (P=0.016). An invasive intracranial pressure monitoring was recommended by the 66% and 58% of the neurosurgeons in LMICs and UHICs, respectively (P<0.001). Antiseizure drugs (P<0.001) were given most frequently in LMICs as, against recommendations, steroids (87% vs. 61% and 86% vs. 81%, respectively). In the LMICs both the evacuation of the contusion and decompressive craniectomy were performed earlier than in UHICs (30% vs. 17% with P<0.001 and 44% vs. 28% with P=0.006, respectively). In the LMICs, the head CT control was performed mostly between 12 and 24 hours from the first imaging (38% vs. 23%, P<0.001). CONCLUSIONS: The current Guidelines on TBI do not always fit to both the resources and circumstances in different countries. Future research and clinical practice guidelines should reflect the greater relevance of TBI in low resource settings.	[Saraceno, Giorgio; Belotti, Francesco; Zanin, Luca; Doglietto, Francesco; Panciani, Pier Paolo; Biroli, Antonio; Agosti, Edoardo; Serioli, Simona; Fontanella, Marco M.] Univ Brescia, Dept Surg Specialties Radiol Sci & Publ Hlth, Unit Neurosurg, Ple Spedali Civili 1, I-25123 Brescia, Italy; [Servadei, Franco] Humanitas Reasearch Hosp, IRCCS, Milan, Italy; [Servadei, Franco] Humanitas Univ, Milan, Italy; [Terzi Di Bergamo, Lodovico] IOR Inst Oncol Res, Bellinzona, Switzerland; [Iaccarino, Corrado] Univ Modena & Reggio Emilia, Univ Hosp Modena, Dept Biomed Metab & Neural Sci, Div Neurosurg, Modena, Italy; [Rubiano, Andres M.] El Bosque Univ, Neurosci Inst, Bogota, Colombia; [Rubiano, Andres M.] Meditech Fdn, Cali, Colombia; [Zoia, Cesare] IRCCS Policlin San Matteo Fdn, Dept Neurosurg, Pavia, Italy; [De Bonis, Pasquale] S Anna Univ Hosp, Dept Neurosurg, Ferrara, Italy; [De Bonis, Pasquale] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Raffa, Giovanni] Messina Univ Hosp, Dept Neurosurg, Messina, Italy; [Hawryluk, Gregory] Univ Manitoba, Sect Neurosurg, Winnipeg Hlth Sci Ctr, Winnipeg, MB, Canada; [Grotenhuis, Andre] Radboud Univ Nijmegen, Dept Neurosurg, Nijmegen, Netherlands; [Demetriades, Andreas K.] Royal Infirm Edinburgh NHS Trust, Dept Neurosurg, Edinburgh, Midlothian, Scotland; [Sala, Francesco] Verona Univ Hosp, Dept Neurosci Biomed & Movement Sci, Sect Neurosurg, Verona, Italy; [Rasulic, Lukas] Univ Belgrade, Fac Med, Clin Ctr Serbia, Clin Neurosurg, Belgrade, Serbia; [Bruneau, Michael] Vrije Univ Brussel VUB, Dept Neurosurg, Brussels, Belgium; [Germano, Isabelle M.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Bosnjak, Roman] Univ Med Ctr Ljubljana, Dept Neurosurg, Ljubljana, Slovenia; [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Regli, Luca] Univ Zurich, Univ Hosp Zurich, Dept Neurosurg, Zurich, Switzerland; [Vukic, Miroslav] Univ Hosp Ctr Zagreb, Dept Neurosurg, Zagreb, Croatia; [Tessitore, Enrico; Schaller, Karl] Univ Geneva, Geneva Univ Hosp, Fac Med, Unit Neurosurg, Geneva, Switzerland; [Chaurasia, Bipin] Bhawani Hosp & Res Ctr, Dept Neurosurg, Muzaffarpur, Birgunj, Nepal; [El-Ghandour, Nasser M.] Cairo Univ, Fac Med, Dept Neurosurg, Cairo, Egypt; [Di Ieva, Antonio] Macquarie Univ, Fac Med Human & Hlth Sci, Dept Clin Med, Sydney, NSW, Australia; [Bongetta, Daniele] ASST Fatebenefratelli Sacco, Dept Neurosurg, Milan, Italy; [Borghesi, Ignazio; Fazio, Marco] Maria Cecilia Hosp, Dept Neurosurg, GVM Care & Res, Cotignola, Ravenna, Italy; [Esene, Ignatius N.] Univ Bamenda, Fac Hlth Sci, Div Neurosurg, Bambili, Cameroon; [Rosseau, Gail] George Washington Univ, Sch Med & Hlth Sci, Dept Neurosurg, Washington, DC 20052 USA; [El Abbadi, Najia] Abulcassis Univ Hlth Sci, Int Cheikh Zaid Hosp, Dept Neurosurg, Rabat, Morocco; [Baccanelli, Matteo] Buenos Aires Italian Hosp, Dept Neurosurg, Buenos Aires, DF, Argentina; [Vajkoczy, Peter] Charite Med Univ, Dept Neurosurg, Berlin, Germany		Belotti, F (corresponding author), Univ Brescia, Dept Surg Specialties Radiol Sci & Publ Hlth, Unit Neurosurg, Ple Spedali Civili 1, I-25123 Brescia, Italy.	francesco.belotti@unimi.it	Doglietto, Francesco/AAB-2800-2022	Doglietto, Francesco/0000-0002-7438-0734			[Anonymous], 2019, HEAD INJ ASS EARL MA; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2016, J NEUROSCI RURAL PRA, V7, P7, DOI 10.4103/0976-3147.172151; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Edwards P, 2005, LANCET, V365, P1957; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Fordington S, 2020, J NEUROL, V267, P3105, DOI 10.1007/s00415-020-09926-w; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majidi S, 2017, NEUROCRIT CARE, V27, P90, DOI 10.1007/s12028-016-0363-6; Mangat HS, 2021, J NEUROSURG, V135, P1190, DOI 10.3171/2020.8.JNS201243; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Ojo O A, 2015, Niger Postgrad Med J, V22, P45; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; R Development Core Team, 2012, R LANG ENV STAT COMP; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; World Bank, 2020 WORLD BANK COUN; Zimmerman A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240528	33	0	0	1	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	OCT	2021	65	5					465	473		10.23736/S0390-5616.21.05475-8			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XD9RC	WOS:000723036000001	34814649				2022-02-06	
J	Sasannejad, C; Sheth, KN				Sasannejad, Cina; Sheth, Kevin N.			Anticoagulation in Acute Neurological Disease	SEMINARS IN NEUROLOGY			English	Article						atrial fibrillation; intracerebral hemorrhage; reversal agents; oral anticoagulant	NONVALVULAR ATRIAL-FIBRILLATION; DIRECT ORAL ANTICOAGULANTS; PROTHROMBIN COMPLEX CONCENTRATE; HEALTH-CARE PROFESSIONALS; FRESH-FROZEN PLASMA; INTRACEREBRAL HEMORRHAGE; RISK-FACTORS; INTRACRANIAL HEMORRHAGE; ANTITHROMBOTIC THERAPY; STROKE PREVENTION	While anticoagulation and its reversal have been of clinical relevance for decades, recent academic and technological advances have expanded the repertoire of its application in neurological disease. The advent of direct oral anticoagulants provides effective, mechanistically elegant, and relatively safer therapeutic options than warfarin for eligible patients at risk for neurological sequelae of prothrombotic states, particularly given the recent availability of corresponding reversal agents. In this review, we examine the provenance, indications, safety, and reversal tools for anticoagulant medications in the context of neurological disease, with specific attention to acute ischemic stroke, cerebral venous sinus thrombosis, and intracerebral hemorrhage. We will use specific clinical scenarios to illustrate the complex factors that must be considered in the use of anticoagulation, including intracranial pathology such as intracerebral hemorrhage, traumatic brain injury, or malignancy; metabolic complications such as chronic kidney disease; pregnancy; and advanced age.	[Sasannejad, Cina; Sheth, Kevin N.] Yale Sch Med, Dept Neurol, Div Neurocrit Care & Emergency Neurol, 333 Cedar St, New Haven, CT 06510 USA		Sheth, KN (corresponding author), Yale Sch Med, Dept Neurol, Div Neurocrit Care & Emergency Neurol, 333 Cedar St, New Haven, CT 06510 USA.	kevin.sheth@yale.edu		Sasannejad, Cina/0000-0001-6617-567X			Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Altavilla R, 2019, STROKE, V50, P2093, DOI 10.1161/STROKEAHA.118.022856; Biffi A, 2017, ANN NEUROL, V82, P755, DOI 10.1002/ana.25079; Carney BJ, 2019, J THROMB HAEMOST, V17, P72, DOI 10.1111/jth.14336; Chai-Adisaksopha C, 2015, J THROMB HAEMOST, V13, P2012, DOI 10.1111/jth.13139; Charidimou A, 2019, NEUROLOGY, V93, pE2192, DOI 10.1212/WNL.0000000000008590; Charidimou A, 2018, INT J STROKE, V13, P117, DOI 10.1177/1747493017741384; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Cohen H, 2016, LANCET HAEMATOL, V3, pE426, DOI 10.1016/S2352-3026(16)30079-5; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Coutinho J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002005, 10.1002/14651858.CD002005.pub2]; Cuker A, 2019, AM J HEMATOL, V94, P697, DOI 10.1002/ajh.25475; Diener HC, 2019, NEW ENGL J MED, V380, P1906, DOI 10.1056/NEJMoa1813959; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Da Silva RMFL, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00018; Ferro JM, 2019, JAMA NEUROL, V76, P1457, DOI 10.1001/jamaneurol.2019.2764; Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P175, DOI 10.2450/2015.0096-15; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; FREDRIKSSON K, 1992, STROKE, V23, P972, DOI 10.1161/01.STR.23.7.972; Frontera JA, 2016, CRIT CARE MED, V44, P2251, DOI 10.1097/CCM.0000000000002057; Frontera JA, 2014, NEUROCRIT CARE, V21, P397, DOI 10.1007/s12028-014-9972-0; Gerner ST, 2019, STROKE, V50, P1392, DOI 10.1161/STROKEAHA.118.023492; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2018, NEW ENGL J MED, V378, P2191, DOI 10.1056/NEJMoa1802686; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; James AH, 2010, CRIT CARE MED, V38, pS57, DOI 10.1097/CCM.0b013e3181c9e2bb; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kaiser J, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104342; Kamel H, 2019, INT J STROKE, V14, P207, DOI 10.1177/1747493018799981; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Koch AW, 2019, BLOOD, V133, P1507, DOI 10.1182/blood-2018-10-880849; Lameijer H, 2018, THROMB RES, V169, P123, DOI 10.1016/j.thromres.2018.07.022; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LEVINE M, 1986, STROKE, V17, P111, DOI 10.1161/01.STR.17.1.111; Lip GYH, 2018, STROKE, V49, P2933, DOI 10.1161/STROKEAHA.118.020232; Macha K, 2019, STROKE, V50, P873, DOI 10.1161/STROKEAHA.118.023877; Makani A, 2020, AM J CARDIOL, V125, P210, DOI 10.1016/j.amjcard.2019.10.033; Malhotra K, 2019, NEUROLOGY, V92, pE2421, DOI 10.1212/WNL.0000000000007534; Marti-Fabregas J, 2019, NEUROLOGY, V92, pE2432, DOI 10.1212/WNL.0000000000007532; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Metso TM, 2007, STROKE, V38, P1837, DOI 10.1161/STROKEAHA.106.479501; Mohr JP, 2001, NEW ENGL J MED, V345, P1444, DOI 10.1056/NEJMoa011258; Murphy MP, 2018, STROKE, V49, P2652, DOI 10.1161/STROKEAHA.118.021799; Murthy SB, 2020, STROKE, V51, P137, DOI 10.1161/STROKEAHA.119.026207; Murthy SB, 2017, STROKE, V48, P1594, DOI 10.1161/STROKEAHA.116.016327; Ordi-Ros J, 2019, ANN INTERN MED, V171, P685, DOI 10.7326/M19-0291; Paciaroni M, 2015, STROKE, V46, P2175, DOI 10.1161/STROKEAHA.115.008891; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pennlert J, 2017, STROKE, V48, P314, DOI 10.1161/STROKEAHA.116.014643; Perreault S, 2019, J STROKE, V21, P195, DOI 10.5853/jos.2018.02243; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Proietti M, 2018, STROKE, V49, P98, DOI 10.1161/STROKEAHA.117.018395; Rogers KC, 2019, AM J MED, V132, P38, DOI 10.1016/j.amjmed.2018.06.028; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Scott CA, 2012, OBSTET GYNECOL, V120, P318, DOI 10.1097/AOG.0b013e31825f287c; Seiffge DJ, 2019, ANN NEUROL, V85, P823, DOI 10.1002/ana.25489; Selim M, 2018, STROKE, V49, P1308, DOI 10.1161/STROKEAHA.117.019539; Shields RC, 2001, MAYO CLIN PROC, V76, P260, DOI 10.4065/76.3.260; Shoamanesh A, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104351; Tarlov N, 2013, J NEUROINTERV SURG, V5, P405, DOI 10.1136/neurintsurg-2012-010359; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; WINTZEN AR, 1984, ANN NEUROL, V16, P553, DOI 10.1002/ana.410160505; Yasaka M, 2002, THROMB RES, V108, P25, DOI 10.1016/S0049-3848(02)00402-4; Yoshida K, 2017, STROKE, V48, P276, DOI 10.1161/STROKEAHA.116.014406; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	73	0	0	2	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	OCT	2021	41	05					530	540		10.1055/s-0041-1733793			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WD2YT	WOS:000704813500007	34619779				2022-02-06	
J	Shommu, NS; Blackwood, J; Jenne, CN; Joffe, AR; Martin, DA; Mickiewicz, B; Brindle, M; Eccles, R; Vogel, HJ; Thompson, GC				Shommu, Nusrat S.; Blackwood, Jaime; Jenne, Craig N.; Joffe, Ari R.; Martin, Dori-Ann; Mickiewicz, Beata; Brindle, Mary; Eccles, Robin; Vogel, Hans J.; Thompson, Graham C.		Alberta Sepsis Network	Metabolomics and Inflammatory Mediator Profiling for the Differentiation of Life-Threatening and Non-Severe Appendicitis in the Pediatric Population	METABOLITES			English	Article						appendicitis; child; bio-profiling; metabolomics; inflammatory protein mediators	POTENTIAL DIAGNOSTIC-APPROACH; TRAUMATIC BRAIN-INJURY; TERM MORTALITY; CHILDREN; APPENDECTOMY; RESPONSES; CHEMOMETRICS; SPECTROSCOPY; PROTEIN; SWEDEN	While children with appendicitis often have excellent clinical outcomes, some develop life-threatening complications including sepsis and organ dysfunction requiring pediatric intensive care unit (PICU) support. Our study applied a metabolomics and inflammatory protein mediator (IPM) profiling approach to determine the bio-profiles of children who developed severe appendicitis compared with those that did not. We performed a prospective case-control study of children aged 0-17 years with a diagnosis of appendicitis. Cases had severe disease resulting in PICU admission. Primary controls had moderate appendicitis (perforation without PICU); secondary controls had mild appendicitis (non-perforated). Serum samples were analyzed using Proton Nuclear Magnetic Resonance (H-1 NMR) Spectroscopy and Gas Chromatography-Mass Spectrometry (GC-MS); IPM analysis was performed using plasma bead-based multiplex profiling. Comparisons were made using multivariate data statistical analysis. Fifty-three children were included (15 severe, 38 non-severe). Separation between severe and moderate appendicitis demonstrated excellent sensitivity and specificity (100%, 88%; 14 compounds), separation between severe and mild appendicitis also showed excellent sensitivity and specificity (91%, 90%; 16 compounds). Biomarker patterns derived from metabolomics and IPM profiling are capable of distinguishing children with severe appendicitis from those with less severe disease. These findings provide an important first step towards developing non-invasive diagnostic tools for clinicians in early identification of children who are at a high risk of developing severe appendicitis.	[Shommu, Nusrat S.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, BioNMR Ctr, Calgary, AB T2N 1N4, Canada; [Blackwood, Jaime; Martin, Dori-Ann; Mickiewicz, Beata; Thompson, Graham C.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Jenne, Craig N.] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB T2N 1N4, Canada; [Jenne, Craig N.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Joffe, Ari R.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2R3, Canada; [Brindle, Mary; Eccles, Robin] Univ Calgary, Cumming Sch Med, Dept Surg, Calgary, AB T2N 1N4, Canada; [Brindle, Mary] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Thompson, Graham C.] Univ Calgary, Cumming Sch Med, Dept Emergency Med, Calgary, AB T2N 1N4, Canada		Thompson, GC (corresponding author), Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB T2N 1N4, Canada.; Thompson, GC (corresponding author), Univ Calgary, Cumming Sch Med, Dept Emergency Med, Calgary, AB T2N 1N4, Canada.	nsshommu@ucalgary.ca; jaime.blackwood@ahs.ca; cnjenne@ucalgary.ca; ari.joffe@ahs.ca; dori-ann.martin@albertahealthservices.ca; bmmickie@ucalgary.ca; mary.brindle@ahs.ca; robin.eccles@ahs.ca; vogel@ucalgary.ca; graham.thompson@albertahealthservices.ca	Thompson, Graham/Y-4180-2019	Thompson, Graham/0000-0002-6781-4186	Alberta Health Services Critical Care Strategic Clinical Network Seed Grant; Alberta Innovates-Health Solutions Team Grant	This research was funded by the Alberta Health Services Critical Care Strategic Clinical Network Seed Grant and Alberta Innovates-Health Solutions Team Grant awarded to the Alberta Sepsis Network.	Abbas MH, 2014, SURG LAPARO ENDO PER, V24, P488, DOI 10.1097/SLE.0000000000000067; Acosta R, 2005, PEDIATR RADIOL, V35, P495, DOI 10.1007/s00247-004-1384-4; Andersson MN, 2011, ANN SURG, V254, P103, DOI 10.1097/SLA.0b013e31821ad9c4; Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Andersson RE, 2013, WORLD J SURG, V37, P974, DOI 10.1007/s00268-012-1856-x; Arlt A, 2015, INNATE IMMUN-LONDON, V21, P30, DOI 10.1177/1753425913515033; Blomqvist PG, 2001, ANN SURG, V233, P455, DOI 10.1097/00000658-200104000-00001; Bundy DG, 2007, JAMA-J AM MED ASSOC, V298, P438, DOI 10.1001/jama.298.4.438; CURRAN TJ, 1993, J PEDIATR SURG, V28, P204, DOI 10.1016/S0022-3468(05)80276-3; Machado SLD, 2016, BIOMARKERS, V21, P530, DOI 10.3109/1354750X.2016.1160426; Eriksson L., 2006, BASIC PRINCIPLES A 1; Guthery SL, 2004, J PEDIATR-US, V144, P589, DOI 10.1016/j.jpeds.2004.02.029; Hachim MY, 2006, SAUDI MED J, V27, P1815; Hennelly KE, 2011, CURR OPIN PEDIATR, V23, P281, DOI 10.1097/MOP.0b013e32834604da; Hummel Jan, 2007, V18, P75, DOI 10.1007/4735_2007_0229; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mickiewicz B., 2014, PEDIAT CRIT CARE MED, V15, P146, DOI [10.1097/01.pcc.0000449371.98387.91, DOI 10.1097/01.PCC.0000449371.98387.91]; Mickiewicz B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35000-7; Mickiewicz B, 2015, J ORTHOP RES, V33, P1631, DOI 10.1002/jor.22949; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1026-2; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0729-0; Mickiewicz B, 2014, CRIT CARE MED, V42, P1140, DOI 10.1097/CCM.0000000000000142; Nance ML, 2000, PEDIATR EMERG CARE, V16, P160, DOI 10.1097/00006565-200006000-00005; Naqvi SA, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2359681; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Ong DST, 2005, J ENDOTOXIN RES, V11, P267, DOI 10.1179/096805105X58698; Orino K, 2008, VET J, V178, P191, DOI 10.1016/j.tvjl.2007.07.006; Rivera-Chavez FA, 2003, ANN SURG, V237, P408, DOI 10.1097/00000658-200303000-00016; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Roberts DJ, 2013, J NEUROTRAUM, V30, P1717, DOI 10.1089/neu.2012.2841; ROTHROCK SG, 1991, ANN EMERG MED, V20, P45, DOI 10.1016/S0196-0644(05)81117-5; Rothrock SG, 2000, ANN EMERG MED, V36, P39, DOI 10.1067/mem.2000.105658; Ruber M, 2006, CLIN EXP IMMUNOL, V143, P117, DOI 10.1111/j.1365-2249.2005.02957.x; Selbst SM, 2005, PEDIATR EMERG CARE, V21, P165; Shommu NS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193563; Shommu NS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22338-1; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Soomro AG, 2008, J LIAQUAT UNIV MED H, V7, P93; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vissers RJ, 2010, EMERG MED CLIN N AM, V28, P103, DOI 10.1016/j.emc.2009.09.003; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Williams N, 1994, J R Coll Surg Edinb, V39, P168; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yegane R.P., 2008, ACTA MED IRAN, V46, P501; Yildirim O, 2006, J INVEST SURG, V19, P345, DOI 10.1080/08941930600985686; Zouari M, 2016, AM J EMERG MED, V34, P189, DOI 10.1016/j.ajem.2015.10.004	52	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-1989		METABOLITES	Metabolites	OCT	2021	11	10							664	10.3390/metabo11100664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP0ZO	WOS:000712870700001	34677379	Green Published, gold			2022-02-06	
J	Shumski, EJ; Kasamatsu, TM; Wilson, KS; Pamukoff, DN				Shumski, Eric J.; Kasamatsu, Tricia M.; Wilson, Kathleen S.; Pamukoff, Derek N.			Drop Landing Biomechanics in Individuals With and Without a Concussion History	JOURNAL OF APPLIED BIOMECHANICS			English	Article						mild traumatic brain injury; jump landing; lower extremity; musculoskeletal injury; injury risk; knee flexion	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; DUAL-TASK GAIT; MUSCULOSKELETAL INJURY; SINGLE-LEG; ACL INJURY; JUMP; RISK; ASSOCIATION; EPIDEMIOLOGY	Research has identified an increased risk of lower extremity injury postconcussion, which may be due to aberrant biomechanics during dynamic tasks. The purpose of this study was to compare the drop landing biomechanics between individuals with and without a concussion history. Twenty-five individuals with and 25 without a concussion history were matched on age (+/- 3 y), sex, and body mass index (+/- 1 kg/m(2)). Three-dimensional landing biomechanics were recorded to obtain dependent variables (peak vertical ground reaction force, loading rate, knee flexion angle and external moment, knee abduction angle and external moment, and knee flexion and abduction angle at ground contact). A 1-way multivariate analysis of variance compared outcomes between groups. There was no difference in drop landing biomechanics between individuals with and without a concussion history (F-10,F-39 = 0.460, P = .877, Wilk Lambda= .918). There was an effect of time since concussion on knee flexion characteristics. Time since most recent concussion explained a significant amount of variation in both peak (Delta R-2 = .177, beta = -0.305, Delta P = .046) and initial ground contact (Delta R-2 = .292, beta = -0.204, Delta P = .008) knee flexion angle after covarying for sex and body mass index. Therefore, time since concussion should be considered when evaluating biomechanical patterns.	[Shumski, Eric J.; Kasamatsu, Tricia M.; Wilson, Kathleen S.; Pamukoff, Derek N.] Calif State Univ Fullerton, Dept Kinesiol, Fullerton, CA 92634 USA; [Shumski, Eric J.] Univ Georgia, UGA Concuss Res Lab, Dept Kinesiol, Athens, GA 30602 USA; [Shumski, Eric J.] Univ Georgia, Biomech Lab, Dept Kinesiol, Athens, GA 30602 USA; [Pamukoff, Derek N.] Western Univ, Sch Kinesiol, London, ON, Canada		Shumski, EJ (corresponding author), Calif State Univ Fullerton, Dept Kinesiol, Fullerton, CA 92634 USA.; Shumski, EJ (corresponding author), Univ Georgia, UGA Concuss Res Lab, Dept Kinesiol, Athens, GA 30602 USA.; Shumski, EJ (corresponding author), Univ Georgia, Biomech Lab, Dept Kinesiol, Athens, GA 30602 USA.	eric.shumski@uga.edu					Aerts I, 2013, J SPORT MED PHYS FIT, V53, P509; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Asaeda M, 2020, ASIA-PAC J SPORT MED, V22, P56, DOI 10.1016/j.asmart.2020.07.002; Bates NA, 2013, J BIOMECH, V46, P1237, DOI 10.1016/j.jbiomech.2013.02.024; BELL AL, 1989, HUM MOVEMENT SCI, V8, P3, DOI 10.1016/0167-9457(89)90020-1; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Caccese JB, 2020, J ATHL TRAINING, V55, P601, DOI 10.4085/1062-6050-164-19; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Cohen J., 1988, STAT POWER ANAL BEHA; Collings TJ, 2019, SPORTS MED, V49, P385, DOI 10.1007/s40279-018-01045-x; Cortes N, 2013, INT J ATHL THER TRAI, V18, P10, DOI 10.1123/ijatt.18.3.10; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Douglass DH, 2003, CLIM RES, V24, P15, DOI 10.3354/cr024015; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Etnoyer J, 2013, J ATHL TRAINING, V48, P161, DOI 10.4085/1062-6050-48.2.09; Garrison S., J ATHL TRAINING, DOI [10.4085/533-20, DOI 10.4085/533-20]; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; Lempke LB, 2021, J SPORT REHABIL, V30, P774, DOI 10.1123/jsr.2020-0310; Leppanen Mari, 2017, Orthop J Sports Med, V5, p2325967117745487, DOI 10.1177/2325967117745487; Leppanen M, 2017, AM J SPORT MED, V45, P386, DOI 10.1177/0363546516665810; Lynall RC, 2020, J ATHL TRAINING, V55, P488, DOI 10.4085/1062-6050-185-19; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMillan AG, 2010, PEDIATR PHYS THER, V22, P34, DOI 10.1097/PEP.0b013e3181cd1868; McNair P J, 1999, J Sci Med Sport, V2, P86, DOI 10.1016/S1440-2440(99)80187-X; McPherson AL, 2020, SPORTS MED, V50, P1203, DOI 10.1007/s40279-020-01262-3; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Myer GD, 2015, BRIT J SPORT MED, V49, P118, DOI 10.1136/bjsports-2013-092536; Onate JA, 2005, AM J SPORT MED, V33, P831, DOI 10.1177/0363546504271499; Padua DA, 2015, J ATHL TRAINING, V50, P589, DOI 10.4085/1062-6050-50.1.10; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Radoi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212541; Russell KA, 2006, J ATHL TRAINING, V41, P166; Sigward SM, 2012, SCAND J MED SCI SPOR, V22, P502, DOI 10.1111/j.1600-0838.2010.01254.x; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Strobach T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00108; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	54	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	OCT	2021	37	5					450	457		10.1123/jab.2021-0097			8	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Sport Sciences	UZ2AL	WOS:000702012600008	34504042				2022-02-06	
J	Smulligan, KL; Wingerson, MJ; Seehusen, CN; Magliato, SN; Wilson, JC; Howell, DR				Smulligan, Katherine L.; Wingerson, Mathew J.; Seehusen, Corrine N.; Magliato, Samantha N.; Wilson, Julie C.; Howell, David R.			Patient perception of dizziness and imbalance does not correlate with gait measures in adolescent athletes post-concussion	GAIT & POSTURE			English	Article						Concussion; Gait; Dizziness; Balance; Dual-task; Assessment	OLD-DAYS BIAS; SPORTS-RELATED CONCUSSION; BALANCE CONTROL; SYMPTOM; PERFORMANCE; DEFICITS; TASK	Background: Dizziness and gait impairments are commonly observed following a concussion, and both are associated with prolonged concussion recovery. Research question: Is there a correlation between combined self-reported dizziness and balance impairment severity with objective gait impairments after concussion? Methods: Participants (n = 51; 15.4 +/- 1.6 years; 51 % female; 7.3 +/- 3.2 days post-injury) age 12-18 years self-reported ratings of dizziness and balance impairment using the Post-Concussion Symptom Inventory (PCSI) within 14 days of injury. Individual ratings of dizziness, balance impairment, and moving clumsily on the PCSI were combined to create a comprehensive dizziness and imbalance score. Participants also completed a smartphone-based gait evaluation under single-task and dual-task conditions. Correlation coefficients (Pearson r for normally distributed and Spearman rho for non-normally distributed variables) were calculated between self-reported symptoms and single and dual-task spatiotemporal gait parameters, specifically step velocity, step time, and step length. Results: Correlation coefficients indicated that there was low to no correlation between self-reported dizziness and imbalance impairment severity and smartphone-obtained gait parameters under single- or dual-task conditions, including step velocity (single-task: r=-0.22, p = 0.13; dual-task: r=-0.05, p = 0.72), step time (single-task: rho = 0.16, p = 0.27; dual-task: rho = 0.14, p = 0.33), and step length (single-task: r=-0.15, p = 0.30; dual-task: r = 0.03, p = 0.84). Significance: Self-reported dizziness and balance impairment severity within the first two weeks of concussion may not reflect objectively measured gait performance, given the lack of association between subjective symptom ratings and functional measures. Further, smartphone collected gait parameters may not provide the necessary sensitivity to detect an association with dizziness. The lack of significant correlation between self-reported symptoms and objective gait performance highlights the importance of using both objective and subjective measures to obtain a more complete picture of concussion deficits.	[Smulligan, Katherine L.; Magliato, Samantha N.; Wilson, Julie C.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Wingerson, Mathew J.; Seehusen, Corrine N.; Wilson, Julie C.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Sports Med Ctr,Dept Orthoped, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu		Wilson, Julie/0000-0002-6834-6257; Howell, David/0000-0002-2955-0191	Children's Hospital Colorado Research Institute Pilot Award Program	This study was funded by the Children's Hospital Colorado Research Institute Pilot Award Program. The study sponsors did not play a role in the study design, data collection, analysis, or interpretation, or the writing and submission of the manuscript.	Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Brilliant AN, 2021, CLIN J SPORT MED, V31, P442, DOI 10.1097/JSM.0000000000000779; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buttner F, 2020, J ORTHOP SPORT PHYS, V50, DOI 10.2519/jospt.2020.9485; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Cohen HS, 2018, LARYNGOSCOPE, V128, P1687, DOI 10.1002/lary.27022; Doherty C, 2017, HUM MOVEMENT SCI, V52, P160, DOI 10.1016/j.humov.2017.02.005; Fino PC, 2019, J HEAD TRAUMA REHAB, V34, pE74, DOI 10.1097/HTR.0000000000000418; Howell DR, 2021, J APPL BIOMECH, V37, P380, DOI 10.1123/jab.2020-0391; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Howell DR, 2020, PHYSICIAN SPORTSMED, V48, P75, DOI 10.1080/00913847.2019.1632155; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hunt Danielle L, 2021, Clin J Sport Med, DOI 10.1097/JSM.0000000000000923; Inness EL, 2019, J HEAD TRAUMA REHAB, V34, pE37, DOI 10.1097/HTR.0000000000000431; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marchetti GF, 2014, J NEUROL PHYS THER, V38, P119, DOI 10.1097/NPT.0000000000000015; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Messerschmidt EL, 2021, J SPORT REHABIL, V30, P988, DOI 10.1123/jsr.2019-0331; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Reneker Jennifer C, 2015, Inj Epidemiol, V2, P22; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silsupadol P, 2017, GAIT POSTURE, V58, P516, DOI 10.1016/j.gaitpost.2017.09.030; Sweeny M, 2021, BRAIN INJURY, V35, P587, DOI 10.1080/02699052.2021.1891288; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Voormolen DC, 2020, BRAIN INJURY, V34, P1001, DOI 10.1080/02699052.2020.1761563; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Zhu WM, 2012, J SPORT HEALTH SCI, V1, P9, DOI 10.1016/j.jshs.2012.02.002	43	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2021	90						289	294		10.1016/j.gaitpost.2021.09.184			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	WK1SH	WOS:000709512400003	34564000				2022-02-06	
J	Somoye, MS; Adetayo, AM; Adeyemo, WL; Ladeinde, AL; Gbotolorun, MO				Somoye, Mayowa Solomon; Adetayo, Adekunle Moses; Adeyemo, Wasiu Lanre; Ladeinde, Akinola Ladipo; Gbotolorun, Micah Olalekan			A comparative study of quality of life of patients with maxillofacial fracture and healthy controls at two tertiary healthcare institutions	JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS			English	Article						Bone fractures; Fixation; Quality of life	FACIAL TRAUMA; INJURY; HEAD	Objectives: Despite treatment, the pre-traumatic facial appearance of patients with maxillofacial fractures might not be able to be restored, and this difference can affect the person's quality of life (QoL). This study was designed to evaluate changes in QoL of people with maxillofacial fractures. Materials and Methods: The study population was comprised of participants with maxillofacial fracture and age- and sex-matched healthy controls without history of such fracture. QoL was measured using the World Health Organization Quality of Life BREF (WHOQOL-BREF) questionnaire, which was administered to the patients before treatment (Time 1), at 6 weeks post-treatment (Time 2), and at 12 weeks postoperatively (Time 3). The values were compared with those of healthy controls. The QoL was compared between closed reduction group and open reduction and internal fixation group. Results: The QoL scores of people with maxillofacial fracture before treatment were significantly lower (P=0.001) than those of healthy controls in all domains of the WHOQOL-BREE The QoL scores in the psychological and social domains of patients with maxillofacial fracture at Time 3 were still lower than those of healthy controls (P =0.001). Conclusion: The QoL of patients with maxillofacial fracture was significantly reduced before treatment in all domains and remained reduced in both psychological and social domains weeks rifler treatment. Therefore, clinicians must be aware of and manage the residual psychosocial issues that can accompany the post-treatment period of maxillofacial injury.	[Somoye, Mayowa Solomon; Adeyemo, Wasiu Lanre; Ladeinde, Akinola Ladipo; Gbotolorun, Micah Olalekan] Lagos Univ, Dept Oral & Maxillofacial Surg, Teaching Hosp, Idi Araba, Nigeria; [Adetayo, Adekunle Moses] Babcock Univ, Benjamin Carson Snr Sch Med, Dept Surg, PMB 4003, Ilisan Remo, Ogun, Nigeria		Adetayo, AM (corresponding author), Babcock Univ, Benjamin Carson Snr Sch Med, Dept Surg, PMB 4003, Ilisan Remo, Ogun, Nigeria.	adetayoa@babcock.edu.ng		Gbotolorun, Olalekan/0000-0002-5375-4530; Adeyemo, Wasiu/0000-0002-0257-7853; Somoye, Mayowa/0000-0003-0715-5788			ADEKEYE EO, 1980, ORAL SURG ORAL MED O, V49, P491, DOI 10.1016/0030-4220(80)90068-7; Atchison K A, 1990, J Dent Educ, V54, P680; Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; Braimah RO, 2020, MAXILLOFACIAL SURG C, P449; Bull R, 1988, SOCIAL PSYCHOL FACIA, P9; De Sousa A, 2010, INDIAN J PLAST SURG, V43, P200, DOI 10.4103/0970-0358.73452; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Hull AM, 2003, BRIT J ORAL MAX SURG, V41, P317, DOI 10.1016/S0266-4356(03)00131-1; Kieser J, 2002, INT J ORAL MAX SURG, V31, P206, DOI 10.1054/ijom.2002.0208; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Krageloh C U, 2011, Educ Health (Abingdon), V24, P545; Lento J, 2004, J ORAL MAXIL SURG, V62, P925, DOI 10.1016/j.joms.2004.02.009; Levine E, 2005, ANN PLAS SURG, V54, P502, DOI 10.1097/01.sap.0000155282.48465.94; NEALE HW, 1986, CLIN PLAST SURG, V13, P119; Omeje KU, 2014, J CRANIO MAXILL SURG, V42, P1821, DOI 10.1016/j.jcms.2014.06.021; SHEPHERD J, 1990, BRIT J SOC WORK, V20, P309; Shetty Vivek, 2003, Dent Clin North Am, V47, P141, DOI 10.1016/S0011-8532(02)00059-9; Stone MB, 2010, J CRANIOFAC SURG, V21, P1358, DOI 10.1097/SCS.0b013e3181ec6872; Tubert-Jeannin S, 2003, COMMUNITY DENT ORAL, V31, P275, DOI 10.1034/j.1600-0528.2003.t01-1-00006.x; Ukpong DI, 2008, BRIT J ORAL MAX SURG, V46, P297, DOI 10.1016/j.bjoms.2007.09.013; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; World Health Organization (WHO), 1946, WHO DEF HLTH PREAMBL, P19	23	0	0	0	0	KOREAN ACAD ORAL & MAXILLOFACIAL SURGERY	SEOUL	B169, SEOUL NATIONAL UNIVERSITY DENTAL HOSPITAL, 101 DAEHAK-RO, JONGNO-GU, SEOUL, 110-768, SOUTH KOREA	2234-7550	2234-5930		J KOR ASSOC ORAL MAX	J. Kor. Assoc. Oral Maxillofac. Surg.	OCT	2021	47	5					351	359		10.5125/jkaoms.2021.47.5.351			9	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	WP4OB	WOS:000713112100003	34713809	Green Published, gold			2022-02-06	
J	Spiera, Z; Hannah, T; Li, AD; Dreher, N; Marayati, NF; Ali, M; Shankar, DS; Durbin, J; Schupper, AJ; Gometz, A; Lovell, M; Choudhri, T				Spiera, Zachary; Hannah, Theodore; Li, Adam; Dreher, Nickolas; Marayati, Naoum Fares; Ali, Muhammad; Shankar, Dhruv S.; Durbin, John; Schupper, Alexander J.; Gometz, Alex; Lovell, Mark; Choudhri, Tanvir			Nonsteroidal anti-inflammatory drug use and concussions in adolescent athletes: incidence, severity, and recovery	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						NSAID; ImPACT; anti-inflammatory; sports-related concussion; trauma	WORLD CUPS; MEDICATION; IBUPROFEN; PREVALENCE; PREDICTORS; MANAGEMENT; OUTCOMES; ASPIRIN; NSAIDS; YOUTH	OBJECTIVE Given concerns about the potential long-term effects of concussion in young athletes, concussion prevention has become a major focus for amateur sports leagues. Athletes have been known to frequently use anti-inflammatory medications to manage injuries, expedite return to play, and treat concussion symptoms. However, the effects of baseline nonsteroidal anti-inflammatory drug (NSAID) use on the susceptibility to head injury and concussion remain unclear. This study aims to assess the effects of preinjury NSAID use on concussion incidence, severity, and recovery in young athletes. METHODS Data from 25,815 ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) tests were obtained through a research agreement with ImPACT Applications Inc. Subjects ranged in age from 12 to 22 years old. Those who reported NSAID use at baseline were assigned to one (anti-inflammatory [AI]) cohort, whereas all others were assigned to the control (CT) cohort. Differences in head trauma and concussion incidence, severity, and recovery were assessed using chi-square tests, unpaired t-tests, and Kaplan-Meier plots. RESULTS The CT cohort comprised a higher percentage (p < 0.0001) of males (66.30%) than the AI cohort (44.16%) and had a significantly greater portion of athletes who played football (p = 0.004). However, no statistically significant differences were found between the two cohorts in terms of the incidence of head trauma (CT = 0.489, AI = 0.500, p = 0.9219), concussion incidence (CT = 0.175, AI = 0.169, p = 0.7201), injury severity, or median concussion recovery time (CT = 8, AI = 8, p = 0.6416). In a multivariable analysis controlling for baseline differences between the cohorts, no association was found between NSAID use and concussion incidence or severity. CONCLUSIONS In this analysis, the authors found no evidence that preinjury use of NSAIDs affects concussion risk in adolescent athletes. They also found no indication that preinjury NSAID use affects the severity of initial injury presentation or concussion recovery.	[Spiera, Zachary; Hannah, Theodore; Li, Adam; Dreher, Nickolas; Marayati, Naoum Fares; Ali, Muhammad; Shankar, Dhruv S.; Durbin, John; Schupper, Alexander J.; Gometz, Alex; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Lovell, Mark] Pittsburgh Fdn, Lovell Hlth Care Fdn, Pittsburgh, PA USA		Spiera, Z (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	zachary.spiera@icahn.mssm.edu		Hannah, Theodore/0000-0001-6527-9725			Alaranta A, 2006, INT J SPORTS MED, V27, P919, DOI 10.1055/s-2006-923811; Baugh CM, 2015, J LAW BIOSCI, V2, P449, DOI 10.1093/jlb/lsv023; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P216, DOI 10.1093/arclin/acx059; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; CDC, 2006, PRINC EP PUBL HLTH P; Chambers CT, 1997, ARCH PEDIAT ADOL MED, V151, P449, DOI 10.1001/archpedi.1997.02170420019003; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Da Silva ER, 2011, BRIT J SPORT MED, V45, P91, DOI 10.1136/bjsm.2009.065342; Davis JS, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000550; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Dietzel Douglas P, 2004, Curr Sports Med Rep, V3, P310; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Enniss Toby M, 2018, Trauma Surg Acute Care Open, V3, pe000153, DOI 10.1136/tsaco-2017-000153; Esquivel AO, 2017, ANN BIOMED ENG, V45, P1581, DOI 10.1007/s10439-017-1809-5; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Gross Jessica Lynn, 2019, Anesthesiol Clin, V37, P79, DOI 10.1016/j.anclin.2018.09.010; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lippi G, 2006, BRIT J SPORT MED, V40, P661, DOI 10.1136/bjsm.2006.027342; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; Martinez L, 2019, CLIN THER, V41, P2612, DOI 10.1016/j.clinthera.2019.10.002; McKeithan L, 2019, MED SCI BASEL, V7, pE44; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Miles S., 2007, XPHARM COMPREHENSIVE, P1; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Petrelli T, 2017, PAED CHILD HEALT-CAN, V22, P2, DOI 10.1093/pch/pxw011; Schallmo MS, 2017, ORTHOP J SPORTS MED, V5; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Tscholl P, 2008, BRIT J SPORT MED, V42, P725, DOI 10.1136/bjsm.2007.045187; Tscholl PM, 2015, BRIT J SPORT MED, V49, P580, DOI 10.1136/bjsports-2015-094784; Valentovic M., 2007, XPHARM COMPREHENSIVE, P1; Warden SJ, 2010, PHYSICIAN SPORTSMED, V38, P132, DOI 10.3810/psm.2010.04.1770; Warner DC, 2002, J ADOLESCENT HEALTH, V30, P150, DOI 10.1016/S1054-139X(01)00325-1; Wick EC, 2017, JAMA SURG, V152, P691, DOI 10.1001/jamasurg.2017.0898; Zangbar B, 2015, AM J SURG, V209, P921, DOI 10.1016/j.amjsurg.2014.05.027; Zhou YJ, 2014, PHARMACOEPIDEM DR S, V23, P43, DOI 10.1002/pds.3463; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	45	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2021	28	4					476	482		10.3171/2021.2.PEDS2115			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	WD5GL	WOS:000704968800003	34330088				2022-02-06	
J	Steel, TL; Afshar, M; Edwards, S; Jolley, SE; Timko, C; Clark, BJ; Douglas, IS; Dzierba, AL; Gershengorn, HB; Gilpin, NW; Godwin, DW; Hough, CL; Maldonado, JR; Mehta, AB; Nelson, LS; Patel, MB; Rastegar, DA; Stollings, JL; Tabakoff, B; Tate, JA; Wong, A; Burnham, EL				Steel, Tessa L.; Afshar, Majid; Edwards, Scott; Jolley, Sarah E.; Timko, Christine; Clark, Brendan J.; Douglas, Ivor S.; Dzierba, Amy L.; Gershengorn, Hayley B.; Gilpin, Nicholas W.; Godwin, Dwayne W.; Hough, Catherine L.; Maldonado, Jose R.; Mehta, Anuj B.; Nelson, Lewis S.; Patel, Mayur B.; Rastegar, Darius A.; Stollings, Joanna L.; Tabakoff, Boris; Tate, Judith A.; Wong, Adrian; Burnham, Ellen L.		Amer Thoracic Soc Assembly Critica; Assembly Behav Sci Hlth Serv Res; Assembly Nursing	Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome An Official American Thoracic Society Research Statement	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						alcohol withdrawal delirium; critical care; translational medical research; clinical studies; quality improvement	MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; CARBOHYDRATE-DEFICIENT TRANSFERRIN; INCREASED ASTROCYTE EXPRESSION; CORTICOTROPIN-RELEASING-FACTOR; INFERIOR COLLICULUS NEURONS; INTERMITTENT ETHANOL VAPOR; GATED CALCIUM-CHANNELS; TRAUMATIC BRAIN-INJURY; CARE-UNIT PATIENTS	Background: Severe alcohol withdrawal syndrome (SAWS) is highly morbid, costly, and common among hospitalized patients, yet minimal evidence exists to guide inpatient management. Research needs in this field are broad, spanning the translational science spectrum. Goals: This research statement aims to describe what is known about SAWS, identify knowledge gaps, and offer recommendations for research in each domain of the Institute of Medicine T-0-T-4 continuum to advance the care of hospitalized patients who experience SAWS. Methods: Clinicians and researchers with unique and complementary expertise in basic, clinical, and implementation research related to unhealthy alcohol consumption and alcohol withdrawal were invited to participate in a workshop at the American Thoracic Society 2019 International Conference. The committee was subdivided into four groups on the basis of interest and expertise: T-0-T-1 (basic science research with translation to humans), T-2 (research translating to patients), T-3 (research translating to clinical practice), and T-4 (research translating to communities). A medical librarian conducted a pragmatic literature search to facilitate this work, and committee members reviewed and supplemented the resulting evidence, identifying key knowledge gaps. Results: The committee identified several investigative opportunities to advance the care of patients with SAWS in each domain of the translational science spectrum. Major themes included 1) the need to investigate non-g-aminobutyric acid pathways for alcohol withdrawal syndrome treatment; 2) harnessing retrospective and electronic health record data to identify risk factors and create objective severity scoring systems, particularly for acutely ill patients with SAWS; 3) the need for more robust comparative-effectiveness data to identify optimal SAWS treatment strategies; and 4) recommendations to accelerate implementation of effective treatments into practice. Conclusions: The dearth of evidence supporting management decisions for hospitalized patients with SAWS, many of whom require critical care, represents both a call to action and an opportunity for the American Thoracic Society and larger scientific communities to improve care for a vulnerable patient population. This report highlights basic, clinical, and implementation research that diverse experts agree will have the greatest impact on improving care for hospitalized patients with SAWS.	[Steel, Tessa L.] Vet Affairs Puget Sound Hlth Care Syst, Seattle Div, Seattle Denver Ctr Innovat, 1660 South Columbian Way S-152, Seattle, WA 98108 USA; [Steel, Tessa L.] Univ Washington, Sch Med, Div Pulm Crit Care & Sleep Med, Seattle, WA USA; [Jolley, Sarah E.; Tabakoff, Boris; Burnham, Ellen L.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Afshar, Majid] Univ Wisconsin, Madison, WI USA; [Clark, Brendan J.] St Anthony Hosp & Med Campus, Lakewood, CO USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA; [Dzierba, Amy L.] New York Presbyterian Hosp, New York, NY USA; [Edwards, Scott; Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Gershengorn, Hayley B.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Godwin, Dwayne W.] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [Hough, Catherine L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Maldonado, Jose R.] Stanford Hlth Care, Stanford, CA USA; [Mehta, Anuj B.] Natl Jewish Hlth, Denver, CO USA; [Nelson, Lewis S.] Rutgers State Univ, Rutgers New Jersey Med Sch, New Brunswick, NJ USA; [Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Rastegar, Darius A.; Stollings, Joanna L.] Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA; [Tate, Judith A.] Ohio State Univ, Columbus, OH 43210 USA; [Timko, Christine] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wong, Adrian] Massachusetts Coll Pharm & Hlth Sci Univ, Boston, MA USA		Steel, TL (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Seattle Div, Seattle Denver Ctr Innovat, 1660 South Columbian Way S-152, Seattle, WA 98108 USA.	tessita@uw.edu					Abrahao KP, 2017, NEURON, V96, P1223, DOI 10.1016/j.neuron.2017.10.032; Abrahao KP, 2017, NEUROPSYCHOPHARMACOL, V42, P1070, DOI 10.1038/npp.2016.251; Afshar M, 2019, J AM MED INFORM ASSN, V26, P254, DOI 10.1093/jamia/ocy166; Afshar M, 2018, ALCOHOL CLIN EXP RES, V42, P2064, DOI 10.1111/acer.13853; Afshar M, 2017, ALCOHOL CLIN EXP RES, V41, P1745, DOI 10.1111/acer.13471; Akinfiresoye LR, 2016, ALCOHOL CLIN EXP RES, V40, P2359, DOI 10.1111/acer.13223; Alele PE, 2005, ALCOHOL CLIN EXP RES, V29, P1027, DOI 10.1097/01.ALC.0000167743.96121.40; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008537.pub2; Amato L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005063.pub3; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Ammar MA, 2021, ANN PHARMACOTHER, V55, P294, DOI 10.1177/1060028020949137; Anker JJ, 2010, NEUROSCI BIOBEHAV R, V35, P315, DOI 10.1016/j.neubiorev.2010.04.003; [Anonymous], 2020, J ADDICT MED, V14, P1, DOI 10.1097/ADM.0000000000000633; [Anonymous], 2004, ETH CHALL DRUG EP IS; [Anonymous], 2019, PUBL HLTH DAT INT; [Anonymous], 2019, DRINK LEV DEF; Avegno EM, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3222; Avegno EM, 2018, J NEUROSCI, V38, P7761, DOI 10.1523/JNEUROSCI.0483-18.2018; Awissi DK, 2013, INTENS CARE MED, V39, P16, DOI 10.1007/s00134-012-2758-y; BALLENGER JC, 1978, BRIT J PSYCHIAT, V133, P1, DOI 10.1192/bjp.133.1.1; Barbash IJ, 2019, CRIT CARE MED, V47, P1026, DOI 10.1097/CCM.0000000000003613; BARCHAS JD, 1985, AM J PSYCHIAT, V142, P838; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bates DW, 2018, HEALTH AFFAIR, V37, P1736, DOI 10.1377/hlthaff.2018.0738; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; Becker HC, 2016, INT REV NEUROBIOL, V126, P157, DOI 10.1016/bs.irn.2016.02.006; Becker HC, 2000, ALCOHOL RES HEALTH, V24, P105; Becker HC, 2006, ALCOHOL ALCOHOLISM, V41, P399, DOI 10.1093/alcalc/agl029; Becker Howard C, 2014, Handb Clin Neurol, V125, P133, DOI 10.1016/B978-0-444-62619-6.00009-4; Becker JB, 2016, PHARMACOL REV, V68, P242, DOI 10.1124/pr.115.011163; Beg Muna, 2016, Perm J, V20, P49, DOI 10.7812/TPP/15-113; Benedict NJ, 2018, DRUG ALCOHOL DEPEN, V192, P303, DOI 10.1016/j.drugalcdep.2018.08.017; Beresford T, 2017, ALCOHOL TREAT Q, V35, P232, DOI 10.1080/07347324.2017.1322418; Berggren U, 2009, ALCOHOL ALCOHOLISM, V44, P382, DOI 10.1093/alcalc/agp012; Bernard GR, 2004, AM J RESP CRIT CARE, V170, P1375, DOI 10.1164/rccm.200406-726ST; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Bielka K, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0075-7; Blum JM, 2013, CHEST, V143, P808, DOI 10.1378/chest.12-2287; Brathen G, 2000, J NEUROL NEUROSUR PS, V68, P342, DOI 10.1136/jnnp.68.3.342; Bray JG, 2018, NEUROPHARMACOLOGY, V135, P113, DOI 10.1016/j.neuropharm.2018.02.031; Breen D, 2005, CRIT CARE, V9, pR200, DOI 10.1186/cc3495; Breese GR, 2016, ALCOHOL, V52, P9, DOI 10.1016/j.alcohol.2016.01.005; Brotherton AL, 2016, PHARMACOTHERAPY, V36, P433, DOI 10.1002/phar.1726; Brum LFS, 2000, PHARMACOL BIOCHEM BE, V67, P411, DOI 10.1016/S0091-3057(00)00400-7; Brummel NE, 2014, CRIT CARE MED, V42, P369, DOI 10.1097/CCM.0b013e3182a645bd; Brust John C M, 2014, Handb Clin Neurol, V125, P123, DOI 10.1016/B978-0-444-62619-6.00008-2; Burapakajornpong Natapon, 2011, Journal of the Medical Association of Thailand, V94, P991; Calling S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224127; Carson SS, 2006, CRIT CARE MED, V34, P1326, DOI 10.1097/01.CCM.0000215513.63207.7F; Carter A, 2012, ADDICTION NEUROETHICS: THE ETHICS OF ADDICTION NEUROSCIENCE RESEARCH AND TREATMENT, P1; Chevreul Karine, 2012, J Clin Psychiatry, V73, pe906, DOI 10.4088/JCP.11r07418; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Cimiotti JP, 2012, AM J INFECT CONTROL, V40, P486, DOI 10.1016/j.ajic.2012.02.029; Clapp P, 2008, ALCOHOL RES HEALTH, V31, P310; Collins FS, 2018, JAMA-J AM MED ASSOC, V320, P129, DOI 10.1001/jama.2018.8826; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Colombo G, 2000, ALCOHOL CLIN EXP RES, V24, P58, DOI 10.1111/j.1530-0277.2000.tb04554.x; Corrigan P, 2017, AM J ADDICTION, V26, P59, DOI 10.1111/ajad.12458; Corrigan PW, 2017, AM J ADDICTION, V26, P67, DOI 10.1111/ajad.12436; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Crispo AL, 2014, PHARMACOTHERAPY, V34, P910, DOI 10.1002/phar.1448; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Daeppen JB, 2002, ARCH INTERN MED, V162, P1117, DOI 10.1001/archinte.162.10.1117; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; De Witte P, 2003, NEUROSCI BIOBEHAV R, V27, P189, DOI 10.1016/S0149-7634(03)00030-7; DeCarolis DD, 2007, PHARMACOTHERAPY, V27, P510, DOI 10.1592/phco.27.4.510; Delery EC, 2020, NEUROPHARMACOLOGY, V174, DOI 10.1016/j.neuropharm.2020.108153; Derde L., 2016, RANDOMIZED EMBEDDED; Devaud LL, 2004, ALCOHOL CLIN EXP RES, V28, P957, DOI 10.1097/01.ALC.0000128225.83916.40; Devaud LL, 2001, ALCOHOL CLIN EXP RES, V25, P1689, DOI 10.1111/j.1530-0277.2001.tb02176.x; Doering-Silveira J, 2014, INT J ENV RES PUB HE, V11, P5783, DOI 10.3390/ijerph110605783; Dolman JM, 2005, ALCOHOL ALCOHOLISM, V40, P515, DOI 10.1093/alcalc/agh189; Donnadieu-Rigole H, 2018, ALCOHOL CLIN EXP RES, V42, P32, DOI 10.1111/acer.13527; Dopp Alex R, 2020, Implement Sci Commun, V1, P17, DOI 10.1186/s43058-020-00020-w; DOUGLAS IS, 2017, AM J RESP CRIT CARE, V194, pA2899; Duby JJ, 2014, J TRAUMA ACUTE CARE, V77, P938, DOI 10.1097/TA.0000000000000352; Edwards Scott, 2016, Prog Brain Res, V223, P63, DOI 10.1016/bs.pbr.2015.07.005; Edwards S, 2012, ADDICT BIOL, V17, P76, DOI 10.1111/j.1369-1600.2010.00291.x; Edwards S, 2012, NEUROPHARMACOLOGY, V62, P1142, DOI 10.1016/j.neuropharm.2011.11.006; Edwards S, 2010, FUTUR NEUROL, V5, P393, DOI 10.2217/FNL.10.14; Egli M, 2012, NEUROSCI BIOBEHAV R, V36, P2179, DOI 10.1016/j.neubiorev.2012.07.010; Ehlers CL, 2018, PSYCHOPHARMACOLOGY, V235, P1783, DOI 10.1007/s00213-018-4888-6; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; Eloma AS, 2018, AM J DRUG ALCOHOL AB, V44, P418, DOI 10.1080/00952990.2017.1362418; Ely EW, 2012, CHEST, V142, P281, DOI 10.1378/chest.12-1189; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P427, DOI 10.1093/alcalc/agr053; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P177, DOI 10.1093/alcalc/agr005; Faingold Carl L, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0928s44; Ferguson JA, 1996, J GEN INTERN MED, V11, P410, DOI 10.1007/BF02600188; Fiellin David A, 2002, Subst Abus, V23, P83, DOI 10.1023/A:1015350005418; Finn DA, 2010, HORM BEHAV, V57, P12, DOI 10.1016/j.yhbeh.2009.07.002; Flores-Bonilla A, 2020, ALCOHOL RES-CURR REV, V40, DOI 10.35946/arcr.v40.2.04; Forg A, 2012, ALCOHOL ALCOHOLISM, V47, P149, DOI 10.1093/alcalc/agr153; Ford E, 2016, J AM MED INFORM ASSN, V23, P1007, DOI 10.1093/jamia/ocv180; FOY A, 1995, DRUG ALCOHOL REV, V14, P49, DOI 10.1080/09595239500185051; Francois B, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0191-y; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Frazee EN, 2014, J CRIT CARE, V29, P298, DOI 10.1016/j.jcrc.2013.11.016; Fukushima K, 2020, EPILEPSY RES, V167, DOI 10.1016/j.eplepsyres.2020.106452; Fullwood JE, 2013, AM J CRIT CARE, V22, P398, DOI 10.4037/ajcc2013283; Gilpin NW, 2015, BIOL PSYCHIAT, V77, P859, DOI 10.1016/j.biopsych.2014.09.008; Gilpin NW, 2012, NEUROSCI BIOBEHAV R, V36, P873, DOI 10.1016/j.neubiorev.2011.11.002; Gilpin Nicholas W, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0929s44; Gipson G, 2016, J CLIN NEUROSCI, V31, P88, DOI 10.1016/j.jocn.2016.02.028; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Gold JA, 2007, CRIT CARE MED, V35, P724, DOI 10.1097/01.CCM.0000256841.28351.80; Goodson CM, 2014, ALCOHOL CLIN EXP RES, V38, P2664, DOI 10.1111/acer.12529; Graef JD, 2011, J NEUROPHYSIOL, V105, P528, DOI 10.1152/jn.00424.2010; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; Greenberg DS, 2015, PSYCHIAT CARE MED PA, P1455; GULYA K, 1991, BRAIN RES, V547, P129; Gupta NM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5172; Hack JB, 2006, J MED TOXICOL, V2, P55, DOI 10.1007/BF03161171; Hammond Drayton A, 2017, Hosp Pharm, V52, P607, DOI 10.1177/0018578717720310; Haugbol SR, 2005, ALCOHOL ALCOHOLISM, V40, P89, DOI 10.1093/alcalc/agh117; Hayner CE, 2009, PHARMACOTHERAPY, V29, P875, DOI 10.1592/phco.29.7.875; Hecksel KA, 2008, MAYO CLIN PROC, V83, P274, DOI 10.4065/83.3.274; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Hendey GW, 2011, AM J EMERG MED, V29, P382, DOI 10.1016/j.ajem.2009.10.010; Hendler RA, 2013, CURR TOP BEHAV NEURO, V13, P489, DOI 10.1007/7854_2011_135; Hernandez RV, 2016, NEUROPHARMACOLOGY, V103, P27, DOI 10.1016/j.neuropharm.2015.12.015; Hill R, 2016, NEUROPSYCHOPHARMACOL, V41, P762, DOI 10.1038/npp.2015.201; IVES TJ, 1991, SOUTHERN MED J, V84, P18, DOI 10.1097/00007611-199101000-00006; Jacob JC, 2017, J PHARMACOL EXP THER, V362, P45, DOI 10.1124/jpet.117.241083; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Janis GC, 1998, ALCOHOL CLIN EXP RES, V22, P2055, DOI 10.1111/j.1530-0277.1998.tb05916.x; Kalluri HSG, 1998, MOL BRAIN RES, V58, P221, DOI 10.1016/S0169-328X(98)00112-0; Kapur JH, 2010, INT J ENV RES PUB HE, V7, P1174, DOI 10.3390/ijerph7031174; Keenan SP, 2000, J EVAL CLIN PRACT, V6, P15, DOI 10.1046/j.1365-2753.2000.00214.x; Kimbrough A, 2017, ALCOHOL CLIN EXP RES, V41, P1886, DOI 10.1111/acer.13484; Klorig DC, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0229-18.2019; Knapp DJ, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030025; Knapp DJ, 2012, METHODS MOL BIOL, V829, P205, DOI 10.1007/978-1-61779-458-2_13; Koob George F, 2014, Handb Clin Neurol, V125, P33, DOI 10.1016/B978-0-444-62619-6.00003-3; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Kraemer Kevin L, 2003, Subst Abus, V24, P197, DOI 10.1023/A:1026099426602; Kurmani Sameer, 2017, Curr Heart Fail Rep, V14, P385, DOI 10.1007/s11897-017-0351-y; Langlois H, 2020, CAN J EMERG MED, V22, P165, DOI 10.1017/cem.2019.421; Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111; Lee D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128770; Lee JH, 2005, J GASTROEN HEPATOL, V20, P1833, DOI 10.1111/j.1440-1746.2005.03932.x; Lee JA, 2019, CLIN TOXICOL, V57, P624, DOI 10.1080/15563650.2018.1542701; Leshner AI, 2013, CTSA PROGRAM NIH OPP; Levine AR, 2019, PHARMACOTHERAPY, V39, P881, DOI 10.1002/phar.2309; Liang J, 2009, J NEUROPHYSIOL, V102, P224, DOI 10.1152/jn.90484.2008; Lindner BK, 2019, J ADDICT MED, V13, P379, DOI 10.1097/ADM.0000000000000510; Lizotte RJ, 2014, CLIN PHARMACOL-ADV A, V6, P171, DOI 10.2147/CPAA.S70490; Longo LP, 2002, J ADDICT DIS, V21, P55, DOI 10.1300/J069v21n02_05; Lorentzen K, 2014, DAN MED J, V61; Lovinger DM, 2013, CURR TOP BEHAV NEURO, V13, P31, DOI 10.1007/7854_2011_143; Ludtke Kimberly A, 2015, Hosp Pharm, V50, P208, DOI 10.1310/hpj5003-208; Luginbuhl M, 2019, DRUG TEST ANAL, V11, P859, DOI 10.1002/dta.2567; Lukan JK, 2002, J TRAUMA, V53, P901, DOI 10.1097/00005373-200211000-00015; Lyon JE, 2011, J HOSP MED, V6, P469, DOI 10.1002/jhm.928; Mainerova B, 2015, BIOMED PAP, V159, P44, DOI 10.5507/bp.2013.089; Maldonado JR, 2008, CRIT CARE CLIN, V24, P789, DOI 10.1016/j.ccc.2008.06.004; Maldonado JR, 2017, CRIT CARE CLIN, V33, P559, DOI 10.1016/j.ccc.2017.03.012; Maldonado JR, 2015, ALCOHOL ALCOHOLISM, V50, P509, DOI 10.1093/alcalc/agv043; Maldonado JR, 2014, ALCOHOL, V48, P375, DOI 10.1016/j.alcohol.2014.01.004; Maldonado JR, 2012, GEN HOSP PSYCHIAT, V34, P611, DOI 10.1016/j.genhosppsych.2012.06.016; Mariani JJ, 2006, AM J ADDICTION, V15, P76, DOI 10.1080/10550490500419110; Marjoua Y, 2012, CURR REV MUSCULOSKE, V5, P265, DOI 10.1007/s12178-012-9137-8; Marshall JC, 2017, CRIT CARE MED, V45, P311, DOI 10.1097/CCM.0000000000002211; Martin CS, 2008, ALCOHOL RES HEALTH, V31, P96; Mayo-Smith MF, 2004, ARCH INTERN MED, V164, P1405, DOI 10.1001/archinte.164.13.1405; MayoSmith MF, 1997, JAMA-J AM MED ASSOC, V278, P144, DOI 10.1001/jama.278.2.144; McCowan C, 2000, CRIT CARE MED, V28, P1781, DOI 10.1097/00003246-200006000-00014; McGinnis MM, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0132-19.2019; McKeon A, 2008, J NEUROL NEUROSUR PS, V79, P854, DOI 10.1136/jnnp.2007.128322; Meade MO, 2004, CRIT CARE MED, V32, P946, DOI 10.1097/01.CCM.0000120056.76356.AD; Mehta S, 2015, CRIT CARE MED, V43, P557, DOI 10.1097/CCM.0000000000000727; METCALFE P, 1995, ALCOHOL ALCOHOLISM, V30, P367; Meystre S M, 2008, Yearb Med Inform, P128; Millum J, 2013, CONTEMP CLIN TRIALS, V36, P510, DOI 10.1016/j.cct.2013.09.003; Minozzi S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005064.pub3; Molina PE, 2014, PHYSIOLOGY, V29, P203, DOI 10.1152/physiol.00055.2013; Monte R, 2010, ALCOHOL ALCOHOLISM, V45, P151, DOI 10.1093/alcalc/agp087; Monte R, 2009, EUR J INTERN MED, V20, P690, DOI 10.1016/j.ejim.2009.07.008; Morad M, 2014, PSYCHOPHARMACOLOGY B, V231; Moss M, 2016, AM J RESP CRIT CARE, V194, P106, DOI 10.1164/rccm.201604-0708ST; Moss M, 2006, LANCET, V368, P2231, DOI 10.1016/S0140-6736(06)69490-7; Mouton AJ, 2016, ALCOHOL CLIN EXP RES, V40, P1671, DOI 10.1111/acer.13133; Mueller SW, 2014, CRIT CARE MED, V42, P1131, DOI 10.1097/CCM.0000000000000141; Mukherjee V, 2017, CURR OPIN CRIT CARE, V23, P412, DOI 10.1097/MCC.0000000000000438; Mulholland PJ, 2012, ALCOHOL, V46, P309, DOI 10.1016/j.alcohol.2011.11.002; Muzyk AJ, 2013, CNS DRUGS, V27, P913, DOI 10.1007/s40263-013-0106-6; Muzyk AJ, 2013, AM J ADDICTION, V22, P113, DOI 10.1111/j.1521-0391.2013.00307.x; Muzyk AJ, 2011, ANN PHARMACOTHER, V45, P649, DOI 10.1345/aph.1P575; Myrick H, 2000, AM J DRUG ALCOHOL AB, V26, P155, DOI 10.1081/ADA-100100597; N'Gouemo P, 2015, EUR NEUROPSYCHOPHARM, V25, P1342, DOI 10.1016/j.euroneuro.2015.04.008; Nair R, 2011, SEMIN ARTHRITIS RHEU, V41, P95, DOI 10.1016/j.semarthrit.2010.12.001; Natividad LA, 2018, ADDICT BIOL, V23, P1117, DOI 10.1111/adb.12568; Nejad S, 2020, PSYCHOSOMATICS, V61, P327, DOI 10.1016/j.psym.2020.01.008; Nelson AC, 2019, AM J EMERG MED, V37, P733, DOI 10.1016/j.ajem.2019.01.002; NGouemo P, 1996, BRAIN RES, V724, P200, DOI 10.1016/0006-8993(96)00304-6; Nichols Taylor A, 2019, Ment Health Clin, V9, P1, DOI 10.9740/mhc.2019.01.001; Nisavic M, 2019, PSYCHOSOMATICS, V60, P458, DOI 10.1016/j.psym.2019.02.002; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Oks M, 2020, J INTENSIVE CARE MED, V35, P844, DOI 10.1177/0885066618783947; Olsen RW, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0325-8; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Park JJH, 2018, CLIN EPIDEMIOL, V10, P343, DOI 10.2147/CLEP.S156708; Patel SB, 2012, AM J RESP CRIT CARE, V185, P486, DOI 10.1164/rccm.201102-0273CI; Pecoraro A, 2014, J GEN INTERN MED, V29, P34, DOI 10.1007/s11606-013-2551-9; Pennings EJM, 2002, ADDICTION, V97, P773, DOI 10.1046/j.1360-0443.2002.00158.x; Perez E, 2015, NEUROPSYCHOPHARMACOL, V40, P2327, DOI 10.1038/npp.2015.80; Philip A, 2016, CHEST, V146, p226A; PINCUS HA, 1992, ARCH GEN PSYCHIAT, V49, P573; Pittman B, 2007, ALCOHOL CLIN EXP RES, V31, P612, DOI 10.1111/j.1530-0277.2007.00345.x; Pizon AF, 2018, CRIT CARE MED, V46, pE768, DOI 10.1097/CCM.0000000000003204; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Pullen E, 2014, SUBST USE MISUSE, V49, P891, DOI 10.3109/10826084.2014.891615; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Ramsey AT, 2019, J CLIN TRANSL SCI, V3, P53, DOI 10.1017/cts.2019.386; Rani CSS, 2006, ALCOHOL, V38, P89, DOI 10.1016/j.alcohol.2006.05.002; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rastegar DA, 2021, J INTENSIVE CARE MED, V36, P1361, DOI 10.1177/0885066620952762; Rastegar DA, 2017, SUBST ABUS, V38, P394, DOI 10.1080/08897077.2017.1354119; Rath M, 2020, ALCOHOL CLIN EXP RES, V44, P1791, DOI 10.1111/acer.14420; Rayner SG, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-12; Rebers S, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0092-6; Reilly W, 2009, ALCOHOL ALCOHOLISM, V44, P561, DOI 10.1093/alcalc/agp049; Reoux JP, 2006, AM J ADDICTION, V15, P85, DOI 10.1080/10550490500419136; Reoux JP, 2002, J ADDICT DIS, V21, P81, DOI 10.1300/J069v21n04_08; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Riker RR, 2001, INTENS CARE MED, V27, P853, DOI 10.1007/s001340100912; Ristuccia RC, 2005, ALCOHOL CLIN EXP RES, V29, P1809, DOI 10.1097/01.alc.0000183010.72764.cd; Roberto M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012195; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Roberts AJ, 2019, BRAIN BEHAV IMMUN, V82, P188, DOI 10.1016/j.bbi.2019.08.185; Roche AM, 2006, DRUG ALCOHOL DEPEN, V83, P1, DOI 10.1016/j.drugalcdep.2005.10.011; Rosenson J, 2013, J EMERG MED, V44, P592, DOI 10.1016/j.jemermed.2012.07.056; Rosenthal RN, 1998, AM J ADDICTION, V7, P189; Roson B, 2016, ALCOHOL ALCOHOLISM, V51, P457, DOI 10.1093/alcalc/agv142; Ryan ML, 2017, NEUROPSYCHOPHARMACOL, V42, P1012, DOI 10.1038/npp.2016.214; SAITZ R, 1994, JAMA-J AM MED ASSOC, V272, P519, DOI 10.1001/jama.272.7.519; Saitz R, 2018, JAMA-J AM MED ASSOC, V320, P766, DOI 10.1001/jama.2018.10061; Salottolo K, 2017, CRIT CARE MED, V45, P867, DOI 10.1097/CCM.0000000000002371; Sander W, 1997, Axone, V19, P10; Sarff M, 2010, CRIT CARE MED, V38, pS494, DOI 10.1097/CCM.0b013e3181ec5412; SCHUCKIT MA, 1995, ADDICTION, V90, P1335, DOI 10.1111/j.1360-0443.1995.tb03551.x; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Seear K, 2020, DRUG ALCOHOL REV, V39, P109, DOI 10.1111/dar.13028; Sessler CN, 2001, SEMIN RESP CRIT CARE, V22, P211, DOI 10.1055/s-2001-13834; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Shan HQ, 2013, ALCOHOL CLIN EXP RES, V37, P1333, DOI 10.1111/acer.12098; Sharrett-Field L, 2013, PFLUG ARCH EUR J PHY, V465, P643, DOI 10.1007/s00424-013-1266-4; Shaw GK, 1998, ALCOHOL ALCOHOLISM, V33, P291; SHAW JM, 1981, J CLIN PSYCHOPHARM, V1, P382, DOI 10.1097/00004714-198111000-00006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Snell LD, 1996, MOL BRAIN RES, V40, P71; Sohraby R, 2014, ANN PHARMACOTHER, V48, P456, DOI 10.1177/1060028013515846; Sousa G, 2017, REV ESP ANEST REANIM, V64, P214, DOI 10.1016/j.redar.2016.07.009; Spies CD, 1996, CRIT CARE MED, V24, P414, DOI 10.1097/00003246-199603000-00009; Spies CD, 2003, INTENS CARE MED, V29, P2230, DOI 10.1007/s00134-003-2033-3; Steel TL, 2021, J ADDICT MED, V15, P376, DOI 10.1097/ADM.0000000000000782; Steel TL, 2021, ADDICT SCI CLIN PRAC, V16, DOI 10.1186/s13722-021-00226-w; Steel TL, 2020, J ADDICT MED, V14, P300, DOI 10.1097/ADM.0000000000000576; Stewart SH, 2014, ALCOHOL CLIN EXP RES, V38, P1706, DOI 10.1111/acer.12442; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Tabakoff B, 2013, PHARMACOL BIOCHEM BE, V113, P20, DOI 10.1016/j.pbb.2013.10.009; Talisa VB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01502; Tanabe J, 2019, ALCOHOL CLIN EXP RES, V43, P2070, DOI 10.1111/acer.14173; Tanchuck-Nipper MA, 2015, BEHAV GENET, V45, P354, DOI 10.1007/s10519-014-9691-5; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; The National Clinical Guideline Centre Royal College of Physicians, 2010, ALCOHOL USE DISORDER; Thomas MP, 1998, J PHARMACOL EXP THER, V287, P87; Tidwell WP, 2018, AM J CRIT CARE, V27, P454, DOI 10.4037/ajcc2018745; Tolonen J, 2013, EUR J EMERG MED, V20, P425, DOI 10.1097/MEJ.0b013e32835c53b3; TURNER RC, 1989, J GEN INTERN MED, V4, P432, DOI 10.1007/BF02599697; ULRICHSEN J, 1995, PSYCHOPHARMACOLOGY, V121, P451, DOI 10.1007/BF02246493; ULRICHSEN J, 1992, PSYCHOPHARMACOLOGY, V107, P97, DOI 10.1007/BF02244972; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; VanderWeide LA, 2016, J INTENSIVE CARE MED, V31, P198, DOI 10.1177/0885066614554908; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Varodayan FP, 2017, NEUROPHARMACOLOGY, V125, P418, DOI 10.1016/j.neuropharm.2017.08.009; Vasilevskis EE, 2012, BEST PRACT RES-CLIN, V26, P277, DOI 10.1016/j.bpa.2012.07.003; Veatch LM, 2007, ALCOHOL CLIN EXP RES, V31, P477, DOI 10.1111/j.1530-0277.2006.00328.x; Veatch LM, 2005, BRAIN RES, V1065, P92, DOI 10.1016/j.brainres.2005.10.047; Veatch LM, 2002, BRAIN RES, V946, P272, DOI 10.1016/S0006-8993(02)02895-0; Vendruscolo LF, 2015, J CLIN INVEST, V125, P3193, DOI 10.1172/JCI79828; Vendruscolo LF, 2014, ALCOHOL, V48, P277, DOI 10.1016/j.alcohol.2013.08.006; Vendruscolo LF, 2012, J NEUROSCI, V32, P7563, DOI 10.1523/JNEUROSCI.0069-12.2012; Viel G, 2012, INT J MOL SCI, V13, P14788, DOI 10.3390/ijms131114788; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Walker MC, 2020, NEUROPHARMACOLOGY, V168, DOI 10.1016/j.neuropharm.2019.107751; Walter HJ, 1999, NEUROCHEM INT, V35, P95, DOI 10.1016/S0197-0186(99)00050-9; Walther L, 2015, ALCOHOL CLIN EXP RES, V39, P2200, DOI 10.1111/acer.12883; Watling S M, 1995, Am J Crit Care, V4, P66; Weinberg JA, 2008, J TRAUMA, V64, P99, DOI 10.1097/TA.0b013e31815eb12a; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Weiss CH, 2016, AM J RESP CRIT CARE, V194, P1015, DOI 10.1164/rccm.201608-1690ST; Weiss CH, 2016, CRIT CARE MED, V44, P1515, DOI 10.1097/CCM.0000000000001710; Wetterling T, 1997, ALCOHOL ALCOHOLISM, V32, P753; Wetterling T, 2006, ALCOHOL ALCOHOLISM, V41, P611, DOI 10.1093/alcalc/agl068; Witkiewitz K, 2015, ALCOHOL CLIN EXP RES, V39, P1557, DOI 10.1111/acer.12800; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wong A, 2015, DRUG ALCOHOL DEPEN, V154, P296, DOI 10.1016/j.drugalcdep.2015.07.005; Wong A, 2015, J CRIT CARE, V30, P405, DOI 10.1016/j.jcrc.2014.10.008; Wood E, 2018, JAMA-J AM MED ASSOC, V320, P825, DOI 10.1001/jama.2018.10574; Wright T, 2006, AM J ADDICTION, V15, P213, DOI 10.1080/10550490600625798; Wu C, 2012, DRUG SAFETY, V35, P769, DOI 10.2165/11599540-000000000-00000; Wurst FM, 2015, ALCOHOL CLIN EXP RES, V39, P2060, DOI 10.1111/acer.12851; Xiao HW, 2018, TOXICOL LETT, V287, P23, DOI 10.1016/j.toxlet.2018.01.021; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	313	0	0	3	3	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	OCT 1	2021	204	7					E61	E87		10.1164/rccm.202108-1845ST			27	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	WE2PI	WOS:000705466800002	34609257	Green Published			2022-02-06	
J	Stinson, ZS; Davelaar, CMF; Kiebzak, GM; Edmonds, EW				Stinson, Zachary S.; Davelaar, Cassidy M. Foley; Kiebzak, Gary M.; Edmonds, Eric W.			Treatment Decisions in Pediatric Sports Medicine: Do Personal and Professional Bias Affect Decision-Making?	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						youth sports; concussion; OCD; sports specialization	JUVENILE OSTEOCHONDRITIS-DISSECANS; MEDIAL PATELLOFEMORAL LIGAMENT; SKELETALLY IMMATURE PATIENTS; ACUTE PATELLAR DISLOCATION; KNEE; CHILDREN; ADOLESCENTS; MANAGEMENT; INJURIES; RECONSTRUCTION	Background: Personal and professional biases can affect decision-making regarding important issues in pediatric sports medicine. Gaining insight into the opinions of health care professionals who specialize in pediatric sports medicine will provide information that may be useful for directing ongoing research in this field. Hypothesis: It was hypothesized that surgeons would demonstrate bias toward early surgical intervention versus nonsurgeons. In addition, it was hypothesized that youth sports medicine professionals who were parents of a child with a previous major sports injury or concussion would be less likely to allow their child to play American tackle football or return to football after a concussion. Study Design: Cross-sectional study. Methods: An online survey was provided to the active members of the Pediatric Research in Sports Medicine Society. We used both professional background information and responses to questions related to personal experiences with youth sports injuries to determine potential factors associated with underlying biases. Survey responses among subgroups were compared using the Fisher exact test. The Pearson correlation coefficient was used to evaluate years in practice versus opioid use. Results: Of the survey participants, 62.5% were pediatric surgeons, and 37.5% represented different nonsurgical youth sports medicine professions. Surgeons were less likely than nonsurgeons to agree to allow their child to return to football after sustaining a concussion and completing a concussion protocol (48% vs 76%, P = .013). Surgeons were more likely than nonsurgeons to agree to both elective shoulder stabilization after a first-time dislocation and elective drilling of a stable knee osteochondritis dissecans (OCD) before nonoperative treatment (41% vs 10%, P = .003 and 52% vs 23%, P = .013, respectively). Those who reported having a child with a concussion history were more likely to support him or her returning to football after a concussion (65% vs 33%, P = .026). Conclusion: Surgeons were more likely to favor elective shoulder-stabilization surgery after a first-time dislocation and drilling of a stable knee OCD instead of nonoperative management. Personal experience of having a child who sustained a major sports injury or concussion did not demonstrate a bias against participation in football or return to football after a concussion.	[Stinson, Zachary S.; Davelaar, Cassidy M. Foley; Kiebzak, Gary M.; Edmonds, Eric W.] Nemours Childrens Hosp, 6535 Nemours Pkwy, Orlando, FL 32827 USA; [Edmonds, Eric W.] Rady Childrens Hosp, San Diego, CA USA		Stinson, ZS (corresponding author), Nemours Childrens Hosp, 6535 Nemours Pkwy, Orlando, FL 32827 USA.	zachary.stinson@nemours.org					AGLIETTI P, 1994, ARTHROSCOPY, V10, P286, DOI 10.1016/S0749-8063(05)80113-6; Anderson AF, 1997, AM J SPORT MED, V25, P830, DOI 10.1177/036354659702500617; Anderson AF, 1997, ARTHROSCOPY, V13, P319, DOI 10.1016/S0749-8063(97)90028-1; Anderson AF, 2015, AM J SPORT MED, V43, P275, DOI 10.1177/0363546514559912; Askenberger M, 2018, AM J SPORT MED, V46, P2328, DOI 10.1177/0363546518770616; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; Cahill, 1995, J Am Acad Orthop Surg, V3, P237; Caine D, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-22; Camanho GL, 2009, ARTHROSCOPY, V25, P620, DOI 10.1016/j.arthro.2008.12.005; Cordasco FA, 2019, AM J SPORT MED, V47, P628, DOI 10.1177/0363546518819217; Cordischi K., 2009, ORTHOPEDICS, V32; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Crawford EA, 2019, J PEDIATR ORTHOPED, V39, P55, DOI 10.1097/BPO.0000000000000960; Cruz AI, 2017, J PEDIATR ORTHOPED, V37, P204, DOI 10.1097/BPO.0000000000000606; Dekker TJ, 2018, J PEDIATR ORTHOPED, V38, P185, DOI 10.1097/BPO.0000000000000792; Dekker TJ, 2017, J BONE JOINT SURG AM, V99, P897, DOI 10.2106/JBJS.16.00758; Dumont GD, 2012, AM J SPORT MED, V40, P2128, DOI 10.1177/0363546512449994; Ekas GR, 2019, AM J SPORT MED, V47, P22, DOI 10.1177/0363546518810750; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Fithian DC, 2004, AM J SPORT MED, V32, P1114, DOI 10.1177/0363546503260788; Ganley TJF., 2002, PED ORTH SOC N AM 20; Garth WP, 1996, AM J SPORT MED, V24, P785, DOI 10.1177/036354659602400614; Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127; Kocher MS, 2018, J BONE JOINT SURG AM, V100, P1087, DOI 10.2106/JBJS.17.01327; Kocher MS, 2002, J PEDIATR ORTHOPED, V22, P452, DOI 10.1097/00004694-200207000-00008; Kocher MS, 2001, AM J SPORT MED, V29, P562, DOI 10.1177/03635465010290050701; Krause M, 2013, AM J SPORT MED, V41, P2384, DOI 10.1177/0363546513496049; Lawrence JTR, 2011, AM J SPORT MED, V39, P2582, DOI 10.1177/0363546511420818; Li XN, 2013, J AM ACAD ORTHOP SUR, V21, P529, DOI [10.5435/JAAOS-21-09-529, 10.5435/00124635-201309020-00004]; Liu JN, 2018, AM J SPORT MED, V46, P3299, DOI 10.1177/0363546517732045; Maenpaa H, 1997, ACTA ORTHOP SCAND, V68, P424, DOI 10.3109/17453679708996255; MCCARROLL JR, 1988, AM J SPORT MED, V16, P44, DOI 10.1177/036354658801600107; Moesch K, 2011, SCAND J MED SCI SPOR, V21, pE282, DOI 10.1111/j.1600-0838.2010.01280.x; Murray JRD, 2007, KNEE, V14, P94, DOI 10.1016/j.knee.2006.11.011; Nikku R, 2005, ACTA ORTHOP, V76, P699, DOI 10.1080/17453670510041790; Nwachukwu BU, 2016, KNEE SURG SPORT TR A, V24, P760, DOI 10.1007/s00167-015-3948-2; Palmu S, 2008, J BONE JOINT SURG AM, V90A, P463, DOI 10.2106/JBJS.G.00072; Popkin CA, 2019, J AM ACAD ORTHOP SUR, V27, pE995, DOI 10.5435/JAAOS-D-18-00187; Post EG, 2019, SPORTS, V7, DOI 10.3390/sports7120247; Postacchini F, 2000, J SHOULDER ELB SURG, V9, P470, DOI 10.1067/mse.2000.108385; Provencher MT, 2021, J AM ACAD ORTHOP SUR, V29, pE51, DOI 10.5435/JAAOS-D-20-00202; Ramski DE, 2014, AM J SPORT MED, V42, P2769, DOI 10.1177/0363546513510889; Stepan JG, 2019, J BONE JOINT SURG AM, V101, P5, DOI 10.2106/JBJS.17.01645; Taylor DC, 1997, AM J SPORT MED, V25, P306, DOI 10.1177/036354659702500306; VANDEMARK RE, 1952, J BONE JOINT SURG AM, V34-A, P143, DOI 10.2106/00004623-195234010-00015; Wall EJ, 2008, J BONE JOINT SURG AM, V90A, P2655, DOI 10.2106/JBJS.G.01103; Wong SE, 2019, J PEDIATR ORTHOPED, V39, pE566, DOI 10.1097/BPO.0000000000001075; Wright RW, 2004, CLIN ORTHOP RELAT R, P239, DOI 10.1097/01.blo.0000128216.10732.d8	49	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2021	9	10							23259671211046258	10.1177/23259671211046258			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	WJ9MO	WOS:000709360800001	34676272	gold, Green Published			2022-02-06	
J	Tanabe, KO; Hayden, ME; Rege, S; Simmons, J; Holstege, CP				Tanabe, Kawai O.; Hayden, Meredith E.; Rege, Saumitra; Simmons, Jessica; Holstege, Christopher P.			Risk factors associated with concussions in a college student population	ANNALS OF EPIDEMIOLOGY			English	Article						concussion; traumatic brain injury; college students; risk factors; data linkage; epidemiological studies	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH OUTCOMES; PREVALENCE	Purpose: To determine risk factors associated with concussion among the general collegiate population using a unique data linkage methodology. Methods: Student health medical, counseling, and disability access service data were linked with uni-versity enrollment data to provide a comprehensive, deidentified dataset of students who sought care at the student health center for concussion from 2016-2020. Using chi-squared tests and logistic regression, characteristics of students with and without concussion were evaluated. Results: During the study period, 506 concussions from 474 students were identified (cumulative inci-dence rate of 51.7 per 10,0 0 0 students). Significant predictors of concussion included: younger age ( < 21 years): odds ratio (OR) = 3.52 (95% confidence intervals [CI], 2.78, 4.50), Greek affiliation: OR = 1.89 (95% CI, 1.56, 2.30), and utilization of counseling and psychological services: OR = 1.92 (95% CI 1.59, 2.32). Of the students with concussion, 47% had at least one other concussion within the preceding year. History of prior hospitalization or medical imaging for head injury increased subsequent concussion risk by 4.5 fold. Conclusions: Linking unique datasets provides a richer understanding of the characteristics and risk fac-tors associated with student concussions than analysis of a single data source. This comprehensive dataset will enable future targeted interventions to prevent and treat college student concussions. (c) 2021 Elsevier Inc. All rights reserved.	[Tanabe, Kawai O.; Hayden, Meredith E.; Simmons, Jessica; Holstege, Christopher P.] Univ Virginia, Dept Student Hlth & Wellness, Div Student Affairs, Charlottesville, VA 22908 USA; [Rege, Saumitra; Holstege, Christopher P.] Univ Virginia, Dept Emergency Med, Div Med Toxicol, Sch Med, Charlottesville, VA 22908 USA		Holstege, CP (corresponding author), Univ Virginia, Dept Student Hlth & Wellness, POB 800760, Charlottesville, VA 22908 USA.	ch2xf@virginia.edu					American College Health Association, 2020, NAT COLL HLTH ASS 3; [Anonymous], 2013, Br J Sports Med, V47, P259; [Anonymous], 2015, CTR DIS CONTROL PREV; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Breck J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17626; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN, P2019; Ngo DA, 2018, DRUG ALCOHOL DEPEN, V183, P89, DOI 10.1016/j.drugalcdep.2017.10.029; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Faul M, 2010, TRAUMATIC BRAIN INJU; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Meske S, 2019, J HEAD TRAUMA REHAB, V34, pE18, DOI 10.1097/HTR.0000000000000407; Putukian M, 2019, AM J SPORT MED, V47, P1236, DOI 10.1177/0363546519830100; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Russell K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215900; Vreeland K., 2017, EXPLORING EFFECTS CO; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3	26	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1047-2797	1873-2585		ANN EPIDEMIOL	Ann. Epidemiol.	OCT	2021	62						77	83		10.1016/j.annepidem.2021.06.009			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	WE5FG	WOS:000705650800013	34174411				2022-02-06	
J	Teneralli, RE; Cepeda, MS; Kern, DM; Novak, GP				Teneralli, Rachel E.; Cepeda, M. Soledad; Kern, David M.; Novak, Gerald P.			Individuals who develop drug-resistant epilepsy within a year after initial diagnosis have higher burden of mental and physical diseases one-year prior to epilepsy diagnosis as compared to those whose seizures were controlled during the same interval	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Drug-resistant epilepsy; Mood disorders; Comorbidities; Population-based; Real-world data	SUDDEN UNEXPECTED DEATH; REAL-WORLD EVIDENCE; QUALITY-OF-LIFE; ILAE COMMISSION; PSYCHIATRIC COMORBIDITIES; INTERNATIONAL-LEAGUE; POSITION PAPER; TASK-FORCE; HEALTH; DEPRESSION	Introduction: Epilepsy is a neurological disease characterized by recurrent, unprovoked seizures and its impact on biological, cognitive, psychological, and social outcomes. An unmet need for finding effective treatment options exists. Identifying medical diagnoses present prior to a diagnosis of epilepsy is an important step in increasing our understanding of how people with epilepsy may respond to therapy, help guide clinicians in managing associated comorbid conditions, and inform future research. Methods: A population-based retrospective comparative cohort study was conducted using administrative claims data to explore differences in medical diagnoses prior to an initial diagnosis of epilepsy between patients with and without drug-resistant epilepsy (DRE) identified within one-year post diagnosis by evaluating standardized mean differences between the groups. Results: A total of 205,183 patients with newly diagnosed epilepsy were identified. Of those, 4.1% (n = 8340) were considered drug resistant one-year post diagnosis. Pain and mood disorders were the common physical and psychiatric diagnoses in both cohorts. Differences between the newly diagnosed epilepsy and DRE cohorts were observed. Patients in the DRE cohort were younger, had more encounters with the healthcare system, and higher burden of disease for both physical (e.g., headache, neuropathy, muscular-skeletal disorders, and traumatic brain injury) and psychiatric diagnoses (e.g., depression, anxiety, bipolar disorder, suicidal thoughts, drug dependency, and sleep disorders). Conclusion: Physical and psychiatric diagnoses are common one year prior to first diagnosis of epilepsy in administrative claims data. Compared to patients without DRE, those who develop DRE within one-year post initial diagnosis demonstrated a higher burden of disease. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Teneralli, Rachel E.; Cepeda, M. Soledad; Kern, David M.] Janssen Res & Dev LLC, Epidemiol, Titusville, NJ USA; [Novak, Gerald P.] Janssen Res & Dev LLC, Neurosci, Titusville, NJ USA		Teneralli, RE (corresponding author), 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA.	RTeneralli@its.jnj.com		Teneralli, Rachel/0000-0003-4340-9001	Janssen Research & Development, LLC.	This work was supported by Janssen Research & Development, LLC. All authors are employees of Janssen Research and Development, LLC.	Allers K, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0494-y; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Baranowski CJ, 2018, SEIZURE-EUR J EPILEP, V60, P190, DOI 10.1016/j.seizure.2018.06.002; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Beghi E, 2009, EXPERT REV NEUROTHER, V9, P291, DOI 10.1586/14737175.9.2.291; Begley CE, 2015, EPILEPSIA, V56, P1376, DOI 10.1111/epi.13084; Bennett CC, 2012, J BIOMED INFORM, V45, P634, DOI 10.1016/j.jbi.2012.02.011; Berger ML, 2017, PHARMACOEPIDEM DR S, V26, P1033, DOI 10.1002/pds.4297; Cardamone L, 2013, BRIT J PHARMACOL, V168, P1531, DOI 10.1111/bph.12052; Cepeda MS, 2020, JMIR PUBLIC HLTH SUR, V6, P37, DOI 10.2196/13018; Cepeda MS, 2018, DEPRESS ANXIETY, V35, P220, DOI 10.1002/da.22705; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Conte F, 2018, SEIZURE-EUR J EPILEP, V62, P74, DOI 10.1016/j.seizure.2018.09.020; Castro SCC, 2018, EPILEPSY BEHAV, V80, P254, DOI 10.1016/j.yebeh.2018.01.022; Devinsky O, 2020, EPILEPSY CURR, V20, p29S, DOI 10.1177/1535759720947438; Elger CE, 2017, SEIZURE-EUR J EPILEP, V44, P184, DOI 10.1016/j.seizure.2016.10.018; Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Fountain NB, 2015, NEUROLOGY, V84, P1483, DOI 10.1212/WNL.0000000000001448; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Gandy M, 2021, EPILEPSIA OPEN, V6, P127, DOI 10.1002/epi4.12455; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Grzonka P, 2019, EPILEPSIA, V60, P996, DOI 10.1111/epi.14738; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hinnell C, 2010, EPILEPSIA, V51, P853, DOI 10.1111/j.1528-1167.2009.02477.x; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Hwang ST, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0825-6; Janousek J, 2013, EPILEPSY BEHAV, V28, P391, DOI 10.1016/j.yebeh.2013.05.012; Josephson CB, 2017, INT REV PSYCHIATR, V29, P409, DOI 10.1080/09540261.2017.1302412; Josephson CB, 2017, JAMA NEUROL, V74, P533, DOI 10.1001/jamaneurol.2016.5042; Kanner AM, 2016, EPILEPSY BEHAV, V64, P306, DOI 10.1016/j.yebeh.2016.06.040; Kanner AM, 2012, LANCET NEUROL, V11, P1093, DOI 10.1016/S1474-4422(12)70201-6; Kanner AM, 2012, EPILEPSY BEHAV, V24, P169, DOI 10.1016/j.yebeh.2012.01.008; Keezer MR, 2016, LANCET NEUROL, V15, P106, DOI 10.1016/S1474-4422(15)00225-2; Kim Dong Wook, 2017, J Epilepsy Res, V7, P7, DOI 10.14581/jer.17002; Kobau R, 2014, EPILEPSY BEHAV, V41, P66, DOI 10.1016/j.yebeh.2014.08.002; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Leach JP, 2012, EPILEPSIA, V53, P48, DOI 10.1111/j.1528-1167.2012.03613.x; Lopez MR, 2019, EPILEPSY BEHAV, V98, P302, DOI 10.1016/j.yebeh.2019.01.027; Mahler B, 2018, NEUROLOGY, V90, pE779, DOI 10.1212/WNL.0000000000005035; Mehndiratta P, 2013, EPILEPSY BEHAV, V28, P36, DOI 10.1016/j.yebeh.2013.03.029; Patel AD, 2018, NEUROLOGY, V91, P829, DOI 10.1212/WNL.0000000000006425; Pazarci NK, 2016, EPILEPSY BEHAV, V55, P101, DOI 10.1016/j.yebeh.2015.12.015; Petrovski S, 2010, NEUROLOGY, V75, P1015, DOI 10.1212/WNL.0b013e3181f25b16; Reich C, 2012, J BIOMED INFORM, V45, P689, DOI 10.1016/j.jbi.2012.05.002; Reid AY, 2012, EPILEPSY RES, V102, P173, DOI 10.1016/j.eplepsyres.2012.05.009; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Samokhvalov AV, 2010, EPILEPSIA, V51, P1177, DOI 10.1111/j.1528-1167.2009.02426.x; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Scorza FA, 2011, CLINICS, V66, P65, DOI 10.1590/S1807-59322011001300008; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Shmuely S, 2017, SEIZURE-EUR J EPILEP, V44, P176, DOI 10.1016/j.seizure.2016.10.001; Sowers LP, 2013, RESP PHYSIOL NEUROBI, V189, P315, DOI 10.1016/j.resp.2013.05.010; Sperling Michael R., 2001, Epilepsy Curr, V1, P21, DOI 10.1046/j.1535-7597.2001.00012.x; Stang PE, 2010, ANN INTERN MED, V153, P600, DOI 10.7326/0003-4819-153-9-201011020-00010; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x; Thijs RD, 2019, CLIN AUTON RES, V29, P131, DOI 10.1007/s10286-019-00603-1; Vyas MV, 2015, EPILEPSY RES, V113, P44, DOI 10.1016/j.eplepsyres.2015.03.002; WHO, 2004, WORLD HEAL ORGAN, P5; WHO Collaborating Centre for Drug Statistics Methodology, 2020, AN THER CHEM ATC CLA	66	0	0	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2021	123								108243	10.1016/j.yebeh.2021.108243			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	US1FC	WOS:000697181000032	34425326	hybrid			2022-02-06	
J	Tennant, JR; Adams, MS; Brown, KE; Staines, WR				Tennant, Jake R.; Adams, Meaghan S.; Brown, Katlyn E.; Staines, W. Richard			Long-term effects of concussion on relevancy-based modulation of somatosensory-evoked potentials	CLINICAL NEUROPHYSIOLOGY			English	Article						Concussion; Traumatic brain injury; Somatosensory processing; Movement-related gating; Prefrontal cortex; Somatosensory-evoked potential	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; THETA-BURST STIMULATION; MEDIAN NERVE; PREFRONTAL CORTEX; VOLUNTARY MOVEMENT; PARIETAL CORTEX; SHORT-LATENCY; MOTOR; SCALP	Objective: The purpose of this investigation was to better understand the effects of concussions on the ability to selectively up or down-regulate incoming somatosensory information based on relevance. Methods: Median nerve somatosensory-evoked potentials (SEPs) were elicited from electrical stimulation and recorded from scalp electrodes while participants completed tasks that altered the relevance of specific somatosensory information being conveyed along the stimulated nerve. Results: Within the control group, SEP amplitudes for task-relevant somatosensory information were significantly greater than for non-relevant somatosensory information at the earliest cortical processing potentials (N20-P27). Alternatively, the concussion history group showed similar SEP amplitudes for all conditions at early processing potentials, however a pattern similar to controls emerged later in the processing stream (P100) where both movement-related gating and facilitation of task-relevant information were present. Conclusions: Previously concussed participants demonstrated impairments in the ability to up-regulate relevant somatosensory information at early processing stages. These effects appear to be chronic, as this pattern was observed on average several years after participants' most recent concussion. Significance: Given the role of the prefrontal cortex in relevancy-based facilitation during movement related gating, these findings lend support to the notion that this brain area may be particularly vulnerable to concussive forces. (c) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Tennant, Jake R.; Adams, Meaghan S.; Brown, Katlyn E.; Staines, W. Richard] Univ Waterloo, Dept Kinesiol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada		Staines, WR (corresponding author), Univ Waterloo, Dept Kinesiol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	jrtennant@uwaterloo.ca; msadams@yorku.ca; kate.brown@uwaterloo.ca; rstaines@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by research funding to WRS from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Adams MS, 2020, FRONT INTEGR NEUROSC, V14, DOI 10.3389/fnint.2020.00033; Adams MS, 2019, EXP BRAIN RES, V237, P2747, DOI 10.1007/s00221-019-05633-9; ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; ALLISON T, 1989, J NEUROPHYSIOL, V62, P711, DOI 10.1152/jn.1989.62.3.711; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Barba C, 2005, CLIN NEUROPHYSIOL, V116, P2664, DOI 10.1016/j.clinph.2005.07.022; Barba C, 2003, NEUROSCI LETT, V344, P161, DOI 10.1016/S0304-3940(03)00378-1; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Brooke JD, 2004, CAN J PHYSIOL PHARM, V82, P723, DOI 10.1139/Y04-045; Brown KE, 2015, EXP BRAIN RES, V233, P927, DOI 10.1007/s00221-014-4168-6; Brown MJN, 2016, NEUROIMAGE, V127, P97, DOI 10.1016/j.neuroimage.2015.11.051; Bunney WE, 1999, SCHIZOPHRENIA BULL, V25, P577, DOI 10.1093/oxfordjournals.schbul.a033402; Cao XH, 2008, NEUROSCI LETT, V435, P152, DOI 10.1016/j.neulet.2008.02.030; Cebolla AM, 2014, NEUROIMAGE, V95, P48, DOI 10.1016/j.neuroimage.2014.03.039; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; CHERON G, 1987, ELECTROEN CLIN NEURO, V67, P537, DOI 10.1016/0013-4694(87)90056-3; CHERON G, 1991, ELECTROEN CLIN NEURO, V80, P522, DOI 10.1016/0168-5597(91)90134-J; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; Desmedt, 1977, ATTENTION VOLUNTARY, V1, P30; DESMEDT JE, 1989, ELECTROEN CLIN NEURO, V74, P321, DOI 10.1016/0168-5597(89)90001-4; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Insola A, 2004, CLIN NEUROPHYSIOL, V115, P104, DOI 10.1016/j.clinph.2003.08.003; Insola A, 2015, CLIN NEUROPHYSIOL, V126, P2366, DOI 10.1016/j.clinph.2015.03.021; Insola A, 2010, CLIN NEUROPHYSIOL, V121, P921, DOI 10.1016/j.clinph.2010.01.006; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; JONES SJ, 1989, ELECTROEN CLIN NEURO, V74, P36, DOI 10.1016/0168-5597(89)90049-X; Kanovsky P, 2003, CLIN NEUROPHYSIOL, V114, P981, DOI 10.1016/S1388-2457(03)00068-3; Kaplan, 1999, NEUROPSYCHOLOGICAL D, P163; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; MAUGUIERE F, 1991, ANN NEUROL, V30, P71, DOI 10.1002/ana.410300113; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morita H, 1998, EXP BRAIN RES, V120, P143, DOI 10.1007/s002210050388; Nakata H, 2003, BRAIN TOPOGR, V15, P211, DOI 10.1023/A:1023908707851; Pandya DN, 1987, FRONTAL LOBES REVISI, P41; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rossini PM, 1999, BRAIN RES, V843, P161, DOI 10.1016/S0006-8993(99)01716-3; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; SKINNER JE, 1976, ELECTROEN CLIN NEURO, V40, P288, DOI 10.1016/0013-4694(76)90152-8; Staines WR, 2000, NEUROREPORT, V11, P1713, DOI 10.1097/00001756-200006050-00024; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; STARR A, 1985, BRAIN RES, V348, P183, DOI 10.1016/0006-8993(85)90377-4; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Tennant J., 2018, THESIS UWSPACE; Valeriani M, 1998, EXP BRAIN RES, V120, P306, DOI 10.1007/s002210050404; Valeriani M, 2000, MUSCLE NERVE, V23, P353, DOI 10.1002/(SICI)1097-4598(200003)23:3<353::AID-MUS6>3.0.CO;2-M; VOGT BA, 1978, J COMP NEUROL, V177, P179, DOI 10.1002/cne.901770202; WOOD CC, 1985, SCIENCE, V227, P1051, DOI 10.1126/science.3975600; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S	59	0	0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2021	132	10					2431	2439		10.1016/j.clinph.2021.06.027			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WD4LR	WOS:000704914800013	34454270				2022-02-06	
J	Tobiansky, DJ; Long, KM; Hamden, JE; Brawn, JD; Fuxjager, MJ				Tobiansky, Daniel J.; Long, Kira M.; Hamden, Jordan E.; Brawn, Jeffrey D.; Fuxjager, Matthew J.			Cost-Reducing Traits for Agonistic Head Collisions: A Case for Neurophysiology	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ENLARGED PERIVASCULAR SPACES; INNATE IMMUNE-RESPONSE; CHOROID-PLEXUS; NEURONAL DAMAGE; ANIMAL-MODELS; EVOLUTION; SYSTEM; TAU; GLUCOCORTICOIDS	Many animal species have evolved extreme behaviors requiring them to engage in repeated high-impact collisions. These behaviors include mating displays like headbutting in sheep and drumming in woodpeckers. To our knowledge, these taxa do not experience any notable acute head trauma, even though the deceleration forces would cause traumatic brain injury in most animals. Previous research has focused on skeletomuscular morphology, biomechanics, and material properties in an attempt to explain how animals moderate these high-impact forces. However, many of these behaviors are understudied, and most morphological or computational studies make assumptions about the behavior without accounting for the physiology of an organism. Studying neurophysiological and immune adaptations that covary with these behaviors can highlight unique or synergistic solutions to seemingly deleterious behavioral displays. Here, we argue that selection for repeated, high-impact head collisions may rely on a suite of coadaptations in intracranial physiology as a cost-reducing mechanism. We propose that there are three physiological systems that could mitigate the effects of repeated head trauma: (1) the innate neuroimmune response; (2) the glymphatic system, and (3) the choroid plexus. These systems are interconnected yet can evolve in an independent manner. We then briefly describe the function of these systems, their role in head trauma, and research that has examined how these systems may evolve to help reduce the cost of repeated, forceful head impacts. Ultimately, we note that little is known about cost-reducing intracranial mechanisms making it a novel field of comparative study that is ripe for exploration.	[Tobiansky, Daniel J.; Fuxjager, Matthew J.] Brown Univ, Biomed Ctr, Providence, RI 02888 USA; [Long, Kira M.; Brawn, Jeffrey D.] Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL USA; [Hamden, Jordan E.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Zool, Vancouver, BC, Canada		Tobiansky, DJ (corresponding author), Brown Univ, Biomed Ctr, Providence, RI 02888 USA.	daniel_tobiansky@brown.edu		Tobiansky, Daniel/0000-0001-6381-3453; Long, Kira/0000-0002-7614-3388; Hamden, Jordan/0000-0002-8152-6113	National Science FoundationNational Science Foundation (NSF) [IOS-1947472]; Manakin Genomics RCN [NSF-DEB 1457541]; University of British Columbia Doctoral Fellowship	This work was supported by the National Science Foundation [IOS-1947472 to M.J.F.], the Manakin Genomics RCN [supported by NSF-DEB 1457541], and the University of British Columbia Doctoral Fellowship to J.E.H.	Ackermans NL, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.09488; Ackermans NL, TRAUMATIC BRAIN INJU; Benveniste H, 2020, J APPL PHYSIOL, V129, P1330, DOI 10.1152/japplphysiol.00852.2019; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Blais V, 2002, ENDOCRINOLOGY, V143, P4820, DOI 10.1210/en.2002-220598; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Cappelli J, 2018, J ANAT, V232, P72, DOI 10.1111/joa.12708; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; CSERR HF, 1980, AM J PHYSIOL, V238, pR76, DOI 10.1152/ajpregu.1980.238.1.R76; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Dani Neil, 1800, Cell, V184, P3056, DOI 10.1016/j.cell.2021.04.003; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Farah G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191526; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gaberel T, 2014, STROKE, V45, P3092, DOI 10.1161/STROKEAHA.114.006617; Garcia M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18772-3; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Gol'din P, 2014, BIOL J LINN SOC, V113, P510, DOI 10.1111/bij.12337; Gonzalez-Perez MP, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-20; Gorman G., 2014, WOODPECKERS WORLD CO; Gottfried-Blackmore A, 2010, GLIA, V58, P1257, DOI 10.1002/glia.21007; Gowans S, 1999, MAR MAMMAL SCI, V15, P1342, DOI 10.1111/j.1748-7692.1999.tb00896.x; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hamden JE, 2021, DEV NEUROBIOL, V81, P189, DOI 10.1002/dneu.22808; HEIER LA, 1989, AM J NEURORADIOL, V10, P929; Holmes MC, 2006, MOL CELL ENDOCRINOL, V248, P9, DOI 10.1016/j.mce.2005.12.002; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kaur J, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060344; KITCHENER A, 1988, J ZOOL, V214, P1, DOI 10.1111/j.1469-7998.1988.tb04983.x; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacLullich AMJ, 2004, J NEUROL NEUROSUR PS, V75, P1519, DOI 10.1136/jnnp.2003.030858; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; Marques F, 2017, NEUROBIOL DIS, V107, P32, DOI 10.1016/j.nbd.2016.08.011; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; McAteer Kelly M, 2017, Concussion, V2, pCNC32, DOI 10.2217/cnc-2016-0031; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mead AF, 2017, ELIFE, V6, DOI 10.7554/eLife.29425; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MELLON SH, 1993, BRAIN RES, V629, P283, DOI 10.1016/0006-8993(93)91332-M; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miles MC, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2628; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; Moller AP, 1996, IBIS, V138, P112; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; Pan Z, 2017, P NATL ACAD SCI USA, V114, P8470, DOI 10.1073/pnas.1702502114; Panagiotopoulou O, 2016, PEERJ, V4, DOI 10.7717/peerj.1895; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Praetorius XJ, 2017, J PHYSL CELL PHYSL, V312, P673; Rico-Guevara A, 2019, BIOL REV, V94, P60, DOI 10.1111/brv.12436; Romo MR, 2016, IMMUNOLOGY, V148, P125, DOI 10.1111/imm.12597; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; SCHAFFER WM, 1968, EVOLUTION, V22, P817, DOI 10.1111/j.1558-5646.1968.tb03480.x; Schuppe ER, 2018, FUNCT ECOL, V32, P450, DOI 10.1111/1365-2435.13010; Schuppe ER, 2016, BEHAV ECOL SOCIOBIOL, V70, P673, DOI 10.1007/s00265-016-2088-0; Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Smirnova I, 2000, GENOME BIOL, V1; Snively E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021422; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Swanson LC, 2020, GENETICS, V216, P1117, DOI 10.1534/genetics.120.303776; Taves MD, 2016, DEV COMP IMMUNOL, V54, P116, DOI 10.1016/j.dci.2015.09.004; Taves MD, 2015, ENDOCRINOLOGY, V156, P511, DOI 10.1210/en.2013-1606; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Tinghitella RM, 2018, BEHAV ECOL, V29, P783, DOI 10.1093/beheco/arx151; Tobiansky DJ, 2020, J ENDOCRINOL, V245, P231, DOI 10.1530/JOE-19-0386; Tobiansky DJ, 2018, ENDOCRINOLOGY, V159, P450, DOI 10.1210/en.2017-00704; Tyler AK, 1993, INT RES COUNC BIOMEC, V21, P93; Vaccari JCD, 2015, J NEUROTRAUM, V32, P228, DOI 10.1089/neu.2014.3436; Vander Linden A, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2199; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WEYMOUTH RD, 1964, ACTA ANAT, V58, P252; Wilczynski W, 2015, BEHAVIOUR, V152, P563, DOI 10.1163/1568539X-00003243; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Wu CW, 2015, J PHYS CONF SER, V628, DOI 10.1088/1742-6596/628/1/012007; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhu L, 2018, P NATL ACAD SCI USA, V115, pE11388, DOI 10.1073/pnas.1808609115	103	0	0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	OCT	2021	61	4					1394	1405		10.1093/icb/icab034			12	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	WN3VB	WOS:000711698500012	33885750				2022-02-06	
J	Totev, K; Dimitrov, G; Toteva, L; Todorov, S; Lungarov, S				Totev, Konstantin; Dimitrov, Georgi; Toteva, Lyubomira; Todorov, Svilen; Lungarov, Steliyan			RISK FACTORS FOR HUMERAL HEAD OSTEONECROSIS IN PATIENTS WITH PROXIMAL HUMERAL FRACTURES TREATED OPERATIVELY	JOURNAL OF IMAB			English	Article						proximal humerus fracture; osteonecrosis; risk factors	EPIDEMIOLOGY; ISCHEMIA	Proximal humerus presents the second most frequent site of posttraumatic osteonecrosis. This complication is usually related to poor functional outcomes. The aim of this study is to identify and analyze the risk factors for posttraumatic humeral head osteonecrosis in surgically treated patients. Ninety-one patients with 92 acute proximal humeral fractures were operated on for a period of 39 months. Operative methods include open reduction and internal fixation and closed reduction and percutaneous fixation. Fractures were classified according to Neer, AO and LEGO classifications. The mean age of patients was 60.9 years. From 91 operated patients for follow-up were available 82. The mean follow-up period was 15 months. Patient data was collected prospectively. Functional results are present using age and gender adjusted Constant score. In 41 patients, the result is excellent, in 28-good, in 11-fair and in 3 poor. Bone union was evident in all cases. No deep wound infections, nerve injuries, vascular injuries and implant failure were observed. Osteonecrosis was seen in 5 (6.1%) patients. Patients with posttraumatic osteonecrosis had significant lower Constant results. Analyzing the pre- and intraoperative factors in patients with osteonecrosis, we find that the most significant factors for this complication are increasing fracture severity and a combination of short medial metaphyseal extension and disrupted medial hinge.	[Totev, Konstantin; Dimitrov, Georgi; Todorov, Svilen; Lungarov, Steliyan] Med Univ Pleven, Fac Med, Dept Orthopaed & Traumatol, Pleven, Bulgaria; [Toteva, Lyubomira] Med Univ Pleven, Dept Phys Med Rehabil Ergotherapy & Sport, Fac Publ Hlth, Pleven, Bulgaria		Totev, K (corresponding author), Med Univ, Fac Med, Dept Orthopaed & Traumatol, 89 Ruse Blv, Pleven 5800, Bulgaria.	kztotev@abv.bg					Bastian JD, 2008, J SHOULDER ELB SURG, V17, P2, DOI 10.1016/j.jse.2007.03.026; Beeres FJP, 2017, ARCH ORTHOP TRAUM SU, V137, P1685, DOI 10.1007/s00402-017-2790-z; Belayneh R, 2018, J ORTHOP TRAUMA, V32, pE387, DOI 10.1097/BOT.0000000000001260; Campochiaro G, 2015, Musculoskelet Surg, V99 Suppl 1, pS9, DOI 10.1007/s12306-015-0358-z; Court-Brown C, 2006, TRAUMA, V1st, P99; Court-Brown CM, 2001, ACTA ORTHOP SCAND, V72, P365, DOI 10.1080/000164701753542023; Dimitrov G, 2011, ORTOP TRAUMA, V3, P104; Frankle MA, 2001, J SHOULDER ELB SURG, V10, P321, DOI 10.1067/mse.2001.113962; Gardner MJ, 2005, CLIN ORTHOP RELAT R, P123, DOI 10.1097/01.blo.0000152872.95806.09; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P1256, DOI 10.2106/00004623-199608000-00018; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; Hettrich CM, 2010, J BONE JOINT SURG AM, V92A, P943, DOI 10.2106/JBJS.H.01144; Large TM, 2019, J AM ACAD ORTHOP SUR, V27, P794, DOI 10.5435/JAAOS-D-18-00225; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Padegimas EM, 2017, J SHOULDER ELB SURG, V26, P1931, DOI 10.1016/j.jse.2017.05.003; Palvanen M, 2006, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000194672.79634.78; Patel S, 2015, INJURY, V46, P1878, DOI 10.1016/j.injury.2015.06.026; Resch H, 2000, TECHNIQUES SHOULDER, V1, P154; Robinson CM, 2019, J BONE JOINT SURG AM, V101, P2129, DOI 10.2106/JBJS.19.00595; Sproul RC, 2011, INJURY, V42, P408, DOI 10.1016/j.injury.2010.11.058; STURZENEGGER M, 1982, ARCH ORTHOP TRAUM SU, V100, P249, DOI 10.1007/BF00381665; Tamai K, 2009, J SHOULDER ELB SURG, V18, P845, DOI 10.1016/j.jse.2009.01.018	22	0	0	0	0	GOSPODIN ILIEV PEYTCHINSKI, ED & PUB	PLEVEN	DROUJBA BL 116, PLEVEN, 5806, BULGARIA	1312-773X			J IMAB	J. IMAB	OCT-DEC	2021	27	4					4072	4076		10.5272/jimab.2021274.4072			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	YE8KA	WOS:000741367200014		gold			2022-02-06	
J	Tsao, J; Hook, M; Shah, P; Bingham, PM				Tsao, Jackie; Hook, Marcus; Shah, Purvi; Bingham, Peter M.			Implementation of Pediatric Emergency Care Applied Research Network Guidelines for Traumatic Brain Injury in a Rural Tertiary Care Center	PEDIATRIC EMERGENCY CARE			English	Article						head trauma; computed tomography; PECARN	NEUROLOGIC EXAMINATION; COMPUTED-TOMOGRAPHY; PREDICTION RULES; HEAD-INJURY; CT; MANAGEMENT; CHILDREN; UTILITY; TRENDS	Objectives To evaluate changes in imaging practices for pediatric head trauma after publication of the Pediatric Emergency Care Applied Research Network (PECARN) guidelines, explore areas for quality improvement regarding neuroradiology referrals. We also sought to determine the prevalence of incidental findings discovered on computed tomographies (CTs) attained for minor head trauma and ascertain disposition in these cases. Methods This retrospective study was conducted at a rural academic center and included 156 children who received CTs for head trauma between 2005 and 2015. Subjects were divided into 2 groups: pre-PECARN publication and post-PECARN publication. Electronic medical records were reviewed to determine whether or not head CTs were obtained according to PECARN guidelines. The proportion of scanned cases and incidental findings in each group was then compared. Results Significantly more subjects met PECARN criteria for head CT during the pre-PECARN period (67.1% vs 50.6%, P = 0.04). Among those who met PECARN criteria, severe mechanism of injury was the most common criterion met in both groups (43.8% pre-PECARN and 26.5% post-PECARN). Nine (5.7%) subjects had incidental findings (similar for both study periods), of which 3 prompted additional diagnostic testing or invasive intervention. Among those who did not meet PECARN criteria, the most common mechanism of injury was fall (<3 ft). Conclusions Implementation of PECARN guidelines at our center remained limited in the 5 years after publication of this practice guide. Clinically insignificant incidental findings were often detected and may heighten patient anxiety.	[Tsao, Jackie; Shah, Purvi] Univ Vermont, Med Ctr, Robert Larner MD Sch Med, Dept Neurosci, Burlington, VT 05401 USA; [Hook, Marcus] Univ Vermont, Med Ctr, Dept Radiol, Burlington, VT 05401 USA; [Bingham, Peter M.] Univ Vermont, Med Ctr, Div Pediat Neurol, Burlington, VT 05401 USA		Bingham, PM (corresponding author), Univ Vermont, Pediat Neurol, Dept Neurosci, 50 Beaumont Ave, Burlington, VT 05401 USA.	Peter.Bingham@uvmhealth.org			Department of Neurosciences, Department of Radiology, and The Robert Larner MD School of Medicine	Supported by the Department of Neurosciences, Department of Radiology, and The Robert Larner MD School of Medicine.	Atabaki SM., 2017, PEDIAT QUAL SAF, V2, P019; Berlin L, 2011, RADIOL CLIN N AM, V49, P245, DOI 10.1016/j.rcl.2010.11.002; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Faul M, 2010, CTR DIS CONTROL PREV; Ferrazzano PA, 2019, J NEUROSURG-PEDIATR, V23, P471, DOI 10.3171/2018.10.PEDS18374; Gerber N, 2019, EMERG RADIOL, V26, P45, DOI 10.1007/s10140-018-1645-4; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Kobe IO, 2017, CHILD NERV SYST, V33, P2147, DOI 10.1007/s00381-017-3577-9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levin DC, 2017, J AM COLL RADIOL, V14, P331, DOI 10.1016/j.jacr.2016.08.025; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Ohana O, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170434; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rogers AJ, 2013, PEDIATRICS, V132, pE356, DOI 10.1542/peds.2013-0299; Schonfeld D, 2015, POSTGRAD MED J, V91, P634, DOI 10.1136/postgradmedj-2013-305004rep; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shahi V, 2015, ACAD RADIOL, V22, P898, DOI 10.1016/j.acra.2015.02.016; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Wylie MC, 2014, PEDIATR EMERG CARE, V30, P680, DOI 10.1097/PEC.0000000000000227	30	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2021	37	10					513	518		10.1097/PEC.0000000000002124			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	WH4QK	WOS:000707664200006	32541400				2022-02-06	
J	Wang, HC; Wang, PM; Lin, YT; Tsai, NW; Lai, YR; Kung, CT; Su, CM; Lu, CH				Wang, Hung-Chen; Wang, Pei-Ming; Lin, Yu-Tsai; Tsai, Nai-Wen; Lai, Yun-Ru; Kung, Chia-Te; Su, Chih-Min; Lu, Cheng-Hsien			Effects of Hyperbaric Oxygen Therapy on Serum Adhesion Molecules, and Serum Oxidative Stress in Patients with Acute Traumatic Brain Injury	JOURNAL OF PERSONALIZED MEDICINE			English	Article						traumatic brain injury; hyperbaric oxygen therapy; oxidative stress; adhesion molecules	INFLAMMATORY RESPONSE; LIPID-PEROXIDATION; HEAD-INJURY; DAMAGE; NEUROINFLAMMATION; ACTIVATION; MICROGLIA; SEVERITY; INFANTS; DEATH	Background: Serum concentrations of adhesion molecules and oxidative stress is thought to participate in the pathobiology of secondary brain injury after acute traumatic brain injury (TBI). We aimed to study the hypothesis that hyperbaric oxygen therapy (HBOT) both improves the adhesion molecules levels and antioxidant capacity. Methods: Thirty blood samples from ten patients after acute TBI were obtained after injury and before and after HBOT. Four patients received early HBOT started two weeks after injury, four patients received late HBOT started ten weeks after injury and two patients did not receive HBOT and served as control in this study. The HBOT patients received total 30 times HBOT in six weeks period. Results: Those serum biomarkers in patients with TBI had not significantly difference in glutathione (GSH), thiobarbituric acid reactive substances (TBARS), soluble intercellular cell adhesion-molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) concentrations on admission between early HBOT, late HBOT, and control group (p = 0.916, p = 0.98, p = 0.306, and p = 0.548, respectively). Serum GSH levels were higher at 10 weeks after injury in the early HBOT group than in the late HBOT group and control group (mean, 1.40 mu mol/L, 1.16 mu mol/L, and 1.05 mu mol/L, respectively). Then the serum GSH level was increased at 18 weeks after injury in the late HBOT group (mean, 1.49 mu mol/L). However, there was only statistically significant difference at Weeks 18 (p = 0.916, p = 0.463, and p = 0.006, at Week 2, Week 10, and Week 18, respectively). Serum TBARS levels were decreased at 10 weeks after injury in the early HBOT group than in the late HBOT group and control group (mean, 11.21 mu mol/L, 17.23 mu mol/L, and 17.14 mu mol/L, respectively). Then the serum TBARS level was decreased at 18 weeks after injury in the late HBOT group (mean, 12.06 mu mol/L). There was statistically significant difference after HBOT (p = 0.98, p = 0.007, and p = 0.018, at Week 2, Week 10, and Week 18, respectively). There was no statistically significant difference between the three groups on sICAM-1 and sVCAM-1 levels from Week 2 to Week 18. Conclusions: HBOT can improve serum oxidative stress in patients after TBI. These molecules may be added as evaluation markers in clinical practice. Perhaps in the future it may also become part of the treatment of patients after acute traumatic brain injury. Further large-scale study may be warrant.</p>	[Wang, Hung-Chen] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 833401, Taiwan; [Wang, Hung-Chen; Wang, Pei-Ming; Lin, Yu-Tsai; Tsai, Nai-Wen; Lai, Yun-Ru; Kung, Chia-Te; Su, Chih-Min; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung 833401, Taiwan; [Wang, Pei-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung 833401, Taiwan; [Lin, Yu-Tsai] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung 833401, Taiwan; [Lin, Yu-Tsai] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan 33302, Taiwan; [Tsai, Nai-Wen; Lai, Yun-Ru; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 833401, Taiwan; [Kung, Chia-Te; Su, Chih-Min] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung 833401, Taiwan; [Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Lu, Cheng-Hsien] Xiamen Chang Gung Mem Hosp, Dept Neurol, Xiamen 361126, Peoples R China		Lu, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung 833401, Taiwan.; Lu, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 833401, Taiwan.; Lu, CH (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.; Lu, CH (corresponding author), Xiamen Chang Gung Mem Hosp, Dept Neurol, Xiamen 361126, Peoples R China.	m82whc@yahoo.com.tw; wangpeming@yahoo.com.tw; whc8131977@gmail.com; tsainw@yahoo.com.tw; yunru.lai@gmail.com; kungchiate@gmail.com; mitosu@gmail.com; hlu99@ms44.url.com.tw		Su, Chih-Min/0000-0002-8121-3977; LIN, YU-TSAI/0000-0002-7311-8638	Chang Gung Memorial Hospital Research ProjectChang Gung Memorial Hospital [CMRPG8J0151]	FundingFunding: This research was funded by grants from the Chang Gung Memorial Hospital Research Project (CMRPG8J0151).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barbosa DJ, 2015, ARCH TOXICOL, V89, P1695, DOI 10.1007/s00204-015-1478-9; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bednar MM, 1997, NEUROL RES, V19, P588; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chandravanshi LP, 2018, BIOL TRACE ELEM RES, V186, P185, DOI 10.1007/s12011-018-1286-1; Chazalviel L, 2016, MED GAS RES, V6, P64, DOI 10.4103/2045-9912.184713; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Fan LM, 2019, J CLIN INVEST, V129, P3374, DOI 10.1172/JCI125173; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Giddings JC, 2005, BIOCHEM SOC T, V33, P406, DOI 10.1042/BST0330406; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; HERBERT V, 1994, STEM CELLS, V12, P289, DOI 10.1002/stem.5530120305; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; LAW MM, 1994, J TRAUMA, V37, P100, DOI 10.1097/00005373-199407000-00017; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; McKeating EG, 1998, BRIT J ANAESTH, V80, P77, DOI 10.1093/bja/80.1.77; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Shin EJ, 2018, NEUROCHEM RES, V43, P66, DOI 10.1007/s11064-017-2318-5; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soriano SG, 2008, EUR J ANAESTH, V25, P154, DOI 10.1017/S0265021507003390; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wang HC, 2013, CLIN CHIM ACTA, V423, P122, DOI 10.1016/j.cca.2013.04.023; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Yang X, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00186; Yu F, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3913981; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang ZW, 2020, BRAIN RES, V1739, DOI 10.1016/j.brainres.2020.146818; Zhou BC, 2016, NEURAL REGEN RES, V11, P1445, DOI 10.4103/1673-5374.191218	49	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4426		J PERS MED	J. Pers. Med.	OCT	2021	11	10							985	10.3390/jpm11100985			10	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	WO7SJ	WOS:000712649200001	34683126	Green Published, gold			2022-02-06	
J	Warner, N; Teo, JT				Warner, Natasha; Teo, James T.			Neurological injury from virtual reality mishap	BMJ CASE REPORTS			English	Article						neurology; cranial nerves; neurological injury; trauma CNS; PNS	VISUAL INPUT	Consumer virtual reality systems are becoming increasingly popular with the increasing availability of devices and gamified technologies. Self-sustained injury risks exist with the use of this technology in the uncontrolled home environment, however, the public awareness of these risks may not be recognised. We present a case of a low- impact virtual reality fall resulting in spinal cord injury, hypoglossal nerve injury, vertebral artery dissection and traumatic brain injury.	[Warner, Natasha] Wellington Hosp, Neurorehabil, London, England; [Teo, James T.] Kings Coll Hosp NHS Fdn Trust, Neurol, London, England; [Teo, James T.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England		Teo, JT (corresponding author), Kings Coll Hosp NHS Fdn Trust, Neurol, London, England.; Teo, JT (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	jamesteo@nhs.net	Teo, James T/D-9696-2011	Teo, James T/0000-0002-6899-8319			Bergeron Mathieu, 2015, Adv Med, V2015, P916735, DOI 10.1155/2015/916735; Birtchnell T., 2020, DIGITAL GEOGRAPHY SO, V1, DOI [10.1016/j.diggeo.2020.100004, DOI 10.1016/J.DIGGEO.2020.100004]; Bloem BR, 1999, J NEUROL NEUROSUR PS, V67, P691, DOI 10.1136/jnnp.67.5.691; Chu YC, 2012, MIL MED, V177, P41, DOI 10.7205/MILMED-D-11-00134; Cunha B, 2020, EUR J PUBLIC HEALTH, V30; DORNAN J, 1978, ARCH PHYS MED REHAB, V59, P586; Energy and Industrial strategy, 2020, SAF DOM VIRT REAL SY; Horiuchi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184552; Oregon State University, 2020, SCIENCEDAILY; Viirre E, 2002, LARYNGOSCOPE, V112, P500, DOI 10.1097/00005537-200203000-00017	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	OCT	2021	14	10							e243424	10.1136/bcr-2021-243424			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WI1FP	WOS:000708112000021	34642218	Green Published, hybrid			2022-02-06	
J	Wilkerson, GB; Nabhan, DC; Perry, TS				Wilkerson, Gary B.; Nabhan, Dustin C.; Perry, Tyler S.			A Novel Approach to Assessment of Perceptual-Motor Efficiency and Training-Induced Improvement in the Performance Capabilities of Elite Athletes	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						sport-related concussion; mild traumatic brain injury; reactive agility; musculoskeletal injury; intra-individual variability; asymmetry; neuromechanics	MUSCULOSKELETAL INJURY RISK; REACTION-TIME VARIABILITY; BRAIN SIGNAL VARIABILITY; SPORT-RELATED CONCUSSION; WHITE-MATTER INTEGRITY; ATTENTIONAL CONTROL; INTRAINDIVIDUAL VARIABILITY; FUNCTIONAL CONNECTIVITY; PERSISTENT INFLUENCE; COGNITIVE CONTROL	Standard clinical assessments of mild traumatic brain injury are inadequate to detect subtle abnormalities that can be revealed by sophisticated diagnostic technology. An association has been observed between sport-related concussion (SRC) and subsequent musculoskeletal injury, but the underlying neurophysiological mechanism is not currently understood. A cohort of 16 elite athletes (10 male, 6 female), which included nine individuals who reported a history of SRC (5 male, 4 female) that occurred between 4 months and 8 years earlier, volunteered to participate in a 12-session program for assessment and training of perceptual-motor efficiency. Performance metrics derived from single- and dual-task whole-body lateral and diagonal reactive movements to virtual reality targets in left and right directions were analyzed separately and combined in various ways to create composite representations of global function. Intra-individual variability across performance domains demonstrated very good SRC history classification accuracy for the earliest 3-session phase of the program (Reaction Time Dispersion AUC = 0.841; Deceleration Dispersion AUC = 0.810; Reaction Time Discrepancy AUC = 0.825, Deceleration Discrepancy AUC = 0.794). Good earliest phase discrimination was also found for Composite Asymmetry between left and right movement directions (AUC = 0.778) and Excursion Average distance beyond the minimal body displacement necessary for virtual target deactivation (AUC = 0.730). Sensitivity derived from Youden's Index for the 6 global factors ranged from 67 to 89% and an identical specificity value of 86% for all of them. Median values demonstrated substantial improvement from the first 3-session phase to the last 3-session phase for Composite Asymmetry and Excursion Average. The results suggest that a Composite Asymmetry value >= 0.15 and an Excursion Average value >= 7 m, provide reasonable qualitative approximations for clinical identification of suboptimal perceptual-motor performance. Despite acknowledged study limitations, the findings support a hypothesized relationship between whole-body reactive agility performance and functional connectivity among brain networks subserving sensory perception, cognitive decision-making, and motor execution. A complex systems approach appears to perform better than traditional data analysis methods for detection of subtle perceptual-motor impairment, which has the potential to advance both clinical management of SRC and training for performance enhancement.	[Wilkerson, Gary B.] Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN 37403 USA; [Nabhan, Dustin C.] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Oslo, Norway; [Perry, Tyler S.] Emory Healthcare, Orthoped & Sports Med, Atlanta, GA USA		Wilkerson, GB (corresponding author), Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN 37403 USA.	Gary-Wilkerson@utc.edu					Adams RA, 2013, BRAIN STRUCT FUNCT, V218, P611, DOI 10.1007/s00429-012-0475-5; Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; Bahr R, 2014, BRIT J SPORT MED, V48, P1265, DOI 10.1136/bjsports-2014-093832; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brett BL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01345; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Buschman TJ, 2015, NEURON, V88, P127, DOI 10.1016/j.neuron.2015.09.017; Cao J, 2014, JAMA-J AM MED ASSOC, V312, P543, DOI 10.1001/jama.2014.9440; Churchill NW, 2021, BRAIN IMAGING BEHAV, V15, P1508, DOI 10.1007/s11682-020-00349-9; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Costa AS, 2019, CLIN NEUROPSYCHOL, V33, P369, DOI 10.1080/13854046.2018.1533587; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; Davidson TW, 2016, CLIN NEUROPHYSIOL, V127, P3364, DOI 10.1016/j.clinph.2016.07.012; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Deco G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03073-5; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; ENOKA RM, 2002, NEUROMECHANICS HUMAN; Erickson KI, 2005, COGNITIVE BRAIN RES, V22, P349, DOI 10.1016/j.cogbrainres.2004.09.004; Ezza H., 2014, J MOL GENET MED, V8, P141, DOI [10.4172/1747-0862.1000141, DOI 10.4172/1747-0862.1000141]; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Fonseca ST, 2020, SPORTS MED, V50, P1757, DOI 10.1007/s40279-020-01326-4; Fueger C, 2018, J CLIN EXP NEUROPSYC, V40, P1074, DOI 10.1080/13803395.2018.1458823; Gallivan JP, 2014, J NEUROSCI, V34, P3119, DOI 10.1523/JNEUROSCI.0060-14.2014; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Grady CL, 2018, NEUROIMAGE, V169, P510, DOI 10.1016/j.neuroimage.2017.12.031; Greene DJ, 2020, NEURON, V105, P742, DOI 10.1016/j.neuron.2019.11.012; Guth T, 2018, SPORTS, V6, DOI 10.3390/sports6010005; Hadlow SM, 2018, J SCI MED SPORT, V21, P950, DOI 10.1016/j.jsams.2018.01.011; Harada GK, 2019, AM J SPORT MED, V47, P3256, DOI 10.1177/0363546519872502; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hegedus EJ, 2015, BRIT J SPORT MED, V49, P1288, DOI 10.1136/bjsports-2015-094796; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Helme M, 2021, PHYS THER SPORT, V49, P204, DOI 10.1016/j.ptsp.2021.03.001; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hogg Jennifer A, 2021, J Clin Transl Res, V7, P100; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; Hosmer DW., 2000, APPL LOGISTIC REGRES; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024; Jensen A.R, 2006, CLOCKING MIND MENTAL, P43; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson BP, 2015, NEUROPSYCHOLOGIA, V72, P22, DOI 10.1016/j.neuropsychologia.2015.03.015; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kung SM, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-020-00283-6; Ledreux A, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00761; Cardoso FDL, 2021, J SPORT SCI, V39, P926, DOI 10.1080/02640414.2020.1851901; Lempke LB, 2020, MED SCI SPORT EXER, V52, P1650, DOI 10.1249/MSS.0000000000002300; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; Lynall RC, 2021, J SPORT REHABIL, V30, P1237, DOI 10.1123/jsr.2021-0021; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; Maffulli N, 2010, BRIT J SPORT MED, V44, P21, DOI 10.1136/bjsm.2009.069526; Marmolejo-Ramos F, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01548; McAuley T, 2006, DEV NEUROPSYCHOL, V29, P447, DOI 10.1207/s15326942dn2903_4; McGinnis RS, 2017, BIOMED SIGNAL PROCES, V32, P150, DOI 10.1016/j.bspc.2016.10.013; McGowan AL, 2019, NEUROPSYCHOLOGIA, V131, P223, DOI 10.1016/j.neuropsychologia.2019.05.026; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Olson RL, 2018, INT J PSYCHOPHYSIOL, V132, P145, DOI 10.1016/j.ijpsycho.2018.01.006; Ozolins B, 2016, BRAIN INJURY, V30, P937, DOI 10.3109/02699052.2016.1147080; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Parr T, 2017, NEUROPSYCHOLOGIA, V104, P92, DOI 10.1016/j.neuropsychologia.2017.08.003; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Quatman CE, 2009, BRIT J SPORT MED, V43, P1100, DOI 10.1136/bjsm.2009.065482; Ridderinkhof KR, 2021, ATTEN PERCEPT PSYCHO, V83, P700, DOI 10.3758/s13414-020-02167-z; Roalf DR, 2016, J ALZHEIMERS DIS, V54, P325, DOI 10.3233/JAD-160259; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schretlen DJ, 2003, J INT NEUROPSYCH SOC, V9, P864, DOI 10.1017/S1355617703960061; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Serpell BG, 2011, J STRENGTH COND RES, V25, P1240, DOI 10.1519/JSC.0b013e3181d682e6; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Servant M, 2019, ATTEN PERCEPT PSYCHO, V81, P2710, DOI 10.3758/s13414-019-01796-3; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shen IH, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6122; Sheppard JM, 2006, J SCI MED SPORT, V9, P342, DOI 10.1016/j.jsams.2006.05.019; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stawski RS, 2019, PSYCHOSOM MED, V81, P81, DOI 10.1097/PSY.0000000000000643; Stawski RS, 2019, J GERONTOL B-PSYCHOL, V74, P397, DOI 10.1093/geronb/gbx115; Stern BD, 2020, PHYS THER SPORT, V41, P43, DOI 10.1016/j.ptsp.2019.10.010; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; Themanson JR, 2015, BRIT J PSYCHOL, V106, P253, DOI 10.1111/bjop.12091; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Urban K, 2021, DEV NEUROREHABIL, V24, P187, DOI 10.1080/17518423.2020.1825539; van Andel S, 2017, HUM MOVEMENT SCI, V51, P59, DOI 10.1016/j.humov.2016.11.004; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Ham IJM, 2014, NEUROSCI BIOBEHAV R, V45, P142, DOI 10.1016/j.neubiorev.2014.05.006; Wahl D, 2021, EXERC SPORT SCI REV, V49, P115, DOI 10.1249/JES.0000000000000242; Wang CH, 2017, NEUROIMAGE, V158, P260, DOI 10.1016/j.neuroimage.2017.07.009; Wawrzyniak AJ, 2016, PSYCHOPHYSIOLOGY, V53, P739, DOI 10.1111/psyp.12617; Wilke J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207481; Wilkerson GB, 2021, PERCEPT MOTOR SKILL, V128, P714, DOI 10.1177/0031512520983680; Wilkerson GB, 2021, J SPORT REHABIL, V30, P844, DOI 10.1123/jsr.2020-0337; Wilkerson GB, 2020, J ATHL TRAINING, V55, P594, DOI 10.4085/1062-6050-0401.19; Wilkerson GB, 2018, MED SCI SPORT EXER, V50, P1750, DOI 10.1249/MSS.0000000000001647; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Wilkerson GB, 2016, CLIN J SPORT MED, V26, P423, DOI 10.1097/JSM.0000000000000280; Williams DP, 2016, PSYCHOPHYSIOLOGY, V53, P1843, DOI 10.1111/psyp.12739; Womack KB, 2017, J NEUROTRAUM, V34, P1539, DOI 10.1089/neu.2016.4670; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Wylie SA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00049; Yanuck SF, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00712; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087	130	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	OCT 1	2021	3								729729	10.3389/fspor.2021.729729			19	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WJ5JO	WOS:000709081100001	34661098	Green Published, gold			2022-02-06	
J	Wilkerson, GB; Bruce, JR; Wilson, AW; Huang, N; Sartipi, M; Acocello, SN; Hogg, JA; Mansouri, M				Wilkerson, Gary B.; Bruce, Jeremy R.; Wilson, Andrew W.; Huang, Neal; Sartipi, Mina; Acocello, Shellie N.; Hogg, Jennifer A.; Mansouri, Misagh			Perceptual-Motor Efficiency and Concussion History Are Prospectively Associated With Injury Occurrences Among High School and Collegiate American Football Players	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; postconcussion syndrome; musculoskeletal injury; injury risk screening	SPORT-RELATED CONCUSSION; SUBSEQUENT INJURY; REMOTE HISTORY; RISK; ACTIVATION; PROGRAM; ADULTS	Background: After a sport-related concussion (SRC), the risk for lower extremity injury is approximately 2 times greater, and the risk for another SRC may be as much as 3 to 5 times greater. Purpose: To assess the predictive validity of screening methods for identification of individual athletes who possess an elevated risk of SRC. Study Design: Case-control study; Level of evidence, 3. Methods: Metrics derived from a smartphone flanker test software application and self-ratings of both musculoskeletal function and overall wellness were acquired from American high school and college football players before study participation. Occurrences of core or lower extremity injury (CLEI) and SRC were documented for all practice sessions and games for 1 season. Receiver operating characteristic and logistic regression analyses were used to identify variables that provided the greatest predictive accuracy for CLEI or SRC occurrence. Results: Overall, there were 87 high school and 74 American college football players included in this study. At least 1 CLEI was sustained by 45% (39/87) of high school players and 55% (41/74) of college players. Predictors of CLEI included the flanker test conflict effect >= 69 milliseconds (odds ratio [OR], 2.12; 90% CI, 1.24-3.62) and a self-reported lifetime history of SRC (OR, 1.70; 90% CI, 0.90-3.23). Of players with neither risk factor, only 38% (29/77) sustained CLEI compared with 61% (51/84) of players with 1 or both of the risk factors (OR, 2.56; 90% CI, 1.50-4.36). SRC was sustained by 7 high school players and 3 college players. Predictors of SRC included the Overall Wellness Index score <= 78 (OR, 9.83; 90% CI, 3.17-30.50), number of postconcussion symptoms >= 4 (OR, 8.35; 90% CI, 2.71-25.72), the Sport Fitness Index score <= 78 (OR, 5.16; 90% CI, 1.70-15.65), history of SRC (OR, 4.03; 90% CI, 1.35-12.03), and the flanker test inverse efficiency ratio >= 1.7 (OR, 3.19; 90% CI, 1.08-9.47). Conclusion: Survey responses and smartphone flanker test metrics predicted greater injury incidence among individual football players classified as high-risk compared with that for players with a low-risk profile.	[Wilkerson, Gary B.; Bruce, Jeremy R.; Wilson, Andrew W.; Huang, Neal; Sartipi, Mina; Acocello, Shellie N.; Hogg, Jennifer A.; Mansouri, Misagh] Univ Tennessee, Chattanooga, TN 37403 USA; [Wilkerson, Gary B.; Wilson, Andrew W.; Acocello, Shellie N.; Hogg, Jennifer A.] Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN 37403 USA; [Bruce, Jeremy R.; Huang, Neal] Univ Tennessee, Dept Orthopaed Surg, Coll Med, Chattanooga, TN 37403 USA; [Sartipi, Mina; Mansouri, Misagh] Univ Tennessee, Ctr Urban Informat & Progress, Chattanooga, TN 37403 USA		Wilkerson, GB (corresponding author), Univ Tennessee, Dept Hlth & Human Performance, Chattanooga, TN 37403 USA.	Gary-Wilkerson@utc.edu			Biomedical Research Initiation Collaborative Grant - University of Tennessee College of Medicine; University of Tennessee Health Science Center, Erlanger Health System; University of Tennessee at Chattanooga	This study was supported by a Biomedical Research Initiation Collaborative Grant, which was internally funded by the University of Tennessee College of Medicine, the University of Tennessee Health Science Center, Erlanger Health System, and the University of Tennessee at Chattanooga. J.R.B. has received education payments from Alpha Orthopedic Systems; nonconsulting fees from Abbott Laboratories; and hospitality payments from Arthrex and Smith & Nephew. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Andujo VD, 2020, CURR SPORT MED REP, V19, P58, DOI 10.1249/JSR.0000000000000683; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Brett BL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01345; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Castellanos J, 2021, SPORTS MED, V51, P567, DOI 10.1007/s40279-020-01390-w; Churchill NW, 2021, BRAIN IMAGING BEHAV, V15, P1508, DOI 10.1007/s11682-020-00349-9; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ellemberg D., 2020, TRANSLATIONAL J AM C, V5, P1, DOI DOI 10.1249/TJX.0000000000000130; Erickson KI, 2005, COGNITIVE BRAIN RES, V22, P349, DOI 10.1016/j.cogbrainres.2004.09.004; Ettenhofer ML, 2018, BRAIN INJURY, V32, P1740, DOI 10.1080/02699052.2018.1511067; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ezza H., 2014, J MOL GENET MED, V8, P141, DOI [10.4172/1747-0862.1000141, DOI 10.4172/1747-0862.1000141]; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Harada GK, 2019, AM J SPORT MED, V47, P3256, DOI 10.1177/0363546519872502; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hellewell SC, 2021, BRAIN IMAGING BEHAV, V15, P1685, DOI 10.1007/s11682-020-00336-0; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Ledreux A, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00761; Matthews RAJ, 2019, AM STAT, V73, P202, DOI 10.1080/00031305.2019.1543136; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McGowan AL, 2019, NEUROPSYCHOLOGIA, V131, P223, DOI 10.1016/j.neuropsychologia.2019.05.026; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Narayana S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00538; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Ozolins B, 2016, BRAIN INJURY, V30, P937, DOI 10.3109/02699052.2016.1147080; Parasuraman R, 2012, NEUROIMAGE, V59, P70, DOI 10.1016/j.neuroimage.2011.04.040; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Rach S, 2011, PSYCHOL RES-PSYCH FO, V75, P77, DOI 10.1007/s00426-010-0289-0; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626; Wilkerson GB, 2021, PERCEPT MOTOR SKILL, V128, P714, DOI 10.1177/0031512520983680; Wilkerson GB, 2016, CLIN J SPORT MED, V26, P423, DOI 10.1097/JSM.0000000000000280; Wilkinson M, 2014, SPORTS MED, V44, P295, DOI 10.1007/s40279-013-0125-y; Wylie SA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00049; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087	58	0	0	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2021	9	10							23259671211051722	10.1177/23259671211051722			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	WN6IS	WOS:000711870800001	34722788	gold, Green Published			2022-02-06	
J	Wong, KR; O'Brien, WT; Sun, MJ; Yamakawa, G; O'Brien, TJ; Mychasiuk, R; Shultz, SR; McDonald, SJ; Brady, RD				Wong, Ker Rui; O'Brien, William T.; Sun, Mujun; Yamakawa, Glenn; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.; McDonald, Stuart J.; Brady, Rhys D.			Serum Neurofilament Light as a Biomarker of Traumatic Brain Injury in the Presence of Concomitant Peripheral Injury	BIOMARKER INSIGHTS			English	Article						Blood biomarker; extracranial injury; bone fracture; polytrauma; SIMOA	CEREBROSPINAL-FLUID; UTILITY	Introduction: Serum neurofilament light (NfL) is an emerging biomarker of traumatic brain injury (TBI). However, the effect of peripheral injuries such as long bone fracture and skeletal muscle injury on serum NfL levels is unknown. Therefore, the aim of this study was to determine whether serum NfL levels can be used as a biomarker of TBI in the presence of concomitant peripheral injuries. Methods: Rats were randomly assigned to one of four injury groups: polytrauma (muscle crush + fracture + TBI; n = 11); peripheral injuries (muscle crush + fracture + sham-TBI; n = 12); TBI-only (sham-muscle crush + sham-fracture + TBI; n = 13); and triple-sham (n = 7). At 2-days post-injury, serum levels of NfL were quantified using a Simoa HD-X Analyzer. Results: Compared to triple-sham rats, serum NfL concentrations were higher in rats with peripheral injuries-only, TBI-only, and polytrauma. When compared to peripheral injury-only rats, serum NfL levels were higher in TBI-only and polytrauma rats. No differences were found between TBI-only and polytrauma rats. Conclusion: Serum NfL levels did not differ between TBI-only and polytrauma rats, indicating that significant peripheral injuries did not affect the sensitivity and specificity of serum NfL as a biomarker of moderate TBI. However, the finding of elevated serum NfL levels in rats with peripheral injuries in the absence of a TBI suggests that the presence of such injuries may limit the utility of NfL as a biomarker of less severe TBI (eg, concussion).	[Wong, Ker Rui; O'Brien, William T.; Sun, Mujun; Yamakawa, Glenn; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.; McDonald, Stuart J.; Brady, Rhys D.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [O'Brien, Terence J.; Shultz, Sandy R.; Brady, Rhys D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia		Brady, RD (corresponding author), Monash Univ, Dept Neurosci, Cent Clin Sch, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	rhys.brady@monash.edu	O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; Shultz, Sandy/0000-0002-2525-8775			Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Brady RD, 2020, BONE, V133, DOI 10.1016/j.bone.2020.115263; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Cryer PC, 1996, PUBLIC HEALTH, V110, P331, DOI 10.1016/S0033-3506(96)80004-7; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Halaas NB, 2018, DEMENT GERIATR COGN, V46, P346, DOI 10.1159/000494754; Hsieh CH, 2018, BIOMED J, V41, P321, DOI 10.1016/j.bj.2018.08.007; Huibregtse ME, 2021, NEUROSCI BIOBEHAV R, V130, P433, DOI 10.1016/j.neubiorev.2021.08.029; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Mariotto S, 2018, J PERIPHER NERV SYST, V23, P174, DOI 10.1111/jns.12279; McDonald Stuart J, 2021, J Neurotrauma, V38, P2652, DOI 10.1089/neu.2021.0011; McDonald SJ, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00256-7; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Morshed S, 2009, J BONE JOINT SURG AM, V91A, P3, DOI 10.2106/JBJS.H.00338; O'Brien WT, 2021, EXP NEUROL, V341, DOI 10.1016/j.expneurol.2021.113698; Pham L, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105151; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Varhaug KN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00338; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	27	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights	OCT	2021	16								11772719211053449	10.1177/11772719211053449			4	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	WN9IS	WOS:000712079600001	34720579	Green Published, gold			2022-02-06	
J	Woo, PYM; Cheung, E; Lau, FWY; Law, NWS; Mak, CKY; Tan, P; Siu, B; Wong, A; Mak, CHK; Chan, KY; Yam, KY; Pang, KY; Po, YC; Lui, WM; Chan, DTM; Poon, WS				Woo, P. Y. M.; Cheung, E.; Lau, F. W. Y.; Law, N. W. S.; Mak, C. K. Y.; Tan, P.; Siu, B.; Wong, A.; Mak, C. H. K.; Chan, K. Y.; Yam, K. Y.; Pang, K. Y.; Po, Y. C.; Lui, W. M.; Chan, D. T. M.; Poon, W. S.			Multicentre study of hospitalised patients with sports- and recreational cycling-related traumatic brain injury in Hong Kong	HONG KONG MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY; BICYCLE HELMETS; HEAD-INJURIES; INTERNATIONAL-CLASSIFICATION; POPULATION; RISK; PREVENTION; CHILDREN; SURVEILLANCE; CONCUSSION	Introduction: Cycling is associated with a greater risk of traumatic brain injury (TBI) than other recreational activities. This study aimed to investigate the epidemiology of sports-related TBI in Hong Kong and to examine predictors for recreational cycling-induced intracranial haemorrhage. Methods: This retrospective multicentre study included patients diagnosed with sports-related TBI in public hospitals in Hong Kong from 2015 to 2019. Computed tomography scans were reviewed by an independent assessor. The primary endpoint was traumatic intracranial haemorrhage. The secondary endpoint was an unfavourable Glasgow Outcome Scale (GOS) score at discharge from hospital. Results: In total, 720 patients were hospitalised with sports-related TBI. The most common sport was cycling (59.2%). The crude incidence of cycling-related TBI was 1.1 per 100 000 population. Cyclists were more likely to exhibit intracranial haemorrhage and an unfavourable GOS score, compared with patients who had TBI because of other sports. Although 47% of cyclists had intracranial haemorrhage, only 15% wore a helmet. In multivariate analysis, significant predictors for intracranial haemorrhage were age >= 60 years, antiplatelet medication, moderate or severe TBI, and skull fracture. Among 426 cyclists, 375 (88%) had mild TBI, and helmet wearing was protective against intracranial haemorrhage, regardless of age, antiplatelet medication intake, and mechanism of injury. Of 426 cyclists, 31 (7.3%) had unfavourable outcomes on discharge from hospital. Conclusions: The incidence of sports-related TBI is low in Hong Kong. Although cycling-related head injuries carried greater risks of intracranial haemorrhage and unfavourable outcomes compared with other sports, most cyclists experienced good recovery. Helmet wearing among recreational cyclists with mild TBI was protective against intracranial haemorrhage and skull fracture.	[Woo, P. Y. M.; Cheung, E.; Lau, F. W. Y.; Law, N. W. S.; Mak, C. K. Y.; Tan, P.; Siu, B.; Wong, A.; Chan, K. Y.] Kwong Wah Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Mak, C. H. K.] Queen Elizabeth Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Yam, K. Y.] Tuen Mun Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Pang, K. Y.] Pamela Youde Nethersole Eastern Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Po, Y. C.] Princess Margaret Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Lui, W. M.] Queen Mary Hosp, Dept Surg, Div Neurosurg, Hong Kong, Peoples R China; [Chan, D. T. M.; Poon, W. S.] Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Peoples R China		Woo, PYM (corresponding author), Kwong Wah Hosp, Dept Neurosurg, Hong Kong, Peoples R China.	wym307@ha.org.hk					Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; American College of Surgeons, BEST PRACT MAN TRAUM; American Medical Association, HELM RID MOT NON MOT; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Bateman-House A, 2014, AM J PUBLIC HEALTH, V104, P986, DOI 10.2105/AJPH.2013.301810; Batty D, 2000, BRIT MED J, V321, P1424, DOI 10.1136/bmj.321.7274.1424; Batty GD, 2004, BRIT MED J, V328, P1089, DOI 10.1136/bmj.328.7448.1089; Beck AJ, 2011, BR J SPORTS MED, V45, pA20; British Medical Association, 2012, HLTH TRANSP HLTH LIV; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, GLASG COM SCAL; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Department of Health Hong Kong SAR Government, 2018, 2025 STRAT ACT PLAN; Gamble T, 2016, PSYCHOL SCI, V27, P289, DOI 10.1177/0956797615620784; Goldacre B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3817; Harris AW, 2012, J SCI MED SPORT, V15, P298, DOI 10.1016/j.jsams.2011.12.005; Hong Kong Cycling Alliance, HELMETS; Hooper C, 2012, J MED ETHICS, V38, P338, DOI 10.1136/medethics-2011-100085; Huang WY, 2019, J EXERC SCI FIT, V17, P14, DOI 10.1016/j.jesf.2018.10.003; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kean J, 2014, ARCH PHYS MED REHAB, V95, P1225, DOI 10.1016/j.apmr.2014.03.023; Lee LL, 2003, HONG KONG J EMERG ME, V10, P81; Liu XJ, 2017, HYPERTENSION, V69, P813, DOI [10.1161/hypertensionaha.116.08994, 10.1161/HYPERTENSIONAHA.116.08994]; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Malm C, 2019, SPORTS, V7, DOI 10.3390/sports7050127; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MCDERMOTT FT, 1992, WORLD J SURG, V16, P379, DOI 10.1007/BF02104435; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; Ng CP, 2001, HONG KONG J EMERG ME, V8, P78; Olivier J, 2019, INT J EPIDEMIOL, V48, P1197, DOI 10.1093/ije/dyz003; Persaud N, 2012, CAN MED ASSOC J, V184, pE921, DOI 10.1503/cmaj.120988; Puckett M, 2016, J COMMUN HEALTH, V41, P1013, DOI 10.1007/s10900-016-0184-8; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Robinson DL, 2006, BMJ-BRIT MED J, V332, P722, DOI 10.1136/bmj.332.7543.722-a; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Strotmeyer SJ, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00249-y; Sze NN, 2011, HONG KONG J EMERG ME, V18, P136, DOI 10.1177/102490791101800302; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2020, NEUROEPIDEMIOLOGY, V54, P192, DOI 10.1159/000505424; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson D C, 2000, Cochrane Database Syst Rev, pCD001855; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655; Transport Department Hong Kong SAR Government, 2019, ROAD TRAFF ACC STAT; Transport Department Hong Kong SAR Government, 2004, CYCL STUD; Transport Department Hong Kong SAR Government, 2020, BE SMART CYCL WEAR B; Transport Department. Hong Kong SAR Government, TRAVEL CHARACTERISTI; van Walraven C, 2011, J CLIN EPIDEMIOL, V64, P1054, DOI 10.1016/j.jclinepi.2011.01.001; Walker I, 2007, ACCIDENT ANAL PREV, V39, P417, DOI 10.1016/j.aap.2006.08.010; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; World Health Organisation, 2006, WHY AR HELM NEED; Xu PP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220785; Yeung JHH, 2009, INJURY, V40, P555, DOI 10.1016/j.injury.2008.08.015	66	0	0	0	0	HONG KONG ACAD MEDICINE PRESS	HONG KONG	9/F/, ROOM 901, 99 WONG CHUK HANG RD, ABERDEEN, HONG KONG, 00000, PEOPLES R CHINA	1024-2708			HONG KONG MED J	Hong Kong Med. J.	OCT	2021	27	5					338	349		10.12809/hkmj208934			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WN6EB	WOS:000711858500005	34706984	gold			2022-02-06	
J	Zaletel, I; Milutinovic, K; Bajcetic, M; Nowakowski, RS				Zaletel, Ivan; Milutinovic, Katarina; Bajcetic, Milos; Nowakowski, Richard S.			Differentiation of Amyloid Plaques Between Alzheimer's Disease and Non-Alzheimer's Disease Individuals Based on Gray-Level Co-occurrence Matrix Texture Analysis	MICROSCOPY AND MICROANALYSIS			English	Article						A beta; dementia; hippocampus; image analysis; neocortex	APOLIPOPROTEIN-E GENOTYPE; BETA-PEPTIDE; HIPPOCAMPUS; NEURITES	Amyloid plaques, one of the main hallmarks of Alzheimer's disease (AD), are classified into diffuse (associated with cognitive impairment) and dense-core types (a common finding in brains of people without Alzheimer's disease (non-AD) and without impaired cognitive function) based on their morphology. We tried to determine the usability of gray-level co-occurrence matrix (GLCM) texture parameters of homogeneity and heterogeneity for the differentiation of amyloid plaque images obtained from AD and non-AD individuals. Images of amyloid-beta (A beta) immunostained brain tissue samples were obtained from the Aging, Dementia and Traumatic Brain Injury Project. A total of 1,039 plaques were isolated from different brain regions of 69 AD and non-AD individuals and used for further GLCM analysis. Images of A beta stained plaques show higher values of heterogeneity parameters and lower values of homogeneity parameters in AD patients, and vice versa in non-AD patients. Additionally, GLCM analysis shows differences in A beta plaque texture between different brain regions in non-AD patients and correlates with variables that characterize patient's dementia status. The present study shows that GLCM texture analysis is an efficient method to discriminate between different types of amyloid plaques based on their morphology and thus can prove as a valuable tool in the neuropathological investigation of dementia.	[Zaletel, Ivan; Milutinovic, Katarina; Bajcetic, Milos] Univ Belgrade, Inst Histol & Embryol Aleksandar D Kost, Fac Med, Belgrade 11000, Serbia; [Nowakowski, Richard S.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA		Zaletel, I (corresponding author), Univ Belgrade, Inst Histol & Embryol Aleksandar D Kost, Fac Med, Belgrade 11000, Serbia.	ivan.zaletel@med.bg.ac.rs	Zaletel, Ivan/O-4681-2016	Zaletel, Ivan/0000-0002-4841-788X	Ministry of Education, Science and Technological Development of the Republic of SerbiaMinistry of Education, Science & Technological Development, Serbia [ON175061]	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. ON175061). The authors express their gratitude to Milan Stojanovic, PhD, for help in radar chart plot design.	Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; D'Andrea MR, 2010, BIOTECH HISTOCHEM, V85, P133, DOI 10.3109/10520290903389445; DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5; Dong SZ, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-18; Dragic M, 2019, MICROSC MICROANAL, V25, P690, DOI 10.1017/S1431927618016306; Drummond E, 2017, ACTA NEUROPATHOL, V133, P933, DOI 10.1007/s00401-017-1691-0; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; Gebejes A., 2013, P C INF MAN SCI ICTI, P375; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kametani F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00025; Liebmann T, 2016, CELL REP, V16, P1138, DOI 10.1016/j.celrep.2016.06.060; McNamara MJ, 1998, ARCH NEUROL-CHICAGO, V55, P1001, DOI 10.1001/archneur.55.7.1001; Meyer HJ, 2017, TRANSL ONCOL, V10, P911, DOI 10.1016/j.tranon.2017.09.003; Miller JA, 2017, ELIFE, V6, DOI 10.7554/eLife.31126; Mohanaiah P, 2013, INT J SCI RES PUBLIC, V3, P1; Pantic I, 2020, MICROSC MICROANAL, V26, P166, DOI 10.1017/S143192762000001X; Pantic I, 2015, J THEOR BIOL, V370, P151, DOI 10.1016/j.jtbi.2015.01.035; Pantic I, 2014, MICROSC MICROANAL, V20, P1373, DOI 10.1017/S1431927614012811; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Pirici D, 2011, NEUROBIOL AGING, V32, P1579, DOI 10.1016/j.neurobiolaging.2009.10.010; Pratiwi M, 2015, PROCEDIA COMPUT SCI, V59, P83, DOI 10.1016/j.procs.2015.07.340; Querol-Vilaseca M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41443-3; Rodriguez GA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-111; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Serrano-Pozo A, 2012, J NEUROPATH EXP NEUR, V71, P694, DOI 10.1097/NEN.0b013e31825e77de; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Stankovic M, 2016, J MICROSC-OXFORD, V261, P277, DOI 10.1111/jmi.12330; Tesic V, 2017, EXP GERONTOL, V98, P62, DOI 10.1016/j.exger.2017.08.010; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Thal DR, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0837-9; Ulrich JD, 2018, J EXP MED, V215, P1047, DOI 10.1084/jem.20171265; Vujasinovic T, 2015, MICROSC MICROANAL, V21, P646, DOI 10.1017/S1431927615000379; Walker RF., 1995, P 3 C DIG IM COMP TE; WANG D, 1995, J NEUROPATH EXP NEUR, V54, P548, DOI 10.1097/00005072-199507000-00009; Whitesell JD, 2019, J COMP NEUROL, V527, P2122, DOI 10.1002/cne.24555; Zolochevska O, 2018, J ALZHEIMERS DIS, V65, P659, DOI 10.3233/JAD-180179	38	0	0	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	OCT	2021	27	5					1146	1153		10.1017/S1431927621012095			8	Materials Science, Multidisciplinary; Microscopy	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Microscopy	US2HJ	WOS:000697254900017	35105417	hybrid			2022-02-06	
J	Bruns, N; Trocchi, P; Felderhoff-Muser, U; Dohna-Schwake, C; Stang, A				Bruns, Nora; Trocchi, Pietro; Felderhoff-Mueser, Ursula; Dohna-Schwake, Christian; Stang, Andreas			Hospitalization and Morbidity Rates After Pediatric Traumatic Brain Injury: A Nation-Wide Population-Based Analysis	FRONTIERS IN PEDIATRICS			English	Article						pediatric traumatic brain injury; epidemiology; incidence rates; mortality; morbidity; hospitalization	HEAD-INJURY; EPIDEMIOLOGY; CHILDREN; GERMANY	Background: Even though traumatic brain injury (TBI) is a major cause of morbidity and mortality in children around the globe, population-based and nation-wide data to assess the burden of TBI is scarce. Methods:Based on diagnosis related groups from nation-wide hospital data, we extracted data on all TBI-related hospitalizations in children < 18 years in Germany between 2014 and 2018. We calculated crude, age-specific and standardized incidence rates for hospitalizations, imaging, intracranial injury, neurosurgery, and mortality. Results:Out of 10.2 million hospitalizations, we identified 458,844 cases with TBI as primary or secondary diagnosis, resulting in a crude incidence rate of 687/100,000 child years (CY). Age-specific rates of computed tomography were below 30/100,000 CY until the age of 10 years and increased to 162/100,000 CY until 17 years of age. Intracranial injury was diagnosed in 2.7%, neurosurgery was performed in 0.7% of patients, and 0.7% were mechanically ventilated. Mortality was 0.67/100,000 CY (0.1%). Conclusions:Despite substantial hospitalization rates for pediatric TBI in Germany, the rates of imaging, the need for mechanical ventilation, neurosurgery and mortality were overall very low. Reasons for hospitalization and measures to reduce unnecessary admissions warrant further investigation.	[Bruns, Nora; Felderhoff-Mueser, Ursula; Dohna-Schwake, Christian] Univ Duisburg Essen, Univ Hosp Essen, Dept Pediat Pediat Intens Care Med 1, Essen, Germany; [Bruns, Nora; Felderhoff-Mueser, Ursula] Univ Duisburg Essen, Univ Hosp Essen, Ctr Translat & Behav Neurosci TNBS, Essen, Germany; [Trocchi, Pietro; Stang, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Stang, Andreas] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA		Bruns, N (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Pediat Pediat Intens Care Med 1, Essen, Germany.; Bruns, N (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Ctr Translat & Behav Neurosci TNBS, Essen, Germany.	nora.bruns@uk-essen.de		Bruns, Nora/0000-0003-3809-1887	Medical Faculty of the University of Duisburg-Essen (IFORES); Stiftung Universitatsmedizin Essen	NB received an internal research grant from the Medical Faculty of the University of Duisburg-Essen (IFORES) and a grant from the Stiftung Universitatsmedizin Essen that enabled the conduction of this work.	Anderson R N, 1998, Natl Vital Stat Rep, V47, P1; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bruns Nora, 2021, Mendeley Data, DOI [10.17632/bdkbc7w8nk.1, 10.17632/BDKBC7W8NK.1, 10.17632/BDKBC7W8NK]; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Eurostat, 2013, REV EUR STAND POP RE; Jorch G., LEITLINIE DAS SCHADE; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Murray C, 2001, AGE STANDARDIZATION, V31; Nacoti M, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.594425; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Stang A, 2009, BRIT J DERMATOL, V161, P99, DOI 10.1111/j.1365-2133.2009.09457.x; Stang A, 2010, CANCER EPIDEMIOL, V34, P13, DOI 10.1016/j.canep.2009.11.007; Walendy V, 2014, NEUROEPIDEMIOLOGY, V42, P90, DOI 10.1159/000355843	20	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	SEP 30	2021	9								747743	10.3389/fped.2021.747743			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WH6HR	WOS:000707776700001	34660495	Green Published, gold			2022-02-06	
J	Cameron, JI				Cameron, Jill, I			Family caregiving research: Reflecting on the past to inform the future	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Caregiver; Neurological injury; Stroke; Traumatic brain injury; Spinal cord injury; Family centered care	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; STROKE CAREGIVERS; SUPPORT NEEDS; CARE CONTINUUM; CENTERED CARE; INTERVENTIONS; DEPRESSION; SURVIVORS; QUALITY	Objective Family caregiving research has evolved since its inception in the late 1970s. The objective of this brief report was to summarize the research areas and findings to date with the goal of highlighting directions for future research. Design Narrative review. Setting Not applicable Participants Published scientific articles in neurological populations including spinal cord injury, traumatic brain injury, and stroke. Interventions Not applicable Outcome Measures Not applicable Results Caregiving research began with a description of the impact of providing care on caregiver health and wellbeing. Intervention research followed to support caregivers in their role and improve caregiving outcomes. Recent reviews conclude a "one size fits all" intervention will not be sufficient to support caregivers. New research suggests caregivers have different patterns of adjustment to the caregiving role highlighting heterogeneity in the caregiving population. Research is also advancing to support patients and families as they transition across care environments by enhancing the timing of intervention delivery. Health care systems do not routinely adopt evidence-based caregiver interventions. As a result, recent research has begun to identify factors that influence the adoption of evidence-based caregiver interventions by health care systems. Ultimately, family centered care that addresses the needs of not only the patient but also the caregiver may be the best way to meet the needs of a heterogeneous group of caregivers across the care continuum. Conclusions Family caregivers make an important contribution to the health and wellbeing of individuals with spinal and other neurological conditions. Ultimately, system changes, like family centered care, may be best suited to meet the complex needs of this heterogeneous group of caregivers.	[Cameron, Jill, I] Univ Toronto, Temerty Fac Med, Rehabil Sci Inst, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave,Off Room 922, Toronto, ON M5G 1V7, Canada		Cameron, JI (corresponding author), Univ Toronto, Temerty Fac Med, Rehabil Sci Inst, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave,Off Room 922, Toronto, ON M5G 1V7, Canada.	jill.cameron@utoronto.ca		Cameron, Jill/0000-0003-4161-1572			Bakas T, 2015, STROKE, V46, P3478, DOI 10.1161/STROKEAHA.115.011099; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Boschen K, 2007, NEUROREHABILITATION, V22, P19; BROCKLEHURST JC, 1981, SOC SCI MED-MED SOC, V15, P35, DOI 10.1016/0271-7123(81)90043-2; Cameron JI, 2008, PATIENT EDUC COUNS, V70, P305, DOI 10.1016/j.pec.2007.10.020; Cameron JI, 2016, NEW ENGL J MED, V374, P1831, DOI 10.1056/NEJMoa1511160; Cameron JI, 2015, CLIN REHABIL, V29, P1129, DOI 10.1177/0269215514564897; Cameron JI, 2014, STROKE, V45, P1084, DOI 10.1161/STROKEAHA.113.004309; Cameron JI, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-18; Cameron JI, 2013, DISABIL REHABIL, V35, P315, DOI 10.3109/09638288.2012.691937; Cameron JI, 2011, STROKE, V42, P302, DOI 10.1161/STROKEAHA.110.597963; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Canas S, 2018, CHESTNUT WOODEN BARR, P1; Clarke DJ, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-96; Creasy KR, 2015, REHABIL NURS, V40, P349, DOI 10.1002/rnj.188; Czerwonka AI, 2015, J CRIT CARE, V30, P242, DOI 10.1016/j.jcrc.2014.10.017; Dalton J, 2018, J HEALTH SERV RES PO, V23, P196, DOI 10.1177/1355819618766559; Decker S D, 1989, Rehabil Nurs, V14, P6; Dunbar SB, 2018, CIRCULATION, V137, pE558, DOI 10.1161/CIR.0000000000000570; Elliott TR, 2014, J CONSULT CLIN PSYCH, V82, P1072, DOI 10.1037/a0037593; Erler KS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01013; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grigorovich A, 2015, ARCH PHYS MED REHAB, V96, P1284, DOI 10.1016/j.apmr.2015.03.004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hollander Marcus J, 2009, Healthc Q, V12, P42; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Jeyathevan G, 2019, TOP SPINAL CORD INJ, V25, P290, DOI 10.1310/sci2504-290; Kokorelias KM, 2021, HEALTH SOC CARE COMM, DOI 10.1111/hsc.13464; Kokorelias KM, 2021, DEMENTIA-LONDON, V20, P2851, DOI 10.1177/14713012211019502; Kokorelias KM, 2020, HEALTH SOC CARE COMM, V28, P325, DOI 10.1111/hsc.12895; Kokorelias KM, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1788655; Kokorelias KM, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4394-5; Lee CM, 2009, CRIT CARE, V13, DOI 10.1186/cc8053; Lynch J, 2017, SPINAL CORD, V55, P964, DOI 10.1038/sc.2017.56; McKay RC, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2019.112456; Minshall C, 2019, TOP STROKE REHABIL, V26, P554, DOI 10.1080/10749357.2019.1625173; Mountain A, 2020, INT J STROKE, V15, P789, DOI 10.1177/1747493019897847; Munce SEP, 2016, BMC NEUROL, V10, DOI 10.1186/s12883-016-0534-2; Munce SEP, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-48; Panzeri A, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02045; Rodakowski J, 2013, CLIN REHABIL, V27, P565, DOI 10.1177/0269215512464503; Smith EM, 2016, SPINAL CORD, V54, P562, DOI 10.1038/sc.2016.8; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; Trezzini B, 2019, SPINAL CORD, V57, P490, DOI 10.1038/s41393-019-0243-y; Tseung V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035559; Tseung V, 2019, STROKE, V50, P3585, DOI 10.1161/STROKEAHA.119.026660; Tseung V, 2021, DISABIL REHABIL, V43, P1145, DOI 10.1080/09638288.2019.1652704; Wissel J, 2013, J STROKE CEREBROVASC, V22, P1, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.021	49	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	SEP 30	2021	44			1	SI		S19	S22		10.1080/10790268.2021.1970883			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WX5FP	WOS:000718622000005	34779725	hybrid			2022-02-06	
J	da Silva, AJF; Doria, ALM				da Silva, Aldo J. F.; Doria, Ana Luisa Malta			Intraventricular Pneumocephalus as a Complication of Ventriculoperitoneal Shunt	CUREUS			English	Article						ventriculoperitoneal shunt; hydrocephalus; pneumocephalus; brain trauma injury; cerebrospinal fluid (csf)	CEREBROSPINAL-FLUID RHINORRHEA	Pneumocephalus is defined as the presence of air in the intracranial cavity, and this complication is rare after ventriculoperitoneal shunt (VPS) surgery. It can be caused by traumatic brain injury (TBI), surgical interventions, and anatomical or spontaneous malformation. We present a case of intraventricular pneumocephalus associated with the placement of a VPS. The patient was a 40-year-old man who had a VPS inserted 10-years ago due to hydrocephalus caused by TBI. He presented to the emergency room with complaints of headache, vomiting, rhinoliquorrhea, and fever. Computed tomography of the skull showed ventricular dilatation with intraventricular pneumocephalus. In a three-dimensional reconstruction, a bone defect was visualized with meningocele at the base of the skull that would explain the cerebrospinal fluid fistula. The meningocele was surgically corrected. After 14 days of antibiotic treatment, a new VPS was placed and the patient progressed satisfactorily. Pneumocephalus associated with VPS is a rare condition that can develop secondary to a combination of the shunt effect and an anatomical defect at the base of the skull. Excessively negative and persistent intracranial pressure of the shunt allows air to enter and fill the existing vacuum through the defect in the skull base. This bone defect may be congenital, due to traumatic brain injury, or a result of hydrocephalus itself. Computed tomography of the skull is an excellent investigation for the visualization of bone defects, and treatment involves a correction of the fistula. Pneumocephalus associated with VPS is rare. The presence of rhinoliquorrhea is a strong indication of the condition. Once the presence of a fistula is confirmed, it should be corrected to prevent worsening of the pneumocephalus.	[da Silva, Aldo J. F.] Santa Monica Teaching Matern Alagoas State Univ H, Pediat Neurosurg Div, Maceio, Alagoas, Brazil; [Doria, Ana Luisa Malta] Fac Med Nova Esperanca FAMENE, Neurosurg, Joao Pessoa, Paraiba, Brazil		da Silva, AJF (corresponding author), Santa Monica Teaching Matern Alagoas State Univ H, Pediat Neurosurg Div, Maceio, Alagoas, Brazil.	neuroaldojose66@gmail.com					Anorbe E, 2000, EUR J RADIOL, V36, P158, DOI 10.1016/S0720-048X(00)00177-7; Banu MA, 2014, J NEUROSURG, V121, P961, DOI 10.3171/2014.5.JNS132028; Dandy WE, 1920, SURG GYNECOL OBSTET, V30, P329; IKEDA K, 1978, J NEUROL NEUROSUR PS, V41, P319, DOI 10.1136/jnnp.41.4.319; JOOMA R, 1983, SURG NEUROL, V20, P231, DOI 10.1016/0090-3019(83)90058-7; Krayenbuhl N, 2005, EUR ARCH OTO-RHINO-L, V262, P135, DOI 10.1007/s00405-004-0754-8; Kuba H, 2000, CHILD NERV SYST, V16, P1, DOI 10.1007/PL00007278; Luckett WH, 1913, SURG GYNECOL OBSTET, V17, P237; Mishra Sarita Kumari, 2016, Iran J Otorhinolaryngol, V28, P39; Pereira CU, 2015, BRAZ J NEUROSURG, V26, P47, DOI [10.22290/jbnc.v26i1.1301, DOI 10.22290/JBNC.V26I1.1301]; PITTS LH, 1975, J NEUROSURG, V43, P631, DOI 10.3171/jns.1975.43.5.0631; WALKER FO, 1986, J NEUROL NEUROSUR PS, V49, P203, DOI 10.1136/jnnp.49.2.203; Yadav Yad Ram, 2016, Asian J Neurosurg, V11, P183, DOI 10.4103/1793-5482.145101	13	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 30	2021	13	9							e18392	10.7759/cureus.18392			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WC7KZ	WOS:000704434300022	34725626	Green Published, gold			2022-02-06	
J	Domensino, AF; Verberne, D; Prince, L; Fish, J; Winegardner, J; Bateman, A; Wilson, B; Ponds, R; van Heugten, C				Domensino, Anne-Fleur; Verberne, Daan; Prince, Leyla; Fish, Jessica; Winegardner, Jill; Bateman, Andrew; Wilson, Barbara; Ponds, Rudolf; van Heugten, Caroline			Client experiences with holistic neuropsychological rehabilitation: "It is an ongoing process"	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Neuropsychological rehabilitation; Holistic; Outcome measurement; Focus groups; Identity	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; STROKE; SELF; PARTICIPATION; IMPACT	The effectiveness of holistic neuropsychological rehabilitation for people with acquired brain injury has previously been demonstrated by means of standardized and routinely administered outcome measures. However, the most important outcomes from the perspective of former clients are largely unknown. This study explored the experience of participating in a holistic neuropsychological rehabilitation programme by conducting three focus groups with twelve former clients who had sustained a brain injury. Data were transcribed verbatim and analysed using thematic analysis. "It is an ongoing process" emerged as the overarching theme for the experience of recovery from brain injury. Four subthemes, or phases, were identified. Participants went through (1) a phase of confrontation, after which they (2) trained their skills and strategies, and (3) experimented with these in daily life. In the end, clients reached a phase of (4) coming to terms with their injury. Participants described increased levels of self-esteem, sense of competence, and adaptation as the most important outcomes of the programme, as these factors helped them regain a sense of identity. The results indicate that including these factors in outcome evaluations of complex interventions after brain injury may be important as they appear essential for capturing the client's perspective on change.	[Domensino, Anne-Fleur; Verberne, Daan; Ponds, Rudolf; van Heugten, Caroline] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands; [Domensino, Anne-Fleur; Verberne, Daan; Ponds, Rudolf; van Heugten, Caroline] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Prince, Leyla; Wilson, Barbara] Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, England; [Fish, Jessica] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Winegardner, Jill] Univ Hosp, Cleveland Med Ctr, Cleveland, OH USA; [Bateman, Andrew] Univ Essex, Sch Hlth & Social Care, Colchester, Essex, England; [van Heugten, Caroline] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands		van Heugten, C (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands.; van Heugten, C (corresponding author), Limburg Brain Injury Ctr, Maastricht, Netherlands.	cvanheugten@maastrichtuniversity.nl		Bateman, Andrew/0000-0002-2547-5921	IBRO	This work was supported by IBRO [grant number: InEurope Short Stay Grants Program].	Agan J, 2008, WORK, V31, P259; Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Beunder Carolina, 2015, Tijdschr Gerontol Geriatr, V46, P196, DOI 10.1007/s12439-015-0139-z; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fish J., 2018, 15 NEUROPSYCHOLOGICA; Goodwin RA, 2016, NEUROREHABILITATION, V39, P53, DOI 10.3233/NRE-161338; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Gustafsson L, 2013, DISABIL REHABIL, V35, P1380, DOI 10.3109/09638288.2012.740134; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; Heugten C.v, 2020, TIJDSCHRIFT NEUROPSY; Hodson T, 2016, BRIT J OCCUP THER, V79, P427, DOI 10.1177/0308022615619420; Holleman M, 2018, NEUROPSYCHOL REHABIL, V28, P649, DOI 10.1080/09602011.2016.1210013; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Krueger R. A., 1997, ANAL REPORTING FOCUS, V6; Krueger R.A., 1997, MODERATING FOCUS GRO, V4; Langdridge D, 2008, SOC PERSONAL PSYCHOL, V2, P1126, DOI 10.1111/j.1751-9004.2008.00114.x; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Morgan D.L., 1998, DEV QUESTIONS FOCUS; Muhr T., 2013, ATLAS TI VERSION 7 0; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rochat L, 2021, J NEUROPSYCHOL, V15, P112, DOI 10.1111/jnp.12212; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Shany-Ur T, 2020, J INT NEUROPSYCH SOC, V26, P130, DOI 10.1017/S1355617719001024; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stets JE, 2014, SOCIOL PERSPECT, V57, P409, DOI 10.1177/0731121414536141; Stiekema APM, 2020, BRAIN INJURY, V34, P421, DOI 10.1080/02699052.2020.1725125; Sturm JW, 2004, STROKE, V35, P2340, DOI 10.1161/01.STR.0000141977.18520.3b; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; van Heugten C, 2020, NEUROPSYCHOL REHABIL, V30, P1598, DOI 10.1080/09602011.2019.1589533; van Mierlo ML, 2015, ARCH PHYS MED REHAB, V96, P1064, DOI 10.1016/j.apmr.2015.01.022; Verdugo MA, 2019, INT J CLIN HLTH PSYC, V19, P189, DOI 10.1016/j.ijchp.2019.06.004; Wade D.T., 2020, WHAT IS REHABILITATI; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilson BA, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P1; Winson R., 2016, BRAIN INJURY REHABIL; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796	49	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1976222		SEP 2021	23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WA1ZZ	WOS:000702693100001	34596002	Green Accepted, hybrid			2022-02-06	
J	Edwards, KA; Greer, K; Leete, J; Lai, C; Devoto, C; Qu, BX; Yarnell, AM; Polejaeva, E; Dell, KC; LoPresti, ML; Walker, P; Wassermann, EM; Carr, W; Stone, JR; Ahlers, ST; Vorn, R; Martin, C; Gill, JM				Edwards, Katie A.; Greer, Kisha; Leete, Jacqueline; Lai, Chen; Devoto, Christina; Qu, Bao-Xi; Yarnell, Angela M.; Polejaeva, Elena; Dell, Kristine C.; LoPresti, Matthew L.; Walker, Peter; Wassermann, Eric M.; Carr, Walter; Stone, James R.; Ahlers, Stephen T.; Vorn, Rany; Martin, Carina; Gill, Jessica M.			Neuronally-derived tau is increased in experienced breachers and is associated with neurobehavioral symptoms	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; AMYLOID-BETA; BLAST EXPOSURE; EXOSOMES; BIOMARKERS; INVENTORY	Military and law enforcement breachers are exposed to many low-level blasts during their training and occupational experiences in which they detonate explosives to force entry into secured structures. There is a concern that exposure to these repetitive blast events in career breachers could result in cumulative neurological effects. This study aimed to determine concentrations of neurofilament light (NF-L), tau, and amyloid-beta 42 (A beta 42) in serum and in neuronal-derived extracellular vesicles (EVs) in an experienced breacher population, and to examine biomarker associations with neurobehavioral symptoms. Thirty-four participants enrolled in the study: 20 experienced breachers and 14 matched military or civilian law enforcement controls. EV tau concentrations were significantly elevated in experienced breachers (0.3301 +/- 0.5225) compared to controls (-0.4279 +/- 0.7557; F = 10.43, p = 0.003). No statistically significant changes were observed in EV levels of NF-L or A beta 42 or in serum levels of NF-L, tau, or A beta 42 (p's > 0.05). Elevated EV tau concentrations correlated with increased Neurobehavioral Symptom Inventory (NSI) score in experienced breachers (r = 0.596, p = 0.015) and predicted higher NSI score (F(1,14) = 7.702, p = 0.015, R-2 = 0.355). These findings show that neuronal-derived EV concentrations of tau are significantly elevated and associated with neurobehavioral symptoms in this sample of experienced breachers who have a history of many low-level blast exposures.	[Edwards, Katie A.; Greer, Kisha; Leete, Jacqueline; Lai, Chen; Devoto, Christina; Qu, Bao-Xi; Vorn, Rany; Martin, Carina; Gill, Jessica M.] Natl Inst Nursing Res, NIH, Bethesda, MD 20814 USA; [Edwards, Katie A.; Devoto, Christina; Qu, Bao-Xi] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Yarnell, Angela M.] Uniformed Serv Univ Hlth Sci, Mil Emergency Med Dept, Bethesda, MD 20814 USA; [Polejaeva, Elena] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32603 USA; [Dell, Kristine C.] Penn State Univ, Dept Psychol, University Pk, PA 16801 USA; [LoPresti, Matthew L.; Carr, Walter] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Walker, Peter] Joint Artificial Intelligence Ctr, Arlington, VA USA; [Wassermann, Eric M.] NINDS, NIH, Bethesda, MD 20814 USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA; [Stone, James R.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22903 USA; [Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA; [Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Gill, JM (corresponding author), Natl Inst Nursing Res, NIH, Bethesda, MD 20814 USA.; Gill, JM (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	gillj@mail.nih.gov		Vorn, Rany/0000-0002-9158-9302	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Open Access funding provided by the National Institutes of Health (NIH).	Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Angiolini F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020254; Banks WA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124407; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020434; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Belding JN, 2020, MIL MED, V185, pE538, DOI 10.1093/milmed/usz289; Belding JN, 2020, J NEUROTRAUM, V37, P2219, DOI 10.1089/neu.2020.6997; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Cao R, 2019, J NEUROTRAUM, V36, P1526, DOI 10.1089/neu.2018.6062; Carr W, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00619; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Osier N, 2018, MOL NEUROBIOL, V55, P9280, DOI 10.1007/s12035-018-1054-4; Pattinson CL, 2019, J TRAUMA STRESS, V32, P546, DOI 10.1002/jts.22418; Pattinson CL, 2018, NAT REV NEUROL, V14, P511, DOI 10.1038/s41582-018-0041-8; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shi M, 2016, ALZHEIMERS DEMENT, V12, P1125, DOI 10.1016/j.jalz.2016.04.003; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Weathers F.W., 1993, 9 ANN C ISTSS	41	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 30	2021	11	1							19527	10.1038/s41598-021-97913-0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WA2RB	WOS:000702737500031	34593828	Green Published, gold			2022-02-06	
J	Eickhoff, A; Cintean, R; Gebhard, F; Kellner, M; Schutze, K; Richter, PH				Eickhoff, Alexander; Cintean, Raffael; Gebhard, Florian; Kellner, Maximilian; Schuetze, Konrad; Richter, Peter H.			Surgical treatment strategies and their radiological potential for correction of proximal radius fractures in children and adolescents	UNFALLCHIRURG			German	Article; Early Access						Correction limitation radial head; Radial head fracture; ECMES; Pediatric fracture; Epiphysiolysis	NECK FRACTURES; REDUCTION TECHNIQUE; CLOSED REDUCTION; INJURIES; FIXATION; MANAGEMENT	Background and objective The isolated proximal radius fracture in children is a quite rare injury. In difference to adults a conservative treatment is often possible. But in case of increasing dislocation the indication for surgery is given. Options for an operative treatment are "closed reduction", "percutaneous reduction", "intramedullary nailing", "open reduction" with and without fixation. Aim of this study is to compare these procedures with each other. Study design and methods This was a retrospective investigation and 82 patients who underwent surgery after an isolated proximal radius fracture were included. Fracture types were classified according to the AO (working group for osteosynthesis questions)/OTA (Orthopedic Trauma Association) classification. The preoperative and postoperative degrees of axis deviation were compared and were considered to be a measure of the quality of treatment. Results The lowest degree of axis deviation resulted by open reduction and implantation of K-wires (15,8 degrees) and implantation of headless compression screws (HCS, 16 degrees). Closed reduction without any fixation resulted in 19 degrees, with implantation of an TEN (titan elastic nail) in 20 degrees and the open reduction without any fixation resulted in 21 degrees of axis deviation. No correlation was observed concerning the fracture type and the postoperative axis deviation. Conclusion The study shows that the postoperative result does not depend on the fracture type (according to the AO/OTA classification) but on the surgical procedure. Despite the good radiological results in open reduction and internal fixation this procedure should be reserved for difficult situations in which less invasive surgical procedures fail, to avoid aseptic bone necrosis.	[Eickhoff, Alexander; Cintean, Raffael; Gebhard, Florian; Kellner, Maximilian; Schuetze, Konrad; Richter, Peter H.] Univ Klinikum Ulm, Klin Unfall Hand Plast & Wiederherstellungschirur, Zentrum Chirurg, Albert Einstein Allee 23, D-89081 Ulm, Germany		Eickhoff, A (corresponding author), Univ Klinikum Ulm, Klin Unfall Hand Plast & Wiederherstellungschirur, Zentrum Chirurg, Albert Einstein Allee 23, D-89081 Ulm, Germany.	alexander.eickhoff@uniklinik-ulm.de					Augustithis GA, 2015, ANN ROY COLL SURG, V97, P316, DOI 10.1308/rcsann.2015.97.4.316; Biberthaler P, 2010, TRAUMA BERUFSKRANKH, V12, P104, DOI 10.1007/s10039-010-1617-8; Cha SM, 2012, INT ORTHOP, V36, P803, DOI 10.1007/s00264-011-1387-3; Du XP, 2019, J INT MED RES, V47, P5497, DOI 10.1177/0300060519825990; Eberl R, 2010, CHIRURG, V81, P915, DOI 10.1007/s00104-010-1915-5; Falciglia F, 2014, J PEDIATR ORTHOPED, V34, P756, DOI 10.1097/BPO.0000000000000299; Fernandez FF, 2014, TRAUMA BERUFSKRANKH, V16, P61, DOI 10.1007/s10039-013-2035-5; Gagliardi ID, 2016, ACTA ORTOP BRAS, V24, P81, DOI 10.1590/1413-785220162402154788; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; Kahl H, 2007, BUNDESGESUNDHEITSBLA, V50, P718, DOI 10.1007/s00103-007-0233-7; Koch P., 2013, RADIUSHALSFRAKTUREN, P593, DOI [10.3238/oup.2013.0593-0596, DOI 10.3238/OUP.2013.0593-0596]; Kruppa C, 2015, INJURY, V46, pS10, DOI 10.1016/S0020-1383(15)30013-9; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Monson R, 2009, J PEDIATR ORTHOPED, V29, P243, DOI 10.1097/BPO.0b013e3181990745; Neher CG, 2003, J PEDIATR ORTHOPED, V23, P626, DOI 10.1097/01241398-200309000-00009; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Pike JM, 2014, CLIN ORTHOP RELAT R, V472, P2120, DOI 10.1007/s11999-014-3519-8; Prathapkumar KR, 2006, J BONE JOINT SURG BR, V88B, P358, DOI 10.1302/0301-620X.88B3.17099; Pring Maya E, 2012, J Pediatr Orthop, V32 Suppl 1, pS14, DOI 10.1097/BPO.0b013e31824b251d; Slongo T., 2007, AO PEDIAT COMPREHENS, DOI [10.1097/01.bpb.0000248569.43251.f9, DOI 10.1097/01.BPB.0000248569.43251.F9]; Tarallo L, 2013, J ORTHOP TRAUMATOL, V14, P291, DOI 10.1007/s10195-013-0252-0; Trabelsi A, 2020, PAN AFR MED J, V36, DOI 10.11604/pamj.2020.36.144.22971; von Laer L., 2004, PEDEAT FRACTURES DIS, V4, P179; VONLAER L, 1981, ORTHOPADE, V10, P264; Wessel LM, 2012, TRAUMA BERUFSKRANKH, V14, P372, DOI 10.1007/s10039-012-1839-z; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	26	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg												10.1007/s00113-021-01083-7		SEP 2021	8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	UZ4LA	WOS:000702177300003	34591137	Bronze			2022-02-06	
J	Leaston, J; Qiao, J; Harding, IC; Kulkarni, P; Gharagouzloo, C; Ebong, E; Ferris, CF				Leaston, Joshua; Qiao, Ju; Harding, Ian C.; Kulkarni, Praveen; Gharagouzloo, Codi; Ebong, Eno; Ferris, Craig F.			Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts	FRONTIERS IN NEUROLOGY			English	Article						concussion; ferumoxytol; cerebral small vessel disease; momentum exchange; quantitative ultrashort time-to-echo; contrast enhanced MRI	SEX-DIFFERENCES; SUPERPARAMAGNETIC NANOPARTICLES; PROFESSIONAL FOOTBALL; COGNITIVE DEFICITS; ANIMAL-MODEL; INJURY; CONCUSSION; TAUOPATHY; DISEASE; MRI	This was an exploratory study designed to evaluate the feasibility of a recently established imaging modality, quantitative ultrashort time-to-echo contrast enhanced (QUTE-CE), to follow the early pathology and vulnerability of the blood brain barrier in response to single and repetitive mild head impacts. A closed-head, momentum exchange model was used to produce three consecutive mild head impacts aimed at the forebrain separated by 24 h each. Animals were measured at baseline and within 1 h of impact. Anatomical images were collected to assess the extent of structural damage. QUTE-CE biomarkers for BBB permeability were calculated on 420,000 voxels in the brain and were registered to a bilateral 3D brain atlas providing site-specific information on 118 anatomical regions. Blood brain barrier permeability was confirmed by extravasation of labeled dextran. All head impacts occurred in the absence of any structural brain damage. A single mild head impact had measurable effects on blood brain barrier permeability and was more significant after the second and third impacts. Affected regions included the prefrontal ctx, basal ganglia, hippocampus, amygdala, and brainstem. Our findings support the concerns raised by the healthcare community regarding mild head injuries in participants in organized contact sports and military personnel in basic training and combat.	[Leaston, Joshua; Kulkarni, Praveen; Gharagouzloo, Codi] Imaginost Inc, Cambridge, MA USA; [Qiao, Ju; Gharagouzloo, Codi; Ferris, Craig F.] Northeastern Univ, Ctr Translat Neuroimaging, Boston, MA 02115 USA; [Harding, Ian C.] Northeastern Univ, Dept Bioengn, Boston, MA USA; [Ebong, Eno] Northeastern Univ, Dept Chem Engn, Boston, MA USA; [Ferris, Craig F.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Ferris, Craig F.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA		Ferris, CF (corresponding author), Northeastern Univ, Ctr Translat Neuroimaging, Boston, MA 02115 USA.; Ferris, CF (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.; Ferris, CF (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.	c.feffis@northeastern.edu			AHA pre-doctoral fellowshipAmerican Heart Association [18PRE33960461]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01-HL125499]; HHMIHoward Hughes Medical Institute	This work was supported by an AHA pre-doctoral fellowship (18PRE33960461), NIH grant (K01-HL125499), HHMI funded Inclusive Excellence Award to Northeastern University (PI Ondrechen) and Imaginostics.	Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bremerich J, 2007, EUR RADIOL, V17, P3017, DOI 10.1007/s00330-007-0712-0; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Cash A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093344; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Franz CK, 2019, J NEUROPHYSIOL, V122, P1174, DOI 10.1152/jn.00572.2018; Freeze WM, 2019, STROKE, V50, P328, DOI 10.1161/STROKEAHA.118.023788; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gharagouzloo CA, 2018, DATA BRIEF, V17, P393, DOI 10.1016/j.dib.2018.01.021; Gharagouzloo CA, 2017, NEUROIMAGE, V163, P24, DOI 10.1016/j.neuroimage.2017.09.003; Gharagouzloo CA, 2015, MAGN RESON MED, V74, P431, DOI 10.1002/mrm.25426; Graves JC, 2015, BRAIN NEUROTRAUMA MO; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Held F, 2017, CLIN SCI, V131, P1001, DOI 10.1042/CS20170004; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kulkarni P, 2020, BRAIN RES BULL, V165, P218, DOI 10.1016/j.brainresbull.2020.10.001; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Li Y, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00221; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52622-7; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Montagne A, 2020, NATURE, V581, P70, DOI 10.1038/s41586-020-2247-3; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Natarajan Reka, 2017, Curr Protoc Neurosci, V79, DOI 10.1002/cpns.25; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nikolakopoulou AM, 2019, NAT NEUROSCI, V22, P1089, DOI 10.1038/s41593-019-0434-z; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Qiao J, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02428-3; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Raja R, 2018, NEUROPHARMACOLOGY, V134, P259, DOI 10.1016/j.neuropharm.2017.10.034; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Report to Congress on Traumatic Brain Injury in the United States: Epidemiology Rehabilitation, 2018, C TRAUM BRAIN US EP; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thrippleton MJ, 2019, ALZHEIMERS DEMENT, V15, P840, DOI 10.1016/j.jalz.2019.01.013; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van de Ven AL, 2017, MOL CANCER THER, V16, P1279, DOI 10.1158/1535-7163.MCT-16-0740; Varallyay CG, 2017, AM J NEURORADIOL, V38, P1297, DOI 10.3174/ajnr.A5188; Veksler R, 2020, BRAIN, V143, P1826, DOI 10.1093/brain/awaa140; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Walker-Samuel S, 2007, PHYS MED BIOL, V52, P75, DOI 10.1088/0031-9155/52/1/006; Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu MM, 2019, NEUROSCI LETT, V705, P206, DOI 10.1016/j.neulet.2019.04.034; Zhou YX, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00581; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	77	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 30	2021	12								729464	10.3389/fneur.2021.729464			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WH5UQ	WOS:000707742800001	34659094	Green Published, gold			2022-02-06	
J	LeBaron, TW; Kharman, J; McCullough, ML				LeBaron, Tyler W.; Kharman, Jason; McCullough, Michael L.			An H-2 -infused, nitric oxide-producing functional beverage as a neuroprotective agent for TBIs and concussions	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Traumatic brain injury; Molecular hydrogen; Nitric oxide; Inflammation; Reactive oxygen specie	TRAUMATIC BRAIN-INJURY; HYDROGEN-RICH WATER; CEREBRAL-BLOOD-FLOW; L-ARGININE; MOLECULAR-HYDROGEN; METABOLIC SYNDROME; OXIDATIVE STRESS; SALINE PROTECTS; ANTIOXIDANT; DAMAGE	Traumatic brain injuries (TBIs) are a leading cause of death and disability. Sports-related TBIs are estimated to be more than several million per year. The pathophysiology of TBIs involves high levels of inflammation, oxidative stress, dysregulation of ion homeostasis, mitochondrial dysfunction, and apoptosis. There is also a reduction in cerebral blood flow, leading to hypoxia and reduced removal of metabolic waste, which further exacerbates the injury. There is currently no recognized effective medical treatment or intervention for TBIs, which may in part be due to the difficulty of drug delivery through the blood-brain barrier. Molecular hydrogen has recently emerged as a neuroprotective medical gas against cerebral infarction and neurodegenerative diseases including TBIs. Its small molecular size and nonpolar nature allow it to easily diffuse through the blood-brain barrier, cell membranes and subcellular compartments. Hydrogen has been shown to exert selective anti-inflammatory, antioxidant, and anti-apoptotic effects by regulating various transcription factors and protein phosphorylation cascades. Nitric oxide is another well-recognized medical gas that plays divergent roles in protecting from and in the recovery of TBIs, as well as in contributing to their pathophysiology and injury. Excessive activation of inducible nitric oxide synthase leads to excess inflammation and oxidative/nitrosative damage as well as a paradoxical nitric oxide depletion in the locations it is needed. Hydrogen regulates nitric oxide production and metabolism, which enhances its benefits while reducing its harms. A novel H2-infused, nitric oxide producing beverage, Hydro Shot, may have important neuroprotective benefits for TBIs. We report preliminary indications that Hydro Shot may be a meaningful adjuvant treatment for TBIs.	[LeBaron, Tyler W.] Comenius Univ, Slovak Acad Sci, Ctr Expt Med, Inst Heart Res,Fac Nat Sci, Bratislava 84104, Slovakia; [LeBaron, Tyler W.] Mol Hydrogen Inst, Cedar, UT 84720 USA; [LeBaron, Tyler W.] Southern Utah Univ, Dept Kinesiol & Outdoor Recreat, Cedar, UT 84720 USA; [Kharman, Jason] Corpus Performance, Dallas, TX 11837 USA; [McCullough, Michael L.] Med Off, Internal Med, Dallas, TX 75201 USA		LeBaron, TW (corresponding author), Comenius Univ, Slovak Acad Sci, Ctr Expt Med, Inst Heart Res,Fac Nat Sci, Bratislava 84104, Slovakia.; LeBaron, TW (corresponding author), Mol Hydrogen Inst, Cedar, UT 84720 USA.; LeBaron, TW (corresponding author), Southern Utah Univ, Dept Kinesiol & Outdoor Recreat, Cedar, UT 84720 USA.	tylerlebaron@suu.edu					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Birdsill AC, 2013, OBESITY, V21, P1313, DOI 10.1002/oby.20170; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Xianjun, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P460; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; D'Amico R, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060898; Ding K, 2020, BRAIN RES, V1743, DOI 10.1016/j.brainres.2020.146924; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Fu Jiangquan, 2018, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V30, P317, DOI 10.3760/cma.j.issn.2095-4352.2018.04.006; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Graham R, 2014, SPORTS RELATED CXONC; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Han L, 2015, BRAIN RES, V1615, P129, DOI 10.1016/j.brainres.2015.04.038; Hayashida K, 2020, FRONT MED-LAUSANNE, V7; Hekierski H, 2019, J NEUROTRAUM, V36, P630, DOI 10.1089/neu.2018.5824; Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096212; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Hu HW, 2021, MED GAS RES, V11, P114, DOI 10.4103/2045-9912.314331; Huang Y, 2011, BRAIN RES, V1378, P125, DOI 10.1016/j.brainres.2010.12.071; Huk I, 1997, CIRCULATION, V96, P667; Iboaya A, 2019, NEUROREHAB NEURAL RE, V33, P975, DOI 10.1177/1545968319883879; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Jiang X, 2019, BEHAV BRAIN RES, V356, P98, DOI 10.1016/j.bbr.2018.05.023; Joris PJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050530; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LeBaron T.W., 2020, J TRANSL SCI, V6, P1, DOI [DOI 10.15761/JTS.1000380, 10.15761/JTS.1000380]; Lebaron TW, 2021, J SCI MED, V3, P1; LeBaron TW, 2020, DIABETES METAB SYNDR, V13, P889, DOI 10.2147/DMSO.S240122; LeBaron TW, 2019, MOLECULES, V24, DOI 10.3390/molecules24112076; LeBaron TW, 2019, CAN J PHYSIOL PHARM, V97, P797, DOI 10.1139/cjpp-2019-0067; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Li TT, 2020, BRAIN RES, V1730, DOI 10.1016/j.brainres.2020.146651; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu HY, 2015, SHOCK, V43, P504, DOI 10.1097/SHK.0000000000000316; Liu Y, 2017, INT J CLIN EXP PATHO, V10, P3807; Mahooti N, 2018, CHILD ADOL PSYCH CL, V27, P93, DOI 10.1016/j.chc.2017.08.005; Mak HKF, 2012, J ALZHEIMERS DIS, V31, P33, DOI 10.3233/JAD-2012-111877; Mizuno K, 2017, MED GAS RES, V7, P247, DOI 10.4103/2045-9912.222448; Moro MA, 2005, FREE RADICAL BIO MED, V39, P1291, DOI 10.1016/j.freeradbiomed.2005.07.010; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; Nishimaki K, 2018, CURR ALZHEIMER RES, V15, P482, DOI 10.2174/1567205014666171106145017; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ono H, 2017, J STROKE CEREBROVASC, V26, P2587, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.012; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Song GH, 2013, J LIPID RES, V54, P1884, DOI 10.1194/jlr.M036640; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Theadom A, 2020, NEUROEPIDEMIOLOGY, V54, P192, DOI 10.1159/000505424; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Tommerdahl M, 2020, J SCI MED, V2; Tommerdahl M., 2019, J SCI MED, V1, P1, DOI [10.37714/josam.v1i1.4, DOI 10.37714/JOSAM.V1I1.4]; Torregrossa AC, 2011, J GERIATR CARDIOL, V8, P230, DOI 10.3724/SP.J.1263.2011.00230; Wang YF, 2020, NEUROL RES, V42, P487, DOI 10.1080/01616412.2020.1747717; Ware JB, 2020, J NEUROTRAUM, V37, P2180, DOI 10.1089/neu.2020.7031; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc11934; Wei LH, 2012, EXP EYE RES, V94, P117, DOI 10.1016/j.exer.2011.11.016; Wijnands KAP, 2015, NUTRIENTS, V7, P1426, DOI 10.3390/nu7031426; WOOD J, 1989, J TRAUMA, V29, P602, DOI 10.1097/00005373-198905000-00011; Yang L, 2016, OPEN MED-WARSAW, V11, P399, DOI 10.1515/med-2016-0072; Yoshida A, 2012, CARDIOVASC DRUG THER, V26, P217, DOI 10.1007/s10557-012-6381-5; Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024; Zhan Y, 2012, CRIT CARE MED, V40, P1291, DOI 10.1097/CCM.0b013e31823da96d; Zhao QH, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147053	72	0	0	0	0	IMR PRESS	ROBINSON	112 ROBINSON RD, ROBINSON, SINGAPORE	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	SEP 30	2021	20	3					667	676		10.31083/j.jin2003071			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WB9TL	WOS:000703907900015	34645100	gold			2022-02-06	
J	Rosenblatt, CK; Harriss, A; Babul, AN; Rosenblatt, SA				Rosenblatt, Cirelle K.; Harriss, Alexandra; Babul, Aliya-Nur; Rosenblatt, Samuel A.			Machine Learning for Subtyping Concussion Using a Clustering Approach	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; artificial intelligence; cluster analysis; interdisciplinary; rehabilitation; mild traumatic brain injury; complexity	IDENTIFICATION; INJURY; SENSITIVITY	Background: Concussion subtypes are typically organized into commonly affected symptom areas or a combination of affected systems, an approach that may be flawed by bias in conceptualization or the inherent limitations of interdisciplinary expertise. Objective: The purpose of this study was to determine whether a bottom-up, unsupervised, machine learning approach, could more accurately support concussion subtyping. Methods: Initial patient intake data as well as objective outcome measures including, the Patient-Reported Outcomes Measurement Information System (PROMIS), Dizziness Handicap Inventory (DHI), Pain Catastrophizing Scale (PCS), and Immediate Post-Concussion Assessment and Cognitive Testing Tool (ImPACT) were retrospectively extracted from the Advance Concussion Clinic's database. A correlation matrix and principal component analysis (PCA) were used to reduce the dimensionality of the dataset. Sklearn's agglomerative clustering algorithm was then applied, and the optimal number of clusters within the patient database were generated. Between-group comparisons among the formed clusters were performed using a Mann-Whitney U test. Results: Two hundred seventy-five patients within the clinics database were analyzed. Five distinct clusters emerged from the data when maximizing the Silhouette score (0.36) and minimizing the Davies-Bouldin score (0.83). Concussion subtypes derived demonstrated clinically distinct profiles, with statistically significant differences (p < 0.05) between all five clusters. Conclusion: This machine learning approach enabled the identification and characterization of five distinct concussion subtypes, which were best understood according to levels of complexity, ranging from Extremely Complex to Minimally Complex. Understanding concussion in terms of Complexity with the utilization of artificial intelligence, could provide a more accurate concussion classification or subtype approach; one that better reflects the true heterogeneity and complex system disruptions associated with mild traumatic brain injury.	[Rosenblatt, Cirelle K.; Harriss, Alexandra; Rosenblatt, Samuel A.] Adv Concuss Clin Inc, Vancouver, BC, Canada; [Rosenblatt, Cirelle K.] Univ British Columbia, Fac Med, Dept Family Practice, Div Sport & Exercise Med, Vancouver, BC, Canada; [Babul, Aliya-Nur] Columbia Univ, Dept Astron, New York, NY 10027 USA		Rosenblatt, CK (corresponding author), Adv Concuss Clin Inc, Vancouver, BC, Canada.; Rosenblatt, CK (corresponding author), Univ British Columbia, Fac Med, Dept Family Practice, Div Sport & Exercise Med, Vancouver, BC, Canada.	crosenblatt@advanceconcussion.com					Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Bergeron MF, 2019, MED SCI SPORT EXER, V51, P1362, DOI 10.1249/MSS.0000000000001903; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94; Dennis J, 2019, J NEUROTRAUM, V36, P2167, DOI 10.1089/neu.2018.5916; Ellis MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01115; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Feeny AK, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.119.007952; Garcia-Vidal C, 2019, EBIOMEDICINE, V46, P27, DOI 10.1016/j.ebiom.2019.07.019; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Hassan Syed Imtiyaz, 2020, International Journal of Information Technology, V12, P1377, DOI 10.1007/s41870-019-00406-7; Hirano S, 2004, INFORM SCIENCES, V159, P155, DOI 10.1016/j.ins.2003.03.011; Hulme Adam, 2015, Inj Epidemiol, V2, P31; IBM Corp, 2019, IBM SPSS STAT WINDOW; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kontos A.P., 2018, CONCUSSION CLIN PROF, P23; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Langdon S., 2020, SPORTS MED, V50, P1829, DOI [10.1007/s40279-020-01321-9, DOI 10.1007/s40279-020-01321-9]; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nakata N, 2019, JPN J RADIOL, V37, P103, DOI 10.1007/s11604-018-0804-6; Permenter C.M., 2021, STATPEARLS, P1; Ranstam J, 2016, OSTEOARTHR CARTILAGE, V24, P763, DOI 10.1016/j.joca.2016.01.008; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2019, J ORTHOP SPORT PHYS, V49, P799, DOI 10.2519/jospt.2019.8926; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Stevens E, 2019, INT J MED INFORM, V129, P29, DOI 10.1016/j.ijmedinf.2019.05.006; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Visscher RMS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214525	40	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	SEP 30	2021	15								716643	10.3389/fnhum.2021.716643			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	WH1NG	WOS:000707453200001	34658816	Green Published, gold			2022-02-06	
J	Rosenbloom, C; Chatterjee, R; Chu, W; Broman, D; Kryger, KO				Rosenbloom, Craig; Chatterjee, Robin; Chu, Wing; Broman, Daniel; Okholm Kryger, Katrine			Sport-related concussion return-to-play practices of medical team staff in elite football in the United Kingdom	SCIENCE AND MEDICINE IN FOOTBALL			English	Article; Early Access						Soccer; rehabilitation; head injury; doctor; physiotherapist; therapist	PROFESSIONAL FOOTBALL; KNOWLEDGE; INJURIES; COACHES	Introduction This study explored sport-related concussion (SRC) return-to-play (RTP) behaviours and attitudes of medical team staff working in elite football in the United Kingdom. Usage and awareness of The Football Association (FA) guidelines, concussion education rates of players and coaching staff, and collection of baseline concussion assessments. Additionally, confidence in managing RTP post-SRC, perceived player under-reporting of symptoms, use of enhanced RTP pathways, and coaching pressure on RTP were investigated. Methods A cross-sectional questionnaire study was distributed online by organisations including or representing medical staff working in elite football in the United Kingdom. Results A total of 112 responses were gathered. High awareness rates of the FA guidelines were found (96%) with variable rates of player and coaching staff concussion education. Baseline concussion assessments were collected by 80% of respondents with 93% feeling very confident or confident in managing the RTP of a player with a SRC. 60% rarely or never experienced coaching pressure around player RTP, and 24% felt players always or very often under-reported symptoms to expedite their return. 90% had a moderate to high confidence in the Sport Concussion Assessment Tool-5 (SCAT-5) as a RTP decision tool, and 66% always or very often used an enhanced RTP pathway. Conclusion Confidence in managing player RTP post SRC and use of enhanced RTP pathways were high, as was confidence in the SCAT-5 as a RTP decision tool. Respondents raised concerns around player under-reporting of symptoms to accelerate RTP post-SRC, and perceived coaching pressure around decision making.	[Rosenbloom, Craig; Broman, Daniel] Football Assoc, Tech Directorate, Burton Upon Trent, England; [Rosenbloom, Craig; Okholm Kryger, Katrine] Queen Mary Univ London, Sport & Exercise Med, London, England; [Chatterjee, Robin] Inst Sport Exercise & Hlth, London, England; [Chatterjee, Robin] British Assoc Sport & Exercise Med, Doncaster, England; [Chu, Wing] Vita Hlth Grp, London, England; [Chu, Wing] Freedom Clin, London, England; [Broman, Daniel] Isokinet Med Grp, London, England; [Okholm Kryger, Katrine] St Marys Univ, Hlth & Appl Sci, London, England; [Okholm Kryger, Katrine] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark		Rosenbloom, C (corresponding author), Football Assoc, Tech Directorate, Burton Upon Trent, England.; Rosenbloom, C (corresponding author), Queen Mary Univ London, London, England.	craig.rosenbloom@thefa.com		Rosenbloom, Craig/0000-0001-6166-209X; Chatterjee, Robin/0000-0002-4858-3642; Okholm Kryger, Katrine/0000-0003-0924-6181			Abraham KJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024607; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Chen YB, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0189-9; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2020, BRIT J SPORT MED, V54, P421, DOI 10.1136/bjsports-2019-100666; Eliakim E, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000675; Feddermann-Demont N, 2014, J SPORT SCI, V32, P1217, DOI 10.1080/02640414.2014.918273; Gouttebarge Vincent, 2021, BMJ Open Sport Exerc Med, V7, pe001086, DOI 10.1136/bmjsem-2021-001086; Gouttebarge V, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000490; Griffin Steffan Arthur, 2017, BMJ Open Sport Exerc Med, V3, pe000174, DOI 10.1136/bmjsem-2016-000174; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Longworth T, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000860; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Rosenbloom C, 2021, SCI MED FOOTBALL, DOI 10.1080/24733938.2021.1892174; Shanley E, 2021, CLIN J SPORT MED, V31, P120, DOI 10.1097/JSM.0000000000000711; The Football Association, 2015, CONC GUID; Tsao J., 2014, ATHLETIC INSIGHT, V6, P93; Turner M, 2021, BRIT J SPORT MED, V55, P539, DOI 10.1136/bjsports-2020-102108; Vedung F, 2020, SCAND J MED SCI SPOR, V30, P947, DOI 10.1111/sms.13644; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009; Yeo PC, 2020, J SPORT SCI MED, V19, P65	29	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football												10.1080/24733938.2021.1983921		SEP 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WA0ZS	WOS:000702624800001					2022-02-06	
J	Toth, L; Czigler, A; Horvath, P; Szarka, N; Kornyei, B; Toth, A; Schwarcz, A; Ungvari, Z; Buki, A; Toth, P				Toth, Luca; Czigler, Andras; Horvath, Peter; Szarka, Nikolett; Kornyei, Balint; Toth, Arnold; Schwarcz, Attila; Ungvari, Zoltan; Buki, Andras; Toth, Peter			The Effect of Mild Traumatic Brain Injury on Cerebral Microbleeds in Aging	FRONTIERS IN AGING NEUROSCIENCE			English	Article						microhemorrages; aging; cognitive decline; traumatic brain injury (TBI); microvascular injury	SUSCEPTIBILITY-WEIGHTED MRI; COGNITIVE DECLINE; MICROHEMORRHAGES	A traumatic brain injury (TBI) induces the formation of cerebral microbleeds (CMBs), which are associated with cognitive impairments, psychiatric disorders, and gait dysfunctions in patients. Elderly people frequently suffer TBIs, especially mild brain trauma (mTBI). Interestingly, aging is also an independent risk factor for the development of CMBs. However, how TBI and aging may interact to promote the development of CMBs is not well established. In order to test the hypothesis that an mTBI exacerbates the development of CMBs in the elderly, we compared the number and cerebral distribution of CMBs and assessed them by analysing susceptibility weighted (SW) MRI in young (25 +/- 10 years old, n = 18) and elder (72 +/- 7 years old, n = 17) patients after an mTBI and in age-matched healthy subjects (young: 25 +/- 6 years old, n = 20; aged: 68 +/- 5 years old, n = 23). We found significantly more CMBs in elder patients after an mTBI compared with young patients; however, we did not observe a significant difference in the number of cerebral microhemorrhages between aged and aged patients with mTBI. The majority of CMBs were found supratentorially (lobar and basal ganglion). The lobar distribution of supratentorial CMBs showed that aging enhances the formation of parietal and occipital CMBs after mTBIs. This suggests that aging and mTBIs do not synergize in the induction of the development of CMBs, and that the different distribution of mTBI-induced CMBs in aged patients may lead to specific age-related clinical characteristics of mTBIs.	[Toth, Luca; Czigler, Andras; Horvath, Peter; Schwarcz, Attila; Buki, Andras; Toth, Peter] Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary; [Toth, Luca; Czigler, Andras; Szarka, Nikolett; Toth, Peter] Univ Pecs, Med Sch, Inst Translat Med, Pecs, Hungary; [Kornyei, Balint; Toth, Arnold] Univ Pecs, Med Sch, Dept Radiol, Pecs, Hungary; [Ungvari, Zoltan] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73190 USA; [Ungvari, Zoltan; Toth, Peter] Semmelweis Univ, Fac Med, Dept Publ Hlth, Budapest, Hungary; [Toth, Peter] ELKH PTE Clin Neurosci MR Res Grp, Pecs, Hungary		Toth, P (corresponding author), Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary.; Toth, P (corresponding author), Univ Pecs, Med Sch, Inst Translat Med, Pecs, Hungary.; Toth, P (corresponding author), ELKH PTE Clin Neurosci MR Res Grp, Pecs, Hungary.	toth.peter@pte.hu			National Research, Development and Innovation OfficeNational Research, Development & Innovation Office (NRDIO) - Hungary [NKFI-FK123798, K-134555]; Hungarian Academy of Sciences Bolyai Research Scholarship; New National Excellence Program of the Ministry for Innovation and Technology [UNKP-20-3-II-PTE-493]; Hungarian Brain Research Program 2.0 Grant [2017-1.2.1-NKP-2017-00002]; Higher Education Institutional Excellence Programme of the Ministry of Human Capacities; Thematic Excellence Program National Excellence Sub-program [2020-4.1.1-TKP2020]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-AG055395, R01-NS100782, R01-AT006526]; Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [OTKA/K-120356];  [EFOP-3.6.2.-16-2017-00008];  [GINOP-2.3.2-15-2016-00048];  [GINOP-2.2.1-15-2017-00067]	This work was supported by grants from the National Research, Development and Innovation Office to PT (NKFI-FK123798) and AB (K-134555), the Hungarian Academy of Sciences Bolyai Research Scholarship to PT, UNKP-20-3-II-PTE-493 New National Excellence Program of the Ministry for Innovation and Technology to PT and LT, EFOP-3.6.2.-16-2017-00008, GINOP-2.3.2-15-2016-00048, GINOP-2.2.1-15-2017-00067 to PT and AB, Hungarian Brain Research Program 2.0 Grant No. 2017-1.2.1-NKP-2017-00002 to AB, the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities to PT and AB, Thematic Excellence Program 2020-4.1.1-TKP2020 National Excellence Sub-program to LT, the National Institute of Health R01-AG055395, R01-NS100782, R01-AT006526 to ZU. This study was funded by the Hungarian Scientific Research Fund Grant No. OTKA/K-120356 to AS and AT.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017; de Laat KF, 2011, STROKE, V42, P494, DOI 10.1161/STROKEAHA.110.596122; Ding J, 2017, NEUROLOGY, V88, P2089, DOI 10.1212/WNL.0000000000003983; Freedman DJ, 2018, NEURON, V97, P1219, DOI 10.1016/j.neuron.2018.01.044; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Go V, 2020, GEROSCIENCE, V42, P1, DOI 10.1007/s11357-019-00115-w; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Levit A, 2020, GEROSCIENCE, V42, P445, DOI 10.1007/s11357-020-00164-6; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Mackinnon CD, 2018, HAND CLINIC, V159, P3, DOI 10.1016/B978-0-444-63916-5.00001-X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nyul-Toth A, 2020, GEROSCIENCE, V42, P1685, DOI 10.1007/s11357-020-00256-3; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rauen K, 2021, GEROSCIENCE, V43, P263, DOI 10.1007/s11357-020-00273-2; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Toth L, 2021, GEROSCIENCE, V43, P125, DOI 10.1007/s11357-020-00280-3; Toth P, 2015, AGING CELL, V14, P400, DOI 10.1111/acel.12315; Ungvari Z, 2018, GEROSCIENCE, V40, P485, DOI 10.1007/s11357-018-0044-9; Ungvari Z, 2017, AM J PHYSIOL-HEART C, V312, pH1128, DOI 10.1152/ajpheart.00780.2016; Wang RM, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00094; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Werring DJ, 2010, J NEUROL SCI, V299, P131, DOI 10.1016/j.jns.2010.08.034; Yakushiji Y, 2016, FRONT NEUROL NEUROSC, V37, P78, DOI 10.1159/000437115	30	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	SEP 30	2021	13								717391	10.3389/fnagi.2021.717391			7	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	WJ3MI	WOS:000708951000001	34658836	Green Published, Green Accepted, gold			2022-02-06	
J	Wetzel-Weaver, A; Bertero, G; Aleton, E; Turlan, JL				Wetzel-Weaver, Audrey; Bertero, Giulio; Aleton, Etienne; Turlan, Jean Luc			Syndrome of the Trephined and ParoxySmal Sympathetic Hyperactivity in a 17-year-old minimally conscious state patient: A Case Report	BRAIN INJURY			English	Article						Autonomic failure; coma scale; cranioplasty; decompressive craniectomy; minimally conscious state; traumatic brain injury	WESSEX HEAD-INJURY; SKIN FLAP SYNDROME; RECOVERY; DEFECTS; SCALE; COMA	Purpose: Syndrome of the Trephined (SoT) is one of the most unknown complications of the Decompressive Craniectomy (DC) after Traumatic Brain Injury (TBI). A combination of neurological clinical criteria and radiological signs after DC is necessary to make its diagnosis. In our case, as the patient was in a minimally conscious state (MCS), it was impossible to clinically assess any neurological deterioration according to the criteria found in the literature. There is no description of clinical diagnostic criteria suitable for patients with MCS apart from the visible 'Skin Flap.' Method: A 17-year-old patient sustained a severe TBI. Two months after the TBI and a DC he exhibited an MCS with a Glasgow Coma Scale (GCS) of 7 and a Wessex Head Injury Matrix (WHIM) of 5. He presented several paroxysmal sympathetic hyperactivity (PSH) episodes a day and developed a sinking skin flap. A cranioplasty was performed. Then, we noticed the gradual disappearance of PSH episodes plus an improvement of the CRS and the WHIM. Results: The evolution of the WHIM data revealed a statistically significant difference (p 0.0047). Conclusion: Further studies should be conducted to assess whether the WHIM and the frequency of PSH episodes may be part of the diagnostic criteria for SoT in MCS patients.	[Wetzel-Weaver, Audrey; Bertero, Giulio; Turlan, Jean Luc] Clin Romande Readaptat, Dept Res, Sion, Switzerland; [Wetzel-Weaver, Audrey] Hop Fribourgeois Hfr, Dept Phys & Rehabil Med, Fribourg, Switzerland; [Aleton, Etienne; Turlan, Jean Luc] Clin Romande Readaptat, Dept Neurorehabil, Sion, Switzerland		Wetzel-Weaver, A (corresponding author), Hop Fribourgeois Hfr, Phys & Rehabil Dept, Chemin Pensionnats 2-6, CH-1752 Sion, Switzerland.	audrey.wetzel@outlook.fr		Bertero, Giulio/0000-0001-7533-0205; Wetzel-Weaver, Audrey/0000-0002-0918-8375			Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Beeler MB, 2020, CLIN AUTON RES, V30, P177, DOI 10.1007/s10286-019-00617-9; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Di Rienzo A, 2020, NEUROSURG REV, V43, P323, DOI 10.1007/s10143-019-01148-7; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Jeyaraj P, 2016, J MAXILLOFAC ORAL SU, V15, P82, DOI 10.1007/s12663-015-0807-0; Jeyaraj P, 2015, J MAXILLOFAC ORAL SU, V14, P666, DOI 10.1007/s12663-014-0673-1; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; Romero FR, 2013, INT J SURG CASE REP, V4, P1007, DOI 10.1016/j.ijscr.2013.08.013; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shald EA, 2020, CRIT CARE NURSE, V40, pE9, DOI 10.4037/ccn2020348; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; TEASDALE G, 1974, LANCET, V2, P81; Vasung L, 2016, NEURORADIOLOGY, V58, P557, DOI 10.1007/s00234-016-1651-8; Wilson FC, 2009, NEUROPSYCHOL REHABIL, V19, P754, DOI 10.1080/09602010902805318; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	18	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1480	1483		10.1080/02699052.2021.1972448		SEP 2021	4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000701507100001	34586939				2022-02-06	
J	Armstrong, E; McCoy, K; Clinch, R; Merritt, M; Speedy, R; McAllister, M; Heine, K; Ciccone, N; Robinson, M; Coffin, J				Armstrong, Elizabeth; McCoy, Kathy; Clinch, Rebecca; Merritt, Maureen; Speedy, Renee; McAllister, Meaghan; Heine, Kym; Ciccone, Natalie; Robinson, Melanie; Coffin, Juli			The development of aboriginal brain injury coordinator positions: a culturally secure rehabilitation service initiative as part of a clinical trial	PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT			English	Article						aboriginal; aboriginal health worker; care coordination; indigenous; indigenous workforce; integrated care; liaison; rehabilitation; stroke; traumatic brain injury	COMMUNICATION DISORDERS; HEALTH; STROKE; EXPERIENCES; AUSTRALIA; WORKERS; OWN	Brain injury, resulting from stroke and traumatic brain injury, is a common occurrence in Australia, with Aboriginal people affected at a significant rate and impact felt by individuals, families and communities. Access to brain injury rehabilitation services for Aboriginal people is reported to be often limited, with very little support outside the hospital environment. Our research involving Aboriginal brain injury survivors and their families to date has revealed that people often manage 'on their own' following such events. Following recommendations from survivors and their families, the Healing Right Way clinical trial, currently underway in Western Australia, has created the role of Aboriginal Brain Injury Coordinator (ABIC) to assist in navigating information and services, particularly after discharge from hospital. Eight positions for this role have been instigated across metropolitan and rural regions in the state. Healing Right Way's aim is to enhance rehabilitation services and improve quality of life for Aboriginal Australians after brain injury. The ABIC's role is to provide education, support, liaison and advocacy services to participants and their families over a six-month period, commencing soon after the participant's stroke or injury has occurred. This paper outlines the development of this role, the partnerships involved, experiences to date and identifies some facilitators and barriers encountered that may impact the role's ongoing sustainability. Details of components of the planned full Process Evaluation of Healing Right Way related to the ABIC role and the partnerships surrounding it are also provided. In combination with the trial's ultimate results, this detail will assist in future service planning and provide a model of culturally secure care for stroke and brain injury services that can also inform other sub-acute and primary care models.	[Armstrong, Elizabeth] Edith Cowan Univ, Fdn Chair Speech Pathol, Perth, WA, Australia; [McCoy, Kathy; Clinch, Rebecca; Speedy, Renee; Heine, Kym] Neurol Council Western Australia, Perth, WA, Australia; [Merritt, Maureen] Geraldton Reg Aboriginal Med Serv, Geraldton, Australia; [McAllister, Meaghan; Ciccone, Natalie] Edith Cowan Univ, Perth, WA, Australia; [Robinson, Melanie] Murdoch Univ, Perth, WA, Australia; [Coffin, Juli] Telethon Kids Inst, Ellison Prof Aboriginal Hlth & Wellbeing, Nedlands, WA, Australia		Armstrong, E (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, 270 Joondalup Dr, Joondalup, WA 6027, Australia.	b.armstrong@ecu.edu.au		Ciccone, Natalie/0000-0002-1822-7217	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1132468]; Western Australian Department of Health; Royal Perth Hospital Medical Research Foundation	This work is supported by the National Health and Medical Research Council (Grant #1132468), Western Australian Department of Health, Royal Perth Hospital Medical Research Foundation.	Armstrong E., BMJ OPEN; Armstrong E, 2021, DISABIL REHABIL, V43, P1903, DOI 10.1080/09638288.2019.1686073; Armstrong E, 2019, BRAIN IMPAIR, V20, P120, DOI 10.1017/BrImp.2019.19; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Bessarab D., 2010, INT J CRIT INDIG STU, V3, P37; Brown Celia A, 2006, BMC Med Res Methodol, V6, P54; Cheng MH, 2007, LANCET, V370, P1533, DOI 10.1016/S0140-6736(07)61648-1; Coffin Juli, 2007, ABORIGINAL ISLANDER, V31, P22; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Esterman Adrian, 2018, Inj Epidemiol, V5, P40, DOI 10.1186/s40621-018-0172-9; Fitts MS, 2019, BRAIN IMPAIR, V20, P137, DOI 10.1017/BrImp.2019.24; Gilroy J, 2017, DISABIL REHABIL, V39, P1664, DOI 10.1080/09638288.2016.1201151; Government of Western Australia Department of Health, 2016, J STROKE CEREBROVASC; Health Workforce Australia, 2011, GROW OUR FUT FIN REP; Jack B., 2010, ROYAL COLL NURS RCN; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-330; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lin I, 2016, AUST J PRIM HEALTH, V22, P377, DOI 10.1071/PY16051; Mackean T, 2020, AUST HEALTH REV, V44, P427, DOI 10.1071/AH19101; May T, 2018, J PAEDIATR CHILD H, V54, P115, DOI 10.1111/jpc.13748; Mccoy K., 2015, AUSTRALASIAN J NEURO, V26, P1; McKenna B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2221-4; Olney S, 2019, POLICY DES PRACT, V2, P275, DOI 10.1080/25741292.2019.1586083; Pugh JD., HEALTH SOC CARE COMM; Riley J., 2017, ADV CLIN NEUROSCIENC, V16, P19; Skoss R., BMJ OPEN; Sustainable Health Review, 2019, SUST HLTH REV FIN RE; Taylor KP, 2009, AUST HEALTH REV, V33, P549, DOI 10.1071/AH090549; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson AM, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05462-5; You JQ, 2015, INT J STROKE, V10, P716, DOI 10.1111/ijs.12429; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	0	0	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1463-4236	1477-1128		PRIM HEALTH CARE RES	Prim. Health Care Res. Dev.	SEP 29	2021	22								e49	10.1017/S1463423621000396			9	Primary Health Care	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX5NE	WOS:000700891100001	34585654	Green Published, gold			2022-02-06	
J	Meliambro, J; Karton, C; Cournoyer, J; Post, A; Hoshizaki, TB; Gilchrist, MD				Meliambro, Julia; Karton, Clara; Cournoyer, Janie; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Comparison of head impact frequency and magnitude in youth tackle football and ice hockey	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article; Early Access						Injury prevention; biomechanics; concussion; neurotrauma; brain trauma	TRAUMATIC BRAIN-INJURIES; IN-VIVO; CONCUSSION; RECONSTRUCTION; ENCEPHALOPATHY; PREDICTORS; EXPOSURE; PLAYERS; SPORTS; MODEL	Repetitive head impacts are a growing concern for youth and adolescent contact sport athletes as they have been linked to long term negative brain health outcomes. Of all contact sports, tackle football and ice hockey have been reported to have the highest incidence of head or brain injury however, each sporting environment is unique with distinct rules and regulations regarding contact and collisions. The purpose of this research was to measure and compare the head impact frequency and estimated magnitude of brain tissue strain, amongst youth tackle football and ice hockey players during game play. Head impact frequency was documented by video analysis of youth tackle football and ice hockey game play. Impact magnitude was determined through physical laboratory reconstructions and finite element modelling to estimate brain tissue strains. Tackle football demonstrated significantly higher impact frequency (P < 0.01) and magnitude of estimated brain tissue strains (P < 0.01) compared to ice hockey. A significantly higher number of higher strain head impacts were documented in tackle football when compared to ice hockey (P < 0.01). These differences suggest that youth football players may experience increased frequency and magnitude of estimated brain tissue strains in comparison to youth hockey.	[Meliambro, Julia; Karton, Clara; Cournoyer, Janie; Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Campolettano Eamon T, 2019, Biomed Sci Instrum, V55, P212; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen W, 2020, SYST BIOL REPROD MED, V15, P1, DOI DOI 10.1080/19396368.2019.1678694; Cournoyer J, 2021, J BIOMECH, V127, DOI 10.1016/j.jbiomech.2021.110689; Cournoyer J, 2019, J ATHL TRAINING, V54, P765, DOI 10.4085/1062-6050-253-18; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dawson L., 2019, J BIOMECH ENG-T ASME, V142, P1; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Fryar Cheryl D, 2012, Vital Health Stat 11, P1; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Karton C, 2021, J BIOMECH, V116, DOI 10.1016/j.jbiomech.2020.110203; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Khatib A., 2019, COMP BRAIN TRAUMA CH; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mennes M, 2014, NEUROIMAGE, V98, P513, DOI 10.1016/j.neuroimage.2014.04.030; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mohan P., 2009, SAE INT; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Oeur A., 2018, EFFECT RECONSTRUCTED; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Paiement B., 2020, COMP BRAIN TRAUMA PR; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Post A, 2021, COMPUT METHOD BIOMEC, V24, P1, DOI 10.1080/10255842.2020.1805442; Post A, 2021, TRAUMA, V23, P24, DOI 10.1177/1460408620916578; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau P., 2014, ANAL CONCUSSION METR; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Urban JE, 2019, J NEUROSURG-PEDIATR, V24, P190, DOI 10.3171/2019.2.PEDS18558; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	67	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.												10.1080/10255842.2021.1987420		SEP 2021	16	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	WE1XH	WOS:000705419900001	34615414				2022-02-06	
J	Ogunfolaji, O; Egu, C; Sebopelo, L; Sichimba, D; Zolo, Y; Mashauri, C; Phiri, E; Sakaiwa, N; Alalade, A; Kanmounye, US				Ogunfolaji, Oloruntoba; Egu, Chinedu; Sebopelo, Lorraine; Sichimba, Dawin; Zolo, Yvan; Mashauri, Crecencia; Phiri, Emmanuel; Sakaiwa, Neontle; Alalade, Andrew; Kanmounye, Ulrick Sidney			Misconceptions About Traumatic Brain Injuries in Five Sub-Saharan African Countries	CUREUS			English	Article						traumatic brain injury; sub-saharan africa; misconceptions; brain injury; africa	COMA; RECOVERY	Background Traumatic Brain Injury (TBI) remains a significant problem in certain regions of the world but receives little attention despite its enormous burden. This discrepancy could consequently lead to various misconceptions among the general public. This study evaluated misconceptions about TBI in five African countries. Methods Data for this cross-sectional study were collected using the Common Misconception about Traumatic Brain Injury (CM-TBI) questionnaire, which was electronically disseminated from January 16 to February 6, 2021. Associations between the percentage of correct answers and independent variables (i.e., sociodemographic characteristics and experience with TBI) were evaluated with the ANOVA test. Additionally, answers to the question items were compared against independent variables using the Chi-Square test. A P-value <0.05 was considered statistically significant. Results A total of 817 adults, 50.2% female (n=410), aged 24.3 +/- 4.3 years, and majoritarily urban dwellers (94.6%, n=773) responded to the survey. They had received tertiary education (79.2%, n=647) and were from Nigeria (77.7%, n=635). Respondents had few misconceptions (mean correct answers=71.7%, 95% CI=71.0-72.4%) and the amnesia domain had the highest level of misconception (39.3%, 95% CI=37.7-40.8%). Surveyees whose friends had TBI were more knowledgeable about TBI (mean score difference=4.1%, 95% CI=1.2-6.9, P=0.01). Additionally, surveyees whose family members had experienced TBI had a better understanding of brain damage (mean score difference=5.7%, 95% CI=2.1-9.2%, P=0.002) and recovery (mean score difference=4.3%, 95% CI=0.40-8.2%, P=0.03). Conclusion This study identified some misconceptions about TBI among young adult Africans. This at-risk population should benefit from targeted education strategies to prevent TBI and reduce TBI patients' stigmatization in Africa.	[Ogunfolaji, Oloruntoba] Univ Ibadan, Coll Med, Gen Med, Ibadan, Nigeria; [Ogunfolaji, Oloruntoba; Sebopelo, Lorraine; Sichimba, Dawin; Zolo, Yvan; Mashauri, Crecencia; Sakaiwa, Neontle; Alalade, Andrew; Kanmounye, Ulrick Sidney] Assoc Future African Neurosurg, Dept Res, Yaounde, Cameroon; [Egu, Chinedu; Phiri, Emmanuel] Univ Nottingham Hosp, Queens Med Ctr, Neurol Surg, Nottingham, England; [Sebopelo, Lorraine] Univ Botswana, Fac Med, Gaborone, Botswana; [Sichimba, Dawin] Copperbelt Univ, Michael Chilufya Sata Sch Med, Fac Med, Kitwe, Zimbabwe; [Zolo, Yvan] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Mashauri, Crecencia] Derzhavin Tambov State Univ, Inst Med, Fac Med, Tambov, Russia; [Alalade, Andrew] Royal Preston Hosp, Neurosurg, Preston, Lancs, England; [Kanmounye, Ulrick Sidney] Bel Campus Univ Technol, Neurosurg, Kinshasa, DEM REP CONGO; [Kanmounye, Ulrick Sidney] Harvard Med Sch, Global Neurosurg Initiat, Boston, MA USA		Ogunfolaji, O (corresponding author), Univ Ibadan, Coll Med, Gen Med, Ibadan, Nigeria.	ooloruntoba@rocketmail.com	Sebopelo, Lorraine Arabang/AAZ-6934-2021; SICHIMBA, DAWIN/ABE-6306-2021; Kanmounye, Ulrick Sidney/AAY-6123-2020	Sebopelo, Lorraine Arabang/0000-0003-3905-4834; SICHIMBA, DAWIN/0000-0002-9829-2325; Kanmounye, Ulrick Sidney/0000-0001-6791-1018			Adeleye AO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00695; Allen Richard J, 2018, F1000Res, V7, P331, DOI 10.12688/f1000research.13737.1; [Anonymous], 2016, ROADS RURAL DEV SUBS; [Anonymous], 2021, ROAD SAFETY; [Anonymous], 2019, WORLD POPULATION PRO; [Anonymous], 2013, ROAD SAFETY AFRICA A; Beuran M, 2015, DEV POLICY REV, V33, P673, DOI 10.1111/dpr.12125; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Chen NYC, 2019, BRAIN INJURY, V33, P1087, DOI 10.1080/02699052.2019.1610797; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Firsching R, 2017, DTSCH ARZTEBL INT, V114, P313, DOI 10.3238/arztebl.2017.0313; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gurusamy J, 2019, BMC NURS, V18, DOI 10.1186/s12912-019-0388-1; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kavusipur Somaye, 2013, Bull Emerg Trauma, V1, P86; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Odonkor ST, 2020, J ADV TRANSPORT, V2020, DOI 10.1155/2020/7047189; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Pretorius C, 2013, SAJP-S AFR J PSYCHI, V19, P75, DOI 10.7196/SAJP.436; Rebbeck T, 2019, J ORTHOP SPORT PHYS, V49, P819, DOI 10.2519/jospt.2019.8946; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Steppacher I, 2016, ANN CLIN TRANSL NEUR, V3, P61, DOI 10.1002/acn3.269; WHO, 2002, WORLD REP VIOL HLTH; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	27	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 29	2021	13	9							e18369	10.7759/cureus.18369			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WD6RE	WOS:000705065700005	34725617	Green Published, gold			2022-02-06	
J	Peek, K; Andersen, J; McKay, MJ; Versteegh, T; Gilchrist, IA; Meyer, T; Gardner, A				Peek, Kerry; Andersen, Jordan; McKay, Marnee J.; Versteegh, Theo; Gilchrist, Ian A.; Meyer, Tim; Gardner, Andrew			The Effect of the FIFA 11+with Added Neck Exercises on Maximal Isometric Neck Strength and Peak Head Impact Magnitude During Heading: A Pilot Study	SPORTS MEDICINE			English	Article; Early Access							RUGBY-UNION; SOCCER; FOOTBALL; ACCELERATION; PROGRAM; INJURY; CONCUSSION; COLLEGIATE; PLAYERS; SEX	Background Higher neck strength has been postulated to reduce head impact magnitude during purposeful heading in football. Objectives This pilot trial explored the effect of a neck exercise programme on (1) neck strength and (2) head impact magnitude during heading in male and female adolescent football players. Methods Boys and girls (aged 12-17 years) were randomised by team to the intervention (5 weeks of supervised neuromuscular neck exercises integrated into part 2 of the FIFA 11 + , completed three times per week) or the control group (usual part 2 of the FIFA 11 + , no neck exercises). Outcomes included isometric neck strength and head impact magnitude (peak linear acceleration and peak angular velocity) during standardised heading from a throw-in (at baseline and 6 weeks) plus completion of an evaluation survey by intervention players and coaches. Results In total, 52 players (n = 31 intervention; n = 21 control) completed the study. Mixed-model analysis of variance (ANOVA) revealed significant differences in neck strength variables (p < 0.001), peak linear acceleration (p = 0.04) and peak angular velocity (p = 0.04) between the intervention and control groups over time. Intervention players demonstrated increases in mean composite neck strength (53.8% intervention vs 15.6% control) as well as decreases in mean peak linear head acceleration during heading (- 11.8% vs - 5.0%) from baseline to follow-up. Reduction in peak angular velocity was more pronounced in girls (- 27.7%) than boys (- 11.5%) in the intervention group. The addition of neck exercises into part 2 of the FIFA 11 + was feasible and accepted by players and coaches. Conclusion On average, players who completed neck exercises demonstrated an increase in isometric neck strength and a decrease in head impact magnitude during heading. These exercises were easily incorporated into usual training. Australian New Zealand Clinical Trials Registry (no: ACTRN12619001375145).	[Peek, Kerry; McKay, Marnee J.] Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Discipline Physiotherapy, Susan Wakil Hlth Bldg, Sydney, NSW, Australia; [Andersen, Jordan] Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Sydney, NSW, Australia; [Versteegh, Theo] Western Univ, Sch Phys Therapy, London, ON, Canada; [Gilchrist, Ian A.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Meyer, Tim] Saarland Univ, Med Fac, Inst Sports & Prevent Med, Saarbrucken, Germany; [Gardner, Andrew] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Gardner, Andrew] Calvary Mater Hosp, Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia		Peek, K (corresponding author), Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Discipline Physiotherapy, Susan Wakil Hlth Bldg, Sydney, NSW, Australia.	Kerry.Peek@sydney.edu.au; jordan.andersen@mq.edu.au; marnee.mckay@sydney.edu.au; tverstee@uwo.ca; ig13@queensu.ca; tim.meyer@mx.uni-saarland.de; Andrew.Gardner@newcastle.edu.au		Andersen, Jordan/0000-0002-3424-9205; Peek, Kerry/0000-0002-2194-3353; Gardner, Andrew/0000-0001-5031-5586	FIFA Research Scholarship grant	This study was funded by a FIFA Research Scholarship grant awarded to Kerry Peek and Andrew Gardner.	Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Becker S, 2019, J SPORT SCI MED, V18, P729; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cecchi NJ, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00331-0; Dick R, 2007, J ATHL TRAINING, V42, P278; Dontje ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195424; Elliott J, 2021, SPORTS MED, V51, P2373, DOI 10.1007/s40279-021-01501-1; Football Association (England), 2021, UPD HEAD GUID; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hamilton DF, 2012, BONE JOINT RES, V1, P152, DOI 10.1302/2046-3758.17.2000079; Hamilton DF, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-32; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Koerte IK, 2020, J NEUROIMAGING, V30, P387, DOI 10.1111/jon.12726; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McCunn R, 2021, SPORTS MED, V51, P2147, DOI 10.1007/s40279-021-01492-z; Muller C, 2021, J STRENGTH COND RES, V35, pS81, DOI 10.1519/JSC.0000000000003822; Naish R, 2013, J SPORT SCI MED, V12, P542; Narimatsu Keishiro, 2015, General Dentistry, V63, P41; Peek K, 2005, PHYS THER SPORT, V6, P195, DOI 10.1016/j.ptsp.2005.07.004; Peek K, 2021, J SCI MED SPORT, V24, P603, DOI 10.1016/j.jsams.2020.12.010; Peek K, 2021, SCI MED FOOTBALL, V5, P195, DOI 10.1080/24733938.2021.1897657; Peek K, 2021, SCI MED FOOTBALL, V5, P175, DOI 10.1080/24733938.2020.1849783; Peek K, 2020, J SCI MED SPORT, V23, P453, DOI 10.1016/j.jsams.2019.11.004; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Russell ER, 2021, JAMA NEUROL, V78, P1057, DOI 10.1001/jamaneurol.2021.2403; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Taha Z, 2015, SADHANA-ACAD P ENG S, V40, P1567, DOI 10.1007/s12046-015-0383-5; Tanaka Y, 2017, DENT TRAUMATOL, V33, P51, DOI 10.1111/edt.12283; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Thorborg K, 2017, BRIT J SPORT MED, V51, P562, DOI 10.1136/bjsports-2016-097066; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Worsey MTO, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9050834; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Ylinen JJ, 1999, CLIN BIOMECH, V14, P217, DOI 10.1016/S0268-0033(98)00063-1	50	0	0	3	3	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.												10.1007/s40279-021-01564-0		SEP 2021	14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UY2NI	WOS:000701365500001	34590247	Bronze, Green Published			2022-02-06	
J	van den Driessche, CRL; Sewalt, CA; van Ditshuizen, JC; Stocker, L; Verhofstad, MHJ; Van Lieshout, EMM; Den Hartog, D				van den Driessche, Claire R. L.; Sewalt, Charlie A.; van Ditshuizen, Jan C.; Stocker, Lisa; Verhofstad, Michiel H. J.; Van Lieshout, Esther M. M.; Den Hartog, Dennis		Dutch Trauma Registry Southwest	Primary admission and secondary transfer of trauma patients to Dutch level I and level II trauma centers: predictors and outcomes	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Transfer; Triage; Major trauma; Level; Trauma center; Predictors; Outcome	SEVERELY INJURED PATIENTS; INTERHOSPITAL TRANSFER; MULTIPLE IMPUTATION; CENTER DESIGNATION; DIRECT TRANSPORT; FLEXIBLE TOOL; CENTER CARE; MORTALITY; SYSTEM; SURVIVAL	Purpose The importance and impact of determining which trauma patients need to be transferred between hospitals, especially considering prehospital triage systems, is evident. The objective of this study was to investigate the association between mortality and primary admission and secondary transfer of patients to level I and II trauma centers, and to identify predictors of primary and secondary admission to a designated level I trauma center. Methods Data from the Dutch Trauma Registry South West (DTR SW) was obtained. Patients >= 18 years who were admitted to a level I or level II trauma center were included. Patients with isolated burn injuries were excluded. In-hospital mortality was compared between patients that were primarily admitted to a level I trauma center, patients that were transferred to a level I trauma center, and patients that were primarily admitted to level II trauma centers. Logistic regression models were used to adjust for potential confounders. A subgroup analysis was done including major trauma (MT) patients (ISS > 15). Predictors determining whether patients were primarily admitted to level I or level II trauma centers or transferred to a level I trauma center were identified using logistic regression models. Results A total of 17,035 patients were included. Patients admitted primarily to a level I center, did not differ significantly in mortality from patients admitted primarily to level II trauma centers (Odds Ratio (OR): 0.73; 95% confidence interval (CI) 0.51-1.06) and patients transferred to level I centers (OR: 0.99; 95%CI 0.57-1.71). Subgroup analyses confirmed these findings for MT patients. Adjusted logistic regression analyses showed that age (OR: 0.96; 95%CI 0.94-0.97), GCS (OR: 0.81; 95%CI 0.77-0.86), AIS head (OR: 2.30; 95%CI 2.07-2.55), AIS neck (OR: 1.74; 95%CI 1.27-2.45) and AIS spine (OR: 3.22; 95%CI 2.87-3.61) are associated with increased odds of transfers to a level I trauma center. Conclusions This retrospective study showed no differences in in-hospital mortality between general trauma patients admitted primarily and secondarily to level I trauma centers. The most prominent predictors regarding transfer of trauma patients were age and neurotrauma. These findings could have practical implications regarding the triage protocols currently used.	[van den Driessche, Claire R. L.; Sewalt, Charlie A.; van Ditshuizen, Jan C.; Stocker, Lisa; Verhofstad, Michiel H. J.; Van Lieshout, Esther M. M.; Den Hartog, Dennis] Erasmus MC Univ Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands; [Sewalt, Charlie A.] Erasmus MC Univ Med Ctr Rotterdam, Ctr Med Decis Making, Dept Publ Hlth, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands; [Stocker, Lisa] Leiden Univ, Dept Anesthesiol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands		Sewalt, CA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.; Sewalt, CA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Ctr Med Decis Making, Dept Publ Hlth, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	c.sewalt@erasmusmc.nl		van Ditshuizen, Jan/0000-0003-0765-0092			Adzemovic T, 2019, J TRAUMA ACUTE CARE, V86, P952, DOI 10.1097/TA.0000000000002248; Ashley DW, 2015, J TRAUMA ACUTE CARE, V78, P706, DOI 10.1097/TA.0000000000000585; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Enders CK, 2017, BEHAV RES THER, V98, P4, DOI 10.1016/j.brat.2016.11.008; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Gauthier J, 2020, BONE MARROW TRANSPL, V55, P675, DOI 10.1038/s41409-019-0679-x; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hamada SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223809; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Kaji AH, 2017, ANN EMERG MED, V70, P161, DOI 10.1016/j.annemergmed.2017.01.040; Kim YJ, 2014, J CLIN NURS, V23, P301, DOI 10.1111/jocn.12129; Li P, 2015, JAMA-J AM MED ASSOC, V314, P1966, DOI 10.1001/jama.2015.15281; LNAZ, 2020, LAND NETW AC ZORG LA; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Rogers FB, 2011, J TRAUMA, V70, P1354, DOI 10.1097/TA.0b013e3182183789; Schellenberg M, 2019, J TRAUMA ACUTE CARE, V87, P865, DOI 10.1097/TA.0000000000002393; Sethi D, 2002, J TRAUMA, V53, P508, DOI 10.1097/00005373-200209000-00019; Uribe-Leitz T, 2020, ANN EMERG MED, V75, P125, DOI 10.1016/j.annemergmed.2019.06.018; Van Ditshuizen JC, 2020, J TRAUMA ACUTE CARE, V89, P801, DOI 10.1097/TA.0000000000002850; van Rein EAJ, 2017, J TRAUMA ACUTE CARE, V83, P328, DOI 10.1097/TA.0000000000001516; Wahle-Gerhardt A, 2018, EMERGENCIAS, V30, P253; Whitaker Iveth Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P301; Williams T, 2013, PREHOSP EMERG CARE, V17, P442, DOI 10.3109/10903127.2013.804137	30	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01790-1		SEP 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UY2FF	WOS:000701344100001	34586442	hybrid			2022-02-06	
J	Weis, CN; Huggins, AA; Miskovich, TA; Fitzgerald, JM; Bennett, KP; Krukowski, JL; Webb, EK; DeRoon-Cassini, TA; Larson, CL				Weis, Carissa N.; Huggins, Ashley A.; Miskovich, Tara A.; Fitzgerald, Jacklynn M.; Bennett, Kenneth P.; Krukowski, Jessica L.; Webb, E. Kate; DeRoon-Cassini, Terri A.; Larson, Christine L.			Acute White Matter Integrity Post-trauma and Prospective Posttraumatic Stress Disorder Symptoms	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						PTSD; DTI; trauma; white matter; brain structure	MAJOR DEPRESSIVE DISORDER; UNCINATE FASCICULUS; TRAUMATIC EVENTS; CORPUS-CALLOSUM; HUMAN BRAIN; PTSD; ABNORMALITIES; VETERANS; CINGULUM; CONNECTIVITY	Background: Little is known about what distinguishes those who are resilient after trauma from those at risk for developing posttraumatic stress disorder (PTSD). Previous work indicates white matter integrity may be a useful biomarker in predicting PTSD. Research has shown changes in the integrity of three white matter tracts-the cingulum bundle, corpus callosum (CC), and uncinate fasciculus (UNC)-in the aftermath of trauma relate to PTSD symptoms. However, few have examined the predictive utility of white matter integrity in the acute aftermath of trauma to predict prospective PTSD symptom severity in a mixed traumatic injury sample. Method: Thus, the current study investigated acute brain structural integrity in 148 individuals being treated for traumatic injuries in the Emergency Department of a Level 1 trauma center. Participants underwent diffusion-weighted magnetic resonance imaging 2 weeks post-trauma and completed several self-report measures at 2-weeks (T1) and 6 months (T2), including the Clinician Administered PTSD Scale for DSM-V (CAPS-5), post-injury. Results: Consistent with previous work, T1 lesser anterior cingulum fractional anisotropy (FA) was marginally related to greater T2 total PTSD symptoms. No other white matter tracts were related to PTSD symptoms. Conclusions: Results demonstrate that in a traumatically injured sample with predominantly subclinical PTSD symptoms at T2, acute white matter integrity after trauma is not robustly related to the development of chronic PTSD symptoms. These findings suggest the timing of evaluating white matter integrity and PTSD is important as white matter differences may not be apparent in the acute period after injury.	[Weis, Carissa N.; Huggins, Ashley A.; Webb, E. Kate; Larson, Christine L.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Miskovich, Tara A.] Sacramento VA Med Ctr VHA, Sacramento, CA USA; [Fitzgerald, Jacklynn M.; Krukowski, Jessica L.] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Bennett, Kenneth P.] Montana VA Hlth Care Syst, Helena, MT USA; [DeRoon-Cassini, Terri A.] Med Coll Wisconsin, Dept Surg, Div Trauma & Acute Care Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA		Weis, CN (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	cweis@mcw.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Funding Support for the work within this article include a NIH grant R01-M1H106574 (PI: CL) and a Medical College of Wisconsin CTSI Pilot Award (PI: Td-C). EW was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 2TL1TR001437.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Akiki TJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0840-4; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Averill Christopher L, 2018, Mol Neuropsychiatry, V4, P75, DOI 10.1159/000490464; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; Bird CM, 2021, J TRAUMA STRESS, V34, P995, DOI 10.1002/jts.22670; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bremner J Douglas, 2006, Dialogues Clin Neurosci, V8, P445; Bremner J Douglas, 2005, J Trauma Dissociation, V6, P51, DOI 10.1300/J229v06n02_06; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Cloitre M, 2019, J TRAUMA STRESS, V32, P833, DOI 10.1002/jts.22454; Conrad D, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1344079; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Dennis EL, 2021, MOL PSYCHIATR, V26, P4315, DOI 10.1038/s41380-019-0631-x; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fani N, 2015, CORTEX, V64, P249, DOI 10.1016/j.cortex.2014.11.006; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flory JD, 2015, DIALOGUES CLIN NEURO, V17, P141; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hanson JL, 2015, DEV PSYCHOPATHOL, V27, P1611, DOI 10.1017/S0954579415000978; Harnett NG, 2020, BRAIN IMAGING BEHAV, V14, P1012, DOI 10.1007/s11682-018-9995-9; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hu H, 2016, J AFFECT DISORDERS, V190, P714, DOI 10.1016/j.jad.2015.09.044; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jakob JMD, 2017, J NERV MENT DIS, V205, P83, DOI 10.1097/NMD.0000000000000581; Jenkins LM, 2016, NEUROIMAGE-CLIN, V12, P1022, DOI 10.1016/j.nicl.2016.09.001; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Ju YM, 2020, J AFFECT DISORDERS, V266, P655, DOI 10.1016/j.jad.2020.01.047; Karam EG, 2014, DEPRESS ANXIETY, V31, P130, DOI 10.1002/da.22169; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Mori S., 2014, INTRO DIFFUSION TENS, V2nd Edn; Olson IR, 2015, DEV COGN NEUROS-NETH, V14, P50, DOI 10.1016/j.dcn.2015.06.003; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; R Core Team, 2020, R LANG ENV STAT COMP; Reuveni I, 2016, HUM BRAIN MAPP, V37, P589, DOI 10.1002/hbm.23051; Rooij S., 2017, NEUROPSYCHOPHARMACOL, V42; Rothbaum BO, 2014, J CLIN PSYCHIAT, V75, P1380, DOI 10.4088/JCP.13m08715; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Saar-Ashkenazy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144766; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Shalev AY, 2019, WORLD PSYCHIATRY, V18, P77, DOI 10.1002/wps.20608; Siehl S, 2018, NEUROIMAGE-CLIN, V19, P581, DOI 10.1016/j.nicl.2018.05.013; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; Suo XL, 2019, HUM BRAIN MAPP, V40, P4801, DOI 10.1002/hbm.24738; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; U.S. Department of Affairs, 2017, US PTSD CHEKL DSMV P; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Weathers F.W., 2013, CLIN ADM PTSD SCAL D; Webb EK, 2021, NEUROBIOL STRESS, V15, DOI 10.1016/j.ynstr.2021.100385; Webb EK, 2021, HEALTH PLACE, V67, DOI 10.1016/j.healthplace.2020.102493; Weis CN, 2021, NEUROIMAGE, V236, DOI 10.1016/j.neuroimage.2021.118076; Weis CN, 2021, PSYCHOL TRAUMA-US, DOI 10.1037/tra0001049; Weis Carissa N, 2018, Chronic Stress (Thousand Oaks), V2, DOI 10.1177/2470547018807134; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang L, 2012, ACTA NEUROPSYCHIATR, V24, P34, DOI 10.1111/j.1601-5215.2011.00580.x	73	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	SEP 29	2021	15								742198	10.3389/fnhum.2021.742198			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	WV3LA	WOS:000717137000001	34658821	Green Published, gold			2022-02-06	
J	Diekfuss, JA; Yuan, WH; Dudley, JA; DiCesare, CA; Panzer, MB; Talavage, TM; Nauman, E; Bonnette, S; Slutsky-Ganesh, AB; Clark, J; Anand, M; Altaye, M; Leach, JL; Lamplot, JD; Galloway, M; Pombo, MW; Hammond, KE; Myer, GD				Diekfuss, Jed A.; Yuan, Weihong; Dudley, Jonathan A.; DiCesare, Christopher A.; Panzer, Matthew B.; Talavage, Thomas M.; Nauman, Eric; Bonnette, Scott; Slutsky-Ganesh, Alexis B.; Clark, Joseph; Anand, Manish; Altaye, Mekibib; Leach, James L.; Lamplot, Joseph D.; Galloway, Marc; Pombo, Mathew W.; Hammond, Kyle E.; Myer, Gregory D.			Evaluation of the Effectiveness of Newer Helmet Designs with Emergent Shell and Padding Technologies Versus Older Helmet Models for Preserving White Matter Following a Season of High School Football	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						High-school sports; In vivo; Helmet rankings; Magnetic resonance imaging; Prospective longitudinal	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; CONCUSSION; MAGNITUDE; RECOVERY; PLAYERS	We aimed to objectively compare the effects of wearing newer, higher-ranked football helmets (HRank) vs. wearing older, lower-ranked helmets (LRank) on pre- to post-season alterations to neuroimaging-derived metrics of athletes' white matter. Fifty-four high-school athletes wore an HRank helmet, and 62 athletes wore an LRank helmet during their competitive football season and completed pre- and post-season diffusion tensor imaging (DTI). Longitudinal within- and between-group DTI metrics [fractional anisotropy (FA) and mean/axial/radial diffusivity (MD, AD, RD)] were analyzed using tract-based spatial statistics. The LRank helmet group exhibited significant pre- to post-season reductions in MD, AD, and RD, the HRank helmet group displayed significant pre- to post-season increases in FA, and both groups showed significant pre- to post-season increases in AD (p's < .05 [corrected]). Between-group analyses revealed the pre- to post-season increase in AD was significantly less for athletes wearing HRank compared to LRank (p < .05 [corrected]). These data provide in vivo evidence that wearing an HRank helmet may be efficacious for preserving white matter from head impact exposure during high school football. Future prospective longitudinal investigations with complimentary imaging and behavioral outcomes are warranted to corroborate these initial in vivo findings.	[Diekfuss, Jed A.; Slutsky-Ganesh, Alexis B.; Anand, Manish; Myer, Gregory D.] Emory Sports Performance & Res Ctr SPARC, Flowery Branch, GA USA; [Diekfuss, Jed A.; Slutsky-Ganesh, Alexis B.; Anand, Manish; Myer, Gregory D.] Emory Sports Med Ctr, Atlanta, GA USA; [Diekfuss, Jed A.; Slutsky-Ganesh, Alexis B.; Anand, Manish; Lamplot, Joseph D.; Pombo, Mathew W.; Hammond, Kyle E.; Myer, Gregory D.] Emory Univ, Sch Med, Dept Orthopaed, Atlanta, GA 30322 USA; [Yuan, Weihong; Dudley, Jonathan A.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Yuan, Weihong; Leach, James L.] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA; [DiCesare, Christopher A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, Charlottesville, VA USA; [Talavage, Thomas M.; Nauman, Eric] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH USA; [Nauman, Eric] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Bonnette, Scott] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Clark, Joseph] Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Leach, James L.] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Galloway, Marc] Mercy Hlth, Cincinnati, OH USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Diekfuss, JA (corresponding author), Emory Univ, Sch Med, Dept Orthopaed, Atlanta, GA 30322 USA.	jed.a.diekfuss@emory.edu	DiCesare, Christopher/AAA-3327-2021	DiCesare, Christopher/0000-0002-6576-4904; Dudley, Jonathan/0000-0002-5189-9568	Q30 Sports Innovations, LLC; Emory University; Cincinnati Children's Hospital Medical Center; National Institutes of Health/NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR067997, R01 AR070474, R01AR055563, R01AR076153, R01 AR077248]	Q30 Sports Innovations, LLC funded Cincinnati Children's Hospital Medical Center for the parent clinical trial evaluating the effects of a jugular vein compression collar on brain white matter during competitive sport. The present, secondary analyses of neuroimaging data for comparison of helmet tech-nologies not included in the intervention arm (i.e., athletes allocated to the non-collar group) of the parent clinical trial was undertaken with internal support from Emory University and Cincinnati Children's Hospital Medical Center. Gregory D. Myer has consulted with Commercial entities to support application to the US Food and Drug Administration but has no financial interest in the commercialization of the products. Dr. Myer's institution receives current and ongoing grant funding from National Institutes of Health/NIAMS Grants U01AR067997, R01 AR070474, R01AR055563, R01AR076153, R01 AR077248 and has received industry sponsored research funding related to brain injury prevention and assessment with Q30 Innovations, LLC, and ElMinda, Ltd. Dr. Myer receives author royalties from Human Kinetics and Wolters Kluwer. Dr. Myer is an inventor of biofeedback technologies (2017 Non Provisional Patent Pending-Augmented and Virtual reality for Sport Performance and Injury Prevention Application filed 11/10/2016 (62/420,119), Software Copyrighted.) designed to enhance rehabilitation and prevent injuries and has potential for future licensing royalties.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bussey MD, 2019, PHYS THER SPORT, V37, P105, DOI 10.1016/j.ptsp.2019.03.012; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cummiskey B, 2019, P I MECH ENG P-J SPO, V233, P301, DOI 10.1177/1754337118823603; Diekfuss JA, 2021, J NEUROSCI RES, V99, P423, DOI 10.1002/jnr.24727; Dudley J, 2020, BRAIN CONNECT, V10, P292, DOI 10.1089/brain.2019.0729; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Funk JR, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039673; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Giudice JS, 2020, ANN BIOMED ENG, V48, P1524, DOI 10.1007/s10439-020-02472-6; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hamish O., 2017, BRIT J SPORT MED, V51, pA4, DOI DOI 10.1136/BJSPORTS-2016-097270.8; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NOCSAE, 2020, STANDARD TEST METHOD, P1; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2012, ANN BIOMED ENG, V40, P2512, DOI 10.1007/s10439-012-0660-y; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881	51	0	0	7	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2863	2874		10.1007/s10439-021-02863-3		SEP 2021	12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000701636200002	34585336				2022-02-06	
J	Joo, H; Bae, J; Park, JW; Lee, BJ; Lee, BD; Bu, Y				Joo, Hyejin; Bae, Jinhyun; Park, Jae-Woo; Lee, Beom-Joon; Lee, Byoung Dae; Bu, Youngmin			Modified Protocol to Enable the Study of Hemorrhage and Hematoma in a Traumatic Brain Injury Mouse Model	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; controlled cortical impact; hemorrhage; mouse; protocol	PROGRESSION; MANAGEMENT; MODERATE	To date, many studies using the controlled cortical impact (CCI) mouse model of traumatic brain injury (TBI) have presented results without presenting the pathophysiology of the injury-core itself or the temporal features of hemorrhage (Hrr). This might be owing to the removal of the injury-core during the histological procedure. We therefore developed a modified protocol to preserve the injury-core. The heads of mice were obtained after perfusion and were post-fixed. The brains were then harvested, retaining the ipsilateral skull bone; these were post-fixed again and sliced using a cryocut. To validate the utility of the procedure, the temporal pattern of Hrr depending on the impacting depth was analyzed. CCI-TBI was induced at the following depths: 1.5 mm (mild Hrr), 2.5 mm (moderate Hrr), and 3.5 mm (severe Hrr). A pharmacological study was also conducted using hemodynamic agents such as warfarin (2 mg/kg) and coagulation factor VIIa (Coa-VIIa, 1 mg/kg). The current protocol enabled the visual observation of the Hrr until 7 days. Hrr peaked at 1-3 days and then decreased to the normal range on the seventh day. It expanded from the affected cortex (mild) to the periphery of the hippocampus (moderate) and the brain ventricle (severe). Pharmacological studies showed that warfarin pre-treatment produced a massively increased Hrr, concurrent with the highest mortality rate and brain injury. Coa-VIIa reduced the side effects of warfarin. Therefore, these results suggest that the current method might be suitable to conduct studies on hemorrhage, hematoma, and the injury-core in experiments using the CCI-TBI mouse model.</p>	[Joo, Hyejin] Kyung Hee Univ, Grad Sch, Dept Sci Korean Med, Seoul, South Korea; [Bae, Jinhyun; Bu, Youngmin] Kyung Hee Univ, Coll Korean Med, Dept Herbal Pharmacol, Seoul, South Korea; [Park, Jae-Woo; Lee, Beom-Joon] Kyung Hee Univ, Coll Korean Med, Dept Internal Med, Seoul, South Korea; [Lee, Byoung Dae] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea		Bu, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Herbal Pharmacol, Seoul, South Korea.; Lee, BD (corresponding author), Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea.	bdaelee@khu.ac.kr; ymbu@khu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A2C1008603]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1A2C1008603).	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chen JQ, 2014, ASIAN PAC J TROP MED, V7, P991, DOI 10.1016/S1995-7645(14)60174-7; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Choi WW, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/7326107; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; Fuller G, 2020, EMERG MED J, V37, P666, DOI 10.1136/emermed-2019-209307; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; George P, 2001, MOUSE BRAIN STEREOTA; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Michalcova J, VNITR LEK, V63, P957, DOI [10.36290/vnl.2017.175, DOI 10.36290/VNL.2017.175]; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Schlunk F, 2012, STROKE, V43, P246, DOI 10.1161/STROKEAHA.111.629360; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu SY, 2019, NEURAL REGEN RES, V14, P997, DOI 10.4103/1673-5374.250579	24	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 28	2021	12								717513	10.3389/fneur.2021.717513			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE9IA	WOS:000705930000001	34650505	gold, Green Published			2022-02-06	
J	Labbadia, R; Camassei, FD; Antonucci, L; Guzzo, I; Muda, AO; Spada, M; Dello Strologo, L				Labbadia, Raffaella; Diomedi Camassei, Francesca; Antonucci, Luca; Guzzo, Isabella; Onetti Muda, Andrea; Spada, Marco; Dello Strologo, Luca			Reversible glomerular damage in disseminated intravascular coagulation	PEDIATRIC TRANSPLANTATION			English	Article						disseminated intravascular coagulation; pediatric; renal transplantation	DONOR	Background Brain death secondary to traumatic brain injury is one of the main sources of organs for transplantation but it can be associated with disseminated intravascular coagulation, which has been considered a relative contraindication for kidney donation. Methods We describe two successful pediatric cases of kidney transplantation from a single donor with disseminated intravascular coagulation. Results A 17-year-old male donor died from head injury and both kidneys were offered to our center. Within 24 h, donor's Hb and platelets dropped to 8.3 g/dl and 32 000/mcl, respectively, serum creatinine reached 2.01 mg/dl, and urinalysis showed proteinuria (300 mg/dl). Pre-implant biopsy showed massive occlusion of glomerular capillaries by fibrin thrombi containing fragmented red blood cells and inflammatory cells, and acute tubular damage. Arterioles and small arteries were spared. A diagnosis of DIC was made. The kidneys were transplanted in a 16-year-old girl and a 13-year-old boy. Slow recovery of graft function was observed in both recipients. On post-operative day 3, platelets dropped to a minimum value of 66 000 and 86 000/mcl, respectively. Diuresis was always present. On day 4, platelets started to rise. Six months later, both recipients attained normal renal function. A six-month protocol biopsy showed no microthrombi or other signs of disseminated intravascular coagulation. Conclusions Despite the limited data available in literature, the outcome of these two cases is positive. Thus, pre-implant kidney biopsy, even if it reveals massive thrombotic occlusion of glomerular capillaries compatible with diagnosis of disseminated intravascular coagulation, should not be considered an absolute contraindication to transplantation.	[Labbadia, Raffaella; Antonucci, Luca; Guzzo, Isabella; Dello Strologo, Luca] Bambino Gesu Childrens Res Hosp, IRCCS, Renal Transplant Unit, Rome, Italy; [Diomedi Camassei, Francesca; Onetti Muda, Andrea] Bambino Gesu Childrens Res Hosp, IRCCS, Pathol, Rome, Italy; [Spada, Marco] Bambino Gesu Childrens Res Hosp, IRCCS, Hepatobiliopancreat Surg Liver & Kidney Transplan, Rome, Italy		Labbadia, R (corresponding author), Bambino Gesu Childrens Res Hosp, Renal Transplant Unit, Piazza S Onofrio 4, I-00165 Rome, Italy.	raffaella.labbadia@opbg.net	Spada, Marco/K-3467-2018	Spada, Marco/0000-0003-0796-6847			[Anonymous], 2016, Nat Rev Dis Primers, V2, P16038, DOI 10.1038/nrdp.2016.38; Bennett WM, 2005, AM J TRANSPLANT, V5, P412, DOI 10.1111/j.1600-6143.2004.00679.x; Foroutan F, 2019, CLIN J AM SOC NEPHRO, V14, P1642, DOI 10.2215/CJN.05560519; Garrouste C, 2019, AM J TRANSPLANT, V19, P448, DOI 10.1111/ajt.15008; GILVERNET S, 1992, TRANSPLANT P, V24, P33; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hart A, 2021, AM J TRANSPLANT, V21, P21, DOI 10.1111/ajt.16502; LEUNISSEN KML, 1986, TRANSPLANTATION, V42, P307; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; Moore EE, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00264-3; Ohashi R, 2014, PATHOL INT, V64, P443, DOI 10.1111/pin.12192; Pastural M, 2001, NEPHROL DIAL TRANSPL, V16, P412, DOI 10.1093/ndt/16.2.412; Soares KC, 2017, TRANSPLANTATION, V101, P1134, DOI 10.1097/TP.0000000000001386; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P1160, DOI 10.2215/CJN.07280810	15	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	FEB	2022	26	1							e14147	10.1111/petr.14147		SEP 2021	4	Pediatrics; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Transplantation	YE3VR	WOS:000701233400001	34585476				2022-02-06	
J	Ponomarenko, A; Tyrtyshnaia, A; Ivashkevich, D; Manzhulo, I				Ponomarenko, Arina; Tyrtyshnaia, Anna; Ivashkevich, Darya; Manzhulo, Igor			Mild Traumatic Brain Injury Contributes to the Development of Delayed Neuroinflammation	NEUROIMMUNOMODULATION			English	Article; Early Access						Mild traumatic brain injury; Microglia; IL1 beta; IL6; CD86; Endocannabinoid system; Cannabinoid receptor type 1	CANNABINOID RECEPTORS; ACTIVATION; MICROGLIA; DEMENTIA; SURVIVAL	Introduction: In recent years, according to the literature, the problem of mild traumatic brain injury (mTBI) has become more and more urgent. Compared to moderate to severe craniocerebral trauma, mTBI occurs in a far greater number of people. The delayed sequelae caused by a single mTBI or multiple mTBIs are a significant public health problem. Methods: A weight-drop model was used for the formation of mTBI. A metal rod weighing 337 g with a blunt tip of 3 mm diameter was uplifted at 8 cm height and held by a lever. The trauma was created by lowering the lever and the rod and free-dropping onto the rat skull. In the cerebral cortex of experimental animals, we analyzed the level of microglial activity (Iba-1-positive system) and the expression of pro-inflammatory markers (IL1 beta, IL6, and CD86). Also, the expression level of the endocannabinoid system receptor (cannabinoid receptor type 1 [CB1]) was assessed in brain samples. Results: Experiments have shown that mTBI increases (1) the amount of microglia (iba-1) activated by the pro-inflammatory pathway (CD86); (2) the level of pro-inflammatory cytokines IL1 beta and IL6; and (3) CB1R activity. Conclusion: Overall, the results of this study indicate that mTBI induces a sustained neuroinflammatory response.& nbsp;(c) 2021 S. Karger AG, Base	[Ponomarenko, Arina; Tyrtyshnaia, Anna; Ivashkevich, Darya; Manzhulo, Igor] Russian Acad Sci, AV Zhirmunsky Natl Sci Ctr Marine Biol, Lab Pharmacol, Far Eastern Branch, Vladivostok, Russia		Ponomarenko, A (corresponding author), Russian Acad Sci, AV Zhirmunsky Natl Sci Ctr Marine Biol, Lab Pharmacol, Far Eastern Branch, Vladivostok, Russia.	arina.ponomarenko.93@mail.ru	Manzhulo, Igor V./F-4480-2016; Ponomarenko, Arina/AAC-8262-2022		Russian Science FoundationRussian Science Foundation (RSF) [17-74-20006]	This study is supported by the Russian Science Foundation (project 17-74-20006).	Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Elmazoglu Z, 2020, NEUROCHEM INT, V140, DOI 10.1016/j.neuint.2020.104817; FAN L, 1995, MOL BRAIN RES, V30, P125; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Gao HM, 2003, J NEUROSCI, V23, P6181; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; HERKENHAM M, 1992, ANN NY ACAD SCI, V654, P19, DOI 10.1111/j.1749-6632.1992.tb25953.x; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Lecca D, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104528; Leonard BE, 2018, ACTA NEUROPSYCHIATR, V30, P1, DOI 10.1017/neu.2016.69; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Maya-Lopez M, 2020, NEUROTOX RES, V37, P126, DOI 10.1007/s12640-019-00083-1; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Micale V, 2007, PHARMACOL RES, V56, P382, DOI 10.1016/j.phrs.2007.09.008; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Nagayama T, 1999, J NEUROSCI, V19, P2987; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; Semple BD., 2012, TRAUMATIC BRAIN SPIN, P155; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Zhang M, 2009, J NEUROIMMUNE PHARM, V4, P249, DOI 10.1007/s11481-009-9148-4	41	0	0	2	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation												10.1159/000519011		SEP 2021	8	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	WB2VP	WOS:000703435500001	34583355				2022-02-06	
J	Cho, SJ; Park, E; Baker, A; Reid, AY				Cho, Sung-Joon; Park, Eugene; Baker, Andrew; Reid, Aylin Y.			Post-Traumatic Epilepsy in Zebrafish Is Drug-Resistant and Impairs Cognitive Function	JOURNAL OF NEUROTRAUMA			English	Article						drug-resistant; post-traumatic epilepsy; seizure; traumatic brain injury; zebrafish	TRAUMATIC BRAIN-INJURY; MODEL; SEIZURES; EPILEPTOGENESIS	Post-traumatic epilepsy (PTE) is acquired epilepsy after traumatic brain injury (TBI). Despite the availability of more than 20 antiseizure medications (ASMs), there is no way at present to prevent epileptogenesis in TBI survivors, and many cases of PTE become drug-resistant. Importantly, the adverse effects of ASMs can significantly affect patients' quality of life. Mammalian models are commonly used for studying refractory PTE, but are expensive and laborious. Zebrafish models have become popular for studying epilepsy, but most focus on larvae, and there have been no reports to date of pharmacological screening in an adult zebrafish model of acquired epilepsy. Valid animal models are critical for understanding PTE and for developing novel therapeutics. The aim of the present study was to characterize the cognitive impairments of a zebrafish model of TBI that leads to the development of PTE. Using combined behavioral and electrophysiological approaches, we also characterized the pharmacological effects of the most commonly used ASMs to manage PTE (valproate, carbamazepine, and phenytoin). Zebrafish with PTE exhibited impairments in learning and memory, difficulty in decision making, and reduced social preference. Valproate and carbamazepine had a limited protective effect against behavioral seizures, and all three drugs failed to significantly reduce electrographical seizures. The negative impacts of TBI and ASMs in zebrafish parallel those observed in other animals, making the zebrafish model of PTE a promising high-throughput model of refractory and drug-resistant epilepsy.	[Cho, Sung-Joon; Reid, Aylin Y.] Univ Hlth Network, Div Fundamental Neurobiol, Krembil Res Inst, Toronto, ON, Canada; [Cho, Sung-Joon] Univ Toronto, Collaborat Program Neurosci, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Anesthesia & Surg, Toronto, ON, Canada; [Reid, Aylin Y.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Cho, Sung-Joon; Park, Eugene; Baker, Andrew] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada		Cho, SJ (corresponding author), Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	sungjoon.cho@utoronto.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MFE-164732, PJT-148507]; National Research Foundation of KoreaNational Research Foundation of Korea [NRF-2019R1A6A3A03032940]; Toronto General & Western Hospital Foundation	This work was supported by Canadian Institutes of Health Research (MFE-164732, S.-J.C.; PJT-148507 A.Y.R), National Research Foundation of Korea (NRF-2019R1A6A3A03032940, S.-J.C.), and Toronto General & Western Hospital Foundation (A.Y.R).	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANDERSEN AE, 1974, P NATL ACAD SCI USA, V71, P21, DOI 10.1073/pnas.71.1.21; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bird Philip D, 2015, J Med Case Rep, V9, P8, DOI 10.1186/1752-1947-9-8; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Camfield PR, 1997, EPILEPSIA, V38, P735, DOI 10.1111/j.1528-1157.1997.tb01245.x; Cho SJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.573303; Cho SJ, 2020, EPILEPSIA, V61, P1774, DOI 10.1111/epi.16589; Cho SJ, 2020, SENSOR ACTUAT B-CHEM, V304, DOI 10.1016/j.snb.2019.127332; Cho SJ, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/9053764; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03482-6; Cho SJ, 2015, IEEE SENSOR, P1434; Cho SJ, 2015, J NEUROPHYSIOL, V114, P2065, DOI 10.1152/jn.00538.2015; Choo BKM, 2019, PROG NEURO-PSYCHOPH, V92, P483, DOI 10.1016/j.pnpbp.2019.02.014; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Colwill RM, 2005, BEHAV PROCESS, V70, P19, DOI 10.1016/j.beproc.2005.03.001; CRAIG I, 1994, EPILEPSIA, V35, P381, DOI 10.1111/j.1528-1157.1994.tb02448.x; Eddins D, 2009, PSYCHOPHARMACOLOGY, V202, P103, DOI 10.1007/s00213-008-1287-4; Genario R, 2020, EUR J NEUROSCI, V52, P2586, DOI 10.1111/ejn.14438; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Gupta P, 2014, INDIAN J PHARM SCI, V76, P157; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Kang HC, 2007, EPILEPSIA, V48, P1716, DOI 10.1111/j.1528-1167.2007.01160.x; Kundap UP, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00515; Larkin M, 2016, CUREUS, V8, DOI 10.7759/cureus.744; Leclercq K, 2015, EPILEPSY BEHAV, V45, P53, DOI 10.1016/j.yebeh.2015.03.019; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Liu XY, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00201; Martinez CS, 2018, NEUROTOXICOL TERATOL, V66, P17, DOI 10.1016/j.ntt.2018.01.008; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Rodriguez A, 2018, METHODS ECOL EVOL, V9, P460, DOI 10.1111/2041-210X.12874; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Turrini L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03087-z; Wang QR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027251; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029	46	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3174	3183		10.1089/neu.2021.0156		SEP 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000700132300001	34409844				2022-02-06	
J	D'Arcy, RCN; Sandhu, JK; Marshall, S; Besemann, M				D'Arcy, Ryan C. N.; Sandhu, Jagdeep K.; Marshall, Shawn; Besemann, Markus			Mitigating Long-Term COVID-19 Consequences on Brain Health	FRONTIERS IN NEUROLOGY			English	Article						SARS-CoV-2; coronavirus; brain inflammation; cognition; neuromodulation; neuroplasticity; mental health; moral injury		COVID-19 is increasingly being linked to brain health impacts. The emerging situation is consistent with evidence of immunological injury to the brain, which has been described as a resulting "brain fog." The situation need not be medicalized but rather clinically managed in terms of improving resilience for an over-stressed nervous system. Pre-existing comparisons include managing post-concussion syndromes and/or brain fog. The objective evaluation of changes in cognitive functioning will be an important clinical starting point, which is being accelerated through pandemic digital health innovations. Pre-morbid brain health can significantly optimize risk factors and existing clinical frameworks provide useful guidance in managing over-stressed COVID-19 nervous systems.	[D'Arcy, Ryan C. N.] HealthTech Connex, Ctr Neurol Studies, Vancouver, BC, Canada; [D'Arcy, Ryan C. N.] Simon Fraser Univ, Fac Sci Appl, Vancouver, BC, Canada; [D'Arcy, Ryan C. N.] Univ British Columbia, DM Ctr Brain Hlth Radiol, Vancouver, BC, Canada; [Sandhu, Jagdeep K.] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Ottawa, ON, Canada; [Sandhu, Jagdeep K.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Marshall, Shawn; Besemann, Markus] Univ Ottawa, Phys Med & Rehabil, Ottawa, ON, Canada; [Besemann, Markus] Canadian Forces Hlth Serv, Rehabil Med, Ottawa, ON, Canada		D'Arcy, RCN (corresponding author), HealthTech Connex, Ctr Neurol Studies, Vancouver, BC, Canada.; D'Arcy, RCN (corresponding author), Simon Fraser Univ, Fac Sci Appl, Vancouver, BC, Canada.; D'Arcy, RCN (corresponding author), Univ British Columbia, DM Ctr Brain Hlth Radiol, Vancouver, BC, Canada.; Besemann, M (corresponding author), Univ Ottawa, Phys Med & Rehabil, Ottawa, ON, Canada.; Besemann, M (corresponding author), Canadian Forces Hlth Serv, Rehabil Med, Ottawa, ON, Canada.	ryan@healthtechconnex.com; markus.besemann@forces.gc.ca			HealthTech Connex's Centre for Neurology Studies (RD).	Funding This publication and related open access publication fees was supported by HealthTech Connex's Centre for Neurology Studies (RD).	Alam SB, 2020, EUR J NEUROL, V27, P2348, DOI 10.1111/ene.14442; [Anonymous], 2012, HOUR FITNESS 23 1 2; Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596; Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586; Bodro M, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000821; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Cohen ME, 2020, LANCET NEUROL, V19, P804, DOI 10.1016/S1474-4422(20)30305-7; Coolen T, 2020, NEUROLOGY, V95, pE2016, DOI 10.1212/WNL.0000000000010116; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; Dourmashkin RR, 1997, J ROY SOC MED, V90, P515, DOI 10.1177/014107689709000916; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Fickling SD, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00347; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Hajra SG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00211; Hajra SG, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1527-2; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Kanberg N, 2020, NEUROLOGY, V95, pE1754, DOI 10.1212/WNL.0000000000010111; Kontoangelos K, 2020, PSYCHIAT INVEST, V17, P491, DOI 10.30773/pi.2020.0161; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Liao YY, 2020, EUR J PHYS REHAB MED, V56, P47, DOI 10.23736/S1973-9087.19.05899-4; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730; Mintzer J, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00204; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; Pawlowski GM, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00968; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937; Saylor D, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2016.53; Smith CJ, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00358; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4; Willows S, 2021, BIOCHEM CELL BIOL, V99, P173, DOI 10.1139/bcb-2020-0341	39	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 27	2021	12								630986	10.3389/fneur.2021.630986			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WV5VG	WOS:000717304000001	34646224	gold, Green Published			2022-02-06	
J	Nabity, PS; Jaramillo, CA; Resick, PA; McGeary, CA; Eapen, BC; Straud, CL; Hale, WJ; Houle, TT; Litz, BT; Mintz, J; Penzien, DB; Young-McCaughan, S; Keane, TM; Peterson, AL; McGeary, DD				Nabity, Paul S.; Jaramillo, Carlos A.; Resick, Patricia A.; McGeary, Cindy A.; Eapen, Blessen C.; Straud, Casey L.; Hale, Willie J.; Houle, Timothy T.; Litz, Brett T.; Mintz, Jim; Penzien, Donald B.; Young-McCaughan, Stacey; Keane, Terence M.; Peterson, Alan L.; McGeary, Donald D.		Consortium Alleviate PTSD	Persistent posttraumatic headaches and functioning in veterans: Injury type can matter	HEADACHE			English	Article						blast; headache; migraine; posttraumatic; traumatic brain injury; veteran	TRAUMATIC BRAIN-INJURY; MILD HEAD TRAUMA; US SOLDIERS; PREVALENCE; SYMPTOMS; VALIDITY; BLAST; IRAQ; TBI; RELIABILITY	Objective To characterize the relationship between head trauma types (blast injury, blunt injury, combined blast+blunt injury) with subsequent headache presentations and functioning. Background Posttraumatic headaches (PTHs), the most common sequelae of traumatic brain injury (TBI), are painful and disabling. More than 400,000 veterans report having experienced a TBI, and understanding the predictors of PTHs may guide treatment developments. Methods This study used a nested-cohort design analyzing baseline data from a randomized clinical trial of cognitive behavioral therapy for PTH (N = 190). Participants had PTH (from blast and/or blunt head trauma) and symptoms of posttraumatic stress disorder (PTSD). The Structured Diagnostic Interview for Headache-Revised and Ohio State University Traumatic Brain Injury Identification Method were used to phenotype headaches and head injury histories, respectively. Results Individuals with persistent PTHs after a combined blast and blunt head trauma were more likely (OR =3.45; 95% CI [1.41, 8.4]) to experience chronic (vs. episodic) PTHs compared with the blunt trauma only group (23/33, 70% vs. 26/65, 40%, respectively); and they were more likely (OR =2.51; 95% CI [1.07, 5.9]) to experience chronic PTH compared with the blast trauma only group (44/92, 48%). There were no differences between head injury type on headache-related disability, depression symptoms, or severity of PTSD symptoms. Conclusion The combination of blast and blunt injuries was associated with headache chronicity, but not headache disability. Considering the refractory nature of chronic headaches, the potential added and synergistic effects of distinct head injuries warrant further study.	[Nabity, Paul S.; McGeary, Cindy A.; Straud, Casey L.; Hale, Willie J.; Mintz, Jim; Young-McCaughan, Stacey; Peterson, Alan L.; McGeary, Donald D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA; [Nabity, Paul S.; McGeary, Cindy A.; Straud, Casey L.; Mintz, Jim; Young-McCaughan, Stacey; Peterson, Alan L.; McGeary, Donald D.] South Texas Vet Hlth Care Syst, Res & Dev Serv, San Antonio, TX USA; [Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Jaramillo, Carlos A.; McGeary, Donald D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, San Antonio, TX 78229 USA; [Resick, Patricia A.] Duke Hlth, Dept Psychiat & Behav Sci, Durham, NC USA; [Eapen, Blessen C.] VA Greater Los Angeles Healthcare Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Phys Med & Rehabil, Los Angeles, CA 90095 USA; [Straud, Casey L.; Hale, Willie J.; Peterson, Alan L.; McGeary, Donald D.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Houle, Timothy T.] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Litz, Brett T.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Litz, Brett T.; Keane, Terence M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Penzien, Donald B.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC 27101 USA; [Penzien, Donald B.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Keane, Terence M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA		Nabity, PS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA.	nabity@uthscsa.edu			Consortium to Alleviate PTSD from the U.S. Department of Defense, Defense Health Program [W81XWH-13-2-0065]; Psychological Health and Traumatic Brain Injury Research Program from the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service [I01CX001136-01]	This research was supported by Consortium to Alleviate PTSD award numbers W81XWH-13-2-0065 from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program, and I01CX001136-01 from the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service.	ANDREW ME, 1992, INT J BIOMED COMPUT, V31, P17, DOI 10.1016/0020-7101(92)90050-3; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, 2019, TBI REL EM DEP ED VI; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Defense Health Agency, 2020, DOD TBI WORLDW NUMB; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Denby E, 2020, J HEAD TRAUMA REHAB, V35, P57, DOI 10.1097/HTR.0000000000000468; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Finkel AG, 2017, NEUROLOGY, V89, P1186, DOI 10.1212/WNL.0000000000004358; Galovski TE, 2021, PSYCHOL TRAUMA-US, V13, P376, DOI 10.1037/tra0000976; Greer N, 2020, J HEAD TRAUMA REHAB, V35, P1, DOI 10.1097/HTR.0000000000000478; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine (IOM), 2014, GULF WAR HLTH; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Klaric JS, 2018, HEADACHE, V58, P1457, DOI 10.1111/head.13416; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kristoffersen ES, 2019, J PSYCHOSOM RES, V116, P83, DOI 10.1016/j.jpsychores.2018.12.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Marcus DA, 2003, HEADACHE, V43, P117, DOI 10.1046/j.1526-4610.2003.03028.x; McGeary DD, 2021, CONT CLIN TRIAL COMM, V21, DOI 10.1016/j.conctc.2021.100699; McGeary DD, 2020, CEPHALALGIA, V40, P1155, DOI 10.1177/0333102420953109; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Rendas-Baum R, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0117-0; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Sahai-Srivastava S, 2017, HEADACHE, V57, P1482, DOI 10.1111/head.13118; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; Weathers FW, PTSD CHECKLIST DSM 5; Xu HM, 2016, WORLD NEUROSURG, V88, P289, DOI 10.1016/j.wneu.2015.12.028	44	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	OCT	2021	61	9					1334	1341		10.1111/head.14210		SEP 2021	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ4KV	WOS:000700523400001	34570899				2022-02-06	
J	Troyanskaya, M; Pastorek, NJ; Walder, A; Wilde, EA; Kennedy, JE; Levin, HS; Scheibel, RS				Troyanskaya, Maya; Pastorek, Nicholas J.; Walder, Annette; Wilde, Elisabeth A.; Kennedy, Jan E.; Levin, Harvey S.; Scheibel, Randall S.			Role of deployment-related mTBI and resilience in perceived participation limitations among Veterans	MILITARY PSYCHOLOGY			English	Article						Veterans; mild traumatic brain injury; social participation; resilience; psychological; posttraumatic stress disorders	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SOCIAL-PARTICIPATION; MENTAL-HEALTH; PSYCHOLOGICAL RESILIENCE; COMMUNITY REINTEGRATION; FUNCTIONAL DISABILITY; FEMALE VETERANS; SERVICE MEMBERS; IRAQ	Problems with social functioning are common following combat deployment, and these may be greater among individuals with a history of traumatic brain injury (TBI). The present investigation examined the impact of mild TBI (mTBI), deployment-related characteristics, and resilience on perceived participation limitations among combat Veterans. This was a cross-sectional study of 143 participants with a history of at least one deployment-related mTBI (TBI group) and 80 without a history of lifetime TBI (Comparison group). Self-report measures of participation, resilience, posttraumatic stress disorder (PTSD) symptoms, and combat exposure were administered. In addition, each participant completed a structured interview to assess lifetime TBI history. The groups did not differ in basic demographics, but significant differences were found for perceived limitations in participation, the presence of PTSD symptoms, and intensity of combat exposure. A stepwise model indicated a significant effect of resilience on reported limitations in participation (adjusted R-2 = 0.61). Individuals with higher resiliency reported a higher degree of social participation, and this effect was stronger in the TBI group. Deployment-related characteristics, including intensity of combat exposure, did not have a significant effect (adjusted R-2 = 0.28) on social participation. The role of resilience should be recognized within post-deployment transition and rehabilitation programs.	[Troyanskaya, Maya; Pastorek, Nicholas J.; Walder, Annette; Levin, Harvey S.; Scheibel, Randall S.] Michael E DeBakey Vet Affairs Med Ctr Houston, 6501 Fannin St,Suite NB132, Houston, TX 77030 USA; [Troyanskaya, Maya; Pastorek, Nicholas J.; Wilde, Elisabeth A.; Levin, Harvey S.; Scheibel, Randall S.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Walder, Annette] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Kennedy, Jan E.] Brooke Army Med Ctr Ft Sam Houston, DefenseTX & Vet Brain Injury Ctr, San Antonio, TX USA; [Kennedy, Jan E.] Gen Dynam Informat Technol Falls Church, Falls Church, VA USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA		Troyanskaya, M (corresponding author), Michael E DeBakey Vet Affairs Med Ctr Houston, 6501 Fannin St,Suite NB132, Houston, TX 77030 USA.	mayat@bcm.edu			United States (US) Department of Veterans Affairs [I01 CX001820, B6812C, O1062-I]; DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	This material is based upon work supported in part by United States (US) Department of Veterans Affairs Merit Review Awards Numbers [I01 CX001820] (PI Scheibel, RS), B6812C (PI-Levin, HS), and [O1062-I] (PI-Scheibel RS). In addition, this work was prepared under contract number HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as US Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the US Government.	*AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P00424; Bagalman, 2013, TRAUMATIC BRAIN INJU; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brown T.T., 2009, INT J SCHOLARLY ACAD, V11, P1; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cogan AM, 2020, ARCH PHYS MED REHAB, V101, P2071, DOI 10.1016/j.apmr.2020.06.030; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dagkas S, 2007, EUR PHYS EDUC REV, V13, P369, DOI 10.1177/1356336X07081800; Dawson-Townsend K, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100424; Department of Veterans Affairs/Department of Defense, 2016, VADOD CLIN PRACT MAN; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Foley EL, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/2606039; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffith LE, 2017, J EPIDEMIOL COMMUN H, V71, P381, DOI 10.1136/jech-2016-207982; Haller M, 2016, SUICIDE LIFE-THREAT, V46, P160, DOI 10.1111/sltb.12181; Hasto J, 2013, NEUROENDOCRINOL LETT, V34, P464; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2013, RETURN HOM IRAQ AFGH; Jagnoor J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-199; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Litz B., 2011, RESILIENCE MENTAL HL, P238, DOI [10.1017/CBO9780511994791.018, DOI 10.1017/CBO9780511994791.018]; Litz BT, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0008; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCulloch K, 2015, J HEAD TRAUMA REHAB, V30, P38, DOI 10.1097/HTR.0000000000000041; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; O'Rourke J, 2019, J HEAD TRAUMA REHAB, V34, P30, DOI 10.1097/HTR.0000000000000405; Pietrzak RH, 2011, J AFFECT DISORDERS, V133, P560, DOI 10.1016/j.jad.2011.04.028; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Piskur B, 2014, CLIN REHABIL, V28, P211, DOI 10.1177/0269215513499029; Polytrauma system of care, 2019, JANUARY 24 2019 ED D; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Rutten BPF, 2013, ACTA PSYCHIAT SCAND, V128, P3, DOI 10.1111/acps.12095; Sanches SA, 2019, SOC PSYCH PSYCH EPID, V54, P1067, DOI 10.1007/s00127-019-01704-y; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schnittker J., 2018, SOCIUS SOCIOLOGICAL, V4, DOI DOI 10.1177/2378023118813017; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith EM, 2016, DISABIL REHABIL-ASSI, V11, P361, DOI 10.3109/17483107.2014.989420; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Taylor MG, 2016, GERONTOLOGIST, V56, P92, DOI 10.1093/geront/gnv662; Troyanskaya M, 2016, J CLIN EXP NEUROPSYC, V38, P811, DOI 10.1080/13803395.2016.1167172; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; Vogt D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020734; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Wingo AP, 2017, PSYCHIAT RES, V249, P206, DOI 10.1016/j.psychres.2017.01.022; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; World Health Organization, 2001, INT CLASS FUNCT DIS	68	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	NOV 2	2021	33	6					426	435		10.1080/08995605.2021.1962191		SEP 2021	10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	XF2DS	WOS:000705434000001					2022-02-06	
J	Wubie, AB; Teshome, GS; Ayele, WE; Abebe, F; Nigussie, TM; Alemu, YB; Mekonnen, MS				Wubie, Azene Bantie; Teshome, Girum Sebsibe; Ayele, Wudie Eneyew; Abebe, Fikirtemariam; Nigussie, Tewodros Mulugeta; Alemu, Yalemgeta Biyazin; Mekonnen, Migbar Sibhat			Survival status and predictors of mortality among children who underwent ventriculoperitoneal shunt surgery at public hospitals in Addis Ababa, Ethiopia	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Early Access						Hydrocephalus; children; survival status; ventriculoperitoneal shunt; Ethiopia	HYDROCEPHALUS; MANAGEMENT; FAILURES; OUTCOMES	Background: Despite the increase in ventriculoperitoneal shunt surgeries performed for children with hydrocephalus, the potential complications and survival of patients after the procedure remains the major challenge for both clinical and public health aspects. This study intends to assess the survival status and scrutinize the predictive factors of mortality among children after a ventriculoperitoneal shunt. Methods: A retrospective cohort study was employed by reviewing charts of 337 systematically selected children who have undergone a ventriculoperitoneal shunt from 2016 to 2018 in Addis Ababa. The extraction tool was used for data collection, Epi-data version 4.4.2 for data entry, and Stata version-14 for cleaning and analysis. Kaplan-Meier curve, log-rank test, and life table were used to describe the data. Cox proportional hazard regression model was used for analysis. Any variable at p < 0.25 in the bi-variable analysis was fitted to multivariate analysis, and significance was declared at p <= 0.05. Then, AHR with 95% CI was used to report the association and test the statistical significance. Finally, texts and tables were used to present the results. Results and Conclusion: The incidence rate of mortality was 58.4 per 1000 child-months of observation with a median survival time of 12 months (95%CI: 9.04-14.96). Communicative hydrocephalus (AHR: 1.99, 95% CI: 1.18-3.36), post-traumatic brain injury (AHR: 7.43, 95% CI: 3.21-16.88), emergency surgery (AHR: 1.86, 95% CI: 1.17-3.13) as well as revised shunt procedure (AHR: 8.01, 95% CI: 6.12-13.43) were independent predictors of death. Besides, sunset eye (ARH: 2.01; 95% CI: 1.17-3.47), rapidly increased head size (ARH: 2.05, 95% CI: 1.14-3.37), prolonged antibiotics treatment (AHR: 2.46, 95% CI: 1.82-7.37), and gram-negative infections (AHR: 1.95, 95% CI: 1.60-12.64) were also significantly associated. Hence, health professionals ought to give special attention to patients with identified predictors.	[Wubie, Azene Bantie; Alemu, Yalemgeta Biyazin] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Teshome, Girum Sebsibe; Abebe, Fikirtemariam] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Ayele, Wudie Eneyew] St Peter Specialized Hosp, Addis Ababa, Ethiopia; [Nigussie, Tewodros Mulugeta; Mekonnen, Migbar Sibhat] Dilla Univ, Coll Hlth Sci & Med, Dilla, Ethiopia		Wubie, AB (corresponding author), Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.	melkaye21@gmail.com			Addis Ababa University	The authors would like to thank data collectors, supervisors, and respective hospitals involved in the study for their wholehearted contributions. We also want to appreciate Addis Ababa University that offered the chance and sponsored this study.	Adalberto PMS., 2017, COCHRANE DB SYST REV, V2017; [Anonymous], 2019, POPULATION ADDIS ABA; Baird LC., 2014, PED, V14, P35; Christian EA, 2016, J NEUROSURG-PEDIATR, V17, P278, DOI 10.3171/2015.6.PEDS15132; Drake J., 2014, NEUROSURGERY, V74, P11; Gora NK, 2017, J PEDIATR NEUROSCI, V12, P313, DOI 10.4103/jpn.JPN_23_17; Hanak BW, 2017, PEDIATR NEUROSURG, V52, P381, DOI 10.1159/000452840; Heyman J, 2017, CHILD NERV SYST, V33, P1309, DOI 10.1007/s00381-017-3423-0; Hussain M., 2012, J AYUB MED COLL ABBO, V24, P3; Ibrahimou B., 2015, ADV EPIDEMIOL, V2015, P1; Khan F, 2016, TURK NEUROSURG, V26, P369, DOI 10.5137/1019-5149.JTN.11447-14.1; Khan F, 2013, CHILD NERV SYST, V29, P791, DOI 10.1007/s00381-012-2004-5; Kim Hae Min, 2015, Korean J Neurotrauma, V11, P106, DOI 10.13004/kjnt.2015.11.2.106; Kulkarni AV, 2010, NEUROSURGERY, V67, P588, DOI 10.1227/01.NEU.0000373199.79462.21; Laeke T, 2017, WORLD NEUROSURG, V100, P30, DOI 10.1016/j.wneu.2016.12.112; Lee JK, 2012, INT J INFECT DIS, V16, pE201, DOI 10.1016/j.ijid.2012.05.780; Lee L, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16277; Low David, 2010, Asian J Neurosurg, V5, P7; Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051; Nigim F, 2015, MOL CLIN ONCOL, V3, P1381, DOI 10.3892/mco.2015.627; Paff M, 2018, INTERDISCIP NEUROSUR, V4, P60; Pal SS., 2017, INT SURG J, V4, P1697; Pan P, 2018, J PEDIATR NEUROSCI, V13, P176, DOI 10.4103/jpn.JPN_29_18; Park MK, 2015, J KOREAN NEUROSURG S, V57, P359, DOI 10.3340/jkns.2015.57.5.359; Reddy GK, 2014, WORLD NEUROSURG, V81, P404, DOI 10.1016/j.wneu.2013.01.096; Rinaldo L, 2018, CLIN NEUROL NEUROSUR, V174, P75, DOI 10.1016/j.clineuro.2018.09.009; Segal-Gidan F, 2015, ALLEN I AI P, P44; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Wasserman S., 2014, SOC NETW ANAL METHOD, V41, P220; Woo PYM, 2016, HONG KONG MED J, V22, P410, DOI 10.12809/hkmj154735	30	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.												10.1080/00207454.2021.1986492		SEP 2021	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YM1FT	WOS:000746327600001	34643151				2022-02-06	
J	Guzowski, NS; Hoelzle, JB; McCrea, MA; Nelson, LD				Guzowski, Nicholas S.; Hoelzle, James B.; McCrea, Michael A.; Nelson, Lindsay D.			Differing associations between measures of somatic symptom reporting, personality, and mild traumatic brain injury (mTBI)	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Concussion; mild traumatic brain injury; personality; somatic symptoms	RESTRUCTURED CLINICAL-SCALES; MISERABLE MINORITY; PROLONGED RECOVERY; UNITED-STATES; BRIEF FORM; PSYCHOPATHOLOGY; CONCUSSION; SPORT; SOMATIZATION; PREDICTORS	Objective Somatic complaints are known to complicate recovery after mild traumatic brain injury (mTBI), but the construct is poorly understood due to evolving definitions of associated disorders and uncertainty related to its position within the broader construct network of psychopathology. Methods: To better understand measures of somatic symptom reporting widely used with mTBI patients, we examined relationships between the Brief Symptom Inventory-18 Somatization (SOM) scale, the Minnesota Multiple Personality Inventory-2-Restructured Form Somatic Complaints (RC1) scale, other measures of psychological and personality functioning, and mTBI in both athlete concussion (n = 100) and civilian trauma (n = 75 mTBI, n = 79 orthopedic injury) samples. Results: The association between post-injury SOM and RC1 was moderate (r=.37-.46) and similar to associations between these inventories and depression and anxiety symptoms. In civilians with mTBI, RC1 was more strongly associated with diverse personality dimensions than SOM. mTBI athletes reported increases in somatic symptoms from pre- to post-injury, with larger group effect sizes on SOM (eta p(2) = 0.34, p < .001) than RC1 (eta p(2) = 0.09, p = .003). Civilian mTBI patients showed a trend for somewhat higher post-injury RC1 scores than orthopedic trauma controls (eta p(2) = 0.02, p = .068). Conclusions: Findings add to the current knowledge of the influence of somatic complaints in mTBI. BSI-18 SOM and MMPI-2-RF RC1 are not interchangeable, as they are only modestly correlated and demonstrate differing associations with other clinical outcomes and mTBI.	[Guzowski, Nicholas S.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Hoelzle, James B.] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA		Nelson, LD (corresponding author), Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53005 USA.	linelson@mcw.edu			US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-0004]; Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment of the Medical College of Wisconsin; Clinical for Advancing Translational Sciences [1ULI-RR031973 (-01)]; National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [8ULITR000055, UL1TR001436]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110856]	This work was supported by the US Army Medical Research and Material Command (award No. W81XWH-12-0004), the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research (award No. W81XWH-14-1-0561), and the Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment of the Medical College of Wisconsin. The REDCap electronic database used for this project was supported by the Clinical for Advancing Translational Sciences (grant 1ULI-RR031973 (-01)), and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), (grants 8ULITR000055 and UL1TR001436). Dr. Nelson also acknowledges funding from the National Institute of Neurological Disorders and Stroke, award #R01 NS110856. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense, NIH, or other funding agencies.	Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Archer R.P., 2016, MINNESOTA MULTIPHASI; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Cohen J., 2013, STAT POWER ANAL BEHA; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Hoelzle JB, 2008, J PERS ASSESS, V90, P443, DOI 10.1080/00223890802248711; Hoelzle JB, 2009, J PERS ASSESS, V91, P175, DOI 10.1080/00223890802634316; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Kotov R, 2011, ARCH GEN PSYCHIAT, V68, P1003, DOI 10.1001/archgenpsychiatry.2011.107; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krueger RF, 2003, J ABNORM PSYCHOL, V112, P437, DOI 10.1037/0021-843X.112.3.437; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee I. A., 2013, CALCULATION TEST DIF; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Marek RJ, 2020, J ABNORM PSYCHOL, V129, P162, DOI 10.1037/abn0000475; Markon KE, 2005, ARCH GEN PSYCHIAT, V62, P1352, DOI 10.1001/archpsyc.62.12.1352; Markon KE, 2013, J PERS DISORD, V27, P554, DOI 10.1521/pedi.2013.27.5.554; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNulty JL, 2014, J PERS ASSESS, V96, P151, DOI 10.1080/00223891.2013.840305; MIDUS, 2018, MIDL US NAT STUD HLT; Nelson LD, 2021, J ABNORM PSYCHOL, V130, P423, DOI 10.1037/abn0000672; Nelson LD, 2018, J NEUROTRAUM, V35, P249, DOI 10.1089/neu.2017.4988; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Parker HA, 2021, J INT NEUROPSYCH SOC, V27, P992, DOI 10.1017/S1355617720001423; Patrick CJ, 2013, PSYCHOL ASSESSMENT, V25, P1332, DOI 10.1037/a0034864; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schnurr, 2013, PTSD CHECKLIST DSM 5; Sellbom M, 2005, J PERS ASSESS, V85, P179, DOI 10.1207/s15327752jpa8502_10; Sellbom M, 2017, J PERS ASSESS, V99, P341, DOI 10.1080/00223891.2016.1206909; Simms LJ, 2005, PSYCHOL ASSESSMENT, V17, P345, DOI 10.1037/1040-3590.17.3.345; Skodol A.V., 2013, PERSONALITY INVENTOR; Smith RC, 2006, J GEN INTERN MED, V21, P671, DOI 10.1111/j.1525-1497.2006.00460.x; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; WechslerD, 2001, WECHSLER TEST ADULT; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133	49	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1985617		SEP 2021	18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WC8YT	WOS:000704538600001	34615438				2022-02-06	
J	Mitchell, RJ; Cameron, CM; McMaugh, A; Lystad, RP; Badgery-Parker, T; Ryder, T				Mitchell, Rebecca J.; Cameron, Cate M.; McMaugh, Anne; Lystad, Reidar P.; Badgery-Parker, Tim; Ryder, Tayhla			The impact of childhood injury and injury severity on school performance and high school completion in Australia: a matched population-based retrospective cohort study	BMC PEDIATRICS			English	Article						Injury; Academic performance; School completion	TRAUMATIC BRAIN-INJURY; ACADEMIC-ACHIEVEMENT; CHILDREN; OUTCOMES; PREDICTORS; STUDENTS; SUPPORT; TRENDS	Background Exploring the impact of injury and injury severity on academic outcomes could assist to identify characteristics of young people likely to require learning support services. This study aims to compare scholastic performance and high school completion of young people hospitalised for an injury compared to young people not hospitalised for an injury by injury severity; and to examine factors influencing scholastic performance and school completion. Method A population-based matched case-comparison cohort study of young people aged <= 18 years hospitalised for an injury during 2005-2018 in New South Wales, Australia using linked birth, health, education and mortality records. The comparison cohort was matched on age, gender and residential postcode. Generalised linear mixed modelling examined risk of performance below the national minimum standard (NMS) on the National Assessment Plan for Literacy and Numeracy (NAPLAN) and generalised linear regression examined risk of not completing high school for injured young people compared to matched peers. Results Injured young people had a higher risk of not achieving the NMS compared to their matched peers for numeracy (ARR: 1.12; 95%CI 1.06-1.17), reading (ARR: 1.09; 95%CI 1.04-1.13), spelling (ARR: 1.13; 95%CI 1.09-1.18), grammar (ARR: 1.11; 95%CI 1.06-1.15), and writing (ARR: 1.07; 95%CI 1.04-1.11). As injury severity increased from minor to serious, the risk of not achieving the NMS generally increased for injured young people compared to matched peers. Injured young people had almost twice the risk of not completing high school at year 10 (ARR: 2.17; 95%CI 1.73-2.72), year 11 (ARR: 1.95; 95%CI 1.78-2.14) or year 12 (ARR: 1.93; 95%CI 1.78-2.08) compared to matched peers. Conclusions The identification of characteristics of young people most likely to encounter problems in the academic environment after sustaining an injury is important to facilitate the potential need for learning support. Assessing learning needs and monitoring return-to-school progress post-injury may aid identification of any ongoing learning support requirements.	[Mitchell, Rebecca J.; Lystad, Reidar P.; Badgery-Parker, Tim; Ryder, Tayhla] Macquarie Univ, Fac Med Hlth & Human Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia; [Cameron, Cate M.] Royal Brisbane & Womens Hosp, Metro North Hosp & Hlth Serv Dist, Jamieson Trauma Inst, Brisbane, Qld, Australia; [Cameron, Cate M.] Queensland Univ Technol QUT, Ctr Healthcare Transformat, Australian Ctr Hlth Serv Innovat AusHSI, Brisbane, Qld, Australia; [McMaugh, Anne] Macquarie Univ, Macquarie Sch Educ, Sydney, NSW, Australia		Mitchell, RJ (corresponding author), Macquarie Univ, Fac Med Hlth & Human Sci, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia.	r.mitchell@mq.edu.au	; Badgery-Parker, Tim/C-3529-2012; Mitchell, Rebecca/J-6105-2012	Ryder, Tayhla/0000-0002-8761-4552; Lystad, Reidar/0000-0003-0506-0902; Badgery-Parker, Tim/0000-0002-1275-1130; Mitchell, Rebecca/0000-0003-1939-1761	philanthropic donor to Macquarie University	This study was funded by a philanthropic donor to Macquarie University.	ACARA, 2017, NAT ASS PROGR LIT NU; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Australian Bureau of Statistics, 2014, 1270055005 AUSTR STA, V5; Australian Bureau of Statistics (ABS), 2011, CENS POP HOUS SOC IN; Australian Curriculum Assessment and Reporting Authority, 2011, NAT ASS PROGR LIT NU; Australian Curriculum Assessment and Reporting Authority, 2014, NAT ASS PROGR LIT NU; Australian Curriculum Assessment and Reporting Authority, 2019, NAT ASS PROGR LIT NU; Australian Curriculum Assessment and Reporting Authority, 2021, NAT ASS PROGR LIT NU; Australian Institute of Health and Welfare, 2016, AUSTR HOSP 2014 15 G; Azzam N, 2018, ARCH DIS CHILD, V103, P444, DOI 10.1136/archdischild-2017-313355; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Crump C, 2013, ANN EPIDEMIOL, V23, P179, DOI 10.1016/j.annepidem.2013.01.001; Dayal S., 2008, MAPPING INJURY SEVER; De Netto RK, 2020, DISABIL REHABIL, V42, P2444, DOI 10.1080/09638288.2019.1637948; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Do VQ, 2020, INJURY, V51, P1769, DOI 10.1016/j.injury.2020.05.035; Edwards JD, 2012, CRIT CARE MED, V40, P2196, DOI 10.1097/CCM.0b013e31824e68cf; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Foster K, 2019, INJURY, V50, P1605, DOI 10.1016/j.injury.2019.05.003; Foster K, 2019, INJURY, V50, P1082, DOI 10.1016/j.injury.2019.01.004; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 2018, BRAIN INJURY, V32, P608, DOI 10.1080/02699052.2018.1433329; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Hoffmann I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194846; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Leach LS, 2012, PSYCHIAT RES, V199, P51, DOI 10.1016/j.psychres.2012.03.040; Maslow GR, 2011, ARCH PEDIAT ADOL MED, V165, P256, DOI 10.1001/archpediatrics.2010.287; Miller CM, 2013, J TRAUMA ACUTE CARE, V75, P250, DOI 10.1097/TA.0b013e3182930fb7; Mitchell R, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000530; Mitchell RJ, 2018, INJURY PREV, V24, P344, DOI 10.1136/injuryprev-2017-042451; Mitchell RJ, 2017, INJURY, V48, P1776, DOI 10.1016/j.injury.2017.06.002; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Woodward M., 2005, EPIDEMIOLOGY STUDY D; World Health Organization, 2017, VIOL INJ PREV; World Health Organization and Unicef, 2008, WORLD REPORT CHILD I	50	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2431		BMC PEDIATR	BMC Pediatr.	SEP 25	2021	21	1							426	10.1186/s12887-021-02891-x			14	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	UU7XT	WOS:000699010100003	34563157	gold, Green Published			2022-02-06	
J	Phaphuangwittayakul, A; Guo, Y; Ying, FL; Dawod, AY; Angkurawaranon, S; Angkurawaranon, C				Phaphuangwittayakul, Aniwat; Guo, Yi; Ying, Fangli; Dawod, Ahmad Yahya; Angkurawaranon, Salita; Angkurawaranon, Chaisiri			An optimal deep learning framework for multi-type hemorrhagic lesions detection and quantification in head CT images for traumatic brain injury	APPLIED INTELLIGENCE			English	Article; Early Access						Traumatic brain injury; Medical imaging; Computed tomography; Deep learning; Brain lesion segmentation; Quantitative assessment algorithm		Traumatic Brain Injury (TBI) could lead to intracranial hemorrhage (ICH), which has now been identified as a major cause of death after trauma if it is not adequately diagnosed and properly treated within the first 24 hours. CT examination is widely preferred for urgent ICH diagnosis, which enables the fast identification and detection of ICH regions. However, the use of it requires the clinical interpretation by experts to identify the subtypes of ICH. Besides, it is unable to provide the details needed to conduct quantitative assessment, such as the volume and thickness of hemorrhagic lesions, which may have prognostic importance to the decision-making on emergency treatment. In this paper, an optimal deep learning framework is proposed to assist the quantitative assessment for ICH diagnosis and the accurate detection of different subtypes of ICH through head CT scan. Firstly, the format of raw input data is converted from 3D DICOM to NIfTI. Secondly, a pre-trained multi-class semantic segmentation model is applied to each slice of CT images, so as to obtain a precise 3D mask of the whole ICH region. Thirdly, a fine-tuned classification neural network is employed to extract the key features from the raw input data and identify the subtypes of ICH. Finally, a quantitative assessment algorithm is adopted to automatically measure both thickness and volume via the 3D shape mask combined with the output probabilities of the classification network. The results of our extensive experiments demonstrate the effectiveness of the proposed framework where the average accuracy of 96.21 percent is achieved for three types of hemorrhage. The capability of our optimal classification model to distinguish between different types of lesion plays a significant role in reducing the false-positive rate in the existing work. Furthermore, the results suggest that our automatic quantitative assessment algorithm is effective in providing clinically relevant quantification in terms of volume and thickness. It is more important than the qualitative assessment conducted through visual inspection to the decision-making on emergency surgical treatment.	[Phaphuangwittayakul, Aniwat; Guo, Yi] East China Univ Sci & Technol, Dept Comp Sci & Engn, Shanghai, Peoples R China; [Guo, Yi] Natl Engn Lab Big Data Distribut & Exchange Techn, Shanghai, Peoples R China; [Guo, Yi] Shanghai Engn Res Ctr Big Data & Internet Audienc, Shanghai, Peoples R China; [Ying, Fangli] East China Univ Sci & Technol, Dept Comp Sci & Engn, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Dawod, Ahmad Yahya] Chiang Mai Univ, Int Coll Digital Innovat ICDI, Chiang Mai, Thailand; [Angkurawaranon, Salita] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai, Thailand; [Angkurawaranon, Chaisiri] Chiang Mai Univ, Fac Med, Dept Family Med, Chiang Mai, Thailand		Ying, FL (corresponding author), East China Univ Sci & Technol, Dept Comp Sci & Engn, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.	aniwat.pha@gmail.com; guoyi@ecust.edu.cn; yfangli@ecust.edu.cn; ahmadyahyadawod.a@cmu.ac.th; salita.ang@cmu.ac.th; chaisiri.a@cmu.ac.th	Ying, Fangli/ABE-3342-2021; Angkurawaranon, Chaisiri/I-6140-2015	Ying, Fangli/0000-0001-8390-3229; Angkurawaranon, Chaisiri/0000-0003-4206-9164	National Key Research and Development Program of China [2018YFC0807105]; Science and Technology Committee of Shanghai Municipality (STCSM) [17DZ1101003, 18511106602, 18DZ2252300]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China; International College of Digital Innovation (ICDI), Chiang Mai University; Faculty of Medicine, Chiang Mai University [143-2562]	This research is financially supported by The National Key Research and Development Program of China (grant number 2018YFC0807105) and Science and Technology Committee of Shanghai Municipality (STCSM) (grant numbers 17DZ1101003, 18511106602 and 18DZ2252300). Partially Supported by Open Funding Project of the State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. Study resources and dataset were supported by International College of Digital Innovation (ICDI) and Faculty of Medicine (grant number 143-2562), Chiang Mai University.	Ahuja S, 2021, APPL INTELL, V51, P571, DOI 10.1007/s10489-020-01826-w; Ai ZX, 2019, J VIS COMMUN IMAGE R, V60, P417, DOI 10.1016/j.jvcir.2019.03.013; Ba J., 2015, ICLR; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Burduja M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20195611; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Chi FL, 2014, WORLD J EMERG MED, V5, P203, DOI [10.5847/wjem.j.issn.1920-8642.2014.03.008, 10.5847/wjem.j.1920-8642.2014.03.008]; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Farzaneh Negar, 2017, Annu Int Conf IEEE Eng Med Biol Soc, V2017, P3069, DOI 10.1109/EMBC.2017.8037505; Flanders Adam E, 2020, Radiol Artif Intell, V2, pe190211, DOI 10.1148/ryai.2020190211; Fong R., 2017, J EMERG CRIT CARE ME, V1, P28; Gao K, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101836; Gupta V, 2019, INDIAN J OPHTHALMOL, V67, P659, DOI 10.4103/ijo.IJO_1187_18; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Hssayeni MD, 2020, DATA, V5, DOI 10.3390/data5010014; Huang ZW, 2020, ACOUST AUST, V48, P287, DOI 10.1007/s40857-020-00175-5; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Jiajie He, 2020, ICBET 2020: Proceedings of the 2020 10th International Conference on Biomedical Engineering and Technology, P117, DOI 10.1145/3397391.3397436; Jnawali K, 2018, PROC SPIE, V10575, DOI 10.1117/12.2293725; Jullabussapa N, 2020, AM J NEURORADIOL, V41, P1937, DOI 10.3174/ajnr.A6731; Kamnitsas K, 2016, LECT NOTES COMPUT SC, V10154, P138, DOI 10.1007/978-3-319-55524-9_14; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Ko H, 2020, IEEE ENG MED BIO, P1290, DOI 10.1109/EMBC44109.2020.9176162; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuo WC, 2019, P NATL ACAD SCI USA, V116, P22737, DOI 10.1073/pnas.1908021116; Lee H, 2019, NAT BIOMED ENG, V3, P173, DOI 10.1038/s41551-018-0324-9; Li XR, 2016, J NEUROSCI METH, V264, P47, DOI 10.1016/j.jneumeth.2016.03.001; Liu JJ, 2019, EBIOMEDICINE, V43, P454, DOI 10.1016/j.ebiom.2019.04.040; Liu Y, 2019, J VIS COMMUN IMAGE R, V63, DOI 10.1016/j.jvcir.2019.06.012; Makaju S, 2018, PROCEDIA COMPUT SCI, V125, P107, DOI 10.1016/j.procs.2017.12.016; Mansour RF, 2021, NEURAL COMPUT APPL, V33, P13831, DOI 10.1007/s00521-021-06020-8; Monteiro M, 2020, LANCET DIGIT HEALTH, V2, pE314, DOI 10.1016/S2589-7500(20)30085-6; Newman T, 2019, INT MICCAI BRAINL WO, P13; Nguyen HQ, 2020, ARXIV PREPRINT ARXIV; Ouellet MC., 2019, HDB SLEEP DISORDERS; Patel A. S., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-019-55481-4, DOI 10.1038/S41598-019-55481-4]; Qizhe Xie, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P10684, DOI 10.1109/CVPR42600.2020.01070; Remedios SW, 2020, MED PHYS, V47, P89, DOI 10.1002/mp.13880; Ronneberger O., 2015, INT C MEDICAL IMAGE, P234, DOI [10.1007/978-3-319-24574-4_28, DOI 10.1007/978-3-319-24574-4_28]; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Shareh MB, 2021, NEURAL COMPUT APPL, V33, P1559, DOI 10.1007/s00521-020-05055-7; Singh A, 2018, INFORM COMMUNICATION, P375; Sirimaharaj W, 2019, J CRANIO MAXILL SURG, V47, P1563, DOI 10.1016/j.jcms.2019.07.013; Tan MX, 2019, PR MACH LEARN RES, V97; Thay S, 2018, 2018 INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION TECHNOLOGY (ICIIT 2018), P18, DOI 10.1145/3193063.3193073; Wang HB, 2020, IEEE MULTIMEDIA, V27, P112, DOI 10.1109/MMUL.2020.2999464; Wang HB, 2020, IEEE T VEH TECHNOL, V69, P10484, DOI 10.1109/TVT.2020.3009162; Ying F, 2021, IEEE T MULTIMED, DOI [10.1109/TMM.2021.3077729, DOI 10.1109/TMM.2021.3077729]; Zhang T, 2021, APPL INTELL, V51, P7679, DOI 10.1007/s10489-021-02271-z; Zhou Zongwei, 2018, Deep Learn Med Image Anal Multimodal Learn Clin Decis Support (2018), V11045, P3, DOI 10.1007/978-3-030-00889-5_1	51	0	0	10	10	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-669X	1573-7497		APPL INTELL	Appl. Intell.												10.1007/s10489-021-02782-9		SEP 2021	19	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	UU7XB	WOS:000699008300001	34764620	Green Published, Bronze			2022-02-06	
J	Zhao, T; Zhang, JY; Wang, ZC; Alturki, R				Zhao, Tong; Zhang, Jingyi; Wang, Zuocan; Alturki, Ryan			An improved deep learning mechanism for EEG recognition in sports health informatics	NEURAL COMPUTING & APPLICATIONS			English	Article; Early Access						Deep learning; EEG signal; Convolutional neural network (CNN); Recurrent neural network (RNN); Health informatics	CLASSIFICATION; ELECTROCARDIOGRAM; FEATURES	A growing number of studies indicate that concussed athletes may have long-term residual electroencephalography (EEG) defects that can last up to ten years after the injury. With the use of conventional concussion screening techniques, these abnormalities are often ignored. As a result, returning to sports earlier can result in recurrent concussions, raising the risk of recurrent concussions with more severe consequences. This study uses deep learning methods to analyze the EEG signals of athletes. It then proposes and designs a channel attention module connected to the input layer of the convolutional neural network (CNN). The proposed approach automatically learns the EEG signals of different channels for recognizing the contribution of the task. The CNN is then connected to the recurrent neural network (RNN) for further processing. Based on this approach, this study combines the residual unit and the channel attention model to propose a convolutional recurrent neural network (CRNN) structure that is highly effective for EEG signal recognition. In this study, the EEG dataset of the Stanford research project has been used for experimental analysis. The performance of the proposed scheme is evaluated with the help of various performance measures. The experimental result shows that the proposed model improves the recognition accuracy from 82.58% of ResNet13 to 85.68% and attained excellent recognition accuracy of 91.05% by using CAMResNet13 + CRNN architecture.	[Zhao, Tong; Zhang, Jingyi] Henan Univ Chinese Med, Sch Phys Educ, Zhengzhou 450046, Henan, Peoples R China; [Wang, Zuocan] Linyi Univ, Sch Sports & Hlth, Linyi 276000, Shandong, Peoples R China; [Alturki, Ryan] Umm Al Qura Univ, Coll Comp & Informat Syst, Dept Informat Sci, Mecca, Saudi Arabia		Wang, ZC (corresponding author), Linyi Univ, Sch Sports & Hlth, Linyi 276000, Shandong, Peoples R China.	2111516032@e.gzhu.edu.cn; zpsheng163@163.com; wangzuocan@lyu.edu.cn; rmturki@uqu.edu.sa	Alturki, Ryan/AAP-8432-2021	Alturki, Ryan/0000-0002-0967-1885	Humanities and Social Science Research Project of Henan Provincial [2021-ZZJH-200]; Special Fund for the Introduction and Training of High-level Talents of Henan University of Chinese Medicine [00104311-2020-1]; Department of EducationUS Department of Education	This paper is supported by Humanities and Social Science Research Project of Henan Provincial; Department of Education Subject Number: 2021-ZZJH-200 and Special Fund for the Introduction and Training of High-level Talents of Henan University of Chinese Medicine: 00104311-2020-1.	Ahangi A, 2013, NEURAL COMPUT APPL, V23, P1319, DOI 10.1007/s00521-012-1074-3; Ang KK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00039; Ashok A, 2013, 2013 INTERNATIONAL CONFERENCE ON CONTROL COMMUNICATION AND COMPUTING (ICCC), P315, DOI 10.1109/ICCC.2013.6731671; Cui Z, 2019, RES EEG SIGNAL ANAL; Dash S., 2020, DEEP LEARNING TECHNI; Gumuslu Elif, 2020, ICMI '20 Companion: Companion Publication of the 2020 International Conference on Multimodal Interaction, P379, DOI 10.1145/3395035.3425199; Guohang F., 2019, ELECTRON WORLD, V568, P54; Hongtao W., 2019, CONTROL THEORY APPL, V036, P589; Hongyu L, 2019, IND INNOV RES; Jan MA, 2021, IEEE T IND INFORM, V17, P5829, DOI [10.1109/TII.2020.3043802, 10.1109/tii.2020.3043802]; Jiancheng L., 1999, APPL ELECT TECHNOL, V07, P14; Jiang XG, 2019, J MED IMAG HEALTH IN, V9, P63, DOI 10.1166/jmihi.2019.2541; Jingxia C., 2019, COMPUT ENG APPL, V55, P109; Lee HK, 2018, 2018 32ND INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN), P906, DOI 10.1109/ICOIN.2018.8343254; Li T., 2019, COMPUT ENG APPL, V055, P99; Liu FF, 2018, J MED IMAG HEALTH IN, V8, P1368, DOI 10.1166/jmihi.2018.2442; Liu YL, 2018, J MED IMAG HEALTH IN, V8, P1502, DOI 10.1166/jmihi.2018.2462; Lu SY, 2018, J MED IMAG HEALTH IN, V8, P1486, DOI 10.1166/jmihi.2018.2459; Mao X, 2005, J BEIJING U AERON AS; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Siuly, 2014, COMPUT METH PROG BIO, V113, P767, DOI [10.1016/j.cmpb.2013.17.070, 10.1016/j.cmpb.2013.12.020]; Siuly S, 2012, IEEE T NEUR SYS REH, V20, P526, DOI 10.1109/TNSRE.2012.2184838; Subasi A, 2007, EXPERT SYST APPL, V32, P1084, DOI 10.1016/j.eswa.2006.02.005; Tabar YR, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2560/14/1/016003; Xianlun T., 2020, ACTA ELECT SIN, V042, P1041; Xungung M, 2020, RECOGNITION MULTICLA; Yang HJ, 2015, IEEE ENG MED BIO, P2620, DOI 10.1109/EMBC.2015.7318929; Yang SH, 2020, COMPUT BIOL MED, V119, DOI 10.1016/j.compbiomed.2020.103671; Yu M, 2021, NEURAL COMPUT APPL, DOI 10.1007/s00521-021-05933-8; Yu Xu, 2021, IEEE J Biomed Health Inform, VPP, DOI 10.1109/JBHI.2021.3069629; Yu X, 2018, KNOWL-BASED SYST, V141, P80, DOI 10.1016/j.knosys.2017.11.010; Yuetian L, 2019, APPL CONVOLUTIONAL N; Zhang J, 2018, J MED IMAG HEALTH IN, V8, P1757, DOI 10.1166/jmihi.2018.2530; Zhao Z, 2019, IEEE ACCESS	34	0	0	7	7	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0941-0643	1433-3058		NEURAL COMPUT APPL	Neural Comput. Appl.												10.1007/s00521-021-06118-z		SEP 2021	13	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	UU7WL	WOS:000699006700004					2022-02-06	
J	Attwood, MJ; Hudd, LJW; Roberts, SP; Irwin, G; Stokes, KA				Attwood, Matthew J.; Hudd, Lewis-Jon W.; Roberts, Simon P.; Irwin, Gareth; Stokes, Keith A.			Eight Weeks of Self-Resisted Neck Strength Training Improves Neck Strength in Age-Grade Rugby Union Players: A Pilot Randomized Controlled Trial	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article; Early Access						concussion; neck strength; rugby football; injury prevention	INJURY-PREVENTION; INTERRATER RELIABILITY; MUSCULOSKELETAL INJURY; CERVICAL RANGE; PROGRAM; CONCUSSION; MOVEMENT; SPORTS; IMPACT; MOTION	Background: Greater neck strength is associated with fewer head and neck injuries. Neck-strengthening programs are commonly burdensome, requiring specialist equipment or significant time commitment, which are barriers to implementation. Hypothesis: Completing a neck-strengthening program will increase isometric neck strength in age-group rugby players. Study Design: A pilot randomized controlled exercise intervention study. Methods: Twenty-eight U18 (under 18) male regional age-group rugby union players were randomized (intervention n =15/control n = 13). An 8-week exercise program was supervised during preseason at the regional training center. Control players continued their "normal practice," which did not include neck-specific strengthening exercises. The 3-times weekly trainer-led intervention program involved a series of 15-second self-resisted contractions, where players pushed maximally against their own head, in forward, backward, left, and right directions. Outcome Measure: Peak isometric neck strength (force N) into neck flexion, extension, and left and right side flexion was measured using a handheld dynamometer. Results: Postintervention between-group mean differences (MDs) in isometric neck strength change were adjusted for baseline strength and favored the intervention for total neck strength (effect size [ES] = 1.2, MD +/- 95% CI = 155.9 +/- 101.9 N, P = 0.004) and for neck strength into extension (ES = 1.0, MD +/- 95% CI = 59.9 +/- 45.4 N, P = 0.01), left side flexion (ES = 0.7, MD +/- 95% CI = 27.5 +/- 26.9 N, P = 0.05), and right side flexion (ES = 1.3, MD +/- 95% CI = 50.5 +/- 34.4 N, P = 0.006). Conclusion: This resource-efficient neck-strengthening program has few barriers to implementation and provides a clear benefit in U18 players' neck strength. While the present study focused on adolescent rugby players, the program may be appropriate across all sports where head and neck injuries are of concern and resources are limited.	[Attwood, Matthew J.; Hudd, Lewis-Jon W.; Irwin, Gareth] Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cyncoed Rd, Cardiff CF23 6XD, Wales; [Roberts, Simon P.; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Stokes, Keith A.] Rugby Football Union, Twickenham, England		Attwood, MJ (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cyncoed Rd, Cardiff CF23 6XD, Wales.	mattwood@cardiffmet.ac.uk					Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Barrett MD, 2015, OPEN ACCESS J SPORTS, V6, P137, DOI 10.2147/OAJSM.S74622; Cazzola D., 2016, P 33 INT C BIOM SPOR, P559; Chiu TTW, 2002, CLIN REHABIL, V16, P851, DOI 10.1191/0269215502cr550oa; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd Edn; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Conley MS, 1997, J APPL PHYSIOL, V83, P2105, DOI 10.1152/jappl.1997.83.6.2105; Cross M, 2017, BRIT J SPORT MED, V51, P309; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Davies M, 2016, PHYS THER SPORT, V19, P36, DOI 10.1016/j.ptsp.2015.10.001; Dempsey AR., 2016, P 33 INT C BIOM SPOR, P551; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fuller CW, 2019, SPORTS MED, V49, P621, DOI 10.1007/s40279-019-01083-z; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Geary K, 2014, CLIN J SPORT MED, V24, P502, DOI 10.1097/JSM.0000000000000071; Hamilton DF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004975; Hamilton DF., 2010, P PHYSIOTHERAPY RES; Hamlin MJ, 2020, J SPORT EXERC SCI, V4, P33; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; McKay CD, 2016, BRIT J SPORT MED, V50, P382, DOI 10.1136/bjsports-2015-095192; Moore IS, 2018, BRIT J SPORT MED, V52, P1137, DOI 10.1136/bjsports-2016-097040; Naish R, 2013, J SPORT SCI MED, V12, P542; O'Brien J, 2014, SPORTS MED, V44, P1305, DOI 10.1007/s40279-014-0208-4; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Raftery M., 2021, BR J SPORTS MED, V55, P527; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Rugby Football Union, WOM RUGB INJ SURV PR; Rugby Football Union, 2017, ACT AD INJ PREV EX P; Rugby Football Union, BUCS SUP RUGB INJ SU; Salmon DM, 2018, J SPORT MED PHYS FIT, V58, P1078, DOI 10.23736/S0022-4707.17.07070-0; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Versteegh T, 2015, PHYSIOTHER CAN, V67, P58, DOI 10.3138/ptc.2013-66; WADSWORTH CT, 1992, J ORTHOP SPORT PHYS, V16, P74, DOI 10.2519/jospt.1992.16.2.74; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191	36	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health											19417381211044736	10.1177/19417381211044736		SEP 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WA7SK	WOS:000703085100001	34558993				2022-02-06	
J	Chojak, R; Kozba-Gosztyla, M; Pawlowski, M; Czapiga, B				Chojak, Rafal; Kozba-Gosztyla, Marta; Pawlowski, Mateusz; Czapiga, Bogdan			Deterioration After Mild Traumatic Brain Injury: A Single-Center Experience With Cost Analysis	FRONTIERS IN NEUROLOGY			English	Article						deterioration; neurosurgical intervention; neurotraumatology; healthcare cost; mild TBI; neurosurgical observation; MTBI	VALIDATION; RISK	Background: Most traumatic brain injuries (TBIs) are mild (GCS score of 13-15). Patients with mild TBI (mTBI) are generally in good condition. In some cases, a neurological deterioration (manifested by a drop of >= 1 point in GCS score) can occur and neurosurgical intervention (NI) may be needed. Because of that, these patients are frequently admitted to a hospital for observation. The aim of our study was to determine the number of patients with mTBI that deteriorate or need NI. We also considered an economic aspect of hospital admissions of these patients. Methods: The study group consisted of 186 adult patients admitted to the neurosurgical department due to mTBI. Patients were divided into three groups according to an initial GCS score. The occurrence of deterioration, need for NI, length of stay (LOS), cost of stay and occurrence of death were analyzed. Results: The deterioration was observed in 7 (3.76%) out of all cases. In 3 (1.61%) of them, the NI was needed. The average LOS was 7.96 days and it was closely linked with an initial GCS score (p < 0.001). The total cost of stay of all patients included in this study was about 1,188,668 PLN (306,357 USD). Conclusion: The deterioration occurred in a small number of patients with mTBI, the need for NI was even less common. Hospitalization of these patients is expensive. Further studies with prognostic model helping decide on admission/discharge are necessary.	[Chojak, Rafal] Wroclaw Med Univ, Fac Med, Wroclaw, Poland; [Kozba-Gosztyla, Marta; Pawlowski, Mateusz; Czapiga, Bogdan] 4th Mil Hosp Wroclaw, Dept Neurosurg, Wroclaw, Poland; [Pawlowski, Mateusz; Czapiga, Bogdan] Wroclaw Med Univ, Fac Hlth Sci, Dept Nervous Syst Dis, Wroclaw, Poland		Chojak, R (corresponding author), Wroclaw Med Univ, Fac Med, Wroclaw, Poland.	rafalchojak@gmail.com		Czapiga, Bogdan/0000-0002-9819-2455			Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	20	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 24	2021	12								588429	10.3389/fneur.2021.588429			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WD7BN	WOS:000705092600001	34630266	Green Published, gold			2022-02-06	
J	Egerod, I; Poulsen, I; Langhorn, L; Aadal, L				Egerod, Ingrid; Poulsen, Ingrid; Langhorn, Leanne; Aadal, Lena			Inclusion, delivery, assessment, and outcomes in longitudinal research on sleep disturbance and agitation in TBI-rehabilitation: lessons learned and future considerations	BRAIN INJURY			English	Article; Early Access						Agitation; outcomes research; rehabilitation; sleep disturbance; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SCALE; SCORE; IMPLEMENTATION; VALIDATION; SEVERITY; DELIRIUM	Purpose This article presents some issues for consideration before scaling from a pilot study to a larger investigation in longitudinal observational studies of traumatic brain injury (TBI) rehabilitation. Materials and methods We present a case to discuss protocol improvements in longitudinal TBI-rehabilitation studies. The case was a pilot study conducted at two university hospitals in Denmark investigating 1-year outcomes related to sleep disturbance and agitation during neurointensive care. We included patients with moderate and severe TBI determined by the Glasgow Coma Scale, sleep disturbance was assessed using actigraphy, and agitation was assessed using the Agitated Behavior Scale. Results Patients (n = 29) were more severely ill and had poorer six-month outcomes in Eastern vs. Western Denmark. Recovery was similar at one-year follow-up. Protocol improvements were needed in relation to inclusion criteria, intervention delivery, patient assessment, and follow-up outcomes. Conclusion In TBI-rehabilitation studies, we suggest adding the severity of disease score to the initial GCS score and a delirium detection score to the ABS score. Actigraphy should not be used during deep sedation. Established procedures should be in place along all stages of the study protocol, including preparation and periodic assessment of study nurses to optimize data quality.	[Egerod, Ingrid] Univ Copenhagen, Rigshosp, Dept Intens Care, Copenhagen, Denmark; [Poulsen, Ingrid] Copenhagen Univ Hosp, Rigshosp, Dept Neurorehabil, Hvidovre, Denmark; [Langhorn, Leanne] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care, Aarhus, Denmark; [Aadal, Lena] Hammel Neurorehabil & Res Ctr, Hammel, Denmark		Egerod, I (corresponding author), Univ Copenhagen, Rigshosp, Intens Care Unit, 4131,Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	ingrid.egerod@regionh.dk	aadal, lena/U-9172-2017	aadal, lena/0000-0001-7365-3916; Poulsen, ingrid/0000-0002-0342-017X; Egerod, Ingrid/0000-0002-9576-4390			Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Collet MO, 2019, AUST CRIT CARE, V32, P299, DOI 10.1016/j.aucc.2018.07.001; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davies P, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-14; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Langhorn L, 2015, J NEUROSCI NURS, V47, pE2, DOI 10.1097/JNN.0000000000000106; Larsen LK, 2020, ACTA ANAESTH SCAND, V64, P1469, DOI 10.1111/aas.13682; Larsen LK, 2020, INTENS CRIT CARE NUR, V59, DOI 10.1016/j.iccn.2020.102816; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lin K., 2020, RANCHOS AMIGOS STATP; Lindahl B, 2015, CRIT CARE NURS Q, V38, P393, DOI 10.1097/CNQ.0000000000000087; Linnan L, 2002, PROCESS EVALUATION P, DOI DOI 10.7326/M18-0850; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; National Academies of Sciences E Medicine Health Medicine D, 2019, BOARD HLTH CARE S CO; Poulsen I, 2021, AUST CRIT CARE, V34, P76, DOI 10.1016/j.aucc.2020.05.006; Poulsen I, 2018, J REHABIL MED, V50, P165, DOI 10.2340/16501977-2300; Rakhit S, 2021, SEMIN RESP CRIT CARE, V42, P127, DOI 10.1055/s-0040-1716493; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Stalnacke BM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9216931; Sveen U, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1773940; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; TEASDALE G, 1974, LANCET, V2, P81; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yavuz-Kodat E, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00551	37	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1978546		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UT7AL	WOS:000698265500001	34550819				2022-02-06	
J	Liu, HB; Xu, WM; Wang, SS; Wei, LF; Hong, JF; Wang, C; Xian, L				Liu, Hai-Bing; Xu, Wei-Ming; Wang, Shou-Sen; Wei, Liang-Feng; Hong, Jing-Fang; Wang, Cheng; Xian, Liang			Analysis of changes in the volume of edema around brain contusions and the influencing factors A single-center, retrospective, observational study	MEDICINE			English	Article						3D slicer software; angiogenesis; brain contusion; brain edema volume; d-dimer; fibrinogen; venous return	CEREBRAL EDEMA; INJURY; COAGULOPATHY	Traumatic brain injury (TBI), a common neurosurgical condition, has well-known treatment guidelines. However, the mechanisms underlying the varying severity of brain edema secondary to TBI are largely unknown, leading to controversial treatments. This study seeks to measure edema volumes around brain contusions in different regions, analyze factors related to differences in edema volume and provide a theoretical basis for brain edema treatment. Data from 113 brain contusion patients treated at the Department of Neurosurgery of Fuzhou General Hospital from January 2017 to November 2019 were analyzed retrospectively. Based on computed tomography (CT) data, the patients were divided into the venous group (brain contusion in regions with large cortical veins, n = 47) and the nonvenous group (brain contusions in other regions, n = 66). Here, 3D Slicer software was used to calculate the brain contusion volume on the first CT obtained after injury and the brain contusion volume and its surrounding edema on the 5th day after injury. The brain contusion volume to surrounding edema volume ratio was calculated, and the number of patients who showed brain contusion progression requiring surgery was determined. Hematocrit (Hct), fibrinogen (Fg), and d-dimer levels within 6 hours and on the 5th day after admission were also compared. Patients in the venous group had a significantly increased percentage of area with edema around the brain contusion compared with patients in the nonvenous group (P < .05), and the 2 groups showed no significant difference in the number of patients with brain contusion progression or surgical treatment (P > .05) or Hct, Fg, or d-dimer (D-D) levels. For all patients, Hct, Fg, and D-D levels within 6 hours after admission were significantly different from those on the 5th day (P < .05 for all). Cortical venous obstruction may be the most important factor influencing edema around brain contusions. The Fg level decreased slightly, and the D-D level increased to its peak rapidly after mild-moderate TBI. This change was followed by a gradual increase in the former and a gradual decrease in the latter.	[Liu, Hai-Bing; Wang, Shou-Sen; Wei, Liang-Feng; Hong, Jing-Fang; Wang, Cheng; Xian, Liang] Fijian Med Univ, Dept Neurosurg, Hosp 900, Fuzong Clin Med Sch, Fuzhou 350025, Fujian, Peoples R China; [Xu, Wei-Ming] Hosp Fuzhou Changle Dist, Dept Neurosurg, Fuzhou, Fujian, Peoples R China		Wang, SS (corresponding author), Fijian Med Univ, Dept Neurosurg, Hosp 900, Fuzong Clin Med Sch, Fuzhou 350025, Fujian, Peoples R China.	wshsen@126.com			Natural Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2018Y0067]; Qihang Fund General Project of Fujian Medical University [2018QH1236]; Major joint funding projects for scientific and technological innovation of Fujian Province of China [2019Y9045]	The Natural Science Foundation of Fujian Province (2018Y0067); Qihang Fund General Project of Fujian Medical University (2018QH1236); and The Major joint funding projects for scientific and technological innovation of Fujian Province of China (2019Y9045).	Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Fair KA, 2021, J NEUROTRAUM, V38, P960, DOI 10.1089/neu.2018.6234; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kim BJ, 2019, ANALYST, V144, P3144, DOI 10.1039/c8an02135j; Kundu B, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.11.132; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Ma XT, 2020, BIOACT MATER, V5, P124, DOI 10.1016/j.bioactmat.2020.01.005; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Netteland DF, 2021, J NEUROSURG, V134, P1912, DOI 10.3171/2020.4.JNS20511; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Passos A, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5111189; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Weitz JI, 2017, J AM COLL CARDIOL, V70, P2411, DOI 10.1016/j.jacc.2017.09.024; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Zusman BE, 2020, CURR TREAT OPTION NE, V22, DOI 10.1007/s11940-020-0614-x	27	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP 24	2021	100	38							e27246	10.1097/MD.0000000000027246			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US9VK	WOS:000697773400043	34559127	Green Published, gold			2022-02-06	
J	Soliman, E; Mills, J; Ju, J; Kaloss, AM; Basso, EKG; Groot, N; Kelly, C; Kowalski, EA; Elhassanny, M; Chen, M; Wang, X; Theus, MH				Soliman, Eman; Mills, Jatia; Ju, Jing; Kaloss, Alexandra M.; Basso, Erwin Kristobal Gudenschwager; Groot, Nathalie; Kelly, Colin; Kowalski, Elizabeth A.; Elhassanny, Mohamed; Chen, Michael; Wang, Xia; Theus, Michelle H.			Conditional Deletion of EphA4 on Cx3cr1-Expressing Microglia Fails to Influence Histopathological Outcome and Blood Brain Barrier Disruption Following Brain Injury	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						neuroinflammation; TMEM119; peripheral monocytes; Eph signaling; innate immune; traumatic brain injury	UP-REGULATION; GENERATION; ACTIVATION; EXPRESSION; EPHRIN-B2; EPHB2	Erythropoietin-producing human hepatocellular receptors play a major role in central nervous system injury. Preclinical and clinical studies revealed the upregulation of erythropoietin-producing human hepatocellular A4 (EphA4) receptors in the brain after acute traumatic brain injury. We have previously reported that Cx3cr1-expressing cells in the peri-lesion show high levels of EphA4 after the induction of controlled cortical impact (CCI) injury in mice. Cx3cr1 is a fractalkine receptor expressed on both resident microglia and peripheral-derived macrophages. The current study aimed to determine the role of microglial-specific EphA4 in CCI-induced damage. We used Cx3cr1(CreER/+) knock-in/knock-out mice, which express EYFP in Cx3cr1-positive cells to establish microglia, EphA4-deficient mice following 1-month tamoxifen injection. Consistent with our previous findings, induction of CCI in wild-type (WT) Cx3cr1(CreER/+)EphA4(+/+) mice increased EphA4 expression on EYFP-positive cells in the peri-lesion. To distinguish between peripheral-derived macrophages and resident microglia, we exploited GFP bone marrow-chimeric mice and found that CCI injury increased EphA4 expression in microglia (TMEM119+GFP-) using immunohistochemistry. Using Cx3cr1(CreER/+)EphA4 (f/f) (KO) mice, we observed that the EphA4 mRNA transcript was undetected in microglia but remained present in whole blood when compared to WT. Finally, we found no difference in lesion volume or blood-brain barrier (BBB) disruption between WT and KO mice at 3 dpi. Our data demonstrate a nonessential role of microglial EphA4 in the acute histopathological outcome in response to CCI.	[Soliman, Eman; Mills, Jatia; Ju, Jing; Kaloss, Alexandra M.; Basso, Erwin Kristobal Gudenschwager; Groot, Nathalie; Kelly, Colin; Kowalski, Elizabeth A.; Elhassanny, Mohamed; Chen, Michael; Wang, Xia; Theus, Michelle H.] Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Soliman, Eman] Zagazig Univ, Fac Pharm, Dept Pharmacol & Toxicol, Zagazig, Egypt; [Theus, Michelle H.] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA; [Theus, Michelle H.] Virginia Tech, Ctr Engn Hlth, Blacksburg, VA 24061 USA		Theus, MH (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Ctr Engn Hlth, Blacksburg, VA 24061 USA.	mtheus@vt.edu			Center for Engineered Health; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS096281, NS119540, NS121103]	We recognize The Center for Engineered Health for grant support cytometry support. This study was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, NS096281, NS119540, and NS121103 (MHT).	Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; Deng XT, 2017, EUR J PAIN, V21, P278, DOI 10.1002/ejp.922; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Du J, 2007, INVEST OPHTH VIS SCI, V48, P5567, DOI 10.1167/iovs.07-0442; Dubbelaar ML, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01753; Ernst AS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0669-7; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P991, DOI 10.1167/iovs.09-3579; Furman NT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68770-0; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hazy A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45089-z; Herrmann JE, 2010, GENESIS, V48, P101, DOI 10.1002/dvg.20587; Holl EK, 2013, METHODS MOL BIOL, V1032, P315, DOI 10.1007/978-1-62703-496-8_24; Honarpisheh P, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02019-5; Jurga AM, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00198; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kowalski EA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1605-2; Lee M, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e5; Li Q, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00520; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Mehta Devang, 2019, Nature, DOI 10.1038/d41586-019-02960-3; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Okyere B, 2020, J CLIN INVEST, V130, P1024, DOI 10.1172/JCI131493; Okyere B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159930; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wei HX, 2019, INFLAMMATION, V42, P572, DOI 10.1007/s10753-018-0914-4; Wes PD, 2016, GLIA, V64, P197, DOI 10.1002/glia.22866; Yang JS, 2018, EXP THER MED, V15, P2219, DOI 10.3892/etm.2018.5702; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu LN, 2017, PAIN PHYSICIAN, V20, pE563; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041	42	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	SEP 24	2021	14								747770	10.3389/fnmol.2021.747770			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WC9OW	WOS:000704580600001	34630039				2022-02-06	
J	Wang, YL; Li, TQ; Liu, JC; Shi, Q; Zhou, C; Yang, CT; Huang, SJ; Chen, Y; Xiong, B				Wang, Yingliang; Li, Tongqiang; Liu, Jiacheng; Shi, Qin; Zhou, Chen; Yang, Chongtu; Huang, Songjiang; Chen, Yang; Xiong, Bin			Endovascular repair of traumatic aortic dissection: a single-center experience	REVIEWS IN CARDIOVASCULAR MEDICINE			English	Article						Aortic dissection; Endovascular aortic repair; Stent; Trauma	LEFT SUBCLAVIAN ARTERY; CLINICAL-PRACTICE-GUIDELINES; THORACIC AORTA; EDITORS CHOICE; INJURY; MANAGEMENT; MORTALITY; COVERAGE; SURGERY; SOCIETY	The data on endovascular aortic repair (EVAR) for traumatic aortic dissection (TAD) are lacking. Hence, this study aimed to evaluate the efficacy of EVAR for TAD and report our experience based on patients from our medical center with a relatively long follow-up. A total of 25 consecutive patients with TAD underwent EVAR from October 2015 to October 2020. The demographics, imaging characteristics, clinical features, treatment details, and follow-up results were reviewed. Urgent EVAR was performed in 3 patients (12%), while the remaining 22 patients (88%) underwent delayed EVAR. Systematic heparinization was used in all patients during the endovascular procedure. The EVAR was technically successful in all patients, with no cases converted into open surgery. No death occurred during the perioperative period. One patient presented with a type II endoleak on postoperative 1-month CT images during a mean follow-up of 42.3 +/- 17.7 months (5-67.5 months) and showed spontaneous regression of the endoleak without any intervention during the subsequent follow-up. All the patients survived until the time of writing, and none of them showed late endoleak, stent migration, paraplegia, and reintervention. The patients with left subclavian artery covered (n = 8) had no obvious ischemia of the arm and brain. The study results demonstrated that EVAR for TAD proved to be safe and effective, and most patients could undergo delayed EVAR. Systematically heparinization during EVAR under the setting of multi-trauma was safe.	[Wang, Yingliang; Li, Tongqiang; Liu, Jiacheng; Shi, Qin; Zhou, Chen; Yang, Chongtu; Huang, Songjiang; Chen, Yang; Xiong, Bin] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430022, Hubei, Peoples R China; [Wang, Yingliang; Li, Tongqiang; Liu, Jiacheng; Shi, Qin; Zhou, Chen; Yang, Chongtu; Huang, Songjiang; Chen, Yang; Xiong, Bin] Hubei Key Lab Mol Imaging, Wuhan 430022, Hubei, Peoples R China		Xiong, B (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan 430022, Hubei, Peoples R China.; Xiong, B (corresponding author), Hubei Key Lab Mol Imaging, Wuhan 430022, Hubei, Peoples R China.	herr_xiong@126.com	Huang, Songjiang/AAB-7942-2022	Huang, Songjiang/0000-0001-5043-7700			Antonello M, 2013, J VASC SURG, V57, P684, DOI 10.1016/j.jvs.2012.08.119; Bae M, 2021, KOREAN J RADIOL, V22, P577, DOI 10.3348/kjr.2020.0989; Cheng YT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7861; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Estrera AL, 2013, J THORAC CARDIOV SUR, V145, pS154, DOI 10.1016/j.jtcvs.2012.11.074; Fox N, 2015, J TRAUMA ACUTE CARE, V78, P136, DOI 10.1097/TA.0000000000000470; Gennai S, 2020, EUR J VASC ENDOVASC, V59, P428, DOI 10.1016/j.ejvs.2019.05.008; Harky A, 2020, J VASC SURG, V71, P270, DOI 10.1016/j.jvs.2019.05.011; Ho VT, 2021, J VASC SURG, V74, P71, DOI 10.1016/j.jvs.2020.12.068; Hundersmarck D, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01432-y; Kaneyuki D, 2019, EUR J CARDIO-THORAC, V56, P307, DOI 10.1093/ejcts/ezz023; Kapoor H, 2020, RADIOGRAPHICS, V40, P1834, DOI 10.1148/rg.2020200066; Klocker J, 2014, J VASC SURG, V60, P64, DOI 10.1016/j.jvs.2014.01.060; Lee CH, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.15; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Li S, 2017, INT ANGIOL, V36, P316, DOI [10.23736/S0392-9590.17.03782, 10.23736/S0392-9590.17.03782-8]; MAGGISANO R, 1995, ANN VASC SURG, V9, P44, DOI 10.1007/BF02015316; Makaloski V, 2021, ANN VASC SURG, V75, P341, DOI 10.1016/j.avsg.2021.01.096; Marcaccio CL, 2018, J VASC SURG, V68, P64, DOI 10.1016/j.jvs.2017.10.084; Pang D, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006642.pub3; Prendes CF, 2021, INTERACT CARDIOV TH, V33, P293, DOI 10.1093/icvts/ivab067; Riambau V, 2017, EUR J VASC ENDOVASC, V53, P4, DOI 10.1016/j.ejvs.2016.06.005; Sepehripour AH, 2011, EUR J VASC ENDOVASC, V41, P758, DOI 10.1016/j.ejvs.2011.01.007; Son SA, 2019, EUR J TRAUMA EMERG S, V45, P965, DOI 10.1007/s00068-019-01166-6; Steuer J, 2015, EUR J VASC ENDOVASC, V50, P460, DOI 10.1016/j.ejvs.2015.05.012; van Prehn J, 2008, J VASC SURG, V47, P1333, DOI 10.1016/j.jvs.2007.12.036; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Yoon WJ, J VASC SURG, V2021	28	0	0	1	1	IMR PRESS	ROBINSON	112 ROBINSON RD, ROBINSON, SINGAPORE	1530-6550	2153-8174		REV CARDIOVASC MED	Rev. Cardiovasc. Med.	SEP 24	2021	22	3					1029	1035		10.31083/j.rcm2203112			7	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	UZ3HQ	WOS:000702099800050	34565104	gold			2022-02-06	
J	Agnihotri, S; Penner, M; Mallory, KD; Xie, L; Hickling, A; Joachimides, N; Widgett, E; Scratch, SE				Agnihotri, Sabrina; Penner, Melanie; Mallory, Kylie D.; Xie, Lucy; Hickling, Andrea; Joachimides, Nicholas; Widgett, Elaine; Scratch, Shannon E.			Healthcare utilization and costs associated with persistent post-concussive symptoms	BRAIN INJURY			English	Article						Healthcare economics; concussion; pediatric; healthcare utilization; interdisciplinary care	TRAUMATIC BRAIN-INJURY; SOCIETAL PERSPECTIVE; INTERVENTION; ONTARIO	Objective To describe the healthcare utilization and costs associated with the interdisciplinary treatment of pediatric persistent post-concussive symptoms (PPCS). Methods A retrospective chart review was conducted with 461 youth referred by community physicians to an interdisciplinary pediatric PPCS outpatient clinic in Ontario, Canada. Healthcare utilization parameters included accessibility, continuity, comprehensiveness, and service productivity. Direct healthcare costs included those incurred by physicians and other interdisciplinary services. Indirect costs per client included travel to the clinic and caregiver productivity loss. Data analyses were completed using descriptive statistics. Results The median age of clients was 15 years (range = 3 to 18). The median wait time for an initial PPCS clinic physician consultation was 71 days, and less than 2 months for other interdisciplinary services. Eighty-two percent of clients were referred to at least one other service after an initial physician consultation. Occupational therapy received the highest proportion of referrals (79%). Total median direct costs per client were approximately $915, with a final accumulated cost of $532 623 for all clients. Caregiver productivity loss was approximately $387 per family. Conclusions Our findings suggest that interdisciplinary PPCS care represents an accessible, comprehensive and cost-saving healthcare model from the client and societal perspectives.	[Agnihotri, Sabrina; Penner, Melanie; Mallory, Kylie D.; Xie, Lucy; Scratch, Shannon E.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Agnihotri, Sabrina] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Penner, Melanie; Scratch, Shannon E.] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Hickling, Andrea; Joachimides, Nicholas; Widgett, Elaine; Scratch, Shannon E.] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Hickling, Andrea] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Scratch, Shannon E.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Agnihotri, S (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	sabrina.agnihotri@mail.utoronto.ca		Hickling, Andrea/0000-0001-6251-6369	Novel Lab	The authors would like to thank all of the children, youth and their families who have been seen through the Pediatric Persistent Concussion Clinic, this research would not be possible without you. We would also like to thank the Pediactric Persistent Concussion Clinic team at Holland Bloorview Kids Rehabilitation Hospital including Cyndy Bryson, Dr. Peter Rumney, Dr. Alysha Ladha, Dr. Ryan Hung, Dr. Janine Hay, Dr. Lily Riggs, Naomi Smith, Debra Moroz, Kim Moody, Erin Kohlmetz, Charlotte Coy and Tess Bardikoff. Lastly, we would like to thank the Novel Lab for their support throughout this project.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bank of Canada, 2021, INFL CALC; Campbell F, 2018, CAN J PAIN, V2, P30, DOI 10.1080/24740527.2017.1415701; Da Silva Roxane Borges, 2011, Healthc Policy, V6, pe106; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Drost RMWA, 2017, INT J TECHNOL ASSESS, V33, P251, DOI 10.1017/S0266462317000526; Graves JM, 2020, J PEDIATR NURS, V51, P15, DOI 10.1016/j.pedn.2019.11.016; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Harris MB, 2019, J HEAD TRAUMA REHAB, V34, P425, DOI 10.1097/HTR.0000000000000544; Ho IK, 2008, J MUSCULOSKELET PAIN, V16, P155, DOI 10.1080/10582450802161853; Hoefgen ER, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0492; Hunt Cindy, 2016, Concussion, V1, pCNC21, DOI 10.2217/cnc-2016-0009; Jonsson B, 2009, EUR J HEALTH ECON, V10, P357, DOI 10.1007/s10198-009-0173-2; Kapadia M, 2019, CURR REV MUSCULOSKE, V12, P57, DOI 10.1007/s12178-019-09533-x; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Ministry of Health and Long-Term Care, 2020, OHIP SCH BEN FEES; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Motiwala Sanober S, 2006, Healthc Policy, V1, P135; Natural Resources Canada, 2020, ENERGY EFFICIENCY TR; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Penner M, 2015, J AUTISM DEV DISORD, V45, P2833, DOI 10.1007/s10803-015-2447-0; Piccininni C, 2017, JAMA PEDIATR, V171, P23, DOI 10.1001/jamapediatrics.2016.2695; Ramage-Morin Pamela L, 2010, Health Rep, V21, P53; Scratch SE, 2019, J HEAD TRAUMA REHAB, V34, P385, DOI 10.1097/HTR.0000000000000542; Starfield B., 2001, PRIMARY CARE BALANCI, V1; Statistics Canada, 2016, CENS PROF 2016; Statistics Canada, 2020, MONTH AV RET PRIC GA; Tumin D, 2018, J PAIN, V19, P973, DOI 10.1016/j.jpain.2018.03.012; Yue JK, 2020, J NEUROSCI RURAL PRA, V11, P23, DOI 10.1055/s-0039-3402581; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	33	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1382	1389		10.1080/02699052.2021.1972151		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000698212000001	34546808				2022-02-06	
J	Coffey, BJ; Threlkeld, ZD; Foulkes, AS; Bodien, YG; Edlow, BL				Coffey, Brian J.; Threlkeld, Zachary D.; Foulkes, Andrea S.; Bodien, Yelena G.; Edlow, Brian L.			Reemergence of the language network during recovery from severe traumatic brain injury: A pilot functional MRI study	BRAIN INJURY			English	Article; Early Access						Traumatic brain injury; language; recovery; functional MRI; consciousness	SPEECH; FMRI; COMPREHENSION; CONNECTIVITY; CONSCIOUSNESS; RELIABILITY; DISORDERS; ANATOMY; DORSAL; ROBUST	Primary Objective We hypothesized that, in patients with acute severe traumatic brain injury (TBI) who recover basic language function, speech-evoked blood-oxygen-level-dependent (BOLD) functional MRI (fMRI) responses within the canonical language network increase over the first 6 months post-injury. Research Design We conducted a prospective, longitudinal fMRI pilot study of adults with acute severe TBI admitted to the intensive care unit. We also enrolled age- and sex-matched healthy subjects. Methods and Procedures We evaluated BOLD signal in bilateral superior temporal gyrus (STG) and inferior frontal gyrus (IFG) regions of interest acutely and approximately 6 months post-injury. Given evidence that regions outside the canonical language network contribute to language processing, we also performed exploratory whole-brain analyses. Main Outcomes and Results Of the 16 patients enrolled, eight returned for follow-up fMRI, all of whom recovered basic language function. We observed speech-evoked longitudinal BOLD increases in the left STG, but not in the right STG, right IFG, or left IFG. Whole-brain analysis revealed increases in the right supramarginal and middle temporal gyri but no differences between patients and healthy subjects (n = 16). Conclusion This pilot study suggests that, in patients with severe TBI who recover language function,speech-evoked BOLD responses in bihemispheric language-processing cortex reemerge by 6 months post-injury.	[Coffey, Brian J.; Threlkeld, Zachary D.; Bodien, Yelena G.; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Harvard Med Sch, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Coffey, Brian J.] Univ Florida, Coll Med, Dept Neurol, Univ Florida Hlth, Gainesville, FL 32611 USA; [Threlkeld, Zachary D.] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Foulkes, Andrea S.] Massachusetts Gen Hosp, Dept Med, Harvard Med Sch, Boston, MA 02114 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA		Bodien, YG (corresponding author), Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, 101 Merrimac St 3rd Floor, Boston, MA 02114 USA.	ybodien@mgh.havard.edu			NIH Director's Office [DP2HD101400]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R21NS109627, RF1NS115268]; James S. McDonnell Foundation; Rappaport Foundation; Tiny Blue Dot Foundation	This work was supported by the NIH Director's Office (DP2HD101400), NIH National Institute of Neurological Disorders and Stroke (K23NS094538, R21NS109627, RF1NS115268), James S. McDonnell Foundation, Rappaport Foundation, and Tiny Blue Dot Foundation.	Acheson DJ, 2013, J COGNITIVE NEUROSCI, V25, P1664, DOI 10.1162/jocn_a_00430; Adapa RM, 2014, HUM BRAIN MAPP, V35, P2935, DOI 10.1002/hbm.22375; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Demir SO, 2006, BRAIN INJURY, V20, P1383, DOI 10.1080/02699050601081844; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fridriksson J, 2016, P NATL ACAD SCI USA, V113, P15108, DOI 10.1073/pnas.1614038114; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Liu XL, 2012, HUM BRAIN MAPP, V33, P2487, DOI 10.1002/hbm.21385; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Murakami T, 2015, J NEUROSCI, V35, P1411, DOI 10.1523/JNEUROSCI.0246-14.2015; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; Otzenberger H, 2005, NEUROPSYCHOLOGY, V19, P484, DOI 10.1037/0894-4105.19.4.484; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Sammler D, 2015, CURR BIOL, V25, P3079, DOI 10.1016/j.cub.2015.10.009; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Scott S., 2000, NEURAL MECH LANGUAGE, P11; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P2041, DOI 10.1016/j.apmr.2020.06.021; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; Tzourio N, 1998, NEUROIMAGE, V8, P1, DOI 10.1006/nimg.1998.0343; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Visser M, 2012, J COGNITIVE NEUROSCI, V24, P1766, DOI 10.1162/jocn_a_00244; Wang FY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0330-7; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yue Q, 2013, NEUROSCIENCE, V237, P87, DOI 10.1016/j.neuroscience.2012.12.067	48	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1972455		SEP 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UT6MX	WOS:000698230300001	34546806				2022-02-06	
J	Dery, J; De Guise, E; Bussieres, EL; Lamontagne, ME				Dery, Julien; De Guise, Elaine; Bussieres, Eve-Line; Lamontagne, Marie-Eve			Prognostic factors for persistent symptoms in adults with mild traumatic brain injury: protocol for an overview of systematic reviews	SYSTEMATIC REVIEWS			English	Article						Overview; Systematic review; Prognosis; Mild traumatic brain injury; Persistent symptoms	POST-CONCUSSION SYMPTOMS; CENTER-TASK-FORCE; RISK-FACTORS; HEAD-INJURY; PREDICTION; AGE	Background: Mild traumatic brain injury (mTBI) is an increasing public health problem that can lead to persistent symptoms that have several functional consequences. Understanding the prognosis of a condition is an important component of clinical decision-making and can help guide the prevention of long-term disabilities of patients with mTBI. Several studies and systematic reviews have been conducted in order to understand prognosis of chronic symptoms following mTBI. We aim to synthesize evidence from systematic reviews on factors that affect the risk of persistent symptoms in mTBI-affected adults. Methods: We will conduct an overview of systematic reviews following steps described in the Cochrane Handbook. We will search in Cochrane, Medline, CINAHL, Embase, PsycINFO, and Epistemonikos for systematic reviews about the prognosis of persistent symptoms following mTBI in the adult population. Two reviewers will independently screen all references and then select eligible reviews based on eligibility criteria. A data extraction grid will be used to extract relevant information. The risk of bias in the included reviews will be assessed using the ROBIS tool. Data will be synthesized into a comprehensive conceptual model in order to have a better understanding of the predictive factors of post-concussion symptoms following mTBI. Discussion: Results will help multiple stakeholders, such as clinicians and rehabilitation program managers, to understand the prognosis of long-term consequences following mTBI. It could guide stakeholders to recognize their patients' prognostic factors and to invest their time and resources in patients who need it the most.	[Dery, Julien; Lamontagne, Marie-Eve] Univ Laval, Dept Rehabil, Pavillon Ferdinand Vandry,Local 2475,1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Dery, Julien; Bussieres, Eve-Line; Lamontagne, Marie-Eve] Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada; [De Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [De Guise, Elaine] McGill Univ Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada; [De Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Bussieres, Eve-Line] Univ Quebec Trois Rivieres, Dept Psychol, 3007 Michel Sarrazin,3600 Rue St Marguerite, Trois Rivieres, PQ G9A 5H7, Canada		Lamontagne, ME (corresponding author), Univ Laval, Dept Rehabil, Pavillon Ferdinand Vandry,Local 2475,1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.; Lamontagne, ME (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada.	marie-eve.lamontagne@fmed.ulaval.ca			Fonds de recherche du Quebec SanteFonds de la Recherche en Sante du Quebec	JD received study grants from the Fonds de recherche du Quebec Sante. MEL and EDG are both Fonds de recherche du Quebec Sante Research Scholars.	Aromataris E, 2015, INT J EVID-BASED HEA, V13, P132, DOI 10.1097/XEB.0000000000000055; Aromataris E, 2014, AM J NURS, V114, P53, DOI 10.1097/01.NAJ.0000444496.24228.2c; Babineau J, 2014, J CAN HEALTH LIBRARI, V35, P68, DOI 10.5596/c14-016; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hartling Lisa, 2014, Evid Based Child Health, V9, P486, DOI 10.1002/ebch.1968; Hartling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049667; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hunt H, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0695-8; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lagace-Legendre C, 2021, J HEAD TRAUMA REHAB, V36, P96, DOI 10.1097/HTR.0000000000000613; Lefebvre C., 2012, INTERTASC INFORM SPE; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lunny C, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0784-8; Lunny C, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0617-1; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mercier E, 2018, J NEUROTRAUM, V35, P609, DOI 10.1089/neu.2017.5013; Mercier E, 2018, BRAIN INJURY, V32, P29, DOI 10.1080/02699052.2017.1385097; Morgan RL, 2018, ENVIRON INT, V121, P1027, DOI 10.1016/j.envint.2018.07.015; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Pieper D, 2014, J CLIN EPIDEMIOL, V67, P368, DOI 10.1016/j.jclinepi.2013.11.007; Pieper D, 2012, J CLIN EPIDEMIOL, V65, P1267, DOI 10.1016/j.jclinepi.2012.06.015; Pollock M., 2021, COCHRANE HDB SYSTEMA; Pollock M, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1252-9; Riley RD, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4597; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI [10.1701/2990.29928, 10.1016/j.jclinepi.2015.06.005]	47	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2046-4053		SYST REV-LONDON	Syst. Rev.	SEP 23	2021	10	1							254	10.1186/s13643-021-01810-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UU2QG	WOS:000698645300001	34556172	gold, Green Published, Green Submitted			2022-02-06	
J	Horan, J; Duddy, JC; Gilmartin, B; Amoo, M; Nolan, D; Corr, P; Ben Husien, M; Bolger, C				Horan, Jack; Duddy, John C.; Gilmartin, Brian; Amoo, Michael; Nolan, Deirdre; Corr, Paula; Ben Husien, Mohammed; Bolger, Ciaran			Neurotrauma admissions and COVID-19: a National Centre experience	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article; Early Access						COVID-19; Neurotrauma; Mortality; Trauma; Traumatic brain injury	EPIDEMIOLOGY; INJURY	Background To investigate the impact of COVID-19 on trauma admissions to a National Neurosurgical Centre in Ireland. Methods Retrospective analysis of a prospectively maintained database of all trauma admissions to the National Neurosurgical Centre at Beaumont Hospital, Dublin, during the period March 1 to May 31, 2019 and 2020. Primary outcome was 30-day mortality rate. Secondary outcomes included time transfer time, time from admission to time of surgery, and intensive care unit (ICU) admissions. Patients under the age of 16 were excluded. Results A total of 32 and 39 patients were admitted to the National Neurosurgical Centre following trauma over the 3-month period in 2020 and 2019 respectively, giving a 17.9% reduction in admissions. The 30-day mortality rate increased from 7.7% in 2019 to 15.6% on 2020 (p = 0.45). Mean transfer time was 4 h 58 min in 2019 and 3 h 55 min in 2020 (0.22). Mean time from admission to time of surgery was 9 h 10 min in 2019 and 5 h 37 min in 2020 respectively (p = 0.35). In 2019, 20 patients (51.3%) were admitted to ICU. This increased to 23 patients (69.7%) in 2020 (p = 0.08). Conclusions Traumatic brain injury 30-day mortality rates increased during the first COVID-19 lockdown period. Trauma admission rates to ICU remained unchanged despite an overall reduction in trauma admissions. Transfer time, time to surgery, and length of stay were impacted by COVID-19. Despite the challenges COVID-19 has posed, it is important to maintain a fully functioning neurosurgical and neurocritical care service during the pandemic.	[Horan, Jack; Duddy, John C.; Gilmartin, Brian; Amoo, Michael; Nolan, Deirdre; Corr, Paula; Ben Husien, Mohammed; Bolger, Ciaran] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland		Horan, J (corresponding author), Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland.	jackhoran27@gmail.com		Amoo, Michael/0000-0001-6886-6714			Ahuja S, 2021, BRIT J NEUROSURG, V35, P181, DOI 10.1080/02688697.2020.1777263; Amoo M, 2021, IRISH J MED SCI, V190, P905, DOI 10.1007/s11845-020-02429-7; Amoo M, 2018, BRIT J NEUROSURG, V32, P585, DOI 10.1080/02688697.2018.1522416; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Antony J, 2020, WORLD NEUROSURG, V139, pE864, DOI 10.1016/j.wneu.2020.05.136; Ashkan K, 2020, ACTA NEUROCHIR, P1; Census. Central Statistics Office, 2019, STATBANK CENS POP; Christey G, 2020, NEW ZEAL MED J, V133, P81; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; Department of Health, 2020, LAT UPD COVID 19 COR; Department of the Taoiseach, 2020, EAS COVID 19 REST 18; Department of the Taoiseach, 2020, STAT TAOIS MEAS TACK; Figueroa JM, 2021, WORLD NEUROSURG, V146, pe1, DOI 10.1016/j.wneu.2020.08.083; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Goyal Nishant, 2020, Surg Neurol Int, V11, P395, DOI 10.25259/SNI_675_2020; Hecht N, 2020, ACTA NEUROCHIR, V162, P1795, DOI 10.1007/s00701-020-04437-z; Horan J, 2021, IRISH J MED SCI, V190, P1281, DOI 10.1007/s11845-021-02504-7; Lubansu A, 2020, WORLD NEUROSURG, V144, pE380, DOI 10.1016/j.wneu.2020.08.168; Luostarinen T, 2020, ACTA NEUROCHIR, V162, P2715, DOI 10.1007/s00701-020-04583-4; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mathiesen T, 2020, ACTA NEUROCHIR, V162, P2221, DOI 10.1007/s00701-020-04482-8; McGuinness MJ, 2020, ANZ J SURG, V90, P2254, DOI 10.1111/ans.16336; Montaner J, 2020, STROKE, V51, P2307, DOI 10.1161/STROKEAHA.120.030106; Mulcahy LT, 2020, BRAIN INJURY, V34, P1610, DOI 10.1080/02699052.2020.1824299; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; National Office of Clincal Audit, 2020, MAJ TRAUM AUD NAT RE; Ryu JA, 2017, J KOREAN MED SCI, V32, P1024, DOI 10.3346/jkms.2017.32.6.1024; Surek A, 2021, EUR J TRAUMA EMERG S, V47, P647, DOI 10.1007/s00068-020-01534-7; Tartara F, 2020, ACTA NEUROCHIR, V162, P1501, DOI 10.1007/s00701-020-04385-8	29	0	0	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.												10.1007/s11845-021-02784-z		SEP 2021	6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UU0ZB	WOS:000698532300001	34554384	Green Published, Bronze			2022-02-06	
J	Roby, PR; Metzger, KB; McDonald, CC; Corwin, DJ; Huber, CM; Patton, DA; Margulies, SS; Grady, MF; Master, CL; Arbogast, KB				Roby, Patricia R.; Metzger, Kristina B.; McDonald, Catherine C.; Corwin, Daniel J.; Huber, Colin M.; Patton, Declan A.; Margulies, Susan S.; Grady, Matthew F.; Master, Christina L.; Arbogast, Kristy B.			Pre- and post-season visio-vestibular function in healthy adolescent athletes	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						(5-10); oculomotor; vision; concussion; sport; balance; gait	OCULOMOTOR PERFORMANCE; HEAD IMPACTS; CONCUSSION; DEFICITS; REHABILITATION; RELIABILITY; ASSOCIATION; SERVICES; SPORTS; POINT	Objective To evaluate pre - to post-season differences in individual subtests of the Visio-Vestibular Examination (VVE) in healthy middle and high school athletes. Methods This prospective cohort study recruited participants from a private suburban United States secondary school. Participants completed a demographic questionnaire prior to the start of their season. A proxy for head impact exposure was estimated by incorporating previously published head impact frequencies by team and sport. The VVE was completed pre - and post-season and consisted of 9 subtests: smooth pursuit, horizontal/vertical saccades and gaze stability, binocular convergence, left/right monocular accommodation, and complex tandem gait. Generalized estimating equations were employed to assess the relative risk of an abnormal VVE outcome based on testing session (pre - vs. post-season). Results Participants included middle and high school athletes (n = 115; female = 59 (51.3%); median age at first assessment = 14.9 years, [IQR = 13.6, 16.0]) during 2017/18 - 2019/20 school years. During pre-season testing, accommodation (10.0%) and complex tandem gait (9.2%) had the largest proportion of abnormal outcomes, while smooth pursuits (10.6%) and convergence (9.5%) had the largest proportion of abnormal outcomes post-season. When assessing the effect of testing session on the relative risk of any abnormal VVE subtest, there were no significant findings (P >= 0.25). Additionally, there were no significant effects of testing session when adjusting for estimated head impact exposure for any VVE subtest (P >= 0.25). Conclusions Visio-vestibular function as measured by the VVE does not change from pre - to post-season in otherwise healthy adolescent athletes. Our findings suggest that the VVE may be stable and robust to typical neurodevelopment occurring in this dynamic age group and help inform post-injury interpretation of visio-vestibular impairments.	[Roby, Patricia R.; Metzger, Kristina B.; McDonald, Catherine C.; Corwin, Daniel J.; Huber, Colin M.; Patton, Declan A.; Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [McDonald, Catherine C.; Corwin, Daniel J.; Grady, Matthew F.; Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [McDonald, Catherine C.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Huber, Colin M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA; [Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med Performance Ctr, Philadelphia, PA 19104 USA		Arbogast, KB (corresponding author), Roberts Pediat Res Bldg,2716 South St,Room 13471, Philadelphia, PA 19146 USA.	arbogast@chop.edu		HUBER, COLIN/0000-0002-0045-5940; McDonald, Catherine/0000-0003-3856-8542; Arbogast, Kristy/0000-0002-1694-4562; Master, Christina/0000-0002-6717-4270; Roby, Patricia/0000-0003-0166-4274; Margulies, Susan/0000-0002-3615-7902; Metzger, Kristi/0000-0002-1376-7994	Shipley School administration	We thank Ronni S. Kessler, MS, Fairuz Mohammed, MS, MPH, Ari Fish, BS, Shelly Sharma, BA, Taylor Valerio, Anne Mozel and Julia Vanni, BS, of Children's Hospital of Philadelphia for their contribution to data collection for this study. In addition, the authors thank the students and parents from the Shipley School for their participation. The authors appreciate the support from the Shipley School administration and athletic department: Steve Piltch, Michael Turner, Mark Duncan, Katelyn Taylor, Dakota Carroll, Kimberly Shaud, and Kayleigh Jenkins.	Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Bretzin AC, 2020, J NEUROL SCI, V416, DOI 10.1016/j.jns.2020.116951; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Corwin DJ, 2020, J EMERG MED, V59, P795, DOI 10.1016/j.jemermed.2020.09.017; Corwin DJ, 2020, AM J EMERG MED, V38, P1847, DOI 10.1016/j.ajem.2020.06.020; Corwin DJ, 2020, MED SCI SPORT EXER, V52, P542, DOI 10.1249/MSS.0000000000002163; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Dhawan PS, 2017, NEUROL-CLIN PRACT, V7, P464, DOI 10.1212/CPJ.0000000000000381; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gallagher VT, 2020, NEUROTRAUMA REP, V1, P169, DOI 10.1089/neur.2020.0051; Gamlin PDR, 2002, ANN NY ACAD SCI, V956, P264, DOI 10.1111/j.1749-6632.2002.tb02825.x; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Huber CM, 2021, ORTHOP J SPORTS MED, V9, DOI 10.1177/2325967120984423; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Joseph JR, 2020, J NEUROSURG, V133, P1886, DOI 10.3171/2019.7.JNS191272; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE174, DOI 10.3928/00904481-20120827-08; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Miyashita TL, 2020, J SPORT REHABIL, V29, P310, DOI 10.1123/jsr.2017-0282; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Paillard T, 2017, NEUROSCI BIOBEHAV R, V72, P129, DOI 10.1016/j.neubiorev.2016.11.015; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Storey EP., 2021, CLIN J SPORT MED; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; White-Schwoch T., 2019, CONCUSSION, V4, P4; White-Schwoch T, 2020, BRAIN INJURY, V34, P236, DOI 10.1080/02699052.2019.1683899; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	60	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1980744		SEP 2021	9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	US7YI	WOS:000697642100001	34521303				2022-02-06	
J	Schmidt, JD; Anderson, M; Rawlins, MW; Foster, CA; Johnson, BR; D'Lauro, C				Schmidt, Julianne D.; Anderson, Melissa; Weber Rawlins, Michelle; Foster, Craig A.; Johnson, Brian R.; D'Lauro, Christopher			Number of prior concussions predict poorer concussion care seeking in military cadets	BRAIN INJURY			English	Article; Early Access						Concussion non-disclosure; concussion reporting; mild traumatic brain injury	REPORTING BEHAVIORS; SCHOOL; ASSOCIATION; KNOWLEDGE; EDUCATION; RECOVERY; INJURIES	Primary objective: To determine whether concussion history predicts concussion care seeking, self-management practices, or confidence to recognize/report. Research design:Cross-sectional. Methods & procedures: 706 United States Air Force Academy (USAFA) cadets completed survey items regarding concussion history (0,1,2,3+), likelihood of reporting a concussion, self-management, and confidence to recognize/report. We used multivariate ordinal and binary logistic regression models to predict responses using concussion history, sex, and race. Main outcomes & results: cadets with 1 (OR = 0.59, 95%CI:0.43-0.82), 2 (OR = 0.55, 95%CI:0.31-0.98), or 3+ (OR = 0.36, 95%CI:0.17-0.78) concussions while at USAFA had respective 41%, 45%, and 64% lower likelihood to report the concussion scenario (ref = no history, p < .001). USAFA cadets with more extensive concussion histories had higher prevalence of not seeking care for a concussion (p < .001); more strongly endorsed self-management (p = .001-0.010); and had greater confidence in their ability to recognize a concussion (p = .005), but not to report (p = .198-0.413). Conclusions: Prior concussion experiences may deter cadets from seeking medical care for future concussions. Interventions should address concussion history and clinicians should consider how the post-concussion management process might deter care seeking.	[Schmidt, Julianne D.; Anderson, Melissa] Univ Georgia, Dept Kinesiol, UGAConcuss Res Lab, Athens, GA 30602 USA; [Weber Rawlins, Michelle] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA; [Foster, Craig A.; D'Lauro, Christopher] USAF Acad, Dept Behav Sci & Leadership, Colorado Springs, CO USA; [Johnson, Brian R.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu		D'Lauro, Christopher/0000-0003-0894-6602	National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults	This study was partially supported by the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults;	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Bailie JM, 2019, AM J SPORT MED, V47, P3505, DOI 10.1177/0363546519883259; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Caccese JB, 2018, NEUROLOGY, V91, pS26; Escolas SM, 2020, MIL MED, V185, P154, DOI 10.1093/milmed/usz259; Foster CA., 2019, J CONCUSSION, V3, p2059700219882876, DOI [10.1177/2059700219882876, DOI 10.1177/2059700219882876]; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Johnson BR, 2018, MIL MED, V183, P101, DOI 10.1093/milmed/usx106; Junge A, 2000, AM J SPORT MED, V28, pS10; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Mc Fie S, 2018, J SCI MED SPORT, V21, P16, DOI 10.1016/j.jsams.2017.07.014; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; O'Brien MJ, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117732516; O'Connor K, 2017, J NEUROL SCI, V381, P758, DOI 10.1016/j.jns.2017.08.2139; Rawlins MLW, 2020, MIL MED, V185, pE269, DOI 10.1093/milmed/usz162; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Remigio-Baker RA, 2020, ARCH PHYS MED REHAB, V101, P1204, DOI 10.1016/j.apmr.2020.02.015; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Weber ML, 2019, BRAIN INJURY, V33, P592, DOI 10.1080/02699052.2019.1568573; Weber Rawlins ML., 2020, J CLIN TRANSL RES, V5, P5	30	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1976418		SEP 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UT6VL	WOS:000698252500001	34546810				2022-02-06	
J	Zhu, YK; Huang, D; Zhao, ZY; Lu, CS				Zhu, Yike; Huang, Dan; Zhao, Zhongyan; Lu, Chuansen			Bioinformatic analysis identifies potential key genes of epilepsy	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; ENCODING NEUTROPHIL ELASTASE; PROTEIN-COUPLED RECEPTORS; TRAUMATIC BRAIN-INJURY; T-CELL-RECEPTOR; ALZHEIMERS-DISEASE; HORMONAL INFLUENCES; NEURONAL MIGRATION; STATUS EPILEPTICUS; MOUSE MODELS	Background Epilepsy is one of the most common brain disorders worldwide. It is usually hard to be identified properly, and a third of patients are drug-resistant. Genes related to the progression and prognosis of epilepsy are particularly needed to be identified. Methods In our study, we downloaded the Gene Expression Omnibus (GEO) microarray expression profiling dataset GSE143272. Differentially expressed genes (DEGs) with a fold change (FC) >1.2 and a P-value <0.05 were identified by GEO2R and grouped in male, female and overlapping DEGs. Functional enrichment analysis and Protein-Protein Interaction (PPI) network analysis were performed. Results In total, 183 DEGs overlapped (77 ups and 106 downs), 302 DEGs (185 ups and 117 downs) in the male dataset, and 750 DEGs (464 ups and 286 downs) in the female dataset were obtained from the GSE143272 dataset. These DEGs were markedly enriched under various Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms. 16 following hub genes were identified based on PPI network analysis: ADCY7, C3AR1, DEGS1, CXCL1 in male-specific DEGs, TOLLIP, ORM1, ELANE, QPCT in female-specific DEGs and FCAR, CD3G, CLEC12A, MOSPD2, CD3D, ALDH3B1, GPR97, PLAUR in overlapping DEGs. Conclusion This discovery-driven study may be useful to provide a novel insight into the diagnosis and treatment of epilepsy. However, more experiments are needed in the future to study the functional roles of these genes in epilepsy.	[Zhu, Yike] Hainan Gen Hosp, Dept Resp Med, Haikou, Hainan, Peoples R China; [Huang, Dan; Zhao, Zhongyan; Lu, Chuansen] Hainan Gen Hosp, Dept Neurol, Haikou, Hainan, Peoples R China		Lu, CS (corresponding author), Hainan Gen Hosp, Dept Neurol, Haikou, Hainan, Peoples R China.	luchuansen@outlook.com		Lu, Chuansen/0000-0002-7452-6000			Achiron A, 2004, Clin Dev Immunol, V11, P299, DOI 10.1080/17402520400001603; ALAM T, 1992, BIOCHEMISTRY-US, V31, P1928, DOI 10.1021/bi00122a005; Alavi MS, 2018, BIOMED PHARMACOTHER, V98, P222, DOI 10.1016/j.biopha.2017.12.056; Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Aleyd E, 2015, IMMUNOL REV, V268, P123, DOI 10.1111/imr.12337; Amini E, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00416; ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; Baart VM, 2020, EJNMMI RES, V10, DOI 10.1186/s13550-020-00673-7; BAUMANN H, 1990, MOL BIOL MED, V7, P147; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Breedveld A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00553; Burgess Darren J, 2015, Nat Rev Genet, V16, P129, DOI 10.1038/nrg3910; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Calabrese M, 2018, EUR J NEUROL, V25, P1103, DOI 10.1111/ene.13727; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Costa C, 2019, NEUROBIOL AGING, V73, P61, DOI 10.1016/j.neurobiolaging.2018.09.006; Costa C, 2016, NEUROBIOL AGING, V48, P161, DOI 10.1016/j.neurobiolaging.2016.08.025; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Crespo-Biel N, 2007, NEUROCHEM INT, V50, P435, DOI 10.1016/j.neuint.2006.10.002; Cruz MT, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00207; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; Dessauer CW, 2017, PHARMACOL REV, V69, P93, DOI 10.1124/pr.116.013078; Dolgin V, 2019, EUR J HUM GENET, V27, P1668, DOI 10.1038/s41431-019-0444-z; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Dyment DA, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.09.005; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fedin A I, 2019, Zh Nevrol Psikhiatr Im S S Korsakova, V119, P97, DOI 10.17116/jnevro201911901197; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; Frye CA, 2008, INT REV NEUROBIOL, V83, P27, DOI 10.1016/S0074-7742(08)00003-2; Fukuda M, 2009, BIOMED RES-TOKYO, V30, P227, DOI 10.2220/biomedres.30.227; Geis C, 2019, J CLIN INVEST, V129, P926, DOI 10.1172/JCI125178; Gokturk B, 2014, SCAND J IMMUNOL, V80, P354, DOI 10.1111/sji.12200; Gorrasi A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122531; Grassi S, 2019, J NEUROCHEM, V148, P600, DOI 10.1111/jnc.14540; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Han H, 2017, AAPS J, V19, P973, DOI 10.1208/s12248-017-0096-2; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Hsu LC, 1997, GENE, V189, P89, DOI 10.1016/S0378-1119(96)00839-6; HSU LC, 1994, GENE, V151, P285, DOI 10.1016/0378-1119(94)90672-6; Humbert-Claude M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0766-5; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; JENNE DE, 1994, AM J RESP CRIT CARE, V150, pS147, DOI 10.1164/ajrccm/150.6_Pt_2.S147; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Karsai G, 2019, J CLIN INVEST, V129, P1229, DOI 10.1172/JCI124159; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kleveland G, 1998, SEIZURE-EUR J EPILEP, V7, P31, DOI 10.1016/S1059-1311(98)90005-X; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Laciak AR, 2020, FEBS J, V287, P173, DOI 10.1111/febs.14997; Lahtinen L, 2009, NEUROSCIENCE, V163, P316, DOI 10.1016/j.neuroscience.2009.06.019; LAINE E, 1990, INFLAMMATION, V14, P1, DOI 10.1007/BF00914025; Lapato AS, 2017, NEUROSCIENCE, V346, P409, DOI 10.1016/j.neuroscience.2017.01.035; Liang ZH, 2009, J ALZHEIMERS DIS, V17, P531, DOI 10.3233/JAD-2009-1069; Lino N, 2014, DEV DYNAM, V243, P676, DOI 10.1002/dvdy.24114; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Liu C, 2017, J CLIN NEUROSCI, V36, P43, DOI 10.1016/j.jocn.2016.10.012; Loscher W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020591; Lucki Natasha C., 2008, V49, P387, DOI 10.1007/978-1-4020-8831-5_15; Luo ZM, 2015, J PHYSIOL BIOCHEM, V71, P329, DOI 10.1007/s13105-015-0389-9; Maes M, 2020, MOL NEUROBIOL, V57, P3334, DOI 10.1007/s12035-020-01949-8; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Marchitti SA, 2010, FREE RADICAL BIO MED, V49, P1432, DOI 10.1016/j.freeradbiomed.2010.08.004; Mariuzza RA, 2020, J BIOL CHEM, V295, P914, DOI 10.1074/jbc.REV119.009411; MATTAMMAL MB, 1995, NEURODEGENERATION, V4, P271, DOI 10.1016/1055-8330(95)90016-0; McHugh JC, 2008, INT REV NEUROBIOL, V83, P11, DOI 10.1016/S0074-7742(08)00002-0; Mendel I, 2017, J IMMUNOL, V198, P2125, DOI 10.4049/jimmunol.1601662; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Mestriner FLAC, 2007, P NATL ACAD SCI USA, V104, P19595, DOI 10.1073/pnas.0709681104; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Mons N, 1998, BRAIN RES, V788, P251, DOI 10.1016/S0006-8993(98)00005-5; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pant DC, 2019, J CLIN INVEST, V129, P1240, DOI 10.1172/JCI123959; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Paudel YN, 2019, ACS CHEM NEUROSCI, V10, P4199, DOI 10.1021/acschemneuro.9b00460; Pearson-Smith JN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112365; Peng YM, 2011, J LEUKOCYTE BIOL, V90, P735, DOI 10.1189/jlb.0211092; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Poser CM, 2003, EPILEPSY BEHAV, V4, P6, DOI 10.1016/S1525-5050(02)00646-7; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Puttachary S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745613; Qureshi IA, 2014, NEUROBIOL DIS, V72, P210, DOI 10.1016/j.nbd.2014.06.019; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Rana A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1192-7; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sagar D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03027-x; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sandhoff K, 2016, BIOCHIMIE, V130, P146, DOI 10.1016/j.biochi.2016.05.004; Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123; Scharfman HE, 2012, FUTUR NEUROL, V7, P177, DOI 10.2217/FNL.12.8; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Semina E, 2016, EUR J CELL BIOL, V95, P295, DOI 10.1016/j.ejcb.2016.05.003; Sen A, 2007, EPILEPSIA, V48, P1447, DOI 10.1111/j.1528-1167.2007.01107.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131461; Shi JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep24649; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Spatola M, 2017, CURR OPIN NEUROL, V30, P345, DOI 10.1097/WCO.0000000000000449; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Sudha K, 2001, CLIN CHIM ACTA, V303, P19, DOI 10.1016/S0009-8981(00)00337-5; Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Tian FF, 2010, CLIN LAB, V56, P127; Tokgoz H, 2013, PEDIAT ALLERG IMM-UK, V24, P257, DOI 10.1111/pai.12063; Aguiar CCT, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/795259; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Veliskova J, 2013, HORM BEHAV, V63, P267, DOI 10.1016/j.yhbeh.2012.03.018; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Waaler PE, 2000, EPILEPSIA, V41, P802, DOI 10.1111/j.1528-1157.2000.tb00246.x; Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020; Wang JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.346; Wang JJ, 2018, ACTA BIOCH BIOPH SIN, V50, P666, DOI 10.1093/abbs/gmy060; Wang ZY, 2018, FISH SHELLFISH IMMUN, V78, P299, DOI 10.1016/j.fsi.2018.04.059; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720, DOI 10.1152/ajpendo.1997.273.4.E720; Wu L, 2014, BRAIN RES BULL, V109, P88, DOI 10.1016/j.brainresbull.2014.09.007; Yacov N, 2020, CLIN EXP IMMUNOL, V201, P105, DOI 10.1111/cei.13448; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yuan W, 2010, MICROVASC RES, V80, P148, DOI 10.1016/j.mvr.2010.03.011; Zhou ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23695	145	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0254326	10.1371/journal.pone.0254326			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	WOS:000725694500006	34555062	gold, Green Published			2022-02-06	
J	Exell, R; Hilari, K; Behn, N				Exell, Roseanne; Hilari, Katerina; Behn, Nicholas			Current practices and beliefs regarding supporting dating skills in rehabilitation for traumatic brain injury: a survey study	BRAIN INJURY			English	Article						Dating; relationships; rehabilitation; communication; brain injury	INCOG RECOMMENDATIONS; EXPERIENCES; ADULTS; AWARENESS; OUTCOMES; INTERVENTIONS; DISABILITIES; INDIVIDUALS; PERCEPTIONS; MANAGEMENT	Background Relationships are important to quality of life after traumatic brain injury (TBI). However, there has been limited research into how to support dating skills or how professionals view this area. Method An online 52-item survey was developed and sent to professionals in the UK involved in rehabilitation after TBI. Recruitment was through professional networks, special interest groups and social media. Results 125 participants from a range of professions completed the survey. Many agreed that dating skills are important in rehabilitation (81.6%), but fewer (51.2%) reported engaging in this work. Psychologists, SLTs and OTs were identified as well placed to address dating skills. Case managers also appeared aware of this work. Participants reported using a range of activities to address dating skills, including managing disinhibited behavior and teaching interaction skills. Perceived barriers were both personal and professional, including lack of resources and feeling embarrassed. Conclusion This study has highlighted an awareness of the importance of dating in brain injury, but professionals face multiple barriers to supporting dating skills. It is possible to draw on recommendations from related areas, including rehabilitation for cognitive communication difficulties and sexual dysfunction with further research to specifically link these areas to dating skills.	[Exell, Roseanne; Hilari, Katerina; Behn, Nicholas] City Univ London, Sch Hlth Sci, London, England		Exell, R (corresponding author), City Univ London, Sch Hlth Sci, London, England.	Roseanne.exell@city.ac.uk		Exell, Roseanne/0000-0001-5541-0689; Hilari, Katerina/0000-0003-2091-4849; Behn, Nicholas/0000-0001-9356-9957	Brain Injury Rehabilitation Trust	The authors would like to thank the people who participated in the study and the organizations who supported this recruitment, including the Brain Injury Rehabilitation Trust.	Annon JS., 1976, J SEX EDUC THER, V2, P1, DOI [10.1080/01614576.1976.11074483, DOI 10.1080/01614576.1976.11074483]; [Anonymous], 2000, SAME YOU REV SERVICE; Backhaus S, 2019, ARCH PHYS MED REHAB, V100, P195, DOI 10.1016/j.apmr.2018.08.174; Backhaus S, 2016, BRAIN INJURY, V30, P975, DOI 10.3109/02699052.2016.1147601; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; Brunsden C, 2017, NEUROPSYCHOL REHABIL, V27, P937, DOI 10.1080/09602011.2015.1109525; Callaway L., 2005, AUSTR OCCUPATIONAL T, V52, P257, DOI [10.1111/j.1440-1630.2005.00492, DOI 10.1111/J.1440-1630.2005.00492]; Cambridge Dictionary, MEAN DAT ENGL; Chandler RJ, 2016, J INTELL DISABIL OFF, V7, P151, DOI 10.1108/JIDOB-11-2015-0045; Chrastina J, 2020, SEX DISABIL, V38, P285, DOI 10.1007/s11195-018-9546-8; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Cunningham A, 2016, COUNS OUTCOME RES EV, V7, P99, DOI DOI 10.1177/2150137816668561; Curtin M, 2011, BRAIN INJURY, V25, P266, DOI 10.3109/02699052.2010.542793; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Exell R, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1845824; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gutman S, 1997, OCCUP THER MENT HLTH, V13, P51; Harris P., 1995, BRIT J LEARN DISABIL, V23, P160; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; IBM Corp, 2019, IBM SPSS STAT WINDOW; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Krantz G, 2016, OJOT, V4; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Lawson HM, 2006, SOC SCI COMPUT REV, V24, P189, DOI 10.1177/0894439305283402; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Mackenzie A, 2015, J REHABIL, V81, P9; McCarthy K, 2018, COLLECTED FACULTY ST, V329, P12; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; MUESER KT, 1987, BEHAV MODIF, V11, P200, DOI 10.1177/01454455870112005; Murphy K, 2007, ARCH PHYS MED REHAB, V88; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; QSR International Pty Ltd, 2018, NVIVO QSR INT VERS 1; Qualtrics, 2019, QUALTR VERS XM; ROSE S, 1993, SEX ROLES, V28, P449; Rosenbaum T, 2014, J SEX MED, V11, P15, DOI 10.1111/jsm.12343; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; The Brain Injury Group, WHAT IS CAS MAN WHAT; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tullis CA, 2013, PSYCHOL SCHOOLS, V50, P866, DOI 10.1002/pits.21713; Valentich M, 1984, SEX DISABIL, V7; VALENTIHEIN DC, 1994, BEHAV MODIF, V18, P32, DOI 10.1177/01454455940181003; Ward KM, 2013, INTELLECT DEV DISAB, V51, P22, DOI 10.1352/1934-9556-51.01.022; Yeates G.N., 2013, NEURODISABILITY PSYC, V1, P151; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvsaker M, 2001, BRAIN INJ SOURCE, V5	61	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1358	1370		10.1080/02699052.2021.1970805		SEP 2021	13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000697433900001	34543134	Green Accepted			2022-02-06	
J	McDonald, SD; Walker, WC; Cusack, SE; Yoash-Gantz, RE; Pickett, TC; Cifu, DX; Tupler, LA				McDonald, Scott D.; Walker, William C.; Cusack, Shannon E.; Yoash-Gantz, Ruth E.; Pickett, Treven C.; Cifu, David X.; Tupler, Larry A.		Va Mid Atlantic Mirecc Workgrp	Health symptoms after war zone deployment-related mild traumatic brain injury: contributions of mental disorders and lifetime brain injuries	BRAIN INJURY			English	Article						Brain concussion; Veterans; stress disorders; mental health; blast injuries; brain injuries; traumatic	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SERVICE MEMBERS; COMBAT VETERANS; SELF-REPORT; IRAQ; TBI; AFGHANISTAN; BLAST; SOLDIERS	Primary Objective To gain a better understanding of the complex relationship between combat deployment-related mild traumatic brain injury (mTBI) and persistent post-concussive symptoms (PPCSs), taking into consideration a wide range of potentially mediating and confounding factors. Research Design Cross-sectional. Methods and Procedures Subjects were 613 U. S. military Veterans and Service Members who served during operations Enduring Freedom, Iraqi Freedom, or New Dawn (OEF/OIF/OND) and completed a structured interview of mental disorders and a battery of questionnaires. Hierarchical binary logistic regression analyses were used to test the hypotheses. Main Outcomes and Results After accounting for mental disorders, lifetime mTBIs outside of OEF/OIF/OND deployment, medical conditions, and injury/demographic characteristics, deployment-related mTBI continued to be associated with several PPCSs (headaches, sleep disturbance, and difficulty making decisions). Deployment-related mTBI was also associated with two symptoms not normally associated with mTBI (nausea/upset stomach and numbness/tingling). Conclusions After adjusting for a wide range of factors, OEF/OIF/OND deployment-related mTBI was still associated with PPCSs on average 10 years after the injury. These findings suggest that mTBI sustained during OEF/OIF/OND deployment may have enduring negative health effects. More studies are needed that prospectively and longitudinally track health and mental health outcomes after TBI.	[McDonald, Scott D.; Walker, William C.; Cifu, David X.] Hunter Holmes McGuire Va Med Ctr, Mental Hlth Serv, Richmond, VA USA; [McDonald, Scott D.; Cusack, Shannon E.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [McDonald, Scott D.; Walker, William C.; Cifu, David X.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA USA; [Cusack, Shannon E.] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet Vipbg, Richmond, VA USA; [Yoash-Gantz, Ruth E.; Tupler, Larry A.] Va Midatlantic Mental Illness Res & Clin Ctr, Durham, NC USA; [Pickett, Treven C.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Tupler, Larry A.; Va Mid Atlantic Mirecc Workgrp] Durham VA Med Ctr, Durham, NC USA; [Tupler, Larry A.] Duke Univ, Med Ctr, Durham, NC USA		McDonald, SD (corresponding author), Cent Virginia VA Hlth Care Syst, Mental Hlth Serv 116B, Richmond, VA 23249 USA.	scott.mcdonald@va.gov	McDonald, Scott/N-3799-2014	McDonald, Scott/0000-0003-1490-0096; Cusack, Shannon/0000-0001-8103-0575	VA Mid-Atlantic Mental Illness, Education, and Clinical Center	This work was supported by the VA Mid-Atlantic Mental Illness, Education, and Clinical Center [0000].	Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carbocation Corporation, 2016, FALSE DISCOVERY RATE; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cook CM, 2016, CLIN NEUROPSYCHOL, V30, P284, DOI 10.1080/13854046.2016.1139186; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Davenport ND, 2015, BRAIN IMAGING BEHAV, V9, P472, DOI 10.1007/s11682-015-9371-y; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW TBI NUMB; Definition of mild traumatic brain injury, 1993, J HEAD TRAUMA REHAB, V8; Department of Defense Department of Veterans Affairs Department of Health and Human Services Department of Education, 2013, NATL RES ACTION PLAN; Department of Veterans Affairs. Screening and evaluation of traumatic brain injury (TBI) In Operation Enduring Freedom (OEF) Operation Iraqi Freedom (OIF) and Operation New Dawn (OND) Veterans, 2017, 1184 VHA; Derogatis L., 1994, SCLR 90 R ADM SCORIN, V3rd; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Freeman M., 2014, J INT NEUROPSYCHOL S, V5, P1; Hannah Fischer, 2015, GUIDE US MILITARY CA; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; McCrae M., 2008, MILD TRAUMATIC BRAIN; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Medcalc Software, COMP PROP CALC; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Skelly Andrea C, 2012, Evid Based Spine Care J, V3, P9, DOI 10.1055/s-0031-1298595; Spector PE, 2011, ORGAN RES METHODS, V14, P287, DOI 10.1177/1094428110369842; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; World Health Organization, 1993, ICD 10 CLASS MENT BE; World Health Organization, 1992, ICD10 WHO, V67, P227	77	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1338	1348		10.1080/02699052.2021.1959058		SEP 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000698221200001	34543115				2022-02-06	
J	Ryan, JJ; Kreiner, DS; Teichner, G; Gontkovsky, ST				Ryan, Joseph J.; Kreiner, David S.; Teichner, Gordon; Gontkovsky, Samuel T.			Validity of the Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-II) as an Indicator of Neurological Disease/Injury: A Pilot Study	BRAIN INJURY			English	Article; Early Access						WASI-II; neurological disease; premorbid IQ; assessment; validity	SENSITIVITY	Purpose Although the Wechsler Abbreviated Scale of Intelligence, Second Edition is commonly used by neuropsychologists in the assessment of intellectual functioning, there is a paucity of published literature examining its utility in detecting neurological disease/injury. This study constitutes an attempt to validate the four-subtest WASI-II (4-FSIQ) for use with patients with neurological disease/injury. Method Participants were 59 patients referred for outpatient neuropsychological evaluation. Thirty-two individuals with diagnoses of dementia, stroke, traumatic brain injury, and other neurological disorders constituted the neurological group. A control group was comprised of 27 individuals with diagnoses of psychiatric disorders or age-related cognitive decline. Results The WASI-II subtest and composite scores of the neurological group were all significantly (ps < .0001) lower than those of the control sample, but pattern differences between the groups were absent. When premorbid IQs and WASI-II IQs were compared, neurological patients with neurological disease/injury displayed evidence of intellectual deterioration; whereas, control participants did not. Conclusions Findings suggest that the 4-WASI-II is sensitive to the biological condition of the brain and provide preliminary validation for its use in the neuropsychological assessment of a diagnostically heterogeneous sample of patients with neurological disorders.	[Ryan, Joseph J.; Kreiner, David S.] Univ Cent Missouri, Dept Psychol Sci, Warrensburg, MO USA; [Teichner, Gordon] Charleston Neuropsychol, Department Psychol Sci, Charleston, SC USA; [Gontkovsky, Samuel T.] Twin Valley Behav Hlthcare, Dept Psychol Sci, Columbus, OH USA		Gontkovsky, ST (corresponding author), Twin Valley Behav Hlthcare, 2200 West Broad St, Columbus, OH 43223 USA.	Samuel.Gontkovsky@mha.ohio.gov					Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Gontkovsky ST, 2017, APPL NEUROPSYCH-ADUL, V24, P288, DOI 10.1080/23279095.2016.1154857; Holdnack JA, 2013, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-386934-0.00005-5; Irby SM, 2013, CAN J SCH PSYCHOL, V28, P295, DOI 10.1177/0829573513493982; McGeehan B., 2017, ARCH ASSESSMENT PSYC, V7, P7; Pearson, 2009, ADV CLIN SOL US WAIS; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Ryan JJ, 2009, INT J NEUROSCI, V119, P1198, DOI 10.1080/00207450902889219; Watkins, 2003, SRMPH, V2, P118; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zhou X., 2011, 2 PEARS	14	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1978547		SEP 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UT6NS	WOS:000698232400001	34546137				2022-02-06	
J	Shao, XW; Wang, CH; Wang, C; Han, L; Han, YR; Nizetic, D; Zhang, Y; Han, L				Shao, Xiaowei; Wang, Chunhua; Wang, Chao; Han, Lei; Han, Yunrui; Nizetic, Dean; Zhang, Yu; Han, Lin			Mechanical Stress Induces a Transient Suppression of Cytokine Secretion in Astrocytes Assessed at the Single-Cell Level with a High-Throughput Microfluidic Chip	ADVANCED HEALTHCARE MATERIALS			English	Article						astrocytes; cytokine secretion; force; single-cell microfluidics	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; FORCE; DIFFERENTIATION; FILAMENTS; NEURONS; PROTEIN; SYSTEM; GROWTH; RISK	Brain cells are constantly subjected to mechanical signals. Astrocytes are the most abundant glial cells of the central nervous system (CNS), which display immunoreactivity and have been suggested as an emerging disease focus in the recent years. However, how mechanical signals regulate astrocyte immunoreactivity, and the cytokine release in particular, remains to be fully characterized. Here, human neural stem cells are used to induce astrocytes, from which the release of 15 types of cytokines are screened, and nine of them are detected using a protein microfluidic chip. When a gentle compressive force is applied, altered cell morphology and reinforced cytoskeleton are observed. The force induces a transient suppression of cytokine secretions including IL-6, MCP-1, and IL-8 in the early astrocytes. Further, using a multiplexed single-cell culture and protein detection microfluidic chip, the mechanical effects at a single-cell level are analyzed, which validates a concerted downregulation by force on IL-6 and MCP-1 secretions in the cells releasing both factors. This work demonstrates an original attempt of employing the protein detection microfluidic chips in the assessment of mechanical regulation on the brain cells at a single-cell resolution, offering novel approach and unique insights for the understanding of the CNS immune regulation.	[Shao, Xiaowei; Wang, Chunhua; Wang, Chao; Han, Lei; Han, Yunrui; Zhang, Yu; Han, Lin] Shandong Univ, Inst Marine Sci & Technol, Qingdao 266237, Peoples R China; [Shao, Xiaowei] Shandong Univ, Suzhou Res Inst, Suzhou 215123, Peoples R China; [Shao, Xiaowei; Nizetic, Dean] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore; [Nizetic, Dean] Queen Mary Univ London, Barts & London Sch Med, Blizard Inst, London E1 2AT, England		Zhang, Y; Han, L (corresponding author), Shandong Univ, Inst Marine Sci & Technol, Qingdao 266237, Peoples R China.	yuzhang@sdu.edu.cn; hanlin@sdu.edu.cn			National Key RD Plan of China [2017YFB0405400]; Major Innovation Projects in Shandong Province [2018YFJH0503]; Natural Science Foundation for Distinguished Young Scientist of Shandong Province [JQ201814]; Shandong University multidisciplinary research and innovation team of young scholars; Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [32000887]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20200222]; Shandong University Foundation for Future Scholar Plan; Wellcome Trust Collaborative Award in ScienceWellcome Trust [217199/Z/19/Z]	This work was supported by the National Key R&D Plan of China (Grant No. 2017YFB0405400), the Major Innovation Projects in Shandong Province (Grant No. 2018YFJH0503), Natural Science Foundation for Distinguished Young Scientist of Shandong Province (Grant No. JQ201814), Shandong University multidisciplinary research and innovation team of young scholars, and Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong. X.S. was funded by the National Natural Science Foundation of China (Grant No. 32000887), Natural Science Foundation of Jiangsu Province (Grant No. BK20200222), and Shandong University Foundation for Future Scholar Plan. D.N. was funded by The Wellcome Trust Collaborative Award in Science 217199/Z/19/Z. The authors would like to thank State Key Laboratory of Microbial Technology, Shandong University for the assistance in confocal microscope observation.	Abuwarda H, 2020, CURR OPIN CELL BIOL, V66, P104, DOI 10.1016/j.ceb.2020.05.012; Albalawi F, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00227; Blaschke S, 2019, J TISSUE ENG REGEN M, V13, P960, DOI 10.1002/term.2838; Bourgeois-Tardif S, 2021, NEUROL SCI, V42, P1287, DOI 10.1007/s10072-020-05002-3; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen Z, 2019, ANNU REV ANAL CHEM, V12, P431, DOI 10.1146/annurev-anchem-061318-115055; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Damodaran K, 2018, MOL BIOL CELL, V29, P3039, DOI 10.1091/mbc.E18-04-0256; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fujiwara S, 2016, MOL BIOL CELL, V27, P954, DOI 10.1091/mbc.E15-06-0417; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Haider MN, 2018, BRAIN INJURY, V32, P809, DOI 10.1080/02699052.2018.1469045; Hall CM, 2021, EUR J NEUROSCI, V53, P3851, DOI 10.1111/ejn.14766; Hao M, 2019, SMALL, V15, DOI 10.1002/smll.201905001; He ZJ, 2020, P NATL ACAD SCI USA, V117, P23869, DOI 10.1073/pnas.2007773117; Ho KKY, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00148; Hoffman H, 2020, WORLD NEUROSURG, V142, pE385, DOI 10.1016/j.wneu.2020.07.022; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Hosomi S, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.520; Hu Y, 2021, NPG ASIA MATER, V13, DOI 10.1038/s41427-021-00304-0; Keene C.D., 2021, BIOL PSYCHIAT; Kim WH, 2019, ANALYST, V144, P1768, DOI 10.1039/c8an01745j; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Lee H, 2019, J CELL SCI, V132, DOI 10.1242/jcs.216911; Lee JU, 2015, BIOSENS BIOELECTRON, V74, P341, DOI 10.1016/j.bios.2015.06.059; Liao MC, 2016, J NEUROSCI, V36, P1730, DOI 10.1523/JNEUROSCI.2735-15.2016; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; Lopez-Meza J, 2016, CYTOTECHNOLOGY, V68, P1287, DOI 10.1007/s10616-015-9889-2; Lu WN, 2017, J NEUROCHEM, V141, P436, DOI 10.1111/jnc.13998; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; Meli L, 2014, STEM CELL RES, V13, P36, DOI 10.1016/j.scr.2014.04.004; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Motz CT, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202100102; Mou XN, 2017, NANOSCALE, V9, P10031, DOI 10.1039/c7nr00744b; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Provin C, 2008, J BIOMECH, V41, P1436, DOI 10.1016/j.jbiomech.2008.02.025; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Satoh K, 2006, BRAIN RES, V1108, P19, DOI 10.1016/j.brainres.2006.06.050; Schug, 2013, ANAL CHEM, P105; Segel M, 2019, NATURE, V573, P130, DOI 10.1038/s41586-019-1484-9; Shang ML, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80576-8; Sofroniew MV, 2020, TRENDS IMMUNOL, V41, P758, DOI 10.1016/j.it.2020.07.004; Song YY, 2019, SCI DATA, V6, DOI 10.1038/sdata.2019.16; Suhaimi H, 2015, CHEM ENG J, V269, P323, DOI 10.1016/j.cej.2015.01.130; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Velasco-Estevez M, 2020, GLIA, V68, P145, DOI 10.1002/glia.23709; Wang CH, 2021, ANAL CHIM ACTA, V1178, DOI 10.1016/j.aca.2021.338791; Yang QQ, 2019, GLIA, V67, P1017, DOI 10.1002/glia.23571; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	59	0	0	22	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	NOV	2021	10	21							2100698	10.1002/adhm.202100698		SEP 2021	11	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	WQ7XX	WOS:000697621900001	34549544				2022-02-06	
J	Snooks, KC; Yan, K; Farias-Moeller, R; Fink, EL; Hanson, SJ				Snooks, Kellie C.; Yan, Ke; Farias-Moeller, Raquel; Fink, Ericka L.; Hanson, Sheila J.			Continuous Electroencephalogram and Antiseizure Medication Use in an International Pediatric Traumatic Brain Injury Population	NEUROCRITICAL CARE			English	Article; Early Access						Anticonvulsants; Brain injuries (traumatic); Electroencephalography; Seizures; Child; Adolescent; Intensive care unit (pediatric); Global health; Critical care outcomes	HEAD-INJURY; SEIZURES; EEG; CHALLENGES; CHILDREN	Background: Electrographic seizures are frequent and associated with worse outcomes following traumatic brain injury (TBI). Despite this, the use of continuous electroencephalogram (cEEG) remains low. Our study describes cEEG usage and treatment dosing antiseizure medications (ASMs) in an international pediatric TBI population, hypothesizing that children monitored with cEEG have an increased rate of treatment ASMs because of electrographic seizure detection, compared with children who are not monitored with cEEG. Methods: This subanalysis of the TBI cohort of the international PANGEA study included children, 7 days to 17 years of age, with acute neurological insults admitted to pediatric intensive care units. We analyzed demographics, injury severity, and therapies including prophylactic or treatment ASMs. We evaluated the relationships between cEEG use, seizure frequency, and receipt of treatment ASMs. similar to 2 or Fisher's exact test was used to analyze categorical variables, and the Kruskal-Wallis or Mann-Whitney U-test was used for continuous variables. Multivariable analysis for treatment ASM use was performed using logistic regression. Results: One hundred-twenty-three of 174 patients with TBI were included. Twenty-seven patients (21.9%) underwent cEEG at any point during pediatric intensive care unit admission. Preexisting seizure disorder (18.2% vs. 2.3%, p = 0.014) and neuromuscular blockade use (52.4% vs. 24.1%, p = 0.011) were more frequently observed in the group monitored on cEEG when compared with those that were not. Presenting median Glasgow Coma Scale score was worse in the cEEG group (7 vs. 9, p = 0.044). There was no significant difference in age, use of intracranial pressure monitoring, or hyperosmolar therapy between the cEEG monitored and nonmonitored groups. Patients who were monitored on cEEG were more likely to receive a treatment dose ASM than those without cEEG monitoring (66.7% vs. 28.1%, p = 0.0002). When compared with those without treatment ASM, the treatment ASM group had more electrographic seizures on their first electroencephalogram following injury (51.6% vs. 4%, p = 0.0001) and more clinical seizures (55.8% vs. 0%, p < 0.0001). Conclusions: Children monitored with cEEG after TBI have an increased prescription of treatment ASMs and clinical and electrographic seizures. The increased rate of treatment ASMs in the cEEG group may indicate increased recognition of electrographic seizures.	[Snooks, Kellie C.; Yan, Ke; Farias-Moeller, Raquel; Hanson, Sheila J.] Med Coll Wisconsin, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Fink, Ericka L.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA USA		Snooks, KC (corresponding author), Med Coll Wisconsin, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA.	ksnooks@mcw.edu		Snooks, Kellie/0000-0001-8439-303X			Alkhamis F, 2020, CLIN EEG NEUROSCI, V51, P420, DOI 10.1177/1550059420925962; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bean JR, 2016, WORLD NEUROSURG, V91, P618, DOI 10.1016/j.wneu.2016.03.069; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Hill CE, 2019, NEUROLOGY, V92, pE9, DOI 10.1212/WNL.0000000000006689; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ostahowski PJ, 2016, J NEUROSURG-PEDIATR, V18, P499, DOI 10.3171/2016.4.PEDS1698; Rumalla K, 2018, J NEUROSURG-PEDIATR, V22, P684, DOI 10.3171/2018.6.PEDS1813; Ruzas CM, 2017, NEUROCRIT CARE, V26, P256, DOI 10.1007/s12028-016-0329-8; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Sharma S, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.612073; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012	22	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01337-7		SEP 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UT7VM	WOS:000698320200001	34553297				2022-02-06	
J	Taing, AS; Mundy, ME; Ponsford, JL; Spitz, G				Taing, Abbie S.; Mundy, Matthew E.; Ponsford, Jennie L.; Spitz, Gershon			Temporal lobe activation during episodic memory encoding following traumatic brain injury	SCIENTIFIC REPORTS			English	Article							HUMAN NEURAL SYSTEM; FACIAL EXPRESSIONS; FACE RECOGNITION; MODERATE; AMNESIA; GAZE; FMRI; HIPPOCAMPUS; IMPAIRMENT; MECHANISMS	The temporal lobes are critical for encoding and retrieving episodic memories. The temporal lobes are preferentially disrupted following a traumatic brain injury (TBI), likely contributing to the difficulties observed in episodic memory. However, the underlying neural changes that precipitate or maintain these difficulties in individuals with TBI remains poorly understood. Here, we use functional magnetic resonance imaging (fMRI) to interrogate the relationship between temporal lobe activation and encoding of episodic stimuli. Participants encoded face, scene, and animal stimuli during an fMRI run. In an out-of-scanner task, participants were required to correctly identify previously displayed stimuli over two presentation runs (each in-scanner stimuli presented twice). Forty-three patients with moderate-severe TBI were recruited and compared with 38 demographically similar healthy controls. The pattern of behavioural performance between groups depended on the stimuli presentation run. The TBI group demonstrated poorer episodic memory for faces and scenes during the first presentation, but not the second presentation. When episodic memory was analysed across all presentation runs, behavioural deficits were only apparent for faces. Interestingly, processing of faces emerged as the only between group-difference on fMRI, whereby TBI participants had an increased signal in the middle temporal gyrus extending to the superior temporal sulcus. These findings provide evidence to suggest that following TBI: (a) episodic memory is preferentially impaired for complex stimuli such as faces, and (b) robust behavioural inefficiencies are reflected in increased activation in specific temporal lobe structures during encoding.	[Taing, Abbie S.; Mundy, Matthew E.; Ponsford, Jennie L.; Spitz, Gershon] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic 3800, Australia; [Taing, Abbie S.; Ponsford, Jennie L.; Spitz, Gershon] Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia		Spitz, G (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic 3800, Australia.; Spitz, G (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	gershon.spitz@monash.edu			National Health and Research Council Early Career Fellowship [APP1104692]; Brain Foundation; Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) HPC facility	GS was funded by a National Health and Research Council Early Career Fellowship (APP1104692) and the Brain Foundation. This work was supported by the Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) HPC facility (www.massive.org.au).In addition, the authors would like to thank the staff at the Acquired Brain Injury Ward at Epworth Hospital (Richmond), Bridge Road Imaging, Monash Biomedical Imaging, and Olivia McConchie at the Monash Epworth Rehabilitation Research Centre for their help with recruitment/data collection. The authors would also like to thank the participants who took part in the study.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; Daneshvar D. H., 2015, TRAUMATIC BRAIN INJU, P219, DOI [10.1016/b978-0-12-398270-4.00016-1, DOI 10.1016/B978-0-12-398270-4.00016-1]; Der G, 2017, INTELLIGENCE, V64, P89, DOI 10.1016/j.intell.2017.08.001; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eichenbaum H, 2017, NAT REV NEUROSCI, V18, P547, DOI 10.1038/nrn.2017.74; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Epstein RA, 2010, CEREB CORTEX, V20, P294, DOI 10.1093/cercor/bhp099; Gillis MM, 2015, BRAIN IMAGING BEHAV, V9, P801, DOI 10.1007/s11682-014-9337-5; Graham KS, 2010, NEUROPSYCHOLOGIA, V48, P831, DOI 10.1016/j.neuropsychologia.2010.01.001; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hoyer W. J., 2006, HDB PSYCHOL AGING, V6th, P209; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Keightley ML, 2011, SOC COGN AFFECT NEUR, V6, P24, DOI 10.1093/scan/nsq003; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kitada R, 2010, NEUROIMAGE, V49, P1677, DOI 10.1016/j.neuroimage.2009.09.014; Lachman ME, 2010, AM J GERIAT PSYCHIAT, V18, P4, DOI 10.1097/JGP.0b013e3181ab8b62; Mallas EJ, 2021, BRAIN, V144, P114, DOI 10.1093/brain/awaa380; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Mundy ME, 2012, NEUROPSYCHOLOGIA, V50, P3053, DOI 10.1016/j.neuropsychologia.2012.07.006; Mundy ME, 2013, J NEUROSCI, V33, P10490, DOI 10.1523/JNEUROSCI.2958-12.2013; Mundy ME, 2009, NEUROREPORT, V20, P1397, DOI 10.1097/WNR.0b013e32832f81f4; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Park J, 2009, NEUROSCIENTIST, V15, P445, DOI 10.1177/1073858409337742; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rogers TT, 2005, J COGNITIVE NEUROSCI, V17, P434, DOI 10.1162/0898929053279531; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Stuss DT, 2005, CURR DIR PSYCHOL SCI, V14, P84, DOI 10.1111/j.0963-7214.2005.00340.x; Taylor KJ, 2007, NEUROPSYCHOLOGIA, V45, P2428, DOI 10.1016/j.neuropsychologia.2007.04.004; Tittle A, 2011, BRAIN INJURY, V25, P933, DOI 10.3109/02699052.2011.597042; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Valentine T, 2006, NEUROPSYCHOL REHABIL, V16, P272, DOI 10.1080/09602010500176443; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001	58	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 22	2021	11	1							18830	10.1038/s41598-021-97953-6			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UW6XJ	WOS:000700297100063	34552133	Green Published, gold			2022-02-06	
J	Xie, N; Hou, Y; Wang, SH; Ai, XP; Bai, JR; Lai, XR; Zhang, Y; Meng, XL; Wang, XB				Xie, Na; Hou, Ya; Wang, Shaohui; Ai, Xiaopeng; Bai, Jinrong; Lai, Xianrong; Zhang, Yi; Meng, Xianli; Wang, Xiaobo			Second near-infrared (NIR-II) imaging: a novel diagnostic technique for brain diseases	REVIEWS IN THE NEUROSCIENCES			English	Article; Early Access						brain diseases; brain tumor; cerebrovascular; NIR-II imaging; toxicity	AG2S QUANTUM DOTS; TUMOR SURGERY; FLUORESCENCE; FLUOROPHORES; MOLECULE; CANCER; WINDOW; BIODISTRIBUTION; NANOPROBES; CHALLENGES	Imaging in the second near-infrared II (NIR-II) window, a kind of biomedical imaging technology with characteristics of high sensitivity, high resolution, and real-time imaging, is commonly used in the diagnosis of brain diseases. Compared with the conventional visible light (400-750 nm) and NIR-I (750-900 nm) imaging, the NIR-II has a longer wavelength of 1000-1700 nm. Notably, the superiorities of NIR-II can minimize the light scattering and autofluorescence of biological tissue with the depth of brain tissue penetration up to 7.4 mm. Herein, we summarized the main principles of NIR-II in animal models of traumatic brain injury, cerebrovascular visualization, brain tumor, inflammation, and stroke. Simultaneously, we encapsulated the in vivo process of NIR-II probes and their in vivo and in vitro toxic effects. We further dissected its limitations and following optimization measures.	[Meng, Xianli; Wang, Xiaobo] Chengdu Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, State Key Lab SouthWestern Chinese Med Resources, Chengdu 611137, Peoples R China; [Xie, Na; Hou, Ya; Ai, Xiaopeng; Bai, Jinrong] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu 611137, Peoples R China; [Wang, Shaohui; Lai, Xianrong; Zhang, Yi] Chengdu Univ Tradit Chinese Med, Ethn Med Acad Heritage Innovat Res Ctr, Chengdu 611137, Peoples R China		Meng, XL; Wang, XB (corresponding author), Chengdu Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, State Key Lab SouthWestern Chinese Med Resources, Chengdu 611137, Peoples R China.	xlm999@cdutcm.edu.cn; VitaDrwang@cdutcm.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82104533]; Science & Technology Department of Sichuan Province [2021YJ0175, 2018JY0467]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2020M683273]; Project First-Class Disciplines Development of Chengdu University of Traditional Chinese Medicine [CZYJC1903]; National Key R&D Program of China [2017YFC1703904]	This work was supported by the National Natural Science Foundation of China (82104533), the Science & Technology Department of Sichuan Province (2021YJ0175 and 2018JY0467), the China Postdoctoral Science Foundation (2020M683273), the Project First-Class Disciplines Development of Chengdu University of Traditional Chinese Medicine (CZYJC1903) and the National Key R&D Program of China (2017YFC1703904).	Ali IU, 2015, ACS NANO, V9, P9470, DOI 10.1021/acsnano.5b05341; Almeida JPM, 2011, NANOMEDICINE-UK, V6, P815, DOI [10.2217/NNM.11.79, 10.2217/nnm.11.79]; Antaris AL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15269; Antaris AL, 2016, NAT MATER, V15, P235, DOI [10.1038/NMAT4476, 10.1038/nmat4476]; Attia ABE, 2019, PHOTOACOUSTICS, V16, DOI 10.1016/j.pacs.2019.100144; Awasthi P, 2020, NANOSCALE, V12, P5678, DOI 10.1039/c9nr10918h; Campbell BCV, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0118-8; Carr JA, 2018, P NATL ACAD SCI USA, V115, P4465, DOI 10.1073/pnas.1718917115; Chen J, 2016, CHEM COMMUN, V52, P4025, DOI 10.1039/c6cc00099a; Chen Y, 2017, NANO LETT, V17, P6330, DOI 10.1021/acs.nanolett.7b03070; Chinnathambi S, 2019, SCI TECHNOL ADV MAT, V20, P337, DOI 10.1080/14686996.2019.1590731; Choi HS, 2009, NANO LETT, V9, P2354, DOI 10.1021/nl900872r; Deng GJ, 2020, ACS NANO, V14, P11452, DOI 10.1021/acsnano.0c03824; Deng ZM, 2018, NANOSCALE, V10, P9393, DOI 10.1039/c8nr00305j; Diao S, 2015, NANO RES, V8, P3027, DOI 10.1007/s12274-015-0808-9; Ding F, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201900260; Ding F, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800973; Ding F, 2017, BIOORGAN MED CHEM, V25, P5179, DOI 10.1016/j.bmc.2017.08.034; Donato H, 2017, EUR J RADIOL, V93, P30, DOI 10.1016/j.ejrad.2017.05.028; Dong XW, 2018, THERANOSTICS, V8, P1481, DOI 10.7150/thno.21254; Egloff-Juras C, 2019, INT J NANOMED, V14, P7823, DOI 10.2147/IJN.S207486; Esenwa C, 2015, VASC HEALTH RISK MAN, V11, P437, DOI 10.2147/VHRM.S63791; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Feng Z, 2019, THERANOSTICS, V9, P5706, DOI 10.7150/thno.31332; Ferguson SD, 2011, DM-DIS MON, V57, P558, DOI 10.1016/j.disamonth.2011.08.020; Fu QR, 2019, ADV MATER, V31, DOI 10.1002/adma.201805875; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Golovynskyi S, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201800141; Gu YP, 2012, J AM CHEM SOC, V134, P79, DOI 10.1021/ja2089553; Guo B, 2019, ADV MATER, V31, DOI 10.1002/adma.201902504; Guo B, 2019, ADV MATER, V31, DOI 10.1002/adma.201808355; Guo B, 2018, ADV MATER, V30, DOI 10.1002/adma.201802591; Guo B, 2017, MATER HORIZ, V4, P1151, DOI 10.1039/c7mh00672a; Han XJ, 2019, NANOSCALE, V11, P799, DOI 10.1039/c8nr07769j; He SQ, 2018, CHEM SOC REV, V47, P4258, DOI 10.1039/c8cs00234g; He Y, 2011, ANGEW CHEM INT EDIT, V50, P5694, DOI 10.1002/anie.201004398; Hong GS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0010; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI [10.1038/nphoton.2014.166, 10.1038/NPHOTON.2014.166]; Hong GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5206; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Hong GS, 2012, ANGEW CHEM INT EDIT, V51, P9818, DOI 10.1002/anie.201206059; Hu ZH, 2020, NAT BIOMED ENG, V4, P259, DOI 10.1038/s41551-019-0494-0; Huang JG, 2020, ANGEW CHEM INT EDIT, V59, P11717, DOI 10.1002/anie.202001783; Huang LY, 2020, ANAL CHEM, V92, P535, DOI 10.1021/acs.analchem.9b04156; Jiang YY, 2019, ADV MATER, V31, DOI 10.1002/adma.201808166; Jiang YY, 2018, ADV MATER, V30, DOI 10.1002/adma.201705980; Jiang YY, 2017, NANO LETT, V17, P4964, DOI 10.1021/acs.nanolett.7b02106; Kane JR, 2019, MOL NEUROBIOL, V56, P6645, DOI 10.1007/s12035-019-1561-y; Kenry, 2018, ADV MATER, V30, DOI 10.1002/adma.201802394; Kurbegovic S, 2018, BIOCONJUGATE CHEM, V29, P3833, DOI 10.1021/acs.bioconjchem.8b00669; Li BH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16924-z; Li BH, 2018, ANGEW CHEM INT EDIT, V57, P7483, DOI 10.1002/anie.201801226; Li CY, 2020, J AM CHEM SOC, V142, P14789, DOI 10.1021/jacs.0c07022; Li CY, 2020, ANGEW CHEM INT EDIT, V59, P247, DOI 10.1002/anie.201911803; Li CY, 2015, SMALL, V11, P4517, DOI 10.1002/smll.201500997; Li JC, 2019, CHEM SOC REV, V48, P38, DOI 10.1039/c8cs00001h; Li QQ, 2020, CHEM COMMUN, V56, P3289, DOI 10.1039/c9cc09865h; Li SL, 2020, ADV MATER, V32, DOI 10.1002/adma.202001146; Li S, 2020, ACS APPL MATER INTER, V12, P43466, DOI 10.1021/acsami.0c12773; Li XL, 2019, THERANOSTICS, V9, P3866, DOI 10.7150/thno.31864; Li XL, 2019, MAT SCI ENG C-MATER, V100, P260, DOI 10.1016/j.msec.2019.02.106; Li Y, 2020, CHEM SCI, V11, P2621, DOI 10.1039/c9sc06567a; Li YB, 2019, ACS NANO, V13, P248, DOI 10.1021/acsnano.8b05431; Lifante J, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000154; Lin JC, 2019, CHEM SCI, V10, P1219, DOI 10.1039/c8sc04363a; Liu HL, 2019, ADV MATER, V31, DOI 10.1002/adma.201901015; Liu HY, 2015, J AM CHEM SOC, V137, P10420, DOI 10.1021/jacs.5b06710; Liu HH, 2019, ACS APPL MATER INTER, V11, P30511, DOI 10.1021/acsami.9b06824; Liu SJ, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201908125; Liu SJ, 2019, J AM CHEM SOC, V141, P5359, DOI 10.1021/jacs.8b13889; Liu YJ, 2019, ADV SCI, V6, DOI 10.1002/advs.201801615; Liu Y, 2020, ANGEW CHEM INT EDIT, V59, P21049, DOI 10.1002/anie.202007886; Liu YS, 2021, CHINESE CHEM LETT, V32, P3061, DOI 10.1016/j.cclet.2021.03.075; Liu Z, 2019, BIOMATERIALS, V219, DOI 10.1016/j.biomaterials.2019.119364; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lowery FJ, 2017, BBA-REV CANCER, V1867, P49, DOI 10.1016/j.bbcan.2016.12.001; Lv RC, 2021, ANAL CHEM, V93, P4984, DOI 10.1021/acs.analchem.1c00374; Mandal Arundhati, 2015, Hematol Oncol Stem Cell Ther, V8, P47, DOI 10.1016/j.hemonc.2014.11.006; Rivas CJM, 2017, INT J PHARMACEUT, V532, P66, DOI 10.1016/j.ijpharm.2017.08.064; Mei J, 2018, ACS APPL MATER INTER, V10, P12217, DOI 10.1021/acsami.7b14343; Miao QQ, 2018, ADV MATER, V30, DOI 10.1002/adma.201801778; Miao YW, 2018, CHEMBIOCHEM, V19, P2522, DOI 10.1002/cbic.201800466; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Muller Jochen, 2013, Recent Results Cancer Res, V187, P221, DOI 10.1007/978-3-642-10853-2_7; Naczynski DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3199; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Qi J, 2020, NANO TODAY, V34, DOI 10.1016/j.nantod.2020.100893; Qi J, 2018, ADV MATER, V30, DOI 10.1002/adma.201706856; Qiu T, 2021, QUANT IMAG MED SURG, V11, P2169, DOI 10.21037/qims-20-845; Raghavan V, 2017, NANOMEDICINE-UK, V12, P457, DOI 10.2217/nnm-2016-0318; Ravindran S, 2018, CURR DRUG METAB, V19, P327, DOI 10.2174/1389200219666180305154119; Ren F, 2020, NANO TODAY, V34, DOI 10.1016/j.nantod.2020.100905; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Saeedi M, 2019, BIOMED PHARMACOTHER, V111, P666, DOI 10.1016/j.biopha.2018.12.133; Saji H, 2017, BIOL PHARM BULL, V40, P1605, DOI 10.1248/bpb.b17-00505; Sen M, 1998, RADIOTHER ONCOL, V46, P33, DOI 10.1016/S0167-8140(97)00124-2; Shaffer TM, 2016, J NUCL MED, V57, P1661, DOI 10.2967/jnumed.116.178624; Sheng ZH, 2018, ADV MATER, V30, DOI 10.1002/adma.201800766; Shiraki T, 2020, ACCOUNTS CHEM RES, V53, P1846, DOI 10.1021/acs.accounts.0c00294; Steinberg I, 2019, PHOTOACOUSTICS, V14, P77, DOI 10.1016/j.pacs.2019.05.001; Sun CX, 2019, J AM CHEM SOC, V141, P19221, DOI 10.1021/jacs.9b10043; Sun TT, 2019, ACS NANO, V13, P7345, DOI 10.1021/acsnano.9b03910; Sun Y, 2018, CHEM SCI, V9, P2092, DOI 10.1039/c7sc04774f; Sun Y, 2017, CHEM SCI, V8, P3489, DOI 10.1039/c7sc00251c; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Takeuchi T, 2019, BIOCONJUGATE CHEM, V30, P1323, DOI 10.1021/acs.bioconjchem.9b00088; Tang H, 2016, ACS APPL MATER INTER, V8, P17859, DOI 10.1021/acsami.6b05057; Upputuri PK, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.4.040901; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Wan H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03505-4; Wang D, 2019, ANGEW CHEM INT EDIT, V58, P5628, DOI 10.1002/anie.201900366; Wang FF, 2019, NAT METHODS, V16, P545, DOI 10.1038/s41592-019-0398-7; Wang PY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05113-8; Wang SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09043-x; Wen GH, 2020, ACS APPL MATER INTER, V12, P33492, DOI 10.1021/acsami.0c08562; Wu W., 2019, NANOMED, V14, P3571, DOI [10.2147/ijn.s198587, DOI 10.2147/IJN.S198587]; Wu YZ, 2013, CHEM SOC REV, V42, P2039, DOI 10.1039/c2cs35346f; Xi Y, 2017, RSC ADV, V7, P50949, DOI 10.1039/c7ra08418h; Xu WH, 2021, ANGEW CHEM INT EDIT, V60, P7476, DOI 10.1002/anie.202005899; Xue ZL, 2018, BIOMATERIALS, V171, P153, DOI 10.1016/j.biomaterials.2018.04.037; Yakavets I, 2020, CANCERS, V12, DOI 10.3390/cancers12123727; Yang YQ, 2019, NANOSCALE, V11, P7754, DOI 10.1039/c9nr00552h; Yang YJ, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102062; Yang YY, 2020, ACS NANO, V14, P13536, DOI 10.1021/acsnano.0c05541; Yu HL, 2021, MOL IMAGING BIOL, V23, P160, DOI 10.1007/s11307-020-01545-1; Yu WB, 2019, SCI BULL, V64, P410, DOI 10.1016/j.scib.2019.02.019; Yu XM, 2019, J MATER CHEM B, V7, P6623, DOI 10.1039/c9tb01381d; Yu ZF, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00496; Yu ZZ, 2021, BIOMATERIALS, V269, DOI 10.1016/j.biomaterials.2020.120459; Zhang C, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819894331; Zhang RR, 2017, NAT REV CLIN ONCOL, V14, P347, DOI 10.1038/nrclinonc.2016.212; Zhang TR, 2007, NANO LETT, V7, P3203, DOI 10.1021/nl071928t; Zhang X, 2020, CHEM ENG J, V385, DOI 10.1016/j.cej.2019.123959; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhang YG, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.728066; Zhang Z, 2020, ANGEW CHEM INT EDIT, V59, P3691, DOI 10.1002/anie.201914397; Zhao DH, 2019, J MATER CHEM B, V7, P2484, DOI 10.1039/c8tb03043j; Zhao JY, 2018, J MATER CHEM B, V6, P349, DOI 10.1039/c7tb02573d; Zhao MY, 2019, ANGEW CHEM INT EDIT, V58, P2050, DOI 10.1002/anie.201812878; Zhao Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08722-z; Zheng YJ, 2021, CHEM SCI, V12, P1843, DOI 10.1039/d0sc04727a; Zhong YT, 2019, NAT BIOTECHNOL, V37, P1322, DOI 10.1038/s41587-019-0262-4; Zhong YT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00917-6; Zhou H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19945-w; Zhou H, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201901224; Zhu SJ, 2018, THERANOSTICS, V8, P4141, DOI 10.7150/thno.27995	147	0	0	23	23	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	2191-0200		REV NEUROSCIENCE	Rev. Neurosci.												10.1515/revneuro-2021-0088		SEP 2021	24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YC3OS	WOS:000739604900001	34551223				2022-02-06	
J	Puvvada, SK; Davenport, EM; Holcomb, JM; Miller, LE; Whitlow, CT; Powers, AK; Maldjian, JA; Stitzel, JD; Urban, JE				Puvvada, Suraj K.; Davenport, Elizabeth M.; Holcomb, James M.; Miller, Logan E.; Whitlow, Christopher T.; Powers, Alexander K.; Maldjian, Joseph A.; Stitzel, Joel D.; Urban, Jillian E.			Relationship Between Time-Weighted Head Impact Exposure on Directional Changes in Diffusion Imaging in Youth Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Football; Concussion; Magnetic resonance imaging; Head injury; Youth Athletes; HIT System; Injury Risk	WHITE-MATTER CHANGES; AXONAL INJURY; BRAIN-INJURY; CONCUSSION; SEASON; GRAY; AGE	Approximately 3.5 million youth and adolescents in the US play football, a sport with one of the highest rates of concussion. Repeated subconcussive head impact exposure (HIE) may lead to negative neurological sequelae. To understand HIE as an independent predictive variable, quantitative cumulative kinematic metrics have been developed to capture the volume (i.e., number), severity (i.e., magnitude), and frequency (i.e., time-weighting by the interval between head impacts). In this study, time-weighted cumulative HIE metrics were compared with directional changes in diffusion tensor imaging (DTI) metrics. Changes in DTI conducted on a per-season, per-player basis were assessed as a dependent variable. Directional changes were defined separately as increases and decreases in the number of abnormal voxels relative to non-contact sport controls. Biomechanical and imaging data from 117 athletes (average age 11.9 +/- 1.0 years) enrolled in this study was analyzed. Cumulative HIE metrics were more strongly correlated with increases in abnormal voxels than decreases in abnormal voxels. Additionally, across DTI sub-measures, increases and decreases in mean diffusivity (MD) had the strongest relationships with HIE metrics (increases in MD: average R-2 = 0.1753, average p = 0.0002; decreases in MD: average R-2 = 0.0997, average p = 0.0073). This encourages further investigation into the physiological phenomena represented by directional changes.	[Puvvada, Suraj K.; Miller, Logan E.; Whitlow, Christopher T.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Davenport, Elizabeth M.; Holcomb, James M.; Maldjian, Joseph A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA		Urban, JE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA.	jurban@wakehealth.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]; Wake Forest School of Medicine Dean's Award	Funding was provided by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health via Grants R01NS094410 and R01NS082453. The authors would also like to thank Brian Tomblin as well as the youth football organizations, the Childress Institute for Pediatric Trauma, and the Wake Forest School of Medicine Dean's Award for supporting this study.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bellamkonda S, 2018, J APPL BIOMECH, V34, P354, DOI 10.1123/jab.2017-0207; Benedetti B, 2006, NEUROLOGY, V66, P535, DOI 10.1212/01.wnl.0000198510.73363.c6; Brett BL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01345; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Campolettano ET, 2020, ANN BIOMED ENG, V48, P1640, DOI 10.1007/s10439-020-02505-0; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DiGuglielmo DM, 2021, J APPL BIOMECH, V37, P145, DOI 10.1123/jab.2020-0145; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gellner RA, 2019, J NEUROSURG-PEDIATR, V24, P47, DOI 10.3171/2019.2.PEDS18176; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Kelley ME, 2021, J NEUROSURG-PEDIATR, V28, P196, DOI 10.3171/2021.1.PEDS20586; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Miller Logan E., 2019, New Developments on Computational Methods and Imaging in Biomechanics and Biomedical Engineering. Lecture Notes in Computational Vision and Biomechanics (LNCVB 33), P121, DOI 10.1007/978-3-030-23073-9_8; Miller LE, 2021, ANN BIOMED ENG, V49, P1083, DOI 10.1007/s10439-020-02685-9; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murugesan G, 2018, PROC SPIE, V10575, DOI 10.1117/12.2293199; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; San Martin Molina Isabel, 2020, eNeuro, V7, DOI 10.1523/ENEURO.0476-19.2020; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2019, J NEUROSURG-PEDIATR, V24, P190, DOI 10.3171/2019.2.PEDS18558; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z	47	0	0	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2852	2862		10.1007/s10439-021-02862-4		SEP 2021	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000698088100003	34549344				2022-02-06	
J	Somebang, K; Rudolph, J; Imhof, I; Li, LY; Niemi, EC; Shigenaga, J; Tran, H; Gill, TM; Lo, I; Zabel, BA; Schmajuk, G; Wipke, BT; Gyoneva, S; Jandreski, L; Craft, M; Benedetto, G; Plowey, ED; Charo, I; Campbell, J; Ye, CJ; Panter, SS; Nakamura, MC; Eckalbar, W; Hsieh, CL				Somebang, Kerri; Rudolph, Joshua; Imhof, Isabella; Li, Luyi; Niemi, Erene C.; Shigenaga, Judy; Tran, Huy; Gill, T. Michael; Lo, Iris; Zabel, Brian A.; Schmajuk, Gabriela; Wipke, Brian T.; Gyoneva, Stefka; Jandreski, Luke; Craft, Michael; Benedetto, Gina; Plowey, Edward D.; Charo, Israel; Campbell, James; Ye, Chun Jimmie; Panter, S. Scott; Nakamura, Mary C.; Eckalbar, Walter; Hsieh, Christine L.			CCR2 deficiency alters activation of microglia subsets in traumatic brain injury	CELL REPORTS			English	Article							MACROPHAGE ACTIVATION; STIMULATED GENES; IMMUNE-RESPONSE; INFLAMMATION; REVEALS; CELLS; MAZE; NEURODEGENERATION; DEGENERATION; NEUROGENESIS	In traumatic brain injury (TBI), a diversity of brain resident and peripherally derived myeloid cells have the potential to worsen damage and/or to assist in healing. We define the heterogeneity of microglia and macrophage phenotypes during TBI in wild-type (WT) mice and Ccr2(-/-) mice, which lack macrophage influx following TBI and are resistant to brain damage. We use unbiased single-cell RNA sequencing methods to uncover 25 microglia, monocyte/macrophage, and dendritic cell subsets in acute TBI and normal brains. We find alterations in transcriptional profiles of microglia subsets in Ccr2(-/-) TBI mice compared to WT TBI mice indicating that infiltrating monocytes/macrophages influence microglia activation to promote a type I IFN response. Preclinical pharmacological blockade of hCCR2 after injury reduces expression of IFN-responsive gene, Irf7, and improves outcomes. These data extend our understanding of myeloid cell diversity and crosstalk in brain trauma and identify therapeutic targets in myeloid subsets.	[Somebang, Kerri; Imhof, Isabella; Li, Luyi; Niemi, Erene C.; Schmajuk, Gabriela; Ye, Chun Jimmie; Nakamura, Mary C.; Hsieh, Christine L.] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Somebang, Kerri; Imhof, Isabella; Li, Luyi; Niemi, Erene C.; Shigenaga, Judy; Tran, Huy; Schmajuk, Gabriela; Panter, S. Scott; Nakamura, Mary C.; Hsieh, Christine L.] San Francisco VA Hlth Care Syst, San Francisco, CA 94121 USA; [Rudolph, Joshua; Eckalbar, Walter] UCSF, Sch Med, Div Pulmonol, Lung Biol Ctr, San Francisco, CA USA; [Shigenaga, Judy] UCSF, Div Endocrinol & Metab, Dept Med, San Francisco, CA USA; [Gill, T. Michael; Lo, Iris] Gladstone Inst, San Francisco, CA USA; [Zabel, Brian A.] Palo Alto Vet Inst Res, Palo Alto, CA USA; [Zabel, Brian A.] Palo Alto VA Hlth Care Syst, Palo Alto, CA USA; [Wipke, Brian T.; Gyoneva, Stefka; Jandreski, Luke; Craft, Michael; Benedetto, Gina; Plowey, Edward D.] Biogen, Cambridge, MA USA; [Charo, Israel; Campbell, James] ChemoCentryx, Mountain View, CA USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Inst Computat Hlth Sci, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA; [Ye, Chun Jimmie] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Ye, Chun Jimmie] Chan Zuckerberg Biohub, San Francisco, CA USA; [Panter, S. Scott] UCSF, Dept Neurol Surg, San Francisco, CA USA; [Wipke, Brian T.] Moderna Inc, Cambridge, MA USA		Hsieh, CL (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.; Hsieh, CL (corresponding author), San Francisco VA Hlth Care Syst, San Francisco, CA 94121 USA.	christine.hsieh@ucsf.edu	Nakamura, Mary/ABI-2887-2020		Department of Veterans Affairs Biomedical Laboratory RDUS Department of Veterans Affairs [BX002690]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 HL135403, R01AR071522, R01AI136972, U01HG012192]; National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR066735, P30AR070155]; Russell/Engelman Rheumatology Research Center at UCSF; United States Department of Veterans Affairs Biomedical Laboratory R&D (BLRD) ServiceUS Department of Veterans Affairs [I01 BX004115]; Chan Zuckerberg Initiative; Department of Veterans Affairs Biomedical Laboratory RD Merit AwardUS Department of Veterans Affairs [BX002994]; S. Scott Panter Research Fund	\We dedicate this manuscript to Dr. S. Scott Panter and Huy Tran, whose devotion and contributions to research were immense and who left us too soon. We thank William E. Seaman for helpful discussions and thoughtful review of the manuscript. We thank James Ryan and David Erle for helpful discussions. C.L.H. and this work were supported by two TBI Merit Awards from the Department of Veterans Affairs Biomedical Laboratory R&D BX002690 and the S. Scott Panter Research Fund. W.E. was supported by NIH R00 HL135403.M.C.N. was supported by the Department of Veterans Affairs Biomedical Laboratory R&D Merit Award BX002994, the National Institute of Arthritis and Musculoskeletal and Skin Diseases Awards R01AR066735 and P30AR070155, and the Russell/Engelman Rheumatology Research Center at UCSF. B.A.Z. was supported by Merit Review Award Number I01 BX004115 from the United States Department of Veterans Affairs Biomedical Laboratory R&D (BLR&D) Service. C.J.Y. is supported by the NIH grants R01AR071522, R01AI136972, U01HG012192 and the Chan Zuckerberg Initiative.	Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen XG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165595; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Chhatbar C, 2018, CELL REP, V25, P118, DOI 10.1016/j.celrep.2018.09.003; Chiot A, 2020, NAT NEUROSCI, V23, P1339, DOI 10.1038/s41593-020-00718-z; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Deerhake ME, 2021, IMMUNITY, V54, P484, DOI 10.1016/j.immuni.2021.01.004; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Flores-Toro JA, 2020, P NATL ACAD SCI USA, V117, P1129, DOI 10.1073/pnas.1910856117; Frigerio CS, 2019, CELL REP, V27, P1293, DOI 10.1016/j.celrep.2019.03.099; Giladi A, 2020, NAT IMMUNOL, V21, P525, DOI 10.1038/s41590-020-0661-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hong SM, 2007, EXP NEUROL, V206, P24, DOI 10.1016/j.expneurol.2007.03.028; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miao ZH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192405; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Possin KL, 2016, J CLIN INVEST, V126, P779, DOI 10.1172/JCI78464; Potts Mathew B, 2006, NeuroRx, V3, P143; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Sullivan T, 2013, AM J PHYSIOL-RENAL, V305, pF1288, DOI 10.1152/ajprenal.00316.2013; Swirski FK, 2018, NAT REV IMMUNOL, V18, P733, DOI 10.1038/s41577-018-0065-8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wahane S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd8811; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689	69	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	SEP 21	2021	36	12							109727	10.1016/j.celrep.2021.109727			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	UU3DU	WOS:000698680800009	34551293	gold, Green Accepted			2022-02-06	
J	AlHashmi, R; Matthews, CR				AlHashmi, Reem; Matthews, Christopher R.			Athletes' understanding of concussion - uncertainty, certainty and the 'expert' on the street	QUALITATIVE RESEARCH IN SPORT EXERCISE AND HEALTH			English	Article; Early Access						concussion; brain injury; combat sport; certainty; uncertainty	SPORT-RELATED CONCUSSION; KNOWLEDGE; PERSPECTIVES; CLINICIAN; IMPACT	Several scholars have examined the uncertainties faced by sport medicine professionals surrounding their diagnosis, treatment and management of concussion. Yet, recent evidence suggests that combat sport athletes seem to have 'reasonably good concussion knowledge'. How, then, have athletes gained such an understanding when medical professionals have not? We argue that this logical inconsistency is most likely an artefact of inflexible, 'snapshot' methodological procedures rather than a nuanced representation of athletes' actual understanding and experiences of concussion. We address this issue by employing immersive research strategies to provide epistemological space for complexities, contradictions and incoherencies that lie within fighters' understanding of such experiences to come to the fore. In so doing, we demonstrate the interdependence between notions of 'uncertainty' and 'certainty' in fighters' knowledge about concussion. Further to this, we propose the idea of 'the expert on the street' to explain the ways in which fighters gained lay medical certainty and highlight the potential problems that are imbedded within this process. To conclude, we suggest that inflexible, 'snapshot' methods will often produce overly reductive answers which do little to support the generation of the solutions which are needed to tackle concussion in sport.	[AlHashmi, Reem; Matthews, Christopher R.] Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England		AlHashmi, R (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	reem.alsayed.alhashmi@gmail.com					Adamson C, 1997, SOCIOL HEALTH ILL, V19, P133, DOI 10.1111/1467-9566.ep10934391; Albrecht, 2000, HDB SOCIAL STUDIES H, P409, DOI DOI 10.4135/9781848608412.N26; AlHashmi R, 2022, INT REV SOCIOL SPORT, V57, P146, DOI 10.1177/1012690220987136; ATKINSON P, 1984, SOC SCI MED, V19, P949, DOI 10.1016/0277-9536(84)90324-1; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Becker H.S., 2017, EVIDENCE; Bennett LL, 2019, PHYSICIAN SPORTSMED, V47, P295, DOI 10.1080/00913847.2018.1552481; Blumer H., 1969, SYMB INTERACT; Channon A., 2020, IN PRESS; Channon A, 2021, INT REV SOCIOL SPORT, V56, P578, DOI 10.1177/1012690220927338; Channon A, 2020, J SCI MED SPORT, V23, P237, DOI 10.1016/j.jsams.2019.10.014; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Conrad P., 1987, RES SOCIOLOGY HLTH C, V6, P1; Conrad P, 2010, J HEALTH SOC BEHAV, V51, pS67, DOI 10.1177/0022146510383495; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; DAVIS F, 1960, AM J SOCIOL, V66, P41, DOI 10.1086/222821; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Follmer B, 2020, PHYSICIAN SPORTSMED, V48, P417, DOI 10.1080/00913847.2020.1729668; FOX RC, 1980, MILBANK FUND Q, V58, P1, DOI 10.2307/3349705; Fox RC., 1957, STUDENT PHYS INTRO S, V3, P207; Gaetz M, 2017, MED HYPOTHESES, V102, P130, DOI 10.1016/j.mehy.2017.03.023; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kotarba J., 1983, CHRONIC PAIN ITS SOC; LIGHT D, 1979, J HEALTH SOC BEHAV, V20, P310, DOI 10.2307/2955407; Liston K., 2019, GAA COACH C DUBL JAN; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Lupkin S., 2012, ABC NEWS; Lystad Reidar P, 2018, Inj Epidemiol, V5, P25, DOI 10.1186/s40621-018-0155-x; Malcolm D, 2021, FRONT SPORTS ACT LIV, V3, DOI 10.3389/fspor.2021.589341; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Matthews C.R., 2021, DOING IMMERSIVE RES; Matthews CR, 2021, INT REV SOCIOL SPORT, V56, P719, DOI 10.1177/1012690220907026; Matthews CR, 2020, QUAL RES SPORT EXERC, V12, P631, DOI 10.1080/2159676X.2019.1664623; Matthews CR, 2019, ROUTL RES SPORT CULT, P102; Matthews CR, 2017, SPORT SOC, V20, P751, DOI 10.1080/17430437.2016.1179735; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Nettleton S, 2006, SOC SCI MED, V62, P1167, DOI 10.1016/j.socscimed.2005.07.030; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Pierret J, 2003, SOCIOL HEALTH ILL, V25, P4, DOI 10.1111/1467-9566.t01-1-00337; Pike E. C. J., 2005, International Review for the Sociology of Sport, V40, P201, DOI 10.1177/1012690205057199; Prus Robert, 1996, SYMB INTERACT; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Schutz A., 1970, A SCHUTZ PHENOMENOLO; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Walk SR, 1997, SOCIOL SPORT J, V14, P22, DOI 10.1123/ssj.14.1.22; Yair G, 2007, SOCIOLOGY, V41, P681, DOI 10.1177/0038038507078923; Young K., 2004, SPORTING BODIES DAMA, P251	58	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2159-676X	2159-6778		QUAL RES SPORT EXERC	Qual. Res. Sport Exerc. Health												10.1080/2159676X.2021.1974928		SEP 2021	16	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	UT6ND	WOS:000698230900001		hybrid			2022-02-06	
J	Darshini, JK; Afsar, M; Vandana, VP; Shukla, D; Rajeswaran, J				Darshini, Jeevendra Kumar; Afsar, Mohammed; Vandana, Valiyaparambath Purushothaman; Shukla, Dhaval; Rajeswaran, Jamuna			The Triad of Cognition, Language, and Communication in Traumatic Brain Injury: A Correlational Study	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injury; language; cognition; communication; executive functioning	EXECUTIVE FUNCTIONS; ABILITIES; CHILDREN	Objectives Traumatic brain injury (TBI) is associated with deficits in cognition, language, and communication along with physical and psychosocial consequences. This study aimed at evaluating the association between cognition, language, and communication in a cohort of patients with TBI in southern India using standardized language specific assessment tools. Materials and Methods The present correlational study included 30 patients with TBI of any severity, that is, mild, moderate, and severe within the postinjury period of 6 to 36 months. Comprehensive evaluation of cognition, language, and communication was done using National Institute of Mental Health and Neurosciences Neuropsychology Battery, Indian adapted versions of Western Aphasia Battery and La Trobe Communication Questionnaire (LCQ) respectively. Data Analysis Measures of descriptive statistics, that is, mean, median, percentages, and frequencies, were used. Raw scores, that is, aphasia quotient (AQ), and subdomain scores for LCQ, that is, LCQ-quality, quantity, relation, manner, and cognition, were calculated. Composite scores for the three neuropsychological domains, that is, attention and processing speed, executive function, learning and memory, were evaluated. Partial correlation was computed for identifying the association between the three variables by controlling for age, education, duration, and severity of injury. Results A significant correlation was found between AQ and measures of attention and executive functioning and all measures of LCQ except LCQ-manner. Further, a significant correlation was found between executive functioning and LCQ-total, LCQquantity, and LCQ cognition. No correlation was found between measures of attention and memory with communication. Conclusion A good language and executive functioning are associated with better communication abilities in patients with TBI thus emphasizing on the importance of a multidisciplinary team for the management of cognitive-communication impairments following a TBI.	[Darshini, Jeevendra Kumar; Vandana, Valiyaparambath Purushothaman] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Speech Pathol & Audiol, Bengaluru 560029, Karnataka, India; [Afsar, Mohammed; Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Psychol, Bengaluru, Karnataka, India; [Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bengaluru, Karnataka, India		Vandana, VP (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Speech Pathol & Audiol, Bengaluru 560029, Karnataka, India.	vpvandana@gmail.com		Afsar, Mohammed/0000-0002-4429-8318; Shukla, Dhaval/0000-0001-7613-1929	Defence Research & Development Organization-Life Sciences Research Board (DRDO-LSRB), Government of India [O/o DG(TM)/81/48222/LSRB-309]	The study was funded by the Defence Research & Development Organization-Life Sciences Research Board (DRDO-LSRB), Government of India (Grant reference No: O/o DG(TM)/81/48222/LSRB-309).	[Anonymous], 1988, ASHA, V30, P79; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chapey R., 2001, COMMUNICATION DISORD, P745; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; College of Audiologists and Speech-Language Pathologists of Ontario, 2002, PREF PRACT GUID COGN; DeLisa JA., 2005, PHYS MED REHABILITAT, V4th ed.; Demir SO, 2006, BRAIN INJURY, V20, P1383, DOI 10.1080/02699050601081844; Demir SO, 2006, J REHABIL MED, V38, P68, DOI 10.1080/16501970510041262; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Hux K., 2008, J MED SPEECH LANGUAG, V16, P83; Karanth, 1980, W APHASIA BATTERY HI; Kaushanskaya M, 2017, J SPEECH LANG HEAR R, V60, P912, DOI 10.1044/2016_JSLHR-L-15-0310; Kertesz A., 1982, W APHASIA BATTERY TE; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; LUDLOW CL, 1986, BRAIN, V109, P55, DOI 10.1093/brain/109.1.55; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Togher L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P603; Turkheimer, 1989, CRITICAL ISSUES NEUR, P161; TVERSKY B, 1969, PERCEPT PSYCHOPHYS, V6, P225, DOI 10.3758/BF03207022; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200	35	0	0	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT	2021	12	04					666	672		10.1055/s-0041-1734008		SEP 2021	7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WP2YT	WOS:000697275700004	34737500	Green Published, gold			2022-02-06	
J	Eagle, SR; Ferris, LM; Mucha, A; Sinnott, A; Marchetti, G; Trbovich, A; Port, N; Clugston, J; Ortega, J; Collins, MW; Broglio, SP; McAllister, T; McCrea, MA; Pasquina, P; Kontos, AP				Eagle, Shawn R.; Ferris, Lyndsey M.; Mucha, Anne; Sinnott, Aaron; Marchetti, Gregory; Trbovich, Alicia; Port, Nicholas; Clugston, Jay; Ortega, Justus; Collins, Michael W.; Broglio, Steven P.; McAllister, Thomas; McCrea, Michael A.; Pasquina, Paul; Kontos, Anthony P.		CARE Consortium Investigators	Minimum detectable change and false positive rates of the vestibular/ocular motor screening (VOMS) tool: an NCAA-DoD care consortium analysis	BRAIN INJURY			English	Article; Early Access						Concussion; vestibular; ocular; VOMS; symptoms	RECOVERY-TIME; CONCUSSION; RELIABILITY; YOUTH; ASSOCIATION; SEX	Objective To derive minimum detectable change (MDC) across individual Vestibular-Ocular Motor Screening (VOMS) items and VOMS overall score in 17-25 years old collegiate athletes and to examine false positive rates. Method Participants (n = 378) completed VOMS pre-season for two consecutive years. MDC was identified for individual VOMS symptom items and NPC distance (cm). Both total and change methods of VOMS scoring were included in analysis. Results Regarding total scoring, MDC for ocular VOMS symptom items was 1 and MDC for vestibular VOMS symptoms items was 2. MDC for NPC was 4 cm and for VOMS overall score was 10. Regarding change scoring, MDC for each VOMS symptom item was 1, and for VOMS overall score was 8. False positives ranged from 5.3% to 15.9%. Conclusions This study presents MDCs for each VOMS item and overall VOMS score, using total and change scoring. These values can be considered true change outside measurement error with 95% confidence in a 17-25 year old collegiate athlete population.	[Eagle, Shawn R.; Mucha, Anne; Sinnott, Aaron; Trbovich, Alicia; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA 15260 USA; [Ferris, Lyndsey M.; Port, Nicholas] Indiana Univ, Sch Optometry, Bloomington, IN USA; [Marchetti, Gregory] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Clugston, Jay] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [Ortega, Justus] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA; [Pasquina, Paul] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA		Eagle, SR (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA 15260 USA.	seagle@pitt.edu		Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program; Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program - Psychological Health and Traumatic Brain Injury ProgramUnited States Department of Defense [W81XWH1420151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program, endorsed by the Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program -Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH1420151.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bowman TG, 2020, J ATHL TRAINING, V55, P312, DOI 10.4085/1062-6050-85-19; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; D'Amico NR., 2019, TEST ORDER DOES NOT; Dobie T, 2001, AVIAT SPACE ENVIR MD, V72, P13; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ., 2021, CHILD, DOI [10.1080/21622965.2021.1911806, DOI 10.1080/21622965.2021.1911806]; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GH G., S QUAL LIFE CANC PAT, V77, pP371; Kontos AP, 2019, ARCH CLIN NEUROPSYCH, V34, P762, DOI 10.1093/arclin/acz026.32; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ml D., 2018, PLOS ONE, V13, P4; Moran RN, 2019, J ATHL TRAINING, V54, P445, DOI 10.4085/1062-6050-220-18; Moran RN, 2019, J NEUROSURG-PEDIATR, V23, P465, DOI 10.3171/2018.10.PEDS18425; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Petit KM, 2019, ARCH CLIN NEUROPSYCH, V34, P744, DOI 10.1093/arclin/acz026.14; Rejas J, 2008, J CLIN EPIDEMIOL, V61, P350, DOI 10.1016/j.jclinepi.2007.05.011; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	28	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1973561		SEP 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	US4XJ	WOS:000697433800001	34543099				2022-02-06	
J	Harlos, AR; Rowson, S				Harlos, Ann R.; Rowson, Steven			Laboratory Reconstructions of Real-world Bicycle Helmet Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Bicycle helmet; Concussion; Acceleration	HEAD-INJURIES; UNITED-STATES; CONCUSSION; RISK	The best way to prevent severe head injury when cycling is to wear a bike helmet. To reduce the rate of head injury in cycling, knowing the nature of real-world head impacts is crucial. Reverse engineering real-world bike helmet impacts in a laboratory setting is an alternative to measuring head impacts directly. This study aims to quantify bike helmet damage using computed tomography (CT) and reconstruct real-world damage with a custom, oblique test rig to recreate real-world impacts. Damaged helmets were borrowed from a helmet manufacturer who runs a helmet warranty program. Each helmet was CT-scanned and the damage metrics were quantified. Helmets of the same model and size were used for in-lab reconstructions of the damaged helmets where normal velocity, tangential velocity, peak linear acceleration (PLA) and peak rotational velocity (PRV) could be measured. The damage metrics of the in-lab dropped helmets were quantified using the same CT scanning process. For each case, a multiple linear regression (MLR) equation was created to define a relationship between the quantified damage metrics of the in-lab tested helmets and the associated measured impact velocities and kinematics. These equations were used to predict the impact kinematics and velocities from the corresponding real-world damaged helmet based on the damage metrics from the original damaged helmet. Average normal velocity (3.5 m/s), tangential velocity (2.5 m/s), PLA (108.0 g), PRV (15.7 rad/s) were calculated based on a sample of 23 helmets. Within these head impact cases, five notes reported a concussion. The difference between the average PLA and PRV for concussive cases versus other impacts were not significantly different, although the average impact kinematics for the concussive cases (PLA = 111.4 g, PRV = 18.5 rad/s) were slightly higher than the remaining cases (PLA = 107.1 g, PRV = 15.0 rad/s). The concussive cases were not indicative of high magnitude impact kinematics.	[Harlos, Ann R.; Rowson, Steven] Virginia Tech, Dept Biomed Engn, Blacksburg, VA 24061 USA		Harlos, AR (corresponding author), Virginia Tech, Dept Biomed Engn, Blacksburg, VA 24061 USA.	harlosa@vt.edu		Harlos, Annellie/0000-0003-0752-7123			Bil M, 2018, SAFETY SCI, V105, P71, DOI 10.1016/j.ssci.2018.02.005; Bland M. L., 2019, BIOMEDICAL ENG MECH; Bland ML, 2020, ANN BIOMED ENG, V48, P2783, DOI 10.1007/s10439-020-02620-y; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Folksam, 2020, BIC HELM 2020 TEST F; Forbes AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185367; Haileyesus T, 2007, INJURY PREV, V13, P202, DOI 10.1136/ip.2006.014019; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Jewett A, 2016, J SAFETY RES, V59, P1, DOI 10.1016/j.jsr.2016.09.001; King A. I., 2003, IRCOBI C LISB PORT; Loftis Kathryn L, 2011, Biomed Sci Instrum, V47, P234; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	28	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2827	2835		10.1007/s10439-021-02860-6		SEP 2021	9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	WH8FD	WOS:000698085200001	34545462	Bronze, Green Published			2022-02-06	
J	Ismael, S; Ishrat, T				Ismael, Saifudeen; Ishrat, Tauheed			Compound 21, a Direct AT2R Agonist, Induces IL-10 and Inhibits Inflammation in Mice Following Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article; Early Access						TBI; AT2R; Compound 21; Inflammation; AQ4	ANGIOTENSIN SYSTEM; STIMULATION	Recent studies demonstrated that the angiotensin type 2 receptor (AT2R) agonist, compound 21 (C21), provides neuroprotection and enhances recovery in experimental stroke. However, C21 has never been tested in traumatic brain injury (TBI). Here, we aim to examine whether C21 confers protection after TBI. Unilateral cortical impact injury was induced in young adult C57BL/6 mice. C21 (0.03 mg/kg, i.p.) was administered at 1 h and 3 h post-TBI. After neurological severity score (NSS) assessments, all animals were sacrificed for immunoblotting analysis at 24 h post-TBI. C21 treatment significantly ameliorated NSS and reduced TBI's biomarkers [high mobility group box 1 (HMGB1), aquaporin-4 (AQ4)] and inflammatory markers [interlukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha)] in the pericontusional areas compared to saline TBI. Further, C21 treatment induced interleukin-10 (IL-10) and phosphorylation of endothelial nitric oxide synthase (eNOS) after TBI. C21 also attenuated pro-apoptotic activation of poly (ADP-ribose) polymerase (PARP) and caspase-3. These findings support the therapeutic potential of C21 against TBI.	[Ismael, Saifudeen; Ishrat, Tauheed] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Ishrat, Tauheed] Univ Tennessee, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Ishrat, Tauheed] Univ Tennessee, Neurosci Inst, Hlth Sci Ctr, Memphis, TN 38163 USA; [Ishrat, Tauheed] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Coll Med, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA		Ishrat, T (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN 38163 USA.; Ishrat, T (corresponding author), Univ Tennessee, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA.; Ishrat, T (corresponding author), Univ Tennessee, Neurosci Inst, Hlth Sci Ctr, Memphis, TN 38163 USA.; Ishrat, T (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Coll Med, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA.	tishrat@uthsc.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS097800]	This work was supported by the National Institute of Health [Grant No. R01-NS097800 (TI)].	Ahmed HA, 2019, BEHAV BRAIN RES, V359, P560, DOI 10.1016/j.bbr.2018.10.010; Ahmed HA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1262-x; Ahmed HA, 2018, BEHAV BRAIN RES, V346, P29, DOI 10.1016/j.bbr.2017.12.007; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Fouda AY, 2017, EUR J PHARMACOL, V799, P128, DOI 10.1016/j.ejphar.2017.02.016; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Ishrat T, 2019, J CEREBR BLOOD F MET, V39, P1635, DOI 10.1177/0271678X18764773; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Iwanami J, 2015, J AM SOC HYPERTENS, V9, P250, DOI 10.1016/j.jash.2015.01.010; Jackson L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030876; Janatpour ZC, 2020, NEURAL REGEN RES, V15, P1025, DOI 10.4103/1673-5374.270304; Mirzahosseini G, 2021, METAB BRAIN DIS, V36, P1079, DOI 10.1007/s11011-021-00728-1; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Wei X, 2016, J HUAZHONG U SCI-MED, V36, P576, DOI 10.1007/s11596-016-1628-1; Yasar S, 2013, NEUROLOGY, V81, P896, DOI 10.1212/WNL.0b013e3182a35228	19	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.												10.1007/s12017-021-08687-7		SEP 2021	5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	US9PI	WOS:000697756600002	34542832				2022-02-06	
J	Kakavas, G; Malliaropoulos, N; Blach, W; Bikos, G; Migliorini, F; Maffulli, N				Kakavas, George; Malliaropoulos, Nikolaos; Blach, Wieslaw; Bikos, Georgios; Migliorini, Filippo; Maffulli, Nicola			Ball heading and subclinical concussion in soccer as a risk factor for anterior cruciate ligament injury	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						ACL; Concussion; Ball heading; Injury; Brain	NEUROCOGNITION	Soccer players have a high risk of anterior cruciate ligament (ACL) injury, a potentially career-ending event. ACL rupture has been linked with abnormal neuromuscular control in the lower limb. Additionally, heading the ball with the unprotected head during game play is increasingly recognized as a major source of exposure to concussive and sub-concussive repetitive head impacts. This article provides a hypothesis of potential connection of ACL injury with ball heading in soccer players. The study reviews literature sources regarding the impact of neurocognitive alterations after ball headings in ACL injuries. Poor baseline neurocognitive performance or impairments in neurocognitive performance via sleep deprivation, psychological stress, or concussion can increase the risk for subsequent musculoskeletal injury.	[Kakavas, George] Fysiotek Spine & Sports Lab, Athens, Greece; [Malliaropoulos, Nikolaos] Thessaloniki Sports Med Clin, Thessaloniki, Greece; [Malliaropoulos, Nikolaos] Barts Hlth NHS Trust, Rheumatol Dept, Ports Clin, London, England; [Malliaropoulos, Nikolaos; Maffulli, Nicola] Queen Mary Univ London, Ctr Sports & Exercise Med, London, England; [Blach, Wieslaw] Univ Sch Phys Educ, Fac Phys Educ & Sport Sci, Paderewskiego 35, PL-51612 Wroclaw, Poland; [Blach, Wieslaw] European Judo Union, Vienna, Austria; [Bikos, Georgios] Euromed Arogi Rehabil Clin, Thessaloniki, Greece; [Migliorini, Filippo] RWTH Univ Hosp, Dept Orthoped Trauma & Reconstruct Surg, Pauwelsstr 31, D-52064 Aachen, Germany; [Maffulli, Nicola] BMI London Independent Hosp, London Sports Care, London, England; [Maffulli, Nicola] Univ Salerno, Sch Med Surg & Dent, Dept Orthopaed, Salerno, Italy; [Maffulli, Nicola] Keele Univ, Sch Pharm & Bioengn, Sch Med, Stoke On Trent, Staffs, England		Migliorini, F (corresponding author), RWTH Univ Hosp, Dept Orthoped Trauma & Reconstruct Surg, Pauwelsstr 31, D-52064 Aachen, Germany.	Migliorini.md@gmail.com	migliorini, filippo/AAZ-9529-2021	migliorini, filippo/0000-0001-7220-1221; Blach, Wieslaw/0000-0002-3559-9151	Projekt DEAL	No external source of funding was used. Open Access funding enabled and organized by Projekt DEAL.	Arendt EA, 1999, J ATHL TRAINING, V34, P86; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; Borotikar BS, 2008, CLIN BIOMECH, V23, P81, DOI 10.1016/j.clinbiomech.2007.08.008; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown TN, 2009, BRIT J SPORT MED, V43, P1049, DOI 10.1136/bjsm.2008.055954; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Kakavas G, 2020, INDIAN J ORTHOP, V54, P275, DOI 10.1007/s43465-020-00045-2; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Williams JM, 1997, BEHAV MED, V22, P160, DOI 10.1080/08964289.1997.10543549; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	18	0	0	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	SEP 19	2021	16	1							566	10.1186/s13018-021-02711-z			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	US1CG	WOS:000697173600001	34538251	Green Accepted, Green Published, gold			2022-02-06	
J	Oyesanya, TO; Harris, G; Cary, MP; Byom, L; Yang, Q; Bettger, JP				Oyesanya, Tolu O.; Harris, Gabrielle; Cary, Michael P. Jr Jr; Byom, Lindsey; Yang, Qing; Bettger, Janet Prvu			Age- and sex-specific predictors of inpatient rehabilitation facility discharge destination for adult patients with traumatic brain injury	BRAIN INJURY			English	Article; Early Access						[MeSH]; brain injuries; traumatic; rehabilitation; outcome assessment; health care	OLDER-ADULTS; INSURANCE; OUTCOMES; MODERATE; GENDER; EPIDEMIOLOGY; DISPARITIES; HEALTH; WOMEN; CARE	Objective : To determine age- and sex-specific predictors of discharge destination among patients with traumatic brain injury (TBI) receiving inpatient rehabilitation facility (IRF) care. Design : Secondary analysis of Uniform Data System for Medical Rehabilitation data. Methods : Logistic regression of patients (N = 221,961) age >= 18, TBI diagnosis, admitted to IRF between 2002 and 2018. Outcome : Discharge destination (subacute vs. home/community settings) Results : Approximately 16% were discharged to subacute vs. 84% home. Younger versus older adults had lower odds of subacute discharge [OR = 0.72; 95% CI: 0.69, 0.76]. Younger females had lower odds of subacute discharge (vs. home) than older females [OR = 0.68; 95% CI: 0.63, 0.74]; younger males had lower odds of subacute discharge (vs. home) than older males [OR = 0.74; 95% CI: 0.70, 0.78]. Younger females versus younger males had lower odds of subacute discharge (vs. home) [OR = 0.83; 95% CI: 0.79, 0.87]. Older females versus older males had lower odds of subacute discharge (vs. home) [OR = 0.93; 95% CI: 0.90, 0.97]. Predictors of discharge destination for age- and sex-stratified groups varied. Conclusions : Younger (vs. older) and female (vs. male) patients had lower odds of subacute discharge vs. home.	[Oyesanya, Tolu O.; Harris, Gabrielle; Cary, Michael P. Jr Jr; Yang, Qing; Bettger, Janet Prvu] Duke Univ, Sch Nursing, DUMC 3322,307 Trent Dr, Durham, NC 27710 USA; [Byom, Lindsey] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC 27515 USA; [Bettger, Janet Prvu] Duke Univ, Sch Med, Durham, NC 27710 USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, DUMC 3322,307 Trent Dr, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu		Byom, Lindsey/0000-0002-2457-1735; Oyesanya, Tolu/0000-0001-8821-4510; Yang, Qing/0000-0003-4844-4690	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD065702]; National Center on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD012530]	This research was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD065702]; National Center on Minority Health and Health Disparities [U54MD012530].	Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; [Anonymous], 2017, UDSPRO SYST; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Centers for Medicare & Medicaid Services, 2012, INP REH FAC PAT ASS; Centers for Medicare & Medicaid Services (CMS) HHS, 2009, Fed Regist, V74, P39761; Centers for Medicare Medicaid Services (CMS) Medicare Shared Saving Program, 2018, QUAL MEAS BENCHM 201; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Elkbuli A, 2020, WORLD J SURG, V44, P1492, DOI 10.1007/s00268-020-05381-w; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Garza N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00112; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Kersey J, 2019, J HEAD TRAUMA REHAB, V34, pE32, DOI 10.1097/HTR.0000000000000442; Kumara AS, 2020, INT J SOC ECON, V47, P244, DOI 10.1108/IJSE-05-2019-0333; Li Wei, 2017, Alzheimers Dement (Amst), V6, P196, DOI 10.1016/j.dadm.2017.01.008; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Oyesanya TO, 2020, BRAIN INJURY, V34, P1222, DOI 10.1080/02699052.2020.1797172; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; SAS Institute, 2014, SAS 9 4 OUTP DEL SYS; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Zarshenas S, 2019, J HEAD TRAUMA REHAB, V34, P52, DOI 10.1097/HTR.0000000000000403; Zarshenas S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016694	40	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1972453		SEP 2021	13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	US4XI	WOS:000697433700001	34543111				2022-02-06	
J	Riley, J; Gleghorn, D; Doudican, BC; Cha, YH				Riley, Jeff; Gleghorn, Diamond; Doudican, Benjamin C.; Cha, Yoon-Hee			Psychological assessment of individuals with Mal de Debarquement Syndrome	JOURNAL OF NEUROLOGY			English	Article; Early Access						Mal de Debarquement Syndrome; Persistent oscillating vertigo; Psychological profile; Vestibular disorder	GENERALIZED ANXIETY DISORDER; TRANSCRANIAL MAGNETIC STIMULATION; EDINBURGH HANDEDNESS INVENTORY; QUALITY-OF-LIFE; CONSTRUCT-VALIDITY; HOSPITAL ANXIETY; SCREENER GAD-7; DEPRESSION; DIZZINESS; PREVALENCE	Objective To report on the psychological, personality, and behavioral profiles of individuals with persistent Mal de Debarquement Syndrome (MdDS). Materials and methods Individuals with MdDS who participated in neuromodulation clinical trials between May 2013 and June 2019 completed a series of standardized psychological questionnaires and underwent the Structural Clinical Interview for DSM-IV-TR (SCID) for specific psychiatric diagnoses. All data reported are from baseline assessments prior to any study interventions. Scores were compared to population norms for adult women. Results Complete datasets were available for 55 women. Mean age of onset of MdDS was 49.0 +/- 11.9 years (range 22-69 years) and median duration of illness of 22 months (6 months-20 years). SCID results were as follows: healthy (48.1%), any lifetime Major Depressive Disorder (35.2%, 7.4% current); any lifetime history of anxiety disorder (11.1%); any lifetime substance use disorders (18.5%, 0% current). Compared to population norms, the MdDS group scored significantly higher on the Patient Health Questionnaire-9 depression scale and the Generalized Anxiety Disorder 7 (GAD-7) anxiety scale, but only the GAD-7 correlated with symptom severity. The NEO-Five Factor Inventory for personality, Positive and Negative Affect Schedule, Behavioral Inhibition System/Behavioral Activation System Scale, and the Empathy Quotient metrics did not correlate with duration of illness. Disability assessed by the 12-item World Health Organization Disability Assessment Schedule 2.0 was 25.7 +/- 6.7, comparable to reports for concussion. Disability correlated with severity of depression, anxiety, neuroticism, and affect but not to severity of MdDS. Conclusions Psychological profiles of MdDS relate to disability but not to duration of illness.	[Riley, Jeff; Cha, Yoon-Hee] Univ Minnesota, 717 Delaware St, Minneapolis, MN 55414 USA; [Gleghorn, Diamond] Missouri State Univ, Springfield, MO USA; [Doudican, Benjamin C.] Oklahoma State Univ, Tulsa, OK USA; [Cha, Yoon-Hee] Laureate Inst Brain Res, Tulsa, OK 74136 USA		Cha, YH (corresponding author), Univ Minnesota, 717 Delaware St, Minneapolis, MN 55414 USA.; Cha, YH (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	ycha@umn.edu		Riley, Jeff/0000-0001-6286-745X	Laureate Institute for Brain Research; William K. Warren Foundation; MdDS Balance Disorders Foundation (YHC)	This work was supported by the Laureate Institute for Brain Research, the William K. Warren Foundation, and the MdDS Balance Disorders Foundation (YHC).	Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Arroll MA, 2016, J HEALTH PSYCHOL, V21, P1339, DOI 10.1177/1359105314553046; Axelsson Erland, 2017, JMIR Ment Health, V4, pe58, DOI 10.2196/mental.7497; Beard C, 2016, J AFFECT DISORDERS, V193, P267, DOI 10.1016/j.jad.2015.12.075; Benton Tami, 2007, Ann Clin Psychiatry, V19, P289, DOI 10.1080/10401230701653542; Best C, 2009, NEUROSCIENCE, V164, P1579, DOI 10.1016/j.neuroscience.2009.09.034; Billones RR, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00960-w; Boothroyd L, 2019, PSYCHIAT RES, V271, P532, DOI 10.1016/j.psychres.2018.12.048; Brody Debra J, 2018, NCHS Data Brief, P1; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cha YH, 2008, J NEUROL, V255, P1038, DOI 10.1007/s00415-008-0837-3; Cha YH, 2020, J VESTIBUL RES-EQUIL, V30, P285, DOI 10.3233/VES-200714; Cha YH, 2019, OTOL NEUROTOL, V40, pE928, DOI 10.1097/MAO.0000000000002341; Cha YH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00261; Cha YH, 2016, BRAIN STIMUL, V9, P539, DOI 10.1016/j.brs.2016.03.016; Cha YH, 2016, OTOL NEUROTOL, V37, P805, DOI 10.1097/MAO.0000000000001045; Cha YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135021; Cha YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049560; Cha Yoon-Hee, 2012, Continuum (Minneap Minn), V18, P1142, DOI 10.1212/01.CON.0000421623.56525.11; Cha YH, 2009, SEMIN NEUROL, V29, P520, DOI 10.1055/s-0029-1241038; Clark BC, 2013, J CLIN NEUROSCI, V20, P446, DOI 10.1016/j.jocn.2012.06.004; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Ding L, 2014, IEEE T BIO-MED ENG, V61, P2070, DOI 10.1109/TBME.2014.2313575; Eckhardt-Henn A, 2003, J ANXIETY DISORD, V17, P369, DOI 10.1016/S0887-6185(02)00226-8; Evans DL, 1999, J CLIN PSYCHIAT, V60, P40; First M.B., 2004, COMPREHENSIVE HDB PS, V2, P134, DOI DOI 10.1002/9780471726753; Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926; Gaynes BN, 2002, J NERV MENT DIS, V190, P799, DOI 10.1097/00005053-200212000-00001; Grant BF, 2005, PSYCHOL MED, V35, P1747, DOI 10.1017/S0033291705006069; Hain TC, 1999, ARCH OTOLARYNGOL, V125, P615, DOI 10.1001/archotol.125.6.615; Hinz A, 2017, J AFFECT DISORDERS, V210, P338, DOI 10.1016/j.jad.2016.12.012; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; Hopwood P, 2000, J CLIN ONCOL, V18, P893, DOI 10.1200/JCO.2000.18.4.893; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahmann C, 2015, J NEUROL NEUROSUR PS, V86, P302, DOI 10.1136/jnnp-2014-307601; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lee YJ, 2013, INT J CLIN PRACT, V67, P363, DOI 10.1111/ijcp.12020; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Macke A, 2012, J NEUROL, V259, P1326, DOI 10.1007/s00415-011-6349-6; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; MCCRAE RR, 1989, MULTIVAR BEHAV RES, V24, P107, DOI 10.1207/s15327906mbr2401_7; Milenkovic S, 2013, LATERALITY, V18, P340, DOI 10.1080/1357650X.2012.683196; Mucci V, 2018, J NEUROL, V265, P486, DOI 10.1007/s00415-017-8725-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Saha Kamala C, 2015, Neurol Clin Pract, V5, P209, DOI 10.1212/CPJ.0000000000000116; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Staab JP, 2014, J PSYCHOSOM RES, V76, P80, DOI 10.1016/j.jpsychores.2013.11.008; Staab JP, 2005, ARCH OTOLARYNGOL, V131, P675, DOI 10.1001/archotol.131.8.675; Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010; Tarvonen-Schroder S, 2019, J REHABIL MED, V51, P675, DOI 10.2340/16501977-2583; Team R, 2015, RSTUDIO INT DEV R; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Veale JF, 2014, LATERALITY, V19, P164, DOI 10.1080/1357650X.2013.783045; Watson D., 1994, PANAS X MANUAL POSIT; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yuan H, 2017, BRAIN CONNECT, V7, P617, DOI 10.1089/brain.2017.0514; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.												10.1007/s00415-021-10767-4		SEP 2021	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	US0OE	WOS:000697135900001	34541614				2022-02-06	
J	Wettervik, TS; Enblad, P; Lewen, A				Svedung Wettervik, Teodor; Enblad, Per; Lewen, Anders			Pre-injury chronic alcohol abuse predicts intracranial hemorrhagic progression, unfavorable clinical outcome, and mortality in severe traumatic brain injury	BRAIN INJURY			English	Article						Alcohol abuse; clinical outcome; hemorrhagic progression; traumatic brain injury	HEAD-INJURY; ETHANOL INTOXICATION; SUBSTANCE-ABUSE; COAGULOPATHY	Objective We aimed to determine the incidence of pre-injury alcohol abuse in TBI at our neurointensive care unit (NICU), the relation to intracranial hemorrhage evolution, and clinical outcome. Methods Patients with TBI treated at our NICU at Uppsala university hospital, Sweden, 2008-2018, were included. Clinical, radiological, and outcome variables were evaluated. Results Of 844 patients with TBI, 147 (17%) had a history of pre-injury alcohol abuse and these patients were slightly older, but had a similar Charlson co-morbidity index as the other patients. They were more often injured by falls and more frequently developed acute subdural hematomas and cerebral contusions. Their platelets were lower and their IVY bleeding time slightly longer. Patients with pre-injury alcohol abuse more often exhibited an intracranial hemorrhage progression on the second computed tomography. Pre-injury alcohol abuse was an independent predictor of increased mortality (odds ratio = 2.96, p-value = 0.001) and decreased favorable outcome (odds ratio = 0.46, p-value = 0.001) in multiple regression analyses. Conclusions Pre-injury alcohol abuse was common in severe TBI, associated with coagulopathy, worse intracranial hemorrhage/injury evolution, and independently predicted poor clinical outcome. These patients deserve more attention in care and research to address specific challenges including disturbed hemostasis.	[Svedung Wettervik, Teodor; Enblad, Per; Lewen, Anders] Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		Svedung Wettervik, Teodor/0000-0002-4556-5721	Department of Neuroscience, Uppsala University	The study was funded by the Department of Neuroscience, Uppsala University.	Calling S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224127; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; COWAN DH, 1980, SEMIN HEMATOL, V17, P137; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ferguson RK, 1997, ALCOHOL ALCOHOLISM, V32, P493; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Salem Raneem O, 2005, Am J Clin Pathol, V123 Suppl, pS96; Shin SS, 2020, NEUROCRIT CARE, V32, P407, DOI 10.1007/s12028-019-00898-y; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Wettervik TS, 2021, ACTA NEUROCHIR, V163, P1403, DOI 10.1007/s00701-021-04816-0; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TSAI GC, 1995, AM J PSYCHIAT, V152, P332; Tsitsopoulos PP, 2020, ACTA NEUROCHIR, V162, P1597, DOI 10.1007/s00701-020-04373-y; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Unsworth DJ, 2017, J CLIN EXP NEUROPSYC, V39, P547, DOI 10.1080/13803395.2016.1248812; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Weil ZM, 2018, ALCOHOL RES-CURR REV, V39, P171; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	38	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1569	1576		10.1080/02699052.2021.1975196		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000698241000001	34543084	hybrid, Green Published			2022-02-06	
J	Tanczos, RL; Shimada, SD				Tanczos, Rachel L.; Shimada, Sean D.			Brain injury severity due to direct head contact from near-side motor vehicle collisions	TRAFFIC INJURY PREVENTION			English	Article						Brain injury; head impact; near-side; NASS-CDS	IMPACTS; RISK	Objective: The objective of this study was to generate functional forms of brain injury risk curves using the National Automotive Sample System Crashworthiness Data System's (NASS-CDS) database for the years of 2001-2015. The population of interest was near-side occupants who experienced a direct head impact with an injury source located lateral to a typical seated position. Methods: Brain injuries were restricted to Abbreviated Injury Scale (AIS) 2005 Update 2008 defined concussions and internal organ injuries of the head. Near-side occupants comprised two major groups, both of which were required to have evidence of head contact (i.e., a head injury with DIRINJ = 1 and SOUCON = 1 or 2): brain injured occupants (MAIS1, MAIS2, MAIS3+ and non-brain injured occupants with some other direct contact head injury (MAIS0). Analyzed cases were required to have an indication of a reasonable crash reconstruction. Injury sources allowed within the final sample consisted of A-pillars, B-pillars, roof/roof rails, impacting vehicles/exterior objects, other components of the vehicle's side interior, and other occupants or otherwise unspecified interior objects. Risk curves for occupants with brain injury severities of MAIS0, MAIS1+, MAIS2+, and MAIS3+were generated using multivariate stepwise logistic regressions. Investigated predictors involved vehicle change in velocity, seat belt use, principal direction of force (PDOF), and injury source type (B-pillar and side window). Results: Multivariate stepwise logistic regressions identified significant predictors of lateral change in velocity (dvlat) for all injury severity categories, and side window injury source (INJSOU = 56, 57, 58, 106, and 107) for MAIS0 and MAIS1thorn risk curves. Although model sensitivity decreased for more severe injury predictions, risk curves dependent on only dvlat yielded accuracies of 70% for all presented models. Conclusions: Real world crashes are often complex and lack the benefit of real time monitoring; however, NASS-CDS post-crash investigations provide data useful for injury risk prediction. Further analysis is needed to determine the effect of data confidence, injury source, and accident sequence restrictions on NASS-CDS sampling biases. The presented models likely favor a more conservative risk prediction due to the limitations of NASS-CDS data collection, AIS code conversion, and unweighted sample analysis.	[Tanczos, Rachel L.; Shimada, Sean D.] Biomech Consultants, 4632 Second St,Suite 100, Davis, CA 95618 USA		Tanczos, RL (corresponding author), Biomech Consultants, 4632 Second St,Suite 100, Davis, CA 95618 USA.	rltanczos@ucdavis.edu					Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; AIS, 2005, ABBREVIATED INJURY S; Bazarian JJ, 2004, ANN EMERG MED, V44, P142, DOI 10.1016/j.annemergmed.2004.03.029; Calspan Corporation, 1993, 1993 NATL ACCIDENT S; Dibb A., 2020, SAE TECHNICAL PAPER; Foster, 1985, SAE T, V94, P220; Freeman MD, 2020, ACCIDENT ANAL PREV, V142, DOI 10.1016/j.aap.2020.105571; Furbish C., 2019, SAE INT J ADV CURR P, V1, P1470; Gennarelli T., 2008, INT RES COUNC BIOM I; Hobbs J., 2019, SAS7BDAT FILE READER; Hostetler ZS, 2020, TRAFFIC INJ PREV, V21, pS112, DOI 10.1080/15389588.2021.1880006; Inamasu J, 2018, ACTA NEUROCHIR, V160, P1921, DOI 10.1007/s00701-018-3656-z; Loftis K., 2017, 25 INT TECHN C ENH S; Mango N., 2011, 22 INT TECHN C ENH S; Morgan RM., 2002, INT RES COUNC BIOM I; Morris A, 1995, ACCIDENT ANAL PREV, V27, P749, DOI 10.1016/0001-4575(95)00020-8; National Highway Traffic Safety Administration (NHTSA, 2016, 2 INJ RISK CURV PROT; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-29; Parenteau CS, 2018, TRAFFIC INJ PREV, V19, P264, DOI 10.1080/15389588.2017.1393664; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Steps, 2000, SAE TECH PAPER, V109, P901; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; U.S. Department of Transportation ( USDOT ), 2012, TP214D09 NAT HIGHW T; Viano DC, 2016, TRAFFIC INJ PREV, V17, P524, DOI 10.1080/15389588.2015.1120295; Watson, 2010, SAE TECHNICAL PAPER	25	0	0	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	OCT 19	2021	22			1	SI		S56	S61		10.1080/15389588.2021.1983177		SEP 2021	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	YM1NE	WOS:000711241200001	34699303				2022-02-06	
J	Thompson, XD; Erdman, NK; Walton, SL; Broshek, DK; Resch, JE				Thompson, Xavier D.; Erdman, Nicholas K.; Walton, Samuel L.; Broshek, Donna K.; Resch, Jacob E.			Reevaluating clinical assessment outcomes after unrestricted return to play following sport-related concussion	BRAIN INJURY			English	Article						Neurocognitive function; postural control; balance; symptoms; recovery	FOOTBALL PLAYERS; HEALTH OUTCOMES; HIGH-SCHOOL; HISTORY; ASSOCIATION; PERFORMANCE; STATEMENT; SYMPTOMS; LIFE	Primary Objective The objective of this study was to examine neurocognition, postural control, and symptomology at multiple timepoints following concussion. We hypothesized that collegiate athletes would perform similar to or better than their baseline in terms of each outcome at both timepoints. Research Design This was a retrospective study of 71 collegiate athletes (18.3 +/- 0.89 years old; 182.2 +/- 10.05 cm; 84.2 +/- 20.07 kg) to observe changes in outcomes from a previously established clinical protocol. Methods and Procedures Participants were administered ImPACT (TM), the Sensory Organization Test (SOT), and the revised head injury scale (HIS-r) prior to their seasons (baseline); upon reporting symptom-free following concussion (post-injury); and approximately 8-months after return-to-play to establish a new baseline. Main Outcomes and Results There were no changes in ImPACT scores or HIS-r reporting over time. ImPACT total symptom score (TSS) decreased over time (p = .002, eta(2)(p) = 0.08). Significant main effects occurred for the SOT equilibrium score (p < .01, eta(2)(p) = 0.34) and Vestibular sensory ratio (p < .001, eta(2)(p) = 0.22). Conclusions Our data suggest no decline in neurocognition, balance, or symptom burden approximately eight months post-injury. As clinicians continue to explore "best practices" for concussion management and potential long-term implications of these injuries it is important to monitor outcome measures longitudinally.	[Thompson, Xavier D.; Resch, Jacob E.] Univ Virginia, UVA Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22904 USA; [Erdman, Nicholas K.] George Mason Univ, Sports Med Res & Testing Lab, Fairfax, VA 22030 USA; [Walton, Samuel L.] UNC Ctr Study Retired Athletes & Matthew Gfeller, Chapel Hill, NC USA; [Broshek, Donna K.] UVA Hlth, UVA Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA		Thompson, XD (corresponding author), Univ Virginia, UVA Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22904 USA.	xt2dw@virginia.edu					Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Chong CD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221892; Conder A, 2020, NEUROREHABILITATION, V46, P167, DOI 10.3233/NRE-192966; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hunt TN, 2017, ATHL TRAIN SPORTS HL, V9, P81, DOI [10.3928/19425864-20170109-02, DOI 10.3928/19425864-20170109-02]; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kunker K, 2020, NEUROL SCI, V41, P1899, DOI 10.1007/s10072-020-04300-0; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lovell M. R., 2016, IMPACT ADM INTERPRET; Lynall RC, 2016, CLIN J SPORT MED, V26, P285, DOI 10.1097/JSM.0000000000000260; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rosenblum DJ, 2020, J NEUROTRAUM, V37, P1211, DOI 10.1089/neu.2019.6813; Row J, 2019, J NEUROTRAUM, V36, P2435, DOI 10.1089/neu.2018.5755; Salazar CL, 2017, DEV NEUROPSYCHOL, V42, P83, DOI 10.1080/87565641.2017.1303701; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	37	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1577	1584		10.1080/02699052.2021.1975818		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000698246400001	34543089				2022-02-06	
J	Ping, XJ; Chai, Z; Wang, WP; Ma, CG; White, FFA; Jin, XM				Ping, Xingjie; Chai, Zhi; Wang, Weiping; Ma, Cungen; White, Fletcher F. A.; Jin, Xiaoming			Blocking receptor for advanced glycation end products (RAGE) or toll-like receptor 4 (TLR4) prevents posttraumatic epileptogenesis in mice	EPILEPSIA			English	Article						neuroinflammation; posttraumatic epilepsy; receptor for advanced glycation end products; toll-like receptor 4; undercut	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; MOBILITY GROUP BOX-1; HEAD-INJURY; INFLAMMATION; EXPRESSION; SEIZURES; HMGB1; EXCITABILITY; HIPPOCAMPAL	Objective Effective treatment for the prevention of posttraumatic epilepsy is still not available. Here, we sought to determine whether blocking receptor for advanced glycation end products (RAGE) or toll-like receptor 4 (TLR4) signaling pathways would prevent posttraumatic epileptogenesis. Methods In a mouse undercut model of posttraumatic epilepsy, daily injections of saline, RAGE monoclonal antibody (mAb), or TAK242, a TLR4 inhibitor, were made for 1 week. Their effects on seizure susceptibility and spontaneous epileptic seizures were evaluated with a pentylenetetrazol (PTZ) test in 2 weeks and with continuous video and wireless electroencephalography (EEG) monitoring between 2 and 6 weeks after injury, respectively. Seizure susceptibility after undercut in RAGE knockout mice was also evaluated with the PTZ test. The lesioned cortex was analyzed with immunohistology. Results Undercut animals treated with RAGE mAb or TAK242 showed significantly higher seizure threshold than saline-treated undercut mice. Consistently, undercut injury in RAGE knockout mice did not cause a reduction in seizure threshold in the PTZ test. EEG and video recordings revealed a significant decrease in the cumulative spontaneous seizure events in the RAGE mAb- or TAK242-treated group (p < 0.001, when the RAGE mAb or TAK242 group is compared with the saline group). The lesioned cortical tissues of RAGE mAb- or TAK242-treated undercut group showed higher neuronal densities of Nissl staining and higher densities of glutamic acid decarboxylase 67-immunoreactive interneurons than the saline-treated undercut group. Immunostaining to GFAP and Iba-1 revealed lower densities of astrocytes and microglia in the cortex of the treatment groups, suggesting reduced glia activation. Significance RAGE and TLR4 signaling are critically involved in posttraumatic epileptogenesis. Blocking these pathways early after traumatic brain injury is a promising strategy for preventing posttraumatic epilepsy.	[Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Ping, Xingjie; White, Fletcher F. A.; Jin, Xiaoming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Chai, Zhi; Ma, Cungen] Shanxi Univ Chinese Med, Coll Basic Med, Neurobiol Res Ctr, Shanxi Key Lab Innovat Drugs Serious Illness, Jinzhong, Peoples R China; [Wang, Weiping] Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Neurol, Hangzhou, Peoples R China; [White, Fletcher F. A.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [White, Fletcher F. A.] Richard L Roudebush VA Med Ctr, Res & Dev Serv, Indianapolis, IN USA; [Jin, Xiaoming] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA		Jin, XM (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, 320 W 15th St,Neurosci Bldg,Room 500C, Indianapolis, IN 46202 USA.	xijin@iupui.edu	Jin, Xiaoming/N-8545-2016	Jin, Xiaoming/0000-0002-8671-8640	Indiana Spinal Cord and Brain Injury Research Fund; Citizens United for Research in Epilepsy	Indiana Spinal Cord and Brain Injury Research Fund; Citizens United for Research in Epilepsy	Aida Y, 2021, J NEUROSURG, V134, P122, DOI 10.3171/2019.8.JNS191269; Allette YM, 2014, BRAIN BEHAV IMMUN, V42, P169, DOI 10.1016/j.bbi.2014.06.199; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Brederson JD, 2016, EUR J PAIN, V20, P607, DOI 10.1002/ejp.775; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Friedman A, 2011, EPILEPSIA, V52, P33, DOI 10.1111/j.1528-1167.2011.03034.x; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gonzalez OC, 2015, J NEUROSCI, V35, P13448, DOI 10.1523/JNEUROSCI.5038-14.2015; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Iori V, 2013, NEUROBIOL DIS, V58, P102, DOI 10.1016/j.nbd.2013.03.006; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Kamide T, 2012, NEUROCHEM INT, V60, P220, DOI 10.1016/j.neuint.2011.12.008; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163807; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Luan GM, 2016, EPILEPSY RES, V123, P36, DOI 10.1016/j.eplepsyres.2016.03.005; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Papp P, 2018, EPILEPSY RES, V145, P40, DOI 10.1016/j.eplepsyres.2018.05.013; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sharma R, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110318; Tai XY, 2018, NEUROPATH APPL NEURO, V44, P70, DOI 10.1111/nan.12458; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; Xie Y, 2017, MOL MED REP, V16, P1691, DOI 10.3892/mmr.2017.6772; Xiong WH, 2011, JOVE-J VIS EXP, DOI 10.3791/2840; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan XS, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0222-3; Yang F, 2015, STROKE, V46, P1328, DOI 10.1161/STROKEAHA.114.008336; Yang H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00484; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zayachkivsky A, 2015, JOVE-J VIS EXP, DOI 10.3791/52554; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003	49	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	DEC	2021	62	12					3105	3116		10.1111/epi.17069		SEP 2021	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XF4CQ	WOS:000696778600001	34535891				2022-02-06	
J	Zonfrillo, MR; Haarbauer-Krupa, J; Wang, J; Durbin, D; Jaffe, KM; Temkin, N; Bell, M; Tulsky, DS; Bertisch, H; Yeates, KO; Rivara, FP				Zonfrillo, Mark R.; Haarbauer-Krupa, Juliet; Wang, Jin; Durbin, Dennis; Jaffe, Kenneth M.; Temkin, Nancy; Bell, Michael; Tulsky, David S.; Bertisch, Hilary; Yeates, Keith Owen; Rivara, Frederick P.			Effect of parental education and household poverty on recovery after traumatic brain injury in school-aged children	BRAIN INJURY			English	Article						Pediatric brain injury; recovery; epidemiology; socioeconomic	QUALITY-OF-LIFE; NEUROCOGNITIVE OUTCOMES; SOCIOECONOMIC-STATUS; BEHAVIOR PROBLEMS; HEALTH; PREDICTORS; INSURANCE; INCOME; REHABILITATION; ASSOCIATION	Objective While prior studies have found parental socioeconomic status (SES) affects the outcomes of pediatric traumatic brain injury (TBI), the longitudinal trajectory of this effect is not well understood. Methods This prospective cohort study included children 8-18 years of age admitted to six sites with a complicated mild (n = 123) or moderate-severe TBI (n = 47). We used caregiver education and household poverty level as predictors, and multiple quality of life and health behavior domains as outcomes. Differences at 6, 12, and 24 months from baseline ratings of pre-injury functioning were compared by SES. We examined the association between measures of SES and domains of functioning over the 24 months post-injury in children with a complicated mild or moderate- severe TBI, and determined how this association varied over time. Results Parental education was associated with recovery among children with complicated mild TBI; outcomes at 6, 12, and 24 months were substantially poorer than at baseline for children with the least educated parents. After moderate-severe TBI, children in households with lower incomes had poorer outcomes compared to baseline across time. Implications Parental education and household income were associated with recovery trajectories for children with TBI of varying severity.	[Zonfrillo, Mark R.] Brown Univ, Dept Emergency Med, Hasbro Childrens Hosp, Providence, RI 02903 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA; [Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Wang, Jin; Jaffe, Kenneth M.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Wang, Jin; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Durbin, Dennis] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Durbin, Dennis] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Washington, DC USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bell, Michael] Childrens Natl Med Ctr, Dept Pediat, Washington, DC USA; [Tulsky, David S.; Rivara, Frederick P.] Univ Delaware, Ctr Assessment Res & Translat, Dept Phys Therapy & Psychol, Newark, DE USA; [Tulsky, David S.; Rivara, Frederick P.] Univ Delaware, Ctr Assessment Res & Translat, Dept Brain Sci, Newark, DE USA; [Bertisch, Hilary] Northwell Hlth, Zucker Hillside Hosp, Glen Oaks, NY USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Zonfrillo, MR (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, 55 Claverick St,2nd Floor, Providence, RI 02903 USA.	zonfrillo@brown.edu	Durbin, Dennis/AAD-7829-2022; Zonfrillo, Mark/H-9403-2017	Zonfrillo, Mark/0000-0002-0610-9563	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196]	This study was funded by the Centers for Disease Control and Prevention, grant number U01CE002196.	Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; Agtarap S, 2021, ASSESSMENT, V28, P1656, DOI 10.1177/1073191120913941; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Belsky J, 2007, EUR J PUBLIC HEALTH, V17, P508, DOI 10.1093/eurpub/ckl261; Brett BL, 2020, AM J SPORT MED, V48, P2783, DOI 10.1177/0363546520946056; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Chaudry A, 2016, ACAD PEDIATR, V16, pS23, DOI 10.1016/j.acap.2015.12.010; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; de Kloet AJ, 2015, J DEV BEHAV PEDIATR, V36, P342, DOI 10.1097/DBP.0000000000000169; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Fuentes MM, 2017, ARCH PHYS MED REHAB, V98, P1763, DOI 10.1016/j.apmr.2016.12.013; Fuentes MM, 2016, ARCH PHYS MED REHAB, V97, P1407, DOI 10.1016/j.apmr.2016.02.026; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon Richard C, 2010, J Appl Meas, V11, P304; Graves JM, 2019, HEALTH SERV RES, V54, P337, DOI 10.1111/1475-6773.13096; Harstad E, 2013, ACAD PEDIATR, V13, P334, DOI 10.1016/j.acap.2013.03.010; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Imami L, 2015, J PEDIATR PSYCHOL, V40, P55, DOI 10.1093/jpepsy/jsu066; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Karr JE, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1850867; Kim KW, 2018, J PEDIATR PSYCHOL, V43, P534, DOI 10.1093/jpepsy/jsx139; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McMorrow S, 2014, HEALTH AFFAIR, V33, P1367, DOI 10.1377/hlthaff.2014.0264; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Sanders LM, 2009, ARCH PEDIAT ADOL MED, V163, P131, DOI 10.1001/archpediatrics.2008.539; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Shonkoff JP, 2016, JAMA PEDIATR, V170, P1003, DOI 10.1001/jamapediatrics.2016.1559; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Ursache A, 2016, PSYCHOPHYSIOLOGY, V53, P71, DOI 10.1111/psyp.12547; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wherry LR, 2016, ACAD PEDIATR, V16, pS98, DOI 10.1016/j.acap.2015.12.011; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zamani A, 2019, EXP NEUROL, V314, P34, DOI 10.1016/j.expneurol.2019.01.007; Zhang WQ, 2016, PSYCHIAT SERV, V67, P908, DOI 10.1176/appi.ps.201500206; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	50	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1371	1381		10.1080/02699052.2021.1972141		SEP 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000696459500001	34529550				2022-02-06	
J	Cinar, E; Saxena, S; McFadyen, BJ; Lamontagne, A; Gagnon, I				Cinar, Eda; Saxena, Shikha; McFadyen, Bradford J.; Lamontagne, Anouk; Gagnon, Isabelle			A prediction model of multiple resource theory for dual task walking	THEORETICAL ISSUES IN ERGONOMICS SCIENCE			English	Article; Early Access						concurrent task; gait; framework; children; adolescent	TRAUMATIC BRAIN-INJURY; CONCURRENT TASK; GAIT PARAMETERS; CHILDREN; BALANCE; MOTOR; PERFORMANCE; ATTENTION; PROPRIOCEPTION; ADOLESCENTS	A model of Multiple Resource Theory (MRT) was created to describe the influence of different concurrent tasks on driving but no such framework exists for DT walking. The objective of this study was to modify MRT model and computational DT framework to explore two task-related concepts-resource demand and resource conflict-in the context of gait and to illustrate the initial validity of the modified model. A literature search was conducted to identify DT walking-related elements related to the MRT model. An instructional guide for utilizing the computational framework was constructed using a modified e-Delphi method. Inter-rater reliability of the constructed guideline was analyzed by Kappa statistics. The initial validity of the modified model was tested using meta-regression analyses. Three new elements were included into the modified model: vestibular and somatosensory perceptions, and locomotor response. The spatial code from the original model was modified into a visuospatial domain. The computational framework was constructed, and two separate guidelines were created for walking and concurrent tasks. Using the guidelines and computational framework, task-related elements were quantified for meta-regression analysis. The analysis showed that the modified model can explain 79% of the variability in speed reduction during DT walking.	[Cinar, Eda; Gagnon, Isabelle] McGill Univ, McGill Univ Hlth Ctr, 5252 Boul Maisonneuve Ouest, Montreal, PQ H4A 3S5, Canada; [Saxena, Shikha] Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada; [McFadyen, Bradford J.] CIUSSS CN, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [McFadyen, Bradford J.] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada; [Lamontagne, Anouk] Jewish Rehabil Hosp Res Site Ctr Rech Interdiscip, Laval, PQ, Canada; [Gagnon, Isabelle] MUHC, Concuss Res Lab, Montreal Childrens Hosp, Montreal, PQ, Canada		Cinar, E (corresponding author), McGill Univ, McGill Univ Hlth Ctr, 5252 Boul Maisonneuve Ouest, Montreal, PQ H4A 3S5, Canada.	eda.cinar@mail.mcgill.ca					Abbruzzese LD, 2014, GAIT POSTURE, V40, P658, DOI 10.1016/j.gaitpost.2014.07.017; Allum JHJ, 1998, GAIT POSTURE, V8, P214, DOI 10.1016/S0966-6362(98)00027-7; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; Bent LR, 2005, EXERC SPORT SCI REV, V33, P107, DOI 10.1097/00003677-200507000-00002; Calvo P., 2008, HDB COGNITIVE SCI EM; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Chauvel G, 2017, GAIT POSTURE, V56, P95, DOI 10.1016/j.gaitpost.2017.04.034; Chen SH, 2018, GAIT POSTURE, V62, P422, DOI 10.1016/j.gaitpost.2018.04.004; Cheng K., 2004, THESIS U TORONTO; Cherng RJ, 2007, GAIT POSTURE, V26, P231, DOI 10.1016/j.gaitpost.2006.09.004; Cherng RJ, 2009, GAIT POSTURE, V29, P204, DOI 10.1016/j.gaitpost.2008.08.003; Cheyne DO, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00237; Cinar E, 2021, J MOTOR BEHAV, V53, P509, DOI 10.1080/00222895.2020.1791038; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Custer RL., 1999, CTE J, V15, DOI [10.21061/jcte.v15i2.702, DOI 10.21061/JCTE.V15I2.702]; Cutting James E, 1981, INTERSENSORY PERCEPT, P249, DOI DOI 10.1007/978-1-4615-9197-9_8; EGETH H, 1975, AM J PSYCHOL, V88, P339, DOI 10.2307/1421603; Forbes PA, 2015, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00094; Frawley W. J., 2003, INT ENCY LINGUISTICS; Gaerlan MG, 2012, J AM ACAD NURSE PRAC, V24, P375, DOI 10.1111/j.1745-7599.2012.00699.x; Getchell N, 2003, J EXP CHILD PSYCHOL, V85, P120, DOI 10.1016/S0022-0965(03)00059-6; Hagmann-von Arx P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00352; Hagmann-von Arx P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144363; Hale KS, 2009, THEOR ISS ERGON SCI, V10, P245, DOI 10.1080/14639220802151310; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; HOGAN N, 1987, EXERCISE SPORT SCI R, V15, P153; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Horrey W. J., 2003, P 2 INT DRIV S HUM F, P7; Howard CS, 2010, INT J AUDIOL, V49, P928, DOI 10.3109/14992027.2010.520036; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Irwin-Chase H, 2000, J EXP CHILD PSYCHOL, V77, P61, DOI 10.1006/jecp.1999.2557; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Medved V., 2000, MEASUREMENT HUMAN LO; Mesly O., 2015, CREATING MODELS PSYC, DOI [10.1007/978-3-319-15753-5, DOI 10.1007/978-3-319-15753-5]; Muehlbauer T, 2013, GAIT POSTURE, V37, P108, DOI 10.1016/j.gaitpost.2012.06.022; Na D G, 2000, Korean J Radiol, V1, P19; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; Niederer D, 2018, GAIT POSTURE, V62, P415, DOI 10.1016/j.gaitpost.2018.04.007; Osman H, 2014, J SPEECH LANG HEAR R, V57, P1503, DOI 10.1044/2014_JSLHR-H-13-0286; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Ryan S., 2020, REHABILITATION MEASU; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Sarno KJ, 1995, INT J AVIAT PSYCHOL, V5, P107, DOI 10.1207/s15327108ijap0501_7; Schieber F., 2003, COMPUTATIONAL MODELI; Schwarz W, 2006, EXP PSYCHOL, V53, P4, DOI 10.1027/1618-3169.53.1.4; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Stanney K, 2004, INT J HUM-COMPUT INT, V17, P229, DOI 10.1207/s15327590ijhc1702_7; Torchiano M, 2011, INT SYMP EMP SOFTWAR, P372, DOI 10.1109/ESEM.2011.51; van Dieen JH, 2015, J NEUROPHYSIOL, V114, P2967, DOI 10.1152/jn.00434.2015; Wickens, 2002, THEORETICAL ISSUES E, V3, P159, DOI [DOI 10.1080/14639220210123806, https://doi.org/10.1080/14639220210123806]; Wickens C. D, 1981, PROCESSING RESOURCES; Wickens C. D., 1991, MULTIPLE TASK PERFOR, P3, DOI DOI 10.1201/9781003069447-2; WICKENS CD, 1983, HUM FACTORS, V25, P227, DOI 10.1177/001872088302500209; Wickens CD, 1980, ATTENTION PERFORM, P239; Wickens CD, 2008, HUM FACTORS, V50, P449, DOI 10.1518/001872008X288394; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Worden TA, 2016, GAIT POSTURE, V50, P159, DOI 10.1016/j.gaitpost.2016.08.033; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	66	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1463-922X	1464-536X		THEOR ISS ERGON SCI	Theor. Iss. Ergon. Sci.												10.1080/1463922X.2021.1981483		SEP 2021	31	Ergonomics	Emerging Sources Citation Index (ESCI)	Engineering	WN5CT	WOS:000711786200001					2022-02-06	
J	LeFloch, MD; Coronado, GS				LeFloch, Marielle D.; Coronado, George S.			Outcome of coxofemoral luxation treated with closed reduction in 51 cats	JOURNAL OF FELINE MEDICINE AND SURGERY			English	Article; Early Access						Hip luxation; coxofemoral luxation; closed reduction; hip reduction	FEMORAL-HEAD; DOGS; STABILIZATION	Objectives The aim of this study was to describe the outcomes and determine the reluxation rate of cats undergoing closed coxofemoral joint reduction, and to investigate potential risk factors for reluxation of the affected coxofemoral joint. Methods Case information was obtained from electronic medical records from Ocean State Veterinary Specialists and Bay State Veterinary Emergency and Specialty Services between January 2008 and May 2020. Data obtained from 51 cats with coxofemoral joint luxations included patient signalment, direction of coxofemoral joint luxation, concurrent injuries, ease of reduction, time of injury to closed reduction, bandage application and outcome. Data were analyzed for association with outcomes. Results Closed reduction of coxofemoral joint luxation in cats had a 51% success rate. The only risk factor demonstrating a statistically significant benefit to the success of closed coxofemoral joint reduction was the application of a bandage (P = 0.02). Conclusions and relevance It may be worth attempting closed coxofemoral joint reduction in cats prior to recommending surgery. Placing a bandage (Ehmer or hobbles) after closed reduction may decrease the risk of the coxofemoral joint reluxating, but more studies are needed to evaluate this further. The outcome after closed reduction management for coxofemoral joint luxation in cats is similar to the previously reported success rate in dogs.	[LeFloch, Marielle D.; Coronado, George S.] Ocean State Vet Specialists, Surg, 1480 South Cty Trail, East Greenwich, RI 02818 USA		LeFloch, MD (corresponding author), Ocean State Vet Specialists, Surg, 1480 South Cty Trail, East Greenwich, RI 02818 USA.	mdlefloch@gmail.com					ABLIN LW, 1991, COMP CONT EDUC PRACT, V13, P1379; BASHER AWP, 1986, VET SURG, V15, P356, DOI 10.1111/j.1532-950X.1986.tb00243.x; BERZON JL, 1980, VET SURG, V9, P88, DOI 10.1111/j.1532-950X.1980.tb01661.x; BONE DL, 1984, VET SURG, V13, P263, DOI 10.1111/j.1532-950X.1984.tb00807.x; Liska WD, 2010, VET SURG, V39, P797, DOI 10.1111/j.1532-950X.2010.00725.x; PEREZAPARICIO FJ, 1993, J SMALL ANIM PRACT, V34, P345, DOI 10.1111/j.1748-5827.1993.tb02708.x; Piermattei DL, 2006, HDB SMALL ANIMAL ORT; Pratesi A, 2012, J SMALL ANIM PRACT, V53, P260, DOI 10.1111/j.1748-5827.2012.01199.x; Schlag AN, 2019, JAVMA-J AM VET MED A, V254, P1436, DOI 10.2460/javma.254.12.1436; Sissener TR, 2009, J SMALL ANIM PRACT, V50, P112, DOI 10.1111/j.1748-5827.2008.00625.x; Yap FW, 2015, J FELINE MED SURG, V17, P704, DOI 10.1177/1098612X14556848	11	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1098-612X	1532-2750		J FELINE MED SURG	J. Feline Med. Surg.											1098612X211041535	10.1177/1098612X211041535		SEP 2021	6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	UR9BR	WOS:000697035800001	34533373				2022-02-06	
J	Liu, YB; Liu, WF; Chen, WC; Li, W; Lin, YL; Xu, CJ; He, HF				Liu, Yi-bin; Liu, Wei-feng; Chen, Wei-can; Li, Wei; Lin, Yan-ling; Xu, Chong-jun; He, He-fan			Dexmedetomidine alleviates traumatic spinal cord injury in rats via inhibiting apoptosis induced by endoplasmic reticulum stress	NEUROLOGICAL RESEARCH			English	Article; Early Access						Dexmedetomidine; traumatic spinal cord injury; endoplasmic reticulum stress; neuroprotection; apoptosis	IMPROVES FUNCTIONAL RECOVERY; INDUCED NEUROTOXICITY; NEURONAL APOPTOSIS; BRAIN; NEUROPROTECTION; PRETREATMENT; EXPRESSION; WORLDWIDE; AUTOPHAGY; PROTEINS	Objective To investigate the protective effect of dexmedetomidine (Dex) on traumatic spinal cord injury (TSCI) and to evaluate the involvement of inhibition of endoplasmic reticulum (ER) stress response in the potential mechanism. Method Sprague-Dawley rats were randomly divided into five groups. The hind limb locomotor function of rats was evaluated at 1, 3 and 7 days after the operation. At 7 days after the operation, spinal cord specimens were obtained for hematoxylin and eosin (H&E), Nissl and TUNEL staining, as well as immunofluorescence and Western blot analyses to detect the level of apoptosis and the levels of proteins related to ER stress. Results 7 days after the operation, Dex treatment promoted the recovery and also inhibited apoptosis of neurons in the spinal cord. Additionally, Dexinhibited the expression of proteins related to ER stress response after spinal cord injury. Conclusions Dex improves the neurological function of rats with TSCI and reduces apoptosis of spinal cord neurons. The potential mechanism is related to the inhibition of the ER stress response.	[Liu, Yi-bin; Liu, Wei-feng; Chen, Wei-can; Lin, Yan-ling; Xu, Chong-jun; He, He-fan] Fujian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, 34 Zhongshan North Rd, Quanzhou 362000, Peoples R China; [Li, Wei] Wuhan Univ, Wuhan Hosp 3, Dept ICU, 241 Pengliuyang Rd, Wuhan 430070, Peoples R China		He, HF (corresponding author), Fujian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, 34 Zhongshan North Rd, Quanzhou 362000, Peoples R China.; Li, W (corresponding author), Wuhan Univ, Wuhan Hosp 3, Dept ICU, 241 Pengliuyang Rd, Wuhan 430070, Peoples R China.	15926166539@163.com; 15860905262@163.com			Quanzhou Science and Technology Project [2017Z014]; Natural Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2018J01289]	This work was supported by the Quanzhou Science and Technology Project [2017Z014] and Natural Science Foundation of Fujian Province [2018J01289].	Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Alam A, 2017, NEUROTOXICOL TERATOL, V60, P102, DOI 10.1016/j.ntt.2017.01.001; Almanza A, 2019, FEBS J, V286, P241, DOI 10.1111/febs.14608; Cheng JX, 2018, J INT MED RES, V46, P2925, DOI 10.1177/0300060518781382; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; Dou HC, 2018, BIOMED PHARMACOTHER, V102, P212, DOI 10.1016/j.biopha.2018.03.074; Gao JD, 2019, BRIT J ANAESTH, V123, P827, DOI 10.1016/j.bja.2019.08.026; Goyagi T, 2019, INT J DEV NEUROSCI, V75, P19, DOI 10.1016/j.ijdevneu.2019.04.002; Goyagi T, 2014, BRAIN RES, V1566, P24, DOI 10.1016/j.brainres.2014.04.013; Grilo AL, 2019, BIOTECHNOL ADV, V37, P459, DOI 10.1016/j.biotechadv.2019.02.012; Gu CL, 2017, NEUROSCI LETT, V636, P282, DOI 10.1016/j.neulet.2016.11.032; He HF, 2018, J NEUROTRAUM, V35, P2591, DOI 10.1089/neu.2017.5625; He ZL, 2017, AM J TRANSL RES, V9, P1075; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Keating GM, 2015, DRUGS, V75, P1119, DOI 10.1007/s40265-015-0419-5; Kim YH, 2017, CLIN ORTHOP SURG, V9, P1, DOI 10.4055/cios.2017.9.1.1; Li FY, 2018, NEUROPEPTIDES, V72, P58, DOI 10.1016/j.npep.2018.10.004; Li HT, 2019, INT J BIOL SCI, V15, P277, DOI 10.7150/ijbs.30348; Li JH, 2019, TOXICOL SCI, V171, P193, DOI 10.1093/toxsci/kfz135; Liu C, 2018, BRAIN RES, V1701, P246, DOI 10.1016/j.brainres.2018.09.007; Lu P, 2018, CELL PHYSIOL BIOCHEM, V47, P1377, DOI 10.1159/000490823; Ning GZ, 2012, J SPINAL CORD MED, V35, P229, DOI 10.1179/2045772312Y.0000000021; Perez-Zoghbi JF, 2017, BRIT J ANAESTH, V119, P506, DOI 10.1093/bja/aex222; Romagnoli S, 2018, MINERVA ANESTESIOL, V84, P731, DOI 10.23736/S0375-9393.18.12350-9; Rong FJ, 2018, EXP THER MED, V15, P4191, DOI 10.3892/etm.2018.5973; Rong H, 2017, BRAIN BEHAV IMMUN, V64, P195, DOI 10.1016/j.bbi.2017.03.006; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Song SL, 2017, J CELL PHYSIOL, V232, P2977, DOI 10.1002/jcp.25785; Sun ZX, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1583-7; Valenzuela V, 2016, BRAIN RES, V1648, P617, DOI 10.1016/j.brainres.2016.04.053; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang WG, 2018, MOL MED REP, V18, P415, DOI 10.3892/mmr.2018.8930; Weerink MAS, 2017, CLIN PHARMACOKINET, V56, P893, DOI 10.1007/s40262-017-0507-7; Wei Y, 2016, MOL MED REP, V14, P3413, DOI 10.3892/mmr.2016.5628; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Xu HL, 2018, INT J NANOMED, V13, P681, DOI 10.2147/IJN.S152246; Xu XB, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180992; Zhao LN, 2019, J CELL MOL MED, V23, P8173, DOI 10.1111/jcmm.14688; Zhu YL, 2019, AM J TRANSL RES, V11, P1938	44	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.												10.1080/01616412.2021.1979750		SEP 2021	10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UR6QH	WOS:000696871000001	34533101				2022-02-06	
J	van der Stelt, CM; Fama, ME; Mccall, JD; Snider, SF; Turkeltaub, PE				van der Stelt, Candace M.; Fama, Mackenzie E.; Mccall, Joshua D.; Snider, Sarah F.; Turkeltaub, Peter E.			Intellectual awareness of naming abilities in people with chronic post-stroke aphasia	NEUROPSYCHOLOGIA			English	Article						Anomia; Aphasia; Awareness; Anosognosia; Self-rating; Voxel-based lesion symptom mapping	TRAUMATIC BRAIN-INJURY; IMPAIRED SELF-AWARENESS; METACOGNITIVE KNOWLEDGE; ASSESSING ANOSOGNOSIA; SPEECH ACQUISITION; ALZHEIMERS-DISEASE; ERROR AWARENESS; LEXICAL ACCESS; DEFICITS; MEMORY	Anosognosia, or lack of self-awareness, is often present following neurological injury and can result in poor functional outcomes. The specific phenomenon of intellectual awareness, the knowledge that a function is impaired in oneself, has not been widely studied in post-stroke aphasia. We aim to identify behavioral and neural correlates of intellectual awareness by comparing stroke survivors' self-reports of anomia to objective naming performance and examining lesion sites. Fifty-three participants with chronic aphasia without severe comprehension deficits rated their naming ability and completed a battery of behavioral tests. We calculated the reliability and accuracy of participant self-ratings, then examined the relationship of poor intellectual awareness to speech, language, and cognitive measures. We used support vector regression lesion-symptom mapping (SVRLSM) to determine lesion locations associated with impaired and preserved intellectual awareness. Reliability and accuracy of self-ratings varied across the participants. Poor intellectual awareness was associated with reduced performance on tasks that rely on semantics. Our SVR-LSM results demonstrated that anterior inferior frontal lesions were associated with poor awareness, while mid-superior temporal lesions were associated with preserved awareness. An anterior-posterior gradient was evident in the unthresholded lesion-symptom maps. While many people with chronic aphasia and relatively intact comprehension can accurately and reliably report the severity of their anomia, others overestimate, underestimate, or inconsistently estimate their naming abilities. Clinicians should consider this when administering self-rating scales, particularly when semantic deficits or anterior inferior frontal lesions are present. Administering self-ratings on multiple days may be useful to check the reliability of patient perceptions.	[van der Stelt, Candace M.; Fama, Mackenzie E.; Mccall, Joshua D.; Turkeltaub, Peter E.] Georgetown Univ, Med Ctr, Ctr Brain Plast & Recovery, Washington, DC 20057 USA; [van der Stelt, Candace M.; Fama, Mackenzie E.; Mccall, Joshua D.; Snider, Sarah F.; Turkeltaub, Peter E.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA; [van der Stelt, Candace M.; Turkeltaub, Peter E.] MedStar Natl Rehabil Hosp, Res Div, Washington, DC USA; [Fama, Mackenzie E.] George Washington Univ, Dept Speech Language & Hearing Sci, Washington, DC 20052 USA		Turkeltaub, PE (corresponding author), 4000 Reservoir Rd NW,Bldg D,Suite 165A, Washington, DC USA.	turkeltp@georgetown.edu		Fama, Mackenzie/0000-0001-8549-7623; van der Stelt, Candace/0000-0003-1265-352X	NIH/NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC014310, F31DC014875, R01DC014960]	This study was funded by the NIH/NIDCD [grant numbers R03DC014310, F31DC014875, R01DC014960]. Financial sponsors did not have a role in conducting the research or preparing the manuscript. We express the deepest gratitude to our participants who made this research possible. We thank Zainab Anbari, Maryam Ghaleh, Katherine Spiegel, Mary Henderson, and Harshini Pyata for contributing to data collection.	ALAJOUANINE T, 1956, BRAIN, V79, P1, DOI 10.1093/brain/79.1.1; Alajouanine T., 1964, REV NEUROL-FRANCE, P5; Allen CM, 2012, APHASIOLOGY, V26, P428, DOI 10.1080/02687038.2011.617436; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bivona U, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01732; BLACKMER ER, 1991, COGNITION, V39, P173, DOI 10.1016/0010-0277(91)90052-6; Butler RA, 2014, BRAIN, V137, P3248, DOI 10.1093/brain/awu286; BUTTERWORTH B, 1987, COGNITION, V26, P1, DOI 10.1016/0010-0277(87)90012-6; Cocchini G, 2012, ACTA NEUROPSYCHOL, V10, P419, DOI 10.5604/17307503.1023693; Cocchini G, 2010, CLIN NEUROPSYCHOL, V24, P1379, DOI 10.1080/13854046.2010.524167; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; de Jong-Hagelstein M, 2012, J INT NEUROPSYCH SOC, V18, P1064, DOI 10.1017/S1355617712000811; Dean MP, 2017, APHASIOLOGY, V31, P725, DOI 10.1080/02687038.2016.1239014; DeMarco AT, 2018, HUM BRAIN MAPP, V39, P4169, DOI 10.1002/hbm.24289; Dockree PM, 2015, J INT NEUROPSYCH SOC, V21, P473, DOI 10.1017/S1355617715000594; Fama ME, 2019, CONSCIOUS COGN, V71, P18, DOI 10.1016/j.concog.2019.03.005; Fama ME, 2019, J SPEECH LANG HEAR R, V62, P106, DOI 10.1044/2018_JSLHR-L-18-0222; Fujimoto H, 2017, NEUROPSYCH DIS TREAT, V13, P1753, DOI 10.2147/NDT.S139177; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Goodglass H., 1992, CONDUCTION APHASIA, P39; Goodglass H., 2001, BDAE BOSTON DIAGNOST; Goverover Y, 2014, NEUROREHABILITATION, V35, P315, DOI 10.3233/NRE-141113; Grutzmann R, 2014, BIOL PSYCHOL, V96, P1, DOI 10.1016/j.biopsycho.2013.10.007; GUENTHER FH, 1994, BIOL CYBERN, V72, P43, DOI 10.1007/BF00206237; Haley KL, 2012, J SPEECH LANG HEAR R, V55, pS1502, DOI 10.1044/1092-4388(2012/11-0318); Hallam B, 2020, NEUROBIOL AGING, V94, P250, DOI 10.1016/j.neurobiolaging.2020.06.011; Harty S, 2013, PSYCHOL AGING, V28, P1032, DOI 10.1037/a0033567; Hecaen H., 1978, HUMAN NEUROPSYCHOLOG; Heilman K.M., 1991, AWARENESS DEFICIT BR, P53; Helm-Estabrooks N., 2014, MANUAL APHASIA APHAS, V3rd; HIBBARD MR, 1992, REHABIL PSYCHOL, V37, P103, DOI 10.1037/0090-5550.37.2.103; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Hoerold D, 2013, NEUROPSYCHOLOGIA, V51, P385, DOI 10.1016/j.neuropsychologia.2012.11.019; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; KERTESZ A, 1977, BRAIN, V100, P1, DOI 10.1093/brain/100.1.1; Kertesz A., 2007, WAB R W APHASIA BATT; Kertesz A, 2010, STUDY ANOSOGNOSIA, P113; KINSBOURNE M, 1963, NEUROPSYCHOLOGIA, V1, P27, DOI 10.1016/0028-3932(63)90010-1; Kolakowsky-Hayner S, 2010, INTRO PATIENT COMPET; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lacey EH, 2017, NEUROREHAB NEURAL RE, V31, P442, DOI 10.1177/1545968316688797; Laine M., 2006, ANOMIA THEORETICAL C; Lee MD., 2013, BAYESIAN COGNITIVE M, DOI [DOI 10.1017/CBO9781139087759, 10.1017/CBO9781139087759]; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Mah YH, 2014, BRAIN, V137, P2522, DOI 10.1093/brain/awu164; MAHER LM, 1994, BRAIN LANG, V46, P402, DOI 10.1006/brln.1994.1022; Mahoney D., 2019, OP J OCCUPAT THERAPY, V7, DOI [https://doi.org/10.15453/2168-6408.1529, DOI 10.15453/2168-6408.1529, 10.15453/2168-6408.1529]; Malouf T, 2014, BRAIN INJURY, V28, P1523, DOI 10.3109/02699052.2014.922700; Mandal Ayan S, 2020, Neurobiol Lang (Camb), V1, P319, DOI 10.1162/nol_a_00015; Marshall J, 1998, BRAIN LANG, V63, P79, DOI 10.1006/brln.1997.1936; MARSHALL RC, 1985, BRAIN LANG, V24, P297, DOI 10.1016/0093-934X(85)90137-3; MARSHALL RC, 1994, APHASIOLOGY, V8, P535, DOI 10.1080/02687039408248680; Martin N, 2018, J NEUROLINGUIST, V48, P199, DOI 10.1016/j.jneuroling.2018.02.006; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Mirman D, 2018, NEUROPSYCHOLOGIA, V115, P112, DOI 10.1016/j.neuropsychologia.2017.08.025; NICKELS L, 1995, CORTEX, V31, P209, DOI 10.1016/S0010-9452(13)80360-7; Nozari Nazbanou, 2020, J Cogn, V3, P19, DOI 10.5334/joc.102; Nozari N, 2011, COGNITIVE PSYCHOL, V63, P1, DOI 10.1016/j.cogpsych.2011.05.001; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Oomen CCE, 2001, CORTEX, V37, P627, DOI 10.1016/S0010-9452(08)70610-5; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Ries SK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00703; Roelofs Ardi, 2020, J Cogn, V3, P18, DOI 10.5334/joc.61; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rubens A. B., 1991, AWARENESS DEFICIT BR, V3rd, P40; Sakurai R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-44; Salmon E, 2006, HUM BRAIN MAPP, V27, P588, DOI 10.1002/hbm.20203; Sansonetti D, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2021.1924794; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schuchard J, 2017, CORTEX, V93, P79, DOI 10.1016/j.cortex.2017.05.008; Schwartz MF, 2016, NEUROPSYCHOLOGIA, V84, P272, DOI 10.1016/j.neuropsychologia.2016.01.027; Shany-Ur T, 2014, BRAIN, V137, P2368, DOI 10.1093/brain/awu161; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Shuren JE, 1996, NEUROLOGY, V47, P845, DOI 10.1212/WNL.47.3.845; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss D.T., 2005, LOST SELF, P50, DOI DOI 10.1093/ACPROF:OSO/9780195173413.003.0005; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tham K., 1999, SCAND J OCCUP THER, V6, P184; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Vigliocco G, 2002, PSYCHOL BULL, V128, P442, DOI 10.1037//0033-2909.128.3.442; Vocat R, 2010, BRAIN, V133, P3578, DOI 10.1093/brain/awq297; Wagner MT, 1997, ALZ DIS ASSOC DIS, V11, P125, DOI 10.1097/00002093-199709000-00004; Walker G.M., 2012, AM J SPEECH-LANG PAT, V21, DOI [10.1044/1058-0360(2012/11-0089, DOI 10.1044/1058-0360(2012/11-0089]; Wallace SJ, 2019, INT J STROKE, V14, P180, DOI 10.1177/1747493018806200; Wessel JR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00088; Zamboni G, 2011, INT J GERIATR PSYCH, V26, P783, DOI 10.1002/gps.2620; Zhang YS, 2014, HUM BRAIN MAPP, V35, P5861, DOI 10.1002/hbm.22590; Zimmermann N, 2017, COGN NEUROPSYCHIATRY, V22, P346, DOI 10.1080/13546805.2017.1330191	99	0	0	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	SEP 17	2021	160								107961	10.1016/j.neuropsychologia.2021.107961			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	UI2KB	WOS:000690441800004	34274379				2022-02-06	
J	Olivares-Hernandez, JD; Balderas-Marquez, JE; Carranza, M; Luna, M; Martinez-Moreno, CG; Aramburo, C				David Olivares-Hernandez, Juan; Elienai Balderas-Marquez, Jerusa; Carranza, Martha; Luna, Maricela; Martinez-Moreno, Carlos G.; Aramburo, Carlos			Growth Hormone (GH) Enhances Endogenous Mechanisms of Neuroprotection and Neuroplasticity after Oxygen and Glucose Deprivation Injury (OGD) and Reoxygenation (OGD/R) in Chicken Hippocampal Cell Cultures	NEURAL PLASTICITY			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; HYPOXIA-ISCHEMIA; GENE-EXPRESSION; SYNAPTIC-TRANSMISSION; NEURONAL APOPTOSIS; REPERFUSION INJURY; KAINIC ACID; BETA-ACTIN; REPLACEMENT	As a classical growth promoter and metabolic regulator, growth hormone (GH) is involved in development of the central nervous system (CNS). This hormone might also act as a neurotrophin, since GH is able to induce neuroprotection, neurite growth, and synaptogenesis during the repair process that occurs in response to neural injury. After an ischemic insult, the neural tissue activates endogenous neuroprotective mechanisms regulated by local neurotrophins that promote tissue recovery. In this work, we investigated the neuroprotective effects of GH in cultured hippocampal neurons exposed to hypoxia-ischemia injury and further reoxygenation. Hippocampal cell cultures obtained from chick embryos were incubated under oxygen-glucose deprivation (OGD, <5% O-2, 1 g/L glucose) conditions for 24 h and simultaneously treated with GH. Then, cells were either collected for analysis or submitted to reoxygenation and normal glucose incubation conditions (OGD/R) for another 24 h, in the presence of GH. Results showed that OGD injury significantly reduced cell survival, the number of cells, dendritic length, and number of neurites, whereas OGD/R stage restored most of those adverse effects. Also, OGD/R increased the mRNA expression of several synaptogenic markers (i.e., NRXN1, NRXN3, NLG1, and GAP43), as well as the growth hormone receptor (GHR). The expression of BDNF, IGF-1, and BMP4 mRNAs was augmented in response to OGD injury, and exposure to OGD/R returned it to normoxic control levels, while the expression of NT-3 increased in both conditions. The addition of GH (10 nM) to hippocampal cultures during OGD reduced apoptosis and induced a significant increase in cell survival, number of cells, and doublecortin immunoreactivity (DCX-IR), above that observed in the OGD/R stage. GH treatment also protected dendrites and neurites during OGD, inducing plastic changes reflected in an increase and complexity of their outgrowths during OGD/R. Furthermore, GH increased the expression of NRXN1, NRXN3, NLG1, and GAP43 after OGD injury. GH also increased the BDNF expression after OGD, but reduced it after OGD/R. Conversely, BMP4 was upregulated by GH after OGD/R. Overall, these results indicate that GH protective actions in the neural tissue may be explained by a synergic combination between its own effect and that of other local neurotrophins regulated by autocrine/paracrine mechanisms, which together accelerate the recovery of tissue damaged by hypoxia-ischemia.	[David Olivares-Hernandez, Juan; Elienai Balderas-Marquez, Jerusa; Carranza, Martha; Luna, Maricela; Martinez-Moreno, Carlos G.; Aramburo, Carlos] Univ Nacl Autonoma Mexico, Dept Neurobiol Celular & Mol, Inst Neurobiol, Campus Juriquilla, Queretaro 76230, Qro, Mexico		Aramburo, C (corresponding author), Univ Nacl Autonoma Mexico, Dept Neurobiol Celular & Mol, Inst Neurobiol, Campus Juriquilla, Queretaro 76230, Qro, Mexico.	aramburo@unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica de la Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA-UNAM, Mexico City, Mexico) [IN208419, IN227020, IN209621]; UNAMUniversidad Nacional Autonoma de Mexico [1130-202-002]; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico City, Mexico)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [285004, CF 2019-214971]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [261533, 921788]	The authors thank Pilgrim's Pride, Queretaro, Mexico, who donated fertilized broiler eggs used during this research. We also thank Dr. Jose avila-Mendoza for critically reading the manuscript, as well as Gerardo Courtois (Lab assistant), Nydia Hernandez-Rios, at the INB-UNAM Microscopy Unit, Adriana Gonzalez-Gallardo, at the INB-UNAM Proteogenomic Unit, and Ramon Martinez-Olvera, at the INB-UNAM Computing Unit, for technical support. This work was supported by grants IN208419, IN227020, and IN209621, from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica de la Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA-UNAM, Mexico City, Mexico) and UNAM grant 1130-202-002 to C.A., as well as by grants 285004 and CF 2019-214971 from Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico City, Mexico). Postdoctoral fellowship to J.D.O.-H (# 261533) and M.Sc. scholarship to J.E.B.-M. (# 921788) were provided by CONACYT.	Aberg ND, 2010, GROWTH HORM IGF RES, V20, P264, DOI 10.1016/j.ghir.2009.12.003; Alba-Betancourt C, 2013, GEN COMP ENDOCR, V183, P17, DOI 10.1016/j.ygcen.2012.12.004; Ara J, 2013, STEM CELL RES, V11, P669, DOI 10.1016/j.scr.2013.04.007; Arce VM, 2013, NEUROSCI RES, V76, P179, DOI 10.1016/j.neures.2013.03.014; Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Avila-Mendoza J, 2016, GEN COMP ENDOCR, V234, P57, DOI 10.1016/j.ygcen.2016.04.004; Baltazar-Lara R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010256; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Chang J, 2018, NEURAL REGEN RES, V13, P1183, DOI 10.4103/1673-5374.235025; Chen HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30459; Chen JL, 2010, J CEREBR BLOOD F MET, V30, P102, DOI 10.1038/jcbfm.2009.187; Cho SG, 2004, NEUROCHEM INT, V45, P117, DOI 10.1016/j.neuint.2003.11.012; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Chung JY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9248542; Datta A, 2020, TRANSL STROKE RES, V11, P1185, DOI 10.1007/s12975-020-00806-z; Olivares-Hernandez JD, 2018, SYNAPSE, V72, DOI 10.1002/syn.22030; Devesa J, 2015, INT J MOL SCI, V16, P30470, DOI 10.3390/ijms161226244; Devesa J, 2011, THER CLIN RISK MANAG, V7, P199, DOI 10.2147/TCRM.S21403; Dijk F, 2007, EXP EYE RES, V84, P858, DOI 10.1016/j.exer.2007.01.006; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Elbornsson M, 2017, EUR J ENDOCRINOL, V176, P99, DOI 10.1530/EJE-16-0875; Fellman V, 1997, PEDIATR RES, V41, P599, DOI 10.1203/00006450-199705000-00001; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; Fleming T, 2018, GEN COMP ENDOCR, V265, P111, DOI 10.1016/j.ygcen.2018.02.011; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Garcia-Garcia F, 2011, BRAIN RES BULL, V84, P252, DOI 10.1016/j.brainresbull.2011.01.003; Gasperi M, 2010, J ENDOCRINOL INVEST, V33, P587, DOI 10.1007/BF03346653; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gustafson K, 1999, PEDIATR RES, V45, P318, DOI 10.1203/00006450-199903000-00005; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; Han TR, 2007, J KOREAN MED SCI, V22, P122, DOI 10.3346/jkms.2007.22.1.122; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harvey S, 2009, ANN NY ACAD SCI, V1163, P414, DOI 10.1111/j.1749-6632.2008.03641.x; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Hendrickson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046918; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Horn AP, 2005, NEUROCHEM RES, V30, P355, DOI 10.1007/s11064-005-2609-0; Houlton J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00790; Jung S, 2017, AM J PHYSIOL-REG I, V312, pR539, DOI 10.1152/ajpregu.00477.2016; Kalda A, 1998, NEUROSCI LETT, V240, P21, DOI 10.1016/S0304-3940(97)00914-2; Kalda A, 1999, NEUROSCIENCE, V92, P7, DOI 10.1016/S0306-4522(98)00726-X; Landucci E, 2016, NEUROPHARMACOLOGY, V108, P39, DOI 10.1016/j.neuropharm.2016.04.043; Larpthaveesarp A, 2015, BRAIN SCI, V5, P165, DOI 10.3390/brainsci5020165; Le Greves M, 2002, P NATL ACAD SCI USA, V99, P7119, DOI 10.1073/pnas.092135399; Le Greves M, 2006, EXP BRAIN RES, V173, P267, DOI 10.1007/s00221-006-0438-2; Li RC, 2011, NEUROSCIENCE, V196, P237, DOI 10.1016/j.neuroscience.2011.08.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X; Lu GW, 1999, NEUROCHEM RES, V24, P625, DOI 10.1023/A:1021092023253; Luna-Acosta JL, 2015, GEN COMP ENDOCR, V224, P148, DOI 10.1016/j.ygcen.2015.07.010; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Martinez-Moreno CG, 2018, EXP EYE RES, V166, P1, DOI 10.1016/j.exer.2017.10.005; Martinez-Moreno CG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184433; Martinez-Moreno CG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020375; Martinez-Moreno CG, 2016, GEN COMP ENDOCR, V234, P68, DOI 10.1016/j.ygcen.2016.03.023; Molina DP, 2012, NEUROBIOL AGING, V33, P1938, DOI 10.1016/j.neurobiolaging.2011.09.014; Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014; Mossberg KA, 2017, J NEUROTRAUM, V34, P845, DOI 10.1089/neu.2016.4552; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Neumann JT, 2015, J CEREBR BLOOD F MET, V35, P121, DOI 10.1038/jcbfm.2014.185; Nyberg F, 1996, HORM RES, V45, P18, DOI 10.1159/000184753; Nylander E, 2020, GROWTH HORM IGF RES, V50, P42, DOI 10.1016/j.ghir.2019.12.003; Ong LK, 2018, STROKE, V49, P1257, DOI 10.1161/STROKEAHA.117.020557; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Regalado-Santiago C, 2013, GROWTH HORM IGF RES, V23, P179, DOI 10.1016/j.ghir.2013.07.002; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rodricks CL, 2008, INT J DEV NEUROSCI, V26, P113, DOI 10.1016/j.ijdevneu.2007.08.006; Sanchez-Bezanilla S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124563; Sanchez-Bezanilla S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020606; Sanders EJ, 2011, GEN COMP ENDOCR, V172, P140, DOI 10.1016/j.ygcen.2010.12.013; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Scheepens A, 1999, MOL BRAIN RES, V68, P88, DOI 10.1016/S0169-328X(99)00051-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin DH, 2004, NEUROSCI LETT, V354, P64, DOI 10.1016/j.neulet.2003.09.070; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; SVENDSEN CN, 1995, EXP BRAIN RES, V102, P407; Thompson A, 2019, INVEST OPHTH VIS SCI, V60, P1748, DOI 10.1167/iovs.18-26449; Tseng GF, 1996, ACTA ANAT, V155, P184; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; Xu HW, 2013, AGEING RES REV, V12, P157, DOI 10.1016/j.arr.2012.05.002; Xu MY, 2019, CNS NEUROSCI THER, V25, P734, DOI 10.1111/cns.13102; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108518; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhu LL, 2005, MOL NEUROBIOL, V31, P231, DOI 10.1385/MN:31:1-3:231	93	0	0	3	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.	SEP 16	2021	2021								9990166	10.1155/2021/9990166			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UW7DN	WOS:000700313700001	34567109	gold, Green Published			2022-02-06	
J	McCabe, CT; Watrous, JR; Eskridge, SL; Galarneau, MR				McCabe, Cameron T.; Watrous, Jessica R.; Eskridge, Susan L.; Galarneau, Michael R.			Mental and physical health, and long-term quality of life among service members injured on deployment	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Health-related quality of life; Military; Extremity injury; Traumatic brain injury; PTSD; Musculoskeletal disorders; Cardiovascular disorders	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MUSCULOSKELETAL INJURIES; CARDIOVASCULAR-DISEASE; SYMPTOMS; VETERANS; OUTCOMES; IRAQ; AFGHANISTAN; PAIN	Background More than 52,000 casualties have been documented in post-9/11 conflicts. Service members with extremity injuries (EIs) or traumatic brain injury (TBI) may be at particular risk for long-term deficits in mental and physical health functioning compared with service members with other injuries. Methods The present study combined medical records with patient reports of mental health and health-related quality of life (HRQOL) for 2,537 service members injured in overseas contingency operations who participated in the Wounded Warrior Recovery Project. Combined parallel-serial mediation models were tested to examine the pathways through which injury is related to mental and physical health conditions, and long-term HRQOL. Results Results revealed that injury was indirectly related to long-term HRQOL via its associations with physical health complications and mental health symptoms. Relative to TBI, EI was associated with a higher likelihood for a postinjury diagnosis for a musculoskeletal condition, which were related to lower levels of later posttraumatic stress disorder (PTSD) symptoms, and higher levels of physical and mental HRQOL. Similarly, EI was related to a lower likelihood for a postinjury PTSD diagnosis, and lower levels of subsequent PTSD symptoms, and therefore higher physical and mental HRQOL relative to those with TBI. Despite this, the prevalence of probable PTSD among those with EI was high (35%). Implications for intervention, rehabilitation, and future research are discussed.	[McCabe, Cameron T.; Watrous, Jessica R.; Eskridge, Susan L.; Galarneau, Michael R.] Naval Hlth Res Ctr, Operat Readiness Directorate, 140 Sylvester Rd, San Diego, CA 92106 USA; [McCabe, Cameron T.; Watrous, Jessica R.; Eskridge, Susan L.] Leidos, 140 Sylvester Rd, San Diego, CA 92106 USA		McCabe, CT (corresponding author), Naval Hlth Res Ctr, Operat Readiness Directorate, 140 Sylvester Rd, San Diego, CA 92106 USA.; McCabe, CT (corresponding author), Leidos, 140 Sylvester Rd, San Diego, CA 92106 USA.	cameron.t.mccabe.ctr@mail.mil		McCabe, Cameron/0000-0001-8395-9142	U.S. Navy Bureau of Medicine and Surgery's Wounded, Ill, and Injured program [60808]; Extremity Trauma and Amputation Center of Excellence (EACE) [N1333]	I am a military service member or employee of the U.S. Government. This work was prepared as part of my official duties. Title 17, U.S.C. 105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. 101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. Report No. 19-06 was supported by the U.S. Navy Bureau of Medicine and Surgery's Wounded, Ill, and Injured program under work unit no. 60808, and the Extremity Trauma and Amputation Center of Excellence (EACE), work unit no. N1333. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center, Institutional Review Board protocol number NHRC.2009.0014.	Angkaw AC, 2015, MIL MED, V180, P670, DOI 10.7205/MILMED-D-14-00473; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Burg MM, 2017, PSYCHOSOM MED, V79, P181, DOI 10.1097/PSY.0000000000000376; Butowicz CM, 2017, ADV WOUND CARE, V6, P269, DOI 10.1089/wound.2016.0714; Cameron KL, 2014, CLIN SPORT MED, V33, P573, DOI 10.1016/j.csm.2014.06.004; Defense Casualty Analysis System, 2017, US MIL CAS OCO CAS S; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; French LM, 2015, TRAUMATIC BRAIN INJU, P263; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Howard JT, 2018, HYPERTENSION, V71, P824, DOI 10.1161/HYPERTENSIONAHA.117.10496; Jones D, 2001, J Ambul Care Manage, V24, P68; Kanefsky R, 2019, PSYCHIAT RES, V279, P34, DOI 10.1016/j.psychres.2019.07.001; Kelsall HL, 2014, PAIN, V155, P685, DOI 10.1016/j.pain.2013.12.025; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Ludt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029334; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mazzone B, 2020, SPINE, V45, P1368, DOI 10.1097/BRS.0000000000003525; Melcer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170569; Melcer T, 2013, J ORTHOP TRAUMA, V27, pE31, DOI 10.1097/BOT.0b013e3182517e1c; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; Muthen LK, 1998, MPLUS USERS GUIDE, V8th; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; Outcalt SD, 2015, J BEHAV MED, V38, P535, DOI 10.1007/s10865-015-9628-3; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; ROTHBERG JM, 1990, JAMA-J AM MED ASSOC, V264, P2241, DOI 10.1001/jama.264.17.2241; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Scott DJ, 2014, J VASC SURG, V59, P173, DOI 10.1016/j.jvs.2013.07.103; Smoley BA, 2008, J AM BOARD FAM MED, V21, P504, DOI 10.3122/jabfm.2008.06.070182; Stewart IJ, 2015, CIRCULATION, V132, P2126, DOI 10.1161/CIRCULATIONAHA.115.016950; Stride C.B., 2015, MPLUS CODE MEDIATION; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Ulmer CS, 2015, J BEHAV MED, V38, P544, DOI 10.1007/s10865-015-9627-4; Waitzkin Howard, 2009, Soc Med (Soc Med Publ Group), V4, P56; Walker LE, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2088; Walter KH, 2019, PSYCHOL SPORT EXERC, V45, DOI 10.1016/j.psychsport.2019.101551; Ware J.E., 1994, SF 36 PHYS MENTAL SU; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watrous JR, 2019, MIL MED, V184, P84, DOI 10.1093/milmed/usy243; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wegener ST, 2011, PAIN, V152, P1349, DOI 10.1016/j.pain.2011.02.020; Woodruff SI, 2017, MIL PSYCHOL, V29, P590, DOI 10.1037/mil0000181	58	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7525		HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	SEP 16	2021	19	1							220	10.1186/s12955-021-01852-3			11	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	UR1ON	WOS:000696525100001	34530831	gold, Green Published			2022-02-06	
J	Anastasia, VP; Gennadii, AB; Viktor, ON; Marina, VZ; Anna, VD				Anastasia, V. Polozova; Gennadii, A. Boyarinov; Viktor, O. Nikolsky; Marina, V. Zolotova; Anna, V. Deryugina			The functional indexes of RBCs and microcirculation in the traumatic brain injury with the action of 2-ethil-6-methil-3-hydroxypiridin succinate	BMC NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); RBC (red blood cells); Microcirculation; 2-ethil-6-methil-3-hydroxipiridin succinate	OXYGENATION; ERYTHROCYTES; PATHOGENESIS; DYSFUNCTION; METABOLISM; DEFICITS; MODELS; SIGNAL	Research aim To study the RBCs functional and metabolic parameters and the microcirculatory brain structure at traumatic brain injury (TBI) under the action of 2-ethyl-6-methyl-3-hydroxypyridine succinate. Methods A closed TBI was modeled by the free fall of a load on the parietooccipital regions of head. We made studies of the influence of 2-ethil-6-methil-3-hydroxipiridin succinate on aggregation and electrophoretic mobility of RBCs, catalase activity, malonic dialdehyde concentration, adenosine triphosphate and 2.3-biphosphoglycerate (2.3 - BPG) concentrations in RBCs. The state of parenchyma and microcirculatory brain mainstream in post-traumatic period of TBI have been studied on micro-preparations. Results The use of 2-ethyl-6-methyl-3-hydroxypyridine succinate under conditions of head injury leads to a decrease in MDA concentration and in aggregation of RBCs, to an increase in the 2.3-BPG concentration and RBC electrophoretic mobility compared to the control (group value). The most pronounced changes under the action of 2-ethyl-6-methyl-3-hydroxypyridine succinate were observed 3-7 days after the TBI. Significant indicators of the restoration of the microvasculature and brain tissue provoked by the use of 2-ethyl-6-methyl-3-hydroxypyridine succinate of were evident from the 7th day unlike the control group, where the restoration of structural morphological parameters was observed only on the 12th day of the post-traumatic period. Fast recovery of blood flow under the action of 2-ethyl-6-methyl-3-hydroxypyridine succinate ensured effective restoration of neurons and glia in comparison with the control group. Conclusions Early and long-term cytoprotective correction intensifies the oxygen transport function of the blood, prevents and / or reduces disorders of microvessels, neurons and glia in the post-traumatic period, thereby provides correction of hypoxic state and drives to the restoration of brain tissues homeostasis.	[Anastasia, V. Polozova; Marina, V. Zolotova; Anna, V. Deryugina] Lobachevsky Univ, Inst Biol & Biomed, Dept Physiol & Anat, 23 Gagarin Ave, Nizhnii Novgorod, Russia; [Anastasia, V. Polozova; Gennadii, A. Boyarinov; Viktor, O. Nikolsky] Minist Hlth Russian Federat, Dept Anesthesiol & Intens Care, Privolzhsky Res Med Univ, Nizhnii Novgorod, Russia		Anastasia, VP (corresponding author), Lobachevsky Univ, Inst Biol & Biomed, Dept Physiol & Anat, 23 Gagarin Ave, Nizhnii Novgorod, Russia.; Anastasia, VP (corresponding author), Minist Hlth Russian Federat, Dept Anesthesiol & Intens Care, Privolzhsky Res Med Univ, Nizhnii Novgorod, Russia.	shumilowanastya@gmail.com	Deryugina, Anna/E-7522-2019		RFBRRussian Foundation for Basic Research (RFBR) [19-34-90081]	The reported study was funded by RFBR [project number 19-34-90081].	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; BEERS RF, 1952, J BIOL CHEM, V195, P133; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Boyarinov G. A., 2017, Cell and Tissue Biology, V11, P65, DOI 10.1134/S1990519X17010023; Bragin DE, 2017, J CEREBR BLOOD F MET, V37, P762, DOI 10.1177/0271678X16684153; Catala A, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00520; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; Derjugina AV, 2006, B EXP BIOL MED, V141, P414, DOI [10.1007/s10517-006-0186-0, DOI 10.1007/S10517-006-0186-0]; Deryugina A. V, 2018, Cell and Tissue Biology, V12, P207, DOI 10.1134/S1990519X18030033; Deryugina AV, 2017, B EXP BIOL MED+, V164, P26, DOI 10.1007/s10517-017-3918-4; Firsov AA., 2017, SOVREMENNAYA MEDITSI, V5, P110; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hamel D, 2014, ARTERIOSCL THROM VAS, V34, P285, DOI 10.1161/ATVBAHA.113.302131; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Jensen FB, 2004, ACTA PHYSIOL SCAND, V182, P215, DOI 10.1111/j.1365-201X.2004.01361.x; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kesarev OG., 2017, RES RESULT PHARM CLI, V3, P3, DOI [10.18413/2500-235X-2017-3-1-3-9, DOI 10.18413/2500-235X-2017-3-1-3-9]; Kuhn V, 2017, ANTIOXID REDOX SIGN, V26, P718, DOI 10.1089/ars.2016.6954; [Лапшина Н.В. Lapshina N.V.], 2018, [Вестник аритмологии, Vestnik aritmologii], P48; Livshic VM., 2007, MEDICINSKIJ LAB ANAL; Maeda N., 2015, J BIORHEOL, V29, P2, DOI [10.17106/jbr.29.2, DOI 10.17106/JBR.29.2]; Meiselman HJ, 2007, INDIAN J EXP BIOL, V45, P9; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Mikhin VP, 2011, RUSS J CARDIOL, P37; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nowak G, 2008, J PHARMACOL EXP THER, V324, P1155, DOI 10.1124/jpet.107.130872; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Schnitzer E, 2007, EUR BIOPHYS J BIOPHY, V36, P499, DOI 10.1007/s00249-007-0146-2; Shumilova A. V., 2018, Eksperimental'naya i Klinicheskaya Farmakologiya, V81, P20, DOI 10.30906/0869-2092-2018-81-3-20-23; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tsutsumi Y, 2005, CIRCULATION, V112, P1248, DOI 10.1161/CIRCULATIONAHA.105.566166; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Zavaliy LB., 2017, RUSSIAN SKLIFOSOVSKY, V7, P44, DOI [10.23934/2223-9022-2018-7-1-44-52, DOI 10.23934/2223-9022-2018-7-1-44-52]; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	48	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	SEP 15	2021	22	1							57	10.1186/s12868-021-00657-w			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ7CE	WOS:000696217900002	34525969	gold, Green Published			2022-02-06	
J	Dunn, A; Pyne, S; Tyson, B; Roth, R; Shahein, A; Erdodi, L				Dunn, Alexa; Pyne, Sadie; Tyson, Brad; Roth, Robert; Shahein, Ayman; Erdodi, Laszlo			Critical Item Analysis Enhances the Classification Accuracy of the Logical Memory Recognition Trial as a Performance Validity Indicator	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; RELIABLE DIGIT SPAN; COMPLEX FIGURE TEST; FALSE-POSITIVE RATES; CARD SORTING TEST; LEARNING TEST-II; SYMPTOM VALIDITY; RESPONSE BIAS; WMS-III	Objective: Replicate previous research on Logical Memory Recognition (LMRecog) and perform a critical item analysis. Method: Performance validity was psychometrically operationalized in a mixed clinical sample of 213 adults. Classification of the LMRecog and nine critical items (CR-9) was computed. Results: LMRecog <= 20 produced a good combination of sensitivity (.30-.35) and specificity (.89-.90). CR-9 >= 5 and >= 6 had comparable classification accuracy. CR-9 >= 5 increased sensitivity by 4% over LMRecog <= 20; CR-9 >= 6 increased specificity by 6-8% over LMRecog <= 20; CR-9 >= 7 increased specificity by 8-15%. Conclusions: Critical item analysis enhances the classification accuracy of the optimal LMRecog cutoff (<= 20).	[Dunn, Alexa; Erdodi, Laszlo] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Pyne, Sadie] Windsor Neuropsychol, Windsor, ON, Canada; [Tyson, Brad] EvergreenHlth Med Ctr, Neurosci Inst, Evergreen Neurosci Inst, Kirkland, WA USA; [Roth, Robert] Dartmouth Hitchcock Med Ctr, Neuropsychol Serv, Lebanon, NH 03766 USA; [Shahein, Ayman] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Erdodi, L (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	lerdodi@gmail.com		Tyson, Brad/0000-0002-5113-790X			Abeare C, 2021, PSYCHOL ASSESSMENT, V33, P90, DOI 10.1037/pas0000958; Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare CA, 2021, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2021.1939027; Abeare CA, 2021, CLIN NEUROPSYCHOL, V35, P1442, DOI 10.1080/13854046.2020.1779348; Abeare K, 2021, PERCEPT MOTOR SKILL, V128, P1373, DOI 10.1177/00315125211019704; Ahn YD, 2019, PSYCHIAT INVEST, V16, P793, DOI 10.30773/pi.2019.0061; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Ashendorf L, 2019, CLIN NEUROPSYCHOL, V33, P1388, DOI 10.1080/13854046.2018.1543454; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bell BD, 2006, J CLIN EXP NEUROPSYC, V28, P1435, DOI 10.1080/13803390500434367; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2013, APPL NEUROPSYCH-ADUL, V20, P233, DOI 10.1080/09084282.2012.695757; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Chafetz MD, 2011, PSYCHOL INJ LAW, V4, P235, DOI 10.1007/s12207-011-9112-5; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Cutler L, 2021, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2021.1884555; Dandachi-FitzGerald B, 2020, J INT NEUROPSYCH SOC, V26, P314, DOI 10.1017/S1355617719001139; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Delis D.C., 2000, CALIFORNIA VERBAL LE; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2021, NEUROREHABILITATION, V49, P179, DOI 10.3233/NRE-218020; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fuermaier ABM, 2017, PSYCHOL ASSESSMENT, V29, P1466, DOI 10.1037/pas0000534; Giromini L, 2019, PSYCHOL INJ LAW, V12, P212, DOI 10.1007/s12207-019-09357-7; Giromini L, 2020, APPL NEUROPSYCH-ADUL, V27, P504, DOI 10.1080/23279095.2019.1570929; Giromini L, 2020, J PERS ASSESS, V102, P563, DOI 10.1080/00223891.2019.1566914; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Guilmette TJ, 1996, PERCEPT MOTOR SKILL, V83, P1007, DOI 10.2466/pms.1996.83.3.1007; Gutchess A.H., 2013, CULTURE BRAIN, V1, P138, DOI [10.1007/s40167-013-0011-3, DOI 10.1007/S40167-013-0011-3]; Gutchess AH, 2009, PROG BRAIN RES, V178, P137, DOI 10.1016/S0079-6123(09)17809-3; Heaton R., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hirst, 2020, ARCH ASSESSMENT PSYC; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kramer JH., 2001, DELIS KAPLAN EXECUTI, DOI [10.1037/t15082-000, DOI 10.1037/T15082-000]; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Lafayette Instrument, 2015, GROOV PEGB US MAN; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lilienfeld SO, 2020, CAN PSYCHOL, V61, P281, DOI 10.1037/cap0000236; Lindstrom W, 2011, CLIN NEUROPSYCHOL, V25, P302, DOI 10.1080/13854046.2010.537280; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; MacAllister WS, 2019, CHILD NEUROPSYCHOL, V25, P1035, DOI 10.1080/09297049.2019.1569606; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Messa I, 2021, AUST J FORENSIC SCI, DOI 10.1080/00450618.2020.1865457; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Olla P, 2021, APPL NEUROPSYCH-ADUL, V28, P647, DOI 10.1080/23279095.2019.1681424; Olsen DH, 2019, CLIN NEUROPSYCHOL, V33, P732, DOI 10.1080/13854046.2018.1501096; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Pearson, 2009, ADV CLIN SOLUTIONS W; Pliskin JI, 2021, ASSESSMENT, V28, P1871, DOI 10.1177/1073191120929093; Price L, 2004, J CLIN EXP NEUROPSYC, V26, P531, DOI 10.1080/13803390490496678; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; RAI J, 2019, APPL NEUROPSYCHOL, DOI DOI 10.1080/23279095.2019.161.1613994; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P1373, DOI 10.1080/13854046.2019.1619839; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sharpe D, 2020, CAN PSYCHOL, V61, P269, DOI 10.1037/cap0000252; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Soble JR, 2020, PSYCHOL INJ LAW, V13, P44, DOI 10.1007/s12207-019-09370-w; Soble JR, 2019, APPL NEUROPSYCH-ADUL, V26, P311, DOI 10.1080/23279095.2017.1418744; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Sugarman MA, 2014, COGN BEHAV NEUROL, V27, P148, DOI 10.1097/WNN.0000000000000035; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler, 2009, ADM SCORING MANUAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Yang LX, 2013, J GERONTOL B-PSYCHOL, V68, P872, DOI 10.1093/geronb/gbt006; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	136	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JUL 4	2021	46	5					327	346		10.1080/87565641.2021.1956499		SEP 2021	20	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UU5HM	WOS:000696265400001	34525856				2022-02-06	
J	Dutrisac, S; Rovt, J; Post, A; Goodwin, S; Cron, GO; Jalali, A; Poon, K; Brien, S; Frei, H; Hoshizaki, TB; Petel, OE				Dutrisac, Scott; Rovt, Jennifer; Post, Andrew; Goodwin, Shannon; Cron, Greg O.; Jalali, Alireza; Poon, Katherine; Brien, Susan; Frei, Hanspeter; Hoshizaki, T. Blaine; Petel, Oren E.			Intracranial Displacement Measurements Within Targeted Anatomical Regions of a Postmortem Human Surrogate Brain Subjected to Impact	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						PMHS; Cadaver; Concussion; Brain trauma; Impact	CORPUS-CALLOSUM; HEAD; INJURY; DEFORMATION; CONCUSSION; STRAIN; TISSUE	The dynamic response of the human brain subjected to impulsive loading conditions is of fundamental importance to the understanding of traumatic brain injuries. Due to the complexity of such measurements, the existing experimental datasets available to researchers are sparse. However, these measurements are used extensively in the validation of complex finite element models used in the design of protective equipment and the development of injury mitigation strategies. The primary objective of this study was to develop a comprehensive methodology to measure displacement in specific anatomical regions of the brain. A state-of-the-art high-speed cineradiography system was used to capture brain motion in post-mortem human surrogate specimens at a rate of 7500 fps. This paper describes the methodology used to capture these data and presents measurements from these tests. Two-dimensional displacement fields are presented and analyzed based on anatomical regions of the brain. These data demonstrated a multi-modal displacement response in several regions of the brain. The full response of the brain consisted of an elastic superposition of a series of bulk rotations of the brain about its centre of gravity. The displacement field could be linked directly to specific anatomical regions. The methods presented mark an improvement in temporal and spatial resolution of data collection, which has implications for our developing understanding of brain trauma.	[Dutrisac, Scott; Rovt, Jennifer; Frei, Hanspeter; Petel, Oren E.] Carleton Univ, Dept Mech & Aerosp Engn, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada; [Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Dept Human Kinet, 200 Lees Ave, Ottawa, ON K1S 5S9, Canada; [Goodwin, Shannon; Jalali, Alireza] Univ Ottawa, Fac Med, Div Clin & Funct Anat, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; [Cron, Greg O.] Univ Ottawa, Fac Med, Dept Radiol, 451 Smyth Rd, Ottawa, ON K1H 8L6, Canada; [Poon, Katherine] Clin Neurooutaouais, 209 Rue Gamelin, Gatineau, PQ J8Y 1W2, Canada; [Brien, Susan] McGill Univ, Fac Med, Dept Neurol & Neurosurg, 3655 Sir William Osler, Montreal, PQ H3G 1Y6, Canada		Petel, OE (corresponding author), Carleton Univ, Dept Mech & Aerosp Engn, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	oren.petel@carleton.ca			CIHRCanadian Institutes of Health Research (CIHR); NSERC through the Collaborative Health Research Program [CPG-151967]; Ontario Ministry of Research and Innovation - Early Research Award [ER-18-14-063]; Canada Foundation for Innovation and Ontario Research Fund [32933]; Ontario Graduate ScholarshipOntario Graduate Scholarship	The authors thank Stephane Magnan, Karen Taylor, and David Koncan for their assistance in the early stages of this experimental work. This work was funded by the CIHR and NSERC through the Collaborative Health Research Program (CPG-151967). OEP received funding support from Ontario Ministry of Research and Innovation -Early Research Award (ER-18-14-063). OEP received funding for the cineradiography equipment from the Canada Foundation for Innovation and Ontario Research Fund (Project 32933). SD received funding through the Ontario Graduate Scholarship.	Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Benson, 1977, SAE TECHNICAL PAPER, DOI [10.4271/770921, DOI 10.4271/770921]; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Duck FA., 2013, PHYS PROPERTIES TISS; Dutrisac S, 2020, THESIS CARLETON U OT; Dutrisac S, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4051527; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gould W.S, 1987, 2 FACTORS CRITICAL P; Guettler A., 2017, QUANTIFYING RESPONSE; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hill DLG, 1998, NEUROSURGERY, V43, P514, DOI 10.1097/00006123-199809000-00066; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI 10.4172/2155-9562.1000181; Karton C., 2014, INFLUENCE IMPACT MAS, P23; King A., 1999, 43 STAPP CAR CRASH C, V350(724), P321; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Lepore N, 2017, 10 INT S MED INF PRO, V9287; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meyers MA., 1994, DYNAMIC BEHAV MAT, DOI [10.1002/9780470172278, DOI 10.1002/9780470172278]; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Petel O.E., STRAIN BASED INVESTI, V2021, DOI [10.31224/osf.io/7jtvw, DOI 10.31224/OSF.IO/7JTVW]; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Post A, 2021, TRAUMA, V23, P24, DOI 10.1177/1460408620916578; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; SHATSKY SA, 1974, J NEUROSURG, V41, P523, DOI 10.3171/jns.1974.41.5.0523; Sonometrics Corporation, SONOSOFT FAQ PRINT D, P2021; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; TAMPIERI D, 1983, AM J NEURORADIOL, V4, P725; Tashman S, 2002, 4 WORLD C BIOM; Thibault L., 1971, P 15 STAPP CAR CRASH; Uur HC, 2014, J CLIN EXP INVESTIG, V5, P368; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Zhao W, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4051050; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293	54	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2836	2851		10.1007/s10439-021-02857-1		SEP 2021	16	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000696155200001	34528151				2022-02-06	
J	Inui, T; Hoffer, M; Balaban, CD				Inui, Takaki; Hoffer, Michael; Balaban, Carey D.			Mild blast wave exposure produces intensity-dependent changes in MMP2 expression patches in rat brains - Findings from different blast severities	BRAIN RESEARCH			English	Article						Traumatic brain injury; MMP2; Mild blast wave; Blood brain barrier; Rat; Animal model	AMYLOID-BETA PEPTIDE; MATRIX METALLOPROTEINASES; CEREBRAL-ISCHEMIA; INJURY; MATRIX-METALLOPROTEINASE-9; BLOOD; DEGRADATION; REPERFUSION; ACTIVATION; DEPOSITION	Matrix metalloproteinase 2 (MMP2) is a gelatinase with multiple functions at the neurovascular interface, including local modification of the glia limitans to facilitate access of immune cells into the brain and amyloidbeta degradation during responses to injury or disease. This study examines regional changes in immunoreactive MMP2 in the rat brain after a single mild (2.7-7.9 psi peak) or moderate (13-17.5 psi peak) blast overpressure (BOP) exposure. Immunopositive MMP2 expression was examined quantitatively in histological sections of decalcified rat heads as a marker at 2, 24, and 72 h after BOP. The MMP2 immunoreactivity was isolated to patchy deposits in brain parenchyma surrounding blood vessels. Separate analyses were conducted for the cerebellum, brain stem caudal to the thalamo-mesencephalic junction, and the cerebrum (including diencephalon). The deposits varied in number, size, staining homogeneity (standard deviation of immunopositive region), and a cumulative measure, the product of size, average intensity and number, as a function of blast intensity and time. The sequences of changes in MMP2 spots from sham control animals suggested that the mild BOP exposure differences normalized within 72 h. However, the responses to moderate exposure revealed a delayed response at 72 h in the subtentorial brain stem and the cerebrum, but not the cerebellum. Hence, local MMP2 responses may be a contextual biomarker for locally regulated responses to widely distributed brain injury foci.	[Inui, Takaki; Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Inui, Takaki] Osaka Mdical Coll, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Hoffer, Michael] Naval Med Ctr San Diego, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA USA; [Hoffer, Michael] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Neurobiol Commun Sci & Disorders & Bioengn, Pittsburgh, PA USA		Inui, T (corresponding author), 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.; Balaban, CD (corresponding author), 107 Eye & Ear Inst,203 Lothrop St, Pittsburgh, PA 15213 USA.	oto064@osaka-med.ac.jp; michael.hoffer@miami.edu; cbalaban@pitt.edu	Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844	Office Naval ResearchOffice of Naval Research [W81XWH15D0011]	The authors would like to acknowledge the skillful histological contributions of Gloria Limetti and Cynthia Stone. This work was supported, in part, by the Office Naval Research [grant number W81XWH15D0011] .	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Balaban C, 2016, J NEUROSCI METH, V272, P56, DOI 10.1016/j.jneumeth.2016.02.001; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Crouch PJ, 2009, J NEUROCHEM, V108, P1198, DOI 10.1111/j.1471-4159.2009.05870.x; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hannocks MJ, 2019, MATRIX BIOL, V75-76, P102, DOI 10.1016/j.matbio.2017.11.007; Hanumegowda UM, 2003, TOXICOL SCI, V76, P237, DOI 10.1093/toxsci/kfg222; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hernandez-Guillamon M, 2015, J BIOL CHEM, V290, P15078, DOI 10.1074/jbc.M114.610931; Hernandez-Guillamon M, 2010, J BIOL CHEM, V285, P27144, DOI 10.1074/jbc.M110.135228; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Isahaya K, 2012, J STROKE CEREBROVASC, V21, P102, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.009; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Park KP, 2009, STROKE, V40, P2836, DOI 10.1161/STROKEAHA.109.554824; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Shi WZ, 2017, MOL MED REP, V15, P2129, DOI 10.3892/mmr.2017.6275; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Suofu Y, 2012, NEUROSCIENCE, V212, P180, DOI 10.1016/j.neuroscience.2012.03.036; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI [10.1089/neu.2009-0959, 10.1089/neu.2009.0959]; The official website of the Military Health System, 2007, DEP DEF HLTH AFF MEM; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yu Q, 2000, GENE DEV, V14, P163	43	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 15	2021	1767								147541	10.1016/j.brainres.2021.147541			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD5HV	WOS:000687238300013	34077763				2022-02-06	
J	McGowan, AL; Bretzin, AC; Anderson, M; Pontifex, MB; Covassin, T				McGowan, Amanda L.; Bretzin, Abigail C.; Anderson, Morgan; Pontifex, Matthew B.; Covassin, Tracey			Paired cognitive flexibility task with symptom factors improves detection of sports-related concussion in high school and collegiate athletes	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Brain concussion; Cognition; Neurocognitive testing; Reaction time; Sideline measures	VISUOSPATIAL ATTENTION DEFICITS; TRAUMATIC BRAIN-INJURY; BASE-LINE; MANAGEMENT; RECOVERY; SENSITIVITY; TRAINERS; QUESTIONNAIRE; SPECIFICITY; PATTERNS	Determining the sensitivity and specificity of short neurocognitive assessments to objectively detect concussion will help clinicians more confidently integrate such tools in clinical management decisions. This study quantified the sensitivity and specificity of a computerized cognitive flexibility task isolating shifts of visuospatial attention in combination with clinical symptoms acutely (< 72 h) following concussion. A total of 100 athletes (53 con-cussed; 47 non-injured control; 42% female) completed computerized neurocognitive testing and clinical symptom reports (Sport Concussion Assessment Tool 3rd edition: SCAT3). Separate discriminant function ana-lyses were performed for individual, combination, and stepwise inclusion of neurocognitive and clinical symp-tomology assessments. Findings revealed the combination of neurocognitive outcomes (i.e., mean reaction time, response accuracy, and response accuracy cost) with clinical symptom factor scores exhibited the greatest sensitivity (95.7%) and specificity (88.7%) as well as the highest positive predictive value (95.9%) and negative predictive value (88%) relative to other approaches. Further, a stepwise approach predicting concussion status using the discriminant functions improved detection of concussion (98.2% sensitivity, 95.7% specificity, 96.4% positive predictive value, and 97.8% negative predictive value) when clinical symptom factors failed to indicate the presence of a concussion. Incorporating a cognitive flexibility task involving shifts of visuospatial attention combined with clinical symptom factor scores may improve clinical decision-making as this approach exceeds the sensitivity and specificity of widely popular neurocognitive test batteries and takes less than 10 min to administer.	[McGowan, Amanda L.] Univ Penn, Annenberg Sch Commun, Addict Hlth & Adolescence Lab, Philadelphia, PA 19104 USA; [Bretzin, Abigail C.] Univ Penn, Penn Injury Sci Ctr, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Anderson, Morgan; Pontifex, Matthew B.; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI USA		McGowan, AL (corresponding author), Univ Penn, Annenberg Sch Commun, 3620 Walnut St, Philadelphia, PA 19104 USA.	amanda.mcgowan@asc.upenn.edu		Bretzin, Abigail/0000-0003-3730-2849	U.S. Navy (Naval Health Research Center) [W911QY-14-C-0098]	This study was funded in part by a contract to BrainScope Company Inc. from the U.S. Navy (Naval Health Research Center) contract #W911QY-14-C-0098.	Anderson M, 2021, J ATHL TRAINING, V56, P157, DOI 10.4085/1062-6050-0102-20; Anderson Morgan, 2020, J Athl Train, V55, P1046, DOI [10.4085/1062-6050-393.19, 10.4085/1062-6050-393-19]; [Anonymous], 2018, NINDS COMMON DATA EL; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cohen PE, 2020, CLIN J SPORT MED, V30, pS61, DOI 10.1097/JSM.0000000000000581; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Guty E, 2021, ARCH CLIN NEUROPSYCH, V36, P746, DOI 10.1093/arclin/acaa092; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; HAMSHER KDS, 1977, CORTEX, V13, P306; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lawrence M. A., 2016, PACKAGE EZ R PACKAGE; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McAllister-Deitrick J, 2022, CLIN J SPORT MED, V32, P56, DOI 10.1097/JSM.0000000000000833; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGee S, 2002, J GEN INTERN MED, V17, P646; McGowan AL, 2019, NEUROPSYCHOLOGIA, V131, P223, DOI 10.1016/j.neuropsychologia.2019.05.026; McGowan AL, 2018, NEUROPSYCHOLOGY, V32, P564, DOI 10.1037/neu0000475; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Pardini D., 2004, BR J SPORTS MED, V38, P661; Piland SG, 2003, J ATHL TRAINING, V38, P104; R Core Team, 2020, R LANG ENV STAT COMP; Rabinowitz AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57220-1; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wilkinson J.L., 1992, NEUROANATOMY MED STU, VSecond, P215, DOI [10.1016/B978-0-7506-1447-4.50016-5, DOI 10.1016/B978-0-7506-1447-4.50016-5]; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	64	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2021	428								117575	10.1016/j.jns.2021.117575			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UI7UK	WOS:000690806900006	34304023				2022-02-06	
J	Sepand, MR; Maghsoudi, AS; Shadboorestan, A; Mirnia, K; Aghsami, M; Raoufi, M				Sepand, Mohammad Reza; Maghsoudi, Armin Salek; Shadboorestan, Amir; Mirnia, Kayvan; Aghsami, Mehdi; Raoufi, Mohammad			Cigarette smoke-induced toxicity consequences of intracellular iron dysregulation and ferroptosis	LIFE SCIENCES			English	Article						Cigarette smoke; Cell death; Ferroptosis; Iron; Oxidative stress	OXIDATIVE STRESS; CELL-DEATH; REACTIVE OXYGEN; RESPIRATORY-TRACT; ZINC TRANSPORTER; EPITHELIAL-CELLS; TOBACCO-SMOKE; CANCER-CELLS; KAPPA-B; LUNG	Despite numerous studies on the mechanisms of cigarette smoking toxicity over the past three decades, some aspects remain obscure. Recent developments have drawn attention to some hopeful indicators that allow us to advance our awareness of cigarette-induced cell death. Ferroptosis is considered a type of governed death of cells distinguished by the iron-dependent lipid hydroperoxide deposition to fatal concentrations. Ferroptosis has been linked with pathological settings such as neurodegenerative diseases, cancer, heart attack, hemorrhagic stroke, traumatic brain injury, ischemia-reperfusion injury, and renal dysfunction. This review tries to explain the causal role of ferroptosis cascade in cigarette smoke-mediated toxicity and cell death, highlighting associations on potential action mechanisms and proposing suggestions for its detoxifying and therapeutic interventions.	[Sepand, Mohammad Reza; Raoufi, Mohammad] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran 1316943551, Iran; [Maghsoudi, Armin Salek] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr PSRC, Inst Pharmaceut Sci TIPS, Toxicol & Dis Grp TDG, Tehran, Iran; [Shadboorestan, Amir] Tarbiat Modares Univ, Fac Med Sci, Dept Toxicol, Tehran, Iran; [Mirnia, Kayvan] Univ Tehran Med Sci, Sch Med, Dept Neonatol, Tehran, Iran; [Aghsami, Mehdi] Iran Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Tehran, Iran; [Raoufi, Mohammad] Univ Siegen, Phys Chem 1, Adolf Reichwein Str 2, D-57076 Siegen, Germany; [Raoufi, Mohammad] Univ Siegen, Res Ctr Micro & Nanochem C, Siegen, Germany		Raoufi, M (corresponding author), Univ Siegen, Phys Chem 1, Adolf Reichwein Str 2, D-57076 Siegen, Germany.	raoufi@chemie.uni-siegen.de		Sepand, Mohammad Reza/0000-0003-0849-989X			Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Akatsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043403; Ali MK, 2017, INT J BIOCHEM CELL B, V88, P181, DOI 10.1016/j.biocel.2017.05.003; Alvarez SW, 2017, NATURE, V551, P639, DOI 10.1038/nature24637; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Arezes J, 2015, INT J LAB HEMATOL, V37, P92, DOI 10.1111/ijlh.12358; Assali A, 2018, NANOMED-NANOTECHNOL, V14, P1891, DOI 10.1016/j.nano.2018.05.016; Avunduk AM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1368, DOI 10.1001/archopht.117.10.1368; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010; Behera SN, 2014, SCI TOTAL ENVIRON, V472, P947, DOI 10.1016/j.scitotenv.2013.11.063; Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Brown CW, 2019, DEV CELL, V51, P575, DOI 10.1016/j.devcel.2019.10.007; Chen H, 2017, TOXICOL RES-UK, V6, P215, DOI 10.1039/c6tx00378h; Chen H, 2015, INT IMMUNOPHARMACOL, V28, P707, DOI 10.1016/j.intimp.2015.07.029; Chen PH, 2020, CELL DEATH DIFFER, V27, P1008, DOI 10.1038/s41418-019-0393-7; Chen X., 2020, FRONT CELL DEV BIOL, V8; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021; Dai J, 2002, AM J RESP CELL MOL, V26, P685, DOI 10.1165/ajrcmb.26.6.4651; Daijo H., 2016, SCI REP-UK, V6, P1; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ebrahimi R, 2019, DARU, V27, P721, DOI 10.1007/s40199-019-00309-9; Fang XX, 2019, P NATL ACAD SCI USA, V116, P2672, DOI 10.1073/pnas.1821022116; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Ferrer E, 2011, EUR RESPIR J, V38, P617, DOI 10.1183/09031936.00105110; Gal K, 2011, CELL STRESS CHAPERON, V16, P369, DOI 10.1007/s12192-010-0249-z; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; GHIO AJ, 1994, AM J PHYSIOL, V266, pL382, DOI 10.1152/ajplung.1994.266.4.L382; Ghio AJ, 1997, J LAB CLIN MED, V129, P53, DOI 10.1016/S0022-2143(97)90161-X; Ghio AJ, 2015, CHEM RES TOXICOL, V28, P2104, DOI 10.1021/acs.chemrestox.5b00270; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Guo LL, 2016, LAB INVEST, V96, P218, DOI 10.1038/labinvest.2015.101; Hajipour MJ, 2019, CHEM REV, V119, P11352, DOI 10.1021/acs.chemrev.8b00323; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Hao YQ, 2015, ONCOL REP, V33, P2438, DOI 10.3892/or.2015.3828; Hassani S, 2020, J PHARM PHARM SCI, V23, P243, DOI 10.18433/jpps31171; Hassani S, 2013, FOOD ADDIT CONTAM A, V30, P413, DOI 10.1080/19440049.2012.761730; Hassannia B, 2018, J CLIN INVEST, V128, P3341, DOI 10.1172/JCI99032; Higashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107856; Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366; Hulina-Tomaskovic A, 2019, BIOCHIMIE, V156, P47, DOI 10.1016/j.biochi.2018.09.010; Hussain MS, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0158-5; Jamsai D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15874-9; Jiang L, 2012, J PATHOL, V228, P366, DOI 10.1002/path.4075; Johnson MD, 2009, CANCER EPIDEM BIOMAR, V18, P3263, DOI 10.1158/1055-9965.EPI-09-0965; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Keglowich L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089875; Kerins MJ, 2018, ANTIOXID REDOX SIGN, V29, P1756, DOI 10.1089/ars.2017.7176; Kim EH, 2018, CANCER LETT, V432, P180, DOI 10.1016/j.canlet.2018.06.018; Kolamunne RT, 2013, REDOX BIOL, V1, P418, DOI 10.1016/j.redox.2013.08.002; Koo JB, 2016, J TOXICOL SCI, V41, P77, DOI 10.2131/jts.41.77; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Kovacs K, 2012, FREE RADICAL BIO MED, V53, P1680, DOI 10.1016/j.freeradbiomed.2012.08.579; Kunzi L, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0205-3; Kwon MY, 2015, ONCOTARGET, V6, P24393, DOI 10.18632/oncotarget.5162; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Lin XX, 2014, TOXICOL MECH METHOD, V24, P575, DOI 10.3109/15376516.2014.956909; Ma S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.208; Maertens RM, 2013, TOXICOLOGY, V308, P60, DOI 10.1016/j.tox.2013.03.008; Maghsoudi AS, 2020, INT J NANOMED, V15, P2219, DOI 10.2147/IJN.S244315; Mahmoudi M., 2020, NANOMEDICINE ISCHEMI; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Martins TA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.571951; Meng P, 2020, ECOTOX ENVIRON SAFE, V194, DOI 10.1016/j.ecoenv.2020.110360; Messner B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.162; MORENO JJ, 1992, CHEM RES TOXICOL, V5, P116, DOI 10.1021/tx00025a020; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Muller T, 2012, CHEM RES TOXICOL, V25, P1805, DOI 10.1021/tx300145n; MUSSALORAUHAMAA H, 1986, ARCH ENVIRON HEALTH, V41, P49, DOI 10.1080/00039896.1986.9935765; Napolitano JR, 2012, AM J PHYSIOL-LUNG C, V302, pL909, DOI 10.1152/ajplung.00351.2011; Nickol AH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007911; Noguchi N, 2008, J CLIN BIOCHEM NUTR, V43, P131, DOI 10.3164/jcbn.2008068; Olea E, 2011, RESP PHYSIOL NEUROBI, V179, P305, DOI 10.1016/j.resp.2011.09.013; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Outten FW, 2009, ANTIOXID REDOX SIGN, V11, P1029, DOI [10.1089/ars.2008.2296, 10.1089/ARS.2008.2296]; Ozgur R, 2015, ANN BOT-LONDON, V116, P541, DOI 10.1093/aob/mcv072; Palazzolo DL, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00663; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Park EJ, 2019, TOXICOL LETT, V303, P55, DOI 10.1016/j.toxlet.2018.12.007; Parseghian MH, 2016, ANN NY ACAD SCI, V1374, P78, DOI 10.1111/nyas.13059; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Posso SV, 2018, INT IMMUNOPHARMACOL, V56, P330, DOI 10.1016/j.intimp.2018.01.045; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rahmani S, 2018, LIFE SCI, V214, P136, DOI 10.1016/j.lfs.2018.10.044; Reiszadeh-Jahromi S, 2019, NEUROCHEM RES, V44, P2482, DOI 10.1007/s11064-019-02865-7; ROBINSON JC, 1975, ARCH ENVIRON HEALTH, V30, P425, DOI 10.1080/00039896.1975.10666743; Rodgman A., 2013, CHEM COMPONENTS TOBA; Rohde P, 2004, NICOTINE TOB RES, V6, P119, DOI 10.1080/14622200310001656948; Sakhatskyy P, 2014, MICROVASC RES, V94, P80, DOI 10.1016/j.mvr.2014.05.003; Salek-Maghsoudi A, 2019, TOXICOLOGY, V411, P1, DOI 10.1016/j.tox.2018.10.014; Sepand M.R., ENVIRON RES; Sepand MR, 2020, NANOMED-NANOTECHNOL, V29, DOI 10.1016/j.nano.2020.102243; Sepand MR, 2020, NANOSCALE, V12, P4935, DOI 10.1039/c9nr08784b; Sepand MR, 2020, ENVIRON SCI POLLUT R, V27, P37488, DOI 10.1007/s11356-020-09360-5; Shadboorestan A, 2019, J APPL TOXICOL, V39, P375, DOI 10.1002/jat.3728; Shadboorestan A, 2016, J ENVIRON SCI HEAL C, V34, P187, DOI 10.1080/10590501.2016.1202756; Sheibani M, 2019, INFLAMMOPHARMACOLOGY, V27, P1071, DOI 10.1007/s10787-019-00586-5; Shibata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083725; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Smith LA, 2010, IMMUNOL RES, V46, P94, DOI 10.1007/s12026-009-8133-6; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Song C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175009; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Sukkar MB, 2017, J THORAC DIS, V9, P4825, DOI 10.21037/jtd.2017.10.153; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Suryadevara V, 2019, AM J PHYSIOL-LUNG C, V317, pL175, DOI 10.1152/ajplung.00320.2018; THOMPSON AB, 1991, J LAB CLIN MED, V117, P493; Toyokuni S, 2019, FREE RADICAL BIO MED, V133, P206, DOI 10.1016/j.freeradbiomed.2018.10.401; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wang GQ, 2017, AUTOPHAGY, V13, P1205, DOI 10.1080/15548627.2017.1301327; Wang Y, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.07.105; Wang Y, 2020, BIOCHEM BIOPH RES CO, V531, P581, DOI 10.1016/j.bbrc.2020.07.032; Wang YQ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00308; Wei S, 2020, J HAZARD MATER, V384, DOI 10.1016/j.jhazmat.2019.121390; West R, 2017, PSYCHOL HEALTH, V32, P1018, DOI 10.1080/08870446.2017.1325890; Wu TS, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00363-1; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Xu T, 2019, J CELL MOL MED, V23, P4900, DOI 10.1111/jcmm.14511; Yamaguchi Y, 2007, J PHARMACOL SCI, V103, P275, DOI 10.1254/jphs.FP0061055; Yan HF, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00428-9; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yatmark P, 2015, PHARMACOLOGY, V96, P192, DOI 10.1159/000438994; Yoshida M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10991-7; Yu KN, 2016, NICOTINE TOB RES, V18, P1877, DOI 10.1093/ntr/ntw079; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P838, DOI 10.1016/j.bbrc.2016.08.034; Zanganeh S, 2016, NAT NANOTECHNOL, V11, P986, DOI [10.1038/nnano.2016.168, 10.1038/NNANO.2016.168]; Zanganeh S, 2019, WIRES NANOMED NANOBI, V11, DOI 10.1002/wnan.1575; Zhou T, 2012, DALTON T, V41, P6371, DOI 10.1039/c2dt12159j	137	0	0	10	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 15	2021	281								119799	10.1016/j.lfs.2021.119799			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	TQ2AO	WOS:000678088200009	34229007				2022-02-06	
J	Wang, FJ; Darby, J				Wang, Fajun; Darby, Joseph			Case Report: Takotsubo Cardiomyopathy After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						case report; Takotsubo cardiomyopathy; traumatic brain injury; stress cardiomyopathy; TBI; diagnosis		Introduction: Takotsubo cardiomyopathy (TCM) or "stress cardiomyopathy" is an uncommon condition characterized by transient cardiac dysfunction with left ventricular apical ballooning in an appropriate clinical context. TCM has been observed in a variety of acute neurological conditions most prominently in patients with aneurysmal subarachnoid hemorrhage and status epilepticus. TCM has only been reported infrequently in association with traumatic brain injury (TBI). Herein we present a patient who developed TCM 3 days after hospital admission with severe TBI.</p> Case Presentation: A 30-year-old male presented to the hospital with an acute subdural hematoma, anisocoria, declining consciousness and CT evidence of uncal herniation after being found down in a hotel room. The patient was taken emergently to the operating room for decompressive hemicraniectomy and hematoma evacuation. On the post-trauma day (PTD) 3, the patient developed acute dyspnea with increased oxygen requirements that improved with diuresis. On PTD 4, nursing staff noted T waive inversions (TWI) on the bedside monitor prompting an electrocardiogram (ECG) that showed a prolonged QTc interval and worsening TWI in leads I, II, aVL, and V2-6. Troponin I level was mildly elevated at 0.63ng/mL. Transthoracic echocardiography (TTE) was subsequently performed and showed a low ejection fraction (EF 26%) with apical hypokinesis and basal hyperkinesis, consistent with TCM. A diagnosis of TCM was confirmed by Cardiology consultation and he was started on a beta-blocker and an ACE inhibitor. Follow-up TTE on PTD 20 showed a normal left ventricular EF.</p> Conclusion: While rarely reported in patients with TBI, TCM developed in an otherwise healthy young male following severe TBI necessitating decompressive hemicraniectomy. TTE should be considered in patients with TBI who have cardio-pulmonary symptoms or unexplained ECG abnormalities.</p>	[Wang, Fajun; Darby, Joseph] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA 15261 USA		Wang, FJ (corresponding author), Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA 15261 USA.	wangf5@upmc.edu			Department of Critical Care Medicine at University of Pittsburgh Medical center	Funding Department of Critical Care Medicine at University of Pittsburgh Medical center will support publication fee.	Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; Cheah CF, 2017, NEUROCRIT CARE, V26, P284, DOI 10.1007/s12028-016-0334-y; Cinotti R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02935-1; Deshmukh A, 2012, AM HEART J, V164, P66, DOI 10.1016/j.ahj.2012.03.020; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Galiuto L, 2010, EUR HEART J, V31, P1319, DOI 10.1093/eurheartj/ehq039; Ghadri JR, 2018, EUR HEART J, V39, P2047, DOI 10.1093/eurheartj/ehy077; Ghadri JR, 2018, EUR HEART J, V39, P2032, DOI 10.1093/eurheartj/ehy076; Klein C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05592-7; Krishnamoorthy Vijay, 2021, J Neurosurg Anesthesiol, DOI 10.1097/ANA.0000000000000772; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Morris NA, 2019, NEUROCRIT CARE, V30, P171, DOI 10.1007/s12028-018-0591-z; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Riley DS, 2017, J CLIN EPIDEMIOL, V89, P218, DOI 10.1016/j.jclinepi.2017.04.026; Schneider B, 2013, INT J CARDIOL, V166, P584, DOI 10.1016/j.ijcard.2011.11.027; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Wittstein IS, 2012, CELL MOL NEUROBIOL, V32, P847, DOI 10.1007/s10571-012-9804-8; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	18	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 15	2021	12								727754	10.3389/fneur.2021.727754			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY2BO	WOS:000701334600001	34603185	gold, Green Published			2022-02-06	
J	Wang, RR; He, M; Xu, JG				Wang, Ruoran; He, Min; Xu, Jianguo			The prognostic value of cardiac troponin T in different age groups of traumatic brain injury patients	ACTA NEUROLOGICA BELGICA			English	Article; Early Access						Troponin T; Traumatic brain injury; Marker; Prognosis	ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; ISCHEMIC-STROKE; SUBARACHNOID HEMORRHAGE; I LEVELS; DYSFUNCTION; ELEVATION; MORTALITY; BIOMARKER; IMPACT	Background The cardiac dysfunction has been confirmed as a common non-neurological complication and associated with increased mortality in traumatic brain injury (TBI) patients. As a biological marker of cardiac injury, the cardiac troponin T (TnT) has been verified correlated with the outcome of some non-traumatic brain injury patients. However, the prognostic value of TnT in TBI patients has not been clearly illustrated. We designed this study to explore the association between TnT and the outcome of TBI patients in different age subgroups. Methods Patients diagnosed with TBI in a prospective critical care database were eligible for this study. Univariate logistic regression analysis was firstly performed to explore the relationship between included variables and mortality. Then, the real effect of TnT on the outcome of different age subgroups was analyzed by multivariate logistic regression analysis adjusting the confounding effects of other significant risk factors. Finally, we draw receiver operating characteristic (ROC) curves to evaluate the prognostic value of TnT in different age groups of TBI patients. Results 520 patients were included in this study with a mortality rate of 20.2%. There were 112 (21.5%) non-elderly patients (age < 65) and 408 (78.5%) elderly patients (age >= 65). Non-survivors had a higher percentage of previous acute myocardial infarction (p = 0.019) and pupil no-reaction (p = 0.028; p = 0.011) than survivors. Survivors had higher GCS (p < 0.001) and lower TnT than non-survivors (p < 0.001). TnT was significantly associated with mortality in non-elderly patients (p = 0.031) but not in overall patients (p = 0.143) and elderly patients (p = 0.456) in multivariate logistic regression analysis. The AUC (area under the ROC curve) value of TnT in overall, non-elderly and elderly patients was 0.644, 0.693 and 0.632, respectively. Combining TnT with GCS increased the sensitivity of predicting the poor outcome in both non-elderly and elderly TBI patients. Conclusion The prognostic value of TnT differed between elderly and non-elderly TBI patients. Level of TnT was associated with mortality of non-elderly TBI patients but not elderly patients. Combining the TnT with GCS could increase the sensitivity of prognosis evaluation.	[Wang, Ruoran; Xu, Jianguo] Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China; [He, Min] Sichuan Univ, West China Hosp, Dept Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China		Xu, JG (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.; He, M (corresponding author), Sichuan Univ, West China Hosp, Dept Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.	hemin19910306@wchscu.cn; xujg@scu.edu.cn			1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University [ZYJC18007]; Key research and development project of science and technology department of Sichuan Province [2019YFS0392]	This study was funded by 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC18007) and Key research and development project of science and technology department of Sichuan Province (2019YFS0392).	Adamson PD, 2018, J AM COLL CARDIOL, V72, P1126, DOI 10.1016/j.jacc.2018.06.051; Alkhachroum AM, 2019, J CLIN NEUROSCI, V64, P83, DOI 10.1016/j.jocn.2019.04.005; Arnadottir A, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.13009; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Bender M, 2020, INJURY, V51, P1189, DOI 10.1016/j.injury.2020.01.002; Braun CK, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00477; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Decavele M, 2018, BRIT J ANAESTH, V120, P1158, DOI 10.1016/j.bja.2018.03.010; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duello KM, 2015, NEUROCRIT CARE, V23, P59, DOI 10.1007/s12028-014-0105-6; Edouard AR, 2004, ANESTHESIOLOGY, V101, P1262; El-Menyar A, 2019, WORLD NEUROSURG, V132, pE169, DOI 10.1016/j.wneu.2019.08.229; El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Fathil MFM, 2015, BIOSENS BIOELECTRON, V70, P209, DOI 10.1016/j.bios.2015.03.037; Gerner ST, 2018, CEREBROVASC DIS, V46, P72, DOI 10.1159/000492395; Gibbons PW, 2019, J CRIT CARE, V54, P130, DOI 10.1016/j.jcrc.2019.08.017; Hamm CW, 2002, CIRCULATION, V106, P2871, DOI 10.1161/01.CIR.0000044342.50593.63; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Hays A, 2006, NEUROLOGY, V66, P1330, DOI 10.1212/01.wnl.0000210523.22944.9b; He YC, 2020, CLIN CARDIOL, V43, P338, DOI 10.1002/clc.23320; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kenigsberg BB, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0999-7; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Kucher N, 2003, EUR HEART J, V24, P1651, DOI 10.1016/S0195-668X(03)00394-4; Lambert E, 2002, J NEUROL SCI, V198, P43, DOI 10.1016/S0022-510X(02)00073-4; Landesberg G, 2014, CRIT CARE MED, V42, P790, DOI 10.1097/CCM.0000000000000107; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Ng ACC, 2013, INT J CARDIOL, V165, P126, DOI 10.1016/j.ijcard.2011.07.107; Omar M, 2017, J CRIT CARE, V41, P1, DOI 10.1016/j.jcrc.2017.04.031; Peddada K, 2016, CEREBROVASC DIS, V42, P213, DOI 10.1159/000445526; Potocki M, 2012, HEART, V98, P558, DOI 10.1136/heartjnl-2011-301269; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Rajan GP, 2004, J TRAUMA, V57, P801, DOI 10.1097/01.TA.0000135157.93649.72; Reichlin T, 2012, AM J MED, V125, P1205, DOI 10.1016/j.amjmed.2012.07.015; Reiter M, 2012, EUR HEART J, V33, P988, DOI 10.1093/eurheartj/ehr376; Rimaz Siamak, 2019, Anesth Pain Med, V9, pe90858, DOI 10.5812/aapm.90858; Roongsritong C, 2004, CHEST, V125, P1877, DOI 10.1378/chest.125.5.1877; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Sandhu R, 2008, AM J CARDIOL, V102, P632, DOI 10.1016/j.amjcard.2008.04.036; Vallabhajosyula S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005930; VanHouten J, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0842-6; Venkata C, 2018, CLIN MED RES, V16, P57, DOI 10.3121/cmr.2018.1437; Xu MM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.697; Yaghi S, 2018, STROKE, V49, P121, DOI 10.1161/STROKEAHA.117.019395; Zhang LM, 2015, J STROKE CEREBROVASC, V24, P2375, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.030; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	51	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.												10.1007/s13760-021-01796-x		SEP 2021	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ6FB	WOS:000696156900001	34528158	Green Submitted			2022-02-06	
J	Zhang, WQ; Hong, J; Zhang, HW; Zheng, WC; Yang, Y				Zhang, Wenqian; Hong, Jun; Zhang, Hanwen; Zheng, Wencheng; Yang, Ying			Astrocyte-derived exosomes protect hippocampal neurons after traumatic brain injury by suppressing mitochondrial oxidative stress and apoptosis	AGING-US			English	Article						exosomes; astrocytes; traumatic brain injury; oxidative stress; apoptosis	SURVIVAL; DEFICITS; GLIA; BIOGENESIS; ACTIVATION; EXPRESSION; PATHWAY; ELEMENT	In this study, we investigated the mechanisms through which astrocyte-derived exosomes (AS-Exos) alleviate traumatic brain injury (TBI)-induced neuronal defects in TBI model rats and mice. Treatment with AS-Exos alleviated neurobehavioral deficits, cognitive impairment, and brain edema in TBI rats. AS-Exos also significantly reduced neuronal cell loss and atrophy in the TBI rats. AS-Exos significantly reduced oxidative stress and mitochondrial H2O2 levels by increasing the activity of antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT) in the hippocampal neurons of TBI rats. TUNEL-staining assays showed that AS-Exos significantly reduced TBI-induced neuronal apoptosis. Mechanistically, AS-Exos ameliorated oxidative stress by activating Nrf2/HO-1 signaling in the hippocampus of TBI rats. In addition, the neuroprotective effects of AS-Exos were abrogated in brain-specific Nrf2-knockout mice subjected to TBI. These findings demonstrate that AS-Exos protects against TBI-induced oxidative stress and neuronal apoptosis by activating Nrf2 signaling in both rat and mouse models.	[Zhang, Wenqian; Hong, Jun; Zhang, Hanwen] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China; [Zhang, Wenqian; Hong, Jun] Tangshan Gongren Hosp, Hebei Inst Head Trauma, Tangshan 063000, Hebei, Peoples R China; [Zhang, Hanwen] North China Univ Sci & Technol, Grad Univ, Tangshan 063000, Hebei, Peoples R China; [Zheng, Wencheng] Tangshan Gongren Hosp, Dept Cardiol, Tangshan 063000, Hebei, Peoples R China; [Yang, Ying] Tangshan Gongren Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China		Hong, J (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China.; Hong, J (corresponding author), Tangshan Gongren Hosp, Hebei Inst Head Trauma, Tangshan 063000, Hebei, Peoples R China.; Yang, Y (corresponding author), Tangshan Gongren Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China.	2633955818@qq.com; yangying1115@126.com			Provincial Natural Science Foundation of Hebei [H2021105003]	This work was supported by the Provincial Natural Science Foundation of Hebei (H2021105003).	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Chaudhuri AD, 2020, GLIA, V68, P128, DOI 10.1002/glia.23708; Chaudhuri AD, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0369-4; Chen W, 2020, J TISSUE ENG REGEN M, V14, P412, DOI 10.1002/term.3002; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cui CM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9245702; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Denzer K, 2000, J CELL SCI, V113, P3365; Dodson M, 2019, ANNU REV PHARMACOL, V59, P555, DOI 10.1146/annurev-pharmtox-010818-021856; Du L, 2021, NEUROTOXICOLOGY, V83, P28, DOI 10.1016/j.neuro.2020.12.006; DUGAN LL, 1995, J NEUROSCI, V15, P4545; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Finnie JW, 2014, VET RES COMMUN, V38, P297, DOI 10.1007/s11259-014-9616-z; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; Gilkerson R, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100126; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Guitart K, 2016, GLIA, V64, P896, DOI 10.1002/glia.22963; Han Y, 2020, DRUG DELIV, V27, P502, DOI 10.1080/10717544.2020.1745328; Hoang TT, 2019, J BIOL CHEM, V294, P15095, DOI 10.1074/jbc.RA119.008491; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Koch RE, 2017, BIOL REV, V92, P1459, DOI 10.1111/brv.12291; Laskowitz DT., 2016, TRANSLATIONAL RES TR, P97; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luarte A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040930; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Martins TS, 2021, J NEUROCHEM, V156, P162, DOI 10.1111/jnc.15112; Moidunny S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-198; Mustaly-Kalimi S, 2018, ANTIOXID REDOX SIGN, V29, P1158, DOI 10.1089/ars.2017.7266; National Research Counci, 2011, GUIDE CARE USE LAB A, V8, DOI 10.17226/12910; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Oswald MCW, 2018, FEBS LETT, V592, P679, DOI 10.1002/1873-3468.12972; Otero-Ortega L, 2018, J CEREBR BLOOD F MET, V38, P767, DOI 10.1177/0271678X17708917; Pandya JD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00605; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Saeed-Zidane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187569; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; Shi M, 2019, PROG NEUROBIOL, V175, P96, DOI 10.1016/j.pneurobio.2019.01.005; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Sonali, 2016, COLLOID SURFACE B, V147, P129, DOI 10.1016/j.colsurfb.2016.07.058; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6; Stelmashook EV, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050124; Vasile F, 2017, BRAIN STRUCT FUNCT, V222, P2017, DOI 10.1007/s00429-017-1383-5; Wang FY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6829271; Wang LF, 2021, EUR J NUTR, V60, P317, DOI 10.1007/s00394-020-02242-z; Wang SW, 2011, J NEUROSCI, V31, P7275, DOI 10.1523/JNEUROSCI.6476-10.2011; Wang T, 2020, BIOMATERIALS, V257, DOI 10.1016/j.biomaterials.2020.120264; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang LM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3753485; Zhang WQ, 2018, MED SCI MONITOR, V24, P1588, DOI 10.12659/MSM.905700	60	0	0	6	6	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	SEP 15	2021	13	17							21642				17	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	WC6XE	WOS:000704398100001	34516406	Green Published, gold			2022-02-06	
J	Zusman, BE; Dixon, CE; Jha, RM; Vagni, VA; Henchir, JJ; Carlson, SW; Janesko-Feldman, KL; Bailey, ZS; Shear, DA; Gilsdorf, JS; Kochanek, PM				Zusman, Benjamin E.; Dixon, C. Edward; Jha, Ruchira M.; Vagni, Vincent A.; Henchir, Jeremy J.; Carlson, Shaun W.; Janesko-Feldman, Keri L.; Bailey, Zachary S.; Shear, Deborah A.; Gilsdorf, Janice S.; Kochanek, Patrick M.			Choice of Whole Blood versus Lactated Ringer's Resuscitation Modifies the Relationship between Blood Pressure Target and Functional Outcome after Traumatic Brain Injury plus Hemorrhagic Shock in Mice	JOURNAL OF NEUROTRAUMA			English	Article						blood pressure target; controlled cortical impact; head injury; hypotension; polytrauma	FLUID RESUSCITATION; TRANSFUSION; PLASMA; THERAPY; IMPACT; SALINE; CELLS; GUIDELINES; PLATELET; EDEMA	Civilian traumatic brain injury (TBI) guidelines recommend resuscitation of patients with hypotensive TBI with crystalloids. Increasing evidence, however, suggests that whole blood (WB) resuscitation may improve physiological and survival outcomes at lower resuscitation volumes, and potentially at a lower mean arterial blood pressure (MAP), than crystalloid after TBI and hemorrhagic shock (HS). The objective of this study was to assess whether WB resuscitation with two different MAP targets improved behavioral and histological outcomes compared with lactated Ringer's (LR) in a mouse model of TBI+HS. Anesthetized mice (n = 40) underwent controlled cortical impact (CCI) followed by HS (MAP = 25-27 mm Hg; 25 min) and were randomized to five groups for a 90 min resuscitation: LR with MAP target of 70 mm Hg (LR70), LR60, WB70, WB60, and monitored sham. Mice received a 20 mL/kg bolus of LR or autologous WB followed by LR boluses (10 mL/kg) every 5 min for MAP below target. Shed blood was reinfused after 90 min. Morris Water Maze testing was performed on days 14-20 post-injury. Mice were euthanized (21 d) to assess contusion and total brain volumes. Latency to find the hidden platform was greater versus sham for LR60 (p < 0.002) and WB70 (p < 0.007) but not LR70 or WB60. The WB resuscitation did not reduce contusion volume or brain tissue loss. The WB targeting a MAP of 60 mm Hg did not compromise function versus a 70 mm Hg target after CCI+HS, but further reduced fluid requirements (p < 0.03). Using LR, higher achieved MAP was associated with better behavioral performance (rho = -0.67, p = 0.028). Use of WB may allow lower MAP targets without compromising functional outcome, which could facilitate pre-hospital TBI resuscitation.	[Zusman, Benjamin E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Bailey, Zachary S.; Shear, Deborah A.; Gilsdorf, Janice S.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD USA; [Dixon, C. Edward; Henchir, Jeremy J.; Carlson, Shaun W.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Vagni, Vincent A.; Janesko-Feldman, Keri L.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Dixon, C. Edward; Vagni, Vincent A.; Henchir, Jeremy J.; Carlson, Shaun W.; Janesko-Feldman, Keri L.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA		Kochanek, PM (corresponding author), John G Rangos Res Ctr, Safar Ctr Resuscitat Res, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.	kochanekpm@pitt.edu			DoDUnited States Department of Defense [W81XWH-17-C-006]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036, R01NS115815]	We would like to thank the DoD (W81XWH-17-C-006) for generous support. We also thank NIH NINDS (K23NS101036, R01NS115815 to R.M.J).	Alvikas J, 2020, J TRAUMA ACUTE CARE, V88, P847, DOI 10.1097/TA.0000000000002640; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Avery P, 2020, EMERG MED J, V37, P370, DOI 10.1136/emermed-2019-209040; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brockman EC, 2017, J NEUROTRAUM, V34, P1337, DOI 10.1089/neu.2016.4656; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Brotfain E, 2012, SHOCK, V38, P630, DOI 10.1097/SHK.0b013e318272d59f; Butler FK, 2017, WILD ENVIRON MED, V28, pS74, DOI 10.1016/j.wem.2016.12.007; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang R, 2017, CRIT CARE CLIN, V33, P15, DOI 10.1016/j.ccc.2016.08.007; Chesnut R M, 1995, New Horiz, V3, P366; Committee on Tactical Combat Casualty Care., 2018, TCCC GUID; Cotton BA, 2013, ANN SURG, V258, P527, DOI 10.1097/SLA.0b013e3182a4ffa0; Dar DE, 2010, SHOCK, V34, P75, DOI 10.1097/SHK.0b013e3181ce2cbc; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Gruen DS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135350; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; Leibowitz A, 2019, EUR J TRAUMA EMERG S, V45, P263, DOI 10.1007/s00068-018-0908-9; Maegele M, 2017, EUR J TRAUMA EMERG S, V43, P439, DOI 10.1007/s00068-017-0771-0; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Naumann DN, 2020, J TRAUMA ACUTE CARE, V89, P792, DOI 10.1097/TA.0000000000002840; Pivalizza EG, 2018, ANESTH ANALG, V127, P157, DOI 10.1213/ANE.0000000000003427; Pulliam KE, 2020, J TRAUMA ACUTE CARE, V89, P665, DOI 10.1097/TA.0000000000002839; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rowell SE, 2016, J NEUROTRAUM, V33, P1054, DOI 10.1089/neu.2014.3478; Seheult JN, 2018, TRANSFUSION, V58, P1838, DOI 10.1111/trf.14779; Seheult JN, 2018, TRANSFUSION, V58, P2280, DOI 10.1111/trf.14771; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Shackelford S., 2017, J SPEC OPER MED, V17, P130; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Stolla M, 2019, TRANSFUSION, V59, P1522, DOI 10.1111/trf.15169; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Weymouth W, 2019, J EMERG MED, V56, P491, DOI 10.1016/j.jemermed.2019.01.024; Wise R, 2017, WORLD J SURG, V41, P1170, DOI 10.1007/s00268-016-3865-7; Yazer MH, 2016, J TRAUMA ACUTE CARE, V81, P21, DOI 10.1097/TA.0000000000001100; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; Zehtabchi S, 2009, ACAD EMERG MED, V16, P371, DOI 10.1111/j.1553-2712.2009.00386.x; Zusman BE, 2021, NEUROCRIT CARE, V34, P781, DOI 10.1007/s12028-020-01084-1	48	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2907	2917		10.1089/neu.2021.0157		SEP 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000696019000001	34269621				2022-02-06	
J	Kontos, AP; Eagle, SR; Holland, CL; Thomas, D; Hickey, R; Santucci, C; Collins, MW				Kontos, Anthony P.; Eagle, Shawn R.; Holland, Cyndi L.; Thomas, Danny; Hickey, Robert; Santucci, Chris; Collins, Michael W.			Effects of the COVID-19 Pandemic on Patients with Concussion Presenting to a Specialty Clinic	JOURNAL OF NEUROTRAUMA			English	Article						concussion; COVID-19; pandemic; specialty care; telehealth		The purpose of this study is to examine the effects of the COVID-19 pandemic on patients presenting with concussion at a specialty clinic. This study used a retrospective cohort design to compare participants (n = 3021) with a suspected concussion, including a Pandemic cohort (n = 1139; March 2020-February 2021) and a Pre-Pandemic cohort (n = 1882; March 2019-February 2020). Concussions and patient characteristics including age, sex, days since injury, and injury mechanism were extracted from an electronic health record. There were 39.5% (n = 743) fewer concussions in Pandemic. Pandemic presented to the clinic 25.8 days later (p < 0.001) and were 1.9 years older (p < 0.001) than Pre-Pandemic. Sport-related concussions decreased 59.6% overall for Pandemic. Pandemic was associated with proportional increases of concussions involving recreational activities (odds ratio [OR] = 6.11; p < 0.001), motor vehicle collisions (OR = 1.39; p < 0.001), and falls/assaults (OR = 1.33; p < 0.001). A total of 9.4% (107/1139) of all Pandemic concussion initial clinical visits were performed using telehealth (0% in Pre-Pandemic). Concussion visit volume to a sub-specialty clinic decreased by approximately 40% during the COVID-19 pandemic and patients presented to the clinic nearly 1 month later. The increase in telehealth highlights the potential to expand clinical care outreach during the current and future pandemics or similar restrictive time periods.	[Kontos, Anthony P.; Eagle, Shawn R.; Holland, Cyndi L.; Santucci, Chris; Collins, Michael W.] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA 15203 USA; [Hickey, Robert] Univ Pittsburgh, Dept Pediat & Emergency Med, Pittsburgh, PA 15203 USA; [Thomas, Danny] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA		Kontos, AP (corresponding author), Univ Pittsburgh, 3850 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu			Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) - CDC/HHS	This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,200,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.	Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ortega R, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMvcm2014809; Rosenbaum L, 2020, NEW ENGL J MED, V382, P2368, DOI 10.1056/NEJMms2009984	11	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2918	2922		10.1089/neu.2021.0203		SEP 2021	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000695673400001	34405700				2022-02-06	
J	Lang, SS; Kilbaugh, T; Friess, S; Sotardi, S; Kim, CT; Mazandi, V; Zhang, BQ; Storm, PB; Heuer, GG; Tucker, A; Ampah, SB; Griffis, H; Raghupathi, R; Huh, JW				Lang, Shih-Shan; Kilbaugh, Todd; Friess, Stuart; Sotardi, Susan; Kim, Chong Tae; Mazandi, Vanessa; Zhang, Bingqing; Storm, Phillip B.; Heuer, Gregory G.; Tucker, Alexander; Ampah, Steve B.; Griffis, Heather; Raghupathi, Ramesh; Huh, Jimmy W.			Trajectory of Long-Term Outcome in Severe Pediatric Diffuse Axonal Injury: An Exploratory Study	FRONTIERS IN NEUROLOGY			English	Article						diffuse axonal injury (DAI); outcome; fever; intracranial hypertension (IH); traumatic brain injury; pediatric	TRAUMATIC BRAIN-INJURY; IMAGING DTI FINDINGS; RECOVERY 10 YEARS; HEAD-INJURY; INTRACRANIAL-PRESSURE; CHILDREN; CHILDHOOD; HYPERTHERMIA; TBI; ADOLESCENTS	Introduction: Pediatric severe traumatic brain injury (TBI) is one of the leading causes of disability and death. One of the classic pathoanatomic brain injury lesions following severe pediatric TBI is diffuse (multifocal) axonal injury (DAI). In this single institution study, our overarching goal was to describe the clinical characteristics and long-term outcome trajectory of severe pediatric TBI patients with DAI. Methods: Pediatric patients (<18 years of age) with severe TBI who had DAI were retrospectively reviewed. We evaluated the effect of age, sex, Glasgow Coma Scale (GCS) score, early fever >= 38.5 degrees C during the first day post-injury, the extent of ICP-directed therapy needed with the Pediatric Intensity Level of Therapy (PILOT) score, and MRI within the first week following trauma and analyzed their association with outcome using the Glasgow Outcome Score-Extended (GOS-E) scale at discharge, 6 months, 1, 5, and 10 years following injury. Results: Fifty-six pediatric patients with severe traumatic DAI were analyzed. The majority of the patients were >5 years of age and male. There were 2 mortalities. At discharge, 56% (30/54) of the surviving patients had unfavorable outcome. Sixty five percent (35/54) of surviving children were followed up to 10 years post-injury, and 71% (25/35) of them made a favorable recovery. Early fever and extensive DAI on MRI were associated with worse long-term outcomes. Conclusion: We describe the long-term trajectory outcome of severe pediatric TBI patients with pure DAI. While this was a single institution study with a small sample size, the majority of the children survived. Over one-third of our surviving children were lost to follow-up. Of the surviving children who had follow-up for 10 years after injury, the majority of these children made a favorable recovery.	[Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.; Tucker, Alexander] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Neurosurg,Dept Neurosurg, Philadelphia, PA 19104 USA; [Kilbaugh, Todd; Mazandi, Vanessa; Huh, Jimmy W.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Friess, Stuart] Washington Univ, St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63110 USA; [Sotardi, Susan] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Radiol & Pediat, Philadelphia, PA 19104 USA; [Kim, Chong Tae] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Phys Med & Rehabil & Pediat, Philadelphia, PA 19104 USA; [Zhang, Bingqing; Ampah, Steve B.; Griffis, Heather] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Data Sci & Biostat Unit, Philadelphia, PA 19104 USA; [Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA		Lang, SS (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Neurosurg,Dept Neurosurg, Philadelphia, PA 19104 USA.	chens4@chop.edu					Abu Hamdeh S, 2019, J NEUROSURG, V131, P604, DOI 10.3171/2018.4.JNS18185; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; GENTRY LR, 1994, RADIOLOGY, V191, P1; Keenan HT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.2624; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2017, CRIT CARE MED, V45, P305, DOI 10.1097/CCM.0000000000002182; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; Lindsey HM, 2020, BRAIN IMAGING BEHAV, V14, P1626, DOI 10.1007/s11682-019-00093-9; Lovett ME, 2018, J NEUROSURG-PEDIATR, V21, P164, DOI 10.3171/2017.8.PEDS17104; Majdan M, 2014, J NEUROTRAUM, V31, P1046, DOI 10.1089/neu.2013.3200; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Meinert E, 2018, PEDIATR CRIT CARE ME, V19, P345, DOI 10.1097/PCC.0000000000001471; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rosario BL, 2018, PEDIATR CRIT CARE ME, V19, P957, DOI 10.1097/PCC.0000000000001676; Ryan NP, 2019, ANN PHYS REHABIL MED, V62, P342, DOI 10.1016/j.rehab.2019.06.014; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Valera EM, 2021, J HEAD TRAUMA REHAB, V36, pE1, DOI 10.1097/HTR.0000000000000652; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857	68	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 14	2021	12								704576	10.3389/fneur.2021.704576			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WD7EL	WOS:000705100200001	34594294	Green Published, gold			2022-02-06	
J	Yuan, WH; Diekfuss, JA; Foss, KDB; Dudley, JA; Leach, JL; Narad, ME; DiCesare, CA; Bonnette, S; Epstein, JN; Logan, K; Altaye, M; Myer, GD				Yuan, Weihong; Diekfuss, Jed A.; Foss, Kim D. Barber; Dudley, Jonathan A.; Leach, James L.; Narad, Megan E.; DiCesare, Christopher A.; Bonnette, Scott; Epstein, Jeffery N.; Logan, Kelsey; Altaye, Mekibib; Myer, Gregory D.			High School Sports-Related Concussion and the Effect of a Jugular Vein Compression Collar: A Prospective Longitudinal Investigation of Neuroimaging and Neurofunctional Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						DTI; graph theory; neck collar; network organization; sports-related concussion; white matter	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; WORKING-MEMORY; SEASON; HEAD; ACTIVATION; NETWORKS; CHILDREN; DIFFUSE	Sports-related concussion (SRC) can exert serious acute and long-term consequences on brain microstructure, function, and behavioral outcomes. We aimed to quantify the alterations in white matter (WM) microstructure and global network organization, and the decrements in behavioral and cognitive outcomes from pre-season to post-concussion in youth athletes who experienced SRC. We also aimed to evaluate whether wearing a jugular compression neck collar, a device designed to mitigate brain "slosh" injury, would mitigate the pre-season to post-concussion alterations in neuroimaging, behavioral, and cognitive outcomes. A total of 488 high school football and soccer athletes (14-18 years old) were prospectively enrolled and assigned to the non-collar group (n = 237) or the collar group (n = 251). The outcomes of the study were the pre-season to post-concussion neuroimaging, behavioral, and cognitive alterations. Forty-six participants (non-collar: n = 24; collar: n = 22) were diagnosed with a SRC during the season. Forty of these 46 athletes (non-collar: n = 20; collar: n = 20) completed neuroimaging assessment. Significant pre-season to post-concussion alterations in WM microstructural integrity and brain network organization were found in these athletes (corrected p < 0.05). The alterations were significantly reduced in collar-wearing athletes compared to non-collar-wearing athletes (corrected p < 0.05). Concussion and collar main effects were identified for some of the behavioral and cognitive outcomes, but no collar by SRC interaction effects were observed in any outcomes. In summary, young athletes exhibited significant WM microstructural and network organizational, and cognitive alterations following SRC. The use of the jugular vein compression collar showed promising evidence to reduce these alterations in high school contact sport athletes.	[Yuan, Weihong; Dudley, Jonathan A.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, 3333 Burnet Ave,MLC 5033, Cincinnati, OH 45229 USA; [Diekfuss, Jed A.; Foss, Kim D. Barber; Myer, Gregory D.] Emory Sports Performance & Res Ctr, Flowery Branch, GA USA; [Diekfuss, Jed A.; Foss, Kim D. Barber; Myer, Gregory D.] Emory Univ, Sch Med, Dept Orthopaed, Atlanta, GA USA; [Leach, James L.; Epstein, Jeffery N.] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Yuan, Weihong; Leach, James L.] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA; [Narad, Megan E.; Epstein, Jeffery N.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [DiCesare, Christopher A.; Bonnette, Scott; Logan, Kelsey] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Narad, Megan E.; Epstein, Jeffery N.; Logan, Kelsey; Altaye, Mekibib] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Logan, Kelsey] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Myer, Gregory D.] Emory Sports Med Ctr, Atlanta, GA USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Yuan, WH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, 3333 Burnet Ave,MLC 5033, Cincinnati, OH 45229 USA.	weihong.yuan@cchmc.org	DiCesare, Christopher/AAA-3327-2021	DiCesare, Christopher/0000-0002-6576-4904	Q30 Sports Innovations, LLC	Q30 Sports Innovations, LLC funded Cincinnati Children's Hospital Medical Center for the parent Clinical Trial testing the effects of the jugular vein compression on brain health outcomes.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Churchill NW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58073-9; Cubon VA, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1165; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Diekfuss JA, 2021, J NEUROSCI RES, V99, P423, DOI 10.1002/jnr.24727; GILLAND O, 1969, AMER J ROENTGENOL RA, V106, P369, DOI 10.2214/ajr.106.2.369; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamish O., 2017, BRIT J SPORT MED, V51, pA4, DOI DOI 10.1136/BJSPORTS-2016-097270.8; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mac Donald CL, 2019, J NEUROTRAUM, V36, P264, DOI 10.1089/neu.2018.5629; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	41	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2811	2821		10.1089/neu.2021.0141		SEP 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000695675900001	34375130				2022-02-06	
J	Zhang, KL; Chai, B; Ji, H; Chen, LQ; Ma, YB; Zhu, LF; Xu, JY; Wu, YQ; Lan, YA; Li, H; Feng, ZG; Xiao, J; Zhang, HY; Xu, K				Zhang, Kailun; Chai, Bo; Ji, Hao; Chen, Liuqing; Ma, Yanbing; Zhu, Lifei; Xu, Jingyu; Wu, Yanqing; Lan, Yinan; Li, Hao; Feng, Zhiguo; Xiao, Jian; Zhang, Hongyu; Xu, Ke			Bioglass promotes wound healing by inhibiting endothelial cell pyroptosis through regulation of the connexin 43/reactive oxygen species (ROS) signaling pathway	LABORATORY INVESTIGATION			English	Article							STEM-CELLS; TISSUE; ANGIOGENESIS; IMPROVES; VASCULARIZATION; INFLAMMASOMES; COMPOSITES; CONSTRUCTS; INJURY; BRAIN	Bioactive glass (BG) has recently shown great promise in soft tissue repair, especially in wound healing; however, the underlying mechanism remains unclear. Pyroptosis is a novel type of programmed cell death that is involved in various traumatic injury diseases. Here, we hypothesized that BG may promote wound healing through suppression of pyroptosis. To test this scenario, we investigated the possible effect of BG on pyroptosis in wound healing both in vivo and in vitro. This study showed that BG can accelerate wound closure, granulation formation, collagen deposition, and angiogenesis. Moreover, western blot analysis and immunofluorescence staining revealed that BG inhibited the expression of pyroptosis-related proteins in vivo and in vitro. In addition, while BG regulated the expression of connexin43 (Cx43), it inhibited reactive oxygen species (ROS) production. Cx43 activation and inhibition experiments further indicate that BG inhibited pyroptosis in endothelial cells by decreasing Cx43 expression and ROS levels. Taken together, these studies suggest that BG promotes wound healing by inhibiting pyroptosis via Cx43/ROS signaling pathway. In this study, the authors demonstrated that bioactive glass promotes granulation formation, collagen deposition and angiogenesis to accelerate wound healing. Bioactive glass down-regulaties the connexin 43/reactive oxygen species signaling pathway to inhibit endothelial cell pyroptosis in vitro and in vivo.	[Zhang, Kailun; Ji, Hao; Chen, Liuqing; Ma, Yanbing; Xu, Jingyu; Wu, Yanqing; Xu, Ke] Wenzhou Univ, Biomed Collaborat Innovat Ctr Wenzhou, Inst Life Sci, Engn Lab Zhejiang Prov Pharmaceut Dev Growth Fact, Wenzhou, Zhejiang, Peoples R China; [Chai, Bo; Zhu, Lifei; Feng, Zhiguo; Xiao, Jian; Zhang, Hongyu] Wenzhou Med Univ, Sch Pharmaceut Sci, Cixi Biomed Res Inst, Wenzhou Wound Repair & Regenerat Key Lab, Wenzhou, Zhejiang, Peoples R China; [Lan, Yinan] Wenzhou Med Univ, Lishui Cent Hosp, Dept Orthoped Surg, Affiliated Hosp 5, Wenzhou, Zhejiang, Peoples R China; [Li, Hao] Wenzhou Med Univ, Lishui Peoples Hosp, Dept Orthoped Surg, Affiliated Hosp 6, Lishui, Zhejiang, Peoples R China		Xu, K (corresponding author), Wenzhou Univ, Biomed Collaborat Innovat Ctr Wenzhou, Inst Life Sci, Engn Lab Zhejiang Prov Pharmaceut Dev Growth Fact, Wenzhou, Zhejiang, Peoples R China.; Xiao, J; Zhang, HY (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Cixi Biomed Res Inst, Wenzhou Wound Repair & Regenerat Key Lab, Wenzhou, Zhejiang, Peoples R China.	xfxj2000@126.com; st_hyz@126.com; godxu1987@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802251, 81772450, 81801233]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LQ18H150003, LQ18H090011, LY19H150001 LY17H090014, LWY20H310001]; Zhejiang Provincial Medical and Health Science and Technology Fund [2018KY186]; Wenzhou science and technology innovation project [ZY2020023, ZY2020026]	This study was jointly supported by the National Natural Science Foundation of China (81802251, 81772450, and 81801233), Zhejiang Provincial Natural Science Foundation of China (LQ18H150003, LQ18H090011, LY19H150001 LY17H090014, and LWY20H310001), Zhejiang Provincial Medical and Health Science and Technology Fund (2018KY186), and Wenzhou science and technology innovation project (ZY2020023 and ZY2020026).	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Butera JA, 2009, J MED CHEM, V52, P908, DOI 10.1021/jm801558d; Cheng ST, 2008, BIOMATERIALS, V29, P4187, DOI 10.1016/j.biomaterials.2008.07.022; Dai WY, 2019, INT IMMUNOPHARMACOL, V66, P215, DOI 10.1016/j.intimp.2018.11.029; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; Ding H, 2020, AM J TRANSL RES, V12, P4326; Dong X, 2017, J MATER CHEM B, V5, P5240, DOI 10.1039/c7tb01211j; El-Gendy R, 2015, TISSUE ENG PT A, V21, P2034, DOI 10.1089/ten.tea.2014.0485; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Gao K, 2015, J CELL MOL MED, V19, P2469, DOI 10.1111/jcmm.12641; Garcia MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029181; Handel M, 2013, TISSUE ENG PT A, V19, P2703, DOI [10.1089/ten.tea.2012.0707, 10.1089/ten.TEA.2012.0707]; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Hench LL, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00194; Hou GQ, 2007, CANCER LETT, V253, P236, DOI 10.1016/j.canlet.2007.01.026; Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5; Hu XL, 2020, INT J BIOL SCI, V16, P2042, DOI 10.7150/ijbs.45467; Huang YR, 2019, ANTIOXID REDOX SIGN, V31, P1194, DOI 10.1089/ars.2018.7636; Jia C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2021-3; Jia SJ, 2006, VASC PHARMACOL, V44, P143, DOI 10.1016/j.vph.2005.09.005; Kim D, 2018, EXP EYE RES, V173, P85, DOI 10.1016/j.exer.2018.05.003; Kong LZ, 2018, ACS APPL MATER INTER, V10, P30103, DOI 10.1021/acsami.8b09191; Kumar A, 2017, J MATER CHEM B, V5, P8786, DOI 10.1039/c7tb01738c; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; Li HY, 2016, BIOMATERIALS, V84, P64, DOI 10.1016/j.biomaterials.2016.01.033; Li XJ, 2015, GLIA, V63, P1553, DOI 10.1002/glia.22826; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lopez-Pastrana J, 2015, J BIOL CHEM, V290, P17485, DOI 10.1074/jbc.M115.641191; Lu FF, 2020, J CELL PHYSIOL, V235, P3207, DOI 10.1002/jcp.29268; Lyu ZL, 2014, NANOSCALE, V6, P6959, DOI 10.1039/c4nr01540a; Ma JW, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-019-1036-y; Ma ZJ, 2020, ACS APPL MATER INTER, V12, P29787, DOI 10.1021/acsami.0c06360; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Mena HA, 2016, J THROMB HAEMOST, V14, P397, DOI 10.1111/jth.13223; Montgomery J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061778; Naseri S, 2017, J MATER CHEM B, V5, P6167, DOI 10.1039/c7tb01221g; Okamoto T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06463-x; Opneja A, 2019, THROMB RES, V179, P56, DOI 10.1016/j.thromres.2019.05.001; Patin J, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104922; Rizwan M, 2017, J BIOMED MATER RES A, V105, P3197, DOI 10.1002/jbm.a.36156; Rodrigues C, 2019, MAT SCI ENG C-MATER, V103, DOI 10.1016/j.msec.2019.109781; Shi Q, 2015, DEV CELL, V35, P483, DOI 10.1016/j.devcel.2015.10.014; Sun ZZ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7879629; Tang YS, 2019, INFLAMM RES, V68, P727, DOI 10.1007/s00011-019-01256-6; Thuringer D, 2016, ONCOTARGET, V7, P28160, DOI 10.18632/oncotarget.8583; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081; Wang SQ, 2020, NANO LETT, V20, P5149, DOI 10.1021/acs.nanolett.0c01371; Wu CX, 2020, BIOMED MATER, V15, DOI 10.1088/1748-605X/ab9421; Wu XX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0257-3; Wu Z, 2021, BIOACT MATER, V6, P823, DOI 10.1016/j.bioactmat.2020.09.011; Xu K, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8586314; Xue YS, 2019, TRENDS IMMUNOL, V40, P1035, DOI 10.1016/j.it.2019.09.005; Yang KL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00888; Yu HF, 2016, ACS APPL MATER INTER, V8, P703, DOI 10.1021/acsami.5b09853; Zhou B, 2018, CELL RES, V28, P1171, DOI 10.1038/s41422-018-0090-y; Zhou YL, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800144; Zou JL, 2017, CELL PHYSIOL BIOCHEM, V42, P1812, DOI 10.1159/000479537; Zou Xiao-rong, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P684; Zou ZW, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/7854389	63	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JAN	2022	102	1					90	101		10.1038/s41374-021-00675-6		SEP 2021	12	Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pathology	XT9VZ	WOS:000695765600002	34521991				2022-02-06	
J	Connolly, LJ; Ponsford, JL; Rajaratnam, SMW; Lockley, SW				Connolly, Laura J.; Ponsford, Jennie L.; Rajaratnam, Shantha M. W.; Lockley, Steven W.			Development of a Home-Based Light Therapy for Fatigue Following Traumatic Brain Injury: Two Case Studies	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; stroke; light therapy; fatigue; sleepiness; sleep disturbance; blue light; melanopsin	RANDOMIZED CONTROLLED-TRIAL; SLEEP DISTURBANCE; DAYTIME SLEEPINESS; REST-ACTIVITY; BRIGHT LIGHT; QUALITY; INSOMNIA; MOOD; PARTICIPATION; DISORDERS	Background and Objectives: Fatigue and sleep disturbance negatively impact quality of life following brain injury and there are no established treatments. Building on research showing efficacy of blue light therapy delivered via a lightbox in reducing fatigue and daytime sleepiness after traumatic brain injury (TBI), this paper describes the development and implementation of a novel in-home light therapy to alleviate fatigue and sleep disturbance in two case studies. Methods: During the 8-week lighting intervention, participants' home lighting was adjusted to provide high intensity, blue-enriched (high melanopic) light all day as a stimulant and dimmer, blue-depleted (low melanopic) light for 3 h before sleep as a soporific. The sham 8-week control condition resembled participants' usual (baseline) lighting conditions (3,000-4,000 K all day). Lighting conditions were crossed-over. Outcomes were measures of fatigue, subjective daytime sleepiness, sleep quality, insomnia symptoms, psychomotor vigilance and mood. Case study participants were a 35-year old male (5 years post-TBI), and a 46-year-old female (22 years post-TBI). Results: The relative proportion of melanopic lux was greater in Treatment lighting than Control during daytime, and lower during evenings. Participants found treatment to be feasible to implement, and was well-tolerated with no serious side effects noted. Self-reported compliance was > 70%. Both cases demonstrated reduced fatigue, sleep disturbance and insomnia symptoms during the treatment lighting intervention. Case 2 additionally showed reductions in daytime sleepiness and depressive symptoms. As expected, symptoms trended toward baseline levels during the control condition. Discussion: Treatment was positively received and compliance rates were high, with no problematic side-effects. Participants expressed interest in continuing the ambient light therapy in their daily lives. Conclusions: These cases studies demonstrate the acceptability and feasibility of implementing a personalized in-home dynamic light treatment for TBI patients, with evidence for efficacy in reducing fatigue and sleep disturbance.	[Connolly, Laura J.; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Connolly, Laura J.; Ponsford, Jennie L.; Rajaratnam, Shantha M. W.; Lockley, Steven W.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA		Connolly, LJ (corresponding author), Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.; Connolly, LJ (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia.	laura.connolly@monash.edu		Rajaratnam, Shantha/0000-0001-7527-8558	Summer Foundation; Monash UniversityMonash University; Epworth HealthCare	This work was supported by funding from The Summer Foundation, Monash University, and Epworth HealthCare. The lighting used in the study was purchased from commercial retailers. The choice of lamps used was based on availability, the appropriate spectrum, cost and compatibility with existing fixtures.	Anderson JL, 2009, ACTA PSYCHIAT SCAND, V120, P203, DOI 10.1111/j.1600-0447.2009.01345.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Chang YJ, 2007, SUPPORT CARE CANCER, V15, P891, DOI 10.1007/s00520-007-0219-x; Chellappa SL, 2013, J SLEEP RES, V22, P573, DOI 10.1111/jsr.12050; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Connolly LJ, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02292-8; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Figueiro MG, 2019, J CLIN SLEEP MED, V15, P1757, DOI 10.5664/jcsm.8078; Figueiro MG, 2014, CLIN INTERV AGING, V9, P1527, DOI 10.2147/CIA.S68557; Glickman G, 2006, BIOL PSYCHIAT, V59, P502, DOI 10.1016/j.biopsych.2005.07.006; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Herf M., 2009, FLUX; Hopkins S, 2017, CURR ALZHEIMER RES, V14, P1053, DOI 10.2174/1567205014666170608091119; Jeste N, 2013, QUAL LIFE RES, V22, P1239, DOI 10.1007/s11136-012-0243-2; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kersey J, 2020, BRAIN INJURY, V34, P708, DOI 10.1080/02699052.2020.1757153; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Liu LQ, 2005, SUPPORT CARE CANCER, V13, P1010, DOI 10.1007/s00520-005-0824-5; Lockley SW, 2006, CURR BIOL, V16, pR795, DOI 10.1016/j.cub.2006.08.039; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rahman SA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89494; Raikes AC, 2020, J HEAD TRAUMA REHAB, V35, pE405, DOI 10.1097/HTR.0000000000000579; Riemersma-van Der Lek RF, 2008, JAMA-J AM MED ASSOC, V299, P2642, DOI 10.1001/jama.299.22.2642; Salva MAQ, 2020, J HEAD TRAUMA REHAB, V35, pE78, DOI 10.1097/HTR.0000000000000500; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Srisurapanont K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246172; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Wahnschaffe A, 2017, CURR ALZHEIMER RES, V14, P1076, DOI 10.2174/1567205014666170608092411; West A, 2019, NEUROREHABILITATION, V45, P187, DOI 10.3233/NRE-192752; Wilhelmsen-Langeland A, 2013, J BIOL RHYTHM, V28, P306, DOI 10.1177/0748730413500126; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 13	2021	12								651498	10.3389/fneur.2021.651498			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UZ7GH	WOS:000702369800001	34589041	gold, Green Published			2022-02-06	
J	Hergenroeder, GW; Yokobori, S; Choi, HA; Schmitt, K; Detry, MA; Schmitt, LH; McGlothlin, A; Puccio, AM; Jagid, J; Kuroda, Y; Nakamura, Y; Suehiro, E; Ahmad, F; Viele, K; Wilde, EA; McCauley, SR; Kitagawa, RS; Temkin, NR; Timmons, SD; Diringer, MN; Dash, PK; Bullock, R; Okonkwo, DO; Berry, DA; Kim, DH				Hergenroeder, Georgene W.; Yokobori, Shoji; Choi, Huimahn Alex; Schmitt, Karl; Detry, Michelle A.; Schmitt, Lisa H.; McGlothlin, Anna; Puccio, Ava M.; Jagid, Jonathan; Kuroda, Yasuhiro; Nakamura, Yukihiko; Suehiro, Eiichi; Ahmad, Faiz; Viele, Kert; Wilde, Elisabeth A.; McCauley, Stephen R.; Kitagawa, Ryan S.; Temkin, Nancy R.; Timmons, Shelly D.; Diringer, Michael N.; Dash, Pramod K.; Bullock, Ross; Okonkwo, David O.; Berry, Donald A.; Kim, Dong H.			Hypothermia for Patients Requiring Evacuation of Subdural Hematoma: A Multicenter Randomized Clinical Trial	NEUROCRITICAL CARE			English	Article; Early Access						Hypothermia (induced); Hematoma (subdural); Brain injuries (traumatic)	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; WHOLE-BODY HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; BIOMARKERS; CARE; METAANALYSES; TEMPERATURE; HEMORRHAGE	Background Hypothermia is neuroprotective in some ischemia-reperfusion injuries. Ischemia-reperfusion injury may occur with traumatic subdural hematoma (SDH). This study aimed to determine whether early induction and maintenance of hypothermia in patients with acute SDH would lead to decreased ischemia-reperfusion injury and improve global neurologic outcome. Methods This international, multicenter randomized controlled trial enrolled adult patients with SDH requiring evacuation of hematoma within 6 h of injury. The intervention was controlled temperature management of hypothermia to 35 degrees C prior to dura opening followed by 33 degrees C for 48 h compared with normothermia (37 degrees C). Investigators randomly assigned patients at a 1:1 ratio between hypothermia and normothermia. Blinded evaluators assessed outcome using a 6-month Glasgow Outcome Scale Extended score. Investigators measured circulating glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 levels. Results Independent statisticians performed an interim analysis of 31 patients to assess the predictive probability of success and the Data and Safety Monitoring Board recommended the early termination of the study because of futility. Thirty-two patients, 16 per arm, were analyzed. Favorable 6-month Glasgow Outcome Scale Extended outcomes were not statistically significantly different between hypothermia vs. normothermia groups (6 of 16, 38% vs. 4 of 16, 25%; odds ratio 1.8 [95% confidence interval 0.39 to infinity], p = .35). Plasma levels of glial fibrillary acidic protein (p = .036), but not ubiquitin C-terminal hydrolase L1 (p = .26), were lower in the patients with favorable outcome compared with those with unfavorable outcome, but differences were not identified by temperature group. Adverse events were similar between groups. Conclusions This trial of hypothermia after acute SDH evacuation was terminated because of a low predictive probability of meeting the study objectives. There was no statistically significant difference in functional outcome identified between temperature groups.	[Hergenroeder, Georgene W.; Choi, Huimahn Alex; Schmitt, Karl; Schmitt, Lisa H.; Kitagawa, Ryan S.; Dash, Pramod K.; Kim, Dong H.] Univ Texas, Hlth Sci Ctr, Vivian L Smith Dept Neurosurg, McGovern Med Sch, 6431 Fannin St,MSB 7156, Houston, TX 77030 USA; [Hergenroeder, Georgene W.; Choi, Huimahn Alex; Schmitt, Karl; Schmitt, Lisa H.; Kitagawa, Ryan S.; Kim, Dong H.] Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA; [Yokobori, Shoji] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Detry, Michelle A.; McGlothlin, Anna; Viele, Kert; Berry, Donald A.] Stat & Software Team, Berry Consultants, Austin, TX USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Jagid, Jonathan; Bullock, Ross] Univ Miami, Jackson Mem Hosp, Dept Neurol Surg, Miami, FL USA; [Kuroda, Yasuhiro] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Miki, Kagawa, Japan; [Nakamura, Yukihiko] Kurume Univ Hosp, Emergency & Crit Care Med, Fukuoka, Japan; [Suehiro, Eiichi] Yamaguchi Univ, Dept Neurosurg, Yamaguchi, Japan; [Ahmad, Faiz] Emory Univ, Sch Med, Grady Mem Hosp, Dept Neurol Surg, Atlanta, GA USA; [Wilde, Elisabeth A.; McCauley, Stephen R.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX USA; [Kitagawa, Ryan S.; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA USA; [Timmons, Shelly D.] Indiana Univ Sch Med, Indiana Univ Hlth, Dept Neurol Surg, Indianapolis, IN USA; [Diringer, Michael N.] Washington Univ, Sch Med, Dept Neurol Neurol Surg Anesthesiol & Occupat The, St Louis, MO USA; [Dash, Pramod K.] Univ Texas, Hlth Sci Ctr, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX USA		Hergenroeder, GW (corresponding author), Univ Texas, Hlth Sci Ctr, Vivian L Smith Dept Neurosurg, McGovern Med Sch, 6431 Fannin St,MSB 7156, Houston, TX 77030 USA.	Georgene.W.Hergenroeder@uth.tmc.edu			Vivian L. Smith Foundation for Neurologic Research; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [JP26293386]; National Institutes of Health/National Center for Advancing Translational Sciences (NIH/NCATS) grants [UL1 TR000445, UL1 TR001105, UL1 TR000371]	The Vivian L. Smith Foundation for Neurologic Research (DHK) and Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) Program (B) Grant number JP26293386 (SY) provided the funding for the trial. ZOLL Circulation Inc provided Quattro catheters, Thermogard devices, training, and technical support. ZOLL Circulation Inc was not involved with the design of the study or the analysis or interpretation of the data. This work was supported by National Institutes of Health/National Center for Advancing Translational Sciences (NIH/NCATS) grants UL1 TR000445, UL1 TR001105 and UL1 TR000371. Study data were collected and managed using Research Electronic Data Capture tools hosted at The University of Texas School of Biomedical Informatics at Houston. Research Electronic Data Capture is a secure, Web-based application designed to support data capture for research studies, providing (1) an intuitive interface for validated data entry, (2) audit trails for tracking data manipulation and export procedures, (3) automated export procedures for seamless data downloads to common statistical packages, and (4) procedures for importing data from external sources [49].	Anderson TN, 2020, J TRAUMA ACUTE CARE, V89, P80, DOI 10.1097/TA.0000000000002706; Andrews PJD, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22450; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Broessner G, 2009, STROKE, V40, pE657, DOI 10.1161/STROKEAHA.109.557652; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TBI REL EM DEP VIS H; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Ebner F, 2020, RESUSCITATION, V154, P61, DOI 10.1016/j.resuscitation.2020.05.016; Fischer M, 2011, NEUROSURGERY, V68, P867, DOI 10.1227/NEU.0b013e318208f5fb; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Greer DM, 2021, NEUROCRIT CARE, V35, P577, DOI 10.1007/s12028-021-01208-1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972; Lascarrou JB, 2019, NEW ENGL J MED, V381, P2327, DOI 10.1056/NEJMoa1906661; Liu H, 2019, P NATL ACAD SCI USA, V116, P4643, DOI 10.1073/pnas.1821282116; Marion DW, 2006, NEUROSURGERY, V58, P655; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 2001, CURR PHARM DESIGN, V7, P1533, DOI 10.2174/1381612013397302; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; NCI NIH 2010. US National Institutes of Health Cancer Institute, COMMON TERMINOLOGY C; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Olah E, 2018, J NEUROTRAUM, V35, P2407, DOI 10.1089/neu.2018.5649; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yokobori S, 2016, METHODS MOL BIOL, V1462, P413, DOI 10.1007/978-1-4939-3816-2_23; Yokobori Shoji, 2013, Acta Neurochir Suppl, V118, P77, DOI 10.1007/978-3-7091-1434-6_13; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725	49	0	0	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01334-w		SEP 2021	13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UP4UT	WOS:000695377900002	34518968	hybrid			2022-02-06	
J	Lindsey, A; Coelho, C				Lindsey, Andre; Coelho, Carl			Passive Elaborative Cueing of Retrieval ProcessesFollowing Traumatic Brain Injury	BRAIN INJURY			English	Article						Cueing; traumatic brain injury; cognitive-communication; elaboration; ERP; priming	PROSPECTIVE MEMORY; WORD RETRIEVAL; VERBAL MEMORY; DEFICITS; CONCRETENESS; POTENTIALS; DEPTH; LEVEL; TESTS; AGE	Purpose: Semantic elaboration is a process in which target information is analyzed in relation to content associated in meaning. The goal of the present study was to examine the use of phrasal cues intended to engage elaborative processes theorized to bolster cognitive performance. Methods: Twenty-two individuals with a history of traumatic brain injury (TBI) and twenty-six neurotypical (NT) individuals were studied. Short phrases intended to elicit elaborative encoding were presented prior to the introduction of a prospective memory task and word-stem completions. Phrases embodied one of three conditions: repeated, semantic, or unrelated information. The stem-completion task was presented between each prospective memory task with fixations serving as cues signaling task completion or functioning as distractors. Event-related potentials (ERPs) were captured during the presentation of word-stems. Following the completion of all word-stems, participants were presented with an old/new recognition task. Results: Linear mixed-effects model analyses revealed a significant effect of condition with respect to word retrieval and recognition memory. Captured ERPs revealed neural signatures resembling a P200. Conclusion: Semantic content increased stimulus saliency, facilitated lexical retrieval, and enhanced retention with the latter process revealing use of semantic cues as a more adept rehearsal strategy than repetition.	[Lindsey, Andre; Coelho, Carl] Univ Connecticut, Dept Speech Language & Hearing Sci, Storrs, CT USA; [Lindsey, Andre] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Lindsey, Andre] Univ Connecticut, Connecticut Inst Brain & Cognit Sci, Storrs, CT USA; [Lindsey, Andre] Nevada State Coll, Dept Educ, Speech Language Pathol, Henderson, NV USA		Lindsey, A (corresponding author), Nevada State Coll, Dept Educ, Speech Pathol, 1300 Nevada State Dr, Henderson, NV 89002 USA.	andre.lindsey@nsc.edu			National Science Foundation IGERTNational Science Foundation (NSF) [DGE-1144399]; National Science FoundationNational Science Foundation (NSF) [IGERT DGE/1144399]	This work was supported by the National Science Foundation IGERT grant DGE-1144399. National Science Foundation [IGERT DGE/1144399];	Barnea A, 1998, J GENET PSYCHOL, V159, P492, DOI 10.1080/00221329809596166; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Barton K., 2018, MUMIN MULTIMODEL INF; Brysbaert M, 2014, BEHAV RES METHODS, V46, P904, DOI 10.3758/s13428-013-0403-5; CHALLIS BH, 1992, J EXP PSYCHOL LEARN, V18, P595, DOI 10.1037/0278-7393.18.3.595; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Craik F.I.M., 1979, LEVELS PROCESSING HU, P385; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Creelman, 2004, DETECTION THEORY USE; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Doyle P. J., 1995, AM J SPEECH-LANG PAT, V4, P130, DOI [10.1044/1058-0360.0404.130, DOI 10.1044/1058-0360.0404.130]; Efstratiadou EA, 2018, J SPEECH LANG HEAR R, V61, P1261, DOI 10.1044/2018_JSLHR-L-16-0330; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FISHER RP, 1980, MEM COGNITION, V8, P400, DOI 10.3758/BF03211136; Fliessbach K, 2006, NEUROIMAGE, V32, P1413, DOI 10.1016/j.neuroimage.2006.06.007; Fratantoni JM, 2017, J NEUROTRAUM, V34, P1017, DOI 10.1089/neu.2016.4651; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; German D. J., 1990, TEST ADOLESCENT ADUL; Hough MS, 2008, APHASIOLOGY, V22, P644, DOI 10.1080/02687030701541024; Key-DeLyria SE, 2016, J SPEECH LANG HEAR R, V59, P759, DOI 10.1044/2016_JSLHR-L-15-0104; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; KLEIN K, 1976, J EXP PSYCHOL-HUM L, V2, P671; KLEIN SB, 1986, J EXP PSYCHOL GEN, V115, P26, DOI 10.1037/0096-3445.115.1.26; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Knuepffer C, 2012, BRAIN LANG, V123, P52, DOI 10.1016/j.bandl.2012.06.009; KRAMER AF, 1987, J EXP PSYCHOL LEARN, V13, P76, DOI 10.1037/0278-7393.13.1.76; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; Lee CY, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00285; Lenth R., 2021, EMMEANS ESTIMATED MA; Lepping R., 2014, INT J PHYS MED REHAB, V3; Lindsey A, 2020, J COMMUN DISORD, V86, DOI 10.1016/j.jcomdis.2020.105998; Lindsey A, 2019, AM J SPEECH-LANG PAT, V28, P330, DOI 10.1044/2018_AJSLP-17-0151; M?ntyl? T., 1996, PROSPECTIVE MEMORY T, P93; Madan CR, 2010, J MEM LANG, V63, P46, DOI 10.1016/j.jml.2010.03.001; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; MOSCOVITCH M, 1976, J VERB LEARN VERB BE, V15, P447, DOI 10.1016/S0022-5371(76)90040-2; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Paivio A., 2013, IMAGERY VERBAL PROCE; Penningroth SL, 2005, APPL COGNITIVE PSYCH, V19, P885, DOI 10.1002/acp.1116; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; R Development Core Team, 2012, R LANG ENV STAT COMP; Raskin SA, 2018, CLIN NEUROPSYCHOL, V32, P891, DOI 10.1080/13854046.2018.1455898; Richardson-Klavehn A, 1998, J EXP PSYCHOL LEARN, V24, P593, DOI 10.1037/0278-7393.24.3.593; RStudio Team, 2015, RSTUDIO INT DEV R; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; SADOSKI M, 1993, J EDUC PSYCHOL, V85, P291, DOI 10.1037/0022-0663.85.2.291; Saltz, 1971, COGNITIVE BASES HUMA; Sauzeon H, 2000, EXP AGING RES, V26, P57, DOI 10.1080/036107300243687; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Sohlberg M., 2001, COGNITIVE REHABILITA; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Wambaugh JL, 2003, APHASIOLOGY, V17, P433, DOI 10.1080/02687030344000085; Wambaugh JL, 2002, J REHABIL RES DEV, V39, P455; WechslerD, 2001, WECHSLER TEST ADULT; Wheeler RL, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01830; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wilson SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192773; Zuccoloto A., 2012, PITTSBG PA PSYCHOL S	71	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1168	1183		10.1080/02699052.2021.1953595		SEP 2021	16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000695090300001	34514915				2022-02-06	
J	Owens, TS; Calverley, TA; Stacey, BS; Rose, G; Fall, L; Tsukamoto, H; Jones, G; Corkill, R; Tuaillon, E; Hirtz, C; Lehmann, S; Marchi, N; Marley, CJ; Bailey, DM				Owens, Thomas S.; Calverley, Thomas A.; Stacey, Benjamin S.; Rose, George; Fall, Lewis; Tsukamoto, Hayato; Jones, Gareth; Corkill, Robin; Tuaillon, Edouard; Hirtz, Christophe; Lehmann, Sylvain; Marchi, Nicola; Marley, Christopher J.; Bailey, Damian M.			Concussion history in rugby union players is associated with depressed cerebrovascular reactivity and cognition	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						cerebral blood flow; cognition; concussion; free radicals; rugby union	CHRONIC TRAUMATIC ENCEPHALOPATHY; TRANSCRANIAL DOPPLER ULTRASOUND; CEREBRAL-BLOOD-FLOW; SPORT; STRESS; HUMANS	Recurrent contact and concussion in rugby union remains a significant public health concern given the potential increased risk of neurodegeneration in later life. This study determined to what extent prior-recurrent contact impacts molecular-hemodynamic biomarkers underpinning cognition in current professional rugby union players with a history of concussion. Measurements were performed in 20 professional rugby union players with an average of 16 (interquartile range [IQR] 13-19) years playing history reporting 3 (IQR 1-4) concussions. They were compared to 17 sex-age-physical activity-and education-matched non-contact controls with no prior history of self-reported concussion. Venous blood was assayed directly for the ascorbate free radical (A(center dot-) electron paramagnetic resonance spectroscopy) nitric oxide metabolites (NO reductive ozone-based chemiluminescence) and select biomarkers of neurovascular unit integrity (NVU chemiluminescence/ELISA). Middle cerebral artery blood flow velocity (MCAv doppler ultrasound) was employed to determine basal perfusion and cerebrovascular reactivity (CVR) to hyper/hypocapnia (CVRCO2Hyper/Hypo). Cognition was assessed by neuropsychometric testing. Elevated systemic oxidative-nitrosative stress was confirmed in the players through increased A(center dot-) (p < 0.001) and suppression of NO bioavailability (p < 0.001). This was accompanied by a lower CVR range (CVRCO2Range; p = 0.045) elevation in neurofilament light-chain (p = 0.010) and frontotemporal impairments in immediate-memory (p = 0.001) delayed-recall (p = 0.048) and fine-motor coordination (p < 0.001). Accelerated cognitive decline subsequent to prior-recurrent contact and concussion history is associated with a free radical-mediated suppression of CVR and neuronal injury providing important mechanistic insight that may help better inform clinical management.	[Owens, Thomas S.; Calverley, Thomas A.; Stacey, Benjamin S.; Rose, George; Tsukamoto, Hayato; Jones, Gareth; Marley, Christopher J.; Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Alfred Russel Wallace Bldg, Pontypridd CF37 4AT, M Glam, Wales; [Fall, Lewis] Univ South Wales, Fac Comp Engn & Sci, Pontypridd, M Glam, Wales; [Tsukamoto, Hayato] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Corkill, Robin] Univ Hosp Wales, Dept Neurol, Cardiff, Wales; [Tuaillon, Edouard] Univ Montpellier, Dept Infect Dis, INSERM, Montpellier, France; [Hirtz, Christophe; Lehmann, Sylvain] Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France; [Marchi, Nicola] Univ Montpellier, Inst Funct Genom, Dept Neurosci, Lab Cerebrovasc & Glia Res, Montpellier, France		Bailey, DM (corresponding author), Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Alfred Russel Wallace Bldg, Pontypridd CF37 4AT, M Glam, Wales.	damian.bailey@southwales.ac.uk	Hirtz, Christophe/AAD-1662-2022; Lehmann, Sylvain/P-1301-2017	Hirtz, Christophe/0000-0002-7313-0629; Owens, Tom/0000-0003-0097-0616; Lehmann, Sylvain/0000-0001-6117-562X; Stacey, Benjamin S/0000-0003-1005-7038; Rose, George/0000-0002-9598-6372; Tuaillon, Edouard/0000-0001-5866-9530; Fall, Lewis/0000-0002-1515-0672	JPR Williams Research Fellowship; Royal SocietyRoyal Society of LondonEuropean Commission [WM170007, IES\R2\192137]; Japan Society for the Promotion of Science Research FellowshipMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [JSPS/OF317]	D.M.B. is supported by a JPR Williams Research Fellowship (for TSO's PhD studentship), Royal Society Wolfson Research Fellowship (#WM170007), Royal Society International Exchanges Award (#IES\R2\192137), and Japan Society for the Promotion of Science Research Fellowship (#JSPS/OF317)	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bailey DM, 2020, NEUROSCIENCE, V441, P142, DOI 10.1016/j.neuroscience.2020.05.048; Bailey DM, 2019, J PHYSIOL-LONDON, V597, P611, DOI 10.1113/JP276898; Bailey DM, 2017, CIRCULATION, V135, P166, DOI 10.1161/CIRCULATIONAHA.116.024226; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bailey DM, 2009, AM J PHYSIOL-REG I, V297, pR1283, DOI 10.1152/ajpregu.00366.2009; BUETTNER GR, 1993, FREE RADICAL BIO MED, V14, P49, DOI 10.1016/0891-5849(93)90508-R; Burley CV, 2020, EXP PHYSIOL, V105, P893, DOI 10.1113/EP087883; Burma JS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14467; Canadian Society for Exercise Physiology, 2017, GET ACT QUEST; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Darlix A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5287-z; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; England Rugby, 2020, ENGL PROF RUGB INJ S; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Lavi S, 2003, CIRCULATION, V107, P1901, DOI 10.1161/01.CIR.0000057973.99140.5A; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marley CJ, 2021, SCAND J MED SCI SPOR, V31, P1908, DOI 10.1111/sms.14018; Marley CJ, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13264; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011	38	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2021	31	12					2291	2299		10.1111/sms.14046		SEP 2021	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WT5VV	WOS:000695002300001	34487582				2022-02-06	
J	Yatziv, SL; Yudco, O; Vaso, K; Mizrahi, A; Devor, M				Yatziv, Shai-Lee; Yudco, Or; Vaso, Kristina; Mizrahi, Adi; Devor, Marshall			Anesthesia in mice activates discrete populations of neurons throughout the brain	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						anesthesia; arousal; c-Fos; coma; loss of consciousness; MPTA; RRID; AB_2298772; TRAP mice	C-FOS; INTRACEREBRAL MICROINJECTION; RETICULAR-FORMATION; GENERAL-ANESTHESIA; PROPOFOL ANESTHESIA; SLEEP-WAKE; CONSCIOUSNESS; PATHWAYS; EXPRESSION; INDUCTION	The brain undergoes rapid, dramatic, and reversible transitioning between states of wakefulness and unconsciousness during natural sleep and in pathological conditions such as hypoxia, hypotension, and concussion. Transitioning can also be induced pharmacologically using general anesthetic agents. The effect is selective. Mobility, sensory perception, memory formation, and awareness are lost while numerous housekeeping functions persist. How is selective transitioning accomplished? Classically a handful of brainstem and diencephalic "arousal nuclei" have been implicated in driving brain-state transitions on the grounds that their net activity systematically varies with brain state. Here we used transgenic targeted recombination in active populations mice	[Yatziv, Shai-Lee; Yudco, Or; Vaso, Kristina; Devor, Marshall] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel; [Mizrahi, Adi] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel; [Devor, Marshall] Hebrew Univ Jerusalem, Ctr Res Pain, Jerusalem, Israel; [Mizrahi, Adi] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel		Devor, M (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel.	marshlu@mail.huji.ac.il		Devor, Marshall/0000-0001-8206-3301	Israel Science FoundationIsrael Science Foundation [224/17]; Fund for Research on Anesthesia at the Hebrew University of Jerusalem; Hebrew University's Seymour and Cecile Alpert Chair in Pain Research; ERCEuropean Research Council (ERC)European Commission [616063]	Israel Science Foundation, Grant/Award Number: 224/17; Fund for Research on Anesthesia at the Hebrew University of Jerusalem; The Hebrew University's Seymour and Cecile Alpert Chair in Pain Research; ERC consolidators, Grant/Award Number: 616063	Abulafia R, 2009, J NEUROSCI, V29, P7053, DOI 10.1523/JNEUROSCI.1357-08.2009; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Alkire MT, 1999, ANESTHESIOLOGY, V90, P701, DOI 10.1097/00000542-199903000-00011; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Andrada J, 2012, ANESTH ANALG, V114, P661, DOI 10.1213/ANE.0b013e3182405228; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; BORBELY AA, 1989, PHYSIOL REV, V69, P605, DOI 10.1152/physrev.1989.69.2.605; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Chung L, 2012, ARCH PHARM RES, V35, P2035, DOI 10.1007/s12272-012-1202-8; Cox J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10763; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DeNardo LA, 2019, NAT NEUROSCI, V22, P460, DOI 10.1038/s41593-018-0318-7; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Devor M, 2016, EUR J NEUROSCI, V43, P846, DOI 10.1111/ejn.13186; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRENCH JD, 1953, AMA ARCH NEUROL PSY, V69, P519, DOI 10.1001/archneurpsyc.1953.02320280107010; Gelegen C, 2018, CURR BIOL, V28, P580, DOI 10.1016/j.cub.2017.12.050; Gerashchenko D, 2008, P NATL ACAD SCI USA, V105, P10227, DOI 10.1073/pnas.0803125105; Goldenberg AM, 2018, NEUROSCIENCE, V369, P152, DOI 10.1016/j.neuroscience.2017.11.007; GRASSIZUCCONI G, 1993, EUR J NEUROSCI, V5, P1071, DOI 10.1111/j.1460-9568.1993.tb00960.x; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Haam J, 2012, J NEUROSCI, V32, P572, DOI 10.1523/JNEUROSCI.3826-11.2012; Hentschke H, 2005, EUR J NEUROSCI, V21, P93, DOI 10.1111/j.1460-9568.2004.03843.x; HERKENHAM M, 1981, BRAIN RES, V210, P461, DOI 10.1016/0006-8993(81)90927-6; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hua T, 2020, NAT NEUROSCI, V23, P854, DOI 10.1038/s41593-020-0632-8; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Jiang-Xie L.-F, 2019, NEURON, V9, P1, DOI [10.1016/j.neuron.2019.03.033, DOI 10.1016/J.NEURON.2019.03.033]; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kelz MB, 2019, ANESTH ANALG, V128, P726, DOI 10.1213/ANE.0000000000004006; Krom AJ, 2020, P NATL ACAD SCI USA, V117, P11770, DOI 10.1073/pnas.1917251117; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lanir-Azaria S, 2018, BEHAV BRAIN RES, V341, P198, DOI 10.1016/j.bbr.2017.12.035; Lazarus M, 2019, HANDB EXP PHARMACOL, V253, P359, DOI 10.1007/164_2017_36; Lellouche Y, 2020, NEUROSCIENCE, V432, P188, DOI 10.1016/j.neuroscience.2020.02.022; Lu J, 2008, J COMP NEUROL, V508, P648, DOI 10.1002/cne.21685; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Ma Wenxin, 2012, Methods Mol Biol, V884, P141, DOI 10.1007/978-1-61779-848-1_9; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; MCQUEEN JK, 1984, NEUROENDOCRINOLOGY, V38, P237, DOI 10.1159/000123897; Meiri G, 2016, EXP NEUROL, V284, P67, DOI 10.1016/j.expneurol.2016.07.014; Mhuircheartaigh RN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006007; Minert A, 2020, ANESTHESIOLOGY, V132, P535, DOI 10.1097/ALN.0000000000003087; Minert A, 2017, J NEUROSCI, V37, P9320, DOI 10.1523/JNEUROSCI.0544-17.2017; Minert A, 2016, EXP NEUROL, V275, P38, DOI 10.1016/j.expneurol.2015.10.001; Morena M, 2017, BEHAV BRAIN RES, V329, P215, DOI 10.1016/j.bbr.2017.04.048; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nourski KV, 2018, J NEUROSCI, V38, P8441, DOI 10.1523/JNEUROSCI.0967-18.2018; OLIVERAS JL, 1991, BRAIN RES, V563, P241, DOI 10.1016/0006-8993(91)91540-H; Pavel MA, 2020, P NATL ACAD SCI USA, V117, P13757, DOI 10.1073/pnas.2004259117; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Raines, 2003, NEURAL MECH ANESTHES; Scharf Matthew T, 2013, Curr Anesthesiol Rep, V3, P1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SHIMOJI K, 1971, ANESTHESIOLOGY, V35, P68, DOI 10.1097/00000542-197107000-00019; Sukhotinsky I, 2005, J COMP NEUROL, V489, P425, DOI 10.1002/cne.20636; Sukhotinsky I, 2007, EUR J NEUROSCI, V25, P1417, DOI 10.1111/j.1460-9568.2007.05399.x; Sukhotinsky I, 2006, J CHEM NEUROANAT, V32, P159, DOI 10.1016/j.jchemneu.2006.08.003; Sukhotinsky I, 2016, ANESTH ANALG, V123, P1274, DOI 10.1213/ANE.0000000000001489; Tasaka G, 2020, NEURON, V107, P566, DOI 10.1016/j.neuron.2020.05.004; Tasaka G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03183-2; Tung A, 2004, SLEEP MED REV, V8, P213, DOI 10.1016/j.smrv.2004.01.003; Valny M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00243; Xu M, 2015, NAT NEUROSCI, V18, P1641, DOI 10.1038/nn.4143; YAMAMOTO S, 1961, ELECTROEN CLIN NEURO, V13, P248, DOI 10.1016/0013-4694(61)90141-9; Yatziv SL, 2020, NEUROSCI LETT, V735, DOI 10.1016/j.neulet.2020.135212; Zanchetti, 1959, ARCH ITAL BIOL, V97, P33; Zhang Z, 2019, CELL, V177, P1293, DOI 10.1016/j.cell.2019.03.041; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	75	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2021	99	12					3284	3305		10.1002/jnr.24950		SEP 2021	22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XT9OE	WOS:000695037800001	34510528				2022-02-06	
J	Banks, RE; Beal, DS; Hunter, EJ				Banks, Russell E.; Beal, Deryk S.; Hunter, Eric J.			Sports Related Concussion Impacts Speech Rate and Muscle Physiology	BRAIN INJURY			English	Article						Sports related concussion (SRC); motor speech; motor control; sEMG	ORAL-DIADOCHOKINESIS; ACTIVITY REFLECTS; DISEASE; DYSARTHRIA; STATEMENT; MARKER	Objective Establish objective and subjective speech rate and muscle function differences between athletes with and without sports related concussion (SRC) histories and provide potential motor speech evaluation in SRC. Methods Over 1,110 speech samples were obtained from 30, 19-22 year-old athletes who had sustained an SRC within the past 2 years and 30 pair-wise matched control athletes with no history of SRC. Speech rate was measured via average time per syllable, average unvoiced time per syllable, and expert perceptual judgment. Speech muscle function was measured via surface electromyography over the obicularis oris, masseter, and segmental triangle. Group differences were assessed using MANOVA, bootstrapping and predictive ROC analyses. Results Athletes with SRC had slower speech rates during DDK tasks than controls as evidenced by longer average time per syllable longer average unvoiced time per syllable and expert judgment of slowed rate. Rate measures were predictive of concussion history. Further, athletes with SRC required more speech muscle activation than controls to complete DDK tasks. Conclusion Clear evidence of slowed speech and increased muscle activation during the completion of DDK tasks in athletes with SRC histories relative to controls. Future work should examine speech rate in acute concussion.	[Banks, Russell E.; Hunter, Eric J.] Michigan State Univ, Dept Commun Sci & Disorders, E Lansing, MI 48824 USA; [Banks, Russell E.; Beal, Deryk S.] Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA; [Beal, Deryk S.] Univ Toronto, Fac Med, Rehabil Sci Inst, Dept Speech Language Pathol, Toronto, ON, Canada		Banks, RE (corresponding author), Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA.	rbanks@mghihp.edu		Banks, Russell/0000-0003-1675-2584; Beal, Deryk/0000-0001-9488-4326; Hunter, Eric/0000-0001-5571-464X	American Speech-Language-Hearing Foundation [New Century Scholarship]; National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC012315]	This work was supported by the American Speech-Language-Hearing Foundation [New Century Scholarship]; National Institute on Deafness and Other Communication Disorders [R01DC012315].	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bottalico P, 2017, J ACOUST SOC AM, V141, pEL26, DOI 10.1121/1.4973312; Claridge-Chang A., 2018, BIORXIV, DOI [10.1101/377978, DOI 10.1101/377978]; Daudet L, 2017, IEEE J BIOMED HEALTH, V21, P496, DOI 10.1109/JBHI.2016.2633509; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Morree HM, 2010, BIOL PSYCHOL, V85, P377, DOI 10.1016/j.biopsycho.2010.08.009; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Falcone M, 2013, INT CONF ACOUST SPEE, P7577, DOI 10.1109/ICASSP.2013.6639136; Ghosh SS, 2008, J SPEECH LANG HEAR R, V51, P1183, DOI 10.1044/1092-4388(2008/07-0119); Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Green JR, 2013, AMYOTROPH LAT SCL FR, V14, P494, DOI 10.3109/21678421.2013.817585; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; HERTRICH I, 1994, BRAIN LANG, V47, P182, DOI 10.1006/brln.1994.1048; Huang DH, 2014, J SPORT SCI MED, V13, P921; Icht M, 2014, J COMMUN DISORD, V48, P27, DOI 10.1016/j.jcomdis.2014.02.002; Kipps, 2017, BRIT J SPORT MED, V51, pA82, DOI [10.1136/bjsports-2016-097270.212, DOI 10.1136/BJSPORTS-2016-097270.212]; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meltzner GS, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aac965; Meltzner GS, 2011, IEEE ENG MED BIO, P4848, DOI 10.1109/IEMBS.2011.6091201; Morrow EL, 2020, BRAIN INJURY, V34, P1590, DOI 10.1080/02699052.2020.1766114; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rong PY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/183027; Rusz J, 2013, J ACOUST SOC AM, V134, P2171, DOI 10.1121/1.4816541; Salvatore A. P., 2019, CLIN ARCH COMMUN DIS, V4, P214, DOI [10.21849/cacd.2019.00150, DOI 10.21849/CACD.2019.00150]; Skodda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032132; Soros P, 2006, NEUROIMAGE, V32, P376, DOI 10.1016/j.neuroimage.2006.02.046; Stepp CE, 2012, J SPEECH LANG HEAR R, V55, P1232, DOI 10.1044/1092-4388(2011/11-0214); Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Vogel AP, 2012, NEUROPSYCHOLOGIA, V50, P3273, DOI 10.1016/j.neuropsychologia.2012.09.011; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Weismer, 1995, AM J SPEECH-LANG PAT, V4, P9, DOI 10.1044/1058-0360.0402.09; Williams P, 2000, CLIN LINGUIST PHONET, V14, P267; Yunusova Y, 2008, J SPEECH LANG HEAR R, V51, P596, DOI 10.1044/1092-4388(2008/043); Yunusova Yana, 2013, J Med Speech Lang Pathol, V21, P1; Zihlmann U, 2017, INTERSPEECH, P3882, DOI 10.21437/Interspeech.2017-1579	42	0	0	4	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1275	1283		10.1080/02699052.2021.1972150		SEP 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000694602400001	34499576	Green Accepted			2022-02-06	
J	Beidler, E; Bogar, K; Wallace, J; McAllister-Deitrick, J; Anderson, M; Schatz, P				Beidler, Erica; Bogar, Kacie; Wallace, Jessica; McAllister-Deitrick, Jamie; Anderson, Morgan; Schatz, Phillip			The burden of unsubstantiated messaging: collegiate athletes' chronic traumatic encephalopathy mechanism beliefs	BRAIN INJURY			English	Article						Chronic traumatic encephalopathy; concussion; injury beliefs; athletes; college	SPORT-RELATED CONCUSSION; REPORTING BEHAVIORS; KNOWLEDGE; EDUCATION; ATTITUDES; PERCEPTIONS; HISTORY; IMPACT	Objective To investigate factors associated with collegiate athletes' beliefs regarding chronic traumatic encephalopathy (CTE) mechanism. Design Cross-sectional study. Methods A total of 838 collegiate athletes (61.9% men) from seven institutions completed a 10-minute survey that captured information relative to demographics, diagnosed concussion history, formal sport-related concussion education, additional sources of concussion information, and beliefs about multiple concussions and premature return-to-play following a head impact as mechanisms for CTE. Results More than half of collegiate athletes believed that multiple concussions (58.2%) and premature return-to-play (59.1%) may cause CTE. Those who reported getting concussion information from sports news had higher odds of believing multiple concussions and premature return-to-play were CTE mechanisms compared to those who did not get information from sports news sources. Additionally, CTE mechanism beliefs were significantly greater in collegiate athletes who were male, had sustained a previous diagnosed concussion, or had acquired concussion information from the NCAA. Conclusions Sports news' reporting of CTE storylines, which highlight former male athletes with complex brain injury histories, may influence collegiate athletes' beliefs about concussion. Therefore, it is recommended that concussion awareness initiatives incorporate information related specifically to CTE to empower collegiate athletes with evidence-based, patient-oriented information and knowledge regarding this condition.	[Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Bogar, Kacie; Schatz, Phillip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL USA; [McAllister-Deitrick, Jamie] Coastal Carolina Univ, Dept Kinesiol, Conway, SC USA; [Anderson, Morgan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Beidler, E (corresponding author), Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA.	johnsone1@duq.edu		Beidler, Erica/0000-0002-0179-5074; Schatz, Philip/0000-0002-6222-6545			AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Barr WB, 2020, CAN PSYCHOL, V61, P151, DOI 10.1037/cap0000210; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cunningham J, 2020, J ATHL TRAINING, V55, P132, DOI 10.4085/1062-6050-297-18; Daugherty J, 2018, BRAIN INJURY, V32, P1773, DOI 10.1080/02699052.2018.1530801; Dolecheck JD, 2020, RES ISSUES CONT ED, V5, P25; Fawcett N, 2017, HEALTH CARE MANAG, V36, P210, DOI 10.1097/HCM.0000000000000169; Feudtner C, 2018, JAMA PEDIATR, V172, P492, DOI 10.1001/jamapediatrics.2017.5242; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P916, DOI 10.1177/1090198119859414; Kroshus E, 2017, J LAW MED ETHICS, V45, P421, DOI 10.1177/1073110517737542; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; McAllister-Deitrick J, 2022, CLIN J SPORT MED, V32, P56, DOI 10.1097/JSM.0000000000000833; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P186, DOI 10.1080/00913847.2019.1671141; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schatz P, 2020, DEV NEUROPSYCHOL, V45, P110, DOI 10.1080/87565641.2020.1766464; Schmidt, 2020, ATHL TRAIN SPORTS HL, V12, P210, DOI [10.3928/19425864-20190618-01, DOI 10.3928/19425864-20190618-01]; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; van Veelen R, 2016, PERS SOC PSYCHOL REV, V20, P3, DOI 10.1177/1088868315576642; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wolfson DI, 2020, BRAIN INJURY, V34, P528, DOI 10.1080/02699052.2020.1725843	41	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1259	1266		10.1080/02699052.2021.1972146		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000694598300001	34499577				2022-02-06	
J	Haider, MN; Cunningham, A; Darling, S; Suffoletto, HN; Freitas, MS; Jain, RK; Willer, B; Leddy, JJ				Haider, Mohammad Nadir; Cunningham, Adam; Darling, Scott; Suffoletto, Heidi N.; Freitas, Michael S.; Jain, Rajiv K.; Willer, Barry; Leddy, John J.			Derivation of the Buffalo Concussion Physical Examination risk of delayed recovery (RDR) score to identify children at risk for persistent postconcussive symptoms	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						brain concussion	SPORTS-RELATED CONCUSSION; US HIGH-SCHOOL; ADOLESCENTS; RELIABILITY; STATEMENT; UTILITY; MODELS; YOUTH; TIME	Objective The Buffalo Concussion Physical Examination (BCPE) is a brief, but pertinent physical examination designed for the subacute, outpatient assessment of concussion. The purpose of this study was to perform the BCPE on a larger sample and derive a scoring system to identify children at risk for Persistent Post-Concussive Symptoms (PPCS, recovery >= 30 days). Methods This prospective, observational cohort study from September 2016 to March 2019 was performed at three university-affiliated concussion clinics. Male and female children (n=270, 14.92 +/- 1.86 years, range 8-18, 38% female) were diagnosed with a concussion within 14 days of injury and followed-up until recovery. Logistic regression was used with history and physical examination variables to predict PPCS and a weighted scoring metric was derived. Results Out of 15 predictor variables, the main effects of 1 preinjury variable (>= 3 previous concussions), 2 injury characteristic variables (days-since-injury and type-of-injury), 3 physical examination variables (orthostatic intolerance (OI), vestibulo-ocular reflex (VOR) and tandem gait) and 2 interaction terms (OI/VOR and tandem gait/type-of-injury) produced a score that was 85% accurate for identifying children with low-risk, medium-risk and high-risk for PPCS on cross-validation. Conclusion The Risk for Delayed Recovery (RDR)-Score allows physicians in an outpatient setting to more accurately predict which children are at greater risk for PPCS early after their injury, and who would benefit most from targeted therapies. The RDR-Score is intended to be used as part of a comprehensive assessment that should include validated symptom checklists, mental health history and adjunct testing (eg, cognitive or physical exertion) where clinically indicated.	[Haider, Mohammad Nadir; Suffoletto, Heidi N.; Freitas, Michael S.; Jain, Rajiv K.; Leddy, John J.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Orthopaed & Sports Med, Buffalo, NY 14214 USA; [Cunningham, Adam] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Biostat, Buffalo, NY USA; [Darling, Scott; Freitas, Michael S.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Family Med, Buffalo, NY USA; [Darling, Scott] Invis Hlth, Amherst, NY USA; [Suffoletto, Heidi N.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Emergency Med, Buffalo, NY USA; [Willer, Barry] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Psychiat, Buffalo, NY USA		Haider, MN (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Orthopaed & Sports Med, Buffalo, NY 14214 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Centre for Advancing Translational Sciences of the National Institutes of Health [UL1TR001412]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444 and by the National Centre for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Arciniegas, 2019, TXB TRAUMATIC BRAIN, P677; Astivia OLO, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0742-8; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Bezherano I., 2019, TRAUMATIC BRAIN INJU; Chang HW, 2016, ELECTRON J STAT, V10, P2511, DOI 10.1214/16-EJS1180; Conder Robert L, 2015, N C Med J, V76, P89; Corwin DJ, 2020, AM J EMERG MED, V38, P1847, DOI 10.1016/j.ajem.2020.06.020; Du W., 2018, CLIN J SPORT MED, DOI 10.1097/JSM.0000000000000687; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Haider MN, 2021, BRAIN INJURY, V35, P226, DOI 10.1080/02699052.2021.1871951; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Juraschek SP, 2017, JAMA INTERN MED, V177, P1316, DOI 10.1001/jamainternmed.2017.2937; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Keselman HJ, 2002, BRIT J MATH STAT PSY, V55, P27, DOI 10.1348/000711002159680; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Lipton RB, 2001, HEADACHE, V41, P854; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Pencina MJ, 2015, JAMA-J AM MED ASSOC, V314, P1063, DOI 10.1001/jama.2015.11082; R Core T, 2013, R LANG ENV STAT COMP; Riley RD, 2019, STAT MED, V38, P1276, DOI 10.1002/sim.7992; Roos KG, 2016, BRAIN INJURY, V30, P531; Roper M, 1996, AM J NURS, V96, P43; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Stewart JM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1673; Trojian T., 2017, CONN MED, V81; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	49	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2021	55	24					1427	+		10.1136/bjsports-2020-103690		SEP 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	XK9EU	WOS:000723296300001	34510003	Bronze			2022-02-06	
J	Sorek, G; Katz-Leurer, M; Gagnon, I; Chevignard, M; Stern, N; Fadida, Y; Kalderon, L; Shaklai, S; Schneider, K				Sorek, Gilad; Katz-Leurer, Michal; Gagnon, Isabelle; Chevignard, Mathilde; Stern, Nurit; Fadida, Yahaloma; Kalderon, Liran; Shaklai, Sharon; Schneider, Kathryn			The development and the inter-rater agreement of a treatment protocol for vestibular/oculomotor rehabilitation in children and adolescents post-moderate-severe TBI	BRAIN INJURY			English	Article; Early Access						Vestibular; oculomotor; rehabilitation; protocol; traumatic brain injury; children and adolescents	TRAUMATIC BRAIN-INJURY; VESTIBULAR REHABILITATION; EYE-MOVEMENTS; CONCUSSION; DIZZINESS; SYMPTOMS; CONSEQUENCES; RELIABILITY; DISORDERS; DEFICITS	Introduction:There is limited evidence investigating the effect of vestibular/oculomotor rehabilitation programs in children and adolescents post moderate-severe TBI at the sub-acute stage. Objective:To describe the development of a treatment protocol for vestibular/oculomotor interventions in this population, and to assess the inter-rater agreement of this protocol as an initial step of a clinical trial. Method:The protocol was developed by 10 health professionals, address the high variability of balance performance, the high prevalence of vestibular/oculomotor abnormalities and the low prevalence of symptoms reported in this population. Results:The protocol enables the clinician to use the assessment during the treatment exercise selection. The training position was defined by the Pediatric Balance Scale. Vestibular/oculomotor exercises were selected using a quantified version of the Vestibular/Ocular Motor Screening. The exercise protocol was selected based on impairment in function or reproduction of symptoms. The protocol planning was implemented by two assessors in 27 children and adolescents post-moderate-severe TBI (median age 14.1 [6-18.4] years) in the sub-acute stage (median 40 [14-162] days since injury). Very high agreement was found (k > 0.72) in all the parameters. Conclusion: This protocol could reliably be used in a randomized control trial that assesses the effect of vestibular/oculomotor rehabilitation program in children and adolescents post moderate-severe TBI at the sub-acute stage.	[Sorek, Gilad; Katz-Leurer, Michal; Kalderon, Liran] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel; [Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Hlth Ctr, Montreal, PQ, Canada; [Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed, Paris, France; [Chevignard, Mathilde] Hop St Maurice, Paris, France; [Stern, Nurit] Alyn Childrens Hosp & Rehabil Ctr, Phys Therapy Dept, Jerusalem, Israel; [Fadida, Yahaloma; Shaklai, Sharon] Lowenstein Rehabil Ctr Raanana, Children Rehabil Dept, Raanana, Israel; [Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Sport Injury Res Prevent Ctr, Calgary, AB, Canada		Sorek, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel.	Giladsork@gmail.com			Israeli Ministry of Health through the European Research Area -the Network of European Funding for Neuroscience Research (ERA-NET NEURON) [13897]	This study was funded by the Israeli Ministry of Health through the European Research Area -the Network of European Funding for Neuroscience Research (ERA-NET NEURON) under grant number 13897 as part of SiMPLyRehab project.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; [Anonymous], 2007, VESTIBULAR REHABILIT, V3rd; Booth M, 2019, INT J ATHL THER TRAI, V24, P100, DOI 10.1123/ijatt.2018-0057; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Ciuffreda K., 2009, OPTOM VIS DEV, V40, P1; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ., 2016, ADV OPHTHALMOL OPTOM, V1, P307, DOI [10.1016/j.yaoo.2016.03.013, DOI 10.1016/J.YAOO.2016.03.013]; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Garcia-Munoz C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020590; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaplan Daniel M, 2010, Harefuah, V149, P697; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Katz-Leurer M, 2012, PHYS THERAPY CHILDRE, P679; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; McKinlay A, 2013, INT NEUROTRAUMA LETT; Mitsutake T, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105214; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; O'Reilly RC., 2020, MANUAL PEDIAT BALANC, V2nd ed; Quatman-Yates CC., 2020, J ORTHOP SPORTS PHYS, V50, P1; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ., 2017, CJSM, V27, pE39; Sharma I., 2018, CJSM, V28, pE71; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sorek G, 2020, BRAIN INJURY, V34, P1480, DOI 10.1080/02699052.2020.1807055; VARTIAINEN E, 1985, INT J PEDIATR OTORHI, V9, P135, DOI 10.1016/S0165-5876(85)80013-6; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wee SK., 2002, PHYS SINGAPORE, V5, P59; Whitney SL, 2005, OTOL NEUROTOL, V26, P1027, DOI 10.1097/01.mao.0000185066.04834.4e; Whitney SL, 2019, J NEUROL PHYS THER, V43, pS31, DOI 10.1097/NPT.0000000000000272; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Yudofsky S., 2011, TXB TRAUMATIC BRAIN, DOI [10.1176/appi.books.9781585624201.js01, DOI 10.1176/APPI.BOOKS.9781585624201.JS01]; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	51	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2021.1972454		SEP 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UO3IR	WOS:000694591700001	34499583				2022-02-06	
J	Ferraris, KP; Yap, MEC; Bautista, MCG; Wardhana, DPW; Maliawan, S; Wirawan, IMA; Rosyidi, RM; Seng, K; Navarro, JE				Ferraris, Kevin Paul; Yap, Maria Eufemia C.; Bautista, Maria Cristina G.; Wardhana, Dewa Putu Wisnu; Maliawan, Sri; Wirawan, I. Made Ady; Rosyidi, Rohadi Muhammad; Seng, Kenny; Navarro, Joseph Erroll			Financial Risk Protection for Neurosurgical Care in Indonesia and the Philippines: A Primer on Health Financing for the Global Neurosurgeon	FRONTIERS IN SURGERY			English	Article						health financing; global neurosurgery; social health insurance; strategic purchasing; conditional cash transfer (CCT); out-of-pocket (OOP) expenses	TRAUMATIC BRAIN-INJURY; CONDITIONAL CASH TRANSFER; SOCIOECONOMIC DISPARITIES; CHILD HEALTH; IMPACT	Which conditions treated by neurosurgeons cause the worst economic hardship in low middle-income in countries? How can public health financing be responsive to the inequities in the delivery of neurosurgical care? This review article frames the objectives of equity, quality, and efficiency in health financing to the goals of global neurosurgery. In order to glean provider perspectives on the affordability of neurosurgical care in low-resource settings, we did a survey of neurosurgeons from Indonesia and the Philippines and identified that the care of socioeconomically disadvantaged patients with malignant intracranial tumors were found to incur the highest out-of-pocket expenses. Additionally, the surveyed neurosurgeons also observed that treatment of traumatic brain injury may have to require greater financial subsidies. It is therefore imperative to frame health financing alongside the goals of equity, efficiency, and quality of neurosurgical care for the impoverished. Using principles and perspectives from managerial economics and public health, we conceptualize an implementation framework that addresses both the supply and demand sides of healthcare provision as applied to neurosurgery. For the supply side, strategic purchasing enables a systematic and contractual management of payment arrangements that provide performance-based economic incentives for providers. For the demand side, conditional cash transfers similarly leverages on financial incentives on the part of patients to reward certain health-seeking behaviors that significantly influence clinical outcomes. These health financing strategies are formulated in order to ultimately build neurosurgical capacity in LMICs, improve access to care for patients, and ensure financial risk protection.	[Ferraris, Kevin Paul; Seng, Kenny; Navarro, Joseph Erroll] Jose R Reyes Mem Med Ctr, Dept Surg, Sect Neurosurg, Manila, Philippines; [Ferraris, Kevin Paul] Las Pinas Gen Hosp, Dept Surg, Las Pinas, Philippines; [Ferraris, Kevin Paul] Satellite Trauma Ctr, Las Pinas, Philippines; [Yap, Maria Eufemia C.] ThinkWell, Manila, Philippines; [Bautista, Maria Cristina G.] Ateneo Manila Univ, Grad Sch Business, Dept Econ Finance & Accounting, Makati, Philippines; [Wardhana, Dewa Putu Wisnu] Udayana Univ, Udayana Univ Hosp, Fac Med, Div Neurosurg,Dept Surg, Bali, Indonesia; [Maliawan, Sri] Udayana Univ, Sanglah Gen Hosp, Fac Med, Div Neurosurg,Dept Surg, Bali, Indonesia; [Wirawan, I. Made Ady] Udayana Univ, Fac Med, Dept Publ Hlth, Bali, Indonesia; [Rosyidi, Rohadi Muhammad] Mataram Univ, West Nusa Tenggara Prov Hosp, Fac Med, Dept Neurosurg, Mataram, Indonesia; [Seng, Kenny] Univ Philippines, Coll Med, Dept Neurosci, Div Neurosurg,Philippine Gen Hosp, Manila, Philippines		Ferraris, KP (corresponding author), Jose R Reyes Mem Med Ctr, Dept Surg, Sect Neurosurg, Manila, Philippines.; Ferraris, KP (corresponding author), Las Pinas Gen Hosp, Dept Surg, Las Pinas, Philippines.; Ferraris, KP (corresponding author), Satellite Trauma Ctr, Las Pinas, Philippines.	kpferraris@gmail.com	Wirawan, I Md Ady/W-3477-2019	Wirawan, I Md Ady/0000-0003-2464-5260; Dewa Putu, Wisnu Wardhana/0000-0001-9934-9859; Ferraris, Kevin Paul/0000-0002-0919-6658			Anderson GA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187293; Attenello FJ, 2015, J NEUROSURG-PEDIATR, V15, P560, DOI 10.3171/2014.11.PEDS14451; Attenello FJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.053; Bautista MCG., 2020, CONTRACTUAL MANAGEME, P337, DOI [10.1007/978-3-662-58482-8_11, DOI 10.1007/978-3-662-58482-8_11]; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Berkman JM, 2019, J NEUROSURG-PEDIATR, V24, P159, DOI 10.3171/2019.4.PEDS18594; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cruz-Flores S, 2011, STROKE, V42, P2091, DOI 10.1161/STR.0b013e3182213e24; Cyprich J, 2021, J NEUROSURG, V134, P742, DOI 10.3171/2019.12.JNS192506; Dayrit MM, 2018, HLTH SYST T, V8, P1; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Elsamadicy AA, 2018, J NEUROSURG-SPINE, V29, P40, DOI 10.3171/2017.12.SPINE171079; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Ferraris KP, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.9.FOCUS20695; Ham EI, 2020, WORLD NEUROSURG, V143, pE88, DOI 10.1016/j.wneu.2020.06.237; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Hoffman Caitlin, 2021, Neurosurg Focus, V50, pE13, DOI 10.3171/2021.1.FOCUS201000; Honda A., 2016, STRATEGIC PURCHASING, V2, P1; Hort K., 2015, PUBLIC HOSP GOVERNAN, V1, P300; Huntington D., 2015, PUBLIC HOSP GOVERNAN, VVol 1, P186; Jorge A, 2018, J NEUROSURG-SPINE, V29, P680, DOI 10.3171/2018.5.SPINE171242; Kanmounye US, 2021, NEUROL INDIA, V69, P12, DOI 10.4103/0028-3886.310098; King M., 1990, PRIMARY SURG, V1; Kulkarni AV, 2008, J PEDIATR-US, V153, P689, DOI 10.1016/j.jpeds.2008.04.068; Leidinger A, 2019, J NEUROSURG-SPINE, V31, P103, DOI 10.3171/2018.12.SPINE18635; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahendradhata Y., 2018, HLTH SYST TRANSIT, V8, P1; Marthias T., 2015, PUBLIC HOSP GOVERNAN, VVol 1, P26; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ferraris KP, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19814; Picazo OF, 2016, STRATEGIC PURCHASING, V2, P158; Roberts MJ., 2004, GETTING HLTH REFORM, P1; Robertson Faith C, 2020, World Neurosurg X, V6, P100060, DOI 10.1016/j.wnsx.2019.100060; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0; Saguin K, 2019, ASIA PAC POLICY STUD, V6, P352, DOI 10.1002/app5.280; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Shrime MG., CASH TRANSFERS MAY I, DOI [10.1101/2021.03.20.21254039, DOI 10.1101/2021.03.20.21254039]; Smith BG, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-041442; Strader C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232761; Strickland BA, 2020, WORLD NEUROSURG, V138, pE787, DOI 10.1016/j.wneu.2020.03.087; Trisnantoro L., 2016, STRATEGIC PURCHASING, V2, P102; Tseng MY, 2006, J NEUROSURG, V105, P297, DOI 10.3171/ped.2006.105.4.297; Uyl-de Groot Carin A, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P235, DOI 10.1586/erp.09.15; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Walker CT, 2014, CHILD NERV SYST, V30, P117, DOI 10.1007/s00381-013-2206-5; Wen T, 2014, NEUROSURGERY, V75, P43, DOI 10.1227/NEU.0000000000000352; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wiysonge CS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011084.pub2; Younus I, 2021, J NEUROSURG, V134, P801, DOI 10.3171/2020.1.JNS192707; Zimmerman A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240528	56	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	SEP 10	2021	8								690851	10.3389/fsurg.2021.690851			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WV9DB	WOS:000717528400001	34568413	Green Published, gold, Green Submitted			2022-02-06	
J	Fiani, B; Pasko, KBD; Sarhadi, K; Covarrubias, C				Fiani, Brian; Pasko, Kory B. Dylan; Sarhadi, Kasra; Covarrubias, Claudia			Current uses, emerging applications, and clinical integration of artificial intelligence in neuroradiology	REVIEWS IN THE NEUROSCIENCES			English	Article; Early Access						artificial intelligence; computational intelligence; computer aided diagnosis; imaging optimization; neuroradiology	CONVOLUTIONAL NEURAL-NETWORKS; HEALTH-CARE PROFESSIONALS; COMPUTED-TOMOGRAPHY; IMAGING PATTERNS; PATIENT SURVIVAL; DEEP; CLASSIFICATION; STROKE; GLIOBLASTOMA; GUIDELINES	Artificial intelligence (AI) is a branch of computer science with a variety of subfields and techniques, exploited to serve as a deductive tool that performs tasks originally requiring human cognition. AI tools and its subdomains are being incorporated into healthcare delivery for the improvement of medical data interpretation encompassing clinical management, diagnostics, and prognostic outcomes. In the field of neuroradiology, AI manifested through deep machine learning and connected neural networks (CNNs) has demonstrated incredible accuracy in identifying pathology and aiding in diagnosis and prognostication in several areas of neurology and neurosurgery. In this literature review, we survey the available clinical data highlighting the utilization of AI in the field of neuroradiology across multiple neurological and neurosurgical subspecialties. In addition, we discuss the emerging role of AI in neuroradiology, its strengths and limitations, as well as future needs in strengthening its role in clinical practice. Our review evaluated data across several subspecialties of neurology and neurosurgery including vascular neurology, spinal pathology, traumatic brain injury (TBI), neuro-oncology, multiple sclerosis, Alzheimer's disease, and epilepsy. AI has established a strong presence within the realm of neuroradiology as a successful and largely supportive technology aiding in the interpretation, diagnosis, and even prognostication of various pathologies. More research is warranted to establish its full scientific validity and determine its maximum potential to aid in optimizing and providing the most accurate imaging interpretation.	[Fiani, Brian] Desert Reg Med Ctr, Dept Neurosurg, 1150 N Indian Canyon Dr, Palm Springs, CA 92262 USA; [Pasko, Kory B. Dylan] Georgetown Univ, Sch Med, 3900 Reservoir Rd NW, Washington, DC 20007 USA; [Sarhadi, Kasra] Univ Washington, Main Hosp, Dept Neurol, 325 9th Ave, Seattle, WA 98104 USA; [Covarrubias, Claudia] Univ Anahuac Queretaro, Sch Med, Cto Univ 1,Fracc 2, Queretaro 76246, Mexico		Fiani, B (corresponding author), Desert Reg Med Ctr, Dept Neurosurg, 1150 N Indian Canyon Dr, Palm Springs, CA 92262 USA.	bfiani@outlook.com					Akbari H, 2018, NEURO-ONCOLOGY, V20, P191; Akbari H, 2016, NEUROSURGERY, V78, P572, DOI 10.1227/NEU.0000000000001202; Akkus Z, 2017, J DIGIT IMAGING, V30, P469, DOI 10.1007/s10278-017-9984-3; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2018, FDA PERM MARK ART IN; [Anonymous], 2019, RSNA INTRACRANIAL HE; Arab A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76459-7; Arbabshirani MR, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0015-z; Armato S.G., 2017, MED IM 2017 COMP AID; Aslani S, 2019, NEUROIMAGE, V196, P1, DOI 10.1016/j.neuroimage.2019.03.068; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Brossard C, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.666875; Brugnara G, 2020, EUR RADIOL, V30, P2356, DOI 10.1007/s00330-019-06593-y; Burduja M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20195611; Burns JE, 2017, RADIOLOGY, V284, P788, DOI 10.1148/radiol.2017162100; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Chang P, 2018, AM J NEURORADIOL, V39, P1201, DOI 10.3174/ajnr.A5667; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Chartrand G, 2017, RADIOGRAPHICS, V37, P2113, DOI 10.1148/rg.2017170077; Chen B, 2019, IEEE ACCESS, V7, P124596, DOI 10.1109/ACCESS.2019.2938402; Chen Yuhua, 2018, 2018 IEEE 15 INT S B, DOI [DOI 10.1109/ISBI.2018.8363679, 10.1109/isbi.2018.8363679]; Dawud AM, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/4629859; Del Gaizo J, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.801; Derkatch S, 2019, RADIOLOGY, V293, P405, DOI 10.1148/radiol.2019190201; Dev KMB, 2019, BIOMED SIGNAL PROCES, V52, P218, DOI 10.1016/j.bspc.2019.04.024; Dhar R, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00687; Ding Y, 2019, RADIOLOGY, V290, P456, DOI 10.1148/radiol.2018180958; Eshaghi A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22265-2; Esmaeilzadeh P, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01191-1; Faron A, 2020, CLIN NEURORADIOL, V30, P591, DOI 10.1007/s00062-019-00809-w; Flanders Adam E, 2020, Radiol Artif Intell, V2, pe190211, DOI 10.1148/ryai.2020190211; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Furlan AJ, 2006, STROKE, V37, P2863, DOI 10.1161/01.STR.0000251852.07152.63; Gleichgerrcht E, 2018, EPILEPSIA, V59, P1643, DOI 10.1111/epi.14528; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; Guberina N, 2018, NEURORADIOLOGY, V60, P889, DOI 10.1007/s00234-018-2066-5; Guo BJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00335; Hao YF, 2018, NEUROIMAGE-CLIN, V17, P962, DOI 10.1016/j.nicl.2017.12.005; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Huang JW, 2020, SPINE J, V20, P590, DOI 10.1016/j.spinee.2019.11.010; Hurford R, 2021, J NEUROL NEUROSUR PS, V92, P542, DOI 10.1136/jnnp-2020-324418; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Kaesmacher J, 2019, STROKE, V50, P880, DOI 10.1161/STROKEAHA.118.023465; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kanber B, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0127-8; Ker J, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092167; Kickingereder P, 2016, RADIOLOGY, V280, P880, DOI 10.1148/radiol.2016160845; Kim JP, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101811; Kiral-Kornek I, 2018, EBIOMEDICINE, V27, P103, DOI 10.1016/j.ebiom.2017.11.032; Korfiatis P, 2017, J DIGIT IMAGING, V30, P622, DOI 10.1007/s10278-017-0009-z; Kuo WC, 2019, P NATL ACAD SCI USA, V116, P22737, DOI 10.1073/pnas.1908021116; Lai CQ, 2019, PROCEEDINGS OF 2019 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND ELECTRICAL ENGINEERING TECHNOLOGY (EEET 2019), P99, DOI 10.1145/3362752.3362758; Lai CQ, 2020, COMPUT INTEL NEUROSC, V2020, DOI 10.1155/2020/8923906; Lessmann N, 2019, MED IMAGE ANAL, V53, P142, DOI 10.1016/j.media.2019.02.005; Li HM, 2019, ALZHEIMERS DEMENT, V15, P1059, DOI 10.1016/j.jalz.2019.02.007; Macyszyn L, 2016, NEURO-ONCOLOGY, V18, P417, DOI 10.1093/neuonc/nov127; Maegerlein C, 2019, RADIOLOGY, V291, P140, DOI 10.1148/radiol.2019181228; Majumdar Arjun, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P583, DOI 10.1109/EMBC.2018.8512336; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; McKinley R, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00717; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Mollura DJ, 2020, RADIOLOGY, V297, P513, DOI 10.1148/radiol.2020201434; Monteiro M, 2020, LANCET DIGIT HEALTH, V2, pE314, DOI 10.1016/S2589-7500(20)30085-6; Nair T, 2020, MED IMAGE ANAL, V59, DOI 10.1016/j.media.2019.101557; Nakao T, 2018, J MAGN RESON IMAGING, V47, P948, DOI 10.1002/jmri.25842; Narayana PA, 2020, RADIOLOGY, V294, P398, DOI 10.1148/radiol.2019191061; Niemeyer F, 2021, INVEST RADIOL, V56, P78, DOI 10.1097/RLI.0000000000000709; Nishi H, 2020, STROKE, V51, P1484, DOI 10.1161/STROKEAHA.119.028101; Olthof AW, 2020, NEURORADIOLOGY, V62, P1265, DOI 10.1007/s00234-020-02424-w; Park A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5600; Park J, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aacdd4; Pinto MF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78212-6; Prevedello LM, 2017, RADIOLOGY, V285, P923, DOI 10.1148/radiol.2017162664; Pszczolkowski S, 2019, COMPUT BIOL MED, V106, P126, DOI 10.1016/j.compbiomed.2019.01.022; Rao B, 2021, ACAD RADIOL, V28, P85, DOI 10.1016/j.acra.2020.01.035; Rathore S, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.2.021219; Rodriguez S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21330-0; Rudie JD, 2019, RADIOLOGY, V290, P607, DOI 10.1148/radiol.2018181928; Sander L, 2019, HUM BRAIN MAPP, V40, P4091, DOI 10.1002/hbm.24687; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Shi Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19527-w; Sichtermann T, 2019, AM J NEURORADIOL, V40, P25, DOI 10.3174/ajnr.A5911; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Titano JJ, 2018, NAT MED, V24, P1337, DOI 10.1038/s41591-018-0147-y; Ueda D, 2021, RADIOLOGY, V299, P675, DOI 10.1148/radiol.2021203692; Ueda D, 2019, RADIOLOGY, V290, P187, DOI 10.1148/radiol.2018180901; van den Brink RL, 2018, NEUROIMAGE-CLIN, V17, P43, DOI 10.1016/j.nicl.2017.10.003; Wang H.-C., 2017, SIMPLE FAST FULLY AU; Wang LS, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101542; Wang SH, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00818; Yang JH, 2021, RADIOLOGY, V298, P155, DOI 10.1148/radiol.2020192154; Yang X, 2020, PROC CVPR IEEE, P2653, DOI 10.1109/CVPR42600.2020.00273; Yao Anthony D, 2020, Radiol Artif Intell, V2, pe190026, DOI 10.1148/ryai.2020190026; Yoo Y, 2019, COMP M BIO BIO E-IV, V7, P250, DOI 10.1080/21681163.2017.1356750; You J., 2019, AUTOMATED COMPUTER E; You J, 2020, FRONT NEUROINFORM, V14, DOI 10.3389/fninf.2020.00013; Yu YN, 2018, IEEE T BIO-MED ENG, V65, P2058, DOI 10.1109/TBME.2017.2783241; Zhang YB, 2018, IEEE T MED IMAGING, V37, P1370, DOI 10.1109/TMI.2018.2823083	99	0	0	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	2191-0200		REV NEUROSCIENCE	Rev. Neurosci.												10.1515/revneuro-2021-0101		SEP 2021	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YC3NU	WOS:000739602500001	34506699				2022-02-06	
J	Fujiwara, Y; Kitano, H; Yamamoto, T; Kokubun, S; Hidai, C				Fujiwara, Yuusuke; Kitano, Hisataka; Yamamoto, Takamitsu; Kokubun, Shinichiro; Hidai, Chiaki			Activation peptide of coagulation factor IX improves the prognosis after traumatic brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Brain injury; Coagulation factor IX; Activation peptide; Vascular permeability; Blood brain barrier	PROTEIN-C; ISCHEMIA	Recently, coagulation factor IX and its activation peptide have been reported to suppress the permeability of vascular endothelial cells. In this study, the therapeutic effects of a synthesized activation peptide is investigated in traumatic brain injury model rats. In cerebral contusion, dysfunction of the blood brain barrier with increasing vascular permeability promotes the progression of neuropathy after injury. The model rats were generated by controlled cortical impact. Then, rats were intravenously injected with 350 mg/kg of the synthesized activation peptide or PBS as a control, every day for a month. Behavioral studies were conducted during a month of observation. For morphological analysis, macro-and microscopic observation were performed. Water content of brain tissue was used to assess edema. To assess the function of blood brain barrier, Evans Blue method was employed. In the neurological ex-aminations and beam-walking, the treated rats performed significantly better than control rats. Mea-surements of cerebral defect volume showed that the treatment significantly reduced it by 82%. Nissl stain showed that neural cells adjacent to impacts were lost in control rats, but saved in treated rats. The treatment significantly reduced brain edema and extravascular leakage of Evans blue. Intravenous in-jection with a synthesized activation peptide significantly reduced damage to neural tissue and improved neural functioning in the model rats. (c) 2021 Elsevier Inc. All rights reserved.	[Fujiwara, Yuusuke; Kitano, Hisataka] Nihon Univ, Div Dent Surg, Sch Med, Tokyo 1738610, Japan; [Yamamoto, Takamitsu] Nihon Univ, Dept Neurol Surg, Sch Med, Tokyo 1738610, Japan; [Kokubun, Shinichiro] Nihon Univ, Dept Biomed Sci, Div Physiol, Sch Med, Tokyo 1738610, Japan; [Hidai, Chiaki] Nihon Univ, Med Educ Ctr, Sch Med, Tokyo 1738610, Japan		Hidai, C (corresponding author), Nihon Univ, Med Educ Ctr, Sch Med, Itabashi Ku, 30-1 Oyaguchikami Cho, Tokyo 1738610, Japan.	fujiwara.yuusuke@nihon-u.ac.jp; kitano.hisataka@nihon-u.ac.jp; yamamoto.takamitsu@nihon-u.ac.jp; kokubun.shinichiro@nihon-u.ac.jp; hidai.chiaki@nihon-u.ac.jp		Fujiwara, Yuusuke/0000-0002-7405-6387			Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Hirose K, 2000, ANN SURG, V232, P272, DOI 10.1097/00000658-200008000-00018; Kitano H, 2015, CELL BIOL INT, V39, P1162, DOI 10.1002/cbin.10491; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Mamiya A, 2016, TRANSL RES, V177, P70, DOI 10.1016/j.trsl.2016.06.006; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Miller YI, 2020, J LIPID RES, V61, P655, DOI 10.1194/jlr.TR119000468; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Osier N.D., 2015, BRAIN NEUROTRAUMA MO, P421; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Povlishock J, 2014, THER HYPOTHERMIA TEM, V4, P3, DOI 10.1089/ther.2014.1502; Takagi T, 2017, J CEREBR BLOOD F MET, V37, P123, DOI 10.1177/0271678X15621499; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Yamauchi T, 2006, STROKE, V37, P1081, DOI 10.1161/01.STR.0000206280.30972.21; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	21	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 10	2021	569						35	40		10.1016/j.bbrc.2021.06.089			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	TD9OD	WOS:000669646200002	34225078				2022-02-06	
J	Gifford, EK; Robbins, EM; Jaquins-Gerstl, A; Rerick, MT; Nwachuku, EL; Weber, SG; Boutelle, MG; Okonkwo, DO; Puccio, AM; Michael, AC				Gifford, Emily K.; Robbins, Elaine M.; Jaquins-Gerstl, Andrea; Rerick, Michael T.; Nwachuku, Enyinna L.; Weber, Stephen G.; Boutelle, Martyn G.; Okonkwo, David O.; Puccio, Ava M.; Michael, Adrian C.			Validation of Dexamethasone-Enhanced Continuous-Online Microdialysis for Monitoring Glucose for 10 Days after Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						microdialysis; dexamethasone; glucose; biosensor; traumatic brain injury; controlled cortical impact	SPREADING DEPOLARIZATIONS; LACTATE; ISCHEMIA; PROBE; DEPRESSION; ASTROCYTES; MODERATE; DELIVERY	Traumatic brain injury (TBI) induces a pathophysiologic state that can be worsened by secondary injury. Monitoring brain metabolism with intracranial microdialysis can provide clinical insights to limit secondary injury in the days following TBI. Recent enhancements to microdialysis include the implementation of continuously operating electrochemical biosensors for monitoring the dialysate sample stream in real time and dexamethasone retrodialysis to mitigate the tissue response to probe insertion. Dexamethasone-enhanced continuous-online microdialysis (Dex-enhanced coMD) records long-lasting declines of glucose after controlled cortical impact in rats and TBI in patients. The present study employed retrodialysis and fluorescence microscopy to investigate the mechanism responsible for the decline of dialysate glucose after injury of the rat cortex. Findings confirm the long-term functionality of Dex-enhanced coMD for monitoring brain glucose after injury, demonstrate that intracranial glucose microdialysis is coupled to glucose utilization in the tissues surrounding the probes, and validate the conclusion that aberrant glucose utilization drives the postinjury glucose decline.	[Gifford, Emily K.; Robbins, Elaine M.; Jaquins-Gerstl, Andrea; Rerick, Michael T.; Weber, Stephen G.; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Nwachuku, Enyinna L.; Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Sch Med, Pittsburgh, PA 15213 USA; [Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England		Michael, AC (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	amichael@pitt.edu		Weber, Stephen/0000-0002-7970-2632	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS102725, R21NS109875]; University of Pittsburgh Center for Biological ImagingUniversity of Pittsburgh [1S10RR028478-01]	This work was funded by the National Institutes of Health (R01NS102725 and R21NS109875) and the University of Pittsburgh Center for Biological Imaging (1S10RR028478-01). The authors thank J. Andrew Holms of the Swanson Center for Product Innovation, Swanson School of Engineering, University of Pittsburgh, for 3D printing the electrode holders used in this work.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdel-Wahab AF, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104511; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Barros LF, 2009, J NEUROCHEM, V109, P94, DOI 10.1111/j.1471-4159.2009.05885.x; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bernardinelli Y, 2004, P NATL ACAD SCI USA, V101, P14937, DOI 10.1073/pnas.0405315101; Bourne R, 2010, FUNDAMENTALS OF DIGITAL IMAGING IN MEDICINE, P1, DOI 10.1007/978-1-84882-087-6; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Gowers SAN, 2015, ANAL CHEM, V87, P7763, DOI 10.1021/acs.analchem.5b01353; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Itoh Y, 2004, J CEREBR BLOOD F MET, V24, P993, DOI 10.1097/01.WCB.0000127661.07591.DE; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Jaquins-Gerstl A, 2009, J NEUROSCI METH, V183, P127, DOI 10.1016/j.jneumeth.2009.06.023; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Kozai TDY, 2015, ACS CHEM NEUROSCI, V6, P48, DOI 10.1021/cn500256e; Liaison O., 2020, HOPE RES; Loaiza A, 2003, J NEUROSCI, V23, P7337; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Patching SG, 2017, MOL NEUROBIOL, V54, P1046, DOI 10.1007/s12035-015-9672-6; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Robbins EM, 2019, ACS CHEM NEUROSCI, V10, P3521, DOI 10.1021/acschemneuro.9b00145; Rogers ML, 2013, ANAL BIOANAL CHEM, V405, P3881, DOI 10.1007/s00216-013-6770-z; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Szablewski L, 2017, J ALZHEIMERS DIS, V55, P1307, DOI 10.3233/JAD-160841; Vali M, 2015, J PHARMACOL EXP THER, V353, P560; Vali M, 2008, J PHARMACOL EXP THER, V327, P32, DOI 10.1124/jpet.108.141093; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; Varner EL, 2017, ACS CHEM NEUROSCI, V8, P1779, DOI 10.1021/acschemneuro.7b00148; Varner EL, 2016, ACS CHEM NEUROSCI, V7, P728, DOI 10.1021/acschemneuro.5b00331; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wicks RT, 2015, NEURO-ONCOLOGY, V17, P70, DOI 10.1093/neuonc/nou143; Wilson RE, 2020, ANAL CHEM, V92, P14558, DOI 10.1021/acs.analchem.0c02799; Wilson RE, 2018, ANAL CHEM, V90, P4561, DOI 10.1021/acs.analchem.7b04965; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang H, 2000, ANAL CHEM, V72, P2042, DOI 10.1021/ac991186r; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024	58	0	0	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	OCT 6	2021	12	19					3588	3597		10.1021/acschemneuro.1c00231		SEP 2021	10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	WF3AZ	WOS:000706182800009	34506125	hybrid			2022-02-06	
J	Langdon, C; Laxe, S; Lehrer, E; Berenguer, J; Alobid, I; Quinto, L; Marino-Sanchez, F; Bernabeu, M; Marin, C; Mullol, J				Langdon, Cristobal; Laxe, Sara; Lehrer, Eduardo; Berenguer, Joan; Alobid, Isam; Quinto, Llorenc; Marino-Sanchez, Franklin; Bernabeu, Montserrat; Marin, Concepcio; Mullol, Joaquim			Loss of smell in patients with traumatic brain injury is associated with neuropsychiatric behavioral alterations	BRAIN INJURY			English	Article						Loss of smell; olfactory disorder; traumatic brain injury; neuropsychiatric disorders; head trauma	PROGNOSTIC-SIGNIFICANCE; OLFACTORY DYSFUNCTION; ODOR IDENTIFICATION; LIFE; EPIDEMIOLOGY; DEPRESSION; VALIDATION; DISORDERS; DIAGNOSIS; DEFICITS	Objective We sought to identify and correlate the severity of traumatic brain injuries (TBIs) associated with olfactory dysfunction with cognitive and behavioral profiles. Participants and Setting Patients with TBI undergoing treatment in a specialized neuro-rehabilitation hospital. Design Prospective study. Main Measures Glasgow Coma Scale (GCS) at the time of injury and during posttraumatic amnesia. Motor functions were assessed with the Functional Instrument Measure and Disability Rating Scales. The Wechsler Adult Intelligence test was used for neuropsychologic assessment and the Neuropsychiatric Inventory was used to assess behavioral changes. The Barcelona Smell Test-24 was used to study subjective smell loss. Results A total of 111 patients with TBI were enrolled (33 females; mean age 32.86 years); 38.73% exhibited smell loss. Patients with no olfactory impairment (OI) had worse TBIs than those with OI (GCS scores 5.65 and 7.74, respectively); no significant differences in cognitive behaviors, such as attention memory, visuoperception, and visuoconstruction, were observed. However, patients with TBI and olfactory dysfunction showed statistically significant alterations in neuropsychiatric behavioral performances such as feeding when compared with patients with TBI without smell loss. Conclusion Olfactory dysfunction in patients with a TBI correlates with altered neuropsychiatric behavioral performances such as feeding, sleeping, and motor behavior.	[Langdon, Cristobal; Lehrer, Eduardo; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Spain; [Langdon, Cristobal; Alobid, Isam; Marino-Sanchez, Franklin; Marin, Concepcio; Mullol, Joaquim] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Immunoallergia Resp Clin & Expt IRCE, Barcelona, Spain; [Langdon, Cristobal; Alobid, Isam; Marin, Concepcio; Mullol, Joaquim] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Barcelona, Spain; [Laxe, Sara] Hosp Clin Barcelona, Phys Med & Rehabil Dept, ICEMEQ, Barcelona, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Dept Radiol, Neuroradiol Unit, Barcelona, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Imaging Diagnost Ctr, Barcelona, Spain; [Quinto, Llorenc] Univ Barcelona, Inst Salut Global Barcelona, Hosp Clin, Barcelona, Spain; [Marino-Sanchez, Franklin] Hosp Univ Ramon y Cajal, ENT Dept, Rhinol & Skull Base Surg Unit, Madrid, Spain; [Bernabeu, Montserrat] Univ Autonoma Barcelona, Inst Univ Neurorehabil Adscrit, Fdn Inst Guttmann, Barcelona, Spain; [Bernabeu, Montserrat] Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain		Langdon, C (corresponding author), Hosp Clin & Univ, Clin & Expt Resp Immunoallergy, IDIBAPS, ENT Dept,Unitat Rinol, C Villarroel 170, Barcelona 08036, Catalonia, Spain.; Langdon, C (corresponding author), Hosp Clin & Univ, Clin & Expt Resp Immunoallergy, IDIBAPS, ENT Dept,Clin Olfacte, C Villarroel 170, Barcelona 08036, Catalonia, Spain.	clangdon@clinic.cat		Langdon, Cristobal/0000-0003-1540-8095	Fundacio La Marato TV3 [110610]	This work was supported by a research grant (110610) from Fundacio La Marato TV3.	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Boada M, 2002, NEUROLOGIA, V17, P317; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Cardesin A, 2006, RHINOLOGY, V44, P83; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Coelho DH, 2016, AURIS NASUS LARYNX, V43, P137, DOI 10.1016/j.anl.2015.08.006; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Drummond M, 2018, J HEAD TRAUMA REHAB, V33, P53, DOI 10.1097/HTR.0000000000000283; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Green P, 2001, NEUROREHABILITATION, V16, P237; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Howell Jessica, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P39, DOI 10.1016/j.wjorl.2018.02.001; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Kohli P, 2016, CHEM SENSES, V41, P479, DOI 10.1093/chemse/bjw061; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Migneault-Bouchard C, 2020, J NEUROL, V267, P138, DOI 10.1007/s00415-019-09564-x; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Neuland C, 2011, LARYNGOSCOPE, V121, P867, DOI 10.1002/lary.21387; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nordin S, 2011, ACTA OTO-LARYNGOL, V131, P826, DOI 10.3109/00016489.2010.539625; Philpott CM, 2014, CHEM SENSES, V39, P711, DOI 10.1093/chemse/bju043; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wehling E, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0463-5; Zang Y, 2019, EUR ARCH OTO-RHINO-L, V276, P2811, DOI 10.1007/s00405-019-05558-7	40	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1418	1424		10.1080/02699052.2021.1972447		SEP 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000693977400001	34495793				2022-02-06	
J	Oyesanya, TO; Harris, G; Loflin, C; Bettger, P				Oyesanya, Tolu O.; Harris, Gabrielle; Loflin, Callan; Bettger, Prvu			Negotiating the transition from acute hospital care to home: perspectives of patients with traumatic brain injury, caregivers and healthcare providers	JOURNAL OF INTEGRATED CARE			English	Article						Brain injuries; Qualitative; Integrated care	PREDICTORS	Purpose The purpose is to explore experiences transitioning home from acute hospital care from perspectives of younger traumatic brain injury (TBI) patients, family caregivers and healthcare providers (HCPs). Design/methodology/approach The authors conducted 54 qualitative interviews (N = 36: 12 patients, 8 caregivers, 16 HCPs) and analyzed data using conventional content analysis. Findings The transition from hospital to home was described as a negotiation, finding a way through these obstacles: (1) preparing for discharge home during acute hospital care; (2) navigating transitions in healthcare and health; (3) addressing recovery concerns, and (4) setting goals to return to normal. Factors influencing the negotiation process included social support, health-related knowledge or training, coping mechanisms, financial stability, and home environment stability. Originality/value Younger TBI patients and caregivers have unique needs during the transition home from the hospital. Needed support from HCPs was inconsistently provided. Findings are foundational for integrated care research and practice with TBI.	[Oyesanya, Tolu O.; Harris, Gabrielle; Loflin, Callan; Bettger, Prvu] Duke Univ, Sch Nursing, Durham, NC 27708 USA; [Bettger, Prvu] Duke Univ, Sch Med, Orthoped, Durham, NC USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27708 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510	Duke University School of Nursing Center for Nursing Research Pilot Award; Duke Center for REACH Equity Career Development Award [U54MD012530]; NIH/NICHD R03 [R03HD101055]	This study was funded by: 1) Duke University School of Nursing Center for Nursing Research Pilot Award (PI, Oyesanya), 2) Duke Center for REACH Equity Career Development Award (Grant #U54MD012530; PI, Johnson; Investigator, Oyesanya), and 3) NIH/NICHD R03 (Grant # R03HD101055; PI, Oyesanya).	Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bettger JP, 2012, ANN INTERN MED, V157, P407, DOI 10.7326/0003-4819-157-6-201209180-00004; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Castor N, 2018, BRAIN INJURY, V32, P1803, DOI 10.1080/02699052.2018.1508748; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Fusch PI, 2015, QUAL REP, V20, P1408; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Labson Margherita C, 2015, Home Healthc Now, V33, P88, DOI 10.1097/NHH.0000000000000182; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Oyesanya TO, 2021, CLIN REHABIL, V35, P1056, DOI 10.1177/0269215520988679; Oyesanya TO, 2021, DISABIL REHABIL, V43, P685, DOI 10.1080/09638288.2019.1638456; Payne L, 2018, BRAIN INJURY, V32, P980, DOI 10.1080/02699052.2018.1468573; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737	24	0	0	0	0	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1476-9018	2042-8685		J INTEGR CARE	J. Integr. Care	DEC 9	2021	29	4			SI		414	424		10.1108/JICA-04-2021-0023		SEP 2021	11	Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	XM1DU	WOS:000695517800001					2022-02-06	
J	Padua, L; Fredda, G; Coraci, D; Reale, G; Glorioso, D; Loreti, C; Pecchioli, C; Bernabei, R				Padua, Luca; Fredda, Giulia; Coraci, Daniele; Reale, Giuseppe; Glorioso, Davide; Loreti, Claudia; Pecchioli, Cristiano; Bernabei, Roberto			COVID-19 and hospital restrictions: physical disconnection and digital re-connection in disorders of consciousness	BRAIN INJURY			English	Article						COVID-19; disorder of consciousness; emotional deprivation; rehabilitation; personalized medicine	TRAUMATIC BRAIN-INJURY; CAREGIVERS; RELATIVES; SCALE; COMA; REHABILITATION; RECOVERY; FAMILY; STATE; DEPRESSION	Purpose: The coronavirus disease 2019 (COVID-19) pandemic forced hospitals to adopt tighter restrictions, the most impacting is no access to visitors. Disorder of consciousness (DOC) due to severe acquired brain injury is a condition needing neurorehabilitation and the role of relatives is essential, hence besides physical "disconnection" digital "re-connection" is crucial. We aimed to assess whether digital communication benefits in patients with DOC, considering the sensorial and emotional deprivation due to the COVID-19 emergency lock-down. Methods: For eleven consecutive patients with DOC admitted to our Intensive Neurorehabilitation Care (mean age: 45; females: 9), two observers registered neurobehavioral changes during a video-calls with their relatives. Heart-rate variability was measured before and during the calls. The video-call was performed by using two displays of different sizes: tablet (T-video-call) and large screen (LS-Video-call). Results: The video-calls impacted on the patients' vigilance and in the relationship with relatives. Moreover, positively impacted on their relatives. The current results showed significant greater impact on patients during the LS-video-call than when they are exposed to T-video-call. Conclusions: During the COVID-19 pandemic, besides the physical disconnection to stop the contagion spread, a "digital re-connection" is needed for all and especially for fragile population groups as patients with DOC.	[Padua, Luca; Glorioso, Davide; Bernabei, Roberto] Univ Cattolica Sacro Cuore, Dept Orthopaed & Geriatr, Rome, Italy; [Padua, Luca; Reale, Giuseppe; Glorioso, Davide] Fdn Policlin Univ A Gemelli IRCCS, UOC High Intens Neurorehabil, Rome, Italy; [Fredda, Giulia] Fdn Policlin Univ A Gemelli IRCCS, UOS Clin Psychol, Rome, Italy; [Coraci, Daniele] Univ Padua, Dept Neurosci, Padua, Italy; [Reale, Giuseppe] Univ Cattolica Sacro Cuore, Dept Neurosci, Rome, Italy; [Loreti, Claudia; Bernabei, Roberto] Fdn Policlin Univ A Gemelli IRCCS, Dept Aging Neurol Orthopaed & Head Neck Sci, Rome, Italy; [Pecchioli, Cristiano] IRCCS San Raffaele Roma, Dept Neurosci, Rome, Italy		Coraci, D (corresponding author), Univ Padua, Dept Neurosci, Padua, Italy.	danielecoraci@aol.com	Padua, Luca/K-5398-2016	Padua, Luca/0000-0003-2570-9326			Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Burkhardt J-M., 2007, INTELLECTICA, V45, P59; Carrion-Plaza A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00157; Codispoti M, 2007, PSYCHOPHYSIOLOGY, V44, P680, DOI 10.1111/j.1469-8986.2007.00545.x; Coraci D, 2020, J MED VIROL, V92, P1739, DOI 10.1002/jmv.25829; Corallo F, 2017, NEUROL SCI, V38, P1249, DOI 10.1007/s10072-017-2941-6; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Formisano R, 1998, EUR J NEUROL, V5, P151, DOI 10.1046/j.1468-1331.1998.520151.x; Formisano R, 2019, CAN J NEUROL SCI, V46, P607, DOI 10.1017/cjn.2019.227; FRANK RG, 1994, BRAIN INJURY, V8, P193, DOI 10.3109/02699059409150972; Gaertner LHC, 2020, BRAIN INJURY, V34, P766, DOI 10.1080/02699052.2020.1753241; Gainotti G, 2015, NEUROPSYCHOLOGIA, V77, P279, DOI 10.1016/j.neuropsychologia.2015.09.002; Galeoto G, 2020, ANN IG MED PREV COMU, V32, P16, DOI 10.7416/ai.2020.2326; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giovannetti AM, 2015, ACTA NEUROL SCAND, V132, P259, DOI 10.1111/ane.12392; Giovannini S, 2018, DRUG AGING, V35, P145, DOI 10.1007/s40266-018-0521-y; Grabe M. E., 1999, VIS COMMUN Q, V6, P4, DOI [DOI 10.1080/15551399909363403, 10.1080/15551399909363403]; Hori Miyako, 2009, Gan To Kagaku Ryoho, V36 Suppl 1, P36; Hou JH, 2012, COMPUT HUM BEHAV, V28, P617, DOI 10.1016/j.chb.2011.11.007; Imani-Goghary Z, 2020, INT J PALLIAT NURS, V26, P301, DOI 10.12968/ijpn.2020.26.6.301; Jahromi ME, 2018, INT J MED INFORM, V115, P128, DOI 10.1016/j.ijmedinf.2018.03.004; Li TS, 2020, EMERG MICROBES INFEC, V9, P582, DOI 10.1080/22221751.2020.1735265; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Lombard M, 2000, HUM COMMUN RES, V26, P75, DOI 10.1111/j.1468-2958.2000.tb00750.x; Lombard M., 1997, COMMUN REP, V10, P95, DOI DOI 10.1080/08934219709367663; Magnani FG, 2020, NEUROL SCI, V41, P2773, DOI 10.1007/s10072-020-04394-6; Majersik JJ, 2020, NEUROLOGY, V94, P1055, DOI 10.1212/WNL.0000000000009564; Moretta P, 2017, REHABIL PSYCHOL, V62, P208, DOI 10.1037/rep0000144; Mykyta L J, 1976, Age Ageing, V5, P87, DOI 10.1093/ageing/5.2.87; Navarre D, 2005, LECT NOTES COMPUT SC, V3585, P170; Ng YX, 2020, MMWR-MORBID MORTAL W, V69, P307, DOI 10.15585/mmwr.mm6911e1; Olff M, 1999, PSYCHIAT RES, V85, P7, DOI 10.1016/S0165-1781(98)00139-5; Pagani M, 2014, J CLIN PSYCHOL MED S, V21, P214, DOI 10.1007/s10880-014-9399-y; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Rochette A, 2014, J REHABIL MED, V46, P16, DOI 10.2340/16501977-1228; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Sattin D, 2014, J NEUROL, V261, P2378, DOI 10.1007/s00415-014-7478-5; Sharon H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074711; SHELLHASE LJ, 1972, SOC CASEWORK-JCSW, V53, P544, DOI 10.1177/104438947205300904; Soeterik SM, 2017, CLIN REHABIL, V31, P1374, DOI 10.1177/0269215517695372; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Sutcliffe A, 2005, INT J HUM-COMPUT ST, V62, P307, DOI 10.1016/j.ijhcs.2004.11.010; Tamm, 1999, SCAND J OCCUP THER, V6, P36, DOI [10.1080/110381299443834, DOI 10.1080/110381299443834]; TEASDALE G, 1974, LANCET, V2, P81; Vetrano DL, 2018, MATURITAS, V107, P19, DOI 10.1016/j.maturitas.2017.09.014; Visch VT, 2010, COGNITION EMOTION, V24, P1439, DOI 10.1080/02699930903498186; Watkins J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m810; Weston S, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00203-20; WHO, 2020, 127 WHO; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wirth W, 2007, MEDIA PSYCHOL, V9, P493, DOI 10.1080/15213260701283079; Zhu JH, 2009, J NEUROTRAUM, V26, P677, DOI 10.1089/neu.2008.0691	55	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1134	1142		10.1080/02699052.2021.1972335		SEP 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000695729400001	34495807				2022-02-06	
J	Schindler, CR; Woschek, M; Franz, JN; Stormann, P; Henrich, D; Marzi, I				Schindler, Cora Rebecca; Woschek, Mathias; Franz, Jan-Niklas; Stoermann, Philipp; Henrich, Dirk; Marzi, Ingo			Influence of Antibiotic Management on Microbial Selection and Infectious Complications After Trauma	FRONTIERS IN MEDICINE			English	Article						polytrauma; traumatic brain injury; Interleukin-6; severely injured patient; Interleukin-10; inflammation	SYSTEMIC INFLAMMATORY RESPONSE; INTERLEUKIN-10 PLASMA-LEVELS; INTENSIVE-CARE MEDICINE; INJURY SEVERITY; CEREBROSPINAL-FLUID; MULTIPLE TRAUMA; PATHOPHYSIOLOGY; EPIDEMIOLOGY; LEUKOCYTOSIS; EXPRESSION	Background: The inflammatory response and post-traumatic complications like infections play an important role in the pathophysiology of severe injuries. This study examines the microbiological aspects in anti-infective treatment of trauma patients and their inflammatory response in post-traumatic infections complications. Patients and Methods: A retrospective analysis of prospectively collected data in trauma patients (ISS >= 16) over a 1-year period (01/2018 to 12/2018) is provided. Patient population was stratified into severely injured patients without post-traumatic infection (inf-PT), and severely injured patients who developed an infection (inf+PT). Results: Of 114 trauma patients, 45 suffered from post-traumatic infection during the first 10 days of hospitalization. Severely injured patients with concomitant traumatic brain injury (PT+TBI) showed the highest rate of post-traumatic infection. Pro-inflammatory reaction was tracked by levels of Interleukin (IL-)6 (day 3: inf+T 190.8 +/- 359.4 pg/dL > inf-PT 56.2 +/- 57.7 pg/mL (mean +/- SD); p = 0.008) and C-Reactive-Protein (CRP, day 3: inf+PT 15.3 mg/dL > inf-PT 6.7 mg/dL, p = 0.001) which were significantly higher in trauma patients who develop an infectious complication and showed a significant positive correlation with the occurrence of infection. The leading entity of infection was pneumonia followed by infections of the urinary tract mainly caused by gram-negative Enterobacteriaceae. 67.5% of all trauma patients received single-shot antibiosis during initial care in trauma bay. The development of secondary colonization was not relevant positively correlated with single-shot antibiosis (r = 0.013, p = 0.895) and prophylactically calculated antibiotic administration (r = 0.066, p = 0.500). Conclusion: Severely injured trauma patients have an increased risk for development of infectious complications, which mainly is pneumonia followed by infection of the urinary tract mainly caused by gram-negative Enterobacteriaceae. Based on the data in this study, the one-time antibiotic and prophylactic calculated use of antibiotics, like Cephalosporins must be critically discussed in terms of their role in the development of post-traumatic infections and microbial selection.	[Schindler, Cora Rebecca; Woschek, Mathias; Franz, Jan-Niklas; Stoermann, Philipp; Henrich, Dirk; Marzi, Ingo] Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany		Schindler, CR (corresponding author), Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	cora.schindler@kgu.de					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balogh ZJ, 2018, EUR J TRAUMA EMERG S, V44, P299, DOI 10.1007/s00068-018-0964-1; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Giannoudis PV, 2008, J TRAUMA, V65, P646, DOI 10.1097/TA.0b013e3181820d48; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; GOSLING P, 1992, INJURY, V23, P483, DOI 10.1016/0020-1383(92)90070-9; Haasper C, 2010, UNFALLCHIRURG, V113, P366, DOI 10.1007/s00113-010-1778-8; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Khodamoradi Y, 2019, DTSCH ARZTEBL INT, V116, P670, DOI 10.3238/arztebl.2019.0670; Lasanianos NG, 2011, INJURY, V42, P617, DOI 10.1016/j.injury.2011.02.011; Lefering R., 2003, ZURUCK ZUK, V2003, P256, DOI [10.1007/978-3-642-55611-1_71, DOI 10.1007/978-3-642-55611-1_71]; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Ma XY, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0104-3; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Meybohm P, 2017, CHIRURG, V88, P867, DOI 10.1007/s00104-017-0506-0; MORGAN AS, 1992, J NATL MED ASSOC, V84, P1019; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; Neumaier M, 2011, CHIRURG, V82, P921, DOI 10.1007/s00104-010-2043-y; Nicola Ratto, 2013, ISRN Orthop, V2013, P329452, DOI 10.1155/2013/329452; Paladino L, 2010, WEST J EMERG MED, V11, P450; Pape HC, 2008, J TRAUMA, V65, P1379, DOI 10.1097/TA.0b013e31818c8e8c; PAPE HC, 1994, BRIT J SURG, V81, P850, DOI 10.1002/bjs.1800810619; Pfeifer R, 2016, CHIRURG, V87, P165, DOI 10.1007/s00104-015-0139-0; Polytrauma Guideline Update Group, 2018, Eur J Trauma Emerg Surg, V44, P3, DOI 10.1007/s00068-018-0922-y; Ponfick M, 2014, NERVENARZT, V85, P195, DOI 10.1007/s00115-013-3958-6; Qiao Z, 2018, EUR J TRAUMA EMERG S, V44, P679, DOI 10.1007/s00068-017-0880-9; Relja B, 2018, EUR J TRAUMA EMERG S, V44, P301, DOI 10.1007/s00068-018-0962-3; Reutter F, 2014, ANAESTHESIST, V63, P73, DOI 10.1007/s00101-013-2282-7; Santucci CA, 2008, WEST J EMERG MED, V9, P81; Sapan HB, 2017, CHIN J TRAUMATOL, V20, P318, DOI 10.1016/j.cjtee.2017.05.003; Schindler CR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155381; Schindler CR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061667; Schneider C., 2013, CHIRURG BASISWEITERB, P43, DOI [10.1007/978-3-642-23804-8_7, DOI 10.1007/978-3-642-23804-8_7]; Schneider CP, 2004, BBA-MOL BASIS DIS, V1689, P22, DOI 10.1016/j.bbadis.2004.01.003; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Stormann P, 2020, EUR J TRAUMA EMERG S, V46, P31, DOI 10.1007/s00068-019-01098-1; Taniguchi T, 1999, AM J EMERG MED, V17, P548, DOI 10.1016/S0735-6757(99)90194-8; Tschoeke SK, 2007, J TRAUMA, V62, P1396, DOI 10.1097/TA.0b013e318047b7f0; van Der Poll Tom, 1997, Clin Microbiol Infect, V3, P605, DOI 10.1111/j.1469-0691.1997.tb00465.x; Verboket R, 2019, UNFALLCHIRURG, V122, P618, DOI 10.1007/s00113-018-0566-8; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Voth M, 2017, WORLD J SURG, V41, P3120, DOI 10.1007/s00268-017-4124-2; Windolf J, 2005, TRAUMA BERUFSKRANKH, V7, P100, DOI [10.1007/s10039-004-0917-2, DOI 10.1007/S10039-004-0917-2]; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wutzler S, 2013, CHIRURG, V84, P753, DOI 10.1007/s00104-013-2477-0; Wutzler S, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0608-4; Zhang YY, 2017, WORLD NEUROSURG, V98, P525, DOI 10.1016/j.wneu.2016.11.040	55	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	SEP 10	2021	8								678382	10.3389/fmed.2021.678382			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UU2OC	WOS:000698639700001	34568354	gold, Green Published			2022-02-06	
J	Stanbouly, D; Murphy, R; Murphy, TX; McDoniell, J; Lee, KC; Chuang, SK				Stanbouly, Dani; Murphy, Richard; Murphy, Terence X.; McDoniell, Jeremy; Lee, Kevin C.; Chuang, Sung-Kiang			Craniomaxillofacial injuries from the sport of wrestling: a query of the National Electronic Injury Surveillance System (NEISS)	ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG			English	Article; Early Access						Craniomaxillofacial trauma; Wrestling; Fractures	HIGH-SCHOOL; CONCUSSION	Purpose The purpose of this study was to provide a novel report on the head and neck injuries from the sport of wrestling and their characteristics in the USA. Materials and methods This is a 20-year retrospective cross-sectional study conducted using the National Electronic Injury Surveillance System (NEISS). Reports were included in the analysis if the injury stemmed from combat with another person. The predictor variables were obtained from both patient and injury characteristics. The principal outcome variable was admission rate, which was used to proxy the severity of the injury at hand. Bivariate analysis (i.e., chi-square and independent sample tests) was used to determine if an association existed between two variables of interest. Results The final sample in our study consisted of 4485 cases of craniomaxillofacial injuries secondary to wrestling. The increase in injuries from the year 2000 to 2019 was significant (P < 0.05). The average age of patients was 15.73 (range: 3 to 59 years old). Virtually all of the injuries occurred in males (95.6%). The majority of patients was under the age of 18 (82.3%). With regard to race, white wrestlers (57.1%) comprised the majority of patients. Insight into race was not available for 1245 patients (27.8%). Most wrestling-related injuries took place during the winter season (60.6%). Concussion was the most common primary diagnosis (29.0%). The head (57.1%) was the most commonly injured craniomaxillofacial region. The most common setting in which the injury took place was a place of recreation/sports (49.9%). Among the mechanisms of injuries, the take-down (26.5%) was the most common. Patients who were thrown/taken down (5.04%) were significantly more likely to get admitted (P < 0.01) relative to patients who were injured otherwise (2.6%). Similarly, patients who fell/tripped (6.6%) were significantly more likely to get admitted (P < 0.05) relative to patients who were injured otherwise (3.1%). While cases of concussion (6.0%) were significantly more likely to get admitted (P < 0.01) relative to other cases, cases of contusions/abrasions (0.6%) were significantly less likely to get admitted (P < 0.01) relative to other cases. Similar to contusions/abrasions (0.2%), lacerations were significantly less likely to get admitted (P < 0.01) relative to other cases. Patients aged 12-18 (P < 0.01) were most likely to suffer concussions, whereas patients aged 19-34 (P < 0.01) were least likely to suffer concussions. In contrast to concussions, patients aged 12-18 (P < 0.01) were least likely to suffer lacerations, whereas patients aged 19-34 (P < 0.01) were most likely to suffer lacerations. Patients aged 6-11 (P < 0.01) were most likely to be thrown/taken-down whereas patients aged 19-34 (P < 0.01) were least likely to be thrown. Patients aged 19-34 (P < 0.01) were most likely to be collided against intentionally, while patients aged 6-11 (P < 0.01) were least likely to be collided against intentionally. Patients aged 34 years or older were most likely to fall/trip, while patients aged 12-18 (P < 0.01) were least likely to fall/trip. Conclusions Certain types of injuries that occur during wrestling are more or less common depending on the age groups involved in the sport. Concussions were the most common injury incurred overall, and the head is the most commonly affected craniomaxillofacial area. Take-downs were the most likely mechanism of injury to lead to hospital admissions. The average number of wrestling injuries increased over 20 years being analyzed in this study. Future studies should investigate methods to lessen concussions in wrestling, decrease the number of illegal moves performed, and look into ways to mitigate harm from take-downs, given the increasing number of injuries acquired from this sport.	[Stanbouly, Dani; Murphy, Richard] Columbia Univ, Coll Dent Med, 630 West 168th St, New York, NY 10032 USA; [Murphy, Terence X.; McDoniell, Jeremy] NYU, Coll Dent, New York, NY USA; [Lee, Kevin C.] Columbia Univ Irving Med Ctr, Div Oral & Maxillofacial Surg, NewYork Presbyterian, New York, NY USA; [Chuang, Sung-Kiang] Univ Penn, Sch Dent Med, Dept Oral & Maxillofacial Surg, Philadelphia, PA 19104 USA		Stanbouly, D (corresponding author), Columbia Univ, Coll Dent Med, 630 West 168th St, New York, NY 10032 USA.	ds3840@cumc.columbia.edu					ADA, 2006, J AM DENT ASSOC, V137, P1712; [Anonymous], 2019, 2019 2020 2020 2021; [Anonymous], 2020, EST PROB COMP COLL A; [Anonymous], 2019, 2018 2019 NATL HIGH; [Anonymous], 2018, POSIT STAT REC MOUTH; Faye D, 2008, Odontostomatol Trop, V31, P29; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Hewett TE, 2005, MED SPORT SCI, V48, P152, DOI 10.1159/000084288; Hojjat H, 2016, ANN OTO RHINOL LARYN, V125, P652, DOI 10.1177/0003489416644617; Jarrett GJ, 1998, AM J SPORT MED, V26, P674, DOI 10.1177/03635465980260051301; Jessen Rachel, 2019, ESPN; Knapik JJ, 2019, SPORTS MED, V49, P1217, DOI 10.1007/s40279-019-01121-w; Lee KC, 2020, J ORAL MAXIL SURG, V78, P1583, DOI 10.1016/j.joms.2020.04.035; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Pasque CB, 2000, AM J SPORT MED, V28, P509, DOI 10.1177/03635465000280041101; Pirruccio K, 2021, J SPORT MED PHYS FIT, V61, P407, DOI 10.23736/S0022-4707.20.11194-0; Register-Mihalik JK., 2011, J ATHL TRAINING, V46, pS15; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; WROBLE RR, 1986, CLIN SPORT MED, V5, P295; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	22	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1865-1550	1865-1569		ORAL MAXILLOFAC SURG	Oral Maxillofac. Surg.-Heidelb.												10.1007/s10006-021-01004-3		SEP 2021	8	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	UO6GS	WOS:000694792400001	34505955				2022-02-06	
J	West, SW; Cross, M; Trewartha, G; Taylor, A; Brooks, J; Kemp, S; Locke, D; Ahmed, O; Stokes, K				West, Stephen W.; Cross, Matthew; Trewartha, Grant; Taylor, Aileen; Brooks, John; Kemp, Simon; Locke, Duncan; Ahmed, Osman; Stokes, Keith			Trends in match concussion incidence and return-to-play time in male professional Rugby Union: A 16-season prospective cohort study	BRAIN INJURY			English	Article						Concussion; injury; rugby; epidemiology; prevention	CONSENSUS STATEMENT; INTERNATIONAL-CONFERENCE; VIDEO ANALYSIS; HEAD-INJURIES; SPORT HELD; WORLD CUP; EPIDEMIOLOGY; ZURICH; EVENTS	Aim To describe trends in the incidence of match concussions and time to return-to-play in professional rugby union. Methods Match concussion incidence (injuries per 1000 player-match-hours) and time to return-to-play (mean and median days absence) were recorded in 3006 male professional rugby union players over 16 seasons (2002/03 - 2018/19). Results From 2002/03 to 2009/10, incidence of concussions was stable at 4.3/1000 player-match-hours. From 2009/10 to 2018/19, there was an increase in concussion incidence, with the highest incidence in 2016/17 at 20.9/1000 player-match-hours (95% CI: 17.9-24.3). Annual prevalence of concussion also increased, suggesting more players were concussed rather than the same players sustaining more concussions. Before the introduction of standardized graduated return-to-play (GRTP) guidelines in 2011, 27% of players returned to play in <6 days. After the introduction of the GRTP, this decreased to 7%, with no players returning in <6 days after 2014/15. Between 2002/03 and 2018/19, incidence of all other injuries remained stable. Conclusions From 2009/10 onwards, the incidence of diagnosed concussions increased. Since the introduction of the GRTP, there has been a dramatic reduction in the number of players returning in <6 days.	[West, Stephen W.; Cross, Matthew; Trewartha, Grant; Stokes, Keith] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [West, Stephen W.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Cross, Matthew] Premier Rugby Ltd, Twickenham, England; [Brooks, John] Connect Hlth, Merton, England; [Brooks, John] MyClin Elsternwick, Melbourne, Vic, Australia; [Kemp, Simon; Locke, Duncan; Stokes, Keith] Rugby Football Union, Twickenham, England; [Kemp, Simon] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London, England; [Ahmed, Osman] Univ Hosp Dorset NHS Fdn Trust, Poole, Dorset, England; [Ahmed, Osman] Univ Portsmouth, Sch Sport Hlth & Exercise Sci, Portsmouth, Hants, England		Stokes, K (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	spsks@bath.ac.uk	; Stokes, Keith/C-2605-2009	Kemp, Simon/0000-0002-3250-2713; West, Stephen/0000-0001-5800-7000; Brooks, John/0000-0003-2935-7858; Stokes, Keith/0000-0002-5049-2838; Trewartha, Grant/0000-0002-9021-8956; Ahmed, Osman/0000-0002-1439-0076	Rugby Football Union; Premier Rugby Ltd.	This work was supported by the Rugby Football Union; Premier Rugby Ltd.	Anstiss T., 2019, ENGLAND PROFESSIONAL; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burger N, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000645; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Di Pietro V, 2021, BRIT J SPORT MED, V55, P1395, DOI 10.1136/bjsports-2020-103274; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2018, SPORTS MED, V48, P1597, DOI 10.1007/s40279-018-0913-5; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, J SPORT SCI, V31, P795, DOI 10.1080/02640414.2012.753156; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Helmy A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5748; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McHugh C, 2021, INT J SPORTS MED, V42, P1191, DOI 10.1055/a-1403-2906; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Murray AD, 2014, BRIT J SPORT MED, V48, P73, DOI 10.1136/bjsports-2012-091844; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Quarrie KL, 2014, BRIT J SPORT MED, V48, P1589, DOI 10.1136/bjsports-2014-094112; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Rugby Football Union, 2014, WORLD 1 TACKL CONC; Stokes KA, 2021, BRIT J SPORT MED, V55, P220, DOI [10.1136/bjsports-2019-101557, 10.1136/bjsports-2020-101983]; Tucker R, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000885; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; West SW, 2021, BRIT J SPORT MED, V55, P676, DOI 10.1136/bjsports-2020-102529; World Rugby, 2014, HEAD INJ ASS AD LAW; World Rugby, 2014, CONC MAN	43	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1235	1244		10.1080/02699052.2021.1972142		SEP 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000693987000001	34495819				2022-02-06	
J	Xie, D; Welgampola, MS; Miller, LA; Young, AS; D'Souza, M; Breen, N; Rosengren, SM				Xie, Danica; Welgampola, Miriam S.; Miller, Laurie A.; Young, Allison S.; D'Souza, Mario; Breen, Nora; Rosengren, Sally M.			Subjective Cognitive Dysfunction in Patients with Dizziness and Vertigo	AUDIOLOGY AND NEURO-OTOLOGY			English	Article; Early Access						Questionnaire; Memory; Cognitive complaints; Attention; Orientation; Spatial processing	POST-CONCUSSION SYMPTOMS; SOMATIC SYMPTOMS; SPATIAL MEMORY; BASE-RATE; TIME; PERFORMANCE; SPACE; DEPRESSION; COMMUNITY; ANXIETY	Introduction: Patients with vestibular disorders sometimes report cognitive difficulties, but there is no consensus about the type or degree of cognitive complaint. We therefore investigated subjective cognitive dysfunction in a well-defined sample of neuro-otology patients and used demographic factors and scores from a measure of depression, anxiety, and stress to control for potential confounding factors. Methods: We asked 126 neuro-otology clinic outpatients whether they experienced difficulties with thinking, memory, or concentration as a result of dizziness or vertigo. They and 42 nonvertiginous control subjects also completed the Neuropsychological Vertigo Inventory (NVI, which measures cognitive, emotional, vision, and motor complaints), the Everyday Memory Questionnaire (EMQ), and Depression, Anxiety, and Stress Scales (DASS). Results: In the initial interview questions, 60% of patients reported experiencing cognitive difficulties. Cognitive questionnaire scores were positively correlated with the overall DASS score and to a lesser extent with age and gender. Therefore, we compared patients and controls on the NVI and EMQ, using these mood and demographic variables as covariates. Linear regression analyses revealed that patients scored significantly worse on the total NVI, NVI cognitive composite, and 3 individual NVI cognition subscales (Attention, Space Perception, and Time Perception), but not the EMQ. Patients also scored significantly worse on the NVI Emotion and Motor subscales. Conclusions: Patients with dizziness and vertigo reported high levels of cognitive dysfunction, affecting attention, perceptions of space and time. Although perceptions of cognitive dysfunction were correlated with emotional distress, they were significantly elevated in patients over and above the impact of depression, anxiety, or stress.	[Xie, Danica; Welgampola, Miriam S.; Miller, Laurie A.; Young, Allison S.; D'Souza, Mario; Rosengren, Sally M.] Univ Sydney, Fac Med & Hlth, Cent Clin Sch, Sydney, NSW, Australia; [Welgampola, Miriam S.; Miller, Laurie A.; Breen, Nora] Royal Prince Alfred Hosp, Inst Clin Neurosci, Camperdown, NSW, Australia; [Rosengren, Sally M.] Royal Prince Alfred Hosp, Neurol Dept, Camperdown, NSW, Australia		Rosengren, SM (corresponding author), Univ Sydney, Fac Med & Hlth, Cent Clin Sch, Sydney, NSW, Australia.; Rosengren, SM (corresponding author), Royal Prince Alfred Hosp, Neurol Dept, Camperdown, NSW, Australia.	sally@srosengren.org			Neuro-Otology Society of Australia (NOTSA); National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [GNT1104772]; University of SydneyUniversity of Sydney	This work was supported by the Neuro-Otology Society of Australia (NOTSA) and the National Health and Medical Research Council of Australia under Grant GNT1104772. Allison S. Young receives scholarship funding from the University of Sydney.	Agrawal Y, 2013, J VESTIBUL RES-EQUIL, V23, P113, DOI 10.3233/VES-130498; Bigelow RT, 2016, J NEUROL NEUROSUR PS, V87, P367, DOI 10.1136/jnnp-2015-310319; Bisdorff A., 2015, J NEUROL SCI PSYCHIA, V1; Black FO, 2004, OTOL NEUROTOL, V25, P559, DOI 10.1097/00129492-200407000-00025; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cornish IM, 2000, BRIT J PSYCHOL, V91, P427, DOI 10.1348/000712600161916; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; DEROUESNE C, 1993, INT J GERIATR PSYCH, V8, P599, DOI 10.1002/gps.930080712; Eckhardt-Henn A, 2008, J NEUROL, V255, P420, DOI 10.1007/s00415-008-0697-x; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gauthier B, 2016, J NEUROSCI, V36, P11891, DOI 10.1523/JNEUROSCI.1400-16.2016; Gil-Gouveia R, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0824-7; Grunfeld EA, 2003, INT J AUDIOL, V42, P161, DOI 10.3109/14992020309090425; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Hitier M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00059; Hufner K, 2007, HIPPOCAMPUS, V17, P471, DOI 10.1002/hipo.20283; Jacob L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48894-8; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kim JM, 2003, DEMENT GERIATR COGN, V15, P218, DOI 10.1159/000068783; Kremmyda O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00139; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Lacroix E, 2016, EUR ARCH OTO-RHINO-L, V273, P4241, DOI 10.1007/s00405-016-4135-x; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Lenze EJ, 2005, J GERIATR PSYCH NEUR, V18, P89, DOI 10.1177/0891988705276251; Liu YF, 2019, OTOL NEUROTOL, V40, pE723, DOI 10.1097/MAO.0000000000002311; Lopez-Escamez JA, 2015, J VESTIBUL RES-EQUIL, V25, P1, DOI 10.3233/VES-150549; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mast FW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00044; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Neuhauser HK, 2016, HAND CLINIC, V137, P67, DOI 10.1016/B978-0-444-63437-5.00005-4; Parkinson C, 2014, J NEUROSCI, V34, P1979, DOI 10.1523/JNEUROSCI.2159-13.2014; Peer M, 2015, P NATL ACAD SCI USA, V112, P11072, DOI 10.1073/pnas.1504242112; Popp P, 2017, J NEUROL, V264, P554, DOI 10.1007/s00415-016-8386-7; Redfern MS, 2004, GAIT POSTURE, V19, P105, DOI 10.1016/S0966-6362(03)00032-8; RICHARDSON JTE, 1995, MEMORY, V3, P187, DOI 10.1080/09658219508258965; Rizk HG, 2020, EAR HEARING, V41, P1020, DOI 10.1097/AUD.0000000000000825; Roh KJ, 2018, J AUDIOL OTOL, V22, P6, DOI 10.7874/jao.2017.00290; Shinder ME, 2010, J VESTIBUL RES-EQUIL, V20, P3, DOI 10.3233/VES-2010-0344; SLOANE PD, 1994, J AM GERIATR SOC, V42, P847, DOI 10.1111/j.1532-5415.1994.tb06556.x; Smith PF, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00084; SUNDERLAND A, 1986, J GERONTOL, V41, P376, DOI 10.1093/geronj/41.3.376; Sunderland A., 1984, EVERYDAY MEMORY ACTI, P193; Taylor CA, 2020, INNOV AGING, V4, DOI 10.1093/geroni/igz045; von Brevern M, 2015, J VESTIBUL RES-EQUIL, V25, P105, DOI 10.3233/VES-150553; Vuralli D, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0933-4; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wang JH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017173; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Wiltink J, 2009, J PSYCHOSOM RES, V66, P417, DOI 10.1016/j.jpsychores.2008.09.012; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Yardley L, 2002, NEUROPSYCHOLOGIA, V40, P373, DOI 10.1016/S0028-3932(01)00113-0; Yardley L, 2001, J NEUROL NEUROSUR PS, V71, P48, DOI 10.1136/jnnp.71.1.48; Yoder RM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00032	56	0	0	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-3030	1421-9700		AUDIOL NEURO-OTOL	Audiol. Neuro-Otol.												10.1159/000518188		SEP 2021	11	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	UQ8RA	WOS:000696325200001	34518461				2022-02-06	
J	Zin, EA; Han, D; Tran, J; Morisson-Welch, N; Visel, M; Kuronen, M; Flannery, JG				Zin, Emilia A.; Han, Daisy; Tran, Jennifer; Morisson-Welch, Nikolas; Visel, Meike; Kuronen, Mervi; Flannery, John G.			Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; TRAUMATIC BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; ACTIVATED MICROGLIA; RESPONSES; MICE; ACCUMULATION; DYSFUNCTION; AAV9	Neuronal ceroid lipofuscinosis (NCL) is a family of neurodegenerative diseases caused by mutations to genes related to lysosomal function. One variant, CNL11, is caused by mutations to the gene encoding the protein progranulin, which regulates neuronal lysosomal function. Absence of progranulin causes cerebellar atrophy, seizures, dementia, and vision loss. As progranulin gene therapies targeting the brain are developed, it is advantageous to focus on the retina, as its characteristics are beneficial for gene therapy development: the retina is easily visible through direct imaging, can be assessed through quantitative methods in vivo, and requires smaller amounts of adeno-associated virus (AAV). In this study we characterize the retinal degeneration in a progranulin knockout mouse model of CLN11 and study the effects of gene replacement at different time points. Mice heterologously expressing progranulin showed a reduction in lipofuscin deposits and microglia infiltration. While mice that receive systemic AAV92YF-scCAG-PGRN at post-natal day 3 or 4 show a reduction in retina thinning, mice injected intravitreally at months 1 and 6 with AAV2.7m8-scCAG-PGRN exhibit no improvement, and mice injected at 12 months of age have thinner retinas than do their controls. Thus, delivery of progranulin proves to be time sensitive and dependent on route of administration, requiring early delivery for optimal therapeutic benefit.	[Zin, Emilia A.; Flannery, John G.] Univ Calif Berkeley, Sch Optometry, Vis Sci Grp, 112 Barker Hall, Berkeley, CA 94720 USA; [Han, Daisy] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Tran, Jennifer; Flannery, John G.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Morisson-Welch, Nikolas; Visel, Meike; Kuronen, Mervi; Flannery, John G.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Flannery, JG (corresponding author), Univ Calif Berkeley, Sch Optometry, Vis Sci Grp, 112 Barker Hall, Berkeley, CA 94720 USA.	flannery@berkeley.edu			Foundation Fighting BlindnessEuropean Commission [TA-GT-0818-0745-UCB]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10RR026866-01]	The research was supported by Foundation Fighting Blindness grant TA-GT-0818-0745-UCB. The authors would like to thank Michael Ward and Ari Green at UCSF for supplying the original mouse breeding pairs, Mei Li for helping with viral preparations, Cameron Baker with manuscript editing, and the CNR Biological Imaging Facility, UC Berkeley. Research reported in this publication was supported in part by the National Institutes of Health S10 program under award number 1S10RR026866-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The graphical abstract was created using BioRender.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Amado DA, 2019, MOL THER, V27, P465, DOI 10.1016/j.ymthe.2018.11.013; Arrant AE, 2018, J NEUROSCI, V38, P2341, DOI 10.1523/JNEUROSCI.3081-17.2018; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Byrne LC, 2015, MOL THER, V23, P290, DOI 10.1038/mt.2014.181; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Dalkara D, 2012, GENE THER, V19, P176, DOI 10.1038/gt.2011.163; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Flannery John G, 2013, Methods Mol Biol, V935, P351, DOI 10.1007/978-1-62703-080-9_25; Hafler B, 2013, INVEST OPHTH VIS SCI, V54; Hafler BP, 2014, BRAIN RES, V1588, P168, DOI 10.1016/j.brainres.2014.09.023; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Holthaus SMK, 2018, MOL THER, V26, P1343, DOI 10.1016/j.ymthe.2018.02.027; Hu C, 2012, GENE THER, V19, P1166, DOI 10.1038/gt.2011.200; Huin V, 2020, BRAIN, V143, P303, DOI 10.1093/brain/awz377; Johnson TB, 2021, MOL THER, V29, P162, DOI 10.1016/j.ymthe.2020.09.033; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Lee CW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0196-6; Ma YB, 2017, EXP GERONTOL, V95, P1, DOI 10.1016/j.exger.2017.05.003; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Mole SE, 2015, BBA-MOL BASIS DIS, V1852, P2237, DOI 10.1016/j.bbadis.2015.05.011; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Pottier C, 2016, J NEUROCHEM, V138, P32, DOI 10.1111/jnc.13622; Radke J, 2015, BBA-MOL BASIS DIS, V1852, P2262, DOI 10.1016/j.bbadis.2015.05.007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; Ward ME, 2014, J EXP MED, V211, P1937, DOI 10.1084/jem.20140214; Zhao PM, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145936; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029	35	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2329-0501		MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.	SEP 10	2021	22									10.1016/j.omtm.2021.05.009			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	UQ1PI	WOS:000695842600005	34485593	Green Published, gold			2022-02-06	
J	Li, HZ; Li, NN; Xing, Y; Zhang, SY; Liu, C; Cai, WX; Hong, W; Zhang, QT				Li, Haozhe; Li, Ningning; Xing, Yan; Zhang, Shengyu; Liu, Chao; Cai, Weixiong; Hong, Wu; Zhang, Qinting			P300 as a Potential Indicator in the Evaluation of Neurocognitive Disorders After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						neurocognitive disorders; traumatic brain injury; event-related potential; P300; daily life ability; social function	EVENT-RELATED POTENTIALS; MILD COGNITIVE IMPAIRMENT; AUDITORY P300; ALZHEIMERS-DISEASE; HEAD-INJURY; SCHIZOPHRENIA; QUETIAPINE; LATENCY; P3A; METAANALYSIS	Few objective indices can be used when evaluating neurocognitive disorders after a traumatic brain injury (TBI). P300 has been widely studied in mental disorders, cognitive dysfunction, and brain injury. Daily life ability and social function are key indices in the assessment of neurocognitive disorders after a TBI. The present study focused on the correlation between P300 and impairment of daily living activity and social function. We enrolled 234 patients with neurocognitive disorders after a TBI according to ICD-10 and 277 age- and gender-matched healthy volunteers. The daily living activity and social function were assessed by the social disability screening schedule (SDSS) scale, activity of daily living (ADL) scale, and scale of personality change following a TBI. P300 was evoked by a visual oddball paradigm. The results showed that the scores of the ADL scale, SDSS scale, and scale of personality change in the patient group were significantly higher than those in the control group. The amplitudes of Fz, Cz, and Pz in the patient group were significantly lower than those in the control group and were negatively correlated with the scores of the ADL and SDSS scales. In conclusion, a lower P300 amplitude means a greater impairment of daily life ability and social function, which suggested more severity of neurocognitive disorders after a TBI. P300 could be a potential indicator in evaluating the severity of neurocognitive disorders after a TBI.</p>	[Li, Haozhe; Xing, Yan; Zhang, Shengyu; Liu, Chao; Cai, Weixiong; Zhang, Qinting] Acad Forens Sci, Shanghai Forens Serv Platform, Shanghai Key Lab Forens Med, Key Lab Forens Sci,Minist Justice, Shanghai, Peoples R China; [Li, Ningning] Hongkou Dist Mental Hlth Ctr, Shanghai, Peoples R China; [Hong, Wu] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai, Peoples R China		Zhang, QT (corresponding author), Acad Forens Sci, Shanghai Forens Serv Platform, Shanghai Key Lab Forens Med, Key Lab Forens Sci,Minist Justice, Shanghai, Peoples R China.; Hong, W (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai, Peoples R China.	drhongwu@126.com; zhangqinting@126.com		Li, Haozhe/0000-0003-1588-1384	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801881, 81001354]; National Key R&D Program of China [2016YFC0800701]; Science and Technology Committee of Shanghai MunicipalityShanghai Science & Technology Committee [20DZ1200300, 19DZ2292700, 17DZ2273200]	This study was supported by the National Natural Science Foundation of China (81801881 and 81001354), the National Key R&D Program of China (2016YFC0800701), and the Science and Technology Committee of Shanghai Municipality (20DZ1200300, 19DZ2292700, and 17DZ2273200).	Alberti A, 2001, HEADACHE, V41, P579, DOI 10.1046/j.1526-4610.2001.041006579.x; Almeida PR, 2011, INT J PSYCHOPHYSIOL, V81, P159, DOI 10.1016/j.ijpsycho.2011.06.006; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Costa L, 2000, BIOL PSYCHIAT, V47, P1064, DOI 10.1016/S0006-3223(99)00317-0; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Deb S, 1999, AM J PSYCHIAT, V156, P374; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Egerhazi Aniko, 2008, Psychiatr Hung, V23, P349; Fan Hui-yu, 2016, Fa Yi Xue Za Zhi, V32, P100; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Geisler MW, 1999, J CLIN EXP NEUROPSYC, V21, P108, DOI 10.1076/jcen.21.1.108.935; Gold LH, 2008, J AM ACAD PSYCHIATRY, V36, pS3; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; Granacher RP., 2003, TRAUMATIC BRAIN INJU; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hansenne M, 2000, NEUROPHYSIOL CLIN, V30, P211, DOI 10.1016/S0987-7053(00)00224-0; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Howe AS, 2014, BRAIN COGNITION, V86, P64, DOI 10.1016/j.bandc.2014.01.015; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Jeon YW, 2001, PSYCHIAT RES, V104, P61, DOI 10.1016/S0165-1781(01)00297-9; Jin J, 2020, IEEE T NEUR SYS REH, V28, P3, DOI 10.1109/TNSRE.2019.2956488; Jin J, 2020, IEEE T BIO-MED ENG, V67, P2585, DOI 10.1109/TBME.2020.2965178; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; Korostenskaja M, 2009, ANN CLIN PSYCHIATRY, V21, P49; Ladouce S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51996-y; Lai CL, 2010, CLIN NEUROPHYSIOL, V121, P194, DOI 10.1016/j.clinph.2009.11.001; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Li X., 2006, CHIN J CLIN REHABIL, V10, P10, DOI [10.12307/j.issn.2095-4344.2006.06.004, DOI 10.12307/J.ISSN.2095-4344.2006.06.004]; [刘子龙 Liu Zilong], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P19; Meares R, 2005, NEUROREPORT, V16, P289, DOI 10.1097/00001756-200502280-00018; Medvidovic Stipe, 2013, Acta Inform Med, V21, P89, DOI 10.5455/aim.2013.21.89-92; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Papadaniil CD, 2016, BRAIN RES, V1648, P425, DOI 10.1016/j.brainres.2016.07.043; Papaliagkas VT, 2011, CLIN NEUROPHYSIOL, V122, P1322, DOI 10.1016/j.clinph.2010.12.036; Park EJ, 2010, PROG NEURO-PSYCHOPH, V34, P674, DOI 10.1016/j.pnpbp.2010.03.011; Park HY, 2015, OCCUP THER INT, V22, P104, DOI 10.1002/oti.1389; Pedroso RV, 2012, BRAZ J OTORHINOLAR, V78, P126, DOI 10.1590/S1808-86942012000400023; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2005, Current Alzheimer Research, V2, P515, DOI 10.2174/156720505774932214; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sirois K, 2019, NEUROPSYCHOL REHABIL, V29, P1383, DOI 10.1080/09602011.2017.1413987; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tripathi Shailendra Mohan, 2015, Ind Psychiatry J, V24, P163, DOI 10.4103/0972-6748.181726; van der Westhuizen N, 2020, AM J AUDIOL, V29, P120, DOI 10.1044/2019_AJA-19-00095; Weddell RA, 2016, BRAIN INJURY, V30, P1362, DOI 10.1080/02699052.2016.1195921; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Yu Y, 2019, IEEE T NEUR SYS REH, V27, P1292, DOI 10.1109/TNSRE.2019.2914916; Zhang Qin-Ting, 2014, Fa Yi Xue Za Zhi, V30, P23; Zhang Y, 2009, PHARMACOPSYCHIATRY, V42, P129, DOI 10.1055/s-0028-1112133; Zhou L, 2019, NORD J PSYCHIAT, V73, P1, DOI 10.1080/08039488.2018.1478991; 夏文涛, 2016, [法医学杂志, Journal of Forensic Medicine], V32, P211	63	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 9	2021	12								690792	10.3389/fneur.2021.690792			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UU2KN	WOS:000698630400001	34566838	Green Published, gold			2022-02-06	
J	Lusardi, TA; Sandau, US; Sakhanenko, NA; Baker, SCB; Wiedrick, JT; Lapidus, JA; Raskind, MA; Li, G; Peskind, ER; Galas, DJ; Quinn, JF; Saugstad, JA				Lusardi, Theresa A.; Sandau, Ursula S.; Sakhanenko, Nikita A.; Baker, Sarah Catherine B.; Wiedrick, Jack T.; Lapidus, Jodi A.; Raskind, Murray A.; Li, Ge; Peskind, Elaine R.; Galas, David J.; Quinn, Joseph F.; Saugstad, Julie A.			Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						veterans; deployment; mild traumatic brain injury; cerebrospinal fluid; microRNA; Alzheimer's disease	ALZHEIMERS-DISEASE; PUTATIVE BIOMARKERS; UP-REGULATION; EXPRESSION; RISK; DEMENTIA; IDENTIFICATION; PROGRESSION; BIOGENESIS; MECHANISMS	A history of traumatic brain injury (TBI) increases the odds of developing Alzheimer's disease (AD). The long latent period between injury and dementia makes it difficult to study molecular changes initiated by TBI that may increase the risk of developing AD. MicroRNA (miRNA) levels are altered in TBI at acute times post-injury (<4 weeks), and in AD. We hypothesized that miRNA levels in cerebrospinal fluid (CSF) following TBI in veterans may be indicative of increased risk for developing AD. Our population of interest is cognitively normal veterans with a history of one or more mild TBI (mTBI) at a chronic time following TBI. We measured miRNA levels in CSF from three groups of participants: (1) community controls with no lifetime history of TBI (ComC); (2) deployed Iraq/Afghanistan veterans with no lifetime history of TBI (DepC), and (3) deployed Iraq/Afghanistan veterans with a history of repetitive blast mTBI (DepTBI). CSF samples were collected at the baseline visit in a longitudinal, multimodal assessment of Gulf War veterans, and represent a heterogenous group of male veterans and community controls. The average time since the last blast mTBI experienced was 4.7 +/- 2.2 years [1.5 - 11.5]. Statistical analysis of TaqMan miRNA array data revealed 18 miRNAs with significant differential expression in the group comparisons: 10 between DepTBI and ComC, 7 between DepC and ComC, and 8 between DepTBI and DepC. We also identified 8 miRNAs with significant differential detection in the group comparisons: 5 in DepTBI vs. ComC, 3 in DepC vs. ComC, and 2 in DepTBI vs. DepC. When we applied our previously developed multivariable dependence analysis, we found 13 miRNAs (6 of which are altered in levels or detection) that show dependencies with participant phenotypes, e.g., ApoE. Target prediction and pathway analysis with miRNAs differentially expressed in DepTBI vs. either DepC or ComC identified canonical pathways highly relevant to TBI including senescence and ephrin receptor signaling, respectively. This study shows that both TBI and deployment result in persistent changes in CSF miRNA levels that are relevant to known miRNA-mediated AD pathology, and which may reflect early events in AD.</p>	[Lusardi, Theresa A.] Oregon Hlth & Sci Univ, Knight Canc Inst, Canc Early Detect Adv Res Ctr, Portland, OR 97201 USA; [Sandau, Ursula S.; Baker, Sarah Catherine B.; Saugstad, Julie A.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Sakhanenko, Nikita A.; Galas, David J.] Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA; [Wiedrick, Jack T.; Lapidus, Jodi A.] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA; [Raskind, Murray A.; Li, Ge; Peskind, Elaine R.] VA Puget Sound Hlth Care Syst, Northwest Mental Illness, Res Educ & Clin Ctr, Seattle, WA USA; [Raskind, Murray A.; Li, Ge; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Li, Ge] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Quinn, Joseph F.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Quinn, Joseph F.] Oregon Hlth & Sci Univ, Sch Med, Parkinson Ctr & Movement Disorders Program, Portland, OR 97201 USA; [Quinn, Joseph F.] Portland VAMC Parkinsons Dis Res Educ & Clin Ctr, Portland, OR USA		Saugstad, JA (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA.	saugstad@ohsu.edu		Sakhanenko, Nikita/0000-0001-6256-4643	Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Alzheimer's Research Program under the United States Army Medical Research Acquisition Activity (USAMRAA) [W81XWH-15-1-0318]; VA Rehabilitation Research and Development Merit Review grantUS Department of Veterans Affairs [B77421]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Alzheimer's Research Program under the United States Army Medical Research Acquisition Activity (USAMRAA) grant award number W81XWH-15-1-0318 (JQ), VA Rehabilitation Research and Development Merit Review grant B77421 (EP), and an anonymous foundation (EP). Opinions, interpretations, conclusion, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Arun P, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00438; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Batistela MS, 2017, INT J NEUROSCI, V127, P547, DOI 10.1080/00207454.2016.1209754; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bi BB, 2019, EXP NEUROBIOL, V28, P362, DOI 10.5607/en.2019.28.3.362; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1007/BF03206605; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Cheng L, 2015, MOL PSYCHIATR, V20, P1188, DOI 10.1038/mp.2014.127; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dal Pozzo V, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10070975; Dalgard CL, 2016, J OCCUP ENVIRON MED, V58, pS97, DOI 10.1097/JOM.0000000000000764; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Denk J, 2018, METHODS MOL BIOL, V1750, P93, DOI 10.1007/978-1-4939-7704-8_6; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Divolis G, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz028; Dorval V, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00024; Duman Joseph G, 2021, Small GTPases, P1, DOI 10.1080/21541248.2021.1885264; El Fatimy R, 2018, ACTA NEUROPATHOL, V136, P537, DOI 10.1007/s00401-018-1880-5; Ferland CL, 2014, ENDOCRINOLOGY, V155, P2942, DOI 10.1210/en.2013-1918; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Galas DJ, 2014, J COMPUT BIOL, V21, P118, DOI 10.1089/cmb.2013.0039; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Ghai V, 2020, J NEUROTRAUM, V37, P1418, DOI 10.1089/neu.2019.6826; Greer K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72380-1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hascup KN., 2020, ALZHEIMERS DEMENT NY, V6, pE12070; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hernandez-Rapp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30953; Herrera-Espejo S, 2019, MOL NEUROBIOL, V56, P8376, DOI 10.1007/s12035-019-01676-9; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Juzwik CA, 2019, PROG NEUROBIOL, V182, DOI 10.1016/j.pneurobio.2019.101664; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kowalski EA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1605-2; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Kumar S, 2016, BBA-MOL BASIS DIS, V1862, P1617, DOI 10.1016/j.bbadis.2016.06.001; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liu QL, 2021, EXP GERONTOL, V144, DOI 10.1016/j.exger.2020.111187; Liu WJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1629-z; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Lusardi TA, 2017, J ALZHEIMERS DIS, V55, P1223, DOI 10.3233/JAD-160835; Ma SQ, 2019, MILITARY MED RES, V6, DOI 10.1186/s40779-019-0203-z; Martinez-Cue C, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00016; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; McGill WJ., 1954, PSYCHOMETRIKA, V2, P97, DOI [10.1007/BF02289159, DOI 10.1007/BF02289159]; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKeever PM, 2018, MOL NEUROBIOL, V55, P8826, DOI 10.1007/s12035-018-1032-x; Mulherkar S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010245; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Peskind ER, 2005, ALZ DIS ASSOC DIS, V19, P220, DOI 10.1097/01.wad.0000194014.43575.fd; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Putteeraj M, 2017, CNS NEUROL DISORD-DR, V16, P1000, DOI 10.2174/1871527316666170807142311; Sakhanenko NA, 2017, J COMPUT BIOL, V24, P1153, DOI 10.1089/cmb.2017.0143; Sakhanenko NA, 2015, J COMPUT BIOL, V22, P1005, DOI 10.1089/cmb.2015.0051; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Sandau US, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12028; Sandau US, 2020, J ALZHEIMERS DIS, V78, P245, DOI 10.3233/JAD-200396; Schwab N, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01190-x; Sen N, 2019, NEURAL REGEN RES, V14, P1215, DOI 10.4103/1673-5374.251305; Sharma HS, 2020, PROG BRAIN RES, V258, P233, DOI 10.1016/bs.pbr.2020.09.009; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sibener L, 2014, ALZHEIMERS DEMENT, V10, pS105, DOI 10.1016/j.jalz.2014.04.011; Slota JA, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020035; Smith PY, 2015, HUM MOL GENET, V24, P6721, DOI 10.1093/hmg/ddv377; Takousis P, 2019, ALZHEIMERS DEMENT, V15, P1468, DOI 10.1016/j.jalz.2019.06.4952; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; Tan ZJ, 2020, ANN CLIN TRANSL NEUR, V7, P742, DOI 10.1002/acn3.51044; Tian Z, 2021, NEUROSCI LETT, V742, DOI 10.1016/j.neulet.2020.135542; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ML, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00153; Wang Y, 2017, NEUROBIOL AGING, V51, P156, DOI 10.1016/j.neurobiolaging.2016.12.015; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Wiedrick JT, 2019, J ALZHEIMERS DIS, V67, P875, DOI 10.3233/JAD-180539; Woeller CF, 2016, J OCCUP ENVIRON MED, V58, pS89, DOI 10.1097/JOM.0000000000000769; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yaffe K, 2019, NEUROLOGY, V92, pE205, DOI 10.1212/WNL.0000000000006778; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004; Yuen EY, 2017, INT J NEUROPSYCHOPH, V20, P948, DOI 10.1093/ijnp/pyx052; Zafari S, 2015, GERONTOLOGY, V61, P497, DOI 10.1159/000375236; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	107	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 9	2021	15								720778	10.3389/fnins.2021.720778			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU5DS	WOS:000698821400001	34580583	Green Published, gold			2022-02-06	
J	Marrosu, F; Mancosu, S; Lai, G; Fraschini, M; Muroni, A; Demuru, M; Monticone, M; Defazio, G				Marrosu, Francesco; Mancosu, Stefano; Lai, Gianluca; Fraschini, Matteo; Muroni, Antonella; Demuru, Matteo; Monticone, Marco; Defazio, Giovanni			Reshaping cortical connectivity in traumatic spinal cord injury: a novel effect of hyperbaric oxygen therapy	SPINAL CORD SERIES AND CASES			English	Article								Introduction Spinal cord injuries (SCIs) represent a severe neuro-traumatic occurrence and an excruciating social burden. Though the hyperbaric oxygen (HBO2) has been credited as a first line therapeutic resource for SCIs, its mechanism of action in the spine is only partially known, while the impingement upon other areas of the nervous system deserves additional investigation. In this study we deem to describe a novel effect of HBO2 in a subject affected by SCI who, along with the clinical improvement, showed a reshaped connectivity in cortical sensory-motor areas. Case presentation A 45 years male presenting severe sensory-motor symptoms following a spinal lesion partially involving the C1 segment was successfully treated with HBO2 cycles. After the dramatic improvement reflected by an excellent optimization of the single performances, it has been investigated whether this result would reveal not only an intrinsic effect upon the spinal cord, but also a better connectivity strength in sensory-motor cortical regions. The results obtained by implementing EEG recordings with EEGLAB auto regressive vector plugins indeed suggest a substantial reshaping of cortico-cortical connectivity after HBO2. Discussion These results show a correlation between positive clinical evolution and a new modulation of cortical connectivity. Though further clinical investigations would clarify as to whether HBO2 might be directly or epiphenomenally involved in this aspect of the network architecture, our report suggests that a comparison between clinical results and the study of brain connectivity represent a holistic approach in investigating the physiopathology of SCIs and in monitoring the treatment.	[Marrosu, Francesco] AIAS Cagliari, Cagliari, Italy; [Mancosu, Stefano; Lai, Gianluca] ATS Sardegna, Intens Care, Cagliari, Italy; [Mancosu, Stefano; Lai, Gianluca] ATS Sardegna, Ctr Hyperbar Med, Cagliari, Italy; [Fraschini, Matteo] Univ Cagliari, Dept Elect & Elect Engn, Cagliari, Italy; [Muroni, Antonella; Demuru, Matteo; Monticone, Marco; Defazio, Giovanni] Univ Cagliari, Dipartimento Sci Med & Sanita Pubbl, Cagliari, Italy		Marrosu, F (corresponding author), AIAS Cagliari, Cagliari, Italy.	francescomarrosu@gmail.com	Monticone, Marco/AAC-4494-2022				Asamoto S, 2000, SPINAL CORD, V38, P538, DOI 10.1038/sj.sc.3101023; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Ebbesen CL, 2018, J NEUROSCI, V38, P9402, DOI 10.1523/JNEUROSCI.1671-18.2018; FORNITO A., 2016, FUNDAMENTALS BRAIN N; Fraschini M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036015; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P535, DOI 10.1179/204577211X13207446293695; Krigolson OE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00109; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Marek S, 2018, DIALOGUES CLIN NEURO, V20, P133; Patel NP, 2017, MED GAS RES, V7, P133, DOI 10.4103/2045-9912.208520; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Ueno M, 2018, CELL REP, V23, P1286, DOI 10.1016/j.celrep.2018.03.137	15	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2058-6124			SPINAL CORD SER CASE	Spinal Cord Ser. Cases	SEP 9	2021	7	1							80	10.1038/s41394-021-00441-2			4	Clinical Neurology; Rehabilitation	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Rehabilitation	UO6YO	WOS:000694839200001	34504060	hybrid, Green Published			2022-02-06	
J	Reddy, DD; Davenport, EM; Yu, FF; Wagner, B; Urban, JE; Whitlow, CT; Stitzel, JD; Maldjian, JA				Reddy, D. D.; Davenport, E. M.; Yu, F. F.; Wagner, B.; Urban, J. E.; Whitlow, C. T.; Stitzel, J. D.; Maldjian, J. A.			Alterations in the Magnetoencephalography Default Mode Effective Connectivity following Concussion	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; RESTING STATE NETWORKS; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; IMAGING APPROACH; FMRI; MEG; SYSTEM; CORTEX	BACKGROUND AND PURPOSE: Magnetoencephalography is sensitive to functional connectivity changes associated with concussion. However, the directional influences between functionally related regions remain unexplored. In this study, we therefore evaluated concussion-related magnetoencephalography-based effective connectivity changes within resting-state default mode network regions. MATERIALS AND METHODS: Resting-state magnetoencephalography was acquired for 8 high school football players with concussion at 3 time points (preseason, postconcussion, postseason), as well as 8 high school football players without concussion and 8 age-matched controls at 2 time points (preseason, postseason). Time-series from the default mode network regions were extracted, and effective connectivity between them was computed for 5 different frequency bands. The default mode network regions were grouped into anterior and posterior default mode networks. The combined posterior-to-anterior and anterior-to-posterior effective connectivity values were averaged to generate 2 sets of values for each subject. The effective connectivity values were compared using a repeated measures ANOVA across time points for the concussed, nonconcussed, and control groups, separately. RESULTS: A significant increase in posterior-to-anterior effective connectivity from preseason to postconcussion (corrected P value?= .013) and a significant decrease in posterior-to-anterior effective connectivity from postconcussion to postseason (corrected P value?= .028) were observed in the concussed group. Changes in effective connectivity were only significant within the delta band. Anterior-to-posterior connectivity demonstrated no significant change. Effective connectivity in the nonconcussed group and controls did not show significant differences. CONCLUSIONS: The unidirectional increase in effective connectivity postconcussion may elucidate compensatory processes, invoking use of posterior regions to aid the function of susceptible anterior regions following brain injury. These findings support the potential value of magnetoencephalography in exploring directional changes of the brain network following concussion.	[Reddy, D. D.; Davenport, E. M.; Yu, F. F.; Wagner, B.; Maldjian, J. A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX 75390 USA; [Urban, J. E.; Whitlow, C. T.; Stitzel, J. D.] Wake Forest Sch Med, Winston Salem, NC 27101 USA		Reddy, DD (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	divya.reddy@utsouthwestern.edu		Davenport, Elizabeth/0000-0002-8765-6584	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS082453, R01 NS091602]	Support for this research was provided by National Institutes of Health R01 NS082453 and R01 NS091602 (J.A.M., J.D.S., C.T.W.).	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; D'Andola Mattia, 2018, Cereb Cortex, V28, P2233, DOI 10.1093/cercor/bhx122; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillebrand A, 2016, P NATL ACAD SCI USA, V113, P3867, DOI 10.1073/pnas.1515657113; Hristopulos DT, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00419; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kabbara A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03420-6; Lee RR, 2014, PROG NEUROL SURG, V28, P94, DOI 10.1159/000358768; Li LY, 2015, IEEE ENG MED BIO, P6963, DOI 10.1109/EMBC.2015.7319994; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Maldjian JA, 2014, NEUROIMAGE, V96, P88, DOI 10.1016/j.neuroimage.2014.03.065; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Nichols S, 2014, J ATHLETIC ENHANCEME, V3, P4, DOI [10.4172/2324-9080.1000155, DOI 10.4172/2324-9080.1000155]; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Schwartz ES, 2010, PEDIATR RADIOL, V40, P50, DOI 10.1007/s00247-009-1451-y; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tana MG, 2012, COMPUT BIOL MED, V42, P943, DOI 10.1016/j.compbiomed.2012.07.003; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tormenti M, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12282; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; WANG L, 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/3870863; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	46	0	0	2	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2021	42	10					1776	1782		10.3174/ajnr.A7232		SEP 2021	7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	YI5PO	WOS:000695575600001	34503943	hybrid			2022-02-06	
J	Summerell, PA; Smillie, LD; Anderson, JFI				Summerell, Patrick A.; Smillie, Luke D.; Anderson, Jacqueline F. I.			Personality traits beyond Neuroticism predict post-concussive symptomatology in the post-acute period after mild traumatic brain injury in premorbidly healthy adults	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Mild traumatic brain injury; Neuroticism; outcome; personality; post-concussive symptoms	HIGHER-ORDER FACTORS; BIG 5; CONSTRUCT-VALIDITY; WECHSLER TEST; HEAD-INJURY; SYMPTOMS; DEPRESSION; COMPLAINTS; DOMAINS; INVENTORY	There is growing evidence that an individual's personality traits are related to post-concussion symptomatology beyond the acute period after mild traumatic brain injury (mTBI). Few studies, however, have analyzed this impact beyond the personality trait of Neuroticism. We examined the impact of personality traits on post-concussion symptoms (PCS) by measuring the Big Five personality domains and their lower-order aspects in 87 pre-morbidly healthy participants assessed 6-12 weeks post-mTBI (n = 53) or physical trauma (n = 34). As expected, Neuroticism predicted PCS endorsement in both groups. Conscientiousness and Openness/intellect were predictive of lower PCS endorsement, but only in the mTBI group. Withdrawal, one aspect within the Neuroticism domain, independently predicted PCS endorsement in the mTBI group; the remaining Neuroticism aspect, Volatility, did not predict PCS endorsement in either group. These findings suggest that individuals high in Neuroticism are more likely to report PCS following mTBI and that this relationship is driven by susceptibility to depression/anxiety symptoms (Withdrawal aspect) rather than irritability (Volatility aspect). Further, they suggest that the current focus on the relationship between Neuroticism and PCS reporting in individuals with mTBI should be broadened to include other personality domains, such as Conscientiousness and Openness/intellect.	[Summerell, Patrick A.; Smillie, Luke D.; Anderson, Jacqueline F. I.] Univ Melbourne, Melbourne Sch Psychol Sci, Redmond Barry Bldg, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F. I.] Alfred Hosp, Psychol Dept, Melbourne, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Redmond Barry Bldg, Melbourne, Vic 3010, Australia.	jfande@unimelb.edu.au		Smillie, Luke/0000-0001-5148-8358			Allen T.A., 2016, OXFORD HDB 5 FACTOR, P1, DOI [10.1152/jn.1998.80.1.1, DOI 10.1152/JN.1998.80.1.1]; Bagby RM, 2016, CLIN PSYCHOL-SCI PR, V23, P365, DOI 10.1111/cpsp.12175; Beck AT, 1993, BECK ANXIETY INVENTO; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Comijs HC, 2002, J AFFECT DISORDERS, V72, P157, DOI 10.1016/S0165-0327(01)00453-0; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Costa PT., 1992, PSYCHOL ASSESS, V4, P5, DOI [10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5]; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; DeYoung CG, 2016, PERSONAL DISORD, V7, P113, DOI 10.1037/per0000170; DeYoung CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00762; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Field A, 2013, DISCOVERING STAT USI; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Ludeke SG, 2019, J PERS, V87, P1025, DOI 10.1111/jopy.12453; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Oldenburg C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020884; Plass AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210138; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd, P1; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Quilty LC, 2013, J AFFECT DISORDERS, V147, P247, DOI 10.1016/j.jad.2012.11.012; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; Schnurr, 2013, PTSD CHECKLIST DSM 5; Silver JM., 2013, MANAGEMENT ADULTS TR, P475; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Skandsen T, 2021, ARCH PHYS MED REHAB, V102, P1102, DOI 10.1016/j.apmr.2020.10.106; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Thalmayer AG, 2011, PSYCHOL ASSESSMENT, V23, P995, DOI 10.1037/a0024165; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; WechslerD, 2001, WECHSLER TEST ADULT; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Wiernik BM, 2019, IND ORGAN PSYCHOL-US, V12, P157, DOI 10.1017/iop.2019.31; Wilson BA, 2010, WIRES COGN SCI, V1, P108, DOI 10.1002/wcs.15; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638	63	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1970554		SEP 2021	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UP2ID	WOS:000695207600001	34514926				2022-02-06	
J	Tourigny, JN; Paquet, V; Fortier, E; Malo, C; Mercier, E; Chauny, JM; Clark, G; Blanchard, PG; Boucher, V; Carmichael, PH; Gariepy, JL; Emond, M				Tourigny, Jean-Nicolas; Paquet, Veronique; Fortier, Emile; Malo, Christian; Mercier, Eric; Chauny, Jean-Marc; Clark, Gregory; Blanchard, Pierre-Gilles; Boucher, Valerie; Carmichael, Pierre-Hugues; Gariepy, Jean-Luc; Emond, Marcel			Predictors of neurosurgical intervention in complicated mild traumatic brain injury patients: a retrospective cohort study	BRAIN INJURY			English	Article						Mild traumatic brain injury; intracranial hemorrhage; neurosurgical intervention	CRANIAL COMPUTED-TOMOGRAPHY; MINIMAL HEAD-INJURY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; CLINICAL-SIGNIFICANCE; INFLUENCE MANAGEMENT; LOW-RISK; CT; DETERIORATION; GUIDELINES	Objectives To determine the predicting demographic, clinical and radiological factors for neurosurgical intervention in complicated mild traumatic brain injury (mTBI) patients. Methods Design: retrospective multicenter cohort study. Participants: patients aged >= 16 presenting to all level-I trauma centers in Quebec between 09/2016 and 12/2017 with mTBI(GCS 13-15) and complication on initial head CT (intracranial hemorrhage/skull fracture). Procedure: Consecutive medical records were reviewed and separated into two groups: no neurosurgical intervention and neurosurgical intervention (NSI). Main outcome: neurosurgical intervention. Analysis: multiple logistic regression model. Results Four hundred and seventy-eight patients were included and 40 underwent NSI. One patient had radiological deterioration but no clinical deterioration prior to surgery. Subdural hemorrhage >= 4 mm width (OR:3.755 [95% CI:1.290-10.928]) and midline shift (OR:7.507 [95% CI: 3.317-16.989]) increased the risk of NSI. Subarachnoid hemorrhage was associated with a lower risk of NSI (OR:0.312 [95% CI: 0.136-0.713]). All other intracranial hemorrhages were not associated with NSI. Conclusion Radiological deterioration was not associated with the incidence of NSI. Subdural hemorrhage and midline shift should be predicting factors for neurosurgery. Some patients with isolated findings such as subarachnoid hemorrhage could be safely managed in their original center without being transferred to a level-I trauma center.	[Tourigny, Jean-Nicolas; Paquet, Veronique; Fortier, Emile; Malo, Christian; Mercier, Eric; Blanchard, Pierre-Gilles; Emond, Marcel] Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Malo, Christian; Mercier, Eric; Blanchard, Pierre-Gilles; Boucher, Valerie; Gariepy, Jean-Luc; Emond, Marcel] Univ Laval, Chu Quebec, Quebec City, PQ, Canada; [Mercier, Eric; Blanchard, Pierre-Gilles; Boucher, Valerie; Emond, Marcel] Vitam Ctr Rech Sante Durable, Quebec City, PQ, Canada; [Chauny, Jean-Marc] Univ Montreal, Montreal, PQ, Canada; [Clark, Gregory] McGill Univ, Montreal, PQ, Canada; [Boucher, Valerie; Carmichael, Pierre-Hugues; Emond, Marcel] Ctr Excellence Sur Vieillissement Quebec, Quebec City, PQ, Canada		Emond, M (corresponding author), Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Frcp C,Chu Quebec,Hop Enfant Jesus, 1401,18e Rue,H-608, Quebec City, PQ G1J 1Z4, Canada.	marcelemond1@me.com		Clark, Gregory/0000-0002-6752-9676	VITAM -Centre de recherche en sante durable	ME has received a research grant from the Centre de recherche sur les soins et les services de premiere ligne de l'Universite Laval (now named VITAM -Centre de recherche en sante durable) (no grant number). The granting institution was in no way involved in the design, data collection and analyses of this study	AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Gupta S, 2020, INT J SURG, V76, P88, DOI 10.1016/j.ijsu.2020.02.016; Institut national d'excellence en sant? et services sociaux (INESSS), 2011, DEC ALG SER NEUR COM; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Martin GE, 2018, J TRAUMA ACUTE CARE, V84, P483, DOI 10.1097/TA.0000000000001767; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Orlando A, 2019, J NEUROSURG, V130, P1616, DOI 10.3171/2018.1.JNS171884; Orlando A, 2017, WORLD NEUROSURG, V107, P94, DOI [10.1016/j.wneu.2017.07.130, 10.1016/J.WNEU.2017.07.130]; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Sharifuddin Ashraf, 2012, Med J Malaysia, V67, P305; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Van Ornam J, 2019, AM J EMERG MED, V37, P1694, DOI 10.1016/j.ajem.2018.12.012; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wang Justin Z, 2019, CMAJ Open, V7, pE511, DOI 10.9778/cmajo.20180188; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	32	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1267	1274		10.1080/02699052.2021.1972147		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000693565200001	34488497				2022-02-06	
J	Yamazaki, M; De Larochelambert, Q; Sauliere, G; Toussaint, JF; Antero, J				Yamazaki, Moi; De Larochelambert, Quentin; Sauliere, Guillaume; Toussaint, Jean-Francois; Antero, Juliana			Heads-Up: Risk-Specific Neurodegenerative Mortality and Years-Saved Analysis on the US Olympian Cohort	FRONTIERS IN PHYSIOLOGY			English	Article						neurodegenerative mortality; sports-related traumatic brain injury; Olympians; longevity; survival	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; DEATH; ASSOCIATION; CONTACT; DISEASE; SPORTS	Purpose: This study aimed to identify the risk of neurodegenerative death (ND) that former Olympians endure due to their participation in sports grouped based on presumed repeated shocks to the head, and to understand the impact of their participation in such elite sports on their total longevity. Materials and Methods: The cohort included all former US Olympians, who participated in the Olympic Games (OG) between 1948 and 1972, and whose vital status and causes of death were verified (n = 2,193). Olympic sports were classified into three categories of exposure: Collision (the highest presumed risk of repeated shocks to the head), Contact, and No-Contact. The Fine-Gray competing risk regression model was used to compare the risk of ND where the No-Contact category was a reference group. The years-saved analysis was performed to quantify the number of years saved or lost to ND and total longevity compared with the US general population. Results: A total of 65 NDs were identified. Collision sports Olympians had a 3.11 (95% CI: 1.31-7.40) higher risk of ND while the Contact group showed a risk of 0.56 (95% CI: 0.21-1.48) compared with the No-Contact sports Olympians. Compared with the general population, the Collision group lost 0.61 (95% CI: -1.16-0.06) years of life from ND, while the Contact group saved 0.4 (95% CI: 0.26-0.54) and the No-Contact group saved 0.09 (-0.09-0.28) years of life up to the age of 90. Regarding the total longevity, Collision, Contact, and No-Contact groups saved 4.67 (95% CI: 3.13-6.22), 5.8 (95% CI: 4.93-6.67), and 6.24 (95% CI: 5.57-6.92) years of life, respectively, from all causes of death. Conclusion: There is an elevated risk of ND among US Olympians, who engaged in sports with the highest presumed risk of repeated shocks to the head compared with those exposed to no such hazard. Such risk does not jeopardize the total longevity among Olympians in Collision sports.	[Yamazaki, Moi; De Larochelambert, Quentin; Sauliere, Guillaume; Toussaint, Jean-Francois; Antero, Juliana] Natl Inst Sport Expertise & Performance INSEP, Inst Biomed & Epidemiol Res Sport IRMES, Paris, France; [Toussaint, Jean-Francois] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, Paris, France		Antero, J (corresponding author), Natl Inst Sport Expertise & Performance INSEP, Inst Biomed & Epidemiol Res Sport IRMES, Paris, France.	Juliana.antero@insep.fr					Antero J, 2021, BRIT J SPORT MED, V55, P206, DOI 10.1136/bjsports-2019-101696; Antero-Jacquemin J, 2018, EUR J EPIDEMIOL, V33, P531, DOI 10.1007/s10654-018-0401-0; Antero-Jacquemin J, 2015, AM J SPORT MED, V43, P1505, DOI 10.1177/0363546515574691; Cierna D, 2019, CLIN J SPORT MED, V29, P336, DOI 10.1097/JSM.0000000000000526; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Division of Nutrition Physical Activity and Obesity and National Center For Chronic Disease Prevention And Health Promotion., 2021, DEF AD OV OB OV OBES; Duncombe SL, 2021, BRIT J SPORT MED, V55, P900, DOI 10.1136/bjsports-2020-102624; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Kettunen JA, 2015, BRIT J SPORT MED, V49, P893, DOI 10.1136/bjsports-2013-093347; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ljungqvist A, 2009, CLIN J SPORT MED, V19, P347, DOI 10.1097/JSM.0b013e3181b7332c; McCradden MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00772; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Popa-Wagner A, 2020, NEURAL REGEN RES, V15, P394, DOI 10.4103/1673-5374.266045; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Radonic V, 2017, CROAT MED J, V58, P263, DOI 10.3325/cmj.2017.58.263; Ramkumar PN, 2019, AM J SPORT MED, V47, P2287, DOI 10.1177/0363546519859542; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Simmons MM, 2017, J ATHL TRAINING, V52, P776, DOI 10.4085/1062-6050-52.4.03; Zwiers R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7456	25	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	SEP 9	2021	12								705616	10.3389/fphys.2021.705616			8	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	UU2OJ	WOS:000698640400001	34566678	Green Published, gold			2022-02-06	
J	Al Barajraji, M; Bogossian, E; Dewitte, O; Gaspard, N; El Hadwe, S; Minini, A; Andre, J; Taccone, FS; Schuind, S; Barrit, S				Al Barajraji, Mejdeddine; Bogossian, Elisa; Dewitte, Olivier; Gaspard, Nicolas; El Hadwe, Salim; Minini, Andrea; Andre, Joachim; Taccone, Fabio Silvio; Schuind, Sophie; Barrit, Sami			Safety profile of an intracranial multimodal monitoring bolt system for neurocritical care: a single-center experience	ACTA NEUROCHIRURGICA			English	Article						PbtO(2); Acute brain injury; Monitoring; Complications	TRAUMATIC BRAIN-INJURY; PARTIAL-PRESSURE; TISSUE OXYGEN	Background Intracranial multimodality monitoring (iMMM) is increasingly used in acute brain-injured patients; however, safety and reliability remain major concerns to its routine implementation. Methods We performed a retrospective study including all patients undergoing iMMM at a single European center between July 2016 and January 2020. Brain tissue oxygenation probe (PbtO(2)), alone or in combination with a microdialysis catheter and/or an 8-contact depth EEG electrode, was inserted using a triple-lumen bolt system and targeting normal-appearing at-risk brain area on the injured side, whenever possible. Surgical complications, adverse events, and technical malfunctions, directly associated with iMMM, were collected. A blinded imaging review was performed by an independent radiologist. Results One hundred thirteen patients with 123 iMMM insertions were included for a median monitoring time of 9 [3-14] days. Of those, 93 (76%) patients had only PbtO(2) probe insertion and 30 (24%) had also microdialysis and/or iEEG monitoring. SAH was the most frequent indication for iMMM (n = 60, 53%). At least one complication was observed in 67/123 (54%) iMMM placement, corresponding to 58/113 (51%) patients. Misplacement was observed in 16/123 (13%), resulting in a total of 6/16 (38%) malfunctioning PbtO(2) catheters. Intracranial hemorrhage was observed in 14 iMMM placements (11%), of which one required surgical drainage. Five placements were complicated by pneumocephalus and 4 with bone fragments; none of these requires additional surgery. No CNS infection related to iMMM was observed. Seven (6%) probes were accidentally dislodged and 2 probes (2%) were accidentally broken. Ten PbtO(2) probes (8%) presented a technical malfunction after a median of 9 [ranges: 2-24] days after initiation of monitoring and 4 of them were replaced. Conclusions In this study, a high occurrence of complications related to iMMM was observed, although most of them did not require specific interventions and did not result in malfunctioning monitoring.	[Al Barajraji, Mejdeddine; Dewitte, Olivier; El Hadwe, Salim; Schuind, Sophie; Barrit, Sami] Univ Libre Bruxelles ULB, Dept Neurosurg, Hop Erasme, Route Lennik 808, B-1070 Brussels, Belgium; [Bogossian, Elisa; Minini, Andrea; Taccone, Fabio Silvio] Univ Libre Bruxelles ULB, Dept Intens Care, Hop Erasme, Brussels, Belgium; [Gaspard, Nicolas] Univ Libre Bruxelles ULB, Dept Neurol, Hop Erasme, Brussels, Belgium; [Andre, Joachim] Univ Libre Bruxelles ULB, Hop Erasme, Dept Radiol, Brussels, Belgium		Al Barajraji, M (corresponding author), Univ Libre Bruxelles ULB, Dept Neurosurg, Hop Erasme, Route Lennik 808, B-1070 Brussels, Belgium.	mejdi.albarajraji@gmail.com	bogossian, elisa/AAY-9516-2021	Gouvea Bogossian, Elisa/0000-0002-2062-465X; AL BARAJRAJI, Mejdeddine/0000-0002-9619-7324			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Bailey RL, 2019, WORLD NEUROSURG, V130, pE62, DOI 10.1016/j.wneu.2019.05.195; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Foreman B, 2018, NEUROCRIT CARE, V29, P469, DOI 10.1007/s12028-018-0551-7; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Samaniego EA, 2019, NEUROSURGERY, V84, pE99, DOI 10.1093/neuros/nyy489; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	21	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2021	163	12					3259	3266		10.1007/s00701-021-04992-z		SEP 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WZ7WX	WOS:000693908400001	34495407	Green Submitted			2022-02-06	
J	Doron, O; Hemphill, JC; Manley, G; Rosenthal, G				Doron, Omer; Hemphill, J. Claude, III; Manley, Geoffrey; Rosenthal, Guy			Improved Pressure Equalization Ratio Following Mannitol Administration in Patients With Severe TBI: A Preliminary Study of a Potential Bedside Marker for Response to Therapy	NEUROCRITICAL CARE			English	Article; Early Access						Pressure equalization ratio; Traumatic brain injury; Intracranial pressure; Mannitol; Response to therapy; External ventricular drain	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; SODIUM-CHLORIDE; HYPERTENSION; TIME; FLOW	Background Performing a cerebrospinal fluid (CSF) drainage challenge can be used to measure the pressure equalization (PE) ratio, which describes the extent to which CSF drainage can equalize pressure to the height of the external ventricular drain and may serve as a correlate of cerebral edema. We sought to assess whether treatment with mannitol improves PE ratio in patients with severe traumatic brain injury (TBI) with elevated intracranial pressure (ICP). Methods We studied consecutive patients with TBI and brain edema on computed tomography scan and an external ventricular drain (EVD), admitted to the neurointensive care unit. PE ratio, defined as ICP prior to CSF drainage minus ICP after CSF drainage divided by ICP prior to CSF drainage minus EVD height, was measured as previously described. Patients were treated with mannitol for raised ICP based on clinical indication and PE ratio measured before and after mannitol administration. Results We studied 20 patients with severe TBI with raised ICP. Mean ICP prior to mannitol treatment was 29 +/- 7 mm Hg. PE ratio rose substantially after mannitol treatment (0.62 +/- 0.24 vs. 0.29 +/- 0.20, p < 0.0001), indicating an improved ability to drain CSF and equalize ICP with the preset height of the EVD. The combination of mannitol and CSF drainage led to an improved reduction in ICP compared with that seen before mannitol therapy (11 +/- 2 mm Hg vs. 6 +/- 2 mm Hg, p < 0.01), and led to a decrease in ICP below the 20 mm Hg threshold in 77% of cases. Conclusions Treatment with mannitol leads to a substantial improvement in PE ratio that reflects the ability to achieve a greater decrease in ICP when CSF drainage is performed after mannitol administration. This preliminary study raises the possibility that PE ratio may be useful to follow response to therapy in patients with cerebral edema and raised ICP. Further studies to determine whether PE ratio may serve as an easily obtained and clinically useful surrogate marker for the extent of brain edema are warranted.	[Doron, Omer; Rosenthal, Guy] Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel; [Doron, Omer] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, Tel Aviv, Israel; [Hemphill, J. Claude, III] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Manley, Geoffrey] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA		Rosenthal, G (corresponding author), Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel.	rosenthalg@hadassah.org.il		Hemphill, Claude/0000-0003-4019-7525			Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Candanedo C, 2019, NEUROCRIT CARE, V30, P340, DOI 10.1007/s12028-018-0612-y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010904.pub2; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; GUILLAUME J, 1951, PRESSE MED, V59, P953; GUILLAUME J, 1951, REV NEUROL, V84, P131; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; HOSSMANN KA, 1971, EXP NEUROL, V32, P163, DOI 10.1016/0014-4886(71)90060-4; Hrabetova S, 2004, NEUROCHEM INT, V45, P467, DOI 10.1016/j.neuint.2003.11.011; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; JAMES HE, 1977, ACTA NEUROCHIR, V36, P189, DOI 10.1007/BF01405391; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MATSUOKA Y, 1982, EXP NEUROL, V77, P599, DOI 10.1016/0014-4886(82)90231-X; MCGRAW CP, 1978, SURG NEUROL, V10, P127; Nakada T, 2019, NEUROSCIENTIST, V25, P155, DOI 10.1177/1073858418775027; Poole D, 2020, NEUROCRIT CARE, V32, P252, DOI 10.1007/s12028-019-00771-y; Schwimmbeck F, 2021, J NEUROSURG ANESTH, V33, P10, DOI 10.1097/ANA.0000000000000644; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Sorani MD, 2008, J NEUROTRAUM, V25, P291, DOI 10.1089/neu.2007.0411; Sorani MD, 2008, J NEUROSURG, V108, P80, DOI 10.3171/JNS/2008/108/01/0080; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA	31	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01332-y		SEP 2021	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UN3CX	WOS:000693896700001	34498204	Bronze, Green Published			2022-02-06	
J	Doust, YV; Rowe, RK; Adelson, PD; Lifshitz, J; Ziebell, JM				Doust, Yasmine, V; Rowe, Rachel K.; Adelson, P. David; Lifshitz, Jonathan; Ziebell, Jenna M.			Age-at-Injury Determines the Extent of Long-Term Neuropathology and Microgliosis After a Diffuse Brain Injury in Male Rats	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; TBI; concussion; aging; puberty; juvenile; age-at-injury; pathology	AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; HEAD TRAUMA; ACCUMULATION; DEGENERATION; INFORMATION; ACTIVATION; MORPHOLOGY; SUSTAINS; DISEASE	Traumatic brain injury (TBI) can occur at any age, from youth to the elderly, and its contribution to age-related neuropathology remains unknown. Few studies have investigated the relationship between age-at-injury and pathophysiology at a discrete biological age. In this study, we report the immunohistochemical analysis of naive rat brains compared to those subjected to diffuse TBI by midline fluid percussion injury (mFPI) at post-natal day (PND) 17, PND35, 2-, 4-, or 6-months of age. All brains were collected when rats were 10-months of age (n = 6-7/group). Generalized linear mixed models were fitted to analyze binomial proportion and count data with R Studio. Amyloid precursor protein (APP) and neurofilament (SMI34, SMI32) neuronal pathology were counted in the corpus callosum (CC) and primary sensory barrel field (S1BF). Phosphorylated TAR DNA-binding protein 43 (pTDP-43) neuropathology was counted in the S1BF and hippocampus. There was a significantly greater extent of APP and SMI34 axonal pathology and pTDP-43 neuropathology following a TBI compared with naives regardless of brain region or age-at-injury. However, age-at-injury did determine the extent of dendritic neurofilament (SMI32) pathology in the CC and S1BF where all brain-injured rats exhibited a greater extent of pathology compared with naive. No significant differences were detected in the extent of astrocyte activation between brain-injured and naive rats. Microglia counts were conducted in the S1BF, hippocampus, ventral posteromedial (VPM) nucleus, zona incerta, and posterior hypothalamic nucleus. There was a significantly greater proportion of deramified microglia, regardless of whether the TBI was recent or remote, but this only occurred in the S1BF and hippocampus. The proportion of microglia with colocalized CD68 and TREM2 in the S1BF was greater in all brain-injured rats compared with naive, regardless of whether the TBI was recent or remote. Only rats with recent TBI exhibited a greater proportion of CD68-positive microglia compared with naive in the hippocampus and posterior hypothalamic nucleus. Whilst, only rats with a remote brain-injury displayed a greater proportion of microglia colocalized with TREM2 in the hippocampus. Thus, chronic alterations in neuronal and microglial characteristics are evident in the injured brain despite the recency of a diffuse brain injury.</p>	[Doust, Yasmine, V; Ziebell, Jenna M.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Coll Hlth & Med, Hobart, Tas, Australia; [Rowe, Rachel K.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Rowe, Rachel K.; Adelson, P. David; Lifshitz, Jonathan; Ziebell, Jenna M.] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Adelson, P. David; Lifshitz, Jonathan; Ziebell, Jenna M.] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Lifshitz, Jonathan] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA		Ziebell, JM (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Coll Hlth & Med, Hobart, Tas, Australia.; Ziebell, JM (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA.; Ziebell, JM (corresponding author), Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ 85004 USA.	jenna.ziebell@utas.edu.au			Arizona Alzheimer's Consortium; University of Arizona, College of Medicine -Phoenix; Phoenix Children's Hospital; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; Bisgrove Scholar award - Foundation Arizona	Research reported in this manuscript was supported by the Arizona Alzheimer's Consortium, with matching funds from the University of Arizona, College of Medicine -Phoenix and Phoenix Children's Hospital. Partial support was provided by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01 NS-065052, Fraternal Order of Eagles, and the J.O. and J.R. Wicking Trust. RR was supported by the Bisgrove Scholar award funded by Science Foundation Arizona. RR completed a portion of these studies as part of the National Neurotrauma SocietyWINTR-VISA.	Agca C, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0281-8; Ahmed ME, 2020, J NEUROTRAUM, V37, P1645, DOI 10.1089/neu.2019.6932; Angelova DM, 2019, J NEUROCHEM, V151, P676, DOI 10.1111/jnc.14860; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beauchamp M., 2010, PRINCIPLES PRACTICE, P315, DOI 10.1017/CBO9780511674815.024; BERCIANO MT, 1995, ANAT RECORD, V243, P129, DOI 10.1002/ar.1092430115; Berning BA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00335; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bromberg CE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00946; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Bubb Emma J, 2017, Brain Neurosci Adv, V1, DOI 10.1177/2398212817723443; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burnham KA., 2002, MODEL SELECTION MULT, V2; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carroll EL, 2020, J NEUROL, V267, P3223, DOI 10.1007/s00415-020-09979-x; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clement T, 2020, GLIA, V68, P528, DOI 10.1002/glia.23736; Cohen J, 2019, AGING CELL, V18, DOI 10.1111/acel.12937; Collins JM, 2020, J NEUROTRAUM, V37, P782, DOI 10.1089/neu.2019.6906; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Early AN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01800-w; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hoffman AN, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.553190; Holloway OG, 2019, SEMIN CELL DEV BIOL, V94, P96, DOI 10.1016/j.semcdb.2019.02.005; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Islam MBAR, 2021, EXP NEUROL, V341, DOI 10.1016/j.expneurol.2021.113714; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabadi SV, 2020, NEUROMETHODS, V152, P315, DOI 10.1007/978-1-4939-9944-6_13; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Karr JE, 2020, ACTA NEUROL SCAND, V141, P183, DOI 10.1111/ane.13190; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; Kolb Bryan, 2011, J Can Acad Child Adolesc Psychiatry, V20, P265; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Landisman CE, 2007, CEREB CORTEX, V17, P2853, DOI 10.1093/cercor/bhm025; Lavallee P, 2005, J NEUROSCI, V25, P7489, DOI 10.1523/JNEUROSCI.2301-05.2005; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Lenth RV., 2021, EMMEANS ESSTIMATED M; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Marmarou CR., 2011, ENCY CLIN NEUROPSYCH, P1914; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Notrica DM, 2021, J PEDIATR SURG, V56, P390, DOI 10.1016/j.jpedsurg.2020.10.019; O'mara A, 2017, J OPEN RES STW, V5, P31, DOI [10.5334/jors.172, DOI 10.5334/JORS.172]; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; Ortiz JB, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01410; Palmer AL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00337; Pereira A, 2007, P NATL ACAD SCI USA, V104, P18286, DOI 10.1073/pnas.0708611104; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Prasad A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00025; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; R Core Team, 2020, R LANG ENV STAT COMP; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Rosin JM, 2019, FRONT NEUROENDOCRIN, V54, DOI 10.1016/j.yfrne.2019.100748; Rowe RK, 2021, J NEUROTRAUM, V38, P2301, DOI 10.1089/neu.2021.0022; Rowe RK, 2018, J NEUROSURG-PEDIATR, V22, P22, DOI 10.3171/2018.1.PEDS17449; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Savage JC, 2019, METHODS MOL BIOL, V2034, P13, DOI 10.1007/978-1-4939-9658-2_2; Sayrs LW, 2020, J INTERPERS VIOLENCE, DOI 10.1177/0886260520967151; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Soung A., 2019, GLIA HLTH DIS, P109; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Tan XL, 2019, J NEUROTRAUM, V36, P87, DOI 10.1089/neu.2017.5491; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Tukker JJ, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.00022; Villapol S., 2018, AMYLOID DIS, P135; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yanguas-Casas N, 2020, AGING CELL, V19, DOI 10.1111/acel.13182; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Zhu ZD, 2020, NEUROBIOL AGING, V93, P85, DOI 10.1016/j.neurobiolaging.2020.03.023; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	108	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 8	2021	12								722526	10.3389/fneur.2021.722526			23	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	US7AB	WOS:000697577400001	34566867	Green Published, Green Accepted, gold			2022-02-06	
J	Elliott, JE; Balba, NM; McBride, AA; Callahan, ML; Street, KT; Butler, MP; Heinricher, MM; Lim, MM				Elliott, Jonathan E.; Balba, Nadir M.; McBride, Alisha A.; Callahan, Megan L.; Street, Kendall T.; Butler, Matthew P.; Heinricher, Mary M.; Lim, Miranda M.			Different Methods for Traumatic Brain Injury Diagnosis Influence Presence and Symptoms of Post-Concussive Syndrome in United States Veterans	JOURNAL OF NEUROTRAUMA			English	Article						chronic pain; concussion; post-concussion syndrome; sleep; traumatic brain injury	SLEEP DISTURBANCES; SEVERITY; PAIN; DEPRESSION; PREVALENCE; VALIDATION; VALIDITY; TBI	Common methods for evaluating history of traumatic brain injury (TBI) include self-report, electronic medical record review (EMR), and structured interviews such as the Head Trauma Events Characteristics (HTEC). Each has strengths and weaknesses, but little is known regarding how TBI diagnostic rates or the associated symptom profile differ among them. This study examined 200 Veterans recruited within the VA Portland Health Care System, each evaluated for TBI using self-report, EMR, and HTEC. Participants also completed validated questionnaires assessing chronic symptom severity in broad health-related domains (pain, sleep, quality of life, post-concussive symptoms). The HTEC was more sensitive (80% of participants in our cohort) than either self-report or EMR alone (40%). As expected from the high sensitivity, participants screening positive for TBI through the HTEC included many people with mild or no post-concussive symptoms. Participants were grouped according to degree of concordance across these diagnostic methods: no TBI, n = 43; or TBI-positive in any one method (TBI-1dx, n = 53), positive in any two (TBI-2dx, n = 45), or positive in all three (TBI-3dx, n = 59). The symptom profile of the TBI-1dx group was indistinguishable from the no TBI group. The TBI-3dx group had the most severe symptom profile. Our results show that understanding the exact methods used to ascertain TBI is essential when interpreting results from other studies, given that results and conclusions may differ dramatically depending on the method. This issue will become even more critical when interpreting data merged from multiple sources within newer, centralized repositories (e.g., Federal Interagency Traumatic Brain Injury Research [FITBIR]).	[Elliott, Jonathan E.; Balba, Nadir M.; McBride, Alisha A.; Callahan, Megan L.; Lim, Miranda M.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P3-RD42, Portland, OR 97239 USA; [Elliott, Jonathan E.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Balba, Nadir M.; Butler, Matthew P.; Heinricher, Mary M.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Heinricher, Mary M.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Street, Kendall T.] Oregon Hlth & Sci Univ, Dept Sch Nursing, Portland, OR 97201 USA; [Butler, Matthew P.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lim, Miranda M.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P3-RD42, Portland, OR 97239 USA.	lmir@ohsu.edu			Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-17-1-0423]; VA Career Development Award [1K2 BX002712, 1K2 RX002947]; Portland VA Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AT002688, TL1TR002371]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award #W81XWH-17-1-0423 to M.M.H.; M.M.L. was supported by VA Career Development Award #1K2 BX002712 and the Portland VA Research Foundation; N.M.B. was supported by NIH grant TL1TR002371; and J.E.E. was supported by NIH grant T32 AT002688 and VA Career Development Award #1K2 RX002947.	Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Centers for Disease Control and Prevention, 2016, INJURY PREVENTION CO; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Elliott JE, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz237; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Haarbauer-Krupa J, 2021, J NEUROTRAUM, V38, P3235, DOI 10.1089/neu.2021.0062; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mastin DF, 2006, J BEHAV MED, V29, P223, DOI 10.1007/s10865-006-9047-6; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Papesh MA, 2019, J NEUROTRAUM, V36, P702, DOI 10.1089/neu.2018.5801; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUTHERFORD WH, 1977, LANCET, V1, P1; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	32	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3126	3136		10.1089/neu.2021.0031		SEP 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000695449700001	34382417				2022-02-06	
J	Helminski, JO; Keller, S; Suckow, M; Stein, A; Grieco, L; Lintakas, R; Reinders, C				Helminski, Janet O.; Keller, Sarah; Suckow, Melissa; Stein, Amy; Grieco, Lauren; Lintakas, Rima; Reinders, Caroline			Reliability of two dissociating tests of phoria in artificially created phoria in normal adults	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						dissociative test; ocular misalignment test; phoria test; skew deviation; vertical diplopia	SKEW DEVIATION; OCULAR TORSION; REPEATABILITY; PREDICT; PRISM	Background The ability of physical therapists (PTs) to accurately identify and reliably measure phoria/tropia is critical in the differential diagnosis of individuals with acute vestibular syndrome and concussion/mild traumatic brain injury. Objectives To determine if PTs may reliably measure phoria and to determine the reliability of two dissociating tests of phoria, the prism neutralized Maddox rod test and modified Thorington method, in normal adults with artificially created phoria. Methods Thirty adults (mean age 24.87 +/- 4.74 years) were randomly assigned to wear trial lenses (1, 2, 4, or 6 pd prism left, plain glass right) to create phoria. In sitting and supine, phoria was measured using prism neutralized Maddox rod test and modified Thorington method. Mean, SD, and range of first neutral endpoint were calculated for each examiner. Percentage of trials in agreement (<= 2 and 4 pd); comparisons within the linear mixed effects regression model; and inter-rater reliability between examiners was calculated with the intra-class correlation coefficient (ICC). Results Participants underwent 20 measurements by each examiner. Trial agreement between examiners was 74% (range 13%-100%) in horizontal and 91% (range 63%-100%) in vertical plane. Maddox rod test had significantly different means between two examiners (P < .05). Modified Thorington test had no significant difference. The Maddox rod test had a significant examiner main effect, examiner 2 always scored lower. Inter-rater correlation coefficient for each test was significant at level of P < .01 (ICC >= 0.67 <= 0.94) except for modified Thorington test in supine, horizontal plane with P < .05 (ICC >= 0.38). Conclusion PTs may reliably measure artificially created phorias using prism neutralized Maddox rod test and modified Thorington method.	[Helminski, Janet O.; Keller, Sarah; Grieco, Lauren; Lintakas, Rima; Reinders, Caroline] Midwestern Univ, Phys Therapy Program, Coll Hlth Sci, 555 31st St, Downers Grove, IL 60515 USA; [Suckow, Melissa] Midwestern Univ, Coll Optometry, Downers Grove, IL 60515 USA; [Stein, Amy] Midwestern Univ, Off Res Sponsored Programs, Downers Grove, IL 60515 USA		Helminski, JO (corresponding author), Midwestern Univ, Phys Therapy Program, Coll Hlth Sci, 555 31st St, Downers Grove, IL 60515 USA.	jhelmi@midwestern.edu		Helminski, Janet/0000-0001-8905-9903	Midwestern University	Midwestern University	Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Brodsky MC, 2006, SURV OPHTHALMOL, V51, P105, DOI 10.1016/j.survophthal.2005.12.008; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Choi JH, 2017, STROKE, V48, P556, DOI 10.1161/STROKEAHA.116.015507; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; Eggers Scott D Z, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P216, DOI 10.1016/j.mayocpiqo.2019.12.003; Howarth PA, 2000, OPTOMETRY VISION SCI, V77, P616, DOI 10.1097/00006324-200011000-00013; Johns HA, 2004, OPTOMETRY VISION SCI, V81, P939; Kattah JC, 2019, J NEUROL PHYS THER, V43, pS42, DOI 10.1097/NPT.0000000000000274; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; KEANE JR, 1975, ARCH NEUROL-CHICAGO, V32, P185, DOI 10.1001/archneur.1975.00490450065009; Korda A, 2021, J NEUROL, DOI 10.1007/s00415-021-10692-6; Kung NH, 2018, J NEURO-OPHTHALMOL, V38, P244, DOI 10.1097/WNO.0000000000000608; Mazock JB, 2004, J ORAL MAXIL SURG, V62, P1298, DOI 10.1016/j.joms.2004.05.211; Otto JMN, 2008, OPHTHAL PHYSL OPT, V28, P550, DOI 10.1111/j.1475-1313.2008.00599.x; Otto JMN, 2008, GRAEF ARCH CLIN EXP, V246, P631, DOI 10.1007/s00417-008-0798-3; Parulekar MV, 2008, ARCH OPHTHALMOL-CHIC, V126, P899, DOI 10.1001/archopht.126.7.899; Pavlou M, 2015, J NEUROL PHYS THER, V39, P215, DOI 10.1097/NPT.0000000000000105; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Rainey BB, 1998, OPTOMETRY VISION SCI, V75, P719, DOI 10.1097/00006324-199810000-00016; Schroeder TL, 1996, OPTOMETRY VISION SCI, V73, P389, DOI 10.1097/00006324-199606000-00006; Suleiman A, 2020, NEURO-OPHTHALMOLOGY, V44, P157, DOI 10.1080/01658107.2019.1653325; Whitney SL, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0395-4	25	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	OCT	2021	6	5					1142	1150		10.1002/lio2.653		SEP 2021	9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	WG1SA	WOS:000695398600001	34667859	gold, Green Published			2022-02-06	
J	Khellaf, A; Garcia, NM; Tajsic, T; Alam, A; Stovell, MG; Killen, MJ; Howe, DJ; Guilfoyle, MR; Jalloh, I; Timofeev, I; Murphy, MP; Carpenter, TA; Menon, DK; Ercole, A; Hutchinson, PJ; Carpenter, KLH; Thelin, EP; Helmy, A				Khellaf, Abdelhakim; Garcia, Nuria Marco; Tajsic, Tamara; Alam, Aftab; Stovell, Matthew G.; Killen, Monica J.; Howe, Duncan J.; Guilfoyle, Mathew R.; Jalloh, Ibrahim; Timofeev, Ivan; Murphy, Michael P.; Carpenter, T. Adrian; Menon, David K.; Ercole, Ari; Hutchinson, Peter J.; Carpenter, Keri L. H.; Thelin, Eric P.; Helmy, Adel			Focally administered succinate improves cerebral metabolism in traumatic brain injury patients with mitochondrial dysfunction	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral metabolism; microdialysis; mitochondrial dysfunction; succinate; traumatic brain injury (Human)	ACID DIMETHYL ESTER; COMBINED MICRODIALYSIS; PERFUSION-PRESSURE; BLOOD-FLOW; DICARBOXYLATE; TRANSPORTERS; MANAGEMENT; SUBSTRATE; ISCHEMIA; INFUSION	Following traumatic brain injury (TBI), raised cerebral lactate/pyruvate ratio (LPR) reflects impaired energy metabolism. Raised LPR correlates with poor outcome and mortality following TBI. We prospectively recruited patients with TBI requiring neurocritical care and multimodal monitoring, and utilised a tiered management protocol targeting LPR. We identified patients with persistent raised LPR despite adequate cerebral glucose and oxygen provision, which we clinically classified as cerebral 'mitochondrial dysfunction' (MD). In patients with TBI and MD, we administered disodium 2,3-C-13(2) succinate (12 mmol/L) by retrodialysis into the monitored region of the brain. We recovered C-13-labelled metabolites by microdialysis and utilised nuclear magnetic resonance spectroscopy (NMR) for identification and quantification. Of 33 patients with complete monitoring, 73% had MD at some point during monitoring. In 5 patients with multimodality-defined MD, succinate administration resulted in reduced LPR(-12%) and raised brain glucose(+17%). NMR of microdialysates demonstrated that the exogenous C-13-labelled succinate was metabolised intracellularly via the tricarboxylic acid cycle. By targeting LPR using a tiered clinical algorithm incorporating intracranial pressure, brain tissue oxygenation and microdialysis parameters, we identified MD in TBI patients requiring neurointensive care. In these, focal succinate administration improved energy metabolism, evidenced by reduction in LPR. Succinate merits further investigation for TBI therapy.	[Khellaf, Abdelhakim; Garcia, Nuria Marco; Tajsic, Tamara; Alam, Aftab; Stovell, Matthew G.; Killen, Monica J.; Guilfoyle, Mathew R.; Jalloh, Ibrahim; Timofeev, Ivan; Hutchinson, Peter J.; Carpenter, Keri L. H.; Thelin, Eric P.; Helmy, Adel] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Khellaf, Abdelhakim] Univ Toronto, Div Neurosurg, St Michaels Hosp, Toronto, ON, Canada; [Stovell, Matthew G.] Walton Ctr, Dept Neurosurg, Liverpool, Merseyside, England; [Howe, Duncan J.] Univ Cambridge, Dept Chem, Cambridge, England; [Murphy, Michael P.] Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge, England; [Carpenter, T. Adrian; Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Menon, David K.; Ercole, Ari] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Thelin, Eric P.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric P.] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden		Helmy, A (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Level 4 A Block,Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0QQ, England.	adelhelmy@cantab.net	; Thelin, Eric/K-2144-2012; Ercole, Ari/B-6288-2009	Stovell, Matthew/0000-0002-4172-4617; Helmy, Adel/0000-0002-0531-0556; Thelin, Eric/0000-0002-2338-4364; Ercole, Ari/0000-0001-8350-8093	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); National Institute for Health ResearchNational Institute for Health Research (NIHR); Academy of Medical Sciences Newton Fellowship; National Institute for Health Research Senior Investigator Awards; Cambridge Australia Oliphant Scholarship; Cambridge Trust; Royal College of Surgeons of England; Swedish Brain Foundation (Hjarnfonden); Swedish Medical Society; Swedish Society for Medical Research; Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Brain Injury MedTech Cooperative; StratNeuro (Karolinska Institutet); ErlingPersson Family Foundation; Region Stockholm	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Medical Research Council (Grant no.G1002277 ID98489) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: NMG-National Institute for Health Research; AA-Academy of Medical Sciences Newton Fellowship; MGS-National Institute for Health Research Biomedical Research Centre, Cambridge; IJ-Medical Research Council (Grant no. G1002277 ID 98489) and National Institute for Health Research Biomedical Research Centre, Cambridge; DKMNational Institute for Health Research Senior Investigator Awards; MJK-Cambridge Australia Oliphant Scholarship in partnership with the Cambridge Trust; PJH-National Institute for Health Research (Professorship, Biomedical Research Centre, Brain Injury MedTech Co-operative, Senior Investigator Award and the Royal College of Surgeons of England; KLHC-National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); EPT-Swedish Brain Foundation (Hj_arnfonden), Swedish Medical Society (SLS) and Swedish Society for Medical Research (SSMF); AH-Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no.G0802251), the NIHR Biomedical Research Centre and the NIHR Brain Injury MedTech Cooperative; StratNeuro (Karolinska Institutet), The ErlingPersson Family Foundation and Region Stockholm (Clinical Research Appointment).	Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2020, J NEUROTRAUM, V37, P1291, DOI 10.1089/neu.2017.5599; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.3.CO;2-5; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; Ferreira FL, 2000, HORM METAB RES, V32, P335, DOI 10.1055/s-2007-978647; Giorgi-Coll S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01149-w; Hejcl A, 2012, J NEUROL SURG PART A, V73, P10, DOI 10.1055/s-0032-1304500; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kekuda R, 1999, J BIOL CHEM, V274, P3422, DOI 10.1074/jbc.274.6.3422; Kelsen J, 2019, J NEUROTRAUM, V36, P3253, DOI 10.1089/neu.2018.6369; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Malaisse WJ, 1997, NUTRITION, V13, P330; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Neonatal Paediatric Pharmacists Group (NPPG); Royal College of Paediatrics and Child Health (RCPCH, 2012, WELLCH SUCC AC MIT D; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P229, DOI 10.1111/j.1399-6576.2012.02783.x; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Palsson-McDermott EM, 2020, CELL RES, V30, P300, DOI 10.1038/s41422-020-0291-z; Peruzzotti-Jametti L, 2018, CELL STEM CELL, V22, P355, DOI 10.1016/j.stem.2018.01.020; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; Piel S, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0186-1; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; R Development Core Team, 2012, R LANG ENV STAT COMP; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Schlessinger A, 2014, J BIOL CHEM, V289, P16998, DOI 10.1074/jbc.M114.554790; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Sonnewald U, 2014, J NEUROCHEM, V131, P399, DOI 10.1111/jnc.12812; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stovell MG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29255-3; Thelin EP, 2017, AAPS J, V19, P367, DOI 10.1208/s12248-016-0027-7; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2; Zhao XY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00030	66	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2022	42	1					39	55	0271678X211042112	10.1177/0271678X211042112		SEP 2021	17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	XV5IY	WOS:000694680000001	34494481	Green Submitted, Green Published, hybrid			2022-02-06	
J	Li, ZL; Zhang, HW; Cao, CZ; Qian, T; Li, H				Li, Zhaolin; Zhang, Hongwei; Cao, Cangzhu; Qian, Tao; Li, Hong			Gangliosides combined with mild hypothermia provides neuroprotection in a rat model of traumatic brain injury	NEUROREPORT			English	Article						apoptosis; ganglioside; mild hypothermia treatment; oxidative stress; traumatic brain injury	OXIDATIVE STRESS; MODERATE HYPOTHERMIA; PROTECTS; GLUCOSE	Traumatic brain injury (TBI) remains a major cause of disability and death in modern society. In this study, we explored the neuroprotection role of the combination of gangliosides (GM) and mild hypothermia (MH) and the potential effect on oxidative stress injuries in a rat model of TBI. All 50 rats were randomized to five groups: (1) NC group: undergoing surgery without hit; (2) TBI group: undergoing surgery with hit; (3) GM group: TBI treated with gangliosides; (4) MHT group: TBI treated with MH; (5) GM+MHT group: TBI treated with gangliosides and MH. Spatial learning impairments, neurological function injury, Evans Blue leakage, brain MRI and oxidative stress injuries were assessed. The protein levels of Cleaved-caspase 3 and CytC were also detected. Both GM and MHT could rescue TBI-induced spatial learning impairments, improve neurological function injury and brain edema. In addition, the combination of them has a better therapeutic effect. Through the MRI, we found that compared with the TBI group, the brain tissue edema area of GM group, MHT group, and GM+MHT group was smaller, the occupancy effect was weakened, and the midline was slightly shifted. Compared with the GM group and MHT group, these changes in the GM+MHT group were much smaller. GM combined with MH-alleviated TBI-induced oxidative stress injuries and apoptosis. Our study reveals that GM and MH potentially provide neuroprotection via the suppression of oxidative stress injuries and apoptosis after TBI in rats.	[Li, Zhaolin; Zhang, Hongwei; Cao, Cangzhu; Li, Hong] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Pingjiang Rd 23, Tianjin 300211, Peoples R China; [Qian, Tao] Hebei Gen Hosp, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China		Li, H (corresponding author), Tianjin Med Univ, Hosp 2, Dept Neurosurg, Pingjiang Rd 23, Tianjin 300211, Peoples R China.	lihongdoc2020@163.com					Bak LK, 2009, J NEUROCHEM, V109, P87, DOI 10.1111/j.1471-4159.2009.05943.x; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Chiou SY, 2013, EXP LUNG RES, V39, P217, DOI 10.3109/01902148.2013.792881; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Gavella M, 2013, ASIAN J ANDROL, V15, P375, DOI 10.1038/aja.2012.144; Gong G, 2018, MOL IMMUNOL, V95, P91, DOI 10.1016/j.molimm.2018.02.001; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Holikova K, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.625167; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kitchen P, 2020, CELL, V181, P784, DOI 10.1016/j.cell.2020.03.037; Kong L, 2015, PHARMACOL RES, V99, P125, DOI 10.1016/j.phrs.2015.05.014; Bordone MP, 2019, J NEUROCHEM, V151, P139, DOI 10.1111/jnc.14829; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Salman MM, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.573775; Salman MM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00386; Sasaki N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081819; Sylvain NJ, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2021.183573; Wang CF, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1248; Wang H, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00015; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Wevers NR, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0108-3; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Xia Z, 2018, TRANSPL P, V50, P3816, DOI 10.1016/j.transproceed.2018.08.010; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yanguas-Casas N, 2019, TOXICOL APPL PHARM, V377, DOI 10.1016/j.taap.2019.114627; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhao CC, 2017, J NEUROTRAUM, V34, P1636, DOI 10.1089/neu.2016.4759	36	0	0	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	SEP 8	2021	32	13					1113	1121		10.1097/WNR.0000000000001703			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TY1BW	WOS:000683520200006	34284446				2022-02-06	
J	Perez-Barcena, J; Pilar, JR; Salazar, O; Crespi, C; Frontera, G; Novo, MA; Guardiola, MB; Llompart-Pou, JA; Ibanez, J; Vaccari, JPD				Perez-Barcena, Jon; Rodriguez Pilar, Javier; Salazar, Osman; Crespi, Catalina; Frontera, Guillem; Andrea Novo, Mariana; Begona Guardiola, Maria; Antonio Llompart-Pou, Juan; Ibanez, Javier; Vaccari, Juan Pablo de Rivero			Serum Caspase-1 as an Independent Prognostic Factor in Traumatic Brain Injured Patients	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Inflammation; Innate immunity; Inflammasome; Caspase 1	CEREBROSPINAL-FLUID; INFLAMMASOME; SYSTEM; INHIBITION; BIOMARKERS; ACTIVATION	Background The objectives of this study were to assess the association between serum caspase 1 levels and known clinical and radiological prognostic factors and determine whether caspase 1was a more powerful predictor of outcome after traumatic brain injury (TBI) than clinical indices alone, to determine the association between the serum levels of caspase 1 and the 6-month outcome, and to evaluate if there is any association between caspase 1 with clinical and radiological variables. Methods This prospective and observational study was conducted in a university hospital and included patients with TBI who required hospital admission. Serum samples were collected at hospital admission and 24 h after TBI. Caspase 1 levels were determined by enzyme-linked immunosorbent assay. Receiver operating characteristic curves were obtained to test the potential of caspase 1 to predict mortality (Glasgow Outcome Scale Extended score of 1) and unfavorable outcome (Glasgow Outcome Scale Extended scores of 1-4). Multivariate logistic regression was used to assess the effect of serum caspase 1 levels, adjusted by known clinical and radiological prognostic indices, on the outcome. Results One hundred thirty-two patients and 33 healthy controls were included. We obtained 6-month outcome in 118 patients. On admission, the mean serum levels of caspase 1 were higher in patients with TBI compared with controls (157.9 vs. 108.5 pg/mL; p < 0.05) but not at 24 h after TBI. Serum caspase 1 levels on admission were higher in patients with unfavorable outcomes (189.5 vs. 144.1 pg/mL; p = 0.009). Similarly, serum caspase 1 levels on admission were higher in patients who died vs. patients who survived (213.6 vs. 146.8 pg/mL; p = 0.03). A logistic regression model showed that the serum caspase 1 level on admission was an independent predictor of 6-month unfavorable outcomes (odds ratio 1.05; 95% confidence interval 1-1.11; p = 0.05). Caspase 1 levels were higher in patients with severe TBI compared with those with moderate TBI, those with mild TBI, and healthy controls (p < 0.001). We did not find any correlation between caspase 1 and the radiological variables studied. Conclusions In this cohort of patients with TBI, we show that serum caspase 1 protein levels on admission are an independent prognostic factor after TBI. Serum caspase 1 levels on admission are higher in patients who will present unfavorable outcomes 6 months after TBI. Caspase 1 levels on admission are associated with the injury severity determined by the Glasgow Coma Scale.	[Perez-Barcena, Jon; Rodriguez Pilar, Javier; Andrea Novo, Mariana; Begona Guardiola, Maria; Antonio Llompart-Pou, Juan] Son Espases Univ Hosp, Intens Care Dept, Carretera Valldemossa 79, Palma De Mallorca 07120, Islas Baleares, Spain; [Salazar, Osman; Ibanez, Javier] Son Espases Univ Hosp, Dept Neurol Surg, Palma De Mallorca, Spain; [Crespi, Catalina; Frontera, Guillem] Son Espases Univ Hosp, Fdn Inst Invest Sanitaria Islas Baleares IdISBa, Palma De Mallorca, Spain; [Vaccari, Juan Pablo de Rivero] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA		Perez-Barcena, J (corresponding author), Son Espases Univ Hosp, Intens Care Dept, Carretera Valldemossa 79, Palma De Mallorca 07120, Islas Baleares, Spain.	juan.perez@ssib.es			Fondo de Investigacion SanitariaInstituto de Salud Carlos III [FIS-PI16/00737]	This work was supported by a public grant from the Fondo de Investigacion Sanitaria to Dr Jon Perez-Barcena (FIS-PI16/00737).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Desu HL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01826-0; Kawata K, 2018, HAND CLINIC, V158, P217, DOI 10.1016/B978-0-444-63954-7.00022-7; Keane RW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00135; Kerr N, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113080; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Kerr N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00309; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Perez-Barcena J, 2021, J NEUROSURG, V134, P1644, DOI 10.3171/2020.2.JNS193079; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Scott XO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134674; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Syed SA, 2018, NEURON, V99, P914, DOI 10.1016/j.neuron.2018.08.001; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072	24	0	0	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01340-y		SEP 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UN3CX	WOS:000693896700004	34498205				2022-02-06	
J	Raggi, A; Monasta, L; Beghi, E; Caso, V; Castelpietra, G; Mondello, S; Giussani, G; Logroscino, G; Magnani, FG; Piccininni, M; Pupillo, E; Ricci, S; Ronfani, L; Santalucia, P; Sattin, D; Schiavolin, S; Toppo, C; Traini, E; Steinmetz, J; Nichols, E; Ma, R; Vos, T; Feigin, V; Leonardi, M				Raggi, Alberto; Monasta, Lorenzo; Beghi, Ettore; Caso, Valeria; Castelpietra, Giulio; Mondello, Stefania; Giussani, Giorgia; Logroscino, Giancarlo; Magnani, Francesca Giulia; Piccininni, Marco; Pupillo, Elisabetta; Ricci, Stefano; Ronfani, Luca; Santalucia, Paola; Sattin, Davide; Schiavolin, Silvia; Toppo, Claudia; Traini, Eugenio; Steinmetz, Jaimie; Nichols, Emma; Ma, Rui; Vos, Theo; Feigin, Valery; Leonardi, Matilde			Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019	JOURNAL OF NEUROLOGY			English	Article; Early Access						Disability; Migraine; Stroke; Dementia; Multiple sclerosis; Motor neuron disease	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; MYASTHENIA-GRAVIS; SURVIVAL; MORTALITY; MIGRAINE; TRENDS; SURVEILLANCE; STRATEGIES; HEADACHE	Background Neurological conditions are highly prevalent and disabling, in particular in the elderly. The Italian population has witnessed sharp ageing and we can thus expect a rising trend in the incidence, prevalence and disability of these conditions. Methods We relied on the Global Burden of Disease 2019 study to extract Italian data on incidence, prevalence and years lived with a disability (YLDs) referred to a broad set of neurological disorders including, brain and nervous system cancers, stroke, encephalitis, meningitis, tetanus, traumatic brain injury, and spinal cord injury. We assessed changes between 1990 and 2019 in counts and age-standardized rates. Results The most prevalent conditions were tension-type headache, migraine, and dementias, whereas the most disabling were migraine, dementias and traumatic brain injury. YLDs associated with neurological conditions increased by 22.5%, but decreased by 2.3% in age-standardized rates. The overall increase in prevalence and YLDs counts was stronger for non-communicable diseases with onset in old age compared to young to adult-age onset ones. The same trends were in the opposite direction when age-standardized rates were taken into account. Conclusions The increase in YLDs associated with neurological conditions is mostly due to population ageing and growth: nevertheless, lived disability and, as a consequence, impact on health systems has increased. Actions are needed to improve outcome and mitigate disability associated with neurological conditions, spanning among diagnosis, treatment, care pathways and workplace interventions.	[Raggi, Alberto; Magnani, Francesca Giulia; Sattin, Davide; Schiavolin, Silvia; Toppo, Claudia; Leonardi, Matilde] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Publ Hlth & Disabil Unit, Via Celoria 11, I-20133 Milan, Italy; [Monasta, Lorenzo; Ronfani, Luca; Traini, Eugenio] IRCCS Materno Infantile Burlo Garofolo, SCR Epidemiol Clin & Ric Servizi Sanitari, Trieste, Italy; [Beghi, Ettore; Giussani, Giorgia; Pupillo, Elisabetta] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Caso, Valeria] Univ Perugia, Stroke Unit, Perugia, Italy; [Caso, Valeria] Univ Perugia, Div Internal & Cardiovasc Med, Perugia, Italy; [Castelpietra, Giulio] Outpatient & Inpatient Care Serv, Cent Hlth Directorate, Reg Friuli Venezia Giulia, Trieste, Italy; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Piccininni, Marco] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany; [Ricci, Stefano] Gubbio & Citta Castello Hosp, Neurol & Stroke Unit, USL Umbria 1, Perugia, Italy; [Santalucia, Paola] Osped San Giuseppe Multimed, Neurol & Stroke Unit, Milan, Italy; [Traini, Eugenio] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Steinmetz, Jaimie; Nichols, Emma; Ma, Rui; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, Australia		Raggi, A (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Neurol Publ Hlth & Disabil Unit, Via Celoria 11, I-20133 Milan, Italy.	alberto.raggi@istituto-besta.it; lorenzo.monasta@burlo.trieste.it; ettore.beghi@marionegri.it; vcaso@hotmail.com; giulio.castelpietra@regione.fvg.it; smondello@unime.it; giorgia.giussani@marionegri.it; giancarlo.logroscino@uniba.it; francesca.magnani@istituto-besta.it; marco.piccininni@charite.de; elisabetta.pupillo@marionegri.it; stefano.ricci@uslumbria1.it; luca.ronfani@burlo.trieste.it; paolasantalucia1@gmail.com; davide.sattin@istituto-besta.it; silvia.schiavolin@istituto-besta.it; claudia.toppo@istituto-besta.it; e.traini@uu.nl; jsteinme@uw.edu; eln1@uw.edu; raym2622@uw.edu; tvos@uw.edu; valery.feigin@aut.ac.nz; matilde.leonardi@istituto-besta.it	Mondello, Stefania/A-1813-2012; Magnani, Francesca/AAI-6629-2021; Monasta, Lorenzo/B-1388-2012; CASO, VALERIA/AAC-5156-2022; Sattin, Davide/AAX-4083-2020; Raggi, Alberto/K-5787-2016	Mondello, Stefania/0000-0002-8587-3614; Magnani, Francesca/0000-0002-6503-3052; Monasta, Lorenzo/0000-0001-7774-548X; CASO, VALERIA/0000-0002-2020-8891; Sattin, Davide/0000-0001-7736-4337; Raggi, Alberto/0000-0002-7433-7779; Piccininni, Marco/0000-0002-1397-0060	Bill and Melinda Gates FoundationBill & Melinda Gates Foundation	None for this article. The GBD initiative is supported by the Bill and Melinda Gates Foundation.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Albrechtsen SS, 2020, DAN MED J, V67; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; Ashina M, 2021, J HEADACHE PAIN, V22, DOI 10.1186/s10194-021-01279-7; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Belvis R, 2021, J HEADACHE PAIN, V22, DOI 10.1186/s10194-021-01267-x; Brown JWL, 2019, JAMA-J AM MED ASSOC, V321, P175, DOI 10.1001/jama.2018.20588; Cevoli S, 2009, CEPHALALGIA, V29, P1285, DOI 10.1111/j.1468-2982.2009.01874.x; Coppo A, 2017, EUR J PUBLIC HEALTH, V27, P717, DOI 10.1093/eurpub/ckw262; D'Onofrio F, 2017, NEUROL SCI, V38, pS117, DOI 10.1007/s10072-017-2901-1; Damian MS, 2013, INTENS CARE MED, V39, P1405, DOI 10.1007/s00134-013-2960-6; Deuschl G, 2020, LANCET PUBLIC HEALTH, V5, pE551, DOI 10.1016/S2468-2667(20)30190-0; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Ferro S, 2017, SPINAL CORD, V55, P1103, DOI 10.1038/sc.2017.88; Ferroli P, 2013, NEUROL SCI, V34, P2107, DOI 10.1007/s10072-013-1345-5; Hill VA, 2017, SEMIN NEUROL, V37, P237, DOI 10.1055/s-0037-1603685; Italian National Institute for Statistics, 2011, FUT DEM PAES PREV RE, P1; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jobin C, 2010, WOMENS HEALTH, V6, P797, DOI 10.2217/WHE.10.69; Kalincik T, 2021, NEUROLOGY, V96, pE783, DOI 10.1212/WNL.0000000000011242; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Kudrow D, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02123-w; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Leonardi M, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0993-0; Leone A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070734; Li MCH, 2018, EPILEPSIA, V59, P273, DOI 10.1111/epi.13964; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6; Lunde HMB, 2017, J NEUROL NEUROSUR PS, V88, P621, DOI 10.1136/jnnp-2016-315238; Mandel M, 2013, BIOMETRICS, V69, P225, DOI 10.1111/biom.12002; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; Mazzola P, 2016, GERONTOLOGIST, V56, P383, DOI 10.1093/geront/gnv152; Patel AP, 2019, LANCET NEUROL, V18, P376, DOI 10.1016/S1474-4422(18)30468-X; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Puledda F, 2017, HEADACHE, V57, P685, DOI 10.1111/head.13069; Raggi A, 2020, J NEUROL NEUROSUR PS, V91, P104, DOI 10.1136/jnnp-2019-320466; Raggi A, 2018, HEADACHE, V58, P913, DOI 10.1111/head.13337; Ragonese P, 2010, EUR J NEUROL, V17, P391, DOI 10.1111/j.1468-1331.2009.02814.x; Reher DS, 2015, POP STUD-J DEMOG, V69, pS57, DOI 10.1080/00324728.2014.963421; Rota E, 2020, HEADACHE, V60, P81, DOI 10.1111/head.13679; Ruiz E, 2016, INT J NEUROSCI, V126, P985, DOI 10.3109/00207454.2015.1090437; Sabatino M, 2016, EUR REG SCI ASS ERSA; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Schroeder RA, 2018, J WOMENS HEALTH, V27, P965, DOI 10.1089/jwh.2018.7274; SERVADEI F, 1988, ITAL J NEUROL SCI, V9, P449, DOI 10.1007/BF02337162; Sheers N, 2014, AMYOTROPH LAT SCL FR, V15, P180, DOI 10.3109/21678421.2014.881376; Sprenger T, 2018, NEUROTHERAPEUTICS, V15, P313, DOI 10.1007/s13311-018-0621-8; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI 10.1016/S1474-4422(18)30322-3; Talbot J, 2021, J HEADACHE PAIN, V22, DOI 10.1186/s10194-020-01214-2; Trojano M, 2019, NEUROL SCI, V40, P155, DOI 10.1007/s10072-018-3610-0; Vernieri Fabrizio, 2021, J Headache Pain, V22, P35, DOI 10.1186/s10194-021-01247-1; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	60	0	0	6	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.												10.1007/s00415-021-10774-5		SEP 2021	19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN2LK	WOS:000693851100001	34498172				2022-02-06	
J	Sadi, L; Sjolin, G; Hulme, RA				Sadi, Lin; Sjolin, Gabriel; Hulme, Rebecka Ahl			Beta-blockade is not associated with improved outcomes in isolated severe extracranial injury: an observational cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Beta blockers; Traumatic injury; Mortality	TRAUMATIC BRAIN-INJURY; ORGAN DYSFUNCTION; MORTALITY; BLOCKERS; NOREPINEPHRINE; PRINCIPLES; PREINJURY; ATENOLOL; EXPOSURE; THERAPY	Background There is evidence supporting the use of beta-blockade in patients with traumatic brain injury. The reduction in sympathetic drive is thought to underlie the relationship between beta-blockade and increased survival. There is little evidence for similar effects in extracranial injuries. This study aimed to assess the association between beta-blockade and survival in patients suffering isolated severe extracranial injuries. Methods Patients treated at an academic urban trauma centre during a 5-year period were retrospectively identified. Adults suffering isolated severe extracranial injury [Injury Severity Score (ISS) >= 16 with Abbreviated Injury Score of <= 2 for any intracranial injury] were included. Patient characteristics and outcomes were collected from the trauma registry and hospital medical records. Patients were subdivided into beta-blocker exposed and unexposed groups. Patients were matched using propensity score matching. Differences were assessed using McNemar's or paired Student's t test. The primary outcome of interest was 90-day mortality and secondary outcome was in-hospital complications. Results 698 patients were included of whom 10.5% were on a beta-blocker. Most patients suffered blunt force trauma (88.5%) with a mean [standard deviation] ISS of 24.6 [10.6]. Unadjusted mortality was higher in patients receiving beta-blockers (34.2% vs. 9.1%, p < 0.001) as were cardiac complications (8.2% vs. 1.4%, p = 0.002). Patients on beta-blockers were significantly older (69.5 [14.1] vs. 43.2 [18.0] years) and of higher comorbidity. After matching, no statistically significant differences were seen in 90-day mortality (34.2% vs. 30.1%, p = 0.690) or in-hospital complications. Conclusions Beta-blocker therapy does not appear to be associated with improved survival in patients with isolated severe extracranial injuries.	[Sadi, Lin] Capio St Gorans Hosp, Dept Surg, Stockholm, Sweden; [Sjolin, Gabriel] Orebro Univ Hosp, Dept Surg, Orebro, Sweden; [Sjolin, Gabriel; Hulme, Rebecka Ahl] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Hulme, Rebecka Ahl] Karolinska Univ Hosp, Dept Surg, Div Trauma & Emergency Surg, Stockholm, Sweden		Hulme, RA (corresponding author), Orebro Univ, Sch Med Sci, Orebro, Sweden.; Hulme, RA (corresponding author), Karolinska Univ Hosp, Dept Surg, Div Trauma & Emergency Surg, Stockholm, Sweden.	rebecka.ahl-hulme@sll.se	Ahl, Rebecka/AAG-4162-2020	Ahl, Rebecka/0000-0001-7930-3845	Orebro University	Open access funding provided by Orebro University.	ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Barron KW, 1995, BASIC SCI REV MED LI, V4th; Bukur M, 2012, AM J SURG, V204, P697, DOI 10.1016/j.amjsurg.2012.02.007; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Eriksson M, 2018, BJS OPEN, V2, P392, DOI 10.1002/bjs5.83; Evans David C, 2014, J Emerg Trauma Shock, V7, P305, DOI 10.4103/0974-2700.142766; Ferraris VA, 2010, J TRAUMA, V69, P645, DOI 10.1097/TA.0b013e3181d8941d; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Hendrick LE, 2016, AM SURGEON, V82, P575; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ismailov RM, 2005, INT J CARDIOL, V105, P141, DOI 10.1016/j.ijcard.2004.11.025; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Johansson P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1605-5; Kemp CD, 2008, AM SURGEON, V74, P866; Krepska A, 2020, IN PRESS; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; MALING HM, 1958, AM J PHYSIOL, V194, P590, DOI 10.1152/ajplegacy.1958.194.3.590; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Mohseni S, 2014, J TRAUMA ACUTE CARE, V76, P804, DOI 10.1097/TA.0000000000000139; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; Poulat P, 1998, EUR J PHARMACOL, V344, P251, DOI 10.1016/S0014-2999(97)01569-0; Rough J, 2009, SURGERY, V145, P235, DOI 10.1016/j.surg.2008.09.013; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	33	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 8	2021	29	1							132	10.1186/s13049-021-00947-6			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UP7AI	WOS:000695528600002	34496923	gold, Green Published			2022-02-06	
J	St Peter, M; Shankar, S; Villwock, J				St Peter, Madeleine; Shankar, Suraj; Villwock, Jennifer			Use of Nasal Airflow-Inducing Maneuver with olfactory training in patients with post-laryngectomy anosmia: a pilot study	SPEECH LANGUAGE AND HEARING			English	Article; Early Access						Laryngectomy; olfactory training; nasal-airflow inducing maneuver	QUALITY-OF-LIFE; TOTAL LARYNGECTOMY; REHABILITATION; HYPOSMIA; SMELL; HEAD	Up to 75% of patients who have undergone a total laryngectomy (TL) suffer from hyposmia or anosmia. The only intervention currently available is the Nasal Airflow-Inducing Maneuver (NAIM), which has been shown to restore smell in about half of TL patients with olfactory deficiencies. Although the NAIM can intermittently provide some mechanical compensation for olfactory loss, there are no therapeutic tools available that consistently provide olfactory stimulation and sensitization after TL. Olfactory training (OT) is a structured smell regimen that has been shown to recover smell in other patient populations with olfactory dysfunction such as post-viral and traumatic brain injury-induced anosmia. Our objective was to propose a low-cost, simple olfactory regimen for TL patients that combines OT and NAIM. In addition, we evaluate for changes in olfactory acuity using Sniffin' Sticks 12 (SST12) and QOL following training. Seven TL patients underwent NAIM training, baseline olfactory testing, and QOL assessments. Five participants completed the 12-14 week training regimen and had repeat olfactory and QOL testing. Two of the five participants had improved SST12 scores, however, QOL scores remained similar to baseline.	[St Peter, Madeleine; Shankar, Suraj; Villwock, Jennifer] Univ Kansas, Dept Otorhinolaryngol, Med Ctr, 4000 Cambridge St, Kansas City, KS 66160 USA		St Peter, M (corresponding author), Univ Kansas, Dept Otorhinolaryngol, Med Ctr, 4000 Cambridge St, Kansas City, KS 66160 USA.	mstpeter@kumc.edu		Villwock, Jennifer/0000-0001-5645-4210; St. Peter, Madeleine/0000-0001-8635-5969			Bussian C, 2010, EUR ARCH OTO-RHINO-L, V267, P261, DOI 10.1007/s00405-009-1068-7; Campbell BH, 2000, LARYNGOSCOPE, V110, P895, DOI 10.1097/00005537-200006000-00003; Ciceliene J, 2018, MEDICINA-LITHUANIA, V54, DOI [10.3390/54020013, 10.3390/medicina54020013]; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; FISHER E W, 1992, Rhinology (Utrecht), V30, P5; Fleiner F, 2012, ENT-EAR NOSE THROAT, V91, P198, DOI 10.1177/014556131209100508; Gurbuz D., 2021, BRAZ J OTORHINOLAR, P58; Haehner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061680; Hilgers FJM, 2002, ARCH OTOLARYNGOL, V128, P648, DOI 10.1001/archotol.128.6.648; HOYE RC, 1970, AM J SURG, V120, P485, DOI 10.1016/S0002-9610(70)80012-5; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Ishikawa Y, 2020, LARYNGOSCOPE, V130, P2013, DOI 10.1002/lary.28727; Kennedy JL, 2013, ANN ALLERG ASTHMA IM, V111, P246, DOI 10.1016/j.anai.2013.06.033; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Mallis A, 2011, EUR REV MED PHARMACO, V15, P937; Mattos JL, 2019, INT FORUM ALLERGY RH, V9, P1144, DOI 10.1002/alr.22392; Miani C., 2020, EUR ARCH OTO-RHINO-L, V260, P529; Mumovic G, 2014, RADIOL ONCOL, V48, P301, DOI 10.2478/raon-2013-0070; Netzer A, 2002, J OTOLARYNGOL, V31, P9, DOI 10.2310/7070.2002.19138; Perry A, 2015, INT J LANG COMM DIS, V50, P467, DOI 10.1111/1460-6984.12148; Possel M, 2020, CHEMOSENS PERCEPT, V13, P37, DOI 10.1007/s12078-019-09261-z; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Risberg-Berlin B, 2006, ARCH OTOLARYNGOL, V132, P301, DOI 10.1001/archotol.132.3.301; Riva G, 2017, ANN OTO RHINOL LARYN, V126, P548, DOI 10.1177/0003489417709794; Silver CE, 2009, EUR ARCH OTO-RHINO-L, V266, P1333, DOI 10.1007/s00405-009-1028-2; Tennen H., 1991, COPING SMELL TASTE D, P787; Veyseller B, 2011, RHINOLOGY, V49, P112, DOI 10.4193/Rhino10.001; Vilaseca I, 2006, HEAD NECK-J SCI SPEC, V28, P313, DOI 10.1002/hed.20268; Vroon P., 1994, VERBORGEN VERLEIDER; Ward E, 2010, CLIN OTOLARYNGOL, V35, P39, DOI 10.1111/j.1749-4486.2009.02050.x; Ward E., 2012, J LARYNGOLOGY VOICE, V2, P10	31	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2050-571X	2050-5728		SPEECH LANG HEARING	Speech Lang. Hearing												10.1080/2050571X.2021.1975227		SEP 2021	6	Audiology & Speech-Language Pathology	Emerging Sources Citation Index (ESCI)	Audiology & Speech-Language Pathology	US5GW	WOS:000697458600001					2022-02-06	
J	Zhang, X; Liu, BH; Li, YY; Duan, GP; Hou, J; Wu, DY				Zhang, Xu; Liu, Baohu; Li, Yuanyuan; Duan, Guoping; Hou, Jun; Wu, Dongyu			Multi-Target and Multi-Session Transcranial Direct Current Stimulation in Patients With Prolonged Disorders of Consciousness: A Controlled Study	FRONTIERS IN NEUROSCIENCE			English	Article						disorders of consciousness; non-invasive brain stimulation; transcranial direct current stimulation; brain networks; non-linear dynamics; electroencephalography	TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; CORTICAL EXCITABILITY; TDCS; STATE; NETWORKS; MEMORY; SCALE	Objectives: To investigate the effect of multi-session transcranial direct current stimulation (tDCS) over the prefrontal area, left dorsolateral prefrontal cortex (DLPFC), and bilateral fronto-temporo-parietal cortices (FTPCs) in patients with prolonged disorders of consciousness (DOC) and to examine the altered cortical interconnections using non-linear electroencephalography (EEG). Methods: In this open-label controlled study, conventional treatments were implemented in both the control and tDCS groups, together with 80 tDCS sessions only in the tDCS group. The order of tDCS targets was as follows: prefrontal area, left FTPC, right FTPC, and left DLPFC. The Coma Recovery Scale-Revised (CRS-R) and non-linear EEG index were evaluated before and after the treatment. Additionally, the modified Glasgow Outcome Scale (mGOS) was used as a follow-up evaluation at 12 months after the disease onset. Results: The CRS-R improved significantly in both groups after the treatment. However, the CRS-R and mGOS were more significantly improved in the tDCS group than in the control group. Among the cross approximate entropy (C-ApEn) indices, the local C-A-P-A and C-A-F-A under the affected painful stimulus condition and all local and remote indices of the unaffected side under the unaffected painful stimulus condition were significantly higher in the tDCS group than in the control group. Multivariate logistic regression analysis revealed that group and type were the main relevant factors based on mGOS improvement. Multivariate linear regression analysis revealed that group, C-A-F-A, and C-U-MTU were the main relevant factors based on CRS-R improvement under the affected painful stimulus conditions, whereas only C-U-MTU and C-U-FPU were relevant under the unaffected painful stimulus condition. Conclusion: Multi-target and multi-session tDCS could improve the cortical connections between the primary sensorimotor and frontal cortices of the affected hemisphere and the prefrontal-parietal and temporo-parietal associative cortical networks of the unaffected hemisphere. Thus, this tDCS protocol may be used as an add-on treatment for prolonged DOC.	[Zhang, Xu; Liu, Baohu; Li, Yuanyuan; Duan, Guoping; Hou, Jun; Wu, Dongyu] China Acad Chinese Med Sci, Wangjing Hosp, Dept Rehabil, Beijing, Peoples R China		Wu, DY (corresponding author), China Acad Chinese Med Sci, Wangjing Hosp, Dept Rehabil, Beijing, Peoples R China.	wudongyu73@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171011, 81572220]; Key Field Project of the 13th Five-Year Plan of the China Academy of Chinese Medical Science [ZZ10-015]; Science and Technology Projects of Beijing [Z121107001012144, Z171100001017111]	This work was supported by the National Natural Science Foundation of China (grant numbers 81171011 and 81572220); the Key Field Project of the 13th Five-Year Plan of the China Academy of Chinese Medical Science (grant number ZZ10-015); and the Science and Technology Projects of Beijing (grant numbers Z121107001012144 and Z171100001017111).	Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Bai Y, 2018, INT J NEUROSCI, V128, P587, DOI 10.1080/00207454.2017.1403440; Bai Y, 2017, NEUROIMAGE-CLIN, V15, P702, DOI 10.1016/j.nicl.2017.01.025; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Cavinato M, 2019, CLIN NEUROPHYSIOL, V130, P231, DOI 10.1016/j.clinph.2018.10.018; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dimitri D, 2017, NEUROCASE, V23, P96, DOI 10.1080/13554794.2017.1305112; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guo YK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00412; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Hermann B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61180-2; Huang WS, 2017, BRAIN STIMUL, V10, P718, DOI 10.1016/j.brs.2017.02.001; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Li L, 2015, CLIN NEUROPHYSIOL, V126, P1539, DOI 10.1016/j.clinph.2014.10.148; Martens G, 2019, BRAIN INJURY, V33, P1679, DOI 10.1080/02699052.2019.1667537; Martens G, 2018, BRAIN STIMUL, V11, P982, DOI 10.1016/j.brs.2018.04.021; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; O'Neil-Pirozzi TM, 2017, INT J NEUROSCI, V127, P592, DOI 10.1080/00207454.2016.1216415; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Wang J, 2019, AM J SPEECH-LANG PAT, V28, P1625, DOI 10.1044/2019_AJSLP-19-0069; Wang J, 2013, NEUROSCI LETT, V549, P29, DOI 10.1016/j.neulet.2013.06.019; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P1956, DOI 10.1016/j.clinph.2011.03.018; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Wu DY, 2015, NEUROSCI LETT, V589, P115, DOI 10.1016/j.neulet.2015.01.045; Wu DY, 2013, ARCH PHYS MED REHAB, V94, P1, DOI 10.1016/j.apmr.2012.07.022; Wu M, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/7089543; Yoon KJ, 2016, J NEUROL SCI, V362, P314, DOI 10.1016/j.jns.2016.02.005; Yuan Y, 2019, AM J SPEECH-LANG PAT, V28, P1381, DOI 10.1044/2019_AJSLP-18-0262; Yuan Y, 2017, TOP STROKE REHABIL, V24, P503, DOI 10.1080/10749357.2017.1322250; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263; Zhang X, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00386; Zhao HC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00685	43	0	0	8	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 8	2021	15								641951	10.3389/fnins.2021.641951			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU0MT	WOS:000698500300001	34566555	Green Published, gold			2022-02-06	
J	Banton, R; Piehler, T; Zander, N; Benjamin, R; Mrozek, R; Duckworth, J; Petel, O				Banton, R.; Piehler, T.; Zander, N.; Benjamin, R.; Mrozek, R.; Duckworth, J.; Petel, O.			Experimental and numerical investigation of blast wave impact on a surrogate head model	SHOCK WAVES			English	Article						Blast wave; Intracranial pressure; Biogel; Surrogate head; High-speed imaging; Shear stress	TRAUMATIC BRAIN-INJURY; RESPONSES; EXPOSURE; RAT	Primary blast wave impact on military personnel is of major concern, particularly as it relates to traumatic brain injury. To gain insights into the brain's response to primary blast impact, the current research employed a surrogate head form filled with biogel brain simulant and subjected it to primary blast waves propagating 180 mm from a 1.7-g cyclotrimethylene trinitramine Class 5 (RDX) explosive charge. The blast impacts to the surrogate head were investigated using combined approach of experiments and computations. More specifically, the combination of (1) high-speed imaging techniques, (2) embedded intracranial pressure sensors, and (3) numerical simulation techniques was used to study the blast wave/head interactions in terms of the external impact loading, intracranial pressures, and deviatoric stresses. The experimental and computational results show that the intracranial wave generated in the surrogate brain was a consequence of blast interactions with the surrogate skull. The resulting intracranial pressures were shown to be within threshold limits that could induce minor or mild traumatic brain injuries. Strong oscillations between compression and volumetric tensions were pronounced in the anterior region of the surrogate brain following frontal blast impact. Focal regions of elevated stress were captured in the simulation at the posterior region of the surrogate brain resulting from multiple reflections off the back of the skull. Deviatoric stress distributions were also revealed at the skull/surrogate brain interface where more dominant forces appeared at the base (interface) of the skull. These results indicate the potential for shearing/tearing of brain tissue material due to blast loading.	[Banton, R.; Piehler, T.; Zander, N.; Benjamin, R.; Mrozek, R.] US Army Combat Capabil Dev Command, Army Res Lab, Aberdeen Proving Ground, MD 21005 USA; [Duckworth, J.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Petel, O.] Carleton Univ, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada		Banton, R (corresponding author), US Army Combat Capabil Dev Command, Army Res Lab, Aberdeen Proving Ground, MD 21005 USA.	rohan.j.banton.civ@mail.mil		Petel, Oren/0000-0003-2169-2424	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL)	The authors would like to thank A. Brundage and the late R. Schmidt of Sandia National Laboratory for many helpful suggestions and advice in using CTH models. Special thanks are also extended to S. Schraml and D. Hofstetter in the use of CTH AMR techniques and the use of numerical pre-and post-processing modeling tools. Thanks are extended to K. McNesby and his team for high-speed imaging capture of the shock wave impact on the physical surrogate head form. Thanks also to M. Biss from Los Alamos National Laboratory on discussions of "Edgerton" shadowgraphy. Additionally, the authors are grateful to S. Kukuck for his many helpful suggestions and review of this manuscript. Finally, the authors would like to thank the CCDC-ARL for funding this research. Funding was provided by Army Research Laboratory.	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; [Anonymous], CONWEP BLAST SIMULAT; [Anonymous], 2016, PMMA VALUES; Banton R., 2018, DYNAMIC BEHAV MAT, V1, P181, DOI [10.1007/978-3-319-62956-8_30, DOI 10.1007/978-3-319-62956-8_30]; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Biss MM, 2010, PROPELL EXPLOS PYROT, V35, P452, DOI 10.1002/prep.200900070; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bowen I G, 1968, DASA2113; Bree, 1999, 43 STAPP CAR CRASH C, P313; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cooper P., 1997, EXPLOSIVES ENG; Cooper P., 1996, INTRO TECHNOLOGY EXP; Defense and Veterans Brain Injury Center, 2019, DOD TBI WORLDW NUMB; DEWEY JM, 1977, J FLUID MECH, V81, P701, DOI 10.1017/S0022112077002304; DEWEY JM, 2001, HDB SHOCK WAVES, V2, P441; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gatto J.A., 2005, 5 PAC S FLOW VIS IM; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Hargather MJ, 2007, SHOCK WAVES, V17, P215, DOI 10.1007/s00193-007-0108-8; Hertel E. S., 1993, P 19 INT S SHOCK WAV, P377, DOI DOI 10.1007/978-3-642-78829-1_61; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Kerley G., 1998, SAND980947 SAND NAT; Kinney GF., 1985, EXPLOSIVE SHOCKS AIR, DOI [10.1007/978-3-642-86682-1, DOI 10.1007/978-3-642-86682-1]; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mrozek RA, 2015, J MECH BEHAV BIOMED, V44, P109, DOI 10.1016/j.jmbbm.2015.01.001; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Ouellet S, 2018, SHOCK WAVES, V28, P19, DOI 10.1007/s00193-017-0771-3; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Settles GS, 2006, AM SCI, V94, P22, DOI 10.1511/2006.1.22; Settles GS., 2001, SCHLIEREN SHADOWGRAP, DOI [10.1007/978-3-642-56640-0, DOI 10.1007/978-3-642-56640-0]; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Taylor P.A., 2001, SAND20011995 CTH VEP; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Ward C., 1980, SAE T, V89, P3867; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	46	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JUL	2021	31	5					481	498		10.1007/s00193-021-01033-7		SEP 2021	18	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	UX0OV	WOS:000695351900001					2022-02-06	
J	Kanakia, KP; Saffari, E; Shrestha, S; Bartanusz, V; Hafeez, S				Kanakia, Kunal P.; Saffari, Ehsan; Shrestha, Sabi; Bartanusz, Viktor; Hafeez, Shaheryar			Refractory Elevated Intracranial Pressure (ICP) in the Setting of a Traumatic Cerebral Sinus Venous Thrombosis (CSVT)	CUREUS			English	Article						intracranial pressure; traumatic brain injury; cerebral sinus venous thrombosis; cranial fracture; intracranial hemorrhage	MANAGEMENT	The management of patients with elevated intracranial pressure (ICP) requires a systematic approach. After the failure of tier zero, tier one, and tier two therapies, all potential secondary causes of elevated ICP must be reviewed. Up to 28% of patients with blunt traumatic brain injury (TBI) develop cerebral sinus venous thrombosis (CSVT), among these, patients up to 55% have occlusive thrombi. A literature review revealed a dearth of specific treatment guidelines in this scenario. Here, we present one such case of refractory elevated ICP due to occlusive CSVT secondary to skull fractures. Initial CT venogram (CTV) on admission showed an occlusive CSVT; however, subsequent CTV on the post-trauma day (PTD) 4 and 6 showed non occlusive thrombi only. The risks of worsening acute TBI-related hemorrhage with systemic anticoagulation versus the benefit of treating an occlusive CSVT are discussed here. In cases of occlusive CSVT with refractory elevated ICP and stable intracranial hemorrhage, the benefit of anticoagulation may outweigh the overall risks of hemorrhage expansion as prolonged uncontrolled ICP elevation is inevitably fatal. In this case, anticoagulation started on PTD 6, led to the resolution of ICP elevation and an excellent outcome for the patient, who was discharged to an acute rehab center, subsequently discharged home with no residual motor deficits, and was able to resume employment. Further prospective trials are necessary to develop guidelines for the management of occlusive CSVT in patients with severe TBI and to determine which patient populations are likely to benefit from early initiation of therapeutic anticoagulation.	[Kanakia, Kunal P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Saffari, Ehsan; Shrestha, Sabi; Bartanusz, Viktor; Hafeez, Shaheryar] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA		Kanakia, KP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA.	kunalkanakia@gmail.com					Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; [Anonymous], 2020, EMERGENCY NEUROLOGIC; Capecchi M, 2018, J THROMB HAEMOST, V16, P1918, DOI 10.1111/jth.14210; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Hersh DS, 2016, NEUROSURGERY, V63, P169; Idiculla PS, 2020, EUR NEUROL, V83, P369, DOI 10.1159/000509802; Ilyas A, 2017, J NEUROINTERV SURG, V9, P1086, DOI 10.1136/neurintsurg-2016-012938; Mansour G, 2021, CHILD NERV SYST, V37, P2847, DOI 10.1007/s00381-021-05204-w; Sadoughi A, 2013, OPEN CRIT CARE MED J, V6, P56; Traumatic Brain Injury, 2013, NEUR CAR SOC PRACT U; Wang WH, 2013, J CLIN NEUROL, V9, P259, DOI 10.3988/jcn.2013.9.4.259	11	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 7	2021	13	9							e17801	10.7759/cureus.17801			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UR8PQ	WOS:000697004500020	34660011	Green Published, gold			2022-02-06	
J	Schafer, ST; Otto, AC; Acevedo, AC; Gorlinger, K; Massberg, S; Kammerer, T; Groene, P				Schaefer, Simon T.; Otto, Anne-Christine; Acevedo, Alice-Christin; Goerlinger, Klaus; Massberg, Steffen; Kammerer, Tobias; Groene, Philipp			Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms	THROMBOSIS JOURNAL			English	Article						Direct-acting oral anticoagulants; Direct thrombin inhibitors; Direct factor Xa inhibitors; Thromboelastometry	DIRECT ORAL ANTICOAGULANTS; TRAUMATIC BRAIN-INJURY; ROTATIONAL THROMBELASTOMETRY; LABORATORY ASSESSMENT; RIVAROXABAN; ENOXAPARIN; THROMBOPROPHYLAXIS; GENERATION; MANAGEMENT; MONITOR	Background: DOAC detection is challenging in emergency situations. Here, we demonstrated recently, that modified thromboelastometric tests can reliably detect and differentiate dabigatran and rivaroxaban. However, whether all DOACs can be detected and differentiated to other coagulopathies is unclear. Therefore, we now tested the hypothesis that a decision tree-based thromboelastometry algorithm enables detection and differentiation of all direct Xa-inhibitors (DXals), the direct thrombin inhibitor (DTI) dabigatran, as well as vitamin K antagonists (VKA) and dilutional coagulopathy (DIL) with high accuracy. Methods: Following ethics committee approval (No 17-525-4), and registration by the German clinical trials database we conducted a prospective observational trial including 50 anticoagulated patients (n = 10 of either DOACNKA) and 20 healthy volunteers. Blood was drawn independent of last intake of coagulation inhibitor. Healthy volunteers served as controls and their blood was diluted to simulate a 50% dilution in vitro. Standard (extrinsic coagulation assay, fibrinogen assay, etc.) and modified thromboelastometric tests (ecarin assay and extrinsic coagulation assay with low tissue factor) were performed. Statistical analyzes included a decision tree analyzes, with depiction of accuracy, sensitivity and specificity, as well as receiver-operating-characteristics (ROC) curve analysis including optimal cut-off values (Youden-Index). Results: First, standard thromboelastometric tests allow a good differentiation between DOACs and VKA, DIL and controls, however they fail to differentiate DXals, DTIs and VKAs reliably resulting in an overall accuracy of 78%. Second, adding modified thromboelastometric tests, 9/10 DTI and 28/30 DXaI patients were detected, resulting in an overall accuracy of 94%. Complex decision trees even increased overall accuracy to 98%. ROC curve analyses confirm the decision-tree-based results showing high sensitivity and specificity for detection and differentiation of DTI, DXals, VKA, DIL, and controls. Conclusions: Decision tree-based machine-learning algorithms using standard and modified thromboelastometric tests allow reliable detection of DTI and DXals, and differentiation to VKA, DIL and controls.	[Schaefer, Simon T.; Otto, Anne-Christine; Acevedo, Alice-Christin; Kammerer, Tobias; Groene, Philipp] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Anaesthesiol, Munich, Germany; [Goerlinger, Klaus] TEM Innovat, Munich, Germany; [Massberg, Steffen] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Internal Med Cardiol 1, Munich, Germany; [Kammerer, Tobias] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Cologne, Germany; [Groene, Philipp] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Marchioninistr 15, D-81377 Munich, Germany		Groene, P (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Anaesthesiol, Munich, Germany.; Groene, P (corresponding author), Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Marchioninistr 15, D-81377 Munich, Germany.	philipp.groene@med.uni-muenchen.de	Kammerer, Tobias/AAA-3175-2019	Kammerer, Tobias/0000-0001-8920-7187; Groene, Philipp/0000-0001-8357-5552	TEM Innovations (Munich, Germany)	Thromboelastometric machines and reagents were provided by TEM Innovations (Munich, Germany). The funding sponsors TEM Innovations had no role in the collection, analysis or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.	Adelmann D, 2014, THROMB RES, V134, P918, DOI 10.1016/j.thromres.2014.08.006; Artang R, 2019, RES PRACT THROMB HAE, V3, P391, DOI 10.1002/rth2.12206; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Boyd J., 2010, C28A3 CLSI, V28; Breimann L., 1984, CLASSIFICATION REGRE; Chappell D, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0538-5; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Crapelli GB, 2016, J CARDIOTHOR VASC AN, V30, P1027, DOI 10.1053/j.jvca.2015.10.017; Dias JD, 2019, J TRAUMA ACUTE CARE, V87, P364, DOI 10.1097/TA.0000000000002357; Ebner M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009807; Ellenberger C, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0440-1; Erber M, 2015, INT J PHARMACEUT, V495, P692, DOI 10.1016/j.ijpharm.2015.09.038; Erber M, 2015, J PHARM SCI-US, V104, P1668, DOI 10.1002/jps.24371; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Fontana P, 2017, THROMB RES, V153, P65, DOI 10.1016/j.thromres.2017.03.019; Friedman RJ, 2010, THROMB RES, V126, P175, DOI 10.1016/j.thromres.2010.03.021; Garcia D, 2013, J THROMB HAEMOST, V11, P245, DOI 10.1111/jth.12096; Gorlinger K, 2013, BRIT J ANAESTH, V110, P222, DOI 10.1093/bja/aes374; Gosselin RC, 2018, THROMB HAEMOSTASIS, V118, P437, DOI 10.1055/s-0038-1627480; Groene P., 2019, ANASTH INTENSIVMED, V60, P344; Hagemo JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0823-y; Harenberg J, 2019, SEMIN THROMB HEMOST, V45, P275, DOI 10.1055/s-0038-1668098; Henskens YMC, 2018, THROMB J, V16, DOI 10.1186/s12959-017-0160-2; Iapichino GE, 2017, SEMIN THROMB HEMOST, V43, P423, DOI 10.1055/s-0037-1599157; Korber MK, 2017, TRANSFUS MED HEMOTH, V44, P100, DOI 10.1159/000470622; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Mani H, 2012, THROMB HAEMOSTASIS, V108, P191, DOI 10.1160/TH11-12-0832; Margetic S, 2020, BIOCHEM MEDICA, V30, DOI 10.11613/BM.2020.010702; Molinaro RJ, 2008, ANESTHESIOLOGY, V109, P160, DOI 10.1097/ALN.0b013e31817885b7; Oblak JP, 2019, J STROKE CEREBROVASC, V28, P768, DOI 10.1016/j.jstrokecerebrovasdis.2018.11.019; Pailleret C, 2019, EUR J ANAESTH, V36, P449, DOI 10.1097/EJA.0000000000000903; Pakraftar S, 2014, WORLD J CLIN CASES, V2, P362, DOI 10.12998/wjcc.v2.i8.362; Reed MJ, 2013, EUR J EMERG MED, V20, P160, DOI 10.1097/MEJ.0b013e3283561261; Samuelson BT, 2017, CHEST, V151, P127, DOI 10.1016/j.chest.2016.08.1462; Schaden E, 2013, WIEN KLIN WOCHENSCHR, V125, P156, DOI 10.1007/s00508-013-0327-1; Schafer ST, 2020, THROMB RES, V190, P103, DOI 10.1016/j.thromres.2020.04.019; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10539; Seyve L, 2018, INT J LAB HEMATOL, V40, P84, DOI 10.1111/ijlh.12744; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Stein P, 2014, ACTA ANAESTH SCAND, V58, P630, DOI 10.1111/aas.12303; Sucker C, 2008, ACTA ANAESTH SCAND, V52, P358, DOI 10.1111/j.1399-6576.2007.01550.x; Taune V, 2017, THROMB RES, V153, P76, DOI 10.1016/j.thromres.2017.03.018; ten Cate H, 2018, INT J LAB HEMATOL, V40, P30, DOI 10.1111/ijlh.12816; ten Cate H, 2017, VASC HEALTH RISK MAN, V13, P457, DOI 10.2147/VHRM.S126265; Tripodi A, 2018, BLOOD TRANSFUS-ITALY, V16, P462, DOI 10.2450/2017.0124-17; Vedovati MC, 2020, J THROMB THROMBOLYS, V49, P251, DOI 10.1007/s11239-019-01956-0; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Young G, 2013, BLOOD, V121, P1944, DOI 10.1182/blood-2012-08-378935	49	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1477-9560			THROMB J	Thromb. J.	SEP 7	2021	19	1							63	10.1186/s12959-021-00313-7			11	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	UM9OL	WOS:000693653700001	34493301	Green Published, gold			2022-02-06	
J	Simoes, E; Sokolov, AN; Hahn, M; Fallgatter, AJ; Brucker, SY; Wallwiener, D; Pavlova, MA				Simoes, Elisabeth; Sokolov, Alexander N.; Hahn, Markus; Fallgatter, Andreas J.; Brucker, Sara Y.; Wallwiener, Diethelm; Pavlova, Marina A.			How Negative Is Negative Information	FRONTIERS IN NEUROSCIENCE			English	Article						negative information; neural networks; devastating events; social cognition; social reasoning; depression and anxiety; breast cancer; gender impact	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; BREAST-CANCER; STEREOTYPE-THREAT; DIAGNOSIS THREAT; COGNITIVE PERFORMANCE; TRAIT ANXIETY; IMPACT; WOMEN; NEUROBIOLOGY	Daily, we face a plenty of negative information that can profoundly affect our perception and behavior. During devastating events such as the current COVID-19 pandemic, negative messages may hinder reasoning at individual level and social decisions in the society at large. These effects vary across genders in neurotypical populations (being more evident in women) and may be even more pronounced in individuals with neuropsychiatric disorders such as depression. Here, we examine how negative information impacts reasoning on a social perception task in females with breast cancer, a life-threatening disease. Two groups of patients and two groups of matched controls (N-TOTAL = 80; median age, 50 years) accomplished a psychometrically standardized social cognition and reasoning task receiving either the standard instruction solely or additional negative information. Performance substantially dropped in patients and matched controls who received negative information compared to those who did not. Moreover, patients with negative information scored much lower not only compared with controls but also with patients without negative information. We suggest the effects of negative information are mediated by the distributed brain networks involved in affective processing and emotional memory. The findings offer novel insights on the impact of negative information on social perception and decision making during life-threatening events, fostering better understanding of its neurobiological underpinnings.	[Simoes, Elisabeth; Sokolov, Alexander N.; Hahn, Markus; Brucker, Sara Y.; Wallwiener, Diethelm] Eberhard Karls Univ Tubingen, Univ Hosp, Dept Womens Hlth, Tubingen, Germany; [Simoes, Elisabeth] Eberhard Karls Univ Tubingen, Univ Hosp, Execut Dept Social Med, Tubingen, Germany; [Sokolov, Alexander N.; Fallgatter, Andreas J.; Pavlova, Marina A.] Eberhard Karls Univ Tubingen, Dept Psychiat & Psychotherapy, Med Sch, Tubingen, Germany; [Sokolov, Alexander N.; Fallgatter, Andreas J.; Pavlova, Marina A.] Eberhard Karls Univ Tubingen, Univ Hosp, Tubingen, Germany; [Sokolov, Alexander N.; Fallgatter, Andreas J.; Pavlova, Marina A.] Tubingen Ctr Mental Hlth TuCMH, Tubingen, Germany		Pavlova, MA (corresponding author), Tubingen Ctr Mental Hlth TuCMH, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de			Hector Foundations [MED1704]; Dr. Antoni Foundation; Department of Womens Health, University Hospital; Medical School, Eberhard Karls University of Tubingen	This study was supported by the Research Grants from the Hector Foundations (MED1704) and Dr. Antoni Foundation to ES and MP, by Department of Womens Health, University Hospital, and by Medical School, Eberhard Karls University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2019, BREAST CANC FACTS FI; Angioli R, 2014, EUR J OBSTET GYN R B, V177, P67, DOI 10.1016/j.ejogrb.2014.03.041; Aquil A, 2021, ANN MED SURG, V65, DOI 10.1016/j.amsu.2021.102278; Arraras JI, 2007, PSYCHO-ONCOL, V16, P249, DOI 10.1002/pon.1047; Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106; Barber SJ, 2017, PERSPECT PSYCHOL SCI, V12, P62, DOI 10.1177/1745691616656345; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Cattaneo Z, 2011, NEUROIMAGE, V56, P1839, DOI 10.1016/j.neuroimage.2011.02.037; Chavanne AV, 2021, AM J PSYCHIAT, V178, P156, DOI 10.1176/appi.ajp.2020.19111153; Cikara M, 2011, PSYCHOL SCI, V22, P306, DOI 10.1177/0956797610397667; DIW/SOEP, 2011, SOEP SURVEY PAPERS, V65; EORTC Quality of Life Group, 2011, QUEST QUAL LIF CANC; Forbes CE, 2018, SOC COGN AFFECT NEUR, V13, P719, DOI 10.1093/scan/nsy043; Forbes CE, 2014, BIOL PSYCHOL, V102, P98, DOI 10.1016/j.biopsycho.2014.07.007; Garssen B, 2013, PSYCHO-ONCOLOGY, V22, P572, DOI 10.1002/pon.3034; Gehring K, 2012, EXPERT REV ANTICANC, V12, P255, DOI [10.1586/era.11.202, 10.1586/ERA.11.202]; Gu RL, 2019, NEUROSCI BIOBEHAV R, V100, P108, DOI 10.1016/j.neubiorev.2019.02.017; Hausmann M, 2009, PSYCHONEUROENDOCRINO, V34, P389, DOI 10.1016/j.psyneuen.2008.09.019; Heisig SR, 2016, PSYCHO-ONCOLOGY, V25, P1485, DOI 10.1002/pon.4089; Heisig SR, 2015, PSYCHO-ONCOLOGY, V24, P130, DOI 10.1002/pon.3611; Hou FS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09738-7; Hur J, 2020, J NEUROSCI, V40, P7949, DOI [10.1523/JNEUROSCI.0704, 10.1523/JNEUROSCI.0704-20.2020]; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Innes KL, 2020, J SPORT EXERCISE PSY, V42, P314, DOI 10.1123/jsep.2019-0280; Israelashvili J, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.648112; Jensen KB, 2014, MOL PSYCHIATR, V19, P392, DOI 10.1038/mp.2012.195; Keyzer-Dekker CMG, 2014, BRIT J HEALTH PSYCH, V19, P783, DOI 10.1111/bjhp.12076; Keyzer-Dekker CMG, 2013, WORLD J SURG, V37, P2140, DOI 10.1007/s00268-013-2088-4; Kim J, 2020, ANN SURG TREAT RES, V98, P215, DOI 10.4174/astr.2020.98.5.215; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li Y, 2021, AM J TRANSL RES, V13, P5165; Martins D, 2021, NEUROSCI BIOBEHAV R, V122, P1, DOI 10.1016/j.neubiorev.2020.12.034; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Murray KS, 2015, BJU INT, V116, P190, DOI 10.1111/bju.13002; Muscatell KA, 2012, SOC PERSONAL PSYCHOL, V6, P890, DOI 10.1111/j.1751-9004.2012.00467.x; Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pavlova M, 2008, J COGNITIVE NEUROSCI, V20, P494, DOI 10.1162/jocn.2008.20034; Pavlova MA, 2017, J NEUROSCI RES, V95, P235, DOI 10.1002/jnr.23871; Pavlova MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114802; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Peters A, 2020, DTSCH ARZTEBL INT, V117, P861, DOI 10.3238/arztebl.2020.0861; Robert Koch-Institut, 2017, KREBS DEUTSCHLAND 20; Schagen SB, 2012, PSYCHO-ONCOLOGY, V21, P1132, DOI 10.1002/pon.2011; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Siedler T., 2009, SCHMOLLERS JB, V129, P367, DOI [10.3790/schm.129.2.367, DOI 10.3790/SCHM.129.2.367]; Simoes E, 2016, GESUNDHEITSWESEN, V78, P97, DOI 10.1055/s-0042-100822; Soriano EC, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.662339; Spencer SJ, 2016, ANNU REV PSYCHOL, V67, P415, DOI 10.1146/annurev-psych-073115-103235; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Thakur M, 2021, INDIA J SURG ONCOL, V12, P251, DOI 10.1007/s13193-021-01296-7; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; von Aster M., 2006, WECHSLER INTELLIGENZ; Wallwiener M, 2016, GEBURTSH FRAUENHEILK, V76, P1065, DOI 10.1055/s-0042-113188; Wenham C., 2020, GENDERED IMPACT COVI; Wraga M, 2007, SOC COGN AFFECT NEUR, V2, P12, DOI 10.1093/scan/nsl041; Wu DJ, 2020, BIOL PSYCHOL, V156, DOI 10.1016/j.biopsycho.2020.107948	62	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 7	2021	15								742576	10.3389/fnins.2021.742576			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	US4BP	WOS:000697377100001	34557072	gold, Green Published			2022-02-06	
J	Andersson, H; Jablonski, GE; Nordahl, SHG; Nordfalk, K; Helseth, E; Martens, C; Roysland, K; Goplen, FK				Andersson, Helene; Jablonski, Greg Eigner; Nordahl, Stein Helge Glad; Nordfalk, Karl; Helseth, Eirik; Martens, Camilla; Roysland, Kjetil; Goplen, Frederik Kragerud			The Risk of Benign Paroxysmal Positional Vertigo After Head Trauma	LARYNGOSCOPE			English	Article						Benign paroxysmal positional vertigo; head trauma; traumatic benign paroxysmal positional vertigo; time criteria	BRAIN-INJURY; DIZZINESS	Objectives Head trauma may cause dislodgement of otoconia and development of benign paroxysmal positional vertigo (BPPV). The risk of developing BPPV is expected to be highest shortly after the trauma, then decrease and approach the risk seen in the general population. The aim of this study was to estimate the risk-time curve of BPPV development after head trauma. Study Design Prospective observational study. Methods Patients with minimal, mild, or moderate head trauma treated at the Department of Neurosurgery or the Department of Orthopedic Emergency at Oslo University Hospital, were interviewed and examined for BPPV using the Dix-Hallpike and supine roll maneuvers. BPPV was diagnosed according to the International diagnostic criteria of the Barany Society. Telephone interviews were conducted at 2, 6, and 12 weeks after the first examination. Results Out of 117 patients, 21% developed traumatic BPPV within 3 months after the trauma. The corresponding numbers were 12% with minimal trauma, 24% with mild, and 40% with moderate trauma. The difference in prevalence between the groups was significant (P = .018). During the first 4 weeks after the trauma, it was observed 20, 3, 0, and 1 BPPV onsets, respectively. No BPPV cases were seen for the remainder of the 3-month follow-up. Conclusion The risk of developing BPPV after minimal-to-moderate head trauma is considerable and related to trauma severity. Most cases occur within few days after the trauma, but any BPPV occurring within the first 2 weeks after head trauma are likely due to the traumatic event. Level of Evidence 3 Laryngoscope, 2021	[Andersson, Helene] Univ Oslo, Fac Med, Oslo, Norway; [Jablonski, Greg Eigner; Helseth, Eirik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Jablonski, Greg Eigner] Oslo Univ Hosp, Rikshosp, Dept Otorhinolaryngol & Head & Neck Surg, Oslo, Norway; [Nordahl, Stein Helge Glad; Martens, Camilla; Goplen, Frederik Kragerud] Haukeland Hosp, Norwegian Natl Advisory Unit Vestibular Disorders, Bergen, Norway; [Nordahl, Stein Helge Glad; Goplen, Frederik Kragerud] Univ Bergen, Dept Clin Med, Bergen, Norway; [Nordfalk, Karl] Nordfalk ENT Clin, Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Martens, Camilla; Goplen, Frederik Kragerud] Haukeland Hosp, Dept Otorhinolaryngol Head & Neck Surg, Bergen, Norway; [Roysland, Kjetil] Univ Oslo, Dept Biostat, Oslo, Norway		Andersson, H (corresponding author), Univ Oslo, Fac Med, Gydas Vei 20, N-1413 Tarnasen, Norway.	helene.andersson@studmed.uio.no	Goplen, Frederik Kragerud/AAM-9670-2020	Goplen, Frederik Kragerud/0000-0002-8022-9483; Andersson, Helene/0000-0001-5395-7699	Medical Student Research Program at Faculty of Medicine, University of Oslo	The authors would like to thank Oslo University Hospital, the Department of Orthopedic Emergency, Division of Orthopedic Surgery with a special gratitude to Knut Melhuus and Martine Enger, and the three surgical intensive care units for enabling recruitment of head trauma patients and for their cooperation during the inclusion period. We also wish to thank the Medical Student Research Program at Faculty of Medicine, University of Oslo for providing funding for the project.	Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chang TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153092; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; de Clercq H, 2017, SAMJ S AFR MED J, V107, P957, DOI [10.7196/SAMJ.2017.v107i11.12472, 10.7196/samj.2017.v107i11.12472]; Deniz K, 2017, INT J ORAL MAX SURG, V46, P309, DOI 10.1016/j.ijom.2016.10.007; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Dlugaiczyk J, 2011, OTOL NEUROTOL, V32, P1285, DOI 10.1097/MAO.0b013e31822e94d9; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fife TD, 2009, SEMIN NEUROL, V29, P500, DOI 10.1055/s-0029-1241041; Giacomini PG, 2009, EUR ARCH OTO-RHINO-L, V266, P1831, DOI 10.1007/s00405-009-0938-3; Gokler O, 2018, J INT ADV OTOL, V14, P295, DOI 10.5152/iao.2018.4384; Gordon Carlos R, 2002, Harefuah, V141, P944; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Jackson LE, 2007, OTOL NEUROTOL, V28, P218, DOI 10.1097/01.mao.0000247825.90774.6b; Johnson EG, 2009, CASE REP MED, V2009, DOI 10.1155/2009/910596; Jozefowicz-Korczynska M, 2018, ADV CLIN EXP MED, V27, P1355, DOI 10.17219/acem/69708; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Magliulo G, 2005, J VESTIBUL RES-EQUIL, V15, P169; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; MCCLURE JA, 1985, J OTOLARYNGOL, V14, P30; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Pisani V, 2015, INT J AUDIOL, V54, P329, DOI 10.3109/14992027.2014.989454; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Viccaro M, 2007, OTOL NEUROTOL, V28, P764, DOI 10.1097/MAO.0b013e318064e8d4; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; von Brevern M, 2015, J VESTIBUL RES-EQUIL, V25, P105, DOI 10.3233/VES-150553; Yang CJ, 2017, ACTA OTO-LARYNGOL, V137, P29, DOI 10.1080/00016489.2016.1217043; Yetiser S, 2019, J INT MED RES, DOI 10.1177/0300060519892370	35	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	FEB	2022	132	2					443	448		10.1002/lary.29851		SEP 2021	6	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	YD3LT	WOS:000692807800001	34487348	Green Published, hybrid			2022-02-06	
J	Dadashi, E; Entezami, P; De Tommasi, C				Dadashi, Eileen; Entezami, Pouya; De Tommasi, Claudio			Epidural hematoma from impact while zorbing	BRAIN INJURY			English	Article						Epidural hematoma; traumatic brain injury; zorbing	INJURY SURVEILLANCE	Injuries suffered while participating in extreme sports account for numerous emergency department visits. Isolated head injuries are a common presentation. Zorbing is an activity native to New Zealand. Like many emerging extreme sports there is little information regarding its safety. We conservatively managed a patient who suffered a skull fracture and epidural hematoma while zorbing. Publications (especially in the medical literature) are lacking regarding zorbing-related injuries. We hope that presenting this case will help elucidate the possibility of severe head injury despite the protective bubble offered by the sport.	[Dadashi, Eileen] York Univ, Toronto, ON, Canada; [Entezami, Pouya] Albany Med Ctr, Dept Neurosurg, 47 New Scotland Ave,MC-10, Albany, NY 12203 USA; [De Tommasi, Claudio] Christchurch Publ Hosp, Canterbury Dist Hlth Board, Dept Neurosurg, Christchurch, New Zealand		Entezami, P (corresponding author), Albany Med Ctr, Dept Neurosurg, 47 New Scotland Ave,MC-10, Albany, NY 12203 USA.	entezap@amc.edu					[Anonymous], 2016, STUFF; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Hainey, 2018, COVENTRY TELEGR 0725; Halani SH, 2016, J CLIN NEUROSCI, V34, P227, DOI 10.1016/j.jocn.2016.08.007; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Laver L, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0560-9; Martin, 2017, ROTORUA DAILY P 0914; Person A., 2009, SYDNEY MORN HERALD; Price R, 2016, STUFF; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Rafi M., 2020, AM SOC MECH ENG DIGI; Roth A., 2013, NEW YORK TIMES; Sharma VK, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114564358	13	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1645	1646		10.1080/02699052.2021.1973103		SEP 2021	2	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000695304500001	34487474				2022-02-06	
J	Daugherty, J; Sarmiento, K; Womack, LS; Breiding, M				Daugherty, Jill; Sarmiento, Kelly; Womack, Lindsay S.; Breiding, Matthew			Symptom profile of affirmative responses to a self-report concussion question, United States 2019	BRAIN INJURY			English	Article						Concussion; injury prevention; survey methodology	TRAUMATIC BRAIN-INJURY; SYSTEM	Information is limited about signs and symptoms experienced by individuals who self-report a concussion within surveys. The objective of this study was to assess the number and types of signs/symptoms adults experienced and whether or not medical attention was reported after sustaining a self-reported concussion in the past year. A sample of 3,624 adults responded to the web-based 2019 FallStyles survey. Respondents were asked if they had sustained a concussion in the past 12 months and if so, which (if any) signs/symptoms they experienced following the injury. The frequency and percentages of symptoms were calculated. Approximately 2.9% of respondents reported a concussion in the past year. Approximately two-thirds of respondents who reported sustaining a recent concussion stated that they experienced two or more signs/symptoms; the remaining one-third reported zero or one symptom. The findings suggest self-report concussion questions need additional improvement, particularly those that capture concussion using a single question, to improve the validity of self-reports.	[Daugherty, Jill; Sarmiento, Kelly; Womack, Lindsay S.; Breiding, Matthew] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Highway Northeast, Atlanta, GA 30341 USA		Daugherty, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Highway Northeast, Atlanta, GA 30341 USA.	xdu1@cdc.gov					[Anonymous], 2017, 59 NATL HLTH STAT, P244; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Centers for Disease Control and Prevention, 2019, SEXUALLY TRANSMITTED, P24; Connecticut Department of Public Health, 2013, 2013 YOUTH RISK BEH; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Daugherty J, 2020, J HEAD TRAUMA REHAB, V35, pE136, DOI 10.1097/HTR.0000000000000534; Koval RR, 2020, ANN EMERG MED, V75, P483, DOI 10.1016/j.annemergmed.2019.08.419; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Ohio Department of Health, 2013, 2013 YOUTH RISK BEH; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Waltzman D, 2021, J HEAD TRAUMA REHAB, V36, pE40, DOI 10.1097/HTR.0000000000000603; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218	15	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1413	1417		10.1080/02699052.2021.1972340		SEP 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000693007000001	34487455				2022-02-06	
J	Derbyshire, S; Maskill, V; Snell, DL				Derbyshire, Sarah; Maskill, Virginia; Snell, Deborah L.			Do concussion clinicians use clinical practice guidelines?	BRAIN INJURY			English	Article						Clinical practice guidelines; concussion outcomes; evidence-based practice; clinician perspectives	IMPLEMENTATION	Objective: Clinical practice guidelines (CPGs) synthesize research evidence for health professionals and improve consistency of clinical care. However, it is unclear if concussion clinicians use them in their practice. We aimed to describe which CPGs New Zealand clinicians used and facilitators and barriers to uptake of these resources. Materials and Methods: We used snowballing recruitment methods to survey New Zealand concussion clinicians. Descriptive statistics and qualitative description were used to evaluate survey responses. Results: Ninety-six clinicians took part in the survey. A majority (70%) indicated they were aware of and had used at least one concussion CPG. Facilitators and barriers to using CPGs related to clinician experience, nature of the CPG, the work context, characteristics of clients and whether strategies were provided to encourage their use. Conclusions: Participants viewed concussion CPGs as helpful tools for informing clinical practice. That less experienced clinicians were less likely to use concussion CPGs than more experienced clinicians suggests there is an opportunity to develop strategies to improve the uptake of CPGs among newer clinicians. This and other areas of further research include how well CPGs capture relevant cultural factors and the role of case complexity in clinicians' willingness to use concussion CPGs.	[Derbyshire, Sarah; Maskill, Virginia] Univ Otago, Ctr Postgrad Nursing Studies, Christchurch, New Zealand; [Snell, Deborah L.] Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand		Snell, DL (corresponding author), Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand.	debbie.snell@otago.ac.nz	Derbyshire, Sarah/AAZ-6271-2021	Snell, Deborah/0000-0003-1664-0603	Centre for Postgraduate Nursing Studies, University of Otago, Christchurch, NZ	Funding was made available by the Centre for Postgraduate Nursing Studies, University of Otago, Christchurch, NZ to facilitate dissemination of the survey to professional bodies. The authors would like to thank the clinicians who offered their time for piloting the online survey questions and participants who gave their time to respond to the survey during a difficult time associated with the COVID-19 pandemic.	Accident Compensation Corporation (ACC), 2020, CONC SERV OP GUID; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Bereznicki BJ, 2015, AUST FAM PHYSICIAN, V44, P933; Bosch M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-018-0841-7; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Brown AM, 2018, AUST J RURAL HEALTH, V26, P134, DOI 10.1111/ajr.12397; Cancelliere C, 2019, J ORTHOP SPORT PHYS, V49, P842, DOI 10.2519/jospt.2019.8849; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; DeMatteo C, 2020, CLIN PEDIATR, V59, P5, DOI 10.1177/0009922819879457; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donnell Z, 2018, J SAFETY RES, V67, P203, DOI 10.1016/j.jsr.2018.09.006; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Francke Anneke L, 2008, BMC Med Inform Decis Mak, V8, P38, DOI 10.1186/1472-6947-8-38; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Hadely KA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-110; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holtgraves T, 2004, PERS SOC PSYCHOL B, V30, P161, DOI 10.1177/0146167203259930; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Medves J, 2010, INT J EVID-BASED HEA, V8, P79, DOI 10.1111/j.1744-1609.2010.00166.x; NZGG, 2006, EV BAS BEST PRACT GU; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Poitras S, 2011, WORK, V39, P465, DOI 10.3233/WOR-2011-1196; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Ritter Lois A., 2007, NEW DIR EVAL, V2007, P5, DOI [DOI 10.1002/EV.230, 10.1002/ev.230]; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sarmiento K, 2018, BRAIN INJURY, V32, P889, DOI 10.1080/02699052.2018.1466197; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Sue, 2007, N DIR EVAL, V115, P23, DOI [10.1002/ev.232, DOI 10.1002/EV.232]; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748	35	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1521	1528		10.1080/02699052.2021.1972451		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000693001500001	34487457				2022-02-06	
J	Klyce, DW; Pugh, M; Perrin, PB				Klyce, Daniel W.; Pugh, Mickeal; Perrin, Paul B.			Factor structure of the Modified Mini Mental State (3MS) exam among participants in inpatient neurorehabilitation	BRAIN INJURY			English	Article						Cognitive screening; modified mini mental state (3ms) exam; inpatient rehabilitation; stroke; traumatic brain injury; factor analysis	REHABILITATION; STROKE; EDUCATION; DEMENTIA; MMSE; AGE	Objective: To evaluate the factor structure of the Modified Mini Mental State (3MS) Exam and its suitability as a cognitive screening tool among individuals admitted to an inpatient rehabilitation unit for new-onset neurological injury/illness. Method: A retrospective chart review was conducted. Of the 187 individuals meeting the inclusion criteria, 116 had a diffuse pattern of neurological injury/illness; 71 had a focal injury/illness. Confirmatory and exploratory factor analyses (CFA; EFA) were conducted for the whole sample and separately by group. Results: The CFA suggested poor fit indices. The EFA of the total sample suggested a three-factor solution (Orientation/Awareness; Learning/Recall and Executive Functioning; Psychomotor Ability). The EFA of the diffuse subsample suggested a three-factor solution (Attention and Learning/Recall; Psychomotor Ability; Expressive Language). The Orientation/Awareness, Learning/Recall, Executive Functioning, Psychomotor Ability, and Expressive Language four-factor solution observed among the focal subsample was considered invalid. Conclusion: The 3MS provides information about the pattern of cognitive performance among individuals in neurorehabilitation; clinicians are advised to interpret total scores with caution. Among individuals with focal injuries/illnesses, clinicians might use the 3MS to compare the pattern of cognitive ability to expectations for performance and to support strengths-based approaches to participation in rehabilitation therapies.	[Klyce, Daniel W.; Perrin, Paul B.] Cent Virginia Vet Affairs Hlth Care Syst, Richmond, VA 23803 USA; [Klyce, Daniel W.] Virginia Commonwealth Univ Hlth Syst, Dept Psychol, Richmond, VA USA; [Klyce, Daniel W.] Sheltering Arms Inst, Psychol Serv, Richmond, VA USA; [Pugh, Mickeal; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA		Klyce, DW (corresponding author), Cent Virginia Vet Affairs Hlth Care Syst, Richmond, VA 23803 USA.	daniel.klyce@vcuhealth.org					ABRAHAM IL, 1994, J AM GERIATR SOC, V42, P750, DOI 10.1111/j.1532-5415.1994.tb06536.x; Arbuckle JL., 2019, AMOS SPSS; Bassuk SS, 2003, J CLIN EPIDEMIOL, V56, P622, DOI 10.1016/S0895-4356(03)00111-2; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bland RC, 2001, CAN J PSYCHIAT, V46, P506, DOI 10.1177/070674370104600604; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; Meyers L. S., 2006, APPL MULTIVARIATE RE; Novack TA., 2010, HDB REHABILITATION P, P165; Rapp SR, 2003, AGING MENT HEALTH, V7, P217, DOI 10.1080/1360786031000101201; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Ryan J, 2019, CLIN NEUROPSYCHOL, V33, P779, DOI 10.1080/13854046.2018.1488996; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P2041, DOI 10.1016/j.apmr.2020.06.021; Suhr JA, 1999, ARCH PHYS MED REHAB, V80, P773, DOI 10.1016/S0003-9993(99)90226-5; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Teng EL., 1991, MANUAL ADM SCORING M; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; Trzepacz PT., 2011, SILVER JM MCALLISTER, P145; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127	24	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1425	1432		10.1080/02699052.2021.1972449		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000693003600001	34487456				2022-02-06	
J	Lv, XD; Lv, FX; Yin, GM; Yi, J; Liu, Y; Tian, Y				Lv, Xiaodan; Lv, Fengxia; Yin, Guimei; Yi, Ju; Liu, Yi; Tian, Ying			Curative Effect of Early Full Nursing Combined with Postdischarge Continuation Nursing on Patients after Craniocerebral Trauma	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							BRAIN-INJURY; INTERVENTIONS; CARE; MANAGEMENT	Early full nursing helps patients with some dysfunctions speed up the reorganization of central nervous system functions and coordinate muscle and limb activities. Postdischarge continuation nursing for patients who have not fully recovered after being discharged from the hospital can transfer nursing work from the hospital to the family to meet their nursing needs. In this study, early full nursing combined with postdischarge continuation nursing was used for patients with traumatic brain injury to explore its efficacy and its impact on patients' motor function, quality of life, and complications. The results of the study show that the total effective rate of the observation group (95.92%) was higher than that of the control group (85.71%). At discharge and 1 month, 3 months, and 6 months after discharge, the upper limb Fugl-Meyer score, lower limb Fugl-Meyer score, ARAT score, FIM score, 4 dimensions of GQOLI-74 score, and Barthel index scores of the observation group were higher than those of the control group in the same period. The postoperative complication rate (10.20%) of the observation group was lower than that of the control group (26.53%). Early full nursing combined with postdischarge continuation nursing can improve the rehabilitation effect, effectively promote the recovery of motor function in patients with traumatic brain injury, improve the quality of life, and reduce postoperative complications.	[Lv, Xiaodan; Yin, Guimei; Yi, Ju; Liu, Yi] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg 2, Kunming 650000, Yunnan, Peoples R China; [Lv, Fengxia] Panzhihua Ctr Dis Control & Prevent, Panzhihua 617099, Sichuan, Peoples R China; [Tian, Ying] Kunming Med Univ, Affiliated Hosp 1, Dept Nursing, Kunming 650000, Yunnan, Peoples R China		Liu, Y (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg 2, Kunming 650000, Yunnan, Peoples R China.; Tian, Y (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Nursing, Kunming 650000, Yunnan, Peoples R China.	chowpuppy@sohu.com; tianyychen@163.com			Yunnan Provincial Health and Family Planning Commission [L-2017022]	The authors are grateful to the participants of this research for their invaluable contributions to this work. This research was supported by the medical leader of the Yunnan Provincial Health and Family Planning Commission (L-2017022).	Aadal L, 2016, REHABIL NURS, V41, P289, DOI 10.1002/rnj.251; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Blaszczyk B, 2019, J CRANIO MAXILL SURG, V47, P287, DOI 10.1016/j.jcms.2018.11.024; Castor N, 2018, BRAIN INJURY, V32, P1803, DOI 10.1080/02699052.2018.1508748; Damkliang J, 2015, J CLIN NURS, V24, P3365, DOI 10.1111/jocn.12923; Dermer M, 2019, CAN MED ASSOC J, V191, pE1363, DOI 10.1503/cmaj.73775; dos Santos ACFS, 2019, J NURS SCHOLARSHIP, V51, P88, DOI 10.1111/jnu.12433; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Harris T, 2018, EMERG MED CLIN N AM, V36, P85, DOI 10.1016/j.emc.2017.08.009; Hoffman MR, 2020, AM SURGEON, V86, P933, DOI 10.1177/0003134820940255; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kochoyan A. L., 2019, Sudebno-Meditsinskaya Ekspertiza, V62, P58, DOI 10.17116/sudmed20196205158; Leonard JM, 2019, INJURY, V50, P1064, DOI 10.1016/j.injury.2019.01.024; Lin Qing, 2017, Nan Fang Yi Ke Da Xue Xue Bao, V37, P337; Lueckel SN, 2019, J HEAD TRAUMA REHAB, V34, pE39, DOI 10.1097/HTR.0000000000000393; Mabire Cedric, 2016, JBI Database System Rev Implement Rep, V14, P217; McNett M, 2018, J NEUROSCI NURS, V50, P155, DOI 10.1097/JNN.0000000000000377; Minen M, 2019, HEADACHE, V59, P151, DOI 10.1111/head.13455; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; Mortimer DS, 2017, J NEUROSCI NURS, V49, P25, DOI 10.1097/JNN.0000000000000253; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Nyholm L, 2017, J NEUROSCI NURS, V49, P49, DOI 10.1097/JNN.0000000000000260; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Olson DM, 2019, J NEUROSCI NURS, V51, P43, DOI 10.1097/JNN.0000000000000426; Oyesanya TO, 2018, J CLIN NURS, V27, P1408, DOI 10.1111/jocn.14298; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pinchuk Viktoriia A, 2019, Wiad Lek, V72, P539; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Williamson LF, 2018, REHABIL NURS, V43, P73, DOI [10.1002/rnj.311, 10.1097/RNJ.0000000000000091]	30	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.	SEP 6	2021	2021								7424855	10.1155/2021/7424855			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	US3HO	WOS:000697324700011	34527065	Green Published, gold			2022-02-06	
J	Malloy, S; Genova, H; Chiaravalloti, N; DeLuca, J; Holtzheimer, P; Wylie, GR				Malloy, S.; Genova, H.; Chiaravalloti, N.; DeLuca, J.; Holtzheimer, P.; Wylie, G. R.			Cognitive fatigue in traumatic brain injury: a pilot study comparing state and trait fatigue	BRAIN INJURY			English	Article						Traumatic brain injury; TBI; fatigue; cognitive fatigue; depression	DEPRESSION; SCALE	Objective Cognitive fatigue is a common and disabling symptom following a traumatic brain injury (TBI). Literature on cognitive fatigue has distinguished between two types of fatigue: "state" fatigue refers to the acute experience of fatigue, whereas "trait" fatigue refers to the susceptibility to fatigue over an extended period. However, it is not clear whether state and trait fatigue are distinguishable constructs. Here, we examine the relationship between state and trait fatigue in individuals with TBI, hypothesizing that trait and state measures assess different constructs. Participants Twenty-one participants with moderate-severe TBI were recruited. Design Participants underwent a cognitively fatiguing task while in an MRI scanner and completed self-report measures examining trait and state fatigue. Results No correlation was found between state and trait fatigue. However, the two measures of trait fatigue, Fatigue Severity Scale (FSS) and the Modified Fatigue Impact Scale (MFIS), correlated with one another; additionally only trait fatigue correlated with depression scores, consistent with the literature. Conclusion These findings suggest that trait and state fatigue may not be interdependent and that it is important to carefully define the type of fatigue under consideration when assessing fatigue in individuals with TBI.	[Malloy, S.; Holtzheimer, P.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Psychiat, Lebanon, NH 03766 USA; [Malloy, S.; Holtzheimer, P.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Surg, Lebanon, NH 03766 USA; [Malloy, S.; Holtzheimer, P.] Vet Affairs Med Ctr 116d, Natl Ctr Posttraumat Stress Disorder, White River Jct, VT USA; [Malloy, S.] Beth Israel Deaconess Med Ctr, Dept Gen Med, Div Res, Boston, MA 02215 USA; [Genova, H.; Chiaravalloti, N.; DeLuca, J.; Wylie, G. R.] Kessler Fdn, W Orange, NJ USA; [Genova, H.; Chiaravalloti, N.; DeLuca, J.; Wylie, G. R.] Rutgers State Univ, Dept Phys Med & Rehabil, Newark, NJ USA; [DeLuca, J.] Rutgers State Univ, Dept Neurol, Newark, NJ USA; [Wylie, G. R.] War Related Illness & Injury Ctr, New Jersey Healthcare Syst, Dept Vet Affairs, E Orange, NJ USA		Wylie, GR (corresponding author), Kessler Fdn, Rocco Ortenzio Neuroimaging Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	smalloy@bidmc.harvard.edu		DeLuca, John/0000-0003-3745-4156	New Jersey Commission for Brain Injury Research [10.005.BIR1]; Kessler Foundation	The authors would like to acknowledge grant support from The New Jersey Commission for Brain Injury Research (10.005.BIR1 to GW and HG), and The Kessler Foundation.	ALLEN BP, 1981, J PERS SOC PSYCHOL, V41, P916, DOI 10.1037/0022-3514.41.5.916; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Brain Injury Associations of America, 2007, ESS BRAIN INJ GUID, P7; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Learmonth YC, 2013, J NEUROL SCI, V331, P102, DOI 10.1016/j.jns.2013.05.023; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Pittion-Vouyovitch S, 2006, J NEUROL SCI, V243, P39, DOI 10.1016/j.jns.2005.11.025; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Sandry J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00214; TEASDALE G, 1974, LANCET, V2, P81; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	20	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1254	1258		10.1080/02699052.2021.1972144		SEP 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000693003900001	34487467				2022-02-06	
J	Mulligan, T; Barker-Collo, S; Gibson, K; Jones, K				Mulligan, Therese; Barker-Collo, Suzanne; Gibson, Kerry; Jones, Kelly			You only get one brain. Adult reflections on acute and ongoing symptom experiences after traumatic brain injury in adolescence	BRAIN INJURY			English	Article						Adolescent; brain injury; qualitative; symptom experiences	QUALITY-OF-LIFE; POST-CONCUSSIVE SYMPTOMS; POSTCONCUSSION SYNDROME; HEAD-INJURY; CHILDREN; OUTCOMES; EPIDEMIOLOGY; SCHOOL; TBI; TRUSTWORTHINESS	Background This research adds to the scarce literature regarding adolescent experiences of traumatic brain injury (TBI). It uses a qualitative methodology to explore the symptoms experienced after sustaining a TBI at this unique stage of development including their persistence into adulthood. Methods Thirteen adults (aged 20-25 years; mean 23 years) who sustained a mild-moderate TBI during adolescence (aged 13-17 years at injury), approximately 7.7 years (range = 6.7-8.0 years) prior, participated in the research. Semi-structured individual interviews, analyzed using thematic analysis, explored participants' experiences surrounding and following their TBIs. Results TBI during adolescence can result in significant acute symptoms, particularly headaches, fatigue, and difficulties in thinking. Participants' descriptions of the extent and impact of these symptoms reflected feelings of frustration and often anxiety and/or depression. Difficulties could persist for years post-TBI and sometimes had not resolved at all. Conclusions Even mild TBI during adolescence can result in significant acute and ongoing symptoms, which can contribute to emotional distress in the long term.	[Mulligan, Therese; Barker-Collo, Suzanne; Gibson, Kerry] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Jones, Kelly] Auckland Univ Technol, Natl Inst Stroke & Appl Neurorehabil, Auckland, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Clin Training Program, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz					Accident Compensation Corporation, 2017, TRAUMATIC BRAIN INJU; Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazeley P., 2013, QUALITATIVE DATA ANA; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Clarke V., THEMATIC ANAL; D'Amato RC., 2010, HDB PEDIAT NEUROPSYC, P47; D'Amato RC., 2010, HDB PEDIAT NEUROPSYC, P963; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Di Battista A, 2015, BRAIN INJURY, V29, P573, DOI 10.3109/02699052.2014.989905; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Doody Owen, 2013, Nurse Res, V20, P28; Dumontheil I, 2014, DEV COGN NEUROS-NETH, V10, P57, DOI 10.1016/j.dcn.2014.07.009; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; ELKIND D, 1979, DEV PSYCHOL, V15, P38, DOI 10.1037/0012-1649.15.1.38; ELKIND D, 1967, CHILD DEV, V38, P1025, DOI 10.1111/j.1467-8624.1967.tb04378.x; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Erikson E., 1968, IDENTITY YOUTH CRISI; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Furlong A, 2011, J SOCIOL, V47, P355, DOI 10.1177/1440783311420787; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hermanns H., 2008, COMPANION QUALITATIV, P295; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Inhelder B., 2013, GROWTH LOGICAL THINK, P334; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leech BL, 2002, PS, V35, P665, DOI 10.1017/S1049096502001129; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Luyckx K, 2006, J ADOLESCENCE, V29, P361, DOI 10.1016/j.adolescence.2005.03.008; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morrow SL, 2005, J COUNS PSYCHOL, V52, P250, DOI 10.1037/0022-0167.52.2.250; Morrow SL, 2007, COUNS PSYCHOL, V35, P209, DOI 10.1177/0011000006286990; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Rennie BJ., 2015, SOCIAL IMPACT TRAUMA; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rodset M, 2008, SCAND J DISABIL RES, V10, P90, DOI 10.1080/15017410801927807; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Snell DL., 2016, J BEHAV BRAIN SCI, V6, P227, DOI [10.4236/jbbs.2016.66023, DOI 10.4236/JBBS.2016.66023]; Srivastava P., 2009, INT J QUAL METHODS, V8, P76, DOI [DOI 10.1177/160940690900800107, 10.1177/160940690900800107]; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Twining P, 2017, COMPUT EDUC, V106, pA1, DOI 10.1016/j.compedu.2016.12.002; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Williams EN, 2009, PSYCHOTHER RES, V19, P576, DOI 10.1080/10503300802702113; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	74	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1308	1315		10.1080/02699052.2021.1972336		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000693837400001	34487437				2022-02-06	
J	Niemeier, JP; Hammond, FM; O'Neil-Pirozzi, TM; Venkatesan, UM; Bushnik, T; Zhang, Y; Kennedy, RE				Niemeier, Janet P.; Hammond, Flora M.; O'Neil-Pirozzi, Therese M.; Venkatesan, Umesh M.; Bushnik, Tamara; Zhang, Yue; Kennedy, Richard E.			Refining understanding of life satisfaction in elderly persons with traumatic brain injury using age-defined cohorts: a TBI model systems study	BRAIN INJURY			English	Article						Traumatic brain injury; elderly; post-acute; participation; life satisfaction	YOUNG-OLD; PARTICIPATION ASSESSMENT; BABY BOOMERS; MIDDLE-OLD; RESILIENCE; SUICIDE; REHABILITATION; OUTCOMES; FUTURE	Objective: Examine effects of age cohort on post-injury life satisfaction in elderly persons with TBI Design: Retrospective cohort Setting: TBI Model Systems centers. Participants: 5,109 elderly participants with TBI in the TBI Model Systems National Database Interventions: Not applicable Main Outcome Measures: Demographics, injury characteristics and cause, outcomes, age at time of analysis, time to follow commands, maximum follow-up period, and scores on the Satisfaction With Life Scale (SWLS) and Participation Assessment with Recombined Tools-Objective (PART-O) scores at 1, 2, 5, or 10 years post-injury. Results: Life satisfaction post-TBI across groups increased with age. The young-old sub-group demonstrated the poorest life satisfaction outcomes, while the oldest sub-group experienced greatest life satisfaction. In contrast, participation decreased with age. Conclusions: Findings show diversity in satisfaction with life following moderate to severe TBI for three elderly age-cohorts. Differences may be due to variations in generation-based lived experience, in perceived meaningfulness of participation, could echo prior evidence of greater resilience in the oldest group, or could reflect bias within the study sample. Further research into between- and within- differences for elderly TBI age cohorts is needed to more precisely meet their needs for physical and functional rehabilitation as well as psychological supports.	[Niemeier, Janet P.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35216 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Indianapolis, IN 46202 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Venkatesan, Umesh M.] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Bushnik, Tamara] New York Univ Langone Hlth, Rusk Rehabil, New York, NY USA; [Zhang, Yue; Kennedy, Richard E.] Univ Alabama Birmingham, Birmingham, AL 35216 USA		Niemeier, JP (corresponding author), Univ Alabama Birmingham, Dept Psychol, Ackerson & Associates, 400 Vestavia Pkwy,Suite 130,Vestavia Hills, Birmingham, AL 35216 USA.	jpniemeier@gmail.com	Kennedy, Richard/K-1525-2018	Kennedy, Richard/0000-0003-4638-126X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): Indiana University School of Medicine [90DRTB0002]; Rusk Rehabilitation [90DPTB0100]; Spaulding/Harvard [90DPTB0011]; University of Alabama [90DPTB0015]; Moss Rehabilitation Research Institute [90DPTB0004]; Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS)	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): Indiana University School of Medicine (grant #90DRTB0002); Rusk Rehabilitation (grant #90DPTB0100); Spaulding/Harvard (grant #90DPTB0011); University of Alabama (grant #90DPTB0015); Moss Rehabilitation Research Institute (grant #90DPTB0004), a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Alaphilippe D., 2013, J GERONTOL B-PSYCHOL, P68540; Amtmann D, 2019, ASSESSMENT, V26, P695, DOI 10.1177/1073191117693921; [Anonymous], 65 OLDER NOT ALL; [Anonymous], MARKETING ARTFULLY; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Au Alma M L, 2017, Curr Gerontol Geriatr Res, V2017, P6215917, DOI 10.1155/2017/6215917; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Daig I, 2009, QUAL LIFE RES, V18, P669, DOI 10.1007/s11136-009-9481-3; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Dittrich DAV., 2015, SOEP PAPERS MULTIDIS, P775; FORMAN DE, 1992, J AM GERIATR SOC, V40, P19, DOI 10.1111/j.1532-5415.1992.tb01823.x; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gause LR, 2017, J HEAD TRAUMA REHAB, V32, P255, DOI 10.1097/HTR.0000000000000309; HAREVEN TK, 1994, ANNU REV SOCIOL, V20, P437, DOI 10.1146/annurev.so.20.080194.002253; Jacobsson L, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0405-y; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Koo YW, 2017, INT PSYCHOGERIATR, V29, P1297, DOI 10.1017/S1041610217000618; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Lichtenberg PA, 2010, HANDBOOK OF ASSESSMENT IN CLINICAL GERONTOLOGY, 2ND EDITION, pXI, DOI 10.1016/B978-0-12-374961-1.10029-6; Lim HJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0369-0; MacLeod S, 2016, GERIATR NURS, V37, P266, DOI 10.1016/j.gerinurse.2016.02.014; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; MCINTOSH JL, 1994, SUICIDE LIFE-THREAT, V24, P334; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Mehta M, 2008, INT J GERIATR PSYCH, V23, P238, DOI 10.1002/gps.1868; Moody HR, 2017, GENERATIONS, V41, P95; Muinos M, 2016, EXP GERONTOL, V75, P30, DOI 10.1016/j.exger.2015.12.006; National Institutes of Health, 2019, REV NIH POL GUID INC; NEUGARTEN BL, 1975, GERONTOLOGIST, V15, P4, DOI 10.1093/geront/15.1_Part_2.4; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Perry SB, 2019, J HEAD TRAUMA REHAB, V34, pE66, DOI 10.1097/HTR.0000000000000415; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Riedy, 2018, J COUNSELOR PRACTICE, V9, P6; Sachs-Ericsson N, 2016, AGING MENT HEALTH, V20, P110, DOI 10.1080/13607863.2015.1099037; Schafer MH, 2013, J GERONTOL B-PSYCHOL, V68, P568, DOI 10.1093/geronb/gbt038; Sima AP, 2019, REHABIL PSYCHOL, V64, P320, DOI 10.1037/rep0000263; TEASDALE G, 1974, LANCET, V2, P81; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zizza CA, 2009, J GERONTOL A-BIOL, V64, P481, DOI 10.1093/gerona/gln045	48	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1284	1291		10.1080/02699052.2021.1972153		SEP 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000695892300001	34516315				2022-02-06	
J	Rubiano, AM; Griswold, DP; Jibaja, M; Rabinstein, AA; Godoy, DA				Rubiano, Andres M.; Griswold, Dylan P.; Jibaja, Manuel; Rabinstein, Alejandro A.; Godoy, Daniel Agustin			Management of severe traumatic brain injury in regions with limited resources	BRAIN INJURY			English	Article						TRAUMATIC brain injury; LMICs; protocols; guidelines; neurotrauma	NEUROSURGERY; CARE	Importance Severe traumatic brain injury (sTBI) is a critical health problem in regions of limited resources (RLRs). Younger populations are among the most impacted. The objective of this review is to analyze recent consensus-based algorithms, protocols and guidelines proposed for the care of patients with TBI in RLRs. Observations The principal mechanisms for sTBI in RLRs are road traffic injuries (RTIs) and violence. Limitations of care include suboptimal or non-existent pre-hospital care, overburdened emergency services, lack of trained human resources, and surgical and intensive care. Low-cost neuromonitoring systems are currently in testing, and formal neurotrauma registries are forming to evaluate both long-term outcomes and best practices at every level of care from hospital transport to the emergency department (ED), to the operating room and intensive care unit (ICU). Conclusions and Relevance The burden of sTBI is highest in RLRs. As working-age adults are the predominantly affected age-group, an increase in disability-adjusted life years (DALYs) generates a loss of economic growth in regions where economic growth is needed most. Four multi-institutional collaborations between high-income countries (HICs) and LMICs have developed evidence and consensus-based documents focused on capacity building for sTBI care as a means of addressing this substantial burden of disease.	[Rubiano, Andres M.] Univ El Bosque, Neurosci & Neurosurg, Bogota, Colombia; [Rubiano, Andres M.] Meditech Fdn, Cali, Colombia; [Rubiano, Andres M.] Univ Cambridge, Neurosci Dept, Global Hlth Res Grp Neurotrauma, Cambridge, England; [Griswold, Dylan P.] Stanford Med Sch, Stanford, CA USA; [Jibaja, Manuel] Sch Med Int Univ, Intens Care Unit, Hosp Eugenio Espejo, Quito, Ecuador; [Rabinstein, Alejandro A.] Mayo Clin, Neurol, Rochester, MN USA; [Rabinstein, Alejandro A.] Mayo Clin, Neurosci ICU, Rochester, MN USA; [Godoy, Daniel Agustin] Sanatorio Pasteur, Neurointens Care Unit, Catamarca, Argentina; [Godoy, Daniel Agustin] Hosp San Juan Bautista, Intens Care, Catamarca, Argentina		Rubiano, AM (corresponding author), El Bosque Univ, MEDITECH Fdn, INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia.	andresrubiano@aol.com	Griswold, Dylan/ABC-7890-2021	Griswold, Dylan/0000-0003-0291-8360	Global Health Research Group on Neurotrauma by the National Institute for Health Research (NIHR) [16/137/105]	This work was supported by the Global Health Research Group on Neurotrauma, which was commissioned by the National Institute for Health Research (NIHR) using United Kingdom Aid from the United Kingdom Government (Project 16/137/105).	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Acharya Krishna Prasad, 2019, Front Res Metr Anal, V4, P3, DOI 10.3389/frma.2019.00003; Aduayi OS, 2015, J NEUROSCI RURAL PRA, V6, P563, DOI 10.4103/0976-3147.165347; Africa Ao, 2016, AOSP S AFR LONG TERM; [Anonymous], 2018, MEDICASUR CURSO ALTA; Bridges EJ, 2015, CRIT CARE NURS CLIN, V27, P199, DOI 10.1016/j.cnc.2015.02.003; Charry JD, 2016, BRIT J NEUROSURG, V30, P235, DOI 10.3109/02688697.2015.1096905; Chesnut RM, 2020, J NEUROTRAUM, V37, P1291, DOI 10.1089/neu.2017.5599; Clavijo A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00112; Corley J, 2019, WORLD NEUROSURG, V132, P434, DOI 10.1016/j.wneu.2019.08.240; Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042; Customizing SD, 2020, J NEUROSCI RURAL PRA, V11, P002, DOI [10.1055/s-0040-1701539, DOI 10.1055/S-0040-1701539]; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Figaji A, 2014, NEUROCRIT CARE, V21, P239, DOI 10.1007/s12028-014-0019-3; Godoy DA, 2020, MED INTENSIVA, V44, P500, DOI 10.1016/j.medin.2020.01.014; Gupta S, 2020, J NEUROSURG, V132, P289, DOI 10.3171/2018.8.JNS182182; Gurney JM, 2020, MIL MED, V185, P148, DOI 10.1093/milmed/usz361; Health CM of, 2014, DIAGN TREATM AD PAT; Hughes JD, 2018, WORLD NEUROSURG, V115, P430, DOI 10.1016/j.wneu.2018.03.220; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Inc NS of A, 2009, MAN AC NEUR RUR REM, P30; Interprofessional Research PR, 2020, J NEUROSCI RURAL PRA, V11, P003, DOI [10.1055/s-0040-1701540, DOI 10.1055/S-0040-1701540]; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Khan T, 2020, J NEUROSCI RURAL PRA, V11, P5, DOI 10.1055/s-0040-1701558; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Kontojannis V, 2019, BRAIN INJURY, V33, P875, DOI 10.1080/02699052.2019.1610796; Mansouri A, 2018, WORLD NEUROSURG, V117, pE679, DOI 10.1016/j.wneu.2018.06.111; Origin 8. American Association of South Asian Neurosurgeons/American Association of Physicians of Indian, 2016, TRAUM BRAIN INJ MULT, V1st; Pen AD, 2020, J NEUROSCI RURAL PRA, V11, P001, DOI [10.1055/s-0040-1701777, DOI 10.1055/S-0040-1701777]; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Ravindra VM, 2018, GLOB SPINE J, V8, P784, DOI 10.1177/2192568218770769; Rosenfeld JV, 2015, ANZ J SURG, V85, P600, DOI 10.1111/ans.13207; Rubiano AM, 2020, J NEUROSCI RURAL PRA, V11, P7, DOI 10.1055/s-0040-1701370; Rubiano AM, 2019, WORLD NEUROSURG, V125, pE82, DOI 10.1016/j.wneu.2019.01.005; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; School. P in GS and SChangeHM, 2019, COMP POL REC HEAD SP, V1st; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6	42	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1317	1325		10.1080/02699052.2021.1972149		SEP 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000693559700001	34493135	hybrid			2022-02-06	
J	Holcomb, JM; Fisicaro, RA; Miller, LE; Yu, FF; Davenport, EM; Xi, Y; Urban, JE; Wagner, B; Powers, AK; Whitlow, CT; Stitzel, JD; Maldjian, JA				Holcomb, James M.; Fisicaro, Ryan A.; Miller, Logan E.; Yu, Fang F.; Davenport, Elizabeth M.; Xi, Yin; Urban, Jillian E.; Wagner, Ben C.; Powers, Alexander K.; Whitlow, Christopher T.; Stitzel, Joel D.; Maldjian, Joseph A.			Regional White Matter Diffusion Changes Associated with the Cumulative Tensile Strain and Strain Rate in Nonconcussed Youth Football Players	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						DTI; FA; football; nonconcussed; strain; strain rate; white matter; youth	TRAUMATIC BRAIN-INJURY; MAXIMUM PRINCIPAL STRAIN; BODY-MASS INDEX; AXONAL DAMAGE; ACUTE MILD; IMPACT; SPORTS; INTEGRITY; SYSTEM; SEASON	The purpose of this study is to assess the relationship between regional white matter diffusion imaging changes and finite element strain measures in nonconcussed youth football players. Pre- and post-season diffusion-weighted imaging was performed in 102 youth football subject-seasons, in which no concussions were diagnosed. The diffusion data were normalized to the IXI template. Percent change in fractional anisotropy (%Delta FA) images were generated. Using data from the head impact telemetry system, the cumulative maximum principal strain one times strain rate (CMPS1 x SR), a measure of the cumulative tensile brain strain and strain rate for one season, was calculated for each subject. Two linear regression analyses were performed to identify significant positive or inverse relationships between CMPS1 x SR and %Delta FA within the international consortium for brain mapping white matter mask. Age, body mass index, days between pre- and post-season imaging, previous brain injury, attention disorder diagnosis, and imaging protocol were included as covariates. False discovery rate correction was used with corrected alphas of 0.025 and voxel thresholds of zero. Controlling for all covariates, a significant, positive linear relationship between %Delta FA and CMPS1 x SR was identified in the bilateral cingulum, fornix, internal capsule, external capsule, corpus callosum, corona radiata, corticospinal tract, cerebral and middle cerebellar peduncle, superior longitudinal fasciculus, and right superior fronto-occipital fasciculus. Post hoc analyses further demonstrated significant %Delta FA differences between high-strain football subjects and noncollision control athletes, no significant %Delta FA differences between low-strain subjects and noncollision control athletes, and that CMPS1 x SR significantly explained more %Delta FA variance than number of head impacts alone.	[Holcomb, James M.; Fisicaro, Ryan A.; Yu, Fang F.; Davenport, Elizabeth M.; Xi, Yin; Wagner, Ben C.; Maldjian, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Miller, Logan E.; Urban, Jillian E.; Powers, Alexander K.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Winston Salem, NC 27101 USA		Holcomb, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.holcomb@utsouthwestern.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]	Research was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Numbers R01NS094410 and R01NS082453.	Alarcon G, 2016, J INT NEUROPSYCH SOC, V22, P281, DOI 10.1017/S1355617715001265; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Celik A, 2016, DIAGN INTERV RADIOL, V22, P101, DOI 10.5152/dir.2015.14440; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cubon VA, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1165; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Fitsiori A, 2011, BRIT J RADIOL, V84, P5, DOI 10.1259/bjr/21946513; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Gattu R., 2009, P INT SOC MAGNETIC R, P2009; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mallott JM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00518; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Repple J, 2018, PSYCHONEUROENDOCRINO, V91, P179, DOI 10.1016/j.psyneuen.2018.03.007; Ruotsalainen I, 2020, DEV COGN NEUROS-NETH, V42, DOI 10.1016/j.dcn.2020.100765; Schaeffer DJ, 2014, PSYCHOPHYSIOLOGY, V51, P728, DOI 10.1111/psyp.12227; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yap YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176997; Yu QL, 2020, CEREB CORTEX, V30, P2674, DOI 10.1093/cercor/bhz268; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	63	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7580		SEP 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UM4TU	WOS:000693325200001	34039024				2022-02-06	
J	La Fountaine, MF; Hohn, AN; Leahy, CL; Testa, AJ; Weir, JP				La Fountaine, Michael F.; Hohn, Asante N.; Leahy, Caroline L.; Testa, Anthony J.; Weir, Joseph P.			Use of Mayer wave activity to demonstrate aberrant cardiovascular autonomic control following sports concussion injury	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES			English	Article						mild traumatic brain injury; sympathetic nervous system; arterial blood pressure regulation; baroreflex	SYMPATHETIC-NERVE ACTIVITY; BLOOD-PRESSURE VARIABILITY; HEART-RATE-VARIABILITY; ARTERIAL-PRESSURE; NEURAL REGULATION; SPECTRAL-ANALYSIS; BAROREFLEX; SENSITIVITY; MECHANISMS; TILT	Dysregulation of cardiovascular autonomic control is gaining recognition as a prevailing consequence of concussion injury. Characterizing the presence of autonomic dysfunction in concussed persons is inconsistent and conventional metrics of autonomic function cannot differentiate the presence/absence of injury. Mayer wave (MW) activity originates through baroreflex adjustments to blood pressure (BP) oscillations that appear in the low-frequency (LF: 0.04-0.15 Hz) band of the BP and heart rate (HR) power spectrum after a fast Fourier transform. We prospectively explored MW activity (similar to 0.1 Hz) in 19 concussed and 19 noninjured athletes for 5 min while seated at rest within 48 h and 1 week of injury. MW activity was derived from the LF band of continuous digital electrocardiogram and beat-to-beat BP signals (LFHR, LF-SBP, MWHR, and MW-SBP, respectively); a proportion between MWBP and MWHR was computed (cMW). At 48 h, the concussion group had a significantly lower MWBP and cMW than controls; these differences were gone by 1 week. MWHR, LFHR, and LF-SBP were not different between groups at either visit. Attenuated sympathetic vasomotor tone was present and the central autonomic mechanisms regulating MW activity to the heart and peripheral vasculature became transiently discordant early after concussion with apparent resolution by 1 week.	[La Fountaine, Michael F.; Hohn, Asante N.; Leahy, Caroline L.] Seton Hall Univ, Dept Phys Therapy, Sch Hlth & Med Sci, 123 Metro Way, Nutley, NJ 07110 USA; [La Fountaine, Michael F.] Hackensack Meridian Sch Med, Dept Med Sci, Nutley, NJ USA; [La Fountaine, Michael F.] Hackensack Meridian Sch Med, Dept Neurol, Nutley, NJ USA; [Hohn, Asante N.] Spectrum Phys Therapy & Athlet Training, Morristown, NJ USA; [Leahy, Caroline L.] SportsCare Phys Therapy, Cedar Knolls, NJ USA; [Testa, Anthony J.] Seton Hall Univ, Ctr Sports Med, S Orange, NJ 07079 USA; [Weir, Joseph P.] Univ Kansas, Dept Hlth Sport & Exercise Sci, Lawrence, KS 66045 USA; [Weir, Joseph P.] Univ Kansas, Osness Human Performance Labs, Lawrence, KS 66045 USA		La Fountaine, MF (corresponding author), Seton Hall Univ, Dept Phys Therapy, Sch Hlth & Med Sci, 123 Metro Way, Nutley, NJ 07110 USA.	lafounmi@shu.edu		Weir, Joseph/0000-0003-0684-2930	New Jersey Commission [CBIR16IRG025]	Preparation of this manuscript was supported by the New Jersey Commission for Brain Injury Research Individual Research Grant #CBIR16IRG025.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Bauer A, 2010, J ELECTROCARDIOL, V43, P649, DOI 10.1016/j.jelectrocard.2010.05.012; Bauer A, 2009, J ELECTROCARDIOL, V42, P602, DOI 10.1016/j.jelectrocard.2009.06.023; Benarroch EE, 2008, NEUROLOGY, V71, P1733, DOI 10.1212/01.wnl.0000335246.93495.92; Bergfeldt L, 2003, J APPL PHYSIOL, V94, P2217, DOI 10.1152/japplphysiol.01037.2002; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Burnstock G., 2012, PRIMER AUTONOMIC NER; Cevese A, 2001, J PHYSIOL-LONDON, V531, P235, DOI 10.1111/j.1469-7793.2001.0235j.x; Chapleau MW, 2001, ANN NY ACAD SCI, V940, P1; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P138, DOI 10.1007/BF02456750; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; FURLAN R, 1990, CIRCULATION, V81, P537, DOI 10.1161/01.CIR.81.2.537; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Ghali MGZ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00395; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; GUZZETTI S, 1994, AM J PHYSIOL, V266, pH1112, DOI 10.1152/ajpheart.1994.266.3.H1112; HAGBARTH KE, 1968, ACTA PHYSIOL SCAND, V74, P96, DOI 10.1111/j.1748-1716.1968.tb04218.x; Haider MN, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.547126; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Houtman S, 2000, CLIN AUTON RES, V10, P207, DOI 10.1007/BF02291358; INOUE K, 1991, AM J PHYSIOL, V260, pH842, DOI 10.1152/ajpheart.1991.260.3.H842; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kamiya A, 2005, AM J PHYSIOL-HEART C, V289, pH1758, DOI 10.1152/ajpheart.01027.2004; KIRCHHEIM HR, 1976, PHYSIOL REV, V56, P100, DOI 10.1152/physrev.1976.56.1.100; KOH J, 1994, J PHYSIOL-LONDON, V474, P483, DOI 10.1113/jphysiol.1994.sp020039; La Fountaine MF, 2019, MED SCI SPORT EXER, V51, P792, DOI 10.1249/MSS.0000000000001833; La Fountaine MF, 2018, INT J PSYCHOPHYSIOL, V132, P155, DOI 10.1016/j.ijpsycho.2017.11.016; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; La Fountaine MF, 2014, INT J CARDIOL, V172, pE511, DOI 10.1016/j.ijcard.2014.01.095; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; LANDGREN S, 1952, ACTA PHYSIOL SCAND, V26, P1; LANDGREN S, 1952, ACTA PHYSIOL SCAND, V26, P35, DOI 10.1111/j.1748-1716.1952.tb00890.x; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mayer, 1876, SBER AKAD WISS WIEN, V74, P281; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Memmini AK, 2021, J ATHL TRAINING, V56, P141, DOI 10.4085/1062-6050-0578.19; Muller A, 2012, J ELECTROCARDIOL, V45, P77, DOI 10.1016/j.jelectrocard.2011.07.010; Munakata M, 2001, AM J HYPERTENS, V14, P141, DOI 10.1016/S0895-7061(00)01236-X; Pagani M, 1997, CIRCULATION, V95, P1441; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; SCHEFFER GJ, 1994, EUR J ANAESTH, V11, P75; Spyer, 1990, CENTRAL REGULATION A, P145; Torrealba F, 1996, NEUROSCIENCE, V71, P77, DOI 10.1016/0306-4522(95)00426-2; Van de Borne P, 2001, AM J PHYSIOL-HEART C, V281, pH559, DOI 10.1152/ajpheart.2001.281.2.H559; White DW, 2015, AUTON NEUROSCI-BASIC, V193, P12, DOI 10.1016/j.autneu.2015.08.004	51	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0077-8923	1749-6632		ANN NY ACAD SCI	Ann. N.Y. Acad. Sci.	JAN	2022	1507	1					121	132		10.1111/nyas.14683		SEP 2021	12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK3LD	WOS:000692646200001	34480369	hybrid			2022-02-06	
J	Summaka, M; Elias, E; Zein, H; Naim, I; Daoud, R; Fares, Y; Nasser, Z				Summaka, Marwa; Elias, Elias; Zein, Hiba; Naim, Ibrahim; Daoud, Rama; Fares, Youssef; Nasser, Zeina			Computed tomography findings as early predictors of long-term language impairment in patients with traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Computed tomography; language impairment; Lebanon; rehabilitation; speech-language pathology; traumatic brain injury	RIGHT-HEMISPHERE; VERBAL FLUENCY; FOLLOW-UP; COMMUNICATION; REHABILITATION; HELSINKI; APHASIA; DEFINITION; DISORDERS; RECOVERY	This study aims to assess the relationship between computed tomography (CT) findings, during the acute phase of hospitalization, and long-term language impairment in people with traumatic brain injury (TBI). Another aim was to assess the receptive and expressive abilities of subjects with TBI based on the location of the injury. This is a retrospective observational study including 49 participants with TBI due to war injuries. The Arabic Diagnostic Aphasia Battery (A-DAB-1) was administered to the participants and the Helsinki CT score was computed to quantify brain damage. The results showed that the Helsinki CT score was negatively correlated with the total score of the A-DAB-1 (r = -0.544, p-value < 0.0001). Simple linear regression supported such findings and reflected an inversely proportional relationship between both variables (p-value < 0.0001). When compared with subjects having right hemisphere damage, subjects with left hemisphere and bilateral brain damage performed more poorly on language tasks respectively as follows: A-DAB-1 overall score (92.08-66.08-70.28, p-value = 0.021), Content of descriptive speech (9.57-6.69-7.22, p-value = 0.034), Verbal fluency (6.57-3.54-3.89, p-value = 0.002), Auditory comprehension (9.71-7.54-7.78, p-value = 0.039), Complex auditory commands (9.71-7.65-7.56, p-value = 0.043), Repetition (9.75-7.08-7.61, p-value = 0.036), Naming (9.93-7.15-8.11, p-value = 0.046). Following TBI, CT findings on admission can significantly predict long-term language abilities, with left side lesions inducing poorer outcomes.	[Summaka, Marwa; Zein, Hiba; Fares, Youssef; Nasser, Zeina] Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Hadath, Lebanon; [Elias, Elias] Swedish Neurosci Inst, Dept Complex & Minimally Invas Spine Surg, Seattle, WA USA; [Naim, Ibrahim] Hlth Rehabil Iintegrat & Res Ctr HRIR, Beirut, Lebanon; [Daoud, Rama] Lebanese Univ, Fac Med Sci, Hadath, Lebanon		Nasser, Z (corresponding author), Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Hadath, Lebanon.	z.nasser@ul.edu.lb	Daoud, Rama/AAY-8084-2021				Al-Thalaya Z, 2018, APHASIOLOGY, V32, P323, DOI 10.1080/02687038.2017.1338661; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Benson D.F., 1985, PRINCIPLES BEHAV NEU; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Blake Margaret Lehman, 2003, Seminars in Speech and Language, V24, P107; Broca P., 1861, B MEM SOC ANAT PARIS, V6, P330; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Chang EF, 2015, J NEUROSURG, V122, P250, DOI 10.3171/2014.10.JNS132647; Devido-Santos M, 2012, ARQ NEURO-PSIQUIAT, V70, P129, DOI 10.1590/S0004-282X2012000200011; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Eshel Inbal, 2019, Phys Med Rehabil Clin N Am, V30, P189, DOI 10.1016/j.pmr.2018.08.005; Fares Y, 2014, NEUROL SCI, V35, P905, DOI 10.1007/s10072-013-1623-2; Flowers HL, 2017, CEREBROVASC DIS EXTR, V7, P21, DOI 10.1159/000457810; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; GESCHWIND N, 1971, NEW ENGL J MED, V284, P654, DOI 10.1056/NEJM197103252841206; Gilmore N, 2019, AM J SPEECH-LANG PAT, V28, P341, DOI 10.1044/2018_AJSLP-17-0153; Gindri Gigiane, 2014, Dement. neuropsychol., V8, P58, DOI 10.1590/S1980-57642014DN81000009; Haddad MC, 2008, CLIN IMAG, V32, P83, DOI 10.1016/j.clinimag.2007.09.007; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Joanette Y, 2008, REV NEUROLOGIA, V46, P481, DOI 10.33588/rn.4608.2008079; Johns CL, 2008, LANG LINGUIST COMPAS, V2, P1038, DOI 10.1111/j.1749-818x.2008.00094.x; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4; Klepousniotou E, 2005, BRAIN LANG, V95, P365, DOI 10.1016/j.bandl.2005.03.001; Kummerer D, 2013, BRAIN, V136, P619, DOI 10.1093/brain/aws354; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; Lichtheim L., 1885, BRAIN, V7, P433, DOI [DOI 10.1093/BRAIN/7.4.433, 10.1093/brain/7.4.433]; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Magnusdottir S, 2013, HUM BRAIN MAPP, V34, P2715, DOI 10.1002/hbm.22096; Mansur Letícia Lessa, 2002, Sao Paulo Med. J., V120, P170, DOI 10.1590/S1516-31802002000600003; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; McAlonan G., 2005, HONG KONG J PSYCHIAT, V15, P77; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Radanovic M, 2003, ARQ NEURO-PSIQUIAT, V61, P34, DOI 10.1590/S0004-282X2003000100006; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; RISSER AH, 1985, J CLIN EXP NEUROPSYC, V7, P463, DOI 10.1080/01688638508401277; Rosenbaum AM, 2018, BRAIN INJURY, V32, P907, DOI 10.1080/02699052.2018.1469040; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Sainson C., 2014, Annals of Physical and Rehabilitation Medicine, V57, P664, DOI 10.1016/j.rehab.2014.08.011; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Summaka M, 2020, BRAIN INJURY, V34, P1229, DOI 10.1080/02699052.2020.1799435; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Tompkins CA, 2008, APHASIOLOGY, V22, P119, DOI 10.1080/02687030601040861; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; Wernicke C, 1974, APHASISCHE SYMPTOMEN, P1; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Yao S, 2017, WORLD NEUROSURG, V101, P528, DOI 10.1016/j.wneu.2017.02.072; Zaninotto AL, 2014, NEUROPSYCH DIS TREAT, V10, P1155, DOI 10.2147/NDT.S62728	64	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1971982		SEP 2021	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UM0AL	WOS:000693003100001	34487454				2022-02-06	
J	Wang, XY; Shi, NQ; Hui, MQ; Jin, H; Gao, SM; Zhou, Q; Zhang, L; Yan, MJ; Shen, HM				Wang, Xiaoyu; Shi, Naiqi; Hui, Meiqi; Jin, Hui; Gao, Shumei; Zhou, Qiao; Zhang, Li; Yan, Meijuan; Shen, Hongmei			The Impact of beta-1,4-Galactosyltransferase V on Microglial Function	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						beta-1,4-Galactosyltransferase V; lipopolysaccharide; microglia; migration; proliferation; tumor necrosis factor receptor; interleukin-1 beta	NECROSIS-FACTOR RECEPTOR; ACTIVATION; DISEASE; CELLS; EXPRESSION; NEUROINFLAMMATION; PROLIFERATION; INFLAMMATION; MECHANISMS; SENSOR	beta-1,4 Galactosyltransferase V (beta-1,4-GalT V) belongs to the beta-1,4 galactosyltransferase family, which modifies proteins and plays a vital role in biological function. Our previous study revealed that beta-1,4-GalT V was expressed in the cortex and hippocampus and participated in the recovery of spatial learning and memory in rats with traumatic brain injury. However, the expression of beta-1,4-GalT V in microglia, resident immune cells in the central nervous system, and its impact on microglia in resting and lipopolysaccharide-triggered activated stages are elusive. In this study, we clarified that beta-1,4-GalT V expresses in microglia, and it regulates microglial migration, proliferation, and release of the inflammatory factors. We also observed that beta-1,4-GalT V affects the expression level of tumor necrosis factor receptor (TNFR)2 instead of TNFR1. These results strongly support the fact that beta-1,4-GalT V is involved in microglial function.	[Wang, Xiaoyu; Hui, Meiqi; Jin, Hui; Gao, Shumei; Zhou, Qiao; Zhang, Li; Yan, Meijuan; Shen, Hongmei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Wang, Xiaoyu; Hui, Meiqi; Jin, Hui; Gao, Shumei; Zhou, Qiao; Zhang, Li; Yan, Meijuan; Shen, Hongmei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China; [Wang, Xiaoyu] Jiangsu Univ, Dept Aoyang Canc Inst, Affiliated Aoyang Hosp, Suzhou, Peoples R China; [Shi, Naiqi] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia		Yan, MJ; Shen, HM (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.; Yan, MJ; Shen, HM (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China.	ymz@ntu.edu.cn; shmhu@ntu.edu.cn	yan, mei/AAA-1379-2022		National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31370803]; Public Health Program of Nantong City [MS22019001, MS22021009]; Science and Technology Program of Zhangjiagang City [ZKS1930]; Natural Science Foundation of the Jiangsu High Education Institute of China [18KJA180009]	This work was supported by grants-in-aid for Scientific Research from National Natural Scientific Foundation of China (No. 31370803, to MY), Public Health Program of Nantong City (Nos. MS22019001 to MY; MS22021009 to HS), Science and Technology Program of Zhangjiagang City (No. ZKS1930, to XW), and Natural Science Foundation of the Jiangsu High Education Institute of China (No. 18KJA180009, to HS).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Casali BT, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040957; Chatterjee S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041816; Cheepsunthorn P, 2001, GLIA, V35, P53, DOI 10.1002/glia.1070; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; DiPatre PL, 1997, J NEUROPATH EXP NEUR, V56, P143, DOI 10.1097/00005072-199702000-00004; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Fan Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00309; Feng LJ, 2019, GLIA, V67, P1434, DOI 10.1002/glia.23616; Ferreira R, 2012, J NEUROCHEM, V120, P93, DOI 10.1111/j.1471-4159.2011.07541.x; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jiang S, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00481-5; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kouno T, 2011, J BIOL CHEM, V286, P31337, DOI 10.1074/jbc.M111.233353; Kraus A, 2021, ELIFE, V10, DOI 10.7554/eLife.66706; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Madore C, 2020, IMMUNITY, V52, P222, DOI 10.1016/j.immuni.2019.12.003; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Moehle MS, 2015, NEUROSCIENCE, V302, P59, DOI 10.1016/j.neuroscience.2014.11.018; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Neal ML, 2020, FASEB J, V34, P1679, DOI 10.1096/fj.201900567RR; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nowacki P, 2019, FOLIA NEUROPATHOL, V57, P249, DOI 10.5114/fn.2019.88453; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Rebelo AL, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02163-6; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Shirane K, 1999, BIOCHEM BIOPH RES CO, V265, P434, DOI 10.1006/bbrc.1999.1684; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Streit WJ, 1997, J MOL MED-JMM, V75, P130, DOI 10.1007/s001090050097; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Yoshihara T, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007545; Zha Z, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5521503; Zhang LL, 2012, J NEUROTRAUM, V29, P851, DOI 10.1089/neu.2011.1882; Zhang ZT, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-019-0179-3	54	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	SEP 3	2021	15								723308	10.3389/fncel.2021.723308			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XF8CX	WOS:000724295500001	34539352	Green Published, gold			2022-02-06	
J	Ye, X; Chen, YL; Wang, JS; Chen, J; Yao, Y; Wang, LL; Zhao, FD				Ye, Xin; Chen, Yilei; Wang, Jiasheng; Chen, Jian; Yao, Ying; Wang, Lin-lin; Zhao, Fengdong			Identification of Circular RNAs Related to Vascular Endothelial Proliferation, Migration, and Angiogenesis After Spinal Cord Injury Using Microarray Analysis in Female Mice	FRONTIERS IN NEUROLOGY			English	Article						angiogenesis; circular RNAs; migration; proliferation; spinal cord injury	BRAIN; CELLS; INVASION; REVEALS; VEGF	Background: Traumatic spinal cord injury (SCI) can result in severe disability and causes a considerable socio-economic burden worldwide. Circular RNAs (circRNAs) are important regulators of gene expression and pathological processes, and may represent therapeutic targets for SCI. To further evaluate the role of circRNAs in SCI, we elucidated circRNA expression profiles related to vascular endothelial proliferation, migration, and angiogenesis during the early stages of secondary injury in a mouse model of SCI. Methods: Microarray analysis was performed to investigate the circRNA expression patterns in the spinal cord 3 days after SCI in female mice. Bioinformatic analyses, including GO enrichment analysis, KEGG pathway analysis, and circRNA-miRNA-mRNA network construction, were conducted to explore the role of circRNA dysregulation in vascular endothelial proliferation, migration, and angiogenesis following SCI. Results: The expression of 1,288 circRNAs was altered (>2-fold change, p < 0.05) in the spinal cord after SCI, consisting of 991 upregulated and 297 downregulated circRNAs. We constructed a circRNA-mRNA network to predict whether these circRNAs could act as "miRNA sponges." We next assessed the association of altered circRNAs with vascular endothelial proliferation, migration, and angiogenesis using GO and KEGG analyses. Using this analysis, we found that a total of 121 circRNAs were correlated with vascular endothelial proliferation, migration, and angiogenesis in the spinal cord after SCI. Conclusions: Our study provides circRNA expression profiles during the early stages of SCI. circRNA.7079, circRNA.7078, and circRNA.6777 were found to play key roles in the vascular endothelial proliferation, migration, and angiogenesis, and may represent therapeutic targets for SCI.	[Ye, Xin] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Peoples R China; [Chen, Yilei; Wang, Jiasheng; Chen, Jian; Zhao, Fengdong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed, Hangzhou, Peoples R China; [Yao, Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurointens Care Unit, Hangzhou, Peoples R China; [Wang, Lin-lin] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Basic Med Sci,Dept Orthopaed, Hangzhou, Peoples R China		Zhao, FD (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed, Hangzhou, Peoples R China.; Wang, LL (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Basic Med Sci,Dept Orthopaed, Hangzhou, Peoples R China.	wanglinlin@zju.edu.cn; zhaofengdong@zju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871796, 81972138]	Funding. This study was partially supported by National Natural Science Foundation of China (No. 81871796 and No. 81972138).	Abhinand CS, 2016, J CELL COMMUN SIGNAL, V10, P347, DOI 10.1007/s12079-016-0352-8; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; Chen MH, 2013, INT J CLIN EXP PATHO, V6, P2312; Cortes-Lopez Mariela, 2016, Yale Journal of Biology and Medicine, V89, P527; DeLisser HM, 1997, AM J PATHOL, V151, P671; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hayashi Y, 2019, AM J PATHOL, V189, P900, DOI 10.1016/j.ajpath.2018.12.005; Huang SL, 2019, CIRCULATION, V139, P2857, DOI 10.1161/CIRCULATIONAHA.118.038361; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jia H, 2019, J NEUROPATH EXP NEUR, V78, P268, DOI 10.1093/jnen/nly126; Jiang YJ, 2019, J NEUROTRAUM, V36, P1018, DOI 10.1089/neu.2018.5647; Kozuki T, 2017, NUCLEIC ACIDS RES, V45, P5995, DOI 10.1093/nar/gkx325; Li BF, 2019, ONCOTARGETS THER, V12, P3207, DOI 10.2147/OTT.S195703; Li CY, 2017, BIOMED PHARMACOTHER, V95, P1514, DOI 10.1016/j.biopha.2017.09.064; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P77, DOI [10.3389/fgene.2013.00077, 10.3389/fgene.2013.00307]; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Mehta SL, 2017, STROKE, V48, P2541, DOI 10.1161/STROKEAHA.117.017469; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Noonan Vanessa K, 2014, Top Spinal Cord Inj Rehabil, V20, P289, DOI 10.1310/sci2004-289; Shang XB, 2018, ONCOL LETT, V16, P3373, DOI 10.3892/ol.2018.8986; Shi ZJ, 2019, J CELL PHYSIOL, V234, P8918, DOI 10.1002/jcp.27560; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Xu LW, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.644239; Yao Y, 2020, BRAIN RES BULL, V164, P157, DOI 10.1016/j.brainresbull.2020.08.004; Zhang HC, 2017, BIOMED PHARMACOTHER, V88, P285, DOI 10.1016/j.biopha.2017.01.023; Zhang S, 2017, MOL THER, V25, P2053, DOI 10.1016/j.ymthe.2017.06.009; Zhong ZY, 2017, CANCER LETT, V403, P305, DOI 10.1016/j.canlet.2017.06.027; Zhou HJ, 2018, AM J PHYSIOL-CELL PH, V315, pC52, DOI 10.1152/ajpcell.00278.2017; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9	33	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 3	2021	12								666750	10.3389/fneur.2021.666750			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UR6FB	WOS:000696841800001	34539543	Green Published, gold			2022-02-06	
J	Zhao, Y; Tan, SW; Huang, ZZ; Shan, FB; Li, P; Ning, YL; Ye, SY; Zhao, ZA; Du, H; Xiong, RP; Yang, N; Peng, Y; Chen, X; Zhou, YG				Zhao, Yan; Tan, Si-Wei; Huang, Zhi-Zhong; Shan, Fa-Bo; Li, Ping; Ning, Ya-Lei; Ye, Shi-Yang; Zhao, Zi-Ai; Du, Hao; Xiong, Ren-Ping; Yang, Nan; Peng, Yan; Chen, Xing; Zhou, Yuan-Guo			NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression	FRONTIERS IN AGING NEUROSCIENCE			English	Article						traumatic brain injury; high mobility group box-1; tau; NLRP3 inflammasome; spatial memory; hippocampus	TRAUMATIC BRAIN-INJURY; AMYLOID-BETA; HMGB1; NEUROINFLAMMATION; PATHOLOGY; TRIGGER; ACCUMULATION; IMPAIRMENT; ACTIVATION; MECHANISMS	Tau hyperphosphorylation is a characteristic alteration present in a range of neurological conditions, such as traumatic brain injury (TBI) and neurodegenerative diseases. Treatments targeting high-mobility group box protein 1 (HMGB1) induce neuroprotective effects in these neuropathologic conditions. However, little is known about the interactions between hyperphosphorylated tau and HMGB1 in neuroinflammation. We established a model of TBI with controlled cortical impacts (CCIs) and a tau hyperphosphorylation model by injecting the virus encoding human P301S tau in mice, and immunofluorescence, western blotting analysis, and behavioral tests were performed to clarify the interaction between phosphorylated tau (p-tau) and HMGB1 levels. We demonstrated that p-tau and HMGB1 were elevated in the spatial memory-related brain regions in mice with TBI and tau-overexpression. Animals with tau-overexpression also had significantly increased nucleotide-binding oligomerization domain-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation, which manifested as increases in apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), activating caspase-1 and interleukin 1 beta (IL-1 beta) levels. In addition, NLRP3(-/-) mice and the HMGB1 inhibitor, glycyrrhizin, were used to explore therapeutic strategies for diseases with p-tau overexpression. Compared with wild-type (WT) mice with tau-overexpression, downregulation of p-tau and HMGB1 was observed in NLRP3(-/-) mice, indicating that HMGB1 alterations were NLRP3-dependent. Moreover, treatment with glycyrrhizin at a late stage markedly reduced p-tau levels and improved performance in the Y- and T-mazes and the ability of tau-overexpressing mice to build nests, which revealed improvements in spatial memory and advanced hippocampal function. The findings identified that p-tau has a triggering role in the modulation of neuroinflammation and spatial memory in an NLRP3-dependent manner, and suggest that treatment with HMGB1 inhibitors may be a better therapeutic strategy for tauopathies.</p>	[Zhao, Yan; Tan, Si-Wei; Huang, Zhi-Zhong; Shan, Fa-Bo; Li, Ping; Ning, Ya-Lei; Ye, Shi-Yang; Du, Hao; Xiong, Ren-Ping; Yang, Nan; Peng, Yan; Chen, Xing; Zhou, Yuan-Guo] Army Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Dept Army Occupat Dis,Daping Hosp, Chongqing, Peoples R China; [Zhao, Yan; Li, Ping; Ning, Ya-Lei; Zhou, Yuan-Guo] Army Med Univ, Inst Brain & Intelligence, Chongqing, Peoples R China; [Zhao, Zi-Ai] Gen Hosp Northern Theater Command, Dept Neurol, Shenyang, Peoples R China		Zhou, YG (corresponding author), Army Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Dept Army Occupat Dis,Daping Hosp, Chongqing, Peoples R China.; Zhou, YG (corresponding author), Army Med Univ, Inst Brain & Intelligence, Chongqing, Peoples R China.	ygzhou@tmmu.edu.cn		Li, Ping/0000-0002-4926-3835	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31771118]; Talent Innovation Training Program of Army Medical Center [2019CXJSB003]	This study was funded by the National Natural Science Foundation of China (Grant No. 31771118) and Talent Innovation Training Program of Army Medical Center (2019CXJSB003).	Albert M, 2019, BRAIN, V142, P1736, DOI 10.1093/brain/awz100; Barthelemy NR, 2020, NAT MED, V26, P398, DOI 10.1038/s41591-020-0781-z; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bruck E, 2020, INTENS CARE MED, V46, P811, DOI 10.1007/s00134-020-05941-7; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen S, 2014, NEUROSCIENCE, V256, P137, DOI 10.1016/j.neuroscience.2013.10.038; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Colin M, 2020, ACTA NEUROPATHOL, V139, P3, DOI 10.1007/s00401-019-02087-9; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Furman JL, 2017, ACTA NEUROPATHOL, V133, P91, DOI 10.1007/s00401-016-1644-z; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haruma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37755; Hei Y, 2018, NEUROSCIENCE, V383, P150, DOI 10.1016/j.neuroscience.2018.05.010; Hou L, 2018, LAB INVEST, V98, P1052, DOI 10.1038/s41374-018-0073-0; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kigerl KA, 2018, BRAIN BEHAV IMMUN, V72, P22, DOI 10.1016/j.bbi.2017.11.018; Kobayashi M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1168-7; Kodama L, 2020, NAT NEUROSCI, V23, P167, DOI 10.1038/s41593-019-0560-7; Kong ZH, 2017, J MOL NEUROSCI, V63, P385, DOI 10.1007/s12031-017-0989-7; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lempriere Sarah, 2020, Nat Rev Neurol, V16, P4, DOI 10.1038/s41582-019-0299-5; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; McAllister BB, 2018, NEUROBIOL STRESS, V9, P199, DOI 10.1016/j.ynstr.2018.10.003; Nan K, 2019, INT IMMUNOPHARMACOL, V67, P294, DOI 10.1016/j.intimp.2018.12.027; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Okuma Y, 2019, WORLD NEUROSURG, V122, pE864, DOI 10.1016/j.wneu.2018.10.164; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Pennisi M, 2017, J NEUROSCI RES, V95, P1360, DOI 10.1002/jnr.23986; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stancu IC, 2019, ACTA NEUROPATHOL, V137, P599, DOI 10.1007/s00401-018-01957-y; Sun Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01518; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Takahata K, 2017, BIOL PSYCHIAT, V81, pS295, DOI 10.1016/j.biopsych.2017.02.796; Takeda S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01274; Thakur V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030881; Thawkar BS, 2019, J NEUROIMMUNOL, V326, P62, DOI 10.1016/j.jneuroim.2018.11.010; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Uzawa A, 2013, CLIN EXP IMMUNOL, V172, P37, DOI 10.1111/cei.12036; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Wang DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46243; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; White CS, 2017, BRAIN PATHOL, V27, P223, DOI 10.1111/bpa.12478; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yi H.J., 2019, J NEUROSURG; Yu SL, 2019, J BIOL CHEM, V294, P8384, DOI 10.1074/jbc.RA118.006508; Zhang KM, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00001; Zhao ZA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02505-6; Zhao ZA, 2017, BEHAV BRAIN RES, V323, P146, DOI 10.1016/j.bbr.2017.02.002	64	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	SEP 3	2021	13								721474	10.3389/fnagi.2021.721474			14	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	UR4GP	WOS:000696709600001	34539383	Green Published, gold			2022-02-06	
J	Alghamdi, K; Albakri, LA; Alotaibi, Y; Alghamdi, AH; Alaidarous, S				Alghamdi, Khalid; Albakri, Lamair A.; Alotaibi, Yazeed; Alghamdi, Ahmed H.; Alaidarous, Salwa			Coexistence of Triphasic Diabetes Insipidus and Cerebral Salt Wasting Syndrome Following Extraction of Sellar/Suprasellar Grade I Pilocytic Astrocytoma	CUREUS			English	Article						diabetes insipidus; cerebral salt-wasting syndrome; sellar/suprasellar astrocytoma; hydroelectrolytic abnormality post-neurosurgery; post-neurosurgery complication	DIAGNOSIS	Water homeostasis disorders, such as syndrome of inappropriate antidiuretic hormone secretion (SIADH), diabetes insipidus (DI), and cerebral salt-wasting syndrome (CSWS), can develop after neurosurgery. Additionally, DI, SIADH, and CSWS have been reported concurrently in association with some neurosurgical conditions, in particular after pituitary gland surgery or as sequelae of post-traumatic brain injury. Therefore, neurosurgeons should expect water homeostasis disorders after the removal of tumors of the sellar/suprasellar region and he prepared to aggressively manage them.	[Alghamdi, Khalid] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Minist Natl Guards Hlth Affairs, Neurosurg,King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Albakri, Lamair A.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Minist Natl Guards Hlth Affairs, Coll Med,King Abdulaziz Med City, Jeddah, Saudi Arabia; [Alotaibi, Yazeed] Alnoor Specialist Hosp, Neurol Surg, Mecca, Saudi Arabia; [Alghamdi, Ahmed H.] King Faisal Specialist Hosp & Res Ctr, Endocrinol, Jeddah, Saudi Arabia; [Alaidarous, Salwa] King Saud Bin Abdulaziz Univ Hlth Sci, Minist Natl Guards Hlth Affairs, King Abdulaziz Med City, Endocrinol, Jeddah, Saudi Arabia		Alghamdi, K (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Minist Natl Guards Hlth Affairs, Neurosurg,King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia.	alghamdi075@ksau-hs.edu.sa					Costa Maria Manuel, 2018, J Med Case Rep, V12, P212, DOI 10.1186/s13256-018-1678-z; Cuesta M, 2016, ENDOCRINOL NUTR, V63, P230, DOI 10.1016/j.endonu.2015.12.007; Edate S, 2015, HORM RES PAEDIAT, V83, P293, DOI 10.1159/000370065; Fenske W, 2012, J CLIN ENDOCR METAB, V97, P3426, DOI 10.1210/jc.2012-1981; Kiran Z, 2017, ENDOCR PRACT, V23, P309, DOI 10.4158/EP161616.OR; Lin JJ, 2009, PEDIATR NEUROL, V40, P84, DOI 10.1016/j.pediatrneurol.2008.09.010; Lopez de Lara D, 2013, OPEN J PEDIAT, V3, P74; Pratheesh R, 2013, CHILD NERV SYST, V29, P941, DOI 10.1007/s00381-013-2041-8; Prete A, 2017, THER ADV ENDOCRINOL, V8, DOI 10.1177/2042018816687240; Qari FA, 2016, SAUDI MED J, V37, P156, DOI 10.15537/smj.2016.2.12848; Shen B, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00499	11	0	0	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 2	2021	13	9							17661	10.7759/cureus.17661			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UK6WQ	WOS:000692108400014	34646703	gold, Green Published			2022-02-06	
J	Campbell, A; Plourde, V; Hartling, L; Scott, SD				Campbell, Alyson; Plourde, Vickie; Hartling, Lisa; Scott, Shannon D.			"You Can't Fix Your Brain": Exploring concussion experiences of children and parents	JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING			English	Article						concussion; mTBI; parent experiences; pediatrics; qualitative research	SYMPTOMS; INJURY; CONSEQUENCES; PERSPECTIVES; KNOWLEDGE; FOCUS	Purpose To explore the experiences, information needs and preferences of children who have had a concussion and their parents who have cared for them. Design Qualitative description. Methods Semi-structured qualitative interviews were conducted via Zoom with children who have had a concussion between ages 5 and 16 years and parents who have cared for a child with a concussion. Interviews were audio-recorded and transcribed. Results Fourteen interviews were conducted with children and parents who have experiences with concussion. Four major themes were identified: (1) mechanism of injury and concussion symptoms experienced by children, (2) parent concerns, emotions, and health care experience with child's concussion, (3) concussions affect more than just your head and, (4) health information seeking, and preferences of parents and children related to concussion. Children and their parents have unique experiences, information needs and preferences regarding concussion. Practice Implications This information offers valuable insights about developing resources about childhood concussion that parents and children will find useful and relevant. This research has direct relevance to healthcare professionals who may encounter children with concussion in their daily practice so they can ensure the needs of children and families are being met. Our findings will be used to create the content for an innovative knowledge translation tool about pediatric concussion.	[Campbell, Alyson; Scott, Shannon D.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Plourde, Vickie] Univ Moncton, Fac Sci Sante & Serv Communautaires, Ecole Psychol, Moncton, NB, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada		Scott, SD (corresponding author), 5-187 Edmonton Clin Hlth Acad,11405-87 Ave NW, Edmonton, AB T6G 1C9, Canada.	shannon.scott@ualberta.ca		Plourde, Vickie/0000-0002-0098-5431; Campbell, Alyson/0000-0001-6542-9949	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RES0030460]	Canadian Institutes of Health Research, Grant/Award Number: RES0030460	Albrecht L, 2017, CAN J EMERG MED, V19, P198, DOI 10.1017/cem.2016.363; Archibald MM, 2019, INT J QUAL METH, V18, DOI 10.1177/1609406919874596; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Campbell Alyson, 2019, CMAJ Open, V7, pE640, DOI 10.9778/cmajo.20190092; Canadian Pediatric Society, 2014, SPORT REL CONC EV MA; Charon R, 2012, ACAD MED, V87, P342, DOI 10.1097/ACM.0b013e3182446fbb; Choudhury R, 2020, HEALTH EXPECT, V23, P1533, DOI 10.1111/hex.13138; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cook Rebecca S, 2006, J Trauma Nurs, V13, P58; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Feiss RS, 2020, J CONCUSSION, DOI [10.1177/2059700219900053, DOI 10.1177/2059700219900053]; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gates M, 2019, PATIENT EDUC COUNS, V102, P864, DOI 10.1016/j.pec.2018.12.013; Government of Canada, 2013, PROV DEF MIN; Government of Canada, 2018, CONC SPORT; Graves JM, 2020, J PEDIATR NURS, V51, P15, DOI 10.1016/j.pedn.2019.11.016; Inc Z.V.C., 2020, SEC GUID; Irwin LG, 2005, QUAL HEALTH RES, V15, P821, DOI 10.1177/1049732304273862; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Khoo K, 2008, J PAEDIATR CHILD H, V44, P419, DOI 10.1111/j.1440-1754.2008.01322.x; Kita H, 2020, BRAIN INJURY, V34, P784, DOI 10.1080/02699052.2020.1753243; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meherali S, 2019, J PATIENT EXPERIENCE, V6, P53, DOI 10.1177/2374373518771362; Minney MJ, 2019, BRAIN INJURY, V33, P168, DOI 10.1080/02699052.2018.1540794; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; QSR International Pty Ltd, 2018, NVIVO QUAL DAT AN SO; Reczek C, 2014, FAM PROCESS, V53, P318, DOI 10.1111/famp.12060; Reed N., 2019, LIVING GUIDELINE DIA; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Scott Shannon D, 2009, Nurs Womens Health, V13, P109, DOI 10.1111/j.1751-486X.2009.01401.x; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tator C, 2019, CAN J NEUROL SCI, V46, P351, DOI 10.1017/cjn.2019.14; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Valovich McLeod T.C, 2018, J SWIMMING RES, V26, P1; Walker, 2017, MED SCI ED, V27, P805, DOI [10.1007/s40670-017-0482-5, DOI 10.1007/S40670-017-0482-5]; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	53	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-0136	1744-6155		J SPEC PEDIATR NURS	J. Spec. Pediatr. Nurs.	JAN	2022	27	1							e12357	10.1111/jspn.12357		SEP 2021	11	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	XY4TM	WOS:000693230900001	34473394				2022-02-06	
J	Fonseca, RS; Metang, P; Egge, N; Liu, YJ; Zuurbier, KR; Sivaprakasam, K; Shirazi, S; Chuah, A; Arneaud, SLB; Konopka, G; Qian, D; Douglas, PM				Fonseca, Rene Solano; Metang, Patrick; Egge, Nathan; Liu, Yingjian; Zuurbier, Kielen R.; Sivaprakasam, Karthigayini; Shirazi, Shawn; Chuah, Ashleigh; Arneaud, Sonja L. B.; Konopka, Genevieve; Qian, Dong; Douglas, Peter M.			Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration	ELIFE			English	Article						traumatic brain injury; neurodegeneration; mitochondria; astrocytes; metabolism; C; elegans; Mouse	CEREBRAL GLUCOSE-UTILIZATION; BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; PHOSPHORYLATION; CONCUSSION; STRESS; MICE	eLife digest Concussion is a type of traumatic brain injury that results from a sudden blow or jolt to the head. Symptoms can include a passing headache, dizziness, confusion or sensitivity to light, but experiencing multiple concussions can have drastic repercussions in later life. Studies of professional athletes have shown that those who experience one or more concussions are prone to developing Alzheimer's and Parkinson's disease, two well-known neurodegenerative diseases. Both conditions involve the progressive loss or breakdown of nerve cells, called neurons. But exactly how this so-called neurodegeneration of brain cells stems from the original, physical injury remains unclear. Head trauma may cause damage to the structural support of a cell or disrupt the flow of electrical impulses through neurons. Energy use and production in damaged cells could shift into overdrive to repair the damage. The chemical properties of different types of brain cells could also make some more vulnerable to trauma than others. Besides neurons, star-shaped support cells in the brain called astrocytes, which may have some protective ability, could also be affected. To investigate which cells may be more susceptible to traumatic injuries, Solano Fonseca et al. modelled the impacts of concussion-like head trauma in roundworms (C. elegans) and mice. In both animals, one type of neuron was extremely vulnerable to cell death after trauma. Neurons that release dopamine, a chemical involved in cell-to-cell communication and the brain's reward system, showed signs of cell damage and deteriorated after injury. Dopaminergic cells, as these cells are called, are involved in motor coordination, and the loss of dopaminergic cells has been linked to both Alzheimer's and Parkinson's disease. Astrocytes, however, had a role in reducing the death of dopaminergic neurons after trauma. In experiments, astrocytes appeared to restore the balance of energy production to meet the increased energy demands of impacted neurons. Single-cell analyses showed that genes involved in metabolism were switched on in astrocytes to produce energy via an alternative pathway. This energetic shift facilitated via astrocytes may help mitigate against some damage to dopamine-producing neurons after trauma, reducing cell death. This work furthers our understanding of cellular changes in the concussed brain. More research will be required to better characterise how this immediate trauma to cells, and the subsequent loss of dopaminergic neurons, impacts brain health long-term. Efforts to design effective therapies to slow or reverse these changes could then follow. Concussion is associated with a myriad of deleterious immediate and long-term consequences. Yet the molecular mechanisms and genetic targets promoting the selective vulnerability of different neural subtypes to dysfunction and degeneration remain unclear. Translating experimental models of blunt force trauma in C. elegans to concussion in mice, we identify a conserved neuroprotective mechanism in which reduction of mitochondrial electron flux through complex IV suppresses trauma-induced degeneration of the highly vulnerable dopaminergic neurons. Reducing cytochrome C oxidase function elevates mitochondrial-derived reactive oxygen species, which signal through the cytosolic hypoxia inducing transcription factor, Hif1a, to promote hyperphosphorylation and inactivation of the pyruvate dehydrogenase, PDHE1 alpha. This critical enzyme initiates the Warburg shunt, which drives energetic reallocation from mitochondrial respiration to astrocyte-mediated glycolysis in a neuroprotective manner. These studies demonstrate a conserved process in which glycolytic preconditioning suppresses Parkinson-like hypersensitivity of dopaminergic neurons to trauma-induced degeneration via redox signaling and the Warburg effect.	[Fonseca, Rene Solano; Metang, Patrick; Egge, Nathan; Zuurbier, Kielen R.; Chuah, Ashleigh; Arneaud, Sonja L. B.; Douglas, Peter M.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Liu, Yingjian; Qian, Dong] Univ Texas Dallas, Dept Mech Engn, Dallas, TX USA; [Zuurbier, Kielen R.; Sivaprakasam, Karthigayini; Konopka, Genevieve] Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dallas, TX 75390 USA; [Sivaprakasam, Karthigayini; Konopka, Genevieve] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Shirazi, Shawn] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Douglas, Peter M.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA		Douglas, PM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Douglas, PM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	peter.douglas@utsouthwestern.edu			Welch FoundationThe Welch Foundation [I-2061-20210327, R01AG061338, RR150089, R00AG042495]	Welch Foundation I-2061-20210327 Peter M Douglas; National Institutes of Health R01AG061338 Peter M Douglas; Cancer Prevention and Research Institute of Texas RR150089 Peter M Douglas; Clayton Foundation for Research Peter M Douglas; National Institutes of Health R00AG042495 Peter M Douglas; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; BRENNER S, 1974, GENETICS, V77, P71; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Egge N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21611-8; Egge N, 2019, DEV CELL, V51, P587, DOI 10.1016/j.devcel.2019.11.001; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; HALL ED, 1993, RES P ARNMD, V71, P81; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Lazzarino G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225774; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mason S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00043; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; STINSON RA, 1984, BIOCHIM BIOPHYS ACTA, V790, P268, DOI 10.1016/0167-4838(84)90031-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wojtovich AP, 2014, REDOX BIOL, V2, P368, DOI 10.1016/j.redox.2014.01.019; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	52	0	0	4	4	eLIFE SCIENCES PUBL LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 2	2021	10								e69438	10.7554/eLife.69438; 10.7554/eLife.69438.sa1; 10.7554/eLife.69438.sa2			23	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	US1GL	WOS:000697184500001		Green Published, gold			2022-02-06	
J	Galovski, TE; Werner, KB; Weaver, TL; Morris, KL; Dondanville, KA; Nanney, J; Wamser-Nanney, R; McGlinchey, G; Fortier, CB; Iverson, KM				Galovski, Tara E.; Werner, Kimberly B.; Weaver, Terri L.; Morris, Kris L.; Dondanville, Katherine A.; Nanney, John; Wamser-Nanney, Rachel; McGlinchey, Gina; Fortier, Catherine B.; Iverson, Katherine M.			Massed Cognitive Processing Therapy for Posttraumatic Stress Disorder in Women Survivors of Intimate Partner Violence	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article; Early Access						cognitive processing therapy; posttraumatic stress disorder; traumatic brain injury; intimate partner violence; women	TRAUMATIC BRAIN-INJURY; INTERVIEW; ABUSE; PTSD	Objective: Survivors of intimate partner violence (IPV) report significant trauma histories, high rates of posttraumatic stress disorder (PTSD), head injuries and comorbid disorders, and multiple barriers to treatment that often preclude the regular attendance and engagement required in typical therapy protocols. The significant challenges faced by IPV survivors needing treatment may be ameliorated by condensing effective treatments for PTSD, such as cognitive processing therapy (CPT), in an accelerated delivery timeline. Method: Using a multiple subject, single case design of six matched pairs of 12 female IPV survivors, we preliminarily tested the relative effectiveness of individual massed CPT delivered over 5 days (mCPT) as compared with standard CPT (sCPT) delivery in women IPV survivors. Assessments included full psychiatric diagnostic interviews, clinical interviews assessing trauma history and head injury prior to treatment, symptom monitoring during treatment, and full repeat assessments at 1 month and 3 months following treatment. Results: No treatment group effect was found for PTSD severity between mCPT and sCPT among intention-to-treat, F(1, 10) = .01, p = .93. Both mCPT and sCPT were associated with significant improvement in PTSD, F(2, 20) = 45.05, p < .001, ds = 1.32-2.38). Conclusion: Overall, findings indicate mCPT appears effective in reducing psychological symptoms for women IPV survivors and suggest that condensed treatment is both palatable and feasible. Accelerated treatment delivery in this population may provide a necessary lifeline for women with IPV-related PTSD.	[Galovski, Tara E.; Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA USA; [Galovski, Tara E.; Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Werner, Kimberly B.] Univ Missouri, Coll Nursing, St Louis, MO 63121 USA; [Weaver, Terri L.] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Morris, Kris L.] Ft Belvoir Community Hosp, Dept Def, Ft Belvoir, VA USA; [Dondanville, Katherine A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, San Antonio, TX 78229 USA; [Nanney, John; Wamser-Nanney, Rachel] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA; [McGlinchey, Gina; Fortier, Catherine B.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Boston, MA USA; [McGlinchey, Gina; Fortier, Catherine B.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [McGlinchey, Gina; Fortier, Catherine B.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Galovski, TE (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, Womens Hlth Sci Div, One Univ Blvd,211 Seton Hall, St Louis, MO 63121 USA.	Tara.Galovski@va.gov	Fortier, Catherine/AAS-2163-2021; Werner, Kimberly/K-6086-2015	Fortier, Catherine/0000-0002-8953-9904; Werner, Kimberly/0000-0001-9321-5884			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Breiding MJ., 2015, INTIMATE PARTNER VIO; Bryan CJ, 2018, J CLIN PSYCHOL, V74, P2070, DOI 10.1002/jclp.22651; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Chard K.M., 2020, EFFECTIVE TREATMENTS, V3rd ed., P210; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Ehlers A, 2014, AM J PSYCHIAT, V171, P294, DOI 10.1176/appi.ajp.2013.13040552; First M.B., 2016, USERS GUIDE SCID 5 S; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Galovski T.E., 2020, FLEXIBLE APPL COGNIT; Galovski TE, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.569335; Galovski TE, 2021, PSYCHOL TRAUMA-US, V13, P376, DOI 10.1037/tra0000976; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Hayes S.C., 1999, SCI PRACTITIONER RES; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Iverson K, 2019, LIFETIME TRAUMA INTE; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Iverson KM, 2011, J CONSULT CLIN PSYCH, V79, P193, DOI 10.1037/a0022512; Iverson KM, 2011, BEHAV THER, V42, P236, DOI 10.1016/j.beth.2010.06.003; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McNulty MC, 2009, OTJR-OCCUP PART HEAL, V29, P183, DOI 10.3928/15394492-20090914-06; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Resick P.A., 2017, COGN PROCESS; SAS Institute Inc, 2013, SAS 9 4 STAT REF; Simmons CA, 2015, J INTERPERS VIOLENCE, V30, P2067, DOI 10.1177/0886260514552275; Smith  T., 2018, PROF COUNSEL, V8, P1, DOI DOI 10.15241/TJS.8.1.1; Tolin DF, 2018, ASSESSMENT, V25, P3, DOI 10.1177/1073191116638410; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Wachen J.S., 2019, CURR TREAT OPT PSYCH, V6, P107, DOI [10.1007/s40501-019-00169-9, DOI 10.1007/S40501-019-00169-9]; Weathers FW, 2013, CLIN ADM PTSD SCALE; Widom CS, 2014, CHILD ABUSE NEGLECT, V38, P650, DOI 10.1016/j.chiabu.2013.11.004; Zalta AK, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1816-6; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	38	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma												10.1037/tra0001100		SEP 2021	12	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	XS6LR	WOS:000733018400001	34472941				2022-02-06	
J	Lou, W; Granstein, JH; Wabl, R; Singh, A; Wahlster, S; Creutzfeldt, CJ				Lou, William; Granstein, Justin H.; Wabl, Rafael; Singh, Amita; Wahlster, Sarah; Creutzfeldt, Claire J.			Taking a Chance to Recover: Families Look Back on the Decision to Pursue Tracheostomy After Severe Acute Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						Tracheostomy; Stroke; Traumatic brain injuries; Intensive care units; Family; Communication; Uncertainty; Prognosis	OF-LIFE CARE; COMMUNICATION; END; PERSPECTIVES; AUTONOMY; MEMBERS	Background Tracheostomy represents one important and value-laden treatment decision after severe acute brain injury (SABI). Whether to pursue this life-sustaining treatment typically hinges on intense conversations between family and clinicians. The aim of this study was, among a cohort of patient who had undergone tracheostomy after SABI, to explore the long-term reflections of patients and their families as they look back on this decision. Methods For this qualitative study, we reviewed the electronic medical records of patients with SABI who underwent tracheostomy. We included all patients who were admitted to our 30-bed neuro-intensive care unit with SABI and underwent tracheostomy between November 2017 and October 2019. Using purposive sampling, we invited survivors and family members to participate in telephone interviews greater than 3 months after SABI until thematic saturation was reached. Interviews were audiotaped, transcribed, and analyzed by using thematic analysis. Results Overall, 38 patients with SABI in the neuro-intensive care unit underwent tracheostomy. The mean age of patients was 49 (range 18-81), with 19 of 38 patients diagnosed with traumatic brain injury and 19 of 38 with stroke. We interviewed 20 family members of 18 of 38 patients at a mean of 16 (SD 9) months after hospitalization. The mean patient age among those with an interview was 50 (range 18-76); the mean modified Rankin Scale score (mRS) was 4.7 (SD 0.8) at hospital discharge. At the time of the interview, ten patients lived at home and two in a skilled nursing facility and had a mean mRS of 2.6 (SD 0.9), and six had died. As families reflected on the decision to proceed with a tracheostomy, two themes emerged. First, families did not remember tracheostomy as a choice because the uncertain chance of recovery rendered the certain alternative of death unacceptable or because they valued survival above all and therefore could not perceive an alternative to life-sustaining treatment. Second, families identified a fundamental need to receive supportive, consistent communication centering around compassion, clarity, and hope. When this need was met, families were able to reflect on the tracheostomy decision with peace, regardless of their loved one's eventual outcome. Conclusions After SABI, prognostic uncertainty almost transcends the concept of choice. Families who proceeded with a tracheostomy saw it as the only option at the time. High-quality communication may mitigate the stress surrounding this high-stakes decision.	[Lou, William; Granstein, Justin H.; Wabl, Rafael; Singh, Amita; Wahlster, Sarah; Creutzfeldt, Claire J.] Univ Washington, Harborview Med Ctr, Dept Neurol, 325 Ninth Ave,Box 359775, Seattle, WA 98104 USA		Creutzfeldt, CJ (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol, 325 Ninth Ave,Box 359775, Seattle, WA 98104 USA.	clairejc@uw.edu			K23 grant award under the National Institute of Neurological Disorders and Stroke	Dr. Creutzfeldt is supported by a K23 grant award under the National Institute of Neurological Disorders and Stroke.	Attride-Stirling J., 2001, QUALITATIVE RES, V1, P385, DOI [10.1177/146879410100100307, DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Back Anthony L, 2003, Ann Intern Med, V138, P439; Botti S, 2009, J CONSUM RES, V36, P337, DOI 10.1086/598969; Brooks LA, 2017, AM J CRIT CARE, V26, P336, DOI 10.4037/ajcc2017774; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Epstein RM, 2011, ANN FAM MED, V9, P454, DOI 10.1370/afm.1301; Everett EA, 2021, NEUROL-CLIN PRACT, V11, P43, DOI 10.1212/CPJ.0000000000000856; Freeman BD, 2012, CRIT CARE MED, V40, P2890, DOI 10.1097/CCM.0b013e31825bc948; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Hough CL, 2015, CRIT CARE MED, V43, P2339, DOI 10.1097/CCM.0000000000001205; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jones K, 2021, NEUROCRIT CARE, V35, P311, DOI 10.1007/s12028-021-01230-3; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Krishnamoorthy V, 2019, NEUROCRIT CARE, V30, P546, DOI 10.1007/s12028-019-00697-5; Kruser JM, 2015, J AM GERIATR SOC, V63, P1805, DOI 10.1111/jgs.13615; Kuehlmeyer K, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-119; Miles M.B., 2013, QUALITATIVE DATA ANA; Oczkowski SJW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1264-y; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Rubin EB, 2016, JAMA INTERN MED, V176, P1557, DOI 10.1001/jamainternmed.2016.4362; Schutz REC, 2018, J NEUROL SCI, V385, P232, DOI 10.1016/j.jns.2017.12.007; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Srivastava P., 2009, INT J QUAL METHODS, V8, P76, DOI [DOI 10.1177/160940690900800107, 10.1177/160940690900800107]; Voumard RR, 2021, CRIT CARE MED, V49, P1322, DOI 10.1097/CCM.0000000000004947; Wahlster S, 2021, NEUROCRIT CARE, V34, P956, DOI 10.1007/s12028-020-01109-9; Zahuranec DB, 2018, J PALLIAT MED, V21, P956, DOI 10.1089/jpm.2017.0604	29	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01335-9		SEP 2021	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK6OV	WOS:000692088000001	34476722	Bronze, Green Published			2022-02-06	
J	McCunn, P; Xu, XY; Moszczynski, A; Li, A; Brown, A; Bartha, R				McCunn, Patrick; Xu, Xiaoyun; Moszczynski, Alexander; Li, Alex; Brown, Arthur; Bartha, Robert			Neurite orientation dispersion and density imaging in a rodent model of acute mild traumatic brain injury	JOURNAL OF NEUROIMAGING			English	Article						controlled cortical impact; diffusion-weighted imaging; magnetic resonance imaging; mild traumatic brain injury; neurite orientation dispersion and density imaging; neuroimaging	CONTROLLED CORTICAL IMPACT; BARRIER; TIME; RAT; NEUROPATHOLOGY; ISOFLURANE; MANAGEMENT; TRANSPORT; EVENTS; DAMAGE	Background and Purpose Identification of changesin brain microstructure following mild traumatic brain injury (mTBI) could be instrumental in understanding the underlying pathophysiology. The purpose of this study was to apply neurite orientation dispersion and density imaging (NODDI) to a rodent model of mTBI to determine whether microstructural changes could be detected immediately following injury. Methods Fifteen adult male Wistar rats were scanned on a Bruker 9.4 Tesla small animal MRI using a multi-shell acquisition (30 b = 1000 s/mm(2) and 60 b = 2000 s/mm(2)). Nine animals experienced a single closed head controlled cortical impact followed by NODDI from 1 to 4 h post injury. Region of interest analysis focused on the corpus callosum and hippocampus. A mixed analysis of variance (ANOVA) was used to determine statistically significant interactions in neurite density index (NDI), orientation dispersion index (ODI), fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity. Follow up repeated-measures ANOVAs were used to determine individual changes over time. Results NDI showed a significant increase in the hippocampus and corpus callosum following injury, while ODI showed increases in the corpus callosum. No significant changes were observed in the sham control animals. No changes were found in FA, MD, AD, or RD. Histological analysis revealed increased glial fibrillary acidic protein staining relative to controls in both the hippocampus and corpus callosum, with evidence of activated astrocytes in these regions. Conclusions Changes in NODDI metrics were detected as early as 1 h following mTBI. No changes were detected with conventional diffusion tensor imaging (DTI) metrics, suggesting that NODDI provides greater sensitivity to microstructural changes than conventional DTI.	[McCunn, Patrick; Xu, Xiaoyun; Moszczynski, Alexander; Li, Alex; Brown, Arthur; Bartha, Robert] Univ Western Ontario, Robarts Res Inst, 1151 Richmond St, London, ON N6A 3K7, Canada; [McCunn, Patrick; Li, Alex; Bartha, Robert] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Li, Alex] Univ Western Ontario, Dept Psychiat, London, ON, Canada; [Li, Alex] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Brown, Arthur] Univ Western Ontario, Dept Neurosci, London, ON, Canada; [Bartha, Robert] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada		Bartha, R (corresponding author), Univ Western Ontario, Robarts Res Inst, 1151 Richmond St, London, ON N6A 3K7, Canada.	rbartha@robarts.ca	Brown, Arthur/K-8328-2013; Bartha, Robert/K-3611-2013	Brown, Arthur/0000-0002-8725-3195; Bartha, Robert/0000-0002-7118-9096; McCunn, Patrick/0000-0003-3858-6441	Canada First Research Excellence Fund	The authors would like to acknowledge theOntario Brain Institute and the Canada First Research Excellence Fund for their funding contributions.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Andersson J.L.R., 2010, NONLINEAR REGISTRATI; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Biechele G, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02046-2; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blum FE, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-16; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caruyer Emmanuel, 2013, Magn Reson Med, V69, P1534, DOI 10.1002/mrm.24736; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; CHI OZ, 1992, ANESTHESIOLOGY, V76, P426, DOI 10.1097/00000542-199203000-00016; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choe MC, 2015, SEMIN NEUROL, V35, P29, DOI 10.1055/s-0035-1544243; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cummings BJ, 2017, J CONCUSSION, V1, P10; Dams-O'Connor K, 2016, ARCH PHYS MED REHAB, V97, pE42; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Grimaldi A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00925; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lafrenaye AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70266-w; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; McCunn P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215974; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Moszczynski AJ, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0816-1; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Oehr LE, 2021, J NEUROTRAUM, V38, P2255, DOI 10.1089/neu.2020.7310; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Patel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161554; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rahaman Petra, 2018, Acad Forensic Pathol, V8, P539, DOI 10.1177/1925362118797728; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sacco S, 2020, AM J NEURORADIOL, V41, P2219, DOI 10.3174/ajnr.A6862; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schwab N, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0822-3; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sveinung, 2013, NEUR AUG 27 29 2013; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; To XV, 2021, J NEUROTRAUM, V38, P967, DOI 10.1089/neu.2019.6944; Wofford KL, 2019, NEURAL REGEN RES, V14, P1481, DOI 10.4103/1673-5374.255958; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Xu XY, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01161-2; To XV, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01098-y; Yi SY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00081; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	87	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	SEP	2021	31	5					879	892		10.1111/jon.12917		SEP 2021	14	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UP8YK	WOS:000693193200001	34473386				2022-02-06	
J	Truong, PH; Crouch, PJ; Hilton, JBW; McLean, CA; Cappai, R; Ciccotosto, GD				Truong, Phan H.; Crouch, Peter J.; Hilton, James B. W.; McLean, Catriona A.; Cappai, Roberto; Ciccotosto, Giuseppe D.			Sex-dependent effects of amyloid precursor-like protein 2 in the SOD1-G37R transgenic mouse model of MND	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Amyloid precursor protein; Amyloid precursor-like protein; Motor neuron disease; SOD1-G37R; Sex differences; Amyotrophic lateral sclerosis	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; MICE LACKING; INDUCED APOPTOSIS; APP; DISEASE; ALS; SURVIVAL; APLP2; KNOCKOUT	Motor neurone disease (MND) is a neurodegenerative disorder characterised by progressive destruction of motor neurons, muscle paralysis and death. The amyloid precursor protein (APP) is highly expressed in the central nervous system and has been shown to modulate disease outcomes in MND. APP is part of a gene family that includes the amyloid precursor-like protein 1 (APLP1) and 2 (APLP2) genes. In the present study, we investigated the role of APLP2 in MND through the examination of human spinal cord tissue and by crossing APLP2 knockout mice with the superoxide dismutase 1 (SOD1-G37R) transgenic mouse model of MND. We found the expression of APLP2 is elevated in the spinal cord from human cases of MND and that this feature of the human disease is reproduced in SOD1-G37R mice at the End-stage of their MND-like phenotype progression. APLP2 deletion in SOD1-G37R mice significantly delayed disease progression and increased the survival of female SOD1-G37R mice. Molecular and biochemical analysis showed female SOD1-G37R:APLP2-/- mice displayed improved innervation of the neuromuscular junction, ameliorated atrophy of muscle fibres with increased APP protein expression levels in the gastrocnemius muscle. These results indicate a sex-dependent role for APLP2 in mutant SOD1-mediated MND and further support the APP family as a potential target for further investigation into the cause and regulation of MND.	[Truong, Phan H.; Crouch, Peter J.; Hilton, James B. W.; Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Biochem & Pharmacol, Parkville, Vic 3010, Australia; [McLean, Catriona A.] Alfred Hosp, Anat Pathol, Melbourne, Vic 3005, Australia; [Truong, Phan H.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, Melbourne, Vic 3010, Australia		Truong, PH; Ciccotosto, GD (corresponding author), Univ Melbourne, Dept Biochem & Pharmacol, Parkville, Vic 3010, Australia.	phan.truong@florey.edu.au; j.ciccotosto@unimelb.edu.au		Hilton, James/0000-0002-2657-3566; Truong, Phan/0000-0002-9964-0678	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; MND Research Australia; Nancy Frances Curry PhD Scholarship	This study was supported by National Health and Medical Research Council of Australia to RC and MND Research Australia (Betty Laidlaw and Jenny Barr Smith Research Grants to PJC and CAM, and Beryl Bayley Fellowship to JBWH). PHT was a recipient of a Nancy Frances Curry PhD Scholarship.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Aggarwal Anju, 2006, Indian Journal of Pediatrics, V73, P225, DOI 10.1007/BF02825486; Akaaboune M, 2000, MOL CELL NEUROSCI, V15, P355, DOI 10.1006/mcne.2000.0834; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bergmans BA, 2010, STEM CELLS, V28, P399, DOI 10.1002/stem.296; Blasco H, 2012, AMYOTROPH LATERAL SC, V13, P585, DOI 10.3109/17482968.2012.706303; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1056/NEJMc1710379]; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Cappai R, 1999, FEBS LETT, V442, P95, DOI 10.1016/S0014-5793(98)01635-4; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Deliz B, 2018, P R HEALTH SCI J, V37, P5; Dharmadasa T, 2017, MED J AUSTRALIA, V206, P357, DOI 10.5694/mja16.01063; Dinet V, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0245-z; Dinet V, 2011, ACTA NEUROPATHOL, V121, P351, DOI 10.1007/s00401-010-0762-2; Eschbach J, 2013, HUM MOL GENET, V22, P3477, DOI 10.1093/hmg/ddt202; Fontana A, 2021, J NEUROL, V268, P2973, DOI 10.1007/s00415-021-10464-2; Frey D, 2000, J NEUROSCI, V20, P2534; Gajowiak A, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmo1.2015.00082; Galvin M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014985; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Grad LI, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024117; Guo J, 1998, INVEST OPHTH VIS SCI, V39, P292; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Heber S, 2000, J NEUROSCI, V20, P7951; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Herman AM, 2012, EXP NEUROL, V235, P297, DOI 10.1016/j.expneurol.2012.02.011; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hilton JB, 2016, METALLOMICS, V8, P1002, DOI 10.1039/c6mt00099a; Hilton JB, 2018, EXP NEUROL, V307, P118, DOI 10.1016/j.expneurol.2018.06.006; Nguyen HP, 2018, TRENDS GENET, V34, P404, DOI 10.1016/j.tig.2018.03.001; Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kim HI, 2018, BIOMOL THER, V26, P335, DOI 10.4062/biomolther.2018.103; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Koistinen H, 2006, MUSCLE NERVE, V34, P444, DOI 10.1002/mus.20612; KUSHNER PD, 1991, J NEUROPATH EXP NEUR, V50, P263, DOI 10.1097/00005072-199105000-00008; LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Lutz C., 2009, WORKING ALS MICE GUI; Luu L, 2019, MOL NEUROBIOL, V56, P13, DOI 10.1007/s12035-018-1070-4; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Martineau E, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0388-19.2020; McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; Moss Alan C, 2007, Transl Oncogenomics, V2, P1; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Needham BE, 2014, METALLOMICS, V6, P598, DOI 10.1039/c3mt00358b; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Peters HL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26293; Peters HL, 2013, CANCER BIOL THER, V14, P752, DOI 10.4161/cbt.25183; Peters HL, 2012, INT J ONCOL, V41, P1464, DOI 10.3892/ijo.2012.1553; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pinares-Garcia P, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080154; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rabinovich-Toidman P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143420; Regitz-Zagrosek V, 2017, PHYSIOL REV, V97, P1, DOI 10.1152/physrev.00021.2015; Riar AK, 2017, HUM MOL GENET, V26, P1318, DOI 10.1093/hmg/ddx049; Santos-Galindo Maria, 2011, Biol Sex Differ, V2, P7, DOI 10.1186/2042-6410-2-7; Sasaki S, 1999, ACTA NEUROPATHOL, V97, P463, DOI 10.1007/s004010051015; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Shiota M, 2010, MOL ENDOCRINOL, V24, P114, DOI 10.1210/me.2009-0302; Steinacker P, 2010, AM J PATHOL, V176, P1409, DOI 10.2353/ajpath.2010.090355; Steinacker P, 2009, J NEURAL TRANSM, V116, P1169, DOI 10.1007/s00702-009-0271-4; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tkatchenko AV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005432; Truong PH, 2019, GLIA, V67, P525, DOI 10.1002/glia.23561; Truong PH, 2019, NEUROCHEM RES, V44, P1356, DOI 10.1007/s11064-018-2669-6; Van den Bosch L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/348765; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Vinsant S, 2013, BRAIN BEHAV, V3, P431, DOI 10.1002/brb3.142; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Webster CP, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00123; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; White AR, 1998, J NEUROSCI, V18, P6207; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xie YY, 2000, NEUROREPORT, V11, P697, DOI 10.1097/00001756-200003200-00009; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Zhou C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-52; Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018	100	0	0	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	OCT	2021	78	19-20					6605	6630		10.1007/s00018-021-03924-5		SEP 2021	26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	WP5UL	WOS:000692083100001	34476545	Green Submitted, Green Published, hybrid			2022-02-06	
J	Acord-Vira, A; Davis, D; Lilly, C				Acord-Vira, Amanda; Davis, Diana; Lilly, Christa			Occupational Performance Limitations After Concussion in College Students	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							QUALITATIVE CONTENT-ANALYSIS; ASSISTIVE TECHNOLOGY; TIME MANAGEMENT	Importance: Occupational performance limitations (OPLs) are poorly understood sequelae of concussion. This study aimed to establish the need for occupational therapy services for people who have sustained a concussion and to support the profession's role in facilitating occupational performance for college students experiencing signs and symptoms after concussion. Objective: To describe the types and frequency of, and assess risk factors for, OPLs in college students after concussion. Design: Cross-sectional descriptive study. Setting: Web-based survey on Qualtrics. Participants: A total of 220 participants completed the survey; of those, 52 (23.6%) self-identified as having sustained a concussion and were further asked about OPLs after the concussion. Results: Eighty-nine percent (n = 46) of the participants reported an OPL in at least one area, and higher OPL scores were associated with the number of concussion symptoms (r = .34, p = .02) and increased recovery time (>= 3 days vs. <3 days, p = .006). Conclusions and Relevance: College students reporting concussions with more symptoms that persisted for longer periods were more likely to experience occupational performance loss. Frequent OPLs were reported in occupations associated with the participants' primary role of student. These results indicate a unique need for occupational therapy intervention with students to facilitate their continued success in academic pursuits. What This Article Adds: People who have sustained a concussion experience OPLs. Occupational therapy has a role in facilitating a return to occupational performance during recovery, especially in helping college students with concussion return to the classroom.	[Acord-Vira, Amanda] Orebro Univ, Fac Med & Hlth, Univ Hlth Care Res Ctr, Orebro, Sweden; [Davis, Diana; Lilly, Christa] Orebro Univ, Fac Med & Hlth, Sch Hlth Sci, Orebro, Sweden		Acord-Vira, A (corresponding author), Orebro Univ, Fac Med & Hlth, Univ Hlth Care Res Ctr, Orebro, Sweden.	kajsa.lidstrom-holmqvist@regionorebrolan.se			Faculty of Medicine and Health, Orebro University	This work was supported by the Faculty of Medicine and Health, Orebro University. The authors report no conflicts of interest.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Claessens BJC, 2007, PERS REV, V36, P255, DOI 10.1108/00483480710726136; Dan O, 2015, J ATTEN DISORD, V19, P231, DOI 10.1177/1087054712454571; Eklund M, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1524-7; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Graneheim UH, 2017, NURS EDUC TODAY, V56, P29, DOI 10.1016/j.nedt.2017.06.002; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Holmefur M, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.032631; Ikiugu M, 2012, BRIT J OCCUP THER, V75, P289, DOI 10.4276/030802212X13383757345229; Langberg Joshua M, 2008, Expert Rev Neurother, V8, P1549, DOI 10.1586/14737175.8.10.1549; Lindstedt H, 2013, DISABIL REHABIL-ASSI, V8, P402, DOI 10.3109/17483107.2013.769120; Mueller AK, 2012, ADHD-ATTEND DEFICIT, V4, P101, DOI 10.1007/s12402-012-0085-3; Thomack B, 2012, WORKPLACE HEALTH SAF, V60, P201, DOI 10.3928/21650799-20120426-05; Valko L, 2010, J NEURAL TRANSM, V117, P1213, DOI 10.1007/s00702-010-0473-9; White S, 2007, PSYCHIAT SERV, V58, P713, DOI 10.1176/appi.ps.58.5.713; World Health Organization, 2001, INT CLASS FUNCT DIS	19	0	0	0	0	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2021	75	5							7505345010	10.5014/ajot.2021.043398			17	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	YK3ER	WOS:000745101100011	34780628				2022-02-06	
J	Aldridge, P; Parish, R; Castle, H; Russell, E; Rout, R; Singh, R				Aldridge, Patrick; Parish, Rachel; Castle, Heather; Russell, Emma; Rout, Raj; Singh, Roohi			Head home: implementation during COVID-19 pandemic	EMERGENCY MEDICINE JOURNAL			English	Article								Background Recent research suggests that between 20% and 50% of paediatric head injuries attending our emergency department (ED) could be safely discharged soon after triage, without the need for medical review, using a 'Head Injury Discharge At Triage' tool (HIDAT). We sought to implement this into clinical practice. Methods Paediatric ED triage staff underwent competency-based assessments for HIDAT with all head injury presentations 1 May to 31 October 2020 included in analysis. We determined which patients were discharged using the tool, which underwent CT of the brain and whether there was a clinically important traumatic brain injury or representation to the ED. Results Of the 1429 patients screened; 610 (43%) screened negative with 250 (18%) discharged by nursing staff. Of the entire cohort, 32 CTs were performed for head injury concerns (6 abnormal) with 1 CT performed in the HIDAT negative group (normal). Of those discharged using HIDAT, four reattended, two with vomiting (no imaging or admission) and two with minor scalp wound infections. Two patients who screened negative declined discharge under the policy with later medical discharge (no imaging or admission). Paediatric ED attendances were 29% lower than in 2018. Conclusion We have successfully implemented HIDAT into local clinical practice. The number discharged (18%) is lower than originally described; this is likely multifactorial. The relationship between COVID-19 and paediatric ED attendances is unclear but decreased attendances suggest those for whom the tool was originally designed are not attending ED and may be accessing other medical/non-medical resources	[Aldridge, Patrick; Castle, Heather; Russell, Emma] Frimley Pk Hosp, NHS Fdn Trust, Paediat Emergency Dept, Frimley GU16 7UJ, England; [Parish, Rachel] Frimley Pk Hosp, NHS Fdn Trust, Emergency Dept, Frimley, England; [Rout, Raj] Sanofi Genzyme, Global Med Affairs, Guildford, Surrey, England; [Singh, Roohi] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England		Aldridge, P (corresponding author), Frimley Pk Hosp, NHS Fdn Trust, Paediat Emergency Dept, Frimley GU16 7UJ, England.	patrickjaldridge@hotmail.com		Aldridge, Patrick/0000-0001-7366-9707			Aldridge P, 2020, EMERG MED J, V37, P680, DOI 10.1136/emermed-2019-208892; Isba R, 2020, ARCH DIS CHILD, V105, P704, DOI 10.1136/archdischild-2020-319385	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	SEP	2021	38	9					692	693		10.1136/emermed-2020-211007			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UO4HE	WOS:000694655400008	34289965	Bronze, Green Published			2022-02-06	
J	Ali, R; Poggi, J; Doberstein, CA; Woo, AS; Oyelese, AA				Ali, Rohaid; Poggi, Jonathan; Doberstein, Cody A.; Woo, Albert S.; Oyelese, Adetokunbo A.			Rubber Bullet Induced Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Ballistic; cranialization; craniofacial; cerebrospinal fluid; rubber; transorbital; trauma	INTRAOPERATIVE COMPUTED-TOMOGRAPHY; LESS-LETHAL WEAPONS; CRANIOFACIAL TRAUMA; FRACTURES; FLUID; MECHANISMS; BALLISTICS; MANAGEMENT; REDUCTION	Rubber bullets have long been known to cause, on rare occasions, traumatic brain injury (TBI). However, neurosurgical literature on this occurrence is limited, and no focused review of this injury pattern has been conducted. The authors present the case of a 28-year-old male struck by a rubber bullet in the left periorbital region, causing TBI in addition to complete left visual loss and complex facial fractures. After developing a cerebrospinal fluid (CSF) leak, the patient was taken to the operating room for combined neurosurgical-craniofacial intervention. Utilizing frameless intraoperative computation tomography navigation assistance, a successful repair was made of both the patient's CSF leak and complex craniofacial injuries. TBI due to a rubber bullet is a rare but severe occurrence. Unfortunately, much of the limited literature on this topic is bereft of demographic, clinical course, injury pattern, and imaging data. Presented here is the first operative case report of TBI due to a rubber bullet. Volume rendered imaging is provided to demonstrate the extent of trauma incurred. Additionally, a methodology for frameless intraoperative computation tomography navigation assistance is shared for consideration, as it served as a helpful adjunct for a combined intracranial-craniofacial surgical repair. The experience of treating the patient's traumatic CSF leak in the context of severe craniofacial and ophthalmologic injuries highlights the need for a multidisciplinary surgical approach that may arise when treating patients with TBI due to a rubber bullet.	[Ali, Rohaid; Poggi, Jonathan; Doberstein, Cody A.; Oyelese, Adetokunbo A.] Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, 593 Eddy St,APC 6, Providence, RI 02903 USA; [Woo, Albert S.] Brown Univ, Warren Alpert Med Sch, Div Plast & Reconstruct Surg, Providence, RI 02903 USA		Oyelese, AA (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, 593 Eddy St,APC 6, Providence, RI 02903 USA.; Oyelese, AA (corresponding author), Rhode Isl Hosp, 593 Eddy St,APC 6, Providence, RI 02903 USA.	aoyelese@lifespan.org					Amelot A, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.10.026; BARACH E, 1986, J TRAUMA, V26, P225, DOI 10.1097/00005373-198603000-00003; Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; Charlier P, 2012, AM J FOREN MED PATH, V33, pE4, DOI 10.1097/PAF.0b013e31823a8c69; Chauvin A, 2019, LANCET, V394, P1616, DOI 10.1016/S0140-6736(19)31807-0; Chegini S, 2016, BRIT J ORAL MAX SURG, V54, P801, DOI 10.1016/j.bjoms.2016.05.016; Darwazeh R, 2018, WORLD NEUROSURG, V116, pE329, DOI 10.1016/j.wneu.2018.04.202; Davis GA, 2000, J CLIN NEUROSCI, V7, P545, DOI 10.1054/jocn.2000.0692; Dreizin D, 2018, RADIOGRAPHICS, V38, P248, DOI 10.1148/rg.2018170074; Farber SJ, 2016, CRANIOMAX TRAUM REC, V9, P313, DOI 10.1055/s-0036-1592093; Haar RJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018154; Hiss J, 1997, MED SCI LAW, V37, P139, DOI 10.1177/002580249703700209; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Huang TY, 2019, J INT MED RES, DOI 10.1177/0300060519886210; Huiszoon WB, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-34; Ifantides C, 2020, OPHTHALMOL THER, DOI 10.1007/s40123-020-00271-9; Ijaz L, 2014, J PEDIATR NEUROSCI, V9, P267, DOI 10.4103/1817-1745.147588; Jacob JT, 2005, J NEUROSURG, V102, P350, DOI 10.3171/ped.2005.102.3.0350; Lavy T, 2003, EYE, V17, P821, DOI 10.1038/sj.eye.6700447; Liu WH, 2011, J EMERG MED, V41, P482, DOI 10.1016/j.jemermed.2008.03.041; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; Maguire K, 2007, EMERG MED J, V24, P103, DOI 10.1136/emj.2006.039503; Mahajna A, 2002, LANCET, V359, P1795, DOI 10.1016/S0140-6736(02)08708-1; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; MILLAR R, 1975, BRIT J SURG, V62, P480, DOI 10.1002/bjs.1800620613; Mitilian D, 2009, ACTA NEUROCHIR, V151, P1295, DOI 10.1007/s00701-009-0418-y; Morrison CS, 2014, CRANIOMAX TRAUM REC, V7, P298, DOI 10.1055/s-0034-1378179; Nissen NJ, 2020, PLAST RECONSTR SURG, V145, P1001, DOI 10.1097/PRS.0000000000006626; ONEILL OR, 1994, SURG NEUROL, V42, P494, DOI 10.1016/0090-3019(94)90079-5; Pascual JM, 2009, ACTA NEUROCHIR, V151, P689, DOI 10.1007/s00701-009-0222-8; Paucic-Kirincic E, 1997, Pediatr Rehabil, V1, P191; Rabie A, 2011, J CRANIOFAC SURG, V22, P1466, DOI 10.1097/SCS.0b013e31821d1982; Roux FE, 2001, NEUROCHIRURGIE, V47, P576; Salzano A, 2000, Radiol Med, V99, P156; Sarkar S, 2015, J CLIN DIAGN RES, V9, pPD8, DOI 10.7860/JCDR/2015/14257.6434; SKEDROS DG, 1993, J OTOLARYNGOL, V22, P341; Stanley R B Jr, 1999, Arch Facial Plast Surg, V1, P19, DOI 10.1001/archfaci.1.1.19; Suyama J, 2003, J EMERG MED, V25, P219, DOI 10.1016/S0736-4679(03)00179-3; Winegar BA, 2013, RADIOGRAPHICS, V33, P3, DOI 10.1148/rg.331125080	39	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2021	32	6					2189	2192		10.1097/SCS.0000000000007733			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UK2MX	WOS:000691810100092	34074930				2022-02-06	
J	Anderson, JFI; Cockle, E				Anderson, Jacqueline F. I.; Cockle, Emily			Investigating the Effect of Fatigue and Psychological Distress on Information Processing Speed in the Postacute Period After Mild Traumatic Brain Injury in Premorbidly Healthy Adults	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Processing speed; fatigue; Depression; Anxiety	DIGIT MODALITIES TEST; MULTIPLE-SCLEROSIS; WORKING-MEMORY; WAIS-III; PERFORMANCE; DEPRESSION; COGNITION; INVENTORY; PATTERNS; LOAD	Impairments in processing speed under conditions of increasing cognitive load have been reported in individuals with mild traumatic brain injury (mTBI). In other conditions that are also associated with white matter disruption, both psychological distress and fatigue have been shown to underlie this impairment. Objective: the current study aimed to investigate whether slowing of processing abilities under conditions of greater cognitive load is independent of fatigue and psychological status in premorbidly healthy individuals with subacute mTBI. Method: using a prospective observational design, we examined 84 individuals with mTBI approximately 8 weeks after injury and 47 healthy control (HC) participants. They were assessed with the Symbol Digit Modality Test, an n-back task and a rate of gain of information choice reaction time task that conforms to Hick's law. Participants were also assessed with measures of fatigue and psychological status. Results: as expected, findings revealed no group differences on simple reaction time tasks, but as task complexity increased, the mTBI group performed more slowly than the HC group. This group difference occurred independently of fatigue and psychological distress levels and was associated with a moderate effect size. Conclusions: during the subacute period after mTBI, premorbidly healthy individuals demonstrate impairment in their ability to rapidly process information as the cognitive load of the task increases beyond simple reaction time requirements. Examination of whether these changes affect resumption of premorbid roles is warranted.	[Anderson, Jacqueline F. I.; Cockle, Emily] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F. I.] Alfred Hosp, Psychol Dept, Commercial Rd, Melbourne, Vic 3181, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	jfande@unimelb.edu.au; emily.cockle@monash.edu.au			University of MelbourneUniversity of Melbourne	The University of Melbourne [2017 MRGSS].	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Anderson JFL, 2008, COGN BEHAV NEUROL, V21, P236, DOI 10.1097/WNN.0b013e31817d74d0; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bai LJ, 2020, HUM BRAIN MAPP, V41, P4431, DOI 10.1002/hbm.25135; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Beck AT, 1993, BECK ANXIETY INVENTO; Bertisch H, 2019, J HEAD TRAUMA REHAB, V34, P36, DOI 10.1097/HTR.0000000000000399; Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003; Bottari C, 2017, NEUROPSYCHOL REHABIL, V27, P871, DOI 10.1080/09602011.2015.1110528; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chiaravalloti ND, 2003, J CLIN EXP NEUROPSYC, V25, P489, DOI 10.1076/jcen.25.4.489.13878; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Crowe SF, 1999, AUST PSYCHOL, V34, P204, DOI 10.1080/00050069908257455; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Diamond BJ, 2008, ARCH CLIN NEUROPSYCH, V23, P189, DOI 10.1016/j.acn.2007.10.002; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Landro NI, 2004, J NEUROL SCI, V217, P211, DOI 10.1016/j.jns.2003.10.012; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MAHURIN RK, 1993, PERCEPT MOTOR SKILL, V77, P107, DOI 10.2466/pms.1993.77.1.107; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd, P1; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Proctor RW, 2018, Q J EXP PSYCHOL, V71, P1281, DOI 10.1080/17470218.2017.1322622; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Tiersky LA, 1998, CLIN NEUROPSYCHOL, V12, P503, DOI 10.1076/clin.12.4.503.7237; Warshawsky-Livne L, 2002, J SAFETY RES, V33, P117, DOI 10.1016/S0022-4375(02)00006-3; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WechslerD, 2001, WECHSLER TEST ADULT; Wu TT, 2018, CEREB CORTEX, V28, P2267, DOI 10.1093/cercor/bhx127; Zakzanis KK, 2017, APPL NEUROPSYCH-ADUL, V24, P559, DOI 10.1080/23279095.2016.1225216	52	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2021	36	6					918	929		10.1093/arclin/acaa123			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UQ0FU	WOS:000695749300006	33388744				2022-02-06	
J	Anderson, KS; Gosselin, N; Sadikot, AF; Lague-Beauvais, M; Kang, ESH; Fogarty, AE; Marcoux, J; Dagher, J; de Guise, E				Anderson, Kirsten S.; Gosselin, Nathalie; Sadikot, Abbas F.; Lague-Beauvais, Maude; Kang, Esther S. H.; Fogarty, Alexandra E.; Marcoux, Judith; Dagher, Jehane; de Guise, Elaine			Pitch and Rhythm Perception and Verbal Short-Term Memory in Acute Traumatic Brain Injury	BRAIN SCIENCES			English	Article						traumatic brain injury; verbal short-term memory; music perception; pitch; rhythm	CONGENITAL AMUSIA EVIDENCE; GLASGOW OUTCOME SCALE; HUMAN AUDITORY-CORTEX; FUNCTIONAL DISSOCIATIONS; RECEPTIVE AMUSIA; WORKING-MEMORY; MUSIC AGNOSIA; DISCRIMINATION; DEFICITS; SENSITIVITY	Music perception deficits are common following acquired brain injury due to stroke, epilepsy surgeries, and aneurysmal clipping. Few studies have examined these deficits following traumatic brain injury (TBI), resulting in an under-diagnosis in this population. We aimed to (1) compare TBI patients to controls on pitch and rhythm perception during the acute phase; (2) determine whether pitch and rhythm perception disorders co-occur; (3) examine lateralization of injury in the context of pitch and rhythm perception; and (4) determine the relationship between verbal short-term memory (STM) and pitch and rhythm perception. Music perception was examined using the Scale and Rhythm tests of the Montreal Battery of Evaluation of Amusia, in association with CT scans to identify lesion laterality. Verbal short-term memory was examined using Digit Span Forward. TBI patients had greater impairment than controls, with 43% demonstrating deficits in pitch perception, and 40% in rhythm perception. Deficits were greater with right hemisphere damage than left. Pitch and rhythm deficits co-occurred 31% of the time, suggesting partly dissociable networks. There was a dissociation between performance on verbal STM and pitch and rhythm perception 39 to 42% of the time (respectively), with most individuals (92%) demonstrating intact verbal STM, with impaired pitch or rhythm perception. The clinical implications of music perception deficits following TBI are discussed.	[Anderson, Kirsten S.; Gosselin, Nathalie; de Guise, Elaine] Univ Montreal, Psychol Dept, Montreal, PQ H2V 2S9, Canada; [Anderson, Kirsten S.; Dagher, Jehane; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ H3S 1M9, Canada; [Anderson, Kirsten S.; Gosselin, Nathalie] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ H2V 2S9, Canada; [Anderson, Kirsten S.; Gosselin, Nathalie] Ctr Res Brain Language & Mus CRBLM, Montreal, PQ H2V 2S9, Canada; [Sadikot, Abbas F.; Lague-Beauvais, Maude; Marcoux, Judith] McGill Univ, Neurol & Neurosurg Dept, Hlth Ctr, Montreal, PQ H4A 3J1, Canada; [Lague-Beauvais, Maude; Marcoux, Judith; Dagher, Jehane] McGill Univ, Traumat Brain Injury Program, Hlth Ctr, Montreal, PQ H3G 1A4, Canada; [Kang, Esther S. H.] McGill Univ, Fac Med, Montreal, PQ H3G 2M1, Canada; [Fogarty, Alexandra E.] Washington Univ, Dept Neurol, Div Phys Med & Rehabil, Sch Med, St Louis, MO 63110 USA; [de Guise, Elaine] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ H4A 3J1, Canada		Anderson, KS; de Guise, E (corresponding author), Univ Montreal, Psychol Dept, Montreal, PQ H2V 2S9, Canada.; Anderson, KS; de Guise, E (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ H3S 1M9, Canada.; Anderson, KS (corresponding author), Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ H2V 2S9, Canada.; Anderson, KS (corresponding author), Ctr Res Brain Language & Mus CRBLM, Montreal, PQ H2V 2S9, Canada.; de Guise, E (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ H4A 3J1, Canada.	kirsten.anderson@umontreal.ca; nathalie.gosselin@umontreal.ca; abbas.sadikot@mcgill.ca; maude.lague-beauvais@muhc.mcgill.ca; shin.h.kang@mail.mcgill.ca; afogarty@wustl.edu; judith.marcoux@mcgill.ca; jehane.dagher@mcgill.ca; elaine.de.guise@umontreal.ca	Fogarty, Alexandra/AAW-9755-2020	Fogarty, Alexandra/0000-0002-6495-1978; de Guise, Elaine/0000-0001-5095-7255; Gosselin, Nathalie/0000-0002-4213-669X	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-142324]; Fonds de recherche du Quebec-Sante (FRSQ) [32548]	This research was funded by the Canadian Institutes of Health Research (CIHR), grant number MOP-142324, and the Fonds de recherche du Quebec-Sante (FRSQ), grant number 32548.	Aboitiz F, 1992, Biol Res, V25, P51; Albouy P, 2019, HUM BRAIN MAPP, V40, P855, DOI 10.1002/hbm.24416; Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Balzani C., 2014, PSYCHOMUSICOLOGY MUS, V24, P117, DOI 10.1037/pmu0000037; Bigler ED, 2015, BRAIN NEUROTRAUMA MO, P1; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Buchsbaum BR, 2005, NEURON, V48, P687, DOI 10.1016/j.neuron.2005.09.029; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; Centers for Disease Control and Prevention, 2015, NATL CENT INJ PREV C, V2, P1; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Chen JL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00009; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Di Pietro M, 2004, NEUROPSYCHOLOGIA, V42, P868, DOI 10.1016/j.neuropsychologia.2003.12.004; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Fiez JA, 1996, J NEUROSCI, V16, P808; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Foxton JM, 2006, BRAIN COGNITION, V62, P24, DOI 10.1016/j.bandc.2006.03.005; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; FRIES W, 1990, NEUROPSYCHOLOGIA, V28, P1317, DOI 10.1016/0028-3932(90)90047-R; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gilbertson S., 2008, MUSIC THERAPY TRAUMA; Gosselin N, 2009, ANN NY ACAD SCI, V1169, P270, DOI 10.1111/j.1749-6632.2009.04762.x; Goulet GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036860; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Henry MJ, 2010, MUSIC PERCEPT, V27, P413, DOI 10.1525/mp.2010.27.5.413; Hirel C, 2017, BRAIN COGNITION, V113, P10, DOI 10.1016/j.bandc.2017.01.003; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Ingram Laura, 2004, Transactions of the Kansas Academy of Science, V107, P165, DOI 10.1660/0022-8443(2004)107[0165:ITWEDG]2.0.CO;2; Jerde TA, 2011, NEUROIMAGE, V57, P1572, DOI 10.1016/j.neuroimage.2011.05.061; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Jones JL, 2009, EAR HEARING, V30, P63, DOI 10.1097/AUD.0b013e31818ff95e; Kline R.B., 2016, PRINCIPLES PRACTICE, V4th, P74; Lagrois ME, 2019, CORTEX, V113, P229, DOI 10.1016/j.cortex.2018.11.036; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Leard-Schneider L, 2020, PSYARXIV, DOI [10.31234/osf.io/w7cbf, DOI 10.31234/OSF.IO/W7CBF]; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Levitin DJ, 2018, ANNU REV PSYCHOL, V69, P51, DOI 10.1146/annurev-psych-122216-011740; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lichtenberger E.O., 2013, ESSENTIALS WAIS 4 AS, V2nd, P1; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marin MM, 2012, NEUROPSYCHOLOGIA, V50, P367, DOI 10.1016/j.neuropsychologia.2011.12.006; MAVLOV L, 1980, CORTEX, V16, P331, DOI 10.1016/S0010-9452(80)80070-0; McChesney-Atkins S, 2003, EPILEPSY BEHAV, V4, P343, DOI 10.1016/S1525-5050(03)00079-9; McDonald C, 2008, MUSIC PERCEPT, V25, P345, DOI 10.1525/MP.2008.25.4.345; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milner B., 1962, INTERHEMISPHERIC REL, P177; Moreau P, 2013, BRAIN COGNITION, V81, P337, DOI 10.1016/j.bandc.2013.01.004; Defilippi ACN, 2019, PSICOL-REFLEX CRIT, V32, DOI 10.1186/s41155-018-0114-z; Omigie D, 2012, MUSIC PERCEPT, V30, P1, DOI 10.1525/MP.2012.30.1.1; Penhune VB, 1999, NEUROPSYCHOLOGIA, V37, P315, DOI 10.1016/S0028-3932(98)00075-X; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PERETZ I, 1993, Q J EXP PSYCHOL-A, V46, P301, DOI 10.1080/14640749308401048; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Peretz I, 1996, J COGNITIVE NEUROSCI, V8, P481, DOI 10.1162/jocn.1996.8.6.481; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Peretz I, 2017, EUR J HUM GENET, V25, P625, DOI 10.1038/ejhg.2017.15; Peretz I, 2016, TRENDS COGN SCI, V20, P857, DOI 10.1016/j.tics.2016.09.002; Pfeifer J, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/tnhum.2015.00161, 10.3389/fnhum.2015.00161]; Pfeuty M, 2010, ATTEN PERCEPT PSYCHO, V72, P763, DOI 10.3758/APP.72.3.763; Phillips-Silver J, 2013, COGN NEUROPSYCHOL, V30, P311, DOI 10.1080/02643294.2013.863183; Piras F, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00217; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Rosslau K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00768; Ruud E., 1997, NORDISK TIDSSKRIFT M, V6, P86, DOI DOI 10.1080/08098139709477902; SALAME P, 1989, Q J EXP PSYCHOL-A, V41, P107, DOI 10.1080/14640748908402355; Samson S, 2001, ANN NY ACAD SCI, V930, P166, DOI 10.1111/j.1749-6632.2001.tb05732.x; Sarkamo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015157; Sarkamo T, 2009, ANN NY ACAD SCI, V1169, P441, DOI 10.1111/j.1749-6632.2009.04765.x; Schaal NK, 2015, BEHAV BRAIN RES, V294, P141, DOI 10.1016/j.bbr.2015.08.003; Schendel ZA, 2007, MEM COGNITION, V35, P640, DOI 10.3758/BF03193302; Schulze K, 2012, ANN NY ACAD SCI, V1252, P229, DOI 10.1111/j.1749-6632.2012.06447.x; Schuppert M, 2000, BRAIN, V123, P546, DOI 10.1093/brain/123.3.546; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Shepherd D, 2020, QUAL LIFE RES, V29, P665, DOI 10.1007/s11136-019-02346-y; Sihvonen AJ, 2019, NEUROSCI BIOBEHAV R, V107, P104, DOI 10.1016/j.neubiorev.2019.08.023; Sihvonen AJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00426; Sihvonen AJ, 2016, J NEUROSCI, V36, P8872, DOI 10.1523/JNEUROSCI.0709-16.2016; Silver J.M., 2019, AM PSYCHIATRIC ASS T, V3rd, P953; Steinke WR, 2001, COGN NEUROPSYCHOL, V18, P411, DOI 10.1080/02643290125702; Talamini F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186773; Terao Y, 2006, NEUROPSYCHOLOGIA, V44, P479, DOI 10.1016/j.neuropsychologia.2005.05.013; Tillmann B, 2016, BRAIN RES, V1640, P251, DOI 10.1016/j.brainres.2015.10.035; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; Vuvan DT, 2018, BEHAV RES METHODS, V50, P662, DOI 10.3758/s13428-017-0892-8; Wechsler D., 1997, WECHSLER MEMORY SCAL; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1985, NEUROPSYCHOLOGIA, V23, P31, DOI 10.1016/0028-3932(85)90041-7; Zatorre RJ, 1998, BRAIN, V121, P1817, DOI 10.1093/brain/121.10.1817; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	108	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	SEP	2021	11	9							1173	10.3390/brainsci11091173			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UV2YD	WOS:000699349800001	34573194	Green Published, gold			2022-02-06	
J	Armstrong, E; Coffin, J; Hersh, D; Katzenellenbogen, JM; Thompson, S; Flicker, L; McAllister, M; Cadilhac, DA; Rai, T; Godecke, E; Hayward, C; Hankey, GJ; Drew, N; Lin, I; Woods, D; Ciccone, N				Armstrong, Elizabeth; Coffin, Juli; Hersh, Deborah; Katzenellenbogen, Judith M.; Thompson, Sandra; Flicker, Leon; McAllister, Meaghan; Cadilhac, Dominique A.; Rai, Tapan; Godecke, Erin; Hayward, Colleen; Hankey, Graeme J.; Drew, Neil; Lin, Ivan; Woods, Deborah; Ciccone, Natalie			Healing Right Way: study protocol for a stepped wedge cluster randomised controlled trial to enhance rehabilitation services and improve quality of life in Aboriginal Australians after brain injury	BMJ OPEN			English	Article						neurological injury; stroke medicine; rehabilitation medicine; health economics	ACQUIRED COMMUNICATION DISORDERS; INDIGENOUS AUSTRALIANS; STROKE SURVIVORS; PEOPLE; SAMPLE	Introduction Despite higher incidence of brain injury among Aboriginal compared with non-Aboriginal Australians, suboptimal engagement exists between rehabilitation services and Aboriginal brain injury survivors. Aboriginal patients often feel culturally insecure in hospital and navigation of services post discharge is complex. Health professionals report feeling ill-equipped working with Aboriginal patients. This study will test the impact of a research-informed culturally secure intervention model for Aboriginal people with brain injury. Methods and analysis Design: Stepped wedge cluster randomised control trial design; intervention sequentially introduced at four pairs of healthcare sites across Western Australia at 26-week intervals. Recruitment: Aboriginal participants aged >= 18 years within 4 weeks of an acute stroke or traumatic brain injury. Intervention: (1) Cultural security training for hospital staff and (2) local, trial-specific, Aboriginal Brain Injury Coordinators supporting participants. Primary outcome: Quality-of-life using EuroQOL-5D-3L (European Quality of Life scale, five dimensions, three severity levels) Visual Analogue Scale score at 26 weeks post injury. Recruitment of 312 participants is estimated to detect a difference of 15 points with 80% power at the 5% significance level. A linear mixed model will be used to assess the between-condition difference. Secondary outcome measures: Modified Rankin Scale, Functional Independence Measure, Modified Caregiver Strain Index, Hospital Anxiety and Depression Scale at 12 and 26 weeks post injury, rehabilitation occasions of service received, hospital compliance with minimum care processes by 26 weeks post injury, acceptability of Intervention Package, feasibility of Aboriginal Brain Injury Coordinator role. Evaluations: An economic evaluation will determine the potential cost-effectiveness of the intervention. Process evaluation will document fidelity to study processes and capture changing contexts including barriers to intervention implementation and acceptability/feasibility of the intervention through participant questionnaires at 12 and 26 weeks. Ethics and dissemination The study has approvals from Aboriginal, university and health services human research ethics committees. Findings will be disseminated through stakeholder reports, participant workshops, peer-reviewed journal articles and conference papers.	[Armstrong, Elizabeth; Hersh, Deborah; McAllister, Meaghan; Godecke, Erin; Ciccone, Natalie] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Coffin, Juli] Telethon Kids Inst, Broome, WA, Australia; [Katzenellenbogen, Judith M.] Univ Western Australia, Sch Populat & Global Hlth, Crawley, WA, Australia; [Thompson, Sandra] Univ Western Australia, Western Australian Ctr Rural Hlth, Perth, WA, Australia; [Flicker, Leon] Univ Western Australia, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Cadilhac, Dominique A.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Rai, Tapan] Univ Technol Sydney, Sch Math & Phys Sci, Sydney, NSW, Australia; [Hayward, Colleen; Drew, Neil] Edith Cowan Univ, Sch Kurongkurl Katitjin, Mt Lawley, WA, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Lin, Ivan] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton Campus, Geraldton, WA, Australia; [Lin, Ivan; Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, WA, Australia		Armstrong, E (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia.	b.armstrong@ecu.edu.au	Godecke, Erin/D-5838-2014; Hankey, Graeme J/H-4968-2014; Thompson, Sandra/H-5955-2014; Rai, Tapan/F-1233-2019; Lin, Ivan/H-5299-2014; Cadilhac, Dominique/I-1912-2014	Godecke, Erin/0000-0002-7210-1295; Hankey, Graeme J/0000-0002-6044-7328; Thompson, Sandra/0000-0003-0327-7155; Rai, Tapan/0000-0003-1610-8983; Lin, Ivan/0000-0001-6901-2569; Katzenellenbogen, Judith/0000-0001-5287-5819; Cadilhac, Dominique/0000-0001-8162-682X	NHMRCNational Health and Medical Research Council of Australia [1132468]; Western Australian Department of Health; Royal Perth Hospital Medical Research Foundation; Bega Garnbirringu Health Services; Geraldton Regional Aboriginal Medical Service; Kimberley Aboriginal Medical Services Council; Stroke Foundation; Neurological Council of Western Australia	This work is supported by NHMRC Grant #1132468 (2017-2022), Western Australian Department of Health, and the Royal Perth Hospital Medical Research Foundation, with the in-kind support of the Neurological Council of Western Australia, Bega Garnbirringu Health Services, Geraldton Regional Aboriginal Medical Service, Kimberley Aboriginal Medical Services Council and the Stroke Foundation.	Aboriginal Health Council of WA, AB COMM CONTR HLTH S; AIATSIS, 2020, AIATSIS COD ETH AB T; Armstrong E., 2014, ENHANCING PERSONAL F; Armstrong E, 2021, DISABIL REHABIL, V43, P1903, DOI 10.1080/09638288.2019.1686073; Armstrong E, 2020, APHASIOLOGY, V34, P1388, DOI 10.1080/02687038.2019.1678107; Armstrong E, 2019, BRAIN IMPAIR, V20, P120, DOI 10.1017/BrImp.2019.19; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Armstrong EM, 2017, INT J SPEECH-LANG PA, V19, P297, DOI 10.1080/17549507.2017.1290136; Australian Bureau of Statistics, 2016, EST AB TORR STRAIT; Australian Government, 2020, CLOS GAP REP; Barr Victoria J, 2003, Hosp Q, V7, P73; Brown Celia A, 2006, BMC Med Res Methodol, V6, P54; Cadilhac DA, 2020, EUR STROKE J, V5, P184, DOI 10.1177/2396987319897466; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Coffin Juli, 2007, ABORIGINAL ISLANDER, V31, P22; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Department of Communications Information Technology and the Arts, 2005, NAT IND LANG SURV RE; Esterman Adrian, 2018, Inj Epidemiol, V5, P40, DOI 10.1186/s40621-018-0172-9; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fitts MS, 2019, BRAIN IMPAIR, V20, P137, DOI 10.1017/BrImp.2019.24; Gilroy J, 2013, AUST ABORIG STUD, P42; Hemming K, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k1614; Hersh D, 2015, INT J SPEECH-LANG PA, V17, P74, DOI 10.3109/17549507.2014.923510; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Husereau D, 2013, INT J TECHNOL ASSESS, V29, P117, DOI 10.1017/S0266462313000160; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kelly J., 2012, MANAGING 2 WORLDS TO; Kilkenny M, 2018, INT J STROKE, V13, P7; Kilkenny MF, 2015, MED J AUSTRALIA, V203, P102, DOI 10.5694/mja15.00021; Kim SK, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0227-3; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Laycock A., 2011, RES INDIGENOUS HLTH; Lin I, 2014, AUST FAM PHYSICIAN, V43, P320; McCoy K., 2015, AUSTRALASIAN J NEURO, V25, P25, DOI [10.21307/ajon-2017-117, DOI 10.21307/AJON-2017-117]; Nakata M, 2007, AUST J INDIG EDUC, V36, P7, DOI 10.1017/S1326011100004646; National Health and Medical Research Council, 2018, KEEP RES TRACK 2 COM; National Health and Medical Research Council, 2018, ETH COND RES AB TORR; National Health and Medical Research Council, 2018, NAT STAT ETH COND HU; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Shahid S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-26; Skoss R., 2021, BMJ OPEN, Vthis issue; Stroke Foundation, 2017, CLIN GUID STROK MAN; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Teoh V, 2009, TOP STROKE REHABIL, V16, P157, DOI 10.1310/tsr1602-157; Therapeutic Goods Administration, 2000, NOT GUID GOOD CLIN P; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vogler J, 2014, BRAIN INJURY, V28, P1381, DOI 10.3109/02699052.2014.919536; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woertman W, 2013, J CLIN EPIDEMIOL, V66, P752, DOI 10.1016/j.jclinepi.2013.01.009; Zhao YJ, 2016, NEUROLOGY, V87, P458, DOI 10.1212/WNL.0000000000002908; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2021	11	9							e045898	10.1136/bmjopen-2020-045898			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UZ1KZ	WOS:000701972000022	34588230	Green Published, gold			2022-02-06	
J	Arumugam, G; Krishnaswamy, V; Nair, JN; Visweswaran, V; Naidu, B; Krishnamurthy, G				Arumugam, Ganesh; Krishnaswamy, Visvanathan; Nair, Jishnu Narayanan; Visweswaran, Vivek; Naidu, Bhaskar; Krishnamurthy, Ganesh			Factors influencing the outcome of patients with traumatic acute subdural hematoma (ASDH) - A single centre analysis	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Acute subdural hematoma; Road traffic accidents; Glasgow Coma Scale; Glasgow outcome scale	BRAIN-INJURY; MORTALITY		[Arumugam, Ganesh; Krishnaswamy, Visvanathan; Nair, Jishnu Narayanan; Visweswaran, Vivek; Naidu, Bhaskar; Krishnamurthy, Ganesh] Sri Ramachandra Inst Higher Educ & Res, Neurosurg Dept Neurosurg, Chennai, Tamil Nadu, India		Krishnaswamy, V (corresponding author), Sri Ramachandra Inst Higher Educ & Res, Neurosurg Dept Neurosurg, Chennai, Tamil Nadu, India.	visvanathan.k@sriramachandra.edu.in		Krishnaswamy, Visvanathan/0000-0002-7196-2851			Adiga Usha S, 2012, BASIC RES J MED CLIN, V1, P15; Alagoz F, 2017, TURK NEUROSURG, V27, P187, DOI 10.5137/1019-5149.JTN.15177-15.2; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2006, GUIDELINES SURG MANA; [Anonymous], 2017, TURK NEUROSURG, V27, P487; Arifin MZ, 2013, J NEUROSURG SCI, V57, P277; Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; Bullock M.R., 2006, NEUROSURGERY, P58; JENNETT B, 1975, LANCET, V1, P480; Kristiansen K., 1960, J OSLO CITY HOSP, V10, P107; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Liao KH, 2016, J CHIN MED ASSOC, V79, P58, DOI 10.1016/j.jcma.2015.10.002; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Moussa WMM, 2018, NEUROSURG REV, V41, P483, DOI 10.1007/s10143-017-0873-5; Nakamura H, NEUROTRAUMATOLOGY; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Saini Navdeep Singh, INDIAN J NEUROTRAUM; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sergides IG, 2006, BRIT J NEUROSURG, V20, P301, DOI 10.1080/02688690600999976; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; World Health Organization, 2008, VIOL INJ DIS BIENN 2; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	28	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2021	25								101130	10.1016/j.inat.2021.101130			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TS1AF	WOS:000679388300010		gold			2022-02-06	
J	Ashwal, S; Siebold, L; Krueger, AC; Wilson, CG				Ashwal, Stephen; Siebold, Lorraine; Krueger, A. Camille; Wilson, Christopher G.			Post-traumatic Neuroinflammation: Relevance to Pediatrics	PEDIATRIC NEUROLOGY			English	Article						Fractal morphology analysis; Cosyntropin; Chemokines; Cytokines; Microglia; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; ANIMAL-MODELS; MICROGLIA; INFLAMMATION; NEUROPROTECTION; RECEPTORS; TURNOVER; NEURODEGENERATION; INTERLEUKIN-10; MELANOCORTINS	Both detrimental and beneficial effects of post-traumatic neuroinflammation have become a major research focus as they offer the potential for immediate as well as delayed targeted reparative therapies. Understanding the complex interactions of central and peripheral immunocompetent cells as well as their mediators on brain injury and recovery is complicated by the temporal, regional, and developmental differences in their response to injuries. Microglia, the brain-resident macrophages, have become central in these investigations as they serve a major surveillance function, have the ability to react swiftly to injury, recruit various cellular and chemical mediators, and monitor the reparative/degenerative processes. In this review we describe selected aspects of this burgeoning literature, describing the critical role of cytokines and chemokines, microglia, advances in neuroimaging, genetics and fractal morphology analysis, our research efforts in this area, and selected aspects of pediatric post-traumatic neuroinflammation. (c) 2021 Elsevier Inc. All rights reserved.	[Ashwal, Stephen; Siebold, Lorraine; Krueger, A. Camille; Wilson, Christopher G.] Loma Linda Univ, Sch Med, Dept Pediat, 11175 Campus St,Rm A1120G, Loma Linda, CA 92350 USA		Ashwal, S (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, 11175 Campus St,Rm A1120G, Loma Linda, CA 92350 USA.	sashwal@llu.edu			Department of Pediatrics, Pediatric Educational Research, and Teaching Fund of Loma Linda University	This study was funded by the Department of Pediatrics, Pediatric Educational Research, and Teaching Fund of Loma Linda University. The authors participated in the preparation of this article and have no personal or institutional conflicts of interest.	Abu Hamdeh S, 2021, J NEUROTRAUM, V38, P1679, DOI 10.1089/neu.2020.7283; Al Mamun A, 2021, IMMUNOBIOLOGY, V226, DOI 10.1016/j.imbio.2020.152033; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Appavu B, 2019, J NEUROSURG-PEDIATR, V23, P661, DOI 10.3171/2019.2.PEDS18384; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Ayubcha C, 2021, EUR J NUCL MED MOL I, V48, P623, DOI 10.1007/s00259-020-04926-4; Bachiller S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00488; Banjara M, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/8385961; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bennett E.R., 2016, TRANSLATIONAL RES TR; Bertolini A, 2009, PHARMACOL RES, V59, P13, DOI 10.1016/j.phrs.2008.10.005; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Bonsack B, 2020, CNS NEUROSCI THER, V26, P603, DOI 10.1111/cns.13378; Carniglia L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158564; Carrier M, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00903; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Cengiz P, 2019, NEUROCHEM INT, V127, P137, DOI 10.1016/j.neuint.2018.12.016; Chen SP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1140-6; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cheray M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00243; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chio CC, 2016, EUR J CLIN INVEST, V46, P1063, DOI 10.1111/eci.12693; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Clark IA, 2021, J ALZHEIMERS DIS, V79, P931, DOI 10.3233/JAD-201186; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cortes D, 2021, NPJ REGEN MED, V6, DOI 10.1038/s41536-020-00114-y; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Dehghanian F, 2020, J MOL NEUROSCI, V70, P677, DOI 10.1007/s12031-019-01475-w; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Espindola OM, 2021, ANN NEUROL, V89, P1041, DOI 10.1002/ana.26041; Eyolfson E, 2020, J NEUROTRAUM, V37, P2718, DOI 10.1089/neu.2020.7195; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Fraunberger E, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110319; Gallo-Payet N, 2016, J MOL ENDOCRINOL, V56, pT135, DOI 10.1530/JME-15-0257; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hazy A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45089-z; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Henry RJ, 2021, NEURAL REGEN RES, V16, P976, DOI 10.4103/1673-5374.297068; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Holloway PM, 2015, ARTERIOSCL THROM VAS, V35, P1936, DOI 10.1161/ATVBAHA.115.305348; Hosomi S, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.520; Huang GH, 2019, J CELL BIOCHEM, V120, P15776, DOI 10.1002/jcb.28848; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kyriazis AD, 2019, NEUROINFORMATICS, V17, P373, DOI 10.1007/s12021-018-9405-x; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Lengel D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.601286; Lisak RP, 2015, EXP NEUROL, V273, P161, DOI 10.1016/j.expneurol.2015.08.012; Maiti P, 2019, J CELL MOL MED, V23, P5211, DOI 10.1111/jcmm.14396; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Montero-Melendez T, 2015, SEMIN IMMUNOL, V27, P216, DOI 10.1016/j.smim.2015.02.003; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Muza P, 2019, NEUROSCIENCE, V404, P297, DOI 10.1016/j.neuroscience.2019.01.049; Nagalakshmi B, 2018, PROG MOL BIOL TRANSL, V157, P263, DOI 10.1016/bs.pmbts.2017.12.013; Nagu P, 2021, REV NEUROSCIENCE, V32, P219, DOI 10.1515/revneuro-2020-0070; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Posti JP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549527; Provenzano F, 2021, TRENDS MOL MED, V27, P47, DOI 10.1016/j.molmed.2020.09.001; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Rowland B, 2020, SHOCK, V53, P24, DOI 10.1097/SHK.0000000000001349; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Savage JC, 2019, METHODS MOL BIOL, V2034, P13, DOI 10.1007/978-1-4939-9658-2_2; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Septyaningtrias DE, 2021, REV NEUROSCIENCE, V32, P427, DOI 10.1515/revneuro-2020-0092; Shi AC, 2020, FRONT NEUROL, V11; Siebold L, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00109; Simmons EC, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113309; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stratoulias V, 2019, EMBO J, V38, DOI 10.15252/embj.2019101997; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Wang XY, 2015, NEUROCHEM RES, V40, P1671, DOI 10.1007/s11064-015-1634-x; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Witcher KG, 2021, J NEUROSCI, V41, P1597, DOI 10.1523/JNEUROSCI.2469-20.2020; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhao JW, 2019, PEERJ, V7, DOI 10.7717/peerj.8324; Zhou YR, 2021, MOL NEUROBIOL, V58, P2803, DOI 10.1007/s12035-021-02293-1	100	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	SEP	2021	122						50	58		10.1016/j.pediatrneurol.2021.04.010			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	UP2DV	WOS:000695196400010	34304972				2022-02-06	
J	Baker, HP; Kahn, AJ; Rosenberg, S; Qin, C; Portney, D; Athiviraham, A				Baker, Hayden P.; Kahn, Adam J.; Rosenberg, Sam; Qin, Charles; Portney, Daniel; Athiviraham, Aravind			NFL total quarter back rating (QBR) is not decreased following sport related concussion injury	SPORT SCIENCES FOR HEALTH			English	Article						NFL; Sport related concussion; QBR; Performance	LEAGUE BASEBALL PITCHERS; TOMMY JOHN SURGERY; PERFORMANCE; EPIDEMIOLOGY; RETURN; STATEMENT; REINJURY; IMPACT	Hypothesis Our hypothesis was that NFL quarterbacks, due to the high-risk nature of the position and social and financial pressures to return to play following SRC, return to play prematurely and, thus, their on-field performance suffers due to the nature of their injury. Methods This study was a case-control study of a retrospective cohort of all NFL quarterbacks who were placed on the injury report for a concussion from 2006 to 2019. The data were compiled using publicly available information extracted from NFL transactions. Reportable injuries were based on the criteria that the injury necessitated a team physician referral or emergent care and resulted in scheduled team practice time being missed. Athletes injured in the pre-season or athletes who were injured and did not return to play during the regular were excluded from the study. There were 4 quarterbacks included in the study who suffered repeated concussions during separate seasons; repeated concussion in the same player was treated as two different data points. No quarterback included suffered multiple concussions within the same season. All active NFL quarterbacks injured during a regular season game were eligible for inclusion as age-matched controls. Quarterbacks included in the concussion injury cohort were excluded from the control group. The MEDCALC case-control matching procedure was used to randomly match cases and controls with a 1:1 allocation ratio, respectively, based on age (matching). Results There was no significant difference in age at injury, years in the NFL when injured, and weeks missed due to injury between the concussion and control groups. There was no statistically significant difference between average season QBR and weekly QBR for the first 6 weeks following return to play after an injury when comparing the concussion to control group. Conclusion QBR in NFL quarterbacks' did not decrease in the weeks returning from concussion when compared with age-matched control group. This finding was contrary to our hypothesis and suggests that a quarterback's functional skill is not significantly affected by an SRC incident by the time he returns to play.	[Baker, Hayden P.; Kahn, Adam J.; Qin, Charles; Portney, Daniel; Athiviraham, Aravind] Univ Chicago, Dept Orthopaed Surg, 5758 S Maryland Ave,Dept 4B, Chicago, IL 60637 USA; [Rosenberg, Sam] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Baker, HP (corresponding author), Univ Chicago, Dept Orthopaed Surg, 5758 S Maryland Ave,Dept 4B, Chicago, IL 60637 USA.	hpbaker65@gmail.com		Rosenberg, Samuel/0000-0001-8570-8267; Baker, Hayden/0000-0002-9306-7006			Abdullah KG, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0535-3; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Burnsed B, 2016, NAT COLL ATHL ASS SA; Conte SA, 2012, AM J SPORT MED, V40, P650, DOI 10.1177/0363546511433030; Covassin T, 2003, J ATHL TRAINING, V38, P238; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Gibson BW, 2007, AM J SPORT MED, V35, P575, DOI 10.1177/0363546506296737; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hannah T, 2019, CUREUS, V11, DOI 10.7759/cureus.6252; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Jildeh TR, 2019, AM J SPORT MED, V47, P2717, DOI 10.1177/0363546519864581; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Makhni EC, 2014, AM J SPORT MED, V42, P1323, DOI 10.1177/0363546514528864; Marshall NE, 2018, ARTHROSCOPY, V34, P473, DOI 10.1016/j.arthro.2017.08.298; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692	32	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1824-7490	1825-1234		SPORT SCI HLTH	Sport Sci. Health	SEP	2021	17	3					535	541		10.1007/s11332-020-00705-8			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UA2FH	WOS:000684979400003					2022-02-06	
J	Balshaw, J; Nicholls, M; Tsai, YL; Chaganti, J				Balshaw, James; Nicholls, Mark; Tsai, Yilun; Chaganti, Joga			Post traumatic herniation of basilar artery into sphenoid sinus with preserved arterial flow-an unusual complication	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Sphenoid fracture; Basilar Artery entrapment; CT Angiography	CLIVUS; FRACTURE	Background: Fractures of the sphenoid sinus and clivus are uncommon and vertebrobasilar herniation within a sphenoid sinus fracture is a rare occurrence, with few reported cases in literature. Such cases are often associated with secondary intracranial ischemia due to vascular injury and secondary thrombotic events which often result in significant disability. We report clinical management of a case of basilar artery herniation with entrapment of the basilar artery into the sphenoid sinus through a fracture of the posterior wall with relatively minimal neurological morbidity. Case report: A previously healthy 20-year-old female was admitted via the Emergency Department (ED) to a metropolitan trauma centre following a fall from a five-storey height. On scene the patient had a Glasgow Coma Scale (GCS) score was 4 with a dilated left pupil. CT scan and CT angiography of the extra and intra cranial arteries revealed fracture of the sphenoid sinus with entrapped basilar artery but with distal preserved flow along with multifocal traumatic brain injury and rib fractures. Conclusion: We discuss briefly the clinical management and progress of the patient along with review of the literature of this uncommon complication of Base of the skull fracture.	[Balshaw, James] St Vincents Hosp, Sydney, NSW, Australia; [Nicholls, Mark; Tsai, Yilun] St Vincents Hosp, Intens Care Unit, Sydney, NSW, Australia; [Chaganti, Joga] St Vincents Hosp, Dept Radiol, Sydney, NSW, Australia		Chaganti, J (corresponding author), St Vincents Hosp, Dept Radiol, Sydney, NSW, Australia.	Joga.chaganti@svha.org.au					Bala A, 2004, J CLIN NEUROSCI, V11, P660, DOI 10.1016/j.jocn.2003.11.008; Chaganti J., 2021, PRACT NEUROL, V21, P101; Fang JQ, 2012, CARDIOVASC INTER RAD, V35, P1237, DOI 10.1007/s00270-012-0353-9; Garcia-Garcia J, 2012, ARCH NEUROL-CHICAGO, V69, P662, DOI 10.1001/archneurol.2011.1155; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; Kaakaji R, 2004, AM J NEURORADIOL, V25, P1348; Kanamori F, 2018, NEUROL MED-CHIR, V58, P356, DOI 10.2176/nmc.cr.2017-0197; Khanna P, 2010, SKULL BASE-INTERD AP, V20, P269, DOI 10.1055/s-0030-1247629; Kliesch S., 2016, CASE REPORTS, V2016; Li L, 2016, INTERV NEURORADIOL, V22, P260, DOI 10.1177/1591019915622162; Sato S, 2001, NEUROL MED-CHIR, V41, P541, DOI 10.2176/nmc.41.541; Taguchi Y, 2000, J TRAUMA, V48, P1148, DOI 10.1097/00005373-200006000-00023; Wang A, 2017, WORLD NEUROSURG, V98, DOI 10.1016/j.wneu.2016.11.068; Yamaoka A, 2018, NEUROL MED-CHIR, V58, P362, DOI 10.2176/nmc.cr.2018-0041	14	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2021	25								101268	10.1016/j.inat.2021.101268			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TS1AR	WOS:000679389600001		gold			2022-02-06	
J	Barbay, S; Zhang, HY; Frost, SB; Peterson, JC; Guggenmos, DJ; Hudson, HM; Bundy, DT; DeJong, SL; Nudo, RJ				Barbay, Scott; Zhang, Hongyu; Frost, Shawn B.; Peterson, Jeremy C.; Guggenmos, David J.; Hudson, Heather M.; Bundy, David T.; DeJong, Stacey L.; Nudo, Randolph J.			A cortical injury model in a non-human primate to assess execution of reach and grasp actions: implications for recovery after traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Tbi; Controlled cortical impact; Brain injury; Motor cortex; Hand; Recovery of function	PRIMARY MOTOR CORTEX; POSTERIOR PARIETAL CORTEX; VENTRAL PREMOTOR CORTEX; SPINAL-CORD; MOVEMENT REPRESENTATIONS; HAND FUNCTION; REORGANIZATION; PLASTICITY; IMPACT; DAMAGE	Background: Technological advances in developing experimentally controlled models of traumatic brain injury (TBI) are prevalent in rodent models and these models have proven invaluable in characterizing temporal changes in brain and behavior after trauma. To date no long-term studies in non-human primates (NHPs) have been published using an experimentally controlled impact device to follow behavioral performance over time. New method: We have employed a controlled cortical impact (CCI) device to create a focal contusion to the hand area in primary motor cortex (M1) of three New World monkeys to characterize changes in reach and grasp function assessed for 3 months after the injury. Results: The CCI destroyed most of M1 hand representation reducing grey matter by 9.6 mm(3), 12.9 mm(3), and 15.5 mm(3) and underlying corona radiata by 7.4 mm(3), 6.9 mm(3), and 5.6 mm(3) respectively. Impaired motor function was confined to the hand contralateral to the injury. Gross hand-use was only mildly affected during the first few days of observation after injury while activity requiring skilled use of the hand was impaired over three months. Comparison with existing method(s): This study is unique in establishing a CCI model of TBI in an NHP resulting in persistent impairments in motor function evident in volitional use of the hand. Conclusions: Establishing an NHP model of TBI is essential to extend current rodent models to the complex neural architecture of the primate brain. Moving forward this model can be used to investigate novel therapeutic interventions to improve or restore impaired motor function after trauma.	[Barbay, Scott; Zhang, Hongyu; Frost, Shawn B.; Guggenmos, David J.; Hudson, Heather M.; Bundy, David T.; Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Phys Med & Rehabil, Kansas City, KS 66103 USA; [Peterson, Jeremy C.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66103 USA; [DeJong, Stacey L.; Nudo, Randolph J.] Univ Kansas, Med Ctr, Landon Ctr Aging, Kansas City, KS 66103 USA; [DeJong, Stacey L.] Univ Iowa, Carver Coll Med, Dept Phys Therapy & Rehabil Sci, Iowa City, IA 52242 USA		Barbay, S (corresponding author), Univ Kansas, Med Ctr, Dept Phys Med & Rehabil, Cort Plast Lab, Kansas City, KS 66160 USA.	sbarbay@kumc.edu		Barbay, Scott/0000-0003-2470-7775	Department of DefenseUnited States Department of Defense [W81XWH-16-1-0503]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS030853]; Foundation for Physical Therapy Inc.	Supported by Department of Defense Award No. W81XWH-16-1-0503 (P.M. and R.J.N.) , the support of NIH grants R01NS030853 (R.J. N.) and supported in part by a New Investigator Fellowship Initiative from the Foundation for Physical Therapy Inc. (S.L.D.) . The authors would like to thank Caleb Dunham for his invaluable technical assis-tance with data acquisition and processing.	Andrews BT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79155-8; Baker SN, 2017, J NEUROSCI, V37, P9778, DOI 10.1523/JNEUROSCI.3368-16.2017; Baker SN, 2011, J PHYSIOL-LONDON, V589, P5603, DOI 10.1113/jphysiol.2011.215160; Barbay S, 2015, STROKE, V46, P1620, DOI 10.1161/STROKEAHA.114.008088; Bury SD, 2009, J NEUROSCI METH, V179, P264, DOI 10.1016/j.jneumeth.2009.02.003; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Cote SL, 2017, J NEUROSCI, V37, P5960, DOI 10.1523/JNEUROSCI.0462-17.2017; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Darling WG, 2021, FRONT SYST NEUROSCI, V15, DOI 10.3389/fnsys.2021.592235; Darling WG, 2018, J NEUROSCI, V38, P6323, DOI 10.1523/JNEUROSCI.0403-18.2018; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; Dea M, 2016, CEREB CORTEX, V26, P1747, DOI 10.1093/cercor/bhv324; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eisner-Janowicz I, 2008, J NEUROPHYSIOL, V100, P1498, DOI 10.1152/jn.90447.2008; Fregosi M, 2018, EUR J NEUROSCI, V48, P2050, DOI 10.1111/ejn.14074; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gharbawie OA, 2010, CEREB CORTEX, V20, P2391, DOI 10.1093/cercor/bhp308; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Hamadjida A, 2016, CURR BIOL, V26, P1737, DOI 10.1016/j.cub.2016.04.068; Harding IH, 2015, NEUROIMAGE, V106, P144, DOI 10.1016/j.neuroimage.2014.11.039; Kaas JH, 2016, J COMP NEUROL, V524, P595, DOI 10.1002/cne.23838; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Lang CE, 2003, J NEUROPHYSIOL, V90, P1160, DOI 10.1152/jn.00130.2003; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; Murphy MD, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00497; Nemoto EM, 2006, ADV EXP MED BIOL, V578, P311; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nudo R.J, 2010, BRAIN REPAIR STROKE, V67, P67; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Osier N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070088; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Plautz EJ, 2016, NEUROREHAB NEURAL RE, V30, P159, DOI 10.1177/1545968315619701; Rinne P, 2018, P NATL ACAD SCI USA, V115, pE536, DOI 10.1073/pnas.1715617115; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rouse AG, 2018, CELL REP, V25, P3158, DOI 10.1016/j.celrep.2018.11.057; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Stepniewska I, 2007, NEUROSCIENCE, V147, P727, DOI 10.1016/j.neuroscience.2007.03.054; Stowe AM, 2008, J CEREBR BLOOD F MET, V28, P612, DOI 10.1038/sj.jcbfm.9600560; Touvykine B, 2020, J NEUROPHYSIOL, V123, P1355, DOI 10.1152/jn.00591.2019; Tsintou M, 2020, NEURAL REGEN RES, V15, P425, DOI 10.4103/1673-5374.266048; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wise SP, 2006, CORTEX, V42, P521, DOI 10.1016/S0010-9452(08)70391-5; Zaaimi B, 2018, J NEUROPHYSIOL, V119, P235, DOI 10.1152/jn.00672.2017	55	0	0	6	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 1	2021	361								109283	10.1016/j.jneumeth.2021.109283			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TY8MG	WOS:000684033400004	34237383				2022-02-06	
J	Basit, RH; Tzerakis, N; Jenkins, SI; Chari, DM				Basit, Raja Haseeb; Tzerakis, Nikolaos; Jenkins, Stuart Iain; Chari, Divya Maitreyi			In vitro model of traumatic brain injury to screen neuro-regenerative biomaterials	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Microglia; Scarring; Immune cells; Astrocyte; Surgical materials	PLATFORM; REVEALS; REPAIR	Penetrating traumatic brain injury (pTBI) causes serious neurological deficits with no clinical regenerative therapies currently available. Tissue engineering strategies using biomaterial-based 'structural bridges' offer high potential to promote neural regeneration post-injury. This includes surgical grade materials which can be repurposed as biological scaffolds to overcome challenges associated with long approval processes and scaleup for human application. However, high throughput, pathomimetic models of pTBI are lacking for the developmental testing of such neuro-materials, representing a bottleneck in this rapidly emergent field. We have established a high throughput and facile culture model containing the major neural cell types which govern biomaterial handling in the central nervous system. We show that induction of traumatic injuries was feasible in the model, with post-injury implantation of a surgical grade biomaterial. Cellular imaging in lesions was achievable using standard epifluorescence microscopy methods. Key pathological features of pTBI were evident in vitro namely immune cell infiltration of lesions/biomaterial, with responses characteristic of cell scarring, namely hypertrophic astrocytes with GFAP upregulation. Based on our observations, we consider the high throughput, inexpensive and facile pTBI model can be used to study biomaterial 'implantation' and evaluate neural cell-biomaterial responses. The model is highly versatile to test a range of laboratory and clinical grade materials for neural regeneration.	[Basit, Raja Haseeb; Jenkins, Stuart Iain; Chari, Divya Maitreyi] Keele Univ, Sch Med, Neural Tissue Engn Keele NTEK, Keele ST5 5BG, Staffs, England; [Tzerakis, Nikolaos] Univ Hosp North Midlands NHS Trust, Royal Stoke Univ Hosp, Dept Neurosurg, Newcastle Rd, Stoke On Trent ST4 6QG, Staffs, England		Chari, DM (corresponding author), Keele Univ, Sch Life Sci, Huxley Bldg, Keele ST5 5BG, Staffs, England.	r.h.basit@keele.ac.uk; Nikolaos.tzerakis@uhnm.nhs.uk; s.i.jenkins@keele.ac.uk; d.chari@keele.ac.uk			NHS; Keele University School of Medicine intercalated bursary award	RHB was supported by an NHS bursary for intercalation year and a Keele University School of Medicine intercalated bursary award.	Balls M, 2009, ATLA-ALTERN LAB ANIM, V37, P255, DOI 10.1177/026119290903700306; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Dias DO, 2018, MATRIX BIOL, V68-69, P561, DOI 10.1016/j.matbio.2018.02.009; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Finch L, 2020, J CONTROL RELEASE, V321, P553, DOI 10.1016/j.jconrel.2020.02.028; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Kumaria A, 2017, ATLA-ALTERN LAB ANIM, V45, P201, DOI 10.1177/026119291704500405; Loggini A, 2020, J CRIT CARE, V56, P159, DOI 10.1016/j.jcrc.2019.12.026; Maclean FL, 2017, ACS BIOMATER SCI ENG, V3, P2542, DOI 10.1021/acsbiomaterials.7b00524; Mahumane GD, 2018, BIOMATER SCI-UK, V6, P2812, DOI 10.1039/c8bm00422f; McCanney G.A., 2018, DRUG DISCOV TODAY DI, V25-26, P11, DOI DOI 10.1016/J.DDMOD.2018.10.005; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Morin-Brureau M, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-11; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Purvis EM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00344; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Tsui C, 2019, ACTA BIOMATER, V83, P13, DOI 10.1016/j.actbio.2018.11.008; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; van Doormaal T, 2018, OPER NEUROSURG, V15, P425, DOI 10.1093/ons/opx260; Van Wyck D.W., 2015, J NEUROL NEUROPHYSIO, V6; Wang HJ, 2018, INT J IMMUNOPATH PH, V31, DOI 10.1177/2058738418801406; Weightman AP, 2016, NANO RES, V9, P2384, DOI 10.1007/s12274-016-1125-7; Weightman AP, 2014, BIOMATERIALS, V35, P3756, DOI 10.1016/j.biomaterials.2014.01.022; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17	30	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	SEP	2021	128								112253	10.1016/j.msec.2021.112253			8	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	UK2FW	WOS:000691791700005	34474815				2022-02-06	
J	Beaulieu, CL; Peng, J; Hade, EM; Montgomery, E; Gilchrist, K; Corrigan, JD; Horn, SD; Bogner, J				Beaulieu, Cynthia L.; Peng, Juan; Hade, Erinn M.; Montgomery, Erin; Gilchrist, Kamie; Corrigan, John D.; Horn, Susan D.; Bogner, Jennifer			Quasi-Contextualized Speech Treatment in Traumatic Brain Injury Inpatient Rehabilitation: Effects on Outcomes During the First Year After Discharge	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; community participation; comparative effectiveness research; evidence-based practice; health services research; propensity score; rehabilitation; speech-language pathology; speech therapy; traumatic brain injury; treatment outcome	LANGUAGE INTERVENTION; PARTICIPATION ASSESSMENT; THERAPY; PATIENT; IMPAIRMENT; CHILDREN; VALIDITY	Objective: To evaluate the effect of providing quasi-contextualized speech therapy, defined as metacognitive, compensatory, or strategy training applied to cognitive and language impairments to facilitate the performance of future real-life activities, on functional outcomes up to 1 year following traumatic brain injury (TBI). Setting: Acute inpatient rehabilitation. Participants: Patients enrolled during the TBI-Practice-Based Evidence (TBI-PBE) study (n = 1760), aged 14 years or older, who sustained a severe, moderate, or complicated mild TBI, received speech therapy in acute inpatient rehabilitation at one of 9 US sites, and consented to follow-up 3 and 9 months postdischarge from inpatient rehabilitation. Design: Propensity score methods applied to a database consisting of multisite, prospective, longitudinal observational data. Main Measures: Participation Assessment with Recombined Tools-Objective-17, FIM Motor and Cognitive scores, Satisfaction With Life Scale, and Patient Health Questionnaire-9. Results: When at least 5% of therapy time employed quasi-contextualized treatment, participants reported better community participation during the year following discharge. Quasi-contextualized treatment was also associated with better motor and cognitive function at discharge and during the year after discharge. The benefit, however, may be dependent upon a balance of rehabilitation time that relied on contextualized treatment. Conclusions: The use of quasi-contextualized treatment may improve outcomes. Care should be taken, however, to not provide quasi-contextualized treatment at the expense of contextualized treatment.	[Beaulieu, Cynthia L.; Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Div Rehabil Psychol, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Peng, Juan; Hade, Erinn M.] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA; [Montgomery, Erin] Ohio State Univ, Med Ctr, Dept Rehabil Serv, Columbus, OH 43210 USA; [Horn, Susan D.] Univ Utah, Sch Med, Dept Populat Hlth Sci, Div Hlth Syst Innovat & Res, Salt Lake City, UT USA; [Gilchrist, Kamie] Intermt Med Ctr, Speech Pathol Dept, Murray, UT USA		Beaulieu, CL (corresponding author), Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Div Rehabil Psychol, 480 Med Ctr Dr, Columbus, OH 43210 USA.	cynthia.beaulieu@osumc.edu; juan.peng@osumc.edu; erinn.hade@osumc.edu; erin.montgomery@osumc.edu; kamie.gilchrist@imail.org; johncorrigan1@me.com; susan.horn@hsc.utah.edu; jennifer.bogner@osumc.edu			Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-1403-13476]; Patient-Centered Outcomes Research Institute (EADI) [16211]; National Institutes of Health, National Center forMedical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability, Independent Living, and Rehabilitation [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]	This study was supported by the Patient-Centered Outcomes Research Institute (grant no. CER-1403-13476 and EADI #16211). The statements presented in this work are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors, or Methodology Committee. Funding for the databases used in this study came from the National Institutes of Health, National Center forMedical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability, Independent Living, and Rehabilitation (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant 2007-ABI-ISIS-525).	Beaulieu CL, 2019, ARCH PHYS MED REHAB, V100, P1827, DOI 10.1016/j.apmr.2019.01.014; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bode RK, 2004, STROKE, V35, P2537, DOI 10.1161/01.STR.0000145200.02380.a3; Bogner J, 2019, ARCH PHYS MED REHAB, V100, P1810, DOI 10.1016/j.apmr.2018.12.037; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brain Injury Association of America, GUID REH CHRON DIS M; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen-Mimran R, 2016, EARLY CHILD EDUC J, V44, P69, DOI 10.1007/s10643-014-0676-z; Culatta B., 2007, COMMUN DISORD Q, V28, P216; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gillam SL, 2012, LANG SPEECH HEAR SER, V43, P276, DOI 10.1044/0161-1461(2011/11-0022); Gillarn RB, 2008, J SPEECH LANG HEAR R, V51, P97, DOI 10.1044/1092-4388(2008/007); GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Institute of Medicine, 2011, COGNITIVE REHABILITA; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuhl PK, 2011, MIND BRAIN EDUC, V5, P128, DOI 10.1111/j.1751-228X.2011.01121.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; McEwen SE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212988; Naimi AI, 2014, EPIDEMIOLOGY, V25, P292, DOI 10.1097/EDE.0000000000000053; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Skidmore ER, 2014, CLIN REHABIL, V28, P378, DOI 10.1177/0269215513502799; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Timpson M, 2019, ARCH PHYS MED REHAB, V100, P1818, DOI 10.1016/j.apmr.2018.11.015; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Zanca JM, 2014, ARCH PHYS MED REHAB, V95, pS55, DOI 10.1016/j.apmr.2013.03.034	35	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E312	E321		10.1097/HTR.0000000000000649			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300005	33656472				2022-02-06	
J	Bektasoglu, PK; Koyuncuoglu, T; Demir, D; Sucu, G; Akakin, D; Eyuboglu, IP; Yuksel, M; Celikoglu, E; Yegen, BC; Gurer, B				Bektasoglu, Pinar Kuru; Koyuncuoglu, Turkan; Demir, Dilan; Sucu, Gizem; Akakin, Dilek; Eyuboglu, Irem Peker; Yuksel, Meral; Celikoglu, Erhan; Yegen, Berrak C.; Gurer, Bora			Neuroprotective Effect of Cinnamaldehyde on Secondary Brain Injury After Traumatic Brain Injury in a Rat Model	WORLD NEUROSURGERY			English	Article						Antiinflammatory; Antioxidant; Cinnamaldehyde; Neuroprotection; Rat; Traumatic brain injury	ROOT GANGLION NEURONS; NECROSIS-FACTOR-ALPHA; CLOSED-HEAD INJURY; HIGH GLUCOSE; TRANS-CINNAMALDEHYDE; INDUCED DAMAGE; TNF-ALPHA; EXPRESSION; NEUROINFLAMMATION; INTERLEUKIN-1	OBJECTIVE: The aim of this study was to investigate the possible neuroprotective effects of cinnamaldehyde (CA) on secondary brain injury after traumatic brain injury (TBI) in a rat model. METHODS: Rats were randomly divided into 4 groups: control (n = 9), TBI (n = 9), vehicle (0.1% Tween 80; n = 8), and CA (100 mg/kg) (n = 9). TBI was induced by the weight-drop model. In brain tissues, myeloperoxidase ac-tivity and the levels of luminol-enhanced and lucigenin-enhanced chemiluminescence were measured. Inter-leukin 1b, interleukin 6, tumor necrosis factor a, tumor growth factor b, caspase-3, and cleaved caspase-3 were evaluated with an enzyme-linked immunosorbent assay method. Brain injury was histopathologically graded after hematoxylin-eosin staining. Y-maze and novel object recognition tests were performed before TBI and within 24 hours of TBI. RESULTS: Higher myeloperoxidase activity levels in the TBI group (P < 0.001) were suppressed in the CA group (P < 0.05). Luminol-enhanced and lucigenin-enhanced chem-iluminescence, which were increased in the TBI group (P < 0.001, for both), were decreased in the group that received CA treatment (P < 0.001 for both). Compared with the increased histologic damage scores in the cerebral cortex and dentate gyrus of the TBI group (P < 0.001), scores of the CA group were lower (P < 0.001). Decreased number of entries and spontaneous alternation percentage in the Y-maze test of the TBI group (P < 0.05 and P < 0.01, respec-tively) were not evident in the CA group. CONCLUSIONS: CA has shown neuroprotective effects by limiting neutrophil recruitment, suppressing reactive oxygen species and reducing histologic damage and acute hippocampal dysfunction.	[Bektasoglu, Pinar Kuru; Celikoglu, Erhan] Univ Hlth Sci, Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Bektasoglu, Pinar Kuru; Yegen, Berrak C.] Marmara Univ, Sch Med, Dept Physiol, Istanbul, Turkey; [Sucu, Gizem; Akakin, Dilek] Marmara Univ, Sch Med, Dept Histol, Istanbul, Turkey; [Eyuboglu, Irem Peker] Marmara Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Koyuncuoglu, Turkan] Biruni Univ, Fac Med, Dept Physiol, Istanbul, Turkey; [Demir, Dilan] Univ Hlth Sci, Kartal Dr Lutfi Kirdar Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Yuksel, Meral] Marmara Univ, Vocat Sch Hlth Related Serv, Dept Med Lab, Istanbul, Turkey; [Gurer, Bora] Istinye Univ, Fac Med, Dept Neurosurg, Istanbul, Turkey		Bektasoglu, PK (corresponding author), Univ Hlth Sci, Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey.; Bektasoglu, PK (corresponding author), Marmara Univ, Sch Med, Dept Physiol, Istanbul, Turkey.	drpinarkuru@gmail.com	Bektasoglu, Pinar Kuru/K-8612-2013; Koyuncuoglu, Turkan/AAD-3962-2021; Koyuncuoglu, Turkan/AAD-3448-2022; Yegen, Berrak/O-6652-2017	Bektasoglu, Pinar Kuru/0000-0001-9889-9955; Koyuncuoglu, Turkan/0000-0003-4749-9470; Koyuncuoglu, Turkan/0000-0003-4749-9470; Yegen, Berrak/0000-0003-0791-0165	University of Health Sciences	This study was supported financially by University of Health Sciences.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arik E, 2020, J ANKARA U FM, V73, P42; Bae WY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020551; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chen YF, 2016, NEUROMOL MED, V18, P322, DOI 10.1007/s12017-016-8395-9; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Darwish H, 2019, METHODS MOL BIOL, V2011, P383, DOI 10.1007/978-1-4939-9554-7_22; Davaatseren M, 2017, MOLECULES, V22, DOI 10.3390/molecules22121868; Demir D, 2019, INJURY, V50, P1586, DOI 10.1016/j.injury.2019.08.036; Deshpande SS, 2001, CRIT REV FOOD SCI, V41, P155, DOI 10.1080/20014091091797; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fu Y, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4730878; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gokce EC, 2015, INJURY, V46, P2146, DOI 10.1016/j.injury.2015.08.017; Guo JY, 2006, EUR J PHARMACOL, V537, P174, DOI 10.1016/j.ejphar.2006.03.002; Guo X, 2017, MED SCI MONITOR, V23, P3844, DOI 10.12659/MSM.906027; Gurer B, 2019, METAB BRAIN DIS, V34, P1737, DOI 10.1007/s11011-019-00480-7; Hajinejad M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1034325; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Ho SC, 2013, FOOD CHEM, V138, P2275, DOI 10.1016/j.foodchem.2012.12.020; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Huang JQ, 2007, THROMB RES, V119, P337, DOI 10.1016/j.thromres.2006.03.001; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kertmen H, 2015, ARCH MED SCI, V11, P1119, DOI 10.5114/aoms.2015.54869; Kim ME, 2018, IMMUNOPHARM IMMUNOT, V40, P219, DOI 10.1080/08923973.2018.1424902; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; KROL W, 1990, BIOCHEM INT, V21, P593; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lueptow LM, 2017, JOVE-J VIS EXP, DOI 10.3791/55718; Lv C, 2017, EUR J PHARMACOL, V815, P487, DOI 10.1016/j.ejphar.2017.09.009; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Nour OAA, 2018, N-S ARCH PHARMACOL, V391, P1203, DOI 10.1007/s00210-018-1547-8; Ozay R, 2017, WORLD NEUROSURG, V104, P634, DOI 10.1016/j.wneu.2017.04.136; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Pyo JH, 2013, BIOL PHARM BULL, V36, P1928, DOI 10.1248/bpb.b13-00537; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Shi Y, 2017, CHIN J INTEGR MED, V23, P663, DOI 10.1007/s11655-017-2405-0; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Subash-Babu P, 2014, BIOMOL THER, V22, P47, DOI 10.4062/biomolther.2013.100; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Toklu HZ, 2009, J SURG RES, V152, P238, DOI 10.1016/j.jss.2008.03.013; Tugtepe H, 2007, REGUL PEPTIDES, V140, P101, DOI 10.1016/j.regpep.2006.11.026; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Wang F, 2015, CELL PHYSIOL BIOCHEM, V36, P315, DOI 10.1159/000374074; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yang D, 2016, CHIN J INTEGR MED, V22, P19, DOI 10.1007/s11655-015-2103-8; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Zhao H, 2014, J PHARMACEUT BIOMED, V89, P150, DOI 10.1016/j.jpba.2013.10.044; Zhao JR, 2015, BRIT J PHARMACOL, V172, P5009, DOI 10.1111/bph.13270; Zhu RY, 2017, PHARMACOL RES, V122, P78, DOI 10.1016/j.phrs.2017.05.019; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	74	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2021	153						E392	E402		10.1016/j.wneu.2021.06.117			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UE5QP	WOS:000687942800033	34224887				2022-02-06	
J	Bethard, JD; Ainger, TJ; Gonciar, A; Nyaradi, Z				Bethard, Jonathan D.; Ainger, Timothy J.; Gonciar, Andre; Nyaradi, Zsolt			Surviving (but not thriving) after cranial vault trauma: A case study from Transylvania	INTERNATIONAL JOURNAL OF PALEOPATHOLOGY			English	Article						Antemortem cranial trauma; Traumatic brain injury; TBI; Care; Szekely region	LEFT SUPRAMARGINAL GYRUS; BLUNT HEAD TRAUMA; BRAIN-INJURY; IMPAIRMENT; MEDIEVAL; LANGUAGE; CONSEQUENCES; NEUROPSYCHOLOGY; BIOARCHAEOLOGY; DISCRIMINATION	Objective: To link an antemortem cranial injury on the left parietal bone with potential neurocognitive consequences. Materials: The skeleton of a male individual from a Sze acute accent kely archaeological site in Transylvania was examined. The skeleton was radiocarbon dated to Cal AD 1450 and AD 1640 and presented a well-healed antemortem penetrating cranial injury on the left parietal bone. Methods: Macroscopic and radiographic analyses were conducted and the cranium was also archived digitally with a Faro FreeStyle3D scanner. In addition, well-known literature from neuroscience was synthesized in order to better understand the likely neurological consequences of the injury. Results: The literature suggests that tasks of attention and working memory, sensory processing, language processing, and vision are affected when the parietal lobe of the brain is injured. Conclusions: Burial 195 did not likely return to a 'normal' life after he survived the cranial injury. Significance: This study demonstrates that bioarcheological interpretations involving antemortem cranial injuries can be enhanced by collaboration with neuroscientists. Bioarcheological interpretations are improved when the consequences of soft tissue injuries are understood. Limitations: This study was limited by a lack of historical documents relevant to the region, time period, and specific case study. In addition, interpretations are cautionary because brain functioning cannot be assessed in vivo in the absence of life. Suggestions for further research: Bioarcheologists who study antemortem cranial injuries should continue to collaborate with neuroscientists.	[Bethard, Jonathan D.] Univ S Florida, Dept Anthropol, 4202 East Fowler Ave,SOC107, Tampa, FL 33620 USA; [Ainger, Timothy J.] Univ Kentucky, Coll Med, Dept Neurol, Kentucky Clin, 740 S Limestone, J-414, Lexington, KY 40536 USA; [Gonciar, Andre] ArchaeoTek Canada LLC, Ottawa, ON, Canada; [Nyaradi, Zsolt] Haaz Rezso Muzeum, Str Beclean 2-6, Odorheiu Secuiesc 535600, Romania		Bethard, JD (corresponding author), Univ S Florida, Dept Anthropol, 4202 East Fowler Ave,SOC107, Tampa, FL 33620 USA.	jbethard@usf.edu		Bethard, Jonathan/0000-0001-9368-6627			Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242; ar adi Z., 2013, MARISIA, VXXXIII, P251; Ardila A, 2014, ARCH CLIN NEUROPSYCH, V29, P828, DOI 10.1093/arclin/acu056; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baxendale S, 2010, EPILEPSIA, V51, P2225, DOI 10.1111/j.1528-1167.2010.02710.x; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Bethard JD, 2019, BIOAR INTER HUM PAST, P252; Bethard JD, 2017, BIOARCHAEOL SOC THEO, P249, DOI 10.1007/978-3-319-56949-9_13; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Blumenfeld H, 2010, NEUROANATOMY THROUGH CLINICAL CASES, SECOND EDITION, P1; Boldsen JL, 2015, P NATL ACAD SCI USA, V112, P1721, DOI 10.1073/pnas.1412511112; Botham AD, 2019, J ARCHAEOL SCI-REP, V27, DOI 10.1016/j.jasrep.2019.101939; Brandstatter A, 2007, ANN HUM GENET, V71, P791, DOI 10.1111/j.1469-1809.2007.00371.x; Buikstra J., 1994, STANDARDS DATA COLLE, V44; Burrell JR, 2015, J NEUROL NEUROSUR PS, V86, P1216, DOI 10.1136/jnnp-2013-307483; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cooper C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216483; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P130, DOI 10.1097/PAF.0b013e31828629ca; Eliopoulos C, 2011, AM J FOREN MED PATH, V32, P153, DOI 10.1097/PAF.0b013e3182156405; Etard O, 2000, NEUROREPORT, V11, P617, DOI 10.1097/00001756-200002280-00036; Fraser J Alexander, 2011, Handb Clin Neurol, V102, P205, DOI 10.1016/B978-0-444-52903-9.00014-5; Freud E, 2016, TRENDS COGN SCI, V20, P773, DOI 10.1016/j.tics.2016.08.003; Fridriksson J, 2015, CEREB CORTEX, V25, P4689, DOI 10.1093/cercor/bhu152; Gabilondo I, 2017, MULT SCLER J, V23, P1276, DOI 10.1177/1352458516676642; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Guyomarc'h P, 2010, J FORENSIC SCI, V55, P423, DOI 10.1111/j.1556-4029.2009.01310.x; Hartwigsen G, 2012, J NEUROSCI, V32, P16162, DOI 10.1523/JNEUROSCI.1010-12.2012; Hassett BR, 2018, ARCHAEOLOGIES, V14, P231, DOI 10.1007/s11759-018-9344-z; Kalnoky N, 2020, SZEKLER NATION AND MEDIEVAL HUNGARY: POLITICS, LAW AND IDENTITY ON THE FRONTIER, P1; Kamali A, 2014, MAGN RESON IMAGING, V32, P796, DOI 10.1016/j.mri.2014.04.002; Katayama Y, 1998, ACT NEUR S, V71, P289; Klales A. R., 2018, MORPHOPASSE MORPHOLO; Knusel C., 2013, ROUTLEDGE HDB BIOARC; Kremer C, 2008, J FORENSIC SCI, V53, P716, DOI 10.1111/j.1556-4029.2008.00725.x; Li H, INT J OSTEOARCHAEOL, V31, P99; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Maksimenko VA, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.052405; Martin D.L., 2012, BIOARCHAEOLOGY VIOLE; Masel B.E., 2014, UNDERSTANDING TRAUMA, P8; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; Metzler I, 2011, HISTORY COMPASS, V9, P45, DOI 10.1111/j.1478-0542.2010.00746.x; Metzler Irina, 2006, DISABILITY MEDIEVAL; Miller H, 2020, INT J PALEOPATHOL, V28, P42, DOI 10.1016/j.ijpp.2019.12.008; Molnar Z, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-3; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Murdock G., 2000, CALVINISM FRONTIER 1; Nickels L, 2011, COGN NEUROPSYCHOL, V28, P475, DOI 10.1080/02643294.2012.672406; Oberhuber M, 2016, CEREB CORTEX, V26, P4212, DOI 10.1093/cercor/bhw251; Papahagi A, 2015, LIBR INF HIST, V31, P35, DOI 10.1179/1758348914Z.00000000073; Peng W, 2019, PROG NEURO-PSYCHOPH, V94, DOI 10.1016/j.pnpbp.2019.109676; Pinel P, 2010, J COGNITIVE NEUROSCI, V22, P48, DOI 10.1162/jocn.2009.21184; Pokines J. T., 2014, MANUAL FORENSIC TAPH, P73; Potok W, 2019, CORTEX, V111, P16, DOI 10.1016/j.cortex.2018.10.010; Redfern R. C., 2016, INJURY TRAUMA BIOARC; Rusconi Elena, 2018, Handb Clin Neurol, V151, P395, DOI 10.1016/B978-0-444-63622-5.00020-6; Sakurai Y, 2010, J NEUROL SCI, V288, P25, DOI 10.1016/j.jns.2009.10.015; Scharrer-Liska G, 2015, OPEN ARCHAEOL, V1, P54, DOI 10.1515/opar-2015-0001; Takaya S, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00119; TANAKA H, 1994, ACTA NEUROCHIR, P524; TEASDALE G, 1974, LANCET, V2, P81; Tilley L, 2015, BIOARCHAEOL SOC THEO, P1, DOI 10.1007/978-3-319-18860-7; Tilley L, 2017, NEW DEV BIOARCHAEOLO; Tilley L, 2014, INT J PALEOPATHOL, V6, P5, DOI 10.1016/j.ijpp.2014.01.003; Tornberg A, 2018, INT J OSTEOARCHAEOL, V28, P188, DOI 10.1002/oa.2646; Torres Colon G.A., 2020, PURPOSEFUL PAIN BIOA, P63; Turkeltaub PE, 2011, NEUROLOGY, V76, P1726, DOI 10.1212/WNL.0b013e31821a44c1; Tzourio-Mazoyer N, 2010, J NEUROSCI, V30, P13314, DOI 10.1523/JNEUROSCI.2593-10.2010; Ulguim P, 2018, ARCHAEOLOGIES, V14, P189, DOI 10.1007/s11759-018-9346-x; Vadas Andras, 2018, EC MEDIEVAL HUNGARY; Vespa P, 2017, CURR OPIN NEUROL, V30, P563, DOI 10.1097/WCO.0000000000000506; Vlooswijk MCG, 2010, NEUROLOGY, V75, P395, DOI 10.1212/WNL.0b013e3181ebdd3e; Voas M.R., J ARCHAEOL SCI-REP, V38; Weber J, 2001, AM J PHYS ANTHROPOL, V114, P352, DOI 10.1002/ajpa.1047.abs; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zejdlik K., 2020, ACTA MUSEL NAPOCENSI, V57, P143; Zejdlik K, 2021, INT J OSTEOARCHAEOL, V31, P66, DOI 10.1002/oa.2925	78	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1879-9817	1879-9825		INT J PALEOPATHOL	Int. J. Paleopathol.	SEP	2021	34						122	129		10.1016/j.ijpp.2021.06.006			8	Paleontology; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Paleontology; Pathology	UA2HJ	WOS:000684985000004	34243131				2022-02-06	
J	Bhardwaj, A; Satapathy, GC; Garg, A; Chawla, V; Jangra, K				Bhardwaj, Ajit; Satapathy, Ganesh C.; Garg, Arpit; Chawla, Vikas; Jangra, Kiran			Incidence of Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury in a Tertiary Care ICU: A Retrospective Cohort Study	JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE			English	Article						dysautonomia; frontal lobe contusion; traumatic brain injury; Glasgow Coma Scale	RISK-FACTORS; DYSAUTONOMIA; MARSHALL	Background Paroxysmal sympathetic hyperactivity (PSH ) is an understudied complication of traumatic brain injury (TBI). PSH usually presents with transient rise in sympathetic outflow, leading to increased blood pressure, heart rate, temperature, respiratory rate, sweating, and posturing activity. We retrospectively analyzed the incidence of PSH in TBI using PSH-assessment measure (PSH-AM) scale. Methods This single-center retrospective cohort study was conducted in traumatic head injury patients admitted in the intensive care unit from January 1, 2016 to December 31, 2019 in a tertiary care center. The data was collected from the hospital database after obtaining approval from the hospital ethics committee. Results A total of 287 patients (18-65 years of age) were admitted to intensive care unit (ICU) with TBI out of which 227 patients were analyzed who had ICU stay for more than 14 days. PSH was diagnosed in 70 (30.8%) patients. Mean age of PSH positive patients was 40 +/- 18 and 49 +/- 11 years for PSH negative patients ( p < 0.001). The age group between 40 and 50 years had a higher incidence of PSH. The age and Glasgow coma score (GCS) were significantly associated with the occurrence of PSH. The GCS score demonstrated good accuracy for predicting the occurrence of PSH with AUC 0.83, 95% CI of 0.775 to 0.886, and a p -value of 0.001. Conclusion We observed that the incidence of PSH was 30.8% in the patients with TBI. Age and GCS were found to have a significant association for predicting the occurrence of PSH. The patients who developed PSH had a longer length of hospital stay in ICU.	[Bhardwaj, Ajit; Satapathy, Ganesh C.; Garg, Arpit; Chawla, Vikas] Crit Care Command Hosp, Dept Anaesthesia, Carriapa Rd, Lucknow 226002, Uttar Pradesh, India; [Jangra, Kiran] Post Grad Inst Med Educ & Res, Dept Anesthesia & Intens Care, Chandigarh, India		Bhardwaj, A (corresponding author), Crit Care Command Hosp, Dept Anaesthesia, Carriapa Rd, Lucknow 226002, Uttar Pradesh, India.	rainaajit@gmail.com		Jangra, Kiran/0000-0001-6932-8272			Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Fernandez-Ortega JF, 2011, J NEUROTRAUM, V28, P1327, DOI 10.1089/neu.2010.1722; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; McCorry LK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710478; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; TEASDALE G, 1974, LANCET, V2, P81; Thomas A, 2019, AM J PHYS MED REHAB, V98, P65, DOI 10.1097/PHM.0000000000000990; Totikov A, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1399-y; Verma R, 2015, INDIAN J CRIT CARE M, V19, P34, DOI 10.4103/0972-5229.148638	31	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2348-0548	2348-926X		J NEUROANAESTH CRIT	J. Neuroanaesthesiol. Crit. Care	SEP	2021	08	03					187	191		10.1055/s-0040-1721553			5	Anesthesiology; Critical Care Medicine; Clinical Neurology	Emerging Sources Citation Index (ESCI)	Anesthesiology; General & Internal Medicine; Neurosciences & Neurology	XH1LT	WOS:000725203700005		gold			2022-02-06	
J	Bloom, DA; Whitney, DC; Gonzalez-Lomas, G; Carter, CW				Bloom, David A.; Whitney, Darryl C.; Gonzalez-Lomas, Guillem; Carter, Cordelia W.			The Incidence of Concussion and Symptom Non-Reporting Among Professional Women's Ice Hockey Players	BULLETIN OF THE HOSPITAL FOR JOINT DISEASES			English	Article							HIGH-SCHOOL; INJURY; EPIDEMIOLOGY; EDUCATION; STRENGTH; GAMES; RATES; RISK; HEAD	Background: Female ice hockey players have rates of sports-related concussion that are similar to male participants at various levels of play, despite differences in the rules that do not allow for body checking in the women's game. At the elite level, there are limited data regarding concussion rates and concussion symptom reporting. Therefore, it was hypothesized that there would be a high incidence of concussion and concussion symptom-reporting in professional women's ice hockey players. Methods: A survey was given to 54 players in the National Women's Hockey League at the end of the 2018-2019 season. Players reported on the number of concussions diagnosed by a physician throughout their careers, the number of times they have had concussion symptoms, if they had ever continued playing after experiencing concussion symptoms, and if they had ever failed to report concussion symptoms to a medical professional or coach. Results: Fifty-four players completed the survey. Thirty-one (57%) respondents reported at least one concussion diagnosed during their playing career, with 16 (30%) reporting two or more diagnosed concussions. Thirty-six (67%) players reported experiencing concussion symptoms at least once, with 26 (48%) reporting two or more occurrences of such symptoms. Of the 36 players who had experienced symptoms of concussion, 25 (69%) reported that they continued playing at least once after experiencing concussion symptoms. Seventeen players (36%) reported that they did not initially tell anyone about their concussion symptoms on at least one occasion, while seven players (19%) never disclosed their symptoms. Conclusion: There is a high incidence of sport-related concussions reported in women's professional ice hockey players as well as an alarming rate of symptom non-reporting. Clinical Relevance: This study provides new data on rates of concussion and symptom non-reporting among female professional ice hockey players and will aid clinicians in decision making when caring for these athletes.	[Bloom, David A.; Whitney, Darryl C.; Gonzalez-Lomas, Guillem; Carter, Cordelia W.] NYU Langone Hlth, NYU Langone Orthoped Hosp, Dept Orthoped Surg, 301 East 17th St, New York, NY 10003 USA		Bloom, DA (corresponding author), NYU Langone Hlth, NYU Langone Orthoped Hosp, Dept Orthoped Surg, 301 East 17th St, New York, NY 10003 USA.	david.bloom@nyulangone.org					Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Agel J, 2007, J ATHL TRAINING, V42, P249; [Anonymous], 2018, IIHF RUL BOOK 2018 2, P168; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Piana LE, 2020, PHYSICIAN SPORTSMED, V48, P46, DOI 10.1080/00913847.2019.1624657; Rawlins MLW, 2020, MIL MED, V185, pE269, DOI 10.1093/milmed/usz162; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	34	0	0	0	0	J MICHAEL RYAN PUBLISHING INC	BYRAM TOWNSHIP	24 CRESCENT DR N, BYRAM TOWNSHIP, NJ 07821 USA	2328-4633	2328-5273		BULL HOSP JT DIS	Bull. Hosp. Jt. Dis.	SEP	2021	79	3					158	162					5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	WC9TP	WOS:000704592900002	34605752				2022-02-06	
J	Brown, AR; Martinez, M				Brown, Andrew R.; Martinez, Marina			Chronic inactivation of the contralesional hindlimb motor cortex after thoracic spinal cord hemisection impedes locomotor recovery in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Hemisection; Rat; Inactivation; Functional recovery; Hindlimb; Locomotion; Motor cortex; Motor map; Intracortical microstimulation	TRAUMATIC BRAIN-INJURY; CENTRAL PATTERN GENERATOR; ELECTRICAL-STIMULATION; PLASTICITY; CAT; FORELIMB; NETWORKS; NEURONS; SYSTEM; REORGANIZATION	After incomplete spinal cord injury (SCI), cortical plasticity is involved in hindlimb locomotor recovery. Nevertheless, whether cortical activity is required for motor map plasticity and recovery remains unresolved. Here, we combined a unilateral thoracic spinal cord injury (SCI) with a cortical inactivation protocol that uncovered a functional role of contralesional cortical activity in hindlimb recovery and ipsilesional map plasticity. In adult rats, left hindlimb paralysis was induced by sectioning half of the spinal cord at the thoracic level (hemisection) and we used a continuous infusion of muscimol (GABAA agonist, 10 mM, 0.11 mu l/h) delivered via implanted osmotic pump (n = 9) to chronically inactivate the contralesional hindlimb motor cortex. Hemisected rats with saline infusion served as a SCI control group (n = 8), and intact rats with muscimol infusion served as an inactivation control group (n = 6). Locomotion was assessed in an open field, on a horizontal ladder, and on a treadmill prior to and for three weeks after hemisection. Cortical inactivation after hemisection significantly impeded hindlimb locomotor recovery in all tasks and specifically disrupted the ability of rats to generate proper flexion of the affected hindlimb during stepping compared to SCI controls, with no significant effect of inactivation in intact rats. Chronic and acute (n = 4) cortical inactivation after hemisection also significantly reduced the representation of the affected hindlimb in the ipsilesional motor cortex derived with intracortical microsimulation (ICMS). Our results provide evidence that residual activity in the contralesional hindlimb motor cortex after thoracic hemisection contributes to spontaneous locomotor recovery and map plasticity.	[Brown, Andrew R.; Martinez, Marina] Univ Montreal, Dept Neurosci, Grp Rech Syst Nerveux Cent GRSNC, Montreal, PQ, Canada; [Brown, Andrew R.; Martinez, Marina] Univ Montreal, Ctr Interdisciplinaire Rech Cerveau Serv Apprenti, Montreal, PQ, Canada; [Brown, Andrew R.; Martinez, Marina] CIUSSS Nord de Ile de Montreal, Montreal, PQ, Canada		Martinez, M (corresponding author), Univ Montreal, Dept Neurosci, 2960,Chemin Tour,Pavillon PG Desmarais, Montreal, PQ H3T 1J4, Canada.	marina.martinez@umontreal.ca		Brown, Andrew/0000-0002-2305-9115; Martinez, Marina/0000-0002-3294-3017	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-142288]; FRQS; Tomas Reader award	This work was supported by an operating grant from the Canadian Institutes for Health Research (CIHR; MOP-142288) to MM. MM was supported by a salary award from Fonds de Recherche Quebec Sante (FRQS). ARB was supported by a fellowship from FRQS and a Tomas Reader award. We thank Yassine Bensaada, Aurelie Flaive, and Maude Duguay for participation in animal handling and data acquisition; Serge Rossignol and Marco Bonizzato for discussion on the manuscript; Numa Dancause, Philippe Drapeau, and Hugo Delivet-Mongrain for technical assistance.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Alluin O, 2011, J NEUROTRAUM, V28, P1963, DOI 10.1089/neu.2011.1840; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Alstermark B, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00103; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Barriere G, 2010, J NEUROPHYSIOL, V104, P1119, DOI 10.1152/jn.00255.2010; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bonizzato M, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abb4422; Bretzner F, 2005, J NEUROPHYSIOL, V94, P657, DOI 10.1152/jn.01245.2004; Brooks VB, 1981, HDB PHYSL 1, P1179, DOI DOI 10.1002/CPHY.CP010226; Brown AR, 2019, JOVE-J VIS EXP, DOI 10.3791/59738; Brown AR, 2018, J NEUROSCI, V38, P9977, DOI 10.1523/JNEUROSCI.1062-18.2018; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; Carmel JB, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00051; Carmel JB, 2014, J NEUROSCI, V34, P462, DOI 10.1523/JNEUROSCI.3315-13.2014; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; DiGiovanna J, 2016, J NEUROSCI, V36, P10440, DOI 10.1523/JNEUROSCI.4343-15.2016; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; ENGLISH AW, 1980, J NEUROPHYSIOL, V44, P270, DOI 10.1152/jn.1980.44.2.270; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Filli L, 2014, J NEUROSCI, V34, P13399, DOI 10.1523/JNEUROSCI.0701-14.2014; Filli L, 2011, BRAIN, V134, P2261, DOI 10.1093/brain/awr167; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Frigon A, 2008, J PHYSIOL-LONDON, V586, P2927, DOI 10.1113/jphysiol.2008.152488; Frost SB, 2015, J NEUROTRAUM, V32, P1666, DOI 10.1089/neu.2015.3961; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Giszter S, 2008, J NEUROPHYSIOL, V100, P839, DOI 10.1152/jn.00866.2007; Gossard JP, 2015, J NEUROSCI, V35, P9446, DOI 10.1523/JNEUROSCI.4502-14.2015; GRILLNER S, 1975, PHYSIOL REV, V55, P247, DOI 10.1104/pp.55.2.247; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; HICKS SP, 1975, AM J ANAT, V143, P1, DOI 10.1002/aja.1001430102; Hillen BK, 2015, J NEUROPHYSIOL, V113, P2666, DOI 10.1152/jn.00507.2014; Hillen BK, 2013, ANN NY ACAD SCI, V1279, P164, DOI 10.1111/nyas.12061; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jiang YQ, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113015; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; Leszczynska AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143602; Lundell H, 2011, NEUROIMAGE, V54, P1254, DOI 10.1016/j.neuroimage.2010.09.009; Manohar A, 2017, ELIFE, V6, DOI 10.7554/eLife.23532; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; Martinez M, 2012, J NEUROPHYSIOL, V108, P124, DOI 10.1152/jn.00073.2012; Martinez M, 2011, J NEUROPHYSIOL, V106, P1969, DOI 10.1152/jn.00368.2011; Martinez M, 2010, EXP NEUROL, V221, P186, DOI 10.1016/j.expneurol.2009.10.022; Martinez M, 2009, J NEUROTRAUM, V26, P1043, DOI 10.1089/neu.2008.0717; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; McCrea DA, 2001, J PHYSIOL-LONDON, V533, P41, DOI 10.1111/j.1469-7793.2001.0041b.x; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Mitchell EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152094; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Nardone R, 2013, NEUROSCI LETT, V552, P21, DOI 10.1016/j.neulet.2013.07.011; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NEWMAN DB, 1989, BRAIN BEHAV EVOLUT, V34, P223, DOI 10.1159/000116508; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Oza CS, 2015, J NEUROSCI, V35, P7174, DOI 10.1523/JNEUROSCI.4366-14.2015; Oza CS, 2014, EXP NEUROL, V256, P57, DOI 10.1016/j.expneurol.2014.03.012; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Philippson M, 1905, AUTONOMIE CENTRALISA; Roelcke U, 1997, J NEUROL NEUROSUR PS, V62, P61, DOI 10.1136/jnnp.62.1.61; Rossignol S, 2009, PHYSIOLOGY, V24, P127, DOI 10.1152/physiol.00042.2008; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnell L, 2011, EUR J NEUROSCI, V34, P1256, DOI 10.1111/j.1460-9568.2011.07862.x; Shah PK, 2013, BRAIN, V136, P3362, DOI 10.1093/brain/awt265; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Teskey GC, 2002, CEREB CORTEX, V12, P98, DOI 10.1093/cercor/12.1.98; Touvykine B, 2020, J NEUROPHYSIOL, V123, P1355, DOI 10.1152/jn.00591.2019; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Vichaya EG, 2009, BRAIN BEHAV IMMUN, V23, P969, DOI 10.1016/j.bbi.2009.05.001; Wen TC, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00028; Yang Q, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112962; Young NA, 2011, J NEUROSCI METH, V196, P60, DOI 10.1016/j.jneumeth.2010.12.028; Zareen N, 2017, EXP NEUROL, V297, P179, DOI 10.1016/j.expneurol.2017.08.004; Zhang N, 2012, INDIAN J MED RES, V135, P287; Zorner B, 2014, BRAIN, V137, P1716, DOI 10.1093/brain/awu078; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	91	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2021	343								113775	10.1016/j.expneurol.2021.113775			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TP4JR	WOS:000677561400006	34081986	hybrid			2022-02-06	
J	Buttner, F; Howell, DR; Doherty, C; Blake, C; Ryan, J; Delahunt, E				Buttner, Fionn; Howell, David R.; Doherty, Cailbhe; Blake, Catherine; Ryan, John; Delahunt, Eamonn			Condition-specific health-related quality of life amongst amateur athletes six months and one-year following sport-related concussion: A prospective, follow-up	PHYSICAL THERAPY IN SPORT			English	Article						Sport; Athletes; Outcomes assessment; Quality of life; Traumatic brain injury; Prospective cohort study	CLINICAL-OUTCOMES ASSESSMENT; 1ST YEAR; POSTCONCUSSION SYMPTOMS; RECOVERY; PREDICTORS; INJURY; HEADACHE; ANXIETY; PROFILE; IMPACT	Objective: To prospectively investigate the condition-specific health-related quality of life (HRQoL) of athletes six months and one-year following sport-related concussion. Design: Prospective, longitudinal study. Setting: Clinical research centre at university school of public health. Participants: Amateur athletes who were diagnosed with sport-related concussion within one-week after presenting to a hospital emergency department were recruited along with sex-, age-, and activity-matched, non-concussed, control athletes. Concussion and control participants were assessed six months and one-year following sport-related concussion and study enrolment, respectively. Main outcome measures: Participants completed the Post-Concussion Symptom Scale and five condition specific HRQoL patient-reported outcome measures Headache Impact Test-6, Fatigue Severity Scale, Neck Disability Index, Generalised Anxiety Disorder-7, and Dizziness Handicap Inventory. We performed Frequentist and Bayesian mixed-design analyses of variance to compare the concussion group and control group at both assessments and quantify whether there was greater evidence in favour of the null hypothesis compared with the alternative hypothesis. Results: At six-month and one-year assessments, the concussion group (n = 47; male = 72%; mean (SD) age = 22.68 (5.07)) and the control group (n = 47; male = 72%; mean (SD) age = 23.81 (4.60)) reported similar clinical symptom severity scores and condition-specific HRQoL. The proportion of athletes in the concussion group with clinically-impaired scores was similar to the proportion of non-concussed athletes with clinically-impaired scores. At six-month and one-year assessments, there was moderate-to very strong evidence that there was no difference between concussion and control participants' perceptions of the effects of headache, fatigue, neck pain, anxiety, and dizziness on HRQoL. Conclusion: There was moderate-to-very strong evidence in favour of no difference between the concussion and control groups on symptom severity scores and condition-specific HRQoL patient reported outcome measures at six-month and one-year assessments. These results suggest that condition-specific HRQoL returns to the levels of non-concussed individuals within six months following sport-related concussion. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Buttner, Fionn; Doherty, Cailbhe; Blake, Catherine; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Ryan, John] St Vincents Univ Hosp, Emergency Dept, Elm Pk, Dublin 4, Ireland; [Doherty, Cailbhe; Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin, Ireland; Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Buttner, F (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland.	fionn.cleirigh-buttner@ucdconnect.ie; david.howell@cuanschutz.edu; cailbhe.doherty@ucd.ie; c.blake@ucd.ie; j.ryan@svuh.ie; eamonn.delahunt@ucd.ie	; Blake, Catherine/M-6728-2016	Doherty, Cailbhe/0000-0002-5284-856X; Blake, Catherine/0000-0002-0600-629X	Government of Ireland Postgraduate Research Scholarship [GOIPG/2016/87]; Irish Research CouncilIrish Research Council for Science, Engineering and Technology	Fionn Buttner acknowledges research funding from a Government of Ireland Postgraduate Research Scholarship (Award ID: GOIPG/2016/87) awarded by the Irish Research Council.	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Buttner F, 2020, J ORTHOP SPORT PHYS, V50, DOI 10.2519/jospt.2020.9485; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cover R, 2018, J ATHL TRAINING, V53, P646, DOI 10.4085/1062-6050-338-17; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jamil T, 2017, BEHAV RES METHODS, V49, P638, DOI 10.3758/s13428-016-0739-8; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lakens D, 2020, J GERONTOL B-PSYCHOL, V75, P45, DOI 10.1093/geronb/gby065; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2019, AM J SPORT MED, V47, P3514, DOI 10.1177/0363546519880175; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; McLeod TV, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000394; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Quintana DS, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1761-4; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wagenmakers E.- J., 2017, PSYCHOL SCI SCRUTINY, P123, DOI [10.1002/9781119095910.ch8, DOI 10.1002/9781119095910.CH8]; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Weber ML, 2019, ANN BIOMED ENG, V47, P2136, DOI 10.1007/s10439-018-02151-7; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	50	0	0	2	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	SEP	2021	51						71	78		10.1016/j.ptsp.2021.06.011			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UL6XT	WOS:000692792500011	34273667	hybrid			2022-02-06	
J	Cairncross, M; Debert, CT; Hunt, C; Bayley, MT; Comper, P; Chandra, T; Silverberg, ND				Cairncross, Molly; Debert, Chantel T.; Hunt, Cindy; Bayley, Mark T.; Comper, Paul; Chandra, Tharshini; Silverberg, Noah D.			Normative Data for the Fear Avoidance Behavior After Traumatic Brain Injury Questionnaire in a Clinical Sample of Adults With Mild TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						avoidance learning; brain concussion; traumatic brain injuries; postconcussion syndrome; surveys and questionnaires	CHRONIC MUSCULOSKELETAL PAIN; CONCUSSION; RECOVERY; SYMPTOMS; MODEL	Objective: Fear avoidance behavior after a concussion or mild traumatic brain injury (mTBI) is associated with a number of adverse outcomes, such as higher symptom burden, emotional distress, and disability. The Fear Avoidance Behavior after Traumatic Brain Injury Questionnaire (FAB-TBI) is a recently developed and validated self-report measure of fear avoidance after mTBI. The objective of this study was to derive clinical normative data for the FAB-TBI. To determine whether demographic stratification was necessary and to further support clinical interpretation, we also explored associations between fear avoidance behavior and demographic and injury variables. Setting: Five concussion clinics in Canada. Participants: Adults who sustained an mTBI (N = 563). Design: Cross-sectional. Main Measures: Participants completed the Fear Avoidance Behavior after Traumatic Brain Injury Questionnaire (FAB-TBI) and measures of postconcussion symptom burden (Rivermead Postconcussion Symptoms Questionnaire, Sport Concussion Assessment Tool-5) at clinic intake. Results: Generalized linear modeling revealed that females reported more fear avoidance than males (95% CI = 0.66 to 2.75), indicating that FAB-TBI normative data should be stratified by sex. Differences between recruitment sites on FAB-TBI scores were reduced but not eliminated by controlling for potential confounds. Loss of consciousness (95% CI =0.61 to 2.76) and higher postconcussion symptom burden (95% CI = 0.79 to 1.03) were also associated with higher FAB-TBI scores, but time since injury was not (95% = CI -0.4 to 0.03). Tables to convert FAB-TBI raw scores to Rasch scores to percentiles are presented. Conclusion: These findings support clinical interpretation of the FAB-TBI and further study of fear avoidance after mTBI.	[Cairncross, Molly; Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Cairncross, Molly; Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Debert, Chantel T.] Univ Calgary, Hotchkiss Brain Inst, Div Phys Med & Rehabil, Dept Clin Neurosci, Calgary, AB, Canada; [Debert, Chantel T.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Hunt, Cindy] St Michaels Hosp, Head Injury Clin, Trauma & Neurosurg Program, Toronto, ON, Canada; [Bayley, Mark T.; Comper, Paul; Chandra, Tharshini] Univ Hlth Network, KITE Res Inst, Toronto Rehabil Inst, Hull Ellis Concuss & Res Clin, Toronto, ON, Canada; [Bayley, Mark T.] Univ Toronto, Fac Med, Div Phys Med & Rehabil, Toronto, ON, Canada; [Comper, Paul] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Silverberg, ND (corresponding author), GF Strong Rehabil Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	molly.cairncross@ubc.ca; Chantel.Debert@albertahealthservices.ca; Cindy.Hunt@unityhealth.to; mark.bayley@uhn.ca; paul.comper@uhn.ca; Tharshini.chandra@uhn.ca; noah.silverberg@ubc.ca			VGH+UBC Hospital Foundation; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Ontario Brain Institute - Government of Ontario; Toronto Rehab Institute Foundation	The VGH+UBC Hospital Foundation contributed operating funds for the present study. N.D.S. received research salary supported from the Michael Smith Foundation for Health Research. The St Michael's Hospital Head Injury Clinic (Unity Health) is in the Concussion Ontario Network: Neuro-informatics to Enhance Clinical-care and Translation (CONNECT) network and received support from the Ontario Brain Institute, funded in part by theGovernment of Ontario. TheHull-Ellis Concussion and Research Clinic receives operating funding from the Toronto Rehab Institute Foundation.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Chrisman SPD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00623; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Schoene D, 2019, CLIN INTERV AGING, V14, P701, DOI 10.2147/CIA.S197857; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Sturgeon JA, 2014, PSYCHOL RES BEHAV MA, V7, P115, DOI 10.2147/PRBM.S44762; Tarkenton T, 2019, ARCH CLIN NEUROPSYCH, V34, P843, DOI 10.1093/arclin/acz035.11; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Wijenberg MLM, 2020, J NEUROTRAUM, V37, P2639, DOI 10.1089/neu.2020.7135; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551	23	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E355	E362		10.1097/HTR.0000000000000669			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300014	33741828	hybrid			2022-02-06	
J	Cancelliere, C; Boyle, E; Cote, P; Holm, LW; Salmi, LR; Cassidy, JD				Cancelliere, Carol; Boyle, Eleanor; Cote, Pierre; Holm, Lena W.; Salmi, Louis-Rachid; Cassidy, J. David			Predicting nonrecovery in adults with incident traffic injuries including post-traumatic headache	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Accidents traffic; Post-traumatic headache; Prognosis; Recovery of function	WHIPLASH-ASSOCIATED DISORDERS; TRAUMATIC BRAIN-INJURY; LOW-BACK-PAIN; CLINICAL-PRACTICE GUIDELINES; 2000-2010 TASK-FORCE; NECK PAIN; PROGNOSTIC-FACTORS; PSYCHOLOGICAL-FACTORS; STRESS-DISORDER; FEAR-AVOIDANCE	Importance: The management of traffic injuries is challenging for clinicians. Knowledge about predictors of nonrecovery from traffic injuries may help to improve patient care. Objective: To develop a prediction model for self-reported overall nonrecovery from traffic injuries six months post-collision in adults with incident traffic injuries including post-traumatic headache (PTH). Design: Inception cohort studies of adults with incident traffic injuries (including PTH) injured in traffic collisions between November 1997 and December 1999 in Saskatchewan, Canada; and between January 2004 and January 2005 in Sweden. Methods: Prediction model development and geographical external validation. Setting: The Saskatchewan cohort (development) was population-based (N = 4,162). The Swedish cohort (vali-dation) (N = 379) were claimants from two insurance companies covering 20% of cars driven in Sweden in 2004. Participants: All adults injured in traffic collisions who completed a baseline questionnaire within 30 days of collision. Excluded were those hospitalized > 2 days, lost consciousness > 30 min, or reported headache < 3/10 on the numerical rating scale. Follow-up rates for both cohorts were approximately 80%. Predictors: Baseline sociodemographic, pre-injury, and injury factors. Outcome: Self-reported nonrecovery from all injuries (not "all better (cured)" on the self-perceived recovery scale) six months after traffic collision. Results: Both cohorts were predominantly female (69.8% in Saskatchewan, 65.2% in Sweden), with median ages 35.9 years (Saskatchewan), and 38.0 years (Sweden). Predictors were age, low back pain, symptoms in arms or hands, hearing problems, sleeping problems, pre-existing headache, and lower recovery expecta-tions. With a positive score (i.e., >= 0.85 probability), the model can rule in the presence of self-reported nonrecovery from all injuries at six months (development: specificity = 91.3%, 95% CI 89.2%-93.0%; sensitivity = 27.8%, 95% CI 26.0%-29.7%; positive likelihood ratio (LR + ) = 3.2, 95% CI 2.5-4.0; negative likelihood ratio (LR-) = 0.79, 95% CI 0.76-0.82; validation: specificity = 72.6%, 95% CI 61.4%- 81.5%; sensitivity = 60.5%, 95% CI 53.9%-66.7%); LR+ = 2.2, 95% CI 1.5-3.3; LR-= 0.5, 95% CI 0.4-0.7). Conclusions and relevance: In adults with incident traffic injuries including PTH, predictors other than those related to baseline head and neck pain drive overall nonrecovery. Developing and testing interventions targeted at the modifiable predictors may help to improve outcomes for adults after traffic collision.	[Cancelliere, Carol; Cote, Pierre; Salmi, Louis-Rachid] Ontario Tech Univ, Fac Hlth Sci, 2000 Simcoe St North,Sci Bldg,Room 3000, Oshawa, ON L1H 7K4, Canada; [Cancelliere, Carol; Cote, Pierre] Ontario Tech Univ, Ctr Disabil Prevent & Rehabil, Toronto, ON, Canada; [Cancelliere, Carol; Cote, Pierre] Canadian Mem Chiropract Coll, Toronto, ON, Canada; [Boyle, Eleanor] Univ Southern Denmark, Fac Hlth Sci, Dept Sport Sci & Clin Biomech, Odense, Denmark; [Cote, Pierre; Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Cote, Pierre] Canadian Mem Chiropract Coll, Div Res & Innovat, Toronto, ON, Canada; [Cote, Pierre] Ontario Tech Univ, Canadian Mem Chiropract Coll CMCC, Canada Res Chair Disabil Prevent & Rehabil, Toronto, ON, Canada; [Holm, Lena W.] Karolinska Inst, Inst Environm Med, Musculoskeletal & Sports Injury Epidemiol Ctr, Stockholm, Sweden; [Salmi, Louis-Rachid] Univ Bordeaux, Bordeaux Sch Publ Hlth, ISPED, F-33000 Bordeaux, France; [Salmi, Louis-Rachid] Ctr INSERM U1219 Bordeaux Populat Hlth, F-33000 Bordeaux, France; [Salmi, Louis-Rachid] CHU Bordeaux, Pole Sante Publ, Serv Informat Med, F-33000 Bordeaux, France		Cancelliere, C (corresponding author), Ontario Tech Univ, Fac Hlth Sci, 2000 Simcoe St North,Sci Bldg,Room 3000, Oshawa, ON L1H 7K4, Canada.	carolina.cancelliere@ontariotechu.ca	Boyle, Eleanor/G-4567-2016	Boyle, Eleanor/0000-0002-9012-9128	Canadian Institutes of Health Research Doctoral AwardCanadian Institutes of Health Research (CIHR)	CC was funded by a Canadian Institutes of Health Research Doctoral Award (2013-2015). The authors declare no conflicts of interest. CC completed the first draft, all analyses, results and interpretation. EB, PC, LWH, LRS, and JDC contributed to all analyses, results and interpretation. JDC conceived of the study. All authors approved the final manuscript.	Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; BLINCOE L, 2002, EC IMPACT MOTOR VEHI; Bohman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-264; Buse DC, 2013, HEADACHE, V53, P1278, DOI 10.1111/head.12150; Cancelliere C, 2020, ACCIDENT ANAL PREV, V142, DOI 10.1016/j.aap.2020.105580; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Carroll LJ, 2012, DISABIL REHABIL, V34, P45, DOI 10.3109/09638288.2011.587085; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Carroll LJ, 2009, J RHEUMATOL, V36, P1063, DOI 10.3899/jrheum.080680; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2007, SPINE, V32, P126, DOI 10.1097/01.brs.0000249526.76788.e8; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Cote P, 2015, ENABLING RECOVERY CO; Cote P, 2007, ARTHRIT RHEUM-ARTHR, V57, P861, DOI 10.1002/art.22775; Cote P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-021283; Crutebo S, 2010, J RHEUMATOL, V37, P1527, DOI 10.3899/jrheum.091321; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; Fejer R, 2005, PAIN, V119, P176, DOI 10.1016/j.pain.2005.09.033; Ferrari R, 2005, ANN RHEUM DIS, V64, P1337, DOI 10.1136/ard.2004.034447; GREMBOWSKI D, 1993, J HEALTH SOC BEHAV, V34, P89, DOI 10.2307/2137237; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hartling L, 2002, ACCIDENT ANAL PREV, V34, P531, DOI 10.1016/S0001-4575(01)00051-3; Hassani-Mahmooei B, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1386-6; Hincapie CA, 2010, J OCCUP ENVIRON MED, V52, P434, DOI 10.1097/JOM.0b013e3181bb806d; Ho KKN, 2019, OSTEOARTHR CARTILAGE, V27, P196, DOI 10.1016/j.joca.2018.09.014; Holm LW, 2008, PLOS MED, V5, P760, DOI 10.1371/journal.pmed.0050105; Holm LW, 2008, SPINE, V33, pS52, DOI 10.1097/BRS.0b013e3181643ece; Hosmer Jr D.W., 2004, APPL LOGISTIC REGRES; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Jensen MP, 2001, PAIN, V91, P317, DOI 10.1016/S0304-3959(00)00459-0; Johansson MS, 2015, EUR J PAIN, V19, P1486, DOI 10.1002/ejp.681; KEEFE FJ, 1992, PAIN, V51, P131, DOI 10.1016/0304-3959(92)90253-8; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lantz PM, 2001, SOC SCI MED, V53, P29, DOI 10.1016/S0277-9536(00)00319-1; Leonardi Matilde, 2005, J Headache Pain, V6, P429, DOI 10.1007/s10194-005-0252-4; Leung L, 2012, INDIAN J PSYCHOL MED, V34, P204, DOI 10.4103/0253-7176.106012; Mann M, 2004, HEALTH EDUC RES, V19, P357, DOI 10.1093/her/cyg041; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Motor Accidents Authority, 2015, MOT ACC AUTH ANN REP; Nash JM, 2006, HEADACHE, V46, P1377, DOI 10.1111/j.1526-4610.2006.00580.x; Naumann RB, 2010, TRAFFIC INJ PREV, V11, P353, DOI 10.1080/15389588.2010.486429; Nederhand MJ, 2004, ARCH PHYS MED REHAB, V85, P496, DOI 10.1016/j.apmr.2003.06.019; Ngo T, 2010, EUR SPINE J, V19, P957, DOI 10.1007/s00586-010-1289-x; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; SCHELP L, 1990, PUBLIC HEALTH, V104, P55, DOI 10.1016/S0033-3506(05)80346-4; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Seeman TE, 2001, ANN NY ACAD SCI, V954, P88; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Statistics Canada,, ANN DEM EST CAN PROV; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Steyerberg E. W., 2009, CLIN PREDICTION MODE, DOI [10.1007/978-0-387-77244-8, 10. 1007/978-0-387-77244-8., DOI 10.1007/978-0-387-77244-8]; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sullivan MJL, 2011, SPINE, V36, pS244, DOI 10.1097/BRS.0b013e3182387fed; Sutton DA, 2016, SPINE J, V16, P1541, DOI 10.1016/j.spinee.2014.06.019; Traeger AC, 2015, JAMA INTERN MED, V175, P733, DOI 10.1001/jamainternmed.2015.0217; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Watson M, 2005, EUR J CANCER, V41, P1710, DOI 10.1016/j.ejca.2005.01.012; Williams M, 2007, SPINE, V32, pE764, DOI 10.1097/BRS.0b013e31815b6565; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035; Wong JJ, 2017, EUR J PAIN, V21, P201, DOI 10.1002/ejp.931; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204; Zelman DC, 2003, PAIN, V106, P35, DOI 10.1016/S0304-3959(03)00274-4	78	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2021	159								106265	10.1016/j.aap.2021.106265			10	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	UK2VA	WOS:000691831500003	34182320				2022-02-06	
J	Caze, T; Vasquez, D; Moffatt, K; Waple, K; Hope, D				Caze, Todd; Vasquez, Desi; Moffatt, Kody; Waple, Kerry; Hope, Debra			A Prospective Pilot Study of Anxiety Sensitivity and Adolescent Sports-Related Concussion	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Adolescent health; Brain injuries; Psychological assessment; Psychosocial outcomes	PANIC-ATTACKS; BRAIN; SYMPTOMS; PATHOGENESIS; CHILDREN; INJURY	Objective: This study examined the relationship of that anxiety sensitivity (AS) with the initial and ongoing symptoms reported by adolescents after sustaining a sports-related concussion (SRC). Method: Participants were 40 adolescents, ages 13-18, presenting for treatment at a children's sports medicine specialty clinic following a diagnosis of either an SRC or a musculoskeletal injury. After the initial clinic intake, participants completed an online survey at three-time points. Survey measures included the self-report graded symptom checklist and the AS Index-3. Researchers used growth curve analysis to examine the relationship between AS Index-3 scores with initial and ongoing symptom reporting over time. The 20 participants sustaining an SRC were matched by age, gender, and race with 20 musculoskeletal injury controls. Results: Concussed adolescents with higher AS scores reported more initial symptoms than did those reporting musculoskeletal injury. AS was not related to the rate of symptom reduction over time for either group. Conclusion: Higher AS moderated the relationship between injury type (concussion vs. musculoskeletal injury) and the total number of initial symptoms reported by adolescent participants, with every unit increase in AS yielding a four-unit increase in initial symptoms reporting. Previous research has shown that elevated initial symptom scores are a strong predictor of protracted recovery in concussion. AS is amenable to brief treatment interventions. It is a potential early target for treatment intervention following diagnosis of adolescent SRC.	[Caze, Todd] Univ Texas Southwestern Med Ctr Dallas, Childrens Hlth Andrews Inst Orthoped & Sports Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Vasquez, Desi] Texas A&M Int Univ, Dept Psychol, Laredo, TX USA; [Moffatt, Kody] Creighton Univ, Sch Med, Childrens Hosp & Med Ctr, Omaha, NE USA; [Waple, Kerry] Childrens Hosp & Med Ctr, Dept Pediat, Omaha, NE USA; [Hope, Debra] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA		Caze, T (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Hlth Andrews Inst Orthoped & Sports Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	todd.caze@gmail.com; Desi.Vasquez@tamiu.edu; kmoffatt@childrensomaha.org; kwaple@childrensomaha.org; dhope1@unl.edu	Vasquez, D.A./AAQ-4311-2020	Vasquez, D.A./0000-0002-9701-3814			Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Arnett P.A., 2019, NEUROPSYCHOLOGY SPOR, DOI DOI 10.1037/0000114-004; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Caze T., 2017, BIG 10 IV LEAG TBI S; Caze T, 2016, BIG 10 IV LEAG TBI S; Caze T.J., 2019, 2019 INT NEUR SOC AN; Caze T.J., 2018, 6 ANN BIG 10 CIC IV; Centers for Disease Control and Prevention, 2017, HEADS; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DONNELL CD, 1990, BEHAV RES THER, V28, P83, DOI 10.1016/0005-7967(90)90058-Q; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossner E. C., 2019, NEUROPSYCHOLOGY SPOR, P71; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Guillot CR, 2015, ADDICT BEHAV, V40, P39, DOI 10.1016/j.addbeh.2014.08.004; Harrington PJ, 1996, AM J PSYCHIAT, V153, P823; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Killgore WDS, 2011, DEPRESS ANXIETY, V28, P243, DOI 10.1002/da.20788; Kontos A. P., 2018, CONCUSSION CLIN PROF; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrea M, 2018, BIG 10 IV LEAG TBI S; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Menon V., 2015, BRAIN MAPPING, V2, P597, DOI 10.1016/B978-0-12-397025-1.00052-X; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Plehn K, 2002, J ANXIETY DISORD, V16, P455, DOI 10.1016/S0887-6185(02)00129-9; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Raudenbush S. W., 2001, HIERARCHIAL LINEAR N; Ricker, 2018, TXB CLIN NEUROPSYCHO, P141; Sabourin BC, 2015, COGN BEHAV THERAPY, V44, P264, DOI 10.1080/16506073.2015.1015163; Schmidt NB, 1999, J ABNORM PSYCHOL, V108, P532, DOI 10.1037/0021-843X.108.3.532; Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355; Schmidt NB, 2007, J ANXIETY DISORD, V21, P302, DOI 10.1016/j.janxdis.2006.06.002; Schmidt NB, 2006, J PSYCHIATR RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009; Schmidt NB, 2014, J CONSULT CLIN PSYCH, V82, P1023, DOI 10.1037/a0036651; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Telch MJ, 1996, J ANXIETY DISORD, V10, P21, DOI 10.1016/0887-6185(95)00032-1; Vasquez Guerrero D. A., 2011, PRAEGER HDB SPORTS M, P135; Watt Margo C., 2006, Cognitive Behaviour Therapy, V35, P248, DOI 10.1080/16506070600898553; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569	49	0	0	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2021	36	6					930	939		10.1093/arclin/acaa113			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UQ0FU	WOS:000695749300007	33313753				2022-02-06	
J	Cheever, KM; Wright, WG; McDevitt, J; Sitler, M; Tierney, RT				Cheever, Kelly M.; Wright, W. Geoffrey; McDevitt, Jane; Sitler, Michael; Tierney, Ryan T.			Exploring the Relationship Between Musculoskeletal Injury and Clinical Outcome Measures of Cervical Sensorimotor Function	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						cervical sensorimotor function; contact sports; injury risk	SUBCONCUSSIVE HEAD IMPACTS; RUGBY UNION PLAYERS; CONCUSSION INCREASES; NECK-STRENGTH; RISK; RANGE; SPINE; SYMPTOMS; POSITION; SYSTEM	The objective of this study was to explore the correlation between preseason measures of cervical sensorimotor function and musculoskeletal injury rates across a contact sport season. The authors hypothesized that athletes with higher sensorimotor dysfunction at baseline would be more likely to suffer an injury. The authors further hypothesized that contact sport participation would lead to greater changes in cervical sensorimotor function across a sport season compared with noncontact controls. Forty-nine collegiate club athletes (26 rugby and 23 noncontact controls) participated in a cohort study. Low positive correlations between baseline sign and symptom severity (r = .383), and score (r = .344), and cervical joint position error (r = .385-.425) and time loss injury were observed. Combining sign and symptom severity score and the neck reposition error predicted musculoskeletal injury status with 80.8% accuracy (area under the curve = 0.80, p = .003). The results suggest preseason deficits in cervical sensorimotor function may be related to future musculoskeletal injury risk. Sign and symptom severity score, Neck Disability Index score, and cervical joint position error can help identify athletes requiring more comprehensive cervical spine assessment that may benefit from preventative intervention.	[Cheever, Kelly M.] Univ Texas San Antonio, Dept Kinesiol, Coll Hlth Community & Policy, San Antonio, TX 78249 USA; [Cheever, Kelly M.] Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX 78249 USA; [Wright, W. Geoffrey; McDevitt, Jane; Tierney, Ryan T.] Temple Univ, Dept Hlth & Rehabil Sci, Coll Publ Hlth, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey; McDevitt, Jane; Tierney, Ryan T.] Temple Univ, Coll Engi Neering, Dept Bioengn, Philadelphia, PA 19122 USA; [McDevitt, Jane; Sitler, Michael; Tierney, Ryan T.] Temple Univ, Dept Kinesiol, Coll Publ Hlth, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey; Tierney, Ryan T.] Temple Univ, Coll Publ Hlth, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey] Temple Univ, Coll Publ Hlth, Dept Bioengn, Philadelphia, PA 19122 USA		Cheever, KM (corresponding author), Univ Texas San Antonio, Dept Kinesiol, Coll Hlth Community & Policy, San Antonio, TX 78249 USA.; Cheever, KM (corresponding author), Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX 78249 USA.	kelly.cheever@utsa.edu			Pennsylvania Athletic Training Society	This work was supported by the Pennsylvania Athletic Training Society.	Allum JHJ, 1997, J VESTIBUL RES-EQUIL, V7, P189; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Berge J, 1999, AM J SPORT MED, V27, P422, DOI 10.1177/03635465990270040401; Boyle R, 2001, ANN NY ACAD SCI, V942, P364; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Castinel BH, 2010, BRIT J SPORT MED, V44, P194, DOI 10.1136/bjsm.2007.045815; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cheever KM, 2017, J BACK MUSCULOSKELET, V30, P991, DOI 10.3233/BMR-169535; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Kartal A, 2004, EUR SPINE J, V13, P76, DOI 10.1007/s00586-003-0623-y; Kato S, 2012, J ORTHOP SCI, V17, P687, DOI 10.1007/s00776-012-0276-y; Kawata K, 2019, J NEUROTRAUM, V36, pA103; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kulkarni V, 2001, NEUROL INDIA, V49, P355; Lark SD, 2007, J SPORT SCI, V25, P887, DOI 10.1080/02640410600944543; Lark SD, 2010, J SPORT SCI, V28, P649, DOI 10.1080/02640411003631968; Lark SD, 2009, J SPORT SCI, V27, P491, DOI 10.1080/02640410802632136; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; MCLAIN RF, 1994, SPINE, V19, P495, DOI 10.1097/00007632-199403000-00001; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Mehnert Michael J, 2005, Pain Physician, V8, P391; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Panjabi MM, 1998, CLIN BIOMECH, V13, P11, DOI 10.1016/S0268-0033(97)00057-0; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Sortland O, 1982, Br J Sports Med, V16, P80; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Versteegh T, 2015, PHYSIOTHER CAN, V67, P58, DOI 10.3138/ptc.2013-66	44	0	0	2	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2021	26	5					262	268		10.1123/ijatt.2020-0033			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UL0AW	WOS:000692325000005					2022-02-06	
J	Chen, M; Ren, AH; Prassas, I; Soosaipillai, A; Lim, B; Fraser, DD; Diamandis, EP				Chen, Michelle; Ren, Annie H.; Prassas, Ioannis; Soosaipillai, Antoninus; Lim, Bryant; Fraser, Douglas D.; Diamandis, Eleftherios P.			Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study	JOURNAL OF APPLIED LABORATORY MEDICINE			English	Article						traumatic brain injury; biomarkers; immunoassay; proximity extension assay; proteomics; multiplex technology	MASS-SPECTROMETRY; TROPONIN-I; S100A12; IDENTIFICATION; SENSITIVITY; SERUM	Background: Traumatic brain injury (TBI) is a significant public health issue affecting nearly 69 million patients worldwide per year. Reliable diagnostic biomarkers are urgently needed to aid in disease diagnosis and prognosis and to guide patient aftercare. Blood biomarkers represent an attractive modality to quickly, cheaply, and objectively evaluate clinical status. We hypothesize that deep and quantitative plasma proteomic profiling with a novel technology, proximity extension assay, may lead to the discovery of diagnostic and/or prognostic biomarkers of TBI. Methods: We used high-throughput proximity extension assays (PEA) to quantify the relative abundance of over 1000 unique proteins in plasma. PEA is a highly sensitive multiplex immunoassay capable of detecting very low-abundance proteins (down to fg/mL) in complex biological matrices. Our patient cohort consisted of severe TBI (sTBI) patients, matched healthy controls, and another non-TBI group that was included in the analysis to validate the specificity of the candidates during the selection process. The obtained protein quantification data was then filtered to identify candidate biomarkers through statistical analysis, literature searches, and comparison to our reference control groups. Results: Overall, we identified 6 novel candidate TBI biomarkers. Candidates exhibit a significant increase in plasma protein abundance in sTBI when comparing between healthy controls and sTBI patients. Candidates generally had low expression in our reference groups compared with the sTBI group. Conclusions: Our preliminary findings represent a starting point for future validation. These biomarkers, either alone or in combination, may have significant clinical utility in aiding in TBI diagnosis, prognosis, and/or management.	[Chen, Michelle; Ren, Annie H.; Lim, Bryant; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Prassas, Ioannis; Soosaipillai, Antoninus; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada; [Fraser, Douglas D.] Western Univ, Dept Pediat, London, ON, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON, Canada; [Diamandis, Eleftherios P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada		Diamandis, EP (corresponding author), Mt Sinai Hosp, 60 Murray St Box 32 Fir 6,Rm L6-201-1, Toronto, ON M5T 3L9, Canada.; Fraser, DD (corresponding author), Western Univ, London Hlth Sci Ctr, Childrens Hosp, Paediat Crit Care Med, Room C2-846,800 Commissioners Rd East, London, ON N6A 5W9, Canada.	douglas.fraser@lhsc.on.ca; eleftherios.diamandis@sinaihealthsystem.ca					Angel TE, 2012, CHEM SOC REV, V41, P3912, DOI 10.1039/c2cs15331a; [Anonymous], TRAUMATIC BRAIN INJU; Aslam B, 2017, J CHROMATOGR SCI, V55, P182, DOI 10.1093/chromsci/bmw167; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bender M, 2020, INJURY, V51, P1189, DOI 10.1016/j.injury.2020.01.002; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davis MT, 2001, PROTEOMICS, V1, P108, DOI 10.1002/1615-9861(200101)1:1<108::AID-PROT108>3.0.CO;2-5; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Du Q, 2018, CLIN CHIM ACTA, V487, P145, DOI 10.1016/j.cca.2018.09.035; Feng MJ, 2018, CLIN CHIM ACTA, V480, P84, DOI 10.1016/j.cca.2018.01.044; Gillio-Meina C, 2013, PEDIATRICS, V131, P754, DOI 10.1542/peds.2012-1181; Hebert AS, 2018, ANAL CHEM, V90, P2333, DOI 10.1021/acs.analchem.7b04808; Ilg EC, 1996, BIOCHEM BIOPH RES CO, V225, P146, DOI 10.1006/bbrc.1996.1144; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu HC, 2011, ANAL CHEM, V83, P6286, DOI 10.1021/ac200911v; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meadows EA, 2017, J INT NEUROPSYCH SOC, V23, P451, DOI 10.1017/S1355617717000352; Meijer B, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/907078; Music M, 2019, MOL CANCER THER, V18, P1844, DOI 10.1158/1535-7163.MCT-19-0132; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Rimaz Siamak, 2019, Anesth Pain Med, V9, pe90858, DOI 10.5812/aapm.90858; Sanchis P, 2020, GLIA, V68, P999, DOI 10.1002/glia.23758; Shi TJ, 2013, J PROTEOME RES, V12, P3353, DOI 10.1021/pr400178v; Shi TJ, 2012, PROTEOMICS, V12, P1074, DOI 10.1002/pmic.201100436; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sundman Mark H, 2014, J Alzheimers Dis Parkinsonism, V4; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Tighe PJ, 2015, PROTEOM CLIN APPL, V9, P406, DOI 10.1002/prca.201400130; Timp W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8978; Vidova V, 2017, ANAL CHIM ACTA, V964, P7, DOI 10.1016/j.aca.2017.01.059; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wu WW, 2012, PROTEOM CLIN APPL, V6, P304, DOI 10.1002/prca.201100107; Xie F, 2011, J BIOL CHEM, V286, P25443, DOI 10.1074/jbc.R110.199703; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021	45	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2576-9456	2475-7241		J APPL LAB MED	J. Appl. Lab. Med.	SEP	2021	6	5					1165	1178		10.1093/jalm/jfab004			14	Medical Laboratory Technology	Emerging Sources Citation Index (ESCI)	Medical Laboratory Technology	UQ7UM	WOS:000696265900008	33778875				2022-02-06	
J	Chen, YC; Wu, NC; Su, HC; Hsu, CC; Chen, KT				Chen, Yi-Chieh; Wu, Nan-Chun; Su, Hsiu-Chen; Hsu, Chien-Chin; Chen, Kuo-Tai			Minor Traumatic Intracranial Hemorrhage: Identifying Prognostic Factors and Comparing Patients with Favorable and Unfavorable Outcomes	WORLD NEUROSURGERY			English	Article						Comorbidity; Geriatric; Neurosurgical intervention; Outcomes; Traumatic brain injury	GLASGOW COMA SCALE; BRAIN-INJURY; MORTALITY PREDICTION; EPIDEMIOLOGY; MANAGEMENT; CARE	-BACKGROUND: Whether patients with minor traumatic intracranial hemorrhage (MTICH) require intensive care remains uncertain. This study aimed to identify the factors affecting the postinjury neurologic outcomes of patients with MTICH to determine optimal care. -METHODS: We retrospectively reviewed the data of all patients with trauma discharged from a tertiary trauma center during a 2-year period and included adult patients with isolated MTICH. Patient Glasgow Outcome Scale (GOS) score at discharge was the primary outcome mea-surement. A GOS score of 4 or 5 was defined as a favorable outcome, and a score of 1e3 was considered an unfavor-able outcome. We compared the clinical data between favorable and unfavorable outcome groups to determine the differences between groups. -RESULTS: Of the 11,814 patients considered, we identi-fied 534 patients who met the inclusion criteria. Older adults accounted for 35.4% of the study cohort. Only 4 complications (0.7%) and 1 mortality (0.2%) were observed during hospitalization. The number of patients who requiring brain surgery, transfusion, mechanical ventila-tion, pressor, or invasive monitor was 5 (0.9%), 5 (0.9%), 3 (5.6%), 0 (0%), and 0 (0%), respectively. After multivariate analysis, we discovered that comorbidities, brain surgery requirement, respiratory rate, and Trauma Injury Severity Score were strongly associated with patient GOS score at discharge. -CONCLUSIONS: MTICH rarely resulted in permanent morbidity and mortality. Older patients exhibited higher incidences of MTICH and were at a higher risk for unfa-vorable outcomes.	[Chen, Yi-Chieh; Hsu, Chien-Chin; Chen, Kuo-Tai] Chi Mei Med Ctr, Emergency Dept, Tainan, Taiwan; [Wu, Nan-Chun; Su, Hsiu-Chen] Chi Mei Med Ctr, Dept Surg, Div Traumatol, Tainan, Taiwan; [Hsu, Chien-Chin] Southern Tainan Univ Technol, Dept Biotechnol, Tainan, Taiwan; [Chen, Kuo-Tai] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan		Chen, KT (corresponding author), Chi Mei Med Ctr, Emergency Dept, Tainan, Taiwan.; Chen, KT (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan.	890502@mail.chimei.org.tw		Chen, Kuo-Tai/0000-0001-6147-9498			Adams SD, 2015, CURR OPIN CRIT CARE, V21, P520, DOI 10.1097/MCC.0000000000000246; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Bureau of Civil Affairs. Taiwan City Government, CIVIL AFFAIRS STAT Y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Kreitzer N, 2017, AM J EMERG MED, V35, P875, DOI 10.1016/j.ajem.2017.01.051; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Moore L, 2010, J TRAUMA, V68, P698, DOI 10.1097/TA.0b013e3181aa093d; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7	22	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2021	153						E428	E434		10.1016/j.wneu.2021.06.137			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UE3YZ	WOS:000687828800001	34229100	hybrid			2022-02-06	
J	Chizuk, HM; Willer, BS; Horn, EC; Haider, MN; Leddy, JJ				Chizuk, Haley M.; Willer, Barry S.; Horn, Emily C.; Haider, Mohammad N.; Leddy, John J.			Sex differences in the Buffalo Concussion Treadmill Test in adolescents with acute sport-related concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Mild traumatic brain injury; Children; Gender; Exercise tolerance		Objectives: The Buffalo Concussion Treadmill Test (BCTT) is a safe and validated tool to assess exercise tolerance after sport-related concussion (SRC). Sex differences may affect the interpretation of this systematic exertion test in the concussed population, which is important for clinicians. The purpose of this study was to examine sex dif-ferences in BCTT performance in adolescents with acute SRC. Design: Prospective cohort. Methods: Male (n = 103, 15.3 +/- 2 years) and female (n = 87, 15.1 +/- 2 years) adolescents with SRC performed the BCTT within 10 days of injury. Heart rate (HR), HR threshold (HRt), Delta HR (difference between resting HR and HRt), symptom severity on Visual Analog Scale (VAS) and symptoms exacerbated on the BCTT were collected and compared. Results: Males had lower resting HR (M: 70.9 +/- 12 vs F: 75.7 +/- 13 bpm, p < 0.01) and reached a lower HRt than females (M: 134.7 +/- 23 vs F: 141.5 +/- 25 bpm, p = 0.05). Sexes did not differ on Delta HR (M: 63.8 +/- 26 vs F: 65.9 +/- 24 bpm, p = 0.57), total treadmill time (M: 9.3 +/- 5 vs F: 8.4 +/- 4 min, p = 0.20), maximum VAS (M: 5.0 +/- 2 vs F: 5.4 +/- 2, p = 0.18) or incidence of a change in VAS (M: 91% vs F: 94%, p = 0.43) on the BCTT. Conclusions: Although males may reach symptom exacerbation at a slightly lower mean HRt than females on the BCTT within 10 days of SRC, the BCTT provides comparable information and both sexes reach symptom exacer-bation at similar Delta HR. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Chizuk, Haley M.; Willer, Barry S.; Leddy, John J.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Rehabil Sci, Buffalo, NY 14260 USA; [Chizuk, Haley M.; Horn, Emily C.; Haider, Mohammad N.; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthoped & Sports Med, Buffalo, NY 14260 USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Chizuk, HM (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Rehabil Sci, Buffalo, NY 14260 USA.; Chizuk, HM (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthoped & Sports Med, Buffalo, NY 14260 USA.	haleychi@buffalo.edu			National Institute of Neurological Disorders and Strokeof the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R42NS119119]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Strokeof the National Institutes of Health under award number 1R01NS094444, National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412t o the Universityat Buffalo and National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R42NS119119. The content is solely the responsibility of the authors and doesnot necessarily represent the official views of the NIH.	Ashley JD, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14622; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Barth JT, 2001, J ATHL TRAINING, V36, P253; BorgG, 1998, BORGS PERCEIVED EXER; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Daugherty SL, 2011, AM HEART J, V161, P908, DOI 10.1016/j.ahj.2011.01.021; Christofaro DGD, 2017, ARQ BRAS CARDIOL, V108, P405, DOI 10.5935/abc.20170050; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fomin A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-127; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kaminsky LA., 2006, ACSMS RESOURCE MANUA, V5; Klimek Ludger, 2017, Allergo J Int, V26, P16, DOI 10.1007/s40629-016-0006-7; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Sharma HB, 2016, J CLIN DIAGN RES, V10, pCC9, DOI 10.7860/JCDR/2016/20873.8831; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Thibault V, 2010, J SPORT SCI MED, V9, P214; Yin X, 2016, J HUM HYPERTENS, V30, P697, DOI 10.1038/jhh.2016.12; Zasler N, 2019, J HEAD TRAUMA REHAB, V34, P409, DOI 10.1097/HTR.0000000000000524	30	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2021	24	9					876	880		10.1016/j.jsams.2021.04.005			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UA2EI	WOS:000684976900005	33992537				2022-02-06	
J	Corrigan, JD				Corrigan, John D.			Traumatic Brain Injury and Treatment of Behavioral Health Conditions	PSYCHIATRIC SERVICES			English	Article							LIFETIME HISTORY; SUBSTANCE MISUSE; MENTAL-HEALTH; UNITED-STATES; HEAD-INJURY; PREVALENCE; OUTCOMES; MODEL; RISK; DISABILITY	Traumatic brain injury (TBI) is a common neurological condition that results from an external force altering normal brain function, whether temporarily or permanently. A concussion is one type of TBI. TBIs vary greatly in severity, which concomitantly creates tremendous variability in their manifestation. The fingerprint of TBI is damage to the frontal areas of the brain, which, with sufficient magnitude, results in impairment of a person's ability to regulate cognition, emotion, and behavior. These consequences of TBI make recognition in the context of treating behavioral health conditions of utmost importance. TBI not only causes behavioral health problems but also produces associated deficits that can undermine the effectiveness of treatment for a behavioral health condition. This overview delineates key characteristics of TBI and describes its association with behavioral health conditions. Mechanisms underlying the relationship between TBI and behavioral health are presented, and a series of recommendations for professionals are proposed. This article is intended to raise awareness about TBI and simultaneously introduce key concepts for accommodating the effects of TBI in behavioral health care.	[Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	johncorrigan1@me.com			National Association of State Mental Health Program Directors (NASMHPD) [CA-3011.3-RPI-01]; NASMHPD [HHSS283201200021I-HHS28342003T]; Substance Abuse and Mental Health Services Administration of the Department of Health andHumanServices through the NASMHPD; Center for Mental Health ServicesUnited States Department of Health & Human Services	The National Association of State Mental Health Program Directors (NASMHPD) contracted with the author to create this work (contract no. CA-3011.3-RPI-01). This work was developed under Task 2.2 of NASMHPD's Technical Assistance Coalition contract/task order HHSS283201200021I-HHS28342003T and was funded by the Center for Mental Health Services and the Substance Abuse and Mental Health Services Administration of the Department of Health andHumanServices through the NASMHPD.	Adams RS, 2019, J HEAD TRAUMA REHAB, V34, P167, DOI 10.1097/HTR.0000000000000481; Adams RS, 2017, J NEUROTRAUM, V34, P1457, DOI 10.1089/neu.2016.4693; Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; Bates ME, 2006, PSYCHOL ADDICT BEHAV, V20, P241, DOI 10.1037/0893-164X.20.3.241; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Cannella LA, 2019, EXP NEUROL, V317, P191, DOI 10.1016/j.expneurol.2019.03.003; Corrigan JD, 2012, BRAIN INJURY MED PRI, V2nd; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Courville CB, 1950, PATHOLOGY CENTRAL NE, V3rd; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Leshner A.I., 2019, MED OPIOID USE DISOR; Lim AC, 2020, AM J DRUG ALCOHOL AB, V46, P565, DOI 10.1080/00952990.2020.1741002; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakase-Richardson R, 2016, J HEAD TRAUMA REHAB, V31, P79, DOI 10.1097/HTR.0000000000000235; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Simpson GK, 2019, SUICIDE PREVENTION N; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Weil ZM, 2019, EXP NEUROL, V317, P284, DOI 10.1016/j.expneurol.2019.03.012; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Yi HG, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000352; Yuh EL, 2012, BRAIN INJURY MED PRI, V2nd	56	0	0	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	SEP	2021	72	9					1057	1064		10.1176/appi.ps.201900561			8	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	UK8HM	WOS:000692205400012	33622044				2022-02-06	
J	Coscia, A; Stolz, U; Barczak, C; Wright, N; Mittermeyer, S; Shams, T; Epstein, S; Kreitzer, N				Coscia, Atticus; Stolz, Uwe; Barczak, Christopher; Wright, Natalie; Mittermeyer, Stephan; Shams, Tanzid; Epstein, Stephen; Kreitzer, Natalie			Use of the Sports Concussion Assessment Tool 3 in Emergency Department Patients With Psychiatric Disease	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion assessment; emergency department; psychiatric disease; SCAT3; symptom evaluation	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; POSTCONCUSSION SYNDROME; SYMPTOMS; RECOVERY; DEPRESSION; PREDICTORS; DIAGNOSIS; SEVERITY; CHILDREN	Objective: The Sports Concussion Assessment Tool 3 (SCAT3) Symptom Evaluation (SE) is used in the emergency department (ED). This study aimed to examine the effects of psychiatric history on the SCAT3 SE symptom severity score (SSS). Setting: Three US EDs. Participants: A total of 272 ED patients with suspected concussion. Design: Prospective, nonrandomized, nonblinded study. The SCAT3 SE SSS, demographic data, medical information, and self-reported psychiatric history were obtained from patients by clinical research staff when they presented to the ED seeking standard clinical care. Concussion diagnoses were determined following a comprehensive assessment by an ED physician trained in managing concussions and adjudicated by supervising physicians. Main Measures: The primary outcome measure was SSS. The association between SSS, self-reported psychiatric disease, and concussion diagnosis was analyzed using multivariable linear regression. Results: 68.4% of subjects were diagnosed with a concussion. After controlling for age, sex, race, history of previous concussion, and interval from injury to ED presentation, self-reported psychiatric history (adjusted regression coefficient (beta(a)): 16.9; confidence interval [CI]: 10.1, 23.6), and concussion diagnosis (beta(a): 21.7; CI: 14.2, 29.2) were both independently associated with a significant increase in SSS. Subjects with a history of concussion had a significantly higher SSS (beta(a): 9.1; CI: 1.8, 16.5). Interval from injury to ED presentation was also associated with a significant increase in SSS (beta(a): 1.6 per 6-hour increase; CI: 0.4, 2.8). Conclusion: Our findings demonstrate that a history of preexisting psychiatric disease, as self-reported by patients with a suspected concussion treated in the ED, is independently associated with significantly higher scores on the SCAT3 SE. This suggests that a history of psychiatric illness may need to be accounted for when the SCAT3 SE is used in the ED for the assessment of concussion.	[Coscia, Atticus; Stolz, Uwe; Barczak, Christopher; Kreitzer, Natalie] Univ Cincinnati, Med Ctr, Dept Emergency Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Wright, Natalie; Mittermeyer, Stephan] Jan Med, Mountain View, CA USA; [Shams, Tanzid] Ballad Hlth, Johnson City, TN USA; [Epstein, Stephen] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02115 USA; [Kreitzer, Natalie] Univ Cincinnati, Med Ctr, Div Neurocrit Care, Cincinnati, OH 45267 USA		Coscia, A (corresponding author), Univ Cincinnati, Med Ctr, Dept Emergency Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	cosciaac@mail.uc.edu; stolzu@ucmail.uc.edu; barczacm@ucmail.uc.edu; nwright@janmedical.com; stephan@janmedical.com; tanzid.shams@balladhealth.org; sepstein@bidmc.harvard.edu; kreitzne@ucmail.uc.edu					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bin Zahid A, 2018, APPL NEUROPSYCH-ADUL, V25, P110, DOI 10.1080/23279095.2016.1248765; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Centers for Disease Control and Prevention, INJURY PREVENTION CO; Chen J, 2019, J SPORT REHABIL, V28, P735, DOI 10.1123/jsr.2018-0166; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Crittendon J, 2006, J ANXIETY DISORD, V20, P1036, DOI 10.1016/j.janxdis.2005.11.006; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Duignan M, 2016, INT EMERG NURS, V26, P47, DOI 10.1016/j.ienj.2015.11.005; GOLD I, 1989, ANN EMERG MED, V18, P875, DOI 10.1016/S0196-0644(89)80217-3; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Kruse AJ, 2018, OPEN ACCESS EMERG M, V10, P113, DOI 10.2147/OAEM.S165995; Lac A, 2018, PSYCHOL ADDICT BEHAV, V32, P40, DOI 10.1037/adb0000343; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moon JR, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0747-0; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; O'Neil B, 2014, MIL MED, V179, P1250, DOI 10.7205/MILMED-D-13-00585; Patrick Sean P, 2017, AEM Educ Train, V1, P346, DOI 10.1002/aet2.10053; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Schriger DL, 2001, ANN EMERG MED, V37, P132, DOI 10.1067/mem.2001.112255; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Substance Abuse and Mental Health Services Administration, KEY SUBSTANCE USE ME; Suskauer SJ, 2019, J HEAD TRAUMA REHAB, V34, P215, DOI 10.1097/HTR.0000000000000455; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WULSIN LR, 1991, INT J PSYCHIAT MED, V21, P37, DOI 10.2190/HFQ4-J41N-6M1E-MBN3; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38	51	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E302	E311		10.1097/HTR.0000000000000648			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300002	33656471				2022-02-06	
J	Costenbader, K; Huda, F; Shand, M; Brown, D; Kraus, M; Taheri, R				Costenbader, Kyle; Huda, Fahimul; Shand, Muhammed; Brown, Derek; Kraus, Marilyn; Taheri, Reza			Small subdural hemorrhages: Does size of intracranial hemorrhage impact symptoms after discharge?	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; OUTCOME PREDICTION; CT; CONCUSSION; DEFICITS; POWER	Intro: Patients with small intracranial hemorrhage at initial presentation (ICHi) have a relatively uneventful hospital course, as compared with larger ICHi. In this study, we tested the null hypothesis that ICHi does not impact the symptom profile of patients with traumatic brain injury (TBI) after discharge. Methods: In this retrospective study, TBI patients over 18 years of age with a head CT at initial presentation and at least one follow-up visit between 2015 and 2018 were included. Those with vascular risk factors, major psychiatric comorbidities, neurologic disorders, and TBI/ CT evidence of ICH within five years were excluded. Patients were stratified based on the presence or absence of ICHL Symptom profiles were characterized during early (0-3 months post-TBI) and late follow up (4-12 months post-TBI). An adapted 15-question Post-Concussion Symptom Scale and a vestibulo-oculomotor (VOM) exam were assessed by a TBI specialist. We compared the age adjusted clinical symptom profiles between those with and without ICHi. Results: 69 patients met inclusion/exclusion criteria. 26 (37.8%) had ICHi and 43 (62.32%) did not have ICH. The seventy of measured symptoms or VOM findings were not more severe in those with ICHi. Age-adjusted analyses did not show any effect on these outcomes. Conclusion: ICHi does not impact the symptom profile of patients with TBI in either short or long term. (C) 2021 Elsevier Inc. All rights reserved.	[Costenbader, Kyle; Huda, Fahimul; Shand, Muhammed; Kraus, Marilyn; Taheri, Reza] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20001 USA; [Brown, Derek] Univ Texas Hlth Sci Ctr Houston, Dept Biostat & Data Sci, Houston, TX 77030 USA		Costenbader, K (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20001 USA.	costenba@gwu.edu; fahim.huda@gmail.com; mshand@gwmail.gwu.edu; derek9@gwmail.gwu.edu; mkraus@mfa.gwu.edu; rtaheri@mfa.gwu.edu	Huda, Fahimul/ABB-8782-2020	Huda, Fahimul/0000-0001-7447-2711			Albertine P, 2016, AM J EMERG MED, V34, P521, DOI 10.1016/j.ajem.2015.12.035; Armao DM, PATHOLOGY MODERN CAS, V2e; Brown AW, 2019, BRAIN INJURY, V33, P610, DOI 10.1080/02699052.2019.1566970; Centers for Disease Control and Prevention, INJURY PREVENTION CO; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Denby E, 2020, J HEAD TRAUMA REHAB, V35, P57, DOI 10.1097/HTR.0000000000000468; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Palacios EM, 2018, EVOLUTION WHITE MATT, DOI [10.1101/345629, DOI 10.1101/345629]; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	33	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2021	47						223	227		10.1016/j.ajem.2021.03.053			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UB8SC	WOS:000686108000039	33915377				2022-02-06	
J	DeFeo, CJ; Morelli, N; Hoch, MC				DeFeo, Courtney J.; Morelli, Nathan; Hoch, Matthew C.			The Comparison Between Instrumented and Observer-Rated Measures of the Modified Balance Error Scoring System: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						concussion; postural control; inertial measurement unit	CONCUSSION-MANAGEMENT; RELIABILITY; DEFICITS; RISK	Clinical Scenario: Postural control deficits are one of the most common impairments associated with sport-related concussion. The Modified Balance Error Scoring System (mBESS) is one of the current standard clinical measures for assessing these deficits; however, it is dependent upon observer-rated measurements. Advancements in inertial measurement units (IMUs) lend themselves to be a viable option in objectifying postural control assessments, such as the mBESS. Clinical Question: Are IMU-based measures of the mBESS more effective than observer-rated measures of the mBESS in identifying patients with sport-related concussion? Summary of Key Findings: Following a systematic search, three studies were included. One study compared observer-rated measures of the Balance Error Scoring System and mBESS to instrumented measures of both tests and determined that the instrumented mBESS had the highest diagnostic accuracy. The results of the second study determined that IMU-based measures were successful in both classifying group and identifying task errors. The final study found that using IMUs increased sensitivity of the mBESS, specifically the double-limb stance, to group classification. Clinical Bottom Line: Instrumentation of the mBESS using IMUs provides more objective and sensitive measures of postural control in patients with SRC. Strength of Recommendation: Due to the consistent, good-quality evidence used to answer this critically appraised topic, the grade of A is recommended by the Strength of Recommendation Taxonomy.	[DeFeo, Courtney J.; Morelli, Nathan; Hoch, Matthew C.] Univ Kentucky, Dept Athlet Training & Clin Nutr, Coll Hlth Sci, Sports Med Res Inst, Lexington, KY 40506 USA		Hoch, MC (corresponding author), Univ Kentucky, Dept Athlet Training & Clin Nutr, Coll Hlth Sci, Sports Med Res Inst, Lexington, KY 40506 USA.	matt.hoch@uky.edu					Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Camps J, 2018, KNOWL-BASED SYST, V139, P119, DOI 10.1016/j.knosys.2017.10.017; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fisher M, 2019, INT J ATHL THER TRAI, V24, P181, DOI 10.1123/ijatt.2018-0089; Ghislieri M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19194075; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Prince J, 2020, J SPORT REHABIL, V29, P122, DOI 10.1123/jsr.2018-0224; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Weiss A, 2011, PHYSIOL MEAS, V32, P2003, DOI 10.1088/0967-3334/32/12/009; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	27	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2021	26	5					245	250		10.1123/ijatt.2020-0061			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UL0AW	WOS:000692325000002					2022-02-06	
J	Eagle, SR; Collins, MW; Dretsch, MN; Uomoto, JM; Connaboy, C; Flanagan, SD; Kontos, AP				Eagle, Shawn R.; Collins, Michael W.; Dretsch, Michael N.; Uomoto, Jay M.; Connaboy, Chris; Flanagan, Shawn D.; Kontos, Anthony P.			Network Analysis of Research on Mild Traumatic Brain Injury in US Military Service Members and Veterans During the Past Decade (2010-2019)	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; military; mTBI; veterans	POSTTRAUMATIC-STRESS-DISORDER; HYPERBARIC-OXYGEN; POSTCONCUSSIVE SYMPTOMS; CORTICAL THICKNESS; POLYTRAUMA SYSTEM; BODILY INJURIES; SUICIDE RISK; BLAST; CONCUSSION; HISTORY	Objective: To evaluate trends in the extant literature on mild traumatic brain injury (mTBI) in military service members and veterans using network analysis based on a comprehensive search of original, peer-reviewed research articles involving human participants published between January 1, 2010, and December 31, 2019. Specifically, we employed network analysis to evaluate associations in the following areas: (1) peer-reviewed journals, (2) authors, (3) organizations/institutions, and (4) relevant key words. Participants: Included studies were published in peer-reviewed journals available on Web of Science database, using US military service members or veterans. Design: Bibliometric network analytical review. Main Measures: Outcomes for each analysis included number of articles, citations, total link strength, and clusters. Results: The top publishing journals were (1) Journal of Head Trauma and Rehabilitation, (2) Military Medicine, (3) Brain Injury, (4) Journal of Neurotrauma, and (5) Journal of Rehabilitation Research and Development. The top publishing authors were (1) French, (2) Lange, (3) Cooper, (4) Vanderploeg, and (5) Brickell. The top research institutions were (1) Defense and Veterans Brain Injury Center, (2) Uniformed Services University of the Health Sciences, (3) University of California San Diego, (4) Walter Reed National Military Medical Center, and (5) Boston University. The top co-occurring key words in this analysis were (1) posttraumatic stress disorder (PTSD), (2) persistent postconcussion symptoms (PPCS), (3) blast injury, (4) postconcussion syndrome (PCS), and (5) Alzheimer's disease. Conclusions: The results of this network analysis indicate a clear focus on veteran health, as well as investigations on chronic effects of mTBI. Research in civilian mTBI indicates that delaying treatment for symptoms and impairments related to mTBI may not be the most precise treatment strategy. Increasing the number of early, active, and targeted treatment trials in military personnel could translate to meaningful improvements in clinical practices for managing mTBI in this population.	[Eagle, Shawn R.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, 3850 S Water St, Pittsburgh, PA 15203 USA; [Connaboy, Chris; Flanagan, Shawn D.] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Collins, Michael W.; Kontos, Anthony P.] UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Dretsch, Michael N.] US Army, Walter Reed Army Inst Res, Med Res Directorate West, Washington, DC USA; [Uomoto, Jay M.] VA Puget Sound Hlth Care Syst, Amer Lake Div, Tacoma, WA USA		Eagle, SR (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 3850 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu; collinsmw@upmc.edu; dretschphd@gmail.com; jay.uomoto@va.gov; connaboy@pitt.edu; sdf29@pitt.edu; akontos@pitt.edu	Connaboy, Christopher/AAH-4514-2020; Flanagan, Shawn/AAC-6018-2021	Connaboy, Christopher/0000-0002-9031-2192; Flanagan, Shawn/0000-0002-6531-4567	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [HT0014-19-C-0004]	The views expressed in this article are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other US government agency. This work was prepared under Contract HT0014-19-C-0004 with the Defense and Veterans Brain Injury Center and, therefore, is defined as US Government work under Title 17 USC 101. Per Title 17 USC 105, copyright protection is not available for any work of the US Government. For more information, contact dha.DVBICinfo@mail.mil.	Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Churchill S, 2016, MIL MED, V181, P40, DOI 10.7205/MILMED-D-15-00148; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cogan AM, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.027599; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Crocker LD, 2019, J INT NEUROPSYCH SOC, V25, P79, DOI 10.1017/S1355617718000851; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Eagle Shawn R, 2020, J Athl Train, DOI 10.4085/280-20; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Galey JL, 2020, MIL MED, V185, pE1229, DOI 10.1093/milmed/usaa025; Group IR, 2007, REBUILDING TRUST REP; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jackson CE, 2017, BRAIN INJURY, V31, P485, DOI 10.1080/02699052.2017.1280740; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Kennedy JE, 2019, MIL MED, V184, P148, DOI 10.1093/milmed/usy321; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kulas JF, 2018, MIL MED, V183, pE114, DOI 10.1093/milmed/usx050; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Larres DT, 2016, MIL MED, V181, P23, DOI 10.7205/MILMED-D-15-00152; Liu W, 2019, J NEUROTRAUM, V36, P2213, DOI 10.1089/neu.2018.5970; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McGlinchey RE, 2014, INT J ENV RES PUB HE, V11, P3046, DOI 10.3390/ijerph110303046; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Miles SR, 2015, MIL MED, V180, P45, DOI 10.7205/MILMED-D-14-00187; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; O'Connor KL, 2018, MIL MED, V183, pE580, DOI 10.1093/milmed/usx130; Ottomanelli L, 2019, J HEAD TRAUMA REHAB, V34, P158, DOI 10.1097/HTR.0000000000000493; Proessl F, 2020, J NEUROTRAUM, V37, P2102, DOI 10.1089/neu.2020.6999; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Rawlins MLW, 2020, MIL MED, V185, pE269, DOI 10.1093/milmed/usz162; Register-Mihalik JK, 2020, MIL MED, V185, pE403, DOI 10.1093/milmed/usz414; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Robinson-Freeman KE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00836; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421; Vanderploeg RD, 2018, REHABIL PSYCHOL, V63, P194, DOI 10.1037/rep0000215; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wolf EJ, 2019, PSYCHOL MED, V49, P791, DOI 10.1017/S0033291718001411	62	0	0	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E345	E354		10.1097/HTR.0000000000000675			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300011	33741827				2022-02-06	
J	Edwards, CD				Edwards, Carla D.			Depression Assessment Challenges and Treatment Strategies in the Athlete	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Athlete; Sport; Psychiatry; Mental health; Depression; Mood	PROFESSIONAL RUGBY UNION; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; PSYCHOLOGICAL RESPONSE; PREVALENCE; SYMPTOMS; RISK; CONCUSSION; DETERMINANTS; RETIREMENT		[Edwards, Carla D.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada		Edwards, CD (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	Edwardcd@mcmaster.ca					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Baum AL, 2005, CLIN SPORT MED, V24, P853, DOI 10.1016/j.csm.2005.06.006; Baum AL, 2000, SPORT PSYCHIAT THEOR, P249; Brown JC, 2017, INT J SPORTS MED, V38, P582, DOI 10.1055/s-0043-103959; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Edwards CD, EMERGENCY PSYCHIAT P, V2021, P459; Epstein RS, 1994, NEUROPSYCHIATRY TRAU; Esfandiari A, 2011, CLIN SPORT MED, V30, P611, DOI 10.1016/j.csm.2011.03.002; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 2018, LANCET, V392, P1789, DOI [DOI 10.1016/S0140-6736(18)32279-7, 10.1016/S0140-6736(18)32279-7]; Gouttebarge V, 2016, J SPORT MED PHYS FIT, V56, P648; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Griggs B, 2016, THE CNN; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Hammond T, 2013, CLIN J SPORT MED, V23, P273, DOI 10.1097/JSM.0b013e318287b870; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Knights S, 2016, J APPL SPORT PSYCHOL, V28, P291, DOI 10.1080/10413200.2015.1128992; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Liu QQ, 2020, J PSYCHIATR RES, V126, P134, DOI 10.1016/j.jpsychires.2019.08.002; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Masten R, 2014, KINESIOLOGY, V46, P127; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Mountjoy M, 2016, BRIT J SPORT MED, V50, P1019, DOI 10.1136/bjsports-2016-096121; Prinz B., 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2016-000124, DOI 10.1136/BMJSEM-2016-000124]; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Reardon CL, 2019, BRIT J SPORT MED, V53, P667, DOI 10.1136/bjsports-2019-100715; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Sanders G, 2017, EUR J SPORT SCI, V17, P1311, DOI 10.1080/17461391.2017.1371795; Schuring N, 2017, KNEE SURG SPORT TR A, V25, P3179, DOI 10.1007/s00167-016-4255-2; SMITH AM, 1994, J ATHL TRAINING, V29, P337; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stirling AE, 2013, INT J SPORT EXERC PS, V11, P87, DOI 10.1080/1612197X.2013.752173; Tofler I., 2005, CLIN SPORTS MED, V24, P4; van Ramele S, 2017, PSYCHOL SPORT EXERC, V28, P85, DOI 10.1016/j.psychsport.2016.10.009; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wippert PM, 2010, J CLIN SPORT PSYCHOL, V4, P133, DOI 10.1123/jcsp.4.2.133; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	42	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2021	44	3			SI		381	392		10.1016/j.psc.2021.04.011			12	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	TY1FN	WOS:000683529700006	34372995				2022-02-06	
J	Elbin, RJ; Schatz, P; Mohler, S; Covassin, T; Herrington, J; Kontos, AP				Elbin, R. J.; Schatz, Philip; Mohler, Samantha; Covassin, Tracey; Herrington, Jesse; Kontos, Anthony P.			Establishing Test-Retest Reliability and Reliable Change for the King-Devick Test in High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; adolescent; King-Devick; sports; vision; assessment	VISUAL SCREENING TOOL; AMATEUR RUGBY UNION; CONCUSSION; ASSOCIATIONS; COMMON; LEAGUE	Objective: To establish test-retest reliability in nonconcussed high school athletes and compare absolute change, reliable change indices (RCIs), and minimal detectable change (MDC) methods for classifying impairment after sport-related concussion. Design: Prospective, repeated measures. Setting: High schools from the Midwest and Central regions of the United States. Participants: A convenience sample of 772 nonconcussed high school athletes (n = 546 men) completed preseason K-D testing. In addition, 69 athletes completed a second postseason K-D test, and 54 athletes sustained a concussion and completed postconcussion K-D tests. Intervention: K-D test. Main Outcome Measures: Data for age, sex, and concussion history were determined using preseason K-D test outcomes. Test-retest reliability, RCIs, and MDCs were calculated using postseason K-D tests (M = 98.9, SD = 9.1 days). Postinjury K-D assessments within 5 days of injury (M = 1.5, SD = 1.5 days) were used to classify impairment on K-D using absolute change, RCI, and MDC methods. Results: Significant effects for age (P < 0.001) and history of concussion (P = 0.001) were supported on baseline K-D time, with no sex differences (P = 0.21). Preseason to postseason reliability for K-D times was 0.60 (intraclass correlation coefficient, 95% CI, 0.43-0.73), although 38% of athletes exhibited slower postseason K-D times compared with baseline. Impairment on K-D exhibited for 72% of the concussed sample using absolute change, 48% using MDC, and 44% using RCI methods. Conclusions: K-D exhibited moderate test-retest reliability across 1 season. Absolute change yielded the highest sensitivity for preinjury to postinjury impairment on the K-D compared with RCI and MDC methods.	[Elbin, R. J.; Mohler, Samantha] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Herrington, Jesse] Mercy Hlth Syst Northwest Arkansas, Mercy Sports Med, Rogers, AR USA; [Kontos, Anthony P.] Univ Pittsburgh, Sports Med Concuss Program, Med Ctr UPMC, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, 155 Stadium Dr, Fayetteville, AR 72701 USA.	rjelbin@uark.edu					Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clugston JR, 2020, CLIN J SPORT MED, V30, pE139, DOI 10.1097/JSM.0000000000000691; Franzen M. D., 2000, RELIABILITY VALIDITY; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heick JD, 2016, ATHLETIC TRAINING SP, V8, P222, DOI DOI 10.3928/19425864-20160509-01; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, LUPUS, V10, P266, DOI 10.1191/096120301680416959; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	29	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					E235	E239		10.1097/JSM.0000000000000772			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400004	31842057				2022-02-06	
J	Elder, KA; Smith, C; Niday, C; Massie, AW; Reat, AM; Haidar, A; Cook, ML; Hoelscher, DM				Elder, Katherine A.; Smith, Carolyn; Niday, Claire; Massie, Alison Winters; Reat, Amanda M.; Haidar, Amier; Cook, Michelle L.; Hoelscher, Deanna M.			Implementing Statewide Health Surveillance in Schools: Processes and Lessons Learned from the Texas SPAN Project	HEALTH BEHAVIOR AND POLICY REVIEW			English	Article						process evaluation; childhood obesity; surveillance; program planning; child health; adolescent health	INTERVENTION; SYSTEMS; CONCUSSIONS	Objective: Prevalence of obesity among youth has increased in the last several decades. Using schools as a place to collect data on childhood obesity is considered by many researchers to be an important component to combating the disease. In this paper, we present process data from the Texas School Physical Activity and Nutrition (SPAN) project, a statewide surveillance system to monitor the prevalence of Texas school-aged children who have overweight/obesity. Methods: We selected 3 Public Health Regions (PHRs), including 30 districts and 140 schools, to represent geographic variability of processes of conducting this surveillance system. We tracked and analyzed administrative and communicative processes to conduct the Texas SPAN in those districts/schools. Results: The results demonstrate significant procedural variability across and within PHRs in implementing Texas SPAN. These variations occurred and are presented at both the district and school levels and relate to parental consent, communication processes, and time lags involved in approval and measurement. Conclusions: Due to the variability in the process data observed across and within PHRs, we recommend researchers interested in establishing obesity surveillance systems work to create statewide and local partnerships, cultivate strong communication, and develop mechanisms for data management.	[Elder, Katherine A.] Calif State Univ, Commun Program, Camarillo, CA 93012 USA; [Smith, Carolyn; Niday, Claire; Massie, Alison Winters; Reat, Amanda M.; Hoelscher, Deanna M.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Michael & Susan Dell Ctr Hlth Living, Austin, TX USA; [Haidar, Amier] Univ Texas Sch Publ Hlth, Houston, TX USA; [Cook, Michelle L.] Dept State Hlth Serv, Austin, TX USA		Elder, KA (corresponding author), Calif State Univ, Commun Program, Camarillo, CA 93012 USA.	katherine.elder@gmail.com			Texas Department of State Health Services	Texas SPAN is funded by the Texas Department of State Health Services.	Abildgaard JS, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01380; Bartholomew LK, 1998, HEALTH EDUC BEHAV, V25, P545, DOI 10.1177/109019819802500502; Blondin KJ, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160060; Child and Adolescent Health Measurement Initiative, 2021, NAT SURV CHILDR HLTH; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Della Torre SB, 2010, J SCHOOL HEALTH, V80, P233, DOI 10.1111/j.1746-1561.2010.00495.x; Escaron AL, 2019, TRANSL BEHAV MED, V9, P899, DOI 10.1093/tbm/ibz116; Forman SG, 2008, SCH MENT HEALTH, V1, P26, DOI DOI 10.1007/S12310-008-9002-5; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green LW, 2013, EVALUATING OBESITY P; Groseclose SL, 2017, ANNU REV PUBL HEALTH, V38, P57, DOI 10.1146/annurev-publhealth-031816-044348; Hall WJ, 2014, TRANSL BEHAV MED, V4, P131, DOI 10.1007/s13142-013-0226-z; Health. Resources Services. Administration, 2021, NAT SURV CHILDR HLTH; Hoelscher DM, 2017, ANNU REV PUBL HEALTH, V38, P187, DOI 10.1146/annurev-publhealth-031816-044537; Kann L, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6506a1; Kim J, 2005, AM J PUBLIC HEALTH, V95, P1588, DOI 10.2105/AJPH.2004.054015; Lorencatto F, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0528-x; Lytle LA, 2001, J NUTR EDUC, V33, P49, DOI 10.1016/S1499-4046(06)60010-9; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mekelburg M., 2020, AUSTIN AM STATESMAN; Moore G, 2014, J EPIDEMIOL COMMUN H, V68, P101, DOI 10.1136/jech-2013-202869; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Partridge SR, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0329-2; Ringeisen H, 2003, SCHOOL PSYCHOL REV, V32, P153; Rouse H, 2019, J SCHOOL HEALTH, V89, P237, DOI 10.1111/josh.12741; Singleton MD, 2020, SUICIDE LIFE-THREAT, V50, P42, DOI 10.1111/sltb.12572; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; Texas Demographic Center, 2021, TEX POP EST PROGR DA; US Centers for Disease Control and Prevention, 2014, BRFSS; US Centers for Disease Control and Prevention, 2020, YRBSS RES; US Department of Commerce, 2018, US SUMM 2010 POP HOU; US Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2030 SCH; Wijnhoven TMA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-806	34	0	0	0	0	PARIS SCHOLAR PUBLISHING LTD	ALHAMBRA	1508 S GARFIELD AVE, ALHAMBRA, CA, UNITED STATES	2326-4403			HEALTH BEHAV POLICY	Health Behav. Policy Rev.	SEP	2021	8	5					412	421		10.14485/HBPR.8.5.2			10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	XG7TS	WOS:000724952700002					2022-02-06	
J	Fang, J; Yuan, Q; Du, ZY; Liu, CB; Xu, H; Yang, WJ; Chen, L; Zhao, JL; Xie, R; Hu, J; Wu, X				Fang, Jiang; Yuan, Qiang; Du, Zhuoying; Liu, Chaobo; Xu, Hao; Yang, Weijian; Chen, Long; Zhao, Jianlan; Xie, Rong; Hu, Jin; Wu, Xing			Contribution of factor VII polymorphisms to coagulopathy in patients with isolated traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Coagulation factor VII; Traumatic brain injury; Polymorphisms; Coagulopathy	COAGULATION-FACTOR-VII; HEMORRHAGIC PROGRESSION; RISK; GENE; DISORDERS; PROMOTER	Background: Coagulopathy is a severe complication of traumatic brain injury (TBI) and can cause secondary injuries and death. Decrease of FVII activity contributes to the coagulopathy and progressive hemorrhagic injury (PHI) in patients with isolated TBI. Some polymorphic loci of coagulation factor VII (FVII) are shown to be essential for FVII activity. However, the relationship between FVII gene polymorphisms and coagulopathy in patients with isolated TBI is still unknown. Therefore, the present study aimed to investigate the relationship between FVII gene polymorphisms and plasma FVIIa levels, and assess whether FVII polymorphisms were associated with TBI-related coagulopathy, PHI, and 6 months GOS in patients with isolated TBI. Methods: One-hundred-forty-nine patients with isolated TBI (from East of China) admitted to Huashan Hospital's Neurological Trauma Center from March 2012 to March 2016 were enrolled in this study. The PolymorphismPolymerase Chain Reaction (PCR) method was used to analyze the five FVII polymorphism loci (-323P0/P10, R353Q, -401G/T, -402G/A, and -670A/C) of these patients. Patients' blood was collected to test the activated partial thromboplastin time, international normalized ratio, platelet, and FVIIa concentrations. Other clinical characteristics were also recorded. Results: The minor alleles of three genotypes of -323 P0/P10, R353Q, and -401G/T each independently associated with 23.3%, 28.6%, and 27.6% lower FVIIa levels, respectively. These polymorphisms explained 21% of the total variance of FVIIa levels (adjusted R2:0.206). The genotype of -323P0/P10 was an independent risk factor for coagulopathy (OR = 2.77, p = 0.043) and PHI (OR = 3.47, p = 0.03) after adjustment for confounding factors in the logistic regression model. Polymorphisms of FVII were not independently associated with 6 months Glasgow Outcome Scale (GOS) of isolated TBI patients. Conclusion: -323P0/P10, R353Q, and -401 G/T genotypes were associated with FVIIa levels. -323P0/P10 genotype was independently associated with traumatic coagulopathy and PHI in isolated TBI patients.	[Fang, Jiang; Yuan, Qiang; Du, Zhuoying; Yang, Weijian; Chen, Long; Zhao, Jianlan; Xie, Rong; Hu, Jin; Wu, Xing] Fudan Univ, Dept Neurosurg, Huashan Hosp, 12 Wulumuqi Zhong Rd, Shanghai, Peoples R China; [Wu, Xing] Shigatse Peoples Hosp, Dept Neurosurg, 28 Shanghai Zhong Rd, Shigatse, Tibet, Peoples R China; [Liu, Chaobo; Xu, Hao] Fudan Univ, Neurosurg Dept, PuDong Hosp, 2800 Gongwei Rd, Shanghai, Peoples R China; [Fang, Jiang; Yuan, Qiang; Du, Zhuoying; Yang, Weijian; Chen, Long; Zhao, Jianlan; Xie, Rong; Hu, Jin; Wu, Xing] Fudan Univ, Neurosurg Inst, Shanghai, Peoples R China; [Fang, Jiang; Yuan, Qiang; Du, Zhuoying; Yang, Weijian; Chen, Long; Zhao, Jianlan; Xie, Rong; Hu, Jin; Wu, Xing] Shanghai Clin Med Ctr Neurosurg, Shanghai, Peoples R China; [Fang, Jiang; Yuan, Qiang; Du, Zhuoying; Yang, Weijian; Chen, Long; Zhao, Jianlan; Xie, Rong; Hu, Jin; Wu, Xing] Shanghai Key Lab Brain Funct Restorat & Neural Re, Shanghai, Peoples R China		Xie, R; Hu, J; Wu, X (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, 12 Wulumuqi Zhong Rd, Shanghai, Peoples R China.; Xie, R; Hu, J (corresponding author), Fudan Univ, Neurosurg Inst, Shanghai, Peoples R China.; Xie, R; Hu, J (corresponding author), Shanghai Clin Med Ctr Neurosurg, Shanghai, Peoples R China.; Xie, R; Hu, J (corresponding author), Shanghai Key Lab Brain Funct Restorat & Neural Re, Shanghai, Peoples R China.	huashan_rongxie@163.com; hujindn@163.com; huashan_wuxing@163.com			National Key R&D Program of China [2018YFA0107900]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81000518, 81271003, 81271375, 81471241]	This study was supported, in part, by funds from National Key R&D Program of China, 2018YFA0107900 and the National Natural Science Foundation of China (NSFC Grants 81000518, 81271003, 81271375, and 81471241) .	Bernardi F, 1996, ARTERIOSCL THROM VAS, V16, P72; Bowman R, 2009, EUR J CLIN NUTR, V63, P771, DOI 10.1038/ejcn.2008.28; Bozzini C, 2004, THROMB HAEMOSTASIS, V92, P541, DOI 10.1160/Th04-02-0130; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corral J, 2001, BLOOD, V97, P2979, DOI 10.1182/blood.V97.10.2979; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Folsom AR, 2007, J THROMB HAEMOST, V5, P1674, DOI 10.1111/j.1538-7836.2007.02620.x; Greisenegger S, 2007, EUR J NEUROL, V14, P1098, DOI 10.1111/j.1468-1331.2007.01906.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lindman AS, 2004, THROMB RES, V113, P57, DOI 10.1016/j.thromres.2004.02.001; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Pollak ES, 1996, J BIOL CHEM, V271, P1738, DOI 10.1074/jbc.271.3.1738; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; van Gent JAN, 2020, ACTA NEUROCHIR, V162, P329, DOI 10.1007/s00701-019-04111-z; van't Hooft FM, 1999, BLOOD, V93, P3432, DOI 10.1182/blood.V93.10.3432.410k16_3432_3441; Wan XY, 2020, J NEUROSURG, V133, P496, DOI 10.3171/2019.4.JNS183472; Wu X, 2014, J TRAUMA ACUTE CARE, V76, P114, DOI 10.1097/TA.0b013e3182a8fe48; Yuan Q, 2017, NEUROSCIENCE, V348, P114, DOI 10.1016/j.neuroscience.2017.02.020; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Yuan Q, 2015, J CRIT CARE, V30, P116, DOI 10.1016/j.jcrc.2014.07.009; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	28	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2021	208								106836	10.1016/j.clineuro.2021.106836			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UR7WG	WOS:000696954100001	34371385				2022-02-06	
J	Fortenbaugh, FC; Gustafson, JA; Fonda, JR; Fortier, CB; Milberg, WP; McGlinchey, RE				Fortenbaugh, Francesca C.; Gustafson, Jennifer A.; Fonda, Jennifer R.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.			Blast mild traumatic brain injury is associated with increased myopia and chronic convergence insufficiency	VISION RESEARCH			English	Article						Traumatic brain injury; Distance acuity; Myopia; Accommodation; Convergence; Posttraumatic pseudomyopia	VISUAL DYSFUNCTION; BOSTON ASSESSMENT; VETERANS; EXPOSURE; AFGHANISTAN; IRAQ; ACCOMMODATION; CONSEQUENCES; IMPAIRMENT; PREVALENCE	While chronic visual symptom complaints are common among Veterans with a history of mild traumatic brain injury (mTBI), research is still ongoing to characterize the pattern of visual deficits that is most strongly associated with mTBI and specifically, the impact of blast-related mTBI on visual functioning. One area that has not been well explored is the potential impact of blast mTBI on refractive error. While myopic shifts have been documented following head injuries in civilian populations, posttraumatic myopic shifts have not been explored in participants with military mTBI. This study investigated the impact of blast mTBIs on a range of visual function measures including distance acuity and refractive error, in a well-characterized cohort of thirty-one Post-9/11 veterans for whom detailed clinical interviews regarding military and TBI history were available. Seventeen participants had a history of blast-related mTBI (blast mTBI + group) while 14 did not (blast mTBI- group). Results show an increased frequency of convergence insufficiency and myopia in the blast mTBI + group relative to the blast mTBI- group. Linear regression analyses further show that deficits in distance acuity and refractive error are associated with the number of blast mTBIs during military service but not the number of non-blast mTBIs or the number of lifetime non-blast TBIs and cannot be accounted for by PTSD. These results are consistent with long-lasting damage following blast mTBI to subcortical visual structures that support both vergence movements and the accommodative functions needed to see clearly objects at varying distances.	[Fortenbaugh, Francesca C.; Gustafson, Jennifer A.; Fonda, Jennifer R.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; Gustafson, Jennifer A.; Fonda, Jennifer R.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; Gustafson, Jennifer A.; Fonda, Jennifer R.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Gustafson, Jennifer A.] VA Boston Healthcare Syst, Optometry Clin, Boston, MA 02130 USA; [Gustafson, Jennifer A.] New England Coll Optometry, Boston, MA USA; [Fonda, Jennifer R.] Boston Univ, Dept Psychiat, Sch Med, Boston, MA 02215 USA		Fortenbaugh, FC (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave,182 JP, Boston, MA 02130 USA.	Francesca_Fortenbaugh@hms.harvard.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904; Gustafson, Jennifer/0000-0002-1719-6586	Department of Veterans Affairs (VA) through the Translational Research Center for TBI and Stress Disorders (TRACTS)US Department of Veterans Affairs; VA Rehabilitation Research & Development Traumatic Brain Injury National Research Center [B3001-C]; Career Development Award from the Department of Veterans Affairs Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [5IK2RX002268]; VA Clinical Science Research & Development Merit Review [CX001327]; National Institute of Health NCCIH grant [R21 AT009430-01]	This research was supported by the Department of Veterans Affairs (VA) through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research & Development Traumatic Brain Injury National Research Center (B3001-C), a Career Development Award from the Department of Veterans Affairs Rehabilitation Research and Development (5IK2RX002268) to F.C.F, a VA Clinical Science Research & Development Merit Review (CX001327) to R.E.M, and a National Institute of Health NCCIH grant (R21 AT009430-01) to W.P.M. The contents within do not represent the views of the Department of Veterans Affairs or the United States government.	Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Amara J, 2014, MIL MED, V179, P964, DOI 10.7205/MILMED-D-13-00559; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Capo-Aponte JE, 2015, J REHABIL RES DEV, V52, P273, DOI 10.1682/JRRD.2014.09.0204; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Casto K. L., 2012, AUDITORY VESTIBULAR; Chan JW, 2019, INVEST OPHTH VIS SCI, V60, P2005, DOI 10.1167/iovs.18-26094; Chan RVP, 2002, J NEURO-OPHTHALMOL, V22, P15, DOI 10.1097/00041327-200203000-00005; Chin DL, 2020, MIL MED, V185, pE711, DOI 10.1093/milmed/usz440; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cogan AM, 2020, PM&R, V12, P301, DOI 10.1002/pmrj.12237; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Flanagan G, 2020, MIL MED, V185, pE1576, DOI 10.1093/milmed/usaa154; Fortenbaugh FC, 2020, J TRAUMA STRESS, V33, P750, DOI 10.1002/jts.22501; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Frick KD, 2019, MIL MED, V184, pE338, DOI 10.1093/milmed/usy420; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Greer N, 2016, PREVALENCE EPIDEMIOL; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hughes Fintan E, 2017, Am J Ophthalmol Case Rep, V8, P28, DOI 10.1016/j.ajoc.2017.09.006; Imburgia A., 2017, INT J OPHTHALMIC PAT, V6, P1, DOI [10.4172/2324-8599.1000209, DOI 10.4172/2324-8599.1000209]; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; London Richard, 2003, Optometry, V74, P111; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Maples W C, 1988, J Am Optom Assoc, V59, P549; Maples W. C., 1992, J BEHAV OPTOM, V3, P143; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Notghi B, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037072; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Palmer Stephen E, 1999, VISION SCI PHOTONS P; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Reynolds Mark E, 2019, MSMR, V26, P13; Reynolds Mark E, 2019, MSMR, V26, P26; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; U.S. Department of Veterans Affairs and U.S. Department of Defence, 2009, VA DOD CLIN GUID MAN VA DOD CLIN GUID MAN; Vespa J. E., 2020, ACS45 US CENS BUR ACS45 US CENS BUR; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Walsh DV, 2015, MIL MED, V180, P178, DOI 10.7205/MILMED-D-14-00230; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Wick B., 2008, CLIN MANAGEMENT BINO; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	80	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	SEP	2021	186						1	12		10.1016/j.visres.2021.04.004			12	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	TH5VG	WOS:000672156900001	34000559				2022-02-06	
J	Fountain, DM; Henry, J; Honeyman, S; O'Connor, P; Sekhon, P; Piper, RJ; Edlmann, E; Martin, M; Whiting, G; Turner, C; Mee, H; Joannides, AJ; Kolias, AG; Hutchinson, PJ				Fountain, Daniel M.; Henry, Jack; Honeyman, Susan; O'Connor, Paul; Sekhon, Priya; Piper, Rory J.; Edlmann, Ellie; Martin, Michael; Whiting, Gemma; Turner, Carole; Mee, Harry; Joannides, Alexis J.; Kolias, Angelos G.; Hutchinson, Peter J.		Uk Cranial Reconstruction Registry; British Neurosurg Trainee Res Coll	First Report of a Multicenter Prospective Registry of Cranioplasty in the United Kingdom and Ireland	NEUROSURGERY			English	Article						Cranioplasty; Craniectomy; Titanium; Autologous; TBI	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DECOMPRESSIVE CRANIECTOMY; COMPLICATIONS; TITANIUM; OUTCOMES; POLYETHERETHERKETONE; HEMICRANIECTOMY; HYDROXYAPATITE; IMPLANTS; TRIAL	BACKGROUND There are many questions that remain unanswered regarding outcomes following cranioplasty including the timing of cranioplasty following craniectomy as well as the material used. OBJECTIVE To establish and evaluate 30-d outcomes for all cranial reconstruction procedures in the United Kingdom (UK) and Ireland through a prospective multicenter cohort study. METHODS Patients undergoing cranioplasty insertion or revision between June 1, 2019 and November 30, 2019 in 25 neurosurgical units were included. Data collected include demographics, craniectomy date and indication, cranioplasty material and date, and 30-d outcome. RESULTS In total, 313 operations were included, consisting of 255 new cranioplasty insertions and 58 revisions. Of the new insertions, the most common indications for craniectomy were traumatic brain injury (n = 110, 43%), cerebral infarct (n = 38, 15%), and aneurysmal subarachnoid hemorrhage (n = 30, 12%). The most common material was titanium (n = 163, 64%). Median time to cranioplasty was 244 d (interquartile range 144-385), with 37 new insertions (15%) within or equal to 90 d. In 30-d follow-up, there were no mortalities. There were 14 readmissions, with 10 patients sustaining a wound infection within 30 d (4%). Of the 58 revisions, the most common reason was due to infection (n = 33, 59%) and skin breakdown (n = 13, 23%). In 41 (71%) cases, the plate was removed during the revision surgery. CONCLUSION This study is the largest prospective study of cranioplasty representing the first results from the UK Cranial Reconstruction Registry, a first national registry focused on cranioplasty with the potential to address outstanding research questions for this procedure.	[Fountain, Daniel M.] Salford Royal NHS Fdn Trust, Manchester Ctr Clin Neuro Sci, Manchester, Lancs, England; [Henry, Jack] Beaumont Hosp, Natl Neurosurg Ctr, Dublin, Ireland; [Honeyman, Susan; Piper, Rory J.] John Radcliffe Hosp, Dept Neurosurg, Oxford, England; [O'Connor, Paul] Univ Hosp Coventry, Coventry, W Midlands, England; [Sekhon, Priya] Kings Coll Hosp London, Dept Neurosurg, London, England; [Edlmann, Ellie] Univ Plymouth, Dept Neurosurg, Plymouth, Devon, England; [Martin, Michael; Joannides, Alexis J.] Orion MedTech Ltd CIC, Cambridge, England; [Whiting, Gemma; Turner, Carole; Mee, Harry; Joannides, Alexis J.; Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Hills Rd, Cambridge CB2 0QQ, England; [Whiting, Gemma; Turner, Carole; Mee, Harry; Joannides, Alexis J.; Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Hills Rd, Cambridge CB2 0QQ, England		Kolias, AG (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Hills Rd, Cambridge CB2 0QQ, England.; Kolias, AG (corresponding author), Univ Cambridge, Hills Rd, Cambridge CB2 0QQ, England.; Fountain, DM (corresponding author), Salford Royal NHS Fdn Trust, Manchester Ctr Clin Neurosci, Stott Lane, Salford M6 8HD, Lancs, England.	Daniel.Fountain@ahs.net; ak721@cam.ac.uk	Ghimire, Prajwal/AAL-7905-2020; Belli, Antonio/I-3799-2015	Ghimire, Prajwal/0000-0003-2884-956X; Solomou, Georgios/0000-0002-9795-0517; Hill, Ciaran/0000-0002-4488-4034; Bulters, Diederik/0000-0001-9884-9050; Bandyopadhyay, Soham/0000-0001-6553-3842; James, Greg/0000-0003-3014-7428; Amoo, Michael/0000-0001-6886-6714; Henry, Jack/0000-0001-5662-198X; Piper, Rory/0000-0002-6422-5853; Lammy, Simon/0000-0003-3199-0038; Edlmann, Ellie/0000-0002-7253-9115; Belli, Antonio/0000-0002-3211-9933; Akhbari, Melika/0000-0001-7634-2515			Alotaibi NM, 2017, J NEUROSURG, V127, P1315, DOI 10.3171/2016.9.JNS161383; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584; Bhaskar IP, 2011, ANZ J SURG, V81, P137, DOI 10.1111/j.1445-2197.2010.05584.x; Broughton E, 2014, BRIT J NEUROSURG, V28, P34, DOI 10.3109/02688697.2013.815319; Buhler D, 2015, STROKE, V46, P819, DOI 10.1161/STROKEAHA.114.007703; Cruz-Flores S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003435.pub2; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Feroze AH, 2015, J NEUROSURG, V123, P1098, DOI 10.3171/2014.11.JNS14622; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Fricia M, 2019, WORLD NEUROSURG, V121, P160, DOI 10.1016/j.wneu.2018.09.199; Ganau M, 2020, J CLIN NEUROSCI, V74, P98, DOI 10.1016/j.jocn.2020.01.087; Goedemans T, 2018, BRIT J NEUROSURG, V32, P149, DOI 10.1080/02688697.2017.1406453; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Honeybul S, 2018, ACTA NEUROCHIR, V160, P885, DOI 10.1007/s00701-018-3514-z; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01357; Jabbarli R, 2017, WORLD NEUROSURG, V98, P689, DOI 10.1016/j.wneu.2016.12.012; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Kolias AG, 2018, CURR TRAUMA REP, V4, P326, DOI 10.1007/s40719-018-0147-x; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Korhonen TK, 2019, J NEUROSURG, V130, P312, DOI 10.3171/2017.8.JNS171857; Liang ES, 2016, BRIT J NEUROSURG, V30, P122, DOI 10.3109/02688697.2015.1080216; Lindner Dirk, 2017, J Neurosurg, V126, P175, DOI 10.3171/2015.10.JNS151245; Liu LM, 2020, BRIT J NEUROSURG, V34, P388, DOI 10.1080/02688697.2020.1742291; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Nagel A, 2009, NEUROCRIT CARE, V11, P384, DOI 10.1007/s12028-009-9269-x; Nasi Davide, 2020, Surg Neurol Int, V11, P94, DOI 10.25259/SNI_120_2020; Ng ZY, 2014, J CRANIOFAC SURG, V25, pE55, DOI 10.1097/SCS.0b013e3182a2f7b6; Punchak M, 2017, J CLIN NEUROSCI, V41, P30, DOI 10.1016/j.jocn.2017.03.028; R Development Core Team, 2012, R LANG ENV STAT COMP; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Thien A, 2015, WORLD NEUROSURG, V83, P176, DOI 10.1016/j.wneu.2014.06.003; van de Vijfeijken SECM, 2018, WORLD NEUROSURG, V117, P443, DOI 10.1016/j.wneu.2018.05.193; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yasuhara T, 2020, NEUROL MED-CHIR, V60, P337, DOI 10.2176/nmc.oa.2020-0051; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zheng WJ, 2018, WORLD NEUROSURG, V120, pE811, DOI 10.1016/j.wneu.2018.08.172	49	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2021	89	3					518	526		10.1093/neuros/nyab220			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UL4BM	WOS:000692598400056	34192745				2022-02-06	
J	Fraser, DD; Chen, M; Ren, A; Miller, MR; Martin, C; Daley, M; Diamandis, EP; Prassas, I				Fraser, Douglas D.; Chen, Michelle; Ren, Annie; Miller, Michael R.; Martin, Claudio; Daley, Mark; Diamandis, Eleftherios P.; Prassas, Ioannis			Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						biomarkers; intensive care unit; outcome; proteomics; traumatic brain injury	TRANSLATIONAL RESEARCH; PATHOPHYSIOLOGY; RECEPTOR	Objectives: Severe traumatic brain injury (sTBI) patients suffer high mortality. Accurate prognostic biomarkers have not been identified. In this exploratory study, we performed targeted proteomics on plasma obtained from sTBI patients to identify potential outcome biomarkers. Methods: Blood sample was collected from patients admitted to the ICU suffering a sTBI, using standardized clinical and computerized tomography (CT) imaging criteria. Age- and sex-matched healthy control subjects and sTBI patients were enrolled. Targeted proteomics was performed on plasma with proximity extension assays (1,161 proteins). Results: Cohorts were well-balanced for age and sex. The majority of sTBI patients were injured in motor vehicle collisions and the most frequent head CT finding was subarachnoid hemorrhage. Mortality rate for sTBI patients was 40%. Feature selection identified the top performing 15 proteins for identifying sTBI patients from healthy control subjects with a classification accuracy of 100%. The sTBI proteome was dominated bymarkers of vascular pathology, immunity/inflammation, cell survival and macrophage/microglia activation. Receiver operating characteristic (ROC) curve analyses demonstrated areas-under-the-curves (AUC) for identifying sTBI that ranged from 0.870-1.000 (p=0.005). When mortality was used as outcome, ROC curve analyses identified the top 3 proteins as Willebrand factor (vWF), Wnt inhibitory factor-1 (WIF-1), and colony stimulating factor-1 (CSF-1). Combining vWF with either WIF-1 or CSF-1 resulted in excellent mortality prediction with AUC of 1.000 for both combinations (p=0.011). Conclusions: Targeted proteomics with feature classification and selection distinguished sTBI patients from matched healthy control subjects. Two protein combinations were identified that accurately predicted sTBI patient mortality. Our exploratory findings require confirmation in larger sTBI patient populations.	[Fraser, Douglas D.] London Hlth Sci Ctr, Lawson Hlth Res Inst, Room C2-C82,800 Commissioners Rd East, London, ON N6A 5W9, Canada; [Fraser, Douglas D.; Miller, Michael R.] Western Univ, Pediat, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Clin Neurol Sci, London, ON, Canada; [Fraser, Douglas D.] NeuroLytixs Inc, Toronto, ON, Canada; [Prassas, Ioannis] Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, Pathol & Lab Med, 60 Murray St Box 32 Floor 6,Room L6-201, Toronto, ON M5T 3L9, Canada; [Diamandis, Eleftherios P.; Prassas, Ioannis] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Chen, Michelle; Ren, Annie; Diamandis, Eleftherios P.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Miller, Michael R.; Martin, Claudio; Daley, Mark] Lawson Hlth Res Inst, London, ON, Canada; [Diamandis, Eleftherios P.] Mt Sinai Hosp, Pathol & Lab Med, Toronto, ON, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Clin Biochem, Toronto, ON, Canada		Fraser, DD (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Room C2-C82,800 Commissioners Rd East, London, ON N6A 5W9, Canada.; Fraser, DD (corresponding author), Western Univ, Pediat, London, ON, Canada.; Fraser, DD (corresponding author), Western Univ, Clin Neurol Sci, London, ON, Canada.; Fraser, DD (corresponding author), NeuroLytixs Inc, Toronto, ON, Canada.; Prassas, I (corresponding author), Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, Pathol & Lab Med, 60 Murray St Box 32 Floor 6,Room L6-201, Toronto, ON M5T 3L9, Canada.; Prassas, I (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.	douglas.fraser@lhsc.on.ca; yprassas@gmail.com	; Daley, Mark/B-5679-2015	Diamandis, Eleftherios/0000-0002-1589-820X; Daley, Mark/0000-0002-6939-9772	Children's Health Foundation	This research is funded by Children's Health Foundation.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Brisson AR, 2012, PEDIATRICS, V129, P153, DOI 10.1542/peds.2011-0134; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Fraser Douglas D, 2020, Crit Care Explor, V2, pe0189, DOI 10.1097/CCE.0000000000000189; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gillio-Meina C, 2013, PEDIATRICS, V131, P754, DOI 10.1542/peds.2012-1181; Greenwood Christina, 2015, Biomol Detect Quantif, V4, P10, DOI 10.1016/j.bdq.2015.04.002; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Horvath Beata, 2004, Exp Clin Cardiol, V9, P31; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Koczula KM, 2016, ESSAYS BIOCHEM, V60, P111, DOI 10.1042/EBC20150012; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Marchetti B, 2013, TRENDS MOL MED, V19, P144, DOI 10.1016/j.molmed.2012.12.001; Menet R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.565667; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Poggi L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00167; Pons V, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00499; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandsmark DK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00246; Siegbahn A, 2017, SCIENCE S, P22; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Tang C, 2018, ADV NEURAL INFORM PR, P2987; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Turgeon AF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013779; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vashist SK, 2019, POINT OF CARE TECHNO, P133; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Xu X, 2020, J THROMB HAEMOST, V18, P3154, DOI 10.1111/jth.15096	40	0	0	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2021	59	10					1662	1669		10.1515/cclm-2021-0103			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	UL5KI	WOS:000692689300017	34144643				2022-02-06	
J	Fure, SCR; Howe, EI; Andelic, N; Brunborg, C; Sveen, U; Roe, C; Rike, PO; Olsen, A; Spjelkavik, O; Ugelstad, H; Lu, J; Ponsford, J; Twamley, EW; Hellstrom, T; Lovstad, M				Fure, Silje C. R.; Howe, Emilie Isager; Andelic, Nada; Brunborg, Cathrine; Sveen, Unni; Roe, Cecilie; Rike, Per-Ola; Olsen, Alexander; Spjelkavik, Oystein; Ugelstad, Helene; Lu, Juan; Ponsford, Jennie; Twamley, Elizabeth W.; Hellstrom, Torgeir; Lovstad, Marianne			Cognitive and vocational rehabilitation after mild-to-moderate traumatic brain injury: A randomised controlled trial	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Mild-to-moderate traumatic brain injury; Concussion; Return to work; Work stability; Vocational rehabilitation; Cognitive rehabilitation	POST-CONCUSSION SYMPTOMS; WORK; RETURN; PREVENTION; STABILITY; THERAPY	Background: Returning to work is often a primary rehabilitation goal after traumatic brain injury (TBI). However, the evidence base for treatment options regarding return to work (RTW) and stable work maintenance remains scarce. Objective: This study aimed to examine the effect of a combined cognitive and vocational intervention on work-related outcomes after mild-to-moderate TBI. Methods: In this study, we compared 6 months of a combined compensatory cognitive training and supported employment (CCT-SE) intervention with 6 months of treatment as usual (TAU) in a randomised controlled trial to examine the effect on time to RTW, work percentage, hours worked per week and work stability. Eligible patients were those with mild-to-moderate TBI who were employed >= 50% at the time of injury, 18 to 60 years old and sick-listed >= 50% at 8 to 12 weeks after injury due to post-concussion symptoms, assessed by the Rivermead Post Concussion Symptoms Questionnaire. Both treatments were provided at the outpatient TBI department at Oslo University Hospital, and follow-ups were conducted at 3, 6 and 12 months after inclusion. Results: We included 116 individuals, 60 randomised to CCT-SE and 56 to TAU. The groups did not differ in characteristics at the 12-month follow-up. Overall, a high proportion had returned to work at 12 months (CCT-SE, 90%; TAU, 84%, P = 0.40), and all except 3 were stably employed after the RTW. However, a significantly higher proportion of participants in the CCT-SE than TAU group had returned to stable employment at 3 months (81% vs. 60%, P = 0.02). Conclusion: These results suggest that the CCT-SE intervention might help patients with mild-to-moderate TBI who are still sick-listed 8 to 12 weeks after injury in an earlier return to stable employment. However, the results should be replicated and a cost-benefit analysis performed before concluding. (C) 2021 The Author(s). Published by Elsevier Masson SAS.	[Fure, Silje C. R.; Howe, Emilie Isager; Andelic, Nada; Sveen, Unni; Roe, Cecilie; Hellstrom, Torgeir] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway; [Fure, Silje C. R.; Andelic, Nada; Roe, Cecilie; Lu, Juan] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Howe, Emilie Isager; Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Sveen, Unni; Lovstad, Marianne] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Rike, Per-Ola] Sunnaas Rehabil Hosp Trust, Dept Res, Nesoddtangen, Norway; [Olsen, Alexander] Norwegian Univ Technol & Sci, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Spjelkavik, Oystein] Oslo Metropolitan Univ, Work Res Inst, Oslo, Norway; [Ugelstad, Helene] Norwegian Labor & Welf Adm, Dept Vocat Rehabil, Oslo, Norway; [Lu, Juan] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Div Epidemiol, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Res Ctr, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Twamley, Elizabeth W.] Ctr Excellence Stress & Mental Hlth, Vet Affairs VA San Diego Healthcare Syst, San Diego, CA USA; [Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA; [Lovstad, Marianne] Sunnaas Rehabil Hosp Trust, Dept Res, Nesoddtangen, Norway; [Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway		Fure, SCR (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway.	siljfu@ous-hf.no	Hellstrom, Torgeir/AAY-6043-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Spjelkavik, Oystein/0000-0003-1151-1263; Fure, Silje Christine Reistad/0000-0001-7926-6298; Lu, Juan/0000-0002-5389-7603	Research Council of NorwayResearch Council of Norway [256689/H10]	This work was supported by the Research Council of Norway (256689/H10) , which had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Becker D.R., 2003, WORKING LIFE PEOPLE, DOI [10.1093/acprof:oso/9780195131215.001.0001, DOI 10.1093/ACPROF:OSO/9780195131215.001.0001]; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Graham CW., 2016, CAMPBELL SYST REV, V12, DOI [10.4073/csr.2016.6, DOI 10.4073/CSR.2016.6]; HOWE EI, 2019, COGENT MED, P00001, DOI DOI 10.1080/2331205X.2019.1565614; Howe EI, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2218-7; Howe EI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.561400; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Reme SE, 2015, OCCUP ENVIRON MED, V72, P745, DOI 10.1136/oemed-2014-102700; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Steenstra IA, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-26; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Sveinsdottir V, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0307-7; TEASDALE G, 1974, LANCET, V2, P81; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; van Oostrom SH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-12; van Velzen JM, 2016, DISABIL REHABIL, V38, P62, DOI 10.3109/09638288.2015.1017057; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852	32	0	0	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2021	64	5			SI				101538	10.1016/j.rehab.2021.101538			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WG9RK	WOS:000707327800018	33957293	Green Published, hybrid			2022-02-06	
J	Garbuz, DG; Zatsepina, OG; Evgen'ev, MB				Garbuz, D. G.; Zatsepina, O. G.; Evgen'ev, M. B.			Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer's Disease Pathogenesis	MOLECULAR BIOLOGY			English	Article						Alzheimer's disease; neurodegeneration; beta-amyloid; tau protein; neuroinflammation	TRAUMATIC BRAIN-INJURY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; A-BETA; MOUSE MODEL; NEURODEGENERATIVE DISORDERS; EXOGENOUS INDUCTION; MOLECULAR-GENETICS; HUMAN TRANSMISSION; SOLUBLE OLIGOMERS; CLINICAL-TRIALS	Alzheimer's disease (AD) is a neurodegenerative disease that inevitably results in dementia and death. Currently, there are no pathogenetically grounded methods for the prevention and treatment of AD, and all current treatment regimens are symptomatic and unable to significantly delay the development of dementia. The accumulation of beta-amyloid peptide (A beta), which is a spontaneous, aggregation-prone, and neurotoxic product of the processing of signaling protein APP (Amyloid Precursor Protein), in brain tissues, primarily in the hippocampus and the frontal cortex, was for a long time considered the main cause of neurodegenerative changes in AD. However, attempts to treat AD based on decreasing A beta production and aggregation did not bring significant clinical results. More and more arguments are arising in favor of the fact that the overproduction of A beta in most cases of AD is not the initial cause, but a concomitant event of pathological processes in the course of the development of sporadic AD. The concept of neuroinflammation has come to the fore, suggesting that inflammatory responses play the leading role in the initiation and development of AD, both in brain tissue and in the periphery. The hypothesis about the key role of neuroinflammation in the pathogenesis of AD opens up new opportunities in the search for ways to treat and prevent this socially significant disease.	[Garbuz, D. G.; Zatsepina, O. G.; Evgen'ev, M. B.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia		Garbuz, DG (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia.	dgarbuz@yandex.ru					Abbott A, 2020, NATURE, V587, P22, DOI 10.1038/d41586-020-03084-9; Aisen PS, 2011, ARCH MED SCI, V7, P102, DOI 10.5114/aoms.2011.20612; Aneja R, 2006, J IMMUNOL, V177, P7184, DOI 10.4049/jimmunol.177.10.7184; Armstrong R A, 2011, Int J Alzheimers Dis, V2011, P630865, DOI 10.4061/2011/630865; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bayer TA, 2015, EUR NEUROPSYCHOPHARM, V25, P713, DOI 10.1016/j.euroneuro.2013.03.007; Benito-Leon J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222505; Bibl M, 2012, J NEURAL TRANSM, V119, P805, DOI 10.1007/s00702-012-0801-3; Bobkova N.V., 2015, USP BIOL KHIM, V55, P351; Bobkova NV, 2014, J ALZHEIMERS DIS, V38, P425, DOI 10.3233/JAD-130779; Bolos Marta, 2017, BioMolecular Concepts, V8, P37, DOI 10.1515/bmc-2016-0029; Borges TJ, 2013, INT J HYPERTHER, V29, P455, DOI 10.3109/02656736.2013.798037; Bourgade K, 2016, J ALZHEIMERS DIS, V50, P1227, DOI 10.3233/JAD-150652; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Briston T, 2018, BIOCHEM SOC T, V46, P829, DOI 10.1042/BST20180025; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Cakala M, 2007, PHARMACOL REP, V59, P164; Cali I, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-017-0503-z; Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050771; Ciccocioppo F, 2020, NEURAL REGEN RES, V15, P850, DOI 10.4103/1673-5374.268971; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; De Mena L, 2017, FLY, V11, P179, DOI 10.1080/19336934.2017.1291104; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DiChiara T, 2017, YALE J BIOL MED, V90, P45; Domise M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26758; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dursun E, 2015, J NEUROIMMUNOL, V283, P50, DOI 10.1016/j.jneuroim.2015.04.014; Duvernoy HM, 2007, BRAIN RES REV, V56, P119, DOI 10.1016/j.brainresrev.2007.06.002; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; [Емелин Андрей Юрьевич Emelin Andrei Yuryevich], 2011, [Неврология, нейропсихиатрия, психосоматика, Nevrologiya, neiropsikhiatriya, psikhosomatika], P5; Evgen'ev M, 2019, J ALZHEIMERS DIS, V67, P1391, DOI 10.3233/JAD-180987; Evgen'ev MB, 2017, J ALZHEIMERS DIS, V59, P1415, DOI 10.3233/JAD-170398; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frost GR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170228; Fulop T, 2019, J NEUROVIROL, V25, P634, DOI 10.1007/s13365-019-00732-3; Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514; Gao Y, 2018, CURR ALZHEIMER RES, V15, P283, DOI 10.2174/1567205014666170417111859; Gaur S, 2015, GERIATR GERONTOL INT, V15, P391, DOI 10.1111/ggi.12425; Ghosh AK, 2015, CYTOKINE, V73, P44, DOI 10.1016/j.cyto.2015.01.018; Go M, 2016, BIOCHEM BIOPH RES CO, V479, P331, DOI 10.1016/j.bbrc.2016.09.073; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Haass C, 1996, CURR OPIN NEUROL, V9, P254, DOI 10.1097/00019052-199608000-00002; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamilton A, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0107-0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; Hartley D, 2015, ALZHEIMERS DEMENT, V11, P700, DOI 10.1016/j.jalz.2014.10.007; He Y, 2012, BIOCHEM BIOPH RES CO, V429, P125, DOI 10.1016/j.bbrc.2012.10.129; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hoozemans JJM, 2011, CNS NEUROL DISORD-DR, V10, P57; Hsu JH, 2014, SHOCK, V42, P540, DOI 10.1097/SHK.0000000000000254; Hung SY, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0355-7; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jaunmuktane Z, 2018, ACTA NEUROPATHOL, V135, P671, DOI 10.1007/s00401-018-1822-2; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamer AR, 2015, NEUROBIOL AGING, V36, P627, DOI 10.1016/j.neurobiolaging.2014.10.038; Kepp KP, 2017, J ALZHEIMERS DIS, V55, P447, DOI 10.3233/JAD-160550; Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1; Kong C, 2019, VIROL SIN, V34, P475, DOI 10.1007/s12250-019-00124-1; Kozin SA, 2019, MOL BIOL+, V53, P896, DOI 10.1134/S0026893319060104; Kozin SA, 2013, NEUROTOX RES, V24, P370, DOI 10.1007/s12640-013-9399-y; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kustanova GA, 2006, CELL STRESS CHAPERON, V11, P276, DOI 10.1379/CSC-195R.1; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lauwers E, 2020, LANCET NEUROL, V19, P872, DOI 10.1016/S1474-4422(20)30238-6; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Leng FD, 2021, NAT REV NEUROL, V17, P157, DOI 10.1038/s41582-020-00435-y; Li Y, 2013, EXPERT OPIN BIOL TH, V13, P1515, DOI 10.1517/14712598.2013.838555; Lin WR, 2002, J PATHOL, V197, P395, DOI 10.1002/path.1127; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meek PD, 1998, PHARMACOTHERAPY, V18, P68; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Millington C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/309129; Mitkevich VA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.492; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Moore AH, 2010, PHARMACEUTICALS, V3, P1812, DOI 10.3390/ph3061812; Mroczko B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071884; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nalivaeva NN, 2020, MECH AGEING DEV, V192, DOI 10.1016/j.mad.2020.111363; Naliyaeya NN, 2019, BRIT J PHARMACOL, V176, P3447, DOI 10.1111/bph.14593; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Nazem A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0291-y; Neumann K, 2011, J ALZHEIMERS DIS, V25, P103, DOI 10.3233/JAD-2011-101641; Olsen I, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.29143; Panza F, 2019, BRAIN, V142, P2905, DOI 10.1093/brain/awz244; Peri F, 2014, J MED CHEM, V57, P3612, DOI 10.1021/jm401006s; Petrushanko IY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27738; Piacentini R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15444; Pimenova AA, 2018, BIOL PSYCHIAT, V83, P300, DOI 10.1016/j.biopsych.2017.05.014; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Purro SA, 2018, NATURE, V564, P415, DOI 10.1038/s41586-018-0790-y; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Qi HL, 2016, J BIOL CHEM, V291, P7742, DOI 10.1074/jbc.M115.700914; Rad SK, 2018, DRUG DES DEV THER, V12, P3999, DOI 10.2147/DDDT.S173970; Reisberg B., 2004, COMPREHENSIVE TXB GE, V3rd ed., P449; Rozhkova E, 2010, ANN NY ACAD SCI, V1197, P94, DOI 10.1111/j.1749-6632.2009.05375.x; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schwarzman AL, 2017, MOL BIOL+, V51, P368, DOI 10.1134/S0026893317030141; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shelkovnikova TA, 2012, MOL BIOL+, V46, P362, DOI 10.1134/S0026893312020161; Sochocka M, 2017, CURR NEUROPHARMACOL, V15, P996, DOI 10.2174/1570159X15666170313122937; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Stoccoro A, 2018, NEURODEGENER DIS MAN, V8, P181, DOI 10.2217/nmt-2018-0004; Sulistio YA, 2016, MOL NEUROBIOL, V53, P905, DOI 10.1007/s12035-014-9063-4; Swerdlow AJ, 2003, NEUROLOGY, V61, P783, DOI 10.1212/01.WNL.0000084000.27403.15; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vinokurov M, 2012, CELL STRESS CHAPERON, V17, P89, DOI 10.1007/s12192-011-0288-0; Walker LC, 2002, PEPTIDES, V23, P1241, DOI 10.1016/S0196-9781(02)00059-1; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Weintraub MK, 2014, BEHAV BRAIN RES, V266, P183, DOI 10.1016/j.bbr.2014.03.009; Weller Jason, 2018, F1000Res, V7, DOI 10.12688/f1000research.14506.1; Wenk GL, 2006, J CLIN PSYCHIAT, V67, P3; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Wong T.H., 2019, NEUROBIOL AGING, V86, DOI [10.1016/j.neurobiolaging.2019.01.015, DOI 10.1016/J.NEUROBIOLAGING.2019.01.015]; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yurinskaya M, 2015, CURR DRUG DELIV, V12, P524, DOI 10.2174/1567201812666150724094207; Zhang F, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay6931; Zhang FJ, 2015, NEUROPSYCH DIS TREAT, V11, P243, DOI 10.2147/NDT.S75546; Zhao LN, 2012, INT J MOL SCI, V13, P7303, DOI 10.3390/ijms13067303	144	0	0	5	5	PLEIADES PUBLISHING INC	NEW YORK	PLEIADES HOUSE, 7 W 54 ST, NEW YORK,  NY, UNITED STATES	0026-8933	1608-3245		MOL BIOL+	Mol. Biol.	SEP	2021	55	5					670	682		10.1134/S002689332104004X			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WJ2GR	WOS:000708867400002	34671002	hybrid			2022-02-06	
J	Gibstein, AR; Chen, K; Nakfoor, B; Gargano, F; Bradley, JP				Gibstein, Alexander R.; Chen, Kevin; Nakfoor, Bruce; Gargano, Francesco; Bradley, James P.			Mandibular Subcondylar Fracture: Improved Functional Outcomes in Selected Patients with Open Treatment	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							CONDYLAR PROCESS FRACTURES; CLOSED TREATMENT; INTERNAL-FIXATION; OPEN REDUCTION; MANAGEMENT	Background: Subcondylar fractures represent 25 to 35 percent of all mandibular fractures, yet the treatment paradigm has remained controversial. Closed treatment relies on the plasticity of the condyle head during recovery, whereas open treatment is challenging and risks facial nerve injury. Perioperative, functional, and patient-reported outcomes were measured to compare methods of open versus closed treatment of subcondylar fractures. Methods: Selected displaced subcondylar fracture cases with open (open reduction and internal fixation of subcondylar fracture with maxillomandibular fixation) versus closed (maxillomandibular fixation) treatment were compared (n = 60). Demographics, perioperative data, complications, persistent symptoms, chin deviation, malocclusion, change in mouth opening, functional scores, and FACE-Q patient satisfaction were recorded. Results: Open versus closed groups had similar demographics and perioperative data, except the open group had longer operating room time (76.39 minutes versus 56.15 minutes). In long-term follow-up, open-treated patients had fewer symptoms (9 percent versus 67 percent), less chin deviation (0 percent versus 40 percent), a less restricted mouth opening (3mm versus 5mm), and better functional scores (1.92 versus 0.861). Transient facial nerve weakness was seen in 6 percent of open cases. Conclusion: For selected subcondylar fracture patients, open treatment with endoscopic assistance, nerve monitoring, and specialized plates provides superior long-term results compared to closed treatment when considering symptoms and functional parameters. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.	Temple Univ, Div Plast Surg, Temple Div Plast & Reconstruct Surg, Northwell Hlth, Philadelphia, PA 19122 USA; Univ Notre Dame, Notre Dame, IN 46556 USA		Bradley, JP (corresponding author), Northwell Plast Surg, 1991 Marcus Ave,Suite 102, Lake Success, NY 11042 USA.	jpbradley4@mac.com					Al-Moraissi EA, 2015, J ORAL MAXIL SURG, V73, P482, DOI 10.1016/j.joms.2014.09.027; Andreasen JO, 2008, DENT TRAUMATOL, V24, P17, DOI 10.1111/j.1600-9657.2006.00498.x; Anehosur V, 2019, OR SURG OR MED OR PA, V128, P479, DOI 10.1016/j.oooo.2018.12.007; Bayat Mohammad, 2016, Electron Physician, V8, P3144; Berner T, 2015, J CRANIO MAXILL SURG, V43, P1404, DOI 10.1016/j.jcms.2015.07.027; Danda AK, 2010, J ORAL MAXIL SURG, V68, P1238, DOI 10.1016/j.joms.2009.09.042; Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P306, DOI 10.1016/j.jcms.2006.03.003; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; Ferretti C, 2005, INT J ORAL MAX SURG, V34, P376, DOI 10.1016/j.ijom.2004.09.003; Fonseca RJ, 2005, ORAL MAXILLOFACIAL T, V1, P530; Hackenberg B, 2014, J CRANIOFAC SURG, V25, P166, DOI 10.1097/SCS.0000000000000498; Hakim Tajamul Ahmad, 2018, Ann Maxillofac Surg, V8, P3, DOI 10.4103/ams.ams_166_17; Handschel J, 2012, J CRANIO MAXILL SURG, V40, pE397, DOI 10.1016/j.jcms.2012.02.012; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; HIDDING J, 1992, J CRANIO MAXILL SURG, V20, P345, DOI 10.1016/S1010-5182(05)80363-4; Kawamoto HK, 2009, PLAST RECONSTR SURG, V124, P1599, DOI 10.1097/PRS.0b013e3181babc1f; Kokemueller H, 2012, J ORAL MAXIL SURG, V70, P384, DOI 10.1016/j.joms.2011.02.035; Kommers SC, 2013, J CRANIO MAXILL SURG, V41, pE221, DOI 10.1016/j.jcms.2013.01.022; KONSTANTINOVIC VS, 1992, J ORAL MAXIL SURG, V50, P349, DOI 10.1016/0278-2391(92)90395-G; Kyzas PA, 2012, J CRANIO MAXILL SURG, V40, pE438, DOI 10.1016/j.jcms.2012.03.002; Sarnat BG, 2010, CRANIOFACIAL BIOL CR, P105; Schneider M, 2008, J ORAL MAXIL SURG, V66, P2537, DOI 10.1016/j.joms.2008.06.107; Shi D, 2015, J CRANIO MAXILL SURG, V43, P402, DOI 10.1016/j.jcms.2014.12.009; Shiju M, 2015, J CRANIO MAXILL SURG, V43, P448, DOI 10.1016/j.jcms.2015.01.012; Stiesch-Scholz V, 2005, J ORAL MAXIL SURG, V63, P1304, DOI 10.1016/j.joms.2005.05.293; Strohl AM, 2017, FACIAL PLAST SURG CL, V25, P577, DOI 10.1016/j.fsc.2017.06.008; ZIDE MF, 1983, J ORAL MAXIL SURG, V41, P89, DOI 10.1016/0278-2391(83)90214-8	27	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	SEP	2021	148	3					398E	406E		10.1097/PRS.0000000000008294			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UG0RR	WOS:000688971300006	34432692				2022-02-06	
J	Glutting, JJ; Davey, A; Wahlquist, VE; Watkins, M; Kaminski, TW				Glutting, Joseph J.; Davey, Adam; Wahlquist, Victoria E.; Watkins, Marley; Kaminski, Thomas W.			Internal (Factorial) Validity of the ANAM using a Cohort of Woman High-School Soccer Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Statistical methods; Test construction; Cognitive enhancement; Executive functions; Head injury; traumatic brain injury; Learning and memory	EXPLORATORY FACTOR-ANALYSIS; GOODNESS-OF-FIT; CONFIRMATORY FACTOR-ANALYSIS; CRONBACHS COEFFICIENT ALPHA; ASSESSMENT METRICS ANAM; SAMPLE-SIZE; NEUROPSYCHOLOGICAL ASSESSMENT; INTERVAL ESTIMATION; MAXIMUM-LIKELIHOOD; SCREE TEST	Introduction :Computerized neuropsychological testing is a cornerstone of sport-related concussion assessment. Female soccer players are at an increased risk for concussion as well as exposures to repetitive head impacts from heading a soccer ball. Our primary aim was to examine factorial validity of the Automated Neuropsychological Assessment Metrics (ANAM) neuropsychological test battery in computing the multiple neurocognitive constructs it purports to measure in a large cohort of interscholastic female soccer players. Methods: Study participants included 218 interscholastic female soccer players (age = 17.00.7 year; mass = 55.56.8 kg; height = 164.7 +/- 6.6 cm) drawn from a large (850+) prospective database examining purposeful heading from four area high schools over a 10-year period. The ANAM-2001 measured neurocognitive performance. Three methods were used to identify integral constructs underlying the ANAM: (a) exploratory factor analysis (EFA), (b) first-order confirmatory factor analysis (CFA), and (c) hierarchical CFA. Results: Neuropsychological phenomena measured by the ANAM-2001 were best reproduced by a hierarchical CFA organization, composed of two lower level factors (Simple Reaction Time, Mental Efficiency) and a single, general composite. Although the ANAM was multidimensional, only the composite was found to possess sufficient construct dimensionality and reliability for clinical score interpretation. Findings failed to uphold suppositions that the ANAM measures seven distinct constructs, or that any of its seven tests provide unique information independent of other constructs, or the composite, to support individual interpretation. Conclusions: Outcomes infer the ANAM possesses factorial-validity evidence, but only scores from the composite appear to sufficiently internally valid, and reliable, to support applied use by practitioners.	[Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE 19716 USA; [Davey, Adam] Univ Delaware, Dept Behav Hlth & Nutr, Newark, DE 19716 USA; [Wahlquist, Victoria E.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Athlet Training Res Lab, Newark, DE 19716 USA; [Watkins, Marley] Univ Delaware, Baylor Univ, Dept Educ Psychol, Newark, DE 19716 USA		Kaminski, TW (corresponding author), Dept Kinesiol & Appl Physiol, 541 S Coll Ave, Newark, DE 19716 USA.	glutting@udel.edu; davey@udel.edu; vwahlq@udel.edu; Marley_Watkins@baylor.edu; kaminski@udel.edu					AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; American Educational Research Association American Psychological Association. National Council on Measurement in Education & Joint Committee on Standards for Educational and Psychological Testing (U.S.), 2014, STAND ED PSYCH TEST, DOI [10.1037/e487712008-001, DOI 10.1037/E487712008-001]; Bandalos D. L., 2019, REVIEWERS GUIDE QUAN, V2nd, P98; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Braden J. P., 2012, CONT INTELLECTUAL AS, V3rd, P739; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Browne MW, 2001, MULTIVAR BEHAV RES, V36, P111, DOI 10.1207/S15327906MBR3601_05; Brunner M, 2012, J PERS, V80, P796, DOI 10.1111/j.1467-6494.2011.00749.x; Canivez G. L., 2016, PRINCIPLES METHODS T, P247; Canivez GL, 2019, APPL MEAS EDUC, V32, P232, DOI 10.1080/08957347.2019.1619562; Canivez GL, 2017, PSYCHOL ASSESSMENT, V29, P458, DOI 10.1037/pas0000358; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Chen FF, 2012, J PERS, V80, P219, DOI 10.1111/j.1467-6494.2011.00739.x; Cho E, 2015, ORGAN RES METHODS, V18, P207, DOI 10.1177/1094428114555994; Comrey A., 1992, 1 COURSE FACTOR ANAL; CRAWFORD CB, 1979, PERCEPT MOTOR SKILL, V49, P223, DOI 10.2466/pms.1979.49.1.223; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; DeVellis R.F., 2017, SCALE DEV THEORY APP; ELWOOD RW, 1993, CLIN PSYCHOL REV, V13, P409, DOI 10.1016/0272-7358(93)90012-B; Embretson, 2010, MEASURING PSYCHOL CO, P97, DOI [10.1037/12074-005, DOI 10.1037/12074-005]; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Ferrando PJ, 2018, PERS INDIV DIFFER, V123, P81, DOI 10.1016/j.paid.2017.11.014; Flora D.B., 2018, STAT METHODS SOCIAL; Flora DB, 2017, CAN J BEHAV SCI, V49, P78, DOI 10.1037/cbs0000069; Fokkema M, 2017, EUR J PSYCHOL ASSESS, V33, P399, DOI 10.1027/1015-5759/a000460; Frazier TW, 2007, J LEARN DISABIL-US, V40, P49, DOI 10.1177/00222194070400010401; Furr R.M., 2011, SCALE CONSTRUCTION P; Garrido LE, 2011, EDUC PSYCHOL MEAS, V71, P551, DOI 10.1177/0013164410389489; Garrido LE, 2016, PSYCHOL METHODS, V21, P93, DOI 10.1037/met0000064; Gerbing DW, 1996, STRUCT EQU MODELING, V3, P62, DOI 10.1080/10705519609540030; Gignac GE, 2013, MULTIVAR BEHAV RES, V48, P639, DOI 10.1080/00273171.2013.804398; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Glutting JJ, 1997, PSYCHOL ASSESSMENT, V9, P295, DOI 10.1037/1040-3590.9.3.295; GLUTTING JJ, 1987, EDUC PSYCHOL MEAS, V47, P607, DOI 10.1177/001316448704700307; Goldberg LR., 2006, DIFFERENTIATING NORM, P209; Gorsuch R.L., 1983, FACTOR ANAL; Gorsuch RL, 2003, HDB PSYCHOL RES METH, P143, DOI 10.1159/000067861; Gregory R.J., 2014, PSYCHOL TESTING HIST, V7; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Hancock G. R., 2001, STRUCTURAL EQUATION, P195; Heene M, 2011, PSYCHOL METHODS, V16, P319, DOI 10.1037/a0024917; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hershberger SL, 2006, QUANT METH EDUC BEHA, P13; Hogarty KY, 2005, EDUC PSYCHOL MEAS, V65, P202, DOI 10.1177/0013164404267287; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu L.T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hunsley J, 2003, PSYCHOL ASSESSMENT, V15, P443, DOI 10.1037/1040-3590.15.4.443; IBM, 2020, IBM SPSS STAT; Ferrando PJ, 2019, EDUC PSYCHOL MEAS, V79, P437, DOI 10.1177/0013164418824755; Johnson DR, 2008, ARCH CLIN NEUROPSYCH, V23, P73, DOI 10.1016/j.acn.2007.10.001; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Jones W. T., 1952, HIST W PHILOS; Joreskog K, 1996, LISREL 8 USERS REFER; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MACCALLUM R, 1986, PSYCHOL BULL, V100, P107, DOI 10.1037/0033-2909.100.1.107; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MACCALLUM RC, 1992, PSYCHOL BULL, V111, P490, DOI 10.1037/0033-2909.111.3.490; Marsh HW, 2005, MULTIVAR APPL SER, P275; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; Maydeu-Olivares A, 2007, PSYCHOL METHODS, V12, P157, DOI 10.1037/1082-989X.12.2.157; McDonald R, 1999, TEST THEORY UNIFIED; MEEHL PE, 1990, PSYCHOL REP, V66, P195, DOI 10.2466/PR0.66.1.195-244; MEREDITH W, 1964, PSYCHOMETRIKA, V29, P177, DOI 10.1007/BF02289699; Messick S., 1989, ED MEASUREMENT, V3, P13; Morin AJS, 2016, STRUCT EQU MODELING, V23, P116, DOI 10.1080/10705511.2014.961800; Mueller R. O., 2019, REVIEWERS GUIDE QUAN, V2nd, P445; MULAIK SA, 1989, PSYCHOL BULL, V105, P430, DOI 10.1037/0033-2909.105.3.430; Mundfrom DJ, 2005, INT J TEST, V5, P159, DOI 10.1207/s15327574ijt0502_4; Muthen L. K., 2018, MPLUS USERS GUIDE; Naglieri J.A., 2013, HDB PSYCHOL ASSESSME, V10, P291; Naifeh JA, 2017, SUICIDE LIFE-THREAT, V47, P589, DOI 10.1111/sltb.12307; Nasser F, 2002, EDUC PSYCHOL MEAS, V62, P397, DOI 10.1177/00164402062003001; Norman GR, 2014, BIOSTATISTICS BARE E, V4th; Osborne J. W., 2012, PRACTICAL ASSESSMENT, V17, P1, DOI DOI 10.7275/h0bd-4d11; Peterson R.A., 2000, MARKET LETT, V11, P261, DOI [DOI 10.1023/A:1008191211004, 10.1023/A:1008191211004]; Preacher KJ, 2013, MULTIVAR BEHAV RES, V48, P28, DOI 10.1080/00273171.2012.710386; Raiche G, 2013, METHODOLOGY-EUR, V9, P23, DOI 10.1027/1614-2241/a000051; Raykov T, 1997, MULTIVAR BEHAV RES, V32, P329, DOI 10.1207/s15327906mbr3204_2; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reise S.P., 2018, WILEY HDB PSYCHOMETR, P675, DOI [10.1002/ 9781118489772.ch22, DOI 10.1002/9781118489772.CH22]; Reise SP, 2013, J PERS ASSESS, V95, P129, DOI 10.1080/00223891.2012.725437; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Retzlaff P, 1999, MS80665 JOHNS SPAC C; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Reynolds C.R., 2009, MEASUREMENT ASSESSME, V2nd ed.; Rice V. J., 2011, AUTOMATED NEUROPSYCH, P1; Rodriguez A, 2016, PSYCHOL METHODS, V21, P137, DOI 10.1037/met0000045; Rodriguez A, 2016, J PERS ASSESS, V98, P223, DOI 10.1080/00223891.2015.1089249; Roskos P. G, 2014, ARCH CLIN NEUROPSYCH, V2, P568, DOI [10.1093/arclin/acu038.171, DOI 10.1093/ARCLIN/ACU038.171]; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; Salvia J., 2017, ASSESSMENT SPECIAL I; Schmitt TA, 2011, J PSYCHOEDUC ASSESS, V29, P304, DOI 10.1177/0734282911406653; Schretlen D., 1997, BRIEF TEST ATTENTION; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweizer K, 2011, EUR J PSYCHOL ASSESS, V27, P143, DOI 10.1027/1015-5759/a000069; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Sellbom M, 2019, PSYCHOL ASSESSMENT, V31, P1428, DOI 10.1037/pas0000623; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Sijtsma K, 2015, NURS RES, V64, P128, DOI 10.1097/NNR.0000000000000077; Sijtsma K, 2012, THEOR PSYCHOL, V22, P786, DOI 10.1177/0959354312454353; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Streiner DL, 2018, J CLIN PSYCHOPHARM, V38, P170, DOI 10.1097/JCP.0000000000000865; Streiner DL, 1998, PSYCHOL REP, V83, P687, DOI 10.2466/PR0.83.6.687-694; Sturman, 2017, PSYCHOL TESTING ASSE; Tabachnick BG, 2019, USING MULTIVARIATE S, V7th; Tanaka J. S., 1993, TESTING STRUCTURAL E, P10; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Trizano-Hermosilla I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00769; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Velicer W.F, 2000, PROBLEMS SOLUTIONS H, P41, DOI DOI 10.1007/978-1-4615-4397-8_3; Velicer WF, 1998, PSYCHOL METHODS, V3, P231, DOI 10.1037/1082-989X.3.2.231; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wahlquist VE, 2019, SCI MED FOOTBALL, V3, P115, DOI 10.1080/24733938.2018.1532104; Wainer H., 2015, SIGNIFICANCE, V12, P16, DOI [10.1111/j.1740-9713.2015.00797.x, DOI 10.1111/J.1740-9713.2015.00797.X]; Watkins M. W, IN PRESS; Watkins M.W., 2013, OMEGA COMPUTER SOFTW; Watkins M.W., 2009, HDB SCH PSYCHOL, V4th, P210; Watkins MW, 2021, SCHOOL PSYCHOL REV, DOI 10.1080/2372966X.2020.1816804; Watkins MW, 2017, CLIN NEUROPSYCHOL, V31, P1113, DOI 10.1080/13854046.2017.1317364; Williams JM, 2003, SPORT PSYCHOL, V17, P16, DOI 10.1123/tsp.17.1.16; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Woodard J., 2002, J INT NEUROPSYCHOLOG, V8, P175; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	133	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2021	36	6					940	953		10.1093/arclin/acaa120			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UQ0FU	WOS:000695749300008	33372968				2022-02-06	
J	Gombay, N; Andrews, GJ				Gombay, Nicole; Andrews, Gavin J.			Living with embodied vibrations: Sensory experiences following a traumatic brain injury	SOCIAL SCIENCE & MEDICINE			English	Article						Concussion; Traumatic brain injury; Senses; Autoethnography; Sleep; Neurophenomenology; Vibration; Non-representational theory; Phenomenology	SLEEP DISTURBANCES; AUTOETHNOGRAPHY; SELF; NEUROSCIENCE; REFLECTIONS; KNOWLEDGES; RESONANCE; SCIENCE	Based on autoethnography, this article adopts a (neuro)phenomenological lens to explore sensory experiences following a traumatic brain injury (TBI). Although focussing particularly on pain, vision, hearing, and somatic experiences connected with sleep, we also touch on how these are interwoven with other symptoms associated with TBIs. We use these experiences to enliven, and thereby enrich, clinical constructions and understandings of 'sensitivity' to light and to noise, as well as 'sleep disturbance'. We conclude with a discussion of how these sensory experiences can be understood in relation to embodied dynamics of vibration, oscillation, and (stochastic) resonance. The article closes with the suggestion that an embodied, sensorial, and phenomenologically informed analysis of the experiences of people with TBIs, particularly in relation, for example, to embodied sensations and perceptions of vibration, might provide novel insights for research and clinical practice.	[Gombay, Nicole] Univ Montreal, Dept Geog, Complexe Sci, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Andrews, Gavin J.] McMaster Univ, Dept Hlth Aging & Soc, Hamilton, ON, Canada		Gombay, N (corresponding author), Univ Montreal, Dept Geog, Complexe Sci, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	nicole.gombay@umontreal.ca					Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; Adair RK, 2002, BIOPHYS J, V82, P1147, DOI 10.1016/S0006-3495(02)75473-8; Adams TonyE., 2015, AUTOETHNOGRAPHY; Andrade GC, 2020, PUBLIC HEALTH NUTR, V23, P1041, DOI 10.1017/S1368980019002623; Andrews GJ, 2019, SOC SCI MED, V231, P13, DOI 10.1016/j.socscimed.2018.01.030; Balenzuela P, 2012, CONTEMP PHYS, V53, P17, DOI 10.1080/00107514.2011.639605; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026672; Bissell D, 2010, TAKING-PLACE: NON-REPRESENTATIONAL THEORIES AND GEOGRAPHY, P79; Bissell D, 2010, AREA, V42, P479, DOI 10.1111/j.1475-4762.2010.00942.x; Bissell D, 2009, ENVIRON PLANN A, V41, P911, DOI 10.1068/a40309; Boldsen S, 2018, CULT MED PSYCHIAT, V42, P893, DOI 10.1007/s11013-018-9590-y; Cadman Louisa, 2009, INT ENCY HUMAN GEOGR, P349, DOI DOI 10.1016/B978-008044910-4.00717-3; Callahan ML, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0867-x; Cameron, 2002, VISCERAL SENSORY NEU; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chang HW, 2016, QUAL HEALTH RES, V26, P443, DOI 10.1177/1049732315627432; Connor S., 2008, SENSES SOC, V3, P205; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; D'Cruz K, 2016, SCAND J OCCUP THER, V23, P30, DOI 10.3109/11038128.2015.1057521; Dahlberg H, 2019, NURS PHILOS, V20, DOI 10.1111/nup.12235; Davidson J, 2016, EMOT SPACE SOC, V18, P28, DOI 10.1016/j.emospa.2016.01.002; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Durham C, INSIGHT ACQUIRED BRA; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Fitzgerald D, 2015, THEOR CULT SOC, V32, P3, DOI 10.1177/0263276414537319; Foss AH, 2007, NEUROREPORT, V18, P1521, DOI 10.1097/WNR.0b013e3282ef6b51; GALLAGHER S., 2010, HDB PHENOMENOLOGY CO; Gallagher S., 2008, PHENOMENOLOGICAL MIN; Geurts K. L., 2005, EMPIRE SENSES SENSUA, P164; Handelman D., 2005, PAIDEUMA, V51, P247; HARAWAY D, 1988, FEMINIST STUD, V14, P575, DOI 10.2307/3178066; Harrison P, 2009, ENVIRON PLANN D, V27, P987, DOI 10.1068/d7907; Howes D., 2006, SENSES SOC, V1, P381, DOI DOI 10.2752/174589206778476225; Illich I, CBC IDEAS 4 CBC IDEAS 4; Judge SM, 2018, ENVIRON PLANN D, V36, P1101, DOI 10.1177/0263775817748944; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kapp SK, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00038; Kazl C, 2019, SEMIN PEDIATR NEUROL, V30, P9, DOI 10.1016/j.spen.2019.03.003; Kidd DE, 2018, WORD TEXT, V8, P48; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Lu LH, 2019, NEUROREHABILITATION, V44, P511, DOI 10.3233/NRE-192702; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Minkowski Eugene., 1970, LIVED TIME PHENOMENO; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Mumbower R, 2019, BRAIN INJURY, V33, P1624, DOI 10.1080/02699052.2019.1658133; Nabasny A., 2019, ARCH PHYS MED REHAB, V100, pE108; Nabasny A, 2020, REHABIL PSYCHOL, V65, P186, DOI 10.1037/rep0000320; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; O'Neill FK, 2009, SOCIOL REV, V56, P216, DOI 10.1111/j.1467-954X.2009.00824.x; Paterson M, 2009, PROG HUM GEOG, V33, P766, DOI 10.1177/0309132509103155; Phoenix C, 2019, SOC SCI MED, V231, P47, DOI 10.1016/j.socscimed.2018.05.006; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Pred R.J., 2005, ONFLOW DYNAMICS CONS; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Proust D, 2011, IAU SYMP P SERIES, P358, DOI 10.1017/S1743921311002535; Pykett J, 2018, T I BRIT GEOGR, V43, P154, DOI 10.1111/tran.12213; Radulescu H, 2003, ANN NY ACAD SCI, V999, P322, DOI 10.1196/annals.1284.043; Rose Nikolas., 1985, PSYCHOL COMPLEX PSYC; Schluppeck D., 2015, SOMATOSENSORY PROCES, P549; Serres Michel, 2008, 5 SENSES PHILOS MING; Shankar S, 2018, QUAL INQ, V24, P56, DOI 10.1177/1077800417728960; Shaw R, 2015, CULT GEOGR, V22, P585, DOI 10.1177/1474474014539250; Silva MT, 2019, SPACE CULT, V22, P10, DOI 10.1177/1206331218775326; Sivertsen M, 2015, PHYSIOTHER THEOR PR, V31, P153, DOI 10.3109/09593985.2014.986350; Sparkes AC, 2000, SOCIOL SPORT J, V17, P21, DOI 10.1123/ssj.17.1.21; Stein B. E., 2002, ENCY HUMAN BRAIN, P227, DOI DOI 10.1016/B0-12-227210-2/00225-9; Thrift N, 2007, INT LIBR SOCIOL, P1; TOOMBS SK, 2001, HDB PHENOMENOLOGY ME; Trower S., 2008, SENSES SOC, V3, P133; Uotinen J, 2011, QUAL HEALTH RES, V21, P1307, DOI 10.1177/1049732311413908; Vannini P., 2015, NONREPRESENTATIONAL; Varela F.J., 1996, J CONSCIOUSNESS STUD, V3, P330; Varela FJ, 2016, EMBODIED MIND: COGNITIVE SCIENCE AND HUMAN EXPERIENCE, P1; Walsh V, 2016, CURATED REFERENCE CO CURATED REFERENCE CO; Waters F, 2016, SCHIZOPHRENIA BULL, V42, P1098, DOI 10.1093/schbul/sbw076; Wright CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156826	77	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536	1873-5347		SOC SCI MED	Soc. Sci. Med.	SEP	2021	284								114233	10.1016/j.socscimed.2021.114233			9	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	TZ0SH	WOS:000684185900013	34325326				2022-02-06	
J	Graham, DL; Madkour, HS; Noble, BL; Schatschneider, C; Stanwood, GD				Graham, Devon L.; Madkour, Haley S.; Noble, Brenda L.; Schatschneider, Chris; Stanwood, Gregg D.			Long-term functional alterations following prenatal GLP-1R activation	NEUROTOXICOLOGY AND TERATOLOGY			English	Article						GLP-1; Development; Brain; Pregnancy; Anxiety; Developmental programming	GLUCAGON-LIKE PEPTIDE-1; TRAUMATIC BRAIN-INJURY; RECEPTOR AGONIST; PARKINSONS-DISEASE; SEX-DIFFERENCES; MOUSE MODEL; EXENDIN-4; EXENATIDE; ANTIDEPRESSANT; PREGNANCY	Evidence supporting the use of glucagon-like peptide-1 (GLP-1) analogues to pharmacologically treat disorders beyond type 2 diabetes and obesity is increasing. However, little is known about how activation of the GLP-1 receptor (GLP-1R) during pregnancy affects maternal and offspring outcomes. We treated female C57Bl/6 J mice prior to conception and throughout gestation with a long-lasting GLP-1R agonist, Exendin-4. While GLP-1R activation has significant effects on food and drug reward, depression, locomotor activity, and cognition in adults, we found few changes in these domains in exendin-4-exposed offspring. Repeated injections of Exendin-4 had minimal effects on the dams and may have enhanced maternal care. Offspring exposed to the drug weighed significantly more than their control counterparts during the preweaning period and demonstrated alterations in anxiety-like outcomes, which indicate a developmental role for GLP-1R modulation in the stress response that may be sex-specific.	[Graham, Devon L.; Madkour, Haley S.; Noble, Brenda L.; Stanwood, Gregg D.] Florida State Univ, Coll Med, Dept Biomed Sci, 1115 W Call St, Tallahassee, FL 32306 USA; [Graham, Devon L.; Madkour, Haley S.; Noble, Brenda L.; Stanwood, Gregg D.] Florida State Univ, Coll Med, Ctr Brain Repair, Tallahassee, FL 32306 USA; [Schatschneider, Chris] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA		Stanwood, GD (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 W Call St, Tallahassee, FL 32306 USA.	gregg.stanwood@med.fsu.edu		Stanwood, Gregg/0000-0001-6005-1203	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 MH110749]; FSU Council on Research Creativity; FSU College of Medicine	We thank Dr. Pradeep Bhide and Deirdre McCarthy for assistance with confocal microscopy as well as Dr. Michael T. Williams for additional advice on statistical modeling. This work was supported by NIH grant R03 MH110749 (DLG), the FSU Council on Research & Creativity (DLG), and the FSU College of Medicine.	ACOG Committee on Practice Bulletins--Obstetrics, 2008, Obstet Gynecol, V111, P1001, DOI 10.1097/AOG.0b013e31816fd910; Alexopoulos AS, 2019, JAMA-J AM MED ASSOC, V321, P1811, DOI 10.1001/jama.2019.4981; Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Anderberg RH, 2016, PSYCHONEUROENDOCRINO, V65, P54, DOI 10.1016/j.psyneuen.2015.11.021; [Anonymous], 2019, MED LETT DRUGS THER, V61, P169; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Braden GC, 2017, J AM ASSOC LAB ANIM, V56, P369; Brown E, 2018, PEPTIDES, V100, P61, DOI 10.1016/j.peptides.2017.12.009; Carpenter AC, 2012, DEV NEUROSCI-BASEL, V34, P250, DOI 10.1159/000336824; Celikyurt IK, 2014, MED SCI MONIT BASIC, V20, P112, DOI 10.12659/MSMBR.891168; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Comninos AN, 2014, HUM REPROD UPDATE, V20, P153, DOI 10.1093/humupd/dmt033; Cork SC, 2015, MOL METAB, V4, P718, DOI 10.1016/j.molmet.2015.07.008; Crawley JN, 2000, WHATS WRONG MY MOUSE; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077284; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069010; Egecioglu E, 2013, PSYCHONEUROENDOCRINO, V38, P1259, DOI 10.1016/j.psyneuen.2012.11.009; Engman J, 2016, PSYCHONEUROENDOCRINO, V63, P34, DOI 10.1016/j.psyneuen.2015.09.012; Erreger K, 2012, PHYSIOL BEHAV, V106, P574, DOI 10.1016/j.physbeh.2012.03.014; Escamilla CO, 2017, NATURE, V551, P227, DOI 10.1038/nature24470; Farahvar S, 2019, EXPERT REV ENDOCRINO, V14, P63, DOI 10.1080/17446651.2018.1476135; Frederick AL, 2015, MOL PSYCHIATR, V20, P1373, DOI 10.1038/mp.2014.166; Frederick AL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00029; Ghosal S, 2017, J NEUROSCI, V37, P184, DOI 10.1523/JNEUROSCI.1104-16.2016; Ghosal S, 2013, PHYSIOL BEHAV, V122, P201, DOI 10.1016/j.physbeh.2013.04.003; Gil-Lozano M, 2010, ENDOCRINOLOGY, V151, P2629, DOI 10.1210/en.2009-0915; Glotfelty EJ, 2020, EXPERT OPIN INV DRUG, V29, P595, DOI 10.1080/13543784.2020.1764534; Golub MS, 2020, NEUROTOXICOL TERATOL, V77, DOI 10.1016/j.ntt.2019.106841; Graham DL, 2013, MOL PSYCHIATR, V18, P961, DOI 10.1038/mp.2012.141; Graham D.L., 2011, DEV REPROD TOXICOLOG, P346; Graham D.L., 2018, HDB DEV NEUROTOXICOL, P287, DOI [10. 1016/B978-0-12-809405-1.00025-0., DOI 10.1016/B978-0-12-809405-1.00025-0]; Graham DL, 2020, J COMP NEUROL, V528, P2445, DOI 10.1002/cne.24905; Graham DL, 2015, SYNAPSE, V69, P434, DOI 10.1002/syn.21830; Graham DL, 2015, ACS CHEM NEUROSCI, V6, P297, DOI 10.1021/cn500235m; Gulec G, 2010, NEUROPEPTIDES, V44, P285, DOI 10.1016/j.npep.2010.02.002; Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565; Hayes MR, 2010, PHYSIOL BEHAV, V100, P503, DOI 10.1016/j.physbeh.2010.02.029; Holscher C, 2018, NEUROPHARMACOLOGY, V136, P251, DOI 10.1016/j.neuropharm.2018.01.040; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Iwai T, 2014, J NEUROSCI RES, V92, P446, DOI 10.1002/jnr.23335; Iwai T, 2009, NEUROSCI RES, V64, P67, DOI 10.1016/j.neures.2009.01.013; Jaramillo TC, 2016, AUTISM RES, V9, P350, DOI 10.1002/aur.1529; Jensterle M, 2019, HUM REPROD UPDATE, V25, P504, DOI 10.1093/humupd/dmz019; Kandzija N, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1617000; Kim DS, 2017, CELL TRANSPLANT, V26, P1560, DOI 10.1177/0963689717721234; Kinzig KP, 2003, J NEUROSCI, V23, P6163; Knauf C, 2008, ENDOCRINOLOGY, V149, P4768, DOI 10.1210/en.2008-0180; Kong LH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20787; Kumar S, 2017, MAYO CLIN PROC, V92, P251, DOI 10.1016/j.mayocp.2016.09.017; Lee SJ, 2018, MOL METAB, V11, P33, DOI 10.1016/j.molmet.2018.03.008; Lencioni C, 2011, J ENDOCRINOL INVEST, V34, pE287, DOI 10.3275/7799; Liu X, 2017, CLIN ENDOCRINOL, V87, P767, DOI 10.1111/cen.13454; Logrip ML, 2017, NEUROPHARMACOLOGY, V114, P123, DOI 10.1016/j.neuropharm.2016.11.021; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; MacLusky NJ, 2000, ENDOCRINOLOGY, V141, P752, DOI 10.1210/en.141.2.752; Mascola MA, 2017, OBSTET GYNECOL, V130, pE81, DOI 10.1097/AOG.0000000000002235; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Moller C, 2002, PROG NEURO-PSYCHOPH, V26, P119, DOI 10.1016/S0278-5846(01)00223-8; Moser VC, 2011, TOXICOL PATHOL, V39, P36, DOI 10.1177/0192623310385255; Nylander M, 2017, REPROD BIOMED ONLINE, V35, P121, DOI 10.1016/j.rbmo.2017.03.023; Outeirino-Iglesias V, 2015, ENDOCRINOLOGY, V156, P4226, DOI 10.1210/en.2014-1978; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Reddy IA, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.86; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Ross EJ, 2015, NEUROPSYCHOPHARMACOL, V40, P61, DOI 10.1038/npp.2014.147; Rozo AV, 2017, MOL METAB, V6, P748, DOI 10.1016/j.molmet.2017.05.006; Salamun V, 2018, EUR J ENDOCRINOL, V179, P1, DOI 10.1530/EJE-18-0175; Salvatore M, 2018, HORM BEHAV, V97, P145, DOI 10.1016/j.yhbeh.2017.10.004; Sanna MD, 2017, NEUROPHARMACOLOGY, V114, P48, DOI 10.1016/j.neuropharm.2016.11.023; Sedman T, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9239530; Sharma AN, 2015, METAB BRAIN DIS, V30, P519, DOI 10.1007/s11011-014-9591-7; Sorensen G, 2015, PHYSIOL BEHAV, V149, P262, DOI 10.1016/j.physbeh.2015.06.013; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Sukumar N, 2018, DIABETES, V67, P2650, DOI 10.2337/db18-0254; Sun ZH, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/1484321; Tatarkiewicz K, 2014, AM J PHYSIOL-REG I, V306, pR490, DOI 10.1152/ajpregu.00495.2013; Trammell TS, 2021, NEUROL SCI, V42, P2911, DOI 10.1007/s10072-020-04910-8; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Viale L, 2015, LANCET, V386, P1845, DOI 10.1016/S0140-6736(15)00045-8; Werner EA, 2016, ARCH WOMEN MENT HLTH, V19, P229, DOI 10.1007/s00737-015-0549-5; Younes ST, 2020, AM J PHYSIOL-HEART C, V318, pH72, DOI 10.1152/ajpheart.00486.2019; Zhang R, 2010, J NEUROSCI, V30, P14907, DOI 10.1523/JNEUROSCI.0522-10.2010	98	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-0362	1872-9738		NEUROTOXICOL TERATOL	Neurotoxicol. Teratol.	SEP-OCT	2021	87								106984	10.1016/j.ntt.2021.106984			13	Neurosciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Toxicology	UR5NE	WOS:000696795200017	33864929				2022-02-06	
J	Guerra, J; Lema, H; Agra, C; Martinez, P; Devesa, J				Guerra, Joaquin; Lema, Hortensia; Agra, Carlos; Martinez, Pedro; Devesa, Jesus			Laryngeal Paralysis Recovered Two Years after a Head Trauma by Growth Hormone Treatment and Neurorehabilitation	REPORTS			English	Article						growth hormone; recurrent nerve injury; speech therapy; neurostimulation; vocal cord paralysis	OCCIPITAL CONDYLE FRACTURE; RECURRENT LARYNGEAL; NERVE; REINNERVATION; RECONSTRUCTION; GH	The aim of this study was to describe the cognitive and speech results obtained after growth hormone (GH) treatment and neurorehabilitation in a man who suffered a traumatic brain injury (TBI). Seventeen months after the accident, the patient was treated with growth hormone (GH), together with neurostimulation and speech therapy. At admission, the flexible laryngoscopy revealed that the left vocal cord was paralyzed, in the paramedian position, a situation compatible with a recurrent nerve injury. Clinical and rehabilitation assessments revealed a prompt improvement in speech and cognitive functions and, following completion of treatment, endoscopic examination showed recovery of vocal cord mobility. These results, together with previous results from our group, indicate that GH treatment is safe and effective for helping neurorehabilitation in chronic speech impairment due to central laryngeal paralysis, as well as impaired cognitive functions.	[Guerra, Joaquin] Med Ctr Foltra, Otolaryngol, Teo 15894, Spain; [Lema, Hortensia] Med Ctr Foltra, Speech Therapy, Teo 15894, Spain; [Agra, Carlos] Med Ctr Foltra, Neurostimulat, Teo 15894, Spain; [Martinez, Pedro] Clin Gaias, Neuroradiol, Santiago De Compostela 15702, Spain; [Devesa, Jesus] Med Ctr Foltra, Sci Direct, Teo 15894, Spain		Guerra, J (corresponding author), Med Ctr Foltra, Otolaryngol, Teo 15894, Spain.; Devesa, J (corresponding author), Med Ctr Foltra, Sci Direct, Teo 15894, Spain.	joaquin.guerra.otorrino@gmail.com; hortelema@gmail.com; carlosagra80@gmail.com; pedromartinezcueto@gmail.com; jesus.devesa@usc.es	; Devesa, Jesus/C-4910-2018	Guerra, Joaquin/0000-0003-2340-0595; Devesa, Jesus/0000-0002-4153-2543			Anthony B, 2020, CURR OTORHINOL REP, V8, P224, DOI 10.1007/s40136-020-00294-7; Araki K, 2018, GENES-BASEL, V9, DOI 10.3390/genes9070316; Baudet ML, 2009, ENDOCRINOLOGY, V150, P2758, DOI 10.1210/en.2008-1242; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; Chen CT, 2016, FORMOS J SURG, V49, P230, DOI 10.1016/j.fjs.2016.08.001; Chen CZ, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.200352; CORMIER PJ, 1992, RADIOGRAPHICS, V12, P1079, DOI 10.1148/radiographics.12.6.1439013; Dalgic A, 2013, J LARYNGOL OTOL, V127, P48, DOI 10.1017/S0022215112002381; Daniero James J, 2014, Curr Otorhinolaryngol Rep, V2, P119; Devesa J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010230; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Devesa J, 2009, J REHABIL MED, V41, P775, DOI 10.2340/16501977-0416; Devesa P, 2012, MUSCLE NERVE, V45, P385, DOI 10.1002/mus.22303; Fang TJ, 2011, LARYNGOSCOPE, V121, P245, DOI 10.1002/lary.21342; Finsterer J, 2015, J NEUROSCI RURAL PRA, V6, P377, DOI 10.4103/0976-3147.158768; Garcia Marcelo de Mattos, 2009, Radiol Bras, V42, P321, DOI 10.1590/S0100-39842009000500012; Halum SL, 2013, ANN OTO RHINOL LARYN, V122, P653, DOI 10.1177/000348941312201009; Hernandez-Morato I, 2013, J ANAT, V222, P451, DOI 10.1111/joa.12031; Nazal CH, 2018, REV BRAS ANESTESIOL, V68, P637, DOI 10.1016/j.bjan.2017.12.011; Ichimura H, 2006, SURG TODAY, V36, P382, DOI 10.1007/s00595-005-3161-x; Kupfer RA, 2013, LARYNGOSCOPE, V123, P2216, DOI 10.1002/lary.24049; Lin RJ, 2019, LARYNGOSCOPE, V129, P943, DOI 10.1002/lary.27530; Lopez J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39738-6; Mattsson P, 2018, WORLD J SURG, V42, P632, DOI 10.1007/s00268-017-4235-9; Miyazaki C, 2000, CLIN NEUROL NEUROSUR, V102, P255, DOI 10.1016/S0303-8467(00)00109-8; Nocera G, 2020, CELL MOL LIFE SCI, V77, P3977, DOI 10.1007/s00018-020-03516-9; Otani S, 1998, Masui, V47, P350; Tomar Gaurav Singh, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-212292; Tuffaha SH, 2016, PLAST RECONSTR SURG, V137, P1771, DOI 10.1097/PRS.0000000000002188; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; Vachha B, 2013, J CLIN IMAG SCI, V3, DOI 10.4103/2156-7514.109751; Venketasubramanian N, 1999, CEREBROVASC DIS, V9, P157, DOI 10.1159/000015947; Waller Augustus, 1851, Edinb Med Surg J, V76, P369; Wang BX, 2016, SCI REP-UK, V6, DOI 10.1038/srep32292; Wang BX, 2016, MOL MED REP, V13, P1234, DOI 10.3892/mmr.2015.4684; Woodson GE, 2007, ANN OTO RHINOL LARYN, V116, P57, DOI 10.1177/000348940711600110	36	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2571-841X		REPORTS-BASEL	Reports	SEP	2021	4	3							19	10.3390/reports4030019			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UY9EB	WOS:000701817300001		gold, Green Submitted			2022-02-06	
J	Haarbauer-Krupa, JK; Register-Mihalik, JK; Nedimyer, AK; Chandran, A; Kay, MC; Gildner, P; Kerr, ZY				Haarbauer-Krupa, Juliet K.; Register-Mihalik, Johna K.; Nedimyer, Aliza K.; Chandran, Avinash; Kay, Melissa C.; Gildner, Paula; Kerr, Zachary Y.			Factors associated with concussion symptom knowledge and attitudes towards concussion care-seeking among parents of children aged 5-10 years	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Parent education; Elementary school; Injury risk; Young children	RISK-TAKING; SPORTS; BEHAVIORS	Background: Understanding parents' concussion-related knowledge and attitudes will contribute to the development of strategies that aim to improve concussion prevention and sport safety for elementary school children. This study investigated the association between parent-and child-related factors and concussion symptom knowledge and care-seeking attitudes among parents of elementary school children (aged 5-10 years). Methods: Four hundred parents of elementary school children completed an online questionnaire capturing parental and child characteristics; concussion symptom knowledge (25 items, range = 0-50; higher = better knowledge); and concussion care-seeking attitudes (five 7-point scale items, range = 5-35; higher = more positive attitudes). Multivariable ordinal logistic regression models identified predictors of higher score levels. Adjusted odds ratios (aOR) with 95% confidence intervals (CI) excluding 1.00 were deemed statistically significant. Results: Select parent and child characteristics were associated with higher score levels for both outcomes. For example, odds of better knowledge level in parents were higher with increased age (10-year increase aOR = 1.59; 95% CI = 1.10-2.28), among females (aOR = 3.90; 95% CI = 2.27-6.70), and among white/non-Hispanics (aOR = 1.79; 95%CI = 1.07- 2.99). Odds of more positive concussion care-seeking attitude levels were higher among parents with a college degree (aOR = 1.98; 95%CI = 1.09-3.60). Child sports participation was not associated with higher score levels for either outcome. Conclusions: Certain elementary school parent characteristics were associated with parents' concussion symptom knowledge and care-seeking attitudes. While the findings suggest providing parents with culturally and demographically relevant concussion education might be helpful, they also emphasize the importance of ensuring education/prevention regardless of their children's sports participation. Practical Applications: Pediatric healthcare providers and elementary schools offer an optimal community-centered location to reach parents with this information within various communities. (c) 2021 National Safety Council and Elsevier Ltd. All rights reserved.	[Haarbauer-Krupa, Juliet K.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Nedimyer, Aliza K.; Kerr, Zachary Y.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Nedimyer, Aliza K.; Gildner, Paula; Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Nedimyer, Aliza K.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA		Haarbauer-Krupa, JK (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,MS-S106-9, Atlanta, GA 30341 USA.	WUK1@cdc.gov		Kossman, Melissa/0000-0001-6653-1363; Nedimyer, Aliza/0000-0002-2714-8529; Haarbauer-Krupa, Juliet/0000-0002-2013-6453	National Center for Injury Prevention and Control, Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002885, 1U01CE002880]; Injury Control Research Center award from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention [R49/CE002479]	This work was partly supported by awards (U01CE002885 and 1U01CE002880) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention. The University of North Carolina Injury Prevention Research Center gratefully acknowledges the support of an Injury Control Research Center award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cook S, 1999, BEHAV THER, V30, P5, DOI 10.1016/S0005-7894(99)80042-2; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kerr ZY, 2021, J SPORT HEALTH SCI, V10, P113, DOI 10.1016/j.jshs.2020.09.001; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kroshus E, 2017, CHILD CARE HLTH DEV, V43, P758, DOI 10.1111/cch.12433; Kroshus E, 2017, HEALTH EDUC BEHAV, P1, DOI [10.1177/10901981177115669, DOI 10.1177/10901981177115669]; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kroshus E, 2019, HEALTH PROMOT PRACT, V20, P372, DOI 10.1177/1524839918790231; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Master C. L., 2020, J PEDIATR-US, P1; Morrongiello BA, 2005, J APPL DEV PSYCHOL, V26, P347, DOI 10.1016/j.appdev.2005.02.003; Morrongiello BA, 2004, J APPL DEV PSYCHOL, V25, P303, DOI 10.1016/j.appdev.2004.04.003; Nanos KN, 2017, MAYO CLIN PROC, V92, P1782, DOI 10.1016/j.mayocp.2017.10.003; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Romm KE, 2018, J SCHOOL HEALTH, V88, P813, DOI 10.1111/josh.12687; Sarmiento K., 2019, J CONCUSSION, V3, P107; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; SMITHER RD, 1992, EDUC PSYCHOL MEAS, V52, P407, DOI 10.1177/0013164492052002016; Suskauer SJ, 2019, J HEAD TRAUMA REHAB, V34, P215, DOI 10.1097/HTR.0000000000000455; Tamimalam A., 2018, J PEDIATR-US, V206, P178; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005	29	0	0	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2021	78						203	209		10.1016/j.jsr.2021.05.003			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	UA7LR	WOS:000685340100020	34399916				2022-02-06	
J	Han, Z; Shi, F; Chen, Y; Dong, XQ; Zhang, B; Li, M				Han, Zhen; Shi, Feng; Chen, Ya; Dong, Xiaoqing; Zhang, Bo; Li, Meng			Relationship between miRNA-433 and SPP1 in the presence of fracture and traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						miR-433; SPP1; callus; heterotopic ossification	CELL-GROWTH; OSTEOPONTIN; MIR-433; DIFFERENTIATION; EXPRESSION; MIGRATION; PROLIFERATION; INVASION; PROTEIN; ROLES	Limb fracture combined with traumatic brain injury (TBI) is one of the most common multiple injuries and patients often suffer from severe craniocerebral injury combined with long bone fracture of the limbs. The present study examined the expression of osteopontin (SPP1) in the tibial fracture callus and heterotopic ossification tissues in craniocerebral injury and investigated its relationship with miR-433. A total of 26 patients with tibial fracture combined with brain injury were included in the TBI group, and 26 patients with simple tibial fracture were included in the control group. The patients received immobilization treatment and callus was collected during the operation. At the time of steel plate removal tissue ossification samples from patients with heterotopic ossification were collected. Peripheral blood was collected from all patients on the morning of the operation day. Expression of miR-433 and SPP1 mRNA was determined by reverse transcription-quantitative PCR and SPP1 protein expression was measured by western blotting. Dual luciferase reporter assay was used to identify the direct interaction between miR-433 and SPP1 mRNA. The human osteoblast line hFOB1.19 was transfected with agomiR-433 to overexpress miR-433 and expression of SPP1 was also examined. TBI enhanced the incidence of callus formation and heterotopic ossification in patients with fracture but did not alter fracture healing time. SPP1 mRNA and protein expression was elevated in patients who had tibial fracture in combination with craniocerebral injury in comparison with controls By contrast, expression of miR-433 was decreased in patients who had tibial fracture in combination with craniocerebral injury in comparison with controls. miR-433 regulated the expression of SPP1 mRNA and protein by directly binding to the 3'-untranslated region of SPP1 mRNA. The present study suggests that SPP1 mRNA and protein levels are increased in the callus, heterotopic ossification tissues and plasma from patients with tibial fracture combined with brain injury in comparison with controls. This elevation may be due to the reduced expression of miR-433.	[Han, Zhen; Shi, Feng; Dong, Xiaoqing; Zhang, Bo; Li, Meng] Jinan Zhangqiu Dist Peoples Hosp, Aid Ctr 1, 220 Huiquan Rd, Jinan 250200, Shandong, Peoples R China; [Chen, Ya] Jinan Zhangqiu Dist Peoples Hosp, Dept Pharm, Jinan 250200, Shandong, Peoples R China		Li, M (corresponding author), Jinan Zhangqiu Dist Peoples Hosp, Aid Ctr 1, 220 Huiquan Rd, Jinan 250200, Shandong, Peoples R China.	kauddgad@163.com			Hospital-level Science and Technology Development Plan Project Fund of Zhangqiu District People's Hospital of Jinan City [2018-17]	This work was supported by a grant from the Hospital-level Science and Technology Development Plan Project Fund of Zhangqiu District People's Hospital of Jinan City (grant no. 2018-17).	Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Chen GJ, 2010, ARTHRITIS RHEUM-US, V62, P2900, DOI 10.1002/art.27603; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Dey D, 2017, TRANSL RES, V186, P95, DOI 10.1016/j.trsl.2017.06.004; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Foster BL, 2018, BONE, V107, P196, DOI 10.1016/j.bone.2017.12.004; Gao SG, 2010, OSTEOARTHR CARTILAGE, V18, P82, DOI 10.1016/j.joca.2009.07.009; Gattorno M, 2004, RHEUMATOLOGY, V43, P1091, DOI 10.1093/rheumatology/keh250; Guo LH, 2013, INT J MOL SCI, V14, P14171, DOI 10.3390/ijms140714171; He HP, 2021, CYTOKINE, V143, DOI 10.1016/j.cyto.2021.155488; Jiang K, 2020, J GENE MED, V22, DOI 10.1002/jgm.3216; Jodoin M, 2019, BONE REP, V11, DOI 10.1016/j.bonr.2019.100222; Kim EJ, 2013, LIFE SCI, V92, P562, DOI 10.1016/j.lfs.2013.01.015; Kobylecki C, 2021, MOV DISORD CLIN PRAC, V8, P385, DOI 10.1002/mdc3.13146; Li JN, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152591; Li Zhengzheng, 2017, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V42, P154, DOI 10.11817/j.issn.1672-7347.2017.02.006; Liang T, 2016, NEOPLASMA, V63, P696, DOI 10.4149/neo_2016_506; Lin X, 2013, LEUKEMIA, V27, P344, DOI 10.1038/leu.2012.224; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Liu S, 2020, EXP THER MED, V19, P2083, DOI 10.3892/etm.2020.8412; Liu Y, 2018, EXP THER MED, V15, P2681, DOI 10.3892/etm.2017.5665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CY, 2017, INT J ONCOL, V50, P1739, DOI 10.3892/ijo.2017.3947; Micha D, 2016, BONE, V84, P169, DOI 10.1016/j.bone.2016.01.004; Pang XC, 2019, PHARMACOL RES, V144, P235, DOI 10.1016/j.phrs.2019.04.030; Qiao JJ, 2019, MOL MED REP, V19, P1867, DOI 10.3892/mmr.2018.9788; Rolfs F, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100078; Shao HY, 2021, BIOENGINEERED, V12, P960, DOI 10.1080/21655979.2021.1900633; Shi QZ, 2018, CELL PHYSIOL BIOCHEM, V46, P2187, DOI 10.1159/000489548; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; Smith SS, 2016, J BIOL CHEM, V291, P21717, DOI 10.1074/jbc.M116.737890; Song SZ, 2019, J CELL PHYSIOL, V234, P18587, DOI 10.1002/jcp.28497; Sun SP, 2017, ONCOTARGET, V8, P5057, DOI 10.18632/oncotarget.13789; Tang XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179860; Tho LC, 2016, THERANOSTICS, V6, P2068, DOI 10.7150/thno.15007; Wang J., 2021, BIOCHEM GENET; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang P, 2020, EXP THER MED, V19, P2310, DOI 10.3892/etm.2020.8441; Yang ZH, 2013, J BIOL CHEM, V288, P28893, DOI 10.1074/jbc.M113.502682; Yu H, 2017, J LARYNGOL OTOL, V131, P955, DOI 10.1017/S002221511700175X; Zhang T, 2018, INT J BIOL SCI, V14, P622, DOI 10.7150/ijbs.24223; Zhao DY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.620476; Zhao XM, 2012, J BIOL CHEM, V287, P31155, DOI 10.1074/jbc.M112.362632; Zhao Y F, 2018, Zhonghua Yi Xue Za Zhi, V98, P3954, DOI 10.3760/cma.j.issn.0376-2491.2018.48.010	45	0	0	4	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2021	22	3							928	10.3892/etm.2021.10360			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	TK6ZZ	WOS:000674305700001	34306197	gold, Green Published			2022-02-06	
J	Harper, MW; Lee, J; Sherman, KA; Uihlein, MJ; Lee, KKK				Harper, Michael W.; Lee, Jonathan; Sherman, Katherine A.; Uihlein, Michael Joseph; Lee, Kenneth Kyung Keun			Wheelchair Athlete Concussion Baseline Data A Pilot Retrospective Analysis	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Concussion; Traumatic Brain Injury; Wheelchair Athlete; Adaptive Sports; Baseline	INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; BASKETBALL INJURIES	Objective The aim of the study was to investigate whether a disabled athlete's underlying disability and concussion history impact the score on baseline testing from a disability modified Graded Symptoms Checklist, Standardized Assessment of Concussion, and Wheelchair Error Scoring System. Study Design This is a retrospective chart review of the 81 veteran wheelchair sports athletes who had baseline concussion evaluations. Demographic data including qualifying disability for the National Veterans Wheelchair Games, scores from the modified Graded Symptoms Checklist, Standardized Assessment of Concussion, and Wheelchair Error Scoring System were analyzed. Results Forty-three percent of wheelchair athletes reported a history of a concussion. Individuals with a history of a concussion displayed more symptoms on the modified Graded Symptoms Checklist (38.8 vs. 24.71, P = 0.0378) as did those who had a qualifying disability in the brain disorder category (54.87 vs. amputees 24.07 and spinal cord disorders 24.9, P = 0.0015). There was no difference in Standardized Assessment of Concussion examination or Wheelchair Error Scoring System scores based on concussion history or qualifying disability. Conclusions Baseline symptom scores from a modified Graded Symptoms Checklist were higher in participants with a history of concussion, independent of their underlying disability, and higher if the athlete's disability was a brain disorder including multiple sclerosis and cerebral vascular accident. Scores on the Standardized Assessment of Concussion examination and Wheelchair Error Scoring System were not affected by the athlete's disability or concussion history. Baseline testing is integral for disabled athletes, especially those with underlying brain disorders and history of concussion.	[Harper, Michael W.; Lee, Kenneth Kyung Keun] Med Coll Wisconsin, Dept Phys Med & Rehabil, Hub Collaborat Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Lee, Jonathan] Case Western Reserve Univ, Milwaukee, WI USA; [Sherman, Katherine A.] Clement J Zablocki Vet Affairs Med Ctr ZVAMC, Milwaukee, WI USA; [Uihlein, Michael Joseph] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Uihlein, Michael Joseph] ZVAMC, Dept Emergency Med, Milwaukee, WI USA; [Lee, Kenneth Kyung Keun] ZVAMC, Spinal Cord Injury Div, Milwaukee, WI USA		Harper, MW (corresponding author), Med Coll Wisconsin, Dept Phys Med & Rehabil, Hub Collaborat Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				National Veterans Wheelchair Games; Clement J. Zablocki Veterans Affairs Medical Center in Milwaukee, WI	This material is the result of work supported with resources of the Clement J. Zablocki Veterans Affairs Medical Center in Milwaukee, WI, and the National Veterans Wheelchair Games. The contents do not represent the views of the US Department of Veterans Affairs or the US Government.	Agel J, 2007, J ATHL TRAINING, V42, P202; CURTIS KA, 1985, PARAPLEGIA, V23, P170, DOI 10.1038/sc.1985.29; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; Dick R, 2007, J ATHL TRAINING, V42, P194; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Gardner S., US TODAY 0425; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kissick J, 2018, PHYS MED REH CLIN N, V29, P299, DOI 10.1016/j.pmr.2018.01.002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Webborn N, 2018, BRIT J SPORT MED, V52, P1157, DOI 10.1136/bjsports-2016-097236; Webborn N, 2016, PM&R, V8, P545, DOI 10.1016/j.pmrj.2015.09.025; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; Wessels KK, 2013, THESIS U ILLINOIS UR, P1	16	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2021	100	9					895	899		10.1097/PHM.0000000000001630			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UC0GH	WOS:000686213400020	33105155				2022-02-06	
J	Haynes, ZA; Collen, JF; Poltavskiy, EA; Walker, LE; Janak, J; Howard, JT; Werner, JK; Wickwire, EM; Holley, AB; Zarzabal, LA; Sim, A; Gundlapalli, A; Stewart, IJ				Haynes, Zachary A.; Collen, Jacob F.; Poltavskiy, Eduard A.; Walker, Lauren E.; Janak, Jud; Howard, Jeffrey T.; Werner, J. Kent; Wickwire, Emerson M.; Holley, Aaron B.; Zarzabal, Lee Ann; Sim, Alan; Gundlapalli, Adi; Stewart, Ian J.			Risk factors of persistent insomnia among survivors of traumatic injury: a retrospective cohort study	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						insomnia; trauma; injury; veterans; TBI; bums; amputation; PTSD; depression; anxiety	SLEEP DISORDERS; COMORBID INSOMNIA; UNITED-STATES; BRAIN-INJURY; PREVALENCE; BURN; DISTURBANCES; SYMPTOMS; SOLDIERS; ONSET	Study Objectives: Insomnia is a diagnosis with broad health and economic implications that has been increasingly recognized in military service members. This trend was concurrent with an increase in traumatic wartime injuries. Accordingly, we sought to determine longitudinal predictors of persistent insomnia in combat veterans who sustained traumatic injuries. Methods: Retrospective cohort study of service members deployed to conflict zones from 2002 to 2016, with longitudinal follow-up in the Veterans Affairs and Military Health Systems. Two cohorts were derived: (1) service members who sustained traumatic injuries and (2) an age-, sex-, and service component-matched cohort of uninjured service members who deployed to a combat zone. Insomnia was defined using International Classification of Diseases, Ninth Revision or International Classification of Diseases, 10th Revision-Clinical Modification codes. Results: The final population of 17,374 service members was followed from date of injury (or date of matched participant's injury) for a median of 8.4 (interquartile range, 5.3-10.7) years. Service members with traumatic injury were at significantly greater risk of developing insomnia than uninjured service members (hazard ratio =1.43; 95% confidence interval, 1.30-1.58) after adjustment. Traumatic brain injury was associated with insomnia compared with patients without traumatic brain injury in the multivariable model: mild/unclassified traumatic brain injury (hazard ratio = 2.07; 95% confidence interval, 1.82-2.35) and moderate/severe/ penetrating traumatic brain injury (hazard ratio = 2.43; 95% confidence interval, 2.06-2.86). Additionally, bum injury (hazard ratio =1.95; 95% confidence interval, 1.47-2.59) and amputation (hazard ratio = 1.61; 95% confidence interval, 1.26-2.06) significantly increased the risk of a diagnosis. Conclusions: Traumatic injuries significantly predicted a diagnosis of insomnia after controlling for mental health disorders. Our findings strongly suggest the need for long-term surveillance of sleep disorders in trauma survivors.	[Haynes, Zachary A.; Collen, Jacob F.; Werner, J. Kent; Holley, Aaron B.] Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Collen, Jacob F.; Werner, J. Kent; Holley, Aaron B.; Stewart, Ian J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Poltavskiy, Eduard A.; Walker, Lauren E.] David Grant USAF Med Ctr, Travis AFB, CA USA; [Janak, Jud] Bexar Data, San Antonio, TX USA; [Howard, Jeffrey T.] Univ Texas San Antonio, San Antonio, TX USA; [Wickwire, Emerson M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Zarzabal, Lee Ann; Sim, Alan] Def Hlth Agcy J6, San Antonio, TX USA; [Gundlapalli, Adi] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA		Haynes, ZA (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	zacharyahaynes@gmail.com			US Air Force Headquarters, Office of the Surgeon General; VA Center of Innovation from the Office of Research and Development of the US Department of Veterans Affairs [I50HX001240]	All authors have seen and approved the final version of this manuscript. This study was funded by the US Air Force Headquarters, Office of the Surgeon General and supported by VA Center of Innovation Award I50HX001240 from the Office of Research and Development of the US Department of Veterans Affairs. EMW's institution received prior research support from the American Academy of Sleep Medicine Foundation, the US Department of Defense, Merck, and ResMed. EMW has served as a scientific consultant for DayZz, Eisai, Merck, and Purdue and is an equity shareholder in WellTap. The authors report no conflicts of interest. The views expressed in this manuscript are those of the author and do not reflect the official policy of the Uniformed Services University, the US Department of Defense, the US Department of the Army/Navy/Air Force, the US Department of Veterans Affairs, or the US government. This work was prepared by a military or civilian employee of the US government as part of the individual's official duties and therefore is in the public domain and does not possess copyright protection.	Albrecht JS, 2019, AM J GERIAT PSYCHIAT, V27, P301, DOI 10.1016/j.jagp.2018.10.017; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; Bahr K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00804; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Blackbourne LH, 2008, CRIT CARE MED, V36, pS304, DOI 10.1097/CCM.0b013e31817e2854; Borders A, 2015, PSYCHOL TRAUMA-US, V7, P76, DOI 10.1037/a0036937; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Caldwell JA, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz112; Caldwell JA, 2017, J SLEEP RES, V26, P665, DOI 10.1111/jsr.12543; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Colvonen PJ, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa119; Dinis J, 2018, SLEEP SCI, V11, P290, DOI 10.5935/1984-0063.20180045; Drake CL, 2014, SLEEP, V37, P1295, DOI 10.5665/sleep.3916; Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555; Howard JT, 2020, J HYPERTENS, V38, P1293, DOI 10.1097/HJH.0000000000002364; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Levenson JC, 2015, CHEST, V147, P1179, DOI 10.1378/chest.14-1617; Lin HT, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1702-2; Longley L, 2018, DIMENS CRIT CARE NUR, V37, P97, DOI 10.1097/DCC.0000000000000284; Melcer T, 2019, PM&R, V11, P577, DOI 10.1002/pmrj.12047; Modest Jacob M, 2020, R I Med J (2013), V103, P19; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morphy H, 2007, SLEEP, V30, P274; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Olfson M, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m12020; Perl VJU, 2019, INJURY, V50, P1138, DOI 10.1016/j.injury.2019.01.005; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pidcoke HF, 2012, J TRAUMA ACUTE CARE, V73, pS445, DOI 10.1097/TA.0b013e3182754796; Robitaille C, 2012, CAN MED ASSOC J, V184, pE49, DOI 10.1503/cmaj.101863; Santaniello JM, 2004, J TRAUMA, V57, P696, DOI 10.1097/01.TA.0000140480.50079.A8; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Smith MT, 2008, PAIN, V138, P497, DOI 10.1016/j.pain.2008.01.028; Tang NKY, 2015, RHEUMATOLOGY, V54, P248, DOI 10.1093/rheumatology/keu283; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timmer ML, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00246; Trevelyan EG, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1639-z; Tubbs AS, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.19m12964; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wang Y, 2018, ADV DRUG DELIVER REV, V123, P3, DOI 10.1016/j.addr.2017.09.018; Watson NF, 2017, J CLIN SLEEP MED, V13, P127, DOI [10.5664/Jcsm.6406, 10.5664/jcsm.6406]; Weintrob AC, 2018, SURG INFECT, V19, P286, DOI 10.1089/sur.2017.240; Wickwire EM, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz007; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Winkelman JW, 2015, NEW ENGL J MED, V373, P1437, DOI 10.1056/NEJMcp1412740; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675; Yoon J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2504-9; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	56	0	0	0	0	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	SEP 1	2021	17	9					1831	1840		10.5664/jcsm.9276			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XW5PP	WOS:000735671300011	33928909				2022-02-06	
J	Hinson, HE; Li, PT; Myers, L; Agarwal, C; Pollock, J; McWeeney, S				Hinson, H. E.; Li, Peter; Myers, Loren; Agarwal, Chinar; Pollock, Jeffrey; McWeeney, Shannon			Incorporating Immunoproteins in the Development of Classification Models of Progression of Intracranial Hemorrhage After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						predictive modeling; progression of intracranial hemorrhage; progressive hemorrhagic injury; traumatic brain injury; traumatic intracranial hemorrhage	COAGULOPATHY; INFLAMMATION; ACTIVATION; TESTS	Objective: To define clinical, radiographic, and blood-based biomarker features to be incorporated into a classification model of progression of intracranial hemorrhage (PICH), and to provide a pilot assessment of those models. Methods: Patients with hemorrhage on admission head computed tomography were identified from a prospectively enrolled cohort of subjects with traumatic brain injury. Initial and follow-up images were interpreted both by 2 independent readers, and disagreements adjudicated. Admission plasma samples were analyzed and principal components (PCs) composed of the immune proteins (IPs) significantly associated with the outcome of interest were selected for further evaluation. A series of logistic regression models were constructed based on (1) clinical variables (CV) and (2) clinical variables + immune proteins (CV+IP). Error rates of these models for correct classification of PICH were estimated; significance was set at P < .05. Results: We identified 106 patients, 36% had PICH. Dichotomized admission Glasgow Coma Scale (P = .004), Marshall score (P = .004), and 3 PCs were significantly associated with PICH. For the CV only model, sensitivity was 1.0 and specificity was 0.29 (95% CI, 0.07-0.67). The CV+IP model performed significantly better, with a sensitivity of 0.93 (95% CI, 0.64-0.99) and a specificity of 1.0 (P = .008). Adjustments to refine the definition of PICH and better define radiographic predictors of PICH did not significantly improve the models' performance. Conclusions: In this pilot investigation, we observed that composites of IPs may improve PICH classification models when combined with CVs. However, overall model performance must be further optimized; results will inform feature inclusion included in follow-up models.	[Hinson, H. E.; Myers, Loren; Agarwal, Chinar] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA; [Li, Peter; Pollock, Jeffrey] Oregon Hlth & Sci Univ, Dept Radiol, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Div Bioinformat & Computat Biol, Portland, OR 97201 USA		Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	hinson@ohsu.edu; lipet@ohsu.edu; lorenjmyers@gmail.com; chinar.ra@gmail.com; pollockj@ohsu.edu; mcweeney@ohsu.edu	Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782	 [UL1TR002369]	This project utilized REDCap, made possible by grant support (UL1TR002369).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Fair KA, 2021, J NEUROTRAUM, V38, P960, DOI 10.1089/neu.2018.6234; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Hinson HE, 2018, J TRAUMA ACUTE CARE, V84, P19, DOI 10.1097/TA.0000000000001627; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Verma S, 2003, CIRCULATION, V108, P736, DOI 10.1161/01.CIR.0000084503.91330.49; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	17	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E322	E328		10.1097/HTR.0000000000000654			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300006	33656476	Green Accepted			2022-02-06	
J	Hofmann, V; Deininger, C; Dobele, S; Konrads, C; Wichlas, F				Hofmann, Valeska; Deininger, Christian; Doebele, Stefan; Konrads, Christian; Wichlas, Florian			Mild Traumatic Brain Injury in Older Adults: Are Routine Second cCT Scans Necessary?	JOURNAL OF CLINICAL MEDICINE			English	Article						anticoagulation; concussion; geriatric trauma; overdiagnosis	INTRACRANIAL HEMORRHAGE; MORTALITY; ANTICOAGULATION; OUTCOMES; FALLS; RISK	Fall-related hospitalizations among older adults have been increasing in recent decades. One of the most common reasons for this is minimal or mild traumatic brain injury (mTBI) in older individuals taking anticoagulant medication. In this study, we analyzed all inpatient stays from January 2017 to December 2019 of patients aged > 75 years with a mTBI on anticoagulant therapy who received at least two cranial computer tomography (cCT) scans. Of 1477 inpatient stays, 39 had primary cranial bleeding, and in 1438 the results of initial scans were negative for cranial bleeding. Of these 1438 cases, 6 suffered secondary bleeding from the control cCT scan. There was no significance for bleeding related to the type of anticoagulation. We conclude that geriatric patients under anticoagulant medication don't need a second cCT scan if the primary cCT was negative for intracranial bleeding and the patient shows no clinical signs of bleeding. These patients can be dismissed but require an evaluation for need of home care or protective measures to prevent recurrent falls. The type of anticoagulant medication does not affect the risk of bleeding.	[Hofmann, Valeska; Doebele, Stefan; Konrads, Christian] Univ Tubingen, BG Trauma Ctr, Dept Trauma & Reconstruct Surg, D-72076 Tubingen, Germany; [Deininger, Christian; Wichlas, Florian] Univ Hosp Salzburg, Dept Orthoped & Traumatol, A-5020 Salzburg, Austria		Hofmann, V (corresponding author), Univ Tubingen, BG Trauma Ctr, Dept Trauma & Reconstruct Surg, D-72076 Tubingen, Germany.	hofmann_valeska@gmx.net; christian.deininger@hotmail.com; sdoebele@bgu-tuebingen.de; ckonrads@bgu-tuebingen.de; fwichlas@icloud.com	Konrads, Christian/A-5481-2017	Konrads, Christian/0000-0002-1285-4615	Open Access Publishing Fund of University of Tubingen	We acknowledge support from the Open Access Publishing Fund of University of Tubingen.	Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Hopewell S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012221.pub2; Keller JM, 2012, J ORTHOP TRAUMA, V26, pE161, DOI 10.1097/BOT.0b013e3182324460; Kirchen-Peters S, 2017, PFLEGE REPORT 2017 S, P153; Klenk J, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0089-x; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Peel NM, 2002, INJ PREV, V8, P280, DOI 10.1136/ip.8.4.280; Pfortmueller C.A., FALL RELATED EMERGEN; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Singh H, 2018, CAN FAM PHYSICIAN, V64, P654; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Walter J, 2019, GERIATR UP2DATE, V1, P55, DOI [10.1055/a-0830-7361, DOI 10.1055/A-0830-7361]; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Zhao RQ, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1359-9	26	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	SEP	2021	10	17							3794	10.3390/jcm10173794			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN9RU	WOS:000694344800001	34501243	gold, Green Published			2022-02-06	
J	Hong, WP; Hong, KJ; Shin, SD; Song, KJ; Kim, TH; Park, JH; Ro, YS; Lee, SC; Kim, CH; Jeong, J				Hong, Won Pyo; Hong, Ki Jeong; Shin, Sang Do; Song, Kyoung Jun; Kim, Tae Han; Park, Jeong Ho; Ro, Young Sun; Lee, Seung Chul; Kim, Chu Hyun; Jeong, Joo			Association of Flow Rate of Prehospital Oxygen Administration and Clinical Outcomes in Severe Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; prehospital; oxygenation; hypoxia; hyperoxia; emergency medical services	ARTERIAL HYPEROXIA; EPIDEMIOLOGY; GUIDELINES	The goal of this study was to investigate the association of prehospital oxygen administration flow with clinical outcome in severe traumatic brain injury (TBI) patients. This was a cross-sectional observational study using an emergency medical services-assessed severe trauma database in South Korea. The sample included adult patients with severe blunt TBI without hypoxia who were treated by EMS providers in 2013 and 2015. Main exposure was prehospital oxygen administration flow rate (no oxygen, low-flow 1 similar to 5, mid-flow 6 similar to 14, high-flow 15 L/min). Primary outcome was in-hospital mortality. A total of 1842 patients with severe TBI were included. The number of patients with no oxygen, low-flow oxygen, mid-flow oxygen, high-flow oxygen was 244, 573, 607, and 418, respectively. Mortality of each group was 34.8%, 32.3%, 39.9%, and 41.1%, respectively. Compared with the no-oxygen group, adjusted odds (95% CI) for mortality in the low-, mid-, and high-flow oxygen groups were 0.86 (0.62-1.20), 1.15 (0.83-1.60), and 1.21 (0.83-1.73), respectively. In the interaction analysis, low-flow oxygen showed lower mortality when prehospital saturation was 94-98% (adjusted odds ratio (AOR): 0.80 (0.67-0.95)) and >= 99% (AOR: 0.69 (0.53-0.91)). High-flow oxygen showed higher mortality when prehospital oxygen saturation was >= 99% (AOR: 1.33 (1.01 similar to 1.74)). Prehospital low-flow oxygen administration was associated with lower in-hospital mortality compared with the no-oxygen group. High-flow administration showed higher mortality.	[Hong, Won Pyo; Hong, Ki Jeong; Shin, Sang Do; Song, Kyoung Jun; Kim, Tae Han; Park, Jeong Ho; Ro, Young Sun; Lee, Seung Chul; Jeong, Joo] Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul 03080, South Korea; [Hong, Won Pyo] Korean Natl Fire Agcy, 119 EMS Div, Sejong City 30128, South Korea; [Hong, Ki Jeong; Shin, Sang Do; Song, Kyoung Jun; Kim, Tae Han; Park, Jeong Ho; Ro, Young Sun; Jeong, Joo] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 03080, South Korea; [Hong, Ki Jeong; Shin, Sang Do; Park, Jeong Ho; Ro, Young Sun; Jeong, Joo] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul 03080, South Korea; [Song, Kyoung Jun; Kim, Tae Han] Seoul Natl Univ, Dept Emergency Med, Boramae Med Ctr, Seoul Metropolitan Govt, Seoul 07061, South Korea; [Lee, Seung Chul] Dongguk Univ, Grad Sch, Goyang Si 10326, South Korea; [Lee, Seung Chul] Dongguk Univ, Ilsan Hosp, Dept Emergency Med, Emergency Med Ctr, Goyang Si 10326, South Korea; [Kim, Chu Hyun] Inje Univ, Coll Med, Dept Emergency Med, Seoul Paik Hosp, Seoul 04551, South Korea		Hong, KJ (corresponding author), Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul 03080, South Korea.; Hong, KJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 03080, South Korea.; Hong, KJ (corresponding author), Seoul Natl Univ Hosp, Dept Emergency Med, Seoul 03080, South Korea.	pyotang@gmail.com; emkjhong@gmail.com; shinsangdo@gmail.com; skci-va@gmail.com; adoong2001@gmail.com; timthe@gmail.com; Ro.youngsun@gmail.com; scl0126@hanmail.net; juliannnn@hanmail.net; yukijeje@gmail.com	Kim, Tae Han/ABH-1646-2021	Kim, Tae Han/0000-0003-3855-081X; Hong, Won Pyo/0000-0001-9293-7404; Park, Jeong Ho/0000-0001-6330-9820; Song, Kyoung Jun/0000-0002-0027-6352; Hong, Ki Jeong/0000-0003-3334-817X			[Anonymous], 2007, HEAD INJ TRIAG ASS I; Bitterman N, 2004, UNDERSEA HYPERBAR M, V31, P63; Bostek C C, 1989, AANA J, V57, P231; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Branson RD, 2013, RESP CARE, V58, P86, DOI 10.4187/respcare.02251; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Cornet AD, 2012, ARCH INTERN MED, V172, P289, DOI 10.1001/archinternmed.2011.624; Damiani E, 2018, CURR OPIN ANESTHESIO, V31, P129, DOI 10.1097/ACO.0000000000000559; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Goldberg Scott A, 2015, Handb Clin Neurol, V127, P367, DOI 10.1016/B978-0-444-52892-6.00023-4; Hopple Joe, 2011, JEMS, V36, P28, DOI 10.1016/S0197-2510(11)70296-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rossi S, 2001, J NEUROTRAUM, V18, P163, DOI 10.1089/08977150150502596; Russell DW, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0370-1; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stolmeijer R, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7841295; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Wolfi CG, 2008, UNFALLCHIRURG, V111, P688, DOI 10.1007/s00113-008-1466-0	30	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	SEP	2021	10	18							4097	10.3390/jcm10184097			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV9FW	WOS:000699776000001	34575206	Green Published, gold, Green Submitted			2022-02-06	
J	Hoshiyama, E; Noguchi, T; Wake, K; Zaitsu, M; Hishinuma, H; Sunaga, J; Haruyama, Y; Takahashi, K; Kobashi, G; Ono, K				Hoshiyama, Eisei; Noguchi, Takafumi; Wake, Koji; Zaitsu, Masayoshi; Hishinuma, Hidekazu; Sunaga, Junri; Haruyama, Yasuo; Takahashi, Kyo; Kobashi, Gen; Ono, Kazuyuki			Characteristics of Emergency Neurological Patients Who Were Transported by Helicopter Emergency Medical Services in Tochigi, Japan	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						geographic distribution; helicopter emergency medical services; Japan; neurological emergency; stroke	TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; POPULATION; STROKE; IMPACT; PREVALENCE; OUTCOMES; EPILEPSY; STAY; RISK	In Japan, reports on the association of individual characteristics, and geographical distance and time with clinical outcomes for neurological emergencies involving helicopter emergency medical services (HEMS) are scarce. Using Tochigi HEMS data (2010-2018), we assessed the characteristics of 1,170 emergency neurological patients (e.g., stroke, neurotrauma, and seizure) at the base hospital, which covered 58% of all HEMS patients in the prefecture. After initial treatment in the emergency room, emergency physicians confirmed the clinical outcomes of each patient compared to those at the incident sites (recovery/non-recovery). We calculated the geographic distance from the base hospital to each incident site, and estimated and adjusted odds ratios (aOR) and 95% confidence intervals (CI) for non-recovery against distance. The mean distance between the incident site and base hospital was 22.0 +/- 11.7 km, and 77.4% of patients recovered following initial treatment. Two peak age groups were observed among emergency neurological diseases, including seizures in patients who were aged < 5 years and stroke and neurotrauma in patients who were aged 70-80 years. The percentages of stroke, traumatic head and brain injury, and seizure were 35.8%, 29.2%, and 22.8%, respectively. The incidence of stroke (aOR = 11.8, 95% CI 6.86-20.3) and neurotrauma (aOR = 4.86, 95% CI 2.78-8.51) independently predicted a poor prognosis. However, no significant association was observed with the distance from the base hospital. Therefore, in the Tochigi prefecture, geographical disparities may not affect the short-term prognosis of patients with neurological emergencies who were transported by HEMS.	[Hoshiyama, Eisei; Wake, Koji; Sunaga, Junri; Ono, Kazuyuki] Dokkyo Med Univ Sch Med, Dept Emergency & Crit Care Med, Mibu, Tochigi, Japan; [Noguchi, Takafumi; Zaitsu, Masayoshi; Hishinuma, Hidekazu; Sunaga, Junri; Takahashi, Kyo; Kobashi, Gen] Dokkyo Med Univ Sch Med, Dept Publ Hlth, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan; [Noguchi, Takafumi; Hishinuma, Hidekazu] Dokkyo Med Univ Sch Nursing, Dept Adult Nursing, Mibu, Tochigi, Japan; [Haruyama, Yasuo] Dokkyo Med Univ Sch Med, Integrated Res Fac Adv Med Sci, Mibu, Tochigi, Japan		Zaitsu, M (corresponding author), Dokkyo Med Univ Sch Med, Dept Publ Hlth, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	m-zaitsu@dokkyomed.ac.jp					Abe T, 2014, CRIT CARE, V18, DOI 10.1186/cc13981; Bershad EM, 2008, NEUROCRIT CARE, V9, P287, DOI 10.1007/s12028-008-9051-5; Camfield P, 2015, EPILEPTIC DISORD, V17, P117, DOI 10.1684/epd.2015.0736; Chen XL, 2018, J TRAUMA ACUTE CARE, V84, P549, DOI 10.1097/TA.0000000000001769; Chu SY, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010020; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Funder KS, 2017, SCAND J TRAUMA RESUS, V25, P1, DOI 10.1186/s13049-017-0363-3; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Gravesteijn BY, 2020, BRIT J ANAESTH, V125, P505, DOI 10.1016/j.bja.2020.05.067; Matsumoto H, 2006, ISR MED ASSOC J, V8, P8; Mayer SA, 2006, NEUROCRIT CARE, V5, P82, DOI 10.1385/NCC:5:2:82; Michaels D, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000211; Mommsen P, 2012, TECHNOL HEALTH CARE, V20, P49, DOI 10.3233/THC-2011-0655; Muramatsu Ken-Ichi, 2019, Air Med J, V38, P437, DOI 10.1016/j.amj.2019.07.016; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Noguchi T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207401; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Risgaard B, 2020, ACTA ANAESTH SCAND, V64, P691, DOI 10.1111/aas.13547; Rzonca P, 2019, ANN AGR ENV MED, V26, P355, DOI 10.26444/aaem/106223; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Takashima N, 2017, CIRC J, V81, P1636, DOI 10.1253/circj.CJ-17-0177; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsuchiya A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0335-z; Turin TC, 2009, NEUROEPIDEMIOLOGY, V32, P53, DOI 10.1159/000170907; Ueno T, 2019, J STROKE CEREBROVASC, V28, P2525, DOI 10.1016/j.jstrokecerebrovasdis.2019.06.010; Venkatasubramanian C, 2020, NEUROCRIT CARE, V32, P636, DOI 10.1007/s12028-019-00810-8; Vital statistics of Japan, 2019, DEATH RAT PER 100000; Wijdicks EFM, 2017, HAND CLINIC, V140, P3, DOI 10.1016/B978-0-444-63600-3.00001-5; Zaitsu M, 2020, CANCER-AM CANCER SOC, V126, P1031, DOI 10.1002/cncr.32590; Zaitsu M, 2019, J AM HEART ASSOC, V8, DOI [10.1161/JAHA.118.011350, 10.1161/jaha.118.011350]; Zakariassen E, 2019, SCAND J PRIM HEALTH, V37, P233, DOI 10.1080/02813432.2019.1608056	32	0	0	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	SEP	2021	255	1					79	89		10.1620/tjem.255.79			11	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	WI5VD	WOS:000708426800011	34588376	gold			2022-02-06	
J	Howley, IW; Bennett, JD; Stein, DM				Howley, Isaac W.; Bennett, Jonathan D.; Stein, Deborah M.			Rapid Detection of Significant Traumatic Brain Injury Requiring Emergency Intervention	AMERICAN SURGEON			English	Article						traumatic brain injury; traumatic brain injuries; head computed tomography; midline shift; basal cisterns	MANAGEMENT; MORTALITY	Moderate and severe traumatic brain injuries (TBI) are a major cause of severe morbidity and mortality; rapid diagnosis and management allow secondary injury to be minimized. Traumatic brain injury is only one of many potential causes of altered mental status; head computed tomography (HCT) is used to definitively diagnose TBI. Despite its widespread use and obvious importance, interpretation of HCT images is rarely covered by formal didactics during general surgery or even acute care surgery training. The schema illustrated here may be applied in a rapid and reliable fashion to HCT images, expediting the diagnosis of clinically significant traumatic brain injury that warrants emergent medical and surgical therapies to reduce intracranial pressure. It consists of 7 normal anatomic structures (cerebrospinal fluid around the brain stem, open fourth ventricle, "baby's butt," "Mickey Mouse ears," absence of midline shift, sulci and gyri, and gray-white differentiation). These 7 features can be seen even as the CT scanner obtains images, allowing the trauma team to expedite medical management of intracranial hypertension and pursue neurosurgical consultation prior to radiologic interpretation if the features are abnormal.	[Howley, Isaac W.] Univ Tennessee, Dept Surg, Hlth Sci Ctr, 910 Madison Ave,Ste 220, Memphis, TN 38112 USA; [Bennett, Jonathan D.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA; [Stein, Deborah M.] Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA		Howley, IW (corresponding author), Univ Tennessee, Dept Surg, Hlth Sci Ctr, 910 Madison Ave,Ste 220, Memphis, TN 38112 USA.	isaac.howley@uthsc.edu		Howley, Isaac/0000-0002-2128-4140			Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Ebadat A., 2016, CURRENT THERAPY TRAU, V2nd ed, P127; Ebadat A., 2016, CURRENT THERAPY TRAU, V2nd ed, P133; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Henry S., 2018, ADV TRAUMA LIFE SUPP, V10th ed, P102; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Killu K., 2017, FUNDAMENTAL CRITICAL, V6th ed, P133; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; O'Brien PF., 2019, ACUTE CARE SURG, V2nd ed, P392; Post AF., 2013, TRAUMA, V7th ed, P356; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Saltzherr TP, 2011, INJURY, V42, P870, DOI 10.1016/j.injury.2010.04.007; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Sugrue M, 2008, ANZ J SURG, V78, P949, DOI 10.1111/j.1445-2197.2008.04711.x; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	19	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2021	87	9					1504	1510		10.1177/0003134820973355			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WP2TH	WOS:000712989600024	33345574				2022-02-06	
J	Hsieh, DY; Lai, YR; Lien, CY; Chang, WN; Huang, CC; Cheng, BC; Kung, CT; Lu, CH				Hsieh, Dong-Y.; Lai, Yun-R.; Lien, Chia-Y.; Chang, Wen-N.; Huang, Chih-C.; Cheng, Ben-C.; Kung, Chia-T.; Lu, Cheng-H.			Sex-based differences in bacterial meningitis in adults: Epidemiology, clinical features, and therapeutic outcomes	JOURNAL OF INFECTION AND PUBLIC HEALTH			English	Article						Clinical features; Culture-proven bacterial meningitis; Epidemiology; Outcome; Sex-based difference	LONG-TERM MORTALITY; PROGNOSTIC-FACTORS; KLEBSIELLA MENINGITIS; ANTIMICROBIAL THERAPY; SOUTHERN TAIWAN; UNITED-STATES; CONSUMPTION	Background: To investigate the sex-based differences in clinical features, causative pathogens, and outcomes of hospital-based culture-proven adult bacterial meningitis. Objective: This retrospective study enrolled 621 patients at a tertiary medical center. To compare changes over time, the presentation of disease among the enrolled patients was divided into two equal time periods: the first study period (1986-2002) and the second study period (2003-2019). Results: Of the 621 patients enrolled in this study, 396 were males and 225 were females. The overall case fatality rate was 30.4% with 30.1% and 31.1% in males and females, respectively. Regarding the causative pathogens, there was a rising incidence of coagulase-negative staphylococcal infections and a decreasing incidence of Klebsiella pneumoniae infection in both male and female in the second study period. The prevalence of patients with nosocomial infection in a postneurosurgical state were 41.9% (68/162) in the first study period and 58.1% (94/162) in the second study period in male group, and 34.8% (32/92) in the first study period and 65.2% (60/92) in the second study period in female group, respectively. Significant factors between the sexes difference included age (P = 0.004), traumatic brain injury (P = 0.01), alcoholism (P < 0.001), brain tumor (P < 0.001), systemic lupus erythematosus (SLE) (P = 0.004), presence of diabetic ketoacidosis/hyperglycemic hyperosmolar state (P = 0.033), brain abscess (P = 0.042), and total protein (P = 0.002) and white blood cell count (P = 0.036) of cerebrospinal fluid data. Conclusion: Our study revealed an increase in the number of patients with nosocomial infection with a postneurosurgical state in both male and female in the second study period. Males were younger and frequently presented with a history of head trauma and alcoholism with concomitant brain abscesses while females presented with SLE and brain tumor. The therapeutic outcome did not show differences between the sexes. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).	[Hsieh, Dong-Y.; Lai, Yun-R.; Lien, Chia-Y.; Chang, Wen-N.; Huang, Chih-C.; Lu, Cheng-H.] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Cheng, Ben-C.] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Med, Kaohsiung, Taiwan; [Kung, Chia-T.] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Emergency Med, Kaohsiung, Taiwan; [Lu, Cheng-H.] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan; [Lu, Cheng-H.] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Lu, Cheng-H.] Xiamen Chang Gung Mem Hosp, Dept Neuol, Xiamen, Fujian, Peoples R China		Lu, CH (corresponding author), Chang Gung Mem Hosp, Dept Neurol, 123,Ta Pei Rd, Kaohsiung, Taiwan.	b9202095@cgmh.org.tw; yunrulai@cgmh.org.tw; u9301024@cgmh.org.tw; cwenneng@ms19.hinet.net; hjc2828@gmail.com; benzmcl@gmail.com; chlu99@ms44.url.com.tw; chlu99@ms44.url.com.tw					Adriani KS, 2007, CLIN INFECT DIS, V45, pE46, DOI 10.1086/520682; AMIR J, 1991, J PEDIATR-US, V119, P938, DOI 10.1016/S0022-3476(05)83049-5; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Chang WN, 2008, INFECTION, V36, P15, DOI 10.1007/s15010-007-7009-8; Chang Wen-Neng, 2012, Acta Neurol Taiwan, V21, P87; Cheng WJ, 2012, ALCOHOL ALCOHOLISM, V47, P372, DOI 10.1093/alcalc/ags034; CHIU WT, 1995, J CLIN NEUROSCI, V2, P210, DOI 10.1016/S0967-5868(95)80004-2; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Dharmarajan L, 2016, J MENINGITIS, V1; Dias SP, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.10.026; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Fang CT, 2000, QJM-MON J ASSOC PHYS, V93, P45, DOI 10.1093/qjmed/93.1.45; Faustini A, 2007, INT J INFECT DIS, V11, P137, DOI 10.1016/j.ijid.2005.12.004; French JA, 2015, EPILEPSIA, V56, P13; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Greenberg M.S., 1997, HDB NEUROSURGERY; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Hsu IL, 2018, INT J ENV RES PUBLIC, P15; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; Hussein K, 2017, CLIN MICROBIOL INFEC, V23, P621, DOI 10.1016/j.cmi.2017.05.013; HWU HG, 1990, ACTA PSYCHIAT SCAND, V82, P295, DOI 10.1111/j.1600-0447.1990.tb01387.x; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Lu CH, 2000, J NEUROL SCI, V182, P36, DOI 10.1016/S0022-510X(00)00445-7; Lu CH, 2002, J CLIN NEUROSCI, V9, P533, DOI 10.1054/jocn.2001.1032; Muralidharan R, 2014, EUR J NEUROL, V21, P447, DOI 10.1111/ene.12328; Muzumdar D, 2011, INT J SURG, V9, P136, DOI 10.1016/j.ijsu.2010.11.005; Ong CT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176705; Roed C, 2012, J INFECTION, V64, P34, DOI 10.1016/j.jinf.2011.10.003; Roed C, 2010, AM J EPIDEMIOL, V172, P309, DOI 10.1093/aje/kwq126; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Sharip A, 2006, PEDIATR INFECT DIS J, V25, P191, DOI 10.1097/01.inf.0000202065.03366.0c; Sigurdardottir B, 1997, ARCH INTERN MED, V157, P425, DOI 10.1001/archinte.157.4.425; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Tang LM, 1997, EPIDEMIOL INFECT, V119, P135, DOI 10.1017/S0950268897007930; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Tsiotou AG, 2005, MED SCI MONITOR, V11, pRA76; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Wang AY, 2014, J AM GERIATR SOC, V62, P2064, DOI 10.1111/jgs.13110; Weckerle CE, 2011, CLIN REV ALLERG IMMU, V40, P42, DOI 10.1007/s12016-009-8192-4; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Worsoe L, 2010, CLIN INFECT DIS, V51, P917, DOI 10.1086/656409	42	0	0	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1876-0341	1876-035X		J INFECT PUBLIC HEAL	J. Infect. Public Health	SEP	2021	14	9					1218	1225		10.1016/j.jiph.2021.08.018			8	Public, Environmental & Occupational Health; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases	UX1GP	WOS:000700595800018	34438332	gold			2022-02-06	
J	Jalal, MLA; Rehman, AU; Farooq, MS; Hussain, W				Jalal, Malik Liaqat Ali; Rehman, Atta Ur; Farooq, Muhammad Shaukat; Hussain, Wajahat			Early Decompressive Craniectomy: A Life Saving Option in Closed Head Trauma	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Craniectomy; Outcome; Glasgow coma scale		Aim: To determine outcome and factors associated with outcome among patients with closed head injury who underwent decompressive craniectomy. Methodology: Cross sectional analytical study conducted in Neurosurgery Department of teaching hospital Dera Ghazi Khan from January, 2021 to June, 2021. Total 105 patients fulfilling the inclusion criteria were enrolled in the study. Approval of ethical review committee was obtained. All the patients with closed head injury which underwent decompressive craniectomy were included. Socio demographic profile, mode of injury, Glasgow Coma Scale (GCS) at admission time, pupillary reaction and timing from hospital admission to surgery, duration of surgery, length of hospital stay and occurrence of CSF leakage was noted. SPSS version 22 was used for data entry and analysis. Results: Head injury was more common in males. 43.8% cases admitted with GCS score between 3-8 and with head injury by road traffic accident. Leakage of CSF was recorded in 13.3% patients. Mortality was recorded in 18.1% patients. GCS at time of admission, time elapsed between admission and surgery and duration of surgery was significantly associated with the outcome. Conclusion: Early decompressive craniectomy significantly reduce death rate in patients with closed head injury.	[Jalal, Malik Liaqat Ali; Rehman, Atta Ur; Farooq, Muhammad Shaukat] DG Khan Med Coll, Neurosurg, Dera Ghazi Khan, Pakistan; [Hussain, Wajahat] Quaid E Azam Med Coll, Community Med, Bahawalpur, Pakistan		Jalal, MLA (corresponding author), DG Khan Med Coll, Neurosurg, Dera Ghazi Khan, Pakistan.						Bhatti JA, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S12; Honeybul S, 2017, J CRIT CARE, V39, P185, DOI 10.1016/j.jcrc.2017.03.006; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Junaid M, 2016, J PAK MED ASSOC, V66, P864; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Saade Nelson, 2014, Rev. Col. Bras. Cir., V41, P256, DOI 10.1590/0100-69912014004006; Siddiqui EU, 2019, J PAK MED ASSOC, V69, P1741, DOI [10.5455/JPMA.296439, 10.5455/JPMA.296439.]; Silva Ana Cristina Veiga, 1800, Neurotrauma Rep, V1, P93, DOI 10.1089/neur.2020.0007; Skaansar O, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01943-6; Ullah S, 2020, NEUROSCIENCES, V25, P169, DOI 10.17712/nsj.2020.3.20190097	10	0	0	0	0	LAHORE MEDICAL RESEARCH CENTER LLP	LAHORE	590, Karim Block, Allama Iqbal Town, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	SEP	2021	15	9					2257	2259		10.53350/pjmhs211592257			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XN1WE	WOS:000729302200034		Bronze			2022-02-06	
J	Jan, J; Gully-Lhonore, C; Lasbleiz, J				Jan, J.; Gully-Lhonore, C.; Lasbleiz, J.			Concussion in female soccer players specificity and management	SCIENCE & SPORTS			French	Article						Female soccer players; Concussion	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; HEAD-INJURIES; ACCELERATION; SYMPTOMS; RISK	The popularity of women's soccer continues to rise and thereby injuries increases and moreover specific ones like concussions. A better knowledge of the women specificity when facing a concussion permits a better patient care. An overview of the specificity of the concussion in female soccer players is performed focused on: causes, anatomical specificity of the skull, muscular specificities, specific symptoms, effects of the menstrual cycle and medical care management specificity. Based on all this reflection, we propose recommendations more specific for female soccer players: a specific type of soccer ball for women, increase the penalties of the player who commits the foul, systematic change of player in case of concussion, specific muscle reinforcement, specific training for heading techniques, provide clear information to the whole staff, a medical check-up including cognitive tests, provide an information about the number of days off and interest of oral contraception (advantages/disadvantages/risks). (C) 2021 Elsevier Masson SAS. All rights reserved.	[Jan, J.] Serv Orthopedie, Clin Sagesse 4, Rennes, France; [Jan, J.; Gully-Lhonore, C.] Federat Francaise Football, Paris, France; [Gully-Lhonore, C.] CHU, Serv Med Sport, Rennes, France; [Lasbleiz, J.] Ctr Hosp Fougeres, Serv Radiol, 24 Rue Courtines, F-35760 Montgermont, France; [Lasbleiz, J.] Univ Rennes, LTSI UMR 1099, 2 Ave Prof Leon Bernard, F-35000 Rennes, France		Lasbleiz, J (corresponding author), Ctr Hosp Fougeres, Serv Radiol, 24 Rue Courtines, F-35760 Montgermont, France.	jeremy.lasbleiz@gmail.com					Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bauman S, 2017, BR J SPORTS MED, V51, pA35; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Clark JF, 2017, MED HYPOTHESES, V100, P10, DOI 10.1016/j.mehy.2016.12.016; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corbin-Berrigan LA, 2018, NEUROREPORT, V29, P559, DOI 10.1097/WNR.0000000000000988; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; MOLLERNIELSEN J, 1989, MED SCI SPORT EXER, V21, P126; Nanos KN, 2017, MAYO CLIN PROC, V92, P1782, DOI 10.1016/j.mayocp.2017.10.003; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Vedung F, 2020, SCAND J MED SCI SPOR, V30, P947, DOI 10.1111/sms.13644; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	30	0	0	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0765-1597			SCI SPORT	Sci. Sports	SEP	2021	36	4					318	322		10.1016/j.scispo.2020.12.006			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UI1MT	WOS:000690381100016					2022-02-06	
J	Jeckell, AS; Fontana, RS				Jeckell, Aaron S.; Fontana, R. Shea			Psychosocial Aspects of Sport-Related Concussion in Youth	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Sport concussion; Psychosocial factors; Concussion recovery	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; 1ST EXPOSURE; LATER-LIFE; SYMPTOMS; RETURN; RISK; REST; AGE		[Jeckell, Aaron S.] Vanderbilt Univ, Dept Psychiat & Behav Hlth, Sch Med, 1500 21st Ave South, Nashville, TN 37212 USA; [Fontana, R. Shea] Univ South Carolina, Dept Psychiat & Behav Hlth, Prisma Hlth Upstate, Sch Med Greenville, 10 Patewood Dr,Suite 130, Greenville, SC 29615 USA		Jeckell, AS (corresponding author), Vanderbilt Univ, Dept Psychiat & Behav Hlth, Sch Med, 1500 21st Ave South, Nashville, TN 37212 USA.	Aaron.jeckell.md@gmail.com		Jeckell, Aaron/0000-0002-5523-1151			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Ardern CL, 2013, BRIT J SPORT MED, V47, P1120, DOI 10.1136/bjsports-2012-091203; Associations NFoSHS, 2019, PART HIGH SCH SPORTS PART HIGH SCH SPORTS; Boone EM, 2006, J RES ADOLESCENCE, V16, P79, DOI 10.1111/j.1532-7795.2006.00122.x; Brassil HE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0200-y; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Davis-Hayes C, 2018, NEUROL-CLIN PRACT, V8, P40, DOI 10.1212/CPJ.0000000000000424; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Farrey T., 2014, ESPN POLL MOST PAREN; Forsdyke D, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094850; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guddal MH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028555; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hoare E, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0432-4; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Knights S, 2016, J APPL SPORT PSYCHOL, V28, P291, DOI 10.1080/10413200.2015.1128992; KRAEMER WJ, 1993, J APPL PHYSIOL, V74, P450; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Ku C, 2020, J HEAD TRAUMA REHAB, V35, P218, DOI 10.1097/HTR.0000000000000547; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Maroon JC, 2015, NEUROLOGY, V85, P1007, DOI 10.1212/WNL.0000000000001942; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Media S, 2019, SFIA SPORTS IND FACI; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pedersen S, 2004, PSYCHOL WOMEN QUART, V28, P412, DOI 10.1111/j.1471-6402.2004.00158.x; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; THORNDIKE A, 1952, NEW ENGL J MED, V247, P554, DOI 10.1056/NEJM195210092471504; UPMC, 2015, KNOWL AR AM CONC ASS KNOWL AR AM CONC ASS; Ward J, 2017, NEW YORK TIMES; Wenzel T., 2013, POSTTRAUMATIC STRESS; Wilfert M., 2014, MIND BODY SPORT UNDE; Zuckerman SL, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0909-4	55	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2021	44	3			SI		469	480		10.1016/j.psc.2021.04.013			12	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	TY1FN	WOS:000683529700013	34373002				2022-02-06	
J	Juengst, S; Supnet, C; Kew, CLN; Silva, V; Vega, M; Han, G; Kelley, B; Smith, ML; Maestre, G				Juengst, ShannonB; Supnet, Charlene; Kew, Chung Lin Novelle; Silva, Valeria; Vega, Marlene; Han, Gang; Kelley, Brendan; Smith, Matthew Lee; Maestre, Gladys			Bilingual problem-solving training for caregivers of adults with dementia: A randomized, factorial-design protocol for the CaDeS trial	CONTEMPORARY CLINICAL TRIALS			English	Article						Caregiver; Dementia; Alzheimer's disease and related dementia; Problem-solving; Spanish language; Dementia care; Psychosocial intervention; Metacognitive strategies	ALZHEIMERS ASSOCIATION WORKGROUPS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; FAMILY CAREGIVERS; INFORMAL CAREGIVERS; MENTAL-HEALTH; PSYCHOSOCIAL INTERVENTIONS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; STROKE SURVIVORS	Objective: Caregivers of individuals with Alzheimer's disease and related dementias (ADRD) often experience debilitating caregiver burden and emotional distress. To address these negative emotional consequences of caregiving, we will test and refine a strategy training intervention - Problem-Solving Training (PST) - that promotes self-efficacy and reduces caregiver burden and depressive symptoms. Previous research supports efficacy of PST; however, we do not know exactly how many PST sessions are needed or if post-training "boosters" are required to maintain PST benefits. Additionally, we translated and culturally-adapted PST into "Descubriendo Soluciones Juntos" (DSJ), our novel intervention for Spanish-speaking caregivers. Method: In this 2 x 2 factorial design randomized controlled trial, we will test remotely-delivered PST/DSJ sessions for both English- and Spanish-speaking caregivers of persons with ADRD to determine the optimal number of PST/DSJ sessions and ongoing "booster" sessions needed to best help caregivers navigate their current and future needs. Aims: 1) Compare the efficacy of three vs. six PST/DSJ sessions each with and without booster sessions for decreasing caregiver burden and depression and enhancing caregiver problem-solving; 2) Identify key factors associated with efficacy of PST/DSJ, including age, gender, primary language, relationship to care recipient, and uptake of the PST/DSJ strategy. Results: These results will establish guidelines needed for an evidence-based, culturally-adapted, and implementable problem-solving intervention to reduce caregiver stress and burden and improve caregiver health and well-being. Conclusion: This work promotes inclusion of diverse and underserved populations and advances therapeutic behavioral interventions that improve the lives of caregivers of individuals with chronic conditions.	[Juengst, ShannonB; Kew, Chung Lin Novelle; Silva, Valeria; Vega, Marlene] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Juengst, ShannonB; Kew, Chung Lin Novelle] Univ Texas Southwestern Med Ctr Dallas, Dept Appl Clin Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Supnet, Charlene; Kelley, Brendan] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Vega, Marlene] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Han, Gang] Texas A&M Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 212 Adriance Lab Rd, College Stn, TX 77843 USA; [Han, Gang; Smith, Matthew Lee] Texas A&M Univ, Ctr Populat Hlth & Aging, 212 Adriance Lab Rd, College Stn, TX 77843 USA; [Smith, Matthew Lee] Texas A&M Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, 212 Adriance Lab Rd, College Stn, TX 77843 USA; [Maestre, Gladys] Univ Texas Rio Grande Valley, Sch Med, One West Univ Blvd, Brownsville, TX 78520 USA		Juengst, S (corresponding author), Dept Phys Med & Rehabil, 5323 Harry Hines Blvd,C506-102, Dallas, TX 75390 USA.	Shannon_Juengst@UTSouthwestern.edu	Janson, Patrick/AAC-7581-2022	Supnet, Charlene/0000-0001-6917-770X; Kew, Novelle/0000-0003-1720-4459; Kelley, Brendan/0000-0002-3440-5191	Texas Alzheimer's Research and Care Consortium [2020-2023]	This work is supported by the Texas Alzheimer's Research and Care Consortium [TARCC 2020, 2020-2023] .	Allen AP, 2017, NEUROSCI BIOBEHAV R, V73, P123, DOI 10.1016/j.neubiorev.2016.12.006; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], CLIN TRIALS METHODOL, V3rd; [Anonymous], 2021, GOAL ATTAINMENT SCAL, V9, DOI [10.1080/096020199389365, DOI 10.1080/096020199389365]; [Anonymous], 2021, DISPROPORTIONATE IMP, DOI [10.1377/hlthaff.2015.0536, DOI 10.1377/HLTHAFF.2015.0536]; [Anonymous], Hispanic/Latino-The Office of Minority Health [Internet]; [Anonymous], ALZHEIMERS AMP DEMEN, DOI [10.1016/j.jalz.2018.06.3063,2021, DOI 10.1016/J.JALZ.2018.06.3063,2021]; [Anonymous], LONG TERM MORTALITY; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Attkisson C. C., 1999, USE PSYCHOL TESTING, P1333; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Beinart N, 2012, DEMENT GER COGN D EX, V2, P638, DOI 10.1159/000345777; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007; Brockway JA, 2016, REHABIL PSYCHOL, V61, P221, DOI 10.1037/rep0000077; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P121, DOI 10.1016/j.jalz.2017.10.009; Cheng HY, 2014, PATIENT EDUC COUNS, V95, P30, DOI 10.1016/j.pec.2014.01.005; Cheng ST, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01547-2; Cheng ST, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1045-9; Chiu M, 2015, INT PSYCHOGERIATR, V27, P937, DOI 10.1017/S1041610214002798; Collins RN, 2020, AGEING SOC, V40, P2355, DOI 10.1017/S0144686X19000527; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; Deb A, 2017, EXPERT REV PHARM OUT, V17, P189, DOI 10.1080/14737167.2017.1313118; Domingues NS, 2018, AM J ALZHEIMERS DIS, V33, P401, DOI 10.1177/1533317518788151; Donders J, 2017, BRAIN INJURY, V31, P1871, DOI 10.1080/02699052.2017.1334962; Dunkin JJ, 1998, NEUROLOGY, V51, pS53, DOI 10.1212/WNL.51.1_Suppl_1.S53; Elliott TR, 2009, BEHAV RES THER, V47, P548, DOI 10.1016/j.brat.2009.03.006; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; Federal Interagency Forum on Aging Related Statistics, 2012, OLD AM 2012 KEY IND; Filshtein TJ, 2019, J ALZHEIMERS DIS, V68, P145, DOI 10.3233/JAD-180992; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Garand L, 2019, INT J GERIATR PSYCH, V34, P957, DOI 10.1002/gps.5095; Gitlin L. N., 2015, FAMILY CAREGIVING NE, P305, DOI DOI 10.1016/B978-0-12-417046-9.00017-9; Gonyea JG, 2016, GERONTOLOGIST, V56, P292, DOI 10.1093/geront/gnu045; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Han G, 2018, STAT INTERFACE, V11, P223, DOI 10.4310/SII.2018.v11.n2.a2; Han G, 2013, J APPL STAT, V40, P2516, DOI 10.1080/02664763.2013.818626; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Isik AT, 2019, INT J GERIATR PSYCH, V34, P1326, DOI 10.1002/gps.4965; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jensen M, 2015, INT J GERIATR PSYCH, V30, P130, DOI 10.1002/gps.4208; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Juengst S.B., 2019, ARCH REHABIL RES CLI, V1; Juengst SB, 2019, CONTEMP CLIN TRIALS, V80, P9, DOI 10.1016/j.cct.2019.03.004; Kim JH, 2015, DEMENT GERIATR COGN, V40, P210, DOI 10.1159/000434626; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kua EH, 2014, PSYCHOGERIATRICS, V14, P196, DOI 10.1111/psyg.12053; Kuzuya M, 2011, AM J GERIAT PSYCHIAT, V19, P382, DOI 10.1097/JGP.0b013e3181e9b98d; Lasprilla JCA, 2009, AM J ALZHEIMERS DIS, V24, P384, DOI 10.1177/1533317509341465; Lim YY, 2018, JAMA NEUROL, V75, P488, DOI 10.1001/jamaneurol.2017.4325; Llanque SM, 2012, AM J ALZHEIMERS DIS, V27, P23, DOI 10.1177/1533317512439794; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Luchsinger JA, 2015, AM J ALZHEIMERS DIS, V30, P584, DOI 10.1177/1533317514568340; Malec JF, 2020, ARCH PHYS MED REHAB, V101, P1090, DOI 10.1016/j.apmr.2019.12.008; Martin M., 1996, REV GERONTOLOGIA, V6, P338; Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Mehta KM, 2017, ALZHEIMERS DEMENT, V13, P72, DOI 10.1016/j.jalz.2016.06.2360; Melgarejo JD, 2020, J ALZHEIMERS DIS, V77, P569, DOI 10.3233/JAD-200430; Meyer OL, 2018, AGING MENT HEALTH, V22, P730, DOI 10.1080/13607863.2017.1317330; Moon H, 2019, AM J GERIAT PSYCHIAT, V27, P241, DOI 10.1016/j.jagp.2018.11.003; Mueller C, 2017, LANCET NEUROL, V16, P390, DOI 10.1016/S1474-4422(17)30074-1; Napoles AM, 2010, AM J ALZHEIMERS DIS, V25, P389, DOI 10.1177/1533317510370957; National Alliance for Caregiviing N, 2020, AM ASS RET PERS CAR; Nezu CM., 2007, SOLVING LIFES PROBLE; Pagan-Torres OM, 2020, HISPANIC J BEHAV SCI, V42, P401, DOI 10.1177/0739986320926524; Parker D, 2008, INT J EVID-BASED HEA, V6, P137, DOI 10.1111/j.1479-6988.2008.00090.x; Pfeiffer K, 2014, J CONSULT CLIN PSYCH, V82, P628, DOI 10.1037/a0036987; Leung P, 2015, INT J GERIATR PSYCH, V30, P1, DOI 10.1002/gps.4166; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Prince M., 2013, GLOBAL IMPACT DEMENT; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; ROBERTS RE, 1984, HISPANIC J BEHAV SCI, V6, P385, DOI 10.1177/07399863840064004; Rodriguez FS, 2018, AM J GERIAT PSYCHIAT, V26, P966, DOI 10.1016/j.jagp.2018.05.011; Rospenda KM, 2010, J ADDICT DIS, V29, P314, DOI 10.1080/10550887.2010.489450; Schulz R, 2003, GERONTOLOGIST, V43, P514, DOI 10.1093/geront/43.4.514; Sheehan O.C., 2020, GERONTOLOGIST, V20; Smith ML, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00403; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Staekenborg SS, 2016, J ALZHEIMERS DIS, V53, P135, DOI 10.3233/JAD-151063; Stall NM, 2019, J AM GERIATR SOC, V67, P609, DOI 10.1111/jgs.15690; Stephan A, 2015, J ADV NURS, V71, P1392, DOI 10.1111/jan.12493; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; Thomas IC, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0947-6; Thunyadee C, 2015, NURS HEALTH SCI, V17, P412, DOI 10.1111/nhs.12205; Toot S., 2016, INT PSYCHOGERIATR, V29, P1; U.S. Department of Labor Bureau of Labor Statistics, 2018, EMPL HOURS EARN CURR; Vega M, 2020, REHABIL PSYCHOL, V65, P337, DOI 10.1037/rep0000310; Vermunt L, 2019, ALZHEIMERS DEMENT, V15, P888, DOI 10.1016/j.jalz.2019.04.001; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Walter E, 2020, GERONTOLOGIST, V60, pE609, DOI 10.1093/geront/gnz118; Wolff JL, 2016, JAMA INTERN MED, V176, P372, DOI 10.1001/jamainternmed.2015.7664; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; Yaffe K, 2007, J AM GERIATR SOC, V55, P758, DOI 10.1111/j.1532-5415.2007.01139.x; Yuan A, 2009, ANN STAT, V37, P2458, DOI 10.1214/08-AOS649	100	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	SEP	2021	108								106506	10.1016/j.cct.2021.106506			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	WA3VA	WOS:000702815400005	34273551	Green Accepted, Green Submitted			2022-02-06	
J	Kajiwara, S; Hasegawa, Y; Negoto, T; Orito, K; Kawano, T; Yoshitomi, M; Sakata, K; Takeshige, N; Yamakawa, Y; Jono, H; Saito, H; Hirayu, N; Takasu, O; Hirohata, M; Morioka, M				Kajiwara, Sosho; Hasegawa, Yu; Negoto, Tetsuya; Orito, Kimihiko; Kawano, Takayuki; Yoshitomi, Munetake; Sakata, Kiyohiko; Takeshige, Nobuyuki; Yamakawa, Yukako; Jono, Hirofumi; Saito, Hideyuki; Hirayu, Nobuhisa; Takasu, Osamu; Hirohata, Masaru; Morioka, Motohiro			Efficacy of a Novel Prophylactic Barbiturate Therapy for Severe Traumatic Brain Injuries: Step-down Infusion of a Barbiturate with Normothermia	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						barbiturate; step-down infusion; normothermia; severe traumatic brain injury; mortality	INTRACRANIAL-PRESSURE; HYPOTHERMIA; MANAGEMENT; THIAMYLAL; COMA	This study aimed to examine the beneficial effects of a novel prophylactic barbiturate therapy, step-down infusion of barbiturates, using thiamylal with normothermia (NOR sdB), on the poor outcome in the patients with severe traumatic brain injuries (sTBI), in comparison with mild hypothermia (MD-HYPO). From January 2000 to March 2019, 4133 patients with TBI were admitted to our hospital. The inclusion criteria were: a Glasgow coma scale (GCS) score of <= 8 on admission, age between 20 and 80 years, intracranial hematoma requiring surgical evacuation of the hematoma with craniotomy and/or external decompression, and patients who underwent management of body temperature and assessed their outcome at 6-12 months. Finally, 43 patients were included in the MD-HYPO (n = 29) and NOR+sdB (n = 14) groups. sdB was initiated intraoperatively or immediately after the surgical treatment. There were no significant differences in patient characteristics, including age, sex, past medical history, GCS on admission, type of intracranial hematoma, and length of hospitalization between the two groups. Although NOR+sdB could not improve the patient's poor outcome either at discharge from the intensive care unit (ICU) or at 6-12 months after admission, the treatment inhibited composite death at discharge from the ICU. The mean value of the maximum intracranial pressure (ICP) in the NOR+sdB group was <20 mmHg throughout the first 120 h. NOR+sdB prevented composite death in the ICU in patients with sTBI, and we may obtain novel insights into the beneficial role of prophylactic barbiturate therapy from suppression of the elevated ICP during the first 120 h.	[Kajiwara, Sosho; Hasegawa, Yu; Negoto, Tetsuya; Orito, Kimihiko; Kawano, Takayuki; Yoshitomi, Munetake; Sakata, Kiyohiko; Takeshige, Nobuyuki; Hirohata, Masaru; Morioka, Motohiro] Kurume Univ, Dept Neurosurg, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan; [Hasegawa, Yu] Int Univ Hlth & Welf, Dept Pharmaceut Sci, Fukuoka, Fukuoka, Japan; [Yamakawa, Yukako; Jono, Hirofumi; Saito, Hideyuki] Kumamoto Univ Hosp, Dept Pharm, Kumamoto, Kumamoto, Japan; [Hirayu, Nobuhisa; Takasu, Osamu] Kurume Univ, Dept Emergency & Crit Care Med, Sch Med, Kurume, Fukuoka, Japan		Morioka, M (corresponding author), Kurume Univ, Dept Neurosurg, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	mmorioka@med.kurume-u.ac.jp					Anania P, 2020, NEUROSURG REV, P1; Battaglini D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.564751; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cordato DJ, 2003, J CLIN NEUROSCI, V10, P283, DOI 10.1016/S0967-5868(03)00034-1; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Irie S, 2020, BRAIN DEV-JPN, V42, P477, DOI 10.1016/j.braindev.2020.04.005; Ishida Y, 2020, SEIZURE-EUR J EPILEP, V80, P12, DOI 10.1016/j.seizure.2020.03.012; Kuga S, 2020, PEDIATR INT, V62, P1346, DOI 10.1111/ped.14331; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Matsui Akiko, 2018, Drugs Real World Outcomes, V5, P137, DOI 10.1007/s40801-018-0136-y; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Yamakawa Y, 2021, PHARMACOL RES PERSPE, V9, DOI 10.1002/prp2.719; Zhu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2391-2	21	0	0	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2021	61	9					528	535		10.2176/nmc.oa.2021-0097			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	US0XA	WOS:000697159800004	34078830	Green Published, gold			2022-02-06	
J	Kettlewell, J; Lindley, R; Radford, K; Patel, P; Bridger, K; Kellezi, B; Timmons, S; Andrews, I; Fallon, S; Lannin, N; Holmes, J; Kendrick, D				Kettlewell, Jade; Lindley, Rebecca; Radford, Kate; Patel, Priya; Bridger, Kay; Kellezi, Blerina; Timmons, Stephen; Andrews, Isabel; Fallon, Stephen; Lannin, Natasha; Holmes, Jain; Kendrick, Denise		ROWTATE Team	Factors Affecting the Delivery and Acceptability of the ROWTATE Telehealth Vocational Rehabilitation Intervention for Traumatic Injury Survivors: A Mixed-Methods Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic injuries; return to work; vocational rehabilitation; patient perspectives; telehealth; acceptability; mixed methods; occupational therapy; clinical psychology	ACQUIRED BRAIN-INJURY; CLINICAL VIDEO TELEHEALTH; SPINAL-CORD-INJURY; WORK; TELEPHONE; RETURN; TELEREHABILITATION; VETERANS; THERAPY; INDIVIDUALS	Background: Returning to work after traumatic injury can be problematic. We developed a vocational telerehabilitation (VR) intervention for trauma survivors, delivered by trained occupational therapists (OTs) and clinical psychologists (CPs), and explored factors affecting delivery and acceptability in a feasibility study. Methods: Surveys pre- (5 OTs, 2 CPs) and post-training (3 OTs, 1 CP); interviews pre- (5 OTs, 2 CPs) and post-intervention (4 trauma survivors, 4 OTs, 2 CPs). Mean survey scores for 14 theoretical domains identified telerehabilitation barriers (score <= 3.5) and facilitators (score >= 5). Interviews were transcribed and thematically analysed. Results: Surveys: pre-training, the only barrier was therapists' intentions to use telerehabilitation (mean = 3.40 +/- 0.23), post-training, 13/14 domains were facilitators. Interviews: barriers/facilitators included environmental context/resources (e.g., technology, patient engagement, privacy/disruptions, travel and access); beliefs about capabilities (e.g., building rapport, complex assessments, knowledge/confidence, third-party feedback and communication style); optimism (e.g., impossible assessments, novel working methods, perceived importance and patient/therapist reluctance) and social/professional role/identity (e.g., therapeutic methods). Training and experience of intervention delivery addressed some barriers and increased facilitators. The intervention was acceptable to trauma survivors and therapists. Conclusion: Despite training and experience in intervention delivery, some barriers remained. Providing some face-to-face delivery where necessary may address certain barriers, but strategies are required to address other barriers.	[Kettlewell, Jade; Timmons, Stephen] Univ Nottingham, Ctr Hlth Innovat Leadership & Learning, Business Sch, Nottingham NG8 1BB, England; [Kettlewell, Jade; Lindley, Rebecca; Radford, Kate; Bridger, Kay; Kellezi, Blerina; Andrews, Isabel; Fallon, Stephen; Holmes, Jain; Kendrick, Denise] Univ Nottingham, Sch Med, Nottingham NG7 2UH, England; [Patel, Priya] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2TU, England; [Bridger, Kay; Kellezi, Blerina] Nottingham Trent Univ, Dept Psychol, Nottingham NG1 4FQ, England; [Lannin, Natasha] Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia		Kettlewell, J (corresponding author), Univ Nottingham, Ctr Hlth Innovat Leadership & Learning, Business Sch, Nottingham NG8 1BB, England.; Kettlewell, J (corresponding author), Univ Nottingham, Sch Med, Nottingham NG7 2UH, England.	Jade.kettlewell2@nottingham.ac.uk; Rebecca.lindley@nottingham.ac.uk; Kate.radford@nottingham.ac.uk; mszpp@nottingham.ac.uk; Kay.bridger@nottingham.ac.uk; Blerina.kellezi@ntu.ac.uk; Stephen.Timmons@nottingham.ac.uk; issyandrews@hotmail.com; fallon@btinternet.com; Natasha.Lannin@monash.edu; Jain.holmes@nottingham.ac.uk; Denise.kendrick@nottingham.ac.uk	; Holmes, Jain/K-2125-2016	Lindley, Rebecca/0000-0002-5224-8230; Lannin, Natasha/0000-0002-2066-8345; Kendrick, Denise/0000-0003-3603-6542; Kellezi, Blerina/0000-0003-4825-3624; Holmes, Jain/0000-0003-2465-102X	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [RP-PG-0617-20001]; National Heart Foundation of AustraliaNational Heart Foundation of Australia [GNT102055]	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference number RP-PG-0617-20001). NL is funded by the National Heart Foundation of Australia (GNT102055). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Brockway JA, 2016, REHABIL PSYCHOL, V61, P221, DOI 10.1037/rep0000077; Caffery LJ, 2017, J TELEMED TELECARE, V23, P835, DOI 10.1177/1357633X17732800; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Coleman JJ, 2015, AM J SPEECH-LANG PAT, V24, P295, DOI 10.1044/2015_AJSLP-14-0028; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Dorstyn D, 2019, SPINAL CORD, V57, P221, DOI 10.1038/s41393-018-0200-1; Escorpizo R, 2011, J OCCUP REHABIL, V21, P126, DOI 10.1007/s10926-011-9292-6; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Hale-Gallardo JL, 2020, J MULTIDISCIP HEALTH, V13, P559, DOI 10.2147/JMDH.S247267; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Jones TM, 2016, PHYS THER, V96, P1982, DOI 10.2522/ptj.20160028; Kairy D, 2014, REV PANAM SALUD PUBL, V35, P337; Kendrick D, 2021, PILOT FEASIBILITY ST, V7, DOI 10.1186/s40814-021-00769-4; Kettlewell J, 2021, CLIN REHABIL, V35, P750, DOI 10.1177/0269215520971777; Kettlewell J, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0611-0; Kingston GA, 2015, DISABIL REHABIL, V37, P423, DOI 10.3109/09638288.2014.923526; Kiselev J, 2015, J GERONTOL NURS, V41, P18, DOI 10.3928/00989134-20141201-01; Kruse CS, 2018, J REHABIL MED, V50, P385, DOI 10.2340/16501977-2302; Levinger P, 2017, PHYS THER SPORT, V27, P29, DOI 10.1016/j.ptsp.2017.06.001; Levy CE, 2015, J REHABIL RES DEV, V52, P361, DOI 10.1682/JRRD.2014.10.0239; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Little JR, 2018, MIL MED, V183, pE148, DOI 10.1093/milmed/usx035; Mallon B, 2007, HEALTH SOC WORK, V32, P139, DOI 10.1093/hsw/32.2.139; Martinez RN, 2017, TELEMED E-HEALTH, V23, P567, DOI 10.1089/tmj.2016.0200; Martinez RN, 2017, PM&R, V9, P231, DOI 10.1016/j.pmrj.2016.07.002; Mehta S, 2019, REHABIL PSYCHOL, V64, P351, DOI 10.1037/rep0000276; Ownsworth T, 2020, J INT NEUROPSYCH SOC, V26, P47, DOI 10.1017/S135561771900078X; Rietdijk R, 2020, J TELEMED TELECARE, DOI 10.1177/1357633X20923824; Roels EH, 2016, SPINAL CORD, V54, P2, DOI 10.1038/sc.2015.133; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Simic T, 2016, AM J SPEECH-LANG PAT, V25, P642, DOI 10.1044/2016_AJSLP-15-0030; Solana J, 2015, IEEE J BIOMED HEALTH, V19, P124, DOI 10.1109/JBHI.2014.2354537; Spencer L., 2003, QUALITY QUALITATIVE; Tenforde AS, 2017, PM&R, V9, pS51, DOI 10.1016/j.pmrj.2017.02.013; Tsaousides T, 2017, J HEAD TRAUMA REHAB, V32, P354, DOI 10.1097/HTR.0000000000000345; Turgoose D, 2018, J TELEMED TELECARE, V24, P575, DOI 10.1177/1357633X17730443; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; World Health Organization, 2010, INJ VIOL FACTS	44	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2021	18	18							9744	10.3390/ijerph18189744			26	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	UX1ZR	WOS:000700646400001	34574670	Green Published, Green Accepted, gold			2022-02-06	
J	Khan, MI; Gilpin, K; Hasan, F; Al Mahmud, KA; Adnan, A				Khan, Md Ishak; Gilpin, Kathleen; Hasan, Fuad; Al Mahmud, Khandakar Abu Hasan; Adnan, Ashfaq			Effect of Strain Rate on Single Tau, Dimerized Tau and Tau-Microtubule Interface: A Molecular Dynamics Simulation Study	BIOMOLECULES			English	Article						tau protein; molecular dynamics; high strain rate; axonal cytoskeleton	NEURODEGENERATIVE DISORDERS; MECHANICAL-PROPERTIES; MYOSIN-FILAMENTS; ACTIN-FILAMENTS; PROLINE-RICH; PROTEIN; BINDING; INJURY; BUNDLE; PHOSPHORYLATION	Microtubule-associated protein (MAP) tau is a cross-linking molecule that provides structural stability to axonal microtubules (MT). It is considered a potential biomarker for Alzheimer's disease (AD), dementia, and other neurological disorders. It is also a signature protein for Traumatic Brain Injury (TBI) assessment. In the case of TBI, extreme dynamic mechanical energies can be felt by the axonal cytoskeletal members. As such, fundamental understandings of the responses of single tau protein, polymerized tau protein, and tau-microtubule interfaces under high-rate mechanical forces are important. This study attempts to determine the high-strain rate mechanical behavior of single tau, dimerized tau, and tau-MT interface using molecular dynamics (MD) simulation. The results show that a single tau protein is a highly stretchable soft polymer. During deformation, first, it significantly unfolds against van der Waals and electrostatic bonds. Then it stretches against strong covalent bonds. We found that tau acts as a viscoelastic material, and its stiffness increases with the strain rate. The unfolding stiffness can be similar to 50-500 MPa, while pure stretching stiffness can be >2 GPa. The dimerized tau model exhibits similar behavior under similar strain rates, and tau sliding from another tau is not observed until it is stretched to >7 times of original length, depending on the strain rate. The tau-MT interface simulations show that very high strain and strain rates are required to separate tau from MT suggesting Tau-MT bonding is stronger than MT subunit bonding between themselves. The dimerized tau-MT interface simulations suggest that tau-tau bonding is stronger than tau-MT bonding. In summary, this study focuses on the structural response of individual cytoskeletal components, namely microtubule (MT) and tau protein. Furthermore, we consider not only the individual response of a component, but also their interaction with each other (such as tau with tau or tau with MT). This study will eventually pave the way to build a bottom-up multiscale brain model and analyze TBI more comprehensively.	[Khan, Md Ishak; Hasan, Fuad; Al Mahmud, Khandakar Abu Hasan; Adnan, Ashfaq] Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA; [Gilpin, Kathleen] Wright State Appl Res Corp, Acad Partnership & Engagement Expt APEX, Beavercreek, OH 45431 USA		Adnan, A (corresponding author), Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA.	mdishak.khan@mays.uta.edu; kathleen.gilpin@navy.mil; fuad.hasan@mays.uta.edu; mahmud.khandakarabuhas@mays.uta.edu; aadnan@uta.edu		Hasan, Fuad/0000-0003-1889-4877; Khan, Md Ishak/0000-0001-7680-9613	Office of Naval Research (ONR)Office of Naval Research [N00014-18-1-2082]	This work has been funded by the Computational Cellular Biology of Blast (C2B2) program through the Office of Naval Research (ONR) (Award #N00014-18-1-2082-Timothy Bentley, Program Manager).	Adnan A, 2018, J MECH BEHAV BIOMED, V86, P375, DOI 10.1016/j.jmbbm.2018.06.031; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Al Mahmud KAH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66591-9; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; Anbu V, 2017, J MOL STRUCT, V1143, P362, DOI 10.1016/j.molstruc.2017.04.098; Barbier P, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00204; Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Battisti A, 2012, MOL SIMULAT, V38, P525, DOI 10.1080/08927022.2011.633347; Becker JS, 2007, J ANAL ATOM SPECTROM, V22, P761, DOI 10.1039/b701440f; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carlsen R.W., 2021, BRAIN MULTIPHYS, V2, DOI [10.1016/j.brain.2021.100024, DOI 10.1016/J.BRAIN.2021.100024]; Castro TG, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9030116; Chandran PL, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011906; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cloots R.J.H., 2010, P IRCOBI C HANN GERM, P119; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; Farhadi T, 2018, DRUG DES DEV THER, V12, P1239, DOI 10.2147/DDDT.S159767; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Gladkevich A, 2007, PROG NEURO-PSYCHOPH, V31, P1347, DOI 10.1016/j.pnpbp.2007.06.005; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hasan F., 2021, ARXIV201213446; HIGUCHI H, 1995, BIOPHYS J, V69, P1000, DOI 10.1016/S0006-3495(95)79975-1; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Jho YS, 2010, BIOPHYS J, V99, P2387, DOI 10.1016/j.bpj.2010.06.056; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Kadavath H, 2015, ANGEW CHEM INT EDIT, V54, P10347, DOI 10.1002/anie.201501714; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; Khan, 2021, MULTISCALE SCI ENG, V3, P67, DOI [10.1007/s42493-021-00060-x, DOI 10.1007/S42493-021-00060-X]; Khan I., 2020, MULTISCALE SCI ENG, V2, P199, DOI [10.1007/s42493-020-00043-4, DOI 10.1007/S42493-020-00043-4]; Khan MI, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11040540; Khan MI, 2021, COMPUT STRUCT BIOTEC, V19, P1738, DOI 10.1016/j.csbj.2021.03.026; Khan MI, 2021, J MECH BEHAV BIOMED, V113, DOI 10.1016/j.jmbbm.2020.104149; Kim JI, 2015, PHYS CHEM CHEM PHYS, V17, P8148, DOI 10.1039/c4cp06100d; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Li X., 2020, BIOSCI BIOTECH BIOCH, V20, P403, DOI [10.1007/s10237-020-01391-8, DOI 10.1080/09168451.2020.1793292, DOI 10.1007/s10237-020-01391-8]; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Mofrad MRK, 2009, ANNU REV FLUID MECH, V41, P433, DOI 10.1146/annurev.fluid.010908.165236; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Nogales E, 1998, NATURE, V393, P191, DOI 10.1038/30288; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Popov KI, 2019, STRUCTURE, V27, P1710, DOI 10.1016/j.str.2019.09.003; Pradeepkiran JA, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166162; Pradeepkiran JA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030260; Pradeepkiran JA, 2019, DRUG DISCOV TODAY, V24, P616, DOI 10.1016/j.drudis.2018.11.005; Pradeepkiran JA, 2015, DRUG DES DEV THER, V9, P1897, DOI 10.2147/DDDT.S77020; Preuss U, 1997, J CELL SCI, V110, P789; Rodney D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108004; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Rycroft CH, 2009, CHAOS, V19, DOI 10.1063/1.3215722; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; Shahinnejad A, 2013, PROCEDIA ENGINEER, V59, P16, DOI 10.1016/j.proeng.2013.05.088; Silber J, 2004, HEARING RES, V197, P112, DOI 10.1016/j.heares.2004.06.006; Sochocka M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1520-6; Sonawane SK, 2018, J MOL NEUROSCI, V65, P480, DOI 10.1007/s12031-018-1111-5; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tolomeo JA, 1997, BIOPHYS J, V73, P2241, DOI 10.1016/S0006-3495(97)78255-9; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu YT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29804-w; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	90	0	0	5	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	SEP	2021	11	9							1308	10.3390/biom11091308			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UV3VB	WOS:000699409400001	34572521	Green Submitted, Green Published, gold			2022-02-06	
J	Kiwango, G; Francis, F; Moshiro, C; Moller, J; Hasselberg, M				Kiwango, George; Francis, Filbert; Moshiro, Candida; Moller, Jette; Hasselberg, Marie			Association between alcohol consumption, marijuana use and road traffic injuries among commercial motorcycle riders: A population-based, case-control study in Dares Salaam, Tanzania	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Alcohol consumption; Marijuana; Motorcycle; Road traffic injuries	PSYCHOACTIVE SUBSTANCE USE; IDENTIFICATION TEST AUDIT; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; RISK-PERCEPTION; ACCIDENTS; BEHAVIOR; CANNABIS; DRIVERS; NOVICE	Background: Alcohol consumption and psychoactive drug use are well-recognised risk factors for road traffic injuries (RTIs). Both types of use may impair and affect drivers' performance. Yet, there is limited literature on their contribution to RTIs among commercial motorcycle riders, particularly in low-and middle-income settings. This study aimed to determine the association between alcohol consumption, marijuana use and RTIs among commercial motorcycle riders in the city of Dar es Salaam, Tanzania. Methods: We conducted a case-control study between July 2018 and March 2019. Cases (n = 164) were commercial motorcycle riders who had sustained an RTIs and attended at a hospital. Controls (n = 400) were commercial motorcycle riders who had not experienced an RTIs that led to hospital attendance during the past six months. Alcohol consumption was assessed using the Alcohol Use Disorder Identification (AUDIT) score, which classified participants as a non-drinker, normal drinker(1-7 scores) and risky drinker (scores >= 8). Marijuana use was assessed through self-reported use in the past year. We estimated odds ratios (ORs) using logistic regression adjusted for sociodemographic, driver-, and work-related factors. Results: Risky drinking was associated with close to six times the odds of RTIs compared to non-drinkers (OR = 5.98, 95% CI: 3.25 - 11.0). The association remained significant even after adjusting for sociodemographic, driving and work-related factors (OR = 2.41, 95% CI: 1.01 - 5.76). The crude odds ratios of RTIs were significantly higher among users of marijuana than non-users (OR = 2.33, 95% CI: 1.38 - 3.95). However, the association did not remain statistically significant after adjusting for confounders (OR = 1.11, 95% CI = 0.49-2.48). Conclusion: Our findings confirm increased odds of RTIs among commercial motorcycle riders with risky drinking behaviour even after taking sociodemographic, driving and work-related factors into account. Unlike alcohol consumption the relationship between marijuana use and RTIs among commercial motorcycle riders was unclear. Since motorcycle riders are more susceptible to the effect of alcohol due to higher demands of balance and coordination and because commercial motorcyclist riders, in particular, they spend a considerable amount of time on the road, our results underscore the importance of addressing hazardous alcohol consumption and marijuana use in future prevention strategies to enhance road safety.	[Kiwango, George; Moshiro, Candida] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Francis, Filbert; Moller, Jette; Hasselberg, Marie] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Francis, Filbert] Natl Inst Med Res, Tanga, Tanzania		Francis, F (corresponding author), Kamlinska Inst, Dept Global Publ Hlth Publ Hlth Epidemiol, Stockholm, Sweden.	filbert.francis@ki.se		Kiwango, George/0000-0002-4796-833X; Moshiro, Candida/0000-0001-7606-2361	Swedish International Development Corporation Agency, Sida	This study was made possible by student research grant from Swedish International Development Corporation Agency, Sida.	Abegaz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103001; Adeloye D, 2016, B WORLD HEALTH ORGAN, V94, P510, DOI 10.2471/BLT.15.163121; Alti-Muazu M, 2008, ANN AFR MED, V7, P67, DOI 10.4103/1596-3519.55678; Amend P.A., 2015, OPPORTUNITIES IMPROV; Babor TF., 2001, ALCOHOL USE DISORDER, V2a ed.; Bishop T., 2018, RAF2114A RECAP FOR D; Bogstrand ST, 2015, ACCIDENT ANAL PREV, V78, P14, DOI 10.1016/j.aap.2014.12.025; Boniface R, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.46.7487; Bradbury A., 2015, TANZANIA MOTORCYCLE; Charman, 2018, ENHANCING UNDERSTAND; COLBURN N, 1993, J TRAUMA, V35, P183, DOI 10.1097/00005373-199308000-00002; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; Creaser JI, 2009, ACCIDENT ANAL PREV, V41, P906, DOI 10.1016/j.aap.2009.04.007; Damacena GN, 2016, CIENC SAUDE COLETIVA, V21, P3777, DOI 10.1590/1413-812320152112.25692015; Dean AG, 2013, OPENEPI OPEN SOURCE; dos Santos WJ, 2019, TRAFFIC INJ PREV, V20, P233, DOI 10.1080/15389588.2019.1579318; Downey LA, 2013, ACCIDENT ANAL PREV, V50, P879, DOI 10.1016/j.aap.2012.07.016; Elvik R, 2013, ACCIDENT ANAL PREV, V60, P254, DOI 10.1016/j.aap.2012.06.017; Falco A, 2013, J SAFETY RES, V46, P47, DOI 10.1016/j.jsr.2013.03.002; Fergusson DM, 2001, ACCIDENT ANAL PREV, V33, P703, DOI 10.1016/S0001-4575(00)00082-8; Freeman J, 2020, ACCIDENT ANAL PREV, V137, DOI 10.1016/j.aap.2019.105428; Frick J.R., 2014, SOEP SURVEY PAPERS; Fujii H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3053-6; Gudaji M.I., 2016, INT J MED MED SCI, V8, P15; Gupta S, 2018, TRAFFIC INJ PREV, V19, P66, DOI 10.1080/15389588.2017.1342821; Heydari ST, 2016, CHIN J TRAUMATOL, V19, P79, DOI 10.1016/j.cjtee.2015.12.006; Hoonpongsimanont W, 2021, SUBST ABUS, V42, P192, DOI 10.1080/08897077.2019.1671936; Hron K, 2010, COMPUT STAT DATA AN, V54, P3095, DOI 10.1016/j.csda.2009.11.023; Inspector General of Police, 2017, CRIM TRAFF INC STAT; Ivers R, 2009, AM J PUBLIC HEALTH, V99, P1638, DOI 10.2105/AJPH.2008.150367; Kasantikul V, 2005, ACCIDENT ANAL PREV, V37, P357, DOI 10.1016/j.aap.2004.07.006; Keall MD, 2004, ACCIDENT ANAL PREV, V36, P49, DOI 10.1016/S0001-4575(02)00114-8; Kuo SCH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4649-1; Latkin C.A E.C., 2017, PHYSIOL BEHAV, V176, P139, DOI [10.1016/j.physbeh.2017.03.040, DOI 10.1016/J.PHYSBEH.2017.03.040]; Latkin CA, 2017, ADDICT BEHAV, V73, P133, DOI 10.1016/j.addbeh.2017.05.005; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Macinko J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134153; MANNERING F, 1995, ACCIDENT ANAL PREV, V27, P21, DOI 10.1016/0001-4575(94)00041-J; Marr J.N., 1999, INTERRELATIONSHIP US; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; Movig KLL, 2004, ACCIDENT ANAL PREV, V36, P631, DOI 10.1016/S0001-4575(03)00084-8; Mundenga MM, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0222-9; NBS, 2017, TANZ FIG 2018; NHTSA, 2008, EFF ALC MOT RID SKIL; O'Brien F, 2016, J ADOLESCENCE, V52, P89, DOI 10.1016/j.adolescence.2016.07.010; O'Kane Carl J, 2002, Emerg Med (Fremantle), V14, P296; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Owoaje ET, 2005, J COMMUNITY MED PRIM, V17, P7, DOI DOI 10.4314/JCMPHC.V17I1.32418; Papalimperi AH, 2019, EXP THER MED, V18, P2299, DOI 10.3892/etm.2019.7787; Ramaekers Johannes G., 2009, P477, DOI 10.1007/978-3-7643-9923-8_29; Ravera S, 2011, BRIT J CLIN PHARMACO, V72, P505, DOI 10.1111/j.1365-2125.2011.03994.x; Rothengatter T.E., 1997, INT C TRAFF TRANSP P; Ruano-Ravina A, 2008, GAC SANIT, V22, P609, DOI 10.1016/S0213-9111(08)75363-9; Rudin-Brown CM, 2013, ACCIDENT ANAL PREV, V50, P895, DOI 10.1016/j.aap.2012.07.018; Sakashita C, 2014, TRANSPORT RES F-TRAF, V22, P126, DOI 10.1016/j.trf.2013.10.005; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Shyhalla K, 2014, TRAFFIC INJ PREV, V15, P325, DOI 10.1080/15389588.2013.822491; Smiley A., 1998, HLTH EFFECTS CANNABI, P526; Staton CA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5144-z; Sumner S.A., 2014, IMPROVING MOTORCYCLE, P1; Sun SW, 1998, ACCIDENT ANAL PREV, V30, P133, DOI 10.1016/S0001-4575(97)00055-9; Tsai MC, 2005, ALCOHOL CLIN EXP RES, V29, P53, DOI 10.1097/01.ALC.0000151986.96710.E0; Nguyen T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207570; Tumwesigye NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148511; Uttra S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072785; Vissoci JRN, 2018, ALCOHOL ALCOHOLISM, V53, P112, DOI 10.1093/alcalc/agx058; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woratanarat P, 2009, ACCIDENT ANAL PREV, V41, P651, DOI 10.1016/j.aap.2009.03.002; Wu PJ, 2019, TRANSPORT RES REC, V2673, P403, DOI 10.1177/0361198118822817; Xiong LL, 2016, AIMS PUBLIC HEALTH, V3, P907, DOI 10.3934/publichealth.2016.4.907	71	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2021	160								106325	10.1016/j.aap.2021.106325			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	UE5WD	WOS:000687957200002	34390892	hybrid			2022-02-06	
J	Knaus, ME; Berg, GM; Vogel, AM; Prince, JM; Burd, RS; Gosain, A				Knaus, Maria E.; Berg, Gina M.; Vogel, Adam M.; Prince, Jose M.; Burd, Randall S.; Gosain, Ankush			The Pediatric Trauma Society Annual Meeting: An Analysis of Scholarly Output From the First 5 Years	JOURNAL OF TRAUMA NURSING			English	Article						Bibliometrics; Conferences; Pediatric; Research; Scholarly activity; Trauma		Background: The Pediatric Trauma Society (PTS) is a multidisciplinary organization, with scientific presentations at its annual meeting addressing trauma care from prehospital through rehabilitation. Objective: The purpose of this study was to identify and describe the scholarly areas of focus of presentations at the annual meeting over the society's first 5 years and evaluate research dissemination. Methods: Data were collected on abstracts presented between 2014 and 2018, including titles, authors, and abstract classification. PubMed and Google Scholar searches identified abstracts that resulted in publications. Journal impact factors were identified. Results: Over 5 years, 491 of 635 (77.3%) abstracts were accepted. The number of submitted and accepted abstracts increased, but the acceptance rate was stable (range = 72.1%-81.2%, p = NS [nonsignificant]). The most frequently accepted categories included "Epidemiology," "Abdominal or Thoracic Trauma," and "Neurosurgery or Traumatic Brain Injury (TBI)," whereas "Trauma Nursing" and "Quality Improvement" were less common. Among the 2014-2016 abstracts, 55.4% of podium and 24.3% of poster presentations were published. Abstracts categorized as "Epidemiology," "Education & Injury Prevention," and "Neurosurgery or TBI" were commonly presented but uncommonly published. The median journal impact factor of publications was 2.1 and 2.0 for podium and poster presentations, respectively (ranging from 0.11 to 10.25). Conclusion: Most of the scholarly effort presented at the PTS remains unpublished. Published work is mainly in low-impact factor journals. Mentorship in the publication process and encouragement of multidisciplinary collaboration within the society are needed to address limitations in the number and potential impact of the scientific content of the annual meeting. This type of analysis is relevant not only to the PTS but also to any professional society seeking to improve its impact.	[Knaus, Maria E.; Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Div Pediat Surg, Memphis, TN 38163 USA; [Berg, Gina M.] Univ Kansas, Sch Med, Dept Family & Community Med, Wichita, KS 67214 USA; [Vogel, Adam M.] Texas Childrens Hosp, Houston, TX 77030 USA; [Vogel, Adam M.] Baylor Coll Med, Dept Surg, Houston, TX USA; [Prince, Jose M.] Zucker Sch Med Hofstra Northwell, Dept Surg, New Hyde Pk, NY USA; [Prince, Jose M.] Cohen Childrens Med Ctr, New Hyde Pk, NY USA; [Burd, Randall S.] Childrens Natl Med Ctr, Div Trauma & Burn Surg, Washington, DC 20010 USA; [Gosain, Ankush] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA		Berg, GM (corresponding author), Univ Kansas, Sch Med, 1010 N Kansas, Wichita, KS 67214 USA.	Maria.Knaus@nationwidechildrens.org; gberg@kumc.edu; adamv@bcm.edu; Jprince@northwell.edu; rburd@childrensnational.org; agosain@uthsc.edu		Knaus, Maria/0000-0002-4751-8304			American College of Surgeons, 2019, VRC STAND FAQS, V2019; Desai N, 2018, J PEDIATR SURG, V53, P1098, DOI 10.1016/j.jpedsurg.2018.02.063; Greig CJ, 2019, J SURG RES, V238, P16, DOI 10.1016/j.jss.2018.11.034; Ivanov A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170056; National Research Council, 2003, SHARING PUBLICATION; Paulus FM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01487; Pediatric Trauma Society (PTS), 2011, HOM PAG; Sprague S, 2003, J BONE JOINT SURG AM, V85A, P158, DOI 10.2106/00004623-200301000-00024	8	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	SEP-OCT	2021	28	5					316	322		10.1097/JTN.0000000000000605			7	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	UM5GU	WOS:000693360000009	34491949				2022-02-06	
J	Knollman-Porter, K; Brown, JA; Wallace, T; Spitz, S				Knollman-Porter, Kelly; Brown, Jessica A.; Wallace, Tracey; Spitz, Shelby			First-Line Health Care Providers' Reported Knowledge of and Referrals to Speech-Language Pathologists for Clients With Mild Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							CONCUSSION-MANAGEMENT; HIGH-SCHOOL; CHILDREN; PATTERNS; MEMORY; RETURN; STUDENTS; ADULTS; SPORT; SYMPTOMATOLOGY	Purpose: People with mild traumatic brain injury (mTBI) may experience deficits in cognition or communication that go unnoticed by first-line health care providers (FHPs). Speech-language pathologists (SLPs) assess and treat these domains yet are often underrepresented on mTBI multidisciplinary teams. This study's aim was to evaluate FHPs' reported knowledge of and referral practices to SLPs for individuals across the life span with mTBI. Method: Physicians, physician assistants, nurse practitioners, nurses, and athletic trainers (n = 126) completed an online survey, including two Likert scale questions and one free response question relating to SLPs' role in mTBI. Results: More than half of FHPs rate their knowledge of the SLP's role in mTBI management as low (somewhat knowledgeable, 29%; not very knowledgeable, 23%). Similarly, nearly two thirds of FHPs indicated rarely (19%) or never (44%), referring to SLPs for management of patients with mTBI. The majority of FHPs' open responses on the role of the SLP in mTBI management were incomplete, with many including domains that were not relevant to an SLP's role in the management of mTBI (e.g., dysphagia). Within the article, we provide results overall and according to individual profession. Conclusions: Results suggest a majority of FHPs lack knowledge in the role of the SLP in the management of mTBI, which may underpin the low referral patterns reported by FHPs for SLP services. Future educational efforts for FHPs regarding the role of SLPs in mTBI care are necessary.	[Knollman-Porter, Kelly; Spitz, Shelby] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA; [Brown, Jessica A.] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA; [Wallace, Tracey] Shepherd Ctr, Complex Concuss Clin, Atlanta, GA USA		Knollman-Porter, K (corresponding author), Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA.	knollmkk@miamioh.edu					ALBERTS MJ, 1992, STROKE, V23, P352, DOI 10.1161/01.STR.23.3.352; American Speech-Language-Hearing Association, 2016, SCOPE PRACTICE SPEEC, DOI [10.1044/policy.SP2016-00343, DOI 10.1044/POLICY.SP2016-00343]; Arndt BG, 2017, ANN FAM MED, V15, P419, DOI 10.1370/afm.2121; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bauman S. M., 2019, J CONCUSSION, V3, DOI [10.1177/2059700219886192, DOI 10.1177/2059700219886192]; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Brown J, 2020, AM J SPEECH-LANG PAT, V29, P1389, DOI 10.1044/2020_AJSLP-19-00131; Brown J, 2019, TOP LANG DISORD, V39, P239, DOI 10.1097/TLD.0000000000000186; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Centers for Disease Control and Prevention, 2019, TBI REL EM DEP VIS H; Ciccia AH, 2016, AM J SPEECH-LANG PAT, V25, P508, DOI 10.1044/2016_AJSLP-15-0087; Cichero JA, 2009, J CLIN NURS, V18, P1649, DOI 10.1111/j.1365-2702.2009.02797.x; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Dollaghan C, 2007, HDB EVIDENCE BASED P; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hagge D. K., 2015, ASHA LEADER, V20, P34, DOI [10.1044/leader.AE.20062015.34, DOI 10.1044/LEADER.AE.20062015.34]; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Heaton S, 2020, INT J SPEECH-LANG PA, V22, P95, DOI 10.1080/17549507.2019.1597922; Hong ER, 2014, RES AUTISM SPECT DIS, V8, P570, DOI 10.1016/j.rasd.2014.01.012; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Ketcham C. J., 2017, CURRENT RES CONCUSSI, V4, P8, DOI [10.1055/s-0037-1603645, DOI 10.1055/S-0037-1603645]; Knollman-Porter K., 2018, AM SPEECH LANG HEAR; Knollman-Porter K., 2018, AM C REH MED, V99, pE3, DOI DOI 10.1016/J.APMR.2018.07.011; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Laane SA, 2020, SEMIN SPEECH LANG, V41, P183, DOI 10.1055/s-0040-1701686; Lohr RH, 2013, MAYO CLIN PROC, V88, P1266, DOI 10.1016/j.mayocp.2013.08.013; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundine JP, 2020, SEMIN SPEECH LANG, V41, P170, DOI 10.1055/s-0040-1701685; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1371, DOI 10.1044/2019_AJSLP-18-0295; Makri A, 2019, TOP LANG DISORD, V39, P276, DOI 10.1097/TLD.0000000000000188; Mashima P, 2019, TOP LANG DISORD, V39, P293, DOI 10.1097/TLD.0000000000000189; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; Miller J. H., 2016, J NEUROSURG-PEDIATR, V17, P379; Mitchell S. H., 2016, ATHLETIC TRAINING SP, V8, P209; Moors G, 2014, SOCIOL METHODOL, V44, P369, DOI 10.1177/0081175013516114; National Collegiate Athletics Association, 2016, CONC DIAGN MAN BEST; Newman L. A., 2003, ASHA LEADER, V8, P1, DOI [10.1044/leader.FTR3.08212003.1, DOI 10.1044/LEADER.FTR3.08212003.1]; Norman R. S., 2020, UPDATING REFINING PR, DOI [10.1044/2020_PERSP-20-00011, DOI 10.1044/2020_PERSP-20-00011]; O'Brien KH, 2020, SEMIN SPEECH LANG, V41, P195, DOI 10.1055/s-0040-1701687; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Poll H., 2015, KNOWLEDGEABLE ARE AM; Ponto Julie, 2015, J Adv Pract Oncol, V6, P168; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Potteiger KL, 2018, INTERNET J ALLIED HE, V16; Qualtrics, QUALTR SEC COMPL; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Salley J, 2020, SEMIN SPEECH LANG, V41, P125, DOI 10.1055/s-0040-1701682; Salvatore AP, 2019, SEMIN SPEECH LANG, V40, P1, DOI 10.1055/s-0038-1676366; Salvatore AP, 2014, SEMIN SPEECH LANG, V35, P153, DOI 10.1055/s-0034-1384675; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Sandhaus S, 2009, J GERONTOL NURS, V35, P20, DOI 10.3928/00989134-20090331-08; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Steel J, 2017, BRAIN INJURY, V31, P1320, DOI 10.1080/02699052.2017.1332385; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; The Physicians Foundation, 2018, 2018 SURV AM PHYS PR; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Van Selm M, 2006, QUAL QUANT, V40, P435, DOI 10.1007/s11135-005-8081-8; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Williams-Butler M. A., 2019, HEALTH-LONDON, V11, P880, DOI [10.4236/health.2019.117071, DOI 10.4236/HEALTH.2019.117071]; Wright J, 2020, TOP LANG DISORD, V40, P6, DOI 10.1097/TLD.0000000000000198; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	85	0	0	2	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	SEP	2021	30	5					2214	2227		10.1044/2021_AJSLP-20-00373			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	UW7WL	WOS:000700363400024	34293269				2022-02-06	
J	Kurtin, DL; Violante, IR; Zimmerman, K; Leech, R; Hampshire, A; Patel, MC; Carmichael, DW; Sharp, DJ; Li, LM				Kurtin, Danielle L.; Violante, Ines R.; Zimmerman, Karl; Leech, Robert; Hampshire, Adam; Patel, Maneesh C.; Carmichael, David W.; Sharp, David J.; Li, Lucia M.			Investigating the interaction between white matter and brain state on tDCS-induced changes in brain network activity	BRAIN STIMULATION			English	Article						Default mode network; Magnetic resonance imaging; Salience network; Stimulation; Traumatic brain injury; White matter structure	SALIENCE NETWORK; MOTOR; CONNECTIVITY; POLARIZATION; REGISTRATION; STIMULATION; CORTEX; ROBUST	Background: Transcranial direct current stimulation (tDCS) is a form of noninvasive brain stimulation whose potential as a cognitive therapy is hindered by our limited understanding of how participant and experimental factors influence its effects. Using functional MRI to study brain networks, we have previously shown in healthy controls that the physiological effects of tDCS are strongly influenced by brain state. We have additionally shown, in both healthy and traumatic brain injury (TBI) populations, that the behavioral effects of tDCS are positively correlated with white matter (WM) structure. Objectives: In this study we investigate how these two factors, WM structure and brain state, interact to shape the effect of tDCS on brain network activity. Methods: We applied anodal, cathodal and sham tDCS to the right inferior frontal gyrus (rIFG) of healthy (n = 22) and TBI participants (n = 34). We used the Choice Reaction Task (CRT) performance to manipulate brain state during tDCS. We acquired simultaneous fMRI to assess activity of cognitive brain networks and used Fractional Anisotropy (FA) as a measure of WM structure. Results: We find that the effects of tDCS on brain network activity in TBI participants are highly dependent on brain state, replicating findings from our previous healthy control study in a separate, patient cohort. We then show that WM structure further modulates the brain-state dependent effects of tDCS on brain network activity. These effects are not unidirectional -in the absence of task with anodal and cathodal tDCS, FA is positively correlated with brain activity in several regions of the default mode network. Conversely, with cathodal tDCS during CRT performance, FA is negatively correlated with brain activity in a salience network region. Conclusions: Our results show that experimental and participant factors interact to have unexpected effects on brain network activity, and that these effects are not fully predictable by studying the factors in isolation. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Kurtin, Danielle L.; Zimmerman, Karl; Hampshire, Adam; Patel, Maneesh C.; Sharp, David J.; Li, Lucia M.] Imperial Coll London, Dept Med, Computat Clin & Cognit Neuroimaging Lab, London, England; [Kurtin, Danielle L.; Violante, Ines R.] Univ Surrey, Sch Psychol, Neuromodulat Lab, Guildford, Surrey, England; [Leech, Robert] Kings Coll London, Ctr Neuroimaging Sci, Denmark Hill, London, England; [Hampshire, Adam; Carmichael, David W.] Kings Coll London, Dept Biomed Imaging, St Thomas Hosp, 3rd Floor Lambeth Wing, London SE1 7EH, England; [Sharp, David J.; Li, Lucia M.] Imperial Care Res & Technol Ctr, Imperial UK Dementia Res Inst, London, England		Li, LM (corresponding author), Imperial Coll London, Dept Med, Computat Clin & Cognit Neuroimaging Lab, London, England.; Kurtin, DL (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, Computat Cognit & Clin Imaging Lab, London W12 0NN, England.	danielle.kurtin18@imperial.ac.uk; lucia.li@imperial.ac.uk	Zimmerman, Karl/AAL-4988-2020; Carmichael, David/A-5391-2009	Zimmerman, Karl/0000-0003-1239-3414; Kurtin, Danielle/0000-0001-5368-6737; Carmichael, David/0000-0001-9972-0718	Wellcome Trust Clinical Research Training FellowshipWellcome Trust [103429/Z/13/Z]; NIHR Academic Clinical Lectureship program; Wellcome TrustWellcome TrustEuropean Commission [103045/Z/13/Z]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/S008314/1]; National Institute for Health Research (NIHR) ProfessorshipNational Institute for Health Research (NIHR)	This work had the following funding: LML was funded by Wellcome Trust Clinical Research Training Fellowship (103429/Z/13/Z) and the NIHR Academic Clinical Lectureship program. I.R.V. was funded by the Wellcome Trust (Ref: 103045/Z/13/Z) and the BBSRC (Ref: BB/S008314/1), DJS is funded by a National Institute for Health Research (NIHR) Professorship.	Abellaneda-Perez K, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01440; Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; Auriat AM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00226; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bortoletto M, 2015, BRAIN STIMUL, V8, P269, DOI 10.1016/j.brs.2014.11.006; Dubreuil-Vall L, 2019, BRAIN STIMUL, V12, P1456, DOI 10.1016/j.brs.2019.06.006; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Giannakakis E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221380; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Gu S, 2017, NEUROIMAGE, V148, P305, DOI 10.1016/j.neuroimage.2017.01.003; Hampshire A, 2015, TRENDS COGN SCI, V19, P445, DOI 10.1016/j.tics.2015.06.006; Hill AT, 2016, BRAIN STIMUL, V9, P197, DOI 10.1016/j.brs.2015.10.006; Hunter MA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00495; Igelstrom KM, 2017, NEUROPSYCHOLOGIA, V105, P70, DOI 10.1016/j.neuropsychologia.2017.01.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kelly RE, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/868976; Krause B, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00025; Li LM, 2019, BRAIN, V142, P3280, DOI 10.1093/brain/awz252; Li LM, 2019, NEUROIMAGE, V185, P425, DOI 10.1016/j.neuroimage.2018.10.069; Li LM, 2019, HUM BRAIN MAPP, V40, P904, DOI 10.1002/hbm.24420; Li LM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00181; Lin RL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41603; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Muldoon SF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005076; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Rudroff T, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00585; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stagg CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00857; Strobach T, 2017, J COGN ENHANCE, V1, P49, DOI 10.1007/s41465-016-0004-1; Violante IR, 2017, ELIFE, V6, DOI [10.7554/elife.22001.001, 10.7554/eLife.22001]; Zhang H, 2010, INT WORKSH BIOM IM R, P83; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	43	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	SEP-OCT	2021	14	5					1261	1270		10.1016/j.brs.2021.08.004			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	US8WN	WOS:000697707200036	34438046	Green Published, Green Submitted, gold			2022-02-06	
J	Kwon, BS; Song, HJ; Lee, JH				Kwon, Bo Sung; Song, Hyung Jun; Lee, Jun Hee			External validation and comparison of the Pediatric Emergency Care Applied Research Network and Canadian Assessment of Tomography for Childhood Head Injury 2 clinical decision rules in children with minor blunt head trauma	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Pediatrics; Tomography; spiral computed; Traumatic brain injuries; Hospital emergency service	COMPUTED-TOMOGRAPHY; PREDICTION RULES; SEDATION	Objective Among the pediatric population with minor head trauma, it is difficult to determine an indication for the usage of brain computerized tomography (CT). Our study aims to compare the efficiency of the most commonly used clinical decision rules: the Pediatric Emergency Care Applied Research Network (PECARN) and Canadian Assessment of Tomography for Childhood Head Injury 2 (CATCH2). Methods This retrospective study investigated whether the PECARN and CATCH2 rules were applicable to Korean children with minor head trauma for reducing the use of brain CT imaging, while detecting intracranial pathology. Results Overall, 251 patients (0-5 years old) admitted to emergency rooms within 24 hours of injury were included between August 2015 to August 2018. The performance results are as follows: the PECARN and CATCH2 rules had a sensitivity of 80.00% (51.91%-95.67%) and 100% (78.20%-100.00%) with a specificity of 28.39% (22.73%-34.60%) and 15.25% (10.92%-20.49%), respectively; the negative predictive values were 98.58% and 100%, respectively. Overall, the CATCH2 rule was more successful than the PECARN rule in detecting intracranial pathology; however, there was no significant difference between them. Furthermore, the PECARN and CATCH2 rules lowered the rate of head CT imaging in our study group. Conclusion Both the rules significantly lowered the rate of indicated brain CT. However, since the CATCH2 rule had higher sensitivity and negative predictive value than the PECARN rule, it is more appropriate to be used in emergency rooms for detecting intracranial pathology in children with minor head trauma.	[Kwon, Bo Sung; Lee, Jun Hee] Wonkwang Univ, Dept Emergency Med, Sanbon Hosp, Gunpo, South Korea; [Song, Hyung Jun] Ewha Womans Univ, Dept Emergency Med, Seoul Hosp, 260 Gonghang Daero, Seoul 07804, South Korea		Song, HJ (corresponding author), Ewha Womans Univ, Dept Emergency Med, Seoul Hosp, 260 Gonghang Daero, Seoul 07804, South Korea.	01076s@eumc.ac.kr					Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Bozan O, 2019, EUR J TRAUMA EMERG S, V45, P849, DOI 10.1007/s00068-017-0865-8; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Goldwasser T, 2015, EUR J EMERG MED, V22, P413, DOI 10.1097/MEJ.0000000000000201; Hoyle JD, 2014, PEDIATR EMERG CARE, V30, P1, DOI 10.1097/PEC.0000000000000059; Jung KY, 2015, PEDIAT EMERG MED J, V2, P67; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Korea Centers for Disease Control and Prevention, 2016, STAT TYP INJ CAUS; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; National Center for Injury Prevention and Control, 2008, TRAUMATIC BRAIN INJU; Oh HY, 2012, KOREAN J RADIOL, V13, P771, DOI 10.3348/kjr.2012.13.6.771; Osmond MH, 2018, CAN MED ASSOC J, V190, pE816, DOI 10.1503/cmaj.170406; Slovis TL, 2002, PEDIATR RADIOL, V32, P217, DOI 10.1007/s00247-002-0669-8; Stiell I.G., 2000, ACAD EMERG MED, V7, P572; Tenny S., 2020, STATPEARLS; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; World Health Organization, 2005, EM TRIAG ASS TREATM	20	0	0	2	2	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	SEP	2021	8	3					182	191		10.15441/ceem.20.123			10	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	WQ2QU	WOS:000713665700004	34649406	Green Published, gold			2022-02-06	
J	Lang, SS; Valeri, A; Storm, PB; Heuer, GG; Tucker, AM; Kennedy, BC; Kozyak, BW; Sinha, A; Kilbaugh, TJ; Huh, JW				Lang, Shih-Shan; Valeri, Amber; Storm, Phillip B.; Heuer, Gregory G.; Tucker, Alexander M.; Kennedy, Benjamin C.; Kozyak, Benjamin W.; Sinha, Anjuli; Kilbaugh, Todd J.; Huh, Jimmy W.			Acute neurological injury in pediatric patients with single-ventricle congenital heart disease	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						intracranial hypertension; congenital heart disease; Glenn physiology; Fontan physiology; carbon dioxide; pediatric; traumatic brain injury; intracranial hemorrhage; cerebral ischemia; mean airway pressure; trauma; vascular disorders	PULMONARY BLOOD-FLOW; CARBON-DIOXIDE; VASCULAR-RESISTANCE; OXYGEN-CONSUMPTION; FONTAN OPERATION; CARDIAC-SURGERY; PRESSURE; CIRCULATION; VENTILATION; INFANTS	OBJECTIVE Single-ventricle congenital heart disease (CHD) in pediatric patients with Glenn and Fontan physiology represents a unique physiology requiring the surgical diversion of the systemic venous return from the superior vena cava (Glenn) and then the inferior vena cava (Fontan) directly to the pulmonary arteries. Because many of these patients are on chronic anticoagulation therapy and may have right-to-left shunts, arrhythmias, or lymphatic disorders that predispose them to bleeding and/or clotting, they are at risk of experiencing neurological injury requiring intubation and positive pressure ventilation, which can significantly hamper pulmonary blood flow and cardiac output. The aim of this study was to describe the complex neurological and cardiopulmonary interactions of these pediatric patients after acute central nervous system (CNS) injury. METHODS The authors retrospectively analyzed the records of pediatric patients who had been admitted to a quaternary children's hospital with CHD palliated to bidirectional Glenn (BDG) or Fontan circulation and acute CNS injury and who had undergone intubation and mechanical ventilation. Patients who had been admitted from 2005 to 2019 were included in the study. Clinical characteristics, surgical outcomes, cardiovascular and pulmonary data, and intracranial pressure data were collected and analyzed. RESULTS Nine pediatric single-ventricle patients met the study inclusion criteria. All had undergone the BDG procedure, and the majority (78%) were status post Fontan palliation. The mean age was 7.4 years (range 1.3-17.3 years). At the time of acute CNS injury, which included traumatic brain injury, intracranial hemorrhage, and cerebral infarct, the median time interval from the most recent cardiac surgical procedure was 3 years (range 2 weeks-11 years). Maintaining normocarbia to mild hypercarbia for most patients during intubation periods did not cause neurological deterioration, and hemodynamic profiles were more favorable as compared to periods of hypocarbia. Hypocarbia was associated with unfavorable hemodynamics but was necessary to decrease intracranial hypertension. Most patients were managed using low mean airway pressure (MAWP) in order to minimize the impact on preload and cardiac output. CONCLUSIONS The authors highlight the complex neurological and cardiopulmonary interactions with respect to partial pressure of arterial CO2 (PaCO2) and MAWP when pediatric CHD patients with single-ventricle physiology require mechanical ventilation. The study data demonstrated that tight control of PaCO2 and minimizing MAWP with the goal of early extubation may be beneficial in this population. A multidisciplinary team of pediatric critical care intensivists, cardiac intensivists and anesthesiologists, and pediatric neurosurgeons and neurologists are recommended to ensure the best possible outcomes.	[Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.; Tucker, Alexander M.; Kennedy, Benjamin C.] Univ Penn, Childrens Hosp Philadelphia, Div Neurosurg, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lang, Shih-Shan; Storm, Phillip B.; Heuer, Gregory G.; Tucker, Alexander M.; Kennedy, Benjamin C.] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA; [Valeri, Amber] Philadelphia Coll Osteopath Med, Dept Neurosurg, Philadelphia, PA USA; [Kozyak, Benjamin W.; Sinha, Anjuli; Kilbaugh, Todd J.; Huh, Jimmy W.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kozyak, Benjamin W.] Childrens Hosp Philadelphia, Div Cardiac Crit Care Med, Philadelphia, PA 19104 USA; [Sinha, Anjuli] Lucile Packard Stanford Childrens Hosp, Div Pediat Cardiol, Palo Alto, CA USA		Lang, SS (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	chens4@email.chop.edu					Bradley SM, 2003, J THORAC CARDIOV SUR, V126, P1033, DOI 10.1016/S0022-5223(03)00203-4; Bradley SM, 1998, CIRCULATION, V98, pII372; Brady KM, 2009, J CARDIOTHOR VASC AN, V23, P215, DOI 10.1053/j.jvca.2008.01.014; Brida M, 2018, CIRCULATION, V137, P508, DOI 10.1161/CIRCULATIONAHA.117.031544; CHANG AC, 1995, CRIT CARE MED, V23, P568, DOI 10.1097/00003246-199503000-00024; de Los Reyes Emily, 2014, Handb Clin Neurol, V119, P49, DOI 10.1016/B978-0-7020-4086-3.00005-9; Dori Y, 2016, CIRCULATION, V133, P1160, DOI 10.1161/CIRCULATIONAHA.115.019710; DUPLESSIS AJ, 1995, PEDIATR NEUROL, V12, P230, DOI 10.1016/0887-8994(95)00027-D; Egbe A, 2018, AM HEART J, V198, P115, DOI 10.1016/j.ahj.2017.12.012; Fogel MA, 2004, CIRCULATION, V110, pII147, DOI 10.1161/01.CIR.0000138346.34596.99; FULLERTON DA, 1993, J THORAC CARDIOV SUR, V106, P528; Gentles TL, 1997, J THORAC CARDIOV SUR, V114, P392, DOI 10.1016/S0022-5223(97)70184-3; Gewillig M, 2016, HEART, V102, P1081, DOI 10.1136/heartjnl-2015-307467; Hoskote A, 2004, J AM COLL CARDIOL, V44, P1501, DOI 10.1016/j.jacc.2004.06.061; Jonas R A, 2000, Heart Lung Circ, V9, P16, DOI 10.1046/j.1444-2892.2000.009001016.x; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kumar TKS, 2017, J THORAC CARDIOV SUR, V154, P2062, DOI 10.1016/j.jtcvs.2017.08.002; Li J, 2005, CRIT CARE MED, V33, P984, DOI 10.1097/01.CCM.0000162665.08685.E2; MADDEN JA, 1993, PHARMACOL THERAPEUT, V59, P229, DOI 10.1016/0163-7258(93)90045-F; Menon S, 2017, PEDIATR CARDIOL, V38, P886, DOI 10.1007/s00246-017-1576-y; Mott AR, 2006, PEDIATR CRIT CARE ME, V7, P346, DOI 10.1097/01.PCC.0000224949.25692.87; PENNY DJ, 1991, BRIT HEART J, V66, P372; PENNY DJ, 1991, INT J CARDIOL, V30, P128, DOI 10.1016/0167-5273(91)90137-E; Petko M, 2003, EUR J CARDIO-THORAC, V24, P255, DOI 10.1016/S1010-7940(03)00257-4; REDINGTON AN, 1991, BRIT HEART J, V65, P213; SALMENPERA M, 1986, ANESTHESIOLOGY, V64, P311, DOI 10.1097/00000542-198603000-00002; Shekerdemian LS, 1997, CIRCULATION, V96, P3934; WILLIAMS DB, 1984, J THORAC CARDIOV SUR, V87, P856	28	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2021	28	3					335	343		10.3171/2021.2.PEDS2142			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	UL3IG	WOS:000692548300002	34243155				2022-02-06	
J	Lecky, FE; Otesile, O; Marincowitz, C; Majdan, M; Nieboer, D; Lingsma, HF; Maegele, M; Citerio, G; Stocchetti, N; Steyerberg, EW; Menon, DK; Maas, AIR; Moyer, C; Moyer, C; Moyer, C; Moyer, C; Moyer, C				Lecky, Fiona E.; Otesile, Olubukola; Marincowitz, Carl; Majdan, Marek; Nieboer, Daan; Lingsma, Hester F.; Maegele, Marc; Citerio, Giuseppe; Stocchetti, Nino; Steyerberg, Ewout W.; Menon, David K.; Maas, Andrew I. R.; Moyer, Caitlin; Moyer, Caitlin; Moyer, Caitlin; Moyer, Caitlin; Moyer, Caitlin			The burden of traumatic brain injury from low-energy falls among patients from 18 countries in the CENTER-TBI Registry: A comparative cohort study	PLOS MEDICINE			English	Article							MAJOR TRAUMA; CARE; CONSCIOUSNESS; EPIDEMIOLOGY; SEVERITY; OUTCOMES; SCORE	Author summary Why was this study done? Traumatic brain injury (TBI) poses a huge global disease burden, considered to mainly result from high-energy transfer mechanisms such as road traffic collisions, sports, falls from a height, and interpersonal violence.People injured through low-energy transfer (ground- or low-level falls) are considered less likely to sustain significant TBI, so can be given lower priority for acute specialist care within emergency medical services (triage decisions).Recent multinational studies challenge these assumptions by identifying falls as an important TBI causal mechanism-but these studies seldom describe fall height.The lack of clarity concerning the low-energy TBI disease burden hampers effective prevention and clinical management. What did the researchers do and find? We studied 21,681 patients with TBI presenting to 56 hospital emergency departments across Europe and Israel using an efficient registry methodology enabling a real-world approach.We found that the 40% of patients with TBI who were injured through low-energy falls were significantly older, more likely to be female, and more likely to be taking pre-injury drugs that prevent blood clotting than patients with TBI sustained through high-energy transfer.Despite similar rates of significant injury on the CT brain scan and of dying in hospital, patients injured through low-energy falls were half as likely to receive critical care or emergency intervention compared to those injured by high-energy transfer. What do these findings mean? Low-energy falls contribute to a significant portion of the TBI disease burden, which will increase as the global population ages.In older people, the assumption that energy transfer predicts brain injury severity and threat to life appears to lack validity.Factors beyond energy transfer level may be more relevant to prehospital and emergency department TBI triage in older people. The appropriateness of providing less intensive acute hospital care after low-energy TBI requires further study.Reduction of TBI disease burden requires specific prevention and therapy initiatives targeted at low-energy TBI. BackgroundTraumatic brain injury (TBI) is an important global public health burden, where those injured by high-energy transfer (e.g., road traffic collisions) are assumed to have more severe injury and are prioritised by emergency medical service trauma triage tools. However recent studies suggest an increasing TBI disease burden in older people injured through low-energy falls. We aimed to assess the prevalence of low-energy falls among patients presenting to hospital with TBI, and to compare their characteristics, care pathways, and outcomes to TBI caused by high-energy trauma. Methods and findingsWe conducted a comparative cohort study utilising the CENTER-TBI (Collaborative European NeuroTrauma Effectiveness Research in TBI) Registry, which recorded patient demographics, injury, care pathway, and acute care outcome data in 56 acute trauma receiving hospitals across 18 countries (17 countries in Europe and Israel). Patients presenting with TBI and indications for computed tomography (CT) brain scan between 2014 to 2018 were purposively sampled. The main study outcomes were (i) the prevalence of low-energy falls causing TBI within the overall cohort and (ii) comparisons of TBI patients injured by low-energy falls to TBI patients injured by high-energy transfer-in terms of demographic and injury characteristics, care pathways, and hospital mortality. In total, 22,782 eligible patients were enrolled, and study outcomes were analysed for 21,681 TBI patients with known injury mechanism; 40% (95% CI 39% to 41%) (8,622/21,681) of patients with TBI were injured by low-energy falls. Compared to 13,059 patients injured by high-energy transfer (HE cohort), the those injured through low-energy falls (LE cohort) were older (LE cohort, median 74 [IQR 56 to 84] years, versus HE cohort, median 42 [IQR 25 to 60] years; p < 0.001), more often female (LE cohort, 50% [95% CI 48% to 51%], versus HE cohort, 32% [95% CI 31% to 34%]; p < 0.001), more frequently taking pre-injury anticoagulants or/and platelet aggregation inhibitors (LE cohort, 44% [95% CI 42% to 45%], versus HE cohort, 13% [95% CI 11% to 14%]; p < 0.001), and less often presenting with moderately or severely impaired conscious level (LE cohort, 7.8% [95% CI 5.6% to 9.8%], versus HE cohort, 10% [95% CI 8.7% to 12%]; p < 0.001), but had similar in-hospital mortality (LE cohort, 6.3% [95% CI 4.2% to 8.3%], versus HE cohort, 7.0% [95% CI 5.3% to 8.6%]; p = 0.83). The CT brain scan traumatic abnormality rate was 3% lower in the LE cohort (LE cohort, 29% [95% CI 27% to 31%], versus HE cohort, 32% [95% CI 31% to 34%]; p < 0.001); individuals in the LE cohort were 50% less likely to receive critical care (LE cohort, 12% [95% CI 9.5% to 13%], versus HE cohort, 24% [95% CI 23% to 26%]; p < 0.001) or emergency interventions (LE cohort, 7.5% [95% CI 5.4% to 9.5%], versus HE cohort, 13% [95% CI 12% to 15%]; p < 0.001) than patients injured by high-energy transfer. The purposive sampling strategy and censorship of patient outcomes beyond hospital discharge are the main study limitations. ConclusionsWe observed that patients sustaining TBI from low-energy falls are an important component of the TBI disease burden and a distinct demographic cohort; further, our findings suggest that energy transfer may not predict intracranial injury or acute care mortality in patients with TBI presenting to hospital. This suggests that factors beyond energy transfer level may be more relevant to prehospital and emergency department TBI triage in older people. A specific focus to improve prevention and care for patients sustaining TBI from low-energy falls is required.	[Lecky, Fiona E.; Otesile, Olubukola; Marincowitz, Carl] Univ Sheffield, Ctr Urgent & Emergency Care Res, Hlth Serv Res Sect, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Lecky, Fiona E.] Salford Royal Hosp, Emergency Dept, Salford, Lancs, England; [Majdan, Marek] Univ Trnava, Dept Publ Hlth, Trnava, Slovakia; [Nieboer, Daan; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Maegele, Marc] Witten Herdecke Univ, Inst Res Operat Med, Cologne, Germany; [Citerio, Giuseppe] Azienda Socio Sanit Terr Monza, Neurointens Care, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy; [Steyerberg, Ewout W.] Leiden Univ Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Lecky, FE (corresponding author), Univ Sheffield, Ctr Urgent & Emergency Care Res, Hlth Serv Res Sect, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.; Lecky, FE (corresponding author), Salford Royal Hosp, Emergency Dept, Salford, Lancs, England.	f.e.lecky@sheffield.ac.uk	; Steyerberg, Ewout/C-1509-2018; van der Jagt, Mathieu/G-1905-2017; Stocchetti, Nino/O-7444-2017	Marincowitz, Carl/0000-0003-3043-7564; Gravesteijn, Benjamin/0000-0001-8096-5803; Nieboer, Daan/0000-0002-4403-6537; Lagares, Alfonso/0000-0003-3996-0554; Steyerberg, Ewout/0000-0002-7787-0122; Lecky, Fiona/0000-0001-6806-0921; van der Naalt, Joukje/0000-0001-9873-2418; van der Jagt, Mathieu/0000-0003-2566-8325; Dark, Paul/0000-0003-3309-0164; Stocchetti, Nino/0000-0003-3250-6834	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150), recipient A.I.R. Maas. Additional funding was obtained from the Hannelore Kohl Stiftung (Germany) - recipient A.I.R. Maas, from OneMind (USA) - recipient A.I.R. Maas and from Integra LifeSciences Corporation (USA) - recipient A.I.R. Maas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Anaesthesiologists, 2020, ASA PHYS STAT CLASS; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banerjee J, 2017, MAJOR TRAUMA OLDER P; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; Coats TJ, 2017, EMERG MED J, V34, P494, DOI 10.1136/emermed-2017-206788; Committee on Injury Scaling Association for the Advancement of Automotive Medicine, 1990, ABBREVIATED INJURY S; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moran CG, 2018, ECLINICALMEDICINE, V2-3, P13, DOI 10.1016/j.eclinm.2018.07.001; National Institute for Health and Care Excellence, 2007, HEAD INJ TRIAG ASS I; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peterson AB, 2020, MMWR-MORBID MORTAL W, V69, P225, DOI 10.15585/mmwr.mm6909a2; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rotondo MF, 2014, RESOURCES OPTIMAL CA; Russell R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1143; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; TEASDALE G, 1974, LANCET, V2, P81; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Vedin T, 2019, EUR J TRAUMA EMERG S, V45, P901, DOI 10.1007/s00068-018-0941-8; World Health Organization, 1992, ICD 10 INT STAT CLAS, V1	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	SEP	2021	18	9							e1003761	10.1371/journal.pmed.1003761			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF8TH	WOS:000724338300003	34520460	Green Published, gold, Green Accepted			2022-02-06	
J	Lepard, JR; Spagiari, R; Corley, J; Barthelemy, EJ; Kim, E; Patterson, R; Venturini, S; Still, MEH; Lo, YT; Rosseau, G; Mekary, RA; Park, KB				Lepard, Jacob R.; Spagiari, Riccardo; Corley, Jacquelyn; Barthelemy, Ernest J.; Kim, Eliana; Patterson, Rolvix; Venturini, Sara; Still, Megan E. H.; Lo, Yu Tung; Rosseau, Gail; Mekary, Rania A.; Park, Kee B.			Differences in outcomes of mandatory motorcycle helmet legislation by country income level: A systematic review and meta-analysis	PLOS MEDICINE			English	Article							ROAD TRAFFIC INJURIES; PREVENTION STRATEGIES; CRASH FATALITIES; HEAD-INJURIES; USE-LAW; IMPACT; CALIFORNIA; ALCOHOL; INTERVENTIONS; MORTALITY	Background The recent Lancet Commission on Legal Determinants of Global Health argues that governance can provide the framework for achieving sustainable development goals. Even though over 90% of fatal road traffic injuries occur in low- and middle-income countries (LMICs) primarily affecting motorcyclists, the utility of helmet laws outside of high-income settings has not been well characterized. We sought to evaluate the differences in outcomes of mandatory motorcycle helmet legislation and determine whether these varied across country income levels. Methods and findings A systematic review and meta-analysis were completed using the PRISMA checklist. A search for relevant articles was conducted using the PubMed, Embase, and Web of Science databases from January 1, 1990 to August 8, 2021. Studies were included if they evaluated helmet usage, mortality from motorcycle crash, or traumatic brain injury (TBI) incidence, with and without enactment of a mandatory helmet law as the intervention. The Newcastle-Ottawa Scale (NOS) was used to rate study quality and funnel plots, and Begg's and Egger's tests were used to assess for small study bias. Pooled odds ratios (ORs) and their 95% confidence intervals (CIs) were stratified by high-income countries (HICs) versus LMICs using the random-effects model. Twenty-five articles were included in the final analysis encompassing a total study population of 31,949,418 people. There were 17 retrospective cohort studies, 2 prospective cohort studies, 1 case-control study, and 5 pre-post design studies. There were 16 studies from HICs and 9 from LMICs. The median NOS score was 6 with a range of 4 to 9. All studies demonstrated higher odds of helmet usage after implementation of helmet law; however, the results were statistically significantly greater in HICs (OR: 53.5; 95% CI: 28.4; 100.7) than in LMICs (OR: 4.82; 95% CI: 3.58; 6.49), p-value comparing both strata < 0.0001. There were significantly lower odds of motorcycle fatalities after enactment of helmet legislation (OR: 0.71; 95% CI: 0.61; 0.83) with no significant difference by income classification, p-value: 0.27. Odds of TBI were statistically significantly lower in HICs (OR: 0.61, 95% CI 0.54 to 0.69) than in LMICs (0.79, 95% CI 0.72 to 0.86) after enactment of law (p-value: 0.0001). Limitations of this study include variability in the methodologies and data sources in the studies included in the meta-analysis as well as the lack of available literature from the lowest income countries or from the African WHO region, in which helmet laws are least commonly present. Conclusions In this study, we observed that mandatory helmet laws had substantial public health benefits in all income contexts, but some outcomes were diminished in LMIC settings where additional measures such as public education and law enforcement might play critical roles.	[Lepard, Jacob R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA; [Lepard, Jacob R.; Corley, Jacquelyn; Barthelemy, Ernest J.; Kim, Eliana; Patterson, Rolvix; Park, Kee B.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Spagiari, Riccardo] Humanitas Univ, Milan, Italy; [Corley, Jacquelyn] Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC USA; [Barthelemy, Ernest J.] Mt Sinai Hlth Syst, Dept Neurosurg, New York, NY USA; [Kim, Eliana] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Patterson, Rolvix] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Venturini, Sara] Aberdeen Royal Infirm, Aberdeen, Scotland; [Still, Megan E. H.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Lo, Yu Tung] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Lo, Yu Tung; Mekary, Rania A.] Harvard Med Sch, Computat Neurosci Outcomes Ctr, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA; [Rosseau, Gail] George Washington Univ, Dept Neurosurg, Sch Med & Hlth Sci, Washington, DC USA; [Mekary, Rania A.] MCPHS Univ, Sch Pharm, Boston, MA USA		Lepard, JR (corresponding author), Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA.; Lepard, JR (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA.	Jlepard@uabmc.edu		Spaggiari, Riccardo/0000-0001-6069-7514; Patterson, Rolvix/0000-0001-7004-615X; Still, Megan/0000-0002-7665-2692; Barthelemy, Ernest/0000-0002-4001-9342; Kim, Eliana/0000-0003-1241-2072	University of Alabama at Birmingham Women's Leadership Council	This manuscript was prepared while Jacob R. Lepard, MD was a Wilson Family Clinical Scholar supported by the University of Alabama at Birmingham Women's Leadership Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl Z., 2018, The Open Public Health Journal, V11, P393, DOI 10.2174/1874944501811010393; [Anonymous], WORLDATLAS; Auman KM, 2002, AM J PUBLIC HEALTH, V92, P1352, DOI 10.2105/AJPH.92.8.1352; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Balk EM, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-97; Banstola A, 2017, TRAFFIC INJ PREV, V18, P357, DOI 10.1080/15389588.2016.1212165; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borenstein M, 2013, PREV SCI, V14, P134, DOI 10.1007/s11121-013-0377-7; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Byrnes Matthew, 2012, Minn Med, V95, P60; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Coben JH, 2007, ACCIDENT ANAL PREV, V39, P190, DOI 10.1016/j.aap.2006.06.018; Commission for Global Road Safety, 2018, WHO WHO GLOB PLAN DE; Corley J, 2019, WORLD NEUROSURG, V132, P434, DOI 10.1016/j.wneu.2019.08.240; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du RY, 2020, J NEUROSURG-PEDIATR, V25, P361, DOI 10.3171/2019.10.PEDS19377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Espitia-Hardeman V, 2008, SALUD PUBLICA MEXICO, V50, pS69, DOI 10.1590/S0036-36342008000700011; Ferrando J, 2000, Inj Prev, V6, P184, DOI 10.1136/ip.6.3.184; French MT, 2012, SOC SCI MED, V75, P1855, DOI 10.1016/j.socscimed.2012.06.022; Gjerde H, 2014, INT J DRUG POLICY, V25, P393, DOI 10.1016/j.drugpo.2014.01.019; Gostin LO, 2019, LANCET, V393, P1857, DOI 10.1016/S0140-6736(19)30233-8; GRIMA FG, 1995, EUR J EPIDEMIOL, V11, P87, DOI 10.1007/BF01719951; Gupta A, 2014, WORLD J SURG, V38, P215, DOI 10.1007/s00268-013-2230-3; Nguyen HT, 2013, INT J INJ CONTROL SA, V20, P192, DOI 10.1080/17457300.2012.706617; Higgins BT, 2015, J ARTHROPLASTY, V30, P419, DOI 10.1016/j.arth.2014.10.020; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hung DV, 2008, ACCIDENT ANAL PREV, V40, P1627, DOI 10.1016/j.aap.2008.05.002; Hyder AA, 2004, B WORLD HEALTH ORGAN, V82, P240; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; KRAUS JF, 1995, AM J PUBLIC HEALTH, V85, P96, DOI 10.2105/AJPH.85.1.96; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; KRAUS JF, 1995, J NEUROTRAUM, V12, P873, DOI 10.1089/neu.1995.12.873; La Torre G, 2007, EUR J PUBLIC HEALTH, V17, P607, DOI 10.1093/eurpub/ckm028; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Lortie CJ, 2020, ECOL EVOL, V10, P10916, DOI 10.1002/ece3.6747; Marya J, 2017, J ORAL MAX SURG MED, V29, P24, DOI 10.1016/j.ajoms.2016.08.008; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; Muni K, 2020, INJURY PREV, V26, P5, DOI 10.1136/injuryprev-2018-043008; Nazif-Munoz JI, 2020, J EPIDEMIOL COMMUN H, V74, P502, DOI 10.1136/jech-2019-213191; Nazif-Munoz JI, 2018, ACCIDENT ANAL PREV, V120, P38, DOI 10.1016/j.aap.2018.07.028; Ha NT, 2018, TRAFFIC INJ PREV, V19, P75, DOI 10.1080/15389588.2017.1322203; O'Connor Lydia R., 2014, Yale Journal of Biology and Medicine, V87, P307; Panichaphongse Viratt, 1995, Journal of the Medical Association of Thailand, V78, P521; Papadimitriou E, 2019, ACCIDENT ANAL PREV, V125, P85, DOI 10.1016/j.aap.2019.01.002; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; PeekAsa C, 1997, ANN EMERG MED, V29, P630, DOI 10.1016/S0196-0644(97)70252-X; Pervin A, 2009, B WORLD HEALTH ORGAN, V87, P369, DOI 10.2471/BLT.08.057109; Proscia Nicole, 2002, Conn Med, V66, P195; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; Tsai M C, 1999, Inj Prev, V5, P290; Nguyen T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207570; Venturini S, 2019, WORLD NEUROSURG, V125, P320, DOI 10.1016/j.wneu.2019.01.255; WHO, INT RED ROAD TRAFF I; World Health Organization, 2014, GLOBAL STATUS REPORT, P67; Youngers EH, 2017, NEUROSURGERY, V81, P416, DOI 10.1093/neuros/nyx053	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	SEP	2021	18	9							e1003795	10.1371/journal.pmed.1003795			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	US9BS	WOS:000697721000001	34534215	Green Published, gold			2022-02-06	
J	Leskovan, JJ; Patel, PD; Pederson, J; Moore, A; Afaneh, A; Brown, LR				Leskovan, John J.; Patel, Puja D.; Pederson, John; Moore, Aaron; Afaneh, Amer; Brown, Laura R.			The effects of marijuana use prior to traumatic brain injury on survival	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Brain injuries; Traumatic; Mortality		Background: Legalization of recreational marijuana throughout the United States has been associated with increased emergency department visits involving marijuana and its metabolites, tetrahydrocannabinol (THC) and cannabinoids. We investigated the relationship between marijuana use and outcomes after all levels of traumatic brain injury (TBI) from a large multi-center regional dataset. Methods: A retrospective review of de-identified patient data from twenty-six regional hospitals, was performed to identify adult patients with mild, moderate, and severe TBI between January 2012 and December 2018, a toxicology screen, and drug screen results. Included patients were divided into four subgroups: 1) No Drugs, 2) THC, 3) Other drugs (one or more drugs not including THC), and 4) THC + Other drugs. The primary outcome was mortality at discharge, while secondary outcomes included days in intensive care unit (ICU), length of hospital stay (LOS), and days on a ventilator. Results: A total of 3,237 patients (median age 46 years [range: 18-97 years]; 31.9% female [1029/3,227]) met the inclusion criteria. Patients in the No Drugs group had significantly higher mortality rates at discharge than the THC (p = 0.0046), Other Drugs (p = 0.0307), and THC + Other Drugs groups (p = 0.0441). On multiple logistic regression, drug status was found not to be an independent predictor of mortality at discharge, while age, Glasgow Coma Scale (GCS), days in the ICU, Injury Severity Score (ISS), LOS, and days on a ventilator were independent predictors. Conclusions: Patients positive for one or more drugs, including marijuana, had significantly lower mortality at discharge than those with no drugs; however, after controlling for confounding variables, drug status was not found to be an independent predictor of mortality at discharge. Therefore, our results indicate no survival benefit for any level of TBI with concomitant drug use, including marijuana, in contrast to recent studies.	[Leskovan, John J.; Moore, Aaron; Afaneh, Amer] Mercy St Vincent Med Ctr, Dept Trauma Surg, Toledo, OH 43608 USA; [Patel, Puja D.; Pederson, John] Super Med Experts, Minneapolis, MN USA; [Brown, Laura R.] Metrohlth Med Ctr, Dept Surg, Cleveland, OH USA		Leskovan, JJ (corresponding author), Mercy St Vincent Med Ctr, Dept Trauma Surg, Toledo, OH 43608 USA.	JJLeskovan@mercy.com; pujadpat@usc.ed; jpederson@supedit.com; Aaron_MooreMD@yahoo.com; amer.afaneh@gmail.com; lrchromy@gmail.com		Pederson, John/0000-0003-2551-4828			Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Gao YY, 2017, AM J TRANSL RES, V9, P887; Goodwin RS, 2008, J ANAL TOXICOL, V32, P562, DOI 10.1093/jat/32.8.562; Hammond CJ, 2021, INT J MENT HEALTH AD, V19, P1963, DOI 10.1007/s11469-020-00292-2; HAUCK WW, 1977, J AM STAT ASSOC, V72, P851, DOI 10.2307/2286473; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; McKight P. E, 2010, CORSINI ENCY PSYCHOL, DOI DOI 10.1002/9780470479216.CORPSY0491; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Nguyen BM, 2014, AM SURGEON, V80, P979; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Ranganathan Priya, 2017, Perspect Clin Res, V8, P148, DOI 10.4103/picr.PICR_87_17; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7327; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wei G, 2017, NEUROIMMUNOMODULAT, V24, P348, DOI 10.1159/000487998; Wei T., 2017, R PACKAGE CORRPLOT V; Zhu H, 2016, J ADDICT MED, V10, P429, DOI 10.1097/ADM.0000000000000256	17	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2021	25								101139	10.1016/j.inat.2021.101139			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TS1AF	WOS:000679388300013		gold			2022-02-06	
J	Li, A; Atem, FD; Venkatachalam, AM; Barnes, A; Stutzman, SE; Olson, DM				Li, Amy; Atem, Folefac D.; Venkatachalam, Aardhra M.; Barnes, Arianna; Stutzman, Sonja E.; Olson, DaiWai M.			ADMISSION GLASGOW COMA SCALE SCORE AS A PREDICTOR OF OUTCOME IN PATIENTS WITHOUT TRAUMATIC BRAIN INJURY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							OF-HEALTH STROKE; INTENSIVE-CARE; FULL OUTLINE; UNRESPONSIVENESS SCORE; AGE; GCS	Background The Glasgow Coma Scale was developed in 1974 as an injury severity score to assess and predict outcome after traumatic brain injury. The tool is now used to score depth of impaired consciousness in patients with and without traumatic brain injury. However, evidence supporting the use of the Glasgow Coma Scale in the latter group is limited. Objective To assess Glasgow Coma Scale score on hospital admission as a predictor of outcome in patients without traumatic brain injury. Methods This was a secondary analysis of prospectively collected data from 3507 patients admitted to 4 hospitals between October 2015 and October 2019. Patients with a primary diagnosis of traumatic brain injury were excluded from this study. Results The mean age of the 3507 participants in the study was 57 years. Participants were primarily female (52%), White (77%), and non-Hispanic (89%). On admission, 90% of patients had a modified Rankin Scale score of 0 to 3 and 72% had a Glasgow Coma Scale score of 13 to 15 (mild injury). Generalized estimating equation modeling indicated that admission Glasgow Coma Scale score did not predict modified Rankin Scale score at discharge in patients not diagnosed with traumatic brain injury (Glasgow Coma Scale score <8: z = -7.89, P < .001; Glasgow Coma Scale score 8-12: z = -4.17, P < .001). Conclusions The Glasgow Coma Scale is not recommended for use in patients without traumatic brain injury; clinicians should use a more appropriate and validated clinical assessment instrument for this patient population.	[Li, Amy] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Atem, Folefac D.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Biostat & Data Sci, Houston, TX 77030 USA; [Venkatachalam, Aardhra M.; Stutzman, Sonja E.; Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Barnes, Arianna] Providence Mission Hosp, Mission Viejo, CA USA; [Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Neurol, Dallas, TX 75390 USA		Olson, DM (corresponding author), 5323 Harry Hines Blvd,CSS,MC 8855, Dallas, TX 75390 USA.	daiwai.olson@utsouthwestern.edu			University of Texas Southwestern Medical Center Department of Nursing; Neuroptics, Inc.	This study was supported by the University of Texas Southwestern Medical Center Department of Nursing and Neuroptics, Inc.	Achilike S, 2020, J NEUROSCI NURS, V52, P277, DOI 10.1097/JNN.0000000000000552; Bouvet P, 2019, AM J CRIT CARE, V28, P477, DOI 10.4037/ajcc2019310; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Broderick JP, 2017, STROKE, V48, P2007, DOI 10.1161/STROKEAHA.117.017866; Enriquez CM, 2019, J NEUROSCI NURS, V51, P142, DOI 10.1097/JNN.0000000000000448; Finocchi C, 2018, NEUROL SCI, V39, P1751, DOI 10.1007/s10072-018-3495-y; Ganesh A, 2018, NEUROLOGY, V91, pE1951, DOI 10.1212/WNL.0000000000006554; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Glance LG, 2008, CURRENT THERAPY TRAU, P10; Hong J, 2016, WORLD NEUROSURG, V87, P422, DOI 10.1016/j.wneu.2015.12.056; Jamal A, 2017, WORLD J EMERG MED, V8, P55, DOI 10.5847/wjem.j.1920-8642.2017.01.010; Kasprowicz M, 2016, BRIT J NEUROSURG, V30, P211, DOI 10.3109/02688697.2016.1161173; Kelly-Hayes M, 2010, J AM GERIATR SOC, V58, pS325, DOI 10.1111/j.1532-5415.2010.02915.x; Li SJ, 2019, J NEUROSCI NURS, V51, P74, DOI 10.1097/JNN.0000000000000424; Lyden P, 2017, STROKE, V48, P513, DOI 10.1161/STROKEAHA.116.015434; Marks MP, 2018, STROKE, V49, P2000, DOI 10.1161/STROKEAHA.118.022147; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; National Academies of Sciences Engineering and Medicine, 2019, EV DIS DET PROC TRAU; Noonan AS, 2016, PUBLIC HEALTH REV, V37, DOI 10.1186/s40985-016-0025-4; Nunn A, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/9482876; Odlum M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25134; Olson DM, 2017, J NEUROSCI NURS, V49, P251, DOI 10.1097/JNN.0000000000000296; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Pandian V, 2019, AM J CRIT CARE, V28, P56, DOI 10.4037/ajcc2019883; Radholm K, 2015, AGE AGEING, V44, P422, DOI 10.1093/ageing/afu198; Ramazani J, 2019, ANN CARD ANAESTH, V22, P143, DOI 10.4103/aca.ACA_25_18; Rao CPV, 2020, NEUROCRIT CARE, V32, P88, DOI 10.1007/s12028-019-00835-z; Siniscalchi Antonio, 2017, Hosp Top, V95, P79, DOI 10.1080/00185868.2017.1322888; Slusarz R, 2019, J NEUROSCI NURS, V51, P221, DOI 10.1097/JNN.0000000000000459; Slusarz R, 2014, J NEUROSCI NURS, V46, P46, DOI 10.1097/JNN.0000000000000028; Suresh V, 2019, INDIAN J ANAESTH, V63, P640, DOI 10.4103/ija.IJA_377_19; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thompson HJ, 2020, J NEUROSCI NURS, V52, P46, DOI 10.1097/JNN.0000000000000498; Wang S, 2019, AM J CRIT CARE, V28, P10, DOI 10.4037/ajcc2019639	35	0	0	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	SEP	2021	30	5					350	355		10.4037/ajcc2021163			6	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	UK8HW	WOS:000692206800003	34467380				2022-02-06	
J	Li, L; Ding, Y; Liu, BY; Wang, ZH; Carlone, DL; Yu, XB; Wei, XW; Zhang, F; Lineaweaver, WC; Yang, B; Xia, WB; Wang, DZ; Zhao, DW				Li, Lu; Ding, Yan; Liu, Baoyi; Wang, Zihua; Carlone, Diana L.; Yu, Xiaobing; Wei, Xiaowei; Zhang, Feng; Lineaweaver, William C.; Yang, Bin; Xia, Weibo; Wang, Da-Zhi; Zhao, Dewei			Transcriptome landscape of the late-stage alcohol-induced osteonecrosis of the human femoral head	BONE			English	Article						ADH1B; Alcohol; Osteonecrosis of femoral head; Hemostasis; Angiogenesis; Bone remodeling; Long non-coding RNAs; lncRNAs; Next generation sequencing	AVASCULAR NECROSIS; ANNOTATION; GENES; BONE	Osteonecrosis resulting from heavy ethanol consumption is one of the major causes of nontraumatic osteonecrosis of the femoral head (ONFH). The underlying pathological and molecular mechanisms remain elusive. In this study, we performed deep RNA sequencing from femoral heads of patients diagnosed with late-stage alcoholinduced ONFH (AIONFH), other types of ONFH and traumatic injury (bone fracture). Genome-wide gene expression analyses identified 690 differentially expressed mRNAs in AIONFH. Gene annotation and pathway analyses revealed significant dysregulated genes involved in hemostasis, angiogenesis and bone remodeling processes from the late-stage AIONFH. Notably, ADH1B, which codes for one of the major alcohol dehydrogenases, is significantly upregulated in AIONFH samples. Further, we found that the ADH1B protein was primarily expressed in smooth muscle cells of the blood vessels, stromal cells and adipocytes of the femoral heads of AIONFH patients; but was absent in other ONFH samples. Our analyses also revealed unique long non-coding RNA (lncRNA) expression profiles and identified novel lncRNAs in AIONFH. In addition, we observed a close coexpression correlation between lncRNAs and mRNAs in AIONFH suggesting that cis-gene regulation represents a major mechanism of action of human femoral lncRNAs. Further, the expression signature of lncRNAs, but not mRNAs, distinguishes AIONFH from other types of ONFH. Taken together, our studies uncovered novel molecular signatures associated with late-stage AIONFH in which the dysregulation of several key signaling pathways within the femoral head may be involved in AIONFH. Subsequently, lncRNAs may serve as potential biomarkers for diagnosis and therapeutic treatment of AIONFH. Further studies are needed to confirm that ADH1B is specifically upregulated in AIONFH and not generally upregulated in patients who consume alcohol excessively.	[Li, Lu; Liu, Baoyi; Wang, Zihua; Yu, Xiaobing; Zhao, Dewei] Dalian Univ, Affiliated Zhongshan Hosp, Dept Orthoped, Dalian, Liaoning, Peoples R China; [Li, Lu; Wei, Xiaowei; Zhao, Dewei] Dalian Univ, Affiliated Zhongshan Hosp, Lab Orthoped, Dalian, Liaoning, Peoples R China; [Li, Lu; Liu, Baoyi; Wang, Zihua; Yu, Xiaobing; Wei, Xiaowei; Zhao, Dewei] Dalian Univ, Affiliated Zhongshan Hosp, Natl Local Joint Engn Lab Dev Orthoped Implant Ma, Dalian, Liaoning, Peoples R China; [Ding, Yan; Wang, Da-Zhi] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Ding, Yan; Yang, Bin] Dalian Univ, Affiliated Zhongshan Hosp, Inst Translat Med, Dalian, Liaoning, Peoples R China; [Carlone, Diana L.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Carlone, Diana L.; Wang, Da-Zhi] Harvard Stem Cell Inst, Cambridge, MA USA; [Zhang, Feng; Lineaweaver, William C.] JMS Burn & Reconstruct Ctr, Jackson, MS USA; [Xia, Weibo] Peking Union Med Coll Hosp, Dept Endocrinol, Beijing, Peoples R China		Zhao, DW (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Orthoped, Dalian, Liaoning, Peoples R China.; Ding, Y (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	yan.ding@childrens.harvard.edu; zhaodewei2016@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371942, 81672139]	This program was funded by grants from the National Natural Science Foundation of China (no.81371942 & no.81672139) .	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Belinky F., 2015, PATHCARDS MULTISOURC; Chao YC, 2003, ALCOHOL ALCOHOLISM, V38, P431, DOI 10.1093/alcalc/agg106; Chung R, 2009, BONE, V44, P878, DOI 10.1016/j.bone.2009.01.377; Cvirn G, 2002, THROMB RES, V105, P433, DOI 10.1016/S0049-3848(02)00042-7; Fang SS, 2018, NUCLEIC ACIDS RES, V46, pD308, DOI 10.1093/nar/gkx1107; GLUECK CJ, 1994, AM J HEMATOL, V45, P156, DOI 10.1002/ajh.2830450212; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hong JM, 2007, OSTEOARTHR CARTILAGE, V15, P688, DOI 10.1016/j.joca.2006.12.007; Huang ZP, 2016, CARDIOVASC RES, V112, P543, DOI 10.1093/cvr/cvw201; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Kerachian MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2009, J ORTHOP RES, V27, P694, DOI 10.1002/jor.20802; Okazaki S, 2013, INT J EXP PATHOL, V94, P312, DOI 10.1111/iep.12035; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pouya F, 2015, ARCH BONE JT SURG-AB, V3, P149; Sakata Ritsu, 2003, Kurume Medical Journal, V50, P121; Seamon J, 2012, ARTHRITIS, DOI 10.1155/2012/601763; Shah P, 2014, J ORAL IMPLANTOL, V40, P330, DOI 10.1563/AAID-JOI-D-11-00173; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang YS, 2003, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000063602.67412.83; Zhao DW, 2015, CHINESE MED J-PEKING, V128, P2843, DOI 10.4103/0366-6999.168017; Zhao DW, 2017, CLIN ORTHOP RELAT R, V475, P2011, DOI 10.1007/s11999-017-5318-5	26	0	0	5	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	8756-3282	1873-2763		BONE	Bone	SEP	2021	150								116012	10.1016/j.bone.2021.116012			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	TE9TZ	WOS:000670351300009	34020076				2022-02-06	
J	Li, MX; Xing, X; Li, ZB; Li, Z				Li, M-X; Xing, X.; Li, Z-B; Li, Z.			Classification and treatment strategies for condylar fractures in children	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Condyle fracture; Children; Classification; Closed treatment; Open treatment	CLOSED TREATMENT; MANAGEMENT; REDUCTION; INJURIES; FIXATION; PATTERNS	In this study, we aimed to describe a classification method (position and displacement (PD) classification) and the corresponding treatment strategies for condylar fractures in children, based on the anatomical position and displacement of the fractures. Moreover, we aimed to explore the effect of the treatment strategies for condylar fractures in children. Such fractures were classified into the following three types by PD classification: condylar head fracture (type A), mildly displaced condylar neck and base fracture (type B), and severely displaced condylar neck and base fracture (type C). According to this classification, we proposed the corresponding treatment strategy of closed treatment for types A and B fractures and open treatment for type C fractures. Eighty-four patients who had 123 condylar fractures (type A = 97, type B = 16, type C = 10) were included in this study. Type A fractures showed the restoration of normal function with favourable remodelling in the condyles. Types B and C fractures had good function and symmetry in the condylar angle and height of the condylar neck. The PD classification and corresponding treatment strategies may serve as a better option for the clinical treatment of condylar fractures in children. (c) 2020 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.	[Li, M-X; Xing, X.; Li, Z-B; Li, Z.] Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Li, M-X; Xing, X.; Li, Z-B; Li, Z.] Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China; [Li, M-X; Xing, X.; Li, Z-B; Li, Z.] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, 237 Luoyu Rd, Wuhan 430079, Peoples R China		Li, Z (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, 237 Luoyu Rd, Wuhan 430079, Peoples R China.	zhili@whu.edu.cn		Li, Mengxun/0000-0001-5553-2221			Bhagol A, 2011, J ORAL MAXIL SURG, V69, P1159, DOI 10.1016/j.joms.2010.05.050; Bruckmoser E, 2012, OR SURG OR MED OR PA, V114, pS86, DOI 10.1016/j.oooo.2011.08.003; Chang SP, 2018, J ORAL MAXIL SURG, V76, DOI 10.1016/j.joms.2018.01.029; Cho BC, 2012, ARCH PLAST SURG-APS, V39, P190, DOI [10.5999/aps.2012.39.4.301, 10.5999/aps.2012.39.3.190]; Choi J, 2005, INT J ORAL MAX SURG, V34, P851, DOI 10.1016/j.ijom.2005.04.005; Chrcanovic BR, 2012, ORAL MAXILLOFAC SURG, V16, P245, DOI 10.1007/s10006-012-0344-7; Deleyiannis FWB, 2006, ANN PLAS SURG, V57, P495, DOI 10.1097/01.sap.0000226943.79337.bf; Dimitroulis G, 1997, AUST DENT J, V42, P367, DOI 10.1111/j.1834-7819.1997.tb06079.x; Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8; Feng ZQ, 2012, BRIT J ORAL MAX SURG, V50, P523, DOI 10.1016/j.bjoms.2011.09.004; Guven O, 2001, J CRANIO MAXILL SURG, V29, P232, DOI 10.1054/jcms.2001.0228; Landes CA, 2008, J ORAL MAXIL SURG, V66, P1184, DOI 10.1016/j.joms.2007.06.667; Laskin DM, 2009, ORAL MAXIL SURG CLIN, V21, P193, DOI 10.1016/j.coms.2008.12.005; Lee C Y, 1993, Ann Dent, V52, P5; Li Z, 2010, DENT TRAUMATOL, V26, P228, DOI 10.1111/j.1600-9657.2010.00895.x; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; Liu CK, 2014, BRIT J ORAL MAX SURG, V52, P144, DOI 10.1016/j.bjoms.2013.10.007; Liu YS, 2013, OR SURG OR MED OR PA, V116, P169, DOI 10.1016/j.oooo.2013.02.023; Namdev R, 2016, DENT TRAUMATOL, V32, P32, DOI 10.1111/edt.12203; Neff A, 2014, CRANIOMAX TRAUM REC, V7, pS44, DOI 10.1055/s-0034-1389559; PROFFIT WR, 1980, AM J ORTHOD DENTOFAC, V78, P1, DOI 10.1016/0002-9416(80)90037-8; Tatsumi H, 2014, INT J ORAL MAX SURG, V43, P185, DOI 10.1016/j.ijom.2013.07.742; THOREN H, 1992, J CRANIO MAXILL SURG, V20, P292, DOI 10.1016/S1010-5182(05)80398-1; Thoren H, 1998, ORAL SURG ORAL MED O, V86, P738, DOI 10.1016/S1079-2104(98)90214-1; Zhou HH, 2014, INT J PEDIATR OTORHI, V78, P1557, DOI 10.1016/j.ijporl.2014.06.031; Zhou HH, 2013, J CRANIO MAXILL SURG, V41, P34, DOI 10.1016/j.jcms.2012.05.007; Zimmermann CE, 2005, INT J ORAL MAX SURG, V34, P823, DOI 10.1016/j.ijom.2005.06.015	27	0	0	5	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	SEP	2021	59	7					776	782		10.1016/j.bjoms.2020.09.016			7	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	UA2IZ	WOS:000684989200007	34127324				2022-02-06	
J	Li, SR; Guyette, F; Brown, J; Zenati, M; Reitz, KM; Eastridge, B; Nirula, R; Vercruysse, GA; O'Keeffe, T; Joseph, B; Neal, MD; Zuckerbraun, BS; Sperry, JL				Li, Shimena R.; Guyette, Francis; Brown, Joshua; Zenati, Mazen; Reitz, Katherine M.; Eastridge, Brian; Nirula, Raminder; Vercruysse, Gary A.; O'Keeffe, Terence; Joseph, Bellal; Neal, Matthew D.; Zuckerbraun, Brian S.; Sperry, Jason L.			Early Prehospital Tranexamic Acid Following Injury Is Associated With a 30-day Survival Benefit A Secondary Analysis of a Randomized Clinical Trial	ANNALS OF SURGERY			English	Article						hemorrhagic shock; prehospital; tranexamic acid; trauma	MULTIPLE ORGAN FAILURE; TRAUMATIC BRAIN-INJURY; EARLY COAGULOPATHY; SHOCK INDEX; MORTALITY; RESUSCITATION; TRANSFUSION; HEMORRHAGE; CRASH-2; PLASMA	Objective: We sought to characterize the timing of administration of prehospital tranexamic acid (TXA) and associated outcome benefits. Background: TXA has been shown to be safe in the prehospital setting post-injury. Methods: We performed a secondary analysis of a recent prehospital randomized TXA clinical trial in injured patients. Those who received prehospital TXA within 1 hour (EARLY) from time of injury were compared to those who received prehospital TXA beyond 1 hour (DELAYED). We included patients with a shock index of >0.9. Primary outcome was 30-day mortality. Kaplan-Meier and Cox Hazard regression were utilized to characterize mortality relationships. Results: EARLY and DELAYED patients had similar demographics, injury characteristics, and shock severity but DELAYED patients had greater prehospital resuscitation requirements and longer prehospital times. Stratified Kaplan-Meier analysis demonstrated significant separation for EARLY patients (N = 238, log-rank chi-square test, 4.99; P = 0.03) with no separation for DELAYED patients (N = 238, log-rank chi-square test, 0.04; P = 0.83). Stratified Cox Hazard regression verified, after controlling for confounders, that EARLY TXA was associated with a 65% lower independent hazard for 30-day mortality [hazard ratio (HR) 0.35, 95% confidence interval (CI) 0.19-0.65, P = 0.001] with no independent survival benefit found in DELAYED patients (HR 1.00, 95% CI 0.63-1.60, P = 0.999). EARLY TXA patients had lower incidence of multiple organ failure and 6-hour and 24-hour transfusion requirements compared to placebo. Conclusions: Administration of prehospital TXA within 1 hour from injury in patients at risk of hemorrhage is associated with 30-day survival benefit, lower incidence of multiple organ failure, and lower transfusion requirements.	[Li, Shimena R.; Brown, Joshua; Zenati, Mazen; Reitz, Katherine M.; Neal, Matthew D.; Zuckerbraun, Brian S.; Sperry, Jason L.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Guyette, Francis] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Brown, Joshua; Zenati, Mazen; Neal, Matthew D.; Zuckerbraun, Brian S.; Sperry, Jason L.] Univ Pittsburgh, Div Trauma & Gen Surg, Pittsburgh Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Eastridge, Brian] Univ Texas Hlth San Antonio, Dept Surg, San Antonio, TX USA; [Nirula, Raminder] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Vercruysse, Gary A.; O'Keeffe, Terence; Joseph, Bellal] Univ Arizona, Dept Surg, Tucson, AZ USA		Sperry, JL (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Sperry, JL (corresponding author), Univ Pittsburgh, Div Trauma & Gen Surg, Pittsburgh Trauma Res Ctr, Pittsburgh, PA 15260 USA.	sperryjl@upmc.edu			US Army Medical Research and Material Command, Fort Detrick, MDU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH 13-2-0080]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5T32HL0098036]	This work was supported by grant W81XWH 13-2-0080 from the US Army Medical Research and Material Command, Fort Detrick, MDand grant 5T32HL0098036 from the National Heart, Lung, and Blood Institute.	Anderson TN, 2020, J HEAD TRAUMA REHAB, V35, P317, DOI 10.1097/HTR.0000000000000619; Ausset S, 2015, J TRAUMA ACUTE CARE, V78, pS70, DOI 10.1097/TA.0000000000000640; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Cole E, 2015, ANN SURG, V261, P390, DOI 10.1097/SLA.0000000000000717; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Gruen DS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16869; Guyette FX, 2021, JAMA SURG, V156, P11, DOI 10.1001/jamasurg.2020.4350; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kunze-Szikszay N, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0314-4; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; National Academies of Sciences Engineering and Medicine, 2016, NAT TRAUM CAR SYST I; Neeki MM, 2018, WEST J EMERG MED, V19, P977, DOI 10.5811/westjem.2018.8.39336; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Olaussen A, 2014, EMERG MED AUSTRALAS, V26, P223, DOI 10.1111/1742-6723.12232; Rappold JF, 2013, TRANSFUSION, V53, p96S, DOI 10.1111/trf.12042; Reitz KM, 2020, J TRAUMA ACUTE CARE, V88, P33, DOI 10.1097/TA.0000000000002485; Roberts I, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1750-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shiraishi A, 2017, BRIT J SURG, V104, P710, DOI 10.1002/bjs.10497; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Stansfield R, 2020, SHOCK, V53, P277, DOI 10.1097/SHK.0000000000001389; Theusinger OM, 2015, ANESTH ANALG, V120, P627, DOI 10.1213/ANE.0000000000000561; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Wafaisade A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1322-5; Wu XW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223406; Zhang ZH, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.02.12; 2019, LANCET BRIT EDITION, V394, P1713	42	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2021	274	3					419	426		10.1097/SLA.0000000000005002			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TY0JW	WOS:000683471400018	34132695				2022-02-06	
J	Libeson, L; Ross, P; Downing, M; Ponsford, J				Libeson, Lauren; Ross, Pamela; Downing, Marina; Ponsford, Jennie			The experience of employers of individuals with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; qualitative research; employers; vocational rehabilitation; return to work	WORK; RETURN; EMPLOYMENT; WORKPLACE; MODERATE	Objectives: To understand the experience of employers of individuals with traumatic brain injury (TBI) who have received comprehensive vocational rehabilitation (VR), the factors involved in supporting an individual with TBI to return to work (RTW), and the support needs of employers. Methods: 12 employers completed semi-structured interviews, which were recorded, transcribed, and analysed thematically. Results: Five main themes were identified: challenges and impact on employer, managing employee post-injury changes, looking after employee wellbeing, managing conflicting emotions, and utilizing sources of support. Although employers received support with operational challenges, findings suggest they were not prepared for the emotional journey. While they struggled to support employees through the difficult process of realizing they could no longer perform at their pre-injury level, employers strove to find appropriate roles and ensure wellbeing for their injured employees. Despite employers' endeavours, they felt this process was demoralizing for some employees. Conclusions: Advising employers on operational as well as emotional support needs of both employees and employers is an ongoing challenge for VR providers. Although unsupportive employers were not well-represented in this sample, the study highlights the challenges faced and strategies used by employers who have a strong personal investment in the successful RTW of their employees.	[Libeson, Lauren; Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Libeson, Lauren; Ross, Pamela; Downing, Marina; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Australia; [Ross, Pamela] Epworth HealthCare, Richmond, Australia		Libeson, L (corresponding author), 2-70 Durrant St, Brighton, Vic 3186, Australia.	lauren.libeson@monash.edu	Ponsford, Jennie/H-8341-2014	Ponsford, Jennie/0000-0003-0430-125X; Downing, Marina/0000-0002-3126-6632			Agency for Clinical Innovation, 2013, INV VOC PROGR OUTC P; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Barbour RS, 2003, QUAL HEALTH RES, V13, P1019, DOI 10.1177/1049732303253331; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Bould E., 2021, BRAIN IMPAIR, V22, P50; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V., 2016, SUCCESSFUL QUALITATI; Burla L, 2008, NURS RES, V57, P113, DOI 10.1097/01.NNR.0000313482.33917.7d; Bush EJ, 2016, BRAIN INJURY, V30, P422, DOI 10.3109/02699052.2015.1131849; Campbell JL, 2013, SOCIOL METHOD RES, V42, P294, DOI 10.1177/0049124113500475; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Conneeley AL., 2013, SOC CARE NEURODISABI, V4, P6; Coole C, 2013, J OCCUP REHABIL, V23, P406, DOI 10.1007/s10926-012-9401-1; Creswell J. W., 2018, RES DESIGN QUALITATI; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Donker-Cools BHPM, 2018, DISABIL REHABIL, V40, P185, DOI 10.1080/09638288.2016.1250118; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Jakobsen K, 2014, SCAND J OCCUP THER, V21, P48, DOI 10.3109/11038128.2013.857717; Liaset IF, 2016, SCAND J OCCUP THER, V23, P446, DOI 10.3109/11038128.2016.1152294; Libeson L., 2021, FACTORS ASS EMPLOYME; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Mcrae P, 2016, AUST J REHABIL COUNS, V22, P76, DOI 10.1017/jrc.2016.14; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI [10.1177/1525-822X02239569, DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Stergiou-Kita M, 2017, WORK, V57, P245, DOI 10.3233/WOR-172556; Tiedtke C, 2014, J OCCUP REHABIL, V24, P399, DOI 10.1007/s10926-013-9465-6; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200	44	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1969252		SEP 2021	23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UJ4BX	WOS:000691233800001	34461816				2022-02-06	
J	Lujan, S; Petroni, G; Castellani, P; Bollada, S; Bell, MJ; Velonjara, J; Vavilala, MS; Mock, C				Lujan, Silvia; Petroni, Gustavo; Castellani, Pablo; Bollada, Sabrina; Bell, Michael J.; Velonjara, Julia; Vavilala, Monica S.; Mock, Charles		PEGASUS-Argentina Author Grp	The Status of Quality Improvement Programs for Pediatric Traumatic Brain Injury Care in Argentina	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Critical care; Quality improvement; Morbidity and mortality; Traumatic brain injury; Pediatric		Introduction: Trauma quality improvement (QI) programs improve care and outcomes for injured patients. Information about QI programs for pediatric traumatic brain injury (TBI) is sparse in Latin America. Methods: We gathered data on the status of QI programs and activities that encompass pediatric TBI at 15 Argentine hospitals. Data were gathered during 2019 and included hospital characteristics, QI practices, presence of a queryable registry, and use of protocols for TBI care. Level of QI activities was compared between hospital types using Fisher's exact test. Results: Most hospitals had guidelines for pediatric TBI care, including management and/or prevention of intracranial pressure (100%) and central-line-associated infections (87%). Morbidity and mortality meetings or other types of case discussions in which quality of pediatric TBI care was discussed were held by all hospitals, with most (53%) having weekly-monthly meetings, but 27% having rare or annual meetings. Sixty percent of hospitals had adequate data for case reviews (fewer than 25% of cases with essential information missing). Fiftythree percent documented discussions that occurred at these meetings and 53% utilized computerized trauma registries. Larger hospitals (> 200 beds) more frequently had adequate data (88%) for case reviews than smaller hospitals (29%, P = 0.046). Hospital size did not affect other QI activities. Conclusions: Most hospitals had guidelines for pediatric TBI care. Adequacy of care was discussed at reasonably frequent case conferences. Opportunities for improvement include increasing documentation of case reviews and improving adequacy of data for case reviews, especially at smaller hospitals. Greater use of computerized trauma registries could provide such data. (C) 2021 Elsevier Inc. All rights reserved.	[Lujan, Silvia; Petroni, Gustavo] Ctr Informat & Invest Clin CIIC, Rosario, Santa Fe, Argentina; [Castellani, Pablo] Hosp Ninos Sor Maria Ludovica, La Plata, Buenos Aires, Argentina; [Bollada, Sabrina] Hosp Int Ninos Eva Peron, Catamarca, Argentina; [Bell, Michael J.] Childrens Natl Hosp, Washington, DC USA; [Velonjara, Julia; Vavilala, Monica S.; Mock, Charles] Harborview Med Ctr, Harboruiew Injury Prevent & Res Ctr, Box 359960,325 Ninth Ave, Seattle, WA 98104 USA		Mock, C (corresponding author), Harborview Med Ctr, Harboruiew Injury Prevent & Res Ctr, Box 359960,325 Ninth Ave, Seattle, WA 98104 USA.	cmock@uw.edu		Velonjara, Julia/0000-0002-7947-094X	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS106560]	The authors declare no conflicts of interest. This study was funded in part by grant 1R01NS106560, from the US National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2019, COUNTR DAT ARG; ClinicalTrials.gov, 2019, PED GUID ADH OUTC AR; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; Health statistics and information systems, 2019, GLOB HLTH EST 2000 2; Juillard CJ, 2009, WORLD J SURG, V33, P1075, DOI 10.1007/s00268-009-9959-8; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LaGrone LN, 2017, INJURY, V48, P1985, DOI 10.1016/j.injury.2017.03.003; LaGrone LN, 2017, WORLD J SURG, V41, P963, DOI 10.1007/s00268-016-3832-3; SAS Institute Inc, 2013, SAS SOFTW VERS 9 4 SASGRAPH 94; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; Vavilala MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189296; Vavilala MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166478; Vincent JL, 2017, INTENS CARE MED, V43, P122, DOI 10.1007/s00134-016-4466-5; WHO, 2010, STRENGTHENING CARE FOR THE INJURED: SUCCESS STORIES AND LESSONS LEARNED FROM AROUND THE WORLD, P1; World Health Organization, 2004, GUIDELINES ESSENTIAL; World Health Organization, 2009, GUID TRAUM QUAL IMPR; Zetlen HL, 2017, J SURG RES, V220, P213, DOI 10.1016/j.jss.2017.06.035	18	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2021	265						71	78		10.1016/j.jss.2021.03.024			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TA4MJ	WOS:000667222700016	33892460				2022-02-06	
J	MacGregor, AJ; Joseph, AR; Markwald, RR; Dougherty, AL				MacGregor, Andrew J.; Joseph, Antony R.; Markwald, Rachel R.; Dougherty, Amber L.			The Relationship Between Blast-related Hearing Threshold Shift and Insomnia in US Military Personnel	MILITARY MEDICINE			English	Article							BRAIN-INJURY; SLEEP; PREVALENCE; QUALITY; FATIGUE; WORKERS; IMPACT; NOISE; IRAQ	Introduction: Hearing loss and insomnia emerged as preeminent sources of morbidity among military service members and veterans who served in the recent Iraq and Afghanistan conflicts. Significant threshold shift (STS), an early indicator of hearing loss, has not been studied in relation to insomnia. This study's objective was to examine the co-occurrence of STS and insomnia among U.S. military personnel with blast-related injury. Materials and Methods: A total of 652 service members who were blast-injured during military operations in Iraq or Afghanistan between 2004 and 2012 were identified from the Blast-Related Auditory Injury Database. Pre- and post-injury audiometric data were used to ascertain new-onset STS, defined as 30 dB or greater increase for the sum of thresholds at 2,000, 3,000, and 4,000 Hz for either ear. Insomnia diagnosed within 2 years post-injury was abstracted from electronic medical records. Multivariable logistic regression analysis examined the relationship between STS and insomnia, while adjusting for age, year of injury, occupation, injury severity, tinnitus and concussion diagnosed in-theater, and PTSD. Results: A majority of the study sample was aged 18-25 years (79.9%) and sustained mild-to-moderate injuries (92.2%). STS was present in 21.1% of service members. Cumulative incidence of diagnosed insomnia was 22.3% and 11.1% for those with and without STS, respectively. After adjusting for covariates, those with STS had nearly 2-times higher odds of insomnia (odds ratio (OR)=1.91, 95% CI=1.12-3.24) compared with those without STS. In multivariable modeling, the strongest association was between PTSD and insomnia (OR=5.57, 95% CI=3.35-9.26). A secondary finding of note was that military personnel with STS had a significantly higher frequency of PTSD compared with those without STS (28.1% vs. 15.2%). Conclusions: Hearing threshold shift was associated with insomnia in military personnel with blast-related injury and could be used to identify service members at risk. Multidisciplinary care is needed to manage the co-occurrence of both conditions during the post-deployment rehabilitation phase. Future research should evaluate the specific mechanisms involved in this relationship and further explore the association between hearing threshold shift and PTSD.	[MacGregor, Andrew J.; Dougherty, Amber L.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA; [Joseph, Antony R.] Illinois State Univ, Commun Sci & Disorders Dept, Hearing Loss Prevent Lab, Normal, IL 61790 USA; [Joseph, Antony R.; Dougherty, Amber L.] Leidos Inc, San Diego, CA 92106 USA; [Markwald, Rachel R.] Naval Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA.			Markwald, Rachel/0000-0002-0432-3937; MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60808]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery under work unit no. 60808.	Alamgir H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0082-5; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; Asplund R, 2003, ARCH GERONTOL GERIAT, V36, P93, DOI 10.1016/S0167-4943(02)00062-6; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Caldwell JA, 2017, J SLEEP RES, V26, P665, DOI 10.1111/jsr.12543; Chattu VK, 2018, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010001; Clarke NA, 2019, AM J AUDIOL, V28, P1015, DOI 10.1044/2019_AJA-19-0026; Commission on Professional Hospital Activities:, 1977, INT CLASSIFICATION D; Department of Defense:, 2010, HEARING CONSERVATION; Dobie RA, 2004, COMM DIS DET IND HEA; DOD Hearing Conservation Working Group DOD Hearing Center of Excellence, HEAR HLTH SURV DAT R; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Fletcher A, 2001, ERGONOMICS, V44, P475, DOI 10.1080/00140130119824; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Greer N, 2016, PREVALENCE EPIDEMIOL; Heupa AB, 2011, BRAZ J OTORHINOLAR, V77, P747, DOI 10.1590/S1808-86942011000600011; HIRSCH FG, 1968, ANN NY ACAD SCI, V152, P147, DOI 10.1111/j.1749-6632.1968.tb11972.x; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; Joseph AR, 2016, J REHABIL RES DEV, V53, P295, DOI 10.1682/JRRD.2015.02.0031; Laroche C, 2000, J ACAD REHABIL AUDIO, V23, P63; Liberman MC, 2016, ADV EXP MED BIOL, V875, P1, DOI 10.1007/978-1-4939-2981-8_1; Lim HM, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0195-7; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; MacGregor AJ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08999-6; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Masterson EA, 2014, J OCCUP ENVIRON MED, V56, P446, DOI 10.1097/JOM.0000000000000124; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Nakajima Kei, 2014, Int J Otolaryngol, V2014, P218218, DOI 10.1155/2014/218218; Nakayama M, 2010, J CLIN SLEEP MED, V6, P445; Pruiksma KE, 2016, PSYCHOL TRAUMA-US, V8, P697, DOI 10.1037/tra0000150; Rabinowitz YG, 2009, MIL MED, V174, P358, DOI 10.7205/MILMED-D-01-5008; Schroedel JG, 2000, AM ANN DEAF, V145, P303, DOI 10.1353/aad.2012.0099; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Test T, 2011, SLEEP, V34, P25, DOI 10.1093/sleep/34.1.25; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; U.S. Department of Veterans Affairs, 2013, VET BEN ADM ANN BEN; Van Campen L E, 1999, J Am Acad Audiol, V10, P231	40	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2021	186	9-10					844	849		10.1093/milmed/usaa567			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP2XJ	WOS:000730733500014	33580669	hybrid			2022-02-06	
J	MacLean, L; Prabhakar, D				MacLean, Lisa; Prabhakar, Deepak			Attention-Deficit/Hyperactivity Disorder and Sports: A Lifespan Perspective	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						ADHD; Athletes; Life span; Sport Psychiatry	DEFICIT HYPERACTIVITY DISORDER; AMERICAN MEDICAL SOCIETY; TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; ADHD; PREVALENCE; SYMPTOMS; CHILDREN; COMORBIDITY; CONCUSSION		[MacLean, Lisa] Henry Ford Hlth Syst, One Ford Pl 1C, Detroit, MI 48202 USA; [Prabhakar, Deepak] Sheppard Pratt, 6501 North Charles St, Baltimore, MD 21204 USA		Prabhakar, D (corresponding author), Sheppard Pratt, 6501 North Charles St, Baltimore, MD 21204 USA.	dprabhakar@sheppardpratt.org					Archer T, 2012, NEUROTOX RES, V21, P195, DOI 10.1007/s12640-011-9260-0; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Egger HL, 2006, INFANT YOUNG CHILD, V19, P109, DOI 10.1097/00001163-200604000-00004; Fischer M, 2002, J ABNORM CHILD PSYCH, V30, P463, DOI 10.1023/A:1019864813776; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Garner AA, 2018, SPORTS MED, V48, P507, DOI 10.1007/s40279-017-0829-5; Gillberg C, 2004, EUR CHILD ADOLES PSY, V13, P80, DOI 10.1007/s00787-004-1008-4; Halperin JM, 2011, NEUROSCI BIOBEHAV R, V35, P621, DOI 10.1016/j.neubiorev.2010.07.006; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hendrickson B., NONMEDICAL USE ADHD; Jensen PS, 2004, PEDIATRICS, V113, P754; Johnson R., 2000, J ATTEN DISORD, V4, P150, DOI [10.1177/108705470000400302, DOI 10.1177/108705470000400302]; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kiluk BD, 2009, J ATTEN DISORD, V12, P499, DOI 10.1177/1087054708320400; Lahey BB, 1998, J AM ACAD CHILD PSY, V37, P695, DOI 10.1097/00004583-199807000-00008; Lavigne JV, 1996, J AM ACAD CHILD PSY, V35, P204, DOI 10.1097/00004583-199602000-00014; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Major League Baseball, MAJOR LEAG BAS JOINT MAJOR LEAG BAS JOINT; McCarthy S, 2009, BRIT J PSYCHIAT, V194, P273, DOI 10.1192/bjp.bp.107.045245; National Football League, POL PERF ENH SUBST POL PERF ENH SUBST; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Parr JW, 2011, CLIN SPORT MED, V30, P591, DOI 10.1016/j.csm.2011.03.007; Perrin JM, 2008, PEDIATRICS, V122, P451, DOI 10.1542/peds.2008-1573; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Reardon CL, 2016, SPORTS MED, V46, P611, DOI 10.1007/s40279-015-0456-y; Regnart J, 2017, EXPERT REV PHARM OUT, V17, P275, DOI 10.1080/14737167.2017.1351878; Sallee FR, 1998, TXB PEDIAT NEUROPSYC, P1351; Sonuga-Barke EJS, 2006, INFANT YOUNG CHILD, V19, P142, DOI 10.1097/00001163-200604000-00007; Sonuga-Barke EJS, 2003, J AM ACAD CHILD PSY, V42, P1335, DOI 10.1097/01.chi.0000087564.34977.21; Stewman CG, 2018, SPORTS HEALTH, V10, P40, DOI 10.1177/1941738117742906; Wilens E, 2004, JAMA-J AM MED ASSOC, V292, P619, DOI 10.1001/jama.292.5.619; World Anti-Doping Agency, MED INF SUPP DEC TUE MED INF SUPP DEC TUE; Young S, 2010, J CHILD PSYCHOL PSYC, V51, P116, DOI 10.1111/j.1469-7610.2009.02191.x	37	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2021	44	3			SI		419	430		10.1016/j.psc.2021.04.014			12	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	TY1FN	WOS:000683529700009	34372998				2022-02-06	
J	Martel, DR; Tanel, MR; Laing, AC				Martel, Daniel R.; Tanel, Michelle R.; Laing, Andrew C.			Impact attenuation provided by older adult protective headwear products during simulated fall-related head impacts	JOURNAL OF REHABILITATION AND ASSISTIVE TECHNOLOGIES ENGINEERING			English	Article						Older adults; head injury; protective devices; impact biomechanics; falls; gmax	TRAUMATIC BRAIN-INJURY; FLOORING SYSTEMS; BICYCLE HELMETS; UNITED-STATES; RISK-FACTORS; ACCELERATIONS; DEATHS	Introduction: While protective headwear products (PHP) are designed to protect older adults from fall-related head injuries, there are limited data on their protective capacity. This study's goal was to assess the impact attenuation provided by commercially available PHP during simulated head impacts. Methods: A drop tower and Hybrid III headform measured the decrease in peak linear acceleration (g(atten)) provided by 12 PHP for front- and back-of-head impacts at low (clinically relevant: 3.5 m/s) and high (5.7 m/s) impact velocities. Results: The range of g(atten) across PHP was larger at the low velocity (56% and 41% for back and frontal impacts, respectively) vs. high velocity condition (27% and 38% for back and frontal impacts, respectively). A significant interaction between impact location and velocity was observed (p < .05), with significantly greater g(atten) for back-of-head compared to front-of-head impacts at the low impact velocity (19% mean difference). While not significant, there was a modest positive association between g(atten) and product padding thickness for back-of-head impacts (p = .095; r = 0.349). Conclusion: This study demonstrates the wide range in impact attenuation across commercially available PHP, and suggests that existing products provide greater impact attenuation during back-of-head impacts. These data may inform evidence-based decisions for clinicians and consumers and help drive industry innovation.	[Martel, Daniel R.; Tanel, Michelle R.; Laing, Andrew C.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada		Laing, AC (corresponding author), Univ Waterloo, Fac Hlth, Dept Kinesiol & Hlth Sci, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	actlaing@uwaterloo.ca		Laing, Andrew/0000-0001-8128-011X	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN2015-03636]; AGE-WELL [AWCAT-2019-143]; Canadian Foundation for InnovationCanada Foundation for Innovation [25351]; Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario [25351]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded in part by operating grants from the Natural Sciences and Engineering Research Council of Canada (RGPIN2015-03636) and AGE-WELL (AWCAT-2019-143), and infrastructure grants from the Canadian Foundation for Innovation (Grant #25351) and the Ontario Ministry of Research and Innovation (Grant #25351).	Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Anderson R, 2005, HEAD INJURY PATHOPHY, P26; ASTM, F144615B ASTM, DOI [10.1520/F1446-15B, DOI 10.1520/F1446-15B]; ASTM, STANDARD TEST METHOD; ASTM, F129217A ASTM, DOI [10.1520/F1292-17A, DOI 10.1520/F1292-17A]; Bailly N, 2018, WILD ENVIRON MED, V29, P151, DOI 10.1016/j.wem.2017.11.007; Bulat T, 2008, CLIN INTERV AGING, V3, P567, DOI 10.2147/CIA.S2529; Caccese V, 2016, EXP TECHNIQUES, V40, P413, DOI [10.1111/ext.12079, 10.1007/s40799-016-0046-4]; Choi WJ, 2015, J BIOMECH, V48, P911, DOI 10.1016/j.jbiomech.2015.02.025; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Cory CZ, 2001, FORENSIC SCI INT, V123, P89, DOI 10.1016/S0379-0738(01)00523-0; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Frizzell ERA, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000361; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Fukaya K, 2008, IND HEALTH, V46, P59, DOI 10.2486/indhealth.46.59; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Glinka MN, 2013, MED ENG PHYS, V35, P108, DOI 10.1016/j.medengphy.2012.04.006; Hajiaghamemar M, 2015, ANN BIOMED ENG, V43, P2143, DOI 10.1007/s10439-015-1255-1; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hoshizaki B., 2013, J NEUROL NEUROPHYSIO, V5, P1, DOI DOI 10.4172/2155-9562.1000181; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Ivancevic VG, 2009, COGN NEURODYNAMICS, V3, P281, DOI 10.1007/s11571-008-9070-0; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Korall AMB, 2015, J AM MED DIR ASSOC, V16, P185, DOI 10.1016/j.jamda.2014.12.004; Mack M G, 2000, Inj Prev, V6, P141, DOI 10.1136/ip.6.2.141; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Peel NM, 2002, INJ PREV, V8, P280, DOI 10.1136/ip.8.4.280; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Santesso N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub5; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Warnica MJ, 2016, P I MECH ENG P-J SPO, V230, P213, DOI 10.1177/1754337115600985; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Yoganandan N, 2006, J BIOMECH, V39, P1347, DOI 10.1016/j.jbiomech.2005.03.016; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	46	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2055-6683			J REHABIL ASSIST TER	J. Rehabil. Assist. Technol. Eng.	SEP 1	2021	8								20556683211050357	10.1177/20556683211050357			10	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	WP7UU	WOS:000713332700001	34877017	Green Published, gold			2022-02-06	
J	Merz, T; McCook, O; Denoix, N; Radermacher, P; Waller, C; Kapapa, T				Merz, Tamara; McCook, Oscar; Denoix, Nicole; Radermacher, Peter; Waller, Christiane; Kapapa, Thomas			Biological Connection of Psychological Stress and Polytrauma under Intensive Care: The Role of Oxytocin and Hydrogen Sulfide	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						early life stress; adverse childhood experiences; posttraumatic stress disorder; traumatic brain injury; acute subdural hematoma; hemorrhagic shock; cystathionine-gamma-lyase; hydrogen sulfide; oxytocin; pig	TRAUMATIC BRAIN-INJURY; EARLY-LIFE STRESS; MITOCHONDRIAL BIOENERGETIC FUNCTION; ADVERSE CHILDHOOD EXPERIENCES; PROLONGED EXPOSURE THERAPY; CYSTATHIONINE-GAMMA-LYASE; MULTIPLE ORGAN FAILURE; ACUTE CYANIDE TOXICITY; BLUNT CHEST TRAUMA; ACUTE LUNG INJURY	This paper explored the potential mediating role of hydrogen sulfide (H2S) and the oxytocin (OT) systems in hemorrhagic shock (HS) and/or traumatic brain injury (TBI). Morbidity and mortality after trauma mainly depend on the presence of HS and/or TBI. Rapid "repayment of the O-2 debt" and prevention of brain tissue hypoxia are cornerstones of the management of both HS and TBI. Restoring tissue perfusion, however, generates an ischemia/reperfusion (I/R) injury due to the formation of reactive oxygen (ROS) and nitrogen (RNS) species. Moreover, pre-existing-medical-conditions (PEMC's) can aggravate the occurrence and severity of complications after trauma. In addition to the "classic" chronic diseases (of cardiovascular or metabolic origin), there is growing awareness of psychological PEMC's, e.g., early life stress (ELS) increases the predisposition to develop post-traumatic-stress-disorder (PTSD) and trauma patients with TBI show a significantly higher incidence of PTSD than patients without TBI. In fact, ELS is known to contribute to the developmental origins of cardiovascular disease. The neurotransmitter H2S is not only essential for the neuroendocrine stress response, but is also a promising therapeutic target in the prevention of chronic diseases induced by ELS. The neuroendocrine hormone OT has fundamental importance for brain development and social behavior, and, thus, is implicated in resilience or vulnerability to traumatic events. OT and H2S have been shown to interact in physical and psychological trauma and could, thus, be therapeutic targets to mitigate the acute post-traumatic effects of chronic PEMC's. OT and H2S both share anti-inflammatory, anti-oxidant, and vasoactive properties; through the reperfusion injury salvage kinase (RISK) pathway, where their signaling mechanisms converge, they act via the regulation of nitric oxide (NO).	[Merz, Tamara; McCook, Oscar; Denoix, Nicole; Radermacher, Peter] Ulm Univ, Med Ctr, Inst Anesthesiol Pathophysiol & Proc Engn, Helmholtzstr 8-1, D-89081 Ulm, Germany; [Denoix, Nicole] Ulm Univ, Med Ctr, Clin Psychosomat Med & Psychotherapy, D-89081 Ulm, Germany; [Waller, Christiane] Paracelsus Med Univ, Nuremberg Gen Hosp, Dept Psychosomat Med & Psychotherapy, D-90471 Nurnberg, Germany; [Kapapa, Thomas] Ulm Univ, Med Ctr, Clin Neurosurg, D-89081 Ulm, Germany		McCook, O (corresponding author), Ulm Univ, Med Ctr, Inst Anesthesiol Pathophysiol & Proc Engn, Helmholtzstr 8-1, D-89081 Ulm, Germany.	tamara.merz@uni-ulm.de; oscar.mccook@uni-ulm.de; nicole.denoix@uni-ulm.de; peter.radermacher@uni-ulm.de; christiane.waller@klinikum-nuernberg.de; Thomas.Kapapa@uniklinik-ulm.de	McCook, Oscar/AAF-1647-2020	McCook, Oscar/0000-0001-7879-7695; Denoix, Nicole/0000-0003-3655-6433	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [251293561-SFB 1149, GRK 2203]	This research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID 251293561-SFB 1149 to P.R. and T.M., and the DFG-funded Graduiertenkolleg "PulmoSens" GRK 2203 to P.R.	Abe K, 1996, J NEUROSCI, V16, P1066; Acero G, 2017, INFLAMMOPHARMACOLOGY, V25, P585, DOI 10.1007/s10787-017-0355-y; Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P557, DOI 10.1016/j.bbabio.2010.01.033; Alves E, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00032; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Amini-Khoei H, 2017, PROG NEURO-PSYCHOPH, V76, P169, DOI 10.1016/j.pnpbp.2017.02.022; Anda RF, 2008, AM J PREV MED, V34, P396, DOI 10.1016/j.amepre.2008.02.002; Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Asfar P, 2005, CRIT CARE MED, V33, P373, DOI 10.1097/01.CCM.0000152253.45901.FB; Asfar P, 2016, CRIT CARE MED, V44, P234, DOI 10.1097/CCM.0000000000001441; Asfar P, 2014, CRIT CARE, V18, DOI 10.1186/cc13782; Balint EM, 2016, GEN HOSP PSYCHIAT, V38, P53, DOI 10.1016/j.genhosppsych.2015.10.002; Barbee RW, 2010, SHOCK, V33, P113, DOI 10.1097/SHK.0b013e3181b8569d; Basu A, 2017, CLIN PSYCHOL-SCI PR, V24, P125, DOI 10.1111/cpsp.12191; Batten SV, 2004, J CLIN PSYCHIAT, V65, P249; Bauer M., 2019, ANN UPDATE INTENSIVE, P167; Baumgart K, 2010, CRIT CARE MED, V38, P588, DOI 10.1097/CCM.0b013e3181b9ed2e; Bebarta VS, 2017, ANN EMERG MED, V69, P718, DOI 10.1016/j.annemergmed.2016.09.034; Bebarta VS, 2012, ANN EMERG MED, V59, P532, DOI 10.1016/j.annemergmed.2012.01.022; Bebarta VS, 2010, ANN EMERG MED, V55, P345, DOI 10.1016/j.annemergmed.2009.09.020; Beloncle F, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-13; Boeck C, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00023; Boeck C, 2018, PSYCHONEUROENDOCRINO, V96, P69, DOI 10.1016/j.psyneuen.2018.05.040; Boeck C, 2018, DEV PSYCHOPATHOL, V30, P539, DOI 10.1017/S0954579417001055; Boeck C, 2016, MITOCHONDRION, V30, P197, DOI 10.1016/j.mito.2016.08.006; Bracht H, 2012, CRIT CARE MED, V40, P2157, DOI 10.1097/CCM.0b013e31824e6b30; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BRONER CW, 1989, CIRC SHOCK, V29, P77; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carter CS, 2020, PHARMACOL REV, V72, P829, DOI 10.1124/pr.120.019398; Carter CS, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00356; Chaby LE, 2017, CURR OPIN BEHAV SCI, V14, P86, DOI 10.1016/j.cobeha.2017.01.001; Chai W, 2012, J SURG RES, V176, P210, DOI 10.1016/j.jss.2011.07.016; Chang JC, 2010, WORLD J CARDIOL, V2, P150, DOI 10.4330/wjc.v2.i6.150; Chaves VE, 2013, PEPTIDES, V45, P9, DOI 10.1016/j.peptides.2013.04.010; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Cirulli F, 2017, CURR OPIN BEHAV SCI, V14, P65, DOI 10.1016/j.cobeha.2016.12.009; Citi V, 2020, BRIT J PHARMACOL, V177, P4931, DOI 10.1111/bph.15230; Coletti R, 2015, HORM BEHAV, V67, P12, DOI 10.1016/j.yhbeh.2014.11.008; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Cruceanu C, 2017, CURR OPIN BEHAV SCI, V14, P167, DOI 10.1016/j.cobeha.2017.04.001; Cunningham TJ, 2014, INT J CHRONIC OBSTR, V9, P1033, DOI 10.2147/COPD.S68226; Daglas M, 2020, J THROMB HAEMOST, V18, P2658, DOI 10.1111/jth.15015; Datzmann T, 2021, J NEUROSURG, V134, P223, DOI 10.3171/2019.9.JNS191789; Datzmann T, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104536; De Berardis D, 2013, CNS NEUROL DISORD-DR, V12, P252; Demiselle J, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0628-2; Denoix N., 2021, INTENSIVE CARE MED E; Denoix N, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080748; Denoix N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00649; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Diaz-Chavez A, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113318; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Dominic P, 2021, REDOX BIOL, V43, DOI 10.1016/j.redox.2021.101982; Donadon MF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00154; Drabek T, 2011, SHOCK, V35, P67, DOI 10.1097/SHK.0b013e3181e86f49; Dusunceli F, 2008, PEPTIDES, V29, P1216, DOI 10.1016/j.peptides.2008.02.010; Dyson A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002310; Ellis BJ, 2021, CLIN PSYCHOL REV, V86, DOI 10.1016/j.cpr.2021.101985; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Elwenspoek MMC, 2017, J IMMUNOL, V199, P4046, DOI 10.4049/jimmunol.1701082; Erbas O, 2013, J SURG RES, V183, P313, DOI 10.1016/j.jss.2012.11.043; Evgen'ev MB, 2020, CELL STRESS CHAPERON, V25, P713, DOI 10.1007/s12192-020-01120-1; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferraris VA, 2010, J TRAUMA, V69, P645, DOI 10.1097/TA.0b013e3181d8941d; Flanagan JC, 2020, CONTEMP CLIN TRIALS, V95, DOI 10.1016/j.cct.2020.106074; Flanagan JC, 2018, J PSYCHIATR RES, V98, P64, DOI 10.1016/j.jpsychires.2017.12.014; Flannigan KL, 2014, P NATL ACAD SCI USA, V111, P13559, DOI 10.1073/pnas.1413390111; Fleshner M, 2013, BRAIN BEHAV IMMUN, V27, P1, DOI 10.1016/j.bbi.2012.08.012; Florian M, 2010, ENDOCRINOLOGY, V151, P482, DOI 10.1210/en.2009-0624; Franz HM, 2019, HEALTH PSYCHOL, V38, P113, DOI 10.1037/hea0000706; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Gao C, 2012, BIOL PHARM BULL, V35, P1029, DOI 10.1248/bpb.b110679; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gonzalez-Pardo H, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10070447; Groger M, 2013, CRIT CARE MED, V41, pE105, DOI 10.1097/CCM.0b013e31827c0b1f; Groger M., 2021, SHOCK, DOI [10.1097/SHK.0000000000001828, DOI 10.1097/SHK.0000000000001828]; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Gu HF, 2012, ATHEROSCLEROSIS, V223, P69, DOI 10.1016/j.atherosclerosis.2012.01.021; Guan RJ, 2019, AGING-US, V11, P11844, DOI 10.18632/aging.102454; Gutkowska J, 2014, BRAZ J MED BIOL RES, V47, P206, DOI 10.1590/1414-431X20133309; Gutkowska J, 2012, J NEUROENDOCRINOL, V24, P599, DOI 10.1111/j.1365-2826.2011.02235.x; Gwarzo IH, 2021, BRAIN INJURY, V35, P554, DOI 10.1080/02699052.2021.1890822; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Harrois A, 2009, CURR OPIN ANESTHESIO, V22, P143, DOI 10.1097/ACO.0b013e328328d1cc; Hartmann C, 2017, SHOCK, V48, P390, DOI 10.1097/SHK.0000000000000879; Hartmann C, 2017, SHOCK, V47, P491, DOI 10.1097/SHK.0000000000000746; Heesen M, 2019, ANAESTHESIA, V74, P1305, DOI 10.1111/anae.14757; Ho DH, 2016, AM J PHYSIOL-HEART C, V310, pH1267, DOI 10.1152/ajpheart.00016.2016; Hoffmann A, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00306; Horn SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215085; Hosli I, 2019, GYNAKOLOGE, V52, P408, DOI 10.1007/s00129-019-4446-2; Iseri SO, 2005, J SURG RES, V126, P73, DOI 10.1016/j.jss.2005.01.021; Issa K, 2013, CRIT CARE, V17, DOI 10.1186/cc12808; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Keresztes M, 2007, STRESS, V10, P271, DOI 10.1080/10253890701248079; Kerezoudis P, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20439; Kingsbury MA, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100794; Krause S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00173; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Ladwig KH, 2014, BUNDESGESUNDHEITSBLA, V57, P1083, DOI 10.1007/s00103-014-2020-6; Lahner D, 2017, UNFALLCHIRURG, V120, P728, DOI 10.1007/s00113-017-0388-0; Lajud N, 2021, J NEUROTRAUM, V38, P411, DOI 10.1089/neu.2020.7354; Lange RT, 2021, J NEUROTRAUM, V38, P63, DOI 10.1089/neu.2019.6852; Latorre E, 2018, AGING-US, V10, P1666, DOI 10.18632/aging.101500; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Leach MR, 2021, CURR OPIN CRIT CARE, V27, P95, DOI 10.1097/MCC.0000000000000810; Lee MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15942-1; Lee MR, 2018, MOL PSYCHIATR, V23, P115, DOI 10.1038/mp.2017.27; Levin HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3046; Levy B, 2010, INTENS CARE MED, V36, P2019, DOI 10.1007/s00134-010-2045-8; Li B, 2017, J PEDIATR SURG, V52, P40, DOI 10.1016/j.jpedsurg.2016.10.013; Li L, 2020, HEART, V106, P1289, DOI 10.1136/heartjnl-2020-316991; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Loria AS, 2014, ACTA PHYSIOL, V210, P277, DOI 10.1111/apha.12189; Ma XT, 2020, J NEUROIMMUNE PHARM, V15, P181, DOI 10.1007/s11481-019-09882-x; Ma YN, 2016, P NATL ACAD SCI USA, V113, P9256, DOI 10.1073/pnas.1604285113; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Mani S, 2014, ANTIOXID REDOX SIGN, V20, P805, DOI 10.1089/ars.2013.5324; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Martins DA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14845-5; Marutani E, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-0296-4; Marutani E, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002125; Matallo J, 2014, NITRIC OXIDE-BIOL CH, V41, P79, DOI 10.1016/j.niox.2014.06.004; McCook O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10163484; McCook O, 2021, NEURAL REGEN RES, V16, P2376, DOI 10.4103/1673-5374.313018; McCook O, 2014, NITRIC OXIDE-BIOL CH, V41, P48, DOI 10.1016/j.niox.2014.03.163; McGeer PL, 2016, J NEUROL NEUROMEDICI, V1, P28; Medland JE, 2016, NEUROGASTROENT MOTIL, V28, P1317, DOI 10.1111/nmo.12828; Mendonca BP, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00300-8; Merz T, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00324-0; Merz T, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00299; Merz T, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0208-z; Merz T, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0207-0; Merz T, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0140-7; Messerer DAC, 2021, NAT REV NEPHROL, V17, P91, DOI 10.1038/s41581-020-00344-9; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Miller GF, 2021, INJURY, V52, P1138, DOI 10.1016/j.injury.2021.01.042; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Mizuta Y, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118074; Modis K, 2014, BRIT J PHARMACOL, V171, P2123, DOI 10.1111/bph.12368; Moghimian M, 2013, J CARDIOL, V61, P79, DOI 10.1016/j.jjcc.2012.08.021; Mok YYP, 2008, INFLAMM RES, V57, P512, DOI 10.1007/s00011-008-7231-6; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Monstein HJ, 2004, REGUL PEPTIDES, V119, P39, DOI 10.1016/j.regpep.2003.12.017; Morava E, 2013, NEUROSCI BIOBEHAV R, V37, P668, DOI 10.1016/j.neubiorev.2013.02.005; Morris MC, 2019, J SURG RES, V244, P63, DOI 10.1016/j.jss.2019.06.023; Morrison ML, 2008, J TRAUMA, V65, P183, DOI 10.1097/TA.0b013e3181507579; Murphy MO, 2017, NEUROSCI BIOBEHAV R, V74, P453, DOI 10.1016/j.neubiorev.2016.07.018; Navarra P, 2000, ANN NY ACAD SCI, V917, P638; Neal MD, 2009, J TRAUMA, V67, P476, DOI 10.1097/TA.0b013e3181ad66bb; Neuwelt EA, 1998, J PHARMACOL EXP THER, V286, P77; Newell EA, 2020, J NEUROTRAUM, V37, P635, DOI 10.1089/neu.2019.6675; Nguyen ITN, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.650968; Nguyen ITN, 2020, KIDNEY INT, V98, P366, DOI 10.1016/j.kint.2020.02.020; Nussbaum BL, 2017, SHOCK, V48, P175, DOI 10.1097/SHK.0000000000000834; NuSSbaum Benedikt L, 2016, Intensive Care Med Exp, V4, P14, DOI 10.1186/s40635-016-0089-y; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; OKSMAN TM, 1981, B EXP BIOL MED+, V92, P1160, DOI 10.1007/BF00829520; Olff M, 2013, PSYCHONEUROENDOCRINO, V38, P1883, DOI 10.1016/j.psyneuen.2013.06.019; Olson KR, 2013, CLIN CHEM LAB MED, V51, P623, DOI 10.1515/cclm-2012-0551; PARIS E. I., 1966, VOENNOMED ZH, V5, P38; Patel N, 2018, J EMERG MED, V55, P408, DOI 10.1016/j.jemermed.2018.04.010; Peleli M, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113833; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; Pohl CS, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13118; Polhemus DJ, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/768607; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Radermacher P, 2021, SHOCK, V55, P138, DOI 10.1097/SHK.0000000000001602; Rault JL, 2013, PHYSIOL BEHAV, V112, P40, DOI 10.1016/j.physbeh.2013.02.007; Reiss AB, 2019, PEPTIDES, V117, DOI 10.1016/j.peptides.2019.05.001; Renieris G, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009473; Renieris G, 2020, SHOCK, V54, P633, DOI 10.1097/SHK.0000000000001562; Reus GZ, 2017, J PSYCHIATR RES, V95, P196, DOI 10.1016/j.jpsychires.2017.08.020; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Roque A, 2016, BRAIN BEHAV IMMUN, V55, P39, DOI 10.1016/j.bbi.2015.09.017; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; Sanchez CM, 2021, J NEUROTRAUM, V38, P555, DOI 10.1089/neu.2020.7267; Sannino S, 2017, DEV NEUROBIOL, V77, P158, DOI 10.1002/dneu.22450; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Satterly SA, 2015, J SURG RES, V199, P197, DOI 10.1016/j.jss.2015.04.001; Schwaiger M, 2016, NEUROPSYCHOPHARMACOL, V41, P2530, DOI 10.1038/npp.2016.57; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Sharma SR, 2020, PHARMACOL THERAPEUT, V214, DOI 10.1016/j.pharmthera.2020.107602; Shields ME, 2016, INT J CHRONIC OBSTR, V11, P2641, DOI 10.2147/COPD.S107549; Shirozu K, 2013, NITRIC OXIDE-BIOL CH, V31, pS21, DOI 10.1016/j.niox.2013.06.035; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Simon F, 2009, CRIT CARE, V13, DOI 10.1186/cc7959; Slopen N, 2012, BRAIN BEHAV IMMUN, V26, P239, DOI 10.1016/j.bbi.2011.11.003; Snijder PM, 2015, BRIT J PHARMACOL, V172, P1494, DOI 10.1111/bph.12825; Snijder PM, 2014, NITRIC OXIDE-BIOL CH, V42, P87, DOI 10.1016/j.niox.2014.10.002; Soares ALG, 2020, HEART, V106, P1310, DOI 10.1136/heartjnl-2019-316320; Stenzel T, 2016, SHOCK, V46, P398, DOI 10.1097/SHK.0000000000000599; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Stolk RF, 2020, AM J RESP CRIT CARE, V202, P830, DOI 10.1164/rccm.202002-0339OC; Stolk RF, 2016, AM J RESP CRIT CARE, V194, P550, DOI 10.1164/rccm.201604-0862CP; Sun JP, 2021, AGING-US, V13, P7180, DOI 10.18632/aging.202575; Szabo C, 2014, BRIT J PHARMACOL, V171, P2099, DOI 10.1111/bph.12369; Szabo C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000721; Szczepanska-Sadowska E, 2020, AM J PHYSIOL-HEART C, V318, pH639, DOI 10.1152/ajpheart.00484.2019; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tezcan E, 2003, EUR ARCH PSY CLIN N, V253, P89, DOI 10.1007/s00406-003-0413-x; Trautwein B, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020233; Tucker LB, 2021, J NEUROTRAUM, V38, P1585, DOI 10.1089/neu.2021.0025; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Veenema AH, 2012, HORM BEHAV, V61, P304, DOI 10.1016/j.yhbeh.2011.12.002; Ventriglio A, 2021, CURR TOP MED CHEM, V21, P1500, DOI 10.2174/1568026621666210701103147; Vincent JL, 2008, BEST PRACT RES-CLIN, V22, P243, DOI 10.1016/j.bpa.2008.03.004; Wagner F, 2011, J TRAUMA, V71, P1659, DOI 10.1097/TA.0b013e318228842e; Waller C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113783; Wang P, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00454; Wang P, 2015, J NEUROIMMUNOL, V289, P152, DOI 10.1016/j.jneuroim.2015.11.001; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wardle TD, 1999, BRIT MED BULL, V55, P744, DOI 10.1258/0007142991902754; Wepler M, 2019, SHOCK, V52, P230, DOI 10.1097/SHK.0000000000001210; Wettervik TS, 2021, J INTENSIVE CARE MED, V36, P1075, DOI 10.1177/0885066620944097; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Wigger DC, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4309605; Worth H, 2016, RESP MED, V111, P64, DOI 10.1016/j.rmed.2015.12.010; Wsol A, 2008, J PHYSIOL PHARMACOL, V59, P123; Wsol A, 2009, STRESS, V12, P517, DOI 10.3109/10253890802687688; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zingg HH, 1996, BAILLIERE CLIN ENDOC, V10, P75, DOI 10.1016/S0950-351X(96)80314-4	240	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	SEP	2021	22	17							9192	10.3390/ijms22179192			25	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Chemistry	UO0SO	WOS:000694414400001	34502097	gold, Green Published			2022-02-06	
J	Moyer, JD; Burgio, MD; Abback, PS; Gauss, T				Moyer, J. D.; Burgio, M. Dioguardi; Abback, P. S.; Gauss, T.			Isolated basilar artery dissection following blunt trauma challenging the Glasgow coma score: A case report	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Basilar artery dissection; Brain injury; Brainstem infarction; Cerebmvascular trauma		Blunt cerebrovascular injury is a very rare complication of blunt trauma and a diagnostic challenge. A 14 year old male fell 10 m sustaining multi system trauma. The atypical Glasgow Coma Score was six with a fully preserved eye component. Initial whole-body CT scanning demonstrated multiple injuries but no obvious brain injury. Trauma management involved non-operative resuscitation and was successful, however profound coma occurred and brain stem reflexes disappeared on day two. Repeat brain CT scan demonstrated multiple cerebral and cerebellar ischemic lesions and no opacification of the vertebral or basilar arteries. Secondary analysis of the first CT scan demonstrated a small focal basilar artery dissection not initially reported. Our case report highlights an unusual cause of coma after traumatic brain injury where the clinical scenario mimics locked in syndrome. In such circumstances cerebrovascular injury, and in particular traumatic basilar artery dissection, must be actively excluded. (C) 2021 Elsevier Inc. All rights reserved.	[Moyer, J. D.; Abback, P. S.; Gauss, T.] Beaujon Hosp, AP HP Nord, Dept Anesthesiol & Crit Care, DMU Parabol, Paris, France; [Burgio, M. Dioguardi] Beaujon Hosp, AP HP Nord, Dept Radiol, Paris, France; [Burgio, M. Dioguardi] INSERM, UMR S1149, Paris, France; [Burgio, M. Dioguardi] Univ Paris, Paris, France		Moyer, JD (corresponding author), Beaujon Univ Hosp, Dept Anesthesiol & Crit Care, 100 Blvd Gen Leclerc, F-92110 Clichy, France.	Jean-denis.moyer@aphp.fr	Burgio, Marco Dioguardi/AAF-2224-2020	Burgio, Marco Dioguardi/0000-0002-3243-6699			Black JA, 2021, J TRAUMA ACUTE CARE, V90, P224, DOI 10.1097/TA.0000000000003010; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Kim DY, 2020, J TRAUMA ACUTE CARE, V88, P875, DOI 10.1097/TA.0000000000002668; Yamaoka A, 2018, NEUROL MED-CHIR, V58, P362, DOI 10.2176/nmc.cr.2018-0041	5	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2021	47								347.e1				3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UB8SC	WOS:000686108000080	33745773				2022-02-06	
J	Mutore, K; Lim, J; Fofana, D; Torres-Reveron, A; Skubic, JJ				Mutore, Kevin; Lim, Jiyun; Fofana, Demba; Torres-Reveron, Annelyn; Skubic, Jeffrey J.			Hearing hoofbeats? Think head and neck trauma: a 10-year NTDB analysis of equestrian-related trauma in the USA	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						horses; accidents; brain injuries	INJURY PATTERNS; SYSTEM	Objective There is a paucity of evidence about traumatic injuries and their sequelae sustained due to equestrian injuries nationally. Methods Retrospective study analyzing National Trauma Data Bank data from 2007 to 2016. Variables collected included age, sex, race, payer status, Injury Severity Score (ISS), hospital length of stay, Glasgow Coma Scale, systolic blood pressure (SBP) at presentation, discharge disposition, and mortality. Patient data were analyzed by anatomic region. Results The most frequent type of injury was in the thorax, but head and neck injuries produced the highest mortality. Increased ISS and an SBP of less than 90 mm Hg were also significant predictors of mortality. Conclusions The risk of hospital admission from equestrian injuries is higher than football, motor vehicle racing, and skiing. Preventive measures and campaigns should be instituted to highlight safety practices and the use of personal protective equipment while on horseback either for sports, leisure, or work.	[Mutore, Kevin; Lim, Jiyun] Univ Texas Rio Grande Valley, Sch Med, Edinburg, TX 78539 USA; [Fofana, Demba] Univ Texas Rio Grande Valley, Sch Math & Stat Sci, Brownsville, TX USA; [Torres-Reveron, Annelyn] DHR Hlth Inst Res & Dev, Ctr Excellence Trauma Res Border Reg, Edinburg, TX USA; [Torres-Reveron, Annelyn] Sur180 Therapeut LLC, Mcallen, TX USA; [Skubic, Jeffrey J.] DHR Hlth, Surg Inst, Edinburg, TX 78539 USA		Skubic, JJ (corresponding author), DHR Hlth, Surg Inst, Edinburg, TX 78539 USA.	j.skubic@dhr-rgv.com					Acton AS, 2020, AM J EMERG MED, V38, P1062, DOI 10.1016/j.ajem.2019.158366; Adler CR, 2019, EMERG RADIOL, V26, P639, DOI 10.1007/s10140-019-01718-8; [Anonymous], 1992, Pediatrics, V89, P512; Associated Press, 1995, NEW YORK TIMES; Author N., 2016, EQUEST; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; BIXBYHAMMETT DM, 1987, AM FAM PHYSICIAN, V36, P209; Carmichael SP, 2014, INJURY, V45, P1479, DOI 10.1016/j.injury.2014.03.016; Chang MC., 2016, NATL TRAUMA DATA BAN; Clarke CN, 2008, AM J SURG, V195, P702, DOI 10.1016/j.amjsurg.2007.11.007; Connor TA, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0193-0; Curry BA, 2016, OCCUP MED-OXFORD, V66, P222, DOI 10.1093/occmed/kqv150; Guyton K, 2013, AM SURGEON, V79, P76; HAMILTON MG, 1993, J TRAUMA, V34, P227, DOI 10.1097/00005373-199302000-00008; Havlik HS, 2010, CURR SPORT MED REP, V9, P299, DOI 10.1249/JSR.0b013e3181f32056; Johnston JM, 2015, SPORTS ENG, V18, P11, DOI 10.1007/s12283-014-0160-4; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Macnab A J, 1996, Inj Prev, V2, P286, DOI 10.1136/ip.2.4.286; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Megia C., 2020, PAIS; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Football League, 2016, WHAT IS HEAD HLTH IN; Olivier J, 2017, TRAFFIC INJ PREV, V18, P755, DOI 10.1080/15389588.2017.1298748; Olsen Cody S, 2016, Inj Epidemiol, V3, P8; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Papachristos A, 2014, INJURY, V45, P1484, DOI 10.1016/j.injury.2014.04.017; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Srinivasan V, 2014, NEUROL RES, V36, P873, DOI 10.1179/1743132814Y.0000000373; Ueeck BA, 2004, J ORAL MAXIL SURG, V62, P693, DOI 10.1016/j.joms.2003.12.010; Workgroup N., 2020, NATL TRAUMA DATA STA; Zuckerman SL, 2019, J NEUROSURG, V130, P1634, DOI 10.3171/2018.1.JNS172733; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030	34	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	SEP	2021	6	1							e000728	10.1136/tsaco-2021-000728			5	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	UW8JN	WOS:000700399300001	34595353	Green Published, gold			2022-02-06	
J	Mutti, C; Rausa, F; Parrino, L				Mutti, Carlotta; Rausa, Francesco; Parrino, Liborio			Sleep in Neurologic Disorders	SLEEP MEDICINE CLINICS			English	Article						Neurological disorders; Epilepsy; Stroke; ALS; Sleep; Encephalitis; Neurodegeneration	CORTICAL SPREADING DEPRESSION; TRAUMATIC BRAIN-INJURY; RAPID-EYE-MOVEMENT; C-REACTIVE PROTEIN; BEHAVIOR DISORDER; STROKE; MIGRAINE; DISEASE; RISK; PATHOPHYSIOLOGY		[Mutti, Carlotta; Rausa, Francesco; Parrino, Liborio] Univ Parma, Sleep Disorders Ctr, Dept Med & Surg, Neurol Unit, Via Gramsci 14, I-43126 Parma, Italy		Parrino, L (corresponding author), Univ Parma, Sleep Disorders Ctr, Dept Med & Surg, Neurol Unit, Via Gramsci 14, I-43126 Parma, Italy.	liborio.parrino@unipr.it	mutti, carlotta/AAC-4994-2022	mutti, carlotta/0000-0002-1930-5045; Rausa, Francesco/0000-0003-2723-1370			Ahmed RM, 2016, SLEEP MED REV, V26, P33, DOI 10.1016/j.smrv.2015.05.007; Al-Khadra Y, 2018, OCHSNER J, V18, P136, DOI 10.31486/toj.17.0091; American Academy of Sleep Medicine (AASM), 2014, INT CLASS SLEEP DIS, V3rd; ANDREOTTI F, 1991, CHRONOBIOL INT, V8, P336, DOI 10.3109/07420529109059170; Aoun R, 2019, NAT SCI SLEEP, V11, P131, DOI 10.2147/NSS.S182158; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arboix A, 2015, WORLD J CLIN CASES, V3, P418, DOI 10.12998/wjcc.v3.i5.418; Asioli GM, 2020, CURR TREAT OPTION NE, V22, DOI 10.1007/s11940-020-0610-1; Aurora RN, 2010, J CLIN SLEEP MED, V6, P85; Aurora SK, 1998, NEUROLOGY, V50, P1111, DOI 10.1212/WNL.50.4.1111; Bahtz R, 2014, J NEUROIMMUNOL, V275, P8, DOI 10.1016/j.jneuroim.2014.08.027; Barbanti P, 2007, CEPHALALGIA, V27, P1115, DOI 10.1111/j.1468-2982.2007.01399.x; Bargiotas P, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz004; Barthlen GM, 2000, EUR J NEUROL, V7, P299, DOI 10.1046/j.1468-1331.2000.00044.x; Bassetti CLA, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01104-2019; Baylan S, 2020, SLEEP MED REV, V49, DOI 10.1016/j.smrv.2019.101222; Bergmann M, 2020, SLEEP MED, V75, P434, DOI 10.1016/j.sleep.2020.09.001; Bisulli F, 2010, EPILEPSIA, V51, P1852, DOI 10.1111/j.1528-1167.2010.02581.x; Boardman HF, 2005, HEADACHE, V45, P657, DOI 10.1111/j.1526-4610.2005.05133.x; Boentert M, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01047-1; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Borda MG, 2021, INT J GERIATR PSYCH, V36, P917, DOI 10.1002/gps.5494; Boulos MI, 2019, SLEEP MED, V56, P177, DOI 10.1016/j.sleep.2018.12.021; Boulos MI, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw080; Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Brown DL, 2020, SLEEP MED, V75, P1, DOI 10.1016/j.sleep.2020.05.004; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castro-Anon O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117808; Cilliler AE, 2020, EPILEPSY BEHAV, V102; Congiu P, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz164; Coppola G, 2007, Cephalalgia, V27, P1427, DOI 10.1111/j.1468-2982.2007.01500.x; Crescimanno G, 2021, AMYOTROPH LAT SCL FR, V22, P46, DOI 10.1080/21678421.2020.1813309; Cykowski MD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0171-1; De Cock VC, 2007, BRAIN, V130, P450, DOI 10.1093/brain/awl363; De Paolis F, 2012, SLEEP MED, V13, P763, DOI 10.1016/j.sleep.2012.01.012; Dharia Sushma M, 2017, Curr Heart Fail Rep, V14, P351, DOI 10.1007/s11897-017-0348-6; Dodick DW, 2003, HEADACHE, V43, P282, DOI 10.1046/j.1526-4610.2003.03055.x; Duss Simone B., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P94, DOI 10.1016/j.nbscr.2016.11.003; Elfil M, 2021, MOVEMENT DISORD, V36, P570, DOI 10.1002/mds.28412; Evangelisti S, 2018, NEUROIMAGE-CLIN, V17, P873, DOI 10.1016/j.nicl.2017.12.002; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Ferguson KA, 1996, CHEST, V110, P664, DOI 10.1378/chest.110.3.664; Ferini-Strambi L, 2021, J ALZHEIMERS DIS, V80, P29, DOI 10.3233/JAD-201066; Ferini-Strambi L, 2020, CURR TREAT OPTION NE, V22, DOI 10.1007/s11940-020-0612-z; Fink JN, 2002, STROKE, V33, P988, DOI 10.1161/01.STR.0000014585.17714.67; Fulk G, 2020, CLIN REHABIL, V34, P1400, DOI 10.1177/0269215520935940; Gaig C, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz133; Gehrman P, 2018, GERIATR NURS, V39, P60, DOI 10.1016/j.gerinurse.2017.06.003; Gelpi E, 2016, ACTA NEUROPATHOL, V132, P531, DOI 10.1007/s00401-016-1591-8; Grimaldi D, 2020, SLEEP, V9; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Halasz P, 2002, NEUROPHYSIOL CLIN, V32, P38, DOI 10.1016/S0987-7053(01)00290-8; Halasz P, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00911; Holland PR, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0844-4; Hope T, 1998, INT J GERIATR PSYCH, V13, P682, DOI 10.1002/(SICI)1099-1166(1998100)13:10<682::AID-GPS847>3.0.CO;2-Y; Hughes JR, 2011, EPILEPSY BEHAV, V20, P247, DOI 10.1016/j.yebeh.2010.10.015; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iranzo A, 2020, NEUROPSYCHOPHARMACOL, V45, P129, DOI 10.1038/s41386-019-0463-z; Javaheri S, 2018, SLEEP, V41, pZSX179; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Joo HR, 2018, NAT REV NEUROSCI, V19, P744, DOI 10.1038/s41583-018-0077-1; Kalmbach DA, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12710; Katzan IL, 2016, SLEEP MED, V21, P70, DOI 10.1016/j.sleep.2016.02.001; Kelman L, 2005, HEADACHE, V45, P904, DOI 10.1111/j.1526-4610.2005.05159.x; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Liguori C, 2019, SLEEP MED, V56, P171, DOI 10.1016/j.sleep.2019.01.003; Lin YK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003554; Lo Coco D, 2010, MOVEMENT DISORD, V25, P2658, DOI 10.1002/mds.23261; Lopez-Cano C, 2019, PLOS ONE, V14; Lowe A, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1856948; Lucia D, 2020, AMYOTROPH LATERAL SC, V16, P1; Malekshahi A, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz185; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; Mantovani S, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12673; Melpignano A, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz142; Modarres M, 2016, NEUROBIOL SLEEP CIRC, V1; Moon HI, 2018, NEUROREHABILITATION, V43, P211, DOI 10.3233/NRE-172351; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morris CJ, 2017, J BIOL RHYTHM, V32, P154, DOI 10.1177/0748730417697537; Munoz-Lopetegi A, 2020, LANCET NEUROL, V19, P1010, DOI 10.1016/S1474-4422(20)30341-0; Murali NS, 2003, FRONT BIOSCI-LANDMRK, V8, pS636, DOI 10.2741/1105; Mutti C, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.600026; Nobili L, 2007, BRAIN, V130, P561, DOI 10.1093/brain/awl322; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Parrino L, 2006, SLEEP MED REV, V10, P267, DOI 10.1016/j.smrv.2005.12.004; Parrino L, 2018, SLEEP MED REV, V39, P98, DOI 10.1016/j.smrv.2017.08.003; Parrino L, 2012, EPILEPSIA, V53, P1178, DOI 10.1111/j.1528-1167.2012.03502.x; Peng WF, 2021, CURR NEUROPHARMACOL, V19, P1264, DOI 10.2174/1570159X19666201230142716; Pham CK, STATPEARLS; Phipps H, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.559318; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Plazzi G, 1997, NEUROLOGY, V48, P1094, DOI 10.1212/WNL.48.4.1094; Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316; Poryazova R, 2015, J SLEEP RES, V24, P54, DOI 10.1111/jsr.12208; Puligheddu M, 2017, EPILEPSIA, V58, P1762, DOI 10.1111/epi.13863; Puligheddu M, 2016, SLEEP MED, V26, P16, DOI 10.1016/j.sleep.2016.05.016; Rains JC, 2018, HEADACHE, V58, P1074, DOI 10.1111/head.13357; Ramanan VK, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000485; Rao VR, 2021, EPILEPSIA, V62, pS15, DOI 10.1111/epi.16611; Richards KC, 2020, J AM MED DIR ASSOC, pS1525; Roccella M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00932; Sabater L, 2014, LANCET NEUROL, V13, P575, DOI 10.1016/S1474-4422(14)70051-1; Samanta D, 2020, STATPEARLS, P2; Fernandez IS, 2012, NEUROLOGY, V78, P1721, DOI 10.1212/WNL.0b013e3182582ff8; Santos C, 2003, Monaldi Arch Chest Dis, V59, P160; Schain AJ, 2017, J NEUROSCI, V37, P2904, DOI 10.1523/JNEUROSCI.3390-16.2017; Scheer FAJL, 2014, BLOOD, V123, P590, DOI 10.1182/blood-2013-07-517060; Schomer D. L., 2011, NIEDERMEYERS ELECTRO; Schutz SG, 2019, SLEEP MED, V60, P178, DOI 10.1016/j.sleep.2019.04.004; Shiota S, 2013, J ALZHEIMERS DIS, V37, P325, DOI 10.3233/JAD-130419; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soekadar SR, 2013, J CLIN SLEEP MED, V9, P951, DOI 10.5664/jcsm.3002; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; St Louis EK, 2017, MAYO CLIN PROC, V92, P1723, DOI 10.1016/j.mayocp.2017.09.007; Staats R, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00104; Steriade M, 1998, Sleep Res Online, V1, P1; Strong MJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.598907; Sun X, 2020, J NEUROL NEUROSUR PS, DOI DOI 10.1136/jnnp-2020-324544; Sun Y, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.578171; Supornsilpchai W, 2006, HEADACHE, V46, P34, DOI 10.1111/j.1526-4610.2006.00310.x; Tassinari CA, 2006, EPILEPSIA, V47, P40, DOI 10.1111/j.1528-1167.2006.00686.x; Teive HAG, 2005, NEUROLOGY, V65, P1455, DOI 10.1212/01.wnl.0000183281.12779.cd; TERZANO MG, 1992, EPILEPSIA, V33, P317, DOI 10.1111/j.1528-1157.1992.tb02322.x; Terzoudi A, 2009, EUR NEUROL, V61, P16, DOI 10.1159/000165344; Tokunaga K, 2020, CEREBROVASC DIS, V49, P619, DOI 10.1159/000511393; Trotti LM, 2012, BRAIN BEHAV IMMUN, V26, P1239, DOI 10.1016/j.bbi.2012.06.003; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Voysey ZJ, 2021, NEUROTHERAPEUTICS, V18, P202, DOI 10.1007/s13311-020-00959-7; Vrijsen B, 2015, J CLIN SLEEP MED, V11, P556, DOI 10.5664/jcsm.4704; Wang J, 2013, EUR J NEUROL, V20, P689, DOI 10.1111/ene.12039; Wang YQ, 2018, CURR NEUROPHARMACOL, V16, P5, DOI 10.2174/1570159X15666170509101237; Weiss SA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00174; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zuzuarregui JRP, 2020, NEUROTHERAPEUTICS, V17, P1480, DOI 10.1007/s13311-020-00938-y	138	0	0	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1556-407X	1556-4088		SLEEP MED CLIN	Sleep Med. Clin.	SEP	2021	16	3			SI		499	512		10.1016/j.jsmc.2021.05.002			14	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TQ7UC	WOS:000678484500008	34325826				2022-02-06	
J	Ng, M; Ali, S; Sue, J; Cullen, N; McCullagh, S; Perera, G; Hosseini, H; Muniz-Rodriguez, F; Deng, ZH				Ng, Maxwell; Ali, Sheliza; Sue, Joanna; Cullen, Nora; McCullagh, Scott; Perera, Gihan; Hosseini, Hossein; Muniz-Rodriguez, Flor; Deng, Zhihui			Beneficial cognitive effect of lamotrigine in severe acquired brain injury: A case report	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Acquired brain injury; Lamotrigine; Cognitive impairment; Rehabilitation; Functional outcome	BIPOLAR DISORDER; THERAPY; EPILEPSY; WORKING; MEMORY	Background: Acquired brain injuries (ABI) can cause various negative sequelae, including cognitive impairment, leading to poor functional outcomes for patients. Evidence is limited on pharmacological interventions to effectively improve the cognitive status of these patients. This study aims to provide evidence for the use of lamotrigine to improve the cognitive status of patients with severe ABI. Case presentation: We report the case of a 29-year-old man who suffered a severe traumatic brain injury secondary to a motor vehicle collision. When admitted to our rehabilitation program three months later, he was in a minimally conscious state, achieving Level III on the Rancho Los Amigos Cognitive Scale. Post-traumatic seizures were well controlled with levetiracetam. Multiple neurostimulants including methylphenidate, amantadine, and venlafaxine were trialed with minimal benefit, thereby prompting the switch of his antiepileptic medication to lamotrigine five months after his injury. The introduction of lamotrigine was followed by relatively rapid and significant improvement in arousal, cognition and communication that preceded levetiracetam being tapered. The patient continued making functional gains over the following year while using lamotrigine. Conclusions: Lamotrigine may potentially provide cognition-enhancing effects independent of its known antiepileptic properties in patients with severe ABI. Further research is required on the role of lamotrigine in patients with ABI.	[Ng, Maxwell] McMaster Univ, Dept Med, Neurol Residency Program, Hamilton, ON, Canada; [Ali, Sheliza; Sue, Joanna; Cullen, Nora; McCullagh, Scott; Perera, Gihan; Hosseini, Hossein; Muniz-Rodriguez, Flor; Deng, Zhihui] Hamilton Hlth Sci, Reg Rehabil Ctr, Hamilton, ON, Canada; [Ali, Sheliza] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Sue, Joanna; McCullagh, Scott] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Cullen, Nora; McCullagh, Scott; Perera, Gihan; Hosseini, Hossein; Muniz-Rodriguez, Flor; Deng, Zhihui] McMaster Univ, Dept Med, Div Phys Med & Rehabil, Hamilton, ON, Canada		Deng, ZH (corresponding author), McMaster Univ, Dept Med, Div Phys Med & Rehabil, Hamilton, ON, Canada.	dengz22@mcmaster.ca					Eddy Clare M, 2011, Ther Adv Neurol Disord, V4, P385, DOI 10.1177/1756285611417920; Faltynek P., 2019, EVIDENCE BASED REV M, V12th, P1; Gutierrez RL, 2005, CNS SPECTRUMS, V10, P800, DOI 10.1017/S1092852900010324; Haldane M, 2008, EUR NEUROPSYCHOPHARM, V18, P48, DOI 10.1016/j.euroneuro.2007.05.009; Han HH, 2015, NEUROREPORT, V26, P723, DOI 10.1097/WNR.0000000000000424; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kaye NS, 2007, J CLIN PSYCHOPHARM, V27, P387, DOI 10.1097/JCP.0b013e3180a76dd2; Liang L, 2015, ALZ DIS ASSOC DIS, V29, P1, DOI 10.1097/WAD.0000000000000076; Marciani MG, 1998, CLIN NEUROPHARMACOL, V21, P41; Meador KJ, 2001, NEUROLOGY, V56, P1177, DOI 10.1212/WNL.56.9.1177; Omura J, 2018, PM&R, V10, P317, DOI 10.1016/j.pmrj.2017.07.080; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Pavuluri MN, 2010, BIPOLAR DISORD, V12, P213, DOI 10.1111/j.1399-5618.2010.00792.x; Ramaratnam S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001909.pub2; Riley DS, 2017, J CLIN EPIDEMIOL, V89, P218, DOI 10.1016/j.jclinepi.2017.04.026; Sajatovic M, 2007, INT J GERIATR PSYCH, V22, P945, DOI 10.1002/gps.1784; Showalter PEC, 2000, BRAIN INJURY, V14, P997; U.S. Food & Drug Administration, 2019, TRAUMATIC BRAIN INJU	18	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2021	25								101186	10.1016/j.inat.2021.101186			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TS1BH	WOS:000679391300004		gold, Green Published			2022-02-06	
J	O'Brien, H; Minich, NM; Langevin, LM; Taylor, HG; Bigler, ED; Cohen, DM; Beauchamp, MH; Craig, WR; Doan, Q; Zemek, R; Bacevice, A; Mihalov, LK; Yeates, KO				O'Brien, Heidi; Minich, Nori M.; Langevin, Lisa Marie; Taylor, H. Gerry; Bigler, Erin D.; Cohen, Daniel M.; Beauchamp, Miriam H.; Craig, William R.; Doan, Quynh; Zemek, Roger; Bacevice, Ann; Mihalov, Leslie K.; Yeates, Keith Owen			Normative and Psychometric Characteristics of the Health and Behavior Inventory Among Children With Mild Orthopedic Injury Presenting to the Emergency Department: Implications for Assessing Postconcussive Symptoms Using the Child Sport Concussion Assessment Tool 5th Edition (Child SCAT5)	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; symptoms; children; adolescents; norms	TRAUMATIC BRAIN-INJURY; RELIABILITY; APPROPRIATE; PARENTS	Objective: The study sought to present normative and psychometric data and reliable change formulas for the Health and Behavior Inventory (HBI), a postconcussive symptom rating scale embedded in the Child Sport Concussion Assessment Tool 5th edition (Child SCAT5). Design: Prospective cohort study with longitudinal follow-up. Setting: Pediatric emergency departments (EDs). Participants: As part of 3 studies conducted in the United States and Canada between 2001 and 2019, 450 children aged 8 to 16 years with mild orthopedic injuries were recruited during ED visits and assessed postacutely (M = 9.38 days, SD = 3.31) and 1 month and 3 months postinjury. Independent variables were rater (child vs parent), sex, and age at injury. Main Outcome Measure: HBI ratings. Methods: Children and parents rated children's symptoms at each time point; parents also rated children's preinjury symptoms retrospectively. Normative data (mean, SD, skewness, kurtosis, and percentiles) were computed for child and parent ratings. Internal consistency was assessed using Cronbach alpha (alpha), and test-retest reliability and interrater agreement were assessed with intraclass correlations (ICCs). Reliable change formulas were computed using linear regression and mixed models. Results: HBI ratings were positively skewed. Mean ratings and percentiles were stable over time. Child and parent ratings demonstrated good-to-excellent internal consistency (alpha 0.76-0.94) and moderate-to-good test-retest reliability (ICC 0.51-0.76 between adjacent assessments). However, parent-child agreement was poor to moderate (ICC 0.31-0.69). Conclusions: The HBI demonstrates acceptable normative and psychometric characteristics. Modest parent-child agreement highlights the importance of multiple informants when assessing postconcussive symptoms. The results will facilitate the use of the HBI in research and clinical practice.	[O'Brien, Heidi] Univ Calgary, Werklund Sch Educ, Calgary, AB, Canada; [Minich, Nori M.; Bacevice, Ann] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Langevin, Lisa Marie] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry; Cohen, Daniel M.; Mihalov, Leslie K.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Craig, William R.] Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Doan, Quynh] Univ British Columbia, BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol AD 255, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca			Pediatric Emergency Research Canada (PERC) network	The authors thank all the children and parents who participated in the studies and the research staff for their assistance in performing the studies. The Canadian study was performed under the auspices of the Pediatric Emergency Research Canada (PERC) network.<SUP>18</SUP>	American Association for Automotive Medicine, 1990, ABBREVIATED INJURY S; Anderson V, 2020, J NEUROTRAUM, V37, P1392, DOI 10.1089/neu.2019.6683; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Bialy L, 2018, PEDIATR EMERG CARE, V34, P138, DOI 10.1097/PEC.0000000000001360; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; EDELBROCK C, 1985, CHILD DEV, V56, P265, DOI 10.1111/j.1467-8624.1985.tb00104.x; Evans E, 2020, J NEUROTRAUM, V37, P1627, DOI 10.1089/neu.2019.6893; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McKinlay A, 2018, J CLIN EXP NEUROPSYC, V40, P285, DOI 10.1080/13803395.2017.1342771; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Patsimas T, 2020, J ATHL TRAINING, V55, P1020, DOI 10.4085/1062-6050-200-19; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; VERHULST FC, 1988, ACTA PSYCHIAT SCAND, V77, P1, DOI 10.1111/j.1600-0447.1988.tb10567.x; Ware AL, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102106; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	30	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					E221	E228		10.1097/JSM.0000000000000943			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400002	33973883				2022-02-06	
J	Obayashi, Y; Uehara, S; Kokuwa, R; Otaka, Y				Obayashi, Yota; Uehara, Shintaro; Kokuwa, Ryu; Otaka, Yohei			Quantitative Evaluation of Facial Expression in a Patient With Minimally Conscious State After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disorders of consciousness; emotion; facial expression; minimally conscious state; traumatic brain injury	VEGETATIVE STATE; RECOVERY; EMOTIONS; SCALE	Objective: To investigate whether automatic facial expression analysis can quantify differences in the intensity of facial responses depending on the affective stimuli in a patient with minimally conscious state (MCS). Methods: We filmed the facial responses of a patient with MCS during the delivery of three 1-minute auditory stimuli: audio clips of comedy movies, a nurse hilariously talking, and recitation of a novel (comedy, nurse, and recitation conditions, respectively). These measures were repeated at least 13 times for each condition on different days for approximately 10 months. The intensity of being "happy" was estimated from the smiling face using a software called FaceReader. The intensity among 5 conditions including those at 2 resting conditions (pre- and poststimuli) was compared using the Kruskal-Wallis test and the Dunn-Bonferroni test for multiple comparisons. Results: Significantly higher values were found in the intensity of being "happy" in the comedy and nurse conditions versus other conditions, with no significant differences between the recitation and pre- or poststimulus conditions. These findings indicate that the automated facial expression analysis can quantify differences in context-dependent facial responses in the patient recruited in this study. Conclusions: This case study demonstrates the feasibility of using automated facial expression analysis to quantitatively evaluate the differences in facial expressions and their corresponding emotions in a single patient with MCS.	[Obayashi, Yota; Kokuwa, Ryu] Fujita Hlth Univ Hosp, Dept Rehabil, Toyoake, Aichi, Japan; [Uehara, Shintaro] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan; [Otaka, Yohei] Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan		Otaka, Y (corresponding author), Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	obayashi@fujita-hu.ac.jp; shintaro.uehara@gmail.com; r-kokuwa@fujita-hu.ac.jp; otaka119@mac.com			National Agency for Automotive Safety and Victims' Aid (NASVA)	This study was partially supported by the National Agency for Automotive Safety and Victims' Aid (NASVA). The authors thank the medical staff of the Care Center for Consciousness Recovery in Fujita Health University Hospital for their help in data collection. The authors also thank Ms Yumika Kitai andMs ChikaMaeda for their help with subjective assessments of facial expressions.	Abe H., 2017, INT J NEUROL NEUROTH, V4, P064; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Cohn J. F., 2007, HDB EMOTION ELICITAT, P203, DOI DOI 10.1007/978-3-540-72348-6_1; Day KV, 2018, NEUROPSYCHOL REHABIL, V28, P1233, DOI 10.1080/09602011.2017.1309322; Ekman, 2005, NEW HDB METHODS NONV, P9; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman P, 1978, MANUAL FACIAL ACTION; Ekman P, 2011, EMOT REV, V3, P364, DOI 10.1177/1754073911410740; Ekman Paul, 1970, CALIFORNIA MENTAL HL, V8, P151; Fujiwara S, 1997, No To Shinkei, V49, P1139; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Laureys S, 2007, SCI AM, V296, P84, DOI 10.1038/scientificamerican0507-84; Lewinski P, 2014, J NEUROSCI PSYCHOL E, V7, P227, DOI 10.1037/npe0000028; Nelson NL, 2013, EMOT REV, V5, P8, DOI 10.1177/1754073912457227; Sayette MA, 2001, J NONVERBAL BEHAV, V25, P167, DOI 10.1023/A:1010671109788; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Skiendziel T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223905	23	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E337	E344		10.1097/HTR.0000000000000666			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300009	33741824				2022-02-06	
J	Octaviana, F; Harisman, J; Wiratman, W; Budikayanti, A				Octaviana, Fitri; Harisman, Jeffri; Wiratman, Winnugroho; Budikayanti, Astri			Altered mental status in moderate-severe traumatic brain injury in Indonesia: the clinical manifestation and EEG features of non-convulsive status epilepticus	HELIYON			English	Article						Altered mental status; Moderate-severe TBI; mSCNC; Non-convulsive status epilepticus	SEIZURES; CRITERIA	Introduction: Moderate-to-severe traumatic brain injury (msTBI) can cause non-convulsive status epilepticus (NCSE). Electroencephalography (EEG) is employed as a diagnostic tool due to the non-specificity of clinical symptoms. This study aimed to identify clinical and EEG features related to NCSE in patients with msTBI. Methods: This was a cross-sectional study. Suspected NCSE in msTBI was examined using EEG data collected in consecutive patients from January 2017 to December 2019 at Dr. Cipto Mangunkusumo Hospital, Jakarta. Diagnoses of NCSE were made based on clinical manifestations and EEG features using the modified Salzburg Consensus Criteria for NCSE (mSCNC). Results: Of the 39 msTBI patients, 19 were diagnosed with NCSE; only two fulfilled the definitive criteria, and the remaining were possible NCSE. Delirium and perceptual impairment were only found in NCSE, while psychomotor agitation was higher (12.8% vs. 5.1% in NCSE vs. non-NCSE). The most common EEG feature was rhythmic activity (>0.5 Hz) without fluctuation, which improved with anti-epileptic drug administration. The Glasgow Coma Scale (GCS) score at onset and at hospitalisation discharge was significantly lower in patients with NCSE. The lesions in NCSE mostly originated from the temporal lobe. Injury to the temporal lobe had a significant relationship with NCSE occurrence (p = 0.036, odds ratio 11.45 [95% confidence interval 1.17-111.6]). Discussion: Post-traumatic NCSE can manifest as an alteration in mental status that could lead to missed diagnosis. In this study, delirium, perceptual impairment, and psychomotor agitation were confirmed as NCSE using EEG. The most common discharge originated from the injured temporal lobe, and this site was a significant factor associated with NCSE in patients with msTBI. Conclusion: NCSE can be found in msTBI cases with clinical manifestations of altered mental status, psychomotor agitation, and hallucination. An injured temporal lobe was a susceptible site for the development of NCSE.	[Octaviana, Fitri; Harisman, Jeffri; Wiratman, Winnugroho; Budikayanti, Astri] Univ Indonesia, Fac Med, Neurol Dept, Depok, Indonesia; [Octaviana, Fitri; Wiratman, Winnugroho; Budikayanti, Astri] Dr Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia		Octaviana, F (corresponding author), Univ Indonesia, Fac Med, Neurol Dept, Depok, Indonesia.; Octaviana, F (corresponding author), Dr Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia.	fitri.octaviana@ui.ac.id	Octaviana, Fitri/AAV-7724-2021	Octaviana, Fitri/0000-0002-9704-7141; Wiratman, Winnugroho/0000-0003-0880-2895			Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Englot DJ, 2010, BRAIN, V133, P3764, DOI 10.1093/brain/awq316; Faried A, 2017, WORLD NEUROSURG, V100, P195, DOI 10.1016/j.wneu.2016.12.133; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Kaplan PW, 2007, EPILEPSIA, V48, P39, DOI 10.1111/j.1528-1167.2007.01345.x; Leitinger M, 2016, LANCET NEUROL, V15, P1054, DOI 10.1016/S1474-4422(16)30137-5; Marcellino CR, 2018, EPILEPTIC DISORD, V20, P551, DOI 10.1684/epd.2018.1015; Sutter R, 2016, NAT REV NEUROL, V12, P281, DOI 10.1038/nrneurol.2016.45; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Zimmermann LL, 2016, NEUROSURG CLIN N AM, V27, P499, DOI 10.1016/j.nec.2016.06.001	13	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	SEP	2021	7	9							e08067	10.1016/j.heliyon.2021.e08067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WD5NG	WOS:000704986500022	34622071	gold, Green Published			2022-02-06	
J	Oh, SK; Park, HJ; Yu, GG; Jeong, SH; Lee, SW; Kim, H				Oh, Se-Kwang; Park, Hyun-Jeong; Yu, Gyeong-Gyu; Jeong, Seong-Hae; Lee, Suk-Woo; Kim, Hoon			Secondary hypoxic ischemia alters neurobehavioral outcomes, neuroinflammation, and oxidative stress in mice exposed to controlled cortical impact	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Traumatic brain injuries; Hypoxia; Inflammation; Behavior; Oxidative stress	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; ANIMAL-MODELS; MEMORY; DAMAGE; PATHOPHYSIOLOGY; HYPOTHERMIA; EXPRESSION; PROGNOSIS; C57BL/6J	Objective Hypoxic ischemia (HI) is a secondary insult that can cause fatal neurologic outcomes after traumatic brain injury (TBI), ranging from mild cognitive deficits to persistent vegetative states. We here aimed to unravel the underlying pathological mechanisms of HI injury in a TBI mouse model. Methods Neurobehavior, neuroinflammation, and oxidative stress were assessed in a mouse model of controlled cortical impact (CCI) injury followed by HI. Mice underwent CCI alone, CCI followed by HI, HI alone, or sham operation. HI was induced by one-vessel carotid ligation with 1 hour of 8% oxygen in nitrogen. Learning and memory were assessed using the novel object recognition test, contextual and cued fear conditioning, and Barnes maze test. Brain cytokine production and oxidative stress-related components were measured. Results Compared to TBI-only animals, TBI followed by HI mice exhibited significantly poorer survival and health scores, spatial learning and memory in the Barnes maze test, discrimination memory in the novel object recognition test, and fear memory following contextual and cued fear conditioning. Malondialdehyde levels were significantly lower, whereas glutathione peroxidase activity was significantly higher in TBI followed by HI mice compared to TBI-only and sham counterparts, respectively. Interleukin-6 levels were significantly higher in TBI followed by HI mice compared to both TBI-only and sham animals. Conclusion Post-traumatic HI aggravated deficits in spatial, fear, and discrimination memory in an experimental TBI mouse model. Our results suggest that increased neuroinflammation and oxidative stress contribute to HI-induced neurobehavioral impairments after TBI.	[Oh, Se-Kwang] Chungnam Natl Univ, Dept Emergency Med, Coll Med, Daejeon, South Korea; [Park, Hyun-Jeong; Yu, Gyeong-Gyu; Lee, Suk-Woo; Kim, Hoon] Chungbuk Natl Univ, Dept Emergency Med, Coll Med, Cheongju 28644, South Korea; [Jeong, Seong-Hae] Chungnam Natl Univ, Dept Neurol, Coll Med, Daejeon, South Korea; [Kim, Hoon] Chungbuk Natl Univ Hosp, Dept Emergency Med, Cheongju, South Korea		Kim, H (corresponding author), Chungbuk Natl Univ, Dept Emergency Med, Coll Med, Cheongju 28644, South Korea.	nichekh2000@chungbuk.ac.kr			Basic Science Research Pro-gram through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2015R1A 2A2A01002303, NRF-2016R1D1A1B04930247]	This research was supported by the Basic Science Research Pro-gram through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2015R1A 2A2A01002303 and NRF-2016R1D1A1B04930247) .	Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Ashman TA, 2006, MT SINAI J MED, V73, P999; Balogh SA, 2002, BEHAV NEUROSCI, V116, P947, DOI 10.1037//0735-7044.116.6.947; Barnes SA, 2015, MOL PSYCHIATR, V20, P1161, DOI 10.1038/mp.2015.113; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Monsalve BC, 2014, NEUROREHABILITATION, V35, P67, DOI 10.3233/NRE-141103; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dawn-Linsley M, 2005, J NEUROSCI METH, V141, P219, DOI 10.1016/j.jneumeth.2004.06.010; Fugate JE, 2013, NEUROLOGY, V81, P40, DOI 10.1212/WNL.0b013e318297ee7e; Gilbert RW, 2003, J CEREBR BLOOD F MET, V23, P1195, DOI 10.1097/01.WCB.0000088763.02615.79; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Lee SW, 2019, CLIN EXP EMERG MED, V6, P125, DOI 10.15441/ceem.18.019; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Popescu C, 2015, J Med Life, V8, P272; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Schaaf KPW, 2013, RESUSCITATION, V84, P873, DOI 10.1016/j.resuscitation.2012.11.021; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Shoji H, 2014, JOVE-J VIS EXP, DOI 10.3791/50871; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Thelin EP, 2016, METHODS MOL BIOL, V1462, P459, DOI 10.1007/978-1-4939-3816-2_26; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Widdel L, 2010, J TRAUMA, V69, P783, DOI 10.1097/TA.0b013e3181b9a071; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zhu XZ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11870-x	43	0	0	0	0	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	SEP	2021	8	3					216	228		10.15441/ceem.20.124			13	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	WQ2QU	WOS:000713665700008	34649410	Green Published, gold			2022-02-06	
J	Okoye, OG; Olaomi, OO; Osi-Ogbu, O; Gwaram, UA				Okoye, Onyedika Godfrey; Olaomi, Oluwole Olayemi; Osi-Ogbu, Ogugua; Gwaram, Usman Adamu			Pattern of trauma in elderly patients seen at the trauma centre of national hospital Abuja, Nigeria	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Trauma; Elderly; Injury severity Score; Injuries; Trauma centre	GERIATRIC TRAUMA; MAJOR TRAUMA; OLDER-ADULTS; MORTALITY; INJURY; EPIDEMIOLOGY; BURDEN	Introduction: The global population is aging, creating challenges for health systems. The mean age of patients with major trauma has increased over time, posing some challenges for trauma system designs. Elderly trauma patients are said to have higher mortality rates and longer hospital and intensive care unit stays. This study is aimed at assessing the pattern of injuries in elderly population in a dedicated trauma centre of a developing economy. Methods: This is a retrospective study of all patients aged 60 years and above seen in the trauma centre of a West African tertiary hospital over a three year period from January 2017 to December 2019. Relevant parameters including Sociodemographic data, injury pattern and injury scores were derived from the trauma registry. Data analysis was done using statistical package for social sciences (SPSS) version 24. Results were presented using tables and a figure. Results: A total of 183 patients aged 60 years and above were enrolled out of 4549 general trauma patients, representing 4% of the trauma patient population seen. Male to female ratio was 2.3 with the mean age of 65 +/- 6.3. The most frequent mechanisms of injury were motor vehicular crash (MVC) (48.4%), followed by falls (16.5%). More proportion of females (21.8%) were significantly found to suffer falls compared to their males (14.2%) counterparts (p < 0.05). Traumatic brain injury was the commonest diagnosis accounting for 24.3% of cases. The predominant revised trauma scores (RTS) and injury severity scores (ISS) were 12 and 1-15 respectively, with overall mortality of 6.1%. Conclusion: The proportion of elderly trauma patients studied in this centre is low. MVC is still the leading mechanism of injury in our elderly trauma population. The mortality rate is however low in this study, in line with the low trauma and severity scores. Preventive measures for MVC should be strongly encouraged to reduce the incidence of elderly trauma patients in this part of the world.	[Okoye, Onyedika Godfrey; Olaomi, Oluwole Olayemi; Gwaram, Usman Adamu] Natl Hosp Abuja, Dept Surg, Abuja, Nigeria; [Osi-Ogbu, Ogugua] Natl Hosp Abuja, Dept Internal Med, Geriatr Unit, Abuja, Nigeria		Okoye, OG (corresponding author), Natl Hosp Abuja, Dept Surg, Abuja, Nigeria.	dronyedika@yahoo.com					Adams SD, 2015, CURR OPIN CRIT CARE, V21, P520, DOI 10.1097/MCC.0000000000000246; Aitken LM, 2010, J AM GERIATR SOC, V58, P442, DOI 10.1111/j.1532-5415.2010.02728.x; American College of Surgeons Committee on Trauma, 2018, ADV TRAUM LIF SUPP A; [Anonymous], 2019, TOT POP NIG GEND; Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banks SE., 2013, ANAESTHESIOL CLIN, V32, P127; Bartels SJ, 2013, NEW ENGL J MED, V368, P493, DOI 10.1056/NEJMp1211456; Beck B, 2018, BJS OPEN, V2, P310, DOI 10.1002/bjs5.80; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; da Silva HC, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.0959.2690; Eschbach D, 2016, CLIN INTERV AGING, V11, P1239, DOI 10.2147/CIA.S109281; Evans D, 2015, CURR OPIN CRIT CARE, V21, P520; Fisher JM, 2017, AGE AGEING, V46, P709, DOI 10.1093/ageing/afx035; Gioffre-Florio M, 2018, G CHIR, V39, P35, DOI 10.11138/gchir/2018.39.1.035; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; Kabir R, 2013, EUR SCI J, V9, P1; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Kirshenbom Dvora, 2017, J Emerg Trauma Shock, V10, P146, DOI [10.4103/jets.jets_62_16, 10.4103/JETS.JETS_62_16]; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, P1197, DOI [10.1097/TA.0000000000000656, 10.1097/TA.0000000000000652]; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Llompart-Pou Juan Antonio, 2017, World J Crit Care Med, V6, P99, DOI 10.5492/wjccm.v6.i2.99; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Medici AC, 2011, DIR DEV, P135; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Nanak Kakwani, 2005, AGEING POVERTY AFRIC; National Bureau of Statistics, 2018, DEM STAT B; Neloska Lenche, 2016, Open Access Maced J Med Sci, V4, P423, DOI 10.3889/oamjms.2016.094; Niven DJ, 2012, AM J SURG, V204, P151, DOI 10.1016/j.amjsurg.2012.02.014; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; OSLER T, 1988, AM J SURG, V156, P537, DOI 10.1016/S0002-9610(88)80548-8; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Rau CS, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0063-1; Saidi H, 2013, SURG SCI, V04, P292; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schoeneberg C, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0045-3; Shankar KN, 2017, WEST J EMERG MED, V18, P785, DOI 10.5811/westjem.2017.5.33615; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; World urbanization prospects, 2020, UN POP EST PROJ MAJ	43	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.	SEP	2021	11	3					347	351		10.1016/j.afjem.2021.06.001			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UF0SW	WOS:000688293700004	34367894	gold, Green Published			2022-02-06	
J	Oley, MH; Oley, MC; Prasetyo, E; Suwito, A; Faruk, M				Oley, Mendy Hatibie; Oley, Maximillian Christian; Prasetyo, Eko; Suwito, Andreas; Faruk, Muhammad			Expanding pneumocephalus due to craniofacial fractures: A case report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Pneumocephalus; Craniofacial fractures; Pericranial rotational flap; Mount Fuji sign; Case report		Introduction: Pneumocephalus (PNC) is the presence of air in the intracranial cavity. The most frequent cause is craniofacial trauma, though there are many etiologies, including surgical procedures. PNC with compression of the frontal lobes and widening of the interhemispheric space between the tips of the frontal lobes results in the characteristic radiological finding of the "Mount Fuji sign". Presentation of case: A 57-year-old man presented to the A&E with loss of consciousness due to a motorcycle collision 9 h prior. He had a GCS of E4M6V5, and a head CT scan revealed minimal PNC forming in both hemispheres. After discharge, severe headaches and rhinorrhea developed. A second CT scan revealed a massive PNC. An operation was then performed via a bicoronal incision to drain the PNC and seal the cranial defect. A burr hole in the calvarium was created, and the cranial defect was closed using a pericranial rotational flap. Postoperation, the patient's headache and rhinorrhea decreased; neither symptom was present at 1-month postoperation. The wounds healed with minimal scarring, and the cosmetic outcome for the craniofacial fracture was acceptable. Discussion: Although the patient may at first present with a mild head injury, this can progress into something much more serious. PNC is difficult to diagnose clinically. Rarely, patients describe a splashing sound upon moving the head (termed bruit hydro-aerique), which can also be auscultated. A head CT scan is the gold standard in the diagnosis of PNC. Pericranial flaps are widely used for dural repair because they are easily accessible and have a lower rate of infection than artificial grafts on expanding PNC. Conclusion: Tension PNC may be slow-growing and increase intracranial pressure to high levels before clinical signs are present. The pericranial rotational flap technique is the best way to close a dura mater defect in cranial base fractures with tension PNC.	[Oley, Mendy Hatibie] Sam Ratulangi Univ, Fac Med, Dept Surg, Plast Reconstruct & Aesthet Surg Div, Jalan Raya Tanawangko 56, Manado City 95162, North Sulawesi, Indonesia; [Oley, Mendy Hatibie] Kandou Hosp, Dept Surg, Plast Reconstruct & Aesthet Surg Div, Manado, Indonesia; [Oley, Mendy Hatibie; Oley, Maximillian Christian] Siloam Hosp Manado, Craniofacial & Cleft Ctr, Manado, Indonesia; [Oley, Maximillian Christian; Prasetyo, Eko] Sam Ratulangi Univ, Fac Med, Dept Surg, Neurosurg Div, Manado, Indonesia; [Oley, Maximillian Christian; Prasetyo, Eko] Kandou Hosp, Dept Surg, Neurosurg Div, Manado, Indonesia; [Oley, Maximillian Christian; Prasetyo, Eko] Siloam Hosp Manado, Neurosci Ctr, Manado, Indonesia; [Suwito, Andreas] Sam Ratulangi Univ, Fac Med, Dept Surg, Manado, Indonesia; [Faruk, Muhammad] Hasanuddin Univ, Fac Med, Dept Surg, Makassar, Indonesia		Oley, MH (corresponding author), Sam Ratulangi Univ, Fac Med, Dept Surg, Plast Reconstruct & Aesthet Surg Div, Jalan Raya Tanawangko 56, Manado City 95162, North Sulawesi, Indonesia.	mendy.hatibie@unsrat.ac.id; max_oley@unsrat.ac.id; ekoprasetyo@unsrat.ac.id; suwitowinardi@gmail.com; faroex8283@gmail.com		Faruk, Muhammad/0000-0002-7079-4585; Oley, Mendy Hatibie/0000-0003-2750-5917; Oley, Maximillian Christian/0000-0001-8317-0790			Abello A.L, 2016, CRIT FIND NEURORADIO, P231, DOI [10.1007/978-3-319-27987-9_24, DOI 10.1007/978-3-319-27987-9_24]; Agha RA, 2020, INT J SURG, V84, P226, DOI 10.1016/j.ijsu.2020.10.034; Al-Aieb A, 2017, INT J SURG CASE REP, V31, P145, DOI 10.1016/j.ijscr.2017.01.038; Eom Ki Seong, 2020, Korean J Neurotrauma, V16, P73, DOI 10.13004/kjnt.2020.16.e9; Harvey JJ, 2016, BJR CASE REP, V2, DOI 10.1259/bjrcr.20150127; Kim D.H., 2017, TRAUMA IMAGE PROCED, V2, P10; Park MC, 2008, SKULL BASE-INTERD AP, V18, P67, DOI 10.1055/s-2007-993046; Pillai Promod, 2017, Int J Crit Illn Inj Sci, V7, P58, DOI 10.4103/IJCIIS.IJCIIS_8_17; Sahoo NK, 2018, J MAXILLOFAC ORAL SU, V17, P286, DOI 10.1007/s12663-017-1036-5; Wardoyo M.S, 2021, MED CLIN PRACTICA, V4, DOI [10.1016/j. mcpsp.2021.100235, DOI 10.1016/J.MCPSP.2021.100235]	10	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.	SEP	2021	86								106314	10.1016/j.ijscr.2021.106314			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	WH0YP	WOS:000707415100014	34418808	Green Published, gold			2022-02-06	
J	Ortiz, SM				Ortiz, Steven M.			Women Caring for Retired Men: A Continuation of Inequality in the Sport Marriage	SOCIOLOGY OF SPORT JOURNAL			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALLERS; RECURRENT CONCUSSION; WIVES; GENDER; WORK; MASCULINITY; DEPRESSION; IDENTITY; PLAYERS	Drawing from longitudinal qualitative research on the heteronormative sport marriage that primarily featured interviews with women married to male professional athletes, this article focuses on how women were affected by and managed their retired husbands' physical and mental-emotional health issues. It explores the women's continued use of self-management strategies they developed during their husband's career as they offered increasingly challenging care work to their husbands and examines how long-held expectations about their caregiver role continued to contribute to post-career gender inequality in their marriages. It captures the women's voices as they discovered that they were not sufficiently prepared for the emerging personal and relational complexities that emerged in retirement.	[Ortiz, Steven M.] Oregon State Univ, Sociol Program, Corvallis, OR 97331 USA		Ortiz, SM (corresponding author), Oregon State Univ, Sociol Program, Corvallis, OR 97331 USA.	sortiz@oregonstate.edu			Oregon State University; University of California, BerkeleyUniversity of California System; American Sociological Association Minority Fellowship Program	The longitudinal qualitative research reported in this article was supported by grants from Oregon State University; the University of California, Berkeley; and the American Sociological Association Minority Fellowship Program. I am deeply indebted to Arlie Russell Hochschild for her inspiration and supportive mentorship. I particularly express my sincere appreciation to the women who participated in my research by generously sharing their lives and heartfelt stories with me. I am also very grateful to two anonymous reviewers for their perceptive comments on an earlier version of this article.	Allison M.T., 1988, SOCIOL SPORT J, V5, P212, DOI 10.1123/ssj.5.3.212; [Anonymous], 2019, HUMAN DEV REPORT; Berg B.L, 2004, QUALITATIVE RES METH, V5th; Bloom L., 2019, LONG IS AVERAGE CARE; Blumer H., 1969, SYMB INTERACT, P1; Carroll J.L., 2001, HIGH PERFORMING FAMI, P23; Chase SE., 2018, SAGE HDB QUALITATIVE, V5, P546; Clayton B., 2004, Soccer and Society, V5, P317, DOI 10.1080/1466097042000279580; Drahota JAT, 1998, SOCIOL SPORT J, V15, P263, DOI 10.1123/ssj.15.3.263; Dunne EM, 2020, CLIN J SPORT MED, V30, P544, DOI 10.1097/JSM.0000000000000628; England P, 1999, ANN AM ACAD POLIT SS, V561, P39, DOI 10.1177/0002716299561001003; England P, 2005, ANNU REV SOCIOL, V31, P381, DOI 10.1146/annurev.soc.31.041304.122317; Farole C.A., 1996, J PERFORMANCE ED, V1, P77; Faure C.E., 2019, APPL RES COACHING AT, P176; Faure CE, 2019, QUAL REP, V24; Folbre N., 2018, OXFORD HDB WOMEN EC, P1; Forsyth CJ, 2007, J SPORT SOC ISSUES, V31, P394, DOI 10.1177/0193723507307812; Gearing B, 1999, J AGING STUD, V13, P43, DOI 10.1016/S0890-4065(99)80005-X; Gmelch G, 2001, J CONTEMP ETHNOGR, V30, P335, DOI 10.1177/089124101030003003; Goffman E., 1967, INTERACTIONAL RITUAL, P47; Goffman E., 1961, LIFE THEATER DRAMATU, P73; Gough C., 2019, AVERAGE PLAYING CARE; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hess C., 2020, C487 I WOM POL RES; Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1; Holstein J.A., 2015, IS THERE LIFE FOOTBA; Jodai K., 2012, FOOTBALL SCI, V9, P50; Jones C, 2014, INT REV SOCIOL SPORT, V49, P485, DOI 10.1177/1012690213516618; Karaffa K, 2015, FAM J, V23, P120, DOI 10.1177/1066480714564381; Kemper R.V., 2002, CHRONICLING CULTURES, pXIII; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Luyster FS, 2017, NAT SCI SLEEP, V9, P31, DOI 10.2147/NSS.S125228; Malcolm D., 2020, CONCUSSION CRISIS SP; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marks S, 2019, CONTINUUM-J MEDIA CU, V33, P435, DOI 10.1080/10304312.2019.1625868; Messerschmidt James W., 2018, HEGEMONIC MASCULINIT; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Ortiz S.M., 2001, QUALITATIVE INQUIRY, V7, P192, DOI [10.1177/107780040100700204, DOI 10.1177/107780040100700204]; Ortiz S.M., 1994, CLIN SOCIOLOGY REV, V12, P48; Ortiz S.M., 2020, SPORT MARRIAGE WOMEN; Ortiz SM, 2004, J CONTEMP ETHNOGR, V33, P466, DOI 10.1177/0891241604265980; Ortiz SM, 2005, QUAL INQ, V11, P265, DOI 10.1177/1077800404269436; Ortiz SM, 2003, SYMB INTERACT, V26, P601, DOI 10.1525/si.2003.26.4.601; PAPANEK H, 1973, AM J SOCIOL, V78, P852, DOI 10.1086/225406; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PAVALKO EK, 1993, GENDER SOC, V7, P548, DOI 10.1177/089124393007004005; Polletta F, 2011, ANNU REV SOCIOL, V37, P109, DOI 10.1146/annurev-soc-081309-150106; Roderick MJ, 2012, J SPORT SOC ISSUES, V36, P317, DOI 10.1177/0193723512445283; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Saldana J., 2003, LONGITUDINAL QUALITA; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Simonetto D, 2019, STUD SYMB INTERACT, V50, P181, DOI 10.1108/S0163-239620190000050009; Stier J., 2007, International Review for the Sociology of Sport, V42, P99, DOI 10.1177/1012690207081830; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Turner R.W, 2018, NOT LONG LIFE CAREER; TURNER RH, 1978, AM J SOCIOL, V84, P1, DOI 10.1086/226738; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Young JA, 2006, BRIT J SPORT MED, V40, P477, DOI 10.1136/bjsm.2005.023341	62	0	0	10	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0741-1235	1543-2785		SOCIOL SPORT J	Sociol. Sport J.	SEP	2021	38	3					293	301		10.1123/ssj.2020-0118			9	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology; Sport Sciences	UA9LT	WOS:000685476500009					2022-02-06	
J	Ozturk, ED; Iaccarino, MA; Hamner, JW; Aaron, SE; Hunt, DL; Meehan, WP; Howell, DR; Tan, CO				Ozturk, Erin D.; Iaccarino, Mary Alexis; Hamner, Jason W.; Aaron, Stacey E.; Hunt, Danielle L.; Meehan, William P. I. I. I. I. I. I.; Howell, David R.; Tan, Can Ozan			Executive dysfunction after multiple concussions is not related to cerebrovascular dysfunction	PHYSIOLOGICAL MEASUREMENT			English	Article						adolescence; neurovascular coupling; concussion	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; AXONAL INJURY; MEMORY; ACTIVATION; DEMENTIA; RECOVERY; ADULTS	Objective. We investigated the relation between prior concussion history and working memory (WM), self-reported cognitive symptom burden, and cerebrovascular function in adolescents and young adults (14-21 years old). Approach. We recruited 59 participants, 34 clinically diagnosed with a sports-related concussion and 25 controls. Concussed subjects were studied at baseline (within 28 days of their injury) and eight weeks after, while control subjects only had one assessment. We assessed WM (n-back task up to four-back), and neurovascular coupling (cerebrovascular responses at middle cerebral artery during n-back tasks) using a transcranial Doppler ultrasonograph. Main results. There was no significant difference in WM between controls and concussed participants (p = 0.402). However, WM capacity was lower in those who had sustained >= 3 concussions (7.1% with WM capacity of four) compared to those with their first ever concussion (33.3%) and controls (28.0%, overall p = 0.025). At the sub-acute point (n = 24), self-reported cognitive symptom burden was mostly resolved in all but two participants. Despite the resolution of symptoms, WM performance was not different eight weeks post injury (p = 0.706). Neurovascular coupling was not different between controls and concussed participants regardless of prior concussion history. Significance. Up to 20% of concussed individuals experience covert sequelae lasting beyond the resolution of self-reported overt symptoms. How a prior history of concussion impacts the potential for sequelae is not well established, and the underlying mechanisms are unknown. Despite no alterations in neurovascular coupling, a history of prior concussion was associated with significant deficits in WM capacity, and lasted beyond self-reported cognitive symptom resolution.	[Ozturk, Erin D.; Hamner, Jason W.; Aaron, Stacey E.; Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Boston, MA 02114 USA; [Iaccarino, Mary Alexis; Aaron, Stacey E.; Tan, Can Ozan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iaccarino, Mary Alexis] Spaulding Rehabil Hosp, Boston, MA USA; [Iaccarino, Mary Alexis] Massachusetts Gen Hosp Children Sports Concuss Pr, Boston, MA USA; [Hunt, Danielle L.; Meehan, William P. I. I. I. I. I. I.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Hunt, Danielle L.; Meehan, William P. I. I. I. I. I. I.; Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P. I. I. I. I. I. I.] Harvard Med Sch, Dept Orthoped Surg, Boston, MA 02115 USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Tan, Can Ozan] Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA 02114 USA		Tan, CO (corresponding author), Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Boston, MA 02114 USA.; Tan, CO (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Tan, CO (corresponding author), Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA 02114 USA.	cotan@mgh.harvard.edu		Howell, David/0000-0002-2955-0191	Eunice Kennedy Shriver National Institute of Child Health& Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS106444]	This research was funded by Eunice Kennedy Shriver National Institute of Child Health& Human Development (R03HD094560, DRH) and the National Institute of Neurological Disorders and Stroke (R03NS106444, COT).	Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Champagne AA, 2021, BRAIN IMAGING BEHAV, V15, P133, DOI 10.1007/s11682-019-00240-2; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hilz MJ, 2017, J NEUROL, V264, P1956, DOI 10.1007/s00415-017-8581-1; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; James KA, 2020, MED SCI SPORT EXER, V52, P388; Jor'dan AJ, 2017, J GERONTOL A-BIOL, V72, P1669, DOI 10.1093/gerona/glx063; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Klingelhofer J, 1997, J CEREBR BLOOD F MET, V17, P577, DOI 10.1097/00004647-199705000-00013; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Medow MS, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13286; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ozturk ED, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0164-z; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Saint Martin M, 2015, J AM GERIATR SOC, V63, P270, DOI 10.1111/jgs.13252; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SILVESTRINI M, 1993, STROKE, V24, P1673, DOI 10.1161/01.STR.24.11.1673; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sorond FA, 2013, NEUROLOGY, V81, P904, DOI 10.1212/WNL.0b013e3182a351aa; Sorond FA, 2011, ANN NEUROL, V70, P213, DOI 10.1002/ana.22433; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	41	0	0	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	SEP 1	2021	42	9							095005	10.1088/1361-6579/ac2207			9	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	UX3RA	WOS:000700759400001	34450608				2022-02-06	
J	Pajer, HB; Asher, AM; Leung, D; Barnett, RR; Joyner, BL; Quinsey, CS				Pajer, Hengameh B.; Asher, Anthony M.; Leung, Dennis; Barnett, Randaline R.; Joyner, Benny L.; Quinsey, Carolyn S.			ADHERENCE TO GUIDELINES FOR MANAGING SEVERE TRAUMATIC BRAIN INJURY IN CHILDREN	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							MANAGEMENT	Pediatric traumatic brain injury (TBI) protocols vary widely among institutions, despite the existence of published guidelines.This study seeks to identify significant differences in management of pediatric TBI across several institutions. Severe pediatric TBI protocols were collected from major US pediatric hospitals through direct communication with trauma staff. Of 24 institutions identified and contacted, 10 did not respond and 5 did not have a pediatric TBI protocol. Pediatric TBI protocols were successfully collected from 9 institutions. These 9 protocols were separated into treatment tiers analogous to those in the 2019 Society of Critical Care Medicine and World Federation of Pediatric Intensive and Critical Care Societies guidelines, and the intervention variables were identified and compared across the 9 institutions. First-line therapies were similar between institutions, including seizure prophylaxis, maintenance of normoglycemia and normothermia, and avoidance of hypoxia, hyponatremia, and hypotension. However, significant variation across institutions was found regarding timing of cerebrospinal fluid drainage, hyperventilation, and neuromuscular blockade. When included in institutional protocols, most therapies are in line with the 2019 guidelines, except for diversion of cerebrospinal fluid, hyperventilation, maintenance of cerebral perfusion pressure, and use of neuromuscular blocking agents. Although these variations may represent differences in style or preference, the optimal timing of these specific treatment variations should be studied to determine the impact of each protocol on clinical outcomes.	[Pajer, Hengameh B.] Campbell Univ, Sch Osteopath Med, Buis Creek, NC USA; [Asher, Anthony M.] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Leung, Dennis; Joyner, Benny L.] Univ N Carolina, Dept Pediat Crit Care, Chapel Hill, NC 27515 USA; [Barnett, Randaline R.; Quinsey, Carolyn S.] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA		Quinsey, CS (corresponding author), 101 Manning Dr, Chapel Hill, NC 27514 USA.	carolyn_quinsey@med.unc.edu			NICHD of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T23HD094671]	Dennis Leung is supported by NICHD of the National Institutes of Health under award number T23HD094671.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Colomina MJ, 2012, MINERVA ANESTESIOL, V78, P358; Desgranges FP, 2014, CHILD NERV SYST, V30, P1393, DOI 10.1007/s00381-014-2417-4; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P12, DOI 10.1097/TA.0000000000001836; O'Reilly C, GUIDELINES MANAGEMEN; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031	15	0	0	1	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	SEP	2021	30	5					402	406		10.4037/ajcc2021111			5	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	UK8HW	WOS:000692206800012	34467382				2022-02-06	
J	Perez-Sanchez, J; de Gea, JMC; Barcelo, SR; Toval, A; Fernandez-Aleman, JL; Garcia-Berna, JA; Popovic, M; Toval, A				Perez-Sanchez, Juanjo; Carrillo de Gea, Juan M.; Rodriguez Barcelo, Sandra; Toval, Angel; Fernandez-Aleman, Jose L.; Garcia-Berna, Jose A.; Popovic, Miroljub; Toval, Ambrosio			Intracranial pressure analysis software: A mapping study and proposal	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Intracranial pressure; ICP; ICP Monitoring; ICP Automated analyisis; Mapping study	TRAUMATIC BRAIN-INJURY; MORPHOLOGICAL FEATURES; B-WAVES; MANAGEMENT; CLASSIFICATION; RECOGNITION; GUIDELINES; ALGORITHM	Introduction Intracranial pressure (ICP) monitoring and analysis are techniques that are, each year, applied to millions of patients with pathologies with million of patients annually. The detection of the so called A and B-waves, and the analysis of subtle changes in C-waves, which are present in ICP waveform, may indicate decreased intracranial compliance, and may improve the clinical outcome. Despite the advances in the field of computerized data analysis, the visual screening of ICP continues to be the means principally employed to detect these waves. To the best of our knowledge, no review study has addressed automated ICP analysis in sufficient detail and a need to research the state of the art of ICP analysis has, therefore, been identified. Methodology This paper presents a systematic mapping study to provide answers to 7 research questions: publication time, venue and source trends, medical tasks undertaken, research methods used, computational systems developed, validation methodology, tools and systems employed for evaluation and research problems identified. An ICP software prototype is presented and evaluated as a consequence of the results. Results A total of 23 papers, published between 1990 and 2020, were selected from 6 online databases. After analyzing these papers, the following information was obtained: diagnosis and monitoring medical tasks were addressed to the same extent, and the main research method used was evaluation research. Several computational systems were identified in the papers, the main one being image classification, while the main analysis objective was single pulse analysis. Correlation with expert analysis was the most frequent validation method, and few of the papers stated the use of a published dataset. Few authors referred to the tools used to build or evaluate the proposed solutions. The most frequent research problem was the need for new analysis methods. These results have inspired us to propose a software prototype with which provide an automated solution that integrates ICP analysis and monitoring techniques. Conclusions The papers in this study were selected and classified with regard to ICP automated analysis methods. Several research gaps were identified, which the authors of this study have employed as a based on which to recommend future work. Furthermore, this study has identified the need for an empirical comparison between methods, which will require the use and development of certain standard metrics. An in-depth analysis conducted by means of systematic literature review is also required. The software prototype evaluation provided positive results, showing that the prototype may be a reliable system for A-wave detection. (c) 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )	[Perez-Sanchez, Juanjo; Carrillo de Gea, Juan M.; Fernandez-Aleman, Jose L.; Garcia-Berna, Jose A.; Toval, Ambrosio] Univ Murcia, Fac Comp Sci, Dept Informat & Syst, Murcia, Spain; [Rodriguez Barcelo, Sandra] Quironsalud Hosp, Dept Neurosurg, Murcia, Spain; [Toval, Angel; Popovic, Miroljub] Univ Murcia, Fac Med, Dept Human Anat & Psychobiol, Murcia, Spain; [Toval, Angel; Popovic, Miroljub] Univ Murcia, Virgen de la Arrixaca Univ Hosp, Inst Biomed Res Murcia, Murcia, Spain		Perez-Sanchez, J (corresponding author), Univ Murcia, Fac Comp Sci, Dept Informat & Syst, Murcia, Spain.	juanjose.perez9@um.es; jmcdg1@um.es; sandrarodriguezbarcelo@gmail.com; j.angel.toval@gmail.com; aleman@um.es; josealberto.garcia1@um.es; miroljub@um.es; atoval@um.es	Fernandez-Aleman, Jose Luis/G-1282-2011; Toval, Ambrosio/P-1180-2014; Popovic, Miroljub/L-5320-2014; Carrillo de Gea, Juan Manuel/P-1224-2014	Fernandez-Aleman, Jose Luis/0000-0002-0176-450X; Toval, Ambrosio/0000-0002-8273-5937; Popovic, Miroljub/0000-0002-1326-3876; Carrillo de Gea, Juan Manuel/0000-0002-3320-622X; Perez Sanchez, Juan Jose/0000-0002-9583-1370; Toval, Angel/0000-0003-4798-1216	Spanish Ministry of Science, Innovation and UniversitiesSpanish Government [RTI2018-098309-B-C33, TIN2017-90689-REDT]; European Regional Development Fund (ERDF)European Commission	This research is part of the BIZDEVOPS-GLOBAL-UMU (RTI2018-098309-B-C33) project, and the Network of Excellence in Software Quality and Sustainability (TIN2017-90689-REDT). Both projects are supported by the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund (ERDF).	Al Saiegh F, 2020, WORLD NEUROSURG, V136, pE535, DOI 10.1016/j.wneu.2020.01.070; AlHinai N., 2020, BIOMED SIGNAL PROCES, P1, DOI 10.1016/B978- 0-12- 818946-7.00001-9; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Beattie ZT, 2008, IEEE ENG MED BIO, P2594, DOI 10.1109/IEMBS.2008.4649731; Bin Ali N, 2018, INFORM SOFTWARE TECH, V99, P133, DOI 10.1016/j.infsof.2018.02.002; Bradshaw D., 2008, TRAUMATIC BRAIN INJU; Calisto A, 2013, IEEE T BIO-MED ENG, V60, P830, DOI 10.1109/TBME.2012.2191550; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Che XR, 2020, WORLD J EMERG MED, V11, P169, DOI 10.5847/wjem.j.1920-8642.2020.03.007; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Eklund A, 2001, J NEUROSURG, V94, P392, DOI 10.3171/jns.2001.94.3.0392; Elixmann IM, 2012, IEEE ENG MED BIO, P3939, DOI 10.1109/EMBC.2012.6346828; Esfandiari N, 2014, EXPERT SYST APPL, V41, P4434, DOI 10.1016/j.eswa.2014.01.011; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; HARA K, 1990, MED INFORM, V15, P125, DOI 10.3109/14639239008997664; Harary M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020465; Holm S, 2008, MED ENG PHYS, V30, P164, DOI 10.1016/j.medengphy.2007.03.003; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; IEEE, 2019, TAXONOMY; Jalali S, 2012, INT SYMP EMP SOFTWAR, P29, DOI 10.1145/2372251.2372257; Jeong EJ, 2015, INT WINT WORKSH BR, P67; Kallergi M., 2005, MED IMAGE ANAL METHO, P433; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kazimierska A, 2021, ACTA NEUROCHIR, V163, P1979, DOI 10.1007/s00701-021-04834-y; Kim DJ, 2012, J NEUROTRAUM, V29, P1354, DOI 10.1089/neu.2011.2018; Kirkness C.J., INTRACRANIAL PRESSUR; Kitchenham B., 2007, ISSUE EBSE 2007 001; Lee HJ, 2016, IEEE T BIO-MED ENG, V63, P2169, DOI 10.1109/TBME.2015.2512278; LEMAIRE JJ, 1994, COMPUT METH PROG BIO, V42, P1, DOI 10.1016/0169-2607(94)90133-3; Li ZH, 2020, CLIN NEUROL NEUROSUR, V189, DOI 10.1016/j.clineuro.2019.105538; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Martinez-Tejada I, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0153-6; Megjhani M, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aaf979; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; Nucci CG, 2016, ACTA NEUROCHIR, V158, P581, DOI 10.1007/s00701-015-2672-5; Papadopoulos A.N., 2005, MED IMAGE ANAL METHO, P51; Perez-Barcena J, 2014, CRIT CARE CLIN, V30, P735, DOI 10.1016/j.ccc.2014.06.005; Petersen K, 2015, INFORM SOFTWARE TECH, V64, P1, DOI 10.1016/j.infsof.2015.03.007; Ren JW, 2020, TRANSL STROKE RES, V11, P1253, DOI 10.1007/s12975-020-00798-w; Scalzo F, 2013, IEEE T BIO-MED ENG, V60, P235, DOI 10.1109/TBME.2012.2210042; Scalzo F, 2012, IEEE PULSE, V3, P49, DOI 10.1109/MPUL.2011.2181024; Scalzo F, 2012, ARTIF INTELL MED, V54, P115, DOI 10.1016/j.artmed.2011.08.007; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Scalzo F, 2008, LECT NOTES COMPUT SC, V5358, P370, DOI 10.1007/978-3-540-89639-5_36; Shadish WR, 2006, SYSTEMATIC REVIEWS IN THE SOCIAL SCIENCES: A PRACTICAL GUIDE, P1; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Sonig A, 2020, WORLD NEUROSURG, V138, P491, DOI 10.1016/j.wneu.2020.03.028; Spiegelberg A, 2018, ACTA NEUROCHIR SUPPL, V126, P243, DOI 10.1007/978-3-319-65798-1_49; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Walter M, 2002, ACT NEUR S, V81, P161; Wieringa R, 2006, REQUIR ENG, V11, P102, DOI 10.1007/s00766-005-0021-6; Wijdicks EFM, 2019, NEUROCRIT CARE, V31, P546, DOI 10.1007/s12028-019-00689-5	59	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	SEP	2021	209								106334	10.1016/j.cmpb.2021.106334			14	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	UU4DQ	WOS:000698749400001	34450483	hybrid			2022-02-06	
J	Pettus, C; Veeh, CA; Renn, TR; Kennedy, SC				Pettus, Carrie; Veeh, Christopher A.; Renn, Tanya R.; Kennedy, Stephanie C.			The Well-Being Development Model: A Theoretical Model to Improve Outcomes among Criminal Justice System-Involved Individuals	SOCIAL SERVICE REVIEW			English	Article						conceptual framework; formerly incarcerated individuals; reentry; well-being	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PRISONER REENTRY; SOCIAL SUPPORT; MENTAL-HEALTH; POSITIVE PSYCHOLOGY; SUBSTANCE-ABUSE; CHILDHOOD VICTIMIZATION; VIOLENT RECIDIVISM; MASS INCARCERATION	This article proposes a new conceptual framework, the Well-Being Development Model (WBDM), to support the development, implementation, and assessment of innovative reentry interventions designed to increase well-being among the millions of individuals released from prisons and jails each year. In contrast to prominent models guiding reentry services, the WBDM increases incarcerated and formerly incarcerated individuals' capacity to reach their full potential while addressing common problems and barriers to success. First, we describe the reentry context, explore the prominent conceptual foundation guiding reentry services, and establish the need for innovation. Then, we map five key facilitators of well-being development onto existing theoretical models and detail WBDM propositions. Finally, we propose how the use of data generated from WBDM-based interventions can redress structural and social disparities throughout the criminal justice system, allowing individuals to develop well-being while policy makers promote public health, public safety, and racial and economic equity.	[Pettus, Carrie; Renn, Tanya R.] Florida State Univ, Coll Social Work, Social Work, Tallahassee, FL 32306 USA; [Pettus, Carrie] Florida State Univ, Coll Social Work, Inst Justice Res & Dev IJRD, Tallahassee, FL 32306 USA; [Veeh, Christopher A.] Univ Iowa, Sch Social Work, Social Work, Iowa City, IA 52242 USA; [Kennedy, Stephanie C.] Florida State Univ, Tallahassee, FL 32306 USA		Pettus, C (corresponding author), Florida State Univ, Coll Social Work, Social Work, Tallahassee, FL 32306 USA.; Pettus, C (corresponding author), Florida State Univ, Coll Social Work, Inst Justice Res & Dev IJRD, Tallahassee, FL 32306 USA.		Renn, Tanya/ABD-5469-2021	Pettus, Carrie/0000-0003-3378-3008			Adan A, 2017, PSYCHIAT RES, V251, P325, DOI 10.1016/j.psychres.2017.02.035; Alper M., 2018, 250975 NCJ BUR JUST; Andrews DA, 2010, PSYCHOL PUBLIC POL L, V16, P39, DOI 10.1037/a0018362; ANDREWS DA, 1990, CRIMINOLOGY, V28, P369, DOI 10.1111/j.1745-9125.1990.tb01330.x; ASPINWALL LG, 2003, PSYCHOL HUMAN STRENG, DOI DOI 10.1037/10566-000; Audet CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069564; Barrenger SL, 2021, CRIM JUSTICE BEHAV, V48, P259, DOI 10.1177/0093854820983844; Bennett T, 2008, AGGRESS VIOLENT BEH, V13, P107, DOI 10.1016/j.avb.2008.02.001; Bobo LawrenceD., 2010, DOING RACE, V21, P322; Boehm JK, 2012, CURR CARDIOVASC RISK, V6, P511, DOI 10.1007/s12170-012-0273-x; Boehmer S, 2007, ANXIETY STRESS COPIN, V20, P61, DOI 10.1080/10615800701195439; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Bonta J., 2007, 20070 PUBL SAF, V6, P1; Bonta J., 2017, PSYCHOL CRIMINAL CON, V6th; Bonta J, 2014, AGGRESS VIOLENT BEH, V19, P278, DOI 10.1016/j.avb.2014.04.014; Bouffard JA, 2006, J OFFENDER REHABIL, V44, P1, DOI 10.1300/J076v44n02_01; Bowling NA, 2010, J OCCUP ORGAN PSYCH, V83, P915, DOI 10.1348/096317909X478557; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Brayne S, 2014, AM SOCIOL REV, V79, P367, DOI 10.1177/0003122414530398; Brinkley-Rubinstein L., 2013, HEAL JUSTICE, V1, P1, DOI [DOI 10.1186/2194-7899-1-3, 10.1186/2194-7899-1-3]; Bronson J., 2017, REPORT PREPARED US D; Bronson J., 2017, DRUG USE DEPENDENCE; Browne C.H., 2014, STRENGTHENING FAMILI; Budde S, 2004, J INTERPERS VIOLENCE, V19, P341, DOI 10.1177/0886260503261157; Bureau of Justice Assistance, 2018, 2 CHANC ACT; Califano Joseph., 2010, BARS 2 SUBSTANCE ABU; Campbell A.-Ph. E. Converse-W. L., 1976, QUALITY AM LIFE PERC; Carruthers C, 2007, THER RECREAT J, V41, P276; Carson E. Ann, 2016, 251149 NCJ BUR JUST; Centers for Disease Control, TRAUMATIC BRAIN INJU; Chan M, 2018, COMPUT HUM BEHAV, V87, P254, DOI 10.1016/j.chb.2018.05.027; Cheng C, 2014, PSYCHOL BULL, V140, P1582, DOI 10.1037/a0037913; Children's Bureau, 2012, ACYFCBIM1204 US DEP; Chopik WJ, 2017, PERS RELATIONSHIP, V24, P408, DOI 10.1111/pere.12187; Cochran JC, 2014, J QUANT CRIMINOL, V30, P317, DOI 10.1007/s10940-013-9205-2; Cohen S., 2000, SOCIAL SUPPORT MEASU; Cooper C, 2001, CURR PSYCHOL, V20, P169, DOI 10.1007/s12144-001-1025-0; Couloute L., 2018, NOWHERE GO HOMELESSN; Covin L, 2012, J FORENSIC PSYCHOL P, V12, P439, DOI 10.1080/15228932.2012.713835; CSG Justice Center, 2019, CONF COSTL; Cullen Francis., 2011, PRISON J, V91, DOI [10.1177/0032885511415224, DOI 10.1177/0032885511415224]; Cullen FT, 2013, CRIME JUSTICE, V42, P299, DOI 10.1086/670395; Cummins, 2000, PSYCHIAT PSYCHOL LAW, V7, DOI [10.1080/13218710009524983, DOI 10.1080/13218710009524983]; Cummins RA, 1996, SOC INDIC RES, V38, P303, DOI 10.1007/BF00292050; DAmico Ronald, 2017, EVALUATION 7 2 CHANC; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Desmarais Sarah L., 2018, HDB RECIDIVISM RISKN, P3; DiBenedetto Rachel., 2019, J LAW POLICY, V27, P414; Diener E, 1997, SOC INDIC RES, V40, P189, DOI 10.1023/A:1006859511756; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1993, SOC INDIC RES, V28, P195, DOI 10.1007/BF01079018; Dowden C, 1999, CRIME DELINQUENCY, V45, P438, DOI 10.1177/0011128799045004002; Dowden C, 2002, PSYCHOL CRIME LAW, V8, P243, DOI 10.1080/10683160208401818; Draine J, 2002, PSYCHIAT SERV, V53, P565, DOI 10.1176/appi.ps.53.5.565; Durand E, 2017, ANN PHYS REHABIL MED, V60, P95, DOI 10.1016/j.rehab.2017.02.003; Duwe G, 2012, JUSTICE Q, V29, P347, DOI 10.1080/07418825.2011.555414; Eckhouse L, 2019, CRIM JUSTICE BEHAV, V46, P185, DOI 10.1177/0093854818811379; Eklund M, 2009, PSYCHIATR REHABIL J, V32, P177, DOI 10.2975/32.3.2009.177.191; Epperson MW, 2014, INT J LAW PSYCHIAT, V37, P427, DOI 10.1016/j.ijlp.2014.02.015; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fazel S, 2012, BRIT J PSYCHIAT, V200, P364, DOI 10.1192/bjp.bp.111.096370; Folkman S., 1984, STRESS; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Freeman K, 2003, DRUG ALCOHOL REV, V22, P409, DOI 10.1080/09595230310001613921; Freire C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01554; Gander F, 2013, J HAPPINESS STUD, V14, P1241, DOI 10.1007/s10902-012-9380-0; Gattino S, 2015, APPL RES QUAL LIFE, V10, P689, DOI 10.1007/s11482-014-9348-9; Giordano PC, 2002, AM J SOCIOL, V107, P990, DOI 10.1086/343191; Giordano PC, 2008, CRIMINOLOGY, V46, P99, DOI 10.1111/j.1745-9125.2008.00104.x; Glaze, 2006, MENTAL HLTH PROBLEMS; Glaze Lauren E., 2009, 228230 NCJ BUR JUST; Gloster AT, 2017, J CONTEXT BEHAV SCI, V6, P166, DOI 10.1016/j.jcbs.2017.02.003; Goffman Alice, 2015, RUN FUGITIVE LIFE AM; GOFFMAN E., 2009, STIGMA NOTES MANAGEM; Golder S, 2015, AM J ORTHOPSYCHIAT, V85, P382, DOI 10.1037/ort0000057; Gottschalk M, 2008, ANNU REV POLIT SCI, V11, P235, DOI 10.1146/annurev.polisci.11.060606.135218; Greenglass ER, 2009, EUR PSYCHOL, V14, P29, DOI 10.1027/1016-9040.14.1.29; Grommon E, 2013, J OFFENDER REHABIL, V52, P287, DOI 10.1080/10509674.2013.782775; Gruhn D, 2008, EMOTION, V8, P753, DOI 10.1037/a0014123; Gustems-Carnicer J, 2013, EUR J PSYCHOL EDUC, V28, P1127, DOI 10.1007/s10212-012-0158-x; Haney C., 2002, PSYCHOL IMPACT INCAR; Hanson RK., 2009, META ANAL EFFECTIVEN; Harding DJ, 2017, P NATL ACAD SCI USA, V114, P11103, DOI 10.1073/pnas.1701544114; Harner HM, 2013, QUAL HEALTH RES, V23, P26, DOI 10.1177/1049732312461452; Harper Browne C., 2016, INNOVATIVE APPROACHE, P1; Hirschi T., 1969, CAUSES DELINQUENCY; Holl Douglas B., 2009, EVALUATION PRISONER; Hood CD, 2016, THER RECREAT J, V50, P103, DOI 10.18666/TRJ-2016-V50-I2-7307; Hood CD, 2007, THER RECREAT J, V41, P298; Huppert F.A, 2014, INTERVENTIONS POLICI, P1, DOI [DOI 10.1002/9781118539415.WBWELL036, https://doi.org/10.1002/9781118539415.wbwell036]; Jacobs Erin, 2007, REPORT EVALUATION CO; Jaggi LJ, 2016, SOC MENT HEALTH, V6, P187, DOI 10.1177/2156869316641730; Jonson CL, 2015, CRIME JUSTICE, V44, P517, DOI 10.1086/681554; Kaeble D., 2018, 251211 NCJ BUR JUST; Katz R.S., 2014, J PAN AFRICAN STUDIE, V7, P25; Keaveny M E, 1999, Issues Ment Health Nurs, V20, P73, DOI 10.1080/016128499248790; Kelley TM, 2011, COUNS PSYCHOTHER RES, V11, P140, DOI 10.1080/14733145.2010.485689; Kennedy SC, 2016, WOMEN CRIM JUSTICE, V26, P77, DOI 10.1080/08974454.2015.1023486; Kennedy SC, 2013, PSYCHIAT QUART, V84, P439, DOI 10.1007/s11126-013-9258-2; Klug HJP, 2015, J HAPPINESS STUD, V16, P37, DOI 10.1007/s10902-013-9493-0; Koopman-Boyden PG, 2009, EDUC GERONTOL, V35, P990, DOI 10.1080/03601270902917745; Krieger N, 2011, AM J PUBLIC HEALTH, V101, P1704, DOI 10.2105/AJPH.2011.300168; Kuo A, 2007, ACT ADAPT AGING, V31, P1, DOI 10.1300/J016v31n03_01; Kuykendall L, 2015, PSYCHOL BULL, V141, P364, DOI 10.1037/a0038508; Lattimore P., 2010, MULTISITE EVALUATION; Lattimore Pamela, 2020, RETHINKING REENTRY, P7; Laws D. R., 2011, DESISTANCE SEXUAL OF; Lee LC, 2012, J CONTEMP CRIM JUST, V28, P96, DOI 10.1177/1043986211432203; Levenson JS, 2010, INT J OFFENDER THER, V54, P307, DOI 10.1177/0306624X08328752; Lin YC, 2014, SOC BEHAV PERSONAL, V42, P1537, DOI 10.2224/sbp.2014.42.9.1537; Lindquist Christine, 2018, CROSS SITE EVALUATIO; Looney A., 2018, WORK OPPORTUNITY INC; Lopez-Aguado P, 2016, SOCIOL COMPASS, V10, P12, DOI 10.1111/soc4.12342; Lubben J., 2015, GRAND CHALLENGES SOC; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Manderscheid RW, 2010, PREV CHRONIC DIS, V7; MARTINSON R, 1974, PUBLIC INTEREST, P22; Maruna S, 2004, PSYCHOL CRIME LAW, V10, P271, DOI 10.1080/10683160410001662762; Maruschak Laura M, 2013, 243826 NCJ BUR JUST; Maslow Abraham., 1954, MOTIVATION PERSONALI; Massoglia M, 2015, ANNU REV SOCIOL, V41, P291, DOI 10.1146/annurev-soc-073014-112326; Mattu, 2016, PROPUBLICA; Mauer M., 2011, PRISON J, V91, p87S, DOI DOI 10.1177/0032885511415227; Mausbach BT, 2007, AGING MENT HEALTH, V11, P339, DOI 10.1080/13607860600963729; Mayordomo T, 2016, J PSYCHOL, V150, P809, DOI 10.1080/00223980.2016.1203276; Mayson SG, 2019, YALE LAW J, V128, P2218; McKernan Patricia., 2017, J COMMUNITY CORRECTI, V27, P24; Meng XF, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1071-7; Miller RJ, 2014, PUNISHM SOC, V16, P305, DOI 10.1177/1462474514527487; Mir J, 2015, ADDICT BEHAV, V46, P25, DOI 10.1016/j.addbeh.2015.02.016; Morrison Maria, 2018, J TRAUMATIC STRESS D, V7; Nagin DS, 2009, CRIME JUSTICE, V38, P115, DOI 10.1086/599202; National Institute of Justice, 2012, SER VIOL OFF REENTR; National Institute of Mental Health, 2019, MENT HLTH INF STAT; Natl Res Council, 2014, GROWTH OF INCARCERATION IN THE UNITED STATES: EXPLORING CAUSES AND CONSEQUENCES, P1; Ndrecka M., 2014, IMPACT REENTRY PROGR; Nkansah-Amankra S, 2013, INT J HEALTH SERV, V43, P217, DOI 10.2190/HS.43.2.c; Pamela K.Lattimore, 2021, ASC DIVISION CORRECT, P367; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Petersilia J, 2004, FED PROBAT, V68, P4; Petersilia Joan, 2009, PRISONERS COME HOME, P249; Pettus K. I., 2013, FELONY DISENFRANCHIS; Pettus-Davis C, 2017, CRIM JUSTICE BEHAV, V44, P1317, DOI 10.1177/0093854817721936; Pettus-Davis C, 2019, J OFFENDER REHABIL, V58, P614, DOI 10.1080/10509674.2019.1635242; Pettus-Davis C, 2019, PSYCHOL MEN MASCULIN, V20, P379, DOI 10.1037/men0000171; Pettus-Davis C, 2014, INT J LAW PSYCHIAT, V37, P512, DOI 10.1016/j.ijlp.2014.02.024; Pettus-Davis C, 2009, J OFFENDER REHABIL, V48, P367, DOI 10.1080/10509670902979447; Pettus-Davis Carrie, 2017, REVERSE CIVIC LEGAL; Pettus-Davis Carrie, 2014, GRAND CHALLENGES SOC; Pettus-Davis Carrie, 2014, J FORENSIC SOCIAL WO, V4, P2; Pettus-Davis Carrie., 2021, ASS WELL BEING REINC; Pettus-Davis Carrie., 2018, 5 KEY MODEL REENTRY; Pettus-Davis Carrie., 2020, PERSPECTIVES J AM PR, V44, P19; Pew Trusts, 2019, SAF CUT INC STAT RET; Phelps MS, 2016, ANN AM ACAD POLIT SS, V663, P185, DOI 10.1177/0002716215596972; Positive Psychology Center, PERMA THEOR WELL BEI; Pressman SD, 2009, PSYCHOSOM MED, V71, P725, DOI 10.1097/PSY.0b013e3181ad7978; Rampey Bobby D., 2016, PROGRAM INT ASSESSME; Ramsey MA, 2015, DEV REV, V36, P58, DOI 10.1016/j.dr.2015.01.003; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Reinhardt JP, 2006, J SOC PERS RELAT, V23, P117, DOI 10.1177/0265407506060182; Renshaw B, 1982, PRISONERS 1925 81; Rolph Laura., 2017, EFFECTS THERAPEUTIC; Roman John, 2007, IMPACT COST BENEFIT; Rothman David J, 1980, CONSCIENCE CONVENIEN; Ryff CD, 2008, J HAPPINESS STUD, V9, P13, DOI 10.1007/s10902-006-9019-0; Ryff CD, 2016, INT HANDB QUALITY, P95, DOI 10.1007/978-3-319-42445-3_6; RYFF CD, 1995, CURR DIR PSYCHOL SCI, V4, P99, DOI 10.1111/1467-8721.ep10772395; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Ryff CD, 2003, J HEALTH SOC BEHAV, V44, P275, DOI 10.2307/1519779; Ryff CD, 1996, PSYCHOTHER PSYCHOSOM, V65, P14, DOI 10.1159/000289026; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Sakala L, 2014, BREAKING MASS INCARC; Sampson R.J., 1993, CRIME MAKING PATHWAY; Sampson RJ, 2010, DAEDALUS-US, V139, P20, DOI 10.1162/DAED_a_00020; Sandstrom GM, 2014, PERS SOC PSYCHOL B, V40, P910, DOI 10.1177/0146167214529799; Sarason IG, 2009, J SOC PERS RELAT, V26, P113, DOI 10.1177/0265407509105526; Scheyett AM, 2013, INT J OFFENDER THER, V57, P578, DOI 10.1177/0306624X12438367; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Seiter RP, 2003, CRIME DELINQUENCY, V49, P360, DOI 10.1177/0011128703049003002; Seligman ME, 2011, FLOURISH VISIONARY N; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Severson ME, 2012, J OFFENDER REHABIL, V51, P295, DOI 10.1080/10509674.2012.677944; Shankar A, 2015, PSYCHOL HEALTH, V30, P686, DOI 10.1080/08870446.2014.979823; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Shuker R., 2008, BRIT J FORENSIC PRAC, V10, P33; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Smith P, 2009, VICTIMS OFFENDERS, V4, P148, DOI 10.1080/15564880802612581; Son J, 2012, SOCIOL FORUM, V27, P658, DOI 10.1111/j.1573-7861.2012.01340.x; Soutter AK, 2014, INT J ADOLESC YOUTH, V19, P496, DOI 10.1080/02673843.2012.754362; SPIEGEL D, 1989, LANCET, V2, P888; Spivak AL, 2013, SOC SCI QUART, V94, P1414, DOI 10.1111/ssqu.12021; Staempfli MB, 2007, J LEISURE RES, V39, P393, DOI 10.1080/00222216.2007.11950114; Straight Talk on Evidence, 2018, LARGE RANDOMIZED TRI; Substance Abuse and Mental Health Services Administration, 2015, SCREEN ASS COOCCURIN; Sykes BL, 2014, ANN AM ACAD POLIT SS, V654, DOI 10.1177/0002716214526345; Taxman Faye S., 2020, RECIDIVISM NEW APPRO, P39; Taxman FS, 2006, CRIME DELINQUENCY, V52, P28, DOI 10.1177/0011128705281754; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Travis J, 2005, CAMB STUD CRIMINOL, P1, DOI 10.1017/CBO9780511813580; Travis J., 2005, THEY ALL COME BACK F; Tripodi SJ, 2014, INT J OFFENDER THER, V58, P394, DOI 10.1177/0306624X12472879; Tripodi SJ, 2013, INT J LAW PSYCHIAT, V36, P30, DOI 10.1016/j.ijlp.2012.11.005; Trotter, 2010, OFFENDER SUPERVISION, P41; Trudel-Fitzgerald C., 2019, BMC PUBLIC HEALTH, V19, P1; Turney K, 2013, SOC MENT HEALTH, V3, P1, DOI 10.1177/2156869312464789; United States Department of Labor, 2007, PRESIDENTS PRISONER; van Eijk G, 2017, PUNISHM SOC, V19, P463, DOI 10.1177/1462474516666282; van Harreveld F, 2007, CRIM JUSTICE BEHAV, V34, P697, DOI 10.1177/0093854806298468; Veeh CA, 2018, SOC WORK, V63, P91, DOI 10.1093/sw/swx050; Veeh Christopher A., 2017, CRIMINAL JUSTICE POL, V28, P238, DOI DOI 10.1177/0887403415575144; Visher C.A., 2011, PRISON J, V91, DOI https://doi.org/10.1177/0032885511415228; Visher CA, 2017, JUSTICE Q, V34, P136, DOI 10.1080/07418825.2015.1115539; Wacquant L., 2009, PUNISHING POOR NEOLI; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Ward T, 2007, REHABILITATION RISK; Ward T, 2006, AGGRESS VIOLENT BEH, V11, P378, DOI 10.1016/j.avb.2006.01.001; Ward T, 2012, CRIM JUSTICE BEHAV, V39, P94, DOI 10.1177/0093854811426085; Weare K, 2011, HEALTH PROMOT INT, V26, pI29, DOI 10.1093/heapro/dar075; Wehrman MM, 2010, J CRIM JUST, V38, P538, DOI 10.1016/j.jcrimjus.2010.04.024; Wei MF, 2011, J PERS, V79, P191, DOI 10.1111/j.1467-6494.2010.00677.x; Weiss LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158092; Western B, 2013, ANN AM ACAD POLIT SS, V647, P166, DOI 10.1177/0002716213475421; Western Bruce, 2006, PUNISHMENT INEQUALIT; Wiese BS, 2002, J VOCAT BEHAV, V60, P321, DOI 10.1006/jvbe.2001.1835; Willis G., 2013, WHAT WORKS OFFENDER, pPP. 305, DOI 10.1002/9781118320655.ch17; Wilson JA, 2014, J CRIM JUST, V42, P527, DOI 10.1016/j.jcrimjus.2014.09.005; Wilson James A., 2006, CRIMINOLOGY PUBLIC P, V5, P303, DOI DOI 10.1111/J.1745-9133.2006.00380.X; Wolff N, 2012, INT J ENV RES PUB HE, V9, P1908, DOI 10.3390/ijerph9051908; Wolff N, 2009, VIOLENCE VICTIMS, V24, P469, DOI 10.1891/0886-6708.24.4.469; World Health Organization, GLOB SCH HLTH INIT; World Health Organization (WHO), 2010, CONCEPTUAL FRAMEWORK; Wu CH, 2015, SOC INDIC RES, V121, P917, DOI 10.1007/s11205-014-0662-2; Yang LQ, 2008, J OCCUP ORGAN PSYCH, V81, P567, DOI 10.1348/096317907X243324; Young JT, 2018, LANCET PUBLIC HEALTH, V3, pE237, DOI 10.1016/S2468-2667(18)30052-5	241	0	0	2	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0037-7961	1537-5404		SOC SERV REV	Soc. Serv. Rev.	SEP 1	2021	95	3					413	468		10.1086/715852			56	Social Work	Social Science Citation Index (SSCI)	Social Work	UU4PJ	WOS:000698784100002		Bronze			2022-02-06	
J	Petushek, EJ; Mortvedt, AI; Nelson, BL; Hamati, MC				Petushek, Erich J.; Mortvedt, Anne Inger; Nelson, Brittany L.; Hamati, Mary C.			The Effect of a Brief, Web-Based Animated Video for Improving Comprehension and Implementation Feasibility for Reducing Anterior Cruciate Ligament Injury: A Three-Arm Randomized Controlled Trial	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						multimedia; learning; motivation; uptake; education; information; knee; coach; sport; behavior change	DECISION-MAKING; PREVENTION PROGRAMS; RISK REDUCTION; KNOWLEDGE; SCIENCE; SPORTS; COACH; PERFORMANCE; ATTITUDES; PSYCHOLOGY	Neuromuscular injury prevention training (IPT) has been shown to reduce anterior cruciate ligament (ACL) injury risk by approximately 50%, but the implementation rate is low. One of the most important modifiable barriers for implementation is coaches' comprehension of risk and intervention strategies. This study aimed to evaluate the effect of a brief, web-based, animated video on ACL injury prevention comprehension and IPT implementation feasibility. Coaches in landing and cutting sports were recruited and randomized into three groups. (1) Intervention: brief multimedia animated video about ACL injury and prevention. (2) Active control: commonly accessed, text-based web resource about ACL injury and prevention. (3) Placebo control: brief multimedia video about concussions. Overall ACL comprehension-composed of basic ACL knowledge, risk knowledge, prevention knowledge, and severity knowledge-as well as implementation feasibility were all measured prior to and immediately following the interventions. Overall ACL comprehension improved the most in the animated video group (Cohen's d = 0.86) and, to a lesser degree, in the active control web-based article group (Cohen's d = 0.39). Both video and web-based article groups had greater implementation feasibility compared to the control group (p = 0.01). Overall, these initial results suggest that a brief, web-based, animated video has the potential to be a superior method for informing stakeholders in order to reduce traumatic injuries in sport.	[Petushek, Erich J.; Mortvedt, Anne Inger; Nelson, Brittany L.] Michigan Technol Univ, Dept Cognit & Learning Sci, Houghton, MI 49931 USA; [Petushek, Erich J.] Michigan Technol Univ, Hlth Res Inst, Houghton, MI 49931 USA; [Hamati, Mary C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA		Petushek, EJ (corresponding author), Michigan Technol Univ, Dept Cognit & Learning Sci, Houghton, MI 49931 USA.; Petushek, EJ (corresponding author), Michigan Technol Univ, Hlth Res Inst, Houghton, MI 49931 USA.	ejpetush@mtu.edu; amrtvedt@mtu.edu; bnelson1@mtu.edu; mchamati@outlook.com					Al-Sultan A.S., 2017, EGYPT J HOSP MED, V69, P2935, DOI [10.12816/0042588, DOI 10.12816/0042588]; Allaire J., 2018, RSTUDIO INT DEV ENV; Anderson SF, 2017, MULTIVAR BEHAV RES, V52, P305, DOI 10.1080/00273171.2017.1289361; Austin CA, 2015, JAMA INTERN MED, V175, P1213, DOI 10.1001/jamainternmed.2015.1679; Austin LC, 2012, INJURY PREV, V18, P124, DOI 10.1136/injuryprev-2011-040079; Azevedo R.F., P HUM FACT ERG SOC A, VVolume 59, P488; Benjamini Y, 2001, ANN STAT, V29, P1165; Bravo E, 2011, 2011 IEEE Global Engineering Education Conference (EDUCON), P638, DOI 10.1109/EDUCON.2011.5773205; Daneshvar Daniel H, 2021, Inquiry, V58, p469580211022641, DOI 10.1177/00469580211022641; Donaldson A, 2019, INJURY PREV, V25, P244, DOI 10.1136/injuryprev-2017-042639; Donaldson A, 2013, BRIT J SPORT MED, V47, P473, DOI 10.1136/bjsports-2013-092323; Feiss R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082665; Fleiss J., 1999, DESIGN ANAL CLIN EXP; Frank BS, 2015, J SCI MED SPORT, V18, P400, DOI 10.1016/j.jsams.2014.06.008; Ghazal S., 2018, CAMBRIDGE HDB EXPERT; Gilbert DT, 2016, SCIENCE, V351, DOI 10.1126/science.aad7243; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goldfarb MJ, 2017, CRIT CARE MED, V45, P1751, DOI 10.1097/CCM.0000000000002624; Gosselin MM, 2013, KNEE, V20, P196, DOI 10.1016/j.knee.2012.11.006; Herzog MM, 2017, JAMA PEDIATR, V171, P808, DOI 10.1001/jamapediatrics.2017.0740; Hilska M., 2021, ORTHOP J SPORTS MED, V9, DOI [10.1177/23259671211005769, DOI 10.1177/23259671211005769]; Iversen MD, 2009, SCAND J MED SCI SPOR, V19, P595, DOI 10.1111/j.1600-0838.2008.00817.x; Joy EA, 2013, J STRENGTH COND RES, V27, P2263, DOI 10.1519/JSC.0b013e31827ef12e; Kay R, 2012, COMPUT EDUC, V59, P619, DOI 10.1016/j.compedu.2012.03.007; Larkin P, 2018, J SPORT SCI, V36, P239, DOI 10.1080/02640414.2017.1298827; Lim SL, 2020, PATIENT, V13, P401, DOI 10.1007/s40271-020-00416-9; Mascarenhas DRD, 2005, SPORT PSYCHOL, V19, P131, DOI 10.1123/tsp.19.2.131; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; Mayer RE, 2003, EDUC PSYCHOL-US, V38, P43, DOI 10.1207/S15326985EP3801_6; McGorry A., ACL INJURIES; Mckay CD, 2014, BRIT J SPORT MED, V48, P1281, DOI 10.1136/bjsports-2014-093543; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mitchko J, 2007, AM J HEALTH EDUC, V38, P99, DOI 10.1080/19325037.2007.10598951; Moore WA, 2012, INNOV EDUC TEACH INT, V49, P401, DOI 10.1080/14703297.2012.728876; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Norcross MF, 2016, J SCI MED SPORT, V19, P299, DOI 10.1016/j.jsams.2015.03.009; O'Brien J., 2016, BMJ OPEN SPORT EXERC, V2, DOI [DOI 10.1136/BMJSEM-2015-000075, 10.1136/bmjsem-2015-000075]; Orr B, 2013, SCAND J MED SCI SPOR, V23, P271, DOI 10.1111/j.1600-0838.2011.01381.x; Petushek E., P INT S HUM FACT ERG; Petushek EJ, 2019, AM J SPORT MED, V47, P1744, DOI 10.1177/0363546518782460; Petushek EJ, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115614799; Petushek EJ, 2015, J SPORT EXERCISE PSY, V37, P291, DOI 10.1123/jsep.2014-0315; Petushek EJ, 2015, AM J SPORT MED, V43, P1640, DOI 10.1177/0363546515580791; Pfile KR, 2017, SCAND J MED SCI SPOR, V27, P1950, DOI 10.1111/sms.12828; Pollard CD, 2006, CLIN J SPORT MED, V16, P223, DOI 10.1097/00042752-200605000-00006; Pryor JL, 2017, J SCI MED SPORT, V20, P861, DOI 10.1016/j.jsams.2017.01.235; Shaffer VA, 2018, ANN BEHAV MED, V52, P429, DOI 10.1093/abm/kax008; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shrout PE, 2018, ANNU REV PSYCHOL, V69, P487, DOI 10.1146/annurev-psych-122216-011845; Silva AF, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.663867; Simkovic M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220889; Smagorinsky P, 2014, CAMBRIDGE HANDBOOK OF THE LEARNING SCIENCES, 2ND EDITION, P605; Soomro N, 2016, AM J SPORT MED, V44, P2415, DOI 10.1177/0363546515618372; Stockwell BR, 2015, CELL, V162, P933, DOI 10.1016/j.cell.2015.08.009; Sugimoto D, 2016, BRIT J SPORT MED, V50, P1259, DOI 10.1136/bjsports-2015-095596; Sugimoto D, 2015, BRIT J SPORT MED, V49, P282, DOI 10.1136/bjsports-2014-093461; Sugimoto D, 2012, J ATHL TRAINING, V47, P714, DOI 10.4085/1062-6050-47.6.10; Volandes AE, 2010, MED DECIS MAKING, V30, P29, DOI 10.1177/0272989X09341587; Weiner BJ, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0635-3; Winston K, 2018, PATIENT EDUC COUNS, V101, P558, DOI 10.1016/j.pec.2017.10.009; Wood FB, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.3.e31; Zack ES, 2019, SURV RES METHODS-GER, V13, P215, DOI 10.18148/srm/2019.v13i2.7262	62	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2021	18	17							9092	10.3390/ijerph18179092			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	UN5WD	WOS:000694085700001	34501680	Green Published			2022-02-06	
J	Powell, LE; Gau, J; Glang, A; Corrigan, JD; Ramirez, M; Slocumb, J				Powell, Laurie E.; Gau, Jeff; Glang, Ann; Corrigan, John D.; Ramirez, Meghan; Slocumb, Jody			Staff Traumatic Brain Injury Skill Builder: Evaluation of an Online Training Program for Paraprofessional Staff Serving Adults With Moderate-Severe TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						allied health personnel; education; brain injuries; traumatic; computer-assisted instruction; empirical research; health knowledge; attitudes; practice; internet-based intervention	REHABILITATION; PEOPLE; TECHNOLOGY; DISABILITY; OUTCOMES; SUPPORT	Objective: To evaluate the online, self-guided, interactive Staff TBI Skill Builder training program for paraprofessional staff. Design: A within-subjects, nonexperimental evaluation involving 79 paraprofessionals and professionals working across a range of settings. Participants completed a pretest (T1), a posttest immediately upon program completion (T2), and follow-up (T3) 60 days after program completion. Measures: (1) Knowledge of basic traumatic brain injury facts; (2) knowledge application; (3) self-efficacy in responding to text-based application scenarios; (4) self-report of skill utilization and effectiveness; and (5) program satisfaction (ease-of-use and usefulness). Results: Participants demonstrated high levels of knowledge, knowledge application, and self-efficacy at pretest. Despite the high pretest levels, participants showed significant improvements in knowledge application (d = 0.50) after using the program. Nonsignificant gains in knowledge (d = 0.13) and self-efficacy (d = 0.02) were found. The use of selected skills significantly increased from posttest to follow-up. Participants reported high program satisfaction; 99% of the participants indicated that they would recommend the program to others. Conclusion: These results demonstrate the feasibility of providing interactive, online training for paraprofessionals serving adults with moderate-severe traumatic brain injury.	[Powell, Laurie E.; Gau, Jeff; Glang, Ann; Ramirez, Meghan; Slocumb, Jody] Univ Oregon, Ctr Brain Injury Res & Training, Rainier Bldg,1244 Walnut St,Ste 220, Eugene, OR 97403 USA; [Corrigan, John D.] Ohio State Univ, Ohio Valley Ctr Brain Injury Prevent & Rehabil, Columbus, OH 43210 USA		Powell, LE (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, Rainier Bldg,1244 Walnut St,Ste 220, Eugene, OR 97403 USA.	lpowell@uoregon.edu; jeffg@ori.org; glanga@cbirt.org; johncorrigan1@me.com; ramirezm@cbirt.org; slocumbj@cbirt.org			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90IF0124]	An institutional review board approved this study. The study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research [90IF0124].	Aguilar JM, 2019, J HEAD TRAUMA REHAB, V34, P65, DOI 10.1097/HTR.0000000000000443; Bates MS, 2016, PHI DELTA KAPPAN, V97, P70, DOI 10.1177/0031721716629662; Becker H., 1993, J HEAD TRAUMA REHAB, V8, P88; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bourgeois MS., 2004, CLIN GERONTOLOGIST, V27, P119, DOI DOI 10.1300/J018V27N01_10; Brain Injury Association of America, 2019, FUND CERT; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Campbell S., 2017, RAC GEND DISP WITH D; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cook DA, 2010, ACAD MED, V85, P909, DOI 10.1097/ACM.0b013e3181d6c319; Ducharme JM, 2001, BRAIN INJURY, V15, P333, DOI 10.1080/02699050010005869; Elbogen EB, 2019, J HEAD TRAUMA REHAB, V34, P1, DOI 10.1097/HTR.0000000000000435; Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699; Fixsen D. L., 2005, IMPLEMENTATION RES S, V231; Glang AE, 2019, J HEAD TRAUMA REHAB, V34, P77, DOI 10.1097/HTR.0000000000000447; Irvine AB, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.01.015; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Knepley KD, 2021, TELEMED E-HEALTH, V27, P239, DOI 10.1089/tmj.2020.0019; Laxe S, 2015, NEUROREHABILITATION, V36, P37, DOI 10.3233/NRE-141189; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2; Moehead A, 2020, J MED INTERNET RES, V22, DOI 10.2196/16808; Ohio Valley Center for Brain Injury Prevention and Rehabilitation, ACCOMM SYMPT TBI; Oliver DP, 2017, TELEMED E-HEALTH, V23, P621, DOI 10.1089/tmj.2016.0183; Poulin V, 2019, DISABIL REHABIL, V41, P1955, DOI 10.1080/09638288.2018.1451560; Powell L, 2020, BRAIN INJURY, V34, P281, DOI 10.1080/02699052.2019.1686773; Reeves T.D., 2013, J ED RES POLICY STUD, V1, P50; Richmond H, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1047-4; Rietdijk R, 2020, J TELEMED TELECARE, DOI 10.1177/1357633X20923824; Rietdijk R, 2020, J SPEECH LANG HEAR R, V63, P615, DOI 10.1044/2019_JSLHR-19-00076; Rietdijk R, 2020, J HEAD TRAUMA REHAB, V35, P241, DOI 10.1097/HTR.0000000000000554; Sinclair PM, 2016, INT J NURS STUD, V57, P70, DOI 10.1016/j.ijnurstu.2016.01.011; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Vaezipour A, 2019, J HEAD TRAUMA REHAB, V34, pE67, DOI 10.1097/HTR.0000000000000462; van der Meer L, 2017, AM J SPEECH-LANG PAT, V26, P1279, DOI 10.1044/2017_AJSLP-16-0125	35	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E329	E336		10.1097/HTR.0000000000000661			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300008	33656483	Green Accepted			2022-02-06	
J	Rasidi, EK				Rasidi, Ellen K.			Successful Treatment of Acute Craniodorsal Coxofemoral Luxation in a Scarlet Ibis (Eudocimus ruber) Using Closed Reduction and a Modified Ehmer Sling	JOURNAL OF AVIAN MEDICINE AND SURGERY			English	Article						coxofemoral luxation; Ehmer sling; closed reduction; suspension sling; avian; scarletibis; Eudocimus ruber	FEMORAL-HEAD OSTECTOMY; TOGGLE-PIN TECHNIQUE; JOINT LUXATION; HIP LUXATION; EXCISION ARTHROPLASTY; SURGICAL-TREATMENT; DOGS; STABILIZATION; MANAGEMENT; NECK	Whereas craniodorsal displacement of the coxofemoral joint is the most common luxation reported in small and large mammals, it occurs less often in avian species. Closed reduction and external coaptation with a modified Ehmer sling is the initial treatment, in most cases, for small animals (eg, dogs, cats) that present with a coxofemoral luxation. However, the Ehmer sling is reported to have a low success rate in treating coxofemoral luxations in these animals. Intractable coxofemoral luxations require an open surgical reduction. A few successful closed reductions of coxofemoral luxations have been reported in avian patients, as well as open reduction surgical techniques to repair avian coxofemoral luxations. The successful treatment of an acute craniodorsal coxofemoral luxation in a scarlet ibis (Eudocimus ruber) with a closed reduction and a modified Ehmer sling is described in this clinical report. The specific characteristics of both the patient and the injury are thought to have contributed to the success in this case.	[Rasidi, Ellen K.] Wildlife Reserves Singapore, Dept Conservat Res & Vet Serv, 80 Mandai Lake Rd, Singapore 729826, Singapore		Rasidi, EK (corresponding author), Wildlife Reserves Singapore, Dept Conservat Res & Vet Serv, 80 Mandai Lake Rd, Singapore 729826, Singapore.	ellen.rasidi@wrs.com.sg					Ahmed Ghalib, 2017, Eur J Orthop Surg Traumatol, V27, P1109, DOI 10.1007/s00590-017-1988-7; Altman R. B., 1982, DIS CAGE AVIARY BIRD, V2e, P383; Amitrano FN, 2014, EQUINE VET EDUC, V26, P255, DOI 10.1111/eve.12156; Avery Bennett R., 1997, P733; Azmanis PN, 2014, VET QUART, V34, P11, DOI 10.1080/01652176.2014.905731; Bartlett G, 2003, AUST VET J, V81, P271, DOI 10.1111/j.1751-0813.2003.tb12570.x; BASHER AWP, 1986, VET SURG, V15, P356, DOI 10.1111/j.1532-950X.1986.tb00243.x; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P133; Beckham HP, 1996, J AM VET MED ASSOC, V208, P81; Beebe MJ, 2016, ORTHOP CLIN N AM, V47, P527, DOI 10.1016/j.ocl.2016.02.002; BENNETT D, 1980, J SMALL ANIM PRACT, V21, P373, DOI 10.1111/j.1748-5827.1980.tb01264.x; Bennett RA, 1998, P C INT WILDL REH CO, P11; BERZON JL, 1980, VET SURG, V9, P88, DOI 10.1111/j.1532-950X.1980.tb01661.x; BONE DL, 1984, VET SURG, V13, P263, DOI 10.1111/j.1532-950X.1984.tb00807.x; Bordelon JT, 2005, VET CLIN N AM-SMALL, V35, P1169, DOI 10.1016/j.cvsm.2005.05.007; Burgdorf-Moisuk A, 2011, J AVIAN MED SURG, V25, P210, DOI 10.1647/2010-016.1; Campbell TW, 1987, P 1 C ZOOL AV MED, P277; Chambers JN, 2004, J ZOO WILDLIFE MED, V35, P569, DOI 10.1638/04-012; Clegg PD, 1996, VET REC, V138, P134, DOI 10.1136/vr.138.6.134; Coleman KA, 2015, J EXOT PET MED, V24, P178, DOI 10.1053/j.jepm.2015.04.006; Demko JL, 2006, JAVMA-J AM VET MED A, V229, P984, DOI 10.2460/javma.229.6.984; Ehmer EE, 1934, N AM VET, V15, P31; Evans HE, 2012, MILLERS ANATOMY DOG, V4th, P158; FLYNN MF, 1994, VET SURG, V23, P311, DOI 10.1111/j.1532-950X.1994.tb00490.x; Fossum TW, 2007, SMALL ANIMAL SURG, V3rd, P1246; FRY PD, 1974, J SMALL ANIM PRACT, V15, P661, DOI 10.1111/j.1748-5827.1974.tb05648.x; Gallego M, 2019, J SMALL ANIM PRACT, V60, P631, DOI 10.1111/jsap.12866; Gottlieb M, 2018, J EMERG MED, V54, P339, DOI 10.1016/j.jemermed.2017.12.002; Greenough PR, 1981, LAMENESS CATTLE, V2nd, P269; Grierson J, 2012, J FELINE MED SURG, V14, P23, DOI 10.1177/1098612X11432824; Gumpenberger M, 2012, AVIAN PATHOL, V41, P465, DOI 10.1080/03079457.2012.712205; Hogervorst T, 2009, ACTA ORTHOP, V80, P1, DOI 10.1080/17453690610046620; Kawamata T, 1996, AUST VET J, V74, P460, DOI 10.1111/j.1751-0813.1996.tb07570.x; LUBBE AM, 1990, J SMALL ANIM PRACT, V31, P234, DOI 10.1111/j.1748-5827.1990.tb00791.x; MACCOY DM, 1989, J AM VET MED ASSOC, V194, P95; Manafzadeh AR, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0727; Marchionatti E, 2014, VET CLIN N AM-FOOD A, V30, P247, DOI 10.1016/j.cvfa.2013.11.001; Martin Howard D., 1995, Journal of the Association of Avian Veterinarians, V8, P164; MEIJ BP, 1992, J SMALL ANIM PRACT, V33, P320, DOI 10.1111/j.1748-5827.1992.tb01157.x; Off W, 2010, VET COMP ORTHOPAED, V23, P297; Ozaydin I, 2003, VET SURG, V32, P46, DOI 10.1053/jvet.2003.50009; Pettit G D, 1971, Vet Clin North Am, V1, P503; Peycke L. E., 2011, NAVC Clinician's Brief, P55; Quinteros DD, 2011, VET SURG, V40, P369, DOI 10.1111/j.1532-950X.2011.00812.x; Risi E, 2005, P EUR ASS AVIAN V, P190; Roush J. K., 2015, NAVC Clinician's Brief, P29; Roush JC, 1980, CURRENT VET THERAPY, V7th, P662; Schlag AN, 2019, JAVMA-J AM VET MED A, V254, P1436, DOI 10.2460/javma.254.12.1436; Simpson AM, 2001, COMP CONT EDUC PRACT, V23, P157; Sissener TR, 2009, J SMALL ANIM PRACT, V50, P112, DOI 10.1111/j.1748-5827.2008.00625.x; Smith JS, 2017, VET SURG, V46, P316, DOI 10.1111/vsu.12604; SQUIRE KRE, 1991, VET SURG, V20, P453, DOI 10.1111/j.1532-950X.1991.tb00354.x; Starke A, 2007, VET SURG, V36, P99, DOI 10.1111/j.1532-950X.2006.00224.x; Stauber E, 2008, J AVIAN MED SURG, V22, P346, DOI 10.1647/2008-027.1; TULLENERS EP, 1987, J AM VET MED ASSOC, V191, P569; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; Yazici MF, 2020, J EXOT PET MED, V33, P7, DOI 10.1053/j.jepm.2020.01.001	57	0	0	2	2	ASSOC AVIAN VETERINARIANS	BOCA RATON	PO BOX 811720, BOCA RATON, FL 33481 USA	1082-6742	1938-2871		J AVIAN MED SURG	J. Avian Med. Surg.	SEP	2021	35	3					350	360		10.1647/20-00004			11	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	WC3MN	WOS:000704164200011	34677034				2022-02-06	
J	Robinson, D; Pyle, L; Foreman, B; Ngwenya, LB; Adeoye, O; Woo, D; Kreitzer, N				Robinson, David; Pyle, Logan; Foreman, Brandon; Ngwenya, Laura B.; Adeoye, Opeolu; Woo, Daniel; Kreitzer, Natalie			Antithrombotic regimens and need for critical care interventions among patients with subdural hematomas	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Subdural hematoma; Traumatic brain injury; Neurotrauma; Intracranial hemorrhage	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; SECONDARY OVERTRIAGE; ADULT PATIENTS; ANTIPLATELET; DISCHARGE; DISPOSITION; GUIDELINES; MANAGEMENT; MORTALITY	Background: Antithrombotic-associated subdural hematomas (SDHs) are increasingly common, and the possibil-ity of clinical deterioration in otherwise stable antithrombotic-associated SDH patients may prompt unnecessary admissions to intensive care units. It is unknown whether all antithrombotic regimens are equally associated with the need for critical care interventions. We sought to compare the frequency of critical care interventions and poor functional outcomes among three cohorts of noncomatose SDH patients: patients on no antithrombotics, patients on anticoagulants, and patients on antiplatelets alone. Methods: We performed a retrospective cohort study on all noncomatose SDH patients (Glasgow Coma Scale > 12) presenting to an academic health system in 2018. The three groups of patients were compared in terms of clinical course and functional outcome. Multivariable logistic regression was used to determine predictors of need for critical care interventions and poor functional outcome at hospital discharge. Results: There were 281 eligible patients presenting with SDHs in 2018, with 126 (45%) patients on no antithrombotics, 106 (38%) patients on antiplatelet medications alone, and 49 (17%) patients on anticoagulants. Significant predictors of critical care interventions were coagulopathy (OR 5.1, P < 0.001), presence of contusions (OR 3, P = 0.007), midline shift (OR 3.4, P = 0.002), and maximum SDH thickness (OR 2.4, P = 0.002). Significant predictors of poor functional outcome were age (OR 1.8, P < 0.001), admission Glasgow Coma Scale score (OR 0.3, P < 0.001), dementia history (OR 4.2, P = 0.001), and coagulopathy (OR 3.5, P = 0.02). Isolated antiplatelet use was not associated with either critical care interventions or functional outcome. Conclusion: Isolated antiplatelet use is not a significant predictor of need for critical care interventions or poor functional outcome among SDH patients and should not be used as a criterion for triage to the intensive care unit. (c) 2021 Elsevier Inc. All rights reserved.	[Robinson, David; Foreman, Brandon; Woo, Daniel] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Pyle, Logan] Univ Pittsburgh, Dept Pulmonol & Crit Care, Med Ctr Hamot, Pittsburgh, PA 15260 USA; [Ngwenya, Laura B.; Adeoye, Opeolu] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Adeoye, Opeolu; Kreitzer, Natalie] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45221 USA; [Foreman, Brandon; Ngwenya, Laura B.] Collaborat Res Acute Neurol Injuries, Cincinnati, OH USA		Robinson, D (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA.	Robin2dv@ucmail.uc.edu; pylelm@upmc.edu; foremabo@ucmail.uc.edu; ngwenyla@ucmail.uc.edu; adeoyeo@ucmail.uc.edu; woodl@ucmail.uc.edu; kreitzne@ucmail.uc.edu		Robinson, David/0000-0003-3221-3599	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996-13]	DR reports funding assistance from the National Institute of Neurological Disorders and Stroke, T32NS047996-13. The funders had no role in conducting, analyzing, or reporting these results.	Alford EN, 2019, J NEUROSURG-PEDIATR, V24, P539, DOI 10.3171/2019.5.PEDS18738; Alves JL, 2016, AM J FOREN MED PATH, V37, P174, DOI 10.1097/PAF.0000000000000255; Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Borczuk P, 2019, WEST J EMERG MED, V20, P307, DOI 10.5811/westjem.2018.12.39337; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Egol A, 1999, CRIT CARE MED, V27, P633; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kreitzer NP, 2015, NEUROCRIT CARE, V23, P427, DOI 10.1007/s12028-015-0187-9; Kuhn EN, 2018, WORLD NEUROSURG, V119, pE374, DOI 10.1016/j.wneu.2018.07.168; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Mathieu F, 2020, J NEUROTRAUM, V37, P2069, DOI 10.1089/neu.2019.6911; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Orlando A, 2019, J NEUROSURG, V130, P1626, DOI 10.3171/2018.1.JNS171906; Orlando A, 2017, WORLD NEUROSURG, V107, P94, DOI [10.1016/j.wneu.2017.07.130, 10.1016/J.WNEU.2017.07.130]; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; R Core Team, 2021, R LANG ENV STAT COMP; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Rhame K, 2021, AM J EMERG MED, V46, P176, DOI 10.1016/j.ajem.2020.06.088; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Tang A, 2014, J TRAUMA ACUTE CARE, V77, P969, DOI 10.1097/TA.0000000000000462; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421; Wu C, 2015, WEST J EMERG MED, V16, P707, DOI 10.5811/westjem.2015.7.27458	41	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2021	47						6	12		10.1016/j.ajem.2021.03.035			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UB8SC	WOS:000686108000002	33744487				2022-02-06	
J	Rodowicz, K; Campolettano, ET; Bruno, AG; Schimpf, N; Rogers, MW				Rodowicz, Kathleen; Campolettano, Eamon T.; Bruno, Alexander G.; Schimpf, Nicole; Rogers, Michael W.			Evaluation of the Effect of a Rear Operator Guard on the Overall Safety for Operators of Standup Lift Trucks	ASCE-ASME JOURNAL OF RISK AND UNCERTAINTY IN ENGINEERING SYSTEMS PART B-MECHANICAL ENGINEERING			English	Article							INJURY; ORIENTATION; CONCUSSION; TOLERANCE; FOOTBALL; IMPACTS	Standup high lift trucks have an open operator compartment designed to allow for easy egress from the truck in the event of an off-dock, off-trailer, or tip-over accident. The open compartment design also protects the operator during nontip-over collision accidents, provided the operator maintains him or herself within the compartment before impact. However, it has been suggested that an additional rear operator guard would better protect operators during nontip-over collision accidents. This study aimed to investigate operator injury potential and kinematics during off-dock and off-trailer accidents where the presence of a rear operator guard prevents the operator from exiting the truck and to evaluate the potential for an operator to restrain him or herself within the operator compartment of a standup lift truck during an off-dock or off-trailer accident. An instrumented anthropomorphic test device (ATD) was subjected to a series of off-dock accidents and a single off-trailer accident utilizing three different standup lift trucks. The kinematics and loads experienced by the ATD were quantified and correlated to human injury potential. Additionally, this study examined the potential for a rear operator guard to impede operator egress during an off-dock or off-trailer accident. Testing demonstrated the potential for serious or greater injury to an operator subjected to an off-dock or off-trailer accident. The authors conclude that a rear guard would negatively impact the overall safety of a standup lift truck in most working environments.	[Rodowicz, Kathleen; Campolettano, Eamon T.] Exponent Inc, Biomech Practice, 3440 Market St,Suite 600, Philadelphia, PA 19104 USA; [Bruno, Alexander G.] Exponent Inc, Biomech Practice, 1075 Worcester St, Natick, MA 01760 USA; [Schimpf, Nicole; Rogers, Michael W.] Fusion Engn, 1804 Ctr Point Circle,Suite 112, Naperville, IL 60563 USA		Rodowicz, K (corresponding author), Exponent Inc, Biomech Practice, 3440 Market St,Suite 600, Philadelphia, PA 19104 USA.	krodowicz@exponent.com; ecampolettano@exponent.com; Alexander.g.bruno@gmail.com; nschimpf@fusioneng.com; mrogers@fusioneng.com					Allsop D., 2002, SKULL FACIAL BONE TR, P254; Allsop D.L., 1991, 912907 SAE, DOI [10.4271/912907, DOI 10.4271/912907]; Annett M.S., 2014, EVALUATION 1 TRANSPO; [Anonymous], 2007, J2111 SAE; ANSI/ITSDF, 2020, B561 ANSIITSDF; Berg F.A., P 19 INT C ENH SAF V, P1; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004248; Cormier Joseph, 2010, Ann Adv Automot Med, V54, P3; Crockett J.D., 1995, SAFETY ENG RISK ANAL, P111; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; Davidsson J., 2009, P INT RES C BIOM IMP, P43; Eppinger R, 1999, DEV IMPROVED INJURY, P1; Gennarelli T., 2005, AIS 2005 ABBREVIATED; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Haffner M., 1985, 856028 SAE; Hopper R.H., 1994, SAE T, P1688; Jackson KE, 2004, J AM HELICOPTER SOC, V49, P127, DOI 10.4050/JAHS.49.127; King A.I., P INT RES C BIOM IMP, P1; Laituri T.R., 2005, 2005010297 SAE, DOI [10.4271/2005-01-0297, DOI 10.4271/2005-01-0297]; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh A., 1993, 933112 SAE, DOI [10.4271/933112, DOI 10.4271/933112]; Mertz H.J., 2016, 2016220018 SAE; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; NHTSA, 2008, NHTSA2006265550114; Ommaya A.K., 1985, BIOMECHANICS TRAUMA; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rodowicz K.A., 2011, 2011011125 SAE, DOI [10.4271/2011-01-1125, DOI 10.4271/2011-01-1125]; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; Schneider D, 1972, 720965 SAE, DOI [10.4271/720965, DOI 10.4271/720965]; Silver J.M., 2018, TXB TRAUMATIC BRAIN; Thomas L.M., 1971, COMP HEAD ACCELERATI, P2894; Toney-Bolger M., 2019, SAE TECHNICAL PAPERS, DOI [10.4271/2019-01-1220, DOI 10.4271/2019-01-1220]; Unterharnscheidt F.J., 1971, 710880 SAE, DOI [10.4271/710880, DOI 10.4271/710880]; Werner S., 2001, SAE T, P869; Wiechel J.F., 2014, IMECE201366795 ASME, DOI [10.1115/IMECE2013-66795, DOI 10.1115/IMECE2013-66795]; Wiechel JF, 2016, ASCE-ASME J RISK UNC, V2, DOI 10.1115/1.4031275; Yoganandan N, 2018, TRAFFIC INJ PREV, V19, P165, DOI 10.1080/15389588.2017.1355549; Young JG, 2012, HUM FACTORS, V54, P316, DOI 10.1177/0018720811433585; Young JG, 2009, HUM FACTORS, V51, P705, DOI 10.1177/0018720809355969; Zoghi-Moghadam M., 2008, IMECE200232463 ASME, DOI [10.1115/IMECE2002-32463, DOI 10.1115/IMECE2002-32463]	46	0	0	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	2332-9017	2332-9025		ASCE-ASME J RISK U B	ASCE-ASME J. Risk Uncertain. Eng. Syst. Part B-Mech. Eng.	SEP 1	2021	7	3							031003	10.1115/1.4050429			13	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	TQ9OW	WOS:000678606100004					2022-02-06	
J	Roitsch, J; Prebor, J; Raymer, AM				Roitsch, Jane; Prebor, Jessica; Raymer, Anastasia M.			Cognitive Assessments for Patients With Neurological Conditions: A Preliminary Survey of Speech-Language Pathology Practice Patterns	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							NEUROPSYCHOLOGISTS; COLLABORATION	Purpose: Speech-language pathologists (SLPs) are often responsible for assessing cognitive disorders that affect communication for individuals with diagnosed or suspected acute or degenerative neurological conditions. However, consensus on appropriate assessment tools for various neurological disorders remains elusive. This preliminary survey was conducted to study current practices in the use of published and unpublished tools by SLPs when assessing cognitive-communication impairments across common neurologic conditions. Method: An 18-item web-based survey was sent to SLPs through ASHA Communities and social media, asking them to select which cognitive assessment tools they use to evaluate the cognitive-communication status of individuals with Parkinson's disease, multiple sclerosis, dementia, stroke (i.e., cerebrovascular accident), and traumatic brain injury. The 100 SLPs who completed the online survey represent a spectrum of professionals seeing neurologic patients across the United States. Results: Among the 100 responding SLPs, no unique pattern of assessment tool use was noted across neurologic disorders as indicated by a chi-square analysis. A common set of nonstandardized and observational assessment practices was reported most commonly, regardless of the neurologic condition. Conclusions: This study shows consistent cognitive assessment practices by SLPs across various neurological conditions rather than unique protocols relevant to the patterns typical across disorders. However, the amount of clinical evaluations supported by informal observation and/or the completion of select subtests of standardized assessment tools is considerable. This preliminary information conflicts with principles of rigorous assessment and increases the risk of erroneous findings when identifying cognitive impairments. Further research into the decision-making process of clinician assessment selection is warranted to encourage consistent, evidence-based practice for persons with cognitive impairments. Better recognition of the limitations imposed by providing clinical services that impact the reliability and validity of cognitive assessments can drive future clinical practice policy and practice recommendations.	[Roitsch, Jane; Raymer, Anastasia M.] Old Dominion Univ, Dept Commun Disorders & Special Educ, Norfolk, VA 23529 USA; [Prebor, Jessica] Old Dominion Univ, Sch Rehabil Sci, Norfolk, VA USA		Roitsch, J (corresponding author), Old Dominion Univ, Dept Commun Disorders & Special Educ, Norfolk, VA 23529 USA.	jroitsch@odu.edu		Raymer, Anastasia/0000-0002-5661-8630			Allen C. K., 1996, ALLEN COGNITIVE LEVE; American Speech-Language-Hearing Association, 2019, SLP HLTH CAR SURV RE; American Speech-Language-Hearing Association, COGN COMM REF GUID A; American Speech-Language-Hearing Association, 2004, PREF PRACT PATT PROF; American Speech-Language-Hearing Association, ASHA 2019 SLP HLTH C; Bayles K. A., 2005, J MED SPEECH-LANG PA, V13, P8; Bayles KA., 1994, FUNCTIONAL LINGUISTI; Blake M.L., 2002, APHASIOLOGY, V16, P537, DOI [10.1080/02687030244000194, DOI 10.1080/02687030244000194]; Brown L., 1982, TEST NONVERBAL INTEL; Burns M. S., 1985, RIC EVALUATION COMMU; Casaletto KB, 2017, J INT NEUROPSYCH SOC, V23, P778, DOI 10.1017/S1355617717001060; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Dooley S, 2019, INT J LANG COMM DIS, V54, P729, DOI 10.1111/1460-6984.12485; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Goldman JG, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0055-3; Goodglass H., 2001, BDAE BOSTON DIAGNOST; Hammill D, 1997, COMPREHENSIVE TEST N; Kalb R, 2018, MULT SCLER J, V24, P1665, DOI 10.1177/1352458518803785; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Mattis S, 1988, DEMENTIA RATING SCAL; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Murray L, 2018, NEUROPSYCHOL REHABIL, V28, P309, DOI 10.1080/09602011.2016.1174718; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Paul-Brown D., 2003, EV TREAT COMM COGN D, DOI [10.1044/policy. TR2003-00137, DOI 10.1044/POLICY.TR2003-00137]; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pimental P. A., 2000, MIRBI 2 MINIINVENTOR; Qualtrics, 2019, QUALTR VERS 62020; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P629; Ross D. G., 1986, RIPA ROSS INFORM PRO; Ross-Swain DG., 1996, ROSS INFORM PROCESSI; Sacco K, 2008, J COGN SCI, V9, P111; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Sarno M. T., 1969, FUNCTIONAL COMMUNICA; Saxton J., 1993, SEVERE IMPAIRMENT BA; Tomoeda C., 1993, ARIZONA BATTERY COMM; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Vogel AP, 2010, J EVAL CLIN PRACT, V16, P1183, DOI 10.1111/j.1365-2753.2009.01291.x; WALLACE GL, 1993, ARCH PHYS MED REHAB, V74, P637, DOI 10.1016/0003-9993(93)90163-5; Wallace SJ, 2019, DISABIL REHABIL, V41, P564, DOI 10.1080/09638288.2017.1400593; Wechsler D, 1987, MEMORY SCALE REVISED; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1	42	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	SEP	2021	30	5					2263	2274		10.1044/2021_AJSLP-20-00187			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	UW7WL	WOS:000700363400028	34280040				2022-02-06	
J	Rubakova, AA; Ivanova, GE; Bulatova, MA				Rubakova, A. A.; Ivanova, G. E.; Bulatova, M. A.			ACTIVATION OF SENSORIMOTOR INTEGRATION PROCESSES WITH A BRAIN-COMPUTER INTERFACE	BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY			English	Article						stroke; ideomotor training; exoskeleton; brain-computer interface; neurorehabilitation; sensorimotor integration	MOTOR CORTEX; REHABILITATION; PLASTICITY; STROKE	A BCI-controlled hand exoskeleton activates neuroplasticity mechanisms, promoting motor learning. The contribution of perception to this phenomenon is understudied. The aim of this study was to assess the impact of sensorimotor integration on the effectiveness of neurorehabilitation based on the learning of a hand opening movement by stroke patients using BCI and to investigate the effect of ideomotor training on spasticity in the paretic hand. The study was conducted in 58 patients (median age: 63 (22; 83) years) with traumatic brain injury, ischemic (76%) or hemorrhagic (24%) stroke in the preceding 2 (1.0; 12.0) months. The patients received 15 (12; 21) ideomotor training sessions with a BMI-controlled hand exoskeleton. Hand function was assessed before and after rehabilitation on the Fugl-Meyer, ARAT, Frenchay, FIM, Rivermead, and Ashworth scales. An increase in muscle strength was observed in 40% of patients during flexion and extension of the radiocarpal joint and in 29% of patients during the abduction and adduction of the joint. Muscle strength simultaneously increased during the abduction and adduction of the radiocarpal joint (p < 0.004). Ideomotor training is ineffective for reducing spasticity because no statistically significant reduction in muscle tone was detected. Improved motor performance of the paretic hand was positively correlated with improvements in daily activities. Motor training of the paretic hand with a robotic orthosis activates kinesthetic receptors, restores sensation and improves fine motor skills through better sensorimotor integration.	[Rubakova, A. A.; Ivanova, G. E.; Bulatova, M. A.] Fed Ctr Brain Res & Neurotechnol FMBA, Moscow, Russia		Rubakova, AA (corresponding author), Ostrovityanova 1,Str 10, Moscow 117997, Russia.	sandrabiolog@inbox.ru		Ivanova, Galina/0000-0003-3180-5525			Bertani R, 2017, NEUROL SCI, V38, P1561, DOI 10.1007/s10072-017-2995-5; Chivukula S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00140; Di Pino G, 2014, NAT REV NEUROL, V10, P597, DOI 10.1038/nrneurol.2014.162; Edwards LL, 2019, FRONT INTEGR NEUROSC, V13, DOI 10.3389/fnint.2019.00016; Espenhahn S, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa161; Friedrich J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71779-0; Frolov A, 2012, NEURAL NETW WORLD, V22, P21, DOI 10.14311/NNW.2012.22.002; Frolov AA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00400; Gassert R, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0383-x; Hosp JA, 2013, NEUROSCIENCE, V250, P557, DOI 10.1016/j.neuroscience.2013.06.060; Jacquey L, 2019, FRONT NEUROROBOTICS, V13, DOI 10.3389/fnbot.2019.00098; Koroleva ES, 2019, BYULLETEN SIB MED, V18, P223, DOI 10.20538/1682-0363-2019-2-223-233; Kotov SV, 2015, MANAH KLINICHESKOJ, P15; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Mahoney JR, 2020, J GERONTOL A-BIOL, V75, P581, DOI 10.1093/gerona/glz117; Mazurek KA, 2020, IEEE T NEUR SYS REH, V28, P287, DOI 10.1109/TNSRE.2019.2941574; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Norman SL, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aad724; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Yoshimura N, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120966	20	0	0	0	0	PIROGOV RUSSIAN NATL RESEARCH MEDICAL UNIV	MOSCOW	UL OSTROVITYANOVA, D 1, MOSCOW, 117997, RUSSIA	2500-1094	2542-1204		B RUSS STATE MED U	Bull. Russ. State Med. Univ.	SEP-OCT	2021		5					28	33		10.24075/brsmu.2021.039			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WW7YQ	WOS:000718127400004		hybrid			2022-02-06	
J	Samaiya, PK; Krishnamurthy, S; Kumar, A				Samaiya, Puneet K.; Krishnamurthy, Sairam; Kumar, Ashok			Mitochondrial dysfunction in perinatal asphyxia: role in pathogenesis and potential therapeutic interventions	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Perinatal asphyxia; Hypoxic-ischemic encephalopathy; Mitochondria; Apoptosis; Excitotoxicity; Apoptosome	NEONATAL HYPOXIA-ISCHEMIA; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; 4 HYDROXY-TEMPO; OXIDATIVE DAMAGE; MAGNESIUM-SULFATE; N-ACETYLCYSTEINE; CELL THERAPY; ERYTHROPOIETIN; MINOCYCLINE	Perinatal asphyxia (PA)-induced brain injury may present as hypoxic-ischemic encephalopathy in the neonatal period, and long-term sequelae such as spastic motor deficits, intellectual disability, seizure disorders and learning disabilities. The brain injury is secondary to both the hypoxic-ischemic event and oxygenation-reperfusion following resuscitation. Following PA, a time-dependent progression of neuronal insult takes place in terms of transition of cell death from necrosis to apoptosis. This transition is the result of time-dependent progression of pathomechanisms which involve excitotoxicity, oxidative stress, and ultimately mitochondrial dysfunction in developing brain. More precisely mitochondrial respiration is suppressed and calcium signalling is dysregulated. Consequently, Bax-dependent mitochondrial permeabilization occurs leading to release of cytochrome c and activation of caspases leading to transition of cell death in developing brain. The therapeutic window lies within this transition process. At present, therapeutic hypothermia (TH) is the only clinical treatment available for treating moderate as well as severe asphyxia in new-born as it attenuates secondary loss of high-energy phosphates (ATP) (Solevag et al. in Free Radic Biol Med 142:113-122, 2019; Gunn et al. in Pediatr Res 81:202-209, 2017), improving both short- and long-term outcomes. Mitoprotective therapies can offer a new avenue of intervention alone or in combination with therapeutic hypothermia for babies with birth asphyxia. This review will explore these mitochondrial pathways, and finally will summarize past and current efforts in targeting these pathways after PA, as a means of identifying new avenues of therapeutic intervention.	[Samaiya, Puneet K.] Shri GS Inst Technol & Sci, Dept Pharm, Indore 452003, Madhya Pradesh, India; [Krishnamurthy, Sairam] Banaras Hindu Univ, Neurotherapeut Lab, Pharmaceut Engn & Technol, Indian Inst Technol, Varanasi 221005, Uttar Pradesh, India; [Kumar, Ashok] BHU, Dept Pediat, Inst Med Sci, Varanasi, Uttar Pradesh, India		Samaiya, PK (corresponding author), Shri GS Inst Technol & Sci, Dept Pharm, Indore 452003, Madhya Pradesh, India.	punit.samaiya@gmail.com		SAMAIYA, PUNEET/0000-0001-7836-8807			Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Adams LE, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030489; Aly H, 2015, J PERINATOL, V35, P186, DOI 10.1038/jp.2014.186; Annink KV, 2017, CURR PHARM DESIGN, V23, P5935, DOI 10.2174/1381612823666170918123307; Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Aridas JDS, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12479; Avasiloaiei A, 2013, PEDIATR INT, V55, P589, DOI 10.1111/ped.12121; Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bellos I, 2021, J MATERN-FETAL NEO M, V34, P3080, DOI 10.1080/14767058.2019.1673722; Bhat MA, 2009, PEDIATRICS, V123, pE764, DOI 10.1542/peds.2007-3642; Boruczkowski D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102433; Borutaite V, 2013, FEBS J, V280, P4999, DOI 10.1111/febs.12353; Buller KM, 2009, J NEUROSCI RES, V87, P599, DOI 10.1002/jnr.21890; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Bylicky MA, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6501031; Chen SD, 2012, FREE RADICAL RES, V46, P940, DOI 10.3109/10715762.2012.674640; Chiarotto GB, 2014, BRAIN RES BULL, V106, P1, DOI 10.1016/j.brainresbull.2014.04.010; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chong ZZ, 2004, J CEREBR BLOOD F MET, V24, P728, DOI 10.1097/01.WCB.0000122746.72175.0E; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Colella M, 2016, EARLY HUM DEV, V102, P1, DOI 10.1016/j.earlhumdev.2016.09.001; Cotten CM, 2014, J PEDIATR-US, V164, P973, DOI 10.1016/j.jpeds.2013.11.036; Dai CS, 2017, J ANTIMICROB CHEMOTH, V72, P1635, DOI 10.1093/jac/dkx037; de Oliveira MR, 2018, MOL NEUROBIOL, V55, P6687, DOI 10.1007/s12035-017-0842-6; de Oliveira MR, 2017, MOL NEUROBIOL, V54, P5961, DOI 10.1007/s12035-016-0100-3; DellAnna E, 1997, EXP BRAIN RES, V115, P105, DOI 10.1007/PL00005670; Dewson Grant, 2015, Cold Spring Harb Protoc, V2015, P467, DOI 10.1101/pdb.prot086447; Donega V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112339; Ebenezer ED, 2019, BJOG-INT J OBSTET GY, V126, P21, DOI 10.1111/1471-0528.15848; Edwards AD, 1997, PEDIATR RES, V42, P684, DOI 10.1203/00006450-199711000-00022; Esposti MD, 2003, J BIOL CHEM, V278, P15749, DOI 10.1074/jbc.M209208200; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Farfan N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207800; Fattuoni C, 2015, MOLECULES, V20, P7000, DOI 10.3390/molecules20047000; Feng YZ, 2006, BRAIN RES BULL, V69, P117, DOI 10.1016/j.brainresbull.2005.11.011; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Freitas-Correa L, 2013, STEM CELL RES, V11, P1407, DOI 10.1016/j.scr.2013.09.016; Garcia S, 2020, HISTOL HISTOPATHOL, V35, P789, DOI 10.14670/HH-18-212; Genc S, 2004, RESTOR NEUROL NEUROS, V22, P105; Gonzales-Portillo GS, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00147; Gunn AJ, 2017, PEDIATR RES, V81, P202, DOI 10.1038/pr.2016.198; Herrera-Marschitz M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00047; Horng LY, 2015, BRIT J PHARMACOL, V172, P4741, DOI 10.1111/bph.13248; Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Huttemann M, 2010, EXP NEUROL, V223, P523, DOI 10.1016/j.expneurol.2010.01.020; Hussain Y, 2019, BEHAV BRAIN RES, V361, P113, DOI 10.1016/j.bbr.2018.12.042; Infante SK, 2013, J NEUROSCI RES, V91, P1152, DOI 10.1002/jnr.23224; Iriyama T, 2009, NEUROSCI LETT, V451, P11, DOI 10.1016/j.neulet.2008.12.021; Jameson RA, 2019, CLIN PERINATOL, V46, P187, DOI 10.1016/j.clp.2019.02.008; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Kabatas S, 2018, CELL TRANSPLANT, V27, P1425, DOI 10.1177/0963689718786692; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lafemina MJ, 2006, PEDIATR RES, V59, P680, DOI 10.1203/01.pdr.0000214891.35363.6a; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Leaw B, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00199; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Lespay-Rebolledo C, 2019, NEUROTOX RES, V36, P472, DOI 10.1007/s12640-019-00064-4; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu P, 2017, EXP THER MED, V14, P5629, DOI 10.3892/etm.2017.5243; Lowe DW, 2017, NEUROPHARMACOLOGY, V123, P186, DOI 10.1016/j.neuropharm.2017.06.004; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Maiwald CA, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1566-8; Malhotra A, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1526-0; Malla RR, 2017, J PERINATOL, V37, P596, DOI 10.1038/jp.2017.17; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MEHMET H, 1994, NEUROSCI LETT, V181, P121, DOI 10.1016/0304-3940(94)90574-6; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Min K, 2013, STEM CELLS, V31, P581, DOI 10.1002/stem.1304; Monaco G, 2015, J BIOL CHEM, V290, P9150, DOI 10.1074/jbc.M114.622514; Moss HG, 2018, J CEREBR BLOOD F MET, V38, P950, DOI 10.1177/0271678X18765828; Nair J, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5070099; Newnam KM, 2011, NEWBORN INFANT NURS, V11, P113, DOI 10.1053/j.nainr.2011.07.003; Nie XJ, 2016, NEUROSCI RES, V108, P24, DOI 10.1016/j.neures.2016.01.008; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Oorschot DE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041487; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Pregnolato S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00417; Qin XP, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00088; Raina A, 2016, ACTA PAEDIATR, V105, pe448, DOI 10.1111/apa.13469; Rainaldi MA, 2016, CLIN PERINATOL, V43, P409, DOI 10.1016/j.clp.2016.04.002; Roka A, 2010, EARLY HUM DEV, V86, P361, DOI 10.1016/j.earlhumdev.2010.05.013; Romero J, 2014, NEUROSCI LETT, V565, P42, DOI 10.1016/j.neulet.2013.10.046; Roucou Xavier, 2001, Cardiology Clinics, V19, P45, DOI 10.1016/S0733-8651(05)70194-6; Samaiya PK, 2018, NEUROTOX RES, V34, P121, DOI 10.1007/s12640-018-9873-7; Samaiya PK, 2017, J NEUROL SCI, V375, P58, DOI 10.1016/j.jns.2017.01.021; Samaiya PK, 2016, INT J DEV NEUROSCI, V52, P55, DOI 10.1016/j.ijdevneu.2016.05.005; Samaiya PK, 2015, J BIOENERG BIOMEMBR, V47, P217, DOI 10.1007/s10863-015-9603-2; Seppet E, 2009, INT J MOL SCI, V10, P2252, DOI 10.3390/ijms10052252; Serrenho I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063142; Silveira RC, 2015, J PEDIAT-BRAZIL, V91, pS78, DOI 10.1016/j.jped.2015.07.004; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh LP, 2012, EXP NEUROL, V238, P79, DOI 10.1016/j.expneurol.2012.08.009; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Solevag AL, 2019, FREE RADICAL BIO MED, V142, P113, DOI 10.1016/j.freeradbiomed.2019.04.028; Spandou E, 2005, BRAIN RES, V1045, P22, DOI 10.1016/j.brainres.2005.03.013; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Subiros N, 2012, THER ADV NEUROL DISO, V5, P161, DOI 10.1177/1756285611434926; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tapia-Bustos A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063275; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang XY, 2010, STROKE, V41, P2050, DOI 10.1161/STROKEAHA.110.589051; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wassink G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00040; Wongprayoon P, 2017, CELL MOL LIFE SCI, V74, P3999, DOI 10.1007/s00018-017-2614-x; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	121	0	0	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	DEC	2021	476	12					4421	4434		10.1007/s11010-021-04253-8		SEP 2021	14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	WK0FB	WOS:000691969600001	34472002				2022-02-06	
J	Sarmiento, K; Daugherty, J; Waltzman, D				Sarmiento, Kelly; Daugherty, Jill; Waltzman, Dana			Effectiveness of the CDC HEADS UP online training on healthcare providers' mTBI knowledge and self-efficacy	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Guideline; Physician; Nurse; Education; Training	CONCUSSION MANAGEMENT; COMPUTED-TOMOGRAPHY; MODEL	Background: Many healthcare providers do not consistently implement recommendations contained in clinical guidelines on mild traumatic brain injury (mTBI). As such, the Centers for Disease Control and Prevention (CDC) created the HEADS UP to Healthcare Providers online training to promote uptake of five key recommendations in the CDC Pediatric mTBI Guideline. Methods: Using data from modules in the CDC HEADS UP to Healthcare Providers online training, healthcare providers' self-reported knowledge and self-efficacy prior to and immediately following completion of the training was analyzed. Results: Improvements for 8 out of the 10 knowledge questions had a high level of practical significance. The knowledge question with the highest level of practical significance pre-to post-test improvement was for the key guideline recommendation on neuroimaging (pre-test correct: 70.2%; post-test correct: 87.8%; (p < 0.0001, Cohen's g = 0.39). Four out of the six questions had a self-efficacy level increase of a high level of practical significance (r > 0.50) between the pre-and post-tests. The self-efficacy question with pre-to post-test improvement with the highest level of practical significance was "I am confident in my ability to manage the return to sports progression for my patients" (p < 0.001; r = 0.54). Conclusions: The HEADS UP to Healthcare Providers online training led to significant improvements in knowledge and self-efficacy related to mTBI diagnosis and management. Expanded use of this training among healthcare providers who commonly provide care for pediatric patients with mTBI may be beneficial. Practical Applications: This study highlights several factors guideline developers may take into consideration when creating an implementation tool, such as using health behavior theories, working with partners and key stakeholders, and focusing on digital-based tools. (c) 2021 National Safety Council and Elsevier Ltd. All rights reserved.	[Sarmiento, Kelly; Daugherty, Jill; Waltzman, Dana] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control NCIPC, Div Injury Prevent, Atlanta, GA 30329 USA		Sarmiento, K (corresponding author), 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	KSarmiento@cdc.gov					[Anonymous], 1974, Health Education Monograph, V2, P324; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Babul Shelina, 2020, J Sports Med (Hindawi Publ Corp), V2020, P8896601, DOI 10.1155/2020/8896601; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Campanella P, 2016, EUR J PUBLIC HEALTH, V26, P60, DOI 10.1093/eurpub/ckv122; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Cohen J, 1998, STAT POWER ANAL BEHA; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2010, ADV HEALTH SCI EDUC, V15, P755, DOI 10.1007/s10459-010-9231-x; Donaworth MA, 2016, PHYSICIAN SPORTSMED, V44, P1, DOI 10.1080/00913847.2016.1135039; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Gagliardi AR, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0247-8; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haider Mohammad N, 2017, Concussion, V2, pCNC40, DOI 10.2217/cnc-2017-0001; Halaweish I, 2018, J PEDIATR SURG, V53, P748, DOI 10.1016/j.jpedsurg.2017.07.008; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Leventhal H., 1980, CONTRIB MED PSYCHOL, V2, P7; Liang L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0668-7; Liang L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0557-0; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Richmond H, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1047-4; So JY, 2013, HEALTH COMMUN, V28, P72, DOI 10.1080/10410236.2012.708633; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Ventola C Lee, 2014, P T, V39, P356	30	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2021	78						221	228		10.1016/j.jsr.2021.04.004			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	UA7LR	WOS:000685340100022	34399918				2022-02-06	
J	Sellier, A; Beucler, N; Desse, N; Julien, C; Tannyeres, P; Bernard, C; Joubert, C; Dagain, A				Sellier, A.; Beucler, N.; Desse, N.; Julien, C.; Tannyeres, P.; Bernard, C.; Joubert, C.; Dagain, A.			Evaluation of neurosurgical training of French military surgeons prior to their deployment	NEUROCHIRURGIE			English	Article						Traumatic brain injury; Decompressive craniectomy; War surgery; Surgical training; Pre-deployment training; Neurosurgical damage control	SALVAGE CRANIOTOMY; OPERATIONS; US	Background. - A specific training course was formalized in 2007 in order to facilitate the management of cranio-encephalic injuries by French military general surgeons during deployment, within the Advanced Course for Deployment Surgery (ACDS). The objective is to evaluate the neurosurgical pre-deployment training course attended by the military surgeons. Methods. - From June 2019 to September 2019, we conducted a cross-sectional survey in the form of adigital self-completed questionnaire, addressed to all graduated military surgeons working in the French Military Training Hospitals. The survey included: (1) a knowledge assessment; and (2) a self-assessment of the training course. The participating surgeons were classified into two groups according to their participation (group 1) or not (group 2) in the neurosurgical module. The main outcome was the score received on the knowledge assessment. Results. - Among the 145 military surgeons currently in service, 76 participated in our study (53%), of which 49 were classified in group 1 (64%) and 27 in group 2 (36%). Group 1 surgeons had a significantly higher score than Group 2 at the knowledge assessment (mean 21.0 +/- 7.1 vs. 17.8 +/- 6.0, P = 0.041). The most successful questions were related to TBI diagnosis and surgical technique, while the least successful questions dealt with "beyond emergency care" and surgical indications. Conclusion. - The French pre-deployment neurosurgical training course provides a strong neurosurgical background, sufficient to perform life-saving procedures in a modern conflict situation. However, neurosurgical specialized advice should be solicited whenever possible to assist the in-theatre surgeon in surgical decisions. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Sellier, A.; Beucler, N.; Desse, N.; Bernard, C.; Joubert, C.; Dagain, A.] St Anne Mil Hosp, Dept Neurosurg, 1 Blvd St Anne,BP 600, F-8800 Toulon 9, France; [Julien, C.] St Anne Mil Hosp, Dept Visceral Surg, Toulon, France; [Tannyeres, P.] French Mil Hlth Serv, Army Med Ctr 9, Med Unit 144, Canjuers, France; [Dagain, A.] Ecole Val de Grace, French Mil Hlth Serv Acad, Paris, France		Sellier, A (corresponding author), St Anne Mil Hosp, Dept Neurosurg, 1 Blvd St Anne,BP 600, F-8800 Toulon 9, France.	aurore.sellier@live.fr					Almairac F, 2014, J VISC SURG, V151, P229, DOI 10.1016/j.jviscsurg.2014.03.010; [Anonymous], 2014, J CHIRE VISCERALE, V151, P504, DOI [10.1016/j.jchirv.2014.10.002.460, DOI 10.1016/J.JCHIRV.2014.10.002.460]; Bonnet S, 2016, J ROY ARMY MED CORPS, V162, P343, DOI 10.1136/jramc-2015-000528; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P183, DOI 10.1136/jramc-2018-000971; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P133, DOI 10.1136/jramc-2017-000881; Dagain A, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18368; Dulou R, 2018, MED ARMEES, V46, P433; Dulou R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1016; Haverkamp FJC, 2018, WORLD J SURG, V42, P3493, DOI 10.1007/s00268-018-4651-5; Hoencamp R, 2014, EUR J TRAUMA EMERG S, V40, P421, DOI 10.1007/s00068-014-0401-z; Hornez E, 2014, J VISC SURG, V151, P481, DOI 10.1016/j.jviscsurg.2014.09.004; Joubert C, 2016, ACTA NEUROCHIR, V158, P1453, DOI 10.1007/s00701-016-2843-z; Mathieu L, 2015, INT ORTHOP, V39, P1887, DOI 10.1007/s00264-015-2741-7; Mauer UM, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1010; Pons F., 2007, E MEMOIRES ACAD NATL, V6, P49; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Tyler JA, 2010, J AM COLL SURGEONS, V211, P658, DOI 10.1016/j.jamcollsurg.2010.07.009	17	0	0	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	SEP	2021	67	5					454	460		10.1016/j.neuchi.2021.03.005			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UJ6KD	WOS:000691391500009	33766563				2022-02-06	
J	Shi, D; Shen, C; Wu, JY; Xu, F; Feng, ZZ; Xiang, DC; Li, JJ; Chen, JH				Shi, Dan; Shen, Chen; Wu, Jiayu; Xu, Feng; Feng, Zhizhong; Xiang, Dingchao; Li, Jianjun; Chen, Junhui			Evaluation of Prognosis of Coma Patients With Acute Brain Injury by Electroencephalogram Bispectral Index Monitoring	JOURNAL OF TRAUMA NURSING			English	Article						Bispectral Index; Brain injury; Full Outline of UnResponsiveness; Glasgow Coma Scale; Glasgow Outcome Scale; Prognosis	SCALE; HYPOTHERMIA; VALUES	Background: The high mortality rate of comatose patients with traumatic brain injury is a prominent public health issue that negatively impacts patients and their families. Objective, reliable tools are needed to guide treatment decisions and prioritize resources. Objective: This study aimed to evaluate the prognostic value of the bispectral index (BIS) in comatose patients with severe brain injury. Methods: This was a retrospective cohort study of 84 patients with severe brain injury and Glasgow Coma Scale (GCS) scores of 8 and less treated from January 2015 to June 2017. Sedatives were withheld at least 24 hr before BIS scoring. The BIS value, GCS scores, and Full Outline of UnResponsiveness (FOUR) were monitored hourly for 48 hr. Based on the Glasgow Outcome Scale (GOS) score, the patients were divided into poor (GOS score: 1-2) and good prognosis groups (GOS score: 3-5). The correlation between BIS and prognosis was analyzed by logistic regression, and the receiver operating characteristic curves were plotted. Results: The mean (SD) of the BIS value: 54.63 (11.76), p = .000; and GCS score: 5.76 (1.87), p = .000, were higher in the good prognosis group than in the poor prognosis group. Lower BIS values and GCS scores were correlated with poorer prognosis. Based on the area under the curve of receiver operating characteristic curves, the optimal diagnostic cutoff value of the BIS was 43.6, and the associated sensitivity and specificity were 85.4% and 74.4%, respectively. Conclusion: Taken together, our study indicates that BIS had good predictive value on prognosis. These findings suggested that BIS could be used to evaluate the severity and prognosis of severe brain injury.	[Shi, Dan] Fifth Peoples Hosp Wuxi City, Dept Neurol, Wuxi, Jiangsu, Peoples R China; [Shen, Chen; Xu, Feng; Feng, Zhizhong; Xiang, Dingchao; Chen, Junhui] 904th Hosp Joint Logist Support Force PLA, Dept Neurosurg, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China; [Wu, Jiayu] 904th Hosp Joint Logist Support Force PLA, Dept Neurol, Wuxi, Jiangsu, Peoples R China; [Li, Jianjun] Peoples Hosp Huishan Dist, Dept Nephrol, Wuxi, Jiangsu, Peoples R China		Chen, JH (corresponding author), 904th Hosp Joint Logist Support Force PLA, Dept Neurosurg, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China.	stone499@163.com; 3988332743@qq.com; 4388974662@qq.com; 369422379@qq.com; 3699644217@qq.com; 188146799@qq.com; 4799612865@qq.com; chen_junhui598@21cn.com			Wuxi Science and technology Development Fund [CSE31N1617]	This study was funded by the Wuxi Science and technology Development Fund (CSE31N1617).	Baldesi O, 2004, EUR J ANAESTH, V21, P324, DOI 10.1017/S0265021504254126; Bigham C., 2012, J INTENSIVE CARE SOC, V13, P314; Chen JH, 2018, EXP THER MED, V15, P4253, DOI 10.3892/etm.2018.5994; Dong L, 2016, CLIN NEUROL NEUROSUR, V148, P42, DOI 10.1016/j.clineuro.2016.06.004; Dou L, 2014, WORLD J EMERG MED, V5, P53, DOI [10.5847/wjem.j.issn.1920-8642.2014.01.009, 10.5847/wjem.j.1920-8642.2014.01.009]; Duarte Leonardo Teixeira Domingues, 2009, Rev. Bras. Anestesiol., V59, P99, DOI 10.1590/S0034-70942009000100013; Dunham CM, 2006, CRIT CARE, V10, DOI 10.1186/cc5097; Gao DQ, 2009, CHIN J CEREBROVASC D, V6, P620; Hayashi K, 2019, J CLIN MONIT COMPUT, V33, P1097, DOI 10.1007/s10877-018-00244-1; Ho KM, 2018, J NEUROSURG SCI, V62, P593, DOI 10.23736/S0390-5616.18.04436-3; Jain N., 2020, BISPECTRAL INDEX, DOI [10.4103/0259-1162.186600, DOI 10.4103/0259-1162.186600]; Johansen JW, 2000, ANESTHESIOLOGY, V93, P1336, DOI 10.1097/00000542-200011000-00029; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Li SJ, 2019, J NEUROSCI NURS, V51, P74, DOI 10.1097/JNN.0000000000000424; Lopez MG, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2021-5; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P71, DOI 10.2147/OAEM.S164221; Mahmood S, 2017, BRAIN INJURY, V31, P1382, DOI 10.1080/02699052.2017.1330966; Mahmood Saeed, 2014, Surg Neurol Int, V5, P141, DOI 10.4103/2152-7806.141890; Mathew JP, 2001, J CLIN ANESTH, V13, P301, DOI 10.1016/S0952-8180(01)00275-6; Medical Advisory Secretariat, 2004, Ont Health Technol Assess Ser, V4, P1; Miao WL, 2018, BRAIN INJURY, V32, P1135, DOI 10.1080/02699052.2018.1476732; Mullaguri N, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01988-7; Rogers JM, 2019, CLIN EEG NEUROSCI, V50, P196, DOI 10.1177/1550059418790708; Sanz-Garcia A, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aadeea; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vivien B, 2003, ANESTHESIOLOGY, V99, P9, DOI 10.1097/00000542-200307000-00006; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Xi CH, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0510-z; Yan KX, 2018, WORLD NEUROSURG, V110, pE671, DOI 10.1016/j.wneu.2017.11.079; Yang Na, 2011, Zhonghua Yi Xue Za Zhi, V91, P2849	31	0	0	6	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	SEP-OCT	2021	28	5					298	303		10.1097/JTN.0000000000000607			6	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	UM5GU	WOS:000693360000006	34491945				2022-02-06	
J	Shively, SB; Priemer, DS; Stein, MB; Perl, DP				Shively, Sharon Baughman; Priemer, David S.; Stein, Murray B.; Perl, Daniel P.			Pathophysiology of Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Neuropsychiatric Clinical Expression	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury (TBI); Chronic traumatic encephalopathy (CTE); Posttraumatic stress disorder (PTSD); Dementia; Tauopathy	POSTTRAUMATIC-STRESS-DISORDER; GLYMPHATIC PATHWAY; ALZHEIMERS-DISEASE; TAU PATHOLOGY; AXONAL INJURY; WHITE-MATTER; PROPAGATE; TAUOPATHY; PRIONS; SYSTEM		[Priemer, David S.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Priemer, David S.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Stein, Murray B.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, F Edward Hebert Sch Med, 4301 Jones Bridge Rd,Room B-3138, Bethesda, MD 20814 USA		Perl, DP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, F Edward Hebert Sch Med, 4301 Jones Bridge Rd,Room B-3138, Bethesda, MD 20814 USA.	daniel.perl@usuhs.edu			Defense Health Agency, U.S. Department of DefenseUnited States Department of Defense	The authors thank Sofia Echelmeyer for her artistry in the illustrations. Funding,in part, was provided by the Defense Health Agency, U.S. Department of Defense.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alosco ML, 2020, ACTA NEUROPATHOL, V140, P495, DOI 10.1007/s00401-020-02197-9; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bonanni L, 2018, J ALZHEIMERS DIS, V63, P203, DOI 10.3233/JAD-171134; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M, 1949, PUNCH DRUNK SYNDROME; Desmarais P, 2020, AM J GERIAT PSYCHIAT, V28, P48, DOI 10.1016/j.jagp.2019.08.006; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gunak MM, 2020, BRIT J PSYCHIAT, V217, P600, DOI 10.1192/bjp.2020.150; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Sheynin J, 2017, NEUROSCI LETT, V649, P133, DOI 10.1016/j.neulet.2016.11.014; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Stahl S., 2013, STAHLS ESSENTIAL PSY; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tsartsalis S, 2018, NEUROBIOL AGING, V62, P34, DOI 10.1016/j.neurobiolaging.2017.10.002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Venneti S, 2010, CLIN LAB MED, V30, P293, DOI 10.1016/j.cll.2009.11.002; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	49	0	0	4	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2021	44	3			SI		443	458		10.1016/j.psc.2021.04.003			16	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	TY1FN	WOS:000683529700011	34373000				2022-02-06	
J	Slovic, Z; Vitosevic, K; Todorovic, D; Vuletic, M; Todorovic, M				Slovic, Zivana; Vitosevic, Katarina; Todorovic, Danijela; Vuletic, Milena; Todorovic, Milos			ANALYSIS OF CRANIO-CEREBRAL INJURIES AND MORTALITY PATTERN IN ROAD TRAFFIC ACCIDENTS- RETROSPECTIVE, AUTOPSY STUDY	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						cranio-cerebral injuries; brain injuries; road traffic accidents; autopsy	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; EPIDEMIOLOGY	Objectives. The aim of this study was to evaluate the prevalence and characteristics of cranio-cerebral injuries among road traffic subjects. Methods. This was a retrospective, analytical, epidemiological and cross-sectional study that investigated road traffic deaths for period between 2001-2016 year. This study included 525 subjects, who died as a result trauma following road traffic Results. In the study sample, 64.6% (339/525) of subjects suffered from cranio-cerebral injuries. There were 256 (75.5%) men and 83 (24.5%) women. Pedestrians, bicyclists and motorcyclists were the most vulnerable participants when it comes to skull bone fractures and brain tissue injuries. From the total number of 525, 55.4% subjects died at the scene of the accident or on their way to the hospital, while 44.6% subjects survived the injuries for a certain period of time. Trimodal distribution of dying was observed: at the scene of the accident, after 6 hours, and after 7 days. Cranio-cerebral injury was the leading cause of death in the group of subjects who died at the scene of the accident and in the group of subjects who survived the injuries for the certain period of time. It was observed that the brainstem lacerations, skull fractures destructions, brain tissue destructions, simultaneous occurrence of cranio-cerebral, chest and abdominal injury or simultaneous occurrence of cranio-cerebral and abdominal injury in a higher percentage lead to death at the scene. Conclusion. Recognition of these features would be useful in designing effective accident prevention strategies and in hospital treatment of RTA trauma patients.	[Slovic, Zivana; Vitosevic, Katarina; Todorovic, Milos] Univ Kragujevac, Fac Med Sci, Dept Forens Med, Kragujevac, Serbia; [Todorovic, Danijela] Univ Kragujevac, Fac Med Sci, Dept Genet, Kragujevac, Serbia; [Vuletic, Milena] Univ Kragujevac, Fac Med Sci, Dept Pathol, Kragujevac, Serbia		Slovic, Z (corresponding author), Univ Kragujevac, Fac Med Sci, Svetozara Markovica 69, Kragujevac 34000, Serbia.	zivanaminic@yahoo.com					Alexis RJ, 2018, J EMERG TRAUMA SHOCK, V11, P205, DOI 10.4103/JETS.JETS_127_17; Andersson AK, 2011, ACCIDENT ANAL PREV, V43, P284, DOI 10.1016/j.aap.2010.08.025; Carson HJ, 2009, J FORENSIC LEG MED, V16, P115, DOI 10.1016/j.jflm.2008.08.013; Chattopadhyay Saurabh, 2010, J Inj Violence Res, V2, P99, DOI 10.5249/jivr.v2i2.46; Clarke DD, 2010, ACCIDENT ANAL PREV, V42, P764, DOI 10.1016/j.aap.2009.11.008; Cvetanovic D, 1991, Vojnosanit Pregl, V48, P23; Daskal Y, 2018, CHIN J TRAUMATOL, V21, P273, DOI 10.1016/j.cjtee.2018.03.001; Berrones-Sanz LD, 2017, GAC MED MEX, V153, P662, DOI [10.24875/GMM.017002812, 10.24875/GMM.17002812]; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; DiMaio JV, 2001, FORENSIC PATHOLOGY; Du RY, 2020, J NEUROSURG-PEDIATR, V25, P361, DOI 10.3171/2019.10.PEDS19377; Faduyile Francis, 2017, Open Access Maced J Med Sci, V5, P112, DOI 10.3889/oamjms.2017.025; Farooqui JM, 2013, AUSTRALAS MED J, V6, P476, DOI 10.4066/AMJ.2013.1839; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Gupta S, 2018, TRAFFIC INJ PREV, V19, P66, DOI 10.1080/15389588.2017.1342821; Hamzeh B, 2016, CHIN J TRAUMATOL, V19, P70, DOI 10.1016/j.cjtee.2015.12.007; Kim SC, 2019, TRAFFIC INJ PREV, V20, P581, DOI 10.1080/15389588.2018.1539840; Kronsbein K, 2020, INT J LEGAL MED, V134, P295, DOI 10.1007/s00414-019-02187-x; Leijdesdorff HA, 2014, J NEUROTRAUM, V31, P459, DOI [10.1089/NEU.2013.3111, 10.1089/neu.2013.3111]; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Menon Anand, 2008, J Forensic Leg Med, V15, P75, DOI 10.1016/j.jflm.2007.06.001; Ndiaye A, 2009, FORENSIC SCI INT, V184, P21, DOI 10.1016/j.forsciint.2008.11.007; Olds K, 2015, J FORENSIC LEG MED, V34, P99, DOI 10.1016/j.jflm.2015.05.018; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pfeifer R, 2017, WORLD J SURG, V41, P3111, DOI 10.1007/s00268-017-4122-4; Reddy SP, 2019, TRAFFIC INJ PREV, V20, P690, DOI 10.1080/15389588.2019.1643016; Rudy BS, 2012, AM J FOREN MED PATH, V33, P268, DOI 10.1097/PAF.0b013e318264b1b8; Shkrum JM, 2007, FORENSIC PATHOLOGY T; Slovic Z, 2020, SERBIAN J EXPT CLIN, DOI [10.2478/sjecr-2020-0052, DOI 10.2478/SJECR-2020-0052]; Slovic ZS, 2021, VOJNOSANIT PREGL, V78, P215, DOI 10.2298/VSP180626064S; Toro K, 2005, FORENSIC SCI INT, V151, P151, DOI 10.1016/j.forsciint.2005.01.014; Van Deynse H, 2019, BRAIN INJURY, V33, P1234, DOI 10.1080/02699052.2019.1641224; Vijay Kumar AG, 2018, INT J FORENS SCI, V3; Wang JW, 2018, MED SCI MONITOR, V24, P3256, DOI 10.12659/MSM.908728; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3	37	0	0	0	0	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	SEP	2021	29	3					287	294		10.4323/rjlm.2021.287			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	YL3LF	WOS:000745795300008					2022-02-06	
J	Solberg, ME; Riggio, S				Solberg, Megan E.; Riggio, Silvana			Neurobehavior and Mild Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Postconcussive syndrome; Neuropsychiatric disorders; Depression; Cognition; Sleep disorders	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; HEAD-INJURY; CONCUSSION; SYMPTOMS; PREDICTORS; IMPACT; POPULATION; PREVALENCE; RISK		[Solberg, Megan E.] Univ Denver, Morgridge Coll Educ, Dept Counseling Psychol, 1999 East Evans Ave, Denver, CO 80208 USA; [Riggio, Silvana] Mt Sinai Sch Med, Dept Psychiat, One Gustave L Levy Pl,Box 1230, New York, NY 10029 USA; [Riggio, Silvana] Mt Sinai Sch Med, Dept Neurol, One Gustave L Levy Pl,Box 1230, New York, NY 10029 USA; [Riggio, Silvana] James J Peters VAMC, Dept Psychiat, 130 West Kingsbridge Rd, Bronx, NY USA		Riggio, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, 1425 Madison Ave, New York, NY 10029 USA.	silvana.riggio@mountsinai.org					Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carney N, 2014, NEUROSURGERY, V75, pS1, DOI 10.1227/NEU.0000000000000434; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; RIGGIO S, 1995, ADV NEUROL, V66, P153; Roy D, 2019, BRAIN INJURY, V33, P1064, DOI 10.1080/02699052.2019.1606447; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Singh R, 2019, BRAIN INJURY, V33, P584, DOI 10.1080/02699052.2019.1566837; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V131, P17; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557	31	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2021	44	3			SI		459	468		10.1016/j.psc.2021.04.004			10	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	TY1FN	WOS:000683529700012	34373001				2022-02-06	
J	Sulimai, N; Brown, J; Lominadze, D				Sulimai, Nurul; Brown, Jason; Lominadze, David			The Effects of Fibrinogen's Interactions with Its Neuronal Receptors, Intercellular Adhesion Molecule-1 and Cellular Prion Protein	BIOMOLECULES			English	Article						mitochondrial activation; neuronal death; proinflammatory cytokine; nitrite; proximity ligation; ROS	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL-CELLS; EXPRESSION; ASTROCYTES; ICAM-1	Neuroinflammatory diseases, such as Alzheimer's disease (AD) and traumatic brain injury (TBI), are associated with the extravascular deposition of the fibrinogen (Fg) derivative fibrin and are accompanied with memory impairment. We found that during the hyperfibrinogenemia that typically occurs during AD and TBI, extravasated Fg was associated with amyloid beta and astrocytic cellular prion protein (PrP(C)). These effects coincided with short-term memory (STM) reduction and neurodegeneration. However, the mechanisms of a direct Fg-neuron interaction and its functional role in neurodegeneration are still unclear. Cultured mouse brain neurons were treated with Fg in the presence or absence of function-blockers of its receptors, PrP(C) or intercellular adhesion molecule-1 (ICAM-1). Associations of Fg with neuronal PrP(C) and ICAM-1 were characterized. The expression of proinflammatory marker interleukin 6 (IL-6) and the generation of reactive oxygen species (ROS), mitochondrial superoxide, and nitrite in neurons were assessed. Fg-induced neuronal death was also evaluated. A strong association of Fg with neuronal PrP(C) and ICAM-1, accompanied with overexpression of IL-6 and enhanced generation of ROS, mitochondrial superoxide, and nitrite as well as the resulting neuronal death, was found. These effects were reduced by blocking the function of neuronal PrP(C) and ICAM-1, suggesting that the direct interaction of Fg with its neuronal receptors can induce overexpression of IL-6 and increase the generation of ROS, nitrite, and mitochondrial superoxide, ultimately leading to neuronal death. These effects can be a mechanism of neurodegeneration and the resultant memory reduction seen during TBI and AD.	[Sulimai, Nurul; Brown, Jason; Lominadze, David] Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33612 USA; [Lominadze, David] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA		Lominadze, D (corresponding author), Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33612 USA.; Lominadze, D (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA.	nurulsulimai@usf.edu; jasonb3@usf.edu; dlominadze@usf.edu		Lominadze, David/0000-0002-9911-4539	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL146832]	This work was supported by the NIH grant # HL146832.	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Avery S., 2012, SYST BIOL FREE RADIC, P89, DOI [10.1007/978-3-642-30018-9_3, DOI 10.1007/978-3-642-30018-9_3]; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Charkviani M, 2020, J NEUROPHYSIOL, V124, P536, DOI 10.1152/jn.00224.2020; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Clark VD, 2018, BRAIN RES, V1699, P158, DOI 10.1016/j.brainres.2018.08.023; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fu BMM, 2003, AM J PHYSIOL-HEART C, V284, pH2124, DOI 10.1152/ajpheart.00894.2002; Harley SL, 2000, ARTERIOSCL THROM VAS, V20, P652, DOI 10.1161/01.ATV.20.3.652; Harley SL, 2000, ENDOTHELIUM-NEW YORK, V7, P149, DOI 10.3109/10623320009072209; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; HERY C, 1995, J NEUROIMMUNOL, V57, P101, DOI 10.1016/0165-5728(94)00168-N; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Jang E, 2013, J IMMUNOL, V191, P5204, DOI 10.4049/jimmunol.1301637; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Jing L, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0035-2; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kauffman Megan E, 2016, React Oxyg Species (Apex), V2, P361, DOI 10.20455/ros.2016.865; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Lominadze D, 2005, AM J PHYSIOL-HEART C, V288, pH1257, DOI 10.1152/ajpheart.00856.2004; Marchant RE, 2002, CURR PROTEIN PEPT SC, V3, P249, DOI 10.2174/1389203023380611; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Muradashvili N, 2021, BRAIN RES, V1751, DOI 10.1016/j.brainres.2020.147208; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Muradashvili N, 2016, J PHYSIOL-LONDON, V594, P5941, DOI 10.1113/JP272558; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, AM J PHYSIOL-CELL PH, V307, pC169, DOI 10.1152/ajpcell.00305.2013; Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166; Onodera T, 2017, P JPN ACAD B-PHYS, V93, P155, DOI 10.2183/pjab.93.010; PEREZ RL, 1995, J IMMUNOL, V154, P1879; POTSCHKA M, 1987, ANAL BIOCHEM, V162, P47, DOI 10.1016/0003-2697(87)90009-1; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Scholz D, 1996, CELL TISSUE RES, V284, P415, DOI 10.1007/s004410050602; Sulimai N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052391; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yates RL, 2017, ANN NEUROL, V82, P259, DOI 10.1002/ana.24997	51	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	SEP	2021	11	9							1381	10.3390/biom11091381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UU8VV	WOS:000699073400001	34572594	Green Published, gold			2022-02-06	
J	Suroto, H; Antoni, I; Siyo, A; Steendam, TC; Prajasari, T; Mulyono, HB; De Vega, B				Suroto, Heri; Antoni, Irene; Siyo, Angelina; Steendam, Tawatha C.; Prajasari, Tabita; Mulyono, Herlambang Budi; De Vega, Brigita			Traumatic Brachial Plexus Injury in Indonesia: An Experience from a Developing Country	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Article; Early Access						traumatic brachial plexus injury; brachial plexus neuropathies; epidemiologic studies; developing countries; nerve reconstruction; reconstructive surgery	VISUAL ANALOG SCALE; EPIDEMIOLOGY; LESIONS; RELIABILITY; TRANSFERS; PALSY	Background Brachial plexus injuries (BPI) cause severe physical disability and major psycho-socioeconomic burden. Although various countries have reported BPI incidence, the data from Indonesia as the fourth most populated country in the world remains unknown. We aim to assess the distribution of traumatic BPI, patients' characteristics, and treatment modalities in Indonesia. Methods A retrospective investigation was performed comprising 491 BPI patients at a tertiary referral hospital in Indonesia from January 2003 to October 2019. Demographic and outcomes data were retrieved from medical records. Results The average BPI patients' age was 27.311.6 years old, with a male/female ratio of 4.6:1. Motorcycle accidents caused the majority (76.1%) of all BPI cases. Concomitant injuries were present in 62.3% of patients, dominated by fractures (57.1%) and brain injuries (25.4%). BPI lesion type was classified into complete (C5-T1, observed in 70% patients), upper (C5-C6, in 15% patients), extended upper (C5-C7, in 14% patients), and lower type (C8-T1, in 1% patients). The average time to surgery was 16.8 months (range 1-120 months), with the majority (76.6%) of the patients was operated on six months after the trauma. Free functional muscle transfer (FFMT) was the most common procedure performed (37%). We also analyzed the functional outcomes (active range of motion (AROM) and muscle power), DASH (Disabilities of the Arm, Shoulder, and Hand) score, and VAS (Visual Analogue Scale) across four most frequent procedures involving nerve reconstruction (FFMT, nerve transfer, external neurolysis, and nerve grafting). We found that FFMT was significantly better than nerve transfer in terms of DASH score and VAS ( p =0.000 and p =0.016, respectively) in complete BPI (C5-T1). Moreover, we also found that nerve grafting resulted in a significantly better shoulder abduction AROM than nerve transfer and external neurolysis in extended upper BPI (C5-C7) ( p =0.033 and p =0.033, respectively). Interestingly, no significant differences were observed in other measurements. Conclusion This study provides an overview of traumatic BPI patients in a single tertiary trauma center in Indonesia, expressing the profile of their characteristics and functional outcomes after surgical procedures.	[Suroto, Heri; Prajasari, Tabita] Univ Airlangga, Dept Orthopaed & Traumatol, Dr Soetomo Gen Acad Hosp, Fac Med, Surabaya, Indonesia; [Antoni, Irene; Siyo, Angelina; De Vega, Brigita] Dr Soetomo Gen Acad Hosp, Cell & Tissue Bank Regenerat Med, Surabaya, Indonesia; [Steendam, Tawatha C.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Mulyono, Herlambang Budi] Univ Cendrawasih, Fac Med, Jayapura Papua, Indonesia; [De Vega, Brigita] UCL, Inst Orthopaed & Musculoskeletal Sci, London, England		Suroto, H (corresponding author), Univ Airlangga, Dept Orthopaed & Traumatol, Dr Soetomo Gen Acad Hosp, Fac Med, Surabaya, Indonesia.	heri-suroto@fk.unair.ac.id		De Vega, Brigita/0000-0003-4350-8480; Suroto, Heri/0000-0002-9384-897X	Orthopedic and Traumatology Department of Dr. Soetomo General Hospital (Surabaya, Indonesia)	We would like to express our gratitude to the Orthopedic and Traumatology Department of Dr. Soetomo General Hospital (Surabaya, Indonesia) for supporting this study and Ms. Evlyn Santoso (administrative staff of Cell and Tissue Bank Dr. Soetomo General Hospital Surabaya) for her editing assistance.	Adeleye AO, 2019, TRAFFIC INJ PREV, V20, P211, DOI 10.1080/15389588.2018.1553085; Adyaksa G, 2021, ANN MED SURG, V63, DOI 10.1016/j.amsu.2021.02.002; Ayhan E, 2020, MICROSURG, V40, P79, DOI 10.1002/micr.30440; Barrie Kimberly A, 2004, Neurosurg Focus, V16, pE8; Beaton D E, 2001, J Hand Ther, V14, P128; Bertelli JA, 2017, J HAND SURG-AM, V42, P443, DOI [10.1016/j.jhsa.2017.03.021, 10.1016/j.jhsa.2017.01021]; Bhandari P S, 2009, Indian J Plast Surg, V42, P150, DOI 10.4103/0970-0358.59272; Bonham C, 2011, TRAUMA, V13, P353, DOI 10.1177/1460408611405298; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; BPS, STAT SOT LAND TRANSP; BPS, STAT SOT LAND TRANSP; BPS, 2020, STAT YB IND 2020; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Carlson BM, 2014, EUR J TRANSL MYOL, V24, P5, DOI 10.4081/ejtm.2014.3293; Cheng HM, 2020, J HAND SURG-EUR VOL, V45, P71, DOI 10.1177/1753193419859373; Cho AB, 2020, ACTA ORTOP BRAS, V28, P16, DOI 10.1590/1413-785220202801224507; Chuang DCC, 2018, J RECONSTR MICROSURG, V34, P669, DOI 10.1055/s-0038-1656719; Chuang David Chwei-Chin, 2009, Plast Reconstr Surg, V124, pe359, DOI 10.1097/PRS.0b013e3181bcf16c; Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274; Dubuisson AS, 2002, NEUROSURGERY, V51, P673, DOI 10.1097/00006123-200209000-00011; Dy Christopher J, 2020, HSS J, V16, P339, DOI 10.1007/s11420-019-09741-8; Dy CJ, 2016, J HAND SURG-AM, V41, P903, DOI 10.1016/j.jhsa.2016.07.054; El-Gammal TA, 2021, J RECONSTR MICROSURG, V37, P704, DOI 10.1055/s-0041-1726029; Elqazaz M, 2016, EGYPTIAN SPINE J, V19, P18, DOI [10.21608/esj.2016.4010, DOI 10.21608/ESJ.2016.4010]; Faglioni W, 2014, ACTA NEUROCHIR, V156, P1025, DOI 10.1007/s00701-013-1948-x; Garg R, 2011, J BONE JOINT SURG AM, V93A, P819, DOI 10.2106/JBJS.I.01602; GOLDIE BS, 1992, J HAND SURG-BRIT EUR, V17B, P86, DOI 10.1016/0266-7681(92)90018-W; Hadi MA, 2019, J PATIENT EXPERIENCE, V6, P133, DOI 10.1177/2374373518786013; Hems T, 2011, J HAND MICROSURG, V3, P6, DOI 10.1007/s12593-011-0031-1; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jain DKA, 2012, INDIAN J PLAST SURG, V45, P498, DOI 10.4103/0970-0358.105960; James MA, 2007, J HAND SURG-AM, V32A, P154, DOI 10.1016/j.jhsa.2006.11.008; Kaiser R, 2020, NEUROSURG REV, V43, P443, DOI 10.1007/s10143-018-1009-2; Kaiser R, 2014, INJURY, V45, P223, DOI 10.1016/j.injury.2012.05.013; Kandenwein JA, 2005, J NEUROSURG, V103, P614, DOI 10.3171/jns.2005.103.4.0614; Koorevaar RCT, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0949-0; Krauss EM, 2016, HAND CLIN, V32, P243, DOI 10.1016/j.hcl.2015.12.010; Leonard S, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000558; Li GY, 2019, ACTA NEUROCHIR, V161, P899, DOI 10.1007/s00701-019-03871-y; Mackinnon SE, 2018, J RECONSTR MICROSURG, V34, P672, DOI 10.1055/s-0038-1639353; Martin E, 2019, J NEUROSURG, V130, P1333, DOI 10.3171/2018.1.JNS172068; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Myles PS, 2017, BRIT J ANAESTH, V118, P424, DOI 10.1093/bja/aew466; NARAKAS AO, 1985, INT ORTHOP, V9, P29, DOI 10.1007/BF00267034; Oliveira CM, 2016, BRAZ NEUROSURG, V35, P193, DOI 10.1055/s-0036-1581082; Oliver JD, 2020, J RECONSTR MICROSURG, V36, P567, DOI 10.1055/s-0040-1713147; POLRI K., HEADQUARTER STATE PO; Potter SM, 2017, J HAND SURG-EUR VOL, V42, P693, DOI 10.1177/1753193417702029; Rasulic L, 2018, ACTA NEUROCHIR, V160, P1837, DOI 10.1007/s00701-018-3640-7; Rhee PC, 2011, J BONE JOINT SURG AM, V93A, P2271, DOI [10.2106/JBJS.J.00922, 10.2106/JBJSJ.00922]; SONGCHAROEN P, 1995, MICROSURG, V16, P35, DOI 10.1002/micr.1920160110; Stiasny J, 2015, DAN MED J, V62; Suroto H, 2021, BRIT J NEUROSURG, V35, P254, DOI 10.1080/02688697.2020.1784846; Swartz KR, 2012, CLIN NEUROL NEUROSUR, V114, P768, DOI 10.1016/j.clineuro.2011.12.035; Terzis JK, 2007, PLAST RECONSTR SURG, V119, p73E, DOI 10.1097/01.prs.0000254859.51903.97; Weber RV., 2004, J HAND SURG-AM, V4, P200, DOI [10.1016/j.jassh.2004.06.011, DOI 10.1016/J.JASSH.2004.06.011]	56	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.												10.1055/s-0041-1735507		SEP 2021	13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UK4WQ	WOS:000691971900002	34470060	hybrid			2022-02-06	
J	Tacke, M; Muller-Felber, W				Tacke, Moritz; Muller-Felber, Wolfgang			Clinical Neurophysiology in the Pediatric Intensive Care Unit	KLINISCHE NEUROPHYSIOLOGIE			German	Article						Neurophysiology; pediatrics; intenisve care unit	SOMATOSENSORY-EVOKED POTENTIALS; SEVERE BRAIN-INJURY; OUTCOMES; BOTULISM	Zusammenfassung Auf padiatrischen Intensivstationen kommt es haufig zum Einsatz neurophysiologischer Untersuchungsmethoden. Bei akuten Enzephalopathien oder in Situationen, in denen ein hohes Risiko fur epileptische Anfalle besteht, werden verschiedene Varianten des EEGs verwendet. Bei Hinweisen auf neuromuskulare Erkrankungen sind die Neurographie, die evozierten Potentiale, und die Elektromyographie die entscheidenden diagnostischen Methoden. Im Falle erworbener Hirnschadigungen wie z.B. nach Reanimationsereignissen oder bei Schadel-Hirn-Traumata konnen sowohl das EEG, als auch die evozierten Potentiale zur Prognoseabschatzung verwendet werden. Die Umstande auf der Intensivstation erschweren bei all diesen Methoden die Durchfuhrung und die Interpretation. Viele Patienten werden mit Medikamenten behandelt, die die Untersuchungsergebnisse beeinflussen (insbesondere Sedativa und Muskelrelaxantien). Elektronische Gerate, z.B. fur die Beatmung der Patienten, konnen zum Auftreten deutlicher Artefakte bei den neurophysiologischen Untersuchungen fuhren. Im vorliegenden Artikel werden die Einsatzbereiche neurophysiologischer Methoden auf padiatrischen Intensivstationen beschrieben und auf Details bei der Anwendung eingegangen. Abstract Clinical neurophysiology methods are frequently employed on pediatric intensive care units. Electroencephalography is an important cornerstone in the evaluation of acute encephalopathies and in situations where an increased risk for cerebral seizures has to be assumed. Nerve conduction studies, electromyography, and evoked potentials are the decisive diagnostic tools in the case of suspected neuromuscular disorders. In the context of acquired brain lesions, e.g. after cardiac arrest or traumatic brain injuries, both the EEG and the evoked potentials are used to assess the prognosis of the patients. The ICU setting leads to additional difficulties in both the execution and the interpretation of all neurophysiological examination methods. Some of the medications used on ICUs, especially sedatives and neuromuscular-blocking drugs, directly influence the results of the examinations. The multitude of electronic devices that are used on ICUs (e.g. ventilators) are a source of technical artifacts that contaminate the neurophysiologic measurements. The article presented here summarizes the use of neurophysiological examinations on the ICU and gives some details regarding their application in this setting.	[Tacke, Moritz; Muller-Felber, Wolfgang] LMU Klinikum Munchen, Dr von Haunersches Kinderspital, Munich, Germany		Muller-Felber, W (corresponding author), Dr v Haunersche Kinderklin, Lindwurmstr, D-480337 Munich, Germany.	Wolfgang.Mueller-Felber@med.uni-muenchen.de					Amantini A, 2012, MINERVA ANESTESIOL, V78, P1067; Arican P, 2018, NEUROPEDIATRICS, V49, P283, DOI 10.1055/s-0038-1654706; Azapagasi E, 2017, TURKISH J PEDIATR, V59, P581, DOI 10.24953/turkjped.2017.05.012; Bosco E, 2011, CRIT CARE, V15, DOI 10.1186/cc10315; Boussuges A, 2020, WORLD J CLIN CASES, V8, P2408, DOI 10.12998/wjcc.v8.i12.2408; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2005, INTENS CARE MED, V31, P840, DOI 10.1007/s00134-005-2634-0; Field-Ridley A, 2016, PEDIATR CRIT CARE ME, V17, P53, DOI 10.1097/PCC.0000000000000538; Kasinathan A, 2021, NEUROCRIT CARE, V34, P927, DOI 10.1007/s12028-020-01123-x; Kongsaengdao S, 2009, MUSCLE NERVE, V40, P271, DOI 10.1002/mus.21256; Korinthenberg R, 2020, EUR J PAEDIATR NEURO, V25, P5, DOI 10.1016/j.ejpn.2020.01.003; Mahmoud AT, 2018, EUR J NEUROL, V25, P991, DOI 10.1111/ene.13649; Mandel R, 2002, J PEDIATR-US, V141, P45, DOI 10.1067/mpd.2002.125005; Muller-Felber W, 1993, Electromyogr Clin Neurophysiol, V33, P335; Schalamon J, 2005, EUR J PEDIATR, V164, P417, DOI 10.1007/s00431-005-1656-5; Uncini A, 2018, CLIN NEUROPHYSIOL, V129, P2586, DOI 10.1016/j.clinph.2018.09.025; Vondracek P, 2006, EUR J PAEDIATR NEURO, V10, P176, DOI 10.1016/j.ejpn.2006.05.006; Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2329, DOI 10.1016/j.clinph.2004.05.009	19	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1434-0275	1439-4081		KLIN NEUROPHYSIOL	Klin. Neurophysiol.	SEP	2021	52	03					161	166		10.1055/a-1532-8135			6	Clinical Neurology; Neuroimaging; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	UP2XL	WOS:000695247500005					2022-02-06	
J	Taher, AW; Falls, CJ; Page, PS; Stadler, JA				Taher, Ayman W.; Falls, Cody J.; Page, Paul S.; Stadler, James A.			Temporary internal Bracing for Pediatric Odontoid Synchondrosis Fracture	CUREUS			English	Article						pediatric; internal bracing; synchondrosis; range of motion; cervical; dens; atlantoaxial; odontoid fracture; c1; c2	CERVICAL-SPINE INJURIES; CHILDREN; AXIS	Children are predisposed to injuries of the upper cervical spine given their relatively immature osteology, ligamentous laxity, underdeveloped musculature, and larger ratios of head to body mass. Odontoid process fractures involving the synchondroses are among the most common of these injuries. Though many of these fractures can be treated conservatively with external bracing, fractures with significant displacement that are unable to be reduced require operative management. In these cases, most patients undergo C1-2 posterior fusion with arthrodesis with permanent limitation to atlantoaxial range of motion (ROM). Here, we present a novel operative approach to manage odontoid synchondrosis fractures with temporary internal bracing via C1-2 posterior instrumentation without arthrodesis. We saw a three-year-old female who presented after a motor vehicle collision with a displaced odontoid synchondrosis fracture that was unable to he adequately reduced in a closed fashion. In an attempt to preserve maximal atlantoaxial ROM, temporary internal bracing was carried out with excellent results.	[Taher, Ayman W.; Stadler, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Neurol Surg, Madison, WI 53706 USA; [Falls, Cody J.] Univ Wisconsin, Sch Med & Publ Hlth, Orthopaed Surg, Madison, WI 53706 USA; [Page, Paul S.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA		Stadler, JA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Neurol Surg, Madison, WI 53706 USA.	stadler@neurosurgery.wisc.edu					Fassett Daniel R, 2006, Neurosurg Focus, V20, pE7; Fulkerson DH, 2012, J NEUROSURG-PEDIATR, V9, P35, DOI 10.3171/2011.10.PEDS11256; Garton HJL, 2002, J NEUROSURG, V96, P350, DOI 10.3171/spi.2002.96.3.0350; Hale DF, 2015, J TRAUMA ACUTE CARE, V78, P943, DOI 10.1097/TA.0000000000000603; Leonard JR, 2014, PEDIATRICS, V133, pE1179, DOI 10.1542/peds.2013-3505; Lustrin ES, 2003, RADIOGRAPHICS, V23, P539, DOI 10.1148/rg.233025121; MANDABACH M, 1993, PEDIATR NEUROSURG, V19, P225, DOI 10.1159/000120737; Medagam Narendra Reddy, 2020, J Orthop Case Rep, V9, P62, DOI 10.13107/jocr.2019.v09.i06.1590; Mortazavi M, 2011, CHILD NERV SYST, V27, P705, DOI 10.1007/s00381-010-1342-4; OGDEN JA, 1983, SKELETAL RADIOL, V9, P157, DOI 10.1007/BF00352547; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; SHERK HH, 1978, J BONE JOINT SURG AM, V60, P921, DOI 10.2106/00004623-197860070-00008	12	0	0	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 1	2021	13	9							e17639	10.7759/cureus.17639			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UK6XD	WOS:000692109800003	34646687	gold, Green Published			2022-02-06	
J	Taylor, MA; Rohan, AV; Runyon, LA; Fenton, SJ; Russell, KW				Taylor, Mark A.; Rohan, Autumn, V; Runyon, Lisa A.; Fenton, Stephen J.; Russell, Katie W.			The "non-preventable" preventable transfer? An analysis of the care from support services that injured children transferred to a level 1 pediatric trauma center receive	JOURNAL OF PEDIATRIC SURGERY			English	Article						Interfacility transfer; Concussion; Telemedicine; Telehealth; Teletrauma	BRAIN-INJURY; CONCUSSION; ADULT	Purpose: Almost 30% of pediatric trauma transfers to our facility have previously been shown to be potentially preventable transfers (PT). However, we sought to evaluate what care from support services these PT received during admission. Methods: Traumatically injured children transferred between January 2014 and June 2019 were retrospectively analyzed. A PT was defined as a child who was discharged within 36 h of arrival without surgical intervention or advanced imaging studies. PT that received support services were compared to those that did not to determine which patients may benefit from these services were their transfers prevented. Results: There were 3212 transfers, and 927 (29%) were PT. When compared to non-PT, PT were younger, closer to our hospital, and had a lower ISS, extremity or C-spine injury, or assault/non-accidental trauma mechanism. PT were less likely to have a chest injury or a CT at the referring hospital. Of the PT, 30% had a support service consulted. PT with higher ISS or a head injury was more likely to receive a consultation with a support service. Conclusions: A significant proportion of these "preventable" transfers still receive important care from support services during their admission. Type of study: Retrospective study. Level of evidence: III (c) 2020 Elsevier Inc. All rights reserved.	[Taylor, Mark A.; Fenton, Stephen J.; Russell, Katie W.] Univ Utah, Dept Surg, Div Pediat Surg, Salt Lake City, UT USA; [Rohan, Autumn, V; Runyon, Lisa A.] Primary Childrens Med Ctr, Salt Lake City, UT USA		Taylor, MA (corresponding author), 30 N 1900 E,RM 3B322, Salt Lake City, UT 84132 USA.	Mark.Taylor@hsc.utah.edu					Castillo RC, 2008, EVIDENCE BENEFICIAL, DOI [10.1016/j.apmr.2008.01.032, DOI 10.1016/J.APMR.2008.01.032]; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Ellis MJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00840; Ellis MJ, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2019.1573163; Fahy AS, 2020, PEDIATR EMERG CARE, V36, pE709, DOI 10.1097/PEC.0000000000001481; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Gausche-Hill M, 2007, PEDIATRICS, V120, P1229, DOI 10.1542/peds.2006-3780; Hewes HA, 2017, J TRAUMA ACUTE CARE, V83, P662, DOI 10.1097/TA.0000000000001560; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Hunt AW, 2018, BRAIN INJURY, V32, P1534, DOI 10.1080/02699052.2018.1502894; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mackel CE, 2018, J NEUROSURG-PEDIATR, V22, P375, DOI 10.3171/2018.5.PEDS182; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Matsushima K, 2013, AM SURGEON, V79, P267; Middleton Kimberly R, 2006, Adv Data, P1; Mollen CJ, 2019, PEDIATR EMERG CARE, V35, P180, DOI 10.1097/PEC.0000000000000957; Myers SR, 2019, PEDIATR EMERG CARE, V35, P1, DOI 10.1097/PEC.0000000000000902; Nance ML, 2009, ARCH PEDIAT ADOL MED, V163, P512, DOI 10.1001/archpediatrics.2009.65; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; Pandit V, 2016, J PEDIATR SURG, V51, P649, DOI 10.1016/j.jpedsurg.2015.12.002; Reuter-Rice K, 2018, REHABIL NURS, V43, P327, DOI 10.1097/rnj.0000000000000116; Snyder CW, 2019, J TRAUMA ACUTE CARE, V86, P92, DOI 10.1097/TA.0000000000002087; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Walther AE, 2016, J PEDIATR SURG, V51, P1346, DOI 10.1016/j.jpedsurg.2016.03.016; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805; Yue JK, 2020, J NEUROSCI RURAL PRA, V11, P23, DOI 10.1055/s-0039-3402581	26	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	SEP	2021	56	9					1638	1642		10.1016/j.jpedsurg.2020.10.017			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	UD6GQ	WOS:000687303900029	33234289				2022-02-06	
J	Traylor, JI; El Ahmadieh, TY; Bedros, NM; Al Adli, N; Stutzman, SE; Venkatachalam, AM; Pernik, MN; Collum, CM; Douglas, PM; Aiyagari, V; Bagley, CA; Olson, DM; Aoun, SG				Traylor, Jeffrey, I; El Ahmadieh, Tarek Y.; Bedros, Nicole M.; Al Adli, Nadeem; Stutzman, Sonja E.; Venkatachalam, Aardhra M.; Pernik, Mark N.; Collum, C. Munro; Douglas, Peter M.; Aiyagari, Venkatesh; Bagley, Carlos A.; Olson, DaiWai M.; Aoun, Salah G.			Quantitative pupillometry in patients with traumatic brain injury and loss of consciousness: A prospective pilot study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Pupillometry; Neurological pupil index; Traumatic brain injury; Concussion; Craniectomy; Glasgow coma scale	INTEROBSERVER AGREEMENT; INTRACRANIAL-PRESSURE; RELIABILITY; IMPACT; CARE	Objective: Loss of consciousness (LOC) is a hallmark feature in Traumatic Brain Injury (TBI), and a strong predictor of outcomes after TBI. The aim of this study was to describe associations between quantitative infrared pupillometry values and LOC, intracranial hypertension, and functional outcomes in patients with TBI. Methods: We conducted a prospective study of patients evaluated at a Level 1 trauma center between November 2019 and February 2020. Pupillometry values including the Neurological Pupil Index (NPi), constriction velocity (CV), and dilation velocity (DV) were obtained. Results: Thirty-six consecutive TBI patients were enrolled. The median (range) age was 48 (range 21-86) years. The mean Glasgow Coma Scale score on arrival was 11.8 (SD = 4.0). DV trichotomized as low (<0.5 mm/s), moderate (0.5-1.0 mm/s), or high (>1.0 mm/s) was significantly associated with LOC (P = .02), and the need for emergent intervention (P < .01). No significant association was observed between LOC and NPi (P = .16); nor between LOC and CV (P = .07). Conclusions: Our data suggests that DV, as a discrete variable, is associated with LOC in TBI. Further investigation of the relationship between discrete pupillometric variables and NPi may be valuable to understand the clinical significance of the pupillary light reflex findings in acute TBI. (c) 2021 Elsevier Ltd. All rights reserved.	[Traylor, Jeffrey, I; El Ahmadieh, Tarek Y.; Al Adli, Nadeem; Pernik, Mark N.; Bagley, Carlos A.; Aoun, Salah G.] UT Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX USA; [Bedros, Nicole M.] Baylor Univ, Med Ctr, Div Trauma, Dept Surg, Waco, TX 76798 USA; [Stutzman, Sonja E.; Venkatachalam, Aardhra M.; Collum, C. Munro] UT Southwestern Med Ctr, ODonnell Brain Inst, Dallas, TX USA; [Douglas, Peter M.] Dept Mol Biol, Dallas, TX USA; [Douglas, Peter M.] Hamon Ctr Regenerat Sci & Med, Dallas, TX USA; [Aiyagari, Venkatesh; Olson, DaiWai M.] UT Southwestern Med Ctr, Dept Neurol, Dallas, TX USA; [Aiyagari, Venkatesh; Olson, DaiWai M.] UT Southwestern Med Ctr, Dept Neurocrit Care, Dallas, TX USA		Aoun, SG (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, 5151 Harry Hines Blvd, Dallas, TX 75235 USA.	salah.aoun@utsouthwestern.edu		Al-Adli, Nadeem/0000-0001-7803-8103	University of Texas Southwestern department of Neurosurgery; University of Texas Southwestern department of Nursing	This study was funded by the University of Texas Southwestern department of Neurosurgery, and the University of Texas Southwestern department of Nursing.	Al-Obaidi SZ, 2019, CRIT CARE EXPLOR, V1, DOI 10.1097/CCE.0000000000000054; Alali AS, 2019, J NEUROSURG, V131, P612, DOI 10.3171/2018.4.JNS173166; Aoun SG, 2020, J NEUROSURG, V132, P27, DOI 10.3171/2018.9.JNS181928; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Capo-Aponte JE, 2013, J SPINE, P4; Carney N, 2014, CONCUSSION GUIDELINE; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Du R, 2005, NEUROSURGERY, V57, P198, DOI 10.1227/01.NEU.0000163425.79170.CB; El Ahmadieh TY, 2020, WORLD NEUROSURG, P145; Fay MP, 2010, BIOSTATISTICS, V11, P373, DOI 10.1093/biostatistics/kxp050; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hanley DF, 2017, LANCET, V389, P603, DOI 10.1016/S0140-6736(16)32410-2; Hoffman H, 2020, J NEUROSURG, V133, P875, DOI 10.3171/2019.5.JNS19459; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Joseph JR, 2020, J NEUROSURG, V133, P1886, DOI 10.3171/2019.7.JNS191272; Khanna R, 2017, CLIN SPINE SURG, V30, pE1338, DOI 10.1097/BSD.0000000000000349; Kim TJ, 2020, NEUROCRIT CARE, V33, P575, DOI 10.1007/s12028-020-00936-0; Lussier BL, 2019, J NEUROSCI NURS, V51, P335, DOI 10.1097/JNN.0000000000000478; Mader MM, 2020, SCI REP-UK, V10, P1; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mazhar K, 2021, CLIN NEUROL NEUROSUR, V200, DOI 10.1016/j.clineuro.2020.106410; McNett M, 2018, J NEUROSCI NURS, V50, P357, DOI 10.1097/JNN.0000000000000401; Obinata H, 2020, RESUSCITATION, V154, P77, DOI 10.1016/j.resuscitation.2020.06.002; Oddo M, 2018, INTENS CARE MED, V44, P2102, DOI 10.1007/s00134-018-5448-6; Olson DM, 2017, J NEUROSCI NURS, V49, P251, DOI 10.1097/JNN.0000000000000296; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Olson DM, 2016, CRIT CARE NURS CLIN, V28, P101, DOI 10.1016/j.cnc.2015.09.003; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ortega-Perez S, 2019, J NEUROSCI NURS, V51, P171, DOI 10.1097/JNN.0000000000000443; Shoyombo I, 2018, SCI REP-UK, P8; Signorell Andri, 2021, CRAN; Stevens AR, 2019, BRAIN INJURY, V33, P1032, DOI 10.1080/02699052.2019.1605621; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tekin K, 2018, CLIN EXP OPTOM, V101, P659, DOI 10.1111/cxo.12659; Thakur B, 2021, BRAIN INJURY, V35, P114, DOI 10.1080/02699052.2020.1861481; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; VANDENBERGE JH, 1979, J NEUROL NEUROSUR PS, V42, P1163, DOI 10.1136/jnnp.42.12.1163; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Weerakoon SM, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104693; Zhao WD, 2016, J CLIN NEUROSCI, V33, P79, DOI 10.1016/j.jocn.2016.01.039	45	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2021	91						88	92		10.1016/j.jocn.2021.06.044			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TY1OM	WOS:000683554800013	34373065				2022-02-06	
J	Trivedi, A; Tercovich, KG; Casbon, AJ; Raber, J; Lowell, C; Noble-Haeusslein, LJ				Trivedi, Alpa; Tercovich, Kayleen G.; Casbon, Amy Jo; Raber, Jacob; Lowell, Clifford; Noble-Haeusslein, Linda J.			Neutrophil-specific deletion of Syk results in recruitment-independent stabilization of the barrier and a long-term improvement in cognitive function after traumatic injury to the developing brain	NEUROBIOLOGY OF DISEASE			English	Article						Neutrophils; Spleen tyrosine kinase; Oxidative stress; Barrier; Learning; Memory; Anxiety	IMMATURE MURINE NEURONS; ANXIETY; DYSFUNCTION; ELASTASE; PATHOGENESIS; EXPRESSION; RECOVERY; PHOSPHORYLATION; TRANSMIGRATION; PERMEABILITY	While traumatic brain injury (TBI) is the leading cause of death and disability in children, we have yet to identify those pathogenic events that determine the extent of recovery. Neutrophils are best known as "first responders" to sites of infection and trauma where they become fully activated, killing pathogens via proteases that are released during degranulation. However, this activational state may generate substantial toxicity in the young brain after TBI that is partially due to developmentally regulated inadequate antioxidant reserves. Neutrophil degranulation is triggered via a downstream signaling pathway that is dependent on spleen tyrosine kinase (Syk). To test the hypothesis that the activational state of neutrophils is a determinant of early pathogenesis and longterm recovery, we compared young, brain-injured conditional knockouts of Syk (sykf/fMRP8-cre+) to congenic littermates (sykf/f). Based upon flow cytometry, there was an extended recruitment of distinct leukocyte subsets, including Ly6G+/Ly6C- and Ly6G+/Ly6Cint, over the first several weeks post-injury which was similar between genotypes. Subsequent assessment of the acutely injured brain revealed a reduction in blood-brain barrier disruption to both high and low molecular weight dextrans and reactive oxygen species in sykf/fMRP8-cre+ mice compared to congenic littermates, and this was associated with greater preservation of claudin 5 and neuronal integrity, as determined by Western blot analyses. At adulthood, motor learning was less affected in brain-injured sykf/fMRP8-cre+ mice as compared to sykf/f mice. Performance in the Morris Water Maze revealed a robust improvement in hippocampal-dependent acquisition and short and long-term spatial memory retention in sykf/ fMRP8-cre+ mice. Subsequent analyses of swim path lengths during hidden platform training and probe trials showed greater thigmotaxis in brain-injured sykf/f mice than sham sykf/f mice and injured sykf/fMRP8-cre+ mice. Our results establish the first mechanistic link between the activation state of neutrophils and long-term functional recovery after traumatic injury to the developing brain. These results also highlight Syk kinase as a novel therapeutic target that could be further developed for the brain-injured child.	[Trivedi, Alpa; Lowell, Clifford] Univ Calif San Francisco, Dept Lab Med, 513 Parnassus Ave,HSE 760, San Francisco, CA 94143 USA; [Trivedi, Alpa; Tercovich, Kayleen G.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Casbon, Amy Jo] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Radiat Med, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Portland, OR 97239 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Neurol, Dell Med Sch, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Psychol, Dell Med Sch, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Coll Liberal Arts, Austin, TX 78712 USA		Trivedi, A (corresponding author), Univ Calif San Francisco, Dept Lab Med, 513 Parnassus Ave,HSE 760, San Francisco, CA 94143 USA.; Trivedi, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	alpa.mahuvakar@ucsf.edu; raberj@ohsu.edu; clifford.lowell@ucsf.edu; linda.noble@austin.utexas.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS077767-05]	The behavioral studies were conducted in the Neurobehavioral Core for Rehabilitation Research at UCSF, with assistance from Sandra Canchola, manager of Core. Flow cytometry was performed using LSR Fortessa in the Parnassus Flow Cytometry Core at UCSF. We thank Ronald Manlapaz for assistance with breeding, genotyping and colony maintenance and Jaclyn Carlson for contributing to the behavioral assays. We thank Destine Krenik and Payel Kundu in the Raber laboratory at OHSU for the thigmotaxis analyses of the water maze data and PCA, respectively. This work was supported by grant from NIH/NINDS 5R01NS077767-05 (to L.J.N) .	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bach DR, 2019, J NEUROSCI, V39, P8517, DOI 10.1523/JNEUROSCI.0412-19.2019; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Bailey KR, 2009, FRONT NEUROSCI, P77; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Catz SD, 2020, J LEUKOCYTE BIOL, V107, P393, DOI 10.1002/JLB.3RI0120-645R; Chang HK, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11857; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; COYLE MG, 1993, AM J PHYSIOL, V264, pH141, DOI 10.1152/ajpheart.1993.264.1.H141; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Gennaro A, 2009, FASEB J, V23, P1750, DOI 10.1096/fj.08-121277; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dyer DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42681; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Greene C, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0123-z; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Ichkova A, 2017, NEUROCHEM INT, V111, P93, DOI 10.1016/j.neuint.2017.03.022; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jimenez JC, 2018, NEURON, V97, P670, DOI 10.1016/j.neuron.2018.01.016; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Koolhaas JM, 2013, JOVE-J VIS EXP, DOI 10.3791/4367; Kurz ARM, 2016, J CLIN INVEST, V126, P4125, DOI 10.1172/JCI87043; Li L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0247-1; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McLean CW, 2005, DEV NEUROSCI-BASEL, V27, P169, DOI 10.1159/000085989; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Mischel RE, 1997, NEUROSCI LETT, V231, P17, DOI 10.1016/S0304-3940(97)00531-4; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Najjar S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00083; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nemeth T, 2020, NAT REV DRUG DISCOV, V19, P253, DOI 10.1038/s41573-019-0054-z; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pooters T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176295; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Potts Mathew B, 2006, NeuroRx, V3, P143; Price L., 2016, TRANSLATIONAL RES TR; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rizk A, 2004, EUR J NEUROSCI, V19, P1992, DOI 10.1111/j.1460-9568.2004.03251.x; Rochford J, 1997, PSYCHOPHARMACOLOGY, V132, P145, DOI 10.1007/s002130050330; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Siddappa AJM, 2002, J NEUROSCI RES, V68, P761, DOI 10.1002/jnr.10246; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Sippel TR, 2015, J CEREBR BLOOD F MET, V35, P1657, DOI 10.1038/jcbfm.2015.103; Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Wang SJ, 2005, J CELL SCI, V118, P2067, DOI 10.1242/jcs.02340; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zhu YS, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00242; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	90	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2021	157								105430	10.1016/j.nbd.2021.105430			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TZ9WB	WOS:000684816800005	34153467	gold			2022-02-06	
J	Uhm, KE; Jung, H; Oh-Park, M; Lee, BR; Kim, EJ; Kim, JH; Lee, SA; Shin, J; Kim, YS; Hyun, C; Ko, N; Lee, J				Uhm, Kyeong Eun; Jung, Heeyoune; Oh-Park, Mooyeon; Lee, Bo Ram; Kim, Eun Joo; Kim, Jung Hwan; Lee, Seung Ah; Shin, Jinyoung; Kim, Yoon-Sook; Hyun, Cheolhwan; Ko, Nayeon; Lee, Jongmin			Reliability and validity of the Korean version of the Caregiver Burden Inventory	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						burden; caregiver; disability; Korean; scale	INFORMAL CAREGIVERS	The purpose of this study was to demonstrate the reliability and validity of the Korean version of the Caregiver Burden Inventory (CBI). The study was conducted as a multicenter cross-sectional survey for caregivers caring for patients with disabilities in outpatient or inpatient rehabilitation clinics. Sociodemographic characteristics and health-related quality of life were collected via questionnaires. The CBI and Burden Interview (BI) were administered, after which internal consistency and factor analysis of the CBI and correlation between the CBI and BI were explored. A total of 151 caregivers participated. The mean age of caregivers was 53.7 +/- 12.4 years, and 80.8 % were women. The majority of caregivers were the main caregivers of stroke, spinal cord injury or traumatic brain injury. The factor analysis confirmed its five factorial structure. The time-dependence and physical burden scores of CBI were higher than those of other factors. All five-dimensional and total scores of CBI showed high internal consistency and were well correlated with BI. In conclusion, the CBI has proven its reliability, construct validity and concurrent validity for caregivers of disabled people and has shown its advantage as a multidimensional measure.	[Uhm, Kyeong Eun; Hyun, Cheolhwan; Ko, Nayeon; Lee, Jongmin] Konkuk Univ, Dept Rehabil Med, Med Ctr, 120-1 Neungdong Ro, Seoul 05030, South Korea; [Jung, Heeyoune] Natl Traff Injury Rehabil Hosp, Dept Rehabil Med, Yangpyeong, South Korea; [Oh-Park, Mooyeon] Burke Rehabil Hosp, Dept Rehabil Med, Montefiore Hlth Syst, New York, NY USA; [Lee, Bo Ram] Kyung Hee Univ, Dept Psychiat, Cheil Hosp, Seoul, South Korea; [Kim, Eun Joo; Kim, Jung Hwan] Kyung Hee Univ, Dept Rehabil Med, Natl Rehabil Ctr, Seoul, South Korea; [Lee, Seung Ah] Kyung Hee Univ, Coll Med, Dept Phys Med & Rehabil, Seoul, South Korea; [Shin, Jinyoung] Konkuk Univ, Dept Family Med, Med Ctr, Seoul, South Korea; [Kim, Yoon-Sook] Konkuk Univ, Dept Qual Improvement, Med Ctr, Seoul, South Korea; [Lee, Jongmin] Konkuk Univ, Int Healthcare Res Inst, Seoul, South Korea		Lee, J (corresponding author), Konkuk Univ, Dept Rehabil Med, Med Ctr, 120-1 Neungdong Ro, Seoul 05030, South Korea.	leej@kuh.ac.kr			Rehabilitation Research & Development Support Program [NRCRSP-EX20013]; National Rehabilitation Center, Ministry of Health and Welfare, Korea	This study was supported by the Rehabilitation Research & Development Support Program (#NRCRSP-EX20013), National Rehabilitation Center, Ministry of Health and Welfare, Korea.	Bartolo M, 2010, J REHABIL MED, V42, P818, DOI 10.2340/16501977-0612; Bastawrous M, 2013, INT J NURS STUD, V50, P431, DOI 10.1016/j.ijnurstu.2012.10.005; Caserta MS, 1996, INT J AGING HUM DEV, V43, P21, DOI 10.2190/2DKF-292P-A53W-W0A8; Chou KR, 2002, NURS RES, V51, P324, DOI 10.1097/00006199-200209000-00009; Conti A, 2019, SPINAL CORD, V57, P75, DOI 10.1038/s41393-018-0179-7; Cruz J, 2017, RESP MED, V128, P13, DOI 10.1016/j.rmed.2017.05.002; de Vet HC, 2011, MEASUREMENT MED PRAC, DOI DOI 10.1017/CBO9780511996214; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Farmer C, 2018, J PEDIATR PSYCHOL, V43, P749, DOI 10.1093/jpepsy/jsy014; Feng Y, 2014, QUAL LIFE RES, V23, P977, DOI 10.1007/s11136-013-0537-z; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Kasuya RT, 2000, POSTGRAD MED, V108, P119, DOI 10.3810/pgm.2000.12.1324; 이형석, 2004, Korean Journal of Clinical Psychology, V23, P1029; Marvardi M, 2005, AGING CLIN EXP RES, V17, P46, DOI 10.1007/BF03337720; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Scholten EWM, 2021, DISABIL REHABIL, V43, P746, DOI 10.1080/09638288.2019.1641847; Streiner D.L., 2015, HLTH MEASUREMENT SCA, V5th ed.; Suk-Jung Han，, 2014, [Journal of Korean Gerontological Nursing, 노인간호학회지], V16, P242, DOI 10.17079/jkgn.2014.16.3.242; Swartz K, 2019, AM FAM PHYSICIAN, V99, P699; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Valer DB, 2015, REV LAT-AM ENFERM, V23, P130, DOI 10.1590/0104-1169.3357.2534; Van Durme T, 2012, INT J NURS STUD, V49, P490, DOI 10.1016/j.ijnurstu.2011.10.011; Vazquez FL, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020217; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa; Whalen Kimberly J, 2009, JBI Libr Syst Rev, V7, P1373; Yun MH., 2011, PERSPECT NUR SCI, V8, P62; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zarit SH., 1985, HIDDEN VICTIMS ALZHE	29	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2021	44	3					209	214		10.1097/MRR.0000000000000474			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	TX5CE	WOS:000683104300004	34034283				2022-02-06	
J	Villareal, H; Al-Bayati, S; Wang, CP; Pugh, MJ; Liss, MA				Villareal, Humberto; Al-Bayati, Sam; Wang, Chen-Pin; Pugh, Mary Jo; Liss, Michael A.			Transitional Care of Service Members With Genitourinary Injury	MILITARY MEDICINE			English	Article							SEXUAL FUNCTION; BLAST INJURY; DYSFUNCTION; MANAGEMENT; TRAUMA	Objective: To improve urotrauma care by describing veterans' current demographics and needs assessment during transitional care to the Veteran Health Administration (VHA) system. Methods: We utilized our previously identified cohorts obtained from the DoD Trauma Registry data for male service members injured in theater linked with VHA electronic health records. We included veterans who received care at VHA at least once from October 2001 through September 2011 for chart review. We investigate demographics, opportunities for care, combat-related trauma, disability, and associated mental health or urologic conditions specifically at the initial encounter with a VHA healthcare provider. Results: We queried 580 veterans' records in VHA from the linked databases. We idenfied that 141 (24.4%) veterans received addional care outside VHA and 17.1% (n=99) of charts had insufficient data for injury validation. Reference to the urotrauma was mentioned in 72% of VHA initial visits (n=416/580). The most common urotrauma occurred to the lower/external genitourinary injury (298, 51%). Of all the veterans identified with genitourinary trauma, approximately 28% (n=160) were referred for urologic consultation, but only 14% were related to the original urotrauma. Ninety percent (522/580) of service members with urotrauma also had a mental health diagnosis, largely post-traumatic stress disorder (PTSD, 70.8%). Conclusions: The majority of men with urotrauma did have contact with VHA, yet there is no systematic approach to baseline assessment or long-term care strategy. However, only a small proportion of DoD-documented urotrauma requires ongoing care. We identified that coordinating care with mental health pathways (PTSD/traumatic brain injury) may be an opportunity to evaluate the long-term effects of urotrauma.	[Villareal, Humberto] Loma Linda Univ, Dept Urol, Loma Linda, CA 92354 USA; [Al-Bayati, Sam; Liss, Michael A.] Univ Texas Hlth Sci Ctr San Antonio, tDept Urol, San Antonio, TX 78229 USA; [Wang, Chen-Pin] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Pugh, Mary Jo] Univ Utah, Dept Med, Div Epidemiol, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Liss, Michael A.] South Texas Vet Healthcare Syst, Dept Surg, San Antonio, TX 78229 USA		Villareal, H (corresponding author), Loma Linda Univ, Dept Urol, Loma Linda, CA 92354 USA.			Liss, Michael/0000-0001-6978-1026; Pugh, Mary Jo/0000-0003-4196-7763	Military Health Institute at the University of Texas Health San Antonio	The research was made possible by a generous grant from the Military Health Institute at the University of Texas Health San Antonio.	Banti M, 2016, J TRAUMA ACUTE CARE, V80, P131, DOI 10.1097/TA.0000000000000864; Breyer BN, 2014, J SEX MED, V11, P75, DOI 10.1111/jsm.12201; Bullen K, 2010, PSYCHO-ONCOLOGY, V19, P933, DOI 10.1002/pon.1642; Edney MT, 2015, UROL PRACT, V2, P73; Ficke JR, 2012, J TRAUMA ACUTE CARE, V73, pS520, DOI 10.1097/TA.0b013e31827559da; Flynn KE, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-40; Greenfield DM, 2010, CANCER-AM CANCER SOC, V116, P1592, DOI 10.1002/cncr.24898; Hudak SJ, 2009, J UROLOGY, V182, P180, DOI 10.1016/j.juro.2009.02.150; Lucas PA, 2014, INJURY, V45, P825, DOI 10.1016/j.injury.2013.12.009; Nnamani NS, 2019, MIL MED, V184, pE297, DOI 10.1093/milmed/usy196; Sharma DM, 2013, J ROY ARMY MED CORPS, V159, P57, DOI 10.1136/jramc-2013-000029; Sharma DM, 2013, J ROY ARMY MED CORPS, V159, P18, DOI 10.1136/jramc-2013-000023; Smith JB, 2018, SEX MED REV, V6, P69, DOI 10.1016/j.sxmr.2017.08.007; Woods DR, 2013, J ROY ARMY MED CORPS, V159, P45, DOI 10.1136/jramc-2013-000022	14	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2021	186	9-10					969	974		10.1093/milmed/usab086			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP2XJ	WOS:000730733500028	33644817	hybrid			2022-02-06	
J	Wagner, JC; Zinos, A; Chen, WL; Conant, L; Malloy, M; Heffernan, J; Quirk, B; Sugar, J; Prost, R; Whelan, JB; Beardsley, SA; Whelan, HT				Wagner, Julie C.; Zinos, Anthony; Chen, Wei-Liang; Conant, Lisa; Malloy, Marsha; Heffernan, Joseph; Quirk, Brendan; Sugar, Jeffrey; Prost, Robert; Whelan, Julian B.; Beardsley, Scott A.; Whelan, Harry T.			Comparison of Whole-Head Functional Near-Infrared Spectroscopy With Functional Magnetic Resonance Imaging and Potential Application in Pediatric Neurology	PEDIATRIC NEUROLOGY			English	Article						fNIRS; fMRI; Motor cortex; Auditory cortex; Functional cortical activity	AUTOREGULATION MEASUREMENT TECHNIQUES; TRAUMATIC BRAIN-INJURY; FMRI; NIRS; RESPONSES; BOLD	Background: Changes in cerebral blood flow in response to neuronal activation can be measured by time dependent fluctuations in hemoglobin species within the brain; this is the basis of functional magnetic resonance imaging (fMRI) and functional near-infrared spectroscopy (fNIRS). There is a clinical need for portable neural imaging systems, such as fNIRS, to accommodate patients who are unable to tolerate an MR environment. Objective: Our objective was to compare task-related full-head fNIRS and fMRI signals across cortical regions. Methods: Eighteen healthy adults completed a same-day fNIRS-fMRI study, in which they performed right-and left-hand finger tapping tasks and a semantic-decision tones-decision task. First-and second level general linear models were applied to both datasets. Results: The finger tapping task showed that significant fNIRS channel activity over the contralateral primary motor cortex corresponded to surface fMRI activity. Similarly, significant fNIRS channel activity over the bilateral temporal lobe corresponded to the same primary auditory regions as surface fMRI during the semantic-decision tones-decision task. Additional channels were significant for this task that did not correspond to surface fMRI activity. Conclusion: Although both imaging modalities showed left-lateralized activation for language processing, the current fNIRS analysis did not show concordant or expected localization at the level necessary for clinical use in individual pediatric epileptic patients. Future work is needed to show whether fNIRS and fMRI are comparable at the source level so that fNIRS can be used in a clinical setting on individual patients. If comparable, such an imaging approach could be applied to children with neurological disorders. (c) 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Wagner, Julie C.; Zinos, Anthony; Beardsley, Scott A.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Wagner, Julie C.; Zinos, Anthony; Beardsley, Scott A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Zinos, Anthony; Conant, Lisa; Malloy, Marsha; Heffernan, Joseph; Quirk, Brendan; Sugar, Jeffrey; Prost, Robert; Whelan, Julian B.; Whelan, Harry T.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Chen, Wei-Liang] Univ Washington, Med Ctr, Sch Med, Seattle, WA 98195 USA; [Chen, Wei-Liang] Seattle Childrens Hosp, Seattle, WA USA; [Malloy, Marsha; Whelan, Julian B.; Whelan, Harry T.] Childrens Hosp Wisconsin, Dept Neurol, Milwaukee, WI 53201 USA		Whelan, HT (corresponding author), Med Coll Wisconsin, Chair Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	hwhelan@mcw.edu	Beardsley, Scott/S-9537-2019	Beardsley, Scott/0000-0001-9254-7924; Conant, Lisa/0000-0002-5050-3437; Sugar, Jeffrey/0000-0002-2861-4835; Chen, Wei-Liang/0000-0002-9754-4113	Bleser Family Foundation Neurology Research Fund; Bleser Endowed Chair in Neurology; Baumann Research Endowment; Office of Naval ResearchOffice of Naval Research [N00014-19-1-2560]	This work was supported by the Bleser Family Foundation Neurology Research Fund (to H.W.), Bleser Endowed Chair in Neurology (to H.W.), the Baumann Research Endowment (to H.W.), and Office of Naval Research Grant No: N00014-19-1-2560 (to H.W.). These funding sources had no involvement in the conduct of the research or the preparation of this manuscript.	Balakrishnan B, 2018, J CLIN MONIT COMPUT, V32, P89, DOI 10.1007/s10877-017-0007-1; Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; BEATON AE, 1974, TECHNOMETRICS, V16, P147, DOI 10.2307/1267936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2008, EPILEPSIA, V49, P1980, DOI 10.1111/j.1528-1167.2008.01683.x; BINDER JR, 1995, ARCH NEUROL-CHICAGO, V52, P593, DOI 10.1001/archneur.1995.00540300067015; Chen WL, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00724; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Faria DD, 2020, NEUROPHOTONICS, V7, DOI 10.1117/1.NPh.7.4.045004; Eggebrecht AT, 2014, NAT PHOTONICS, V8, P448, DOI 10.1038/nphoton.2014.107; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Fishburn FA, 2019, NEUROIMAGE, V184, P171, DOI 10.1016/j.neuroimage.2018.09.025; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Hern ~andez-Martin E, 2017, NEUROPHOTONICS, V4, P1; HIRAOKA M, 1993, PHYS MED BIOL, V38, P1859, DOI 10.1088/0031-9155/38/12/011; Hoffman GM, 2017, ANN THORAC SURG, V103, P1527, DOI 10.1016/j.athoracsur.2016.09.100; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hong KS, 2019, J INNOV OPT HEAL SCI, V12, DOI 10.1142/S179354581930012X; Huppert T, 2017, NEUROPATHOLOGY, V4, P1; Huppert TJ, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.010401; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Janecek JK, 2013, EPILEPSIA, V54, P314, DOI 10.1111/epi.12068; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Maggioni E, 2015, NEUROIMAGE, V108, P410, DOI 10.1016/j.neuroimage.2014.12.074; Monrad P, 2015, J NEAR INFRARED SPEC, V23, P209, DOI 10.1255/jnirs.1170; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; Santosa H, 2018, ALGORITHMS, V11, DOI 10.3390/a11050073; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wijeakumar S, 2017, NEUROIMAGE, V147, P204, DOI 10.1016/j.neuroimage.2016.12.007; Wintermark P, 2014, NEUROIMAGE, V85, P287, DOI 10.1016/j.neuroimage.2013.04.072; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085; Zhang XF, 2005, OPT EXPRESS, V13, P5513, DOI 10.1364/OPEX.13.005513	41	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	SEP	2021	122						68	75		10.1016/j.pediatrneurol.2021.06.003			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	UP2DV	WOS:000695196400013	34301451	hybrid			2022-02-06	
J	Wang, DX; Napoli, AM; Webb, AR; Etzel, C; Baird, J; Milzman, D				Wang, David X.; Napoli, Anthony M.; Webb, Alex R.; Etzel, Christine; Baird, Janette; Milzman, David			Player age and initial helmet contact among American football players	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Concussions; Chronic traumatic encephalopathy; Tackle football	HEAD IMPACT EXPOSURE; CONCUSSION	Objective: Concussions and chronic traumatic encephalopathy (CTE) related to professional football has received much attention within emergency care and sports medicine. Research suggests that some of this may be due to a greater likelihood of initial helmet contact (IHC), however this association has not been studied across all age groups. This study aims to investigate the association between player age and IHC in American football. Methods: Retrospective review of championship games between 2016 and 2018 at 6 levels of amateur tackle football as well as the National Football League (NFL). Trained raters classified plays as IHC using pre-specified criteria. A priori power analysis established the requisite impacts needed to establish non-inferiority of the incidence rate of IHC across the levels of play. Results: Thirty-seven games representing 2912 hits were rated. The overall incidence of IHC was 16% across all groups, ranging from 12.6% to 18.9%. All but 2 of the non-NFL divisions had a statistically reduced risk of IHC when compared with the NFL, with relative risk ratios ranging from 0.55-0.92. IHC initiated by defensive participants were twice as high as offensive participants (RR 2.04, p < 0.01) while 6% [95% CI 5.4-7.2] of all hits were helmet-on-helmet contact. Conclusions: There is a high rate of IHC with a lower relative risk of IHC at most levels of play compared to the NFL. Further research is necessary to determine the impact of IHC; the high rates across all age groups suggests an important role for education and prevention. (c) 2021 Elsevier Inc. All rights reserved.	[Wang, David X.] Allegheny Hlth Network, Dept Orthoped, Pittsburgh, PA USA; [Napoli, Anthony M.; Etzel, Christine; Baird, Janette] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Webb, Alex R.] Emory Univ, Dept Orthopaed Surg, Atlanta, GA 30322 USA; [Milzman, David] Georgetown Univ, Sch Med, Washington, DC USA		Napoli, AM (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA.	anapoli@lifespan.org		Etzel, Christine M/0000-0003-4302-9498			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; [Anonymous], 2011, NONFATAL TRAUMATIC B; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Harmon Katherine J, 2018, Inj Epidemiol, V5, P23, DOI 10.1186/s40621-018-0152-0; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Schussler E, 2018, INT J SPORTS PHYS TH, V13, P229, DOI 10.26603/ijspt20180229; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350	17	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2021	47						115	118		10.1016/j.ajem.2021.03.039			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UB8SC	WOS:000686108000020	33794473				2022-02-06	
J	Warmath, D; Winterstein, AP; Myrden, S				Warmath, Dee; Winterstein, Andrew P.; Myrden, Susan			Sport Motivation as a Possible Indicator of Concussion Reporting Intentions Among Young Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						education; sport; reporting; concussion	HIGH-SCHOOL; INTRINSIC MOTIVATION; EXTRINSIC MOTIVATION; SELF-DETERMINATION; FOOTBALL PLAYERS; BEHAVIOR; PERSISTENCE; PREDICTORS; EXPERTISE	Objective: To assess the relationship between sport motivation and intentions to report concussion symptoms among young adult athletes. Design: Cross-sectional study (level of evidence: 3). Subjects: One thousand three hundred five young adult athletes of various sports and levels of competitiveness from the Survey Sampling International panel. Methods: Data were collected through an online survey. Ordinary least squares regression was used to examine the relationship between motivation and reporting intentions controlling for competitiveness and perceived risk of injury. Results: Athletes who play their sport for self-regulated (autonomous) reasons have higher intentions to seek care for concussion-like symptoms, whereas those who play to achieve gains external to the sport or avoid punishment (controlled motivation) have lower intentions. A one-point increase in autonomous motivation was associated with an 11.5-point increase in reporting intention (t = 6.629, P < 0.001), whereas a one-point increase in controlled motivation was associated with an 8.1-point decrease in reporting intention (t = -4.562, P < 0.001). Betas from the model suggested that autonomous motivation had a stronger effect than controlled motivation (0.226 vs -0.163). Conclusions: Innovation in care, concussion education, and cultivation of team culture supportive of autonomous motivation could increase concussion reporting. Measuring sport motivation may reveal which athletes require more proactive attention to ensure symptoms are not concealed. Furthermore, messages to reinforce autonomous motivation may increase willingness to report.	[Warmath, Dee] Univ Georgia, Coll Family & Consumer Sci, Athens, GA 30602 USA; [Winterstein, Andrew P.] Univ Wisconsin, Sch Educ, Dept Kinesiol, Madison, WI USA; [Myrden, Susan] Univ Maine, Maine Business Sch, Orono, ME USA		Warmath, D (corresponding author), Univ Georgia, Coll Family & Consumer Sci, Dept Financial Planning Housing & Consumer Econ, Dawson Hall,305 Sanford Dr, Athens, GA 30602 USA.	warmath@uga.edu		Warmath, Dee/0000-0001-8301-1386	National Collegiate Athletic Association; Department of Defense Mind Matters Challenge Grant	This research was funded by a National Collegiate Athletic Association and Department of Defense Mind Matters Challenge Grant.	Alexandris K, 2002, J LEISURE RES, V34, P233, DOI 10.1080/00222216.2002.11949970; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Chatzisarantis NLD, 2004, BRIT J SOC PSYCHOL, V43, P551, DOI 10.1348/0144666042565399; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Deci E. L., 1975, INTRINSIC MOTIVATION; Deci E.L., 1980, ADV EXP SOC PSYCHOL, V13, P39, DOI DOI 10.1016/S0065-2601(08)60130-6; GARLAND DJ, 1990, PERCEPT MOTOR SKILL, V70, P1299, DOI 10.2466/PMS.70.4.1299-1314; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; PELLETIER LG, 1995, J SPORT EXERCISE PSY, V17, P35, DOI 10.1123/jsep.17.1.35; Pelletier LG, 2001, MOTIV EMOTION, V25, P279, DOI 10.1023/A:1014805132406; Pelletier LG, 2007, INTRINSIC MOTIVATION, P331; Porter L. W., 1968, MANAGEMENT ATTITUDES; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sarrazin P, 2002, EUR J SOC PSYCHOL, V32, P395, DOI 10.1002/ejsp.98; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5; VALLERAND RJ, 1992, J PERS, V60, P599, DOI 10.1111/j.1467-6494.1992.tb00922.x; Vallerand RJ, 1997, J PERS SOC PSYCHOL, V72, P1161, DOI 10.1037/0022-3514.72.5.1161	29	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					E216	E220		10.1097/JSM.0000000000000804			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400001	32852306				2022-02-06	
J	Wasicek, PJ; Kantar, RS; Yoon, J; Elegbede, A; Nam, AJ				Wasicek, Philip J.; Kantar, Rami S.; Yoon, Joshua; Elegbede, Adekunle; Nam, Arthur J.			Survival Following Self-Inflicted Gunshot Injuries to the Face Using the National Trauma Data Bank	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Facial fractures; facial trauma; gunshot wounds; self-inflicted gunshot wounds; trauma	BLUNT CEREBROVASCULAR INJURIES; WOUNDS; TRANSPLANTATION; MANAGEMENT; PREDICTORS; DIAGNOSIS; CARE	Introduction: Self-inflicted gunshot wounds to the face frequently result in devastating injuries; however, there is a paucity of large experiences describing determinants of mortality and outcomes. Methods: Using the National Trauma Databank from 2007 to 2015, patients suffering self-inflicted firearm facial injuries were included. Results: Over 9 years 7869 patients were included: 87.7% were male, 46.4% suffered traumatic brain injury (TBI) and overall in-hospital mortality was 44.7%. The majority (67.8%) of in-hospital mortality occurred within the first 24 hours. Using multiple regression, advanced age (>65 years), presence of TBI, admission hypotension, and decreased Glasgow coma score were each independently associated with increased odds of mortality (all P < 0.001). Mandible or combined mandible/midface fracture injury patterns were most likely to survive (P < 0.001). Of those surviving to hospital discharge, the median [interquartile range] length of stay was 13 [6, 23] days, 86.6% required an intensive care unit stay with 67% requiring intubation and 42.5% tracheostomy. Among survivors, the combined mandible and midface fracture pattern resulted in the highest rates of tracheostomy (70.5%), gastrostomy tube placement (50.5%), and facial operations (87.0%) with a median [interquartile range] of 5 [3, 7] operative trips (all P < 0.001). Conclusions: Self-inflicted facial firearm injuries are highly morbid injuries with the majority of in-hospital deaths occurring the first hospital day. Differences including concomitant TBI, facial injury pattern, neurologic status, and presence of hypotension on admission were independently associated with survival/death. More extensive facial injuries (combined mandible and midface fracture patterns) were more likely to survive and required more intensive interventions.	[Wasicek, Philip J.; Kantar, Rami S.; Yoon, Joshua; Elegbede, Adekunle; Nam, Arthur J.] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Sch Med, Div Plast & Reconstruct Surg, 22 S Greene St, Baltimore, MD 21201 USA		Wasicek, PJ (corresponding author), Univ Maryland, R Adams Cowley Shock Trauma Ctr, Sch Med, Div Plast & Reconstruct Surg, 22 S Greene St, Baltimore, MD 21201 USA.	pwasicek@som.umaryland.edu					Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; CALHOUN KH, 1988, ARCH OTOLARYNGOL, V114, P513; DEMOORE GM, 1994, MED J AUSTRALIA, V160, P421, DOI 10.5694/j.1326-5377.1994.tb138267.x; Elegbede A, 2020, OPHTHAL PLAST RECONS, V36, P152, DOI 10.1097/IOP.0000000000001499; Elegbede A, 2019, PLAST RECONSTR SURG, V144, P415, DOI 10.1097/PRS.0000000000005842; Faul M, TRAUMATIC BRAIN INJU; FRIERSON RL, 1990, PSYCHOSOMATICS, V31, P67, DOI 10.1016/S0033-3182(90)72219-0; Johnson J, 2012, INT J ORAL MAX SURG, V41, P895, DOI 10.1016/j.ijom.2012.05.013; Kantar RS, 2019, PLAST RECONSTR SURG, V144, p264E, DOI 10.1097/PRS.0000000000005885; Kaufman Y, 2009, CRANIOMAX TRAUM REC, V2, P85, DOI 10.1055/s-0029-1202595; Kiwanuka H, 2016, J PLAST RECONSTR AES, V69, P1636, DOI 10.1016/j.bjps.2016.08.014; Marschall JS., 2020, J ORAL MAXIL SURG, V78; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Murphy JA, 2018, BRIT J ORAL MAX SURG, V56, P173, DOI 10.1016/j.bjoms.2017.12.018; Mutze S, 2005, RADIOLOGY, V237, P884, DOI 10.1148/radiol.2373042189; Ozturk S, 2006, J CRANIOFAC SURG, V17, P1072; Peled M, 2012, CRANIOMAX TRAUM REC, V5, P31, DOI 10.1055/s-0031-1293518; SHUCK LW, 1980, J TRAUMA, V20, P370, DOI 10.1097/00005373-198020050-00002; Steenburg SD, 2012, EUR RADIOL, V22, P1837, DOI 10.1007/s00330-012-2439-9; Vayvada H, 2005, J CRANIOFAC SURG, V16, P794, DOI 10.1097/01.scs.0000180014.06352.65; Williams ST, 2011, PSYCHOSOMATICS, V52, P34, DOI 10.1016/j.psym.2010.11.019	23	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2021	32	6					2064	2067		10.1097/SCS.0000000000007634			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UK2MX	WOS:000691810100063	33770041				2022-02-06	
J	Welch, V; Mathew, CM; Babelmorad, P; Li, YF; Ghogomu, ET; Borg, J; Conde, M; Kristjansson, E; Lyddiatt, A; Marcus, S; Nickerson, JW; Pottie, K; Rogers, M; Sadana, R; Saran, A; Shea, B; Sheehy, L; Sveistrup, H; Tanuseputro, P; Thompson-Coon, J; Walker, P; Zhang, W; Howe, TE				Welch, Vivian; Mathew, Christine M.; Babelmorad, Panteha; Li, Yanfei; Ghogomu, Elizabeth T.; Borg, Johan; Conde, Monserrat; Kristjansson, Elizabeth; Lyddiatt, Anne; Marcus, Sue; Nickerson, Jason W.; Pottie, Kevin; Rogers, Morwenna; Sadana, Ritu; Saran, Ashrita; Shea, Beverly; Sheehy, Lisa; Sveistrup, Heidi; Tanuseputro, Peter; Thompson-Coon, Joanna; Walker, Peter; Zhang, Wei; Howe, Tracey E.			Health, social care and technological interventions to improve functional ability of older adults living at home: An evidence and gap map	CAMPBELL SYSTEMATIC REVIEWS			English	Article							RANDOMIZED-CONTROLLED-TRIAL; QUALITY-OF-LIFE; LONG-TERM-CARE; MILD COGNITIVE IMPAIRMENT; CHRONIC HEART-FAILURE; FRAIL ELDERLY-PEOPLE; PHYSICAL-ACTIVITY INTERVENTIONS; TRAUMATIC BRAIN-INJURY; LOW-INTENSITY EXERCISE; WHOLE-BODY VIBRATION	Background: By 2030, the global population of people older than 60 years is expected to be higher than the number of children under 10 years, resulting in major health and social care system implications worldwide. Without a supportive environment, whether social or built, diminished functional ability may arise in older people. Functional ability comprises an individual's intrinsic capacity and people's interaction with their environment enabling them to be and do what they value. Objectives: This evidence and gap map aims to identify primary studies and systematic reviews of health and social support services as well as assistive devices designed to support functional ability among older adults living at home or in other places of residence. Search Methods: We systematically searched from inception to August 2018 in: MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, CENTRAL, CINAHL, PsycINFO, AgeLine, Campbell Library, ASSIA, Social Science Citation Index and Social Policy & Practice. We conducted a focused search for grey literature and protocols of studies (e.g., ProQuest Theses and Dissertation Global, conference abstract databases, Help Age, PROSPERO, Cochrane and Campbell libraries and ClinicalTrials.gov). Selection Criteria: Screening and data extraction were performed independently in duplicate according to our intervention and outcome framework. We included completed and on-going systematic reviews and randomized controlled trials of effectiveness on health and social support services provided at home, assistive products and technology for personal indoor and outdoor mobility and transportation as well as design, construction and building products and technology of buildings for private use such as wheelchairs, and ramps. Data Collection and Analysis:We coded interventions and outcomes, and the number of studies that assessed health inequities across equity factors. We mapped outcomes based on the International Classification of Function, Disability and Health (ICF) adapted categories: intrinsic capacities (body function and structures) and functional abilities (activities). We assessed methodological quality of systematic reviews using the AMSTAR II checklist. Main Results: After de-duplication, 10,783 records were screened. The map includes 548 studies (120 systematic reviews and 428 randomized controlled trials). Interventions and outcomes were classified using domains from the International Classification of Function, Disability and Health (ICF) framework. Most systematic reviews (n = 71, 59%) were rated low or critically low for methodological quality. The most common interventions were home-based rehabilitation for older adults (n = 276) and home-based health services for disease prevention (n = 233), mostly delivered by visiting healthcare professionals (n = 474). There was a relative paucity of studies on personal mobility, building adaptations, family support, personal support and befriending or friendly visits. The most measured intrinsic capacity domains were mental function (n = 269) and neuromusculoskeletal function (n = 164). The most measured outcomes for functional ability were basic needs (n = 277) and mobility (n = 160). There were few studies which evaluated outcome domains of social participation, financial security, ability to maintain relationships and communication. There was a lack of studies in low- and middle-income countries (LMICs) and a gap in the assessment of health equity issues. Authors' Conclusions: There is substantial evidence for interventions to promote functional ability in older adults at home including mostly home-based rehabilitation for older adults and home-based health services for disease prevention. Remotely delivered home-based services are of greater importance to policy-makers and practitioners in the context of the COVID-19 pandemic. This map of studies published prior to the pandemic provides an initial resource to identify relevant home-based services which may be of interest for policy-makers and practitioners, such as home-based rehabilitation and social support, although these interventions would likely require further adaptation for online delivery during the COVID-19 pandemic. There is a need to strengthen assessment of social support and mobility interventions and outcomes related to making decisions, building relationships, financial security, and communication in future studies. More studies are needed to assess LMIC contexts and health equity issues.	[Welch, Vivian] Bruyere Res Inst, Methods Ctr, Ottawa, ON K1N 5C8, Canada; [Mathew, Christine M.; Ghogomu, Elizabeth T.; Shea, Beverly; Sheehy, Lisa; Sveistrup, Heidi] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada; [Babelmorad, Panteha] Univ Ottawa, Ottawa, ON, Canada; [Li, Yanfei] Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, Lanzhou, Peoples R China; [Borg, Johan] Lund Univ, Malmo, Sweden; [Conde, Monserrat] Cochrane Campbell Global Ageing Partnership Field, Faro, Portugal; [Kristjansson, Elizabeth] Univ Ottawa, Fac Social Sci, Sch Psychol, Ottawa, ON, Canada; [Marcus, Sue] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Nickerson, Jason W.] Inst Populat Hlth, Ottawa, ON, Canada; [Pottie, Kevin] Univ Ottawa, Family Med, Ottawa, ON, Canada; [Rogers, Morwenna] Univ Exeter, NIHR Arc, South West Peninsula PenARC, Med Sch, Exeter, Devon, England; [Sadana, Ritu] WHO, Geneva, Switzerland; [Saran, Ashrita] Campbell Collaborat, Delhi, India; [Sveistrup, Heidi] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Tanuseputro, Peter] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Thompson-Coon, Joanna] Univ Exeter, NIHR Arc South West Peninsula PenARC, Med Sch, Exeter, Devon, England; [Walker, Peter] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Zhang, Wei] WHO, Access Med Vaccines & Hlth Prod, Geneva, Switzerland; [Howe, Tracey E.] City Glasgow Coll, Glasgow, Lanark, Scotland		Welch, V (corresponding author), Bruyere Res Inst, Methods Ctr, Ottawa, ON K1N 5C8, Canada.	vwelch@campbellcollaboration.org		Zhang, Wei/0000-0002-6022-6832; Saran, Ashrita/0000-0003-3261-6654			Abrisqueta-Gomez J., 2013, ALZHEIMERS DEMENTIA, V1, pP495, DOI [10.1016/j.jalz.2013.05.1021, DOI 10.1016/J.JALZ.2013.05.1021]; Aceros JC, 2016, CIENC SAUDE COLETIVA, V21, P2413, DOI 10.1590/1413-81232015218.13472015; Acierno R, 2017, BEHAV RES THER, V89, P57, DOI 10.1016/j.brat.2016.11.009; Acorn Michelle, 2008, Evid Based Nurs, V11, P22, DOI 10.1136/ebn.11.1.22; Adachi K, 2001, Gan To Kagaku Ryoho, V28 Suppl 1, P133; Ades PA, 2003, MED SCI SPORT EXER, V35, P1265, DOI 10.1249/01.MSS.0000079044.21828.0E; Afifi M, 2014, J HOUS ELDER, V28, P107, DOI 10.1080/02763893.2013.858095; Agmon M., 2018, NEUROREHABILITATION, V32, P354, DOI [10.1177/1545968318765497, DOI 10.1177/1545968318765497]; Agree EM, 1999, SOC SCI MED, V48, P427, DOI 10.1016/S0277-9536(98)00369-4; Agree EM, 2005, J GERONTOL B-PSYCHOL, V60, pS272, DOI 10.1093/geronb/60.5.S272; Aguado O, 2010, HEART LUNG, V39, pS14, DOI 10.1016/j.hrtlng.2010.04.010; Aguglia E, 2004, Am J Alzheimers Dis Other Demen, V19, P248, DOI 10.1177/153331750401900403; Ahlner-Elmqvist M, 2008, J PAIN SYMPTOM MANAG, V36, P217, DOI 10.1016/j.jpainsymman.2007.10.010; Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; Aj K., 2016, ALZHEIMERS DEMENT S; Akesson N, 2018, PHYS OCCUP THER GERI, V36, P14, DOI 10.1080/02703181.2017.1380113; Akiyama A, 2011, ARCH GERONTOL GERIAT, V52, pE85, DOI 10.1016/j.archger.2010.07.011; Al-Sari UA, 2018, OSTEOPOROSIS INT, V29, P19, DOI 10.1007/s00198-017-4287-6; Albertsen IM, 2012, GERONTOLOGY, V58, P419, DOI 10.1159/000337495; Albornos-Munoz L, 2018, J ADV NURS, V74, P1700, DOI 10.1111/jan.13583; Alessi CA, 1997, J AM GERIATR SOC, V45, P1044, DOI 10.1111/j.1532-5415.1997.tb05964.x; Alkan H, 2011, TURK J GERIATR, V14, P26; Alldred DP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009095.pub2; Allen KR, 2012, POPUL HEALTH MANAG, V15, P71, DOI 10.1089/pop.2011.0004; Allen RS, 2014, J PAIN SYMPTOM MANAG, V48, P590, DOI 10.1016/j.jpainsymman.2013.11.012; Allen S A, 1999, Home Health Care Serv Q, V18, P43; Allen S. A., 1996, CASE MANAGEMENT NURS; Allen VJ, 2014, J ADV NURS, V70, P1323, DOI 10.1111/jan.12293; Anderson O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008931.pub3; Ann B. K., 1998, DISS ABSTR INT B, V58, P5106; Ann G. E., 2002, THESIS PROQUEST INFO; [Anonymous], 2006, EVIDENCE BASE REV MO; [Anonymous], 2008, J CARDIOPULM REHABIL; [Anonymous], 2016, EFFECT EARLY NUTR FO, DOI DOI 10.1007/S12603-016-0706-1; [Anonymous], 2013, CHICTR; [Anonymous], 2016, INT J BEHAV MED; [Anonymous], 2018, AM J GERIATRIC PSY S; Antoniak AE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014619; Anttila H, 2012, TRADIT DISCOV, V24, P9; Aoun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123012; Apostolo J, 2016, INT J NURS STUD, V58, P59, DOI 10.1016/j.ijnurstu.2016.02.006; APPLEBAUM R, 1990, GERONTOLOGIST, V30, P444, DOI 10.1093/geront/30.4.444; Arai T, 2007, AM J PHYS MED REHAB, V86, P133, DOI 10.1097/PHM.0b013e31802ef29d; Aranda R. R., 1974, CILS MODEL SOCIAL RE; Arbesman M, 2012, AM J OCCUP THER, V66, P277, DOI 10.5014/ajot.2012.003327; Arean PA, 2008, INT J GERIATR PSYCH, V23, P1086, DOI 10.1002/gps.2100; Arif MJ, 2014, TECHNOL HEALTH CARE, V22, P677, DOI 10.3233/THC-140851; Armstrong JJ, 2016, PHYSIOTHER CAN, V68, P346, DOI 10.3138/ptc.2014-66; Aronson J, 1996, GENDER SOC, V10, P59, DOI 10.1177/089124396010001005; Ashok Sharmila, 2017, Journal of Medical Engineering & Technology, V41, P46, DOI 10.1080/03091902.2016.1210685; Ashworth NL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004017.pub2; Picorelli AMA, 2014, J PHYSIOTHER, V60, P151, DOI 10.1016/j.jphys.2014.06.012; Atienza AA, 2001, J AGING PHYS ACTIV, V9, pS38, DOI 10.1123/japa.9.s1.s38; Auger C, 2008, AM J PHYS MED REHAB, V87, P666, DOI 10.1097/PHM.0b013e31816de163; Bahar-Fuchs A, 2017, J ALZHEIMERS DIS, V60, P889, DOI 10.3233/JAD-170404; Bainbridge D, 2016, J AM GERIATR SOC, V64, P632, DOI 10.1111/jgs.14025; Baker KR, 2001, J RHEUMATOL, V28, P1655; Baker PRA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010321.pub2; Bakker TJEM, 2011, AM J GERIAT PSYCHIAT, V19, P507, DOI 10.1097/JGP.0b013e3181eafdc6; Baldwin C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009840.pub2; Banerjee S, 2015, LANCET, V385, P587, DOI 10.1016/S0140-6736(14)61596-8; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Bashour HN, 2008, PUBLIC HEALTH NURS, V25, P115, DOI 10.1111/j.1525-1446.2008.00688.x; Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bates A, 2018, J PHYSIOTHER, V64, P121, DOI 10.1016/j.jphys.2017.10.001; Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4; Beck A. M., 2016, CLIN NUTR, V35, pS160; Ben Mortenson W, 2013, AM J PHYS MED REHAB, V92, P297, DOI 10.1097/PHM.0b013e31827d65bf; Bentur N, 1996, PHYS OCCUPATIONAL TH, V14, P51; Best KL, 2016, ARCH PHYS MED REHAB, V97, P37, DOI 10.1016/j.apmr.2015.08.425; Best KL, 2014, CAN J OCCUP THER, V81, P308, DOI 10.1177/0008417414546743; Best P. M., 1971, HOT MEALS ELDERLY ME; Beurskens R., 2016, PRAVENTION REHABILIT, V28, P39, DOI [10.5414/NHX01713, DOI 10.5414/NHX01713]; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Bischoff-Ferrari H., 2017, SPITEX SPITAL AUTONO; Bishop M, 2015, J VOCAT REHABIL, V42, P153, DOI 10.3233/JVR-150732; Bismuth S, 2012, CAH ANNEE GERONTOL, V4, P310, DOI 10.1007/s12612-012-0308-4; Blackwood J, 2016, J NUTR HEALTH AGING, V20, P138, DOI 10.1007/s12603-015-0598-5; Blake H, 2009, CLIN REHABIL, V23, P873, DOI 10.1177/0269215509337449; Bleijenberg N, 2017, WORLDV EVID-BASED NU, V14, P210, DOI 10.1111/wvn.12235; Bleijenberg N, 2013, J ADV NURS, V69, P2262, DOI 10.1111/jan.12110; Boland L, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0395-y; Bolscher-Niehuis MJTV, 2016, INT J NURS STUD, V61, P230, DOI 10.1016/j.ijnurstu.2016.06.014; Borell L., 2018, ASSIST 10 INTERVENTI; Boucher P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-58; Boyd M L, 1996, Nurs Manage, V27, P31; Bozorgi AAJ, 2016, OCCUP THER INT, V23, P143, DOI 10.1002/oti.1419; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Brandao GS, 2018, MULTIDISCIP RESP MED, V13, DOI 10.1186/s40248-017-0114-3; Brandt A., 2011, PHYSIOTHERAPY UK, V1, peS74, DOI [10.1016/j.physio.2011. 04.002, DOI 10.1016/J.PHYSI0.2011.04.002]; BRAUN KL, 1987, J AM GERIATR SOC, V35, P387, DOI 10.1111/j.1532-5415.1987.tb04659.x; BRAUN KL, 1991, GERONTOLOGIST, V31, P648, DOI 10.1093/geront/31.5.648; Brettschneider C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0817-0; Brismee JM, 2007, CLIN REHABIL, V21, P99, DOI 10.1177/0269215506070505; Britian O., 1999, EVIDENCE BASED NURSI, V2, P20; Bruun-Olsen V, 2013, DISABIL REHABIL, V35, P2008, DOI 10.3109/09638288.2013.770084; BULL MJ, 1994, J ADV NURS, V19, P503, DOI 10.1111/j.1365-2648.1994.tb01113.x; Caplan G. A., 2010, J AM GERIATRICS SOC, V1, pS7, DOI [10.1111/j.1532-5415.2010.02850.x, DOI 10.1111/J.1532-5415.2010.02850.X]; Cardemil F., 2013, OTOLARYNGOLOGY HEAD, V1, pP108, DOI [10.1177/0194599813495815a223, DOI 10.1177/0194599813495815A223]; Carlson BL, 2007, HEALTH SERV RES, V42, P467, DOI 10.1111/j.1475-6773.2006.00673.x; Carlson M, 2019, J SPINAL CORD MED, V42, P2, DOI 10.1080/10790268.2017.1313931; Cesari M, 2018, J GERONTOL A-BIOL, V73, P1653, DOI 10.1093/gerona/gly011; CHALLIS D, 1991, AGE AGEING, V20, P245, DOI 10.1093/ageing/20.4.245; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AWK, 2016, LANCET, V388, P23; Chan AWK, 2017, CLIN INTERV AGING, V12, P85, DOI 10.2147/CIA.S124604; Chan R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008006.pub2; Chandler D, 1997, AM J OCCUP THER, V51, P921, DOI 10.5014/ajot.51.10.921; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Cherubini A, 2012, DRUG AGING, V29, P463, DOI 10.2165/11631750-000000000-00000; Chesbro SR, 2005, TOP GERIATR REHABIL, V21, P323; Chiatti C, 2015, AGING MENT HEALTH, V19, P517, DOI 10.1080/13607863.2014.954526; Chien CL, 2008, AUST J PHYSIOTHER, V54, P87, DOI 10.1016/S0004-9514(08)70041-2; Chiu CWY, 2004, OTJR-OCCUP PART HEAL, V24, P113, DOI 10.1177/153944920402400305; Chiu M, 2015, INT PSYCHOGERIATR, V27, P937, DOI 10.1017/S1041610214002798; Choi NG, 2014, AM J GERIAT PSYCHIAT, V22, P263, DOI 10.1016/j.jagp.2013.01.037; Choyce J, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0366-x; Cifu DX, 2010, GENERATIONS, V34, P64; Ciliska D, 1996, CAN J PUBLIC HEALTH, V87, P193; Claes-Eric N., 1991, TRANSPORTATION STUDI, V13; Clark H., 1998, COMMUNITY CARE, V16, P22; Clarke P, 2005, CAN J AGING, V24, P191, DOI 10.1353/cja.2005.0059; Clegg A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009537.pub2; Clemson L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4547; COLEMAN BJ, 1995, INT J HEALTH SERV, V25, P455, DOI 10.2190/FYP6-DLWY-WKKT-6NNJ; Cook EDM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006929.pub2; Coster S, 2018, INT J NURS STUD, V78, P76, DOI 10.1016/j.ijnurstu.2017.10.009; Cumming J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005260.pub3; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Cyarto EV, 2006, J SCI MED SPORT, V9, P402, DOI 10.1016/j.jsams.2006.06.020; Dale SB, 2006, MED CARE, V44, P760, DOI 10.1097/01.mlr.0000218849.32512.3f; Dalton J, 2018, J HEALTH SERV RES PO, V23, P196, DOI 10.1177/1355819618766559; DANIELS N, 1982, MILBANK FUND Q, V60, P51, DOI 10.2307/3349700; Danilovich MK, 2017, J APPL GERONTOL, V36, P553, DOI 10.1177/0733464815625833; Dapp U, 2011, J GERONTOL A-BIOL, V66, P591, DOI 10.1093/gerona/glr021; Davidson V., 2018, REHABILITATION ONCOL, V36, pE8, DOI [10.1097/01.REO. 0000000000000098, DOI 10.1097/01.RE0.0000000000000098]; Davison TE, 2016, GERIATR NURS, V37, P25, DOI 10.1016/j.gerinurse.2015.08.013; Day L, 2012, ARCH PHYS MED REHAB, V93, P1400, DOI 10.1016/j.apmr.2012.03.018; de Roos P, 2018, PHYSIOTHERAPY, V104, P116, DOI 10.1016/j.physio.2016.08.005; de van der Schueren M., 2017, INCREASE PROTEIN INT; de Vries NM, 2016, J CACHEXIA SARCOPENI, V7, P422, DOI 10.1002/jcsm.12091; Del Aguila M, 2006, AUSTRALAS J AGEING, V25, P134, DOI 10.1111/j.1741-6612.2006.00168.x; del-Pino-Casado R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217648; Delbaere K, 2006, ACTA CLIN BELG, V61, P340, DOI 10.1179/acb.2006.054; Dellasega Cheryl, 2002, J Gerontol Nurs, V28, P40; Digital Solution Foundary and EPPI-Centre, 2020, EPPI MAPP VERS 125; Dohrn IM, 2017, J GERIATR PHYS THER, V40, P102, DOI 10.1519/JPT.0000000000000077; DONALDSON C, 1990, J HEALTH ECON, V9, P103, DOI 10.1016/0167-6296(90)90043-3; DONALDSON C, 1991, AGE AGEING, V20, P160, DOI 10.1093/ageing/20.3.160; Douglas JW, 2015, J ACAD NUTR DIET, V115, P1815, DOI 10.1016/j.jand.2015.06.376; Douma JG, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0024-1; Dozeman E, 2012, INT PSYCHOGERIATR, V24, P1242, DOI 10.1017/S1041610212000178; Dozeman E, 2011, INT PSYCHOGERIATR, V23, P969, DOI 10.1017/S1041610211000202; Dreizler J, 2014, J CLIN NURS, V23, P911, DOI 10.1111/jocn.12237; Drummond AER, 2013, CLIN REHABIL, V27, P387, DOI 10.1177/0269215512462145; Drury L, 2017, J COMMUNITY APPL SOC, V27, P65, DOI 10.1002/casp.2294; Duckworth JM, 2013, HOME HLTH CARE MAN P, V25, P212, DOI 10.1177/1084822313484760; Dumoulin C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub3; Eklund K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-76; El-Khoury F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3830; Elbadawy MA, 2017, CLIN J PAIN, V33, P254, DOI 10.1097/AJP.0000000000000404; Engberg S, 1997, Adv Pract Nurs Q, V3, P48; Esbensen AJ, 2016, AJIDD-AM J INTELLECT, V121, P13, DOI 10.1352/1944-7558-121.1.13; Fahlman MM, 2007, J GERONTOL NURS, V33, P32; Fairhall N., 2015, PHYSIOTHERAPY UK, V1, peS371, DOI [10.1016/j.physio.2015.03.588, DOI 10.1016/J.PHYSI0.2015.03.588]; Fances M. H., 2011, PREVENTION PATIENT F; Fanning J, 2018, J BEHAV MED, V41, P299, DOI 10.1007/s10865-017-9903-6; Farmer Bonnie Cashin, 2006, Home Healthc Nurse, V24, P449, DOI 10.1097/00004045-200607000-00009; Feldman PH, 2005, HEALTH SERV RES, V40, P865, DOI 10.1111/j.1475-6773.2005.00389.x; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; Fernandez-Barres S, 2017, INT J NURS STUD, V70, P131, DOI 10.1016/j.ijnurstu.2017.02.020; Fields NL, 2014, J APPL GERONTOL, V33, P130, DOI 10.1177/0733464812443308; Finkelstein E, 2012, J AM GERIATR SOC, V60, pS174; Fischer SM, 2015, J PAIN SYMPTOM MANAG, V49, P657, DOI 10.1016/j.jpainsymman.2014.08.011; FITZGERALD JF, 1994, ARCH INTERN MED, V154, P1721, DOI 10.1001/archinte.154.15.1721; Fleet E, 2014, J ANTIMICROB CHEMOTH, V69, P2265, DOI 10.1093/jac/dku115; Flora PK, 2007, J INTERGENER RELATSH, V4, P63, DOI 10.1300/J194v04n04_05; Forbes Dorothy, 2002, Evid Based Nurs, V5, P118, DOI 10.1136/ebn.5.4.118; Forster A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1921-8; Forster A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001730.pub2; Fowler C, 2015, GERIATR NURS, V36, P25, DOI 10.1016/j.gerinurse.2014.09.002; Galle F, 2017, GERIATR GERONTOL INT, V17, P1421, DOI 10.1111/ggi.12879; Garcon L, 2016, GERONTOLOGIST, V56, pS293, DOI 10.1093/geront/gnw005; Gary R, 2006, J GERONTOL NURS, V32, P31, DOI 10.3928/00989134-20060701-05; Gaynor EJ, 2014, AGE AGEING, V43, P429, DOI 10.1093/ageing/afu026; Ghassemzadeh Roya, 2013, Acta Med Iran, V51, P254; Gianoudis J., 2011, J SCI MED SPORT, V14, pe12, DOI [10.1016/j.jsams.2011.11.026, DOI 10.1016/J.JSAMS.2011.11.026]; Gibson T. S., 2002, EFFECTS HOME BASED R; Gielen AC, 2013, J BURN CARE RES, V34, pE250, DOI 10.1097/BCR.0b013e3182685b3a; Giesbrecht EM, 2012, GERONTOLOGY, V58, P378, DOI 10.1159/000334819; Gine-Garriga M, 2010, J AGING PHYS ACTIV, V18, P401, DOI 10.1123/japa.18.4.401; Giordano A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0378-z; Gleeson M, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2012-040726; Goedendorp MM, 2017, PATIENT EDUC COUNS, V100, P1177, DOI 10.1016/j.pec.2017.01.006; Gordon D. S., 1990, SOC SERV RES, V1990, P24; Gosman-Hedstrom G, 2002, INT J TECHNOL ASSESS, V18, P520; Gothe NP, 2014, J AM GERIATR SOC, V62, P285, DOI 10.1111/jgs.12654; Gottlieb LM, 2019, ANN FAM MED, V17, P77, DOI 10.1370/afm.2339; Graff MJL, 2003, OTJR-OCCUP PART HEAL, V23, P155, DOI 10.1177/153944920302300403; Graham-Phillips A, 2016, J AM GERIATR SOC, V64, P1662, DOI 10.1111/jgs.14204; Gray YL, 1997, J PROF NURS, V13, P56, DOI 10.1016/S8755-7223(97)80027-0; Griffiths P., 2013, PROTOCOL EVALUATING; Griffiths P., 2000, EVIDENCE BASED NURSI, V3, P127; Guidetti S, 2010, SCAND J OCCUP THER, V17, P276, DOI 10.3109/11038120903281169; Guidon M, 2013, DISABIL REHABIL, V35, P397, DOI 10.3109/09638288.2012.694963; Guitard P, 2013, ASSIST TECHNOL, V25, P139, DOI 10.1080/10400435.2012.732654; Haines TP, 2009, CLIN REHABIL, V23, P973, DOI 10.1177/0269215509338998; Halvarsson A, 2015, CLIN REHABIL, V29, P365, DOI 10.1177/0269215514544983; Hariprasad VR, 2013, INDIAN J PSYCHIAT, V55, pS364, DOI 10.4103/0019-5545.116310; Harrison MB, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-243; Hauer K., 2015, HOME BASED EXERCISE; Hayashi N., 2011, ALZHEIMERS DEMENTIA, V1, pS644, DOI [10.1016/j.jalz. 2011.05.1846, DOI 10.1016/J.JALZ.2011.05.1846]; Heneka N, 2016, PALLIATIVE MED, V30, P520, DOI 10.1177/0269216315615002; Hennig Tais Regina, 2012, J. Soc. Bras. Fonoaudiol., V24, P26, DOI 10.1590/S2179-64912012000100006; HENRARD JC, 1991, SOC POLICY ADMIN, V25, P184, DOI 10.1111/j.1467-9515.1991.tb00514.x; Herke M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011542.pub2; Hillcoat-Nalletamby S, 2014, J GERONTOL B-PSYCHOL, V69, P419, DOI 10.1093/geronb/gbu008; Hinkka K, 2007, J REHABIL MED, V39, P473, DOI 10.2340/16501977-0078; Hinrichs T, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-263; Hiroko K., 2003, EFFECTS AROMATHERAPY; Hirsch C., 2015, ACP J CLUB, V162, P1; Hofstad H, 2013, INT J STROKE, V8, P582, DOI 10.1111/j.1747-4949.2012.00825.x; Holthe T, 2018, CLIN INTERV AGING, V13, P863, DOI 10.2147/CIA.S154717; Hongdao M., 2004, DEMAND PERSONAL ASSI; Hori M., 2014, CANC CHEMOTHERAPY S1, V41, P33; Hu X, 2007, JPN J PHYS FIT SPORT, V56, P409, DOI 10.7600/jspfsm.56.409; Huang TT, 2004, PUBLIC HEALTH NURS, V21, P247, DOI 10.1111/j.0737-1209.2004.21307.x; HUGHES SL, 1987, HEALTH SERV RES, V22, P19; Hum AYM, 2018, PROG PALLIAT CARE, V26, P65, DOI 10.1080/09699260.2018.1442286; Humbert Jennie, 2007, Can Nurse, V103, P30; Hummel SL, 2017, J CARD FAIL, V23, P830, DOI 10.1016/j.cardfail.2017.10.005; Hung LC, 2003, ARCH GERONTOL GERIAT, V36, P259, DOI 10.1016/S0167-4943(02)00170-X; Iecovich Esther, 2007, J Aging Soc Policy, V19, P105; IFUDU O, 1994, AM J KIDNEY DIS, V23, P394, DOI 10.1016/S0272-6386(12)81002-X; Ihsan H. Z., 2013, IMPROVING QUALITY CA; Ilieva EM, 2013, EUR J PHYS REHAB MED, V49, P579; Iliffe S, 2015, PROGRAM GRANTS APPL, V3, P1, DOI DOI 10.3310/PGFAR03030; Iliffe S, 2015, BRIT J GEN PRACT, V65, pE731, DOI 10.3399/bjgp15X687361; Intiso D, 2012, J NEPHROL, V25, pS90, DOI 10.5301/jn.5000138; Istvandity L, 2017, COMPLEMENT THER CLIN, V28, P18, DOI 10.1016/j.ctcp.2017.03.003; Iversen MD, 2012, ORTHOP NURS, V31, P103, DOI 10.1097/NOR.0b013e31824fce07; Iyengar KP, 2007, DISABIL REHABIL, V29, P495, DOI 10.1080/09638280600841471; Jacobson BH, 2011, CLIN REHABIL, V25, P549, DOI 10.1177/0269215510392390; Jan M., 2017, COCHRANE DATABASE SY, V8, DOI 10.1002/ 14651858.CD002840.pub4; Jansen CP, 2013, Z GERONTOL GERIATR, V46, P26; Jeon MY, 2015, MED SCI MONITOR, V21, P3696, DOI 10.12659/MSM.895519; Jessup James V, 2003, Biol Res Nurs, V4, P171, DOI 10.1177/1099800402239628; Joan O., 2004, COCHRANE DATABASE SY, V1, DOI 10.1002/14651858. CD002802.pub2; Jobe JB, 2001, CONTROL CLIN TRIALS, V22, P453, DOI 10.1016/S0197-2456(01)00139-8; John A. A., 2000, IDENTIFICATION MANAG; Johnen B, 2018, AGING CLIN EXP RES, V30, P819, DOI 10.1007/s40520-017-0830-8; JOHNSON IS, 1988, J ADV NURS, V13, P565, DOI 10.1111/j.1365-2648.1988.tb01449.x; Joranson N, 2017, J ADV NURS, V73, P1531, DOI 10.1111/jan.13307; Jung S, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2642-3; Justina LYW, 2014, ARCH GERONTOL GERIAT, V59, P317, DOI 10.1016/j.archger.2014.05.008; Jyvakorpi SK, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-66; Kamioka H, 2006, J EPIDEMIOL, V16, P35, DOI 10.2188/jea.16.35; Kamioka Hirohoru, 2004, Journal of Japanese Association of Physical Medicine Balneology and Climatology, V67, P202; Karlsson B., 2012, KLIN SYGEPLEJE, V26, P23; Karlsson MK, 2013, OSTEOPOROSIS INT, V24, P747, DOI 10.1007/s00198-012-2256-7; Karmarkar A. M., 2009, PRESCRIPTION OUTCOME; Karmarkar AM, 2010, DISABIL REHABIL-ASSI, V5, P428, DOI 10.3109/17483107.2010.481346; Karmarkar AM, 2009, DISABIL REHABIL-ASSI, V4, P337, DOI 10.1080/17483100903038543; Katzel L. I., 2016, MULTIMODEL EXERCISE; Kawagoshi A, 2015, RESP MED, V109, P364, DOI 10.1016/j.rmed.2015.01.008; Keall MD, 2017, INJURY PREV, V23, P22, DOI 10.1136/injuryprev-2015-041947; Keeney T, 2017, J AM GERIATR SOC, V65, P2707, DOI 10.1111/jgs.15136; Kegelmeyer DA, 2013, GAIT POSTURE, V38, P20, DOI 10.1016/j.gaitpost.2012.10.027; Kelly ME, 2014, AGEING RES REV, V15, P28, DOI 10.1016/j.arr.2014.02.004; Kemmler W, 2010, AM J PREV MED, V38, P279, DOI 10.1016/j.amepre.2009.10.042; Kendall JC, 2018, CHIROPR MAN THER, V26, DOI 10.1186/s12998-018-0183-1; Kerschan K, 1998, AM J PHYS MED REHAB, V77, P326, DOI 10.1097/00002060-199807000-00013; KERSKI D, 1987, J GERONTOL, V42, P191, DOI 10.1093/geronj/42.2.191; Kerwin Maureen, 2012, Stud Health Technol Inform, V177, P254; King AII, 2012, HEALTH SOC CARE COMM, V20, P70, DOI 10.1111/j.1365-2524.2011.01020.x; Kiosses DN, 2015, J ALZHEIMERS DIS, V48, P453, DOI 10.3233/JAD-150200; Kiosses DN, 2010, AM J GERIAT PSYCHIAT, V18, P988, DOI 10.1097/JGP.0b013e3181d6947d; Kirch W., 2008, ENCY PUBLIC HLTH, DOI [10.1007/978-1-4020-5614-7_1209, DOI 10.1007/978-1-4020-5614-7_1209]; Kolt GS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-404; Konick-McMahan Joanne, 2003, J Gerontol Nurs, V29, P35; Konno Rie, 2012, JBI Libr Syst Rev, V10, P4622; Kono A, 2009, AGING CLIN EXP RES, V21, P167; KRAVITZ RL, 1994, J AM GERIATR SOC, V42, P1229, DOI 10.1111/j.1532-5415.1994.tb06502.x; Kristen D., 2000, GERONTOLOGIST, V40, P397; Kruse RL, 2013, CLIN TRIALS, V10, P160, DOI 10.1177/1740774512461858; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Kunik ME, 2017, AM J GERIAT PSYCHIAT, V25, P144, DOI 10.1016/j.jagp.2016.04.009; Kuo LM, 2016, GERIATR NURS, V37, P376, DOI 10.1016/j.gerinurse.2016.05.005; Kuo LM, 2013, INT J GERIATR PSYCH, V28, P504, DOI 10.1002/gps.3853; Kusumoto A, 2007, GERONTOLOGY, V53, P348, DOI 10.1159/000104252; Lacroix A, 2016, GERONTOLOGY, V62, P275, DOI 10.1159/000442087; Lahtinen A, 2017, CLIN REHABIL, V31, P672, DOI 10.1177/0269215516651480; Lahtinen A, 2015, CLIN REHABIL, V29, P892, DOI 10.1177/0269215514559423; Lai CKY, 2017, J AM MED DIR ASSOC, V18, P509, DOI 10.1016/j.jamda.2016.12.084; Lam LCW, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.03.008; Laming N, 2017, BRIT J OCCUP THER, V80, P73; Lapid MI, 2006, J AM GERIATR SOC, V54, pS196; Laufer Y, 2002, CLIN REHABIL, V16, P141, DOI 10.1191/0269215502cr481oa; Leinonen R, 2007, SCAND J MED SCI SPOR, V17, P156, DOI 10.1111/j.1600-0838.2006.00536.x; Leone E., 2012, REV NEUROPSYCHOLOGIE, V4, P114, DOI [10.3917/rne.042.0114, DOI 10.3917/RNE.042.0114]; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; LEVINE RE, 1993, AM J OCCUP THER, V47, P147, DOI 10.5014/ajot.47.2.147; Levy-Storms L, 2008, PATIENT EDUC COUNS, V73, P8, DOI 10.1016/j.pec.2008.05.026; Li XY, 2017, RES GERONTOL NURS, V10, P121, DOI 10.3928/19404921-20170411-02; Liberopoulos G, 2009, J CLIN EPIDEMIOL, V62, P1218, DOI 10.1016/j.jclinepi.2008.12.009; Liebel D., 2008, DISS ABSTR INT B, V68, P5860; Lim W. K., 2005, INTERNAL MED J, V35, pA54; Lim WK, 2003, MED J AUSTRALIA, V178, P262, DOI 10.5694/j.1326-5377.2003.tb05191.x; Lin JS, 2012, J AM GERIATR SOC, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x; Lingler J. H., 2014, ALZHEIMERS DEMENTIA, V10, pP737; Littlewood C, 2016, CLIN REHABIL, V30, P686, DOI 10.1177/0269215515593784; Liu JYW, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-78; Liu LL, 2016, INT J MED INFORM, V91, P44, DOI 10.1016/j.ijmedinf.2016.04.007; Livingston G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6276; Lord SR, 2003, J AM GERIATR SOC, V51, P1685, DOI 10.1046/j.1532-5415.2003.51551.x; Low LF, 2015, INT PSYCHOGERIATR, V27, P1593, DOI 10.1017/S1041610215000137; Low LF, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-124; Lu DF, 2013, GERIATR NURS, V34, P314, DOI 10.1016/j.gerinurse.2013.05.003; Luger E, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.04.018; Lum C, 2011, J EXP CRIMINOL, V7, P3, DOI 10.1007/s11292-010-9108-2; Lundqvist M, 2015, COMMUNITY DENT HLTH, V32, P39, DOI 10.1922/CDH_3407Lundqvist05; Luukinen H, 2006, SCAND J PRIM HEALTH, V24, P199, DOI 10.1080/02813430600958476; Maghsoudi E, 2015, RES J PHARM BIOL CHE, V6, P793; Majewski M, 2015, ADV CLIN EXP MED, V24, P1079, DOI 10.17219/acem/31679; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; Mameletzi D, 2011, CLIN REHABIL, V25, P217, DOI 10.1177/0269215510380825; Mangione KK, 2010, PHYS THER REHABIL J, V90, P1711, DOI 10.2522/ptj.20100270; Marasinghe Keshini Madara, 1800, BMJ Innov, V1, P182; Marasinghe KM, 2016, DISABIL REHABIL-ASSI, V11, P353, DOI 10.3109/17483107.2015.1087061; Marioni G, 2013, AGE, V35, P2315, DOI 10.1007/s11357-012-9494-7; Markle-Reid M, 2013, J EVAL CLIN PRACT, V19, P118, DOI 10.1111/j.1365-2753.2011.01782.x; Marston A, 2007, INT J THER REHABIL, V14, P229, DOI 10.12968/ijtr.2007.14.5.23541; Martini DN, 2018, ARCH PHYS MED REHAB, V99, P2050, DOI 10.1016/j.apmr.2018.05.023; Mason A, 2007, J AM GERIATR SOC, V55, P290, DOI 10.1111/j.1532-5415.2006.01037.x; Mazzuca K B, 1997, J Community Health Nurs, V14, P211, DOI 10.1207/s15327655jchn1404_1; McCusker J, 2001, J AM GERIATR SOC, V49, P1272, DOI 10.1046/j.1532-5415.2001.49254.x; McEwan R. T., 1992, SCREENING ELDERLY GE; McMillan S. C., 2005, J PALLIATIVE MED, V8, P132; MCNEIL JK, 1995, J APPL GERONTOL, V14, P333, DOI 10.1177/073346489501400307; Medical Advisory Secretariat, 2008, Ont Health Technol Assess Ser, V8, P1; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006876.pub4; MELIN AL, 1995, AGING-CLIN EXP RES, V7, P247, DOI 10.1007/BF03324326; Melis RJF, 2010, DISABIL REHABIL, V32, P937, DOI 10.3109/09638280903381006; Melis RJF, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-65; Mello JD, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.11.007; Mercadante S, 2011, J PAIN SYMPTOM MANAG, V41, P754, DOI 10.1016/j.jpainsymman.2010.07.013; Merom D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002112; Messecar D., 1999, EVIDENCE BASED NURSI, V2, P50; Messecar D., 2003, EVIDENCE BASED NURSI, V6, P116; Michaud HN, 2017, J AM ACAD AUDIOL, V28, P596, DOI 10.3766/jaaa.15090; Mikkelsen LR, 2017, CLIN REHABIL, V31, P11, DOI 10.1177/0269215516628305; Miller KL, 2010, J GERIATR PHYS THER, V33, P85, DOI 10.1097/JPT.0b013e3181df0035; Mitchell S., 1987, SOCIAL SERVICES INSI, V2, P15; Mitseva Anelia, 2012, Curr Gerontol Geriatr Res, V2012, P401705, DOI 10.1155/2012/401705; MoffaTrotter ME, 1996, TOP GERIATR REHABIL, V12, P46; Moholdt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041199; Molloy GJ, 2006, EUR J CARDIOV PREV R, V13, P381, DOI 10.1097/00149831-200606000-00014; Monteau D, 2010, CAH ANNEE GERONTOL, V2, P176, DOI 10.1007/s12612-010-0123-8; Montgomery C., 2010, EFFECTS QUANTITATIVE; Moore M, 2016, J AGING PHYS ACTIV, V24, P158, DOI 10.1123/japa.2014-0218; Morag T., 2017, PROTOCOL EFFECT COGN; Morey MC, 2015, CANCER-AM CANCER SOC, V121, P4433, DOI 10.1002/cncr.29684; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Morin S., 2017, PROTOCOL HIP MOBILE; Mottram P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003542.pub2; Mozley CG, 2007, AGING MENT HEALTH, V11, P99, DOI 10.1080/13607860600637810; Mozolic J, 2008, GERONTOLOGIST, V48, P492; Muller C, 2014, Z EVIDENZ FORTBILD Q, V108, pS36, DOI 10.1016/j.zefq.2014.09.003; Mukamel DB, 2007, MILBANK Q, V85, P499, DOI 10.1111/j.1468-0009.2007.00497.x; Munday J., 2013, JBI DATABASE SYSTEMA, V11, P112; Mustian Karen M, 2009, J Support Oncol, V7, P158; Ndiok A, 2019, SCAND J CARING SCI, V33, P185, DOI 10.1111/scs.12619; Neil T., 1989, J SOCIAL POLICY, V18, P465; Nelson K., 2016, PROTOCOL VETERAN PEE; Ness A., 2018, CANADIAN J EMERGEN S, V20, pS6, DOI [10.1017/cem.2018.62, DOI 10.1017/CEM.2018.62]; Neville C., 2015, WATERMEMORIES SWIMMI; Newbury J, 2000, BRIT MED J, V321, P512, DOI 10.1136/bmj.321.7259.512; Newcomer R, 1999, HEALTH SERV RES, V34, P669; Nguyen SA, 2015, AM J GERIAT PSYCHIAT, V23, pS71, DOI 10.1016/j.jagp.2014.12.068; Nieman CL, 2017, GERONTOLOGIST, V57, P1173, DOI 10.1093/geront/gnw153; Niemela K, 2012, ARCH GERONTOL GERIAT, V54, pE376, DOI 10.1016/j.archger.2011.10.006; Niemela K, 2011, AGING CLIN EXP RES, V23, P279, DOI 10.3275/7230; Nijs KAND, 2006, J GERONTOL A-BIOL, V61, P935, DOI 10.1093/gerona/61.9.935; NIKOLAUS T, 1995, Z GERONTOL GERIATR, V28, P47; Nikoletou D, 2016, DISABIL REHABIL, V38, P250, DOI 10.3109/09638288.2015.1036171; Nilsson P, 2012, SCAND J OCCUP THER, V19, P404, DOI 10.3109/11038128.2011.620983; Nishiguchi S, 2015, J AM GERIATR SOC, V63, P1355, DOI 10.1111/jgs.13481; NOELKER LS, 1989, J GERONTOL, V44, pS63, DOI 10.1093/geronj/44.2.S63; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Nour K., 2002, Therapeutic Recreation Journal, V36, P48; Nourhashemi F., 2015, PROTOCOL SAFEWALKER; O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005; OCONNELL PG, 1989, ARCH PHYS MED REHAB, V70, P451, DOI 10.1016/0003-9993(89)90005-1; Oleske D M, 1988, Home Health Care Serv Q, V9, P45, DOI 10.1300/J027v09n01_04; Oliveira J, 2016, J AGING PHYS ACTIV, V24, pS108; Ollonqvist K, 2008, HEALTH SOC CARE COMM, V16, P115, DOI 10.1111/j.1365-2524.2007.00733.x; Olsen C, 2016, GERIATR NURS, V37, P284, DOI 10.1016/j.gerinurse.2016.04.002; Opinder S., 2016, HLTH SERVICES DELIVE, V4, DOI [10.3310/hsdr04070, DOI 10.3310/HSDR04070]; Orrell M, 2007, INT J GERIATR PSYCH, V22, P1127, DOI 10.1002/gps.1801; Orrell M, 2014, BRIT J PSYCHIAT, V204, P454, DOI 10.1192/bjp.bp.113.137414; Ottmann G, 2013, HEALTH SOC CARE COMM, V21, P563, DOI 10.1111/hsc.12025; Overbeek A, 2018, J AM GERIATR SOC, V66, P1089, DOI 10.1111/jgs.15333; Padulo J, 2018, GERIATR GERONTOL INT, V18, P658, DOI 10.1111/ggi.13262; Palvanen M, 2012, OSTEOPOROSIS INT, V23, pS140; Pan RH, 2018, CLIN REHABIL, V32, P37, DOI 10.1177/0269215517714830; Park J, 2017, J AM GERIATR SOC, V65, P592, DOI 10.1111/jgs.14717; Parsons M, 2013, HEALTH SOC CARE COMM, V21, P536, DOI 10.1111/hsc.12045; PATHY MSJ, 1992, LANCET, V340, P890, DOI 10.1016/0140-6736(92)93294-W; Payette H, 2002, J AM DIET ASSOC, V102, P1088, DOI 10.1016/S0002-8223(02)90245-2; Pearson NK, 2007, BRIT DENT J, V203, DOI 10.1038/bdj.2007.569; Perula LA, 2012, ARCH PHYS MED REHAB, V93, P1677, DOI 10.1016/j.apmr.2012.03.035; Pflaum M, 2016, Z GERONTOL GERIATR, V49, P366, DOI 10.1007/s00391-015-1007-8; Pihl E, 2011, EUR J CARDIOVASC NUR, V10, P150, DOI 10.1016/j.ejcnurse.2011.03.002; Pine ZM, 2002, J AM GERIATR SOC, V50, P263; Plath D, 2009, J AGING SOC POLICY, V21, P209, DOI 10.1080/08959420902733173; Ploeg J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1480; Podd S, 2015, EUR CARDIOL REV, V10, P1, DOI 10.15420/ecr.2015.10.2.1; Pollack C. D., 1998, THESIS; Pollock RD, 2012, CLIN REHABIL, V26, P915, DOI 10.1177/0269215511435688; Pozet A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1622-8; Pressler K., 2015, DISS ABSTR INT A, V76; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Prizer LP, 2018, GERONTOLOGIST, V58, pS74, DOI 10.1093/geront/gnx103; Pynnonen K, 2018, AGING MENT HEALTH, V22, P77, DOI 10.1080/13607863.2016.1232367; Ramsay E., 2011, PHYSIOTHERAPY, V1, peS1034, DOI 10.1016/j.physio.2011. 04; Rana AKMM, 2010, PUBLIC HEALTH, V124, P705, DOI 10.1016/j.puhe.2010.07.005; Ranganathan M, 2012, Ind Psychiatry J, V21, P173, DOI 10.4103/0972-6748.119655; Rantanen T, 2012, J AGING PHYS ACTIV, V20, pS320; Ratzka A. D., 1986, WORLD REHABILITATION, V34; REDFORD JB, 1993, ARCH PHYS MED REHAB, V74, P877, DOI 10.1016/0003-9993(93)90016-4; Reeder B, 2013, INT J MED INFORM, V82, P565, DOI 10.1016/j.ijmedinf.2013.03.007; Reid MC, 2017, J AM GERIATR SOC, V65, P1667, DOI 10.1111/jgs.14836; Reid Una V, 2002, Evid Based Nurs, V5, P19, DOI 10.1136/ebn.5.1.19; Rentschler AJ, 2008, J REHABIL RES DEV, V45, P1281, DOI 10.1682/JRRD.2007.10.0160; Resnick B, 2013, ANNU REV NURS RES-SE, V31, P175, DOI 10.1891/0739-6686.31.175; Ricauda NA, 2004, J AM GERIATR SOC, V52, P278, DOI 10.1111/j.1532-5415.2004.52069.x; Richardson J P, 1989, Md Med J, V38, P149; Rideout Elizabeth, 2004, Evid Based Nurs, V7, P20, DOI 10.1136/ebn.7.1.20; Rizzo JA, 1996, MED CARE, V34, P954, DOI 10.1097/00005650-199609000-00007; Robert P., 2016, GERONTECHNOLOGY, V15, P80; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Robinson H, 2013, J AM MED DIR ASSOC, V14, P661, DOI 10.1016/j.jamda.2013.02.007; Roger C., 2011, SCREENING HEARING LO; Rogers C, 2018, J RACIAL ETHN HEALTH, V5, P1315, DOI 10.1007/s40615-018-0480-3; Romskaug R, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1900-0; Rooij D. S., 2010, EUROPEAN GERIATRIC M, V1, pS129, DOI [10.1016/j.eurger.2010.07.009, DOI 10.1016/J.EURGER.2010.07.009]; Rossi LP, 2014, TOP GERIATR REHABIL, V30, P256, DOI 10.1097/TGR.0000000000000035; Routasalo PE, 2009, J ADV NURS, V65, P297, DOI 10.1111/j.1365-2648.2008.04837.x; RUBIN CD, 1992, J AM GERIATR SOC, V40, P989, DOI 10.1111/j.1532-5415.1992.tb04474.x; Rubio Acuna M., 2013, GEROKOMOS, V24, P78; Rudilla D, 2016, PALLIAT SUPPORT CARE, V14, P321, DOI 10.1017/S1478951515001182; Ruikes FGH, 2016, J AM BOARD FAM MED, V29, P209, DOI 10.3122/jabfm.2016.02.150214; Ryburn B, 2009, HEALTH SOC CARE COMM, V17, P225, DOI 10.1111/j.1365-2524.2008.00809.x; Rydwik E, 2010, ARCH GERONTOL GERIAT, V51, P283, DOI 10.1016/j.archger.2009.12.001; Sadana R., 2018, DEP AGEING LIFE COUR; Sadana R, 2016, GERONTOLOGIST, V56, pS178, DOI 10.1093/geront/gnw034; Sahyoun NR, 2014, NUTR CLIN PRACT, V29, P459, DOI 10.1177/0884533614536446; Sakurai R, 2013, AGING CLIN EXP RES, V25, P453, DOI 10.1007/s40520-013-0080-3; Sakurai Ryota, 2011, Nihon Ronen Igakkai Zasshi, V48, P352; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sampedro M., 2015, PROTOCOL WORKSHOP PR; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Sanford J A, 1995, Assist Technol, V7, P36; Sayers SP, 2003, AM J PHYS MED REHAB, V82, P605, DOI 10.1097/01.PHM.0000078225.71442.B6; Schoenmakers B, 2010, AGING MENT HEALTH, V14, P44, DOI 10.1080/13607860902845533; Schoonhoven L, 2015, INT J NURS STUD, V52, P112, DOI 10.1016/j.ijnurstu.2014.08.001; SCHWARTZ P J, 1990, Health and Social Work, V15, P152; Seitz D., 2014, ALZHEIMERS DEMENTIA, V4, pP736; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Sharoni SKA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192417; Sharoni SKA, 2016, INT J OLDER PEOPLE N, V11, P214, DOI 10.1111/opn.12112; Sharpe R, 2016, INT J BEHAV MED, V23, pS248; Shaw KL, 2008, TOP GERIATR REHABIL, V24, P315; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Sheppad S., 1998, RANDOMISED CONTROLLE; Shepperd S, 1998, J PUBLIC HEALTH MED, V20, P344, DOI 10.1093/oxfordjournals.pubmed.a024778; Sherrington C, 2004, ARCH PHYS MED REHAB, V85, P710, DOI 10.1016/S0003-9993(03)00620-8; Sherwood D. A., 1980, EFFECTS HOMEMAKER DA; SHERWOOD S, 1986, AM J PUBLIC HEALTH, V76, P38, DOI 10.2105/AJPH.76.1.38; Shigekazu U., 2012, INT J GERIATRIC PSYC, V27, P1206, DOI [10.1002/gps.2835, DOI 10.1002/GPS.2835]; Shimada H, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0263-9; Shishehgar Majid, 2018, Smart Health, V7-8, P1, DOI 10.1016/j.smhl.2018.03.002; Sidel V W, 1990, J Community Health, V15, P163, DOI 10.1007/BF01350254; Stoltz P, 2004, SCAND J CARING SCI, V18, P111, DOI 10.1111/j.1471-6712.2004.00269.x; Thoreau R, 2015, J TRANSP HEALTH, V2, P269, DOI 10.1016/j.jth.2015.03.005; Ukawa S, 2015, INT J GERIATR PSYCH, V30, P887, DOI 10.1002/gps.4311; United Nations, 2020, SUSTAINABLE DEV GOAL; United Nations Department of Economic and Social Affairs Population Division (UNDESA), 2017, ESAPWP248 UN DEP EC, P1; Vass M, 2005, J AM GERIATR SOC, V53, P563, DOI 10.1111/j.1532-5415.2005.53201.x; Webb J. R., 2012, AM J RESP CRITICAL C, P185, DOI [10. 1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2881, DOI 10.1164/AJRCCM-C0NFERENCE.2012.185.1_MEETINGABSTRACTS.A2881]; Wilsher H. S., 2014, EUROPEAN GERIATRIC M, V1, pS70; World Health Organization, 2017, MENT HLTH OLD AD; World Health Organization, 2018, 3 UN HIGH LEV M NCDS; World Health Organization, 2011, WHO STUD GLOB AGEING; World Health Organization, 2016, PREV UNS AB, P1; World Health Organization, 2015, WORLD REP AG HLTH; World Health Organization, 2016, WORLD HLTH ASS 69 MU; World Health Organization, 2007, INT CLASS FUNCT DIS; Andren S, 2008, SCAND J CARING SCI, V22, P98, DOI 10.1111/j.1471-6712.2007.00498.x; Wanderley FAC, 2015, J APPL GERONTOL, V34, pNP143, DOI 10.1177/0733464812468502; De Vriendt P, 2016, J NUTR HEALTH AGING, V20, P35, DOI 10.1007/s12603-015-0581-1; Torres-Arreola LD, 2009, J CLIN NURS, V18, P2993, DOI 10.1111/j.1365-2702.2009.02862.x; Eloranta S, 2010, J INTERPROF CARE, V24, P198, DOI 10.3109/13561820903078272; Evans S, 2007, AGE AGEING, V36, P431, DOI 10.1093/ageing/afm034; Lester D, 2016, J AGING PHYS ACTIV, V24, pS16; Palmer M., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001308.PUB2; Pedersen PU, 2005, J CLIN NURS, V14, P247, DOI 10.1111/j.1365-2702.2004.00874.x; Simmons S., 1996, NURSING HOMES LONG T, V45, P32; SIMMONS SF, 1995, J AM GERIATR SOC, V43, P384, DOI 10.1111/j.1532-5415.1995.tb05812.x; Singh M. A. F., 2018, PROTOCOL HOMECARE CA; Singh M. F., 2017, PROTOCOL BRAIN TRAIN; Siragusa S, 2005, ANN ONCOL, V16, P136, DOI 10.1093/annonc/mdi923; Sjosten NA, 2008, INT J GERIATR PSYCH, V23, P504, DOI 10.1002/gps.1927; Sladek RM, 2011, CONTEMP CLIN TRIALS, V32, P717, DOI 10.1016/j.cct.2011.05.004; Snilstveit B., 2013, POLICY RES WORKING P, P6725; Snilstveit B., 2017, 3IE EVIDENCE GAP MAP; Snilstveit B, 2016, J CLIN EPIDEMIOL, V79, P120, DOI 10.1016/j.jclinepi.2016.05.015; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Sosnoff JJ, 2014, CLIN REHABIL, V28, P254, DOI 10.1177/0269215513501092; Sprange K, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-302; Stark S, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0478-4; Stathi A, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2603-x; STEIN SR, 1981, J AM GERIATR SOC, V29, P411, DOI 10.1111/j.1532-5415.1981.tb02380.x; Stelmack J. A., 2005, IOVS, V46; Stenvall M, 2007, J REHABIL MED, V39, P232, DOI 10.2340/16501977-0045; Steultjens E., 2006, AUSTR OCCUPATIONAL T, V53, P243; Stevens-Lapsley J. E., 2016, IMPROVING REHABILITA; Stevenson J, 1981, Geriatr Nurs, V2, P127; Stewart S, 2005, AGE AGEING, V34, P41, DOI 10.1093/ageing/afh230; Stewart S, 2016, CIRCULATION, V133, P1867, DOI 10.1161/CIRCULATIONAHA.116.020730; Stewart Simon, 2006, Evid Based Nurs, V9, P23, DOI 10.1136/ebn.9.1.23; Stolle C, 2012, Z GERONTOL GERIATR, V45, P315, DOI 10.1007/s00391-011-0221-2; Stow R, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0952-2; STRAW LB, 1991, J VISUAL IMPAIR BLIN, V85, P291; STUCK AE, 1995, AGING-CLIN EXP RES, V7, P218, DOI 10.1007/BF03324319; Stuck AE, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-2; Sturkenboom IHWM, 2016, CLIN REHABIL, V30, P1186, DOI 10.1177/0269215515622038; Sungkarat S, 2017, J AM GERIATR SOC, V65, P721, DOI 10.1111/jgs.14594; Suwanwela NC, 2002, CEREBROVASC DIS, V13, P267, DOI 10.1159/000057854; Swank AM, 2011, J STRENGTH COND RES, V25, P318, DOI 10.1519/JSC.0b013e318202e431; Tanner JA, 2013, AM J GERIAT PSYCHIAT, V21, pS97, DOI 10.1016/j.jagp.2012.12.129; Tappen RM, 2014, RES GERONTOL NURS, V7, P14, DOI 10.3928/19404921-20131009-01; Tasiemski T, 2005, NEUROREHABILITATION, V20, P253; Taule T, 2015, SCAND J CARING SCI, V29, P651, DOI 10.1111/scs.12193; Tennsledt S, 1998, J GERONTOL B-PSYCHOL, V53, pP384, DOI 10.1093/geronb/53B.6.P384; Thomas J., 2010, EPPI REV 4 SOFTWARE; Thomas J., EPPI REV ADV SOFTWAR; Thomas R, 2007, CAN J AGING, V26, P379, DOI 10.3138/cja.26.4.379; Thulesius H, 2002, PALLIATIVE MED, V16, P347, DOI 10.1191/0269216302pm568oa; Tibaek S, 2014, CLIN REHABIL, V28, P319, DOI 10.1177/0269215513501524; Tiedemann A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1380-7; Tiedemann A, 2013, J GERONTOL A-BIOL, V68, P1068, DOI 10.1093/gerona/glt087; Timonen L, 2002, INT J GERIATR PSYCH, V17, P1106, DOI 10.1002/gps.757; Timonen L, 2002, SCAND J MED SCI SPOR, V12, P186, DOI 10.1034/j.1600-0838.2002.120310.x; TINETTI ME, 1993, J AM GERIATR SOC, V41, P315, DOI 10.1111/j.1532-5415.1993.tb06710.x; Toevs S. E., 2000, THESIS; Toot S, 2011, INT J GERIATR PSYCH, V26, P1221, DOI 10.1002/gps.2686; Torres SJ, 2017, BRIT J NUTR, V117, P1550, DOI 10.1017/S0007114517001507; TOSELAND RW, 1990, SOC WORK, V35, P209; Towfighi A, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0792-7; Tracy C., 2012, DISS ABSTR INT B, V73, P237; Troyer JL, 2010, J AM DIET ASSOC, V110, P1840, DOI 10.1016/j.jada.2010.09.013; Tsai CL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00294; Tse MMY, 2016, J AM GERIATR SOC, V64, pE86, DOI 10.1111/jgs.14374; Tsuchihashi-Makaya M, 2011, J CARDIOL, V58, P165, DOI 10.1016/j.jjcc.2011.04.004; Ukawa S, 2012, AUSTRALAS J AGEING, V31, P187, DOI 10.1111/j.1741-6612.2012.00589.x; Ukawa S, 2012, INT J GERIATR PSYCH, V27, P557, DOI 10.1002/gps.2753; Ullmann G., 2017, BMC COMPLEMENTARY S1, V17, P317, DOI [10. 1186/s12906-017-1783-3, DOI 10.1186/S12906-017-1783-3]; Uy C, 2008, AUSTRALAS J AGEING, V27, P43, DOI 10.1111/j.1741-6612.2007.00277.x; Vaapio S, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-20; Vahlberg B, 2017, DISABIL REHABIL, V39, P1207, DOI 10.1080/09638288.2016.1191551; van Achterberg T, 2016, INT J OLDER PEOPLE N, V11, P121, DOI 10.1111/opn.12104; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; van Hout Hein P J, 2005, BMC Geriatr, V5, P11, DOI 10.1186/1471-2318-5-11; van Mulligen-van de Belt E C M, 2013, Tijdschr Gerontol Geriatr, V44, P215, DOI 10.1007/s12439-013-0042-4; van Ooijen MW, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-34; Van Spall HGC, 2018, AM HEART J, V199, P75, DOI 10.1016/j.ahj.2017.12.013; Vandepitte S, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0373-4; Vandepitte S, 2016, INT J GERIATR PSYCH, V31, P1277, DOI 10.1002/gps.4504; VanDeVelde-Coke S., 2004, THESIS; Vass M, 2004, GERONTOLOGIST, V44, P360; Venturelli M, 2010, EXP AGING RES, V36, P190, DOI 10.1080/03610731003613771; Verloo H, 2015, DEMENT GER COGN D EX, V5, P176, DOI 10.1159/000375444; VETTER NJ, 1984, BRIT MED J, V288, P369, DOI 10.1136/bmj.288.6414.369; VICTOR CR, 1988, ARCH GERONTOL GERIAT, V7, P83, DOI 10.1016/0167-4943(88)90023-4; Vincent L., 2005, GERONTECHNOLOGY, V3, P159; Viswanathan P., 2007, GERIAT AGING, V10, P253; von Humboldt S, 2014, REV ARGENT CLIN PSIC, V23, P219; Vroomen JLM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037444; Wang CJ, 2013, GERIATR NURS, V34, P138, DOI 10.1016/j.gerinurse.2012.12.013; Wang J, 2017, J WOMEN AGING, V29, P294, DOI 10.1080/08952841.2016.1187536; Wang RH, 2011, ASSIST TECHNOL, V23, P117, DOI 10.1080/10400435.2010.541406; Wang WR, 2016, EUR J CARDIOVASC NUR, V15, P398, DOI 10.1177/1474515115586904; Ward P R, 1978, Br J Audiol, V12, P127, DOI 10.3109/03005367809078864; Warland A, 1991, Br J Audiol, V25, P399, DOI 10.3109/03005369109076615; Warner LM, 2016, PSYCHOL HEALTH, V31, P1145, DOI 10.1080/08870446.2016.1185523; Waterman H, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1565-0; Weiss Z, 2004, INT J REHABIL RES, V27, P119, DOI 10.1097/01.mrr.0000128059.54064.58; Welch V, 2019, CAMPBELL SYST REV, V15, DOI 10.1002/cl2.1054; Welford C, 2012, INT J OLDER PEOPLE N, V7, P65, DOI 10.1111/j.1748-3743.2012.00311.x; White H, 2020, CAMPBELL SYST REV, V16, DOI 10.1002/cl2.1125; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Whitehead PJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013448; Whitehead PJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011868; Whittemore R, 2014, PUBLIC HEALTH NURS, V31, P317, DOI 10.1111/phn.12093; Whitten P, 2007, J TELEMED TELECARE, V13, P69, DOI 10.1258/135763307780096249; Wilhelmson K, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-24; William A., 1991, J AM GERIATRICS SO S, V39, p2S; Williams K., 2013, J CLIN OUTCOMES MANA, V20, P507; Williams S, 2015, J AGING PHYS ACTIV, V23, P588, DOI 10.1123/japa.2014-0182; Wilson A, 1999, BRIT MED J, V319, P1542, DOI 10.1136/bmj.319.7224.1542; Wilson D, 2005, CAN J NURS RES, V37, P138; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Wittwer J., 2016, PROTOCOL MOVE MUSIC; Wolinsky F, 2011, GERONTOLOGIST, V51, P580; Wong EYS, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2562-2; Wong FKY, 2015, AGE AGEING, V44, P143, DOI 10.1093/ageing/afu166; Wong FKY, 2014, AGE AGEING, V43, P91, DOI 10.1093/ageing/aft123; Wongcharoen S, 2017, GAIT POSTURE, V52, P147, DOI 10.1016/j.gaitpost.2016.11.036; Woolrych R., 2016, MEDICINA S, V49, P5; Wu CY, 2007, ARCH PHYS MED REHAB, V88, P273, DOI 10.1016/j.apmr.2006.11.021; Wu Y., 2017, DIET EXERCISE CARDIO; Wu YT, 2008, CARDIOLOGY, V111, P87, DOI 10.1159/000119695; Wyatt GK, 2004, RES NURS HEALTH, V27, P322, DOI 10.1002/nur.20032; Wyers CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-212; Yoon J, 2018, ANN INTERN MED, V168, P846, DOI 10.7326/M17-3039; Yu DSF, 2016, J AM GERIATR SOC, V64, P2144, DOI 10.1111/jgs.14259; Yu-Yahiro JA, 2009, PM&R, V1, P308, DOI 10.1016/j.pmrj.2009.02.008; Yuk L. K., 2004, IMPROVING QUALITY LI; Yusif S, 2016, INT J MED INFORM, V94, P112, DOI 10.1016/j.ijmedinf.2016.07.004; Zarit SH, 2017, AGING MENT HEALTH, V21, P224, DOI 10.1080/13607863.2015.1128881; Zeeuwe Petra E M, 2006, BMC Geriatr, V6, P6; Zhang L, 2014, CLIN REHABIL, V28, P59, DOI 10.1177/0269215513492162; Zhao YA, 2017, GERIATR NURS, V38, P491, DOI 10.1016/j.gerinurse.2017.02.011; Zhe W., 2008, SENIORS HOUSING CARE, V16, P97; Zheng GH, 2016, BRIT J SPORT MED, V50, P1443, DOI 10.1136/bjsports-2015-095699; Zimmer J G, 1990, J Aging Health, V2, P357, DOI 10.1177/089826439000200305; ZIMMER JG, 1984, J AM GERIATR SOC, V32, P288, DOI 10.1111/j.1532-5415.1984.tb02023.x	640	0	0	13	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1891-1803		CAMPBELL SYST REV	Campbell Syst. Rev.	SEP	2021	17	3							e1175	10.1002/cl2.1175			245	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	UP8TM	WOS:000695646200005		gold, Green Published			2022-02-06	
J	Whiffin, CJ; Smith, BG; Esene, IN; Karekezi, C; Bashford, T; Khan, MM; Hutchinson, PJ; Kolias, AG; Solla, DJF; Paiva, WS; Figaji, A				Whiffin, Charlotte Jane; Smith, Brandon George; Esene, Ignatius N.; Karekezi, Claire; Bashford, Tom; Khan, Muhammad Mukhtar; Hutchinson, Peter John; Kolias, Angelos G.; Fontoura Solla, Davi Jorge; Paiva, Wellingson S.; Figaji, Anthony			Neurosurgeons' experiences of conducting and disseminating clinical research in low-income and middle-income countries: a reflexive thematic analysis	BMJ OPEN			English	Article						neurosurgery; neurological injury; qualitative research		Objectives Low-income and-middle-income countries (LMICs) are increasing investment in research and development, yet there remains a paucity of neurotrauma research published by those in LMICs. The aim of this study was to understand neurosurgeons' experiences of, aspirations for, and ability to conduct and disseminate clinical research in LMICs. Design This was a two-stage inductive qualitative study situated within the naturalistic paradigm. This study committed to an interpretivist way of knowing (epistemology), and considered reality subjective and multiple (ontology). Data collection used online methods and included a web-based survey tool for demographic data, an asynchronous online focus group and follow-up semistructured interviews. Data were analysed using Braun and Clarke's Reflexive Thematic Analysis supported by NVivo V.12. Setting LMICs. Participants In April-July 2020, 26 neurosurgeons from 11 LMICs participated in this study (n=24 in the focus groups, n=20 in follow-up interviews). Results The analysis gave rise to five themes: The local landscape; creating capacity; reach and impact; collaborative inquiry; growth and sustainability. Each theme contained an inhibitor and stimulus to neurosurgeons conducting and disseminating clinical research, interpreted as 'the neurosurgical research potential in LMICs'. Mentorship, education, infrastructure, impact and engagement were identified as specific accelerators. Whereas lack of generalisability, absence of dissemination and dissemination without peer review may desensitise the impact of research conducted by neurosurgeons. Conclusion The geographical, political and population complexities make research endeavour challenging for neurosurgeons in LMICs. Yet in spite of, and because of, these complexities LMICs provide rich opportunities to advance global neurosurgery. More studies are required to evaluate the specific effects of accelerators of research conducted by neurosurgeons and to understand the effects of desensitisers on high-quality, high-impact clinical research.	[Whiffin, Charlotte Jane; Smith, Brandon George; Esene, Ignatius N.; Bashford, Tom; Hutchinson, Peter John; Kolias, Angelos G.; Paiva, Wellingson S.; Figaji, Anthony] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Whiffin, Charlotte Jane] Univ Derby, Coll Hlth Psychol & Social Care, Derby, England; [Smith, Brandon George; Bashford, Tom; Hutchinson, Peter John; Kolias, Angelos G.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Esene, Ignatius N.] Univ Bamenda, Fac Hlth Sci, Neurosurg Div, Bambili, Nw Region, Cameroon; [Karekezi, Claire] Rwanda Mil Hosp, Dept Neurosurg, Kigali City, Rwanda; [Karekezi, Claire; Khan, Muhammad Mukhtar] World Federat Neurosurg Soc, Young Neurosurg Comm, Nyon, Switzerland; [Khan, Muhammad Mukhtar] Northwest Gen Hosp & Res Ctr, Northwest Sch Med, Neurosurg, Peshawar, Khyber Pakhtunk, Pakistan; [Fontoura Solla, Davi Jorge; Paiva, Wellingson S.] Univ Sao Paulo, Dept Neurol, Div Neurosurg, Sao Paulo, Brazil; [Figaji, Anthony] Red Cross Childrens Hosp, Div Neurosurg, Cape Town, South Africa; [Figaji, Anthony] Univ Cape Town, Cape Town, South Africa		Whiffin, CJ (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.; Whiffin, CJ (corresponding author), Univ Derby, Coll Hlth Psychol & Social Care, Derby, England.	c.whiffin@derby.ac.uk	Paiva, Wellingson S/G-5517-2013; Bashford, Tom/H-9586-2019; Solla, Davi/E-6988-2013	Paiva, Wellingson S/0000-0002-5165-7040; Bashford, Tom/0000-0003-0228-9779; Smith, Brandon/0000-0001-8471-1368; Hutchinson, Peter/0000-0002-2796-1835; Whiffin, Charlotte/0000-0002-9767-2123; Solla, Davi/0000-0002-5092-6595	National Institute for Health Research Global Health Research Group on Neurotrauma project [16/137/105]	This work was supported by the National Institute for Health Research Global Health Research Group on Neurotrauma project 16/137/105.	Beuving J, 2015, DOING QUALITATIVE RESEARCH: THE CRAFT OF NATURALISTIC INQUIRY, P1; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Braun V, 2021, QUAL RES SPORT EXERC, V13, P201, DOI 10.1080/2159676X.2019.1704846; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Butler-Kisber L., 2010, QUAL INQ, V1st; Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE; Denzin N.K., 2017, SAGE HDB QUALITATIVE; Dye C., 2013, WORLD HLTH REPORT RE; Franzen SRP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012332; Greenhalgh T., 2014, READ PAPER BASICS EV; Griswold DP, 2020, NEUROSURGERY, V87, P476, DOI 10.1093/neuros/nyaa049; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; Larkan F, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0152-1; Lincoln YS., 1985, NATURALISTIC INQUIRY, DOI 10.1016/0147-1767(85)90062-8; London L, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.698; Madsie N., LEVEL PLAYING FIELD; McCoy D, 2004, LANCET, V364, P1630, DOI 10.1016/S0140-6736(04)17319-4; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375092, 10.1080/13814788.2017.1375091]; Nicholls D, 2017, INT J THER REHABIL, V24, P114, DOI 10.12968/ijtr.2017.24.3.114; Rabbani F, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3616-6; Renosa MDC, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004193; Robert E, 2014, INT J HEALTH POLICY, V3, P7, DOI 10.15171/ijhpm.2014.55; Servadei F, 2019, WORLD NEUROSURG, V130, pE822, DOI 10.1016/j.wneu.2019.06.230; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; Vasquez EE, 2013, GLOB PUBLIC HEALTH, V8, pS104, DOI 10.1080/17441692.2013.786117; Walsh A, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0488-4; Whiffin CJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038939; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Worldbank, WORLD BANK LIST EC 2	34	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2021	11	9							e051806	10.1136/bmjopen-2021-051806			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW8SR	WOS:000700423700009	34551952	gold, Green Published			2022-02-06	
J	Wiegers, EJA; Trapani, T; Gabbe, BJ; Gantner, D; Lecky, F; Maas, AIR; Menon, DK; Murray, L; Rosenfeld, JV; Vallance, S; Lingsma, HF; Steyerberg, EW; Cooper, DJ				Wiegers, Eveline J. A.; Trapani, Tony; Gabbe, Belinda J.; Gantner, Dashiell; Lecky, Fiona; Maas, Andrew I. R.; Menon, David K.; Murray, Lynnette; V. Rosenfeld, Jeffrey; Vallance, Shirley; Lingsma, Hester F.; Steyerberg, Ewout W.; Cooper, D. James		CENTER TBI OzENTER TBI Investigat; Collaboration Grps CENTER TBI OzEN	Characteristics, management and outcomes of patients with severe traumatic brain injury in Victoria, Australia compared to United Kingdom and Europe: A comparison between two harmonised prospective cohort studies	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Trauma systems; Intensive care; Outcome comparison; Comparative effectiveness research	DECOMPRESSIVE CRANIECTOMY; ECONOMIC COST; MAJOR TRAUMA; CENTER-TBI; REHABILITATION; TRIAL	Objective: The aim of this manuscript is to compare characteristics, management, and outcomes of patients with severe Traumatic Brain Injury (TBI) between Australia, the United Kingdom (UK) and Europe. Methods: We enrolled patients with severe TBI in Victoria, Australia (OzENTER-TBI), in the UK and Europe (CENTER-TBI) from 2015 to 2017. Main outcome measures were mortality and unfavourable outcome (Glasgow Outcome Scale Extended < 5) 6 months after injury. Expected outcomes were compared according to the IMPACT-CT prognostic model, with observed to expected (O/E) ratios and 95% confidence intervals. Results: We included 107 patients from Australia, 171 from UK, and 596 from Europe. Compared to the UK and Europe, patients in Australia were younger (median 32 vs 44 vs 44 years), a larger proportion had secondary brain insults including hypotension (30% vs 17% vs 21%) and a larger proportion received ICP monitoring (75% vs 74% vs 58%). Hospital length of stay was shorter in Australia than in the UK (median: 17 vs 23 vs 16 days), and a higher proportion of patients were discharged to a rehabilitation unit in Australia than in the UK and Europe (64% vs 26% vs 28%). Mortality overall was lower than expected (27% vs 35%, O/E ratio 0.77 [95% CI: 0.64 - 0.87]. O/E ratios were comparable between regions for mortality in Australia 0.86 [95% CI: 0.49-1.23] vs UK 0.82 [0.51-1.15] vs Europe 0.76 [0.60-0.87]). Unfavourable outcome rates overall were in line with historic expectations (O/E ratio 1.32 [0.96-1.68] vs 1.13 [0.841.42] vs 0.96 [0.85-1.09]). Conclusions: There are major differences in case-mix between Australia, UK, and Europe; Australian patients are younger and have a higher rate of secondary brain insults. Despite some differences in management and discharge policies, mortality was less than expected overall, and did not differ between regions. Functional outcomes were similar between regions, but worse than expected, emphasizing the need to improve treatment for patients with severe TBI. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )	[Wiegers, Eveline J. A.; Lingsma, Hester F.; Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Wiegers, Eveline J. A.; Trapani, Tony; Gabbe, Belinda J.; Gantner, Dashiell; Murray, Lynnette; Vallance, Shirley; Cooper, D. James] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Hlth Data Res UK, Swansea, W Glam, Wales; [Gantner, Dashiell; Cooper, D. James] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Hlth Serv Res Sect, Sheffield, S Yorkshire, England; [Lecky, Fiona] Salford Royal Hosp, Emergency Dept, Salford, Lancs, England; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [V. Rosenfeld, Jeffrey] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [V. Rosenfeld, Jeffrey] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands		Wiegers, EJA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.; Wiegers, EJA (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	e.wiegers@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; Maas, Andrew I.R./C-5584-2013; Rosenfeld, Jeffrey/I-2904-2014	Posti, Jussi P./0000-0002-5925-5193; Takala, Riikka/0000-0001-6342-0043; Trapani, Tony/0000-0001-7771-3760; Maas, Andrew I.R./0000-0003-1612-1264; Rosenfeld, Jeffrey/0000-0003-3827-9898; Gabbe, Belinda/0000-0001-7096-7688; Wiegers, Eveline/0000-0003-1768-7550	InTBIR	The authors would like to thank all patients for their participation in the CENTER-TBI study and the OzENTER-TBI study. The authors would like to thank all principal investigators and researchers for ICU data collection and for sharing their valuable expertise. We would like to thank the InTBIR funders and investigators for the collaboration and support.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Aries M, 2015, CRIT CARE, V19, P1; Burton Adrian, 2017, Lancet Neurol, V16, P958, DOI 10.1016/S1474-4422(17)30358-7; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Collie A, 2010, INJURY PREV, V16, pA25, DOI 10.1136/ip.2010.029215.92; Cooper DJ, 2020, J NEUROTRAUM, V37, P810, DOI 10.1089/neu.2019.6869; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Economics A., 2009, EC COST SPINAL CORD, P31; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Lazaridis C, 2019, NEUROCRIT CARE, V31, P22, DOI 10.1007/s12028-019-00719-2; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Magee F, 2019, MED J AUSTRALIA, V210, P493, DOI 10.5694/mja2.12028; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Smith M, 2018, ANESTHESIOLOGY, V128, P401, DOI 10.1097/ALN.0000000000001885; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2021	52	9					2576	2587		10.1016/j.injury.2021.04.033			12	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	UM0JY	WOS:000693028300014	33910683	hybrid, Green Accepted, Green Published			2022-02-06	
J	Wright, F; Docherty, PD; Williams, E; Greybe, D; Arora, H; Kabaliuk, N				Wright, Frederick; Docherty, Paul D.; Williams, Elisabeth; Greybe, Desney; Arora, Hari; Kabaliuk, Natalia			An in-silico study of the effect of non-linear skin dynamics on skin-mounted accelerometer inference of skull motion	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Soft tissue artefact; Skin modelling; Head impact; Skin-mounted sensor; Accelerometer	LEAGUE PLAYERS; HEAD IMPACTS; BRAIN-INJURY; THRESHOLD; JUNIOR; MODEL; TEAM; BIOMECHANICS; ACCURACY; RISK	Accurate and precise analysis of head impact telemetry data is important for development of biomechanical models and methodologies to decrease the risk of traumatic brain injury. Systematic review suggests that much existing data lacks verification. Soft tissue artefact is a common problem that is not frequently addressed. This paper outlines a method of modelling the coupled, non-linear, skull-skin-sensor system. The model is based on a second order underdamped spring mass damper system that incorporates non-linear values to account for the complex dynamic nature of skin. MATLAB was used to simulate the estimated movement of a sensor mounted to the skin relative to measurements collected via a mouthguard sensor. The non-linear elastic and damping models were developed from descriptions in literature. The model assumed a sensor of 8 g, mounted behind the ear. Results were compared to a typical linear system. In small impacts, the linear and non-linear models provided similar accelerations to the skull. However, in large impacts, the acceleration of the sensor was estimated to be 158% greater than the skull acceleration when modelled non-linearly, while a linear model showed only a 0.7% increase. This implies that for small impacts, the nonlinearity of skin-skull dynamics is not an important char-acteristic for modelling. However, in large impacts, the non-linearity of the skin-skull dynamic can lead to drastic over-estimates of skull acceleration when using skin mounted accelerometers. In Brief: The system of an accelerometric sensor mounted to the skin is often used to assess the accelerations experienced by athletes during impacts. By developing a non-linear model of the skull-skin-sensor model, the importance of accounting for the non-linear nature of skin while taking telemetry measurements of head ac-celeration during impact is demonstrated.	[Docherty, Paul D.] Univ Canterbury, Dept Mech Engn, Private Bag 4800, Christchurch 8140, New Zealand; [Williams, Elisabeth; Greybe, Desney] Furtwangen Univ, Inst Syst Med, Furtwangen, Germany; [Arora, Hari] Swansea Univ, Appl Sports Technol Exercise & Med ASTEM, Fac Sci & Engn, Swansea, W Glam, Wales; Swansea Univ, Fac Sci & Engn, Zienkiewicz Centre Computat Engn ZCCE, Swansea, W Glam, Wales		Docherty, PD (corresponding author), Univ Canterbury, Dept Mech Engn, Private Bag 4800, Christchurch 8140, New Zealand.	paul.docherty@canterbury.ac.nz		Docherty, Paul/0000-0003-1661-2573			Bartsch A., 2014, VALIDATION INTELLIGE; Bartsch AJ, 2019, IEEE ENG MED BIO, P2068, DOI 10.1109/EMBC.2019.8856907; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Butler BJ, 2015, BIOINSPIR BIOMIM NAN, V4, P133, DOI 10.1680/bbn.14.00028; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gissane C., 2019, J SPORTS MED THER, V4, P024; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Greybe DG, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00324-z; Hecimovich M, 2018, J SPORT SCI MED, V17, P547; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Joodaki H, 2018, P I MECH ENG H, V232, P323, DOI 10.1177/0954411918759801; Jor JWY, 2013, WIRES SYST BIOL MED, V5, P539, DOI 10.1002/wsbm.1228; Khatyr F, 2004, SKIN RES TECHNOL, V10, P96, DOI 10.1111/j.1600-0846.2004.00057.x; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2017, ARC J RES SPORTS MED, V2, P9; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Lapeer RJ, 2011, IEEE T BIO-MED ENG, V58, P1013, DOI 10.1109/TBME.2009.2038364; Lucchetti L, 1998, J BIOMECH, V31, P977, DOI 10.1016/S0021-9290(98)00083-9; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Parker M., 2016, IDENTIFICATION MECH; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shenoi B. A., 2006, INTRO DIGITAL SIGNAL; Shergold OA, 2006, INT J IMPACT ENG, V32, P1384, DOI 10.1016/j.ijimpeng.2004.11.010; Shultz R, 2011, GAIT POSTURE, V34, P44, DOI 10.1016/j.gaitpost.2011.03.008; Sutula D, 2020, J MECH BEHAV BIOMED, V112, DOI 10.1016/j.jmbbm.2020.103999; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	41	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	SEP	2021	70								102986	10.1016/j.bspc.2021.102986			7	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WP7EI	WOS:000713289700004					2022-02-06	
J	Wu, D; Kumal, JPP; Lu, XD; Li, YX; Mao, DS; Tang, XD; Nie, MT; Liu, X; Sun, L; Liu, B; Zhang, YF				Wu, Di; Kumal, Jay Prakash P.; Lu, Xiaodi; Li, Yixuan; Mao, Dongsheng; Tang, Xudong; Nie, Meitong; Liu, Xin; Sun, Liang; Liu, Bin; Zhang, Yafang			Traumatic Brain Injury Accelerates the Onset of Cognitive Dysfunction and Aggravates Alzheimer's-Like Pathology in the Hippocampus by Altering the Phenotype of Microglia in the APP/PS1 Mouse Model	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; Alzheimer's disease; A beta plaque pathology; neuroinflammation; microglia	OBJECT RECOGNITION; DISEASE; EXPRESSION; RECEPTOR; EPIDEMIOLOGY; PHAGOCYTOSIS; POPULATION; RATS	An increasing number of studies have suggested that traumatic brain injury (TBI) is associated with some neurodegenerative diseases, including Alzheimer's disease (AD). Various aspects of the mechanism of TBI-induced AD have been elucidated. However, there are also studies opposing the view that TBI is one of the causes of AD. In the present study, we demonstrated that TBI exacerbated the disruption of hippocampal-dependent learning and memory, worsened the reductions in neuronal cell density and synapse formation, and aggravated the deposition of A beta plaques in the hippocampi of APP/PS1 mice. We also found that TBI rapidly activated microglia in the central nervous system (CNS) and that this effect lasted for at least for 3 weeks. Furthermore, TBI boosted A beta-related microglia-mediated neuroinflammation in the hippocampi of APP/PS1 mice and the transformation of microglia toward the proinflammatory phenotype. Therefore, our experiments suggest that TBI accelerates the onset of cognitive dysfunction and Alzheimer-like pathology in the APP/PS1 mouse model, at least partly by altering microglial reactions and polarization.	[Wu, Di; Liu, Bin] Harbin Med Univ, Affiliated Hosp 4, Dept Neurol, Harbin, Peoples R China; [Kumal, Jay Prakash P.; Li, Yixuan; Mao, Dongsheng; Tang, Xudong; Nie, Meitong; Sun, Liang; Zhang, Yafang] Harbin Med Univ, Dept Human Anat, Harbin, Peoples R China; [Kumal, Jay Prakash P.; Li, Yixuan; Mao, Dongsheng; Tang, Xudong; Nie, Meitong; Sun, Liang; Zhang, Yafang] Harbin Med Univ, Minist Educ, Key Lab Preservat Human Genet Resources & Dis Con, Harbin, Peoples R China; [Lu, Xiaodi] Harbin Med Univ, Dept Anesthesiol, Canc Hosp, Harbin, Peoples R China; [Liu, Xin] Gen Hosp Northern Theater Command, Dept Neurol, Shenyang, Peoples R China		Liu, B (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Neurol, Harbin, Peoples R China.; Sun, L; Zhang, YF (corresponding author), Harbin Med Univ, Dept Human Anat, Harbin, Peoples R China.; Sun, L; Zhang, YF (corresponding author), Harbin Med Univ, Minist Educ, Key Lab Preservat Human Genet Resources & Dis Con, Harbin, Peoples R China.	sunliang@hrbmu.edu.cn; ican58@163.com; zhangyf@ems.hrbmu.edu.cn	Kumal, Jay Prakash Prasad/V-1020-2017	Kumal, Jay Prakash Prasad/0000-0002-7664-9311	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82003392]	This study was supported by the National Natural Science Foundation of China (82003392).	al-Dahhak R, 2018, CLIN GERIATR MED, V34, P617, DOI 10.1016/j.cger.2018.06.008; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Bedard M, 2020, J CLIN EXP NEUROPSYC, V42, P344, DOI 10.1080/13803395.2020.1714552; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Colom-Cadena M, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00588-4; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dietrich K, 2018, MOLECULES, V23, DOI 10.3390/molecules23040718; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Hirbec HE, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00227; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kawahara K, 2012, NEUROSCIENCE, V207, P243, DOI 10.1016/j.neuroscience.2012.01.049; Knierim JJ, 2015, CURR BIOL, V25, pR1116, DOI 10.1016/j.cub.2015.10.049; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kolos Ye A, 2015, Morfologiia, V147, P78; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marschner L, 2019, BEHAV BRAIN RES, V365, P222, DOI 10.1016/j.bbr.2018.02.040; Mathiasen J.R., 2010, CURR PROTOC PHARM, V49, DOI [10.1002/0471141755.ph0559s49, DOI 10.1002/0471141755.PH0559S49]; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Moro F, 2021, BRIT J ANAESTH, V126, P256, DOI 10.1016/j.bja.2020.08.027; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Riedel WJ, 2015, HANDB EXP PHARMACOL, V228, P215, DOI 10.1007/978-3-319-16522-6_7; Sawangjit A, 2018, NATURE, V564, P109, DOI 10.1038/s41586-018-0716-8; Schorr GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092633; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Szarka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133223; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weldon DT, 1998, J NEUROSCI, V18, P2161; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Wirz KTS, 2013, NEUROBIOL AGING, V34, P1328, DOI 10.1016/j.neurobiolaging.2012.11.008; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Xia ED, 2019, NEUROSCIENCE, V417, P57, DOI 10.1016/j.neuroscience.2019.08.010; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang R, 2012, J ALZHEIMERS DIS, V31, P801, DOI 10.3233/JAD-2012-120151	55	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 1	2021	12								666430	10.3389/fneur.2021.666430			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UR7DA	WOS:000696904100001	34539542	gold, Green Published, Green Submitted			2022-02-06	
J	Wyrwa, JM; Shirel, TM; Hostetter, TA; Schneider, AL; Hoffmire, CA; Stearns-Yoder, KA; Forster, JE; Odom, NE; Brenner, LA				Wyrwa, Jordan M.; Shirel, Tyler M.; Hostetter, Trisha A.; Schneider, Alexandra L.; Hoffmire, Claire A.; Stearns-Yoder, Kelly A.; Forster, Jeri E.; Odom, Nathan E.; Brenner, Lisa A.			Suicide After Stroke in the United States Veteran Health Administration Population	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Rehabilitation; Stroke; Suicide; Veterans	RISK	Objective: To evaluate risk for suicide among veterans with a history of stroke, seeking care within the Veterans Health Administration (VHA), we analyzed existing clinical data. Design: This retrospective cohort study was approved and performed in accordance with the local Institutional Review Board. Veterans were identified via the VHA's Corporate Data Warehouse. Initial eligibility criteria included confirmed veteran status and at least 90 days of VHA utilization between fiscal years 2001-2015. Cox proportional hazards models were used to assess the association between history of stroke and suicide. Among those veterans who died by suicide, the association between history of stroke and method of suicide was also investigated. Setting: VHA. Participants: Veterans with at least 90 days of VHA utilization between fiscal years 2001-2015 (N=1,647,671). Data from these 1,647,671 veterans were analyzed (1,405,762 without stroke and 241,909 with stroke). Interventions: Not applicable. Main Outcome Measures: Suicide and method of suicide. Results: The fully adjusted model, which controlled for age, sex, mental health diagnoses, mild traumatic brain injury, and modified Charlson/ Deyo Index (stroke-related diagnoses excluded), demonstrated a hazard ratio of 1.13 (95% confidence interval, 1.02-1.25; P=.02). The majority of suicides in both cohorts was by firearm, and a significantly larger proportion of suicides occurred by firearm in the group with stroke than the cohort without (81.2% vs 76.6%). Conclusions: Findings suggest that veterans with a history of stroke are at increased risk for suicide, specifically by firearm, compared with veterans without a history of stroke. Increased efforts are needed to address the mental health needs and lethal means safety of veterans with a history of stroke, with the goal of improving function and decreasing negative psychiatric outcomes, such as suicide. Archives of Physical Medicine and Rehabilitation 2021;102:1729-34 (c) 2021 The American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.	[Wyrwa, Jordan M.; Shirel, Tyler M.; Hoffmire, Claire A.; Stearns-Yoder, Kelly A.; Forster, Jeri E.; Odom, Nathan E.; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, 12631 17th Ave,Mail Stop F493 AO1,Rm 2510, Aurora, CO 80045 USA; [Hostetter, Trisha A.; Schneider, Alexandra L.; Hoffmire, Claire A.; Stearns-Yoder, Kelly A.; Forster, Jeri E.; Brenner, Lisa A.] Vet Affairs VA Rocky Mt Mental Illness Res Educ &, Aurora, CO USA		Wyrwa, JM (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, 12631 17th Ave,Mail Stop F493 AO1,Rm 2510, Aurora, CO 80045 USA.	jordan.wyrwa@cuanschutz.edu		Wyrwa, Jordan/0000-0002-5455-5859	Department of Veterans Affairs, VA Rocky MIRECCUS Department of Veterans Affairs; Department of Physical Medicine and Rehabilitation, University of Colorado, Anschutz Medical Campus	Supported by the Department of Veterans Affairs, VA Rocky MIRECC, and the Department of Physical Medicine and Rehabilitation, University of Colorado, Anschutz Medical Campus. The views, opinions, and findings contained in this article are those of the authors and should not be construed as an official Department of Veterans Affairs position, policy, or decision unless so designated by other documentation.	Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; Bravata DM, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003157; Brophy MT, 2004, J AM GERIATR SOC, V52, P1151, DOI 10.1111/j.1532-5415.2004.52314.x; Clancy C, 2018, TREATMENT ACUTE ISCH, P8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eriksson M, 2015, NEUROLOGY, V84, P1732, DOI 10.1212/WNL.0000000000001514; Erlangsen A, 2020, JAMA-J AM MED ASSOC, V323, P444, DOI 10.1001/jama.2019.21834; Fassberg MM, 2016, AGING MENT HEALTH, V20, P166, DOI 10.1080/13607863.2015.1083945; Haney EM, 2012, SUICIDE RISK FACTORS; Haroz EE, 2020, SUICIDE LIFE-THREAT, V50, P422, DOI 10.1111/sltb.12598; Hedegaard H, NCHS DATA BRIEF; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Jollant F, 2008, AM J PSYCHIAT, V165, P740, DOI 10.1176/appi.ajp.2008.07081239; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; National Institute of Mental Health, SUICIDE; Ni YZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192586; Olson KL, 2014, AM J MANAG CARE, V20, pE27; Reker DM, 2002, MED CARE, V40, P96, DOI 10.1097/00005650-200202000-00004; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363; Shelef L, 2014, EUR PSYCHIAT, V29, P498, DOI 10.1016/j.eurpsy.2014.01.006; Stenager EN, 1998, BRIT MED J, V316, P1206, DOI 10.1136/bmj.316.7139.1206; Szanto K, 2017, AM J GERIAT PSYCHIAT, V25, P630, DOI 10.1016/j.jagp.2017.02.012; Teasdale TW, 2001, J EPIDEMIOL COMMUN H, V55, P863, DOI 10.1136/jech.55.12.863; Teasell R, 2018, STROKE REHABILITATIO; Vadini F, 2018, J AFFECT DISORDERS, V225, P273, DOI 10.1016/j.jad.2017.08.030; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561; Woodfield R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140533	32	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2021	102	9					1729	1734		10.1016/j.apmr.2021.03.009			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	UM6OC	WOS:000693448900006	33811852				2022-02-06	
J	Yang, CY; Gao, C; Liu, NC; Zhu, YT; Zhu, X; Su, XL; Zhang, Q; Wu, YL; Zhang, CH; Liu, A; Lin, WF; Tao, LY; Yang, HL; Lin, J				Yang, Chengyuan; Gao, Cheng; Liu, Naicheng; Zhu, Yitong; Zhu, Xu; Su, Xinlin; Zhang, Qin; Wu, Yanglin; Zhang, Chenhui; Liu, Ang; Lin, Weifeng; Tao, Luyang; Yang, Huilin; Lin, Jun			The effect of traumatic brain injury on bone healing from a novel exosome centered perspective in a mice model	JOURNAL OF ORTHOPAEDIC TRANSLATION			English	Article						Traumatic brain injury; Bone healing; Exosomes; Liposomes; Osteoblasts; miRNAs	MESENCHYMAL STEM-CELLS; NEUROGENIC HETEROTOPIC OSSIFICATION; OSTEOGENIC DIFFERENTIATION; PROTEOMIC ANALYSIS; OSTEOBLASTS; EXPRESSION; FRACTURES; MICRORNAS; MECHANISM; BARRIER	Background: In patients with traumatic brain injury (TBI) combined with long bone fracture, the fracture healing is always faster than that of patients with single fracture, which is characterized by more callus growth at the fracture site and even ectopic ossification. Exosomes are nanoscale membrane vesicles secreted by cells, which contain cell-specific proteins, miRNAs, and mRNAs. Methods: In this study, we used exosomes as the entry point to explore the mechanism of brain trauma promoting fracture healing. We established a model of tibia fracture with TBI in mice to observe the callus growth and expression of osteogenic factors at the fracture site. Blood samples of model mice were further collected, exosomes in plasma were extracted by ultra-centrifugation method, and then identified and acted on osteoblasts cultured in vitro. The effects of exosomes on osteoblast differentiation at the cell, protein and gene levels were investigated by Western Blot and q-PCR, respectively. Furthermore, miRNA sequencing of exosomes was performed to identify a pattern of miRNAs that were present at increased or decreased levels. Results: The results suggested that plasma exosomes after TBI had the ability to promote the proliferation and differentiation of osteoblasts, which might be due to the increased expression of osteoblast-related miRNA in exosomes. They were transmitted to the osteoblasts at the fracture site, so as to achieve the role of promoting osteogenic differentiation. Conclusion: The TBI-derived exosomes may have potential applications for promoting fracture healing in future. The Translational Potential of this Article: Plasma exosomes early after TBI have the ability to promote osteoblast proliferation and differentiation. The mechanism may be achieved by miRNA in exosomes. Plasma exosomes may be used as breakthrough clinical treatment for delayed or non-union fractures.	[Yang, Chengyuan; Liu, Naicheng; Zhu, Xu; Su, Xinlin; Zhang, Qin; Wu, Yanglin; Zhang, Chenhui; Liu, Ang; Yang, Huilin; Lin, Jun] Soochow Univ, Dept Orthopaed Surg, Affiliated Hosp 1, 899 Pinghai Rd, Suzhou 215006, Jiangsu, Peoples R China; [Gao, Cheng; Tao, Luyang] Soochow Univ, Dept Forens Med, Suzhou, Peoples R China; [Zhu, Yitong] Suzhou Vocat Hlth Coll, Suzhou Key Lab Med Biotechnol, Suzhou, Peoples R China; [Lin, Weifeng] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel		Yang, HL; Lin, J (corresponding author), Soochow Univ, Dept Orthopaed Surg, Affiliated Hosp 1, 899 Pinghai Rd, Suzhou 215006, Jiangsu, Peoples R China.; Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, Med Sch, 178 East Ganjiang Rd, Suzhou 215213, Peoples R China.	taoluyang@suda.edu.cn; suzhouspine@163.com; linjun@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871789, 82172387, 81702214, 81802200]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20180052]; Gusu Health Talents Program [GSWS2020023]; Suzhou Municipal Science and Technology Bureau [SYS2019018]; General Project of Suzhou Vocational Health College [szwzy201907]	This work was supported by the National Natural Science Foundation of China (81871789, 82172387, 81702214, 81802200) , the Natural Science Foundation of Jiangsu Province (BK20180052) , and Gusu Health Talents Program (GSWS2020023) , Suzhou Municipal Science and Technology Bureau (SYS2019018) and the General Project of Suzhou Vocational Health College (szwzy201907) .	Ausk BJ, 2015, CLIN ORTHOP RELAT R, V473, P2825, DOI 10.1007/s11999-015-4271-4; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Cui YZ, 2016, FEBS LETT, V590, P185, DOI 10.1002/1873-3468.12024; Davies OG, 2015, CALCIFIED TISSUE INT, V97, P432, DOI 10.1007/s00223-015-0034-1; Deng LL, 2015, BONE, V79, P37, DOI 10.1016/j.bone.2015.05.022; Ge M, 2015, BIOCHEM BIOPH RES CO, V467, P27, DOI 10.1016/j.bbrc.2015.09.135; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Huang MQ, 2017, BIOCHEM BIOPH RES CO, V491, P571, DOI 10.1016/j.bbrc.2017.07.163; Huang W, 2012, J ORAL MAXIL SURG, V70, P2135, DOI 10.1016/j.joms.2012.04.016; Huynh N, 2016, J DENT RES, V95, P673, DOI 10.1177/0022034516633189; Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017; Kelch S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16113-x; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li J, 2015, BONE, V78, P130, DOI 10.1016/j.bone.2015.05.003; Li PF, 2016, GENE, V591, P69, DOI 10.1016/j.gene.2016.06.045; Li WY, 2018, ACS APPL MATER INTER, V10, P5240, DOI 10.1021/acsami.7b17620; Liu L, 2019, BIOMATERIALS, V192, P523, DOI 10.1016/j.biomaterials.2018.11.007; Mollahosseini M, 2021, J MOL NEUROSCI, V71, P162, DOI 10.1007/s12031-020-01640-6; Morgan WE, 2014, J CHIROPR MED, V13, P260, DOI 10.1016/j.jcm.2014.08.001; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171281; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Vasanthan P, 2015, J CELL MOL MED, V19, P566, DOI 10.1111/jcmm.12381; Wang GL, 2018, INT J MOL MED, V41, P791, DOI 10.3892/ijmm.2017.3261; Wei F, 2019, ACTA BIOMATER, V86, P480, DOI 10.1016/j.actbio.2019.01.006; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Zhang R, 2018, THER CLIN RISK MANAG, V14, P2315, DOI 10.2147/TCRM.S182325; Zuo R, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1121-9	42	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2214-031X			J ORTHOP TRANSL	J. Orthop. Transl.	SEP	2021	30						70	81		10.1016/j.jot.2021.09.003			12	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	WK2PM	WOS:000709573100008	34611516	Green Published, gold			2022-02-06	
J	Yang, Y; Shen, LK; Xu, M; Chen, L; Lu, W; Wang, WH				Yang, Yan; Shen, Likui; Xu, Min; Chen, Long; Lu, Wei; Wang, Wenhua			Serum calprotectin as a prognostic predictor in severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article							ISCHEMIC-STROKE; PROTEINS; S100A9; COMA	Background: Calprotectin plays an important role during inflammation. We intended to explore the prognostic value of serum calprotectin levels in patients with severe traumatic brain injury (sTBI). Methods: In this prospective cohort study of 149 sTBI patients, we determined the relationship between serum calprotectin levels and 90-day overall survival plus poor outcome (Glasgow outcome scale score of 1-3) after sTBI, and analyzed its associations with Rotterdam computerized tomography (CT) scores, Glasgow coma scale (GCS) scores and two markers of inflammatory reaction including serum C-reactive protein levels and blood leucocyte count. Results: Serum calprotectin levels were significantly correlated with Rotterdam CT scores, GCS scores, serum Creactive protein levels and blood leucocyte count. Patients with poor outcome at 90 days displayed higher serum calprotectin levels than the other remainders. Serum calprotectin appeared as an independent predictor for 90day overall survival and poor outcome. Under receiver operating characteristic curve, serum calprotectin levels exhibited an efficient discrimination capacity for 90-day poor outcome. Conclusions: Serum calprotectin levels are significantly correlated with inflammation, trauma severity and poor outcome at 90 days in sTBI patients, suggesting that serum calprotectin may be a biomarker for providing complementary prognostic information to identify patients at risk of poor outcome after sTBI.	[Yang, Yan] Jiangsu Univ, Affiliated Kunshan Hosp, Dept Crit Care Med, Kunshan 215300, Peoples R China; [Shen, Likui] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Suzhou Kowloon Hosp, Shanghai 266021, Peoples R China; [Xu, Min; Chen, Long; Lu, Wei; Wang, Wenhua] Nanjing Univ Chinese Med, Dept Neurosurg, Kunshan Hosp Tradit Chinese Med, Kunshan 215300, Jiangsu, Peoples R China		Wang, WH (corresponding author), Nanjing Univ Chinese Med, Dept Neurosurg, Kunshan Hosp Tradit Chinese Med, Kunshan 215300, Jiangsu, Peoples R China.	wangwenhua1969@126.com			suzhou science and technology project [SYS2020067]	Funding This work was supported by grants from the suzhou science and technology project (SYS2020067) .	Balanca B, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052439; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Chatzopoulos A, 2017, HELL J CARDIOL, V58, P456, DOI 10.1016/j.hjc.2017.07.002; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Guo DX, 2020, CLIN CHEM, V66, P706, DOI 10.1093/clinchem/hvaa069; He G.Y., FRONT NEUROSCI-SWITZ, V14; JENNETT B, 1975, LANCET, V1, P480; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kawano T, 2018, HYPERTENSION, V72, P1355, DOI 10.1161/HYPERTENSIONAHA.118.11316; Killen MJ, 2019, EXPERT REV NEUROTHER, V19, P227, DOI 10.1080/14737175.2019.1582332; Marta-Enguita J, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02047-1; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033; Striz I, 2004, PHYSIOL RES, V53, P245; TEASDALE G, 1974, LANCET, V2, P81; Wang CC, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104770; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Waqas M, 2016, BRIT J NEUROSURG, V30, P258, DOI 10.3109/02688697.2016.1139047; Williams OH, 2015, J NEUROL, V262, P1394, DOI 10.1007/s00415-015-7741-4; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003	25	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	SEP	2021	520						101	107		10.1016/j.cca.2021.06.009			7	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	TK8IR	WOS:000674397400001	34102135				2022-02-06	
J	Yengo-Kahn, AM; Hibshman, N; Bezzerides, M; Feldman, MJ; Vukovic, AA; Mummareddy, N; Zhao, SL; Penrod, CH; Bonfield, CM; Vance, EH				Yengo-Kahn, Aaron M.; Hibshman, Natalie; Bezzerides, Michael; Feldman, Michael J.; Vukovic, Adam A.; Mummareddy, Nishit; Zhao, Shilin; Penrod, Cody H.; Bonfield, Christopher M.; Vance, E. Haley			Improving Discharge Instructions Following a Concussion Diagnosis in the Pediatric Emergency Department: A Pre-post Intervention Study	PEDIATRIC QUALITY & SAFETY			English	Article							TRAUMATIC BRAIN-INJURIES; READABILITY; STATEMENT; CHILDREN; VISITS	Introduction: Many children are discharged from the pediatric emergency department (PED) with incomplete or inappropriate instructions following a concussion. Our objective was to evaluate the effectiveness of a simple intervention in improving discharge instruction disbursement and completeness following PED diagnosis of concussion. Methods: A pre/post intervention study of 935 patients (375 preintervention and 560 postintervention) ages 5-19, diagnosed with a concussion and discharged from the PED between July 2016 and November 2019, was performed at a single United States pediatric tertiary-care center. Dedicated provider education sessions were held, and a consensus guideline-based set of discharge instructions were implemented in the electronic health record. Primary outcomes included the presence of return-to-play (RTP) instructions, return-to-learn (RTL) instructions, follow-up recommendations, and "complete" discharge (ie, all 3 components present). Statistical process control charts were generated and tested for special cause variation. Results: More patients received instructions for RTP (87% versus 59%) and RTL (60% versus 3%), and a complete discharge was more frequent (45% versus 2%), following the conclusion of the intervention. Only the improvement in RTP instructions was completely sustained into the following academic year, whereas RTL and complete discharge rates declined to 27% and 20%, respectively. Conclusions: A simple, low-cost intervention such as peer-to-peer education and consensus guideline-based discharge instruction templates can significantly improve discharge readiness after pediatric concussion. Further work is needed to maintain progress and continue improvements, at our large academic trauma center.	[Yengo-Kahn, Aaron M.; Feldman, Michael J.; Mummareddy, Nishit; Bonfield, Christopher M.; Vance, E. Haley] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224,1161 21st Ave S, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Hibshman, Natalie; Mummareddy, Nishit; Bonfield, Christopher M.; Vance, E. Haley] Vanderbilt Univ, Med Ctr, Vanderbilt Sport Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Hibshman, Natalie; Bezzerides, Michael; Mummareddy, Nishit; Bonfield, Christopher M.; Vance, E. Haley] Vanderbilt Univ, Monroe Carrell Jr Hosp, Surg Outcomes Ctr Kids, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hibshman, Natalie; Bezzerides, Michael; Feldman, Michael J.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Vukovic, Adam A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Vukovic, Adam A.] Cincinnati Childrens Hosp, Div Pediat Emergency Med, Cincinnati, OH USA; [Zhao, Shilin] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN 37212 USA; [Penrod, Cody H.] Univ Louisville, Sch Med, Div Pediat Emergency Med, Louisville, KY 40292 USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224,1161 21st Ave S, Nashville, TN 37212 USA.	a.yengo@vumc.org					Anhoj J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121349; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Chadwick Whitney, 2019, Hosp Pediatr, V9, P523, DOI 10.1542/hpeds.2018-0251; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Curran JA, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0995-7; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; DeMatteo CA, 2021, CLIN J SPORT MED, V31, pE406, DOI 10.1097/JSM.0000000000000800; Fereday S., GUIDE QUALITY IMPROV; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hammad EA, 2014, BRIT J CLIN PHARMACO, V78, P1453, DOI 10.1111/bcp.12463; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Lane AD, 2017, J EMERG MED, V52, P690, DOI 10.1016/j.jemermed.2016.12.017; Lee T., 2017, RETURN LEARN RETURN; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundine JP, 2020, BRAIN INJURY, V34, P262, DOI 10.1080/02699052.2019.1690679; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Montgomery DC., 2013, INTRO STAT QUALITY C, V7th, P204; Mueller SK, 2015, J AM MED INFORM ASSN, V22, P857, DOI 10.1093/jamia/ocv005; Peterson AB, 2019, SURVEILLANCE REPORT; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Tarimala A, 2019, J PEDIATR-US, V206, P178, DOI 10.1016/j.jpeds.2018.10.021; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Unaka NI, 2017, J HOSP MED, V12, P551, DOI 10.12788/jhm.2770; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123	32	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA		2472-0054		PEDIATR QUAL SAF	Pediatr. Qual. Saf.	SEP-OCT	2021	6	5							e456	10.1097/pq9.0000000000000456			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	WR0DH	WOS:000714179600022	34476308				2022-02-06	
J	Ymer, L; McKay, A; Wong, D; Frencham, K; Grima, N; Tran, J; Nguyen, S; Junge, M; Murray, J; Spitz, G; Ponsford, J				Ymer, Lucy; McKay, Adam; Wong, Dana; Frencham, Kate; Grima, Natalie; Tran, Joanna; Nguyen, Sylvia; Junge, Moira; Murray, Jade; Spitz, Gershon; Ponsford, Jennie			Cognitive behavioural therapy versus health education for sleep disturbance and fatigue after acquired brain injury: A pilot randomised trial	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Cognitive behavioural therapy; Acquired brain injury; Sleep; Fatigue; Health education	DAYTIME SLEEPINESS; INSOMNIA; SEVERITY; QUALITY; INDEX; PREVALENCE; MODEL	Background: Sleep disturbance and fatigue are highly prevalent after acquired brain injury (ABI) and are associated with poor functional outcomes. Cognitive behavioural therapy (CBT) is a promising treatment for sleep and fatigue problems after ABI, although comparison with an active control is needed to establish efficacy. Objectives: We compared CBT for sleep disturbance and fatigue (CBT-SF) with a health education (HE) intervention to control for non-specific therapy effects. Methods: In a parallel-group, pilot randomised controlled trial, 51 individuals with traumatic brain injury (n = 22) and stroke (n = 29) and clinically significant sleep and/or fatigue problems were randomised 2:1 to 8 weeks of a CBT-SF (n = 34) or HE intervention (n = 17), both adapted for cognitive impairments. Participants were assessed at baseline, post-treatment, and 2 and 4 months post-treatment. The primary outcome was the Pittsburgh Sleep Quality Index; secondary outcomes included measures of fatigue, sleepiness, mood, quality of life, activity levels, self-efficacy and actigraphy sleep measures. Results: The CBT-SF led to significantly greater improvements in sleep quality as compared with HE, during treatment and at 2 months [95% confidence interval (CI)-24.83;-7.71], as well as significant reductions in fatigue maintained at all time points, which were not evident with HE (95% CI-1.86; 0.23). HE led to delayed improvement in sleep quality at 4 months post-treatment and in depression (95% CI-1.37;-0.09) at 2 months post-treatment. CBT-SF led to significant gains in self-efficacy (95% CI 0.15; 0.53) and mental health (95% CI 1.82; 65.06). Conclusions: CBT-SF can be an effective treatment option for sleep disturbance and fatigue after ABI, over and above HE. HE may provide delayed benefit for sleep, possibly by improving mood. Trial Registration: Australia New Zealand Clinical Trials Registry: ACTRN12617000879369 (registered 15/06/ 2017) and ACTRN12617000878370 (registered 15/06/2017). (c) 2021 Elsevier Masson SAS. All rights reserved.	[Ymer, Lucy; McKay, Adam; Wong, Dana; Grima, Natalie; Junge, Moira; Murray, Jade; Spitz, Gershon; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Ymer, Lucy; McKay, Adam; Wong, Dana; Frencham, Kate; Grima, Natalie; Tran, Joanna; Nguyen, Sylvia; Murray, Jade; Spitz, Gershon; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ymer, Lucy; McKay, Adam; Nguyen, Sylvia] Epworth Rehabil, Dept Psychol, Melbourne, Vic, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia		Ymer, L (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	lucy.ymer1@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480; Wong, Dana/0000-0001-9619-1929	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1174473, APP1023043]	This work was partly supported by the National Health and Medical Research Council (grant nos. APP1174473, APP1023043).	Baylan S, 2020, SLEEP MED REV, V49, DOI 10.1016/j.smrv.2019.101222; Berginstrom N, 2020, BRAIN INJURY, V34, P415, DOI 10.1080/02699052.2020.1725124; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Coetzer R., 2001, PSYCHIATR BULL, V25, P421, DOI [https://doi.org/10.1192/pb.25.11.421, DOI 10.1192/PB.25.11.421]; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Cumming TB, 2016, INT J STROKE, V11, P968, DOI 10.1177/1747493016669861; Delis D. C., 2000, MANUAL CALIFORNIAN V; Driver S, 2018, NEUROREHABILITATION, V43, P347, DOI 10.3233/NRE-182536; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hassett L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub3; Herron K, 2018, BEHAV COGN PSYCHOTH, V46, P641, DOI 10.1017/S1352465818000061; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kim Y, 2019, GERIATR GERONTOL INT, V19, P1226, DOI 10.1111/ggi.13797; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuppuswamy A, 2015, J NEUROL NEUROSUR PS, V86, P902, DOI 10.1136/jnnp-2015-310431; Lerdal A, 2017, J STROKE CEREBROVASC, V26, P523, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.130; Lin FH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017667; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lowe A, 2020, DISABIL REHABIL, V42, P1041, DOI 10.1080/09638288.2018.1516819; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Mitchell LJ, 2019, SLEEP MED REV, V47, P90, DOI 10.1016/j.smrv.2019.06.002; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nguyen S, 2019, NEUROPSYCHOL REHABIL, V29, P723, DOI 10.1080/09602011.2017.1326945; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Park JuHyung, 2019, J Phys Ther Sci, V31, P149, DOI 10.1589/jpts.31.149; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Raina KD, 2016, J HEAD TRAUMA REHAB, V31, pE41, DOI 10.1097/HTR.0000000000000196; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Siengsukon CF, 2020, MULT SCLER RELAT DIS, V40, DOI 10.1016/j.msard.2020.101958; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Ymer L, 2021, J HEAD TRAUMA REHAB; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242	50	0	0	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2021	64	5			SI				101560	10.1016/j.rehab.2021.101560			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WG9RK	WOS:000707327800013	34311119				2022-02-06	
J	Zhang, MQ; Hamblin, MH; Yin, KJ				Zhang, Mengqi; Hamblin, Milton H.; Yin, Ke-Jie			Long non-coding RNAs mediate cerebral vascular pathologies after CNS injuries	NEUROCHEMISTRY INTERNATIONAL			English	Article						Long non-coding RNAs; Cerebral vascular pathologies; Therapeutics; Stroke; Traumatic brain injury; Spinal cord injury	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; LNCRNA MEG3; ANTISENSE OLIGONUCLEOTIDES; INTRACEREBRAL HEMORRHAGE; INFLAMMATORY RESPONSE; BARRIER DISRUPTION; EMERGING ROLES	Central nervous system (CNS) injuries are one of the leading causes of morbidity and mortality worldwide, accompanied with high medical costs and a decreased quality of life. Brain vascular disorders are involved in the pathological processes of CNS injuries and might play key roles for their recovery and prognosis. Recently, increasing evidence has shown that long non-coding RNAs (lncRNAs), which comprise a very heterogeneous group of non-protein-coding RNAs greater than 200 nucleotides, have emerged as functional mediators in the regulation of vascular homeostasis under pathophysiological conditions. Remarkably, lncRNAs can regulate gene transcription and translation, thus interfering with gene expression and signaling pathways by different mechanisms. Hence, a deeper insight into the function and regulatory mechanisms of lncRNAs following CNS injury, especially cerebrovascular-related lncRNAs, could help in establishing potential therapeutic strategies to improve or inhibit neurological disorders. In this review, we highlight recent advancements in understanding of the role of lncRNAs and their application in mediating cerebrovascular pathologies after CNS injury.	[Zhang, Mengqi; Yin, Ke-Jie] Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Dept Neurol, Sch Med, S514 BST,200 Lothrop St, Pittsburgh, PA 15213 USA; [Hamblin, Milton H.] Tulane Univ, Dept Pharmacol, Sch Med, 1430 Tulane Ave SL-83, New Orleans, LA 70112 USA; [Yin, Ke-Jie] Vet Affairs Pittsburgh Healthcare Syst, Geriatr Res, Educ & Clin Ctr, Pittsburgh, PA 15261 USA		Yin, KJ (corresponding author), Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Dept Neurol, Sch Med, S514 BST,200 Lothrop St, Pittsburgh, PA 15213 USA.	yink2@upmc.edu		Zhang, Mengqi/0000-0003-2090-6320	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS112181, I01BX004837]; Department of Veterans AffairsUS Department of Veterans Affairs	This work was supported by the National Institutes of Health Grant NS112181 (K.J. Yin) ; K.J. Yin is also supported by the Merit Review Grant I01BX004837 from the Department of Veterans Affairs.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bai Y, 2014, STROKE, V45, P383, DOI 10.1161/STROKEAHA.113.003393; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0282-x; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Boguszewska-Czubara A, 2019, CURR MED CHEM, V26, P3208, DOI 10.2174/0929867325666180514111500; Boulberdaa M, 2016, MOL THER, V24, P978, DOI 10.1038/mt.2016.41; Cai H, 2017, ONCOGENE, V36, P318, DOI 10.1038/onc.2016.212; CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; Cantor A.B, 2018, HEMATOLOGY, Vseventh, P334; Cao DW, 2020, ACTA PHARMACOL SIN, V41, P22, DOI 10.1038/s41401-019-0284-y; Cao Y., METAB BRAIN DIS, V35, P1361; Chandran R, 2017, NEUROCHEM INT, V111, P12, DOI 10.1016/j.neuint.2017.01.015; Chen JX, 2020, BRAIN RES BULL, V162, P20, DOI 10.1016/j.brainresbull.2020.04.017; Chen SC, 2017, BIOCHEM BIOPH RES CO, V485, P167, DOI 10.1016/j.bbrc.2017.02.043; Cheng JP, 2018, ACTA NEUROPATHOL, V136, P507, DOI 10.1007/s00401-018-1893-0; Cheng SQ, 2021, J MOL NEUROSCI, V71, P169, DOI 10.1007/s12031-020-01623-7; Cheng X, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00744; Chowdhury TA, 2018, ARTERIOSCL THROM VAS, V38, P1562, DOI 10.1161/ATVBAHA.118.310848; D'Souza S, 2015, J NEUROSURG ANESTH, V27, P222, DOI 10.1097/ANA.0000000000000130; Dahariya S, 2019, MOL IMMUNOL, V112, P82, DOI 10.1016/j.molimm.2019.04.011; Das S, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/HCG.0000000000000062; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Deng WJ, 2020, J CELL PHYSIOL, V235, P4571, DOI 10.1002/jcp.29334; Dharap A, 2013, ASN NEURO, V5, P283, DOI 10.1042/AN20130029; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dong BZ, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12499; Fan JF, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.594571; Feng LJ, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22629; Fisher Mark, 2008, Rev Neurol Dis, V5 Suppl 1, pS4; Gao G, 2020, NANOSCALE RES LETT, V15, DOI 10.1186/s11671-020-03357-2; Gao Q, 2020, AM J TRANSL RES, V12, P2738; Gareev I, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090155; Ghafouri-Fard S, 2020, VASC PHARMACOL, V133, DOI 10.1016/j.vph.2020.106778; Gittleman H, 2017, J NEURO-ONCOL, V133, P265, DOI 10.1007/s11060-017-2449-1; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goff LA, 2015, P NATL ACAD SCI USA, V112, P6855, DOI 10.1073/pnas.1411263112; Gordon FE, 2010, ENDOCRINOLOGY, V151, P2443, DOI 10.1210/en.2009-1151; Guo D, 2017, CELL PHYSIOL BIOCHEM, V43, P182, DOI 10.1159/000480337; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; He ZZ, 2020, AGING-US, V12, P20285, DOI 10.18632/aging.103800; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Hong SH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4931-3;539; Hu SK, 2020, BRAIN RES, V1732, DOI 10.1016/j.brainres.2020.146681; Huang HY, 2018, CELL TRANSPLANT, V27, P310, DOI 10.1177/0963689717746999; Hulshoff MS, 2019, CARDIOVASC RES, V115, P1716, DOI 10.1093/cvr/cvz211; Hung J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01655; Jae N, 2020, CIRC RES, V126, P1127, DOI 10.1161/CIRCRESAHA.119.315938; Jae N, 2019, VASC PHARMACOL, V114, P13, DOI 10.1016/j.vph.2018.03.003; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Jiang ZS, 2018, INT J BIOL MACROMOL, V120, P66, DOI 10.1016/j.ijbiomac.2018.08.002; Jin DS, 2019, INT J SURG, V69, P68, DOI 10.1016/j.ijsu.2019.07.023; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim JM, 2019, ANN CLIN TRANSL NEUR, V6, P2014, DOI 10.1002/acn3.50894; Kok FO, 2019, VASC PHARMACOL, V114, P23, DOI 10.1016/j.vph.2018.06.004; Kumar DBU, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106279; Kumar H, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0576-3; Lee KT, 2017, BMB REP, V50, P226, DOI 10.5483/BMBRep.2017.50.4.025; Leisegang MS, 2017, CIRCULATION, V136, P65, DOI 10.1161/CIRCULATIONAHA.116.026991; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Li JW, 2018, EUR REV MED PHARMACO, V22, P7614, DOI 10.26355/eurrev_201811_16375; Li KG, 2010, BLOOD, V115, P133, DOI 10.1182/blood-2009-09-242180; Li YQ, 2017, NAT MED, V23, P733, DOI 10.1038/nm.4331; Li Z, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12483; Li ZJ, 2017, NEUROSCIENCE, V354, P1, DOI 10.1016/j.neuroscience.2017.04.017; Liang Z, 2018, EUR REV MED PHARMACO, V22, P2824, DOI 10.26355/eurrev_201805_14983; Liu JY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.466; Liu XM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00201; Liu Y, 2018, BIOMED PHARMACOTHER, V98, P856, DOI 10.1016/j.biopha.2017.12.079; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Long FQ, 2018, NEURAL REGEN RES, V13, P1919, DOI 10.4103/1673-5374.238717; Lu G, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005363; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Lv L, 2021, INT J NEUROSCI, V131, P1162, DOI 10.1080/00207454.2020.1782904; Lyu Q, 2019, P NATL ACAD SCI USA, V116, P546, DOI 10.1073/pnas.1810729116; Ma J, 2020, CELL ONCOL, V43, P377, DOI 10.1007/s13402-019-00493-5; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Ma SC, 2018, ONCOL REP, V39, P1441, DOI 10.3892/or.2018.6208; Man HSJ, 2018, P NATL ACAD SCI USA, V115, P2401, DOI 10.1073/pnas.1715182115; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Meng XR, 2019, ONCOTARGETS THER, V12, P11487, DOI 10.2147/OTT.S228439; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Neumann P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02431-1; Oh SY, 2010, OLIGONUCLEOTIDES, V20, P225, DOI 10.1089/oli.2010.0238; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Ozduman K, 2010, NEUROSURGERY, V66, P538, DOI 10.1227/01.NEU.0000365615.24973.26; Pallan PS, 2011, NUCLEIC ACIDS RES, V39, P3482, DOI 10.1093/nar/gkq1270; Pan CY, 2020, MOL THER-NUCL ACIDS, V21, P983, DOI 10.1016/j.omtn.2020.07.028; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Qi X, 2017, NEUROSCIENCE, V348, P98, DOI 10.1016/j.neuroscience.2017.02.002; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Ren HB, 2020, BRAZ J MED BIOL RES, V53, DOI [10.1590/1414-431X20209174, 10.1590/1414-431x20209174]; Riva P, 2016, CURR ALZHEIMER RES, V13, P1219, DOI 10.2174/1567205013666160622112234; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Shao HF, 2019, EUR REV MED PHARMACO, V23, P4341, DOI 10.26355/eurrev_201905_17940; Sharp FR, 2011, J CEREBR BLOOD F MET, V31, P1513, DOI 10.1038/jcbfm.2011.45; Shimizu Fumitaka, 2018, Immunol Med, V41, P120, DOI 10.1080/25785826.2018.1531190; Simion V, 2019, VASC PHARMACOL, V114, P145, DOI 10.1016/j.vph.2018.01.003; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Pham TM, 2018, NEUROEPIDEMIOLOGY, V50, P195, DOI 10.1159/000488145; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Wang HY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00215; Wang HW, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00635-0; Wang J, 2017, AGING DIS, V8, P71, DOI 10.14336/AD.2016.0530; Wang MP, 2020, J ATHEROSCLER THROMB, V27, P718, DOI 10.5551/jat.50674; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wang YR, 2018, LIFE SCI, V211, P189, DOI 10.1016/j.lfs.2018.08.072; Wen J, 2018, EUR REV MED PHARMACO, V22, P2817, DOI 10.26355/eurrev_201805_14981; Wilusz JE, 2016, BBA-GENE REGUL MECH, V1859, P128, DOI 10.1016/j.bbagrm.2015.06.003; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu ZM, 2017, MOL NEUROBIOL, V54, P7686, DOI 10.1007/s12035-016-0354-9; Wu ZM, 2017, MOL NEUROBIOL, V54, P7670, DOI 10.1007/s12035-016-0246-z; Wu ZH, 2017, AM J TRANSL RES, V9, P3326; Xiang YX, 2020, AGING-US, V12, P3156, DOI 10.18632/aging.102790; Xu Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.57; Yan HL, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0047-y; Yan HL, 2016, NEUROSCIENCE, V337, P191, DOI 10.1016/j.neuroscience.2016.09.017; Yang CJ, 2019, AM J PHYSIOL-CELL PH, V316, pC135, DOI 10.1152/ajpcell.00136.2018; Yang Q, 2020, EXP MOL PATHOL, V112, DOI 10.1016/j.yexmp.2019.104343; Yang S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0155-8; Yang X, 2019, BRAIN RES, V1714, P174, DOI 10.1016/j.brainres.2018.11.003; Yao Y, 2019, J CEREBR BLOOD F MET, V39, P3, DOI 10.1177/0271678X18801467; Yi M, 2019, CELL CYCLE, V18, P2332, DOI 10.1080/15384101.2019.1647024; Yin KJ, 2015, CURR VASC PHARMACOL, V13, P352, DOI 10.2174/15701611113119990016; Yin KJ, 2014, NEUROCHEM INT, V77, P9, DOI 10.1016/j.neuint.2014.03.013; Yu T, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023209; Zhang B, 2017, ONCOTARGET, V8, P17347, DOI 10.18632/oncotarget.14468; Zhang HF, 2018, CELL CYCLE, V17, P1992, DOI 10.1080/15384101.2018.1509622; Zhang HF, 2018, RNA BIOL, V15, P1071, DOI 10.1080/15476286.2018.1493333; Zhang J, 2016, EXP NEUROL, V277, P162, DOI 10.1016/j.expneurol.2015.12.014; Zhang J, 2019, LIFE SCI, V237, DOI 10.1016/j.lfs.2019.116929; Zhang J, 2020, CNS NEUROSCI THER, V26, P1207, DOI 10.1111/cns.13472; Zhang L, 2019, MOL THER-NUCL ACIDS, V17, P754, DOI 10.1016/j.omtn.2019.07.013; Zhang L, 2018, J CELL BIOCHEM, V119, P5460, DOI 10.1002/jcb.26705; Zhang MQ, 2020, AGING-US, V12, P1759, DOI 10.18632/aging.102712; Zhang T, 2021, NEURAL REGEN RES, V16, P772, DOI 10.4103/1673-5374.295335; Zhang X, 2019, J CELL MOL MED, V23, P6120, DOI 10.1111/jcmm.14480; Zhang XJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061723; Zhang XJ, 2019, NEUROSCIENTIST, V25, P22, DOI 10.1177/1073858418769556; Zhang XJ, 2017, RNA BIOL, V14, P1705, DOI 10.1080/15476286.2017.1358347; Zhang XJ, 2017, J NEUROSCI, V37, P1797, DOI 10.1523/JNEUROSCI.3389-16.2017; Zhao M, 2018, NEUROSCIENCE, V390, P231, DOI 10.1016/j.neuroscience.2018.08.029; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zheng J, 2016, MOL THER, V24, P1199, DOI 10.1038/mt.2016.71; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhou ZW, 2019, BRAIN RES, V1707, P90, DOI 10.1016/j.brainres.2018.10.031; Zhu M, 2018, J STROKE CEREBROVASC, V27, P326, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.009; Zuo XL, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-019-0839-x	164	0	0	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2021	148								105102	10.1016/j.neuint.2021.105102			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TM9LE	WOS:000675867400008	34153353				2022-02-06	
J	Zhao, JQ; Qu, DJ; Xi, ZH; Huan, Y; Zhang, K; Yu, CY; Yang, DD; Kang, JJ; Lin, W; Wu, SX; Wang, YZ				Zhao, Jiqian; Qu, Dujie; Xi, Zihan; Huan, Yu; Zhang, Kun; Yu, Caiyong; Yang, Dingding; Kang, Junjun; Lin, Wei; Wu, Shengxi; Wang, Yazhou			Mitochondria transplantation protects traumatic brain injury via promoting neuronal survival and astrocytic BDNF	TRANSLATIONAL RESEARCH			English	Article							MOTOR-NEURONS; DYSFUNCTION; MICROGLIA; CELLS; RATS; DNA	Traumatic brain injury (TBI) is one of the leading causes of disability and paralysis around the world. Secondary injury, characterized by progressive neuronal loss and astrogliosis, plays important roles in the post-TBI cognitive impairment and mood disorder. Unfortunately, there still lacks effective treatments, particularly surgery interferences for it. Recent findings of intercellular mitochondria transfer implies a potential therapeutic value of mitochondria transplantation for TBI, which has not been tested yet. In the present study, we demonstrated a quick dysfunction of mitochondria, up-regulation of Tom20 in the injured cortex and subsequent cognitive and mood impairment. Our data demonstrated that mitochondria derived from allogeneic liver or autogeneic muscle stimulated similar microglial activation in brain parenchyma. In vitro experiments showed that exogenous mitochondria could be easily internalized by neurons, astrocytes, and microglia, except for oligodendrocytes. Mitochondria transplantation effectively rescued neuronal apoptosis, restored the expression of Tom20 and the phosphorylation of JNK. Further analysis revealed that mitochondria transplantation in injured cortex induced a significant up-regulation of BDNF in reactive astrocytes, improved animals' spatial memory and alleviated anxiety. In together, our data indicate that mitochondria transplantation may has the potential of clinical translation for TBI treatment, in combination with surgery.	[Zhao, Jiqian; Zhang, Kun; Yu, Caiyong; Yang, Dingding; Kang, Junjun; Wu, Shengxi; Wang, Yazhou] Fourth Mil Med Univ, Sch Basic, Dept Neurobiol, Med, Xian, Shaanxi, Peoples R China; [Zhao, Jiqian; Zhang, Kun; Yu, Caiyong; Yang, Dingding; Kang, Junjun; Wu, Shengxi; Wang, Yazhou] Fourth Mil Med Univ, Sch Basic, Inst Neurosci, Med, Xian, Shaanxi, Peoples R China; [Qu, Dujie] Luochuan Cty Hosp, Dept Gen Practice, Yanan, Shaanxi, Peoples R China; [Xi, Zihan] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Huan, Yu; Lin, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China		Lin, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China.; Wu, SX; Wang, YZ (corresponding author), Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian, Shaanxi, Peoples R China.; Wu, SX; Wang, YZ (corresponding author), Fourth Mil Med Univ, Sch Basic Med, Inst Neurosci, Xian, Shaanxi, Peoples R China.	linwei@fmmu.edu.cn; shengxi@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81730035, 31970907]	The manuscript has been reviewed by and approved by all named authors. This work was supported by the National Natural Science Foundation of China to Dr. Shengxi Wu (Grant No. 81730035) and to Dr. Yazhou Wang (Grant No. 31970907).	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burt R, 2019, BLOOD, V134, P1415, DOI 10.1182/blood.2019001398; Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Eisenberg-Bord M, 2017, FEBS J, V284, P196, DOI 10.1111/febs.13778; Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Gingras M, 2007, J NEUROSCI METH, V163, P111, DOI 10.1016/j.jneumeth.2007.02.024; Giralt A, 2010, GENE THER, V17, P1294, DOI 10.1038/gt.2010.71; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Heslop KA, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113728; Huang HL, 2015, INT J CLIN EXP MED, V8, P5103; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Li HYZ, 2019, THERANOSTICS, V9, P2017, DOI 10.7150/thno.29400; Liu KM, 2019, MICROVASC RES, V123, P74, DOI 10.1016/j.mvr.2019.01.001; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Roushandeh AM, 2019, CYTOTECHNOLOGY, V71, P647, DOI 10.1007/s10616-019-00302-9; Sinha P, 2016, CURR OPIN GENET DEV, V38, P97, DOI 10.1016/j.gde.2016.05.002; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun C, 2019, THERANOSTICS, V9, P3595, DOI 10.7150/thno.33100; Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107; West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21; Yan CY, 2020, MOL NEUROBIOL, V57, P3875, DOI 10.1007/s12035-020-01994-3; Zhou B, 2018, CELL RES, V28, P1171, DOI 10.1038/s41422-018-0090-y	31	0	0	7	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	SEP	2021	235						102	114		10.1016/j.trsl.2021.03.017			13	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	TS9GE	WOS:000679954700008	33798765				2022-02-06	
J	Zhao, XN; Liu, S; Yang, XH; Liu, YN; Liu, G; Fan, K; Ma, JM				Zhao, Xinnan; Liu, Shuang; Yang, Xiaohan; Liu, Yanna; Liu, Gang; Fan, Kai; Ma, Jianmei			Cathepsin C aggravates neuroinflammation via promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Cathepsin C; Neuroinflammation; CCL2; CXCL2	DIPEPTIDYL-PEPTIDASE-I; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NEUTROPHIL RECRUITMENT; MAST-CELL; MOLECULAR-CLONING; INJURY; CHEMOKINES; EXPRESSION; MOUSE; ACTIVATION	Objective: Chemokines regulate infiltration of immune cells to brain in inflammation. Cathepsin C (CatC), a lysosomal protease, has been found to participate in neuroinflammation. However, how CatC affects chemokines expression in neuroinflammation triggered by traumatic brain injury (TBI) remains unclear. Here, we investigated the effects of CatC on chemokines and neuroinflammation in TBI. Methods: The present study used CatC knockdown (KD) and overexpression (OE) mice to generate cryogenic brain lesion model and determined effects of CatC on expression of chemokines CCL2, CCL5 and CXCL2 and infiltration of immune cells in acute and chronic phases of the lesion. Further, cellular sources of various chemokines were demonstrated in vitro. Values were compared with wild type (WT) mice. Results: The results found that 6 h after lesion, CatC expression,IL-1 beta and TNF-alpha mRNA and protein expression were strongly induced in the lesions; CCL2 and CXCL2 mRNA and protein expression were increased in CatC OE mice, while decreased in CatC KD mice. On the 3rd day after lesion, macrophages and neutrophils were mainly infiltrated to the lesions. Simultaneously, Iba-1+ cells in CatC OE mice were increased, while MPO + cells in CatC KD mice were decreased. In contrast, on the 28th day after lesion, a few lymphocytes were infiltrated surrounding new blood vessels. CatC OE mice showed larger volumes of scar areas, higher expression of CCL2, CXCL2,IL-1 beta,TNF-alpha,IL-6 and iNOS, as well as stronger GFAP+ and Iba-1+ signals, while CatC KD mice had reversed effects. No significant differences of CCL5 expression were found in various genotype mice. Further, in vitro study demonstrated CatC-induced expression of CCL2 were mainly derived from microglia and neurons, while CXCL2 derived from microglia and astrocytes. Conclusion: Our data indicate that CatC aggravates neuroinflammation via promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion, providing potential cellular and molecular targets for future intervention of TBI and other neuroinflammatory diseases.	[Zhao, Xinnan; Liu, Shuang; Liu, Yanna; Liu, Gang; Fan, Kai; Ma, Jianmei] Dalian Med Univ, Coll Basic Med Sci, Dept Anat, Dalian, Liaoning, Peoples R China; [Yang, Xiaohan] Dalian Med Univ, Coll Basic Med Sci, Dept Morphol, Dalian, Liaoning, Peoples R China; [Ma, Jianmei] Dalian Med Univ, Natl Local Joint Engn Res Ctr Drug Res & Dev R&D, Dalian, Liaoning, Peoples R China		Fan, K; Ma, JM (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Anat, Dalian, Liaoning, Peoples R China.	zhaonana1991@live.com; 741517237@qq.com; xiaohan-yxh@163.com; liuyanna_7@hotmail.com; 1957825811@qq.com; 2286130554@qq.com; ma_jianmei@hotmail.com		Zhao, Xinnan/0000-0002-0556-1881	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671180]; Liaoning Revitalization Talents Program [XLYC1808031]; Liaoning Provincial Program for Top Discipline of Basic Medical Sciences and Natural Science Foundation of Liaoning Province [2015020256]	This research was supported by the National Natural Science Foundation of China (81671180) , Liaoning Revitalization Talents Program (XLYC1808031) , Liaoning Provincial Program for Top Discipline of Basic Medical Sciences and Natural Science Foundation of Liaoning Province (2015020256) .	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI200213462; Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Astrup LB, 2019, NEUROL RES, V41, P399, DOI 10.1080/01616412.2019.1573455; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; BERNSTEIN HG, 1989, J HIRNFORSCH, V30, P613; Bourbeau Jean, 2009, Proc Am Thorac Soc, V6, P553, DOI 10.1513/pats.200906-039DS; Boutte AM, 2020, J NEUROTRAUM, V37, P1574, DOI 10.1089/neu.2019.6537; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Czapski GA, 2010, BRAIN RES, V1356, P85, DOI 10.1016/j.brainres.2010.07.096; Dambach H, 2014, EPILEPSIA, V55, P184, DOI 10.1111/epi.12473; Day RB, 2012, CELL MOL LIFE SCI, V69, P1415, DOI 10.1007/s00018-011-0870-8; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Deussing J, 2002, GENOMICS, V79, P225, DOI 10.1006/geno.2002.6696; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Durose WW, 2019, J NEUROCHEM, V148, P413, DOI 10.1111/jnc.14581; Dzenko KA, 2001, J NEUROSCI, V21, P9214, DOI 10.1523/JNEUROSCI.21-23-09214.2001; Fan K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-96; Furman NT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68770-0; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giovannoni F, 2020, TRENDS IMMUNOL, V41, P805, DOI 10.1016/j.it.2020.07.007; Groblewska M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103704; Guo FY, 2020, FASEB J, V34, P1872, DOI 10.1096/fj.201902203RR; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hamon Y, 2016, J BIOL CHEM, V291, P8486, DOI 10.1074/jbc.M115.707109; Hu Y, 2005, ARTHRITIS RHEUM-US, V52, P2553, DOI 10.1002/art.21192; ISHIDOH K, 1991, J BIOL CHEM, V266, P16312; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Karababa A, 2017, NEUROCHEM RES, V42, P737, DOI 10.1007/s11064-016-2060-4; Karim H, 2018, P NATL ACAD SCI USA, V115, P6291, DOI 10.1073/pnas.1721732115; Kingham PJ, 2000, J NEUROCHEM, V74, P1452, DOI 10.1046/j.1471-4159.2000.0741452.x; Liang JJ, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00152; Linnerbauer M., 2020, NEURON; Liu LR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01024; Liu Q, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1398-3; Ma JM, 2011, J NEUROSCI RES, V89, P639, DOI 10.1002/jnr.22567; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGuire MJ, 1997, BBA-GENE STRUCT EXPR, V1351, P267, DOI 10.1016/S0167-4781(97)00021-3; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; Molnar T, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104951; NAKANISHI H, 1994, EXP NEUROL, V126, P119, DOI 10.1006/exnr.1994.1048; Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104; PARIS A, 1995, FEBS LETT, V369, P326, DOI 10.1016/0014-5793(95)00777-7; Petanceska S, 1996, J BIOL CHEM, V271, P4403; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rajarathnam K, 2019, CELL SIGNAL, V54, P69, DOI 10.1016/j.cellsig.2018.11.004; Ransohoff RM, 2015, NEUROTHERAPEUTICS, V12, P896, DOI 10.1007/s13311-015-0385-3; Rao NV, 1997, J BIOL CHEM, V272, P10260; Raslan Furat, 2012, Exp Transl Stroke Med, V4, P6, DOI 10.1186/2040-7378-4-6; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; RYAN RE, 1995, J NEUROCHEM, V65, P1035; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Sheth PD, 2003, BIOCHEM PHARMACOL, V66, P2251, DOI 10.1016/j.bcp.2003.08.002; Shi GP, 2007, FUTUR CARDIOL, V3, P591, DOI 10.2217/14796678.3.6.591; Shimizu T, 2017, GLIA, V65, P917, DOI 10.1002/glia.23134; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Trettel F, 2020, NEUROSCIENCE, V439, P230, DOI 10.1016/j.neuroscience.2019.07.035; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; VALENTE AJ, 1992, CIRCULATION, V86, P20; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Yao Y, 2011, J NEUROCHEM, V118, P215, DOI 10.1111/j.1471-4159.2011.07319.x; Yoshiyama Y, 2000, NEUROSCI LETT, V290, P125, DOI 10.1016/S0304-3940(00)01326-4; Zigrnond RE, 2019, PROG NEUROBIOL, V173, P102, DOI 10.1016/j.pneurobio.2018.12.001	74	0	0	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2021	148								105107	10.1016/j.neuint.2021.105107			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TM9ML	WOS:000675870700003	34171415				2022-02-06	
J	Zhong, LY; Liu, P; Fan, JF; Luo, YM				Zhong, Liyuan; Liu, Ping; Fan, Junfen; Luo, Yumin			Long non-coding RNA H19: Physiological functions and involvements in central nervous system disorders	NEUROCHEMISTRY INTERNATIONAL			English	Article						H19; lncRNA H19; Central nervous disorders; Physiological functions	HUMAN GLIOMA-CELLS; ISCHEMIA-REPERFUSION INJURY; SPINAL-CORD-INJURY; LNCRNA H19; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; BRAIN-DAMAGE; EXPRESSION; GROWTH; TEMOZOLOMIDE	Central nervous system (CNS) disorders are some of the most complex and challenging diseases because of the intricate structure and functions of the CNS. Long non-coding RNA (LncRNA) H19, which had been mistaken for "transcription noise" previously, has now been found to be closely related to the development and homeostasis of the CNS. Several recent studies indicate that it plays an important role in the pathogenesis, treatment, and even prognosis of CNS disorders. LncRNA H19 is correlated with susceptibility to various CNS disorders such as intracranial aneurysms, ischemic stroke, glioma, and neuroblastoma. Moreover, it participates in the pathogenesis of CNS disorders by regulating transcription, translation, and signaling pathways, suggesting that it is a promising biomarker and therapeutic target for these disorders. This article reviews the functions and mechanisms of lncRNA H19 in various CNS disorders, including cerebral ischemia, cerebral hemorrhage, glioma, pituitary adenoma, neuroblastoma, Parkinson's disease, Alzheimer's disease, traumatic spinal cord injury, neuropathic pain, and temporal lobe epilepsy, to provide a theoretical basis for further research on the role of lncRNA H19 in CNS disorders.	[Zhong, Liyuan; Liu, Ping; Fan, Junfen; Luo, Yumin] Capital Med Univ, Xuanwu Hosp, Inst Cerebrovasc Dis Res, 45 Changchun St, Beijing 100053, Peoples R China; [Zhong, Liyuan; Liu, Ping; Fan, Junfen; Luo, Yumin] Capital Med Univ, Xuanwu Hosp, Dept Neurol, 45 Changchun St, Beijing 100053, Peoples R China; [Luo, Yumin] Beijing Geriatr Med Res Ctr, Beijing 100053, Peoples R China; [Luo, Yumin] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing 100053, Peoples R China; [Luo, Yumin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100053, Peoples R China		Fan, JF; Luo, YM (corresponding author), Capital Med Univ, Xuanwu Hosp, Inst Cerebrovasc Dis Res, 45 Changchun St, Beijing 100053, Peoples R China.; Fan, JF; Luo, YM (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, 45 Changchun St, Beijing 100053, Peoples R China.	fanjunfen@xwhosp.org; yumin111@ccmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82001268, 81771413, 81971222]; Capital Funds for Health Improvement and Research [202021032]	This work was supported by the National Natural Science Foundation of China (82001268, 81771413, and 81971222) , and Capital Funds for Health Improvement and Research (202021032) .	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360; Bedner P, 2015, BRAIN, V138, P1208, DOI 10.1093/brain/awv067; Chen J, 2016, SCI CHINA LIFE SCI, V59, P227, DOI 10.1007/s11427-016-5010-0; Chen L, 2018, ONCOL RES, V26, P1419, DOI 10.3727/096504018X15178768577951; Chen Y, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/9490639; Chen ZP, 2019, INT J BIOL MACROMOL, V121, P546, DOI 10.1016/j.ijbiomac.2018.10.033; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Delas MJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170121; Deng YH, 2016, NEURAL REGEN RES, V11, P1108, DOI 10.4103/1673-5374.187045; Deng YJ, 2020, MOL THER-NUCL ACIDS, V20, P86, DOI 10.1016/j.omtn.2020.02.003; Ding L, 2020, NEURAL REGEN RES, V15, P1560, DOI 10.4103/1673-5374.274348; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Duan SB, 2018, ONCOTARGETS THER, V11, P6395, DOI 10.2147/OTT.S173244; Eliasson L, 2020, J MOL BIOL, V432, P1419, DOI 10.1016/j.jmb.2019.09.017; Ersahin M, 2009, J PINEAL RES, V46, P324, DOI 10.1111/j.1600-079X.2009.00664.x; Fan BY, 2020, STEM CELLS, V38, P973, DOI 10.1002/stem.3189; Fang H, 2021, AM J PATHOL, V191, P503, DOI 10.1016/j.ajpath.2020.11.014; Fazi Barbara, 2018, Oncotarget, V9, P15512, DOI 10.18632/oncotarget.24496; Feng M, 2021, NEUROSCI RES, V163, P52, DOI 10.1016/j.neures.2020.03.005; Ferre F, 2016, BRIEF BIOINFORM, V17, P106, DOI 10.1093/bib/bbv031; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gao N, 2020, NEUROSCIENCE, V437, P117, DOI 10.1016/j.neuroscience.2020.04.020; Gross BA, 2019, JAMA-J AM MED ASSOC, V321, P1295, DOI 10.1001/jama.2019.2413; Gu EY, 2021, J MOL NEUROSCI, V71, P1256, DOI 10.1007/s12031-020-01751-0; Guan N, 2019, EUR REV MED PHARMACO, V23, P4243, DOI 10.26355/eurrev_201905_17929; Han CL, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12856; Han CL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0496-y; Han CL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1139-z; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hou GQ, 2020, MOL THER-NUCL ACIDS, V19, P523, DOI 10.1016/j.omtn.2019.12.002; Hu C, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181582; Hu Q, 2018, CELL PHYSIOL BIOCHEM, V50, P233, DOI 10.1159/000494002; Hu SK, 2020, BRAIN RES, V1732, DOI 10.1016/j.brainres.2020.146681; Huang J, 2019, METAB BRAIN DIS, V34, P1011, DOI 10.1007/s11011-019-00417-0; Huang YJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00032; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Idda ML, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1463; Iwasaki H, 2019, J NIPPON MED SCH, V86, P215, DOI 10.1272/jnms.JNMS.2018_86-402; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jia LW, 2018, ONCOTARGETS THER, V11, P313, DOI 10.2147/OTT.S154339; Jia P, 2016, CANCER LETT, V381, P359, DOI 10.1016/j.canlet.2016.08.009; Jiang JJ, 2020, AGING-US, V12, P8820, DOI 10.18632/aging.102877; Jiang PF, 2016, ONCOTARGETS THER, V9, P3501, DOI 10.2147/OTT.S96278; Jiang XC, 2016, J NEUROSURG, V124, P129, DOI [10.3171/2014.12.JNS1426, 10.3171/2014.12.JNS1426.test]; Keam SP, 2017, J PROTEOME RES, V16, P413, DOI 10.1021/acs.jproteome.6b00267; Kim JM, 2019, ANN CLIN TRANSL NEUR, V6, P2014, DOI 10.1002/acn3.50894; Kraus TFJ, 2017, MOL NEUROBIOL, V54, P2869, DOI 10.1007/s12035-016-9854-x; Kraus TFJ, 2015, J NEURAL TRANSM, V122, P1045, DOI 10.1007/s00702-014-1352-6; Kutlu G, 2005, EPILEPSY BEHAV, V6, P353, DOI 10.1016/j.yebeh.2004.12.013; Lawton MT, 2017, NEW ENGL J MED, V377, P257, DOI 10.1056/NEJMcp1605827; Lecerf C, 2019, CELL MOL LIFE SCI, V76, P4673, DOI 10.1007/s00018-019-03240-z; Li C, 2015, AM J TRANSL RES, V7, P1747; Li H, 2017, WORLD NEUROSURG, V97, P684, DOI 10.1016/j.wneu.2016.10.016; Li H, 2020, BIOCHEM CELL BIOL, V98, P525, DOI 10.1139/bcb-2019-0281; Li K, 2020, J PAIN RES, V13, P2113, DOI 10.2147/JPR.S240273; Li WG, 2016, CELL MOL NEUROBIOL, V36, P1219, DOI 10.1007/s10571-015-0320-5; Li X, 2021, TRANSL NEUROSCI, V12, P103, DOI 10.1515/tnsci-2021-0013; Li Y, 2019, J CANCER, V10, P6358, DOI 10.7150/jca.37564; Li ZH, 2018, ONCOGENE, V37, P2714, DOI 10.1038/s41388-018-0133-3; Liu ZZ, 2020, NEOPLASMA, V67, P111, DOI 10.4149/neo_2019_190121N61; Lloret A, 2015, FREE RADICAL BIO MED, V83, P186, DOI 10.1016/j.freeradbiomed.2015.02.028; Lopes MBS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10169; Lozano-Urena Anna, 2017, Brain Plast, V3, P89, DOI 10.3233/BPL-160041; Lu TY, 2018, INT J DEV NEUROSCI, V67, P46, DOI 10.1016/j.ijdevneu.2018.03.009; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Marques BL, 2019, SEMIN CELL DEV BIOL, V95, P98, DOI 10.1016/j.semcdb.2018.12.003; Melmed S, 2020, NEW ENGL J MED, V382, P937, DOI 10.1056/NEJMra1810772; Mussbacher M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00085; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Pan JX, 2020, J CELL PHYSIOL, V235, P2171, DOI 10.1002/jcp.29127; Parab A, 2019, WORLD NEUROSURG, V126, pE982, DOI 10.1016/j.wneu.2019.02.203; Perez JD, 2016, ANNU REV NEUROSCI, V39, P347, DOI 10.1146/annurev-neuro-061010-113708; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Rezaei M, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02081-3; Schwartz AY, 2000, NEUROSURGERY, V47, P208, DOI 10.1097/00006123-200007000-00042; Shen LK, 2020, ANN CLIN BIOCHEM, V57, P365, DOI 10.1177/0004563220941888; Shi X, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00196-w; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086365; Texakalidis P, 2019, WORLD NEUROSURG, V130, P277, DOI 10.1016/j.wneu.2019.07.093; Tolbert VP, 2017, CURR OPIN GENET DEV, V42, P81, DOI 10.1016/j.gde.2017.03.008; Tucci V, 2019, CELL, V176, P952, DOI 10.1016/j.cell.2019.01.043; Vogel G, 2001, SCIENCE, V291, P1184, DOI 10.1126/science.291.5507.1184; Vroonen L, 2019, NEUROENDOCRINOLOGY, V109, P20, DOI 10.1159/000497746; Wang CR, 2020, ENVIRON HEALTH-GLOB, V19, DOI 10.1186/s12940-020-00677-9; Wang J, 2019, BRAIN RES BULL, V150, P111, DOI 10.1016/j.brainresbull.2019.05.009; Wang J, 2017, STROKE, V48, P2211, DOI 10.1161/STROKEAHA.117.017387; Wang J, 2017, AGING DIS, V8, P71, DOI 10.14336/AD.2016.0530; Wang L, 2021, NEUROSCI LETT, V753, DOI 10.1016/j.neulet.2021.135855; Wang W, 2017, ONCOTARGET, V8, P2477, DOI 10.18632/oncotarget.13908; Wei R, 2019, EXP NEUROL, V314, P100, DOI 10.1016/j.expneurol.2019.01.009; Wen Jing, 2020, Transl Perioper Pain Med, V7, P176; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2016, NAT REV NEUROL, V12, P69, DOI 10.1038/nrneurol.2015.242; Wu WN, 2017, SCI REP-UK, V7, DOI 10.1038/srep45029; Wu ZR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06853-3; Wu ZR, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.111033; Xiao ZP, 2019, AGING-US, V11, P3585, DOI 10.18632/aging.101999; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Xu J, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11770; Yang J, 2018, CELL BIOL INT, V42, P867, DOI 10.1002/cbin.10954; Yang S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0155-8; Ye MJ, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.11862; Yu JL, 2019, J CELL PHYSIOL, V234, P10655, DOI 10.1002/jcp.27746; Zeng H, 2020, ARCH GYNECOL OBSTET, V301, P671, DOI 10.1007/s00404-020-05469-7; Zeng J, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8768327; Zhang HN, 2018, LIFE SCI, V213, P258, DOI 10.1016/j.lfs.2018.10.028; Zhang L, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0418-4; Zhang T, 2016, EUR REV MED PHARMACO, V20, P4891; Zhang YY, 2021, CELL CYCLE, V20, P112, DOI 10.1080/15384101.2020.1863681; Zhang Y, 2020, NEUROCHEM RES, V45, P1700, DOI 10.1007/s11064-020-03035-w; Zhang Y, 2019, J CLIN ENDOCR METAB, V104, P6345, DOI 10.1210/jc.2019-00536; Zhao HT, 2016, ARCH BIOCHEM BIOPHYS, V610, P1, DOI 10.1016/j.abb.2016.09.014; Zhao W, 2021, NEUROREPORT, V32, P352, DOI 10.1097/WNR.0000000000001602; Zhou Q, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-00995-z; Zhu HW, 2020, AM J PERINAT, DOI 10.1055/s-0040-1718947; Zhu RX, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0402-7; Zimmer-Bensch G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111399	122	0	0	5	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2021	148								105072	10.1016/j.neuint.2021.105072			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TM9LE	WOS:000675867400013	34058282	hybrid			2022-02-06	
J	Zilberman, A; Cornelison, RC				Zilberman, Aleeza; Cornelison, R. Chase			Microphysiological models of the central nervous system with fluid flow	BRAIN RESEARCH BULLETIN			English	Article						Microphysiological; Hydrogel; Microfluidic; Bioprinting; Organoid; Neural tissue; Shear stress; Fluid flow	ON-A-CHIP; PATIENT-DERIVED GLIOBLASTOMA; REGIONAL BRAIN STIFFNESS; PLURIPOTENT STEM-CELLS; IN-VITRO; INTERSTITIAL FLOW; NEURAL TISSUE; CEREBROSPINAL-FLUID; FUNCTIONAL-NEURONS; GLYMPHATIC SYSTEM	There are over 1,000 described neurological and neurodegenerative disorders affecting nearly 100 million Americans - roughly one third of the U.S. population. Collectively, treatment of neurological conditions is estimated to cost $800 billion every year. Lowering this societal burden will require developing better model systems in which to study these diverse disorders. Microphysiological systems are promising tools for modeling healthy and diseased neural tissues to study mechanisms and treatment of neuropathology. One major benefit of microphysiological systems is the ability to incorporate biophysical forces, namely the forces derived from biological fluid flow. Fluid flow in the central nervous system (CNS) is a complex but important element of physiology, and pathologies as diverse as traumatic or ischemic injury, cancer, neurodegenerative disease, and natural aging have all been found to alter flow pathways. In this review, we summarize recent advances in threedimensional microphysiological systems for studying the biology and therapy of CNS disorders and highlight the ability and growing need to incorporate biological fluid flow in these miniaturized model systems.	[Zilberman, Aleeza; Cornelison, R. Chase] Univ Massachusetts, Dept Biomed Engn, Amherst, MA 01003 USA		Cornelison, RC (corresponding author), Univ Massachusetts, Dept Biomed Engn, Amherst, MA 01003 USA.	rcornelison@umass.edu			University of Massachusetts Amhest	This work was funded by Start-up Funds from the University of Massachusetts Amhest.	Abe Y, 2019, APL BIOENG, V3, DOI 10.1063/1.5094735; Abelseth E, 2019, ACS BIOMATER SCI ENG, V5, P234, DOI 10.1021/acsbiomaterials.8b01235; Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Alonzo LF, 2015, LAB CHIP, V15, P3521, DOI 10.1039/c5lc00507h; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Attier-Zmudka J, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00087; Avendano A, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00006; Axpe E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17245-x; Bacyinski A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00101; Badimon A, 2020, NATURE, V586, P417, DOI 10.1038/s41586-020-2777-8; Bang S, 2019, BIOMICROFLUIDICS, V13, DOI 10.1063/1.5120555; Bang S, 2016, ADV HEALTHC MATER, V5, P159, DOI 10.1002/adhm.201500397; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Barnes JM, 2017, J CELL SCI, V130, P71, DOI 10.1242/jcs.191742; Barry C, 2017, EXP BIOL MED, V242, P1679, DOI 10.1177/1535370217715028; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Bolognin S, 2019, ADV SCI, V6, DOI 10.1002/advs.201800927; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Booth HDE, 2017, TRENDS NEUROSCI, V40, P358, DOI 10.1016/j.tins.2017.04.001; Bowser DA, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab41b4; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brassard JA, 2019, CELL STEM CELL, V24, P860, DOI 10.1016/j.stem.2019.05.005; Butler HM, 2020, MATERIALIA, V12, DOI 10.1016/j.mtla.2020.100737; Cadena M, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202001600; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Cairns DM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay8828; Cano-Jaimez M, 2020, J NEUROSCI METH, V330, DOI 10.1016/j.jneumeth.2019.108452; Catterton MA, 2018, LAB CHIP, V18, P2003, DOI 10.1039/c8lc00204e; Cederquist GY, 2019, NAT BIOTECHNOL, V37, P436, DOI 10.1038/s41587-019-0085-3; Chatterjee K, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13020212; Chatterjee K, 2020, J NEUROSCI METH, V333, DOI 10.1016/j.jneumeth.2019.108541; Chen J, 2014, J NEUROSCI RES, V92, P307, DOI 10.1002/jnr.23311; Chiavari M, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050111; Choudhury D, 2018, TRENDS BIOTECHNOL, V36, P787, DOI 10.1016/j.tibtech.2018.03.003; Cornelison RC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35141-9; Cornelison RC, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aaab82; Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044; Croft CL, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0346-0; D'Aiuto L, 2014, ORGANOGENESIS, V10, P365, DOI 10.1080/15476278.2015.1011921; Da Mesquita S, 2021, NATURE, V593, P255, DOI 10.1038/s41586-021-03489-0; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; De Schepper S, 2021, DEV NEUROBIOL, V81, P507, DOI 10.1002/dneu.22777; Demers CJ, 2016, DEVELOPMENT, V143, P1884, DOI 10.1242/dev.126847; DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]; Doussau F, 2017, EXPERT OPIN DRUG DIS, V12, P1011, DOI 10.1080/17460441.2017.1356285; Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075; East E, 2013, REGEN MED, V8, P739, DOI 10.2217/rme.13.61; Eisemann T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4007-4; Esworthy TJ, 2019, INT J SMART NANO MAT, V10, P177, DOI 10.1080/19475411.2019.1631899; Fang A, 2019, INT J BIOPRINTING, V5, P90, DOI 10.18063/ijb.v5i2.235; Fedorchak NJ, 2021, SEMIN CELL DEV BIOL, V111, P52, DOI 10.1016/j.semcdb.2020.05.025; Feeney CJ, 2008, BRAIN RES, V1198, P1, DOI 10.1016/j.brainres.2007.12.049; Flores-Obando RE, 2018, JOVE-J VIS EXP, DOI 10.3791/57543; Frimat JP, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00100; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Gaudet AD, 2018, NEUROTHERAPEUTICS, V15, P554, DOI 10.1007/s13311-018-0630-7; Geissler SA, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa55c; George S, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0335-3; Ghuman H, 2016, BIOMATERIALS, V91, P166, DOI 10.1016/j.biomaterials.2016.03.014; Gilmour A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01349; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Gorle N, 2018, BRAIN BEHAV IMMUN, V69, P35, DOI 10.1016/j.bbi.2017.12.010; Goshi N, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01819-z; Gottipati MK, 2020, ACTA BIOMATER, V117, P273, DOI 10.1016/j.actbio.2020.09.057; Gu L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06457; Gu Q, 2018, METHODS MOL BIOL, V1758, P129, DOI 10.1007/978-1-4939-7741-3_10; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Guttenplan KA, 2019, J EXP MED, V216, P71, DOI 10.1084/jem.20180200; Haring AP, 2019, BIOFABRICATION, V11, DOI 10.1088/1758-5090/ab02c9; Haring AP, 2017, STEM CELL REV REP, V13, P381, DOI 10.1007/s12015-017-9738-0; Harris AR, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4619-8; Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008; Holloway PM, 2016, STROKE, V47, P561, DOI 10.1161/STROKEAHA.115.011932; Holt Leanne M, 2019, Curr Protoc Neurosci, V88, pe71, DOI 10.1002/cpns.71; Homan KA, 2019, NAT METHODS, V16, P255, DOI 10.1038/s41592-019-0325-y; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Hor JH, 2020, METHOD CELL BIOL, V159, P257, DOI 10.1016/bs.mcb.2020.03.010; Hrishi AP, 2019, INDIAN J CRIT CARE M, V23, pS115, DOI 10.5005/jp-journals-10071-23187; Iliff J, 2019, J PHYSIOL-LONDON, V597, P4417, DOI 10.1113/JP277635; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ishizuka Y, 2020, J NEUROSCI METH, V333, DOI 10.1016/j.jneumeth.2019.108578; Iyer NR, 2016, EXP NEUROL, V277, P305, DOI 10.1016/j.expneurol.2016.01.011; Jacob F, 2020, CELL STEM CELL, V27, P937, DOI 10.1016/j.stem.2020.09.016; Jang JM, 2015, ACS APPL MATER INTER, V7, P2183, DOI 10.1021/am508292t; Joung D, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801850; Kadohama T, 2007, J CELL PHYSIOL, V212, P244, DOI 10.1002/jcp.21024; Kaneko N., 2018, CELL STEM CELL, V2, P865; Karzbrun E, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6010009; Khaing Z.Z., 2015, J MATER CHEM B, P1, DOI [10.1039/x0xx00000x, DOI 10.1039/X0XX00000X]; Khaing ZZ, 2017, J NEUROTRAUM, V34, P645, DOI 10.1089/neu.2016.4490; Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033; Kilic O, 2016, LAB CHIP, V16, P4152, DOI 10.1039/c6lc00946h; Kingsmore KM, 2018, APL BIOENG, V2, DOI 10.1063/1.5023503; Kingsmore KM, 2016, INTEGR BIOL-UK, V8, P1246, DOI 10.1039/c6ib00167j; Knowlton S, 2018, TRENDS NEUROSCI, V41, P31, DOI 10.1016/j.tins.2017.11.001; Krencik R, 2017, STEM CELL REP, V9, P1745, DOI 10.1016/j.stemcr.2017.10.026; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Laghmouchi A, 2020, SCAND J IMMUNOL, V92, DOI 10.1111/sji.12924; Lam D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40128-1; Li NW, 2018, INTEGR BIOL-UK, V10, DOI 10.1039/c8ib00116b; Li Q, 2016, MOL NEUROBIOL, V53, P4226, DOI 10.1007/s12035-015-9362-4; Li R, 2018, MOL BIOL CELL, V29, P1927, DOI 10.1091/mbc.E18-03-0164; Lian Hong, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1989; Liaudanskaya V, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.202000122; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin CH, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01771-y; Lin HS, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa663b; Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022; Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4; Madl CM, 2017, NAT MATER, V16, P1233, DOI [10.1038/NMAT5020, 10.1038/nmat5020]; Marchi N, 2016, J NEUROSCI METH, V260, P118, DOI 10.1016/j.jneumeth.2015.06.011; Martinez-Cerdeno V, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00104; Matias D, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00235; Matsuda T, 2019, NEURON, V101, P472, DOI 10.1016/j.neuron.2018.12.010; Mazrouei R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71452-6; Mazzone GL, 2014, J NEUROCHEM, V130, P598, DOI 10.1111/jnc.12748; McCrary MW, 2020, ACTA BIOMATER, V111, P1, DOI 10.1016/j.actbio.2020.05.031; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Meng FW, 2015, BIOMATERIALS, V46, P131, DOI 10.1016/j.biomaterials.2014.12.044; Merrill JE, 2009, NEUROPSYCHOPHARMACOL, V34, P55, DOI 10.1038/npp.2008.145; Mestre H, 2020, SCIENCE, V367, P1211, DOI 10.1126/science.aax7171; Mestre H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07318-3; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Mitchell MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00044; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Morin-Brureau M, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-11; Morrison HW, 2016, NEUROSCIENCE, V339, P85, DOI 10.1016/j.neuroscience.2016.09.047; Muir VG, 2021, CHEM REV, V121, P10908, DOI 10.1021/acs.chemrev.0c00923; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Murphy MC, 2016, NEUROIMAGE-CLIN, V10, P283, DOI 10.1016/j.nicl.2015.12.007; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Nakada T, 2019, NEUROSCIENTIST, V25, P155, DOI 10.1177/1073858418775027; Ngo TB, 2020, ACS BIOMATER SCI ENG, V6, P6819, DOI 10.1021/acsbiomaterials.0c00940; Olstad EW, 2019, CURR BIOL, V29, P229, DOI 10.1016/j.cub.2018.11.059; Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2; Osaki T, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700489; Pagan-Diaz GJ, 2019, P NATL ACAD SCI USA, V116, P25932, DOI 10.1073/pnas.1916138116; Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P362, DOI 10.14573/altex.1609122; Park J, 2015, LAB CHIP, V15, P141, DOI 10.1039/c4lc00962b; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Park MG, 2017, EXP NEUROBIOL, V26, P71, DOI 10.5607/en.2017.26.2.71; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Patani R, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1036974; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Penney J, 2020, MOL PSYCHIATR, V25, P148, DOI 10.1038/s41380-019-0468-3; Phan DTT, 2017, EXP BIOL MED, V242, P1669, DOI 10.1177/1535370217694100; Pollen AA, 2019, CELL, V176, P743, DOI 10.1016/j.cell.2019.01.017; Pomeshchik Y, 2020, STEM CELL REP, V15, P256, DOI 10.1016/j.stemcr.2020.06.001; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; Qian XY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166074; Qiu BN, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201910250; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Rauti R, 2020, ISR J CHEM, V60, P1141, DOI 10.1002/ijch.201900052; Ravi VM, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900305; Ray LA, 2019, FLUIDS, V4, DOI 10.3390/fluids4040196; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Romero-Leguizamon CR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37606-3; Russell LN, 2017, ACS BIOMATER SCI ENG, V3, P3459, DOI 10.1021/acsbiomaterials.7b00374; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Schroten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039835; Schwarz N, 2019, ELIFE, V8, DOI 10.7554/eLife.48417; Serrano JC, 2021, ANNU REV FLUID MECH, V53, P411, DOI 10.1146/annurev-fluid-072220-013845; Shetty AK, 2020, AGING DIS, V11, P200, DOI 10.14336/AD.2020.0103; Shim S, 2019, LAB CHIP, V19, P1013, DOI 10.1039/c8lc00957k; Sidar B, 2019, LAB CHIP, V19, P3552, DOI 10.1039/c9lc00653b; Simmnacher K, 2020, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00571; Skylar-Scott MA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2459; Smits LM, 2019, NPJ PARKINSON DIS, V5, DOI 10.1038/s41531-019-0078-4; Sniadecki NJ, 2010, ENDOCRINOLOGY, V151, P451, DOI 10.1210/en.2009-0932; Sofroniew MV, 2020, TRENDS IMMUNOL, V41, P758, DOI 10.1016/j.it.2020.07.004; Song L., SCI REP-UK, V9, P1; Song LQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42439-9; Sood D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54248-1; Spencer KC, 2017, LAB CHIP, V17, P795, DOI 10.1039/c6lc01411a; Spitzer SO, 2019, NEURON, V101, P459, DOI 10.1016/j.neuron.2018.12.020; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Takamura T, 2020, J MAGN RESON IMAGING, V51, P727, DOI 10.1002/jmri.26881; Tarbell JM, 2013, BIOMECH MODEL MECHAN, V12, P111, DOI 10.1007/s10237-012-0385-8; Tate KM, 2019, BRAIN RES BULL, V150, P21, DOI 10.1016/j.brainresbull.2019.04.027; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thomas M, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00069; Tian A, 2020, J NEUROSCI, V40, P1186, DOI 10.1523/JNEUROSCI.0519-19.2019; Trujillo CA, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202012523; Tyzack GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01283-z; Uzarski JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057004; Vainchtein ID, 2020, TRENDS NEUROSCI, V43, P144, DOI 10.1016/j.tins.2020.01.003; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Venkatesh HS, 2019, NATURE, V573, P539, DOI 10.1038/s41586-019-1563-y; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Volpato V, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.042317; Wakida NM, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.596577; Wang YQ, 2018, LAB CHIP, V18, P851, DOI 10.1039/c7lc01084b; Watson PMD, 2017, SLAS DISCOV, V22, P583, DOI 10.1177/2472555217691450; Wevers NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep38856; Wickham J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00283; Xiao WK, 2020, MATRIX BIOL, V85-86, P128, DOI 10.1016/j.matbio.2019.04.003; Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048; Yamashita T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47482-0; Yang LT, 2020, ADV MATER, V32, DOI 10.1002/adma.202002578; Yi HG, 2019, NAT BIOMED ENG, V3, P509, DOI 10.1038/s41551-019-0363-x; Zhou X, 2018, ACS APPL MATER INTER, V10, P8993, DOI 10.1021/acsami.7b18197	210	0	0	11	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2021	174						72	83		10.1016/j.brainresbull.2021.05.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TQ2DG	WOS:000678095500003	34029679				2022-02-06	
J	Badner, A; Reinhardt, EK; Nguyen, TV; Midani, N; Marshall, AT; Lepe, CA; Echeverria, K; Lepe, JJ; Torrecampo, V; Bertan, SH; Tran, SH; Anderson, AJ; Cummings, BJ				Badner, Anna; Reinhardt, Emily K.; Nguyen, Theodore V.; Midani, Nicole; Marshall, Andrew T.; Lepe, Cherie A.; Echeverria, Karla; Lepe, Javier J.; Torrecampo, Vincent; Bertan, Sara H.; Tran, Serinee H.; Anderson, Aileen J.; Cummings, Brian J.			Freshly Thawed Cryobanked Human Neural Stem Cells Engraft within Endogenous Neurogenic Niches and Restore Cognitive Function after Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						chronic traumatic brain injury; human neural stem cells; immunomodulation; hippocampal neurogenesis	RAT MODEL; TRANSPLANTATION; DIFFERENTIATION; CONSOLIDATION; PREVENTION; MENINGES; NEURONS; MAZE; FORM	Human neural stem cells (hNSCs) have potential as a cell therapy after traumatic brain injury (TBI). While various studies have demonstrated the efficacy of NSCs from ongoing culture, there is a significant gap in our understanding of freshly thawed cells from cryobanked stocks-a more clinically relevant source. To address these shortfalls, the therapeutic potential of our previously validated Shef-6.0 human embryonic stem cell (hESC)-derived hNSC line was tested after long-term cryostorage and thawing before transplant. Immunodeficient athymic nude rats received a moderate unilateral controlled cortical impact (CCI) injury. At four weeks post-injury, 6 x 10(5) freshly thawed hNSCs were transplanted into six injection sites (two ipsi- and four contra-lateral) with 53.4% of cells surviving three months post-transplant. Interestingly, most hNSCs were engrafted in the meninges and the lining of lateral ventricles, associated with high CXCR4 expression and a chemotactic response to SDF1alpha (CXCL12). While some expressed markers of neuron, astrocyte, and oligodendrocyte lineages, the majority remained progenitors, identified through doublecortin expression (78.1%). Importantly, transplantation resulted in improved spatial learning and memory in Morris water maze navigation and reduced risk taking in an elevated plus maze. Investigating potential mechanisms of action, we identified an increase in ipsilateral host hippocampus cornu ammonis (CA) neuron survival, contralateral dentate gyrus (DG) volume, and DG neural progenitor morphology as well as a reduction in neuroinflammation. Together, these findings validate the potential of hNSCs to improve function after TBI and demonstrate that long-term biobanking of cells and thawing aliquots before use may be suitable for clinical deployment.	[Badner, Anna; Reinhardt, Emily K.; Nguyen, Theodore V.; Midani, Nicole; Lepe, Cherie A.; Echeverria, Karla; Lepe, Javier J.; Torrecampo, Vincent; Bertan, Sara H.; Tran, Serinee H.; Anderson, Aileen J.; Cummings, Brian J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA USA; [Reinhardt, Emily K.; Bertan, Sara H.; Tran, Serinee H.; Anderson, Aileen J.; Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Anderson, Aileen J.; Cummings, Brian J.] Univ Calif Irvine, Phys Med & Rehabil, Irvine, CA USA; [Anderson, Aileen J.; Cummings, Brian J.] Univ Calif Irvine, Anat & Neurobiol, Irvine, CA USA; [Marshall, Andrew T.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA		Cummings, BJ (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Inst Memory Impairments & Neurol Disorders, 845 Hlth Sci Rd, Irvine, CA 92697 USA.	cummings@uci.edu	Badner, Anna/N-8035-2019	Badner, Anna/0000-0002-5244-6165; Tran, Serinee/0000-0002-0582-8603	CIRMCalifornia Institute for Regenerative Medicine [DISC2-10195, TRAN1-11548, EDUC2-08383]	This study was supported by CIRM DISC2-10195 and CIRM TRAN1-11548. Javier Lepe was a CIRM intern funded through the CIRM Grant EDUC2-08383.	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Badner A, 2017, EXPERT OPIN BIOL TH, V17, P529, DOI 10.1080/14712598.2017.1308481; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Bifari F, 2017, CELL STEM CELL, V20, P360, DOI 10.1016/j.stem.2016.10.020; Chinnadurai R, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.003; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Furmanski O, 2019, JOVE-J VIS EXP, DOI 10.3791/59561; Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Hannocks MJ, 2019, MATRIX BIOL, V75-76, P102, DOI 10.1016/j.matbio.2017.11.007; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Haus DL, 2014, STEM CELL RES, V13, P214, DOI 10.1016/j.scr.2014.06.008; Hooshmand MJ, 2017, J IMMUNOL, V199, P1069, DOI 10.4049/jimmunol.1600064; Huang J, 2020, P NATL ACAD SCI USA, V117, P12952, DOI 10.1073/pnas.1912839117; Jansen EM, 1996, BRAIN RES, V708, P93, DOI 10.1016/0006-8993(95)01288-5; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; KASAI M, 1981, NATURE, V291, P334, DOI 10.1038/291334a0; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Leo P, 2016, TRANSLATIONAL RES TR; Lipsitz YY, 2016, NAT BIOTECHNOL, V34, P393, DOI 10.1038/nbt.3525; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Moll G, 2014, STEM CELLS, V32, P2430, DOI 10.1002/stem.1729; Nakagomi Takayuki, 2017, Stem Cell Investig, V4, P22, DOI 10.21037/sci.2017.03.09; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Shetty AK, 2016, STEM CELL TRANSL MED, V5, P1204, DOI 10.5966/sctm.2015-0270; Sun MK, 2020, J NEUROTRAUM, V37, P1358, DOI 10.1089/neu.2019.6443; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XL, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00353; Wei ZZ, 2016, CELL TRANSPLANT, V25, P797, DOI 10.3727/096368916X690403; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Willis CM, 2020, BRAIN RES, V1729, DOI 10.1016/j.brainres.2019.146615; Woitke F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183463; Woods EJ, 2016, CYTOTHERAPY, V18, P697, DOI 10.1016/j.jcyt.2016.03.295; Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068; Young ME, 2021, LEARN BEHAV, V49, P307, DOI 10.3758/s13420-020-00457-y	48	0	0	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0045		AUG 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1LA	WOS:000691734700001	34130484				2022-02-06	
J	Fauzi, SA; Sharina, YN; Ibrahim, M				Fauzi, Shazana Ahmad; Sharina, Yusof Nor; Ibrahim, Mohtar			Isolated Traumatic Bitemporal Hemianopia	CUREUS			English	Article						bitemporal hemianopia; optic chiasm; severe head injury; traumatic chiasmal injury; traumatic chiasmal syndrome	CHIASMAL SYNDROME	Bitemporal hemianopia is a rare presentation following severe head injury, which causes a delay in detection of the visual symptoms. This is a case of traumatic bitemporal hemianopia in a 20-year-old gentleman after an alleged motorbike accident. He was intubated following a severe head injury. The ophthalmologic assessment was performed after he regained consciousness and complained of acute blurring of vision in bilateral eyes. The visual acuity was 2/60 on the right eye and 4/60 on the left eye. Bilateral eyes anterior and posterior segments examination were unremarkable. Confrontation visual field testing discovered bitemporal hemianopia. Plain computed tomography (CT) scan of the brain showed right frontal bone fracture extending to the right orbital roof, superomedial wall of the right orbit, bilateral lamina papyracea, ethmoidal air cells, roof and bilateral walls of sphenoid sinus. He was treated conservatively by the ophthalmology team. Subsequent follow-ups showed improvement of visual acuity which were 6/6 on the right eye and 6/6 on the left eye. Humphrey visual field test confirmed the persistence of bitemporal hemianopia. His good visual acuity does not correlate with the severity of the field defect. Therefore, surveillance for bitemporal scotoma is necessary for all head injuries with severe midline facial bone fractures.	[Fauzi, Shazana Ahmad; Ibrahim, Mohtar] Univ Sains Malaysia, Dept Ophthalmol & Visual Sci, Sch Med Sci, Kubang Kerian, Malaysia; [Fauzi, Shazana Ahmad; Sharina, Yusof Nor] Hosp Raja Perempuan Zainab II, Dept Ophthalmol, Kota Baharu, Kelantan, Malaysia		Fauzi, SA (corresponding author), Univ Sains Malaysia, Dept Ophthalmol & Visual Sci, Sch Med Sci, Kubang Kerian, Malaysia.; Fauzi, SA (corresponding author), Hosp Raja Perempuan Zainab II, Dept Ophthalmol, Kota Baharu, Kelantan, Malaysia.	drshazana17@gmail.com					Elnahry AG, 2019, NEURO-OPHTHALMOLOGY, V43, P205, DOI 10.1080/01658107.2018.1521842; Gurses B, 2006, EUR J RADIOL EXTRA, V57, P1, DOI [10.1016/j.ejrex.2005.11.004, DOI 10.1016/J.EJREX.2005.11.004]; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; HEINZ GW, 1994, AM J OPHTHALMOL, V117, P90, DOI 10.1016/S0002-9394(14)73020-X; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Vellayan Mookan Loganathan, 2018, Am J Ophthalmol Case Rep, V9, P119, DOI 10.1016/j.ajoc.2018.01.029; Vora TK, 2015, NEURO-OPHTHALMOLOGY, V39, P253, DOI 10.3109/01658107.2015.1071412; Yazici B, 2016, ULUS TRAVMA ACIL CER, V22, P97, DOI 10.5505/tjtes.2015.90540	9	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	AUG 31	2021	13	8							e17593	10.7759/cureus.17593			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UK2GE	WOS:000691792500009	34646645	gold, Green Published			2022-02-06	
J	Gagnon-Roy, M; Bier, N; Boule-Riley, S; Keurentjes, H; Shun, PLW; Le Dorze, G; Bottari, C				Gagnon-Roy, Mireille; Bier, Nathalie; Boule-Riley, Stephanie; Keurentjes, Heidi; Shun, Priscilla Lam Wai; Le Dorze, Guylaine; Bottari, Carolina			Providing Verbal Assistance When Assessing Individuals Living with a Traumatic Brain Injury Fournir une assistance verbale lors de l'evaluation des personnes vivant avec une lesion cerebrale traumatique	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Clinical reasoning; Cognition disorders; Activities of daily living; Case studies	PERFORMING ACTIVITIES; COGNITIVE STRUCTURE; EXECUTIVE DEFICITS; IADL PROFILE; VALIDITY; PEOPLE	Background. Occupational therapists play a major role in identifying the assistance needs of individuals living with a traumatic brain injury. However, to obtain an accurate assessment, verbal assistance should be provided only when necessary, according to the person's needs. Purpose. This study aimed to understand (1) how verbal assistance is provided during an evaluation of Instrumental Activities of Daily Living and (2) why it is provided in this manner. Method. Interviews were conducted with three expert occupational therapists using their own videotaped evaluation and a "think-aloud" method to explore their clinical reasoning when providing verbal assistance. Data were analyzed using thematic analysis. Findings. The process of providing verbal assistance was recognized as flexible and nonlinear, and influenced by various factors including the participants' level of understanding of the client's abilities. Implications. This information will help therapists better understand how and when to provide verbal assistance when assessing their clients.	[Gagnon-Roy, Mireille] Univ Montreal, Rehabil Sci, Montreal, PQ, Canada; [Bier, Nathalie] Univ Montreal, Occupat Therapy, Montreal, PQ, Canada; [Bier, Nathalie] Res Ctr Inst Univ Geriatrie, Montreal, PQ, Canada; [Boule-Riley, Stephanie] Ctr Integre Sante & Serv Sociaux Laurentides, Home Care Support Serv, St Jerome, PQ, Canada; [Keurentjes, Heidi] Ctr Monteregien Readapt, Inpatient Rehabil Unit, Longueuil, PQ, Canada; [Shun, Priscilla Lam Wai] Univ Montreal, Sch Rehabil, Rehabil Sci, Montreal, PQ, Canada; [Le Dorze, Guylaine] Univ Montreal, Fac Med, Sch Speech Language Pathol & Audiol, Montreal, PQ, Canada; [Le Dorze, Guylaine; Bottari, Carolina] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ, Canada		Gagnon-Roy, M (corresponding author), Univ Montreal UdeM, Rehabil Sci Program, 7077 Av Du Parc, Montreal, PQ H3N 1X7, Canada.; Gagnon-Roy, M (corresponding author), CIUSSS Ctr Sud de Ile de Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, Inst Univ Readaptat Deficience Phys Montreal, 6363 Ch Hudson, Montreal, PQ H3S 1M9, Canada.	mireille.gagnon-roy@umontreal.ca		Gagnon-Roy, Mireille/0000-0001-9668-7289	Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec [252232, 33403]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Fonds de Recherche du Quebec-Sante (grant numbers 252232 and 33403).	Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; DRAPEAU M, 2004, PRAT PSYCHOL, V0010, P00079, DOI DOI 10.1016/J.PRPS.2004.01.004; Durning SJ, 2013, MED TEACH, V35, P720, DOI 10.3109/0142159X.2013.801938; Edward D., 2011, FDN PRACTICE OCCUPAT, P209; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P223; FLEMING MH, 1991, AM J OCCUP THER, V45, P988, DOI 10.5014/ajot.45.11.988; Fonteyn M.E., 1993, QUAL HEALTH RES, V3, DOI [DOI 10.1177/104973239300300403, https://doi.org/10.1177/104973239300300403]; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Haskins E.C., 2012, COGNITIVE REHABILITA; Haywood HC, 2007, DYNAMIC ASSESSMENT IN PRACTICE: CLINICAL AND EDUCATIONAL APPLICATIONS, P1; Haywood HC, 2002, PEABY J EDUC, V77, P40, DOI 10.1207/S15327930PJE7702_5; INESSS-ONF, 2016, CLIN PRACTICE GUIDEL; Katz N, 2012, AM J OCCUP THER, V66, P207, DOI 10.5014/ajot.2012.002469; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Le Dorze G, 2014, OPEN J THER REHABIL, V2, P182, DOI DOI 10.4236/OJTR.2014.24024; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lidz, 1992, LEARN INDIVID DIFFER, V4, P125, DOI 10.1016/1041-6080(92)90009-4; Miller, 2003, J COGNITIVE ED PSYCH, V3, P137, DOI 10.1891/194589503787383046; Missiuna C, 1987, CANADIAN J OCCUPATIO, V54, P17, DOI 10.1177/000841748705400105; O'Neill B, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000358; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Ranka, 1996, PRPP RES TRAINING MA, P1; Thomas KR, 2014, NEUROPSYCHOLOGY, V28, P123, DOI 10.1037/neu0000039; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Toglia J, 2009, AM J OCCUP THER, V63, P569, DOI 10.5014/ajot.63.5.569; Unsworth C.A., 2004, BRIT J OCCUPATIONAL, V67, P10, DOI 10.1177/030802260406700103; Wang J, 2019, DISABIL REHABIL-ASSI, V14, P817, DOI 10.1080/17483107.2018.1499144; Yin R. K, 1984, CASE STUDY RES DESIG, DOI DOI 10.1097/FCH.0B013E31822DDA9E; Yin R. K., 1994, CASE STUDY RES DESIG, V2nd; Yin RK., 2014, CASE STUDY RES DESIG, V5	38	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	DEC	2021	88	4					306	318	00084174211034263	10.1177/00084174211034263		AUG 2021	13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	XG8KX	WOS:000692216900001	34463153	hybrid, Green Published			2022-02-06	
J	Snegireva, N; Derman, W; Patricios, J; Welman, K				Snegireva, Nadja; Derman, Wayne; Patricios, Jon; Welman, Karen			Eye tracking to assess concussions: an intra-rater reliability study with healthy youth and adult athletes of selected contact and collision team sports	EXPERIMENTAL BRAIN RESEARCH			English	Article						Eye movement measurements; Return to sport; Football (soccer); Rugby Union; Reproducibility of results	SMALLEST REAL DIFFERENCE; TEST-RETEST RELIABILITY; BLINK RATE; SMOOTH-PURSUIT; CORRELATION-COEFFICIENTS; GAZE STABILITY; BRAIN-INJURY; MOVEMENT; HEAD; REPRODUCIBILITY	Eye movements that are dependent on cognition hold promise in assessing sports-related concussions but research on reliability of eye tracking measurements in athletic cohorts is very limited. This observational test-retest study aimed to establish whether eye tracking technology is a reliable tool for assessing sports-related concussions in youth and adult athletes partaking in contact and collision team sports. Forty-three youth (15.4 +/- 2.2 years) and 27 adult (22.2 +/- 2.9 years) Rugby Union and soccer players completed the study. Eye movements were recorded using SMIRED250mobile while participants completed a test battery twice, with a 1-week interval that included self-paced saccade (SPS), fixation stability, memory-guided sequence (MGS), smooth pursuit (SP), and antisaccades (AS) tasks. Intra-class correlation coefficient (ICC), measurement error (SEM) and smallest real difference (SRD) were calculated for 47 variables. Seventeen variables achieved an ICC > 0.50. In the adults, saccade count in SPS had good reliability (ICC = 0.86, SRD = 146.6 saccades). In the youth, the average blink duration in MGS had excellent reliability (ICC = 0.99, SRD = 59.4 ms); directional errors in AS tasks and gain of diagonal SP had good reliability (ICC = 0.78 and 0.77, SRD = 25.3 and 395.1%, respectively). Four metrics were found in this study to be reliable candidates for further biomarker validity research in contact and collision sport cohorts. Many variables failed to present a sufficient level of robustness for a practical diagnostic tool; possibly, because athletic cohorts have higher homogeneity, along with latent adverse effects of undetected concussions and repetitive head impacts. Since reliability of a measure can influence type II error, effect sizes, and confidence intervals, it is strongly advocated to conduct dedicated reliability evaluations prior to any validity studies.	[Snegireva, Nadja; Welman, Karen] Stellenbosch Univ, Dept Sport Sci, Movement Lab, Stellenbosch, South Africa; [Derman, Wayne] Stellenbosch Univ, Fac Med & Hlth Sci, Inst Sport & Exercise Med, Cape Town, South Africa; [Derman, Wayne] Int Olymp Comm IOC Res Ctr, Cape Town, South Africa; [Patricios, Jon] Univ Witwatersrand, Fac Hlth Sci, Wits Inst Sport & Hlth, Johannesburg, South Africa		Snegireva, N (corresponding author), Stellenbosch Univ, Dept Sport Sci, Movement Lab, Stellenbosch, South Africa.	nadja.snegireva@gmail.com			FIFA Research Scholarship	This work was supported by a FIFA Research Scholarship.	Abusharha AA, 2017, CLIN OPTOM, V9, P133, DOI 10.2147/OPTO.S142718; [Anonymous], 2005, Paediatr Child Health, V10, P343; Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Arifin WN., 2018, ED MED J, V10, P67, DOI [DOI 10.21315/EIMJ2018.10.3.8, 10.21315/eimj2018.10.3.8]; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Bargary G, 2017, VISION RES, V141, P157, DOI 10.1016/j.visres.2017.03.001; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Berchicci M, 2012, BIOL PSYCHOL, V90, P10, DOI 10.1016/j.biopsycho.2012.02.014; Bijvank JAN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200695; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Bolte, 2018, OPTOM VIS PERFORM, V6, P119; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Carson N, 2018, INT J GERIATR PSYCH, V33, P379, DOI 10.1002/gps.4756; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cochrane GD, 2019, OPTOMETRY VISION SCI, V96, P256, DOI 10.1097/OPX.0000000000001364; Colzato LS, 2009, EXP BRAIN RES, V196, P467, DOI 10.1007/s00221-009-1862-x; Conklin K., 2018, EYE TRACKING GUIDE A, DOI [10.1017/9781108233279, DOI 10.1017/9781108233279]; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; Di Stasi LL, 2012, TRANSPORT RES C-EMER, V21, P122, DOI 10.1016/j.trc.2011.07.002; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Farris-Trimble A, 2013, J SPEECH LANG HEAR R, V56, P1328, DOI 10.1044/1092-4388(2012/12-0145); Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Giraudeau B, 2001, STAT MED, V20, P3205, DOI 10.1002/sim.935; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Green SS., 2015, CURR RES CONCUSSION, V2, P61; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holmqvist K., 2011, EYE TRACKING COMPREH; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Hvelplund KT, 2014, MONTI, P201, DOI 10.6035/MonTI.2014.ne1.6; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Jongkees BJ, 2016, NEUROSCI BIOBEHAV R, V71, P58, DOI 10.1016/j.neubiorev.2016.08.020; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; KARSON CN, 1984, NEUROLOGY, V34, P677, DOI 10.1212/WNL.34.5.677; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; KITAGAWA M, 1994, NEUROLOGY, V44, P2285, DOI 10.1212/WNL.44.12.2285; Kleineidam L, 2019, EUR ARCH PSY CLIN N, V269, P921, DOI 10.1007/s00406-018-0973-4; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Leigh RJ, 2015, NEUROLOGY EYE MOVEME, DOI [10.1093/med/9780199969289.001.0001, DOI 10.1093/MED/9780199969289.001.0001]; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marandi RZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31577-1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Murray NG, 2017, CLIN BIOMECH, V44, P21, DOI 10.1016/j.clinbiomech.2017.03.002; Murray NP, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.2; Niehorster DC, 2018, BEHAV RES METHODS, V50, P213, DOI 10.3758/s13428-017-0863-0; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; Ousler GW, 2014, CLIN OPHTHALMOL, V8, P869, DOI 10.2147/OPTH.S56783; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; Post MW, 2016, ARCH PHYS MED REHAB, V97, P1051, DOI 10.1016/j.apmr.2016.04.001; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; RAO CR, 1971, J MULTIVAR ANAL, V1, P445, DOI DOI 10.1016/0047-259X(71)90019-4; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; ROYBYRNE P, 1995, BIOL PSYCHIAT, V38, P92, DOI 10.1016/0006-3223(94)00225-R; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Schuck P, 2003, INT J REHABIL RES, V26, P85, DOI 10.1097/00004356-200306000-00002; SensoMotoric Instruments, 2015, SMI RED250MOBILE SPE; Shaikh AG, 2018, CEREBELLUM, V17, P252, DOI 10.1007/s12311-017-0910-5; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Skinner IW, 2018, BEHAV RES METHODS, V50, P1778, DOI 10.3758/s13428-017-0946-y; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; Stuart S, 2016, MED ENG PHYS, V38, P308, DOI 10.1016/j.medengphy.2015.12.001; Subramaniam A, 2018, PSYCHIAT RES, V259, P154, DOI 10.1016/j.psychres.2017.10.011; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Sundaram V, 2019, J SCI MED SPORT, V22, P1287, DOI 10.1016/j.jsams.2019.07.015; Suzuki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119147; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Tyagi A, 2019, IEEE J TRANSL ENG HE, V5, P1; Unsworth N, 2019, COGN AFFECT BEHAV NE, V19, P1074, DOI 10.3758/s13415-019-00709-z; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	94	0	0	4	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	NOV	2021	239	11					3289	3302		10.1007/s00221-021-06205-6		AUG 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WL2BU	WOS:000691659600002	34467416				2022-02-06	
J	Estrada-Rojo, F; Carmona-Aparicio, L; Arriaga-Avila, V; Coballase-Urrutia, E; Perez-Arredondo, A; Guevara-Guzman, R; Cardenas-Rodriguez, N; Navarro, L				Estrada-Rojo, Francisco; Carmona-Aparicio, Liliana; Arriaga-Avila, Virginia; Coballase-Urrutia, Elvia; Perez-Arredondo, Adan; Guevara-Guzman, Rosalinda; Cardenas-Rodriguez, Noemi; Navarro, Luz			Effects of time-of-day on the concentration of defined excitatory and inhibitory amino acids in the cerebrospinal fluid of rats: a microdialysis study	AMINO ACIDS			English	Article						Amino acid neurotransmitters; Microdialysis; Diurnal variation; E; I index; GLX index; Glutamatergic processing index	TRAUMATIC BRAIN-INJURY; CIRCADIAN-RHYTHMS; GLUTAMINE-SYNTHETASE; AWAKE RAT; GABA; GLYCINE; NEUROTRANSMITTERS; RECEPTORS; MELATONIN; STRIATUM	Amino acid neurotransmitters are responsible for many physiological and pathological processes, and their cerebral concentrations respond to external influences such as the light-dark cycle and to the synthesis, release, and recapture rhythms and form part of the biochemical relationships derived from excitatory-inhibitory (E/I), glutamine-glutamate sum (GLX), glutamatergic processing (glutamine-glutamate ratio) and excitotoxic indexes. The changes in these variables during a 24-h period (1 day) are important because they allow organisms to adapt to external stimuli and form part of physiological processes. Under pathological conditions, the damage produced by acute events may depend on diurnal variations. Therefore, it is important to analyze the extracellular levels of amino acids as well as the above-mentioned indexes over a 24-h period. We focused on determining the cerebrospinal fluid levels of different amino acid neurotransmitters, and the E/I, GLX, glutamatergic processing and excitotoxic indexes, determined by microdialysis over a 24-h cycle. Our results showed significant changes during the 24-h light/dark cycle. Specifically, we found increments in the levels of glutamate (325%), GABA (550%), glutamine (300%), glycine (194%), alanine (304%) and the GLX index (263%) throughout the day, and the maximum levels of glutamate, glutamine, glycine, and alanine were obtained during the last period of the light period. In conclusion, the concentration of some amino acid neurotransmitters and the GLX index show variations depending on the light-dark cycle.	[Estrada-Rojo, Francisco; Arriaga-Avila, Virginia; Perez-Arredondo, Adan; Guevara-Guzman, Rosalinda; Navarro, Luz] Univ Nacl Autonoma Mexico, UNAM, Univ Nacl Autonoma Mexico, Fac Med,Physiol Dept, Mexico City 04510, DF, Mexico; [Estrada-Rojo, Francisco] Univ Nacl Autonoma Mexico, Grad Program Biol Sci, Mexico City 04510, DF, Mexico; [Carmona-Aparicio, Liliana; Coballase-Urrutia, Elvia; Cardenas-Rodriguez, Noemi] Natl Inst Pediat, Lab Neurosci, Mexico City 04530, DF, Mexico; [Perez-Arredondo, Adan] Univ Nacl Autonoma Mexico, Grad Program Med Sci, Mexico City 04510, DF, Mexico		Navarro, L (corresponding author), Univ Nacl Autonoma Mexico, UNAM, Univ Nacl Autonoma Mexico, Fac Med,Physiol Dept, Mexico City 04510, DF, Mexico.; Carmona-Aparicio, L (corresponding author), Natl Inst Pediat, Lab Neurosci, Mexico City 04530, DF, Mexico.	fesro@hotmail.com; c_apariccio@yahoo.com.mx; vikarriaga@hotmail.com; elcoballase@yahoo.com.mx; aparredondo23@yahoo.com.mx; rguevara@unam.mx; noemicr2001@yahoo.com.mx; lnavarro@unam.mx		COBALLASE-URRUTIA, ELVIA/0000-0002-1309-0784; Navarro, Luz/0000-0002-5519-0871; Guevara-Guzman, Rosalinda/0000-0002-4833-3862; Carmona-Aparicio, Liliana/0000-0001-8721-9387	Programa de Posgrado de Ciencias Biologicas y Programa de Posgrado Ciencias Medicas, Odontologicas y de la Salud, UNAM; CONACyT, MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [547418]	We thank Sergio Humberto Larios-Godinez and Biol. Ricardo Trejo-Chavez for the technical assistance provided. We thank the "Programa de Posgrado de Ciencias Biologicas y Programa de Posgrado Ciencias Medicas, Odontologicas y de la Salud, UNAM" and Scholarship No. 547418 (CONACyT, Mexico) for supporting Adan Perez-Arredondo during his studies at the Doctoral Program of the Medical, Dental and Health Sciences, Clinical Experimental Health Research, Clinical Pharmacology, UNAM, Mexico.	BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Baker S, 2020, PHYSL CERBRAL SPINAL; Batllori M, 2016, SEMIN PEDIATR NEUROL, V23, P273, DOI 10.1016/j.spen.2016.11.002; BONDOLI A, 1981, RESUSCITATION, V9, P119, DOI 10.1016/0300-9572(81)90021-6; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; CHOMA PP, 1979, PHARMACOLOGY, V19, P307, DOI 10.1159/000137330; CURTIS DR, 1960, J NEUROCHEM, V6, P117, DOI 10.1111/j.1471-4159.1960.tb13458.x; Dal-Cim T, 2016, NEUROTOX RES, V29, P460, DOI 10.1007/s12640-015-9595-z; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Dehghani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23176; Dietrich WD, 1996, ADV NEUROL, V71, P177; Duvilanski BH, 2003, CHRONOBIOL INT, V20, P271, DOI 10.1081/CBI-120018577; Estrada-Rojo F, 2020, REV MEX NEUROCIENC, V21, P31, DOI 10.24875/RMN.19000069; Estrada-Rojo Francisco, 2018, BMC Res Notes, V11, P150, DOI 10.1186/s13104-018-3258-0; Franco-Perez J, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01716-y; GARFINKEL A, 1983, AM J PHYSIOL, V245, pR455, DOI 10.1152/ajpregu.1983.245.4.R455; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P39, DOI 10.1016/0304-3940(91)90889-2; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Groos G.A., 1982, P96; Gu H, 2019, NEUROIMAGE, V185, P388, DOI 10.1016/j.neuroimage.2018.10.055; Hall MH, 2015, NEUROIMAGE, V111, P186, DOI 10.1016/j.neuroimage.2015.02.014; Harsing LG, 2013, BRAIN RES BULL, V93, P110, DOI 10.1016/j.brainresbull.2012.12.002; Hashimoto K, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-6; Henderson J., 2000, RAPID ACCURATE SENSI; Honma S, 1996, AM J PHYSIOL-REG I, V271, pR579, DOI 10.1152/ajpregu.1996.271.3.R579; Jagannath A, 2017, HUM MOL GENET, V26, pR128, DOI 10.1093/hmg/ddx240; Jayakumar AR, 2016, ADV NEUROBIOL, V13, P327, DOI 10.1007/978-3-319-45096-4_13; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Leenaars Cathalijn H. C., 2018, Journal of Circadian Rhythms, V16, P12, DOI 10.5334/jcr.172; Levine J, 2000, BIOL PSYCHIAT, V47, P586, DOI 10.1016/S0006-3223(99)00284-X; Marquez de Prado B., 2000, Journal of Pineal Research, V29, P209, DOI 10.1034/j.1600-0633.2002.290403.x; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; Meng T, 2015, NEUROSCIENCE, V286, P308, DOI 10.1016/j.neuroscience.2014.11.062; Moreno-Medinilla EE, 2016, REV NEUROLOGIA, V62, P502, DOI 10.33588/rn.6211.2015419; Mortazavi MM, 2014, CHILD NERV SYST, V30, P19, DOI 10.1007/s00381-013-2321-3; Naum G, 2001, NEUROSCI LETT, V310, P178, DOI 10.1016/S0304-3940(01)02129-2; Ono D, 2018, J PHYSIOL SCI, V68, P333, DOI 10.1007/s12576-018-0604-x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PERLOW MJ, 1979, J NEUROCHEM, V32, P265, DOI 10.1111/j.1471-4159.1979.tb04543.x; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rodan LH, 2015, PEDIATR NEUROL, V53, P277, DOI 10.1016/j.pediatrneurol.2015.04.016; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Suleiman GH., 2005, MEDICRIT, V2, P107, DOI 10.5413/mrmc.2005.27.48; Tapia-Osorio A, 2013, BEHAV BRAIN RES, V252, P1, DOI 10.1016/j.bbr.2013.05.028; Vinall PE, 2000, J NEUROSURG, V93, P82, DOI 10.3171/jns.2000.93.1.0082; WALLIS RA, 1994, BRAIN RES, V664, P115, DOI 10.1016/0006-8993(94)91961-5; Wardlaw SL, 2014, J CLIN ENDOCR METAB, V99, P2540, DOI 10.1210/jc.2013-4087; WIRZJUSTICE A, 1987, PROG NEUROBIOL, V29, P219, DOI 10.1016/0301-0082(87)90022-0; WOOD ER, 1993, NEUROREPORT, V4, P151, DOI 10.1097/00001756-199302000-00009; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	54	0	0	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	OCT	2021	53	10					1597	1607		10.1007/s00726-021-03070-z		AUG 2021	11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WH3VX	WOS:000691197000001	34459991				2022-02-06	
J	Fujiwara, G; Okada, Y; Sakakibara, T; Yamaki, T; Hashimoto, N				Fujiwara, Gaku; Okada, Yohei; Sakakibara, Takehiko; Yamaki, Tarumi; Hashimoto, Naoya			The Association Between D-dimer Levels and Long-Term Neurological Outcomes of Patients with Traumatic Brain Injury: An Analysis of a Nationwide Observational Neurotrauma Database in Japan	NEUROCRITICAL CARE			English	Article; Early Access						Brain; Brain injuries; Cohort studies; D-dimer; Health care	DISSEMINATED INTRAVASCULAR COAGULATION; COAGULOPATHY; CLASSIFICATION; PROGRESSION; PREDICT; TESTS	Background We evaluated the association between D-dimer (DD) levels and long-term neurological prognoses among patients with isolated traumatic brain injury. Methods Using data from multiple centers in the Japanese Neurotrauma Data Bank, we conducted an observational retrospective cohort study. Patients with isolated traumatic brain injury (head Abbreviated Injury Scale score > 2; any other Abbreviated Injury Scale score < 3) who were registered in the Japanese Neurotrauma Data Bank from 2015 to 2017 were recruited. We excluded patients younger than age 16 years and those who developed cardiac arrest at hospital admission. We also excluded patients with unknown Glasgow Outcome Scale (GOS) scores at 6 months after injury and those with unknown DD levels. The primary outcome was the association of DD levels with GOS scores at 6 months. We defined GOS scores 1 to 3 as poor and GOS scores 4 and 5 as good. The secondary outcome was the association of DD levels with mortality at 6 months after injury. We conducted multivariate logistic regression analyses to calculate the adjusted odds ratios of DD levels at hospital admission and GOS scores at 6 months as tertiles with 95% confidence intervals (CIs). A total of 293 patients were enrolled (median age 67 years; interquartile range 51-79 years). The median DD level was 27.1 mg/L (interquartile range 9.7-70.8 mg/L), and 58.0% (n = 170) had poor GOS scores at 6 months. Results The multivariable logistic regression analysis indicated that the adjusted odds ratios were 2.52 (95% CI 1.10-5.77) for middle DD levels with poor GOS scores at 6 months and 5.81 (95% CI 2.37-14.2) for high DD levels with poor GOS scores at 6 months. Conclusions We revealed an association between DD levels and poor long-term neurological outcomes among patients with isolated traumatic brain injury.	[Fujiwara, Gaku; Hashimoto, Naoya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurosurg, Kyoto, Japan; [Okada, Yohei] Kyoto Univ, Sch Publ Hlth, Dept Prevent Serv, Kyoto, Japan; [Sakakibara, Takehiko; Yamaki, Tarumi] Kyoto Kujo Hosp, Dept Neurosurg, Kyoto, Japan		Fujiwara, G (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurosurg, Kyoto, Japan.	gakufujiwara@hotmail.com	OKADA, YOHEI/ABI-3017-2020	OKADA, YOHEI/0000-0002-2266-476X; Fujiwara, Gaku/0000-0002-2799-9243			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Elbarouni B, 2010, AM HEART J, V160, P420, DOI 10.1016/j.ahj.2010.05.036; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Fukutake K, 2016, JPN J THROMBOSIS HEM, P653; Gando S, 2013, J THROMB HAEMOST, V11, P826, DOI 10.1111/jth.12190; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Hayakawa M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1811-1; Hayakawa M, 2016, SHOCK, V45, P308, DOI 10.1097/SHK.0000000000000542; Hondo K, 2013, J AM COLL SURGEONS, V217, P850, DOI 10.1016/j.jamcollsurg.2013.05.026; Ishii K, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0606-6; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; Karibe Hiroshi, 2020, No Shinkei Geka, V48, P673, DOI 10.11477/mf.1436204253; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Kushimoto S, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0196-6; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P87, DOI 10.1097/TA.0b013e3182598c70; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Lee DH, 2018, EUR J TRAUMA EMERG S, V44, P291, DOI 10.1007/s00068-017-0844-0; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Miyata K, 2016, J NEUROSURG, V124, P527, DOI 10.3171/2015.3.JNS141895; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Okada Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029706; Okino R., 2020, NEUROTRAUMATOLOGY, V43, P5; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Suehiro E., 2019, NEUROTRAUMATOLOGY, V42, P71; Suehiro E, 2017, J NEUROTRAUM, V34, P2230, DOI 10.1089/neu.2016.4948; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011774	46	0	0	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01329-7		AUG 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UJ3CV	WOS:000691168600001	34462882				2022-02-06	
J	Janas, AM; Qin, FF; Hamilton, S; Jiang, B; Baier, N; Wintermark, M; Threlkeld, Z; Lee, S				Janas, Anna M.; Qin, FeiFei; Hamilton, Scott; Jiang, Bin; Baier, Nicole; Wintermark, Max; Threlkeld, Zachary; Lee, Sarah			Diffuse Axonal Injury Grade on Early MRI is Associated with Worse Outcome in Children with Moderate-Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Pediatric neurocritical care; Magnetic resonance imaging; Neuroimaging; Diffuse axonal injury	INTENSIVE-CARE-UNIT; PROGNOSTIC VALUE; HEAD-INJURY; PREDICTION; STATES	Background: Traumatic brain injury (TBI) is the leading cause of death and disability in children, but effective tools for predicting outcome remain elusive. Although many pediatric patients receive early magnetic resonance imaging (MRI), data on its utility in prognostication are lacking. Diffuse axonal injury (DAI) is a hallmark of TBI detected on early MRI and was shown previously to improve prognostication in adult patients with TBI. In this exploratory study, we investigated whether DAI grade correlates with functional outcome and improves prognostic accuracy when combined with core clinical variables and computed tomography (CT) biomarkers in pediatric patients with moderate-severe TBI (msTBI). Methods: Pediatric patients (<= 19 years) who were admitted to two regional level one trauma centers with a diagnosis of msTBI (Glasgow Coma Scale [GCS] score < 13) between 2011 and 2019 were identified through retrospective chart review. Patients who underwent brain MRI within 30 days of injury and had documented clinical follow-up after discharge were included. Age, pupil reactivity, and initial motor GCS score were collected as part of the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) model. Imaging was reviewed to calculate the Rotterdam score (CT) and DAI grade (MRI) and to evaluate for presence of hypoxic-ischemic injury (MRI). The primary outcome measure was the Pediatric Cerebral Performance Category Scale (PCPCS) score at 6 months after TBI, with favorable outcome defined as PCPCS scores 1-3 and unfavorable outcome defined as PCPCS scores 4-6. The secondary outcome measure was discharge disposition to home versus to an inpatient rehabilitation facility. Result: Of 55 patients included in the study, 45 (82%) had severe TBI. The most common mechanism of injury was motor vehicle collision (71%). Initial head CT scans showed acute hemorrhage in 84% of patients. MRI was acquired a median of 5 days after injury, and hemorrhagic DAI lesions were detected in 87% of patients. Each 1-point increase in DAI grade increased the odds of unfavorable functional outcome by 2.4-fold. When controlling for core IMPACT clinical variables, neither the DAI grade nor the Rotterdam score was independently correlated with outcome and neither significantly improved outcome prediction over the IMPACT model alone. Conclusions: A higher DAI grade on early MRI is associated with worse 6-month functional outcome and with discharge to inpatient rehabilitation in children with acute msTBI in a univariate analysis but does not independently correlate with outcome when controlling for the GCS score. Addition of the DAI grade to the core IMPACT model does not significantly improve prediction of poor neurological outcome. Further study is needed to elucidate the utility of early MRI in children with msTBI.	[Janas, Anna M.; Hamilton, Scott; Threlkeld, Zachary; Lee, Sarah] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Qin, FeiFei] Stanford Univ, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA; [Jiang, Bin; Wintermark, Max] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Baier, Nicole] Santa Clara Valley Med Ctr, Dept Pediat, San Jose, CA 95128 USA; [Janas, Anna M.] Univ Colorado, Dept Pediat, Anschurz Med Campus, Aurora, CO 80045 USA		Janas, AM (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Janas, AM (corresponding author), Univ Colorado, Dept Pediat, Anschurz Med Campus, Aurora, CO 80045 USA.	anna.janas@childrenscolorado.org		Janas, Anna/0000-0002-7924-4424	Stanford Neurology Neuroscience Scholars Track	AMJ is grateful to Pawel Janas and Anthony Brohan for their help with statistics and graphs, as well as to Dr. Frank Longo and Dr. Paul Fisher for their support through the Stanford Neurology Neuroscience Scholars Track.	Aldossary NM, 2019, J AFFECT DISORDERS, V243, P1, DOI 10.1016/j.jad.2018.09.001; Au AK, 2018, NEUROCRIT CARE, V28, P26, DOI 10.1007/s12028-017-0414-7; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrazzano PA, 2019, J NEUROSURG-PEDIATR, V23, P471, DOI 10.3171/2018.10.PEDS18374; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; FInk EL, 2020, RESUSCITATION, V157, P185, DOI 10.1016/j.resuscitation.2020.06.033; Fink EL, 2016, RESUSCITATION, V101, P65, DOI 10.1016/j.resuscitation.2016.01.024; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENTRY LR, 1994, RADIOLOGY, V191, P1; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; HALE AT, 2018, NEUROSURG FOCUS, V45, P1; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Ho KM, 2018, WORLD NEUROSURG, V112, P277, DOI 10.1016/j.wneu.2018.01.203; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mikkonen ED, 2019, J NEUROSURG-PEDIATR, V24, P476, DOI 10.3171/2019.7.PEDS1983a; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nenadovic V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094942; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	39	0	0	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01336-8		AUG 2021	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UJ3CV	WOS:000691168600003	34462880	Bronze, Green Published			2022-02-06	
J	Bektasoglu, PK; Koyuncuoglu, T; Akbulut, S; Akakin, D; Eyuboglu, IP; Erzik, C; Yuksel, M; Kurtel, H				Kuru Bektasoglu, Pinar; Koyuncuoglu, Turkan; Akbulut, Selin; Akakin, Dilek; Eyuboglu, Irem Peker; Erzik, Can; Yuksel, Meral; Kurtel, Hizir			Neuroprotective Effect of Plasminogen Activator Inhibitor-1 Antagonist in the Rat Model of Mild Traumatic Brain Injury	INFLAMMATION			English	Article						antioxidant; anti-inflammatory; neuroprotection; Plasminogen activator inhibitor-1 antagonist; traumatic brain injury	NF-KAPPA-B; ROLES; THROMBOGENESIS; CONSEQUENCES; PROTEINASE; EXPRESSION; PROTEASE; CLEAVAGE; RELEASE; STROKE	Plasminogen activator inhibitor-1 (PAI-1) antagonists are known for their neuroprotective effects. In this study, it was aimed to investigate the possible protective effects of PAI-1 antagonists in a rat mild traumatic brain injury (TBI) model. Sprague-Dawley male rats were grouped as sham (n = 7), TBI (n = 9), and TBI + PAI-1 antagonist (5 and 10 mg/kg TM5441 and TM5484; n = 6-7). Under anesthesia, TBI was induced by dropping a metal 300-g weight from a height of 1 m on the skull. Before and 24-h after trauma neurological examination, tail suspension, Y-maze, and novel object recognition tests were performed. Twenty-four hours after TBI, the rats were decapitated and activities of myeloperoxidase, nitric oxide release, luminol-, and lucigenin-enhanced chemiluminescence were measured. Also, interleukin-1 beta, interleukin-6, tumor necrosis factor, interleukin-10, tumor growth factor-beta, caspase-3, cleaved caspase-3, and PAI levels were measured with the ELISA method in the brain tissue. Brain injury was graded histopathologically following hematoxylin-eosin staining. Western blot and immunohistochemical investigation for low-density lipoprotein receptor, matrix metalloproteinase-3, and nuclear factor-kappa B were also performed. Data were analyzed using GraphPad Prism 8.0 (GraphPad Software, San Diego, CA, USA) and expressed as means +/- SEM. Values of p < 0.05 were considered to be statistically significant. Higher levels of myeloperoxidase activity in the TBI group (p < 0.05) were found to be suppressed in 5 and 10 mg/kg TM5441 treatment groups (p < 0.05-p < 0.01). The tail suspension test score was increased in the TBI group (p < 0.001) and decreased in all treatment groups (p < 0.05-0.001). The histologic damage score was increased statistically significantly in the cortex, dentate gyrus, and CA3 regions in the TBI group (p < 0.01-0.001), decreased in the treatment groups in the cortex and dentate gyrus (p < 0.05-0.001). PAI antagonists, especially TM5441, have antioxidant and anti-inflammatory properties against mild TBI in the acute period. Behavioral test results were also improved after PAI antagonist treatment after mild TBI.	[Kuru Bektasoglu, Pinar; Kurtel, Hizir] Marmara Univ, Dept Physiol, Inst Hlth Sci, Istanbul, Turkey; [Kuru Bektasoglu, Pinar] Univ Hlth Sci, Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Koyuncuoglu, Turkan] Biruni Univ, Dept Physiol, Sch Med, Istanbul, Turkey; [Akbulut, Selin; Akakin, Dilek] Marmara Univ, Dept Histol & Embryol, Sch Med, Istanbul, Turkey; [Eyuboglu, Irem Peker; Erzik, Can] Marmara Univ, Dept Med Biol, Sch Med, Istanbul, Turkey; [Yuksel, Meral] Marmara Univ, Vocat Sch Hlth Serv, Dept Med Lab Tech, Istanbul, Turkey		Bektasoglu, PK (corresponding author), Marmara Univ, Dept Physiol, Inst Hlth Sci, Istanbul, Turkey.	pnr.kuru@gmail.com	Erzik, Can/AAZ-5485-2021; Bektasoglu, Pinar Kuru/K-8612-2013; Koyuncuoglu, Turkan/AAD-3962-2021; Koyuncuoglu, Turkan/AAD-3448-2022	Erzik, Can/0000-0002-7914-1169; Bektasoglu, Pinar Kuru/0000-0001-9889-9955; Koyuncuoglu, Turkan/0000-0003-4749-9470; Koyuncuoglu, Turkan/0000-0003-4749-9470	Marmara University Scientific Research Projects Coordination UnitMarmara University	This work was supported by Marmara University Scientific Research Projects Coordination Unit.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Beuth W, 1996, Neurol Neurochir Pol, V30, P427; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chan SL, 2018, STROKE, V49, P1969, DOI 10.1161/STROKEAHA.118.022056; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Condron M, 2018, J TRAUMA ACUTE CARE, V85, P888, DOI 10.1097/TA.0000000000002040; Demir D, 2019, INJURY, V50, P1586, DOI 10.1016/j.injury.2019.08.036; Deshpande SS, 2001, CRIT REV FOOD SCI, V41, P155, DOI 10.1080/20014091091797; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; Eren M, 2014, SEMIN THROMB HEMOST, V40, P645, DOI 10.1055/s-0034-1387883; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giesen PLA, 2000, SEMIN THROMB HEMOST, V26, P379, DOI 10.1055/s-2000-8456; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Griemert EV, 2019, ANN NEUROL, V85, P667, DOI 10.1002/ana.25458; Griemert EV, 2019, TRANSL STROKE RES, V10, P372, DOI 10.1007/s12975-018-0644-9; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Hultman K, 2010, J NEUROSCI RES, V88, P2441, DOI 10.1002/jnr.22412; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Kang SJ, 2020, P NATL ACAD SCI USA, V117, P22351, DOI 10.1073/pnas.2010229117; KIKUCHI K, 1993, ANAL CHEM, V65, P1794, DOI 10.1021/ac00061a025; KIKUCHI K, 1993, J BIOL CHEM, V268, P23106; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Liu B, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1847; Liu PF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180620; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUEPTOW LM, 2017, JOVE-J VIS EXP, V126, DOI DOI 10.3791/55718; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall CA, 2019, BRAIN INJURY, V33, P255, DOI 10.1080/02699052.2018.1553308; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Miles SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184265; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Pelisch N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124510; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; SIMPSON AJ, 1991, J CLIN PATHOL, V44, P139, DOI 10.1136/jcp.44.2.139; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5; Toklu HZ, 2009, J SURG RES, V152, P238, DOI 10.1016/j.jss.2008.03.013; Tugtepe H, 2007, REGUL PEPTIDES, V140, P101, DOI 10.1016/j.regpep.2006.11.026; Tuttolomondo A, 2009, ATHEROSCLEROSIS, V203, P503, DOI 10.1016/j.atherosclerosis.2008.06.030; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; VANDERPOLL T, 1991, J EXP MED, V174, P729, DOI 10.1084/jem.174.3.729; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang D, 2009, J NEUROSCI, V29, P8669, DOI 10.1523/JNEUROSCI.1117-09.2009; Yang Li, 2007, Neurosci Bull, V23, P307, DOI 10.1007/s12264-007-0046-6; Zaninotto Ana Luiza, 2019, Dement. neuropsychol., V13, P172, DOI 10.1590/1980-57642018dn13-020005	76	0	0	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	DEC	2021	44	6					2499	2517		10.1007/s10753-021-01520-0		AUG 2021	19	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	XD3VY	WOS:000691757800003	34460025	Green Submitted			2022-02-06	
J	Morales, JS; Castillo-Garcia, A; Valenzuela, PL; Saco-Ledo, G; Manas, A; Santos-Lozano, A; Lucia, A				Morales, Javier S.; Castillo-Garcia, Adrian; Valenzuela, Pedro L.; Saco-Ledo, Gonzalo; Manas, Asier; Santos-Lozano, Alejandro; Lucia, Alejandro			Mortality from mental disorders and suicide in male professional American football and soccer players: A meta-analysis	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						chronic traumatic encephalopathy; concussion; professional athletes; traumatic brain injury	LEAGUE PLAYERS; RISK; CONCUSSION; COHORT; HEALTH; DEATH	Objective To determine the risk of mortality from mental disorders and suicide in professional sports associated with repeated head impacts. Methods A systematic search was performed in PubMed, Web of Science, Scopus, and SPORTDiscus (since inception to June 8, 2021) to find studies comparing the incidence of mortality from mental disorders or suicide in former or active professional athletes of sports characterized by repeated head impacts vs athletes with no such exposure or the general non-athletic population. Results Seven retrospective studies of moderate-to-high quality that included data from boxers and from basketball, ice hockey, soccer, and National Football League (NFL) players, respectively (total = 27 477 athletes, 100% male) met all inclusion criteria. Former male NFL players (n = 13 217) had a lower risk of mortality from mental disorders (standard mortality rate [SMR] = 0.30; 0.12-0.77; p = 0.012) and suicide (SMR = 0.54; 0.37-0.78; p < 0.001) than the general population. This finding was also corroborated in male soccer players (n = 13,065; SMR = 0.55; 0.46-0.67; p < 0.001). Male athletes participating in sports associated with repeated head impacts (n = 18,606) had also a lower risk of all-cause, cardiovascular disease (CVD), and cancer mortality (all p < 0.01) than the general population. Conclusions Participation of male athletes in American football or soccer at the professional level might confer a certain protective effect against mortality from mental disorders or suicide, besides its association with a lower risk of all-cause, CVD, or cancer-related mortality.	[Morales, Javier S.] Univ Cadiz, Fac Educ Sci, Dept Phys Educ, MOVE IT Res Grp, Cadiz 11003, Spain; [Castillo-Garcia, Adrian] Fissac Physiol Hlth & Phys Act, Madrid, Spain; [Valenzuela, Pedro L.; Lucia, Alejandro] Univ Europea Madrid, Fac Sport Sci, Madrid, Spain; [Saco-Ledo, Gonzalo] Natl Res Ctr Human Evolut CENIEH, Bioenergy & Mot Anal Lab, Burgos, Spain; [Manas, Asier] Univ Castilla La Mancha Toledo, GENUD Toledo Res Grp, Toledo, Spain; [Manas, Asier; Lucia, Alejandro] CIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain; [Santos-Lozano, Alejandro] European Univ Miguel de Cervantes, Dept Hlth Sci, I HLTH, Valladolid, Spain; [Santos-Lozano, Alejandro; Lucia, Alejandro] Inst Invest Sanitaria Hosp, Phys Act & Hlth Lab, Octubre Imas12 12, Madrid, Spain		Morales, JS (corresponding author), Univ Cadiz, Fac Educ Sci, Dept Phys Educ, MOVE IT Res Grp, Cadiz 11003, Spain.	javier.salvador@uca.es	Bote, Asier Manas/S-8856-2017; Morales, Javier S/AAI-2399-2019; Saco-Ledo, Gonzalo/AAG-6333-2021; Santos-Lozano, Alejandro/L-3948-2017	Bote, Asier Manas/0000-0002-1683-1365; Morales, Javier S/0000-0002-3255-3246; Saco-Ledo, Gonzalo/0000-0002-0100-7541; Santos-Lozano, Alejandro/0000-0002-2309-3583; Valenzuela Tallon, Pedro Luis/0000-0003-1730-3369	Spanish Ministry of Science and Innovation (Instituto de Salud Carlos III)Instituto de Salud Carlos IIISpanish Government [PI18/00139]	This work was supported by the Spanish Ministry of Science and Innovation (Instituto de Salud Carlos III) [grant PI18/00139, AL]	Antero J, 2021, BRIT J SPORT MED, V55, P206, DOI 10.1136/bjsports-2019-101696; Baker JG, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000420; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Bax L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-40; Chekroud SR, 2018, LANCET PSYCHIAT, V5, P739, DOI 10.1016/S2215-0366(18)30227-X; Clarke PM, 2015, BRIT J SPORT MED, V49, P898, DOI 10.1136/bjsports-2015-e8308rep; Duncombe SL, 2021, BRIT J SPORT MED, V55, P900, DOI 10.1136/bjsports-2020-102624; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Gallo V, 2020, J NEUROL NEUROSUR PS, V91, P455, DOI 10.1136/jnnp-2019-321170; Garatachea N, 2014, MAYO CLIN PROC, V89, P1195, DOI 10.1016/j.mayocp.2014.06.004; Gorczynski P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004412.pub2; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P332, DOI 10.1093/arclin/acz023; Kettunen JA, 2015, BRIT J SPORT MED, V49, P893, DOI 10.1136/bjsports-2013-093347; Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Levin HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3046; Lincoln AE, 2018, MED SCI SPORT EXER, V50, P486, DOI 10.1249/MSS.0000000000001466; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Mez J, 2020, NEUROLOGY, V94; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Riecher-Rossler A, 2017, LANCET PSYCHIAT, V4, P8, DOI 10.1016/S2215-0366(16)30348-0; Russell ER, 2020, J NEUROL NEUROSUR PS, V91, P1256, DOI 10.1136/jnnp-2020-323315; Schuch FB, 2019, DEPRESS ANXIETY, V36, P846, DOI 10.1002/da.22915; Schuch FB, 2018, AM J PSYCHIAT, V175, P631, DOI 10.1176/appi.ajp.2018.17111194; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; Wang DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110728; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451	31	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2021	31	12					2241	2248		10.1111/sms.14038		AUG 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	WT5VV	WOS:000690988200001	34416791	hybrid, Green Published			2022-02-06	
J	Morgan, MA; Logan, MW; Arnio, AN				Morgan, Mark A.; Logan, Matthew W.; Arnio, Ashley N.			Hazardous Duty: Investigating Resistance to Police at the Point of Arrest Among Incarcerated Military Veterans	ARMED FORCES & SOCIETY			English	Article; Early Access						arrest; military veterans; policing; resistance; use of force	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-DISORDER; LIFE-COURSE; MULTIPLE IMPUTATION; US MILITARY; SERVICE; BEHAVIOR; RISK; PREVALENCE	The link between military service and crime has been a subject of investigation for several decades. Although research has examined the likelihood of arrest, incarceration, and recidivism across military cohorts, relatively little is known about the circumstances surrounding police contact and suspect behavior at the exact moment of arrest. This is a critical oversight given that what transpires during an arrest can have a marked impact on downstream criminal justice outcomes, including access to diversionary programming like veterans treatment courts. Using a nationally representative survey of prison inmates, this study analyzes veteran and nonveteran self-reports of their arrest controlling for a host of relevant demographic, mental health, and criminal history variables. Findings indicate that veterans are significantly less likely to resist the police at arrest. These results provide further support to the sentiment that military culture and training can have a lasting behavioral influence on those who experience it.	[Morgan, Mark A.] Univ Dayton, Dept Criminal Justice & Secur Studies, 300 Coll Pk, Dayton, OH 45469 USA; [Logan, Matthew W.; Arnio, Ashley N.] Texas State Univ, Sch Criminal Justice & Criminol, San Marcos, TX USA		Morgan, MA (corresponding author), Univ Dayton, Dept Criminal Justice & Secur Studies, 300 Coll Pk, Dayton, OH 45469 USA.	mmorgan2@udayton.edu					Ahlin E.M., 2020, CRIMINAL JUSTICE REV, V45, P319; Alpert G.P., 2004, POLICE Q, V7, P475, DOI [10.1177/1098611103260507, DOI 10.1177/1098611103260507]; Armor D., 2004, ALL VOLUNTEER FORCE; Athens L, 2015, DEVIANT BEHAV, V36, P625, DOI 10.1080/01639625.2014.951577; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bachman JG, 2000, MIL PSYCHOL, V12, P1, DOI 10.1207/S15327876MP1201_1; Bachman JG, 2001, ARMED FORCES SOC, V27, P461, DOI 10.1177/0095327X0102700307; Baktir Y., 2020, DEVIANT BEHAV, V41, P233; Baldwin JM, 2019, J OFFENDER REHABIL, V58, P1, DOI 10.1080/10509674.2018.1549181; Beaver KM, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015573352; Belvedere K., 2005, CRIMINAL JUSTICE REV, V30, P30, DOI DOI 10.1177/0734016805275675; Benda BB, 2003, PSYCHIATR REHABIL J, V26, P332, DOI 10.2975/26.2003.332.345; Blonigen D.M., 2016, CRIMINAL JUSTICE POL, V27, P812, DOI [DOI 10.1177/0887403414562602, 10.1177/0887403414562602]; Bolger PC, 2015, AM J CRIM JUSTICE, V40, P466, DOI 10.1007/s12103-014-9278-y; Booth-Kewley S, 2010, AGGRESSIVE BEHAV, V36, P330, DOI 10.1002/ab.20355; Bouffard L. A., 2004, CRIME PUNISHMENT PAT, P129; Bouffard LA, 2005, ARMED FORCES SOC, V31, P273, DOI 10.1177/0095327X0503100206; Bouffard LA, 2003, CRIMINOLOGY, V41, P491, DOI 10.1111/j.1745-9125.2003.tb00995.x; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Bronson J., 2015, VETERANS PRISON JAIL; Brooke E.J., 2020, CORRECTIONS, V5, P292, DOI [10.1080/23774657.2018.1542284, DOI 10.1080/23774657.2018.1542284]; BROOKE EJ, 2018, CRIMINAL JUSTICE POL, V0029; Brooke EJ, 2019, CRIME DELINQUENCY, V65, P1925, DOI 10.1177/0011128718779570; Camins J.S., 2021, TRAUMATOLOGY, DOI [10.1037/trm0000309, DOI 10.1037/TRM0000309]; Campbell DJ, 2010, ARMED FORCES SOC, V36, P327, DOI 10.1177/0095327X09335945; Cavanaugh J.M., 2011, NEW ENGLAND LAW REV, V45, P463; Cowper TJ., 2000, POLICE Q, V3, P228; CRAWFORD C, 2002, POLICE PRACTICE RES, V0003; Dai MY, 2019, POLICING, V42, P571, DOI 10.1108/PIJPSM-08-2018-0110; Daylor JM, 2019, J CRIM JUST, V63, P49, DOI 10.1016/j.jcrimjus.2019.04.002; Denkmann L., 2019, HELP VETERANS CRISIS; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Drapela LA, 2019, JUSTICE Q, V36, P1023, DOI 10.1080/07418825.2018.1481221; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Elder G.H., 1991, MILITARY PSYCHOL, V3, P215, DOI [10.1207/s15327876mp0304_3, DOI 10.1207/S15327876MP0304_3]; Elder GH, 2010, SOC SCI QUART, V91, P455, DOI 10.1111/j.1540-6237.2010.00702.x; Engel R.S., 2019, POWER ARREST LESSONS, P29; Engel RS, 2003, J CRIM JUST, V31, P475, DOI 10.1016/S0047-2352(03)00052-7; Finlay AK, 2019, SEX ABUSE-J RES TR, V31, P560, DOI 10.1177/1079063218793633; Fox John, 2008, APPL REGRESSION ANAL; Frailing K, 2010, INT J LAW PSYCHIAT, V33, P207, DOI 10.1016/j.ijlp.2010.06.001; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; GARNER JH, 1995, CRIMINAL JUSTICE REV, V0020; Gonzalez JMR, 2019, J PUBLIC HEALTH-UK, V41, pE245, DOI 10.1093/pubmed/fdy151; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Greenberg GA, 2012, INT J OFFENDER THER, V56, P646, DOI 10.1177/0306624X11406091; Greenberg GA, 2009, PSYCHIAT QUART, V80, P41, DOI 10.1007/s11126-009-9092-8; Grossman D., 1996, KILLING PSYCHOL COST; Hall LK, 2011, SOC WORK HEALTH CARE, V50, P4, DOI 10.1080/00981389.2010.513914; Hartley RD., 2019, CRIMINAL JUSTICE POL, V30, P52, DOI [10.1177/0887403416650490, DOI 10.1177/0887403416650490]; Hartley Tara A, 2013, Int J Emerg Ment Health, V15, P241; Hine KA, 2021, POLICE Q, V24, P135, DOI 10.1177/1098611120957767; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivie D, 2011, POLICING, V34, P49, DOI 10.1108/13639511111106605; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; JOHNSON BD, 2005, JUSTICE RES POLICY, V0007; Johnson RR, 2011, CRIM JUSTICE BEHAV, V38, P127, DOI 10.1177/0093854810388160; Kalich DM, 2006, DEVIANT BEHAV, V27, P569, DOI 10.1080/01639620600887295; Kirchner JE, 2011, J RURAL HEALTH, V27, P416, DOI 10.1111/j.1748-0361.2011.00362.x; Klein Daniel., 2014, STAT SOFTWARE COMPON; Kunzia R., 2019, WASH POST; Logan M.W., 2017, CRIMINAL JUSTICE POL, V28, P814, DOI [10.1177/0887403415623033, DOI 10.1177/0887403415623033]; Logan MW, 2021, J CRIM JUST, V72, DOI 10.1016/j.jcrimjus.2020.101762; Logan MW, 2021, PSYCHIAT QUART, V92, P1147, DOI 10.1007/s11126-021-09883-1; Long J.S., 2014, REGRESSION MODELS CA; Lowenkamp C.T., 2005, CRIMINOL PUBLIC POL, V4, P263, DOI DOI 10.1111/J.1745-9133.2005.00021.X; Lutz A., 2008, J POLITICAL MIL SOCI, V36, P167; MacLean A, 2007, ANNU REV SOCIOL, V33, P175, DOI 10.1146/annurev.soc.33.040406.131710; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Manzoni P, 2006, CRIM JUSTICE BEHAV, V33, P613, DOI 10.1177/0093854806288039; Mastrofski SD, 2002, CRIMINOLOGY, V40, P519, DOI 10.1111/j.1745-9125.2002.tb00965.x; May D.C., 2017, CRIMINAL JUSTICE POL, V28, P770; MCFALL ME, 1992, J STUD ALCOHOL, V53, P357, DOI 10.15288/jsa.1992.53.357; Moore J, 2021, CRIME DELINQUENCY, V67, P344, DOI 10.1177/0011128720944075; Morabito MS, 2007, PSYCHIAT SERV, V58, P1582, DOI 10.1176/appi.ps.58.12.1582; Morabito MS, 2015, CRIMINOL PUBLIC POL, V14, P253, DOI 10.1111/1745-9133.12127; Morgan MA, 2019, AM J CRIM JUSTICE, V44, P746, DOI 10.1007/s12103-018-9458-2; Mulvey P, 2014, POLICING, V37, P404, DOI 10.1108/PIJPSM-07-2013-0076; Mumola CJ., 2007, VETERANS STATE FEDER; Novak KJ, 2005, POLICING, V28, P493, DOI 10.1108/13639510510614573; Orak U, 2021, CRIME DELINQUENCY, V67, P1046, DOI 10.1177/0011128719850497; Petrakis IL, 2011, AM J ADDICTION, V20, P185, DOI 10.1111/j.1521-0391.2011.00126.x; Phillips SW, 2008, J CRIM JUST, V36, P307, DOI 10.1016/j.jcrimjus.2008.06.002; Pickett J, 2019, POLICING, V42, P537, DOI 10.1108/PIJPSM-09-2018-0133; Redmond SA, 2015, WORK, V50, P9, DOI 10.3233/WOR-141987; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Rossler MT, 2012, POLICE Q, V15, P3, DOI [10.1177/1098611111432679, 10.1177/1098611112451262]; Sampson RJ, 1996, AM SOCIOL REV, V61, P347, DOI 10.2307/2096353; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; Shernock S., 2017, CRIMINAL JUSTICE POL, V28, P61; Snowden DL, 2017, SOC PSYCH PSYCH EPID, V52, P605, DOI 10.1007/s00127-017-1342-8; Soeters Joseph., 2006, HDB SOCIOLOGY MILITA; Stacer MJ, 2015, PRISON J, V95, P199, DOI 10.1177/0032885515575267; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; SYKES RE, 1975, AM J SOCIOL, V81, P584, DOI 10.1086/226109; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Teachman J, 2016, SOC SCI RES, V60, P74, DOI 10.1016/j.ssresearch.2016.04.003; Teeters JB, 2017, SUBST ABUSE REHABIL, V8, P69, DOI 10.2147/SAR.S116720; Terrill W, 2002, JUSTICE Q, V19, P215, DOI 10.1080/07418820200095221; Timko C, 2014, J OFFENDER REHABIL, V53, P620, DOI 10.1080/10509674.2014.956964; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; Tyler Tom R., 1990, WHY PEOPLE OBEY LAW; van Ginkel JR, 2020, J PERS ASSESS, V102, P297, DOI 10.1080/00223891.2018.1530680; Vespa JE, 2020, THOSE WHO SERVED AM; Villanueva A., 2019, MENTAL EVALUATION TE; von Hippel PT, 2009, SOCIOL METHODOL, V39, P265, DOI 10.1111/j.1467-9531.2009.01215.x; Weaver CM, 2013, PSYCHOL SERV, V10, P66, DOI 10.1037/a0029651; Whichard C, 2016, J RES CRIME DELINQ, V53, P564, DOI 10.1177/0022427816632571; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White MD, 2012, JUSTICE Q, V29, P258, DOI 10.1080/07418825.2011.560890; Woodruff T, 2006, ARMED FORCES SOC, V32, P353, DOI 10.1177/0095327X05283040; Wooldredge J, 2012, JUSTICE Q, V29, P41, DOI 10.1080/07418825.2011.559480; Wright JP, 2005, J RES CRIME DELINQ, V42, P55, DOI 10.1177/0022427804270436	115	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0095-327X	1556-0848		ARMED FORCES SOC	Armed Forces Soc.											0095327X211042061	10.1177/0095327X211042061		AUG 2021	24	Political Science; Sociology	Social Science Citation Index (SSCI)	Government & Law; Sociology	UL4DR	WOS:000692604100001					2022-02-06	
J	Dell, KC; Staph, J; Hillary, FG				Dell, Kristine C.; Staph, Jason; Hillary, Frank G.			Traumatic brain injury in the homeless: health, injury mechanisms, and hospital course	BRAIN INJURY			English	Article						Traumatic brain injury; homeless; preexisting conditions; race; assault	MEDICAL ADVICE; HOUSED INDIVIDUALS; CARE UTILIZATION; FOLLOW-UP; ADULTS; VETERANS; VICTIMIZATION; READMISSION; PREDICTORS; OUTCOMES	Primary Objective Established literature demonstrates that homeless individuals experience both greater disease burden and risk of experiencing traumatic brain injury (TBI) than the general population. Similarly, shared risk factors for both homelessness and/or TBI may exacerbate the risk of repetitive neurotrauma within homeless populations. Research Design We leveraged a state-wide trauma registry, the Pennsylvania Trauma Outcome Study (PTOS), to characterize 609 patients discharged to homeless (58% TBI, 42% orthopedic injury (OI)) in comparison to 609 randomly sampled adult patients discharged to home. Methods and Procedures We implemented Chi-square tests to examine preexisting health conditions (PECs), hospital course, and injury mechanisms for both patient groups. Main Outcomes and Results Homelessness affects a greater proportion of nonwhite patients, and homeless patients present for care with increased frequencies of psychiatric and substance use PECs, and alcohol-positive TBI. Furthermore, assault impacts a larger proportion of homeless patients, and the window for overnight assault risk resulting in TBI is extended for these patients compared to patients discharged to home. Conclusion Given the shifting conceptualization of TBI as a chronic condition, identifying homeless patients on admission to trauma centers, rather than retrospectively at discharge, can enhance understanding of the challenges facing the homeless as they age with both a complex neurotrauma history and multimorbidity.	[Dell, Kristine C.; Staph, Jason; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	fgh3@psu.edu			Pennsylvania Department of Health [PA-DOH SAP#4100077082]	This work was funded by the Pennsylvania Department of Health under Grant PA-DOH SAP#4100077082.	[Anonymous], 2020, ALZHEIMERS DEMENT, V16, P391, DOI 10.1002/alz.12068; [Anonymous], 2020, HOM PA HOM INF PENN; [Anonymous], 2017, PENNSYLVANIA TRAUMA; Bacciardi S, 2017, RIV PSICHIATR, V52, P40, DOI 10.1708/2631.27053; Balla S, 2020, MAYO CLIN PROC, V95, P660, DOI 10.1016/j.mayocp.2020.01.013; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; Brenner EK, 2020, BRAIN INJURY, V34, P801, DOI 10.1080/02699052.2020.1741033; Brenner LA, 2017, BRAIN INJURY, V31, P1731, DOI 10.1080/02699052.2017.1376758; Burke SL, 2018, J NATL MED ASSOC, V110, P314, DOI 10.1016/j.jnma.2017.06.007; Choi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024459; Currie LB, 2018, HEALTH SERV RES, V53, P3400, DOI 10.1111/1475-6773.12992; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; de Angelis P, 2019, J SURG RES, V242, P357, DOI 10.1016/j.jss.2019.04.073; de Guise E, 2014, BRAIN INJURY, V28, P1288, DOI 10.3109/02699052.2014.916820; Gebregziabher M, 2018, SOC SCI MED, V211, P198, DOI 10.1016/j.socscimed.2018.06.020; Golub A, 2013, SUBST USE MISUSE, V48, P811, DOI 10.3109/10826084.2013.796988; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Kucukboyaci NE, 2018, ARCH PHYS MED REHAB, V99, P2365, DOI 10.1016/j.apmr.2017.11.016; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Liew TYS, 2019, FRONT SURG, V6, DOI 10.3389/fsurg.2019.00037; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Marcoux J, 2017, CAN J NEUROL SCI, V44, P311, DOI 10.1017/cjn.2016.241; Maremmani AGI, 2017, J NERV MENT DIS, V205, P173, DOI 10.1097/NMD.0000000000000462; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; Mejia-Lancheros C, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08499-7; Nikoo M, 2017, J HEAD TRAUMA REHAB, V32, pE19, DOI 10.1097/HTR.0000000000000262; O'Reilly GM, 2015, INJURY, V46, P201, DOI 10.1016/j.injury.2014.09.010; Pennsylvania Department of Transportation, 2020, PENNS SPAT DAT ACC P; R Development Core Team, 2008, R LANG ENV STAT COMP; Racine MW, 2020, MED CARE, V58, P27, DOI 10.1097/MLR.0000000000001234; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Roy L, 2016, INT J LAW PSYCHIAT, V49, P75, DOI 10.1016/j.ijlp.2016.05.013; Roy L, 2014, PSYCHIAT SERV, V65, P739, DOI 10.1176/appi.ps.201200515; Saab D, 2016, J GEN INTERN MED, V31, P1011, DOI 10.1007/s11606-016-3680-8; Schmitt Angelika, 2019, Brain Plast, V5, P39, DOI 10.3233/BPL-190081; Schmitt T, 2017, J NEUROTRAUM, V34, P3301, DOI 10.1089/neu.2017.5076; Sherafat S, 2013, J MANIP PHYSIOL THER, V36, P111, DOI 10.1016/j.jmpt.2012.12.005; Song MJ, 2018, J HEAD TRAUMA REHAB, V33, P185, DOI 10.1097/HTR.0000000000000310; Stearns CR, 2017, J HOSP MED, V12, P11, DOI 10.1002/jhm.2672; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; The U.S. Department of Housing and Urban Development, 2019, 2019 ANN HOM ASS REP; Titan A, 2018, MED CARE, V56, P460, DOI 10.1097/MLR.0000000000000915; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Topolovec-Vranic J, 2013, BRAIN INJURY, V27, P1600, DOI 10.3109/02699052.2013.823666; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Twamley EW, 2019, PSYCHIAT RES, V271, P167, DOI 10.1016/j.psychres.2018.11.049; Wessels AM, 2011, ALZHEIMERS DEMENT, V7, P418, DOI 10.1016/j.jalz.2010.07.003	49	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1192	1200		10.1080/02699052.2021.1958009		AUG 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000691140400001	34460346				2022-02-06	
J	Dey, S; Kumar, R; Tarat, A				Dey, Sandeep; Kumar, Ramesh; Tarat, Abhijit			Evaluation of Electrolyte Imbalance in Patients With Traumatic Brain Injury Admitted in the Central ICU of a Tertiary Care Centre: A Prospective Observational Study	CUREUS			English	Article						traumatic brain injury; hyponatraemia; hypokalaemia; hypomagnesemia; hypoalbuminemia	NEUROLOGIC PATIENTS; HEAD; HYPOMAGNESEMIA; HYPONATREMIA; ALBUMIN; SODIUM	Introduction Electrolyte imbalance is a salient finding in traumatic brain injury which can derail their clinical course of recovery in physical and cognitive health while prolonging the hospital stay. Objective This study aims to understand the variation in electrolyte profile that occurs in traumatic brain injury patients which can help in better patient management. Materials and method 50 trauma patients with head injury (Group A) and 50 patients without head injury (Group B) admitted in Central ICU (CICU) under the Department of Anaesthesiology, Assam Medical College and Hospital (AMCH) were selected and analysed with regard to their electrolyte variability. Result All trauma patients with head injury developed an imbalance to one or more electrolytes. Then mean electrolyte level in trauma patients with a head injury and in trauma patients without head injury were 139.3 +/- 7.45 vs 143.65 +/- 8.89, p<0.05 (sodium), 3.49 +/- 0.44 vs 3.88 +/- 0.49, p<0.05 (potassium), 7.81 +/- 0.5 vs 8.9 +/- 0.35, p<0.05 (calcium) and 2 +/- 0.33 vs 2.47 +/- 0.41, p<0.05 (magnesium) respectively. Also, patients in the head injury group had a higher incidence of hypoalbuminemia than patients without head injury 2.47 +/- 0.67 vs 2.83 +/- 0.74 (p<0.05). Conclusion We conclude that traumatic brain injury patients have a greater risk of electrolyte imbalance, viz. hyponatremia, hypokalaemia, hypocalcaemia as well as hypomagnesemia, and hypophosphatemia along with hypoalbuminemia.	[Dey, Sandeep] Jorhat Med Coll & Hosp, Dept Anaesthesiol, Jorhat, Assam, India; [Kumar, Ramesh] Assam Med Coll & Hosp, Dept Anaesthesiol, Dibrugarh, Assam, India		Dey, S (corresponding author), Jorhat Med Coll & Hosp, Dept Anaesthesiol, Jorhat, Assam, India.	sandeep.dey09@gmail.com					Adiga Usha S, 2012, BASIC RES J MED CLIN, V1, P15; [Anonymous], 2013, UN DECADE ACTION ROA; BALLMER PE, 1995, J CLIN INVEST, V95, P39, DOI 10.1172/JCI117668; CHERNOW B, 1989, CHEST, V95, P391, DOI 10.1378/chest.95.2.391; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; da Cunha DF, 2000, AM J NEPHROL, V20, P37, DOI 10.1159/000013553; DESAI TK, 1988, AM J MED, V84, P209, DOI 10.1016/0002-9343(88)90415-9; Diringer MN, 2006, NEUROLOGIST, V12, P117, DOI 10.1097/01.nrl.0000215741.01699.77; FRUIN AH, 1986, SURG NEUROL, V25, P25, DOI 10.1016/0090-3019(86)90109-6; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; Gupta S, 2014, INT J CONCRETE TECHN, V1, P1; Gurkanlar D, 2009, TURK NEUROSURG, V19, P211; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Jain A, 2017, IOSR JDMS, V16, P55; Limaye C S, 2011, J Assoc Physicians India, V59, P19; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; National Crime Records Bureau, 2019, ACC DEATHS SUIC IND; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; RUBEIZ GJ, 1993, CRIT CARE MED, V21, P203, DOI 10.1097/00003246-199302000-00010; Suman S, 2016, J ANESTH CRIT CARE, V5, DOI [10.15406/jaccoa.2016.05.00184, DOI 10.15406/JACCOA.2016.05.00184]; Taha MM, 2015, INTERNET J NEUROSURG, V11, P1; Tanemoto M, 2008, QJM-INT J MED, V101, P827, DOI 10.1093/qjmed/hcn104; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; WEBB S, 1975, JAMA-J AM MED ASSOC, V233, P23, DOI 10.1001/jama.233.1.23; WHANG R, 1985, ARCH INTERN MED, V145, P1686, DOI 10.1001/archinte.145.9.1686; WHANG R, 1984, ARCH INTERN MED, V144, P1794, DOI 10.1001/archinte.144.9.1794; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010; Zaloga G, 2000, TXB CRITICAL CARE, V862, P862	29	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	AUG 28	2021	13	8							e17517	10.7759/cureus.17517			13	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UK0PE	WOS:000691676600006	34595082	Green Published, gold			2022-02-06	
J	Singh, A; Ganpule, SG; Khan, MK; Iqbal, MA				Singh, A.; Ganpule, S. G.; Khan, M. K.; Iqbal, M. A.			Measurement of brain simulant strains in head surrogate under impact loading	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain simulant strain; Impact; Traumatic brain injury; Falx and tentorium	DIFFUSE AXONAL INJURY; MECHANICAL-PROPERTIES; CORPUS-CALLOSUM; DEFORMATION; ABNORMALITIES; KINEMATICS; MODEL; FALX; SKIN	Impact-induced traumatic brain injury (TBI) is a major source of disability and mortality. Knowledge of brain strains during impact (accelerative) loading is critical for the overall management of TBI, including the development of injury thresholds, personal protective equipment, and validation of computational models. Despite these needs, the current understanding of brain strains in humans or humanlike surrogates is limited, especially for injury causing loading magnitudes. Toward this end, we measured full-field, in-plane (2D) strains in a brain simulant using the hemispherical head surrogate. The hemispherical head was mounted on the Hybrid-III neck and subjected to impact loading using a linear impactor system. The resulting head kinematics was measured using a triaxial accelerometer and angular rate sensors. Dynamic, 2D strains in a brain simulant were obtained using high-speed imaging and digital image correlation. Concurrent finite element (FE) simulations of the experiment were also performed to gain additional insights. The role of stiff membranes of the head was also studied using experiments. Our results suggest that rotational modes dominate the response of the brain simulant. The wave propagation in the brain simulant as a result of impact has a timescale of similar to 100 ms. We obtain peak strains of similar to 20%, similar to 40%, similar to 60% for peak rotational accelerations of similar to 838, similar to 5170, similar to 11,860 rad/s(2), respectively. Further, peak strains in cortical regions are higher than subcortical regions by up to similar to 70%. The agreement between the experiments and FE simulations is reasonable in terms of spatiotemporal evolution of strain pattern and peak strain magnitudes. Experiments with the addition of falx and tentorium indicate significant strain concentration (up to 115%) in the brain simulant near the interface of falx or tentorium and brain simulant. Overall, this work provides important insights into the biomechanics of strain in the brain simulant during impact loading.	[Singh, A.; Ganpule, S. G.] Indian Inst Technol Roorkee, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India; [Khan, M. K.; Iqbal, M. A.] Indian Inst Technol Roorkee, Dept Civil Engn, Roorkee 247667, Uttar Pradesh, India		Ganpule, SG (corresponding author), Indian Inst Technol Roorkee, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India.	ganpule@me.iitr.ac.in			Department of Science and Technology (DST)Department of Science & Technology (India) [ECR-2017-000417]; Ministry of Human Resource Development	Authors thank Dr. A. K. Knutsen and Dr. D. L. Pham of the Henry M. Jackson Foundation for the Advancement of Military Medicine for providing statistical strain data in human volunteers. We thank Dr. M. M. Joglekar and Dr. Sunil Sutar for proofreading the final manuscript. We also thank the anonymous reviewers for their detailed reviews and constructive suggestions that have helped in improving the manuscript. SGG acknowledges financial support from the Department of Science and Technology (DST) under the grant ECR-2017-000417. AS and MKK acknowledge fellowship from the Ministry of Human Resource Development.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Bayly PV, 2008, J MECH PHYS SOLIDS, V56, P2036, DOI 10.1016/j.jmps.2007.10.012; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Blaber J, 2015, EXP MECH, V55, P1105, DOI 10.1007/s11340-015-0009-1; Blaber J., 2017, NCORR INSTRUCTION MA; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; Chanda A, 2017, P I MECH ENG H, V231, P80, DOI 10.1177/0954411916679438; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; CHU TC, 1985, EXP MECH, V25, P232, DOI 10.1007/BF02325092; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Forte AE, 2015, FOOD HYDROCOLLOID, V46, P180, DOI 10.1016/j.foodhyd.2014.12.028; Fung Y.C., 2013, BIOMECHANICS MECH PR; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Hild, 2012, FULL FIELD MEASUREME; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ibrahim NG, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000956; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jones EM, 2018, GOOD PRACTICES GUIDE, DOI 10.32720/ idics/gpg.ed1/print; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Knutsen Andrew K, 2020, Brain Multiphys, V1, DOI 10.1016/j.brain.2020.100015; Kwon J, 2010, J BIOMECH, V43, P420, DOI 10.1016/j.jbiomech.2009.10.008; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Meaney D, 1995, P 1995 INT RES C BIO, P233; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Nie X, 2011, EXP MECH, V51, P1527, DOI 10.1007/s11340-011-9481-4; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Pan B, 2011, OPT LASER ENG, V49, P841, DOI 10.1016/j.optlaseng.2011.02.023; Petel OE, 2021, PARAMETRIC ANAL EMBE; Pham DL, COMPUTATIONAL BIOMEC; Richler D, 2014, EXP MECH, V54, P805, DOI 10.1007/s11340-014-9848-4; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Salisbury CP, 2009, EXP MECH, V49, P829, DOI 10.1007/s11340-008-9207-4; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shergold OA, 2006, INT J IMPACT ENG, V32, P1384, DOI 10.1016/j.ijimpeng.2004.11.010; Smith DR, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046199; Sutton MA, 2009, IMAGE CORRELATION FOR SHAPE, MOTION AND DEFORMATION MEASUREMENTS: BASIC CONCEPTS, THEORY AND APPLICATIONS, P1, DOI [10.1007/978-0-387-78747-3, 10.1007/978-0-387-78747-3_5]; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang KH, 2011, BIOL MED PHYS BIOMED, P91, DOI 10.1007/978-1-4419-9997-9_5; Zhao W, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4051050; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293	71	0	0	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	DEC	2021	20	6					2319	2334		10.1007/s10237-021-01509-6		AUG 2021	16	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WY8CZ	WOS:000690695100001	34455505				2022-02-06	
J	Tadyanemhandu, C; van Aswegen, H; Ntsiea, V				Tadyanemhandu, Cathrine; van Aswegen, Heleen; Ntsiea, Veronica			Barriers and facilitators to implementation of early mobilisation of critically ill patients in Zimbabwean and South African public sector hospitals: a qualitative study	DISABILITY AND REHABILITATION			English	Article; Early Access						Mobilisation; physiotherapy; barriers; facilitators; critically ill	INTENSIVE-CARE-UNIT; TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; POINT-PREVALENCE; CRITICAL ILLNESS; ADULT PATIENTS; NEW-ZEALAND; TASK-FORCE; REHABILITATION; ICU	Purpose Implementing early mobilisation in intensive care is challenging, and a detailed knowledge of factors that may hinder or facilitate implementation is essential for success. The study was done to explore the perceived barriers and facilitators to early mobilisation by physiotherapists in Zimbabwean and South African public sector hospital ICUs. Methods A qualitative study was done in eight public sector hospitals from South Africa and four hospitals from Zimbabwe. Physiotherapists from the participating hospitals who had at least two years working experience in ICU were invited to participate in semi-structured, in-depth, face-to-face interviews. Purposive sampling was done. Data collected included interpretation of early mobilisation, perceived barriers, and facilitators to early mobilisation. Data analysis was done using the content analysis method. Findings A total of 22 physiotherapists were interviewed. In defining the activities regarded as early mobilisation, there was diversity in relation to the specific activities and the nature of the patients in which the defined activities were suitable for. Perceived barriers which emerged included lack of professional autonomy or boundaries, motivation, and clinical skills. Perceived facilitators to early mobilisation included the availability of guidelines, good communication, adequate staff, and mobilisation equipment. Conclusions Barriers and facilitators to early mobilisation are multifactorial. There is need for multidisciplinary team collaboration and planning before implementing early mobilisation activities.Implications to rehabilitation Professional roles/identity and or boundaries emerged to be a barrier that hinder implementation of early mobilisation if not clearly defined. Non-rotational physiotherapy coverage was highlighted to be important in facilitating good communication and teamwork and sustainability of services in ICU. Good communication channels and referrals between different disciplines should be employed in ICU to prevent delay in rendering services to ICU patients.	[Tadyanemhandu, Cathrine; van Aswegen, Heleen; Ntsiea, Veronica] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Physiotherapy, Parktown, South Africa		Tadyanemhandu, C (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Physiotherapy, ZA-2193 Johannesburg, South Africa.	cathytadya@gmail.com	; Ntsiea, Mokgobadibe/Q-7858-2017	tadyanemhandu, cathrine/0000-0003-1610-3699; Ntsiea, Mokgobadibe/0000-0003-4208-5498; van Aswegen, Helena/0000-0003-1926-4690	Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43 TW009343, D43 TW010137, D43 TW009539]; University of California Global Health Institute; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Dental & Craniofacial ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR); National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)	Research reported in this publication was supported by the Fogarty International Center, Grant/Award Numbers (D43 TW009343, D43 TW010137, D43 TW009539); University of California Global Health Institute; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute of Dental & Craniofacial Research; National Institute of Mental Health; National Institute of Nursing Research.	Adler Joseph, 2012, Cardiopulm Phys Ther J, V23, P5; Anekwe DE, 2020, J PHYSIOTHER, V66, P120, DOI 10.1016/j.jphys.2020.03.001; Argent AC, 2009, SOUTH AFR J CRIT CAR, V25, P4; Asher A, 2013, CRIT CARE NURS Q, V36, P101, DOI 10.1097/CNQ.0b013e318275357e; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Bakhru RN, 2016, ANN AM THORAC SOC, V13, P1527, DOI 10.1513/AnnalsATS.201601-078OC; Barber EA, 2015, AUST CRIT CARE, V28, P177, DOI 10.1016/j.aucc.2014.11.001; Bassett R, 2015, JT COMM J QUAL PATIE, V41, P62, DOI 10.1016/S1553-7250(15)41010-4; Bengtsson M., 2016, NURSINGPLUS OPEN, V2, P8, DOI [10.1016/J.NPLS.2016.01.001, 10.1016/j.npls.2016.01.001]; Berney SC, 2013, CRIT CARE RESUSC, V15, P260; Boehm LM, 2016, DIMENS CRIT CARE NUR, V35, P339, DOI 10.1097/DCC.0000000000000208; Brock C, 2018, HEART LUNG, V47, P380, DOI 10.1016/j.hrtlng.2018.04.004; Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Capell EL, 2019, AUST CRIT CARE, V32, P185, DOI 10.1016/j.aucc.2018.05.005; Carrothers KM, 2013, CRIT CARE MED, V41, pS128, DOI 10.1097/CCM.0b013e3182a2c2b1; Castro-Avila AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130722; Chiarici A, 2019, ARCH PHYS MED REHAB, V100, P1506, DOI 10.1016/j.apmr.2019.01.015; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e31819d67b5, 10.1097/CCM.0b013e3181b6fa29]; Dubb R, 2016, ANN AM THORAC SOC, V13, P724, DOI 10.1513/AnnalsATS.201509-586CME; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Engel HJ, 2013, PHYS THER, V93, P975, DOI 10.2522/ptj.20110420; Fontela PC, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e241; Goddard SL, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0273-0; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Harrold ME, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1033-3; Hodgson CL, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1998-9; Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y; Hodgson CL, 2013, CRIT CARE, V17, DOI 10.1186/cc11820; Jerome E, 2017, SAMJ S AFR MED J, V107, P621, DOI [10.7196/SAMJ.2017.v107i7.10562, 10.7196/samj.2017.v107i7.10562]; Jolley SE, 2015, ANN AM THORAC SOC, V12, P209, DOI 10.1513/AnnalsATS.201410-480OC; Jolley SE, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-84; Jolley SE, 2017, CRIT CARE MED, V45, P205, DOI 10.1097/CCM.0000000000002058; Kayambu G, 2013, CRIT CARE MED, V41, P1543, DOI 10.1097/CCM.0b013e31827ca637; Koo Karen K Y, 2016, CMAJ Open, V4, pE448; Korstjens I, 2017, EUR J GEN PRACT, V24, P120, DOI 10.1080/13814788.2017.1375092; Kumar, 2015, INT ENCY COMMUNICATI, V8, P1, DOI [10.1002/9781118541555.wbiepc065, DOI 10.1002/9781118541555.WBIEPC065]; Laing GL, 2014, WORLD J SURG, V38, P1699, DOI 10.1007/s00268-014-2448-8; Malone D, 2015, PHYS THER, V95, P1335, DOI 10.2522/ptj.20140417; Marshall JC, 2017, J CRIT CARE, V37, P270, DOI 10.1016/j.jcrc.2016.07.015; Nydahl P, 2017, ANN AM THORAC SOC, V14, P766, DOI 10.1513/AnnalsATS.201611-843SR; Nydahl P, 2014, CRIT CARE MED, V42, P1178, DOI 10.1097/CCM.0000000000000149; Okafor UV, 2009, INDIAN J CRIT CARE M, V13, P25, DOI 10.4103/0972-5229.53112; Parry SM, 2017, INTENS CARE MED, V43, P531, DOI 10.1007/s00134-017-4685-4; Parry SM, 2017, J CRIT CARE, V38, P137, DOI 10.1016/j.jcrc.2016.11.005; Phelan S, 2018, INT J NURS STUD, V77, P91, DOI 10.1016/j.ijnurstu.2017.09.019; Plani N., 2017, EUR J PHYSIOTHER, V19, P31; Roberson AR, 2018, HEART LUNG, V47, P1, DOI 10.1016/j.hrtlng.2017.10.003; Rosman J, 2013, NEUROSURGERY, V73, P354, DOI 10.1227/01.neu.0000430762.08458.49; Schaller SJ, 2019, INTENS CARE MED, V45, P201, DOI 10.1007/s00134-019-05528-x; Sibilla A, 2020, J INTENSIVE CARE MED, V35, P55, DOI 10.1177/0885066617728486; Skinner EH, 2016, PHYSIOTHER THEOR PR, V32, P468, DOI 10.3109/09593985.2016.1145311; Stiller Kathy, 2004, Physiotherapy Theory and Practice, V20, P175, DOI 10.1080/09593980490487474; Tadyanemhandu C, 2018, SOUTH AFR J CRIT CAR, V34, P16, DOI [10.7196/sajcc.2017.v34i1.343, 10.7196/SAJCC.2017.v34i1.343]; Tadyanemhandu C, 2021, J EVAL CLIN PRACT, V27, P42, DOI 10.1111/jep.13378; TEAM Study Investigators, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0765-4; Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Twose Paul, 2019, J Intensive Care Soc, V20, P118, DOI 10.1177/1751143718807019; Valentin A, 2011, INTENS CARE MED, V37, P1575, DOI 10.1007/s00134-011-2300-7; van Aswegen H, 2017, J EVAL CLIN PRACT, V23, P1258, DOI 10.1111/jep.12774; van Willigen Z., 2016, BMJ QUAL IMPROV REP, V5; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	63	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1970827		AUG 2021	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	UJ4IO	WOS:000691251100001	34461792				2022-02-06	
J	Zurlinden, T; Savransky, A; Everhart, DE				Zurlinden, Taylor; Savransky, Anya; Everhart, D. Erik			Utilizing the BAT-LQ to assess TBI incidence in a college student population	BRAIN INJURY			English	Article						Mild brain injury; sport; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; CONCUSSION; INTERVIEW; FOOTBALL; POLICIES; PLAYERS; SYSTEM; TRENDS	Objective: Although the annual number of traumatic brain injuries (TBIs) reported in the US exceeds two million, data suggests that this is an underestimate. The goal of this study was to understand lifetime TBI incidence among a sample of college students. Additionally, this study examined whether a single yes/no question regarding TBI history was sufficient to gather accurate information about TBI incidence in college students. Design: Participants were asked a single TBI question and administered the BAT-LQ. Main Measures: The BAT-LQ is a screening tool designed to assess for probable lifetime TBIs. Results: Data from 121 participants were analyzed for this study. On the single-question, 24.8% of participants reported experiencing a TBI. However, upon further prompting, 76.8% of all participants reported experiencing a blow to the head accompanied by at least one diagnostic symptom of a TBI, suggesting a probable TBI based on best-practice diagnosis guidelines. Conclusion: The results of this study suggest that increased education about TBI is warranted to ensure that individuals receive care for probable TBIs, as many individuals likely lack knowledge about what constitutes a TBI diagnosis. Additionally, the results suggest that a single question may not be sufficient to capture true lifetime TBI incidence.	[Zurlinden, Taylor; Savransky, Anya; Everhart, D. Erik] East Carolina Univ, Dept Psychol, Rawl Bldg, Greenville, NC 27858 USA		Zurlinden, T (corresponding author), East Carolina Univ, Dept Psychol, Rawl Bldg, Greenville, NC 27858 USA.	hobbsta17@students.ecu.edu		Everhart, Daniel/0000-0002-6615-653X			Agimi Y, 2018, AM J PUBLIC HEALTH, V108, P683, DOI 10.2105/AJPH.2018.304347; [Anonymous], 2013, DIAGN STAT MAN MENT, P625; Brown J, 2017, NEUROREHABILITATION, V41, P483, DOI 10.3233/NRE-162065; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control Prevention; National Center for Injury Prevention and Control; Division of Unintentional Injury Prevention, 2014, REP C TRAUM BRAIN IN; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gardner JE, 2019, NEUROSURGERY, V85, pE842, DOI 10.1093/neuros/nyz140; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Hansen C, 2019, PEDIATR NEUROL, V90, P31, DOI 10.1016/j.pediatrneurol.2018.09.015; Jacobs K, 2017, WORK, V58, P45, DOI 10.3233/WOR-172596; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Marion DW, 2018, MIL MED, V183, P65, DOI 10.1093/milmed/usy118; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Martinez S, 2016, J AM COLL HEALTH, V64, P390, DOI 10.1080/07448481.2016.1167057; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKee A., 2013, ALZHEIMERS DEMENT, V9, P438, DOI [10.1016/j.jalz.2013.05.868, DOI 10.1016/JJALZ.2013.05.868]; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00091; Sabo D., 2019, STATE HIGH SCH SPORT; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Viano DC, 2017, TRAFFIC INJ PREV, V18, P616, DOI 10.1080/15389588.2017.1285023; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Zollman, 2016, MANUAL TRAUMATIC BRA; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1229	1234		10.1080/02699052.2021.1972140		AUG 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000689614200001	34436938				2022-02-06	
J	Abio, A; Bovet, P; Valentin, B; Barnighausen, T; Shaikh, MA; Posti, JP; Wilson, ML				Abio, Anne; Bovet, Pascal; Valentin, Bernard; Barnighausen, Till; Shaikh, Masood Ali; Posti, Jussi P.; Wilson, Michael Lowery			Changes in Mortality Related to Traumatic Brain Injuries in the Seychelles from 1989 to 2018	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injuries; Seychelles; mortality; low-middle income country; Africa	UNITED-STATES; EPIDEMIOLOGY; TRENDS; MANAGEMENT; OUTCOMES; CARE; HOSPITALIZATION	Introduction: Traumatic Brain Injuries (TBIs) are a significant source of disability and mortality, which disproportionately affect low- and middle-income countries. The Republic of Seychelles is a country in the African region that has experienced rapid socio-economic development and one in which all deaths and the age distribution of the population have been enumerated for the past few decades. The aim of this study was to investigate TBI-related mortality changes in the Republic of Seychelles during 1989-2018. Methods: All TBI-related deaths were ascertained using the national Civil Registration and Vital Statistics System. Age- and sex-standardised mortality rates (per 100,000 person-years) were standardised to the age distribution of the World Health Organisation standard population. Results: The 30-year age-standardised TBI-related mortality rates were 22.6 (95% CI 19.9, 25.2) in males and 4.0 (95% CI 2.9, 5.1) in females. Road traffic collisions were the leading contributor to TBI-related mortality [10.0 (95% CI 8.2, 11.8) in males and 2.7 (95% CI 1.8, 3.6) in females, P > 0.05]. TBI-related mortality was most frequent at age 20-39 years in males (8.0) and at age 0-19 in females (1.4). Comparing 2004-2018 vs. 1989-2003, the age-standardised mortality rates changed in males/females by -20%/-11% (all cause mortality), -24%/+39.4% (TBIs) and +1%/+34.8% (road traffic injury-related TBI). Conclusion: TBI-related mortality rates were much higher in males but decreased over time. Road traffic collisions were the single greatest contributor to TBI mortality, emphasising the importance of road safety measures.	[Abio, Anne; Shaikh, Masood Ali] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neurosci, Injury Epidemiol & Prevent Res Grp, Turku, Finland; [Abio, Anne; Shaikh, Masood Ali; Posti, Jussi P.] Univ Turku, Turku, Finland; [Abio, Anne; Barnighausen, Till; Wilson, Michael Lowery] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Bovet, Pascal] Univ Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland; [Bovet, Pascal; Valentin, Bernard] Minist Hlth, Victoria, Seychelles; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr, Turku, Finland		Wilson, ML (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.	michael.wilson@uni-heideiberg.de	Posti, Jussi P./Y-2908-2019; Bovet, Pascal/F-4477-2011	Posti, Jussi P./0000-0002-5925-5193; Bovet, Pascal/0000-0002-0242-4259	EDCTP/TDR Clinical Research and Development Fellowship Program, World Health Organisation, Geneva, Switzerland; The John Harvey Lowery Foundation, USA; University of Turku Joint Research Grant Fund, Finland; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences [11123, 11129]; Maire Taponen Foundation; Alexander von Humboldt-Stiftung, Bonn, GermanyAlexander von Humboldt Foundation; Ruprecht-Karls-Universitat Heidelberg	AA was supported by the EDCTP/TDR Clinical Research and Development Fellowship Program, World Health Organisation, Geneva, Switzerland; a grant from The John Harvey Lowery Foundation, USA; and the University of Turku Joint Research Grant Fund, Finland. JP received funding from Academy of Finland (#17379) and Government's Special Financial Transfer tied to academic research in Health Sciences (#11123 and #11129). JP also received a grant from Maire Taponen Foundation. ML was funded by a grant from the Alexander von Humboldt-Stiftung, Bonn, Germany. We also acknowledge the important contribution of the late Joachim Didon, who had been compiling mortality data in the Health Statistics Section of the Ministry of Health of Seychelles, over the past 30 years. We acknowledge financial support by the Open Access Publishing Fund of Ruprecht-Karls-Universitat Heidelberg.	Abio A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79228-8; Ahmad OB, 2001, AGE STANDARDIZATION; Albrecht JS, 2019, J AM GERIATR SOC, V67, P124, DOI 10.1111/jgs.15661; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Boniface Respicious, 2017, Pan Afr Med J, V26, P140, DOI 10.11604/pamj.2017.26.140.10345; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Chiarelli PE, 2009, AUST J PHYSIOTHER, V55, P89, DOI 10.1016/S0004-9514(09)70038-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Davey S., 2004, 1090 GLOB FOR HLTH R; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ilmaniemi S, 2019, J EPIDEMIOL COMMUN H, V73, P451, DOI 10.1136/jech-2018-211960; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Landes M, 2017, AFR J EMERG MED, V7, P130, DOI 10.1016/j.afjem.2017.04.001; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; Nyam TTE, 2018, WORLD NEUROSURG, V113, pE328, DOI 10.1016/j.wneu.2018.02.027; Ortiz-Prado E, 2020, NEUROEPIDEMIOLOGY, V54, P33, DOI 10.1159/000502580; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Posti JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41913-8; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stringhini S, 2012, STROKE, V43, P2283, DOI 10.1161/STROKEAHA.112.658468; Sung KC, 2015, J NEUROTRAUM, V32, P1078, DOI 10.1089/neu.2014.3509; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; WHO, 2014, INJ VIOL FACTS; World Bank, WORLD BANK POP SEYCH	44	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 27	2021	12								720434	10.3389/fneur.2021.720434			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UT3FG	WOS:000698005100001	34512529	gold, Green Published			2022-02-06	
J	Froese, L; Dian, J; Batson, C; Gomez, A; Sainbhi, AS; Unger, B; Zeiler, FA				Froese, Logan; Dian, Joshua; Batson, Carleen; Gomez, Alwyn; Sainbhi, Amanjyot Singh; Unger, Bertram; Zeiler, Frederick A.			Computer Vision for Continuous Bedside Pharmacological Data Extraction: A Novel Application of Artificial Intelligence for Clinical Data Recording and Biomedical Research	FRONTIERS IN BIG DATA			English	Article						computer vision; image modification; opitcal character recognition; system integration; data integration	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR REACTIVITY; QUALITY; IMPACT; MODEL	Introduction: As real time data processing is integrated with medical care for traumatic brain injury (TBI) patients, there is a requirement for devices to have digital output. However, there are still many devices that fail to have the required hardware to export real time data into an acceptable digital format or in a continuously updating manner. This is particularly the case for many intravenous pumps and older technological systems. Such accurate and digital real time data integration within TBI care and other fields is critical as we move towards digitizing healthcare information and integrating clinical data streams to improve bedside care. We propose to address this gap in technology by building a system that employs Optical Character Recognition through computer vision, using real time images from a pump monitor to extract the desired real time information. Methods: Using freely available software and readily available technology, we built a script that extracts real time images from a medication pump and then processes them using Optical Character Recognition to create digital text from the image. This text was then transferred to an ICM + real-time monitoring software in parallel with other retrieved physiological data. Results: The prototype that was built works effectively for our device, with source code openly available to interested end-users. However, future work is required for a more universal application of such a system. Conclusion: Advances here can improve medical information collection in the clinical environment, eliminating human error with bedside charting, and aid in data integration for biomedical research where many complex data sets can be seamlessly integrated digitally. Our design demonstrates a simple adaptation of current technology to help with this integration.	[Froese, Logan; Sainbhi, Amanjyot Singh; Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Dian, Joshua; Gomez, Alwyn; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Batson, Carleen; Gomez, Alwyn; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada; [Unger, Bertram] Univ Manitoba, Rady Fac Hlth Sci, Dept Med, Sect Crit Care, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England		Froese, L (corresponding author), Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada.	log.froese@gmail.com		Zeiler, Frederick/0000-0003-1737-0510; Sainbhi, Amanjyot Singh/0000-0003-3231-5683	Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; University of Manitoba Department of Surgery GFT Grant; University Research Grant Program (URGP); United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS) [R03NS114335-01]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [432061]; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation [38583]; Research Manitoba [3906]; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Centre on Aging; University of Manitoba Rudy Falk Clinician-Scientist Professorship; University of Manitoba-Department of Surgery GFT Research Grant; University of Manitoba Office of Research Services (ORS)-University Research Grant Program (URGP); Centre on Aging Fellowship at the University of Manitoba; University of Manitoba Clinician Investigator Program	This work was directly supported by the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the University of Manitoba Department of Surgery GFT Grant and University Research Grant Program (URGP). In addition, FAZ receives research support from the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS) (Grant #: R03NS114335-01), the Canadian Institutes of Health Research (CIHR) (Grant #: 432061), the Canada Foundation for Innovation (CFI) (Project #: 38583), Research Manitoba (Grant #: 3906), the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Centre on Aging, and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. LF is supported through the University of Manitoba-Department of Surgery GFT Research Grant,and the University of Manitoba Office of Research Services (ORS)-University Research Grant Program (URGP). CB is supported through the Centre on Aging Fellowship at the University of Manitoba. AG is supported through the University of Manitoba Clinician Investigator Program.	Allan J., 2003, SIGIR Forum, V37, P31; Le AD, 2019, LECT NOTES COMPUT SC, V11814, P705, DOI 10.1007/978-3-030-35653-8_50; [Anonymous], WELCOME PYSERIALS DO; [Anonymous], IM THRESH; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2005, ACT NEUR S, V95, P25; Barchard KA, 2011, COMPUT HUM BEHAV, V27, P1834, DOI 10.1016/j.chb.2011.04.004; Bradski G, 2000, OPENCV LIB; Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carvalho M.C., 2016, OPTICAL CHARACTER RE, P207, DOI [10.1002/9783527801954.app2, DOI 10.1002/9783527801954.APP2]; Carvalho M.C., 2021, MIAU MICROBALANCE AU, V10, DOI [10.1016/j.ohx.2021.e00215, DOI 10.1016/J.OHX.2021.E00215]; Carvalho MC, 2013, JALA-J LAB AUTOM, V18, P328, DOI 10.1177/2211068213476288; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Cheng H, 1997, IS&T 50TH ANNUAL CONFERENCE, FINAL PROGRAM AND PROCEEDINGS, P417; Delaney NF, 2013, JALA-J LAB AUTOM, V18, P171, DOI 10.1177/2211068212460237; Feng GT, 2006, IEEE T IMAGE PROCESS, V15, P3152, DOI 10.1109/TIP.2006.877493; Fischer S., 1995, P 3 ACM INT C MULT, P295, DOI [10.1145/217279.215283, DOI 10.1145/217279.215283]; Froese L, 2020, NEUROTRAUMA REP, V1, P157, DOI 10.1089/neur.2020.0028; Froese L, 2020, ACTA NEUROCHIR, V162, P2683, DOI 10.1007/s00701-020-04579-0; Hatchett S., 1991, NULL MODEM EMULATOR; Jung K, 2004, PATTERN RECOGN, V37, P977, DOI 10.1016/j.patcog.2003.10.012; Karthikeyan S., 2021, IEEE T CIRCUITS SYST, V1, DOI [10.1109/tcsvt.2021.3087641, DOI 10.1109/TCSVT.2021.3087641]; Kim S, 2002, INT C PATT RECOG, P216, DOI 10.1109/ICPR.2002.1047833; Klein SP, 2021, J NEUROTRAUM, V38, P506, DOI 10.1089/neu.2020.7160; Lee M, 2007, PYTESSERACT PYTHON T; Li HP, 2000, IEEE T IMAGE PROCESS, V9, P147, DOI 10.1109/83.817607; Li HP, 1999, ACM MULTIMEDIA 99, PROCEEDINGS, P19; Lundh F., 1999, INTRO TKINTER; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Matchett KB, 2017, CANCERS, V9, DOI 10.3390/cancers9110146; Mokhtar K, 2018, 2018 13TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS (DAS), P429, DOI 10.1109/DAS.2018.63; Namysl Marcin, 2019, 2019 International Conference on Document Analysis and Recognition (ICDAR). Proceedings, P295, DOI 10.1109/ICDAR.2019.00055; Oakley JP, 1998, IEEE T IMAGE PROCESS, V7, P167, DOI 10.1109/83.660994; OpenCV, CANNY EDGE DETECTION; Park SH, 1999, ELECTRON LETT, V35, P1475, DOI 10.1049/el:19990977; Schantz Herbert F., 1982, HIST OCR OPTICAL CHA; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Wemhoener D, 2013, PROC INT CONF DOC, P160, DOI 10.1109/ICDAR.2013.39; Witten I.H., 2004, INT J DIGIT LIB, V4, P56, DOI [10.1007/s00799-003-0066-4, DOI 10.1007/S00799-003-0066-4]; Yalniz I. Z., 2012, Proceedings of the 10th IAPR International Workshop on Document Analysis Systems (DAS 2012), P48, DOI 10.1109/DAS.2012.18; Yalniz IZ, 2019, IEEE T PATTERN ANAL, V41, P49, DOI 10.1109/TPAMI.2017.2780108; Yin Y, 2019, IEEE ACCESS, V7, P47043, DOI 10.1109/ACCESS.2019.2909401; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2021, J NEUROSURG ANESTH, V33, P28, DOI 10.1097/ANA.0000000000000616; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	48	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-909X		FRONT BIG DATA	Front. Big Data	AUG 27	2021	4								689358	10.3389/fdata.2021.689358			9	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Computer Science; Science & Technology - Other Topics	WV9TH	WOS:000717571100001	34514379	Green Published, gold			2022-02-06	
J	Pinggera, D; Steiger, R; Bauer, M; Kerschbaumer, J; Beer, R; Rietzler, A; Grams, AE; Gizewski, ER; Thom, C; Petr, O				Pinggera, Daniel; Steiger, Ruth; Bauer, Marlies; Kerschbaumer, Johannes; Beer, Ronny; Rietzler, Andreas; Grams, Astrid E.; Gizewski, Elke R.; Thome, Claudius; Petr, Ondra			Repeated P-31-Magnetic Resonance Spectroscopy in Severe Traumatic Brain Injury: Insights into Cerebral Energy Status and Altered Metabolism	JOURNAL OF NEUROTRAUMA			English	Article						cerebral energy status; cerebral metabolism; repeated neuroimaging; severe traumatic brain injury; P-31-magnetic resonance spectroscopy	POTENTIAL MECHANISMS; PHOSPHORUS	Phosphorous magnetic resonance spectroscopy (P-31-MRS) is suited to noninvasively investigate energy metabolism and to detect molecules containing phosphorus in the human brain. The aim of this longitudinal study was to perform P-31-MRS at two different time points (within 72 h and between day 10-14) after severe traumatic brain injury (sTBI) to reveal alterations in cerebral energy metabolism. Twenty-six ventilated patients with sTBI, aged between 20 and 75 years, with a median initial Glasgow Coma Scale score of 5 were analyzed prospectively. The P-31-MRS data of the structurally more affected side were compared with data from contralateral normal appearing areas and with data of age- and gender-matched healthy controls. There were no significant intraindividual differences between the lesioned and the less affected side at either of the time points. In the acute phase, phosphocreatine/adenosine triphosphate (PCr/ATP) and phosphocreatine/inorganic phosphate (PCr/Pi) were significantly elevated whereas phosphomonoesters/phosphodiesters (PME/PDE) and Pi/ATP were significantly decreased in contrast to healthy controls. In the subacute phase, these differences gradually dissipated, remaining lower Pi/ATP ratio, and only partly altered levels of PCr/Pi and PME/PDE. Our data affirm that cerebral metabolism is globally altered after sTBI, demonstrating the diffuse impairment of brain bioenergetics at multiple levels, with resultant developments in terms of time.	[Pinggera, Daniel; Bauer, Marlies; Kerschbaumer, Johannes; Thome, Claudius; Petr, Ondra] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Steiger, Ruth; Rietzler, Andreas; Grams, Astrid E.; Gizewski, Elke R.] Med Univ Innsbruck, Dept Neuroradiol, Anichstr 35, A-6020 Innsbruck, Austria; [Beer, Ronny] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Rietzler, Andreas; Grams, Astrid E.; Gizewski, Elke R.] Med Univ Innsbruck, Neuroimaging Res Core Facil, Innsbruck, Austria		Steiger, R (corresponding author), Med Univ Innsbruck, Dept Neuroradiol, Anichstr 35, A-6020 Innsbruck, Austria.	ruth.steiger@i-med.ac.at	Bauer, Marlies/ABC-2537-2021	Bauer, Marlies/0000-0002-2338-8349; Gizewski, Elke Ruth/0000-0001-6859-8377			Agoston DV, 2019, J NEUROTRAUM, V36, P1724, DOI 10.1089/neu.2018.6261; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Bender M, 2021, J INTENSIVE CARE MED, V36, P419, DOI 10.1177/0885066619891063; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; CADOUXHUDSON TAD, 1990, ACTA NEUROCHIR, V104, P1, DOI 10.1007/BF01842884; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Daly, 1987, PHOSPHOLIPID METABOL; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Hattingen E, 2009, MAGN RESON MATER PHY, V22, P33, DOI 10.1007/s10334-008-0145-z; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Kamble RB, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/10176.5139; Kemp GJ, 2000, DEV NEUROSCI-BASEL, V22, P418, DOI 10.1159/000017471; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langan C, 2009, MOL PSYCHIATR, V14, P833, DOI 10.1038/mp.2009.39; Liu YC, 2017, QUANT IMAG MED SURG, V7, P707, DOI 10.21037/qims.2017.11.03; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; NILSSON L, 1974, J NEUROCHEM, V23, P29, DOI 10.1111/j.1471-4159.1974.tb06912.x; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pinggera D, 2021, NEUROCRIT CARE, V34, P432, DOI 10.1007/s12028-020-01042-x; Pinggera D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00219; Shi XF, 2015, BIPOLAR DISORD, V17, P743, DOI 10.1111/bdi.12339; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Steiger Ruth, 2018, Case Rep Radiol, V2018, P7806395, DOI 10.1155/2018/7806395; Stovell MG, 2020, J CEREBR BLOOD F MET, V40, P67, DOI 10.1177/0271678X18799176; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Veiga Viviane Cordeiro, 2019, Rev. bras. ter. intensiva, V31, P15, DOI [10.5935/0103-507X.20190003, 10.5935/0103-507x.20190003]; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	48	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2822	2830		10.1089/neu.2021.0143		AUG 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000696020700001	34235953				2022-02-06	
J	Race, NS; Andrews, KD; Lungwitz, EA; Alvarez, SMV; Warner, TR; Acosta, G; Cao, JY; Lu, KH; Liu, ZM; Dietrich, AD; Majumdar, S; Shekhar, A; Truitt, WA; Shi, RY				Race, Nicholas S.; Andrews, Katharine D.; Lungwitz, Elizabeth A.; Alvarez, Sasha M. Vega; Warner, Timothy R.; Acosta, Glen; Cao, Jiayue; Lu, Kun-han; Liu, Zhongming; Dietrich, Amy D.; Majumdar, Sreeparna; Shekhar, Anantha; Truitt, William A.; Shi, Riyi			Psychosocial impairment following mild blast-induced traumatic brain injury in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Psychosocial; Safety learning; Brain injury; Head trauma; Blast	METABOTROPIC GLUTAMATE RECEPTORS; CONDITIONED FEAR RESPONSES; TANDEM MASS-SPECTROMETRY; MEDIAL PREFRONTAL CORTEX; SOCIAL COGNITION; OXIDATIVE STRESS; INDUCED TINNITUS; HUMAN URINE; PSYCHIATRIC-DISORDERS; LIQUID-CHROMATOGRAPHY	Traumatic brain injury (TBI) is associated with increased risk for mental health disorders, impacting post-injury quality of life and societal reintegration. TBI is also associated with deficits in psychosocial processing, defined as the cognitive integration of social and emotional behaviors, however little is known about how these deficits manifest and their contributions to post-TBI mental health. In this pre-clinical investigation using rats, a single mild blast TBI (mbTBI) induced impairment of psychosocial processing in the absence of confounding physical polytrauma, post-injury motor deficits, affective abnormalities, or deficits in non-social behavior. Impairment severity correlated with acute upregulations of a known oxidative stress metabolite, 3-hydroxypropylmercapturic acid (3-HPMA), in urine. Resting state fMRI alterations in the acute post-injury period implicated key brain regions known to regulate psychosocial behavior, including orbitofrontal cortex (OFC), which is congruent with our previous report of elevated acrolein, a marker of neurotrauma and 3-HPMA precursor, in this region following mbTBI. OFC of mbTBI-exposed rats demonstrated elevated mRNA expression of metabotropic glutamate receptors 1 and 5 (mGluR1/5) and injection of mGluR1/5-selective agonist in OFC of uninjured rats approximated mbTBI-induced psychosocial processing impairment, demonstrating a novel role for OFC in this psychosocial behavior. Furthermore, OFC may serve as a hotspot for TBI-induced disruption of psychosocial processing and subsequent mental health disorders.	[Race, Nicholas S.; Cao, Jiayue; Liu, Zhongming; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN USA; [Race, Nicholas S.; Andrews, Katharine D.] Indiana Univ Sch Med, Training Program, Indianapolis, IN 46202 USA; [Andrews, Katharine D.; Lungwitz, Elizabeth A.; Warner, Timothy R.; Dietrich, Amy D.; Majumdar, Sreeparna; Shekhar, Anantha; Truitt, William A.] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Andrews, Katharine D.; Lungwitz, Elizabeth A.; Majumdar, Sreeparna] Indiana Univ Sch Med, Program Med Neurosci, Indianapolis, IN 46202 USA; [Alvarez, Sasha M. Vega; Shi, Riyi] Purdue Univ, PULSe Interdisciplinary Life Sci Program, W Lafayette, IN USA; [Warner, Timothy R.; Dietrich, Amy D.; Truitt, William A.] Indiana Univ Sch Med, Dept Anat Cellular Biol & Physiol, Indianapolis, IN 46202 USA; [Acosta, Glen; Shi, Riyi] Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN USA; [Cao, Jiayue; Lu, Kun-han; Liu, Zhongming; Shi, Riyi] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN USA; [Lu, Kun-han; Liu, Zhongming] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN USA; [Shekhar, Anantha] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Shekhar, Anantha] Indiana Univ Sch Med, Indiana Clin & Translat Sci Inst, Indianapolis, IN 46202 USA; [Shi, Riyi] Ctr Paralysis Res, W Lafayette, IN USA		Truitt, WA (corresponding author), 320W 15th St Off 314G, Indianapolis, IN 46202 USA.; Shi, RY (corresponding author), 625 Harrison St, W Lafayette, IN 47907 USA.	btruitt@iu.edu; riyi@purdue.edu		Andrews, Katharine/0000-0001-6072-5423; Liu, Zhongming/0000-0002-8773-4204; Majumdar, Sreeparna/0000-0002-3564-3853; Race, Nicholas/0000-0002-2683-1692	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Center for Advancing Translational Sciences, of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [R01MH106568, R01MH104402, R21NS090244, R21NS115094, UL1TR002529]; Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health [204200, 19920]; Indiana Clinical and Translational Sciences Institute through Collaboration in Biomedical Translational Research (CBR/CTR) Pilot Program Grant [RR025761]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	Research reported in this publication was supported by National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, and National Center for Advancing Translational Sciences, of the National Institutes of Health under award numbers R01MH106568 to WT, R01MH104402 to ZL, R21NS090244 & R21NS115094 to RS and UL1TR002529 to AS. This work was also supported in part by the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (Grants No. 204200 to R.S. & 19920 to W.T.), and Indiana Clinical and Translational Sciences Institute through Collaboration in Biomedical Translational Research (CBR/CTR) Pilot Program Grant (Grant No. RR025761 to RS & WT).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Acosta G., 2019, MOL CELL NEUROSCI; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Anderson KM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03811-x; Baldwin SA, 2007, J CONSULT CLIN PSYCH, V75, P842, DOI 10.1037/0022-006X.75.6.842; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Carmella SG, 2007, CHEM RES TOXICOL, V20, P986, DOI 10.1021/tx700075y; Carter GC, 2012, DEPRESS ANXIETY, V29, P340, DOI 10.1002/da.21918; Cf.D.Ca. Prevention, 2015, REPORT C TRAUMATIC B; Chen CH, 2013, ANAL CHEM, V85, P11843, DOI 10.1021/ac4025279; CHERMAT R, 1986, J PHARMACOL-PARIS, V17, P348; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Christianson JP, 2012, J NEUROSCI, V32, P14118, DOI 10.1523/JNEUROSCI.3340-12.2012; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1200506109, 10.1073/pnas.1101934108]; Dour HJ, 2014, DEPRESS ANXIETY, V31, P436, DOI 10.1002/da.22216; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Drew PJ, 2019, CURR OPIN NEUROBIOL, V58, P61, DOI 10.1016/j.conb.2019.06.004; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Eckert E, 2010, J CHROMATOGR B, V878, P2506, DOI 10.1016/j.jchromb.2009.09.003; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; FILE SE, 1984, POL J PHARMACOL PHAR, V36, P505; Garcia-Gonzalez D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28271-7; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hornstein EA, 2018, CURR DIR PSYCHOL SCI, V27, P25, DOI 10.1177/0963721417729036; Izquierdo A, 2017, J NEUROSCI, V37, P10529, DOI 10.1523/JNEUROSCI.1678-17.2017; Jennings JH, 2019, NATURE, V565, P645, DOI 10.1038/s41586-018-0866-8; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Kiyokawa Y, 2014, BEHAV BRAIN RES, V267, P189, DOI 10.1016/j.bbr.2014.03.043; KOLB B, 1974, PHYSIOL BEHAV, V13, P637, DOI 10.1016/0031-9384(74)90234-0; Kong E, 2014, NEUROPSYCHOPHARMACOL, V39, P515, DOI 10.1038/npp.2013.191; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lungwitz EA, 2014, NEUROPSYCHOPHARMACOL, V39, P1009, DOI 10.1038/npp.2013.302; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; Majumdar S, 2018, NEUROBIOLOGY OF ABNORMAL EMOTION AND MOTIVATED BEHAVIORS: INTEGRATING ANIMAL AND HUMAN RESEARCH, P225, DOI 10.1016/B978-0-12-813693-5.00012-5; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Mikami K, 2016, PHYSIOL BEHAV, V163, P123, DOI 10.1016/j.physbeh.2016.05.001; Miller S.C, 2015, OCCUP ENVIRON MED; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mukherjee S, 2013, NEUROPHARMACOLOGY, V66, P65, DOI 10.1016/j.neuropharm.2012.06.005; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Newman AJ, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002183; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Orff H.J, 2015, J SLEEP DISORD, V2016; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Parent RA, 1998, TOXICOL SCI, V43, P110, DOI 10.1093/toxsci/43.2.110; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; Pollak DD, 2010, ANN MED, V42, P115, DOI 10.3109/07853890903583666; Ponsford J., 2018, J NEUROPSYCHIATRY CL; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Race N, 2017, J NEUROPHYSIOL; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sagara Y, 1998, J NEUROSCI, V18, P6662; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Sarlitto MC, 2018, NEUROSCIENCE, V379, P350, DOI 10.1016/j.neuroscience.2018.03.037; Schettgen T, 2008, RAPID COMMUN MASS SP, V22, P2629, DOI 10.1002/rcm.3659; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; SHEKHAR A, 1995, PHARMACOL BIOCHEM BE, V50, P253, DOI 10.1016/0091-3057(94)00307-5; Shi R., 2019, ANIMAL MODELS ACUTE, P367; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Song S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16959; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Truitt WA, 2007, PSYCHOPHARMACOLOGY, V191, P107, DOI 10.1007/s00213-006-0674-y; Truitt WA, 2015, PSYCHOPHARMACOLOGY, V232, P639, DOI 10.1007/s00213-014-3702-3; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van der Kooij MA, 2012, NEUROSCI BIOBEHAV R, V36, P1763, DOI 10.1016/j.neubiorev.2011.10.006; Walls M.K, 2015, J NEUROSURG; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yan WY, 2010, J CHROMATOGR SCI, V48, P194, DOI 10.1093/chromsci/48.3.194; Zheng LX, 2013, J NEUROTRAUM, V30, P1334, DOI 10.1089/neu.2013.2888	102	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 27	2021	412								113405	10.1016/j.bbr.2021.113405			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TH5WJ	WOS:000672159800004	34097900				2022-02-06	
J	Sowter, N; King, L; Calderbank, A; Eccles, FJR				Sowter, Natalie; King, Lorraine; Calderbank, Amy; Eccles, Fiona J. R.			Factors predicting first appointment attendance at a traumatic brain injury clinical neuropsychology outpatient clinic: a logistic regression analysis	DISABILITY AND REHABILITATION			English	Article; Early Access						Logistic regression; patient appointments; TBI; traumatic brain injury; triage; waiting lists	NONATTENDANCE; NEUROREHABILITATION; REHABILITATION; THERAPY	Background The purpose of our study was to investigate factors which predicted first appointment attendance within a traumatic brain injury (TBI) neuropsychology outpatient department. Materials and methods A newly introduced telephone triaging system was implemented in a clinical neuropsychology service for individuals with a TBI. The effects of receiving a triage telephone call, amongst other variables, were analysed as predictors of attendance at the first face-to-face clinic appointment. The data from 161 individuals were analysed using routine patient information collected by the clinical neuropsychology service. Logistic regression analyses were performed to investigate predictors of first appointment clinic attendance. Results Logistic regression analyses identified higher age, shorter waiting times, and answering the triage call as potential predictors of attendance, highlighting where the service might focus efforts to facilitate attendance. Conclusions Both patient and service factors were found to be significant predictors of patient attendance. Further service evaluation could explore patients' experiences of triage telephone calls, and investigate relationships between waiting times and neuropsychological outcomes.	[Sowter, Natalie; Eccles, Fiona J. R.] Univ Lancaster, Fac Hlth & Med, Lancaster, England; [Sowter, Natalie; King, Lorraine; Calderbank, Amy] Salford Royal NHS Fdn Trust, Dept Clin Neuropsychol, Salford, Lancs, England		Sowter, N (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster, England.; Sowter, N (corresponding author), Salford Royal Hosp, Dept Clin Neuropsychol, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	natalie.sowter2@srft.nhs.uk		Eccles, Fiona Juliet Rosalind/0000-0003-1484-2703			Adeponle AB, 2007, MENT HEALTH RELIG CU, V10, P609, DOI 10.1080/13674670601054024; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Carey TA, 2009, COGN BEH THER, V2, P211, DOI 10.1017/S1754470X09000208; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Daniels MK, 2009, J FORENSIC PSYCHI PS, V20, P964, DOI 10.1080/14789940903174204; Division of Neuropsychology, 2015, CLIN NEUROPSYCHOLOGY; Faiz KW, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3057-2; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gallucci G, 2005, PSYCHIAT SERV, V56, P344, DOI 10.1176/appi.ps.56.3.344; Giunta D, 2013, PATIENT PREFER ADHER, V7, P1163, DOI 10.2147/PPA.S51841; Greenwood R, 2004, BRIT J NEUROSURG, V18, P573, DOI 10.1080/02688690400022888; Howitt D, 2011, INTRO SPSS STAT PSYC, VFifth; King L., 2017, NEUROPSYCHOLOGIST, V3, P54; Kruse GR, 2002, PSYCHIATR SERV, V53, P1173, DOI 10.1176/appi.ps.53.9.1173; Lam Kenneth, 2018, CMAJ Open, V6, pE587, DOI 10.9778/cmajo.20180069; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Leung GM, 2003, MED CARE, V41, P1293, DOI 10.1097/01.MLR.0000093481.93107.C2; MacDonald J, 2000, PSYCHIAT SERV, V51, P812, DOI 10.1176/appi.ps.51.6.812; Mark RE, 2014, CLIN NEUROPSYCHOL, V28, P49, DOI 10.1080/13854046.2013.854837; McLean S, 2014, HEAL SERV DELIV RES, V2, P1, DOI 10.3310/hsdr02340; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Parente R., 2011, ENCY CLIN NEUROPSYCH; Parikh A, 2010, AM J MED, V123, P542, DOI 10.1016/j.amjmed.2009.11.022; Paterson BL., 2010, J NURS HEALTHC CHRON, V2, P63, DOI [10.1111/j.1752-9824.2010.01048.x, DOI 10.1111/J.1752-9824.2010.01048.X]; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sheridan R, 2019, CANCER EPIDEMIOL, V63, DOI 10.1016/j.canep.2019.101588; Snell D, 2006, NEW ZEAL MED J, V119, P66; Sowter N., 2019, NEUROPSYCHOLOGIST, V8, P46; Taylor NF, 2012, ARCH PHYS MED REHAB, V93, P21, DOI 10.1016/j.apmr.2011.08.007; Thompson JN, 2013, BRIT J NEUROSURG, V27, P24, DOI 10.3109/02688697.2012.714818; Ulrichsen KM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00912; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Yeates G.N., 2013, NEURODISABILITY PSYC, V1, P151	35	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1970254		AUG 2021	6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	UI8EU	WOS:000690833900001	34482782	hybrid			2022-02-06	
J	Zheng, P; Bai, QK; Feng, JG; Zhao, B; Duan, J; Zhao, L; Liu, N; Ren, DB; Zou, SF; Chen, W				Zheng, Ping; Bai, Qingke; Feng, Jiugeng; Zhao, Bing; Duan, Jian; Zhao, Lin; Liu, Ning; Ren, Dabin; Zou, Shufeng; Chen, Wei			Neonatal microglia and proteinase inhibitors-treated adult microglia improve traumatic brain injury in rats by resolving the neuroinflammation	BIOENGINEERING & TRANSLATIONAL MEDICINE			English	Article						adult microglia; neonatal microglia; protease inhibitor; traumatic brain injury	PATHOPHYSIOLOGY; ACTIVATION; EXPRESSION; PHENOTYPE; CELLS	Microglia participate in the regulation of neuroinflammation caused by traumatic brain injury (TBI). This research aimed to explore the repair effects of intracranial injection of neonatal microglia or protease-treated adult microglia on TBI in rat model. Lateral fluid percussion injury was used to establish rat brain injury model. E64 and serpinA3N were employed for the treatment of adult microglia. Cleaved caspase-3 level was analyzed through immunoblotting assay. Enzyme-linked immunosorbent assay was employed to analyze cytokine and chemokine levels. Astrocytosis and microgliosis were shown by immunofluorescence. The cognitive function of rats was analyzed by water maze. The injection of neonatal microglia inhibited cell apoptosis, reduced astrocytosis and microgliosis, decreased the level of chemokines and cytokines in cortex and ipsilateral hippocampus, and improved cognitive function of TBI rat model. The transplantation of peptidase inhibitors-treated adult microglia also inhibited cell apoptosis, reduced astrocytosis and microgliosis, and improved cognitive function of rats with TBI. The transplantation of either neonatal microglia or peptidase inhibitors-treated adult microglia significantly inhibited the pathogenesis of TBI in rat model, while untreated adult microglia showed no significant effect.	[Zheng, Ping; Chen, Wei] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Neurosurg, Shanghai 200120, Peoples R China; [Bai, Qingke] Peoples Hosp Shanghai Pudong New Area, Dept Neurol, Shanghai, Peoples R China; [Feng, Jiugeng; Duan, Jian; Zou, Shufeng] Nanchang Univ, Dept Neurosurg, Affiliated Hosp 1, Nanchang 330008, Jiangxi, Peoples R China; [Zhao, Bing; Ren, Dabin; Chen, Wei] Peoples Hosp Shanghai Pudong New Area, Dept Neurosurg, Shanghai 201299, Peoples R China; [Zhao, Lin; Liu, Ning] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 330008, Peoples R China		Chen, W (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Med, Dept Neurosurg, Shanghai 200120, Peoples R China.; Zou, SF (corresponding author), Nanchang Univ, Dept Neurosurg, Affiliated Hosp 1, Nanchang 330008, Jiangxi, Peoples R China.; Chen, W (corresponding author), Peoples Hosp Shanghai Pudong New Area, Dept Neurosurg, Shanghai 201299, Peoples R China.; Chen, W (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 330008, Peoples R China.	1812492699@qq.com; weichen445@163.com		Zheng, Ping/0000-0002-3928-3875; Chen, Wei/0000-0001-7438-3241	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82171366, 81771332, 81571184, 81960236]; Outstanding Youth Project of Jiangxi Province [2020ACBL216005]; Shanghai Natural Science FoundationNatural Science Foundation of Shanghai [19ZR1447400]; Key Discipline Construction Project of Pudong Health Bureau of Shanghai [PWZxk2017-23]; Leading Personnel Training Program of Pudong New Area Health System [PWR12018-07]; Key project of Jiangxi Provincial Department of Education [GJJ190022]	National Natural Science Foundation of China, Grant/Award Numbers: 82171366, 81771332, 81571184, 81960236; Outstanding Youth Project of Jiangxi Province, Grant/Award Number: 2020ACBL216005; Shanghai Natural Science Foundation, Grant/Award Number: 19ZR1447400; Key Discipline Construction Project of Pudong Health Bureau of Shanghai, Grant/Award Number: PWZxk2017-23; Leading Personnel Training Program of Pudong New Area Health System, Grant/Award Number: PWR12018-07; Key project of Jiangxi Provincial Department of Education, Grant/Award Number: GJJ190022	Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen W, 2019, J CHEM NEUROANAT, V99, P1, DOI 10.1016/j.jchemneu.2019.05.003; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; GLENN JA, 1992, J ANAT, V180, P109; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Habib P, 2014, J MOL NEUROSCI, V52, P277, DOI 10.1007/s12031-013-0137-y; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hughes AN, 2020, NAT NEUROSCI, V23, P1055, DOI 10.1038/s41593-020-0654-2; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kou DW, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20187076, 10.1590/1414-431x20187076]; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Laffer B, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00430; Li Y, 2020, NATURE, V587, P613, DOI 10.1038/s41586-020-2795-6; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Miya D, 1997, J NEUROSCI, V17, P4856; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7	33	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2380-6761		BIOENG TRANSL MED	Bioeng. Transl. Med.	JAN	2022	7	1							e10249	10.1002/btm2.10249		AUG 2021	9	Biotechnology & Applied Microbiology; Engineering, Biomedical; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Engineering; Pharmacology & Pharmacy	YK3MA	WOS:000689705600001	35079627	gold, Green Published, Green Accepted			2022-02-06	
J	Choi, JE; Chang, YR; Mun, IK; Jung, JY; Lee, MY; Yun, JH				Choi, Ji Eun; Chang, Ye Rim; Mun, In-Kwon; Jung, Jae Yun; Lee, Min Young; Yun, Jung-Ho			Inner Ear Symptoms Are Prevalent in Patients with High Head Abbreviated Injury Scale Scores after Blunt Head Trauma	AUDIOLOGY AND NEURO-OTOLOGY			English	Article; Early Access						Brain injuries; Scale; Hearing loss; Dizziness; Nystagmus	SENSORINEURAL HEARING-LOSS; BRAIN-INJURY; DIZZINESS; VERTIGO	Introduction: The purpose of this article was to determine the prevalence of inner ear symptoms in patients with blunt head trauma and to explore whether the severity of head trauma was associated with the incidence of such symptoms. Methods: We performed a retrospective review of 56 patients admitted with blunt head trauma who underwent audiovestibular evaluation within 1 month after injury. Two scales were used to measure the severity of trauma; these were the Glasgow Coma Scale (GCS) and the Head Abbreviated Injury Scale (H-AIS). Patients with sensorineural-type hearing loss, or dizziness with nystagmus, were considered to have inner ear symptoms. Results: About half of all patients (45%) with blunt head trauma showed trauma-related inner ear symptoms. Patients with inner ear symptoms were significantly more likely to have H-AIS scores >= 4 than those without inner ear symptoms (p = 0.004), even without concomitant temporal bone fracture (p > 0.05). Also, patients with inner ear symptoms required a statistically significantly longer time (measured from admission) before undergoing their ontological evaluations than did those without such symptoms (p = 0.002), possibly due to prolonged bed rest and use of sedatives. Conclusion: Thus, detailed history-taking and early evaluation using trauma scales are essential for all patients suffering from severe head trauma. It may be necessary to initiate early treatment of traumatic inner ear diseases.	[Choi, Ji Eun; Mun, In-Kwon; Jung, Jae Yun; Lee, Min Young] Dankook Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Cheonan, South Korea; [Chang, Ye Rim] Dankook Univ Hosp, Trauma Ctr, Dept Trauma Surg, Cheonan, South Korea; [Chang, Ye Rim] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea; [Yun, Jung-Ho] Dankook Univ Hosp, Trauma Ctr, Dept Neurosurg, Cheonan, South Korea		Lee, MY (corresponding author), Dankook Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Cheonan, South Korea.; Yun, JH (corresponding author), Dankook Univ Hosp, Trauma Ctr, Dept Neurosurg, Cheonan, South Korea.	eyeglass210@gmail.com; tjburk@hanmail.net	Lee, Min Young/AAM-8435-2020	Lee, Min Young/0000-0002-6860-8042	Basic Science Research -Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2020R1A6A1A03043283]	This research was supported by the Basic Science Research -Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1A6A1A03043283).	Adeleye AO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00695; Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; BROWNSON RJ, 1986, LARYNGOSCOPE, V96, P166; Brusis T, 2011, LARYNGO RHINO OTOL, V90, P73, DOI 10.1055/s-0030-1267938; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; de Clercq H, 2017, SAMJ S AFR MED J, V107, P957, DOI [10.7196/SAMJ.2017.v107i11.12472, 10.7196/samj.2017.v107i11.12472]; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz RC, 2016, J NEUROL SURG PART B, V77, P419, DOI 10.1055/s-0036-1584197; Emerson LP, 2011, INDIAN J OTOLARYNGOL, V63, P45, DOI 10.1007/s12070-011-0117-x; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; GYO K, 1988, LARYNGOSCOPE, V98, P332; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Kim MT, 2019, ACTA OTO-LARYNGOL, V139, P552, DOI [10.1080/00016489.2019.1606438, 10.1080/00016489.2019.1685682]; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Lacour M, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00285; Lee SU, 2014, OTOL NEUROTOL, V35, P495, DOI 10.1097/MAO.0000000000000250; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Macdonald NK, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00141; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; SCHUKNECHT HF, 1969, ANN OTO RHINOL LARYN, V78, P253, DOI 10.1177/000348946907800205	22	0	0	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-3030	1421-9700		AUDIOL NEURO-OTOL	Audiol. Neuro-Otol.												10.1159/000518189		AUG 2021	8	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	UK7NQ	WOS:000692153400001	34515057				2022-02-06	
J	Craig, A; Pozzato, I; Arora, M; Middleton, J; Rodrigues, D; McBain, C; Tran, Y; Davis, GM; Gopinath, B; Kifley, A; Krassioukov, A; Braithwaite, J; Mitchell, R; Gustin, SM; Schoffl, J; Cameron, ID				Craig, Ashley; Pozzato, Ilaria; Arora, Mohit; Middleton, James; Rodrigues, Dianah; McBain, Candice; Tran, Yvonne; Davis, Glen M.; Gopinath, Bamini; Kifley, Annette; Krassioukov, Andrei; Braithwaite, Jeffrey; Mitchell, Rebecca; Gustin, Sylvia M.; Schoffl, Jacob; Cameron, Ian D.			A neuro-cardiac self-regulation therapy to improve autonomic and neural function after SCI: a randomized controlled trial protocol	BMC NEUROLOGY			English	Article						Respiration; Electrocardiography; Electroencephalography; Near infra-red spectroscopy; heart rate variability feedback; cognitive impairment; mood disorder; autonomic nervous system; spinal cord injury	HEART-RATE-VARIABILITY; SPINAL-CORD-INJURY; COGNITIVE IMPAIRMENT; MOOD STATES; PAIN; BIOFEEDBACK; FATIGUE; RELIABILITY; VALIDITY; ADULTS	Background: Spinal cord injury (SCI) is associated with autonomic imbalance and significant secondary conditions, including cardiac and brain dysfunction that adversely impact health and wellbeing. This study will investigate the effectiveness (intention-to-treat) of a neuro-cardiac self-regulation therapy to improve autonomic and neural/brain activity in adults with SCI living in the community. Methods: A two-arm parallel, randomised controlled trial in which adults with SCI living in the community post-rehabilitation will be randomly assigned to a treatment or control group. The treatment group (N = 60) aged 18-70 years with a chronic traumatic or non-traumatic SCI, will receive intervention sessions once per week for 10 weeks, designed to regulate autonomic activity using computer-based feedback of heart rate variability and controlled breathing (called HRV-F). Comprehensive neurophysiological and psychological assessment will occur at baseline, immediate post-treatment, and 6 and 12-months post-treatment. Primary outcome measures include electrocardiography/heart rate variability (to assess autonomic nervous system function) and transcranial doppler sonography (to assess cerebral blood circulation in basal cerebral arteries). Secondary outcomes measures include continuous blood pressure, electroencephalography, functional near-infrared spectroscopy, respiration/breath rate, electrooculography, cognitive capacity, psychological status, pain, fatigue, sleep and quality of life. Controls (N = 60) will receive usual community care, reading material and a brief telephone call once per week for 10 weeks and be similarly assessed over the same time period as the HRV-F group. Linear mixed model analysis with repeated measures will determine effectiveness of HRV-F and latent class mixture modelling used to determine trajectories for primary and selected secondary outcomes of interest. Discussion: Treatments for improving autonomic function after SCI are limited. It is therefore important to establish whether a neuro-cardiac self-regulation therapy can result in improved autonomic functioning post-SCI, as well as whether HRV-F is associated with better outcomes for secondary conditions such as cardiovascular health, cognitive capacity and mental health.	[Craig, Ashley; Pozzato, Ilaria; Arora, Mohit; Middleton, James; Rodrigues, Dianah; McBain, Candice; Kifley, Annette; Schoffl, Jacob; Cameron, Ian D.] Univ Sydney, John Walsh Ctr Rehabil Res, Northern Sydney Local Hlth Dist, Kolling Inst,Northern Clin Sch,Fac Med & Hlth, St Leonards, NSW 2065, Australia; [Tran, Yvonne; Gopinath, Bamini] Macquarie Univ, Macquarie Univ Hearing MU Hearing, N Ryde, NSW 2113, Australia; [Davis, Glen M.] Univ Sydney, Fac Med & Hlth, Exercise & Sports Sci, Sydney, NSW, Australia; [Krassioukov, Andrei] Univ British Columbia, Fac Med, ICORD, Columbia, BC V5Z 1M9, Canada; [Braithwaite, Jeffrey; Mitchell, Rebecca] Macquarie Univ, Ctr Healthcare Resilience & Implementat Sci, Australian Inst Hlth Innovat, Hlth Syst Res, N Ryde, NSW 2113, Australia; [Gustin, Sylvia M.] Univ New South Wales, Fac Sci, Sch Psychol, Kensington, NSW, Australia		Craig, A (corresponding author), Univ Sydney, John Walsh Ctr Rehabil Res, Northern Sydney Local Hlth Dist, Kolling Inst,Northern Clin Sch,Fac Med & Hlth, St Leonards, NSW 2065, Australia.	a.craig@sydney.edu.au	Arora, Mohit/D-3373-2015; Braithwaite, Jeffrey/AAN-1467-2020; Mitchell, Rebecca/J-6105-2012	Arora, Mohit/0000-0003-1024-3682; Braithwaite, Jeffrey/0000-0003-0296-4957; Schoffl, Jacob/0000-0003-4582-732X; Mitchell, Rebecca/0000-0003-1939-1761; Craig, Ashley/0000-0001-7647-7604; Tran, Yvonne/0000-0002-1741-4205	NSW Ministry of Health, Australia; University of Sydney, AustraliaUniversity of Sydney	The study was competitively funded by the NSW Ministry of Health, Australia and The University of Sydney, Australia. The NSW Ministry of Health peer reviewed the application, seeking international anonymous reviews on the research protocol from international experts which the investigators were able to address. Otherwise, the funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results.	Ali R, 2002, ADDICTION, V97, P1183; Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Bazanova O. M., 2013, Human Physiology, V39, P86, DOI 10.1134/S0362119712060035; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Biering-Sorensen F, 2018, AUTON NEUROSCI-BASIC, V209, P4, DOI 10.1016/j.autneu.2017.02.004; Boord P, 2008, SPINAL CORD, V46, P118, DOI 10.1038/sj.sc.3102077; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chen WL, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00724; Clay-Williams R, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-369; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Craig A, 2018, J PSYCHOSOM RES, V112, P90, DOI 10.1016/j.jpsychores.2018.07.007; Craig A, 2020, SPINAL CORD, V58, P831, DOI 10.1038/s41393-020-0425-7; Craig A, 2017, J PAIN, V18, P800, DOI 10.1016/j.jpain.2017.02.431; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Craig A, 2012, J PSYCHOSOM RES, V73, P205, DOI 10.1016/j.jpsychores.2012.07.005; Darrow D, 2019, J NEUROTRAUM, V36, P2325, DOI 10.1089/neu.2018.6006; Del Pozo JM, 2004, AM HEART J, V147, pG1, DOI 10.1016/j.ahj.2003.08.013; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; Faul F., 2014, G POWER VERSION 3 1; Forchheimer MB, 2011, ARCH PHYS MED REHAB, V92, P419, DOI 10.1016/j.apmr.2010.08.029; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Giannoccaro MP, 2013, SLEEP MED REV, V17, P399, DOI 10.1016/j.smrv.2012.12.005; Goessl VC, 2017, PSYCHOL MED, V47, P2578, DOI 10.1017/S0033291717001003; Grassner L, 2016, THER ADV NEUROL DISO, V9, P85, DOI 10.1177/1756285615621687; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hassett AL, 2007, APPL PSYCHOPHYS BIOF, V32, P1, DOI 10.1007/s10484-006-9028-0; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hubli M, 2015, AM J HYPERTENS, V28, P173, DOI 10.1093/ajh/hpu122; Kalpakjian CZ, 2007, J SPINAL CORD MED, V30, P131, DOI 10.1080/10790268.2007.11753924; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kushki A, 2011, PHYSIOL MEAS, V32, P1529, DOI 10.1088/0967-3334/32/10/002; Lehrer F, 2006, CHEST, V129, P278, DOI 10.1378/chest.129.2.278; Lehrer PM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00756; Little RJ, 1999, STAT MED, V18, P2465, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2465::AID-SIM269>3.0.CO;2-2; McDonald SD, 2018, REHABIL PSYCHOL, V63, P372, DOI 10.1037/rep0000230; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Middleton JW, 2016, ARCH PHYS MED REHAB, V97, P2130, DOI 10.1016/j.apmr.2016.05.027; Monteiro, 2010, ALCOHOL SMOKING SUBS; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nolan RP, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2005.03.015; Oikawa O., 2007, JAPANESE J BIOFEEDBA, V34, P17; Park G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00278; Phillips AA, 2018, J NEUROTRAUM, V35, P446, DOI 10.1089/neu.2017.5082; Phillips AA, 2013, J NEUROTRAUM, V30, P1551, DOI 10.1089/neu.2013.2972; Prinsloo GE, 2013, APPL PSYCHOPHYS BIOF, V38, P45, DOI 10.1007/s10484-012-9207-0; Rabbia F, 2004, CLIN DRUG INVEST, V24, P651, DOI 10.2165/00044011-200424110-00004; Rodrigues D, 2016, SPINAL CORD, V54, P292, DOI 10.1038/sc.2015.174; Sachdeva R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102464; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Sandalic D, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01899-7; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Shaffer F, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.570400; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Sitaram R, 2017, NAT REV NEUROSCI, V18, P86, DOI 10.1038/nrn.2016.164; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Tran Y, 2004, SPINAL CORD, V42, P73, DOI 10.1038/sj.sc.3101543; Tran Y, 2009, J PSYCHOPHYSIOL, V23, P143, DOI 10.1027/0269-8803.23.3.143; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; Walterfang M, 2006, AUST NZ J PSYCHIAT, V40, P995, DOI 10.1111/j.1440-1614.2006.01923.x; Wan D, 2014, J SPINAL CORD MED, V37, P2, DOI 10.1179/2045772313Y.0000000098; Widerstrom-Noga E, 2008, SPINAL CORD, V46, P818, DOI 10.1038/sc.2008.64; Zucker T., 2013, BIOFEEDBACK, V41, P98, DOI [10.5298/1081-5937-41.3.08, DOI 10.5298/1081-5937-41.3.08]; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	69	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	AUG 26	2021	21	1							329	10.1186/s12883-021-02355-w			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UI9IK	WOS:000690910900001	34445983	gold, Green Published			2022-02-06	
J	Kirchner, T; Lefering, R; Sandkamp, R; Eberbach, H; Schumm, K; Schmal, H; Bayer, J				Kirchner, Tim; Lefering, Rolf; Sandkamp, Richard; Eberbach, Helge; Schumm, Klaus; Schmal, Hagen; Bayer, Joerg		TraumaRegister DGU	Thromboembolic complications among multiple injured patients with pelvic injuries: identifying risk factors for possible patient-tailored prophylaxis	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Multiple trauma; Thromboembolic event; Injury Severity Score; Pelvic fracture; Acetabular fracture	DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; TRAUMA PATIENTS; GUIDELINES; COAGULOPATHY; ASSOCIATION; PREVENTION; FRACTURES; SCORE	Background Patients with pelvic and/or acetabular fractures are at high risk of developing thromboembolic (TE) complications. In our study we investigate TE complications and the potential negative effects of concomitant pelvic or acetabular injuries in multiple injured patients according to pelvic/acetabular injury severity and fracture classification. Methods The TraumaRegister DGU (R) was analyzed between 2010 and 2019. Multiple injured patients with pelvic and/or acetabular fractures with ISS >= 16 suffering from TE complications were identified. We conducted a univariate and multivariate analysis with TE events as independent variable to examine potential risk factors and contributing factors. Results 10.634 patients met our inclusion criteria. The overall TE incidence was 4.9%. Independent risk factors for the development of TE complications were sepsis, >= 10 operative interventions, mass transfusion (>= 10 PRBCs), age >= 65 years and AIS(Abdomen) >= 3 (all p < 0.001). No correlation was found for overall injury severity (ISS), moderate traumatic brain injury, additional injury to lower extremities, type B and C pelvic fracture according to Tile/AO/OTA and closed or open acetabular fracture. Conclusions Multiple injured patients suffering from pelvic and/or acetabular fractures are at high risk of developing thromboembolic complications. Independent risk factors for the development of thromboembolic events in our study cohort were age >= 65 years, mass transfusion, AIS(Abdomen) >= 3, sepsis and >= 10 surgery procedures. Among multiple injured patients with acetabular or pelvic injuries the severity of these injuries seems to have no further impact on thromboembolic risk. Our study, however, highlights the major impact of early hemorrhage and septic complications on thromboembolic risk in severely injured trauma patients. This may lead to individualized screening examinations and a patient-tailored thromboprophylaxis in high-risk patients for TE. Furthermore, the number of surgical interventions should be minimized in these patients to reduce thromboembolic risk.	[Kirchner, Tim; Sandkamp, Richard; Eberbach, Helge; Schumm, Klaus; Schmal, Hagen; Bayer, Joerg] Albert Ludwigs Univ Freiburg, Fac Med, Med Ctr, Dept Orthoped & Trauma Surg, Hugstetter Str 55, D-79106 Freiburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Fac Hlth, IFOM Inst Res Operat Med, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Schmal, Hagen] Univ Hosp Odense, Dept Orthoped Surg, Sdr Blvd 29, DK-5000 Odense C, Denmark; [TraumaRegister DGU] German Trauma Soc, Comm Emergency Med Intens Care & Trauma Managemen, Sekt NIS, Berlin, Germany		Bayer, J (corresponding author), Albert Ludwigs Univ Freiburg, Fac Med, Med Ctr, Dept Orthoped & Trauma Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.	joerg.bayer@uniklinik-freiburg.de		Bayer, Jorg/0000-0001-5446-6840	German Research Foundation (DFG)German Research Foundation (DFG); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing.	Afshari A, 2018, EUR J ANAESTH, V35, P77, DOI 10.1097/EJA.0000000000000729; Aggarwal Sameer, 2020, J Clin Orthop Trauma, V11, P1002, DOI 10.1016/j.jcot.2020.09.011; Agudelo JF, 2005, ORTHOPEDICS, V28, P1164; Association for the Advancement of Automotive Medicine, 2018, ABBREVIATED INJURY S, V6th; Azu MC, 2007, AM SURGEON, V73, P1228; Bagaria V, 2006, POSTGRAD MED J, V82, P136, DOI 10.1136/pgmj.2005.034512; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chapman BC, 2013, AM J SURG, V206, P917, DOI 10.1016/j.amjsurg.2013.07.024; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Dwyer EP, 2019, J ORTHOP SURG-HONG K, V27, P1, DOI 10.1177/2309499019832815; Faraoni D, 2014, MINER ANESTESIOL, V80, P8; Fuchs S, 2005, J BONE JOINT SURG BR, V87B, P1117, DOI 10.1302/0301-620X.87B8.15680; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Godat LN, 2015, J TRAUMA ACUTE CARE, V78, P475, DOI 10.1097/TA.0000000000000556; Karcutskie CA, 2017, JAMA SURG, V152, P35, DOI 10.1001/jamasurg.2016.3116; Kellam JF, 2018, J ORTHOP TRAUMA, V32, pS1, DOI [10.1097/BOT.0000000000001063, 10.1097/BOT.0000000000001062]; Kim JW, 2014, J ORTHOP SCI, V19, P471, DOI 10.1007/s00776-014-0553-z; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Letournel E, 1993, FRACTURES ACETABULUM; Ley EJ, 2020, J TRAUMA ACUTE CARE, V89, P971, DOI 10.1097/TA.0000000000002830; Lichte P, 2015, INT ORTHOP, V39, P947, DOI 10.1007/s00264-015-2698-6; Lim PK, 2020, J AM ACAD ORTHOP SUR, V28, P750, DOI 10.5435/JAAOS-D-19-00409; Lowe JA, 2020, J ORTHOP TRAUMA, V34, P418, DOI 10.1097/BOT.0000000000001790; Myers SR, 2019, SURGERY, V166, P416, DOI 10.1016/j.surg.2019.04.014; National Institute for Health and Care Excellence, 2010, VEN THROMB AD RED RI; Nelson JT, 2020, J SURG RES, V246, P182, DOI 10.1016/j.jss.2019.09.012; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Park JS, 2018, INJURY, V49, P1155, DOI 10.1016/j.injury.2018.04.026; Park MS, 2016, THROMB RES, V144, P40, DOI 10.1016/j.thromres.2016.03.026; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 2001, SURGERY, V130, P1, DOI 10.1067/msy.2001.114558; S3-Guideline, 2015, PROPH VEN THROMB VTE, V2nd; Sen Ramesh Kumar, 2011, J Orthop Surg (Hong Kong), V19, P18; Stannard JP, 2001, J BONE JOINT SURG AM, V83A, P1047, DOI 10.2106/00004623-200107000-00010; Tile M., 2015, FRACTURES PELVIS ACE, DOI [10.1055/b-003-121618, DOI 10.1055/B-003-121618]; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V76, P1270, DOI 10.1097/TA.0000000000000233; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Walker PF, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000367	42	0	0	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	AUG 26	2021	16	1							42	10.1186/s13017-021-00388-7			12	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	UJ0IU	WOS:000690979700001	34446032				2022-02-06	
J	Sathananthan, N; Dimech-Betancourt, B; Morris, E; Vicendese, D; Knox, L; Gillanders, D; Das Nair, R; Wong, D				Sathananthan, Nick; Dimech-Betancourt, Bleydy; Morris, Eric; Vicendese, Don; Knox, Lucy; Gillanders, David; Das Nair, Roshan; Wong, Dana			A single-case experimental evaluation of a new group-based intervention to enhance adjustment to life with acquired brain injury: VaLiANT (valued living after neurological trauma)	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Acquired brain injury; Adjustment; Acceptance and commitment therapy; Cognitive rehabilitation; Valued living	COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; COMMITMENT THERAPY; HOSPITAL ANXIETY; POSTSTROKE DEPRESSION; MEANINGFUL CHANGE; VISUAL ANALYSIS; MENTAL-HEALTH; STROKE; ACCEPTANCE	Adjustment to life with acquired brain injury (ABI) requires self-identity and behaviour to be updated, incorporating injury-related changes. Identifying and enabling new values-consistent behaviours could facilitate this process. We evaluated the feasibility, acceptability, and preliminary efficacy of VaLiANT, a new group intervention that aims to enhance "valued living" following ABI. We used a non-concurrent multiple baseline single-case experimental design (SCED) with an 8-week follow-up phase and randomization to multiple baseline lengths (5-7 weeks). Eight participants (50% women, aged 26-65; 4 Stroke, 3 Traumatic Brain Injury, 1 Epilepsy) attended eight group sessions with assessments before, during, and after the group. Target behaviour was valued living, assessed weekly by the Valued Living Questionnaire. Secondary outcomes included measures of wellbeing, mood, psychological acceptance, self-efficacy regarding ABI consequences, cognitive complaints, and intervention acceptability. Target behaviour was analysed through visual and statistical analysis while secondary outcome data were analysed via reliable change indices and descriptive statistics. Target behaviour data displayed no convincing patterns of improvement. Reliable improvements were found for most participants on secondary outcomes, particularly subjective wellbeing and anxiety. Intervention delivery was feasible with high acceptability ratings. Further investigation of VaLiANT is warranted, based on the feasibility and acceptability of intervention delivery and signals of efficacy identified across adjustment-related secondary outcomes.	[Sathananthan, Nick; Dimech-Betancourt, Bleydy; Morris, Eric; Knox, Lucy; Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Vicendese, Don] La Trobe Univ, Dept Math & Stat, Melbourne, Vic, Australia; [Vicendese, Don] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Gillanders, David] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Das Nair, Roshan] Univ Nottingham, Inst Mental Hlth, Nottingham, England; [Das Nair, Roshan] Univ Nottingham, Sch Med, Nottingham, England		Wong, D (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia.	d.wong@latrobe.edu.au		Sathananthan, Nick/0000-0001-8905-1426; Morris, Eric/0000-0001-5815-1213; Wong, Dana/0000-0001-9619-1929; Dimech-Betancourt, Bleydy/0000-0001-6990-7338; Vicendese, Don/0000-0002-0176-0314	La Trobe University Sport, Exercise, and Rehabilitation Research Focus Area Grant Ready Scheme	This work was supported by the La Trobe University Sport, Exercise, and Rehabilitation Research Focus Area Grant Ready Scheme. The authors would also like to thank Dr. Coco Bernard for completion of treatment fidelity ratings, Emma Giliberto for co-facilitating both VaLiANT groups and her assistance with baseline assessments, and Mark Tyler for co-facilitating both VaLiANT groups.	Andrew NE, 2014, INT J STROKE, V9, P106, DOI 10.1111/ijs.12325; [Anonymous], 2015, C TRAUM BRAIN INJ US; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Beadle EJ, 2018, J HEAD TRAUMA REHAB, V33, pE42, DOI 10.1097/HTR.0000000000000360; Bergstrom A, 2017, SCAND J OCCUP THER, V24, P339, DOI 10.1080/11038128.2016.1245782; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bohlmeijer ET, 2011, BEHAV RES THER, V49, P62, DOI 10.1016/j.brat.2010.10.003; Borek AJ, 2019, HEALTH PSYCHOL REV, V13, P227, DOI 10.1080/17437199.2019.1625282; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Brassington L, 2016, J CONTEXT BEHAV SCI, V5, P208, DOI 10.1016/j.jcbs.2016.09.001; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bulte I, 2013, J MOD APPL STAT METH, V12, P450, DOI 10.22237/jmasm/1383280020; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; de Graaf JA, 2021, NEUROPSYCHOL REHABIL, V31, P1207, DOI 10.1080/09602011.2020.1769687; De Wit L, 2017, DISABIL REHABIL, V39, P1435, DOI 10.1080/09638288.2016.1200676; Deloitte Access Economics, 2013, EC IMP STROK AUSTR; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dindo L, 2017, NEUROTHERAPEUTICS, V14, P546, DOI 10.1007/s13311-017-0521-3; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Economics A., 2009, EC COST SPINAL CORD, P31; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Evans S., 2017, NEUROPSYCHOLOGIST, V3, P58; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Ferrer R, 2014, PSYCHOL ASSESSMENT, V26, P370, DOI 10.1037/a0035419; Fledderus M, 2010, AM J PUBLIC HEALTH, V100, P2372, DOI 10.2105/AJPH.2010.196196; Gadidi V, 2011, ARCH PHYS MED REHAB, V92, P1802, DOI 10.1016/j.apmr.2011.06.014; Gall SL, 2009, CEREBROVASC DIS, V27, P123, DOI 10.1159/000177919; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Gillers S., 2014, NEURO DISABIL PSYCHO, V2, P19; Gloede TD, 2014, STROKE, V45, P3389, DOI 10.1161/STROKEAHA.114.006200; Gloster AT, 2020, J CONTEXT BEHAV SCI, V18, P181, DOI 10.1016/j.jcbs.2020.09.009; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Graham CD, 2016, CLIN PSYCHOL REV, V46, P46, DOI 10.1016/j.cpr.2016.04.009; Graham CD, 2015, CLIN CASE STUD, V14, P83, DOI 10.1177/1534650114539386; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Hackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Kimonides S, 2018, TOP STROKE REHABIL, V25, P514, DOI 10.1080/10749357.2018.1489570; Krasny-Pacini A, 2018, ANN PHYS REHABIL MED, V61, P164, DOI 10.1016/j.rehab.2017.12.002; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; Lane JD, 2014, NEUROPSYCHOL REHABIL, V24, P445, DOI 10.1080/09602011.2013.815636; Large R, 2020, NEUROPSYCHOL REHABIL, V30, P1477, DOI 10.1080/09602011.2019.1589531; Ledford JR, 2018, BRAIN IMPAIR, V19, P4, DOI 10.1017/BrImp.2017.16; Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Loetscher T, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002842.pub3; Majumdar S, 2019, BRIT J CLIN PSYCHOL, V58, P70, DOI 10.1111/bjc.12198; Manolov, 2014, R CODE ESTIMATING PR; Mellon L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0288-2; Ramos-Lima MJM, 2018, CLINICS, V73, DOI 10.6061/clinics/2017/e418; Michelson SE, 2011, DEPRESS ANXIETY, V28, P358, DOI 10.1002/da.20793; Moeyaert X., 2021, EVIDENCE BASED COMMU, DOI [https://doi.org/10.1080/17489539.2021.1933727, DOI 10.1080/17489539.2021.1933727]; Mole JA, 2020, NEUROPSYCHOL REHABIL, V30, P346, DOI 10.1080/09602011.2018.1464934; Nijsse B, 2017, NEUROPSYCHOL REHABIL, V27, P99, DOI 10.1080/09602011.2015.1065280; O'Donoghue E.K., 2018, ACT PSYCHOSIS RECOVE; Pais C, 2019, NEUROPSYCHOL REHABIL, V29, P625, DOI 10.1080/09602011.2017.1313745; Pearson, 2009, ADV CLIN SOLUTIONS W; Peng CYJ, 2018, J MOD APPL STAT METH, V17, DOI 10.22237/jmasm/1525133280; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radford K., 2010, MAKING MOST YOUR MEM; Rogers JM, 2018, NEUROPSYCHOL REV, V28, P285, DOI 10.1007/s11065-018-9378-4; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Sandera AM, 2021, NEUROPSYCHOL REHABIL, V31, P1105, DOI 10.1080/09602011.2020.1762670; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2014, NEUROPSYCHOL REHABIL, V24, P202, DOI 10.1080/09602011.2013.878252; Sheppard SC, 2010, INT J MS CARE, V12, P200, DOI DOI 10.7224/1537-2073-12.4.200; Smout M, 2014, J CONTEXTUAL BEHAV S, V3, P164, DOI 10.1016/j.jcbs.2014.06.001; Tate R., 2016, ARCH SCI PSYCHOL, V4, P10, DOI [DOI 10.1037/ARC0000027, 10.1037/arc0000027]; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Thomas SA, 2019, HEALTH TECHNOL ASSES, V23, P1, DOI 10.3310/hta23470; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wang SB, 2018, J AFFECT DISORDERS, V235, P589, DOI 10.1016/j.jad.2018.04.011; Wersebe H, 2017, J CONTEXT BEHAV SCI, V6, P63, DOI 10.1016/j.jcbs.2016.11.005; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; White O. R., 1980, EXCEPTIONAL TEACHING; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whiting DL, 2018, CLIN PSYCHOL-UK, V22, P230, DOI 10.1111/cp.12118; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Whyte E, 2011, PM&R, V3, pS45, DOI 10.1016/j.pmrj.2011.05.007; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706; Withiel TD, 2020, NEUROPSYCHOL REHABIL, V30, P829, DOI 10.1080/09602011.2018.1503083; Withiel TD, 2020, DISABIL REHABIL, V42, P3033, DOI 10.1080/09638288.2019.1579260; Withiel TD, 2019, J REHABIL MED, V51, P343, DOI 10.2340/16501977-2540; Wolery M, 2010, J SPEC EDUC, V44, P18, DOI 10.1177/0022466908328009; Wong D, 2021, TOP STROKE REHABIL, V28, P410, DOI 10.1080/10749357.2020.1838084; World Health Organization, 2001, INT CLASS FUNCT DIS; Yucesoy-Ozkan S, 2020, BRIT J SPEC EDUC, V47, P67, DOI 10.1111/1467-8578.12294; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	107	0	0	4	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1971094		AUG 2021	33	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UF1JC	WOS:000688336600001	34433379				2022-02-06	
J	Sugden, N; Thomas, M; Kiernan, M; Wilesmith, M				Sugden, Nicole; Thomas, Matt; Kiernan, Michael; Wilesmith, Michele			Validation of the Prospective Memory Concerns Questionnaire (PMCQ)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						prospective memory; questionnaire; self-report; validation; memory for intentions	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; NORMATIVE DATA; NEUROLOGICAL DISORDERS; ONGOING ACTIVITY; LATENT STRUCTURE; AGE; ADULTS; PRMQ	Prospective memory (PM), the ability to remember to complete intended tasks, is essential for successfully completing activities of daily living. PM impairments are common in people with neuropathology such as acquired brain injury and dementia. These PM impairments affect individuals' capabilities in key aspects of daily living including their health, safety, and independence. The Prospective Memory Concerns Questionnaire (PMCQ) was designed as a self-report measure to understand individuals' concerns about their memory. This questionnaire may help identify issues with PM which in turn may assist clinicians in the targeted implementation of memory compensation strategies. The PMCQ was developed using Rasch and classical test methodologies, with subscales measuring frequency of forgetting behaviors, memory concerns, and retrieval failures. The current study aimed to confirm the factor structure of the PMCQ for use in adults in the general population. The study also aimed to examine relationships between the PMCQ and naturalistic performance-based measures of PM to determine how the self-report PMCQ could be used in conjunction with performance-based measures. A community dwelling sample of 558 adults completed the PMCQ, an event-based naturalistic PM task, and time-based naturalistic PM task. Confirmatory factor analyses (CFAs) indicated that a higher order model with three subscales containing 35 items produced acceptable fit [RMSEA = 0.056 (90% CI 0.054, 0.060), SRMR = 0.062, CFI = 0.915, TLI = 0.909] The PMCQ demonstrated good internal consistency (total alpha = 0.95, subscales: alpha = 0.88-0.89). The Forgetting Behaviors subscale significantly correlated with performance on the event-based naturalistic PM task (r = -0.14, p < 0.01). The Memory Concerns and Retrieval Failures subscales did not correlate significantly with performance-based PM tasks. These findings suggest that the PMCQ may be best suited for assessing individuals' concerns about their forgetting behaviors and identifying appropriate compensation strategies or support services. It is recommended that the PMCQ be used alongside performance-based PM tasks and other cognitive measures to comprehensively assess PM. It was concluded that the PMCQ is a suitable measure for use in adults in the general population. Further validation research of the PMCQ in general population and clinical samples will determine the measures' sensitivity and specificity in identifying PM impairments.</p>	[Sugden, Nicole; Thomas, Matt; Kiernan, Michael; Wilesmith, Michele] Charles Sturt Univ, Sch Psychol, Bathurst, NSW, Australia; [Thomas, Matt] Marathon Hlth, Bathurst, NSW, Australia; [Thomas, Matt] Western New South Wales Local Hlth Dist, Bathurst, NSW, Australia		Sugden, N (corresponding author), Charles Sturt Univ, Sch Psychol, Bathurst, NSW, Australia.	nisugden@csu.edu.au	Sugden, Nicole/ABE-8629-2021	Sugden, Nicole/0000-0002-7010-1136	Charles Sturt University, School of Psychology; Charles Sturt University	Funding for this project was provided by the Charles Sturt University, School of Psychology. Funding for open access publishing was provided by the Charles Sturt University Open Access Publishing Scheme.	Altgassen M, 2010, AGING NEUROPSYCHOL C, V17, P312, DOI 10.1080/13825580903281308; Buchanan T, 2005, BEHAV RES METHODS, V37, P148, DOI 10.3758/BF03206409; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Chen XJ, 2015, PSYCHIAT RES, V226, P14, DOI 10.1016/j.psychres.2015.01.011; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; COREN S, 1993, BEHAV RES THER, V31, P215, DOI 10.1016/0005-7967(93)90076-7; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; Einstein, 2007, PROSPECTIVE MEMORY O; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Evald L, 2018, DISABIL REHABIL, V40, P2250, DOI 10.1080/09638288.2017.1333633; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Haas M, 2020, MEMORY, V28, P196, DOI 10.1080/09658211.2019.1707227; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hering A, 2018, J INT NEUROPSYCH SOC, V24, P640, DOI 10.1017/S1355617718000152; Hertzog C., 2014, SAGE HDB APPL MEMORY, DOI DOI 10.4135/9781446294703.N24; Hicks JL, 2000, J EXP PSYCHOL LEARN, V26, P1160, DOI 10.1037/0278-7393.26.5.1160; Hogan C, 2016, BRAIN IMPAIR, V17, P123, DOI 10.1017/BrImp.2016.12; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ibm Corp, 2020, IBM SPSS S STAT WIND; Ihle A, 2013, PSYCHOL AGING, V28, P714, DOI 10.1037/a0033653; Ihle A, 2012, AGING NEUROPSYCHOL C, V19, P84, DOI 10.1080/13825585.2011.629288; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; Murray G, 2009, AUST J PSYCHOL, V61, P167, DOI 10.1080/00049530802326784; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Niedzwienska A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239581; Philips L.H., 2008, PROSPECTIVE MEMORY C; R Core Team, 2020, R LANG ENV STAT COMP; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin S.A., 1998, PROSPECTIVE MEMORY T; Raskin SA, 2018, CLIN NEUROPSYCHOL, V32, P891, DOI 10.1080/13854046.2018.1455898; Raskin SA, 2019, NEUROPSYCHOL REHABIL, V29, P289, DOI 10.1080/09602011.2017.1294082; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Ronnlund M, 2008, SCAND J PSYCHOL, V49, P11, DOI 10.1111/j.1467-9450.2007.00600.x; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Shi DX, 2020, STRUCT EQU MODELING, V27, P1, DOI 10.1080/10705511.2019.1611434; Shum D., 2014, COMPREHENSIVE ASSESS; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2012, AGING NEUROPSYCHOL C, V19, P495, DOI 10.1080/13825585.2011.633161; Sugden N., 2015, PROSPECTIVE MEMORY C; Sugden N, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2021.1875851; Thompson CL, 2015, GERONTOLOGY, V61, P251, DOI 10.1159/000371347; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; van den Berg E, 2012, J INT NEUROPSYCH SOC, V18, P706, DOI 10.1017/S1355617712000331; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Withiel TD, 2019, J REHABIL MED, V51, P343, DOI 10.2340/16501977-2540; Xia Y, 2019, BEHAV RES METHODS, V51, P409, DOI 10.3758/s13428-018-1055-2; Zogg JB, 2012, J BEHAV MED, V35, P47, DOI 10.1007/s10865-011-9341-9	64	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	AUG 26	2021	15								686850	10.3389/fnhum.2021.686850			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	US6QY	WOS:000697552500001	34512292	gold, Green Published			2022-02-06	
J	Terneusen, A; Winkens, I; Smeets, S; Prigatano, G; Porcerelli, J; Kamoo, R; van Heugten, C; Ponds, R				Terneusen, Anneke; Winkens, Ieke; Smeets, Sanne; Prigatano, George; Porcerelli, John; Kamoo, Ray; van Heugten, Caroline; Ponds, Rudolf			Impaired self-awareness and denial of disability in a community sample of people with traumatic brain injury	DISABILITY AND REHABILITATION			English	Article; Early Access						Self-awareness; denial of disability; community-dwelling traumatic brain injury; neuropsychological assessment; rehabilitation	PARTICIPANTS AGED 24-81; VERBAL FLUENCY; NORMATIVE DATA; DEFICITS; DEPRESSION; EDUCATION	Purpose To examine the nature and severity of impaired self-awareness (ISA) and denial of disability (DD) in a community-dwelling traumatic brain injury (TBI) population. Additionally, to investigate reliability, internal consistency, and feasibility of the Clinician's Rating Scale for evaluating Impaired Self-Awareness and Denial of Disability after brain injury (CRS-ISA-DD). Materials and methods ISA and DD were studied using the CRS-ISA-DD in a cross-sectional study with 78 TBI patients (3.1 years post-injury). Results 42% of individuals approached consented to participate in this study. Most participants showed one or more symptoms of ISA and DD, but severity scores were in the lower range (ISA: 13.2 +/- 16.2; DD: 9.4 +/- 10.7). The CRS-ISA-DD takes <10 min to complete, has excellent inter-rater reliability (ISA: ICC(2,1) = 0.928; DD: ICC(2,1) = 0.835), and acceptable-good internal consistency (ISA: alpha = 0.819; DD: alpha = 0.645). ISA severity correlated with neuropsychological test scores (r(s) = -0.30 to -0.47) and injury severity. DD severity correlated with anxiety (r(s) = -0.22) but not with avoidance coping or defense mechanisms. Conclusions Low levels of ISA and DD occurred in this sample of TBI patients. The CRS-ISA-DD is a reliable and feasible instrument. We recommend using it as a diagnostic tool to differentiate between ISA and DD once self-awareness problems have been identified.	[Terneusen, Anneke; Winkens, Ieke; van Heugten, Caroline] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Terneusen, Anneke; Winkens, Ieke; van Heugten, Caroline; Ponds, Rudolf] Maastricht Univ, Limburg Brain Injury Ctr, Maastricht, Netherlands; [Smeets, Sanne; van Heugten, Caroline; Ponds, Rudolf] Maastricht Univ, MHeNS Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Prigatano, George] Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ 85013 USA; [Porcerelli, John] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Serv, Detroit, MI USA; [Ponds, Rudolf] Amsterdam Univ Med Ctr, Dept Med Psychol, Amsterdam, Netherlands		Terneusen, A (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.; Terneusen, A (corresponding author), Maastricht Univ, Limburg Brain Injury Ctr, Maastricht, Netherlands.	anneke.terneusen@maastrichtuniversity.nl		Terneusen, Anneke/0000-0001-5819-7932; ponds, rudolf/0000-0002-9748-4659	foundation 'De Drie Lichten' in the NetherlandsNetherlands Government	This work was financially supported by the foundation 'De Drie Lichten' in the Netherlands.	Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Belchev Z, 2017, BRIT J CLIN PSYCHOL, V56, P213, DOI 10.1111/bjc.12134; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BRAND N, 1985, J GEN PSYCHOL, V112, P201, DOI 10.1080/00221309.1985.9711004; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Cramer P, 2002, J PERS, V70, P103, DOI 10.1111/1467-6494.00180; Cramer P, 2003, J RES PERS, V37, P76, DOI 10.1016/S0092-6566(02)00528-7; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Fleming JM, 1996, BRAIN INJURY, V10, P1; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hannay HJ., 2004, NEUROPSYCHOLOGICAL A, V4, P157; Heaton R. K., 2004, REVISED COMPREHENSIV; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Leung DPK, 2011, INT J REHABIL RES, V34, P187, DOI 10.1097/MRR.0b013e3283487f31; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Pettemeridou E, 2020, NEUROREHABILITATION, V46, P109, DOI 10.3233/NRE-192963; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP., 2010, STUDY ANOSOGNOSIA, P495; Raizman R., 2020, SCI REP-UK, V10, P1; Reitan RM., 1955, MANUAL ADM NEUROPSYC; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TEASDALE G, 1974, LANCET, V2, P81; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van der Elst W, 2006, J CLIN EXP NEUROPSYC, V28, P998, DOI 10.1080/13803390591004428; VEGA A, 1967, J CONSULT PSYCHOL, V31, P619, DOI 10.1037/h0025112; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wilson BA., 1997, BEHAV ASSESSMENT DYS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1970247		AUG 2021	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	UI8NU	WOS:000690857300001	34455888	hybrid			2022-02-06	
J	Alimagham, FC; Hutter, D; Marco-Garcia, N; Gould, E; Highland, VH; Huefner, A; Giorgi-Coll, S; Killen, MJ; Zakrzewska, AP; Elliott, SR; Carpenter, KLH; Hutchinson, PJ; Hutter, T				Alimagham, Farah C.; Hutter, Dan; Marco-Garcia, Nuria; Gould, Emma; Highland, Victoria H.; Huefner, Anna; Giorgi-Coll, Susan; Killen, Monica J.; Zakrzewska, Agnieszka P.; Elliott, Stephen R.; Carpenter, Keri L. H.; Hutchinson, Peter J.; Hutter, Tanya			Cerebral Microdialysate Metabolite Monitoring using Mid-infrared Spectroscopy	ANALYTICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; GLUCOSE; LACTATE; LASERS; BLOOD	The brains of patients suffering from traumatic brain-injury (TBI) undergo dynamic chemical changes in the days following the initial trauma. Accurate and timely monitoring of these changes is of paramount importance for improved patient outcome. Conventional brain-chemistry monitoring is performed off-line by collecting and manually transferring microdialysis samples to an enzymatic colorimetric bedside analyzer every hour, which detects and quantifies the molecules of interest. However, offline, hourly monitoring means that any subhourly neurochemical changes, which may be detrimental to patients, go unseen and thus untreated. Mid-infrared (mid-IR) spectroscopy allows rapid, reagent-free, molecular fingerprinting of liquid samples, and can be easily integrated with microfluidics. We used mid-IR transmission spectroscopy to analyze glucose, lactate, and pyruvate, three relevant brain metabolites, in the extracellular brain fluid of two TBI patients, sampled via microdialysis. Detection limits of 0.5, 0.2, and 0.1 mM were achieved for pure glucose, lactate, and pyruvate, respectively, in perfusion fluid using an external cavity-quantum cascade laser (EC-QCL) system with an integrated transmission flow-cell. Microdialysates were collected hourly, then pooled (3-4 h), and measured consecutively using the standard ISCUSflex analyzer and the EC-QCL system. There was a strong correlation between the compound concentrations obtained using the conventional bedside analyzer and the acquired mid-IR absorbance spectra, where a partial-least-squares regression model was implemented to compute concentrations. This study demonstrates the potential utility of mid-IR spectroscopy for continuous, automated, reagent-free, and online monitoring of the dynamic chemical changes in TBI patients, allowing a more timely response to adverse brain metabolism and consequently improving patient outcomes.	[Hutter, Dan] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Alimagham, Farah C.; Marco-Garcia, Nuria; Gould, Emma; Giorgi-Coll, Susan; Killen, Monica J.; Zakrzewska, Agnieszka P.; Carpenter, Keri L. H.; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Alimagham, Farah C.; Highland, Victoria H.; Huefner, Anna; Elliott, Stephen R.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Hutter, Tanya] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA; [Hutter, Tanya] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Hutter, Tanya] Univ Texas Austin, Walker Dept Mech Engn, Austin, TX 78712 USA		Alimagham, FC (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England.; Alimagham, FC (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.; Hutter, T (corresponding author), Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA.; Hutter, T (corresponding author), Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA.; Hutter, T (corresponding author), Univ Texas Austin, Walker Dept Mech Engn, Austin, TX 78712 USA.	fca21@cam.ac.uk; tanya.hutter@utexas.edu			National Institute for Health Research (NIHR) [NIHR i4i Challenge Award] [II-C5-071520005]; NIHR i4i Product Development Award [NIHR200986]; UK Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/L015889/1]; Department of Chemistry, the University of Cambridge; Wellcome Trust-the University of Cambridge ISSF Junior Interdisciplinary Fellowship; Darwin College, Cambridge, UK; L'Oreal-UNESCO For Women in Science Fellowship UK Ireland; NIHR Biomedical Research Centre, Cambridge, UK; NIHR Biomedical Research Center Cambridge; NIHR Senior Investigator Award; Royal College of Surgeons of England	This study was funded by the National Institute for Health Research (NIHR) [NIHR i4i Challenge Award (II-C5-071520005) and the NIHR i4i Product Development Award (NIHR200986)]. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. F.C.A. was supported by the UK Engineering and Physical Sciences Research Council (EPSRC) for the EPSRC CDT Studentship (grant no. EP/L015889/1). V.H.H. acknowledges the Department of Chemistry, the University of Cambridge for financial support. A.H. was supported by the Wellcome Trust.the University of Cambridge ISSF Junior Interdisciplinary Fellowship. T.H. acknowledges support from Darwin College, Cambridge, UK and L'Oreal-UNESCO For Women in Science Fellowship UK & Ireland. K.L.H.C. acknowledges support from the NIHR Biomedical Research Centre, Cambridge, UK. P.J.H. is also supported by the NIHR Biomedical Research Center Cambridge, NIHR Senior Investigator Award, and the Royal College of Surgeons of England.	Akhgar CK, 2020, ANAL CHEM, V92, P9901, DOI 10.1021/acs.analchem.0c01406; Alimagham F., BIOCHEM ENG J, V2021, P167; Alimagham F, 2019, RSC ADV, V9, P21186, DOI 10.1039/c9ra04104d; American E., 1995, J CHEM EDUC, V72, pA93; Booth MA, 2018, ANAL CHEM, V90, P2, DOI 10.1021/acs.analchem.7b04224; Brandstetter M, 2013, APPL PHYS B-LASERS O, V110, P233, DOI 10.1007/s00340-012-5080-z; Brandstetter M, 2012, SENSOR ACTUAT B-CHEM, V170, P189, DOI 10.1016/j.snb.2011.06.081; Brandstetter M, 2010, PROCEDIA ENGINEER, V5, P1001, DOI 10.1016/j.proeng.2010.09.278; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Gowers SAN, 2020, ANALYST, V145, P1894, DOI 10.1039/c9an01950b; Gowers SAN, 2019, LAB CHIP, V19, P2537, DOI 10.1039/c9lc00400a; HEISE HM, 1989, ANAL CHEM, V61, P2009, DOI 10.1021/ac00193a004; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Kwasnica C, 2008, ARCH PHYS MED REHAB, V89, pS15, DOI 10.1016/j.apmr.2007.12.006; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Liakat S, 2013, BIOMED OPT EXPRESS, V4, P1083, DOI 10.1364/BOE.4.001083; Perro A, 2016, REACT CHEM ENG, V1, P577, DOI 10.1039/c6re00127k; Petibois C, 2000, J LAB CLIN MED, V135, P210, DOI 10.1067/mlc.2000.104460; Popa D, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092076; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Schadle T, 2016, APPL SPECTROSC, V70, P1625, DOI 10.1177/0003702816659668; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Wu W, 2013, SCI REP-UK, V3, P1, DOI 10.1038/srep03302	26	0	0	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	SEP 7	2021	93	35					11929	11936		10.1021/acs.analchem.1c01149		AUG 2021	8	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	UP6TU	WOS:000695511600006	34432431	Green Published, hybrid			2022-02-06	
J	Alshareef, A; Wu, TT; Giudice, JS; Panzer, MB				Alshareef, Ahmed; Wu, Taotao; Giudice, J. Sebastian; Panzer, Matthew B.			Toward subject-specific evaluation: methods of evaluating finite element brain models using experimental high-rate rotational brain motion	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Brain deformation; Sonomicrometry; Model evaluation; Subject-specific	HEAD; INJURY; DEFORMATION; VALIDATION; GENERATION; STRAIN; MASS	Computational models of the brain have become the gold standard in biomechanics to understand, predict, and mitigate traumatic brain injuries. Many models have been created and evaluated with limited experimental data and without accounting for subject-specific morphometry of the specimens in the dataset. Recent advancements in the measurement of brain motion using sonomicrometry allow for a comprehensive evaluation of brain model biofidelity using a high-rate, rotational brain motion dataset. In this study, four methods were used to determine the best technique to compare nodal displacement to experimental brain motion, including a new morphing method to match subject-specific inner skull geometry. Three finite element brain models were evaluated in this study: the isotropic GHBMC and SIMon models, as well as an anisotropic model with explicitly embedded axons (UVA-EAM). Using a weighted cross-correlation score (between 0 and 1), the anisotropic model yielded the highest average scores across specimens and loading conditions ranging from 0.53 to 0.63, followed by the isotropic GHBMC with average scores ranging from 0.46 to 0.58, and then the SIMon model with average scores ranging from 0.36 to 0.51. The choice of comparison method did not significantly affect the cross-correlation score, and differences of global strain up to 0.1 were found for the morphed geometry relative to baseline models. The morphed or scaled geometry is recommended when evaluating computational brain models to capture the subject-specific skull geometry of the experimental specimens.	[Alshareef, Ahmed; Wu, Taotao; Giudice, J. Sebastian; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomechan, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomechan, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	aa4kw@virginia.edu; tw2dx@virginia.edu; jsg4fd@virginia.edu; panzer@virginia.edu		Panzer, Matthew/0000-0002-4500-9442	National Highway Traffic Safety Administration [DTNH221500022/0002]	This study was sponsored in part by the National Highway Traffic Safety Administration under contract number DTNH221500022/0002.	Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2020, BIOMED SIGNAL PROCES, V56, DOI 10.1016/j.bspc.2019.101691; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bayly PV, 2021, ANN BIOMED ENG, V49, P2677, DOI 10.1007/s10439-021-02820-0; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bian KW, 2020, BIOMECH MODEL MECHAN, V19, P2323, DOI 10.1007/s10237-020-01341-4; Bryan R, 2010, MED ENG PHYS, V32, P57, DOI 10.1016/j.medengphy.2009.10.008; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deck C, 2009, International Journal of Vehicle Safety, V4, P85, DOI 10.1504/IJVS.2009.028921; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gehre C., 2009, 21 ESV C STUTTG, V1, P09; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giudice JS, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.664268; Giudice JS, 2020, ANN BIOMED ENG, V48, P2412, DOI 10.1007/s10439-020-02584-z; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; Haffner, 1983, SAE T, P486; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1829, DOI 10.1007/s10439-019-02351-9; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knutsen Andrew K, 2020, Brain Multiphys, V1, DOI 10.1016/j.brain.2020.100015; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kouchi, 2005, SAE TECHNICAL PAPER; Kurt M, 2019, J NEUROIMAGING, V29, P440, DOI 10.1111/jon.12619; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller LE, 2021, ANN BIOMED ENG, V49, P1083, DOI 10.1007/s10439-020-02685-9; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Okamoto RJ, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519840444; Panzer MB, 2012, THESIS DUKE U; Park G, 2017, COMPUT METHOD BIOMEC, V20, P1151, DOI 10.1080/10255842.2017.1340459; Reynier KA, 2020, ANN BIOMED ENG, V48, P2751, DOI 10.1007/s10439-020-02609-7; Rohr K, 2001, IEEE T MED IMAGING, V20, P526, DOI 10.1109/42.929618; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Sahoo D, 2015, MED BIOL ENG COMPUT, V53, P869, DOI 10.1007/s11517-015-1295-6; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Takahashi, 2015, SAE TECHNICAL PAPER; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wu TT, 2021, J NEUROTRAUM, V38, P1879, DOI 10.1089/neu.2020.7445; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1; Zou H, 2007, INT J CRASHWORTHINES, V12, P341, DOI 10.1080/13588260701433024	72	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	DEC	2021	20	6					2301	2317		10.1007/s10237-021-01508-7		AUG 2021	17	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WY8CZ	WOS:000688401200001	34432184				2022-02-06	
J	Cameron, S; Weltman, JG; Fletcher, DJ				Cameron, Starr; Weltman, Joel G.; Fletcher, Daniel J.			The prognostic value of admission point-of-care testing and modified Glasgow Coma Scale score in dogs and cats with traumatic brain injuries (2007-2010): 212 cases	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						canine; feline; head trauma; hyperglycemia; outcome	GLUCOSE-TOLERANCE TESTS; HEAD TRAUMA; URBAN DOGS; HYPERGLYCEMIA; MECHANISMS; IMPACT; DAMAGE; GLUCOMETER; ISCHEMIA	Objective To investigate the association between admission point-of-care parameters and survival to discharge in dogs and cats with traumatic brain injury (TBI). Design Retrospective study 2007-2010. Setting A rural university teaching hospital and an urban private practice teaching hospital. Animals One hundred thirty-one dogs and 81 cats admitted to the emergency service with evidence of head injury based on history from the owner or physical exam. Measurements and Main Results In dogs, nonsurvivors had significantly higher glucose concentrations at admission than survivors (median = 8.49 mmol/L [153 mg/dl] vs 6.83 mmol/L [123 mg/dl], p = 0.039). In cats, there was no significant difference in admission glucose between survivors and nonsurvivors (median = 10.21 mmol/L [184 mg/dl] vs 10.93 mmol/L [197 mg/dl], p = 0.17). Modified Glasgow Coma Scale (MGCS) score was available for 105 of the 131 dogs (80%) and was significantly higher in survivors than in nonsurvivors (median = 16 vs 11, p < 0.0001). MGCS was available for 45 of the 81 cats (56%) and was significantly higher in survivors than in nonsurvivors (median = 17 vs 14, p = 0.0005). The relative prognostic value of the admission point-of-care testing parameters and MGCS were assessed using a stepwise linear regression model, which included admission glucose, pH, base excess, sodium, and MGCS. In dogs, only admission glucose was an independent predictor of survival (odds ratio = 1.027, 95% confidence interval, 1.0042-1.05, p = 0.019). Conclusions These results suggest that, as in people with TBI, increased blood glucose concentrations may have prognostic significance in dogs with TBI but not in cats. In addition, MGCS score may be predictive of survival in both dogs and cats with TBI.	[Cameron, Starr] Univ Wisconsin, Sch Vet Med, Dept Med Sci, 2015 Linden Dr, Madison, WI 53706 USA; [Weltman, Joel G.] Anim Med Ctr, Emergency & Crit Care Dept, New York, NY USA; [Fletcher, Daniel J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY USA		Cameron, S (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, 2015 Linden Dr, Madison, WI 53706 USA.	starr.cameron@wisc.edu					Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; BLACK PR, 1982, ANN SURG, V196, P420, DOI 10.1097/00000658-198210000-00005; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHURCH DB, 1980, RES VET SCI, V29, P353, DOI 10.1016/S0034-5288(18)32641-9; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Dobromylskyj MJ, 2010, VET REC, V167, P438, DOI 10.1136/vr.c4260; Hall KE, 2018, J VET EMERG CRIT CAR, V28, P497, DOI 10.1111/vec.12766; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Hewson-Hughes AK, 2011, BRIT J NUTR, V106, pS101, DOI 10.1017/S0007114511000857; Hoenig M, 2002, J VET INTERN MED, V16, P529, DOI 10.1892/0891-6640(2002)016&lt;0529:IOGDOI&gt;2.3.CO;2; HOFFMAN WE, 1990, ANESTHESIOLOGY, V72, P1045, DOI 10.1097/00000542-199006000-00015; Hollis AR, 2008, J VET INTERN MED, V22, P1189, DOI 10.1111/j.1939-1676.2008.0148.x; Hopkins AL, 1996, VET CLIN N AM-SMALL, V26, P875, DOI 10.1016/S0195-5616(96)50110-5; Hopper K, 2012, J VET INTERN MED, V26, P1107, DOI 10.1111/j.1939-1676.2012.00983.x; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kawai N, 1997, STROKE, V28, P149, DOI 10.1161/01.STR.28.1.149; Kohen CJ, 2018, J VET EMERG CRIT CAR, V28, P54, DOI 10.1111/vec.12676; KOLATA RJ, 1975, J AM VET MED ASSOC, V167, P938; KOLATA RJ, 1974, J AM VET MED ASSOC, V164, P499; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; Paladino L, 2010, J TRAUMA, V69, P41, DOI 10.1097/TA.0b013e3181c9f0cb; Paul AEH, 2011, AM J VET RES, V72, P1204, DOI 10.2460/ajvr.72.9.1204; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schaffartzik W, 2007, ANAESTHESIST, V56, P478, DOI 10.1007/s00101-007-1166-0; Sharma D, 2015, J VET EMERG CRIT CAR, V25, P631, DOI 10.1111/vec.12328; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Sieber-Ruckstuhl NS, 2003, SCHWEIZ ARCH TIERH, V145, P537, DOI 10.1024/0036-7281.145.11.537; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; Takanashi Y, 2001, No To Shinkei, V53, P61; Tauk BS, 2015, JAVMA-J AM VET MED A, V246, P1327, DOI 10.2460/javma.246.12.1327; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	46	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1479-3261	1476-4431		J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	JAN	2022	32	1					75	82		10.1111/vec.13108		AUG 2021	8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	YP2OO	WOS:000688196500001	34432934				2022-02-06	
J	Dhakal, S; He, L; Lyuboslavsky, P; Sidhu, C; Chrenek, MA; Sellers, JT; Boatright, JH; Geisert, EE; Setterholm, NA; McDonald, FE; Iuvone, PM				Dhakal, Susov; He, Li; Lyuboslavsky, Polina; Sidhu, Curran; Chrenek, Micah A.; Sellers, Jana T.; Boatright, Jeffrey H.; Geisert, Eldon E.; Setterholm, Noah A.; McDonald, Frank E.; Iuvone, P. Michael			A Tropomycin-Related Kinase B Receptor Activator for the Management of Ocular Blast-Induced Vision Loss	JOURNAL OF NEUROTRAUMA			English	Article						axon injury; BDNF; TrkB receptor; HIOC; neuroprotection; ocular blast injury; traumatic optic neuropathy	NEUROTROPHIC FACTOR; N-ACETYLTRANSFERASE; MOUSE MODEL; GANGLION; MECHANISMS; SURVIVAL; TRAUMA; MELATONIN; INJURY; RHYTHM	Pressure waves from explosions or other traumatic events can damage the neurons of the eye and visual centers of the brain, leading to functional loss of vision. There are currently few treatments for such injuries that can be deployed rapidly to mitigate damage. Brain-derived neurotrophic factor (BDNF) and activation of its receptor tropomycin-related kinase B (TrkB) have neuroprotective effects in a number of degeneration models. Small molecule activators of TrkB, such as N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide (HIOC), cross the blood-brain and blood-retina barriers after systemic administration. We characterize the effects of blast-induced ocular trauma on retinal and visual function. We show that systemic administration of HIOC, a potent small molecule activator of the BDNF/TrkB receptor, preserves visual function in mice exposed to ocular blast injury. The HIOC treatment for one week preserves visual function for at least four months. The HIOC treatment effectively protected vision when the initial dose was administered up to 3 h after blast, but not if the initial treatment was delayed for 24 h. We provide evidence that the therapeutic effect of HIOC is mediated by activation of BDNF/TrkB receptors. The results indicate that HIOC may be useful for managing ocular blast injury and other forms of traumatic optic neuropathy.	[Dhakal, Susov; He, Li; Lyuboslavsky, Polina; Sidhu, Curran; Chrenek, Micah A.; Sellers, Jana T.; Boatright, Jeffrey H.; Geisert, Eldon E.; Iuvone, P. Michael] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Setterholm, Noah A.; McDonald, Frank E.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Iuvone, P. Michael] Emory Univ, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA; [Dhakal, Susov] Monash Univ, Dept Physiol, Melbourne, Vic, Australia; [Lyuboslavsky, Polina] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Setterholm, Noah A.] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Irvine, CA USA		Iuvone, PM (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, 1365 Clifton Rd NE, Atlanta, GA 30322 USA.	miuvone@emory.edu			Department of Defense, through the US Army Medical Research and Development Command [W81XWH-18-1-0700, W81XWH-12-1-0436, W81XWH12-1-0255]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30EY06360, R01EY028859]; VAUS Department of Veterans Affairs [I01RX002806]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB)	This study was supported by the Department of Defense, through the US Army Medical Research and Development Command under Awards W81XWH-18-1-0700, W81XWH-12-1-0436, and W81XWH12-1-0255 (PMI, EEG), by the NIH P30EY06360 (Emory Vision Core, PMI) and R01EY028859 (JHB), by the VA via I01RX002806 (JHB/PMI), by unrestricted funds from Research to Prevent Blindness, and by a gift from the Abraham J. and Phyllis Katz Foundation (JHB/PMI).	Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Baba K, 2018, P NATL ACAD SCI USA, V115, P13099, DOI 10.1073/pnas.1808137115; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chan RK, 2012, J TRAUMA ACUTE CARE, V73, pS453, DOI 10.1097/TA.0b013e3182754868; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferrari L.R., 1996, ANESTHESIOL CLIN N A, V14, P125; Field DT, 2014, HANDBOOK OF NUTRITION, DIET, AND THE EYE, P403, DOI 10.1016/B978-0-12-401717-7.00041-1; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Iuvone PM, 2014, ADV EXP MED BIOL, V801, P765, DOI 10.1007/978-1-4614-3209-8_96; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jones K, 2016, J NEUROTRAUM, V33, P1194, DOI 10.1089/neu.2015.4022; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; McClenaghan FC, 2011, CURR OPIN OPHTHALMOL, V22, P426, DOI 10.1097/ICU.0b013e3283499420; Mitre M, 2017, CLIN SCI, V131, P13, DOI 10.1042/CS20160044; Mocchetti Italo, 2004, Critical Reviews in Neurobiology, V16, P51, DOI 10.1615/CritRevNeurobiol.v16.i12.50; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Oxenkrug G, 2005, ANN NY ACAD SCI, V1053, P334, DOI 10.1196/annals.1344.029; Podbielska M, 2016, J NEUROCHEM, V139, P440, DOI 10.1111/jnc.13774; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Raymond ID, 2008, MOL VIS, V14, P1559; Setterholm NA, 2015, TETRAHEDRON LETT, V56, P3413, DOI 10.1016/j.tetlet.2015.01.167; Shen JY, 2012, P NATL ACAD SCI USA, V109, P3540, DOI 10.1073/pnas.1119201109; Sherwood D, 2014, INVEST OPHTH VIS SCI, V55, P1124, DOI 10.1167/iovs.13-13295; Sompol P, 2011, P NATL ACAD SCI USA, V108, P8844, DOI 10.1073/pnas.1105114108; Struebing FL, 2018, J NEUROTRAUM, V35, P118, DOI 10.1089/neu.2017.5104; Tang JJ, 2015, NEUROBIOL DIS, V78, P126, DOI 10.1016/j.nbd.2015.01.009; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1007/BF03206648; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	45	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2896	2906		10.1089/neu.2020.7392		AUG 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000688716800001	34353120				2022-02-06	
J	Fronczak, KM; Li, YM; Henchir, J; Dixon, CE; Carlson, SW				Fronczak, Katherine M.; Li, Youming; Henchir, Jeremy; Dixon, C. Edward; Carlson, Shaun W.			Reductions in Synaptic Vesicle Glycoprotein 2 Isoforms in the Cortex and Hippocampus in a Rat Model of Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Synapse; Traumatic brain injury; Neurotransmission; Hippocampus; Cortex; Vesicle	CONTROLLED CORTICAL IMPACT; DENTATE GYRUS; PROTEIN 2A; POSTTRAUMATIC EPILEPSY; BINDING-SITE; SV2; LEVETIRACETAM; MICE; RELEASE; EPILEPTOGENESIS	Traumatic brain injury (TBI) can produce lasting cognitive, emotional, and somatic difficulties that can impact quality of life for patients living with an injury. Impaired hippocampal function and synaptic alterations have been implicated in contributing to cognitive difficulties in experimental TBI models. In the synapse, neuronal communication is facilitated by the regulated release of neurotransmitters from docking presynaptic vesicles. The synaptic vesicle glycoprotein 2 (SV2) isoforms SV2A and SV2B play central roles in the maintenance of the readily releasable pool of vesicles and the coupling of calcium to the N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex responsible for vesicle docking. Recently, we reported the findings of TBI-induced reductions in presynaptic vesicle density and SNARE complex formation; however, the effect of TBI on SV2 is unknown. To investigate this, rats were subjected to controlled cortical impact (CCI) or sham control surgery. Abundance of SV2A and SV2B were assessed at 1, 3, 7, and 14 days post-injury by immunoblot. SV2A and SV2B were reduced in the cortex at several time points and in the hippocampus at every time point assessed. Immunohistochemical staining and quantitative intensity measurements completed at 14 days post-injury revealed reduced SV2A immunoreactivity in all hippocampal subregions and reduced SV2B immunoreactivity in the molecular layer after CCI. Reductions in SV2A abundance and immunoreactivity occurred concomitantly with motor dysfunction and spatial learning and memory impairments in the 2 weeks post-injury. These findings provide novel evidence for the effect of TBI on SV2 with implications for impaired neurotransmission neurobehavioral dysfunction after TBI.	[Fronczak, Katherine M.; Li, Youming; Henchir, Jeremy; Dixon, C. Edward; Carlson, Shaun W.] Univ Pittsburgh, Neurol Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Carlson, SW (corresponding author), Univ Pittsburgh, Neurol Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	KMF111@pitt.edu; yol8@pitt.edu; jjhst22@pitt.edu; dixoec@upmc.edu; carlsons@pitt.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS111099, 5R01NS079061]; Chuck Noll Foundation; Walter L. Copeland Fund of The Pittsburgh Foundation	This work was supported by the National Institutes of Health Grant 1R21NS111099 (SWC) and 5R01NS079061 (CED), The Chuck Noll Foundation (SWC), and the Walter L. Copeland Fund of The Pittsburgh Foundation (SWC).	Agtarap SD, 2021, J NEUROTRAUM, V38, P546, DOI 10.1089/neu.2020.7055; Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Bartholome O, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00148; Beitchman JA, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01434; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Butler CR, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0134-17.2017; Carlson SW, 2021, MOL NEUROBIOL, V58, P362, DOI 10.1007/s12035-020-02123-w; Carlson SW, 2018, J NEUROTRAUM, V35, P2827, DOI 10.1089/neu.2017.5509; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Chen YH, 2016, BRAIN RES, V1642, P581, DOI 10.1016/j.brainres.2016.04.013; Contreras-Garcia Itzel Jatziri, 2018, Epilepsy Behav, V88, P283, DOI 10.1016/j.yebeh.2018.08.023; Crevecoeur J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-87; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Folweiler Kaitlin A, 2020, eNeuro, V7, DOI 10.1523/ENEURO.0195-19.2020; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Frankowski JC, 2019, NEUROBIOL DIS, V129, P208, DOI 10.1016/j.nbd.2018.07.022; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Hanaya R, 2012, NEUROSCIENCE, V221, P12, DOI 10.1016/j.neuroscience.2012.06.058; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Konan LM, 2019, J NEUROTRAUM, V36, P2117, DOI 10.1089/neu.2018.6260; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; Ondek K, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113360; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheehan Patricia, 2019, Small GTPases, V10, P54, DOI 10.1080/21541248.2016.1270392; Sheehan P, 2016, J NEUROSCI, V36, P8668, DOI 10.1523/JNEUROSCI.0725-16.2016; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Wright MJ, 2020, BRAIN INJURY, V34, P1666, DOI 10.1080/02699052.2020.1825806; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	71	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2021	58	11					6006	6019		10.1007/s12035-021-02534-3		AUG 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WZ5XS	WOS:000688378600002	34435329				2022-02-06	
J	Zhu, YR; Chen, ZJ; You, WD; Wang, YD; Tu, MD; Zheng, PD; Wen, L; Yang, XF				Zhu, Yuanrun; Chen, Zijian; You, Wendong; Wang, Yadong; Tu, Mengdi; Zheng, Peidong; Wen, Liang; Yang, Xiaofeng			A Retrospective Clinical Analysis of the Serum Bile Acid Alteration Caused by Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; bile acid; retrospective study; brain-gut axis; gut microbiota	TAUROURSODEOXYCHOLIC ACID; STROKE; RISK	Traumatic brain injury (TBI) can cause damage to peripheral organ systems, such as digestive organ system, and alterations of gut microbiota in addition to brain injury. Our previous study found that TBI induced gastrointestinal dysfunction accompanied by alterations of bile acid metabolism. Bile acid and its receptors have been reported to play important roles in various neurological diseases. To further examine the changes of bile acid metabolism in TBI patients, we performed a retrospective clinical analysis. In this study, 177 patients were included, and the results showed that TBI patients had more frequent antibiotic use compared with a control group. Regression analysis identified TBI as an independent factor for reduction of serum bile acid level (B = -1.762, p = 0.006), even with antibiotic use taken into a regression model. Sub-group regression analysis of TBI patients showed that antibiotic use was negatively associated with bile acid level, while creatinine and triglyceride were positively associated with bile acid level. In conclusion, these data indicated that TBI could greatly reduce serum bile acid. This study provided preliminary but novel clinical evidence of TBI interfering with bile acid metabolism, and further studies with large sample sizes are needed to validate these findings in the future.	[Zhu, Yuanrun; You, Wendong; Wang, Yadong; Wen, Liang; Yang, Xiaofeng] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China; [Chen, Zijian; Tu, Mengdi; Zheng, Peidong] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China; [Chen, Zijian] Zhejiang Chinese Med Univ, Shaoxing Hosp Tradit Chinese Med, Shaoxing, Peoples R China		Wen, L; Yang, XF (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China.	wenliang@zju.edu.cn; zjcswk@zju.edu.cn					Ahlin S, 2019, BRIT J SURG, V106, P1178, DOI 10.1002/bjs.11208; Bajaj JS, 2019, NAT REV GASTRO HEPAT, V16, P235, DOI 10.1038/s41575-018-0099-1; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Behr C, 2019, TOXICOL APPL PHARM, V363, P79, DOI 10.1016/j.taap.2018.11.012; Blanchet M, 2018, CURR MED CHEM, V25, P3613, DOI 10.2174/0929867325666180309113737; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charach G, 2020, ATHEROSCLEROSIS, V293, P79, DOI 10.1016/j.atherosclerosis.2019.12.010; Chavez-Talavera O, 2019, CURR OPIN LIPIDOL, V30, P244, DOI 10.1097/MOL.0000000000000597; Chen L, 2019, J NEURORESTORATOLOGY, V7, P1, DOI [10.26599/JNR.2019.9040004, 10.18178/jacn.2019.7.1.263]; Chu C, 2019, NATURE, V574, P543, DOI 10.1038/s41586-019-1644-y; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Dawes LG, 2007, AM J SURG, V194, P623, DOI 10.1016/j.amjsurg.2007.07.017; Enright EF, 2018, PHARMACOL RES, V133, P170, DOI 10.1016/j.phrs.2018.04.009; Garcia JM, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00386; Gronbeck KR, 2016, NEUROCRIT CARE, V25, P153, DOI 10.1007/s12028-015-0225-7; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Kennedy EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01534; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Liang H, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02087-1; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Pan PF, 2019, NEUROL SCI, V40, P1105, DOI 10.1007/s10072-019-03739-0; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Winston JA, 2020, GUT MICROBES, V11, P158, DOI 10.1080/19490976.2019.1674124; Yanguas-Casas N, 2017, J CELL PHYSIOL, V232, P2231, DOI 10.1002/jcp.25742; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; You WD, 2021, J NEUROTRAUM, DOI 10.1089/neu.2020.7526; Zuo G, 2019, FREE RADICAL BIO MED, V143, P441, DOI 10.1016/j.freeradbiomed.2019.09.002	34	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 25	2021	12								624378	10.3389/fneur.2021.624378			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UH0IR	WOS:000689625200005	34512494	gold, Green Published			2022-02-06	
J	Barrett, JP; Knoblach, SM; Bhattacharya, S; Gordish-Dressman, H; Stoica, BA; Loane, DJ				Barrett, James P.; Knoblach, Susan M.; Bhattacharya, Surajit; Gordish-Dressman, Heather; Stoica, Bogdan A.; Loane, David J.			Traumatic Brain Injury Induces cGAS Activation and Type I Interferon Signaling in Aged Mice	FRONTIERS IN IMMUNOLOGY			English	Article						type I interferons; traumatic brain injury; aging; neuroinflammation; microglia	GENE-EXPRESSION; IFN-BETA; CNS; RESPONSES; DRIVES; NEUROINFLAMMATION; NEURODEGENERATION; INDUCTION; MICROGLIA; PROGRESSION	Aging adversely affects inflammatory processes in the brain, which has important implications in the progression of neurodegenerative disease. Following traumatic brain injury (TBI), aged animals exhibit worsened neurological function and exacerbated microglial-associated neuroinflammation. Type I Interferons (IFN-I) contribute to the development of TBI neuropathology. Further, the Cyclic GMP-AMP Synthase (cGAS) and Stimulator of Interferon Genes (STING) pathway, a key inducer of IFN-I responses, has been implicated in neuroinflammatory activity in several age-related neurodegenerative diseases. Here, we set out to investigate the effects of TBI on cGAS/STING activation, IFN-I signaling and neuroinflammation in young and aged C57Bl/6 male mice. Using a controlled cortical impact model, we evaluated transcriptomic changes in the injured cortex at 24 hours post-injury, and confirmed activation of key neuroinflammatory pathways in biochemical studies. TBI induced changes were highly enriched for transcripts that were involved in inflammatory responses to stress and host defense. Deeper analysis revealed that TBI increased expression of IFN-I related genes (e.g. Ifnb1, Irf7, Ifi204, Isg15) and IFN-I signaling in the injured cortex of aged compared to young mice. There was also a significant age-related increase in the activation of the DNA-recognition pathway, cGAS, which is a key mechanism to propagate IFN-I responses. Finally, enhanced IFN-I signaling in the aged TBI brain was confirmed by increased phosphorylation of STAT1, an important IFN-I effector molecule. This age-related activation of cGAS and IFN-I signaling may prove to be a mechanistic link between microglial-associated neuroinflammation and neurodegeneration in the aged TBI brain.	[Barrett, James P.; Stoica, Bogdan A.; Loane, David J.] Univ Maryland, Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol & Shock, Sch Med, Baltimore, MD 21201 USA; [Knoblach, Susan M.; Bhattacharya, Surajit] Childrens Natl Hlth Syst, Ctr Genet Med Res, Childrens Res Inst, Washington, DC USA; [Knoblach, Susan M.] George Washington Univ, Dept Genom & Precis Med, Sch Med & Hlth Sci, Washington, DC USA; [Gordish-Dressman, Heather] Childrens Natl Hlth Syst, Childrens Res Inst, Ctr Translat Sci, Washington, DC USA; [Gordish-Dressman, Heather] George Washington Univ, Dept Pediat, Sch Med & Hlth Sci, Washington, DC USA; [Stoica, Bogdan A.] Baltimore VA Med Ctr, Vet Affairs VA Maryland Hlth Care Syst, Baltimore, MD USA; [Loane, David J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland		Barrett, JP; Loane, DJ (corresponding author), Univ Maryland, Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol & Shock, Sch Med, Baltimore, MD 21201 USA.; Loane, DJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	james.barrett@som.umaryland.edu; loanedj@tcd.ie	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Barrett, James/0000-0002-0924-9449	NCMRR-DC Core for Molecular and Functional Outcome Measures in Rehabilitation Medicine NICHD [R24HD050846]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082308, R01NS110756, R01NS096002]; U.S. Veterans AffairsUS Department of Veterans Affairs [1I01 RX001993]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [17/FRL/4860]	This work was supported, in part, by NCMRR-DC Core for Molecular and Functional Outcome Measures in Rehabilitation Medicine NICHD R24HD050846 (DL/SK), NIH R01NS082308 (DL), NIH R01NS110756 (DL/BS), NIH R01NS096002 (BS), U.S. Veterans Affairs grant 1I01 RX001993 (BS), and Science Foundation Ireland grant 17/FRL/4860 (DL).	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Androvic P, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107777; Banos-Lara MD, 2013, J VIROL, V87, P1242, DOI 10.1128/JVI.01213-12; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Blank T, 2017, GLIA, V65, P1397, DOI 10.1002/glia.23154; Bolivar S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01368; Brand FJ, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0101-4; Cheng WY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01297; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Dias AG, 2019, TRENDS MICROBIOL, V27, P75, DOI 10.1016/j.tim.2018.08.007; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Ennerfelt HE, 2020, IMMUNOL REV, V297, P225, DOI 10.1111/imr.12896; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Fitz NF, 2019, BRIT J PHARMACOL, V176, P3599, DOI 10.1111/bph.14668; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fryer AL, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621501; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Goldmann T, 2016, CURR OPIN NEUROBIOL, V36, P38, DOI 10.1016/j.conb.2015.09.003; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Gunthner R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/731023; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hamann L, 2019, GERONTOLOGY, V65, P145, DOI 10.1159/000492972; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Iadecola C, 1999, J EXP MED, V189, P719, DOI 10.1084/jem.189.4.719; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jiang R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/787023; Johnson MB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01817-1; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Katayama T, 2007, INT J ONCOL, V31, P613; Kell AM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008483; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Korvatska O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.559342; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Li Q, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911002; Li Q, 2019, NEUROSCIENCE, V412, P16, DOI 10.1016/j.neuroscience.2019.05.025; Li T, 2017, NEUROMOL MED, V19, P541, DOI 10.1007/s12017-017-8468-4; Liu CF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Main BS, 2016, GLIA, V64, P1590, DOI 10.1002/glia.23028; Makarevich O, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02774-6; Malireddi RKS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00406; McDonough A, 2017, J NEUROSCI, V37, P8292, DOI 10.1523/JNEUROSCI.0725-17.2017; McGarry N, 2021, BRAIN BEHAV IMMUN, V95, P413, DOI 10.1016/j.bbi.2021.04.016; Mishchenko MI, 2019, OPT LETT, V44, P419, DOI 10.1364/OL.44.000419; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Nazmi A, 2019, GLIA, V67, P1254, DOI 10.1002/glia.23592; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; Paul A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01831; Paul BD, 2021, TRENDS NEUROSCI, V44, P83, DOI 10.1016/j.tins.2020.10.008; Peng YC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01830-4; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reinert LS, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136824; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Roy-O'Reilly M, 2018, ENDOCRINOLOGY, V159, P3120, DOI 10.1210/en.2018-00465; Salem M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-181; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Schreiber G, 2017, J BIOL CHEM, V292, P7285, DOI 10.1074/jbc.R116.774562; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Subramaniam PS, 1997, J INTERF CYTOK RES, V17, P11, DOI 10.1089/jir.1997.17.11; Sun M, 2020, NEUROSCI BIOBEHAV R, V109, P114, DOI 10.1016/j.neubiorev.2019.12.027; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tanaka T, 2015, GLIA, V63, P595, DOI 10.1002/glia.22770; Tang YQ, 2020, ACTA GEOTECH, V15, P2205, DOI 10.1007/s11440-019-00890-y; Taylor JM, 2018, J NEURAL TRANSM, V125, P797, DOI 10.1007/s00702-017-1745-4; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Todd BP, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02197-w; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tsai MH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01448; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wan QY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00189; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Wong G, 2018, ZOOL RES, V39, P3, DOI 10.24272/j.issn.2095-8137.2017.052; Wuertz KM, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007899; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zahid A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.613039; Zhang YG, 2014, J IMMUNOL, V193, P2394, DOI 10.4049/jimmunol.1302718; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	107	0	0	9	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	AUG 24	2021	12									10.3389/fimmu.2021.710608			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ3NB	WOS:000695973000001	34504493	gold, Green Published			2022-02-06	
J	Broglio, SP; McAllister, T; Katz, BP; LaPradd, M; Zhou, WX; McCrea, MA				Broglio, Steven P.; McAllister, Thomas; Katz, Barry P.; LaPradd, Michelle; Zhou, Wenxian; McCrea, Michael A.		CARE Consortium Investigators	The Natural History of Sport-Related Concussion in Collegiate Athletes: Findings from the NCAA-DoD CARE Consortium	SPORTS MEDICINE			English	Article							RECOVERY-TIME; POSITION STATEMENT; FOOTBALL PLAYERS; HIGH-SCHOOL; SYMPTOMS; EPIDEMIOLOGY; PREDICTORS; CHILDREN; SEX	Background Sport-related concussion is recognized as a significant injury with variable recovery rates. Objective This study defined the acute natural history of sport concussion in male and female collegiate athletes participating in a broad array of sports. Methods We conducted a prospective, longitudinal investigation among collegiate student athletes (n = 34,709) from 30 academic institutions. Primary outcomes included the time (days) from injury until initiation of a return to participation (RTP) protocol and time from injury until medical clearance for unrestricted RTP. Results Concussed athletes (n = 1751, 19.2 years, 63.2% male) participating in 22 different sports began the RTP protocol in a median 6.4 (IQR 3.7-11.8) days. Time to initiate the RTP protocol was lengthened by less frequent post-injury assessments, greater initial post-injury symptom severity, limited contact sports participation, practice/training injuries, and three or more prior concussions. The median total RTP duration was 12.8 (IQR 8.7-20.1) days. Total RTP duration was shorter with ADHD medication usage, males, and greater assessment frequency; while greater initial post-injury symptom severity, practice-/training-related injuries, and three or more prior concussions had longer recoveries. Conclusion Although median recovery times are consistent with previous guidelines, it was not until 1 month post-injury that a preponderance of collegiate athletes were cleared to begin the RTP protocol (92%) or cleared for unrestricted sport participation (85%). Intrinsic and extrinsic factors had a small effect, altering recovery trajectories by up to 2 days, suggesting a largely unified approach to post-injury monitoring and management across all athletes. These data represent a shift from previous classification parameters of normal clinical recovery.	[Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, 830 N Univ Ave, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ, Dept Psychiat, Indianapolis, IN USA; [Katz, Barry P.; Zhou, Wenxian] Indiana Univ Sch Med, Richard M Fairbanks Sch Publ Hlth, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46202 USA; [LaPradd, Michelle] Indiana Univ Sch Med, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		Broglio, SP (corresponding author), Univ Michigan, Michigan Concuss Ctr, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	broglio@umich.edu			National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program [W81XWH1420151]	Data collection and sharing for this project was conducted with support from the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program, endorsed by the Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program-Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH1420151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Master CL, 2021, BRIT J SPORT MED, V55, P1387, DOI 10.1136/bjsports-2020-103316; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yeates KO, 2019, J NEUROTRAUM, V36, P1758, DOI 10.1089/neu.2018.6009; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	34	0	0	2	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	FEB	2022	52	2					403	415		10.1007/s40279-021-01541-7		AUG 2021	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YP9HE	WOS:000687925700001	34427877				2022-02-06	
J	Ingram, PB; Morris, NM; Golden, B; Youngren, WA; Fulton, JA; Sharpnack, J				Ingram, Paul B.; Morris, Nicole M.; Golden, Brittney; Youngren, Westley A.; Fulton, Joe A.; Sharpnack, James			The Influence of Service Era: Comparing Personality Assessment Inventory (PAI) Scale Scores Within a Posttraumatic Stress Disorder Treatment Clinic (PCT)	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article; Early Access						PAI; Veteran affairs; Psychological assessment; PTSD; Service era	TRAUMATIC BRAIN-INJURY; MILITARY SERVICE; SUICIDAL IDEATION; COMBAT VETERANS; WAR VETERANS; IRAQ; AFGHANISTAN; SYMPTOMS; GULF; CARE	Research is mixed on the role of service era in symptom endorsement among Veterans, with differences emerging depending on the instrument evaluated. This study compares Personality Assessment Inventory (PAI) scale scores of VA test-takers who served during the Vietnam, Desert Storm, or Post-9/11 service eras. The sample was collected at a VA Posttraumatic Stress Disorder Clinical Team. Associations between gender and combat exposure were also examined as covariates. Results suggest that Veterans' self-report on the PAI is influenced by service era, even after accounting for gender and combat exposure during deployment. The largest differences were between Vietnam or Post-9/11 Veterans and those from the Gulf War era. Symptom differences typically varied across scales commonly associated with symptoms of trauma exposure/posttraumatic stress disorder. Implications for the clinical use of, and research with, the PAI and other broadband personality assessments within the VA healthcare system and trauma treatment settings are discussed.	[Ingram, Paul B.; Morris, Nicole M.; Golden, Brittney] Texas Tech Univ, Dept Psychol Sci, 2810 18th St, Lubbock, TX 79424 USA; [Ingram, Paul B.; Sharpnack, James] Eastern Kansas Vet Healthcare Syst, Topeka, KS 66622 USA; [Youngren, Westley A.; Fulton, Joe A.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA		Ingram, PB (corresponding author), Texas Tech Univ, Dept Psychol Sci, 2810 18th St, Lubbock, TX 79424 USA.; Ingram, PB (corresponding author), Eastern Kansas Vet Healthcare Syst, Topeka, KS 66622 USA.	pbingram@gmail.com	Ingram, Paul/ABB-3657-2020	Ingram, Paul/0000-0002-5409-4896			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychological Association, 2017, ETH PRINC PSYCH COD; American Psychological Association, 2017, MULTICULTURAL GUIDEL; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Ashrafioun L, 2016, J AFFECT DISORDERS, V189, P344, DOI 10.1016/j.jad.2015.09.014; Atuel HR, 2018, CLIN SOC WORK J, V46, P74, DOI 10.1007/s10615-018-0651-z; Bellet BW, 2018, ASSESSMENT, V25, P1074, DOI 10.1177/1073191116681627; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Boress K, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1900400; Boyd JE, 2015, PSYCHIATR REHABIL J, V38, P132, DOI 10.1037/prj0000122; Brown W, 2016, MIL PSYCHOL, V28, P418, DOI 10.1037/mil0000133; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Cancio R, 2021, J ETHN SUBST ABUSE, V20, P77, DOI 10.1080/15332640.2019.1571978; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Cohen J, 1998, STAT POWER ANAL BEHA; Coll JE., 2016, CARING MILITARY GUID; Conner KR, 2014, J AFFECT DISORDERS, V166, P1, DOI 10.1016/j.jad.2014.04.067; Department of Veteran Affairs, 2018, NATL CTR VET AN STAT; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Fontana A, 2008, J NERV MENT DIS, V196, P513, DOI 10.1097/NMD.0b013e31817cf6e6; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; GaIatzer-Levy IR, 2018, CLIN PSYCHOL REV, V63, P41, DOI 10.1016/j.cpr.2018.05.008; Gaines MV, 2013, ASSESSMENT, V20, P437, DOI 10.1177/1073191112458146; Glenn DM, 2002, J CLIN PSYCHOL, V58, P371, DOI 10.1002/jclp.1149; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; Hart, 2015, MILITARY BEHAV HLTH, V3, P83, DOI [https://doi.org/10.1080/21635781.2014.995254, DOI 10.1080/21635781.2014.995254]; Hawes SW, 2009, PSYCHOL ASSESSMENT, V21, P112, DOI 10.1037/a0015036; Hoge CW, 2014, J CLIN PSYCHIAT, V75, pE1439, DOI 10.4088/JCP.14com09616; Ilgen MA, 2012, J CONSULT CLIN PSYCH, V80, P323, DOI 10.1037/a0028266; Ingram PB, 2021, CURR PSYCHOL, V40, P5267, DOI 10.1007/s12144-019-00486-5; Ingram PB, 2020, J CLIN PSYCHOL MED S, V27, P366, DOI 10.1007/s10880-019-09650-2; Ingram PB, 2020, PSYCHOL SERV, V17, P355, DOI 10.1037/ser0000339; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kaplan MS, 2012, AM J PUBLIC HEALTH, V102, pS21, DOI 10.2105/AJPH.2011.300611; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacLean A, 2007, ANNU REV SOCIOL, V33, P175, DOI 10.1146/annurev.soc.33.040406.131710; Magruder KM, 2009, PSYCHIAT ANN, V39, P778, DOI 10.3928/00485713-20090728-04; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; MCCARROLL JE, 1995, AM J PSYCHIAT, V152, P939; Meca A, 2020, MIL PSYCHOL, V32, P408, DOI 10.1080/08995605.2020.1802400; Meyer EG, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0662-9; Migliore LA., 2016, MILITARY BEHAV HLTH, V4, P183, DOI [10.1080/21635781.2015.1133351, DOI 10.1080/21635781.2015.1133351]; Miller MW, 2008, J TRAUMA STRESS, V21, P58, DOI 10.1002/jts.20303; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 1996, INTERPRETIVE GUIDE P; Morey LC, 2011, PSYCHOL ASSESSMENT, V23, P456, DOI 10.1037/a0022173; Morgan RO, 2005, HEALTH SERV RES, V40, P1573, DOI 10.1111/j.1475-6773.2005.00448.x; Mozley SL, 2005, J PSYCHOPATHOL BEHAV, V27, P179, DOI 10.1007/s10862-005-0634-6; National Center for Veterans Analysis and Statistics, 2014, TRENDS UT VA PROGR S; Nuciari M, 2018, HDB SOCIOLOGY MILITA, P477, DOI DOI 10.1007/978-3-319-71602-2_25; Orazem RJ, 2017, PSYCHOL TRAUMA-US, V9, P4, DOI 10.1037/tra0000225; Oslin DW, 2006, J GEN INTERN MED, V21, P46, DOI 10.1111/j.1525-1497.2005.0267.x; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Quartana PJ, 2014, AM J PUBLIC HEALTH, V104, P1671, DOI 10.2105/AJPH.2014.301971; Ray CL, 2017, PSYCHOL INJ LAW, V10, P223, DOI 10.1007/s12207-017-9289-3; Reisman M., 2016, PHARM THERAPEUTICS, V41, P632; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; ROSNOW RL, 1989, PSYCHOL BULL, V105, P143, DOI 10.1037/0033-2909.105.1.143; Russo AC, 2018, ARCH CLIN NEUROPSYCH, V33, P1046, DOI 10.1093/arclin/acx139; Stellman JM, 2018, AM J PUBLIC HEALTH, V108, P726, DOI 10.2105/AJPH.2018.304426; Stretch RH, 1996, MIL MED, V161, P407, DOI 10.1093/milmed/161.7.407; Teigen JM, 2006, POLIT RES QUART, V59, P601, DOI 10.1177/106591290605900409; Tellegen A., 2011, MINNESOTA MULTIPHASI; United States Census Bureau, 2020, THOS WHO SERV AM VET; WEISS DS, 1992, J TRAUMA STRESS, V5, P365, DOI 10.1002/jts.2490050304; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; Wilmoth JM, 2010, J GERONTOL B-PSYCHOL, V65, P744, DOI 10.1093/geronb/gbq072; WOLFE J, 1993, J SOC ISSUES, V49, P15, DOI 10.1111/j.1540-4560.1993.tb01179.x; Wright CV, 2017, PROF PSYCHOL-RES PR, V48, P73, DOI 10.1037/pro0000086; Yee J, 2021, MIL MED, V186, P559, DOI 10.1093/milmed/usaa308; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079; Yoder M, 2012, PSYCHOL SERV, V9, P16, DOI 10.1037/a0026279; Zwiebach L, 2019, COGN BEH THER, V12, DOI 10.1017/S1754470X18000132	77	0	0	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583	1573-3572		J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings												10.1007/s10880-021-09812-1		AUG 2021	12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UE5CH	WOS:000687905600001	34427816				2022-02-06	
J	Chao, K; Wang, D; Yang, HF; Ma, N; Liu, QL; Sun, XG; Sun, RQ				Chao, Ke; Wang, Dong; Yang, Hongfu; Ma, Ning; Liu, Qilong; Sun, Xiaoge; Sun, Rongqing			Beneficial Effect of Immune-Enhanced Enteral Nutrition on Immune Function in Patients With Severe Neurological Diseases: A Single-Center Randomized Controlled Trial	FRONTIERS IN NUTRITION			English	Article						critical illness; nutritional status (NPK); cellular immunity; enteral nutrition; neurologic disease; randomized controlled trial	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; CO-STIMULATION; IMMUNONUTRITION; SUPPORT; ADULT; GUIDELINES; ROUTINE; SYSTEM; CD27	Background: Undernutrition is the main reason for the use of artificial nutrition in patients with severe neurological diseases. However, the clinical and immunological outcomes of enteral nutrition supplemented with immunomodulatory nutrients in these patients remain unclear. Methods: In this single-center, randomized controlled study, 57 patients with severe neurological diseases were randomly divided into the following two groups according to the type of enteral nutrition they would receive: immune-enhancing (IE) (n = 27) and non-IE (NIE) (n = 30). The IE and NIE groups received enteral nutrition supplemented with immunomodulatory nutrients and standard enteral nutrition, respectively. We compared the nutritional status and the state of cellular immunity between the patients of the two groups. Clinical and immunological variables were evaluated following nutritional treatment. Results: Feeding intolerance was lower in the IE than that in the NIE group (P = 0.04). However, there were no significant differences between the results of the two groups in terms of length of stay in the intensive care unit or hospital, extubation time, or body mass index (P > 0.05). The CD4+ T-lymphocyte count and CD4(+)/CD8+ ratio in the peripheral blood increased significantly in the IE group. The expression of CD28 activated cell surface markers was higher in the IE than in the NIE group. In addition, increased plasma interferon-gamma levels were recorded in the IE group, whereas the levels of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, IL-8, and IL-10 decreased. Conclusions: Immune-enhanced enteral nutrition could improve the immune status and feeding tolerance in patients with severe neurological diseases.	[Chao, Ke] Henan Prov Chest Hosp, Extracardiac Care Unit, Zhengzhou, Peoples R China; [Wang, Dong; Yang, Hongfu; Ma, Ning; Liu, Qilong; Sun, Xiaoge; Sun, Rongqing] Zhengzhou Univ, Intens Care Unit, Affiliated Hosp 1, Zhengzhou, Peoples R China		Sun, RQ (corresponding author), Zhengzhou Univ, Intens Care Unit, Affiliated Hosp 1, Zhengzhou, Peoples R China.	rongqing.sun@126.com			National Clinical Key Specialty Construction Projects [2011-873]; Henan Medical Science and Technology Research Plan [LHGJ20190746]	This study was supported by grants from the National Clinical Key Specialty Construction Projects (No. 2011-873). Joint Co-construction Project of Henan Medical Science and Technology Research Plan (LHGJ20190746).	Amantea D, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00241; Beale RJ, 1999, CRIT CARE MED, V27, P2799, DOI 10.1097/00003246-199912000-00032; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Cai C, 2016, TUMOR BIOL, V37, P8209, DOI 10.1007/s13277-015-4687-1; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen ZH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040373; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Donegan JJ, 2014, J NEUROSCI, V34, P953, DOI 10.1523/JNEUROSCI.3968-13.2014; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Gao T, 2019, J CRIT CARE, V52, P219, DOI 10.1016/j.jcrc.2019.05.008; Han RR, 2017, STROKE, V48, P2255, DOI 10.1161/STROKEAHA.117.016705; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Janakiram M, 2017, IMMUNOL REV, V276, P26, DOI 10.1111/imr.12521; Kirilovsky A, 2016, INT IMMUNOL, V28, P373, DOI 10.1093/intimm/dxw021; Klek S, 2014, WORLD J SURG, V38, P803, DOI 10.1007/s00268-013-2323-z; Kotlega D, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/6676247; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Luo ZZ, 2018, JPEN-PARENTER ENTER, V42, P758, DOI 10.1177/0148607117715439; Mao XY, 2021, PHARMACOL THERAPEUT, V226, DOI 10.1016/j.pharmthera.2021.107861; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mendivil CO, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.617652; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; Moghaddas A, 2016, CLIN NUTR, V35, P783, DOI 10.1016/j.clnu.2015.07.001; Montejo JC, 2003, CLIN NUTR, V22, P221, DOI 10.1016/S0261-5614(03)00007-4; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Painter TJ, 2015, INT J SURG, V21, P70, DOI 10.1016/j.ijsu.2015.07.008; Phillips SM, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00013; Qiu CF, 2017, JPEN-PARENTER ENTER, V41, P785, DOI 10.1177/0148607115601858; Radrizzani D, 2006, INTENS CARE MED, V32, P1191, DOI 10.1007/s00134-006-0238-y; Rattanachaiwong S, 2020, CLIN NUTR, V39, P3419, DOI 10.1016/j.clnu.2020.02.035; Reintam A, 2009, ACTA ANAESTH SCAND, V53, P318, DOI 10.1111/j.1399-6576.2008.01860.x; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rong YD, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-1007-9; Samary CS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1573-1; Sanmamed MF, 2015, SEMIN ONCOL, V42, P640, DOI 10.1053/j.seminoncol.2015.05.014; Shankar B, 2015, J CRIT CARE, V30, P473, DOI 10.1016/j.jcrc.2015.02.009; Sharma K, 2019, NUTR CLIN PRACT, V34, P12, DOI 10.1002/ncp.10232; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Sun J, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1583951; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Vermeulen MAR, 2016, JPEN-PARENTER ENTER, V40, P264, DOI 10.1177/0148607114567199; Walrand S, 2001, AM J CLIN NUTR, V74, P670; Wang GL, 2013, J SURG RES, V183, P592, DOI 10.1016/j.jss.2012.12.010; Xu CJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-141; Yamaura K, 2010, AM J TRANSPLANT, V10, P1210, DOI 10.1111/j.1600-6143.2010.03089.x; Yan X, 2017, CLIN NUTR, V36, P710, DOI 10.1016/j.clnu.2016.06.011	51	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-861X			FRONT NUTR	Front. Nutr.	AUG 23	2021	8								685422	10.3389/fnut.2021.685422			8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	WV9VD	WOS:000717575900001	34497819	gold, Green Published			2022-02-06	
J	Santo, MPD; Faria, CS; Solla, DJF; Pipek, LZ; Belon, AR; Jeng, BP; de Andrade, AF; Teixeira, MJ; Paiva, WS				do Espirito Santo, Marcelo Prudente; Faria, Caroline Silverio; Fontoura Solla, Davi Jorge; Pipek, Leonardo Zumerkorn; Belon, Alessandro Rodrigo; Jeng, Brasil Ping; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial	INTENSIVE CARE MEDICINE EXPERIMENTAL			English	Article						Inflammatory markers; Intracranial hypertension; Animal model; Cytokines; Inflammation	TRAUMATIC BRAIN-INJURY; IN-VIVO; BIOMARKERS; MANAGEMENT	Background: Intracranial hypertension (ICH) is a common final pathway of most neurosurgical pathologies and leads to poor prognosis if not detected and treated properly. Inflammatory markers have been assessed in clinical scenarios of neurological injuries, in which systemic and brain tissue aggressions may introduce bias. There is a lack of studies under controlled settings to isolate the ICH effect on inflammation. This study aims to evaluate the effects of ICH on the serum concentration of cytokines as biomarkers of neuroinflammation in an experimental model which isolates ICH from potential confounding variables. Methods: An established model of ICH using an intracerebral pediatric bladder catheter and a multisensor intraparenchymal catheter was used in adult pigs (Sus domesticus). The animals were randomly allocated to 2 groups based on the catheter balloon volume used to simulate the ICP increase (4 ml or 7 ml). Cytokines were measured in 4 timepoints during the experiment: (1) 15 min before balloon insufflation; (2) 5 min after insufflation; (3) 125 min after insufflation; (4) 60 min after deflation. The following cytokines were measured IL-1 alpha; IL-1 beta; IL-1ra; IL-2; IL-4; IL-6; IL-8; IL-10; IL-12; IL-18; TNFa. Generalized estimating equations were modeled to compare the ICP and cytokines values between the groups along the experiment. The study sample size was powered to detect interactions between the groups and the study moments with an effect size (f) of at least 0.3. The ARRIVE checklist was followed. Results: A total of 20 animals were studied (10 in each group, 4 ml or 7 ml balloon volume insufflation). The animal model was successful in increasing the ICP along the moments of the experiment (p < 0,001) and in creating an ICP gradient between the groups (p = 0,004). The interaction term (moment x group) was also significant (p < 0,001). There was a significant association between ICP elevation and most cytokines variation. The cytokines IL-1 alpha, IL-1 beta, IL1-ra, IL-6, IL-12, and IL-18 increased, whereas IL-2, IL-4, and TNF-alpha decreased. IL-10 did not vary significantly in response to the ICP elevation. Conclusion: The serum concentration of cytokines varied in response to intracranial hypertension. The study demonstrated the specific changes in each cytokine afterintracranial hypertension and provides key information to guide neuroinflammation clinical research. The proposed experiment was successful as an animal model to the study of neuroinflammation biomarkers.	[do Espirito Santo, Marcelo Prudente; Faria, Caroline Silverio; Fontoura Solla, Davi Jorge; Pipek, Leonardo Zumerkorn; Belon, Alessandro Rodrigo; Jeng, Brasil Ping; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Div Neurosurg, Med Sch, Sao Paulo, Brazil		Pipek, LZ (corresponding author), Univ Sao Paulo, Div Neurosurg, Med Sch, Sao Paulo, Brazil.	leonardo.pipek@fm.usp.br	Pipek, Leonardo Zumerkorn/AAC-7363-2019; Paiva, Wellingson S/G-5517-2013	Pipek, Leonardo Zumerkorn/0000-0001-5268-4668; Paiva, Wellingson S/0000-0002-5165-7040; Prudente do Espirito Santo, Marcelo/0000-0002-7833-3054; Faria, Caroline/0000-0001-5272-2169			Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Brough D, 2015, EXP PHYSIOL, V100, P1488, DOI 10.1113/EP085135; Conlon P J, 1989, Biotechnol Ther, V1, P31; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; de Andrade AF, 2013, ARQ NEURO-PSIQUIAT, V71, P802, DOI 10.1590/0004-282X20130126; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; JONES AT, 1993, BLOOD, V82, P1133; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Marcolini E, 2019, EMERG MED CLIN N AM, V37, P529, DOI 10.1016/j.emc.2019.04.001; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Martin CE, 2013, BLOOD, V121, P4484, DOI 10.1182/blood-2012-08-449215; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; Naraoka M, 2019, WORLD NEUROSURG, V129, pE63, DOI 10.1016/j.wneu.2019.05.009; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Vincent JL, 2020, CRIT CARE CLIN, V36, P177, DOI 10.1016/j.ccc.2019.08.014; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147	22	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2197-425X			INTENS CARE MED EXP	Int. Care Med. Exp.	AUG 23	2021	9	1							42	10.1186/s40635-021-00408-5			13	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UD4CD	WOS:000687155100001	34423394	Green Published, gold			2022-02-06	
J	Read, C; Wignell, A; Stewart, C; Davies, P				Read, Claire; Wignell, Andrew; Stewart, Craig; Davies, Patrick			Clinical effects of hypertonic saline boluses in children with severe traumatic brain injury	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article; Early Access						cerebral perfusion pressure; hyperosmolar agent; hypertonic saline; mean arterial pressure; raised intracranial pressure; traumatic brain injury	INTRACRANIAL HYPERTENSION; THERAPY	Aim To quantify the effects of 3% hypertonic saline (HTS) boluses on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in children. Methods A retrospective study of patients admitted to a regional neurosurgical children's intensive care unit. Results A total of 156 HTS boluses were given to children with traumatic brain injury. ICP decreased 6 mmHg (P < 0.01) and CPP increased 4 mmHg (P = 0.003) 1-h post-bolus. Effects persisted for 3 h post-dose ICP was 5 mmHg lower) and 4 h post-bolus CPP was 3 mmHg higher. ICP change was not associated with pre-bolus serum sodium concentration. Conclusions Hypertonic saline 3% at 5 mL/kg is an effective osmolar therapy for reducing ICP and increasing CPP in children for up to 3 h. '53-53' is a suitable guide - 5 mL/kg of 3% HTS will on average decrease ICP by at least 5 mmHg for 3 h. Pre-bolus serum sodium concentration is not correlated with effect size.	[Read, Claire; Wignell, Andrew; Stewart, Craig; Davies, Patrick] Nottingham Childrens Hosp, Paediat Crit Care Unit, Derby Rd, Nottingham NG7 2UH, England; [Read, Claire; Davies, Patrick] Univ Nottingham, Sch Med, Nottingham, England; [Wignell, Andrew] Nottingham Univ Hosp NHS Trust, Pharm Dept, Nottingham, England		Davies, P (corresponding author), Nottingham Childrens Hosp, Paediat Crit Care Unit, Derby Rd, Nottingham NG7 2UH, England.	patrick.davies@nuh.nhs.uk		Read (BMedSci), Claire/0000-0002-8023-635X			[Anonymous], 2019, GUIDELINES; [Anonymous], 2019, NEED NHS ETH APPR; [Anonymous], 2014, NICE HEAD INJ TRIAG; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Fenn Norman E 3rd, 2019, J Pediatr Pharmacol Ther, V24, P465, DOI 10.5863/1551-6776-24.6.465; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Furdek M, 2017, VNITR LEK, V63, P200; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Mangat HS, 2020, NEUROSURGERY, V86, P221, DOI 10.1093/neuros/nyz046; Nakagawa K, 2012, J CLIN ANESTH, V24, P318, DOI 10.1016/j.jclinane.2011.10.011; Piper BJ, 2015, ANAESTH INTENS CARE, V43, P204, DOI 10.1177/0310057X1504300210; Rallis D, 2017, J CRIT CARE, V38, P52, DOI 10.1016/j.jcrc.2016.10.014; Rameshkumar R, 2020, PEDIATR CRIT CARE ME, V21, P1071, DOI 10.1097/PCC.0000000000002557; Roumeliotis N, 2016, CHILD NERV SYST, V32, P2363, DOI 10.1007/s00381-016-3231-y; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stiff JL., 2017, ANESTH ANALG, V58, P42; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; Wells DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11678; Wu AG, 2019, PEDIATR CRIT CARE ME, V20, P466, DOI 10.1097/PCC.0000000000001867	25	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health												10.1111/jpc.15695		AUG 2021	5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	UD8LO	WOS:000687454600001	34427010				2022-02-06	
J	Tsuneoka, H; Tosaka, M; Nakata, S; Ishii, N; Osawa, S; Shimauchi-Ohtaki, H; Honda, F; Yoshimoto, Y				Tsuneoka, Haruka; Tosaka, Masahiko; Nakata, Satoshi; Ishii, Nobukazu; Osawa, Sho; Shimauchi-Ohtaki, Hiroya; Honda, Fumiaki; Yoshimoto, Yuhei			Emergent surgical evacuation of traumatic intracranial hematoma in patients with preoperative thrombocytopenia: surgical risk and early outcome	ACTA NEUROLOGICA BELGICA			English	Article; Early Access						Traumatic brain injury; Thrombocytopenia; Coagulopathy; Craniotomy; Outcome	PROGRESSIVE HEMORRHAGIC INJURY; BRAIN-INJURY; TIME-COURSE; COAGULOPATHY; COAGULATION	Background Surgical evacuation of intracranial hematoma, including epidural, subdural, intracerebral, and intraventricular hematoma, is recommended in patients with traumatic brain injury (TBI) for prevention of cerebral herniation and possible saving of life. However, preoperative coagulopathy is a major concern for emergent surgery on patients with severe TBI. Methods We reviewed 65 consecutive patients with severe TBI who underwent emergency craniotomy for intracranial hematomas. Results Univariate analysis showed preoperative pupil abnormality, absence of pupil light reflex, respiratory failure, preoperative thrombocytopenia (< 100 x 10(9)/L), increased activated partial thromboplastin time (> 36 s), low fibrinogen (< 150 mg/dL), platelet transfusion, red cell concentrate transfusion, and presence of brain contusion and traumatic subarachnoid hemorrhage (SAH) on computed tomography were correlated with poor outcome (death or vegetative state). Multivariate analysis revealed that pupil abnormality (p = 0.001; odds ratio [OR] 0.064, 95% confidence interval [CI] 0.012-0.344), preoperative thrombocytopenia (p = 0.016; OR 0.101, 95% CI 0.016-0.656), and traumatic SAH (p = 0.021; OR 0.211, 95% CI 0.057-0.791) were significant factors. Investigation of the 14 patients with preoperative thrombocytopenia found the emergency surgery was successful, with no postoperative bleeding during hospitalization. However, half of the patients died, and almost a quarter remained in the vegetative state mainly associated with severe cerebral edema. Conclusions Emergent craniotomy for patients with severe TBI who have preoperative thrombocytopenia is often successful, but the prognosis is often poor. Emergency medical care teams and neurosurgeons should be aware of this discrepancy between successful surgery and poor prognosis in these patients. Further study may be needed on the cerebral edema regulator function of platelets.	[Tsuneoka, Haruka; Tosaka, Masahiko; Nakata, Satoshi; Ishii, Nobukazu; Osawa, Sho; Shimauchi-Ohtaki, Hiroya; Honda, Fumiaki; Yoshimoto, Yuhei] Gunma Univ, Dept Neurosurg, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan		Tosaka, M (corresponding author), Gunma Univ, Dept Neurosurg, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	nstosaka@gunma-u.ac.jp		Tosaka, Masahiko/0000-0002-4430-751X			Armand R, 2003, TRANSFUS MED REV, V17, P223, DOI 10.1016/S0887-7963(03)00022-1; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CHAN KH, 1989, J NEUROSURG, V71, P38, DOI 10.3171/jns.1989.71.1.0038; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; Cooper SW, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000313; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gao C, 2020, J NEUROCHEM, V154, P190, DOI 10.1111/jnc.14983; Gura M, 2011, TURK NEUROSURG, V21, P210, DOI 10.5137/1019-5149.JTN.3574-10.1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kerezoudis P, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20439; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Lorente L, 2020, NEUROCRIT CARE, V32, P790, DOI 10.1007/s12028-019-00800-w; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Marion DW, 2006, NEUROSURGERY, V58, P655; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Nakagawa Kazuma, 2013, Hawaii J Med Public Health, V72, P129; Prasad GL, 2018, WORLD NEUROSURG, V111, pE221, DOI 10.1016/j.wneu.2017.12.034; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Shibahashi K, 2017, WORLD NEUROSURG, V106, P589, DOI 10.1016/j.wneu.2017.07.025; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	34	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.												10.1007/s13760-021-01786-z		AUG 2021	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD8YX	WOS:000687489400001	34426955				2022-02-06	
J	Vetro-Kalseth, D; Vaudreuil, R; Segall, LE				Vetro-Kalseth, Danielle; Vaudreuil, Rebecca; Segall, Lorna E.			Treatment description and case series report of a phased music therapy group to support Veteran reintegration	MILITARY PSYCHOLOGY			English	Article						Music therapy; military; Veterans; reintegration	MILITARY	Music therapy is becoming increasingly prevalent in rehabilitation programs serving military and Veteran populations in the United States. Music therapy is integrated into interdisciplinary models and positioned to treat brain injury, post-traumatic stress disorder, and other psychological health conditions at military installations and Veteran medical centers nationwide. Phased group music therapy is delivered in a longitudinal treatment model to assist in the rehabilitation of service members and Veterans. Different phases of group music therapy are aligned with a treatment trajectory that exists on a clinic to community continuum to support recovery and reintegration. This article provides a description and case presentations of clinical programming. Information was accessed from patients' electronic medical records, clinical documentation, therapist observation, and patient interviews. Interviews were transcribed and a content analysis was conducted by the authors. Emergent themes from the patient interviews included social relationships, community reintegration and transition, and post-military occupational success. Patients reported that group music therapy provided skill-building opportunities that were helpful for them during military service transitions, specifically active duty to Veteran status. Support skills included rapport-building and enhanced camaraderie. Furthermore, music therapy appeared to bolster peer connections through shared experiences, which decreased isolation, increased socialization, and supported reintegration.	[Vetro-Kalseth, Danielle] Joint Base Elmendorf Richardson, Mild Traumat Brain Injury Clin, Anchorage, AK USA; [Vetro-Kalseth, Danielle; Vaudreuil, Rebecca] Henry M Jackson Fdn Adv Mil Med Inc, Creat Forces NEA Mil Healing Arts Network, Bethesda, MD USA; [Segall, Lorna E.] Univ Louisville, Dept Music Therapy, Louisville, KY 40292 USA		Vetro-Kalseth, D (corresponding author), 730 Woodmar Pl, Anchorage, AK 99515 USA.	danielle.v.kalseth.ctr@mail.mil			National Endowment for the Arts, Creative Forces(R): NEA Military Healing Arts Network	This work was supported by the National Endowment for the Arts, Creative Forces (R): NEA Military Healing Arts Network.	Ahern J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128599; Allegria M, 2010, I MED NATL ACAD, V1, P1; American Music Therapy Association, 2014, MUS THER MIL POP; American Music Therapy Association & Certification Board for Music Therapists. AMTA & CBMT, 2015, SCOP MUS THER PRACT; Baker FA, 2013, ART PSYCHOTHER, V40, P20, DOI 10.1016/j.aip.2012.09.004; Bensimon M, 2008, ART PSYCHOTHER, V35, P34, DOI 10.1016/j.aip.2007.09.002; Betts D., 2020, 2020 MIL HLTH SYST R; Betts D., 2020, ADV CREATIVE FORCES; Blake R.L., 1994, MUSIC THER PERSPECT, V12, P125, DOI [10.1093/mtp/12.2.125, DOI 10.1093/MTP/12.2.125]; Bradt J, 2019, ART PSYCHOTHER, V62, P19, DOI 10.1016/j.aip.2018.11.004; Bradt J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub2; Bronson H, 2018, MUSIC THER PERSPECT, V36, P195, DOI 10.1093/mtp/miy006; Brown S, 2000, ORIGINS OF MUSIC, P271; Burt, 1995, MUSIC THERAPY PERSPE, V13, P110, DOI [10.1093/mtp/13.2.110, DOI 10.1093/mtp/13.2.110]; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Defense and Veterans Brain Injury Center, 2017, RES REV MILD TRAUM B; Dixon M., 2002, MUSIC MUSIC THERAPY, P119; Koenig CJ, 2014, PATIENT EDUC COUNS, V95, P414, DOI 10.1016/j.pec.2014.03.016; National Endowments for the Arts, CREAT FORC NEA MIL H; Nissen Trygve, 2014, BMC Res Notes, V7, P264, DOI 10.1186/1756-0500-7-264; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Pothoulaki M, 2012, J MUSIC THER, V49, P45, DOI 10.1093/jmt/49.1.45; Rorke MA, 1996, J MUSIC THER, V33, P189, DOI 10.1093/jmt/33.3.189; Silverman MJ, 2019, COMMUNITY MENT HLT J, V55, P615, DOI 10.1007/s10597-018-0319-8; Soshensky R, 2011, MUSIC THER PERSPECT, V29, P23, DOI 10.1093/mtp/29.1.23; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; US. War Department, 1945, MUS REC ASF CONV GEN; Vaudreuil R, 2020, MUSIC THER PERSPECT, V38, P167, DOI 10.1093/mtp/miaa006; Vaudreuil R, 2020, DISABIL REHABIL-ASSI, DOI 10.1080/17483107.2020.1775312; Vaudreuil R, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00119; Wands L, 2013, ADV NURS SCI, V36, P186, DOI 10.1097/ANS.0b013e31829edcbe	31	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	NOV 2	2021	33	6					446	452		10.1080/08995605.2021.1962194		AUG 2021	7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	XF2DS	WOS:000688417900001		hybrid			2022-02-06	
J	Kullmann, A; Ashmore, RC; Braverman, A; Mazur, C; Snapp, H; Williams, E; Szczupak, M; Murphy, S; Marshall, K; Crawford, J; Balaban, CD; Hoffer, M; Kiderman, A				Kullmann, Aura; Ashmore, Robin C.; Braverman, Alexandr; Mazur, Christian; Snapp, Hillary; Williams, Erin; Szczupak, Mikhaylo; Murphy, Sara; Marshall, Kathryn; Crawford, James; Balaban, Carey D.; Hoffer, Michael; Kiderman, Alexander			Normative data for ages 18-45 for ocular motor and vestibular testing using eye tracking	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						concussion; eye tracking; mild traumatic brain injury; mTBI; Neurolign Dx 100; neurological conditions; NOTC; rotation tests; vestibular conditions	HARMONIC ACCELERATION TEST; TRAUMATIC BRAIN-INJURY; PSEUDORANDOM ROTATION TEST; OPTOKINETIC NYSTAGMUS; VESTIBULOOCULAR REFLEX; BLAST EXPOSURE; DYSFUNCTION; BALANCE; ABNORMALITIES; CONSEQUENCES	Objective Eye tracking technology has been employed in assessing ocular motor and vestibular function following vestibular and neurologic conditions, including traumatic brain injury (TBI). Assessments include tests that provide visual and motion (rotation) stimuli while recording horizontal, vertical, and torsional eye movements. While some of these tests have shown diagnostic promise in previous studies, their use in clinical practice is limited by the lack of normative data. The goal of this study was to construct normative reference ranges to be used when comparing patients' results. Methods Optokinetic response, subjective visual horizontal and vertical, and rotation tests were administered to male and female volunteers, ages 18-45, who were free from neurological, vestibular disorders, or other head injuries. Tests were administered using either a rotatory chair or a portable virtual reality-like goggle equipped with video-oculography. Results Reference values for eye movements in response to different patterns of stimuli were analyzed from 290 to 449 participants. Analysis of gender (self-reported) or age when grouped as pediatric (late adolescent; 18-21 years of age) and adult (21-45 years of age) revealed no effects on the test metrics. Data were pooled and presented for each test metric as the 95% reference interval (RI) with 90% confidence intervals (CI) on upper and lower limits of the RI. Conclusions This normative database can serve as a tool to aid in diagnosis, treatment, and/or rehabilitation protocols for vestibular and neurological conditions, including mild TBI (mTBI). This database has been cleared by the FDA for use in clinical practice (K192186). Level of evidence 2b	[Kullmann, Aura; Ashmore, Robin C.; Mazur, Christian; Kiderman, Alexander] Neurolign USA LLC, 128 Gamma Dr, Pittsburgh, PA 15238 USA; [Braverman, Alexandr] Hebrew Univ Jerusalem, Jerusalem, Israel; [Snapp, Hillary; Williams, Erin; Szczupak, Mikhaylo; Hoffer, Michael] Univ Miami, Miller Sch Med, Dept Otorhinolaryngol, Miami, FL 33136 USA; [Murphy, Sara] Naval Med Ctr, San Diego, CA USA; [Murphy, Sara; Marshall, Kathryn] Hearing Ctr Excellence, Dept Def, San Antonio, TX USA; [Marshall, Kathryn; Crawford, James] Madigan Army Med Ctr, Tacoma, WA 98431 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Hoffer, Michael] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA		Kullmann, A (corresponding author), Neurolign USA LLC, 128 Gamma Dr, Pittsburgh, PA 15238 USA.	aura.kullmann@gmail.com		Crawford, James/0000-0001-7599-647X; Snapp, Hillary/0000-0002-2000-5357	Department of DefenseUnited States Department of Defense [W81XWH-12-C0205, W81XWH-13-C-0008]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R43DC014611, R44HD100247]	Department of Defense, Grant/Award Numbers: W81XWH-12-C0205, W81XWH-13-C-0008; National Institutes of Health, Grant/Award Numbers: R43DC014611, R44HD100247	Agrawal Y, 2013, J VESTIBUL RES-EQUIL, V23, P113, DOI 10.3233/VES-130498; Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Casto K. L., 2012, AUDITORY VESTIBULAR; Chan FM, 2016, LARYNGOSCOPE, V126, P460, DOI 10.1002/lary.25497; Chandrasekhar SS, 2013, NEUROREHABILITATION, V32, P445, DOI 10.3233/NRE-130867; Chien WWD, 2014, OTOL NEUROTOL, V35, P577, DOI 10.1097/MAO.0000000000000238; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cochrane GD, 2021, J HEAD TRAUMA REHAB, V36, P264, DOI 10.1097/HTR.0000000000000651; Cochrane GD, 2019, OPTOMETRY VISION SCI, V96, P256, DOI 10.1097/OPX.0000000000001364; Cohen HS, 2014, SOUTH MED J, V107, P549, DOI 10.14423/SMJ.000000000000017; Crampton A, 2021, NEUROCHIRURGIE, V67, P231, DOI 10.1016/j.neuchi.2021.01.002; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; Engelken E J, 1993, Biomed Sci Instrum, V29, P319; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Fujiwara M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173707; Furman JM, 2016, J VESTIBUL RES-EQUIL, V26, P447, DOI 10.3233/VES-160595; Garbutt S, 2004, J NEUROL NEUROSUR PS, V75, P1386, DOI 10.1136/jnnp.2003.027367; Gioacchini FM, 2014, INT J PEDIATR OTORHI, V78, P718, DOI 10.1016/j.ijporl.2014.02.009; GORDON CR, 1993, HEADACHE, V33, P129, DOI 10.1111/j.1526-4610.1993.hed3303129.x; HAMID MA, 1990, NEUROL CLIN, V8, P287, DOI 10.1016/S0733-8619(18)30356-6; Hardin AP, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2151; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hoffer ME, 2019, LARYNGOSCOPE INVEST, V4, P124, DOI 10.1002/lio2.231; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Hoffer ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146039; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Horn, 2010, DEFINING ESTABLISHIN; Horn P.S., 2005, REFERENCE INTERVALS; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Kendall PC, 2000, J CONSULT CLIN PSYCH, V68, P767, DOI 10.1037/0022-006X.68.5.767; King JE, 2018, MIL MED, V183, P237, DOI 10.1093/milmed/usx170; Lee MY, 2004, LARYNGOSCOPE, V114, P897, DOI 10.1097/00005537-200405000-00021; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; LI CW, 1991, LARYNGOSCOPE, V101, P192; Maes L, 2011, INT J AUDIOL, V50, P566, DOI 10.3109/14992027.2011.576706; Maes L, 2010, EAR HEARING, V31, P84, DOI 10.1097/AUD.0b013e3181b9640e; Maes L, 2008, J VESTIBUL RES-EQUIL, V18, P197; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; MOLLER C, 1990, ACTA OTO-LARYNGOL, V109, P15, DOI 10.3109/00016489009107410; OLSON JE, 1981, LARYNGOSCOPE, V91, P1270; OLSSON JE, 1991, LARYNGOSCOPE, V101, P1; Peterka R J, 1990, J Vestib Res, V1, P49; Probst R, 1983, Adv Otorhinolaryngol, V30, P159; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shin YJ, 2006, AM J OPHTHALMOL, V141, P327, DOI 10.1016/j.ajo.2005.09.025; Suzuki M, 1989, Acta Otolaryngol Suppl, V468, P317; Toupet M, 2015, OTOL NEUROTOL, V36, P1074, DOI 10.1097/MAO.0000000000000771; Valmaggia C, 2004, BRIT J OPHTHALMOL, V88, P1577, DOI 10.1136/bjo.2004.044222; Valmaggia C, 2003, INVEST OPHTH VIS SCI, V44, P5142, DOI 10.1167/iovs.03-0322; WALL C, 1984, ACTA OTO-LARYNGOL, V98, P270, DOI 10.3109/00016488409107563; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Zalewski C. K, 2018, ROTATIONAL VESTIBULA; Zalewski CK, 2015, OTOLARYNG HEAD NECK, V153, P257, DOI 10.1177/0194599815585098	59	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	OCT	2021	6	5					1116	1127		10.1002/lio2.632		AUG 2021	12	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	WG1SA	WOS:000686916700001	34667856	gold, Green Published			2022-02-06	
J	Caba, E; Sherman, MD; Farizatto, KLG; Alcira, B; Wang, HW; Giardina, C; Shin, DG; Sandefur, CI; Bahr, BA				Caba, Ebru; Sherman, Marcus D.; Farizatto, Karen L. G.; Alcira, Britney; Wang, Hsin-wei; Giardina, Charles; Shin, Dong-Guk; Sandefur, Conner I.; Bahr, Ben A.			Excitotoxic stimulation activates distinct pathogenic and protective expression signatures in the hippocampus	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						compensatory signalling; excitotoxic response; gene array; neuroprotection; repair pathway; transcription factor	NF-KAPPA-B; GENE-EXPRESSION; MICROARRAY ANALYSIS; CELL-DEATH; SIGNAL-TRANSDUCTION; CEREBRAL-ISCHEMIA; C-FOS; BRAIN; SURVIVAL; NEURONS	Excitotoxic events underlying ischaemic and traumatic brain injuries activate degenerative and protective pathways, particularly in the hippocampus. To understand opposing pathways that determine the brain's response to excitotoxicity, we used hippocampal explants, thereby eliminating systemic variables during a precise protocol of excitatory stimulation. N-methyl-d-aspartate (NMDA) was applied for 20 min and total RNA isolated one and 24 h later for neurobiology-specific microarrays. Distinct groups of genes exhibited early vs. delayed induction, with 63 genes exclusively reduced 24-h post-insult. Egr-1 and NOR-1 displayed biphasic transcriptional modulation: early induction followed by delayed suppression. Opposing events of NMDA-induced genes linked to pathogenesis and cell survival constituted the early expression signature. Delayed degenerative indicators (up-regulated pathogenic genes, down-regulated pro-survival genes) and opposing compensatory responses (down-regulated pathogenic genes, up-regulated pro-survival genes) generated networks with temporal gene profiles mirroring coexpression network clustering. We then used the expression profiles to test whether NF-kappa B, a potent transcription factor implicated in both degenerative and protective pathways, is involved in the opposing responses. The NF-kappa B inhibitor MG-132 indeed altered NMDA-mediated transcriptional changes, revealing components of opposing expression signatures that converge on the single response element. Overall, this study identified counteracting avenues among the distinct responses to excitotoxicity, thereby suggesting multi-target treatment strategies and implications for predictive medicine.	[Caba, Ebru] Vertex Pharmaceut, Cambridge, MA USA; [Caba, Ebru; Bahr, Ben A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT USA; [Caba, Ebru; Bahr, Ben A.] Univ Connecticut, Neurosci Program, Storrs, CT USA; [Sherman, Marcus D.; Farizatto, Karen L. G.; Alcira, Britney; Bahr, Ben A.] Univ North Carolina Pembroke, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA; [Sherman, Marcus D.; Farizatto, Karen L. G.; Alcira, Britney; Sandefur, Conner I.; Bahr, Ben A.] Univ North Carolina Pembroke, Dept Biol, Pembroke, NC USA; [Wang, Hsin-wei; Shin, Dong-Guk] Univ Connecticut, Bioinformat & Biocomp Inst, Storrs, CT USA; [Wang, Hsin-wei; Shin, Dong-Guk] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Giardina, Charles] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Sandefur, Conner I.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27515 USA; [Sandefur, Conner I.] Sandefur Modeling, Pittsboro, NC USA; [Bahr, Ben A.] Univ N Carolina, Department Chem & Phys, Pembroke, NC USA; [Caba, Ebru] CureVac Inc, 250 Summer St, Boston, MA USA		Bahr, BA (corresponding author), Univ North Carolina Pembroke, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA.	Bahr@uncp.edu			National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R41AG031590, 1G11HD052381, R25GM077634]; University of Connecticut Research Foundation; Boehringer Ingelheim fellowshipBoehringer Ingelheim; University of Connecticut Neurosciences Program	We thank Michael Almeida, Armando Corona and Jordon Smink for excellent laboratory assistance. The work was supported in part by grants from the National Institutes of Health, USA (1R41AG031590 to BAB, 1G11HD052381 subaward to BAB, R25GM077634 to University of North Carolina-Pembroke), University of Connecticut Research Foundation (BAB), University of Connecticut Neurosciences Program (EC) and by a Boehringer Ingelheim fellowship (EC). The funding agencies had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Almeida MF, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12936; Bahr BA, 2002, EXP NEUROL, V174, P37, DOI 10.1006/exnr.2001.7852; Bahr BA, 2000, J NEUROSCI RES, V59, P827, DOI 10.1002/(SICI)1097-4547(20000315)59:6<827::AID-JNR15>3.0.CO;2-Q; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Caba E, 2004, ACTA NEUROPATHOL, V108, P173, DOI 10.1007/s00401-004-0876-5; Caba E, 2002, J NEUROSCI RES, V67, P787, DOI 10.1002/jnr.10163; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Cho SH, 2001, J CEREBR BLOOD F MET, V21, P550, DOI 10.1097/00004647-200105000-00009; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Cotter R, 2002, J NEUROVIROL, V8, P585, DOI 10.1080/13550280290100950; Croft CL, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0346-0; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dresselhaus EC, 2018, J NEUROSCI, V38, P4093, DOI 10.1523/JNEUROSCI.2663-16.2018; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Farizatto KLG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42934-z; Feldman EL, 1997, NEUROBIOL DIS, V4, P201, DOI 10.1006/nbdi.1997.0156; Fernandes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099958; Fitzgerald LR, 1996, J NEUROCHEM, V66, P429; Gan J, 2020, J CELL MOL MED, V24, P149, DOI 10.1111/jcmm.14676; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Guo CJ, 2003, J NEUROCHEM, V84, P997, DOI 10.1046/j.1471-4159.2003.01609.x; Hickey RW, 2000, MOL BRAIN RES, V79, P169; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iadecola C, 1999, J EXP MED, V189, P719, DOI 10.1084/jem.189.4.719; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Karanian DA, 2005, J NEUROSCI, V25, P7813, DOI 10.1523/JNEUROSCI.2347-05.2005; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Lee DJ, 2015, J INVEST DERMATOL, V135, P2012, DOI 10.1038/jid.2015.119; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Lushnikova IV, 2004, J CELL MOL MED, V8, P241, DOI 10.1111/j.1582-4934.2004.tb00279.x; Lv Y, 2020, FRONT BIOSCI-LANDMRK, V25, P683, DOI 10.2741/4828; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Nagata T, 2004, MOL BRAIN RES, V121, P1, DOI 10.1016/j.molbrainres.2003.10.023; Ninkina NN, 2001, MAMM GENOME, V12, P862, DOI 10.1007/s00335-001-3039-1; Ohkubo T, 2000, MOL CELL ENDOCRINOL, V162, P151, DOI 10.1016/S0303-7207(00)00222-7; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; R Development Core Team, 2012, R LANG ENV STAT COMP; Rickhag M, 2006, J NEUROCHEM, V96, P14, DOI 10.1111/j.1471-4159.2005.03508.x; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Simoes AP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0351-1; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vaccari JCD, 2006, P NATL ACAD SCI USA, V103, P16971, DOI 10.1073/pnas.0608068103; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wei HP, 2016, TRANSL STROKE RES, V7, P497, DOI 10.1007/s12975-016-0484-4; Wenzel A, 2002, J NEUROCHEM, V80, P1089, DOI 10.1046/j.0022-3042.2002.00807.x; Winter C, 2002, MOL BRAIN RES, V104, P194, DOI 10.1016/S0169-328X(02)00378-9; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Yang Chuanhong, 2002, Chin J Traumatol, V5, P232; Zheng S, 2002, DEV BRAIN RES, V136, P101, DOI 10.1016/S0165-3806(02)00348-6; Zhou XJ, 2013, J BIOL CHEM, V288, P24151, DOI 10.1074/jbc.M113.482000	61	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	SEP	2021	25	18					9011	9027		10.1111/jcmm.16864		AUG 2021	17	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	UP1DY	WOS:000686498600001	34414662	Green Published, gold			2022-02-06	
J	Luo, YX; He, XW; Yang, MF; Du, CN; Jin, XQ				Luo, Yunxing; He, Xiwu; Yang, Mingfei; Du, Chaonan; Jin, Xiaoqing			A prognostic scoring system for operated acute epidural hematoma based on gray-white matter ratio	MEDICINE			English	Article						acute epidural hematoma; computed tomography; gray-white matter; nomogram; prognosis	TRAUMATIC BRAIN-INJURY; CLASSIFICATION; PREDICTION	To determine the prognostic risk factors of patients with acute epidural hematoma (AEDH), a scoring system was established based on gray-white matter ratio (GWR) and internal verification was performed. All patients with AEDH who underwent surgical treatment in Qinghai Provincial People's Hospital from January 2013 to June 2019 were continuously collected. The clinical and imaging data of the patients were collected. According to Glasgow Outcome Scale at 3 months after operation, the patients were divided into poor and good prognosis groups, respectively. The GWR value of the nonhematoma side was measured at the inner capsule area. Univariate and multivariate analyses were used. Independent predictors significantly related to the prognosis of AEDH were screened out and a nomogram was established based on these factors. A total of 170 cases were included in this study, the Glasgow Coma Score (severe and moderate), cerebral hernia, midline shift, preoperative GWR, postoperative GWR, hematoma thickness/midline shift, time from coma to surgery, and decompression of bone flap were the independent risk factors for predicting the poor prognosis of AEDH. Moreover, the prediction ability of nomogram was higher than any other independent predictive factors. The nomogram model established represents the most effective factor to predict the prognosis of operated AEDH. The scoring system is characterized by high accuracy, simplicity and feasibility, with a wide range of clinical application prospects.	[Luo, Yunxing; Du, Chaonan] Qinghai Univ, Grad Sch, Xining 810016, Qinghai, Peoples R China; [He, Xiwu] Fifth Peoples Hosp Qinghai Prov, Dept Neurosurg, Xining 810007, Qinghai, Peoples R China; [Yang, Mingfei; Jin, Xiaoqing] Qinghai Prov Peoples Hosp, Dept Neurosurg, Xining 810007, Qinghai, Peoples R China		Yang, MF (corresponding author), Qinghai Prov Peoples Hosp, 2 Gonghe Rd, Xining 810007, Qinghai, Peoples R China.	iloveyoucmu@163.com			Science and Technology Department of Qinghai Province [2020-SF-136]	This study was funded by the Science and Technology Department of Qinghai Province (2020-SF-136).	Bonney PA, 2020, WORLD NEUROSURG, V134, pE460, DOI 10.1016/j.wneu.2019.10.098; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Gentsch A, 2015, CLIN NEURORADIOL, V25, P49, DOI 10.1007/s00062-013-0281-3; Graziano Francesca, 2015, Surg Neurol Int, V6, P77, DOI 10.4103/2152-7806.156871; Guo C, 2017, NEUROL SCI, V38, P2111, DOI 10.1007/s10072-017-3121-4; Jin XQ, 2019, WORLD NEUROSURG, V124, pE266, DOI 10.1016/j.wneu.2018.12.081; Kim H, 2019, J NEUROSURG, V131, P1243, DOI 10.3171/2018.5.JNS172711; Lee MC, 2006, J MAGN RESON IMAGING, V23, P257, DOI 10.1002/jmri.20506; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zhang YH, 2018, WORLD NEUROSURG, V110, P206, DOI 10.1016/j.wneu.2017.11.047	15	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG 20	2021	100	33							e26888	10.1097/MD.0000000000026888			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UA7MQ	WOS:000685342600020	34414943	Green Published, gold			2022-02-06	
J	Seguin, CM; Culver, DM; Mellalieu, SD; Christie, S; Goss, J; Roorda, S				Seguin, Cassandra M.; Culver, Diane M.; Mellalieu, Stephen D.; Christie, Sommer; Goss, Judy; Roorda, Sieger			What's Our Role? Mental Performance Consultants' Perspectives on Supporting Concussed Athletes	JOURNAL OF SPORT PSYCHOLOGY IN ACTION			English	Article; Early Access						Sport-related concussion; return-to-play; sport psychology; community of practice		Bloom et al. (2020) advocated that mental performance consultants (MPCs) can play an important supporting role in the psychosocial recovery and well-being of concussed athletes. The rapid advancement of knowledge and limited resources designed for MPCs present challenges in facilitating this support. To address these challenges, a group of MPCs formed a community of practice to help define our role in this domain. In this article, we have attempted to translate our knowledge of concussion and related psychosocial support into an accessible narrative and approach that can help MPCs better understand our role in providing support to concussed athletes throughout the phases of return-to-play.	[Seguin, Cassandra M.; Culver, Diane M.] Univ Ottawa, Ottawa, ON, Canada; [Mellalieu, Stephen D.] Cardiff Metropolitan Univ, Cardiff, Wales; [Christie, Sommer] McGill Univ, Montreal, PQ, Canada; [Goss, Judy] Wrestling Canada Lutte, Ottawa, ON, Canada; [Roorda, Sieger] Univ Ottawa, Sports Serv, Ottawa, ON, Canada		Seguin, CM (corresponding author), Univ Ottawa, Sch Human Kinet, 125 Univ, Ottawa, ON K1N 6N5, Canada.	csegu043@uottawa.ca		Seguin, Cassandra/0000-0001-5863-6923; Mellalieu, Stephen/0000-0003-2868-3328; Culver, Diane M/0000-0002-8117-2722			Bloom GA, 2020, J APPL SPORT PSYCHOL, DOI 10.1080/10413200.2020.1843200; Ivarsson A, 2017, SPORTS MED, V47, P353, DOI 10.1007/s40279-016-0578-x; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos A., 2019, PSYCHOL ASPECTS SPOR, P37, DOI DOI 10.4324/9781351200516-4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Pennock KF, 2020, INT REV SPORT EXER P, DOI 10.1080/1750984X.2020.1824243; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Seguin C.M., 2019, PSYCHOL ASPECTS SPOR, P83, DOI [https://doi.org/10.4324/9781351200516-7, DOI 10.4324/9781351200516-7]; Wenger E., 2002, CULTIVATING COMMUNIT, DOI 10.5465/amle.2009.41788855; Wiese-Bjornstal D.M., 2015, KINESIOL REV, V4, P169, DOI [https://doi.org/10.1123/kr.2015-0012, DOI 10.1123/KR.2015-0012]	10	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2152-0704	2152-0712		J SPORT PSYCHOL ACTI	J. Sport Psychol. Action												10.1080/21520704.2021.1971811		AUG 2021	12	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	UM0HY	WOS:000693023000001					2022-02-06	
J	Tsai, PY; Chen, YC; Wang, JY; Chung, KH; Lai, CH				Tsai, Ping-Yen; Chen, Yang-Ching; Wang, Jia-Yi; Chung, Kuo-Hsuan; Lai, Chien-Hung			Effect of repetitive transcranial magnetic stimulation on depression and cognition in individuals with traumatic brain injury: a systematic review and meta-analysis	SCIENTIFIC REPORTS			English	Article							DORSOLATERAL PREFRONTAL CORTEX; TREATMENT-RESISTANT DEPRESSION; MAJOR DEPRESSION; PARKINSON DISEASE; RTMS; SYMPTOMS; IMPAIRMENT; RECOVERY; SEQUELAE	Repetitive transcranial magnetic stimulation (rTMS) is an FDA-approved therapy in major depressive disorder. However, its treatment efficacy on depression after traumatic brain injury (TBI) remains inconclusive. We conducted a meta-analysis to assess the effectiveness of executing rTMS over dorsolateral prefrontal cortex (DLPFC) on depression, cognitive impairment and post-concussion syndrome in individuals with traumatic brain injury. This study contained seven randomized controlled trials that published before April 5, 2020 in PubMed, Embase, Scopus, Cochrane, and Web of Science databases. The rTMS had significant anti-depressant effect (SMD = 1.03, p = 0.02), but the effects dissipated at 1-month follow-up (SMD = 0.39, p = 0.62). In the subgroup analysis, only applying rTMS to left DLPFC area of post-TBI patients showed significant anti-depressant effect (SMD = 0.98, p = 0.04). Moreover, current data observed that rTMS on post-TBI patients possessed substantial improvement in visuospatial memory (SMD = 0.39, p < 0.0001), but wasn't in processing speed (SMD = - 0.18, p = 0.32) and selective attention (SMD = 0.21, p = 0.31). In addition, the effect of rTMS is not superior to sham on postconcussion syndrome. In conclusion, the short-term antidepressant effect of left DLPFC rTMS in patients with TBI was significant. However, the effectiveness of rTMS on cognition and postconcussion syndrome in patients with post-TBI depression was limited.	[Tsai, Ping-Yen] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chen, Yang-Ching] Taipei Med Univ, Coll Med, Sch Med, Dept Family Med, Taipei, Taiwan; [Chen, Yang-Ching] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Neurosci Res Ctr, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Lai, Chien-Hung] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lai, Chien-Hung] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, 252 Wu Hsing St, Taipei 110, Taiwan		Lai, CH (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan.; Lai, CH (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, 252 Wu Hsing St, Taipei 110, Taiwan.	chlai@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351; Tsai, Ping-Yen/0000-0001-8863-2966; Chung, Kuo-Hsuan/0000-0002-5570-3972; Lai, Chien-Hung/0000-0002-5765-3120	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 109-2221-E-038-006, MOST 110-2221-E-038-011, MOST 110-2314-B-038-106]; Higher Education Sprout Project by the Ministry of Education [DP2-110-21121-01-N-02-02]; Taipei Medical University Hospital [110 IIT02]; Sunny Brain Tumor and Brain Disease Research and Development Fund from Taipei Medical University, Taipei, Taiwan	This work was partially supported by grants from the Ministry of Science and Technology of Taiwan (MOST 109-2221-E-038-006 and MOST 110-2221-E-038-011, and MOST 110-2314-B-038-106), the Higher Education Sprout Project by the Ministry of Education (DP2-110-21121-01-N-02-02), Taipei Medical University Hospital (110 IIT02) and Sunny Brain Tumor and Brain Disease Research and Development Fund from Taipei Medical University, Taipei, Taiwan. This manuscript was edited by Wallace Academic Editing.	Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cao X, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00413; Chang Jinlong, 2020, Int J Physiol Pathophysiol Pharmacol, V12, P128; Chou YH, 2015, JAMA NEUROL, V72, P432, DOI 10.1001/jamaneurol.2014.4380; Cohen RB, 2009, DEPRESS ANXIETY, V26, P682, DOI 10.1002/da.20486; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dunner DL, 2014, J CLIN PSYCHIAT, V75, P1394, DOI 10.4088/JCP.13m08977; Gaynes BN, 2014, J CLIN PSYCHIAT, V75, P477, DOI 10.4088/JCP.13r08815; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Guan HY, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0745-6; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Hoy KE, 2019, J NEUROTRAUM, V36, P2092, DOI 10.1089/neu.2018.6097; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kim TD, 2019, EXP NEUROBIOL, V28, P1, DOI 10.5607/en.2019.28.1.1; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Lee SA, 2018, MED SCI MONITOR, V24, P8789, DOI 10.12659/MSM.911385; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Li BJ, 2018, CNS NEUROSCI THER, V24, P1004, DOI 10.1111/cns.12998; Li J, 2016, NEURAL REGEN RES, V11, P1584, DOI 10.4103/1673-5374.193236; Liao X, 2015, J ALZHEIMERS DIS, V48, P463, DOI 10.3233/JAD-150346; Martin DM, 2017, DEPRESS ANXIETY, V34, P1029, DOI 10.1002/da.22658; Moussavi Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41923-6; Novack TA, 2000, BRAIN INJURY, V14, P987; Ouellet MC, 2018, J NEUROTRAUM, V35, P1620, DOI 10.1089/neu.2017.5379; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Pink AE, 2021, NEUROPSYCHOL REHABIL, V31, P479, DOI 10.1080/09602011.2019.1706585; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2019, J NEUROPSYCH CLIN N, V31, P306, DOI 10.1176/appi.neuropsych.17110338; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Schulze L, 2018, BRAIN STIMUL, V11, P327, DOI 10.1016/j.brs.2017.11.002; Shao D, 2021, BRAZ J MED BIOL RES, V54, DOI [10.1590/1414-431X202010010, 10.1590/1414-431x202010010]; Siddiqi SH, 2019, J NEUROTRAUM, V36, P1361, DOI 10.1089/neu.2018.5889; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Stilling J, 2020, J NEUROTRAUM, V37, P312, DOI 10.1089/neu.2019.6692; Tam JW, 2013, CLIN NEUROPSYCHOL, V27, P962, DOI 10.1080/13854046.2013.797500; Teng S, 2017, EUR PSYCHIAT, V41, P75, DOI 10.1016/j.eurpsy.2016.11.002; Trevizol AP, 2019, INT J GERIATR PSYCH, V34, P822, DOI 10.1002/gps.5091; Wang J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00186; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Xie CL, 2015, NEUROL SCI, V36, P1751, DOI 10.1007/s10072-015-2345-4; Zhang YQ, 2015, BRAZ J MED BIOL RES, V48, P198, DOI 10.1590/1414-431X20144270	48	0	0	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 20	2021	11	1							16940	10.1038/s41598-021-95838-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6PB	WOS:000687326500008	34417481	Green Published, gold			2022-02-06	
J	Carver, CM; DeWitt, HR; Stoja, AP; Shapiro, MS				Carver, Chase M.; DeWitt, Haley R.; Stoja, Aiola P.; Shapiro, Mark S.			Blockade of TRPC Channels Limits Cholinergic-Driven Hyperexcitability and Seizure Susceptibility After Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						ion channels; TRPC channels; hippocampus; epilepsy; seizure; traumatic brain injury; epileptogenesis; hyperexcitability	CONTROLLED CORTICAL IMPACT; VESICULAR ACETYLCHOLINE TRANSPORTER; RECEPTOR POTENTIAL CHANNELS; DENTATE GYRUS; RAT-BRAIN; REGIONAL-DISTRIBUTION; BINDING-SITES; MESSENGER-RNA; HEAD-INJURY; MODULATION	We investigated the contribution of excitatory transient receptor potential canonical (TRPC) cation channels to posttraumatic hyperexcitability in the brain 7 days following controlled cortical impact model of traumatic brain injury (TBI) to the parietal cortex in male adult mice. We investigated if TRPC1/TRPC4/TRPC5 channel expression is upregulated in excitatory neurons after TBI in contribution to epileptogenic hyperexcitability in key hippocampal and cortical circuits that have substantial cholinergic innervation. This was tested by measuring TRPC1/TRPC4/TRPC5 protein and messenger RNA (mRNA) expression, assays of cholinergic function, neuronal Ca2+ imaging in brain slices, and seizure susceptibility after TBI. We found region-specific increases in expression of TRPC1, TRPC4, and TRPC5 subunits in the hippocampus and cortex following TBI. The dentate gyrus, CA3 region, and cortex all exhibited robust upregulation of TRPC4 mRNA and protein. TBI increased cFos activity in dentate gyrus granule cells (DGGCs) and layer 5 pyramidal neurons both at the time of TBI and 7 days post-TBI. DGGCs displayed greater magnitude and duration of acetylcholine-induced rises in intracellular Ca2+ in brain slices from mice subjected to TBI. The TBI mice also exhibited greater seizure susceptibility in response to pentylenetetrazol-induced kindling. Blockade of TRPC4/TRPC5 channels with M084 reduced neuronal hyperexcitation and impeded epileptogenic progression of kindling. We observed that the time-dependent upregulation of TRPC4/TRPC5-containing channels alters cholinergic responses and activity of principal neurons acting to increase proexcitatory sensitivity. The underlying mechanism includes acutely decreased acetylcholinesterase function, resulting in greater G(q/11)-coupled muscarinic receptor activation of TRPC channels. Overall, our evidence suggests that TBI-induced plasticity of TRPC channels strongly contributes to overt hyperexcitability and primes the hippocampus and cortex for seizures.</p>	[Carver, Chase M.; DeWitt, Haley R.; Stoja, Aiola P.; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA		Carver, CM (corresponding author), Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	carverc@uthscsa.edu			Department of Defense, Congressionally Directed Medical Research Program AwardUnited States Department of Defense [W81XWH-1-19-0400]	This work was supported by the Department of Defense, Congressionally Directed Medical Research Program Award W81XWH-1-19-0400 to CC.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Arboit A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020365; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Barros VN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00072; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Bolkvadze T, 2016, EPILEPSY BEHAV, V60, P187, DOI 10.1016/j.yebeh.2016.04.038; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Boychuk JA, 2016, EXP NEUROL, V277, P178, DOI 10.1016/j.expneurol.2016.01.005; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carrillo-Mora P, 2017, CLIN NEUROPHARMACOL, V40, P131, DOI 10.1097/WNF.0000000000000217; Carver CM, 2019, J NEUROSCI, V39, P1566, DOI 10.1523/JNEUROSCI.1781-18.2018; Cherian AK, 2019, BEHAV NEUROSCI, V133, P448, DOI 10.1037/bne0000310; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Czigner A, 2004, INT J MOL MED, V14, P247; Dalrymple A, 2002, MOL HUM REPROD, V8, P946, DOI 10.1093/molehr/8.10.946; Dannenberg H, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00102; Dannenberg H, 2015, J NEUROSCI, V35, P8394, DOI 10.1523/JNEUROSCI.4460-14.2015; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P405; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Eltes T, 2019, J PHYSIOL-LONDON, V597, P2925, DOI 10.1113/JP277681; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; GOLARAI G, 1992, BRAIN RES, V593, P257, DOI 10.1016/0006-8993(92)91316-7; Grant CV, 2019, BREAST CANCER RES TR, V177, P345, DOI 10.1007/s10549-019-05324-7; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jahn HM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24085-9; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kim DS, 2013, CELL MOL NEUROBIOL, V33, P99, DOI 10.1007/s10571-012-9875-6; Kim J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010073; Kim YJ, 2015, NEUROSCIENCE, V307, P215, DOI 10.1016/j.neuroscience.2015.08.054; Ko AR, 2017, NEUROPHARMACOLOGY, V121, P120, DOI 10.1016/j.neuropharm.2017.05.004; Ko J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38443-0; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Lee YM, 2003, AM J PHYSIOL-GASTR L, V284, pG604, DOI 10.1152/ajpgi.00069.2002; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu XCM, 2020, J NEUROTRAUM, V37, P236, DOI 10.1089/neu.2019.6573; Luo L, 2008, HIPPOCAMPUS, V18, P989, DOI 10.1002/hipo.20461; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Morales-Weil K, 2020, NEUROSCIENCE, V428, P242, DOI 10.1016/j.neuroscience.2019.12.033; Mori MX, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00022; Neuberger EJ, 2019, J NEUROSCI RES, V97, P1335, DOI 10.1002/jnr.24202; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Ostberg A, 2018, J HEAD TRAUMA REHAB, V33, P25, DOI 10.1097/HTR.0000000000000279; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pabst M, 2016, NEURON, V90, P853, DOI 10.1016/j.neuron.2016.04.003; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Phelan KD, 2017, EPILEPSIA, V58, P247, DOI 10.1111/epi.13648; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rohacs Tibor, 2013, Advances in Biological Regulation, V53, P341, DOI 10.1016/j.jbior.2013.07.004; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santillo MF, 2015, J PHARMACOL TOX MET, V76, P15, DOI 10.1016/j.vascn.2015.07.002; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Smith C.J, 2012, J VIS EXP, V69; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Soni N, 2019, J NEUROTRAUM, V36, P1306, DOI 10.1089/neu.2018.5972; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Tai C, 2011, HIPPOCAMPUS, V21, P958, DOI 10.1002/hipo.20807; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Teles-Grilo Ruivo Leonor M, 2013, Front Synaptic Neurosci, V5, P2, DOI 10.3389/fnsyn.2013.00002; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Tseng PH, 2004, BIOCHEMISTRY-US, V43, P11701, DOI 10.1021/bi049349f; Valny M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00243; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Verkhratsky A, 2014, REV PHYSIOL BIOCH P, V166, P1, DOI 10.1007/112_2013_15; Vigil FA, 2020, J CEREBR BLOOD F MET, V40, P1256, DOI 10.1177/0271678X19857818; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Villasana LE, 2019, J NEUROTRAUM, V36, P2454, DOI 10.1089/neu.2018.6162; Vinayagam D, 2020, ELIFE, V9, DOI 10.7554/eLife.60603; Wang HB, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107497; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wust RCI, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202003031; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; Yang LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136255; Yi F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80245-w; Zheng F, 2017, ADV EXP MED BIOL, V976, P123, DOI 10.1007/978-94-024-1088-4_11; Zheng F, 2014, CELLS-BASEL, V3, P288, DOI 10.3390/cells3020288; Zhu Michael X, 2004, Novartis Found Symp, V258, P44; Zhu YM, 2015, BRIT J PHARMACOL, V172, P3495, DOI 10.1111/bph.13140; Zimmerman G, 2008, EUR J NEUROSCI, V27, P965, DOI 10.1111/j.1460-9568.2008.06070.x	121	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 19	2021	15								681144	10.3389/fnins.2021.681144			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL5KU	WOS:000692690500001	34489621	Green Published, gold			2022-02-06	
J	Espinosa, AC; Jimenez, JAF; Vazquez, PR; Aceves, GAG; Ayala, AP				Espinosa, Alejandro Ceja; Jimenez, Jose Alfonso Franco; Vazquez, Paola Reyes; Aceves, Guillermo Axayacalt Gutierrez; Ayala, Aurelio Ponce			Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus Secondary to Delayed Intracerebellar Hematoma	CUREUS			English	Article						post-traumatic hydrocephalus; cerebellar hematoma; endoscopic third ventriculostomy; posterior fossa hemorrhage; neuroendoscopy; management of obstructive hydrocephalus	CEREBELLAR INFARCTION	Nowadays, endoscopic third ventriculostomy (ETV) in neurosurgery has yielded good clinical results in various conditions. Intraventricular endoscopic procedures can be performed in different pathologies and not only in non-communicating hydrocephalus. This is presented accordingly in this clinical case. We present the case of a patient who suffered a blunt traumatic brain injury (TBI) in the occipital region. Upon his arrival at the medical facility, he displayed altered neurological status and showed symptoms of aggressiveness, slurred speech, and gait ataxia. Initial non-contrast brain computed tomography scan presented a cerebellar traumatic subacute hematoma and secondary hydrocephalus. Therefore, we performed an ETV. In most reported cases of cerebellar contusions among patients with TBI, the treatment was suboccipital craniectomy, clot evacuation, and external ventricular drainage (EVD). Unlike this case, the determined procedure was minimally invasive through ETV for the resolution of hydrocephalus with good clinical outcomes in addition to low morbidity and mortality. This case shows in the setting of delayed intracerebellar traumatic hematoma with secondary hydrocephalus being the main cause of neurological deterioration, a minimally invasive treatment such as ETV is suitable.	[Espinosa, Alejandro Ceja] Inst Nacl Neurol & Neurocirug, Dept Vasc Neurosurg, Mexico City, DF, Mexico; [Jimenez, Jose Alfonso Franco] Hosp Nino, Inst Materno Infantil Estado Mexico, Dept Pediat Neurosurg, Toluca De Lerdo, Mexico; [Vazquez, Paola Reyes] Inst Mexicano Seguro Social, Dept Neurol Surg, Monterrey, Mexico; [Aceves, Guillermo Axayacalt Gutierrez] Inst Nacl Neurol & Neurocirug, Dept Radioneurosurg, Mexico City, DF, Mexico; [Ayala, Aurelio Ponce] Hosp Juarez Mexico, Dept Neurol Surg, Mexico City, DF, Mexico		Vazquez, PR (corresponding author), Inst Mexicano Seguro Social, Dept Neurol Surg, Monterrey, Mexico.	paolareyes.doc@gmail.com					Amar AP, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.2.FOCUS11369; Baldauf J, 2006, NEUROSURGERY, V59, P539, DOI 10.1227/01.NEU.0000228681.45125.E9; El-Gaidi MA, 2015, J NEUROSURG-PEDIATR, V15, P4, DOI 10.3171/2014.8.PEDS14146; Hsieh CY, 2008, CLIN NEUROL NEUROSUR, V110, P71, DOI 10.1016/j.clineuro.2007.08.012; Khattar NK, 2019, WORLD NEUROSURG, V129, pE35, DOI 10.1016/j.wneu.2019.04.164; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; Kuramatsu JB, 2019, JAMA-J AM MED ASSOC, V322, P1392, DOI 10.1001/jama.2019.13014; Moscardini-Martelli Julia, 2021, Surg Neurol Int, V12, P334, DOI 10.25259/SNI_140_2021; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Nashimoto Takeo, 2015, No Shinkei Geka, V43, P901, DOI 10.11477/mf.1436203144; Nixon M, 2014, NEUROL CLIN, V32, P943, DOI 10.1016/j.ncl.2014.07.010; Singh Rahul, 2020, Asian J Neurosurg, V15, P882, DOI 10.4103/ajns.AJNS_309_20; Yoshimura K, 2007, MINIM INVAS NEUROSUR, V50, P270, DOI 10.1055/s-2007-990293	13	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	AUG 19	2021	13	8							e17302	10.7759/cureus.17302			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UD0JO	WOS:000686903800003	34552836	gold, Green Published			2022-02-06	
J	Gerhalter, T; Cloos, M; Chen, AM; Dehkharghani, S; Peralta, R; Babb, JS; Zarate, A; Bushnik, T; Silver, JM; Im, BS; Wall, S; Baete, S; Madelin, G; Kirov, II				Gerhalter, Teresa; Cloos, Martijn; Chen, Anna M.; Dehkharghani, Seena; Peralta, Rosemary; Babb, James S.; Zarate, Alejandro; Bushnik, Tamara; Silver, Jonathan M.; Im, Brian S.; Wall, Stephen; Baete, Steven; Madelin, Guillaume; Kirov, Ivan I.			T-1 and T-2 quantification using magnetic resonance fingerprinting in mild traumatic brain injury	EUROPEAN RADIOLOGY			English	Article						Traumatic brain injury; Magnetic resonance fingerprinting; Relaxation; Clinical outcome	DIFFUSE AXONAL INJURY; CONCUSSION; SYMPTOMS; MRI; UPDATE	Objectives To assess whether MR fingerprinting (MRF)-based relaxation properties exhibit cross-sectional and prospective correlations with patient outcome and compare the results with those from DTI. Methods Clinical imaging, MRF, and DTI were acquired in patients (24 +/- 10 days after injury (timepoint 1) and 90 +/- 17 days after injury (timepoint 2)) and once in controls. Patient outcome was assessed with global functioning, symptom profile, and neuropsychological testing. ADC and fractional anisotropy (FA) from DTI and T-1 and T-2 from MRF were compared in 12 gray and white matter regions with Mann-Whitney tests. Bivariate associations between MR measures and outcome were assessed using the Spearman correlation and logistic regression. Results Data from 22 patients (38 +/- 12 years; 17 women) and 18 controls (32 +/- 8 years; 12 women) were analyzed. Fourteen patients (37 +/- 12 years; 11 women) returned for timepoint 2, while two patients provided only timepoint 2 clinical outcome data. At timepoint 1, there were no differences between patients and controls in T-1, T-2, and ADC, while FA was lower in mTBI frontal white matter. T-1 at timepoint 1 and the change in T-1 exhibited more (n = 18) moderate to strong correlations (|r|= 0.6-0.85) with clinical outcome at timepoint 2 than T-2 (n = 3), FA (n = 7), and ADC (n = 2). High T-1 at timepoint 1, and serially increasing T-1, accounted for five of the six MR measures with the highest utility for identification of non-recovered patients at timepoint 2 (AUC > 0.80). Conclusion T-1 derived from MRF was found to have higher utility than T-2, FA, and ADC for predicting 3-month outcome after mTBI.	[Gerhalter, Teresa; Cloos, Martijn; Chen, Anna M.; Dehkharghani, Seena; Peralta, Rosemary; Babb, James S.; Baete, Steven; Madelin, Guillaume; Kirov, Ivan I.] NYU, Dept Radiol, Ctr Biomed Imaging, Grossman Sch Med, 560 1St Ave, New York, NY 10016 USA; [Cloos, Martijn] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Dehkharghani, Seena; Kirov, Ivan I.] NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA; [Zarate, Alejandro; Bushnik, Tamara; Im, Brian S.] NYU, Dept Rehabil Med, Grossman Sch Med, New York, NY USA; [Silver, Jonathan M.] NYU, Dept Psychiat, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Wall, Stephen] NYU, Ronald O Perelman Dept Emergency Med, Grossman Sch Med, New York, NY USA; [Baete, Steven; Kirov, Ivan I.] NYU, Dept Radiol, Grossman Sch Med, Ctr Adv Imaging Innovat & Res, 660 First Ave, New York, NY 10003 USA		Madelin, G; Kirov, II (corresponding author), NYU, Dept Radiol, Ctr Biomed Imaging, Grossman Sch Med, 560 1St Ave, New York, NY 10016 USA.; Kirov, II (corresponding author), NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA.; Kirov, II (corresponding author), NYU, Dept Radiol, Grossman Sch Med, Ctr Adv Imaging Innovat & Res, 660 First Ave, New York, NY 10003 USA.	guillaume.madelin@nyulangone.org; ivan.kirov@nyulangone.org		Cloos, Martijn/0000-0002-0636-234X; Dehkharghani, Seena/0000-0002-3141-1094; Bushnik, Tamara/0000-0003-3328-257X; Gerhalter, Teresa/0000-0001-9734-4632; , Anna/0000-0002-8466-7536	United States' National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097494, R01EB026456]	This study has received funding by the United States' National Institutes of Health (NIH) through grants numbers R01NS097494 and R01EB026456.	Badve C, 2017, AM J NEURORADIOL, V38, P492, DOI 10.3174/ajnr.A5035; Benjamini D, 2021, BRAIN, V144, P800, DOI 10.1093/brain/awaa447; Beran R, 2018, J MIL VETERANS HEALT, V26, P20; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cloos MA, 2019, J MAGN RESON IMAGING, V50, P810, DOI 10.1002/jmri.26615; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gerhalter T, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab051; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hutter BO, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420911295; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keil VC, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4157; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kumar R, 2003, MAGN RESON IMAGING, V21, P893, DOI 10.1016/S0730-725X(03)00189-9; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mikheev, 2013, INT J CARS S1, V8, P289; Mikheev A, 2008, J MAGN RESON IMAGING, V27, P1235, DOI 10.1002/jmri.21372; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yu ZD, 2018, MAGN RESON IMAGING, V54, P241, DOI 10.1016/j.mri.2018.09.002	40	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	FEB	2022	32	2					1308	1319		10.1007/s00330-021-08235-8		AUG 2021	12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	YP6DJ	WOS:000686449000001	34410458				2022-02-06	
J	Gilbert, AW; Bering, JM; Anderson, LC				Gilbert, Alexander W.; Bering, Jesse M.; Anderson, Lynley C.			Addressing head injury risk in youth football: are heading guidelines the answer?	SCIENCE AND MEDICINE IN FOOTBALL			English	Article; Early Access						Concussion; Subconcussion; Prevention; Policy	STATES HIGH-SCHOOL; DESCRIPTIVE EPIDEMIOLOGY; SCIENTIFIC UNCERTAINTY; SURVEILLANCE SYSTEM; SOCCER INJURIES; BRAIN-INJURY; CONCUSSION; SPORTS; ACCELERATION; PREVENTION	Background Recent findings of neurodegenerative pathology in former professional football players have once again called into question the role that "heading", a fundamental aspect of the game, plays in the onset of neurological disease. By introducing guidelines aimed at limiting heading among youth players, the United Kingdom recently joined the United States as the only two nations yet to implement heading regulation in response to growing concerns surrounding football's head injury burden. Purpose Evaluating the efficacy of risk mitigation strategies requires the continual reviewal of available evidence, however, youth heading guidelines have yet to undergo such an empirical evaluation. This review aims to address this absence by first discussing the literature informing heading-related health risk, followed by an assessment of the decision to limit youth heading in response to this research. Main Findings The risk of injury due to heading remains highly uncertain, especially as it pertains to youth players for whom epidemiological data is severely lacking. However, consideration of policy making under conditions of scientific uncertainty, as well as intrinsic risk factors of acute head injury in children and adolescents, currently warrants a precautionary approach to youth heading regulation. Conclusions Further research must be pursued to ensure that future risk management strategies remain grounded in evidence and enhance the safety of football for vulnerable individuals. While our understanding of the neurological outcomes of heading remains limited, the adoption of heading guidelines reflects an appropriate response to uncertain risk.	[Gilbert, Alexander W.] A133 Union St East, Dunedin 9016, New Zealand; [Gilbert, Alexander W.; Bering, Jesse M.] Univ Otago, Ctr Sci Commun, Dunedin, New Zealand; [Anderson, Lynley C.] Univ Otago, Bioeth Ctr, Dunedin, New Zealand		Gilbert, AW (corresponding author), A133 Union St East, Dunedin 9016, New Zealand.	gilal110@student.otago.ac.nz					Agel J, 2007, J ATHL TRAINING, V42, P270; [Anonymous], 2020, FA; Arnone D, 2006, NEUROPSYCHOBIOLOGY, V54, P107, DOI 10.1159/000096992; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bamac B, 2011, BIOL SPORT, V28, P177, DOI 10.5604/959284; Beaudouin F, 2020, SCAND J MED SCI SPOR, V30, P1506, DOI 10.1111/sms.13694; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; BODANSKY D, 1991, ENVIRONMENT, V33, P4, DOI 10.1080/00139157.1991.9929978; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Chiampas GT, 2018, SCI MED FOOTBALL, V2, P80, DOI 10.1080/24733938.2017.1421771; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Dick R, 2007, J ATHL TRAINING, V42, P278; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Faude O, 2017, SCAND J MED SCI SPOR, V27, P1986, DOI 10.1111/sms.12839; Faude O, 2013, SPORTS MED, V43, P819, DOI 10.1007/s40279-013-0061-x; Forbes CR, 2016, APPL NEUROPSYCH-CHIL, V5, P14, DOI 10.1080/21622965.2014.933108; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gollier C, 2003, J RISK UNCERTAINTY, V27, P77, DOI 10.1023/A:1025576823096; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A, 2019, SCI MED FOOTBALL, V3, P109, DOI 10.1080/24733938.2018.1506591; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2020, SCI MED FOOTBALL, V4, P93, DOI 10.1080/24733938.2019.1677937; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kontos AP, 2020, SCI MED FOOTBALL, V4, P87, DOI 10.1080/24733938.2020.1736327; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; O'Kane JW, 2016, PHYSICIAN SPORTSMED, V44, P190, DOI 10.1080/00913847.2016.1149423; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Oliveira TG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235609; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Resnik D. B., 2003, STUD HIST PHILOS M P, V34, P329; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Russell ER, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028654; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Spinks AB, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.033605; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tarnutzer AA, 2018, SCI MED FOOTBALL, V2, P75, DOI 10.1080/24733938.2017.1386793; US Club Soccer, 2015, CONC HEAD INJ; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	70	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football												10.1080/24733938.2021.1967435		AUG 2021	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UB8IH	WOS:000686082500001					2022-02-06	
J	Huang, HC; Yu, PH; Tsai, MS; Chien, KLO; Chen, WON; Huang, CH				Huang, Hui-Chun; Yu, Ping-Hsun; Tsai, Min-Shan; Chien, Kuo-Liong; Chen, Wen-Jone; Huang, Chien-Hua			Prior beta-blocker treatment improves outcomes in out-of-hospital cardiac arrest patients with non-shockable rhythms	SCIENTIFIC REPORTS			English	Article							HEART-FAILURE; INSUFFICIENCY BISOPROLOL; HEALTH-INSURANCE; MORTALITY; RESUSCITATION; THERAPY; SEPSIS; TAIWAN	The prognosis of out of cardiac arrest is poor and most cardiac arrest patients suffered from the non-shockable rhythm especially in patients without pre-existing cardiovascular diseases and medication prescription. Beta-blocker (ss-blocker) therapy has been shown to improve outcomes in cardiovascular diseases such as heart failure, ischemia related cardiac, and brain injuries. Therefore, we investigated whether prior ss-blockers use was associated with reduced mortality in patients with cardiac arrest and non-shockable rhythm. We conducted a population-based retrospective cohort study using multivariate propensity score-based regression to control for differences among patients with cardiac arrest. A total of 104,568 adult patients suffering a non-traumatic and non-shockable rhythm cardiac arrest between 2005 and 2011 were identified. ss-blocker prescription at least 30 days prior to the cardiac arrest event was defines as the ss-blockers group. We chose 12.5 mg carvedilol as the cut-off value and defined greater or equal to carvedilol 12.5 mg per day and its equivalent dose as high-dose group. After multivariate propensity score-based logistic regression analysis, patients with prior ss-blockers use were associated with better 1-year survival [adjusted odds ratio (OR), 1.15, 95% confidence interval (CI) 1.01-1.30; P = 0.031]. Compared to non-ss-blocker use group and prior low-dose ss-blockers use group, prior high-dose ss-blockers use group was associated with higher mechanical ventilator wean success rate (adjusted OR 1.19, 95% CI 1.01-1.41, P = 0.042). In conclusion, prior high dose ss-blockers use was associated with a better 1-year survival and higher weaning rate in patients with non-shockable cardiac arrest.	[Huang, Hui-Chun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol, Taipei, Taiwan; [Huang, Hui-Chun; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Yu, Ping-Hsun] Taipei Hosp, Minist Hlth & Welf, Dept Emergency Med, New Taipei, Taiwan; [Tsai, Min-Shan; Chen, Wen-Jone; Huang, Chien-Hua] Natl Taiwan Univ, Coll Med, Dept Emergency Med, 7 Chung Shan South Rd, Taipei 100, Taiwan		Huang, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Emergency Med, 7 Chung Shan South Rd, Taipei 100, Taiwan.	chhuang5940@ntu.edu.tw		HUANG, CHIEN-HUA/0000-0003-2981-4537; CHEN, WEN-JONE/0000-0002-2098-5922; TSAI, MIN-SHAN/0000-0002-2862-7572			Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bro-Jeppesen J, 2016, RESUSCITATION, V107, P71, DOI 10.1016/j.resuscitation.2016.08.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Farshi R, 1999, J AM COLL CARDIOL, V33, P304, DOI 10.1016/S0735-1097(98)00561-0; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; Gheorghiade M, 2003, CIRCULATION, V107, P1570, DOI 10.1161/01.CIR.0000065187.80707.18; Granfeldt A, 2016, RESUSCITATION, V108, P40, DOI 10.1016/j.resuscitation.2016.08.024; Hsu WT, 2020, HYPERTENSION, V75, P483, DOI 10.1161/HYPERTENSIONAHA.119.13197; Huang CH, 2019, AM J CARDIOL, V123, P1572, DOI 10.1016/j.amjcard.2019.02.018; Jo S, 2015, AM J EMERG MED, V33, P1725, DOI 10.1016/j.ajem.2015.08.004; Kim BS, 2019, INT HEART J, V60, P1284, DOI 10.1536/ihj.19-175; Lechat P, 1999, LANCET, V353, P9; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Maynard C, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001693; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Ng CJ, 2011, EMERG MED J, V28, P1026, DOI 10.1136/emj.2010.094185; Poupin P, 2020, INT J CARDIOL, V314, P64, DOI 10.1016/j.ijcard.2020.03.060; Prabhu SD, 2000, CIRCULATION, V101, P2103, DOI 10.1161/01.CIR.101.17.2103; Sander D, 2001, NEUROLOGY, V57, P833, DOI 10.1212/WNL.57.5.833; Savitz SI, 2000, J CEREBR BLOOD F MET, V20, P1197, DOI 10.1097/00004647-200008000-00005; Simon T, 2003, EUR HEART J, V24, P554, DOI 10.1016/S0195-668X(02)00743-1; Sykora M, 2015, STROKE, V46, P1269, DOI 10.1161/STROKEAHA.114.008260; Thygesen K, 2018, J AM COLL CARDIOL, V72, P2231, DOI [10.1016/j.jacc.2018.08.1038, 10.1093/eurheartj/ehy462]; Nguyen TL, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0338-0; Uffen JW, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046518; Yang JH, 2014, JACC-CARDIOVASC INTE, V7, P592, DOI 10.1016/j.jcin.2013.12.206	30	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 19	2021	11	1							16804	10.1038/s41598-021-96070-8			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UC8JQ	WOS:000686768700086	34413355	gold, Green Published			2022-02-06	
J	Milosevic, M; Nakanishi, T; Sasaki, A; Yamaguchi, A; Nomura, T; Popovic, MR; Nakazawa, K				Milosevic, Matija; Nakanishi, Tomoya; Sasaki, Atsushi; Yamaguchi, Akiko; Nomura, Taishin; Popovic, Milos R.; Nakazawa, Kimitaka			Cortical Re-organization After Traumatic Brain Injury Elicited Using Functional Electrical Stimulation Therapy: A Case Report	FRONTIERS IN NEUROSCIENCE			English	Article						brain injury; functional electrical stimulation; functional electrical stimulation therapy; neuroplasticity; rehabilitation	TRANSCRANIAL MAGNETIC STIMULATION; INDUCED MOVEMENT THERAPY; MOTOR CORTEX; NERVE-STIMULATION; MEDIAN NERVE; RECOVERY; STROKE; SYSTEM; REPRESENTATIONS; REHABILITATION	Functional electrical stimulation therapy (FEST) can improve motor function after neurological injuries. However, little is known about cortical changes after FEST and weather it can improve motor function after traumatic brain injury (TBI). Our study examined cortical changes and motor improvements in one male participant with chronic TBI suffering from mild motor impairment affecting the right upper-limb during 3-months of FEST and during 3-months follow-up. In total, 36 sessions of FEST were applied to enable upper-limb grasping and reaching movements. Short-term assessments carried out using transcranial magnetic stimulation (TMS) showed reduced cortical silent period (CSP), indicating cortical and/or subcortical inhibition after each intervention. At the same time, no changes in motor evoked potentials (MEPs) were observed. Long-term assessments showed increased MEP corticospinal excitability after 12-weeks of FEST, which seemed to remain during both follow-ups, while no changes in CSP were observed. Similarly, long-term assessments using TMS mapping showed larger hand MEP area in the primary motor cortex (M1) after 12-weeks of FEST as well as during both follow-ups. Corroborating TMS results, functional magnetic resonance imaging (fMRI) data showed M1 activations increased during hand grip and finger pinch tasks after 12-weeks of FEST, while gradual reduction of activity compared to after the intervention was seen during follow-ups. Widespread changes were seen not only in the M1, but also sensory, parietal rostroventral, supplementary motor, and premotor areas in both contralateral and ipsilateral hemispheres, especially during the finger pinch task. Drawing test performance showed improvements after the intervention and during follow-ups. Our findings suggest that task-specific and repetitive FEST can effectively increase cortical activations by integrating voluntary motor commands and sensorimotor network through functional electrical stimulation (FES). Overall, our results demonstrated cortical re-organization in an individual with chronic TBI after FEST.	[Milosevic, Matija; Nomura, Taishin] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Osaka, Japan; [Nakanishi, Tomoya; Sasaki, Atsushi; Yamaguchi, Akiko; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Nakanishi, Tomoya; Sasaki, Atsushi] Japan Soc Promot Sci, Tokyo, Japan; [Popovic, Milos R.] Univ Toronto, Inst Biomed Engn, Toronto, ON, Canada; [Popovic, Milos R.] Univ Hlth Network, Toronto Rehabil Inst, KITE, Toronto, ON, Canada; [Popovic, Milos R.] Univ Hlth Network, CRANIA, Toronto, ON, Canada		Milosevic, M (corresponding author), Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Osaka, Japan.	matija@bpe.es.osaka-u.ac.jp	Nomura, Taishin/J-8408-2012	Nomura, Taishin/0000-0002-6545-2097; Yuasa, Akiko/0000-0003-1808-2369	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18H04082, 18KK0272, 19K23606, 20K19412]	This project was funded by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research: KAKENHI (Grants #: 18H04082, 18KK0272, 19K23606, and 20K19412).	Blickenstorfer A, 2009, HUM BRAIN MAPP, V30, P963, DOI 10.1002/hbm.20559; Bloem BR, 2020, EXP BRAIN RES, V238, P1593, DOI 10.1007/s00221-020-05763-5; Boakye M, 2000, J NEUROSURG, V93, P774, DOI 10.3171/jns.2000.93.5.0774; Boroojerdi B, 2001, CLIN NEUROPHYSIOL, V112, P931, DOI 10.1016/S1388-2457(01)00523-5; Butefisch CM, 2006, J PHYSIOL-PARIS, V99, P437, DOI 10.1016/j.jphysparis.2006.03.001; Carson RG, 2021, J PHYSIOL-LONDON, V599, P2375, DOI 10.1113/JP278298; Ciccarelli O, 2006, J NEUROL, V253, P882, DOI 10.1007/s00415-006-0125-z; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; D'Errico J., 2005, SURFACE FITTING USIN; de Sousa DG, 2016, J PHYSIOTHER, V62, P203, DOI 10.1016/j.jphys.2016.08.004; Dui LG, 2020, JMIR SERIOUS GAMES, V8, DOI 10.2196/20126; Farzan F, 2014, NEUROMETHODS, V89, P69, DOI 10.1007/978-1-4939-0879-0_5; FITTS PM, 1992, J EXP PSYCHOL GEN, V121, P262, DOI 10.1037/0096-3445.121.3.262; Fraser C, 2002, NEURON, V34, P831, DOI 10.1016/S0896-6273(02)00705-5; Friston K. J., 1994, Human Brain Mapping, V2, P189, DOI 10.1002/hbm.460020402; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FUGLMEYER AR, 1980, SCAND J REHABIL MED, P85; Gandolla M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4192718; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; Hess A, 1999, EXP BRAIN RES, V124, P321, DOI 10.1007/s002210050629; Hinkley LB, 2007, J NEUROPHYSIOL, V97, P1288, DOI 10.1152/jn.00733.2006; Iftime-Nielsen SD, 2012, HUM BRAIN MAPP, V33, P40, DOI 10.1002/hbm.21191; Itotani K., 2016, RIGAKURYOHO KAGAKU, V31, P67, DOI [10.1589/rika.31.67, DOI 10.1589/RIKA.31.67]; Kapadia NM, 2011, ARTIF ORGANS, V35, P212, DOI 10.1111/j.1525-1594.2011.01216.x; Kawashima N, 2013, PHYSIOTHER CAN, V65, P20, DOI 10.3138/ptc.2011-36; Korvenoja A, 1999, HUM BRAIN MAPP, V8, P13, DOI 10.1002/(SICI)1097-0193(1999)8:1<13::AID-HBM2>3.0.CO;2-B; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McCain K, 2017, J NEUROL PHYS THER, V41, P173, DOI 10.1097/NPT.0000000000000190; MORTIFEE P, 1994, ELECTROEN CLIN NEURO, V93, P131, DOI 10.1016/0168-5597(94)90076-0; Murata Y, 2008, J NEUROPHYSIOL, V99, P773, DOI 10.1152/jn.01001.2007; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Oostra K, 1997, BRAIN INJURY, V11, P761, DOI 10.1080/026990597123133; Popovic MB, 2003, J REHABIL RES DEV, V40, P443, DOI 10.1682/JRRD.2003.09.0443; Popovic MR, 2002, NEUROL RES, V24, P443, DOI 10.1179/016164102101200311; Popovic MR, 2001, SPINAL CORD, V39, P403, DOI 10.1038/sj.sc.3101191; Quandt Fanny, 2014, Exp Transl Stroke Med, V6, P9, DOI 10.1186/2040-7378-6-9; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Ridding MC, 2001, CLIN NEUROPHYSIOL, V112, P1461, DOI 10.1016/S1388-2457(01)00592-2; Sasaki K, 2012, BIOMED RES-TOKYO, V33, P89, DOI 10.2220/biomedres.33.89; Seitz RJ, 2005, ACT NEUR S, V93, P65; Shin HK, 2008, NEUROSCI LETT, V442, P174, DOI 10.1016/j.neulet.2008.07.026; Simpson LA, 2013, NEUROREHAB NEURAL RE, V27, P240, DOI 10.1177/1545968312461719; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; Tazoe T, 2021, J PHYSIOL-LONDON, V599, P5031, DOI 10.1113/JP281430; Thrasher TA, 2008, NEUROREHAB NEURAL RE, V22, P706, DOI 10.1177/1545968308317436; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Uehara S, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146365; Uy J, 2002, BRAIN TOPOGR, V14, P293, DOI 10.1023/A:1015752711146; van de Ruit M, 2015, BRAIN STIMUL, V8, P231, DOI 10.1016/j.brs.2014.10.020; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; WILSON SA, 1993, J NEUROL SCI, V118, P134, DOI 10.1016/0022-510X(93)90102-5; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wolters A., 2008, OXFORD HDB TRANSCRAN, P91; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058	62	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 19	2021	15								693861	10.3389/fnins.2021.693861			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL3UI	WOS:000692579800001	34489624	gold, Green Submitted, Green Published			2022-02-06	
J	Qiburi, Q; Temuqile, T; Baigude, H				Qiburi, Qiburi; Temuqile, Temuqile; Baigude, Huricha			Synergistic Regulation of Microglia Gene Expression by Natural Molecules in Herbal Medicine	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; RECEPTOR 4; G-CSF; ACTIVATION; STROKE; INFLAMMATION; APOPTOSIS; ALIGNMENT; RATS	The activated microglia contribute to stroke-induced neuroinflammation by upregulating the expression of a pleura of genes that are characterized as either proinflammatory or anti-inflammatory. The natural products alantolactone (Ala) and dehydrodiisoeugenol (Deh) found in Inula helenium L. and Myristica fragrans Houtt., respectively, are regularly used in traditional herb medicine, which play anti-inflammatory and antioxidant roles via regulation of canonical pathways such as nuclear factor kappa B (NF-kappa B) in microglia and microphages. To illustrate the full spectra of gene expression alteration in microglia treated with Ala, Deh, and the mixture of Ala and Deh (denoted as Mix), we performed RNA-seq analysis of total RNA extracted from lipopolysaccharide- (LPS-) treated microglia subsequently exposed to Ala, Deh, and Mix. While both chemicals regulated the gene expression that facilitates an anti-inflammatory polarization, the mixture exerted some distinctive synergic regulatory effect, which differed from either of the chemicals alone. Our data provide important evidence for further research on the therapeutic mechanism of traditional medicine including Eerdun Wurile (EW).	[Qiburi, Qiburi; Baigude, Huricha] Inner Mongolia Univ, Sch Chem & Chem Engn, Inst Mongolian Med Chem, Hohhot 010020, Inner Mongolia, Peoples R China; [Temuqile, Temuqile] Int Hosp Mongolian Med, Hohhot 010021, Inner Mongolia, Peoples R China		Baigude, H (corresponding author), Inner Mongolia Univ, Sch Chem & Chem Engn, Inst Mongolian Med Chem, Hohhot 010020, Inner Mongolia, Peoples R China.; Temuqile, T (corresponding author), Int Hosp Mongolian Med, Hohhot 010021, Inner Mongolia, Peoples R China.	tmqyx01@gmail.com; hbaigude@imu.edu.cn			Inner Mongolia Plan of Science and Technology [201802145, 201802118]; Natural Science Foundation of Inner Mongolia Autonomous Region [2021MS02009, 2017MS0821]; Research Institute of Mongolian Medicine of Inner Mongolia Autonomous Region [2016YJS31]; Department of Finance of Inner Mongolia Autonomous Region, China [CZT_201701]	This research was kindly supported by Inner Mongolia Plan of Science and Technology (201802145 and 201802118), Natural Science Foundation of Inner Mongolia Autonomous Region (2021MS02009 and 2017MS0821), internal funding from the Research Institute of Mongolian Medicine of Inner Mongolia Autonomous Region (2016YJS31), and funding from the Department of Finance of Inner Mongolia Autonomous Region (CZT_201701), China.	Chau M, 2011, ACTA NEUROCHIR SUPPL, V111, P299, DOI 10.1007/978-3-7091-0693-8_50; Dang XM, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01358-4; Dezerega A, 2010, INT ENDOD J, V43, P902, DOI 10.1111/j.1365-2591.2010.01764.x; Gaowa S, 2018, J ETHNOPHARMACOL, V222, P249, DOI 10.1016/j.jep.2018.05.011; Guo Y, 2013, NEUROSCIENCE, V238, P1, DOI 10.1016/j.neuroscience.2013.01.047; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Ji W, 2017, CELL MOL NEUROBIOL, V37, P683, DOI 10.1007/s10571-016-0404-x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CW, 2020, MOLECULES, V25, DOI 10.3390/molecules25215198; Li L, 2019, ARTIF CELL NANOMED B, V47, P1917, DOI 10.1080/21691401.2019.1614016; Li L, 2020, ANN VASC SURG, V68, P476, DOI 10.1016/j.avsg.2020.04.047; Li Q, 2013, J NEUROSCI RES, V91, P861, DOI 10.1002/jnr.23218; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lu CZ, 2007, FRONT BIOSCI, V12, P2869, DOI 10.2741/2278; Murakami Y, 2005, ARCH BIOCHEM BIOPHYS, V434, P326, DOI 10.1016/j.abb.2004.11.013; Mylka V, 2018, AUTOPHAGY, V14, P2049, DOI 10.1080/15548627.2018.1495681; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Peng W, 2017, IMMUNOL RES, V65, P888, DOI 10.1007/s12026-017-8928-9; Qiburi Q, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112241; Sanchez-Martin P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222836; Scibior Dorota, 2006, Postepy Hig Med Dosw (Online), V60, P170; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sun MS, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3804979; Taka E, 2015, J NEUROIMMUNOL, V286, P5, DOI 10.1016/j.jneuroim.2015.06.011; Tan LW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070739; Wang B, 2017, REV BRAS FARMACOGN, V27, P369, DOI 10.1016/j.bjp.2017.02.003; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang X, 2018, AM J TRANSL RES, V10, P368; Wang YC, 2013, STROKE, V44, P2545, DOI 10.1161/STROKEAHA.113.001038; Wood HM, 2008, J UROLOGY, V180, P753, DOI 10.1016/j.juro.2008.03.182; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Zhou YC, 2015, INT J MOL MED, V36, P43, DOI 10.3892/ijmm.2015.2205; Zhu HM, 2019, PROG NEUROBIOL, V178, P6, DOI 10.1016/j.pneurobio.2019.03.003	41	0	0	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.	AUG 19	2021	2021								9920364	10.1155/2021/9920364			15	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	UJ2KZ	WOS:000691122200001	34457033	Green Published, gold			2022-02-06	
J	Wang, XP; Zhong, J; Lei, T; Chen, D; Wang, HJ; Zhu, LN; Chu, SS; Liu, L				Wang, Xueping; Zhong, Jie; Lei, Ting; Chen, Deng; Wang, Haijiao; Zhu, Lina; Chu, Shanshan; Liu, Ling			An Artificial Neural Network Prediction Model for Posttraumatic Epilepsy: Retrospective Cohort Study	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						artificial neural network; posttraumatic epilepsy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; LOGISTIC-REGRESSION; NOMOGRAM MODEL; RISK-FACTORS; SEIZURES; VALIDATION; OUTCOMES; AGE	Background: Posttraumatic epilepsy (PTE) is a common sequela after traumatic brain injury (TBI), and identifying high-risk patients with PTE is necessary for their better treatment. Although artificial neural network (ANN) prediction models have been reported and are superior to traditional models, the ANN prediction model for PTE is lacking. Objective: We aim to train and validate an ANN model to anticipate the risks of PTE. Methods: The training cohort was TBI patients registered at West China Hospital. We used a 5-fold cross-validation approach to train and test the ANN model to avoid overfitting; 21 independent variables were used as input neurons in the ANN models, using a back-propagation algorithm to minimize the loss function. Finally, we obtained sensitivity, specificity, and accuracy of each ANN model from the 5 rounds of cross-validation and compared the accuracy with a nomogram prediction model built in our previous work based on the same population. In addition, we evaluated the performance of the model using patients registered at Chengdu Shang Jin Nan Fu Hospital (testing cohort 1) and Sichuan Provincial People's Hospital (testing cohort 2) between January 1, 2013, and March 1, 2015. Results: For the training cohort, we enrolled 1301 TBI patients from January 1, 2011, to December 31, 2017. The prevalence of PTE was 12.8% (166/1301, 95% CI 10.9%-14.6%). Of the TBI patients registered in testing cohort 1, PTE prevalence was 10.5% (44/421, 95% CI 7.5%-13.4%). Of the TBI patients registered in testing cohort 2, PTE prevalence was 6.1% (25/413, 95% CI 3.7%-8.4%). The results of the ANN model show that, the area under the receiver operating characteristic curve in the training cohort was 0.907 (95% CI 0.889-0.924), testing cohort 1 was 0.867 (95% CI 0.842-0.893), and testing cohort 2 was 0.859 (95% CI 0.826-0.890). Second, the average accuracy of the training cohort was 0.557 (95% CI 0.510-0.620), with 0.470 (95% CI 0.414-0.526) in testing cohort 1 and 0.344 (95% CI 0.287-0.401) in testing cohort 2. In addition, sensitivity, specificity, positive predictive values and negative predictors in the training cohort (testing cohort 1 and testing cohort 2) were 0.80 (0.83 and 0.80), 0.86 (0.80 and 0.84), 91% (85% and 78%), and 86% (80% and 83%), respectively. When calibrating this ANN model, Brier scored 0.121 in testing cohort 1 and 0.127 in testing cohort 2. Compared with the nomogram model, the ANN prediction model had a higher accuracy (P=.01). Conclusions: This study shows that the ANN model can predict the risk of PTE and is superior to the risk estimated based on traditional statistical methods. However, the calibration of the model is a bit poor, and we need to calibrate it on a large sample size set and further improve the model.	[Wang, Xueping; Chen, Deng; Wang, Haijiao; Zhu, Lina; Chu, Shanshan; Liu, Ling] Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China; [Zhong, Jie] Sichuan Prov Peoples Hosp, Dept Ophthalmol, Chengdu, Peoples R China; [Lei, Ting] Sichuan Univ, West China Hosp, Shang Jin Nan Fu Hosp, Dept Neurosurg, Chengdu, Peoples R China		Liu, L (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China.	zjllxx1968@163.com		Liu, Ling/0000-0001-7588-6086	1.3.5 Project for Disciplines of Excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [2019HXFH048]; Science & Technology Department of Sichuan Province [2021YFS0174]	This study was funded by grant 2019HXFH048 from the 1 center dot 3 center dot 5 Project for Disciplines of Excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University, and grant 2021YFS0174 from the Science & Technology Department of Sichuan Province.	Agarwal V, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6240; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bentley P, 2014, NEUROIMAGE-CLIN, V4, P635, DOI 10.1016/j.nicl.2014.02.003; Brier GW, 1950, MON WEATHER REV, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Celik G, 2014, J STROKE CEREBROVASC, V23, P1506, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.018; Chan KL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00171; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Davis J., 2006, PROC 23 INT C MACH L, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gottol GT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00296; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Huang SQ, 2010, HYPERTENS RES, V33, P722, DOI 10.1038/hr.2010.73; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Manning T, 2014, BIOENGINEERED, V5, P80, DOI 10.4161/bioe.26997; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Rao VR, 2015, SEMIN NEUROL, V35, P57, DOI 10.1055/s-0035-1544239; Renganathan V, 2019, BRATISL MED J, V120, P536, DOI 10.4149/BLL_2019_087; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; Santus E, 2021, J MED INTERNET RES, V23, DOI 10.2196/22453; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tekkesin AI, 2019, ANATOL J CARDIOL, V22, P8, DOI 10.14744/AnatolJCardiol.2019.28661; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Wang XP, 2021, SEIZURE-EUR J EPILEP, V88, P36, DOI 10.1016/j.seizure.2021.03.023; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007; Zhou ZG, 2016, RADIOTHER ONCOL, V119, P501, DOI 10.1016/j.radonc.2016.04.029	37	0	0	6	6	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	AUG 19	2021	23	8							e25090	10.2196/25090			14	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	UE7WA	WOS:000688092800005	34420931	gold, Green Published			2022-02-06	
J	Dobryakova, E; Zuckerman, S; Sandry, J				Dobryakova, Ekaterina; Zuckerman, Suzanne; Sandry, Joshua			Neural correlates of extrinsic and intrinsic outcome processing during learning in individuals with TBI: a pilot investigation	BRAIN IMAGING AND BEHAVIOR			English	Article; Early Access						Traumatic brain injury; Functional MRI; Learning; Striatum; Rehabilitation; Feedback	TRAUMATIC BRAIN-INJURY; VENTRAL STRIATUM; DECISION-MAKING; WORKING-MEMORY; REWARD; FEEDBACK; DEFICITS; ACTIVATION; DOPAMINE; DYSFUNCTION	Outcome processing, the ability to learn from feedback, is an important component of adaptive behavior and rehabilitation. Evidence from healthy adults implicates the striatum and dopamine in outcome processing. Animal research shows that damage to dopaminergic pathways in the brain can lead to a disruption of dopamine tone and transmission. Such evidence thus suggests that persons with TBI experience deficits in outcome processing. However, no research has directly investigated outcome processing and associated neural mechanisms in TBI. Here, we examine outcome processing in individuals with TBI during learning. Given that TBI negatively impacts striatal and dopaminergic systems, we hypothesize that individuals with TBI exhibit deficits in learning from outcomes. To test this hypothesis, individuals with moderate-to-severe TBI and healthy adults were presented with a declarative paired-associate word learning task. Outcomes indicating performance accuracy were presented immediately during task performance and in the form of either monetary or performance-based feedback. Two types of feedback provided the opportunity to test whether extrinsic and intrinsic motivational aspects of outcome presentation play a role during learning and outcome processing. Our results show that individuals with TBI exhibited impaired learning from feedback compared to healthy participants. Additionally, individuals with TBI exhibited increased activation in the striatum during outcome processing. The results of this study suggest that outcome processing and learning from immediate outcomes is impaired in individuals with TBI and might be related to inefficient use of neural resources during task performance as reflected by increased activation of the striatum.	[Dobryakova, Ekaterina; Zuckerman, Suzanne] Kessler Fdn, Ctr Traumat Brain Injury Res, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA; [Dobryakova, Ekaterina] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Sandry, Joshua] Montclair State Univ, Dept Psychol, 1 Normal Ave, Montclair, NJ USA		Dobryakova, E (corresponding author), Kessler Fdn, Ctr Traumat Brain Injury Res, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA.; Dobryakova, E (corresponding author), Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA.	EDobryakova@kesslerfoundation.org	Dobryakova, Ekaterina/ABD-2853-2021	Dobryakova, Ekaterina/0000-0002-6005-2115	New Jersey Health Foundation [PC103-17]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG-1501-02630]	This work was supported by the New Jersey Health Foundation (Grant No. #PC103-17) and the National Multiple Sclerosis Society Grant No. RG-1501-02630), awarded to Ekaterina Dobryakova, PhD.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Albrecht K, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00303; Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beck SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009251; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Daniel R, 2010, J NEUROSCI, V30, P47, DOI 10.1523/JNEUROSCI.2205-09.2010; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DePasque S, 2015, NEUROIMAGE, V119, P175, DOI 10.1016/j.neuroimage.2015.06.046; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dobryakova E, 2013, COGN AFFECT BEHAV NE, V13, P725, DOI 10.3758/s13415-013-0182-6; du Plessis S, 2018, PARKINSONISM RELAT D, V48, P82, DOI 10.1016/j.parkreldis.2017.12.024; Engstrom M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01071; Foerde K, 2013, J NEUROSCI, V33, P5698, DOI 10.1523/JNEUROSCI.5217-12.2013; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gavelin HM, 2017, PSYCHIAT RES-NEUROIM, V269, P17, DOI 10.1016/j.pscychresns.2017.08.008; Gawlowska M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00935; Gogolla N, 2017, CURR BIOL, V27, pR580, DOI 10.1016/j.cub.2017.05.010; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffiths KR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00101; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN., 2011, NEUROBIOLOGY SENSATI, DOI DOI 10.1201/B10776-15; Heilbronner SR, 2016, ANNU REV NEUROSCI, V39, P149, DOI 10.1146/annurev-neuro-070815-013952; Hiebert NM, 2014, NEUROIMAGE, V101, P448, DOI 10.1016/j.neuroimage.2014.07.013; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Horowitz TS, 2018, TRENDS NEUROSCI, V41, P493, DOI 10.1016/j.tins.2018.05.001; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jenkins PO, 2020, J NEUROL NEUROSUR PS, V91, P631, DOI 10.1136/jnnp-2019-321759; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Krishna G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020588; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Manning L, 2008, BEHAV BRAIN RES, V192, P143, DOI 10.1016/j.bbr.2008.04.001; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Poston KL, 2016, ANN NEUROL, V79, P448, DOI 10.1002/ana.24585; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Pujara M, 2014, NEUROSCIENTIST, V20, P82, DOI 10.1177/1073858413499407; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Sandry J, 2015, NEURODEGENER DIS MAN, V5, P1, DOI [10.2217/nmt.14.51, 10.2217/NMT.14.51]; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 1999, BRAIN INJURY, V13, P889; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Schultz W, 1998, Adv Pharmacol, V42, P686; Selzer M., 2006, TXB NEURAL REPAIR RE; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spirou A, 2019, J HEAD TRAUMA REHAB, V34, pE19, DOI 10.1097/HTR.0000000000000482; Swanson SD, 2014, COGN AFFECT BEHAV NE, V14, P610, DOI 10.3758/s13415-014-0269-8; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Tricomi E., 2017, RECENT DEV NEUROSCIE; Tricomi E, 2008, NEUROIMAGE, V41, P1154, DOI 10.1016/j.neuroimage.2008.02.066; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van der Vegt JPM, 2013, BRAIN, V136, P1192, DOI 10.1093/brain/awt027; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652	76	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.												10.1007/s11682-021-00508-6		AUG 2021	11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UB8NX	WOS:000686097100003	34406636	Green Submitted			2022-02-06	
J	Radlicz, C; Jackson, K; Hautmann, A; Shi, JX; Yang, JZ				Radlicz, Chris; Jackson, Kenneth; Hautmann, Amanda; Shi, Junxin; Yang, Jingzhen			Influence of insurance type on rate and type of initial concussion-related medical visits among youth	BMC PUBLIC HEALTH			English	Article						Traumatic brain injury; Insurance; Health care utilization; Children	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT UTILIZATION; UNITED-STATES; AUDITING ACCESS; SPECIALTY CARE; HEAD-INJURY; CHILDREN; SPORTS; TRENDS; EPIDEMIOLOGY	Background A growing number of studies report increased concussion-related health care utilization in recent years, but factors impacting care-seeking behaviors among youth following a concussion are not well described. This study aimed to evaluate the influence of insurance type on the rate and type of initial concussion visits and the time from injury to the initial visit in youth. Methods We extracted and analyzed initial concussion-related medical visits for youth ages 10 to 17 from electronic health records. Patients must have visited Nationwide Children's Hospital's (NCH) concussion clinic at least once between 7/1/2012 and 12/31/2017. We evaluated the trends and patterns of initial concussion visits across the study period using regression analyses. Results Of 4955 unique concussion visits included, 60.1% were males, 80.5% were white, and 69.5% were paid by private insurance. Patients' average age was 13.9 years (SD = 3.7). The rate of the initial concussion visits per 10,000 NCH visits was consistently higher in privately insured than publicly insured youth throughout the study period (P < .0001). Privately insured youth had greater odds of initial concussion visits to sports medicine clinics (AOR = 1.45, 95% CI = 1.20, 1.76) but lower odds of initial concussion visits to the ED/urgent care (AOR = 0.74, 95% CI = 0.60, 0.90) than publicly insured youth. Days from injury to initial concussion visit significantly decreased among both insurance types throughout the study (P < .0001), with a greater decrease observed in publicly insured than privately insured youth (P = .011). Conclusions Results on the differences in the rate, type, and time of initial concussion-related visits may help inform more efficient care of concussion among youth with different types of insurance.	[Radlicz, Chris; Hautmann, Amanda; Shi, Junxin; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr,RBIII WB5403, Columbus, OH 43205 USA; [Jackson, Kenneth] Nationwide Childrens Hosp, Biostat Resource, Columbus, OH USA; [Jackson, Kenneth] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr,RBIII WB5403, Columbus, OH 43205 USA.; Yang, JZ (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.	Ginger.Yang@nationwidechildrens.org		Radlicz, Chris/0000-0002-5102-9351	Centers for Disease Control and Prevention National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [3 R49 CE002106-05S1]	This research work was funded by Centers for Disease Control and Prevention National Center for Injury Prevention and Control (3 R49 CE002106-05S1). The funding body played no role in the design of the study, in the collection, analysis and interpretation of data, or in writing the manuscript.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bisgaier J, 2012, ARCH PEDIAT ADOL MED, V166, P304, DOI 10.1001/archpediatrics.2011.1158; Bisgaier J, 2011, NEW ENGL J MED, V364, P2324, DOI 10.1056/NEJMsa1013285; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Copley M, 2020, J RACIAL ETHN HEALTH, V7, P571, DOI 10.1007/s40615-019-00686-6; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cuff SC, 2019, RES SPORTS MED, V27, P11, DOI 10.1080/15438627.2018.1502186; Curry AE, 2019, J PEDIATR-US, V210, P13, DOI 10.1016/j.jpeds.2019.04.001; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Fabricant PD, 2019, J PEDIATR ORTHOPED, V39, pE552, DOI 10.1097/BPO.0000000000001329; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fuentes MM, 2017, ARCH PHYS MED REHAB, V98, P1763, DOI 10.1016/j.apmr.2016.12.013; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Goldstein IM, 2014, HEALTH AFFAIR, V33, P1861, DOI 10.1377/hlthaff.2014.0208; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hardesty W, 2019, J EMERG MED, V56, P571, DOI 10.1016/j.jemermed.2019.01.001; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Jayanthi NA, 2018, SPORTS HEALTH, V10, P303, DOI 10.1177/1941738118778510; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; National Federation of State High School Associations, 2017 18 HIGH SCH ATH; Newton A, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00283-w; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schlichting LE, 2017, ACAD EMERG MED, V24, P1483, DOI 10.1111/acem.13281; Singichetti B, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000397; Stead TS, 2016, CUREUS, V8, DOI 10.7759/cureus.755; Tarimala A, 2019, J PEDIATR-US, V206, P178, DOI 10.1016/j.jpeds.2018.10.021; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zibulewsky J, 2001, Proc (Bayl Univ Med Cent), V14, P339; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	42	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	AUG 18	2021	21	1							1565	10.1186/s12889-021-11586-y			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	UC6IK	WOS:000686627400001	34407798	Green Published, gold			2022-02-06	
J	Vos, L; Williams, MW; Spielman, L; Ochoa, A; Ngan, E; Leon-Novelo, L; Sherer, M				Vos, Leia; Williams, Michael W.; Spielman, Lisa; Ochoa, Andrea; Ngan, Esther; Leon-Novelo, Luis; Sherer, Mark			Understanding loss to follow-up in a longitudinal study of people with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; longitudinal study; attrition; lost to follow-up	FACTORS INFLUENCING ATTRITION; SYSTEMATIC BIAS; REHABILITATION; REPRESENTATIVENESS; PREDICTORS; LITERACY; BEHAVIOR; HEALTH; LIFE	Objective To examine factors related to attrition in a traumatic brain injury (TBI) study sample assessed up to 15 years after injury. Participants One thousand twenty-eight participants with TBI who completed the year 1 follow-up assessment at a TBI Model Systems Center between 1992 and 2018. Method Secondary analysis of data from a prospective longitudinal cohort study considering follow-up data collection completion status at years 1, 2, 5, 10, and 15. Results In univariable analyses, multiple factors were associated with loss to follow-up (LOFU) including being a member of a socially disadvantaged group, substance use history, residence, payor, cause of injury, and results of earlier follow-up attempts. In a multiple logistic regression analysis examining the prediction of follow-up condition at 10 or 15 years post-injury, only payor and race/ethnicity were significant predictors. Hispanic ethnicity was associated with higher odds of LOFU, and these participants often spoke Spanish and were born outside of the United States. Conclusions The findings suggest a need to understand sociodemographic variables and their influence on participant attrition in longitudinal TBI research. With a better understanding of these predictors, procedures can be developed to address retention of participants who are identified as being at increased risk for study drop out.	[Vos, Leia] Zablocki VA Med Ctr, Acute Mental Hlth, Milwaukee, WI USA; [Vos, Leia] Med Coll Wisconsin, Dept Psychiat & Behav Med, 5000 WNatl Ave, Milwaukee, WI 53295 USA; [Williams, Michael W.; Ochoa, Andrea] Univ Houston, Dept Psychol, Houston, TX USA; [Williams, Michael W.; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Spielman, Lisa] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Ngan, Esther; Leon-Novelo, Luis] Univ Texas Hlth Sci Ctr Houston, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Vos, L (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, 5000 WNatl Ave, Milwaukee, WI 53295 USA.	leia.demaagd@gmail.com		Vos, Leia/0000-0003-1253-9129	National Institute of Disability, Independent Living, and Rehabilitation Research grant [90DPTB0016]	Preparation of this manuscript was partially supported by the National Institute of Disability, Independent Living, and Rehabilitation Research grant #90DPTB0016.NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represen the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federa Government;<#funding-source;> National Institute on Disability, Independent Living, and Rehabilitation Research </#fundingsource;> [<#award-id;> 90DPTB0016 </#award-id;>];	Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bambs CE, 2013, ANN EPIDEMIOL, V23, P328, DOI 10.1016/j.annepidem.2013.02.007; Bamer AM, 2020, J BURN CARE RES, V41, P270, DOI 10.1093/jbcr/irz186; Bell ML, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8668; Bennetts SK, 2021, INT J SOC RES METHOD, V24, P135, DOI 10.1080/13645579.2020.1765104; Blaha RZ, 2015, J HEAD TRAUMA REHAB, V30, pE33, DOI 10.1097/HTR.0000000000000059; Burke SL, 2019, AGING CLIN EXP RES, V31, P1283, DOI 10.1007/s40520-018-1087-6; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Friis K, 2016, J HEALTH COMMUN, V21, P54, DOI 10.1080/10810730.2016.1201175; Gabbe BJ, 2015, BURNS, V41, P1732, DOI 10.1016/j.burns.2015.09.005; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Holavanahalli RK, 2006, J BURN CARE RES, V27, P703, DOI 10.1097/01.BCR.0000238085.87863.81; Kim H, 2018, TOP SPINAL CORD INJ, V24, P97, DOI 10.1310/sci2402-97; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Langley JD, 2013, INJURY PREV, V19, P428, DOI 10.1136/injuryprev-2012-040685; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; Mychasiuk R, 2012, CHILD CARE HLTH DEV, V38, P753, DOI 10.1111/j.1365-2214.2011.01326.x; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Salthouse TA, 2014, J GERONTOL B-PSYCHOL, V69, P567, DOI 10.1093/geronb/gbt046; Sander AM, 2018, J HEAD TRAUMA REHAB, V33, P219, DOI 10.1097/HTR.0000000000000395; Traumatic Brain Injury Model Systems National Database, 2019, TRAUMATIC BRAIN INJU; Van Beijsterveldt CEM, 2002, J CLIN EPIDEMIOL, V55, P216, DOI 10.1016/S0895-4356(01)00473-5; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Williams IL, 2014, EVAL PROGRAM PLANN, V45, P82, DOI 10.1016/j.evalprogplan.2014.04.001	31	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1349	1357		10.1080/02699052.2021.1963474		AUG 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000685839300001	34403276				2022-02-06	
J	Braun, NJ; Liao, DZ; Alford, PW				Braun, Nicholas J.; Liao, Dezhi; Alford, Patrick W.			Orientation of neurites influences severity of mechanically induced tau pathology	BIOPHYSICAL JOURNAL			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY PREDICTION; VISCOELASTIC PROPERTIES; CONTRACTILITY DEPENDS; DENDRITIC SPINES; SILENT SYNAPSES; AXONAL STRAIN; MISLOCALIZATION; EPIDEMIOLOGY; MICROTUBULES	Chronic traumatic encephalopathy is a neurodegenerative disease associated with repeated traumatic brain injury (TBI). Chronic traumatic encephalopathy is a tauopathy, in which cognitive decline is accompanied by the accumulation of neurofibrillary tangles of the protein tau in patients' brains. We recently found that mechanical force alone can induce tau mislocalization to dendritic spines and loss of synaptic function in in vitro neuronal cultures with random cell organization. However, in the brain, neurons are highly aligned, so here we aimed to determine how neuronal organization influences early-stage tauopathy caused by mechanical injury. Using microfabricated cell culture constructs to control the growth of neurites and an in vitro simulated TBI device to apply controlled mechanical deformation, we found that neuronal orientation with respect to the direction of a uniaxial high-strain-rate stretch injury influences the degree of tau pathology in injured neurons. We found that a mechanical stretch applied parallel to the neurite alignment induces greater mislocalization of tau proteins to dendritic spines than does a stretch with the same strain applied perpendicular to the neurites. Synaptic function, characterized by the amplitude of miniature excitatory postsynaptic currents, was similarly decreased in neurons with neurites aligned parallel to stretch, whereas in neurons aligned perpendicular to stretch, it had little to no functional loss. Experimental injury parameters (strain, strain rate, direction of stretch) were combined with a standard viscoelastic solid model to show that in our in vitro model, neurite work density during stretch correlates with tau mislocalization. These findings suggest that in a TBI, the magnitude of brain deformation is not wholly predictive of neurodegenerative consequences of TBI but that deformation relative to local neuronal architecture and the neurite mechanical energy during injury are better metrics for predicting trauma-induced tauopathy.	[Braun, Nicholas J.; Alford, Patrick W.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Liao, Dezhi] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA		Alford, PW (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.; Liao, DZ (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	liaox020@umn.edu; pwalford@umn.edu			National Science FoundationNational Science Foundation (NSF) [CMMI-1935834]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21-NS096437-01, R61 NS115089-01]; Minnesota Higher Education Grant; Institute of Engineering Medicine at the University of Minnesota seed grant; UMN-Mayo Partnership Grant; National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI) [ECCS-1542202]	Funding support was provided by the National Science Foundation, CMMI1935834 (P.W.A. and D.L.); National Institutes of Health, R21-NS09643701 (D.L. and P.W.A.); R61 NS115089-01 (D.L.); Minnesota Higher Education Grant (D.L. and P.W.A.); Institute of Engineering Medicine at the University of Minnesota seed grant (P.W.A. and D.L.); and UMN-Mayo Partnership Grant (D.L.). Portions of this work were conducted in the Minnesota Nano Center, which is supported by the National Science Foundation through the National Nano Coordinated Infrastructure Network (NNCI) under Award Number ECCS-1542202.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Braun NJ, 2020, P NATL ACAD SCI USA, V117, P29069, DOI 10.1073/pnas.2008306117; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chong FP, 2018, CELL MOL NEUROBIOL, V38, P965, DOI 10.1007/s10571-017-0574-1; Cinelli I, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3118; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; da Costa NM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00016; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dzaja D, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00103; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kingston Robert E, 2003, Curr Protoc Mol Biol, VChapter 9, DOI 10.1002/0471142727.mb0901s63; Knutsen A. K., 2020, BRAIN MULTIPHYS, V1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liao DZ, 2014, EUR J NEUROSCI, V39, P1202, DOI 10.1111/ejn.12504; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller EC, 2014, EUR J NEUROSCI, V39, P1214, DOI 10.1111/ejn.12507; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nakayama Y, 2001, J NEUROTRAUM, V18, P545, DOI 10.1089/089771501300227341; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ray A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14923; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rothermel TM, 2020, J BIOMECH, V111, DOI 10.1016/j.jbiomech.2020.110005; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Stemper BD, 2016, ANN BIOMED ENG, V44, P3252, DOI 10.1007/s10439-016-1647-x; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Steucke KE, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036454; Steucke KE, 2015, J BIOMECH, V48, P3044, DOI 10.1016/j.jbiomech.2015.07.029; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teravskis PJ, 2020, NEUROSCIENTIST, V26, P503, DOI 10.1177/1073858420916696; Teravskis PJ, 2021, J PHYSIOL-LONDON, V599, P2483, DOI 10.1113/JP277459; Teravskis PJ, 2018, J NEUROSCI, V38, P9754, DOI 10.1523/JNEUROSCI.0344-18.2018; Villegas M, 2018, ANAL CHIM ACTA, V1000, P248, DOI 10.1016/j.aca.2017.11.063; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Win Z, 2018, BIOPHYS J, V115, P2044, DOI 10.1016/j.bpj.2018.09.027; Win Z, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036440; Win Z, 2014, INTEGR BIOL-UK, V6, P1201, DOI 10.1039/c4ib00193a; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Ye GJC, 2014, INTEGR BIOL-UK, V6, P152, DOI 10.1039/c3ib40230d	85	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	AUG 17	2021	120	16					3272	3282		10.1016/j.bpj.2021.07.011			11	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	UC2ET	WOS:000686346200007	34293301				2022-02-06	
J	Maruyama, BA; Abrams, G; Kornblith, E; Posecion, LF; McQuaid, JR; Neylan, TC; Groberio, J; Chen, AJW; Novakovic-Agopian, T				Maruyama, Brian A.; Abrams, Gary; Kornblith, Erica; Posecion, Lainie F.; McQuaid, John R.; Neylan, Thomas C.; Groberio, Jessica; Chen, Anthony J-W; Novakovic-Agopian, Tatjana			Improvement in executive functioning after Goal-Oriented Attentional Self-Regulation training is associated with reduction in PTSD hyperarousal symptoms among veterans with comorbid PTSD and mild TBI	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Cognitive rehabilitation; Post-traumatic stress disorder; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AFGHANISTAN VETERANS; MILITARY TBI; IRAQ; REHABILITATION; MANAGEMENT; EXPOSURE; THERAPY; RISK	Goal-Oriented Attentional Self-Regulation (GOALS) is a cognitive rehabilitation training program that combines mindfulness-based attention regulation with individualized goal management strategies to improve functioning in daily life after traumatic brain injury (TBI). While not a specific target of GOALS training, previous research has indicated improvements in emotional functioning following GOALS training, specifically symptoms related to depression and posttraumatic stress disorder (PTSD). The current study is based on the hypothesis that improvements in cognitive control processes related to executive functioning and attention after GOALS training generalize to improvements in emotional functioning, thereby resulting in reductions in emotional distress. The current study analyzed archival data from 33 Veteran participants with a confirmed diagnosis of PTSD and a history of mild TBI who received either GOALS training or a psychoeducational intervention matched for time, therapist attention, and participation format. Regression analysis was used to assess the strength of the relationship between improvements in Overall Attention/Executive Functioning and decreases in hyperarousal symptoms associated with PTSD. Results from the regression analysis revealed that improvements in Overall Attention/Executive Functioning after GOALS was significantly associated with reductions in hyperarousal symptoms associated with PTSD (R-2 = 0.26, F-(1,F-15) = 5.01, beta = -.51, p < .05). The current findings suggest that cognitive improvements after GOALS training may lead to changes in emotional functioning, resulting in decreased emotional distress. This is important, particularly in VA settings, because the results potentially highlight additional areas of research and focus on the treatment of comorbid mild TBI and PTSD among Veterans.	[Maruyama, Brian A.; Abrams, Gary; Kornblith, Erica; Posecion, Lainie F.; McQuaid, John R.; Neylan, Thomas C.; Groberio, Jessica; Novakovic-Agopian, Tatjana] San Francisco VA Hlth Care Syst, Dept Vet Affairs, San Francisco, CA 94121 USA; [Abrams, Gary; Kornblith, Erica; McQuaid, John R.; Neylan, Thomas C.; Chen, Anthony J-W; Novakovic-Agopian, Tatjana] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chen, Anthony J-W] VA Northern Calif Hlth Care Syst, Dept Vet Affairs, Martinez, CA USA		Maruyama, BA; Novakovic-Agopian, T (corresponding author), San Francisco VA Hlth Care Syst, Dept Vet Affairs, San Francisco, CA 94121 USA.	Dr.Brian.Maruyama@gmail.com; Tatjana.Novakovic-Agopian@va.gov			Department of Veterans Affairs Rehabilitation Research & Development Service Merit Review AwardUS Department of Veterans Affairs [VA 1IO1RX00111101A1]; VA Office of Academic Affiliations (OAA) TBI/Polytrauma Rehabilitation Research Fellowship	This material is based upon work supported by the Department of Veterans Affairs Rehabilitation Research & Development Service Merit Review Award to Tatjana Novakovic-Agopian, VA 1IO1RX00111101A1. Additional support provided by the VA Office of Academic Affiliations (OAA) TBI/Polytrauma Rehabilitation Research Fellowship to Brian A. Maruyama.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Clausen AN, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00062; Defense and Veterans Brain Injury Center, 2021, DOD TRAUM BRAIN INJ; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Foa E.B., 2007, PROLONGED EXPOSURE T, V1; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Heaton RK, 2004, COMPREHENSIVE NORMS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IBMCorp, 2016, IBM SPSS STAT WINDOW; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Judah MR, 2018, J HEAD TRAUMA REHAB, V33, pE10, DOI 10.1097/HTR.0000000000000356; Jurick SM, 2018, J HEAD TRAUMA REHAB, V33, pE41, DOI 10.1097/HTR.0000000000000313; Kornblith E, 2020, APPL NEUROPSYCH-ADUL, V27, P108, DOI 10.1080/23279095.2018.1490738; Kremen WS, 2007, ARCH GEN PSYCHIAT, V64, P361, DOI 10.1001/archpsyc.64.3.361; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak, 2008, MANUAL MAYO PORTLAND; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Loya F, 2017, REHABIL RES PRACT, V2017, DOI 10.1155/2017/8379347; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Novakovic-Agopian T, 2021, J NEUROTRAUM, V38, P582, DOI 10.1089/neu.2019.6806; Novakovic-Agopian T, 2018, J NEUROTRAUM, V35, P2784, DOI 10.1089/neu.2017.5529; Novakovic-Agopian T, 2019, BRAIN INJURY, V33, P1513, DOI 10.1080/02699052.2019.1645357; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Posecion L., 2019, INT NEUR SOC 2019 AN; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rauch S., 2019, PROLONGED EXPOSURE T; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wechsler, 1997, WECHSLER ADULT INTEL; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	48	0	0	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1960531		AUG 2021	9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UC2XO	WOS:000686395200001	34410839				2022-02-06	
J	Babl, FE; Anderson, V; Rausa, VC; Anderson, N; Pugh, R; Chau, T; Clarke, C; Fabiano, F; Fan, F; Hearps, S; Parkin, G; Takagi, M; Davis, G				Babl, Franz E.; Anderson, Vicki; Rausa, Vanessa C.; Anderson, Nicholas; Pugh, Remy; Chau, Tracey; Clarke, Cathriona; Fabiano, Fabian; Fan, Feiven; Hearps, Stephen; Parkin, Georgia; Takagi, Michael; Davis, Gavin			Accuracy of Components of the SCAT5 and ChildSCAT5 to Identify Children with Concussion	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						pediatric; concussion; assessment; diagnosis		The Sport Concussion Assessment Tool 5 (th) Edition (SCAT5) is a standardized measure of concussion. In this prospective observational study, the ability of the SCAT5 and ChildSCAT5 to differentiate between children with and without a concussion was examined. Concussed children (n=91) and controls (n=106) were recruited from an emergency department in three equal-sized age bands (5-8/9-12/13-16 years). Analysis of covariance models (adjusting for participant age) were used to analyze group differences on components of the SCAT5. On the SCAT5 and ChildSCAT5, respectively, youth with concussion reported a greater number ( d =1.47; d= 0.52 ) and severity ( d= 1.27; d= 0.72) of symptoms than controls (all p <0.001). ChildSCAT5 parent-rated number ( d =0.98) an d severity ( d =1.04) of symptoms were greater for the concussion group (all p <0.001). Acceptable levels of between-group discrimination were identified for SCAT5 symptom number (AUC=0.86) and severity (AUC=0.84) and ChildSCAT5 parent-rated symptom number (AUC=0.76) and severity (AUC=0.78). Our findings support the utility of the SCAT5 and ChildSCAT5 to accurately distinguish between children with and without a concussion.	[Babl, Franz E.; Anderson, Vicki; Rausa, Vanessa C.; Anderson, Nicholas; Pugh, Remy; Chau, Tracey; Clarke, Cathriona; Fabiano, Fabian; Fan, Feiven; Hearps, Stephen; Parkin, Georgia; Takagi, Michael; Davis, Gavin] Murdoch Childrens Res Inst, Dept Clin Sci, Parkville, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia; [Anderson, Vicki; Takagi, Michael] Univ Melbourne, Dept Sch Psychol Sci, Parkville, Vic, Australia; [Anderson, Vicki] Royal Children Hosp, Dept Psychol Serv, Parkville, Vic, Australia; [Davis, Gavin] Austin Hosp, Dept Neurosurg, Heidelberg, Vic, Australia; [Davis, Gavin] Cabrini Hosp, Dept Neurosurg, Malvern, Australia		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Clin Sci Res, Level 4 West, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au		Parkin, Georgia/0000-0002-0588-2239; Takagi, Michael/0000-0003-2903-7598	National Health and Medical Research Council Practitioner Fellowship, Canberra, AustraliaNational Health and Medical Research Council of Australia; Royal Children's Hospital Foundation, Melbourne, Australia	Franz Babl has been in part funded by a National Health and Medical Research Council Practitioner Fellowship, Canberra, Australia, and the Royal Children's Hospital Foundation, Melbourne, Australia.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Bruce JM, 2021, BRIT J SPORT MED, V55, P557, DOI 10.1136/bjsports-2020-102072; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Shapiro JS, 2021, J NEUROTRAUM, DOI 10.1089/neu.2020.7414; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	19	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.												10.1055/a-1533-1700		AUG 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UA4YJ	WOS:000685168400002	34399426				2022-02-06	
J	Delmonico, RL; Theodore, BR; Sandel, ME; Armstrong, MA; Camicia, M				Delmonico, Richard L.; Theodore, Brian R.; Sandel, M. Elizabeth; Armstrong, Mary Anne; Camicia, Michelle			Prevalence of depression and anxiety disorders following mild traumatic brain injury	PM&R			English	Article; Early Access							PSYCHIATRIC-ILLNESS; UNITED-STATES; DIAGNOSIS; HEALTH	Background Previous studies have identified an association between traumatic brain injuries and the development of psychiatric disorders in general. However, these studies were subject to limitations that demonstrate the need for a study of a large, clearly defined mild traumatic brain injury (mTBI) population within an integrated healthcare system. Objective To determine the prevalence and relative risk of postinjury affective disorders over 4 years following mTBI. Design Cohort study of mTBI cases and matched controls, over a 4-year period. Setting An integrated healthcare delivery system in California. Patients A total of 9428 adult health plan members diagnosed with mTBI from 2000-2007 and enrolled in the year before injury, during which no TBI was ascertained. Control participants included 18,856 individuals selected based on the following criteria: Two unexposed health plan members per each mTBI-exposed patient were randomly selected and individually matched for age, gender, race/ethnicity, and medical comorbidities. Interventions Not applicable. Main Outcome Measures A diagnosis of affective disorder (depressive, anxiety, and adjustment disorders) in the 4 years after mTBI or the reference date, determined according to the International Classification of Diseases, Ninth Revision, Clinical Modification as well as the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Results Affective disorders were most prominent during the first 12 months with 23% following mTBI and 14% in the control group. Four-year aggregate adjusted odds ratios for having an affective disorder following mTBI were 1.2 (95% CI: 1.1, 1.2; p < .001) and 1.5 (95% CI: 1.5, 1.6; p < .001) for patients with and without prior affective disorders, respectively. Conclusion mTBI was associated with a significantly increased risk of having subsequent affective disorders. Screening for and addressing affective disorders at earlier stages following the injury is an important step to avoid persisting conditions that may pose a barrier to full recovery.	[Delmonico, Richard L.; Theodore, Brian R.; Camicia, Michelle] Kaiser Permanente Vallejo Med Ctr, Kaiser Fdn Rehabil Ctr, 975 Sereno Dr, Vallejo, CA 94589 USA; [Sandel, M. Elizabeth] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Armstrong, Mary Anne] Kaiser Permanente, Div Res, Oakland, CA USA		Delmonico, RL (corresponding author), Kaiser Permanente Vallejo Med Ctr, Kaiser Fdn Rehabil Ctr, 975 Sereno Dr, Vallejo, CA 94589 USA.	richard.l.delmonico@kp.org		Delmonico, Richard/0000-0002-3194-3840	Kaiser Permanente Community Benefits Grant	The authors wish to thank the following collaborators for their assistance with study design and/or data analysis: Lue-Yen Tucker, BA, Division of Research, Kaiser Permanente, Oakland, CA; Joseph Terdiman, MD, Division of Research, Kaiser Permanente, Oakland, CA; Rachel Whitmer, PhD, Division of Research, Kaiser Permanente, Oakland, CA; Jed Appleman, PhD, Kaiser Foundation Rehabilitation Center, Vallejo, CA. This study was funded by the Kaiser Permanente Community Benefits Grant, awarded January 2012 to the Corresponding Author.	Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Centers for Disease Control and Prevention, 2009, HEADS FACTS PHYS MIL; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Gordon NP, 2015, SIMILARITY ADULT KAI; Guillamondegui OD., 2011, TRAUMATIC BRAIN INJU; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joyce S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017858; Kennedy JE, 2019, MIL MED, V184, P148, DOI 10.1093/milmed/usy321; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lau KM, 2016, BRAIN INJURY, V30, P287, DOI 10.3109/02699052.2015.1089601; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Medicode, 1999, ICD 9 CM INT CLASS D, V5th; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petersen LA, 2005, MED CARE, V43, P61; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2019, NEUROPSYCHOLOGY, V33, P560, DOI 10.1037/neu0000516; Thurman DJ., 1996, P ANN M AM PUBL HLTH; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Verisk Health, 2008, DXCG RISK SOL US GUI; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	34	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12657		AUG 2021	10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UB2RY	WOS:000685699600001	34156769				2022-02-06	
J	Hayes, JP; Pierce, ME; Valerio, KE; Miller, MW; Huber, BR; Fortier, CB; Fonda, JR; Milberg, W; McGlinchey, R				Hayes, Jasmeet P.; Pierce, Meghan E.; Valerio, Kate E.; Miller, Mark W.; Huber, Bertrand Russell; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William; McGlinchey, Regina			The association between blast exposure and transdiagnostic health symptoms on systemic inflammation	NEUROPSYCHOPHARMACOLOGY			English	Article; Early Access							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; STRUCTURED CLINICAL INTERVIEW; GROWTH-HORMONE DEFICIENCY; MILITARY PERSONNEL; METABOLIC SYNDROME; OXIDATIVE STRESS; DSM-IV; OUTCOMES	Chronic elevation of systemic inflammation is observed in a wide range of disorders including PTSD, depression, and traumatic brain injury. Although previous work has demonstrated a link between inflammation and various diagnoses separately, few studies have examined transdiagnostic symptoms and inflammation within the same model. The objective of this study was to examine relationships between psychiatric and health variables and systemic inflammation and to determine whether mild traumatic brain injury (mTBI) and/or exposure to blast munitions moderate these relationships. Confirmatory factor analysis in a large sample (N = 357) of post-9/11 Veterans demonstrated a good fit to a four-factor model reflecting traumatic stress, affective, somatic, and metabolic latent variables. Hierarchical regression models revealed that each of the latent variables were associated with higher levels of systemic inflammation. However, the strongest relationship with inflammation emerged among those who had both war-zone blast exposures and metabolic dysregulation, even after adjusting for mental health latent variables. Exploratory analyses showed that blast exposure was associated with metabolic dysregulation in a dose-response manner, with self-reported closer blast proximity associated with the greatest metabolic dysregulation. Together, these results provide a greater understanding of the types of symptoms most strongly associated with inflammation and underscore the importance of maintaining a healthy lifestyle to reduce the impact of obesity and other metabolic symptoms on future chronic disease in younger to middle-aged Veterans.	[Hayes, Jasmeet P.; Valerio, Kate E.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Hayes, Jasmeet P.; Valerio, Kate E.] Ohio State Univ, Chron Brain Injury Initiat, Columbus, OH 43210 USA; [Pierce, Meghan E.; Miller, Mark W.; Huber, Bertrand Russell; Fonda, Jennifer R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Pierce, Meghan E.; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William; McGlinchey, Regina] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Miller, Mark W.; Huber, Bertrand Russell] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William; McGlinchey, Regina] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Hayes, JP (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.; Hayes, JP (corresponding author), Ohio State Univ, Chron Brain Injury Initiat, Columbus, OH 43210 USA.	hayes.1075@osu.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021; Miller, Mark/G-7322-2011	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904; Miller, Mark/0000-0001-6393-8563; Hayes, Jasmeet/0000-0002-5157-0666	National Institutes of Health (NIH), NIA grant [R01AG058822]; Department of Veterans Affairs by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]	This work was supported by the National Institutes of Health (NIH), NIA grant number R01AG058822 to JPH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This research was also supported in part by the Department of Veterans Affairs by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B9254-C).	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Ansley SD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020403; Armour C, 2016, CLIN PSYCHOL REV, V44, P60, DOI 10.1016/j.cpr.2015.12.003; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Ciarlone SL, 2020, J NEUROSCI RES, V98, P1174, DOI 10.1002/jnr.24604; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fortenbaugh FC, 2020, J TRAUMA STRESS, V33, P750, DOI 10.1002/jts.22501; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haapakoski R, 2015, BRAIN BEHAV IMMUN, V49, P206, DOI 10.1016/j.bbi.2015.06.001; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ioachimescu AG, 2015, PITUITARY, V18, P535, DOI 10.1007/s11102-014-0606-5; Iob E, 2020, MOL PSYCHIATR, V25, P1130, DOI 10.1038/s41380-019-0501-6; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; Lasseter H.C., 2020, CYTOKINE X, V2, DOI [10.1016/j.cytox.2020.100027, DOI 10.1016/J.CYTOX.2020.100027]; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Marsland AL, 2010, METABOLISM, V59, P1801, DOI 10.1016/j.metabol.2010.05.015; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Michopoulos V, 2017, NEUROPSYCHOPHARMACOL, V42, P254, DOI 10.1038/npp.2016.146; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Pinto JV, 2017, NEUROSCI BIOBEHAV R, V83, P97, DOI 10.1016/j.neubiorev.2017.10.001; Raines AM, 2020, ADDICT BEHAV, V104, DOI 10.1016/j.addbeh.2019.106285; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Roberta I, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0729-y; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rush T, 2016, OBESITY, V24, P1582, DOI 10.1002/oby.21513; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Speer K, 2018, J INFLAMM RES, V11, P111, DOI 10.2147/JIR.S155903; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Takeda S, 2013, NEUROBIOL AGING, V34, P2064, DOI 10.1016/j.neurobiolaging.2013.02.010; Tapp ZM, 2020, J NEUROTRAUM, V37, P1829, DOI 10.1089/neu.2020.7010; Temizkan S, 2019, PITUITARY, V22, P220, DOI 10.1007/s11102-019-00941-3; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; VandeVord PJ, 2016, J NEUROTRAUM, V33, P82, DOI 10.1089/neu.2014.3786; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237	67	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology												10.1038/s41386-021-01138-8		AUG 2021	8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	UA8GQ	WOS:000685395300008	34400776	Green Submitted			2022-02-06	
J	Waggoner, LE; Madias, MI; Hurtado, AA; Kwon, EJ				Waggoner, Lauren E.; Madias, Marianne I.; Hurtado, Alan A.; Kwon, Ester J.			Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury	AAPS JOURNAL			English	Article						nanoparticles; peptides; pharmacokinetics; surface engineering; traumatic brain injury	CORE-SHELL NANOPARTICLES; CONTROLLED CORTICAL IMPACT; SURFACE-CHARGE; TARGETED DELIVERY; PROTEIN CORONA; POLYMERIC NANOPARTICLES; CELLULAR UPTAKE; SIRNA DELIVERY; TUMOR; BARRIER	Peptides are used to control the pharmacokinetic profiles of nanoparticles due to their ability to influence tissue accumulation and cellular interactions. However, beyond the study of specific peptides, there is a lack of understanding of how peptide physicochemical properties affect nanoparticle pharmacokinetics, particularly in the context of traumatic brain injury (TBI). We engineered nanoparticle surfaces with peptides that possess a range of physicochemical properties and evaluated their distribution after two routes of administration: direct injection into a healthy mouse brain and systemic delivery in a mouse model of TBI. In both administration routes, we found that peptide-modified nanoparticle pharmacokinetics were influenced by the charge characteristics of the peptide. When peptide-modified nanoparticles are delivered directly into the brain, nanoparticles modified with positively charged peptides displayed restricted distribution from the injection site compared to nanoparticles modified with neutral, zwitterionic, or negatively charged peptides. After intravenous administration in a TBI mouse model, positively charged peptide-modified nanoparticles accumulated more in off-target organs, including the heart, lung, and kidneys, than zwitterionic, neutral, or negatively charged peptide-modified nanoparticles. The increase in off-target organ accumulation of positively charged peptide-modified nanoparticles was concomitant with a relative decrease in accumulation in the injured brain compared to zwitterionic, neutral, or negatively charged peptide-modified nanoparticles. Understanding how nanoparticle pharmacokinetics are influenced by the physicochemical properties of peptides presented on the nanoparticle surface is relevant to the development of nanoparticle-based TBI therapeutics and broadly applicable to nanotherapeutic design, including synthetic nanoparticles and viruses.	[Waggoner, Lauren E.] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Madias, Marianne I.; Hurtado, Alan A.; Kwon, Ester J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA		Kwon, EJ (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	ejkwon@ucsd.edu		Waggoner, Lauren/0000-0001-8641-0577	National Institutes of Health Director's New Innovator AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2NS111507]; National Science Foundation (NSF)National Science Foundation (NSF)	This work was supported by the National Institutes of Health Director's New Innovator Award number 1DP2NS111507. M.I.M. is supported by the National Science Foundation (NSF) Graduate Research Fellowship Program. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF.	Accardo A, 2010, MOL BIOSYST, V6, P878, DOI 10.1039/b923147a; Akinc A, 2019, NAT NANOTECHNOL, V14, P1084, DOI 10.1038/s41565-019-0591-y; Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bobo D, 2016, PHARM RES-DORDR, V33, P2373, DOI 10.1007/s11095-016-1958-5; Boyd BJ, 2015, J DRUG TARGET, V23, P847, DOI 10.3109/1061186X.2015.1034280; Brissette R, 2006, CURR OPIN DRUG DISC, V9, P363; Busher JT., 1990, CLIN METHODS HIST PH; Corbett JCW, 2011, ELECTROPHORESIS, V32, P1787, DOI 10.1002/elps.201100108; Cruz LJ, 2016, J CONTROL RELEASE, V223, P31, DOI 10.1016/j.jconrel.2015.12.029; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Doktorovova S, 2012, EUR J PHARM SCI, V45, P606, DOI 10.1016/j.ejps.2011.12.016; Du HR, 2011, MOL PHARMACEUT, V8, P1224, DOI 10.1021/mp200039s; Feng QY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19628-z; Ferrari R, 2014, COLLOID SURFACE B, V123, P639, DOI 10.1016/j.colsurfb.2014.10.003; GREF R, 1995, ADV DRUG DELIVER REV, V16, P215, DOI 10.1016/0169-409X(95)00026-4; Gunawan C, 2014, J MATER CHEM B, V2, P2060, DOI 10.1039/c3tb21526a; Gupta M, 2014, MOL PHARMACEUT, V11, P697, DOI 10.1021/mp400404p; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Huhn D, 2013, ACS NANO, V7, P3253, DOI 10.1021/nn3059295; Jadia R, 2018, PHOTOCHEM PHOTOBIOL, V94, P765, DOI 10.1111/php.12903; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Jo DH, 2015, NANOMED-NANOTECHNOL, V11, P1603, DOI 10.1016/j.nano.2015.04.015; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Joo J, 2016, NANOSCALE HORIZ, V1, P407, DOI [10.1039/C6NH00082G, 10.1039/c6nh00082g]; Kandell RM, 2021, MOL PHARMACEUT, V18, P522, DOI 10.1021/acs.molpharmaceut.0c00287; Kang JY, 2016, ADV MATER, V28, P7962, DOI 10.1002/adma.201600634; Khan S, 2013, J PHYS CHEM LETT, V4, P3747, DOI 10.1021/jz401874u; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Kuai R, 2011, MOL PHARMACEUT, V8, P2151, DOI 10.1021/mp200100f; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kwon EJ, 2016, ACS NANO, V10, P7926, DOI 10.1021/acsnano.6b03858; Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Lim K, 1992, POLY ETHYLENE GLYCOL, P29; Liu T, 2015, NANO TODAY, V10, P11, DOI 10.1016/j.nantod.2014.12.003; Liu YX, 2011, BIOMATERIALS, V32, P8291, DOI 10.1016/j.biomaterials.2011.07.037; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11825-2; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; MacKay JA, 2005, BRAIN RES, V1035, P139, DOI 10.1016/j.brainres.2004.12.007; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Miller HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52622-7; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/nnano.2012.207, 10.1038/NNANO.2012.207]; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Ouyang B, 2020, NAT MATER, V19, P1362, DOI 10.1038/s41563-020-0755-z; Rohovie MJ, 2017, BIOENG TRANSL MED, V2, P43, DOI 10.1002/btm2.10049; Sarko D, 2010, MOL PHARMACEUT, V7, P2224, DOI 10.1021/mp100223d; Sellappan P, 2019, J NEUROSCI METH, V312, P37, DOI 10.1016/j.jneumeth.2018.10.027; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Song E., 2017, NAT COMMUN, V19, P8; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sukhanova A, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2457-x; Sun XL, 2017, THERANOSTICS, V7, P319, DOI 10.7150/thno.18078; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Wu P, 2019, INT J NANOMED, V14, P4059, DOI 10.2147/IJN.S202353; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Xiao Y, 2012, J HAZARD MATER, V215, P146, DOI 10.1016/j.jhazmat.2012.02.043; Xu F, 2009, INT J PHARMACEUT, V377, P199, DOI 10.1016/j.ijpharm.2009.05.015; Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5; Yamankurt G, 2019, NAT BIOMED ENG, V3, P318, DOI 10.1038/s41551-019-0351-1; Yang Q, 2014, MOL PHARMACEUT, V11, P1250, DOI 10.1021/mp400703d; Yue ZG, 2011, BIOMACROMOLECULES, V12, P2440, DOI 10.1021/bm101482r; Zahr AS, 2006, LANGMUIR, V22, P8178, DOI 10.1021/la060951b	78	0	0	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1550-7416			AAPS J	AAPS J.	AUG 16	2021	23	5							100	10.1208/s12248-021-00626-5			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UC6ZA	WOS:000686670600001	34401968	Green Published, hybrid			2022-02-06	
J	Caccese, J; Schmidt, J; Moody, J; Broglio, S; McAllister, T; McCrea, M; Pasquina, P; Buckley, T				Caccese, Jaclyn; Schmidt, Julianne; Moody, Jena; Broglio, Steven; McAllister, Thomas; McCrea, Michael; Pasquina, Paul; Buckley, Thomas		CARE Consortium Investigators	Association between sports participation history and age of first exposure to high-risk sports with concussion history	RESEARCH IN SPORTS MEDICINE			English	Article; Early Access						repetitive head impacts; mild traumatic brain injury (mTBI); paediatric; American football	LIFE COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; HIGH-SCHOOL; FOOTBALL; DEPRESSION; SYMPTOMS; YOUTH	The purpose of this study was to examine the association between sports participation history, including estimated age of first exposure (eAFE) to high-risk sports, and concussion history in first year (i.e., freshmen) collegiate athletes. Athletes increased their odds of sustaining a pre-college concussion by 5% [odds ratio(OR) = 1.05 (95%CI:1.05-1.06)] for each additional year of contact sports participation - 24% of all student athletes reported one or more pre-college concussions. When eAFE was analysed dichotomously at age 12, a greater proportion of those who started playing football before age 12 reported a positive concussion history compared to those who started playing football at age 12 or later (X-2 = 4.483, p = 0.034, Phi = 0.049). When eAFE was analysed continuously, later eAFE to women's high-risk sports was associated with a lower likelihood of sustaining a pre-college concussion [OR = 0.93 (95%CI:0.88-0.98)]. Our findings suggest that there is a relationship between eAFE to football and to women's high-risk sports and concussion history.	[Caccese, Jaclyn] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Schmidt, Julianne] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Moody, Jena] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Broglio, Steven] Univ Michigan, Michigan Concuss Ctr, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Sch Med, Hlth Sci & Walter Reed Natl Mil Med Ctr, Dept Phys Med & Rehabil, Bethesda, MD USA; [Buckley, Thomas] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, NJ USA		Caccese, J (corresponding author), Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu		Caccese, Jaclyn/0000-0003-2329-3603	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs; Department of DefenseUnited States Department of Defense [W81XWH1420151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program, endorsed by the Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program -Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH1420151. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2020, SPORTS MED, V50, P1377, DOI 10.1007/s40279-020-01261-4; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cohen J., 2013, STAT POWER ANAL BEHA; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; The Aspen Institute, SPORT PARTICIPATION; The National Federation of State High School Associations, 2018, HIGH SCH ATHL PART S	31	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.												10.1080/15438627.2021.1966008		AUG 2021	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UB4SQ	WOS:000685838300001	34402703	hybrid			2022-02-06	
J	Galovic, M; Erlandsson, K; Fryer, TD; Hong, YT; Manavaki, R; Sari, H; Chetcuti, S; Thomas, BA; Fisher, M; Sephton, S; Canales, R; Russell, JJ; Sander, K; Arstad, E; Aigbirhio, FI; Groves, AM; Duncan, JS; Thielemans, K; Hutton, BF; Coles, JP; Koepp, MJ				Galovic, Marian; Erlandsson, Kjell; Fryer, Tim D.; Hong, Young T.; Manavaki, Roido; Sari, Hasan; Chetcuti, Sarah; Thomas, Benjamin A.; Fisher, Martin; Sephton, Selena; Canales, Roberto; Russell, Joseph J.; Sander, Kerstin; Arstad, Erik; Aigbirhio, Franklin I.; Groves, Ashley M.; Duncan, John S.; Thielemans, Kris; Hutton, Brian F.; Coles, Jonathan P.; Koepp, Matthias J.		NEST Investigators	Validation of a combined image derived input function and venous sampling approach for the quantification of [F-18]GE-179 PET binding in the brain	NEUROIMAGE			English	Article						Positron emission tomography; Input function; NMDA receptor	VOLUME CORRECTION TECHNIQUES; NMDA RECEPTOR; EMISSION-TOMOGRAPHY; FDG-PET; TRACER; EXCITOTOXICITY; SEGMENTATION	Blood-based kinetic analysis of PET data relies on an accurate estimate of the arterial plasma input function (PIF). An alternative to invasive measurements from arterial sampling is an image-derived input function (IDIF). However, an IDIF provides the whole blood radioactivity concentration, rather than the required free tracer radioactivity concentration in plasma. To estimate the tracer PIF, we corrected an IDIF from the carotid artery with estimates of plasma parent fraction (PF) and plasma-to-whole blood (PWB) ratio obtained from five venous samples. We compared the combined IDIF + venous approach to gold standard data from arterial sampling in 10 healthy volunteers undergoing [F-18]GE-179 brain PET imaging of the NMDA receptor. Arterial and venous PF and PWB ratio estimates determined from 7 patients with traumatic brain injury (TBI) were also compared to assess the potential effect of medication. There was high agreement between areas under the curves of the estimates of PF (r = 0.99, p < 0.001), PWB ratio (r = 0.93, p < 0.001), and the PIF (r = 0.92, p < 0.001) as well as total distribution volume (V-T) in 11 regions across the brain (r = 0.95, p < 0.001). IDIF + venous V-T had a mean bias of -1.7% and a comparable regional coefficient of variation (arterial: 21.3 +/- 2.5%, IDIF + venous: 21.5 +/- 2.0%). Simplification of the IDIF + venous method to use only one venous sample provided less accurate V-T estimates (mean bias 9.9%; r = 0.71, p < 0.001). A version of the method that avoids the need for blood sampling by combining the IDIF with population-based PF and PWB ratio estimates systematically underestimated V-T (mean bias - 20.9%), and produced V-T estimates with a poor correlation to those obtained using arterial data (r = 0.45, p < 0.001). Arterial and venous blood data from 7 TBI patients showed high correlations for PF (r = 0.92, p = 0.003) and PWB ratio (r = 0.93, p = 0.003). In conclusion, the IDIF + venous method with five venous samples provides a viable alternative to arterial sampling for quantification of [F-18]GE-179 V-T.	[Galovic, Marian] Univ Hosp Zurich, Dept Neurol, Clin Neurosci Ctr, Zurich, Switzerland; [Galovic, Marian; Duncan, John S.; Koepp, Matthias J.] UCL, UCL Queen Sq Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Galovic, Marian; Duncan, John S.; Koepp, Matthias J.] Chalfont Ctr Epilepsy, MRI Unit, Gerrards Cross, Bucks, England; [Erlandsson, Kjell; Sari, Hasan; Thomas, Benjamin A.; Groves, Ashley M.; Thielemans, Kris; Hutton, Brian F.] UCL, Inst Nucl Med, London, England; [Fryer, Tim D.; Hong, Young T.; Fisher, Martin; Sephton, Selena; Canales, Roberto; Russell, Joseph J.; Aigbirhio, Franklin I.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Manavaki, Roido] Univ Cambridge, Dept Radiol, Cambridge, England; [Sari, Hasan] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Sari, Hasan] Harvard Med Sch, Charlestown, MA USA; [Chetcuti, Sarah; Coles, Jonathan P.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England; [Sander, Kerstin; Arstad, Erik] UCL, Ctr Radiopharmaceut Chem, London, England		Koepp, MJ (corresponding author), UCL, UCL Queen Sq Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	m.koepp@ucl.ac.uk	Sari, Hasan/AAW-9952-2021; Thielemans, Kris/AAG-9208-2019	Sari, Hasan/0000-0002-1504-1767; Thielemans, Kris/0000-0002-5514-199X; Galovic, Marian/0000-0002-2307-071X; Duncan, John S/0000-0002-1373-0681; Coles, Jonathan/0000-0003-4013-679X	MRC PET Neuroscience programme grant (Training and Novel Probes Programme in PET Neurochemistry) [MR/K02308X/1]; MRC Developmental Pathway Funding Scheme grantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L013215/1]	This work has been funded by an MRC PET Neuroscience programme grant (Training and Novel Probes Programme in PET Neurochemistry -MR/K02308X/1) and by an MRC Developmental Pathway Funding Scheme grant (MR/L013215/1).	Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Cardoso MJ, 2015, IEEE T MED IMAGING, V34, P1976, DOI 10.1109/TMI.2015.2418298; Chen K, 2007, PHYS MED BIOL, V52, P7055, DOI 10.1088/0031-9155/52/23/019; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Erlandsson K, 2012, PHYS MED BIOL, V57, pR119, DOI 10.1088/0031-9155/57/21/R119; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; FENG D, 1993, INT J BIOMED COMPUT, V32, P95, DOI 10.1016/0020-7101(93)90049-C; Feng D, 1997, IEEE Trans Inf Technol Biomed, V1, P243, DOI 10.1109/4233.681168; Greuter H, 2011, J NUCL MED, V52; Gunn RN, 1998, NEUROIMAGE, V8, P426, DOI 10.1006/nimg.1998.0379; Hahn A, 2012, NEUROIMAGE, V62, P199, DOI 10.1016/j.neuroimage.2012.04.047; Hutton, 2014, J NUCL MED, V55, P2123; Jodas DS, 2016, COMPUT BIOL MED, V79, P233, DOI 10.1016/j.compbiomed.2016.10.021; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; McGinnity CJ, 2015, J NEUROL NEUROSUR PS, V86, P1150, DOI 10.1136/jnnp-2014-309897; McGinnity CJ, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0396-2; McGinnity CJ, 2014, J NUCL MED, V55, P423, DOI 10.2967/jnumed.113.130641; Meyer PT, 2005, SYNAPSE, V55, P212, DOI 10.1002/syn.20113; Murrough JW, 2013, AM J PSYCHIAT, V170, P1134, DOI 10.1176/appi.ajp.2013.13030392; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Pellock JM, 2006, EPILEPSY RES, V71, P89, DOI 10.1016/j.eplepsyres.2006.06.020; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Sari H, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0412-6; Sari H, 2017, J CEREBR BLOOD F MET, V37, P1398, DOI 10.1177/0271678X16656197; Takagi S, 2004, ANN NUCL MED, V18, P297, DOI 10.1007/BF02984467; Thomas BA, 2016, PHYS MED BIOL, V61, P7975, DOI 10.1088/0031-9155/61/22/7975; Vibholm AK, 2021, J CEREBR BLOOD F MET, V41, P1301, DOI 10.1177/0271678X20954928; Wakita K, 2000, J NUCL MED, V41, P1484; Zanotti-Fregonara P, 2012, EUR J NUCL MED MOL I, V39, P651, DOI 10.1007/s00259-011-2004-9; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zanotti-Fregonara P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017056	32	0	0	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG 15	2021	237								118194	10.1016/j.neuroimage.2021.118194			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	TG0YK	WOS:000671138600007	34023451	Green Published, Green Accepted, Green Submitted, gold			2022-02-06	
J	Ozcelik, EE; Celik, S				Ozcelik, Emine Ezgi; Celik, Selda			Comparison of the Turkish versions of the Glasgow coma scale and four score used by intensive care nurses for neurological evaluation	JOURNAL OF CLINICAL NURSING			English	Article; Early Access						critical care nursing; FOUR score; Glasgow coma scale; neurologic examination	TRAUMATIC BRAIN-INJURY; FULL OUTLINE; UNRESPONSIVENESS SCORE; INTERRATER RELIABILITY; PREDICTIVE-VALIDITY; VALIDATION; STROKE; UNIT; MORTALITY	Objective This study aimed to compare the use of the Turkish versions of the Glasgow Coma Scale (GCS) and Full Outline of UnResponsiveness (FOUR) Score by intensive care nurses in neurological evaluation. Materials and Methods This cross-sectional study was conducted between July 2018 and March 2019 with 92 patients in the general intensive care unit (ICU) of the training and research hospital of a private university. Data were collected using nurse and patient information forms, the GCS and the FOUR Score. The patients were evaluated by 27 intensive care nurses. To evaluate interrater reliability of the GCS and FOUR Score, each patient in the study was evaluated using both scales by two nurses who were blinded to each other's responses. Results Comparison of the patients' mean GCS and FOUR Score values from the two nurses revealed no significant difference in subscale or total scores (p > 0.05). Evaluation of interrater reliability demonstrated very good agreement (kappa = 0.935, p < 0.001). There was also very good agreement between the results of the two nurse groups when the patients' total scores were categorised according to the cut-off points for the two instruments (kappa = 0.927, p < 0.001). Conclusion This study demonstrated excellent agreement in the Turkish GCS and FOUR Score values, indicating that both scales can be used in neurological evaluation. Both instruments are reliable and easily applied by ICU nurses. Relevance to Clinical Practice The Turkish versions of the FOUR Score and GCS are both appropriate for use in intensive care units and are reliable tools for use by intensive care unit nurses.	[Ozcelik, Emine Ezgi] Taksim Educ & Res Hosp, Minist Hlth, Istanbul, Turkey; [Celik, Selda] Univ Hlth Sci Turkey, Hamidiye Fac Nursing, Istanbul, Turkey		Ozcelik, EE (corresponding author), Taksim Educ & Res Hosp, Minist Hlth, Istanbul, Turkey.	ezgiozcelik94@gmail.com		Celik, Selda/0000-0003-4328-3189; Ozcelik, Emine Ezgi/0000-0003-0447-5946			Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; [Anonymous], 2021, ENHANCING QUALITY TR; Baratloo A, 2016, ARCH IRAN MED, V19, P215, DOI 0161903/AIM.0011; Bayraktar YS, 2019, TURK NEUROSURG, V29, P285, DOI 10.5137/1019-5149.JTN.24175-18.2; Bhaskar S., 2017, CLIN SURG, V2, P1; Brooker K.J., 2015, CRITICAL CARE NURSIN, V1, P13, DOI [10.1002/9781118992845.ch2, DOI 10.1002/9781118992845.CH2]; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Burns E., 2011, OXFORD AM HDB CLIN E; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Evcili G., 2016, KOCAELI MED J, V5, P58; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Gen? Y., 2009, TURKIYE KLIN J BIOST, V1, P59; Ghelichkhani P., 2018, EMERGENCY TEHRAN IRA, V6, P1; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P193, DOI 10.4103/1658-354X.130708; Gujjar AR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.009; Hickey J., 2013, CLIN PRACTICE NEUROL; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Jalali R., 2014, PUBLISHING CORPORATI, V2014, P1; Karadag Arli S, 2018, ACIBADEM U SAGLIK BI, V9, P220; Kasprowicz M, 2016, BRIT J NEUROSURG, V30, P211, DOI 10.3109/02688697.2016.1161173; Keykha A., 2017, J CRITICAL CARE NURS, V10, P1; Khajeh A, 2014, IRAN J PEDIATR, V24, P603; Khanal K, 2016, INDIAN J CRIT CARE M, V20, P473, DOI 10.4103/0972-5229.188199; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Lange RT, 2011, ENCY CLIN NEUROPSYCH; Lee TKP, 2017, HONG KONG J EMERG ME, V24, P230, DOI 10.1177/1024907917724723; Mansour OY, 2015, ALEX J MED, V51, P247, DOI 10.1016/j.ajme.2014.10.002; Marshall JC, 2017, J CRIT CARE, V37, P270, DOI 10.1016/j.jcrc.2016.07.015; Matis G, 2008, ACTA NEUROL BELG, V108, P75; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McNett MM, 2016, J NEUROSCI NURS, V48, P207, DOI 10.1097/JNN.0000000000000225; Momenyan S, 2017, NEUROCRIT CARE, V27, P229, DOI 10.1007/s12028-016-0324-0; Munakomi S., 2015, NEUROSCIENCE MED, V6, P116; Nyam TTE, 2017, NEUROCRIT CARE, V26, P225, DOI 10.1007/s12028-016-0326-y; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Orken DN, 2010, TRAK UNIV TIP FAK DE, V27, P28; Peng J, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0508-9; Ramazani J., 2018, MEDIZINISCHE KLIN IN, V114, P717; Sahin A.S., 2015, J CONT MED, V5, P167; Sepahvand E, 2016, TURK NEUROSURG, V26, P720, DOI 10.5137/1019-5149.JTN.13536-14.0; Sepit D., 2005, HEMSIRELIKTE EGITIM, V2, P12; Surabenjawong Usapan, 2017, Journal of the Medical Association of Thailand, V100, P960; TEASDALE G, 1974, LANCET, V2, P81; Temiz NC, 2018, TURK NEUROSURG, V28, P248, DOI 10.5137/1019-5149.JTN.19504-16.0; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435; Zappa S, 2020, J INTENSIVE CARE MED, V35, P203, DOI 10.1177/0885066617738714	51	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.												10.1111/jocn.16001		AUG 2021	10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	UA8RS	WOS:000685424100001	34396609				2022-02-06	
J	Mangum, RW; Tolle-Fu, KA; Hale, AC; Gradwohl, BD; Spencer, RJ				Mangum, Ryan W.; Tolle-Fu, Kathryn A.; Hale, Andrew C.; Gradwohl, Brian D.; Spencer, Robert J.			The Savage Organizational Scoring System for the Rey-Osterrieth Complex Figure Test: Norms and New Data From Veterans in a Traumatic Brain Injury Clinic	PERCEPTUAL AND MOTOR SKILLS			English	Article						Rey-Osterreith Complex Figure Test; executive functioning; mild TBI; neuropsychological testing; psychometrics; Savage Organizational Scoring System; neuropsychological assessment	NONVERBAL MEMORY IMPAIRMENT; OBSESSIVE-COMPULSIVE DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; CENTRAL COHERENCE; SYMPTOMS	The Rey-Osterrieth Complex Figure Test (RCFT) permits quantifying diverse cognitive abilities, including executive function (EF). We evaluated the psychometric properties of a scoring procedure for the RCFT, the Savage Organizational Scoring System (SOSS), that awards points for drawing the largest structural elements of the figures as continuous wholes. This was a two-phase study: first, we conducted a systematic literature search for studies using the SOSS, and aggregated previously published data for healthy controls to create a normative database; second, we observed performances from veterans evaluated for traumatic brain injury (TBI), examining the reliability of their SOSS scores, the SOSS correlations with two EF measures and the participants' self-reported cognitive functioning, and then compared their mean scores to normative expectations. Across our literature-derived normative database, the aggregated mean SOSS score was 4.12 (SD = 1.72), which was marginally higher than that of our veteran participants evaluated for TBI, 3.72 (SD = 1.79). The SOSS had modest internal consistency (alpha = .59). Unlike the criterion EF measures, the SOSS was not significantly related to self-reported cognitive functioning. The SOSS shared a small, significant correlation with Trails B and Shipley Abstraction; but RCFT Copy scores were more strongly related to these tests, and the SOSS added no significant incremental predictive value beyond the RCFT Copy score. However, SOSS scores did predict RCFT Recall beyond RCFT Copy scores. We conclude that the SOSS has modest reliability and is predictive of RCFT Recall scores, but it is not strongly correlated with other EF measures, and it is only minimally affected by mild TBI.	[Mangum, Ryan W.; Tolle-Fu, Kathryn A.; Hale, Andrew C.; Gradwohl, Brian D.; Spencer, Robert J.] VA Ann Arbor Healthcare Syst, Mental Hlth Serv, Ann Arbor, MI USA		Mangum, RW (corresponding author), VA Ann Arbor Healthcare, Mental Hlth 116C,2215 Fuller Rd, Ann Arbor, MI 48105 USA.	RyanMangumPhD@gmail.com		Mangum, Ryan/0000-0002-2813-8293			Aloi M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0395-z; Behnken A, 2010, J AFFECT DISORDERS, V122, P144, DOI 10.1016/j.jad.2009.07.010; BENNETTLEVY J, 1984, BRIT J CLIN PSYCHOL, V23, P109, DOI 10.1111/j.2044-8260.1984.tb00634.x; Bohne A, 2005, J CLIN EXP NEUROPSYC, V27, P385, DOI 10.1080/13803390490520418; Buhlmann U, 2006, PSYCHIAT RES, V144, P109, DOI 10.1016/j.psychres.2005.10.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Deckersbach T, 2000, J CLIN EXP NEUROPSYC, V22, P640, DOI 10.1076/1380-3395(200010)22:5;1-9;FT640; Deckersbach T, 2004, PSYCHOL MED, V34, P823, DOI 10.1017/S0033291703001685; Dinn AA, 2012, NOROPSIKIYATRI ARS, V49, P145, DOI 10.4274/npa.y6306; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Folbrecht JR, 1999, CLIN NEUROPSYCHOL, V13, P442, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT442; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Hamby S. L., 1993, PSYCHOL ASSESSMENT, V5, P27, DOI 10.1037/1040-3590.5.1.27; Hartl TL, 2004, DEPRESS ANXIETY, V20, P59, DOI 10.1002/da.20010; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; Kaplan E., 2003, HDB REY OSTERRIETH C, P45; Kaplan E., 2003, HDB REY OSTERRIETH C, P57; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kisser JE, 2012, ARCH CLIN NEUROPSYCH, V27, P749, DOI 10.1093/arclin/acs082; Kuelz AK, 2006, J CLIN EXP NEUROPSYC, V28, P1273, DOI 10.1080/13803390500507246; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lindner SE, 2013, EUR EAT DISORD REV, V21, P115, DOI 10.1002/erv.2213; Lopez C, 2008, INT J EAT DISORDER, V41, P143, DOI 10.1002/eat.20478; Massman, 1992, NEUROPSYCHOLOGY, V6, P43, DOI [10.1037/0894-4105.6.1.43, DOI 10.1037/0894-4105.6.1.43]; Mataix-Cols D, 2003, J CLIN EXP NEUROPSYC, V25, P842, DOI 10.1076/jcen.25.6.842.16470; Meyers JE., 1995, REY COMPLEX FIGURE T; Mitrushina M., 2009, NEUROPSYCHOLOGICAL A, P101; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moritz S, 2005, J CLIN EXP NEUROPSYC, V27, P795, DOI 10.1080/13803390490918480; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Penades R, 2005, PSYCHIAT RES, V133, P81, DOI 10.1016/j.psychres.2004.09.005; Poreh, 2006, QUANTIFIED PROCESS A, P283; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Savage CR, 2000, NEUROPSYCHOLOGY, V14, P141, DOI 10.1037/0894-4105.14.1.141; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Segalas C, 2011, DEPRESS ANXIETY, V28, P932, DOI 10.1002/da.20836; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Sherman BJ, 2006, INT J EAT DISORDER, V39, P468, DOI 10.1002/eat.20300; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Smith SR, 2007, J NEUROPSYCHOL, V1, P39, DOI 10.1348/174866407X180800; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spencer RJ, 2009, J CLIN EXP NEUROPSYC, V31, P373, DOI 10.1080/13803390802206398; Stern R., 1999, BOSTON QUALITATIVE S; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Troyer AK, 1997, CLIN NEUROPSYCHOL, V11, P381, DOI 10.1080/13854049708400467; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Zachary, 2000, SHIPLEY I LIVING SCA	52	0	0	6	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	DEC	2021	128	6					2561	2581	00315125211039380	10.1177/00315125211039380		AUG 2021	21	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	XM3MI	WOS:000684884600001	34396818				2022-02-06	
J	Anzalone, C; Bridges, RM; Luedke, JC; Decker, SL				Anzalone, Christopher; Bridges, Rachel M.; Luedke, Jessica C.; Decker, Scott L.			Neurocognitive correlates of persisting concussion symptoms in youth	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Cognitive testing; concussion; mild traumatic brain injury; neurocognitive testing; persistent post-concussion syndrome; persisting symptoms after concussion; post-concussion syndrome	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; PROCESSING SPEED; HEAD TRAUMA; MILD; EPIDEMIOLOGY; MANAGEMENT	Many patients that experience a concussion have impairing symptoms that persist beyond typical recovery timeframes. Concussion symptoms often remit within a month, but persisting impairments are difficult to characterize and attribute to concussion given the poorly defined diagnostic criteria of post-concussion syndrome and inadequate understanding of the cognitive symptoms associated with this condition. The current study aims to clarify the cognitive profiles of school-aged concussion patients (n = 21; N = 36; 64% male) that have persisting symptoms to improve the clinical identification methods for this condition. Logistic regression was used to explore the importance of cognitive processing speed and working memory for identifying patients with persisting concussion symptoms (PCS). Additional exploratory analyses were conducted to clarify cognitive domains that may be impacted by having PCS. Findings indicate processing speed and working memory abilities alone are not adequate to identify patients with PCS. Further, measures of processing speed, fluid reasoning, working memory, and long-term retrieval together were found to be necessary to identify those who had a prior concussion with PCS. These findings indicate clinical neuropsychological batteries must include measures of these four cognitive domains when assessing school-aged patients with chronic symptoms that extend beyond three months following injury.	[Anzalone, Christopher; Bridges, Rachel M.; Luedke, Jessica C.; Decker, Scott L.] Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA		Anzalone, C (corresponding author), Barnwell Coll, 1512 Pendleton St,Suite 220, Columbia, SC 29208 USA.	anzalonc@email.sc.edu					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baum GL, 2020, P NATL ACAD SCI USA, V117, P771, DOI 10.1073/pnas.1912034117; Blumenfeld H, 2010, NEUROANATOMY THROUGH CLINICAL CASES, SECOND EDITION, P1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chung S, 2019, AM J NEURORADIOL, V40, P1438, DOI 10.3174/ajnr.A6146; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Ferraracci J, 2021, APPL NEUROPSYCH-CHIL, V10, P247, DOI 10.1080/21622965.2019.1675523; Flanagan D., 2007, ESSENTIALS CROSS BAT, V2nd, P146; Frenette LC, 2019, BRAIN INJURY, V33, P189, DOI 10.1080/02699052.2018.1542506; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kirelik SB, 2016, J EMERG MED, V50, P320, DOI 10.1016/j.jemermed.2015.02.054; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Masterson CJ, 2019, J CLIN EXP NEUROPSYC, V41, P925, DOI 10.1080/13803395.2019.1641184; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister-Deitrick J, 2020, AM J SPORT MED, V48, P991, DOI 10.1177/0363546520902701; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Nelson CA, 2000, DEVELOPMENTAL SCI, V3, P115, DOI 10.1111/1467-7687.00104; Ngwenya LB, 2018, BRAIN INJURY, V32, P1071, DOI 10.1080/02699052.2018.1481527; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sarkar S.K., 2010, AUST J BASIC APPL SC, V6, P5813; Schrank F. A., 2018, WOODCOCK JOHNSON 4 T; Schrank F.A, 2014, WOODCOCK JOHNSON 4 T; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zakzanis KK, 2017, APPL NEUROPSYCH-ADUL, V24, P559, DOI 10.1080/23279095.2016.1225216	44	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1961260		AUG 2021	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UA2UE	WOS:000685018300001	34392768				2022-02-06	
J	Fischer, NJ				Fischer, Nicholas J.			Mortality following severe liver trauma is declining at Auckland City Hospital: a 14-year experience, 2006-2020	NEW ZEALAND MEDICAL JOURNAL			English	Article							MANAGEMENT	INTRODUCTION: Liver injuries sustained in blunt and penetrating abdominal trauma may cause serious patient morbidity and even mortality. AIM: To review the recent experience of liver trauma at Auckland City Hospital, describing the mechanism of injury, patient management, outcomes and complications. METHODS: A retrospective cohort study was performed, including all patients admitted to Auckland City Hospital with liver trauma identified from the trauma registry. Patient clinical records and radiology were systematically examined. RESULTS: Between 2006-2020, 450 patients were admitted with liver trauma, of whom 92 patients (20%) were transferred from other hospitals. Blunt injury mechanisms, most commonly motor-vehicle crashes, predominated (87%). Stabbings were the most common penetrating mechanism. Over half of liver injuries were low risk American Association for the Surgery of Trauma (AAST) grade I and II (56%), whereas 20% were severe grade IV and V. Non-operative management was undertaken in 72% of patients with blunt liver trauma and 92% of patients with penetrating liver trauma underwent surgery. Liver complications occurred in 11% of patients, most commonly bile leaks (7%), followed by delayed haemorrhage (2%). Thirty-two patients died (7%), with co-existing severe traumatic brain injury as the leading cause of death. There was a significant reduction in death from haemorrhage in patients with grade IV and V liver trauma between the first and second half of the study period (p=0.0091). CONCLUSION: Although the incidence and severity of liver trauma at Auckland City Hospital remained stable, there was a reduction in mortality, particularly death as a result of haemorrhage.	[Fischer, Nicholas J.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand		Fischer, NJ (corresponding author), Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand.	NFischer@adhb.govt.nz		Fischer, Nicholas/0000-0001-9145-5702			Brooks A, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000551; Cole E, 2021, ANN SURG, V273, P1215, DOI 10.1097/SLA.0000000000003657; Feliciano D, TRAUMA, P2021; Hommes M, 2015, INJURY, V46, P837, DOI 10.1016/j.injury.2014.11.019; Kozar RA, 2018, J TRAUMA ACUTE CARE, V85, P1119, DOI 10.1097/TA.0000000000002058; Matthes G, 2003, WORLD J SURG, V27, P1124, DOI 10.1007/s00268-003-6981-0; Richardson JD, 2000, ANN SURG, V232, P324, DOI 10.1097/00000658-200009000-00004; Suen K, 2016, ANZ J SURG, V86, P894, DOI 10.1111/ans.13248; Tarchouli M, 2018, HEPATOB PANCREAT DIS, V17, P39, DOI 10.1016/j.hbpd.2018.01.013	9	0	0	0	0	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	AUG 13	2021	134	1540					16	24					9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UB0KI	WOS:000685541600003	34482385				2022-02-06	
J	Popp, KH; Groner, JB; Stalla, GK				Popp, Kathrin H.; Groener, Jan B.; Stalla, Gunter K.			Pituitary gland and contact sports	GYNAKOLOGISCHE ENDOKRINOLOGIE			German	Article						Athletes; Head collisions; Traumatic brain injuries; Pituitary insufficiency; Hormone replacement therapy	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; REPLACEMENT THERAPY; BODY-COMPOSITION; AMATEUR BOXERS; DYSFUNCTION; CONCUSSION; INSUFFICIENCY; PREVALENCE	Sports-related traumatic brain injuries frequently occur and often remain underdiagnosed. They affect both professional and recreational athletes. Sports-related pituitary injuries increase morbidity, decrease the quality of life and in severe cases complete pituitary deficiency can lead to increased mortality if left undiagnosed and untreated. Mild sports-related traumatic brain injuries can also sometimes lead to a temporary pituitary insufficiency due to shear forces and other factors. After trauma the somatotropic and gonadotropic pituitary axes most frequently fail. Symptoms such as chronic fatigue (fatigue syndrome), decreased drive, depressed mood, physical exhaustion, unclear anemia, loss of libido, erectile dysfunction, fever of unclear etiology, weight loss or cognitive deficits can be indications of hypopituitarism. The diagnosis is made by basal hormonal analysis and dynamic endocrinological function testing in the chronic phase after trauma. Treatment is performed by hormone replacement. The aim should be to achieve values within the average normal range for the patient's age.	[Popp, Kathrin H.; Groener, Jan B.; Stalla, Gunter K.] MEDICOVER Munchen, Neuroendokrinol, Orleanspl 3, D-81667 Munich, Germany; [Popp, Kathrin H.] Univ Klin Ulm, Med Klin Innere Med 1, Ulm, Germany; [Stalla, Gunter K.] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 4, Munich, Germany		Popp, KH (corresponding author), MEDICOVER Munchen, Neuroendokrinol, Orleanspl 3, D-81667 Munich, Germany.	Kathrin.Popp@medicover.de					Auer M, 2013, DEUT MED WOCHENSCHR, V138, P831, DOI 10.1055/s-0033-1343099; Bennett LL, 2019, PHYSICIAN SPORTSMED, V47, P295, DOI 10.1080/00913847.2018.1552481; Diederich S., 2020, REFERENZ ENDOKRINOLO, V1; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gotherstrom G, 2001, J CLIN ENDOCR METAB, V86, P4657, DOI 10.1210/jc.86.10.4657; Hacioglu A, 2019, PITUITARY, V22, P322, DOI 10.1007/s11102-019-00937-z; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P3335, DOI 10.1210/jc.80.11.3335; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Krewer C, 2016, J NEUROTRAUM, V33, P1544, DOI 10.1089/neu.2015.4109; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; Lithgow K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0247-1; Mossberg KA, 2008, J CLIN ENDOCR METAB, V93, P2581, DOI 10.1210/jc.2008-0368; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Cenci MCP, 2009, PITUITARY, V12, P322, DOI 10.1007/s11102-009-0182-2; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, OBES METAB-MILAN, V4, P118; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	26	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1610-2894	1610-2908		GYNAKOL ENDOKRINOL	Gynakol. Endokrinol.	SEP	2021	19	3					196	204		10.1007/s10304-021-00397-4		AUG 2021	9	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	UJ0DH	WOS:000684750600002					2022-02-06	
J	Ramos-Languren, LE; Avila-Luna, A; Garcia-Diaz, G; Rodriguez-Labrada, R; Vazquez-Mojena, Y; Parra-Cid, C; Montes, S; Bueno-Nava, A; Gonzalez-Pina, R				Ramos-Languren, Laura E.; Avila-Luna, Alberto; Garcia-Diaz, Gabriela; Rodriguez-Labrada, Roberto; Vazquez-Mojena, Yaimee; Parra-Cid, Carmen; Montes, Sergio; Bueno-Nava, Antonio; Gonzalez-Pina, Rigoberto			Glutamate, Glutamine, GABA and Oxidative Products in the Pons Following Cortical Injury and Their Role in Motor Functional Recovery	NEUROCHEMICAL RESEARCH			English	Article						Brain injury; Pons; Cerebellum; Lipid peroxidation; Rats	TRAUMATIC BRAIN-INJURY; SPONTANEOUSLY HYPERTENSIVE-RATS; LIPID-PEROXIDATION; ISCHEMIC-STROKE; CORTEX; NOREPINEPHRINE; IRON; GLUTATHIONE; AMPHETAMINE; CONTUSION	Brain injury leads to an excitatory phase followed by an inhibitory phase in the brain. The clinical sequelae caused by cerebral injury seem to be a response to remote functional inhibition of cerebral nuclei located far from the motor cortex but anatomically related to the injury site. It appears that such functional inhibition is mediated by an increase in lipid peroxidation (LP). To test this hypothesis, we report data from 80 rats that were allocated to the following groups: the sham group (n = 40), in which rats received an intracortical infusion of artificial cerebrospinal fluid (CSF); the injury group (n = 20), in which rats received CSF containing ferrous chloride (FeCl2, 50 mM); and the recovery group (n = 20), in which rats were injured and allowed to recover. Beam-walking, sensorimotor and spontaneous motor activity tests were performed to evaluate motor performance after injury. Lipid fluorescent products (LFPs) were measured in the pons. The total pontine contents of glutamate (GLU), glutamine (GLN) and gamma-aminobutyric acid (GABA) were also measured. In injured rats, the motor deficits, LFPs and total GABA and GLN contents in the pons were increased, while the GLU level was decreased. In contrast, in recovering rats, none of the studied variables were significantly different from those in sham rats. Thus, motor impairment after cortical injury seems to be mediated by an inhibitory pontine response, and functional recovery may result from a pontine restoration of the GLN-GLU-GABA cycle, while LP may be a primary mechanism leading to remote pontine inhibition after cortical injury.	[Gonzalez-Pina, Rigoberto] Natl Geriatr Inst, Lab Aging Biol, Av Contreras 428, Mexico City 10200, DF, Mexico; [Ramos-Languren, Laura E.] Univ Nacl Autonoma Mexico, Fac Psychol Coordinat Psychobiol & Neurosci, Fac Psychol, Av Univ 3040, Mexico City 04510, DF, Mexico; [Avila-Luna, Alberto; Parra-Cid, Carmen; Bueno-Nava, Antonio] Natl Inst Rehabil LGII, Calz Mexico Xochimilco 289, Mexico City 14389, DF, Mexico; [Garcia-Diaz, Gabriela; Gonzalez-Pina, Rigoberto] IPN, Sect Postgrad Studies & Res, High Med Sch, Mexico City 11340, DF, Mexico; [Rodriguez-Labrada, Roberto] Univ Holguin, Sch Phys Culture, Ave XX Aniversario, Holguin 80100, Cuba; [Rodriguez-Labrada, Roberto; Vazquez-Mojena, Yaimee] Cuban Ctr Neurosci, Calle 190 Entre 25 & 27, Havana 11300, Cuba; [Montes, Sergio] Autonomous Univ Tamaulipas, Reynosa Aztlan Multidisciplinary Unit, Aztlan 88740, Tamaulipas, Mexico; [Gonzalez-Pina, Rigoberto] Univ Amer, Dept Special Educ, Mexico City Coll, Puebla 223, Mexico City 06700, DF, Mexico		Gonzalez-Pina, R (corresponding author), Natl Geriatr Inst, Lab Aging Biol, Av Contreras 428, Mexico City 10200, DF, Mexico.; Gonzalez-Pina, R (corresponding author), IPN, Sect Postgrad Studies & Res, High Med Sch, Mexico City 11340, DF, Mexico.; Gonzalez-Pina, R (corresponding author), Univ Amer, Dept Special Educ, Mexico City Coll, Puebla 223, Mexico City 06700, DF, Mexico.	higgo@prodigy.net.mx	Montes, Sergio/AAU-1004-2020	Montes, Sergio/0000-0002-0138-0784; Bueno-Nava, Antonio/0000-0003-0291-4554; Parra-Cid, Carmen/0000-0003-1251-4271	PAPIIT-UNAMPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IA203319]; National Council of Science and Technology CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [CB 2016-287614-M]	This work was supported by PAPIIT-UNAM (Grant: IA203319 to L.E. R.-L.) and the National Council of Science and Technology CONACYT (Grant: CB 2016-287614-M to R.G.-P. and A.B.-N.).	Ahmad SO, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e03047; Amores-Sanchez MI, 1999, MOL GENET METAB, V67, P100, DOI 10.1006/mgme.1999.2857; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; [Anonymous], 2001, DIARIO OFICIAL FEDER; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Biagini G, 1997, CLIN SCI, V93, P401, DOI 10.1042/cs0930401; Biagini G, 2008, J NEUROPATH EXP NEUR, V67, P687, DOI 10.1097/NEN.0b013e318181b8ae; BOYESON MG, 1992, BRAIN RES BULL, V29, P435, DOI 10.1016/0361-9230(92)90080-H; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; Bueno-Nava A, 2008, NEUROSCI LETT, V443, P32, DOI 10.1016/j.neulet.2008.07.046; Bueno-Nava A, 2010, NEUROCHEM RES, V35, P1538, DOI 10.1007/s11064-010-0213-4; Cenni G, 2006, EUR J NEUROSCI, V24, P1633, DOI 10.1111/j.1460-9568.2006.05046.x; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Diaz-Ruiz A, 2007, NEUROCHEM RES, V32, P57, DOI 10.1007/s11064-006-9225-5; dos Santos PS, 2011, EUR J PHARMACOL, V668, P65, DOI 10.1016/j.ejphar.2011.06.035; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Festing MFW, 2018, LAB ANIM-UK, V52, P341, DOI 10.1177/0023677217738268; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gaschler MM, 2017, BIOCHEM BIOPH RES CO, V482, P419, DOI 10.1016/j.bbrc.2016.10.086; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; Goldstein LB, 2000, NEUROPHARMACOLOGY, V39, P852, DOI 10.1016/S0028-3908(99)00249-X; Gonzalez-Pina R, 2006, NEUROCHEM RES, V31, P1443, DOI 10.1007/s11064-006-9196-6; GonzalezPina R, 1997, NEUROCHEM RES, V22, P63, DOI 10.1023/A:1027329405112; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Halliwell B, 1997, J NEUROCHEM, V69, P1330; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kim JS, 2019, STROKE, V50, P2700, DOI 10.1161/STROKEAHA.119.025723; Kim Y, 2019, ARCH PHYS MED REHAB, V100, P1308, DOI 10.1016/j.apmr.2019.01.026; Kim Y, 2018, J STROKE CEREBROVASC, V27, P2445, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.039; Kim YK, 2014, NEUROREHAB NEURAL RE, V28, P576, DOI 10.1177/1545968313520411; KROBERT KA, 1994, J NEUROCHEM, V62, P2233; LAI YY, 1993, J COMP NEUROL, V336, P321, DOI 10.1002/cne.903360302; Liu WC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1396-5; Maharaj DS, 2003, LIFE SCI, V72, P1367, DOI 10.1016/S0024-3205(02)02405-0; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mc William, 1993, CANADIAN COUNCIL ANI, V1, P211; Montes S, 2003, NEUROCHEM RES, V28, P911, DOI 10.1023/A:1023279527545; MURAKAMI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1459, DOI 10.1271/bbb.59.1459; Niimura K, 1999, NEUROLOGY, V52, P792, DOI 10.1212/WNL.52.4.792; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; PETITO CK, 1992, BRAIN RES, V569, P275, DOI 10.1016/0006-8993(92)90639-Q; Petrova J, 2016, INT J STROKE, V11, pNP16, DOI 10.1177/1747493015607509; RAFALOWSKA U, 1989, FREE RADICAL BIO MED, V6, P485, DOI 10.1016/0891-5849(89)90041-5; Rahman AA, 2021, TRANSL STROKE RES, V12, P1, DOI 10.1007/s12975-020-00841-w; Ramos-Languren LE, 2016, BEHAV BRAIN RES, V297, P297, DOI 10.1016/j.bbr.2015.10.009; SANTAMARIA A, 1993, NEUROSCI LETT, V159, P51, DOI 10.1016/0304-3940(93)90796-N; Serteser M, 2001, ACTA NEUROL SCAND, V103, P43, DOI 10.1034/j.1600-0404.2001.00142.x; She X, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00776; Suzuki H, 2015, TRANSL STROKE RES, V6, P1, DOI 10.1007/s12975-014-0380-8; Tejada S, 2007, BRAIN RES BULL, V71, P372, DOI 10.1016/j.brainresbull.2006.10.005; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; TRIGGS WJ, 1984, J NEUROCHEM, V42, P976, DOI 10.1111/j.1471-4159.1984.tb12699.x; Urrutia PJ, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010061; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Walls AB, 2015, NEUROCHEM RES, V40, P402, DOI 10.1007/s11064-014-1473-1; Watson C., 1982, RAT BRAIN STEREOTAXI, P13, DOI 10.1016/B978-0-12-547620-1.50010-2; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yang S, 2018, MED SCI MONITOR, V24, P3804, DOI 10.12659/MSM.907734; Yasen AL, 2018, J NEUROPHYSIOL, V120, P1318, DOI 10.1152/jn.00896.2017; Zhang DN, 2019, NEUROTOX RES, V35, P360, DOI 10.1007/s12640-018-9961-8; Zhang YF, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.615372; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	78	0	0	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2021	46	12					3179	3189		10.1007/s11064-021-03417-8		AUG 2021	11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WK0CQ	WOS:000684749600001	34387812				2022-02-06	
J	Stukaneva, ME; Pushchina, EV				Stukaneva, M. E.; Pushchina, E., V			Constitutive Neurogenesis in the Brain of Different Vertebrate Groups	NEUROPHYSIOLOGY			English	Article						constitutive neurogenesis; neuronal stem cells; evolution; vertebrates; mammals; cerebral trauma; neurodegeneration	HIPPOCAMPAL CELL-PROLIFERATION; MAJOR DEPRESSIVE DISORDER; NEURAL STEM-CELLS; ADULT NEUROGENESIS; NEURONAL REGENERATION; DENTATE GYRUS; SOCIAL-ENVIRONMENT; STRUCTURAL-CHANGES; ZEBRAFISH BRAIN; SPATIAL MEMORY	This review discusses the similarities and differences in the processes of constitutive ("adult") neurogenesis, which have arisen in the course of evolution in higher and lower vertebrates. The data on the features of the regenerative potential in various animal species manifested under conditions of damage to the CNS and the possibilities for restoration due to the regeneration capabilities are analyzed. The influence of a number of factors on the formation of newly created neurons in the adult brain, namely of the effects of different stresses and nutritional status, those of physical exercise, socio-sexual interactions, size of the brain, and aging process, are described. The influence of CNS damage on the processes of neurogenesis at the cellular and molecular levels is discussed in detail. Activation of the potential of structural plasticity of the CNS may open up new opportunities for the development of therapeutic approaches for the treatment of neurodegenerative (in particular age-related) diseases and consequences of the traumatic brain injuries. Mechanisms of regulation of the development of neuronal stem cells, characteristics of the neurogenic zones, processes of migration of newly formed neurons, and their integration into the existing neural networks in the adult brain are analyzed. Special attention is paid to the contradictions in recent publications in the most authoritative scientific journals, which initiated a large number of discussions on whether constitutive neurogenesis does occur in the CNS structures (first of all, in the hippocampus) of adult humans.	[Stukaneva, M. E.; Pushchina, E., V] Russian Acad Sci NSCMB FEB RAS, Zhirmunsky Natl Sci Ctr Marine Biol, Far Eastern Branch, Vladivostok, Russia; [Pushchina, E., V] Natl Acad Sci Ukraine, Bogomolets Inst Physiol, Kiev, Ukraine		Stukaneva, ME (corresponding author), Russian Acad Sci NSCMB FEB RAS, Zhirmunsky Natl Sci Ctr Marine Biol, Far Eastern Branch, Vladivostok, Russia.	stykanyova@mail.ru; puschina@mail.ru					Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Akbari EM, 2007, BEHAV NEUROSCI, V121, P1001, DOI 10.1037/0735-7044.121.5.1001; Albright JE, 2016, NEUROSCI LETT, V615, P50, DOI 10.1016/j.neulet.2016.01.019; Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; Amrein I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000455; Amrein I, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00085; Amrein I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021295; Anderson ML, 2012, NEUROSCIENCE, V224, P202, DOI 10.1016/j.neuroscience.2012.08.018; Arnold SE, 1996, J COMP NEUROL, V367, P274, DOI 10.1002/(SICI)1096-9861(19960401)367:2<274::AID-CNE9>3.0.CO;2-2; Bartkowska K, 2008, EUR J NEUROSCI, V27, P1710, DOI 10.1111/j.1460-9568.2008.06133.x; Bastien-Dionne PO, 2010, J COMP NEUROL, V518, P1847, DOI 10.1002/cne.22307; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bedos M, 2018, FRONT NEUROENDOCRIN, V51, P68, DOI 10.1016/j.yfrne.2018.02.004; Benitez-Santana T, 2017, DEV NEUROBIOL, V77, P26, DOI 10.1002/dneu.22406; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Brus M, 2013, J COMP NEUROL, V521, P169, DOI 10.1002/cne.23169; Burger DK, 2013, BEHAV BRAIN RES, V236, P131, DOI 10.1016/j.bbr.2012.08.044; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Cattan A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/126078; Cavegn N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00059; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Cipriani S, 2018, CEREB CORTEX, V28, P2458, DOI 10.1093/cercor/bhy096; Cobb JA, 2013, J PSYCHIATR RES, V47, P299, DOI 10.1016/j.jpsychires.2012.10.020; Cope EC, 2019, CELL STEM CELL, V24, P690, DOI 10.1016/j.stem.2019.03.023; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Dalla C, 2008, NEUROPSYCHOPHARMACOL, V33, P1559, DOI 10.1038/sj.npp.1301533; De Miguel Z, 2019, MOL PSYCHIATR, V24, P1178, DOI 10.1038/s41380-017-0013-1; Dennis CV, 2016, NEUROPATH APPL NEURO, V42, P621, DOI 10.1111/nan.12337; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Edelmann K, 2013, J COMP NEUROL, V521, P3099, DOI 10.1002/cne.23347; Epp JR, 2009, HIPPOCAMPUS, V19, P1040, DOI 10.1002/hipo.20546; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fan XL, 2017, ANNU REV NEUROSCI, V40, P251, DOI 10.1146/annurev-neuro-072116-031357; Fares J, 2019, INT J NEUROSCI, V129, P598, DOI 10.1080/00207454.2018.1545771; Feliciano DM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018846; Fowler CD, 2002, J NEUROBIOL, V51, P115, DOI 10.1002/neu.10042; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Ganz J, 2012, J COMP NEUROL, V520, P633, DOI 10.1002/cne.22757; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Ghosh S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5815439; Gonzalez-Granero S, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P169, DOI 10.1007/978-4-431-53933-9_6; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Harris L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9745315; Hauser T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-43; Hazlerigg DG, 2013, CHRONOBIOL INT, V30, P548, DOI 10.3109/07420528.2012.754450; Holschbach MA, 2017, PSYCHONEUROENDOCRINO, V76, P97, DOI 10.1016/j.psyneuen.2016.10.023; Hoshaw BA, 2006, BEHAV BRAIN RES, V175, P343, DOI 10.1016/j.bbr.2006.09.004; Huang YS, 2013, BIOL PSYCHIAT, V74, P62, DOI 10.1016/j.biopsych.2013.01.005; Cuartero MI, 2019, J CLIN INVEST, V129, P1536, DOI 10.1172/JCI120412; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; Jonasson LS, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00336; Kempermann G., 2011, ADULT NEUROGENSIS ST; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kempermann G, 2018, CELL STEM CELL, V23, P25, DOI 10.1016/j.stem.2018.04.004; Kirste I, 2015, BRAIN STRUCT FUNCT, V220, P1221, DOI 10.1007/s00429-013-0679-3; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kiuchi T, 2012, NEUROSCIENCE, V207, P208, DOI 10.1016/j.neuroscience.2012.01.023; Klaus F, 2012, BEHAV BRAIN RES, V227, P363, DOI 10.1016/j.bbr.2011.04.027; Kleemeyer MM, 2016, NEUROIMAGE, V131, P155, DOI 10.1016/j.neuroimage.2015.11.026; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kumar Ashutosh, 2019, Innov Clin Neurosci, V16, P30; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; LaDage LD, 2011, P ROY SOC B-BIOL SCI, V278, P138, DOI 10.1098/rspb.2010.0861; Lau BWM, 2011, CELL TRANSPLANT, V20, P21, DOI 10.3727/096368910X532765; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lindsey BW, 2014, DEV NEUROBIOL, V74, P1053, DOI 10.1002/dneu.22183; Lipp HP, 2016, BRAIN BEHAV EVOLUT, V87, P205, DOI 10.1159/000446905; Llorens-Martin Maria, 2018, Brain Plast, V4, P111, DOI 10.3233/BPL-180065; Loureiro M, 2008, ZOOTAXA, P1; Lucassen PJ, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021303; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Margotta Vito, 2005, Italian Journal of Anatomy and Embryology, V110, P59; Maruska KP, 2011, ENDOCRINOLOGY, V152, P281, DOI 10.1210/en.2010-0875; Mathews KJ, 2017, AGING CELL, V16, P1195, DOI 10.1111/acel.12641; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mooney SJ, 2014, SOC NEUROSCI-UK, V9, P108, DOI 10.1080/17470919.2014.882862; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Morrison BE, 2016, NEURAL REGEN RES, V11, P878, DOI 10.4103/1673-5374.184449; Ngwenya LB, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00102; Olivera-Pasilio V, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00437; Oppenheim RW, 2019, DEV NEUROBIOL, V79, P268, DOI 10.1002/dneu.22674; Paredes MF, 2016, J COMP NEUROL, V524, P646, DOI 10.1002/cne.23896; Patzke N, 2015, BRAIN STRUCT FUNCT, V220, P361, DOI 10.1007/s00429-013-0660-1; Pekcec A, 2008, AGING CELL, V7, P368, DOI 10.1111/j.1474-9726.2008.00392.x; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pravosudov VV, 2005, J NEUROBIOL, V62, P31, DOI 10.1002/neu.20065; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Raucci F, 2006, J CHEM NEUROANAT, V32, P127, DOI 10.1016/j.jchemneu.2006.08.001; Schaefers ATU, 2013, NEUROSCIENCE, V228, P120, DOI 10.1016/j.neuroscience.2012.10.020; Sergeev, 2016, VESTN SOB MOL UCH SP, V4, P110; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Shimazaki Takuya, 2016, Keio Journal of Medicine, V65, P1, DOI 10.2302/kjm.2015-0005-IR; Shors TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18960; Snyder JS, 2019, TRENDS NEUROSCI, V42, P164, DOI 10.1016/j.tins.2018.12.001; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Staffend NA, 2014, DEV NEUROBIOL, V74, P633, DOI 10.1002/dneu.22160; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Swanson MEV, 2017, J ANIM SCI, V95, P4381, DOI 10.2527/jas2017.1710; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Thiele J, 2005, ANIM BEHAV, V69, P315, DOI 10.1016/j.anbehav.2004.05.012; Tozzini ET, 2012, AGING CELL, V11, P241, DOI 10.1111/j.1474-9726.2011.00781.x; Traniello IM, 2014, DEV NEUROBIOL, V74, P514, DOI 10.1002/dneu.22145; Trinchero MF, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01000; Wiget F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00719; Zupanc GKH, 2006, REGEN MED, V1, P207, DOI 10.2217/17460751.1.2.207; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	120	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-2977	1573-9007		NEUROPHYSIOLOGY+	Neurophysiology	NOV	2020	52	6					456	470		10.1007/s11062-021-09904-6		AUG 2021	15	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	UC7AC	WOS:000684756500001					2022-02-06	
J	Yeargin, SW; Lininger, MR; Coughlin, M; Hirschhorn, RM; Jurewicz, P; Moore, M; O'Connell, H; Mensch, J				Yeargin, Susan W.; Lininger, Monica R.; Coughlin, Margaret; Hirschhorn, Rebecca M.; Jurewicz, Patrick; Moore, Matthew; O'Connell, Hayley; Mensch, James			Improper Fit in American Youth Football Helmets Across One Competitive Season	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Athletic injuries; Head protective devices; Risk factors; Concussion; Pediatric; Tackle; Helmet; Football; Youth	HIGH-SCHOOL FOOTBALL; EMERGENCY-DEPARTMENT; CONCUSSION; SPORTS; INJURIES; IMPACT; EPIDEMIOLOGY; REDUCE	Improper helmet fit is related to sport-related concussion symptomology. The objective of this study was to determine the prevalence of improperly fit helmets in American youth tackle football players across one competitive season. Four recreation leagues including 147 players (45.2 +/- 14.7 cm, 147.5 +/- 9.0 kg), aged 7-12 years, participated in pre-season and post-season data collection timepoints. Participant and league demographics were collected at pre-season. Helmet fit was assessed at pre- and post-season using a 13-item checklist. A helmet was defined as improperly fit if failed to comply with or more of the checklist items. Most players (84%) rented helmets from the league. At preseason, 71.4% of helmets, and at post-season 79.6%, were improperly fit with no significant change over time (p = 0.14). Of the 105 improperly fit helmets at the start of the season, 61% were still considered improperly fit at post season. The 11-12 year old age group had significantly more improperly fit helmets than the 7-10 year old age group at post-season (p = 0.033), but not pre-season (p = 0.655). American youth football players depend on the league to fit their helmet. Most players did not meet at least one checklist criteria. Helmets improperly fit at preseason were still not fit at post.	[Yeargin, Susan W.; Coughlin, Margaret; Hirschhorn, Rebecca M.; Jurewicz, Patrick; Moore, Matthew; O'Connell, Hayley; Mensch, James] Univ South Carolina, Dept Exercise Sci, 921 Assembly St,Publ Hlth Res Ctr Rm 226, Columbia, SC 29208 USA; [Lininger, Monica R.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA		Yeargin, SW (corresponding author), Univ South Carolina, Dept Exercise Sci, 921 Assembly St,Publ Hlth Res Ctr Rm 226, Columbia, SC 29208 USA.	syeargin@mailbox.sc.edu	Hirschhorn, Rebecca/AAC-8952-2019	Hirschhorn, Rebecca/0000-0001-6305-7926			Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Baylor College of Medicine, 2010, AG BAS PED GROWTH RE; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Campolettano ET, 2020, ANN BIOMED ENG, V48, P1640, DOI 10.1007/s10439-020-02505-0; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Center for Disease Control, GET HEADS FOOTB HELM; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Erdtmann F, 2015, MIL MED, V180, P123, DOI 10.7205/MILMED-D-14-00516; Faure, 2015, APPL RES COACHING AT, V30, P56; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Holcomb KE., 2017, J ATHL TRAINING, V52, pS70; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Maerlender A, 2020, ANN BIOMED ENG, V48, P2691, DOI 10.1007/s10439-020-02625-7; Malina RM, 2007, J PEDIATR-US, V151, P378, DOI 10.1016/j.jpeds.2007.03.044; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McGuine T, 1997, AM SOC TEST MATER, V1305, P83, DOI 10.1520/STP11775S; NOCSAE, 2011, STAND PERF SPEC NEWL; Parkinson GW, 2003, PEDIATRICS, V112, P320, DOI 10.1542/peds.112.2.320; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Phillips N, 2020, ANN BIOMED ENG, V48, P2508, DOI 10.1007/s10439-020-02624-8; Riddell Inc, FOOTBA HELM FITT GUI; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Savino AK, 2020, ANN BIOMED ENG, V48, P2763, DOI 10.1007/s10439-020-02548-3; Swartz EE, 2007, J ATHL TRAINING, V42, P11; Williams R.M., 2014, ATHLETIC TRAINING SP, V6, P206, DOI [10.3928/19425864-20140916-05, DOI 10.3928/19425864-20140916-05]	39	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2924	2931		10.1007/s10439-021-02817-9		AUG 2021	8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000684770800001	34389900				2022-02-06	
J	Zakrzewska, AP; Placek, MM; Czosnyka, M; Kasprowicz, M; Lang, EW				Zakrzewska, Agnieszka P.; Placek, Michal M.; Czosnyka, Marek; Kasprowicz, Magdalena; Lang, Erhard W.			Intracranial pulse pressure waveform analysis using the higher harmonics centroid	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Intracranial pressure; Intracranial pressure pulse waveform; Plateau waves; ICP monitoring	SYSTEMS-ANALYSIS; PLATEAU WAVES; AMPLITUDE; ORIGIN; FLOW; ICP	Background The pulse waveform of intracranial pressure (ICP) is its distinctive feature almost always present in the clinical recordings. In most cases, it changes proportionally to rising ICP, and observation of these changes may be clinically useful. We introduce the higher harmonics centroid (HHC) which can be defined as the center of mass of harmonics of the ICP pulse waveform from the 2nd to 10th, where mass corresponds to amplitudes of these harmonics. We investigate the changes in HHC during ICP monitoring, including isolated episodes of ICP plateau waves. Material and methods Recordings from 325 patients treated between 2002 and 2010 were reviewed. Twenty-six patients with ICP plateau waves were identified. In the first step, the correlation between HHC and ICP was examined for the entire monitoring period. In the second step, the above relation was calculated separately for periods of elevated ICP during plateau wave and the baseline. Results For the values averaged over the whole monitoring period, ICP (22.3 +/- 6.9 mm Hg) correlates significantly (R = 0.45, p = 0.022) with HHC (3.64 +/- 0.46). During the ICP plateau waves (ICP increased from 20.9 +/- 6.0 to 53.7 +/- 9.7 mm Hg, p < 10(-16)), we found a significant decrease in HHC (from 3.65 +/- 0.48 to 3.21 +/- 0.33, p = 10(-5)). Conclusions The good correlation between HHC and ICP supports the clinical application of pressure waveform analysis in addition to the recording of ICP number only. Mean ICP may be distorted by a zero drift, but HHC remains immune to this error. Further research is required to test whether a decline in HHC with elevated ICP can be an early warning sign of intracranial hypertension, whether individual breakpoints of correlation between ICP and its centroid are of clinical importance.	[Zakrzewska, Agnieszka P.; Placek, Michal M.; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Placek, Michal M.; Kasprowicz, Magdalena] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland; [Lang, Erhard W.] Red Cross Hosp, Neurosurg Associates, Kassel, Germany; [Lang, Erhard W.] Georg August Univ, Dept Neurosurg, Fac Med, Gottingen, Germany; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Kasprowicz, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	magdalena.kasprowicz@pwr.edu.pl		Kasprowicz, Magdalena/0000-0002-2271-7737	National Science Centre, PolandNational Science Centre, Poland [UMO-019/35/B/ST7/00500]; NHRI, Cambridge Centre of Biomedical Research	MK is supported by the National Science Centre, Poland (grant no. UMO-019/35/B/ST7/00500).; MC is supported by NHRI, Cambridge Centre of Biomedical Research.	ADOLPH RJ, 1967, AM J PHYSIOL, V212, P840, DOI 10.1152/ajplegacy.1967.212.4.840; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Baledent O, 2006, J MAGN RESON IMAGING, V24, P995, DOI 10.1002/jmri.20722; Berdyga J., 1993, INTRACRANIAL PRESSUR, P372, DOI [10.1007/978-3-642-77789-9_80, DOI 10.1007/978-3-642-77789-9_80]; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; CHOPP M, 1980, J NEUROSURG, V53, P516, DOI 10.3171/jns.1980.53.4.0516; CHRISTEN L, 1989, Neurological Research, V11, P197; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; DUNBAR HS, 1966, ARCH NEUROL-CHICAGO, V14, P624, DOI 10.1001/archneur.1966.00470120056009; Fuentes J M, 1979, Anesth Analg (Paris), V36, P429; Germon K, 1988, J Neurosci Nurs, V20, P344; Grossman R, 1986, INTRACRANIAL PRESSUR, P260; Grossman R, 1989, INTRACRANIAL PRESSUR, P124; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; HIRAI O, 1984, SURG NEUROL, V21, P67, DOI 10.1016/0090-3019(84)90404-X; Kuhner A, 1976, INTRACRANIAL PRESSUR, P157; Lang EW, 2003, J NEUROSURG, V98, P214, DOI 10.3171/jns.2003.98.1.0214; LIN ES, 1991, BRIT J ANAESTH, V66, P476, DOI 10.1093/bja/66.4.476; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; NORNES H, 1977, ACTA NEUROCHIR, V38, P177, DOI 10.1007/BF01401089; PIPER IR, 1990, ACT NEUR S, V51, P387; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SULLIVAN HG, 1977, J NEUROSURG, V47, P532, DOI 10.3171/jns.1977.47.4.0532; TAKIZAWA H, 1987, NEUROSURGERY, V20, P355, DOI 10.1227/00006123-198703000-00001; Tsuncda S, 1980, INTRACRANIAL PRESSUR, P188; Unnerback M, 2018, ACTA NEUROCHIR, V160, P219, DOI 10.1007/s00701-017-3435-2; Varsos GV, 2013, NEUROCRIT CARE, V18, P341, DOI 10.1007/s12028-013-9830-5; Zou R, 2008, J NEUROS-PEDIATR, V2, P83, DOI 10.3171/PED/2008/2/7/083	38	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2021	163	12					3249	3258		10.1007/s00701-021-04958-1		AUG 2021	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WZ7WX	WOS:000684796200001	34387744	Green Published, hybrid			2022-02-06	
J	Arango, JI; George, L; Griswold, DP; Johnson, ED; Suarez, MN; Caquimbo, LD; Molano, M; Echeverri, RA; Rubiano, AM; Adelson, PD				Arango, Jorge, I; George, Laeth; Griswold, Dylan P.; Johnson, Erica D.; Suarez, Maria N.; Caquimbo, Laura D.; Molano, Milton; Echeverri, Raul A.; Rubiano, Andres M.; Adelson, P. David			Severe Pediatric TBI Management in a Middle-Income Country and a High-Income Country: A Comparative Assessment of Two Centers	FRONTIERS IN SURGERY			English	Article						traumatic brain injury; pediatric neurosurgery; global health; TBI; pediatric	TRAUMATIC BRAIN-INJURY; OUTCOMES	Background: Traumatic brain injury (TBI) is a global public health issue with over 10 million deaths or hospitalizations each year. However, access to specialized care is dependent on institutional resources and public health policy. Phoenix Children's Hospital USA (PCH) and the Neiva University Hospital, Colombia (NUH) compared the management and outcomes of pediatric patients with severe TBI over 5 years to establish differences between outcomes of patients managed in countries of varying resources availability. Methods: We conducted a retrospective review of individuals between 0 and 17 years of age, with a diagnosis of severe TBI and admitted to PCH and NUH between 2010 and 2015. Data collected included Glasgow coma scores, intensive care unit monitoring, and Glasgow outcome scores. Pearson Chi-square, Fisher exact, T-test, or Wilcoxon-rank sum test was used to compare outcomes. Results: One hundred and one subjects met the inclusion criteria. NUH employed intracranial pressure monitoring less frequently than PCH (p = 0.000), but surgical decompression and subdural evacuation were higher at PCH (p = 0.031 and p = 0.003). Mortality rates were similar between the institutions (15% PCH, 17% NUH) as were functional outcomes (52% PCH, 54% NUH). Conclusions: Differences between centers included time to specialized care and utilization of monitoring. No significant differences were evidenced in survival and the overall functional outcomes.	[Arango, Jorge, I; Adelson, P. David] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Arango, Jorge, I; Adelson, P. David] Phoenix Childrens Hosp, Phoenix, AZ USA; [George, Laeth] Univ Arizona, Dept Neurosurg, Coll Med Phoenix, Phoenix, AZ USA; [Griswold, Dylan P.] Univ Cambridge, Dept Neurosurg, Cambridge, England; [Griswold, Dylan P.] Stanford Univ, Sch Med, Stanford, CA USA; [Johnson, Erica D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Suarez, Maria N.; Caquimbo, Laura D.; Molano, Milton] South Colombian Univ, Sch Med, Neiva, Colombia; [Molano, Milton; Echeverri, Raul A.; Rubiano, Andres M.] MEDITECH Fdn, Cali, Colombia; [Echeverri, Raul A.; Rubiano, Andres M.] Vallesalud Clin, Neurol Surg Serv, Cali, Colombia; [Echeverri, Raul A.; Rubiano, Andres M.] El Bosque Univ, INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia		Rubiano, AM (corresponding author), MEDITECH Fdn, Cali, Colombia.; Rubiano, AM (corresponding author), Vallesalud Clin, Neurol Surg Serv, Cali, Colombia.; Rubiano, AM (corresponding author), El Bosque Univ, INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia.	rubianoam@gmail.com	Griswold, Dylan/ABC-7890-2021	Griswold, Dylan/0000-0003-0291-8360	Gates Cambridge Trust [OPP1144]	DG was supported by the Gates Cambridge Trust OPP1144.	[Anonymous], 2018, BEST HOSP PEDIAT NEU; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; Correa MA, 2000, COLOMB MEDICA, V31, P77; Elsawaf Y, 2020, WORLD NEUROSURG, V138, P9, DOI 10.1016/j.wneu.2020.02.065; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Manfiotto M, 2019, WORLD NEUROSURG, V129, pE56, DOI 10.1016/j.wneu.2019.04.215; Murray C. J., 1996, GLOBAL HLTH STAT COM; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Santacruz LF, ABORDAJE INICIAL SER, P233; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tickell KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212395; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507	21	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	AUG 12	2021	8								670546	10.3389/fsurg.2021.670546			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TZ6JF	WOS:000684576300001	34458313	Green Published, gold			2022-02-06	
J	Elghazouani, F				Elghazouani, Fatima			Schizophrenia and Hyperostosis Frontalis Interna with History of Head Injury	CASE REPORTS IN MEDICINE			English	Article								Hyperostosis frontalis interna is an irregular thickening of the frontal bone. Its etiology is unknown. It has been rarely linked with schizophrenia and head injury. Case Presentation. We describe an unusual case of a 44-year-old female with schizophrenia and hyperostosis frontalis interna having a history of head trauma. At the age of 3 years, she had a head injury that could be classified as mild traumatic brain injury. She presents a family history of schizophrenia. She was admitted for resistant schizophrenic disorder. The cranial computed tomography showed bilateral and asymmetrical hyperostosis of the frontal bone that was more pronounced on the right side. This corresponds to the impact of the trauma with frontal atrophy without any metabolic or endocrinal abnormalities. Conclusion. We surmise that the long-term pathological effects of traumatic brain injury, including hyperostosis frontalis interna, are likely to interact with genetic vulnerability and may lead to schizophrenic disorder.	[Elghazouani, Fatima] Univ Mohammed First, Fac Med & Pharm, Dept Psychiat, Maternoinfant & Mental Hlth Res Lab, Oujda, Morocco		Elghazouani, F (corresponding author), Univ Mohammed First, Fac Med & Pharm, Dept Psychiat, Maternoinfant & Mental Hlth Res Lab, Oujda, Morocco.	fatima2elghazouani@gmail.com		Elghazouani, Fatima/0000-0001-5158-7022			Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Li Yaxiong, 2017, Child Neurol Open, V4, p2329048X17700556, DOI 10.1177/2329048X17700556; May H, 2012, AM J HUM BIOL, V24, P812, DOI 10.1002/ajhb.22325; MENDEZ MF, 1992, J AM GERIATR SOC, V40, P1095, DOI 10.1111/j.1532-5415.1992.tb01796.x; NOTKIN J, 1953, AM J PSYCHIAT, V109, P929, DOI 10.1176/ajp.109.12.929; Renner CIE, 2015, J CLIN MED, V4, P1815, DOI 10.3390/jcm4091815; Zhang WJ, 2015, AM J PSYCHIAT, V172, P995, DOI 10.1176/appi.ajp.2015.14091108	8	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.	AUG 12	2021	2021								6634640	10.1155/2021/6634640			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UD7WP	WOS:000687415500001	34422059	Green Published, gold			2022-02-06	
J	Embolo, FN; Bellamkonda, N; Dickson, D; Motwani, G; Mbeboh, SN; Mbiarikai, M; Oben, E; Oke, R; Dicker, RA; Juillard, C; Christie, SA; Chichom-Mefire, A				Embolo, Frida N.; Bellamkonda, Nikhil; Dickson, Drusia; Motwani, Girish; Mbeboh, Susan N.; Mbiarikai, Mbianyor; Oben, Eunice; Oke, Rasheedat; Dicker, Rochelle A.; Juillard, Catherine; Christie, S. Ariane; Chichom-Mefire, Alain			Epidemiology of traumatic brain injury based on clinical symptoms amongst inhabitants of the Southwest Region of Cameroon: a community-based study	BRAIN INJURY			English	Article						Traumatic brain injury; Cameroon; sub-Saharan Africa; TBI	GLOBAL SURGERY; IMPACT; HEALTH; CARE; LEGISLATION; COST	Background The majority of studies investigating the epidemiology of traumatic brain injury (TBI) in sub-Saharan Africa are primarily hospital-based, missing fatal, mild, and other cases of TBI that do not present to formal care settings. This study aims to bridge this gap in data by describing the epidemiology of TBI in the Southwest Region of Cameroon. Methods This was a cross-sectional community-based study. Using a three-stage cluster sampling, local research assistants surveyed households with a pre-tested questionnaire to identify individuals with symptoms of TBI in nine health districts in the Southwest Region of Cameroon from 2016 to 2017. Results Data gathered on 8,065 individuals revealed 78 cases of suspected TBI. Road traffic injury (RTI) comprised 55% of subjects' mechanism of injury. Formal medical care was sought by 82.1% of subjects; three subjects died at the time of injury. Following injury, 59% of subjects reported difficulty affording basic necessities and 87.2% of subjects were unable to perform activities of their primary occupation. Conclusions This study postulates an incidence of TBI in Southwest Cameroon of 975.57 per 100,000 individuals, significantly greater than prior findings. A large proportion of TBI is secondary to RTI.	[Embolo, Frida N.; Mbeboh, Susan N.; Oben, Eunice; Chichom-Mefire, Alain] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Embolo, Frida N.; Dickson, Drusia; Motwani, Girish; Mbiarikai, Mbianyor; Oben, Eunice; Christie, S. Ariane] Univ Calif San Francisco, Ctr Global Surg Studies, Dept Surg, San Francisco, CA 94143 USA; [Bellamkonda, Nikhil; Mbeboh, Susan N.; Oke, Rasheedat; Dicker, Rochelle A.; Juillard, Catherine] Univ Calif Los Angeles, Dept Surg, Program Adv Surg Equ, Los Angeles, CA 90095 USA		Juillard, C (corresponding author), MPH Univ Calif, Dept Gen Surg, 10833 Le Conte Ave,CHS 72-215, Los Angeles, CA 90095 USA.	cjuillard@mednet.ucla.edu			Association for Academic Surgery (AAS) Global Surgery Research Fellowship Award	S. Ariane Christie was supported by the Association for Academic Surgery (AAS) Global Surgery Research Fellowship Award.	Bachani AM, 2017, PUBLIC HEALTH, V144, pS23, DOI 10.1016/j.puhe.2016.12.005; Bishai D, 2008, INJURY PREV, V14, P223, DOI 10.1136/ip.2008.018341; Boniface Respicious, 2017, Pan Afr Med J, V26, P140, DOI 10.11604/pamj.2017.26.140.10345; Cannoodt L, 2012, INT J HEALTH PLAN M, V27, pe104, DOI 10.1002/hpm.1098; Centers for Disease Control and Prevention, 2019, SEX TRANSM DIS SURV, P1; Chichom-Mefire A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180784; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Christie SA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5171; CITI, 2017, RES ETH COMPL TRAIN; Demographiques I, STRUCT POP IND DEM; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; El-Ghandour NMF, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19804; Gupta S, 2017, WORLD NEUROSURG, V100, P267, DOI 10.1016/j.wneu.2016.12.104; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hode L, 2017, WORLD NEUROSURG, V99, P210, DOI 10.1016/j.wneu.2016.11.083; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, ASIA-PAC J PUBLIC HE, V19, P16, DOI 10.1177/10105395070190020401; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institut National de la Statistique-INS/Cameroun and ICF. International, 2012, ENQ DEM SANT IND MUL; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Juillard CJ, 2014, WORLD J SURG, V38, P2534, DOI 10.1007/s00268-014-2604-1; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; McGee Kara, 2004, Inj Control Saf Promot, V11, P303, DOI 10.1080/156609704/233/327505; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; Nadesan-Reddy N, 2013, SAMJ, S. Afr. med. j., V103, P621, DOI 10.7196/samj.7024; Ndoumbe A., 2018, OPEN J MODERN NEUROS, V08, P119, DOI [10.4236/ojmn.2018.81010, DOI 10.4236/OJMN.2018.81010]; Ogunkeyede OS, 2019, TRAFFIC INJ PREV, V20, pS174, DOI 10.1080/15389588.2019.1659584; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; StataCorp, 2014, STAT STAT SOFTW REL, DOI [10.2307/2234838, DOI 10.2307/2234838]; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Surgeons OverSeas, 2012, SURG OV ASS SURG NEE; The American Association for Public Opinion Research, 2016, 9 AM ASS PUBL OP RES, V9; The World Bank, OFF EXCH RAT LCU PER; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198	44	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1184	1191		10.1080/02699052.2021.1957150		AUG 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000684445400001	34383629				2022-02-06	
J	Gowrisankaran, S; Shah, AS; Roberts, TL; Wiecek, E; Chinn, RN; Hawash, KK; O'Brien, MJ; Howell, DR; Meehan, WP; Raghuram, A				Gowrisankaran, Sowjanya; Shah, Ankoor S.; Roberts, Tawna L.; Wiecek, Emily; Chinn, Ryan N.; Hawash, Karameh K.; O'Brien, Michael J.; Howell, David R.; Meehan, William P.; Raghuram, Aparna			Association between post-concussion symptoms and oculomotor deficits among adolescents	BRAIN INJURY			English	Article						Concussion; symptom surveys; vision; adolescent	TRAUMATIC BRAIN-INJURY; CONVERGENCE INSUFFICIENCY; VISUAL FUNCTION; RELIABILITY; VISION; SPECIFICITY; SENSITIVITY; DYSFUNCTION; IMPAIRMENT; FREQUENCY	Purpose To examine the association between Post-Concussion Symptom Scale (PCSS) scores, Convergence Insufficiency Symptom Survey (CISS) scores, and oculomotor deficits post-concussion. Methods Records of adolescent patients examined in a multidisciplinary concussion clinic between July 2014 and May 2019 were reviewed. PCSS and CISS scores, results of eye examination and oculomotor assessment, concussion history, and demographics were abstracted. Results One hundred and forty patient records (median age, 15.3 years; 52 males, presented 109 days (median) from their most recent concussion) met inclusion criteria. Mean total scores on PCSS and CISS were 46.67 +/- 25.89 and 27.13 +/- 13.22, respectively, and were moderately correlated with each other (r = 0.53, p < .001). Oculomotor deficits were observed in 123 (88%) patients. Step-wise linear regression identified increased PCSS total score to be significantly associated with decreased amplitude of accommodation (p < .001). Increased CISS total score was significantly associated with receded near point of convergence, developmental eye movement test error scores, and cause of concussion. Conclusion High PCSS scores may indicate an accommodation deficit and thus prompt an oculomotor assessment in patients following a concussion. Using the CISS and a detailed oculomotor assessment may reveal underlying oculomotor deficits, which may benefit from treatment.	[Gowrisankaran, Sowjanya; Shah, Ankoor S.; Wiecek, Emily; Chinn, Ryan N.; Raghuram, Aparna] Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA; [Shah, Ankoor S.] Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA USA; [Shah, Ankoor S.; Wiecek, Emily; Raghuram, Aparna] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Roberts, Tawna L.] Stanford Univ, Spencer Ctr Vis Res, Byers Eye Inst, Palo Alto, CA 94304 USA; [Hawash, Karameh K.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hawash, Karameh K.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [O'Brien, Michael J.; Meehan, William P.] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Dept Orthoped, Div Sports Med, Boston, MA 02115 USA; [O'Brien, Michael J.; Meehan, William P.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA 02115 USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado Denver, Dept Orthoped, Sch Med, Aurora, CO USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Raghuram, A (corresponding author), Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	aparna.raghuram@childrens.harvard.edu		Raghuram, Aparna/0000-0002-2913-6046; Howell, David/0000-0002-2955-0191	Children's Hospital Ophthalmology Foundation Award; American Academy of Optometry Career Starter Grant; Research to Prevent Blindness Award (Stanford University); National Eye Institute (Stanford University) National Eye Institute, National Institutes of Health, Department of Health and Human Services [P30-EY026877]	Children's Hospital Ophthalmology Foundation Award (AR); American Academy of Optometry Career Starter Grant (AR); Research to Prevent Blindness Award (Stanford University -TLR); and National Eye Institute P30-EY026877 (Stanford University-TLR) National Eye Institute, National Institutes of Health, Department of Health and Human Services	Atowa UC, 2019, OPHTHAL EPIDEMIOL, V26, P121, DOI 10.1080/09286586.2018.1532523; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Hussaindeen JR, 2017, CLIN EXP OPTOM, V100, P642, DOI 10.1111/cxo.12496; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDougal DH, 2015, COMPR PHYSIOL, V5, P439, DOI 10.1002/cphy.c140014; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Raghuram A, 2018, JAMA OPHTHALMOL, V136, P1089, DOI 10.1001/jamaophthalmol.2018.2797; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Rouse MW, 1998, OPTOMETRY VISION SCI, V75, P88, DOI 10.1097/00006324-199802000-00012; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Stevens R., 2020, CJSM; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Wajuihian Samuel Otabor, 2016, J Optom, V9, P246, DOI 10.1016/j.optom.2015.10.006	41	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1218	1228		10.1080/02699052.2021.1959065		AUG 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000684528600001	34383619				2022-02-06	
J	Malekahmadi, M; Shadnoush, M; Islam, SMS; Shirvani, A; Pahlavani, N; Navashenaq, JG; Firouzi, S; McVicar, J; Nematy, M; Zali, MR; Moghaddam, OM; Norouzy, A				Malekahmadi, Mahsa; Shadnoush, Mahdi; Islam, Sheikh Mohammed Shariful; Shirvani, Armin; Pahlavani, Naseh; Navashenaq, Jamshid Gholizadeh; Firouzi, Safieh; McVicar, Jenna; Nematy, Mohsen; Zali, Mohammad Reza; Moghaddam, Omid Moradi; Norouzy, Abdolreza			The effect of French maritime pine bark extract supplementation on inflammation, nutritional and clinical status in critically ill patients with traumatic brain injury: A randomized controlled trial	PHYTOTHERAPY RESEARCH			English	Article						critical care; French maritime pine bark extract; inflammation; nutrition support; Oligopin; traumatic brain injury	PROCYANIDIN-RICH EXTRACT; DOUBLE-BLIND; RISK-FACTORS; PYCNOGENOL(R); DISEASE; DYSFUNCTION; MANAGEMENT; PLASMA; SCORE	Inflammation plays an important role in the pathophysiology of traumatic brain injury (TBI). Based on the anti-inflammatory properties of French maritime pine bark extract and the neuroprotective effects, we aimed to evaluate the effects of its supplementation on TBI. Sixty-seven TBI patients admitted to the intensive care units (ICUs) were enrolled. After stabilizing the hemodynamic status, the intervention group received 150 mg of French maritime pine bark extract supplementation (Oligopin) with enteral nutrition for 10 days. The control group received a placebo. Inflammatory status and oxidative stress markers were measured three times. Also, clinical and nutritional statuses were assessed. Supplementation, significantly decreased IL-6 (beta = -53.43 pg/ml, 95% confidence interval [CI] = -91.74, -15.13, p = .006), IL-1 beta (beta = -111.66 pg/ml, 95% CI = -183.79, -39.5402, p = .002) and C-reactive protein (beta = -19.99 mg/L, 95% CI = -27.23, -12.76, p > .001) in the intervention group compared to control group after 10 days. Clinical scores including acute physiology and chronic health evaluation II and sequential organ failure assessment were reduced (beta = -3.72, 95% CI = -5.96, -1.49, p = .001and beta = -2.07, 95% CI = -3.23, -0.90, p < .001, respectively), and Nutric score was reduced compared to control group (beta = -.60, 95% CI = -1.08, -0.12, p = .01). The survival rate was higher by 15% in the intervention group compared to control group. Oligopin supplementation in TBI patients in ICU reduced inflammation and improved the clinical status and malnutrition score and thereby reducing the mortality rate.	[Malekahmadi, Mahsa; Firouzi, Safieh; Zali, Mohammad Reza] Univ Tehran Med Sci, Dept Clin Nutr, Imam Khomeini Hosp Complex, Tehran, Iran; [Malekahmadi, Mahsa; Nematy, Mohsen; Norouzy, Abdolreza] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad 0071151303, Razavi Khorasan, Iran; [Shadnoush, Mahdi] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Tehran, Iran; [Islam, Sheikh Mohammed Shariful; McVicar, Jenna] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr IPAN, Melbourne, Vic, Australia; [Shirvani, Armin] Shahid Beheshti Univ Med Sci, Virtual Sch Med Educ & Management, Tehran, Iran; [Pahlavani, Naseh] Torbat Heydariyeh Univ Med Sci, Hlth Sci Res Ctr, Torbat Heydariyeh, Iran; [Pahlavani, Naseh] Kurdistan Univ Med Sci, Cellular & Mol Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran; [Navashenaq, Jamshid Gholizadeh] Bam Univ Med Sci, Sch Med, Student Res Comm, Bam, Iran; [Moghaddam, Omid Moradi] Iran Univ Med Sci, Trauma & Injury Res Ctr, Crit Care Dept, Rasoul E Akram Complex Hosp, Tehran 1998619653, Iran		Norouzy, A (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad 0071151303, Razavi Khorasan, Iran.; Moghaddam, OM (corresponding author), Iran Univ Med Sci, Trauma & Injury Res Ctr, Crit Care Dept, Rasoul E Akram Complex Hosp, Tehran 1998619653, Iran.	ommcc@gmail.com; norouzya@mums.ac.ir	zali, mohammadreza/AAD-4452-2022; Pahlavani, Naseh/Y-5149-2019	Pahlavani, Naseh/0000-0001-7960-7267	Mashhad University of Medical Sciences; Trauma and Injury Research Center of Iran University of Medical Sciences	Thanks to the medical staff of the Rasoul-e-Akram Hospital of Iran University of Medical Sciences, especially Dr Mohammad Niyakanlahiji and Mrs Taraneh Rezaei for helping us to conduct this research project. This manuscript is based on a PhD dissertation. The trial is funded by the Mashhad University of Medical Sciences, and the Trauma and Injury Research Center of Iran University of Medical Sciences and was peer reviewed as part of the funding application process. These centers support all stages of study (the design of the study and collection, analysis, and interpretation of data and in writing the manuscript).	Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; Belcaro G, 2013, PHYTOTHER RES, V27, P1572, DOI 10.1002/ptr.4883; Belcaro G, 2008, REDOX REP, V13, P271, DOI 10.1179/135100008X309019; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cesarone MR, 2010, J CARDIOVASC PHARM T, V15, P41, DOI 10.1177/1074248409356063; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Drieling RL, 2010, ARCH INTERN MED, V170, P1541, DOI 10.1001/archinternmed.2010.310; Enseleit F, 2012, EUR HEART J, V33, P1589, DOI 10.1093/eurheartj/ehr482; Grimm Tanja, 2006, J Inflamm (Lond), V3, P1, DOI 10.1186/1476-9255-3-1; Gulati OP, 2015, PHYTOTHER RES, V29, P949, DOI 10.1002/ptr.5341; Hu S, 2015, INT ANGIOL, V34, P43; Kagan I, 2015, INTENS CARE MED, V41, P460, DOI 10.1007/s00134-015-3646-z; Khorana Jiraporn, 2009, Journal of the Medical Association of Thailand, V92, P188; Luzzi R, 2017, MINERVA GINECOL, V69, P29, DOI 10.23736/S0026-4784.16.03913-7; Malekahmadi M, 2020, TRIALS, V21, DOI 10.1186/s13063-019-4008-x; Malekahmadi M, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104472; Mazandarani PD, 2016, EMERGENCY, V4, P88; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Mukhopadhyay A, 2017, CLIN NUTR, V36, P1143, DOI 10.1016/j.clnu.2016.08.004; Norris CM, 2016, EXP NEUROL, V276, P5, DOI 10.1016/j.expneurol.2015.11.006; Ozoner B, 2019, NEUROSCI LETT, V704, P169, DOI 10.1016/j.neulet.2019.04.010; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Painter TJ, 2015, INT J SURG, V21, P70, DOI 10.1016/j.ijsu.2015.07.008; Pan JZ, 2020, ESSENTIALS OF NEUROSURGICAL ANESTHESIA & CRITICAL CARE: STRATEGIES FOR PREVENTION, EARLY DETECTION, AND SUCCESSFUL MANAGEMENT OF PERIOPERATIVE COMPLICATIONS, 2ND EDITION, P67, DOI 10.1007/978-3-030-17410-1_10; Petrassi C, 2000, PHYTOMEDICINE, V7, P383, DOI 10.1016/S0944-7113(00)80059-8; Rai VRH, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0369-4; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Safari S, 2016, TURK J EMERG MED, V16, P146, DOI 10.1016/j.tjem.2016.09.005; Schafer A, 2006, BIOMED PHARMACOTHER, V60, P5, DOI 10.1016/j.biopha.2005.08.006; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Sedighiyan M., 2018, Acta Medica Iranica, V56, P196; Stuard S, 2010, Panminerva Med, V52, P27; Valls RM, 2016, PHYTOMEDICINE, V23, P1451, DOI 10.1016/j.phymed.2016.08.007; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838	35	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	SEP	2021	35	9					5178	5188		10.1002/ptr.7187		AUG 2021	11	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UW4JT	WOS:000684161600001	34382717				2022-02-06	
J	Muzzi, D; Blaeser, AM; Niedecker, J; Gonzalez-Lomas, G				Muzzi, Don; Blaeser, Anna M.; Niedecker, John; Gonzalez-Lomas, Guillem			Epidemiology of professional bare-knuckle fighting injuries	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Bare-knuckle fighting; injuries; boxing; epidemiology; concussion; traumatic brain injury (TBI)		Background Professional bare-knuckle fighting (BKF) is a variation of boxing which held its first modern legal event in 2018 in Wyoming. Since then, the sport has expanded with state-sanctioned events held in Florida, Missouri, Mississippi, Kansas, and Alabama. The purpose of this study was to evaluate the epidemiology of injuries in bare-knuckle fighting bouts and to discern any trends which may distinguish it from traditional boxing with padded gloves. Methods Observational data collection for all state-sanctioned professional bare-knuckle fighting bouts was conducted sequentially over a two-year period from June of 2018 through November of 2020. Information related to fight outcome, injury diagnosis, and injury location was documented. This data was then analyzed and the incidence rates by injury type and location were calculated. Results There were 141 bouts conducted during the study period. Out of the 282 individual combatants, 105 (36.6%) sustained at least one injury during the event and 123 total injuries were recorded. In total, 98 (34.8%) lacerations were recorded; on average, 6.2 +- 4.5 sutures were required per laceration. There were 5 superficial hand lacerations and 80 facial lacerations. Seventeen (6.0%) fractures occurred, with 8 hand fractures, 6 nasal fractures, 2 orbital fractures, and 2 dental fractures. There were 8 (2.8%) periorbital hematomas sustained by fighters. Transfer to the hospital was required on 5 (1.8%) separate occasions, twice for orbital fractures and 3 times for traumatic brain injuries. In all, there were 8 (2.8%) concussions with symptoms. Conclusion The most frequent injuries in BKF include lacerations and hand fractures. Concussions are relatively uncommon compared to other injuries.	[Muzzi, Don; Blaeser, Anna M.; Niedecker, John; Gonzalez-Lomas, Guillem] New York Univ Langone Hlth, New York, NY 10016 USA		Blaeser, AM (corresponding author), New York Univ Langone Hlth, New York, NY 10016 USA.	anna.blaeser@nyulangone.org		Blaeser, Anna/0000-0003-0060-1618			Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Boddy K., 2019, BOXING CULTURAL HIST; Horns J, 2015, J EXP BIOL, V218, P3215, DOI 10.1242/jeb.125831; Karpman S, 2016, CLIN J SPORT MED, V26, P332, DOI 10.1097/JSM.0000000000000235; Loosemore M, 2015, BRIT J SPORT MED, V49, P1100, DOI 10.1136/bjsports-2015-094755; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morgan MH, 2013, J EXP BIOL, V216, P236, DOI 10.1242/jeb.075713; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; SMITH PK, 1986, J HUM MOVEMENT STUD, V12, P153; Velasco G, 2019, NEUROLOGY, V93, pS11, DOI 10.1212/01.wnl.0000580936.14660.4e; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	12	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1955604		AUG 2021	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	TZ3VN	WOS:000684403500001	34380362				2022-02-06	
J	Fisher, O; Berger, I; Grossman, ES; Maeir, A				Fisher, Orit; Berger, Itai; Grossman, Ephraim S.; Maeir, Adina			Online and Intellectual Awareness of Executive Functioning in Daily Life among Adolescents with and without ADHD	JOURNAL OF ATTENTION DISORDERS			English	Article; Early Access						self-awareness; self-monitoring; metacognition; ecological assessment; teenagers; functional impairment; overestimation; Positive Illusory Bias (PIB); BRIEF	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POSITIVE ILLUSORY BIAS; TRAUMATIC BRAIN-INJURY; PERFORMANCE-BASED ASSESSMENT; CALENDAR PLANNING ACTIVITY; SELF-AWARENESS; METACOGNITIVE KNOWLEDGE; CHILDREN; DEFICITS; PERCEPTIONS	Objective Executive function deficits (EFD) are a central mechanism underlying negative outcomes in ADHD. This study examined awareness of EFD manifested in "real-time" task performance (Online Awareness) and in general self-knowledge of daily activities, outside the context of a specific task (Intellectual Awareness) among adolescents with and without ADHD. Methods 102 adolescents with (n = 52) and without (n = 50) ADHD were administered Weekly Calendar Planning Activity (WCPA) and Behavior Rating Inventory of Executive Function (BRIEF). Parents completed the BRIEF parent version. Awareness was defined using the discrepancy paradigm: performance versus estimation on WCPA for online awareness; self versus parent report on the BRIEF for intellectual awareness. Results Adolescents with ADHD overestimated their performance on the WCPA and underestimated their EFD on the BRIEF compared to parent's ratings. The discrepancy scores in both types of awareness were significantly larger among ADHD than controls (p < .005). Conclusions Adolescents with ADHD demonstrate significantly lower rates of online and intellectual awareness of EFD compared to controls.	[Fisher, Orit] Hebrew Univ Jerusalem, Sch Occupat Therapy, Jerusalem, Israel; [Berger, Itai] Hebrew Univ Jerusalem, Paul Baerwald Sch Social Work & Social Welf, Jerusalem, Israel; [Maeir, Adina] Hebrew Univ Jerusalem, Sch Occupat Therapy, Fac Med, Jerusalem, Israel; [Berger, Itai] Ben Gurion Univ Negev, Beer Sheva, Israel; [Grossman, Ephraim S.] Ariel Univ, Dept Educ, Ariel, Israel		Fisher, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Occupat Therapy, POB 24026 Mt Scopus, IL-91240 Jerusalem, Israel.	orit.fisher@mail.huji.ac.il		Fisher, Orit/0000-0003-3522-6221; Maeir, Adina/0000-0002-3356-5847			American Psychiatric Association (APA), 2013, DSM DIAGN STAT MAN M DSM DIAGN STAT MAN M, V5th; Ardila A, 2016, PSYCHOL NEUROSCI, V9, P215, DOI [10.1037/pne0000052, DOI 10.1037/PNE0000052]; Asherson P, 2016, LANCET PSYCHIAT, V3, P568, DOI 10.1016/S2215-0366(16)30032-3; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Barkley RA, 2007, J SAFETY RES, V38, P113, DOI 10.1016/j.jsr.2006.09.004; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bourchtein E, 2017, J ABNORM CHILD PSYCH, V45, P1063, DOI 10.1007/s10802-016-0248-3; Brown T.E., 2013, NEW UNDERSTANDING AD; Bunford N, 2018, J ATTEN DISORD, V22, P66, DOI 10.1177/1087054714527793; Bussing R, 2012, J ADOLESCENT HEALTH, V51, P593, DOI 10.1016/j.jadohealth.2012.03.004; Conner K.C, 2000, CONNERS RATING SCALE; Demetriou A, 2009, LEARN INDIVID DIFFER, V19, P181, DOI 10.1016/j.lindif.2008.10.007; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Esnaola I, 2020, J RES ADOLESCENCE, V30, P100, DOI 10.1111/jora.12451; Fabiano GA, 2018, J ATTEN DISORD, V22, P1150, DOI 10.1177/1087054715616186; Fefer SA, 2018, J ATTEN DISORD, V22, P1113, DOI 10.1177/1087054715573993; Flavell J.H., 2001, COGNITIVE DEV, V4th ed.; Frazier TW, 2007, J LEARN DISABIL-US, V40, P49, DOI 10.1177/00222194070400010401; Gioia, 2004, BRIEF SR BEHAV RATIN; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Goverover Y, 2014, NEUROREHABILITATION, V35, P315, DOI 10.3233/NRE-141113; Groom MJ, 2010, J CHILD PSYCHOL PSYC, V51, P66, DOI 10.1111/j.1469-7610.2009.02128.x; Harter, 2012, SELF PERCEPTION PROF; Hoza B, 2004, J CONSULT CLIN PSYCH, V72, P382, DOI 10.1037/0022-006X.72.3.382; Hoza B, 2002, J ABNORM PSYCHOL, V111, P268, DOI 10.1037//0021-843X.111.2.268; Hoza B, 2012, J CONSULT CLIN PSYCH, V80, P245, DOI 10.1037/a0027299; Jiang YY, 2017, J ABNORM CHILD PSYCH, V45, P1051, DOI 10.1007/s10802-016-0232-y; Kastner L., 2022, AM J OCCUP THER, V76; Katz N., 2011, COGNITION OCCUPATION, V3rd ed., P13; Kaufman J, 1996, KIDDIE SADS PL; Khan MU, 2019, J CHILD ADOL PSYCHOP, V29, P398, DOI 10.1089/cap.2018.0153; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Lahav O, 2018, J ATTEN DISORD, V22, P368, DOI 10.1177/1087054714564621; Levanon-Erez N, 2019, BRIT J OCCUP THER, V82, P618, DOI 10.1177/0308022619860978; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lyons KE, 2011, ADV CHILD DEV BEHAV, V40, P379; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; McQuade JD, 2017, J ABNORM CHILD PSYCH, V45, P289, DOI 10.1007/s10802-016-0172-6; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Molina BSG, 2018, J CHILD PSYCHOL PSYC, V59, P692, DOI 10.1111/jcpp.12855; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Owens JS, 2003, J CONSULT CLIN PSYCH, V71, P680, DOI 10.1037/0022-006X.71.4.680; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ratzon NZ, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.020164; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Russell AE, 2016, CHILD PSYCHIAT HUM D, V47, P440, DOI 10.1007/s10578-015-0578-3; Silverstein MJ, 2020, J ATTEN DISORD, V24, P41, DOI 10.1177/1087054718804347; Steward KA, 2017, J ATTEN DISORD, V21, P316, DOI 10.1177/1087054714530782; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J., 2018, COGNITION OCCUPATION, P355; Toglia J, 2015, WEEKLY CALENDAR PLAN; Toglia J., 2018, COGNITION OCCUPATION, V4th e, P129; Toglia J., 2018, COGNITION OCCUPATION, V4th ed., P143; Toglia J, 2013, AM J OCCUP THER, V67, P515, DOI 10.5014/ajot.2013.008482; Tu JW, 2019, J PEDIATR PSYCHOL, V44, P576, DOI 10.1093/jpepsy/jsy109; Turgay A, 2012, J CLIN PSYCHIAT, V73, P192, DOI 10.4088/JCP.10m06628; Vohs K. D., 2016, HDB SELF REGULATION; Volz-Sidiropoulou E, 2016, J ATTEN DISORD, V20, P178, DOI 10.1177/1087054713489849; Vukman KB, 2010, EDUC STUD-UK, V36, P259, DOI 10.1080/03055690903180376; Wallisch A, 2018, OTJR-OCCUP PART HEAL, V38, P6, DOI 10.1177/1539449217727118; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Wehmeier PM, 2015, ADHD-ATTEND DEFICIT, V7, P165, DOI 10.1007/s12402-014-0156-8; Weil LG, 2013, CONSCIOUS COGN, V22, P264, DOI 10.1016/j.concog.2013.01.004; Weiner NW, 2012, AM J OCCUP THER, V66, P699, DOI 10.5014/ajot.2012.004754; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Xu GF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1471; Zelazo PD, 2015, DEV REV, V38, P55, DOI 10.1016/j.dr.2015.07.001; Zlotnik S, 2020, NEUROPSYCHOL REHABIL, V30, P333, DOI 10.1080/09602011.2018.1468272; Zlotnik S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00015	76	0	0	4	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.											10870547211031982	10.1177/10870547211031982		AUG 2021	11	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	TY7YG	WOS:000683995600001	34378435				2022-02-06	
J	Gradisek, P; Carrara, G; Antiga, L; Bottazzi, B; Chieregato, A; Csomos, A; Fainardi, E; Filekovic, S; Fleming, J; Hadjisavvas, A; Kaps, R; Kyprianou, T; Latini, R; Lazar, I; Masson, S; Mikaszewska-Sokolewicz, M; Novelli, D; Paci, G; Xirouchaki, N; Zanier, E; Nattino, G; Bertolini, G				Gradisek, Primoz; Carrara, Greta; Antiga, Luca; Bottazzi, Barbara; Chieregato, Arturo; Csomos, Akos; Fainardi, Enrico; Filekovic, Suada; Fleming, Joanne; Hadjisavvas, Andreas; Kaps, Rafael; Kyprianou, Theodoros; Latini, Roberto; Lazar, Isaac; Masson, Serge; Mikaszewska-Sokolewicz, Malgorzata; Novelli, Deborah; Paci, Giulia; Xirouchaki, Nektaria; Zanier, Elisa; Nattino, Giovanni; Bertolini, Guido		CREACTIVE Consortium	Prognostic Value of a Combination of Circulating Biomarkers in Critically Ill Patients with Traumatic Brain Injury: Results from the European CREACTIVE Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						circulating biomarkers; cluster analysis; Glasgow outcome scale; traumatic Brain Injury	C-TERMINAL HYDROLASE-L1; PROTEIN; IMPROVE	Individualized patient care is essential to reduce the global burden of traumatic brain injury (TBI). This pilot study focused on TBI patients admitted to intensive care units (ICUs) and aimed at identifying patterns of circulating biomarkers associated with the disability level at 6 months from injury, measured by the extended Glasgow Outcome Scale (GOS-E). The concentration of 107 biomarkers, including proteins related to inflammation, innate immunity, TBI, and central nervous system, were quantified in blood samples collected on ICU admission from 80 patients. Patients were randomly selected among those prospectively enrolled in the Collaborative Research on Acute Traumatic Brain Injury in Intensive Care Medicine in Europe (CREACTIVE) observational study. Six biomarkers were selected to be associated with indicators of primary or secondary brain injury: three glial proteins (glial cell-derived neurotrophic factor, glial fibrillary acidic protein, and S100 calcium-binding protein B) and three cytokines (stem cell factor, fibroblast growth factor [FGF] 23 and FGF19). The subjects were grouped into three clusters according to the expression of these proteins. The distribution of the 6-month GOS-E was significantly different across clusters (p < 0.001). In two clusters, the number of 6-month deaths or vegetative states was significantly lower than expected, as calculated according to a customization of the corticosteroid randomization after significant head injury (CRASH) scores (observed/expected [O/E] events = 0.00, 95% confidence interval [CI]: 0.00-0.90 and 0.00, 95% CI: 0.00-0.94). In one cluster, less-than-expected unfavorable outcomes (O/E = 0.50, 95% CI: 0.05-0.95) and more-than-expected good recoveries (O/E = 1.55, 95% CI: 1.05-2.06) were observed. The improved prognostic accuracy of the pattern of these six circulating biomarkers at ICU admission upon established clinical parameters and computed tomography results needs validation in larger, independent cohorts. Nonetheless, the results of this pilot study are promising and will prompt further research in personalized medicine for TBI patients.	[Gradisek, Primoz; Filekovic, Suada] Univ Med Ctr Ljubljana, Clin Dept Anesthesiol & Intens Therapy, Ljubljana, Slovenia; [Gradisek, Primoz; Filekovic, Suada] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Carrara, Greta; Fleming, Joanne; Paci, Giulia; Nattino, Giovanni; Bertolini, Guido] Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Lab Clin Epidemiol, Bergamo, Italy; [Antiga, Luca] Orobix, Bergamo, Italy; [Bottazzi, Barbara] Humanitas Clin & Res Ctr IRCCS, Milan, Italy; [Chieregato, Arturo] Grande Osped Metropolitano Niguarda, Neurointens Care Unit, Milan, Italy; [Csomos, Akos] Hungarian Army Med Ctr, Budapest, Hungary; [Fainardi, Enrico] Univ Florence, Dept Expt & Clin Biomed Sci, Neuroradiol Unit, Florence, Italy; [Hadjisavvas, Andreas] Cyprus Inst Neurol & Genet, Nicosia, Cyprus; [Kaps, Rafael] Gen Hosp Novo Mesto, Novo Mesto, Slovenia; [Kyprianou, Theodoros] Univ Nicosia, Med Sch, Nicosia, Cyprus; [Kyprianou, Theodoros] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England; [Latini, Roberto; Masson, Serge] Ist Ric Farmacol Mario Negri IRCCS, Dept Cardiovasc Med, Lab Cardiovasc Clin Pharmacol, Milan, Italy; [Lazar, Isaac] Ben Gurion Univ Negev, Dept Hlth Sci, Beer Sheva, Israel; [Mikaszewska-Sokolewicz, Malgorzata] Med Univ Warsaw, Clin Anesthesia & Intens Care, Warsaw, Poland; [Novelli, Deborah] Ist Ric Farmacol Mario Negri IRCCS, Dept Cardiovasc Med, Lab Cardiopulm Physiopathol, Milan, Italy; [Xirouchaki, Nektaria] Univ Hosp Heraklion, Iraklion, Greece; [Zanier, Elisa] Ist Ric Farmacol Mario Negri IRCCS, Lab Acute Brain Injury & Therapeut Strategies, Dept Neurosci, Milan, Italy		Nattino, G (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Publ Hlth, Lab Clin Epidemiol, Via GB Camozzi 3, I-24020 Ranica, BG, Italy.	giovanni.nattino@marionegri.it	Nattino, Giovanni/T-7306-2019; Mikaszewska-Sokolewicz, Malgorzata/U-7927-2018; Lazar, Isaac/N-6133-2016	Nattino, Giovanni/0000-0002-3034-6251; Mikaszewska-Sokolewicz, Malgorzata/0000-0002-1148-7817; Castioni, Carlo Alberto/0000-0002-8895-425X; Lazar, Isaac/0000-0001-9450-5226; Kyprianou, Theodoros/0000-0001-8272-7630; bocci, maria grazia/0000-0001-6100-8442	European UnionEuropean Commission [602714]	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement number 602714.	Azevedo MD, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020456; Bratton S.L., 2007, J NEUROTRAUMA S1 J NEUROTRAUMA S1, V1, pS55; Czeiter E., 2020, BLOOD BIOMARKERS ADM; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; GiViTI and CREACTIVE coordinating center, 2021, CREACTIVE PROJ CREACTIVE PROJ; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; HOSMER DW, 1995, STAT MED, V14, P2161, DOI 10.1002/sim.4780141909; Huie JR, 2021, J NEUROTRAUM, V38, P2514, DOI 10.1089/neu.2019.6762; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Marksteiner J, 2011, NEUROBIOL AGING, V32, P539, DOI 10.1016/j.neurobiolaging.2009.03.011; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Pirracchio R, 2018, STAT METHODS MED RES, V27, P286, DOI 10.1177/0962280215627335; Qiu XC, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01160-3; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Talebi M, 2021, NEUROL SCI, V42, P2291, DOI 10.1007/s10072-020-04807-6; TEASDALE G, 1974, LANCET, V2, P81; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zamperoni A, 2020, MINERVA ANESTESIOL, V86, P719, DOI 10.23736/S0375-9393.20.14280-9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	35	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0066		AUG 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TZ2QY	WOS:000684321800001	34235978				2022-02-06	
J	McAllister, D; Akers, C; Boldt, B; Mitchell, LA; Tranvinh, E; Douglas, D; Goubran, M; Rosenberg, J; Georgiadis, M; Karimpoor, M; DiGiacomo, P; Mouchawar, N; Grant, G; Camarillo, D; Wintermark, M; Zeineh, MM				McAllister, Derek; Akers, Carolyn; Boldt, Brian; Mitchell, Lex A.; Tranvinh, Eric; Douglas, David; Goubran, Maged; Rosenberg, Jarrett; Georgiadis, Marios; Karimpoor, Mahta; DiGiacomo, Phillip; Mouchawar, Nicole; Grant, Gerald; Camarillo, David; Wintermark, Max; Zeineh, Michael M.			Neuroradiologic Evaluation of MRI in High-Contact Sports	FRONTIERS IN NEUROLOGY			English	Article						mild TBI; concussion; MRI; sports; neuroanatomy; football	TRAUMATIC BRAIN-INJURY; CAVUM SEPTI PELLUCIDI; HEAD IMPACT EXPOSURES; HIPPOCAMPAL VOLUME; OUTCOME PREDICTION; ABNORMALITIES; CONCUSSION; DISEASE; SPACES	Background and Purpose: Athletes participating in high-contact sports experience repeated head trauma. Anatomical findings, such as a cavum septum pellucidum, prominent CSF spaces, and hippocampal volume reductions, have been observed in cases of mild traumatic brain injury. The extent to which these neuroanatomical findings are associated with high-contact sports is unknown. The purpose of this study was to determine whether there are subtle neuroanatomic differences between athletes participating in high-contact sports compared to low-contact athletic controls. Materials and Methods: We performed longitudinal structural brain MRI scans in 63 football (high-contact) and 34 volleyball (low-contact control) male collegiate athletes with up to 4 years of follow-up, evaluating a total of 315 MRI scans. Board-certified neuroradiologists performed semi-quantitative visual analysis of neuroanatomic findings, including: cavum septum pellucidum type and size, extent of perivascular spaces, prominence of CSF spaces, white matter hyperintensities, arterial spin labeling perfusion asymmetries, fractional anisotropy holes, and hippocampal size. Results: At baseline, cavum septum pellucidum length was greater in football compared to volleyball controls (p = 0.02). All other comparisons were statistically equivalent after multiple comparison correction. Within football at baseline, the following trends that did not survive multiple comparison correction were observed: more years of prior football exposure exhibited a trend toward more perivascular spaces (p = 0.03 uncorrected), and lower baseline Standardized Concussion Assessment Tool scores toward more perivascular spaces (p = 0.02 uncorrected) and a smaller right hippocampal size (p = 0.02 uncorrected). Conclusion: Head impacts in high-contact sport (football) athletes may be associated with increased cavum septum pellucidum length compared to low-contact sport (volleyball) athletic controls. Other investigated neuroradiology metrics were generally equivalent between sports.	[McAllister, Derek; Akers, Carolyn; Mitchell, Lex A.; Tranvinh, Eric; Douglas, David; Goubran, Maged; Rosenberg, Jarrett; Georgiadis, Marios; Karimpoor, Mahta; DiGiacomo, Phillip; Mouchawar, Nicole; Wintermark, Max; Zeineh, Michael M.] Stanford Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Boldt, Brian] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Boldt, Brian] Madigan Army Med Ctr, Dept Radiol, Tacoma, WA 98431 USA; [Mitchell, Lex A.] Hawaii Permanente Med Grp, Honolulu, HI USA; [Mitchell, Lex A.] John A Burns Sch Med, Honolulu, HI USA; [Goubran, Maged] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Goubran, Maged] Univ Toronto, Sunnybrook Res Inst, Hurvitz Brain Sci Program, Toronto, ON, Canada; [Goubran, Maged] Univ Toronto, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Grant, Gerald] Stanford Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Zeineh, MM (corresponding author), Stanford Sch Med, Dept Radiol, Stanford, CA 94305 USA.	mzeineh@stanford.edu		Goubran, Maged/0000-0001-5880-0818; Akers, Carolyn/0000-0001-9367-6795	Radiological Society of North America; American Society of Neuroradiology; Pac-12 Conference's Student-Athlete Health and Well-Being Initiative; General Electric HealthcareGeneral ElectricGE Healthcare	This research was conducted with funding from the Radiological Society of North America, the American Society of Neuroradiology, and the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative. The authors also declare that this study received funding from General Electric Healthcare. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Berginstrom N, 2020, BRAIN INJURY, V34, P415, DOI 10.1080/02699052.2020.1725124; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Kang KM, 2015, AM J NEURORADIOL, V36, P1662, DOI 10.3174/ajnr.A4366; Koerte IK, 2016, TRANSLATIONAL RES TR; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Lee JK, 2017, AM J NEURORADIOL, V38, P1303, DOI 10.3174/ajnr.A5175; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mills BD, 2020, NEUROIMAGE, V217, DOI 10.1016/j.neuroimage.2020.116864; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Parivash SN, 2019, J NEUROTRAUM, V36, P2762, DOI 10.1089/neu.2018.6357; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; SCHELTENS P, 1995, J NEUROL, V242, P557, DOI 10.1007/BF00868807; SCHWIDDE JT, 1952, AMA ARCH NEUROL PSY, V67, P625, DOI 10.1001/archneurpsyc.1952.02320170043006; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	52	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 11	2021	12								701948	10.3389/fneur.2021.701948			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UA4GB	WOS:000685118200006	34456852	Green Published, gold			2022-02-06	
J	Reiber, C; Stein, AA; Miller, I; Tarawneh, O; Kazim, SF; Schmidt, MH; Cole, CD; Bowers, CA				Reiber, Cody; Stein, Alan A.; Miller, Ivan; Tarawneh, Omar; Kazim, Syed Faraz; Schmidt, Meic H.; Cole, Chad D.; Bowers, Christian A.			A Perennial Threat: A Case Series of Tree-Related Neurotrauma	CUREUS			English	Article						tree collisions; neurotrauma; outcomes; injury patterns; accidents	INJURIES; SKIERS	Background Despite their devastating nature, injuries due to tree-related-traumas are sparsely reported in the literature. Over the last several years, the incidence of tree-related traumatic injuries presenting to our level one trauma center, in Westchester, New York, has been concerning. The present study was undertaken to evaluate the clinical presentation, injury pattern, and outcomes of tree-related neurotrauma at our institution. In addition, we describe the injury pattern and medical management of several relevant cases of tree-related neurotrauma. Methods We conducted a retrospective analysis of tree-related neurotrauma over a five-year period from January of 2014 to March of 2019 at Westchester Medical Center (WMC) and Maria Fareri Children's Hospital, a level one trauma center. Patients presenting with neurotrauma that necessitated neurosurgical care were eligible for inclusion in this case series. Tree-related injury was defined as any trauma that was sustained as a direct result of collision with a tree. Results We identified 21 patients who sustained tree-related trauma. The cohort age ranged from 15 to 68 (mean=38 years). Injuries included seven skull fractures, four cases of subdural hematoma (SDH), six cases of intracranial hemorrhagic contusion, 14 spinal fractures, three cases of epidural hematoma (EDH), one case of spinal cord contusion, three vascular injuries, one case of dural laceration, and one case of pneumocephalus, with several patients suffering multiple injuries. Of the 21 patients, seven were female, and 12 were injured when their motor vehicle struck a tree. All but four patients were taken to the operating room for neurosurgical treatment, and nine of 21 patients were taken emergently to the operating room upon arrival. Conclusion The potential for serious head injuries with long-term neurologic sequelae exists with tree-related trauma. Clinicians should be advised of the challenging management of injuries secondary to tree-related trauma, and a greater emphasis should be placed on raising awareness of these accidental, but devastating injuries. Finally, a great majority of these injuries can be prevented or reduced in severity through helmet use and by adhering to safety guidelines.	[Reiber, Cody; Tarawneh, Omar] New York Med Coll, Sch Med, Westchester, NY USA; [Stein, Alan A.] New York Med Coll, Neurosurg, Westchester, NY USA; [Miller, Ivan] Westchester Med Ctr, Emergency Med, Valhalla, NY USA; [Kazim, Syed Faraz] Univ New Mexico Hosp, Neurosurg, Albuquerque, NM USA; [Schmidt, Meic H.; Cole, Chad D.; Bowers, Christian A.] Univ New Mexico, Sch Med, Neurosurg, Albuquerque, NM 87131 USA		Bowers, CA (corresponding author), Univ New Mexico, Sch Med, Neurosurg, Albuquerque, NM 87131 USA.	cabowers@salud.unm.edu					Centers for Disease C, 2004, MMWR MORB MORTAL WKL, V53, P835; FRIERMOOD TG, 1994, J ORTHOP TRAUMA, V8, P116, DOI 10.1097/00005131-199404000-00007; Gagnon EB, 2005, AM SURGEON, V71, P194; Hakakian D, 2018, AM SURGEON, V84, pE407; Hamilton Kimberly, 2017, WMJ, V116, P201; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Liu HT, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/1749-7922-10-2; Matthes G, 2007, ZBL CHIR, V132, P142, DOI 10.1055/s-2007-960646; Nowak DJ, 2012, LANDSCAPE URBAN PLAN, V107, P21, DOI 10.1016/j.landurbplan.2012.04.005; Walsh RA, 2017, AUST NZ J PUBL HEAL, V41, P121, DOI 10.1111/1753-6405.12614	11	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	AUG 11	2021	13	8							e17104	10.7759/cureus.17104			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UL4GA	WOS:000692610200021	34527490	gold, Green Published			2022-02-06	
J	Ritzer, EE; Yang, JZ; Kistamgari, S; Collins, CL; Smith, GA				Ritzer, Erin E.; Yang, Jingzhen; Kistamgari, Sandhya; Collins, Christy L.; Smith, Gary A.			An epidemiologic comparison of acute and overuse injuries in high school sports	INJURY EPIDEMIOLOGY			English	Article						High School Athletes; Gender-Comparable Sports; Injury Reporting	US HIGH-SCHOOL; COLLEGIATE; PATTERNS; GIRLS; BOYS	Background Acute and overuse injuries affect millions of high school athletes annually and a better understanding of differences between these injuries is needed to help guide prevention, treatment, and rehabilitation strategies. This study compares acute and overuse injuries using a nationally representative sample of high school athletes. Methods Injuries among United States high school athletes participating in 5 boys' sports (football, soccer, basketball, wrestling, baseball) and 4 girls' sports (soccer, volleyball, basketball, softball) reported in the High School RIO (TM) surveillance system during the 2006-07 through 2018-19 school years were classified as acute or overuse. National estimates and injury rates were calculated. Results Of 17 434 646 estimated injuries, 92.0 % were acute and 8.0 % were overuse. The acute injury rate was higher than the overuse injury rate among both male (Rate Ratio [RR] 16.38, 95 % CI: 15.70-17.10) and female (RR 8.14, 95 % CI: 7.71-8.60) athletes. The overuse injury rate per 10,000 athlete exposures among female athletes (1.8) was slightly higher than among males (1.4). The rate of acute injury compared with the rate of overuse injury was higher during competition (RR 32.00, 95 % CI: 29.93-34.22) than practice (RR 7.19, 95 % CI: 6.91-7.47). Boys' football contributed the most acute (42.1 %) and overuse (23.7 %) injuries among the 9 sports. Among female sports, girls' soccer contributed the most acute (15.6 % of all acute injuries) and overuse (19.4 % of all overuse injuries) injuries. The lower extremity was most commonly injured in acute (48.9 %) and overuse (65.9 %) injuries. Ligament sprain (31.7 %) and concussion (21.0 %) were the most common acute injury diagnoses, while muscle strain (23.3 %) and tendonitis (23.2 %) were the most common overuse injury diagnoses. Compared with acute injuries, overuse injuries were more likely to result in time loss from sports participation of < 1 week among both boys and girls and across most sports. Acute injuries were more likely than overuse injuries to cause a time loss of 1-3 weeks or medical disqualification from sports participation. Conclusions Acute and overuse injuries display many differences that provide opportunities for data-informed athlete preparation, treatment, and rehabilitation, which may reduce injuries and improve injury outcomes in high school athletics.	[Ritzer, Erin E.; Yang, Jingzhen; Kistamgari, Sandhya; Smith, Gary A.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Ritzer, Erin E.] Lake Erie Coll Osteopath Med, 5000 Lakewood Ranch Blvd, Bradenton, FL 34211 USA; [Yang, Jingzhen; Smith, Gary A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent, 401 West Michigan St,Suite 500, Indianapolis, IN USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA.; Smith, GA (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.	Gary.Smith@nationwidechildrens.org					[Anonymous], 2019, PARTICIPATION HIGH S; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Cuff S, 2010, CLIN PEDIATR, V49, P731, DOI 10.1177/0009922810363154; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Hubbard TJ, 2008, J ATHL TRAINING, V43, P523, DOI 10.4085/1062-6050-43.5.523; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2011, CLIN J SPORT MED, V21, P101, DOI 10.1097/JSM.0b013e31820bd1b6; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Liller KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216217; Maffulli N, 2010, PHYSICIAN SPORTSMED, V38, P29, DOI 10.3810/psm.2010.06.1780; Merkel DL, 2013, OPEN ACCESS J SPORTS, V4, P151, DOI 10.2147/OAJSM.S33556; Post EG, 2020, SPORTS HEALTH, V12, P36, DOI 10.1177/1941738119886855; Powell JW, 1999, J ATHL TRAINING, V34, P277; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Roos KG, 2014, SPORTS MED, V44, P405, DOI 10.1007/s40279-013-0124-z; Saper MG, 2018, AM J SPORT MED, V46, P37, DOI 10.1177/0363546517734172; Schroeder AN, 2015, J PEDIATR-US, V166, P600, DOI 10.1016/j.jpeds.2014.09.037; Shanley E, 2011, J ATHL TRAINING, V46, P648; Shuer ML, 1997, WESTERN J MED, V166, P104; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; Tamura K, 2020, J ATHL TRAINING, V55, P6, DOI 10.4085/1062-6050-452-18; Welton KL, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117745788; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yang JZ, 2012, J ATHL TRAINING, V47, P198; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Zachrisson AL, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00239-0	31	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	AUG 11	2021	8	1							51	10.1186/s40621-021-00344-8			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	UA5WP	WOS:000685232500001	34380551	Green Published, gold			2022-02-06	
J	Schwartz, JA; Wright, EM; Spohn, R; Campagna, MF; Steiner, B; Epinger, E				Schwartz, Joseph A.; Wright, Emily M.; Spohn, Ryan; Campagna, Michael F.; Steiner, Benjamin; Epinger, Ebonie			Changes in Jail Admissions Before and After Traumatic Brain Injury	JOURNAL OF QUANTITATIVE CRIMINOLOGY			English	Article; Early Access						Traumatic brain injury; Collateral consequences; Criminal justice contact; Jail	ADVERSE OUTCOMES; HEAD-INJURIES; SELF-CONTROL; PREVALENCE; AGGRESSION; POPULATION; VICTIMIZATION; DELINQUENCY; OFFENDERS; HEALTH	Objectives Traumatic brain injury (TBI) is differentially concentrated within incarcerated populations. Despite the consistency of this observation, the timing of within-individual changes in criminal justice contact in relation to TBI remains under-investigated. For example, previous studies have primarily considered TBI as a causal influence of later criminal justice contact. However, TBI may also serve as a consequence of criminal justice contact or a criminogenic lifestyle. The current study simultaneously observes both possibilities by examining criminal justice contact before, around the time of, and after the first reported TBI. Methods Drawing from a combination of self-report and lifetime official record data from a jail cohort admitted between February 2017 and September 2017 and who sustained their first reported TBI at age 21 or older (N = 531), the current study examines jail admissions in the 24 months before and 24 months after the first reported TBI and across eight biannual intervals (N = 4,248 person-periods). Results Any and misdemeanor admissions slightly increased pre-TBI and continued to increase around the time of and following TBI, never returning to pre-TBI levels. Felony admissions remained stable around the time of injury and increased post-TBI. Further analyses that incorporated a comparison group revealed that these patterns are unique to the TBI group and not a result of a larger systematic process. Conclusions These findings indicate that the probability of jail admission is greatest post-TBI, but also increases leading up to sustaining a TBI.	[Schwartz, Joseph A.] Florida State Univ, Coll Criminol & Criminal Justice, 304A Coll Criminol & Criminal Justice Bldg, Tallahassee, FL 32306 USA; [Schwartz, Joseph A.] King Abdulaziz Univ, Ctr Social & Humanities Res, Jeddah, Saudi Arabia; [Wright, Emily M.; Spohn, Ryan; Campagna, Michael F.; Steiner, Benjamin; Epinger, Ebonie] Univ Nebraska, Sch Criminol & Criminal Justice, Omaha, NE 68182 USA; [Wright, Emily M.; Spohn, Ryan; Campagna, Michael F.] Univ Nebraska, Nebraska Ctr Justice Res, Omaha, NE 68182 USA		Schwartz, JA (corresponding author), Florida State Univ, Coll Criminol & Criminal Justice, 304A Coll Criminol & Criminal Justice Bldg, Tallahassee, FL 32306 USA.; Schwartz, JA (corresponding author), King Abdulaziz Univ, Ctr Social & Humanities Res, Jeddah, Saudi Arabia.	jaschwartz@fsu.edu	Campagna, Michael/AAD-3860-2021	Campagna, Michael/0000-0001-6454-5286; Schwartz, Joseph/0000-0001-5777-0573			Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Berk R, 2010, J EXP CRIMINOL, V6, P191, DOI 10.1007/s11292-010-9095-3; Blakemore S-J, 2018, INVENTING OURSELVES; Bronson J., 2017, REPORT PREPARED US D; Bronson J., 2017, DRUG USE DEPENDENCE; Centers for Disease Control and Prevention, 2017, C TRAUM BRAIN INJ US C TRAUM BRAIN INJ US; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Connolly EJ, 2019, J ADOLESCENT HEALTH, V65, P79, DOI 10.1016/j.jadohealth.2018.12.023; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dean CW, 1996, CRIMINOLOGY, V34, P547, DOI 10.1111/j.1745-9125.1996.tb01219.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Fahmy C, 2020, J CRIM JUST, V67, DOI 10.1016/j.jcrimjus.2020.101658; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2016, LANCET PSYCHIAT, V3, P871, DOI 10.1016/S2215-0366(16)30142-0; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Glover N, 2018, CRIM JUSTICE BEHAV, V45, P885, DOI 10.1177/0093854818765043; Gottfredson M. R., 1990, GEN THEORY CRIME; HORNEY J, 1995, AM SOCIOL REV, V60, P655, DOI 10.2307/2096316; Jackson TL, 2017, J EPIDEMIOL COMMUN H, V71, P800, DOI 10.1136/jech-2016-208582; Jennings WG, 2012, AGGRESS VIOLENT BEH, V17, P16, DOI 10.1016/j.avb.2011.09.003; Kirk DS, 2018, ANNU REV CRIMINOL, V1, P171, DOI 10.1146/annurev-criminol-032317-092045; Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2; Massoglia M, 2015, ANNU REV SOCIOL, V41, P291, DOI 10.1146/annurev-soc-073014-112326; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; O'Rourke C, 2018, BRAIN INJURY, V32, P1787, DOI 10.1080/02699052.2018.1539872; Pinheiro JC, 2020, nlme: Linear and Nonlinear Mixed Effects Models_. R package version 31-151; Polito MZ, 2010, J AM ACAD NURSE PRAC, V22, P504, DOI 10.1111/j.1745-7599.2010.00540.x; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Pratt TC, 2016, VICTIMS OFFENDERS, V11, P335, DOI 10.1080/15564886.2015.1057351; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Rocque M, 2015, CRIMINOL CRIM JUSTIC, V15, P340, DOI 10.1177/1748895814547710; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sariaslan A, 2016, JAMA PSYCHIAT, V73, P796, DOI 10.1001/jamapsychiatry.2016.1349; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schreck C. J., 1999, JUSTICE Q, V16, P633, DOI [DOI 10.1080/07418829900094291, 10.1080/07418829900094291]; Schreck CJ, 2006, J QUANT CRIMINOL, V22, P319, DOI 10.1007/s10940-006-9014-y; Schwartz JA, 2020, J EXP CRIMINOL, V16, P407, DOI 10.1007/s11292-020-09439-6; Schwartz JA, 2021, JUSTICE Q, V38, P196, DOI 10.1080/07418825.2019.1599044; Schwartz JA, 2019, CURR OPIN PSYCHOL, V27, P67, DOI 10.1016/j.copsyc.2018.09.006; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Skrondal A., 2012, MULTILEVEL LONGITUDI, V3rd; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Visher CA, 2017, JUSTICE Q, V34, P136, DOI 10.1080/07418825.2015.1115539; Visher CA, 2011, JUSTICE Q, V28, P698, DOI 10.1080/07418825.2010.535553; Wall K, 2018, CRIM JUSTICE BEHAV, V45, P1588, DOI 10.1177/0093854818778082; Western B, 2015, AM J SOCIOL, V120, P1512, DOI 10.1086/681301; Wood S. N, 2017, GEN ADDITIVE MODELS, V2nd, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Wright BRE, 2001, CRIMINOLOGY, V39, P321, DOI 10.1111/j.1745-9125.2001.tb00925.x; Zhang SX, 2006, CRIME DELINQUENCY, V52, P551, DOI 10.1177/0011128705282594; Zhao QY, 2017, J CAUSAL INFERENCE, V5, DOI 10.1515/jci-2016-0010	66	0	0	5	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0748-4518	1573-7799		J QUANT CRIMINOL	J. Quant. Criminol.												10.1007/s10940-021-09524-7		AUG 2021	24	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	TY9II	WOS:000684091100001		Bronze, Green Submitted			2022-02-06	
J	Takahashi, AAR; Teixeira, SB; Galafassi, GZ; Silva, MBA; Comprido, VF; Martinez, AGS; de Lima, LA; Sousa, LVD; de Aguiar, PHP				Takahashi, Andre Akira Ramos; Teixeira, Saulo Barros; Galafassi, Giovanna Zambo; Silva, Maria Beatriz Almeida; Comprido, Victoria Fernandez; Martinez, Anne Gabriele Senne; de Lima, Leonardo Alfano; Sousa, Luiz Vinicius de Alcantara; de Aguiar, Paulo Henrique Pires			Epidemiological Pattern of Traumatic Brain Injury in Brazil between 2008 and 2019	BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA			English	Article						traumatic brain injury; trauma; incidence; epidemiology; Brazil	PREVENTION	Introduction Traumatic brain injuries (TBIs) are a public health problem with high economic impact, as well as an important cause of death and sequela in polytrauma patients, affecting mainly young adults. Objective To analyze the temporal trend of TBI incidence in Brazil between 2008 and 2019, according to age group and gender. Methods An ecological study, based on secondary data from hospital admissions for TBI in all Brazilian states between 2008 and 2019. The numbers were collected using the hospital information systemof the Unified Health System in Brazil. We performed a descriptive analysis using the data obtained. Linear regression models were used to measure the incidence trend of TBI in the period adopted. Results The state of Piaui had the highest increase in the incidence of TBI in the country in the last 10 years (coefficient beta = 63.43 e p = 0.002). The main concern, though, is the increase in the incidence of TBI amongst children (0-4 years old) in the states of Ceara (beta = 31.22 and p< 0.001 for boys; beta = 42.20 and p< 0.001 for girls), Parana (beta = 37.26 and p = 0.011 for boys; beta = 25.90 and p = 0.015 for girls), Pernambuco (beta = 20.08 and p = 0.016 for girls), Mato Grosso (beta = 18.76 and p = 0.005 for boys; beta = 16.11 and p = 0.035 for girls), and Distrito Federal (beta = 48.87 and p = 0.004 for girls; beta = 48.28 and p = 0.006 for boys). Conclusion The analysis of the results is able to point out improvements that can be made. Besides that, it is remarkably important to redirect public polices to preventive medicine sincemany of the TBI causes are avoidable through awareness and education of the population.	[Takahashi, Andre Akira Ramos; Galafassi, Giovanna Zambo; Silva, Maria Beatriz Almeida; Comprido, Victoria Fernandez; Martinez, Anne Gabriele Senne] Fac Med ABC, Santo Andre, SP, Brazil; [Teixeira, Saulo Barros] Fac Med ABC, Dept Neurosurg, Santo Andre, SP, Brazil; [de Lima, Leonardo Alfano; Sousa, Luiz Vinicius de Alcantara] Fac Med ABC, Dept Epidemiol, Santo Andre, SP, Brazil; [de Aguiar, Paulo Henrique Pires] Fac Med ABC, Dept Neurol & Neurosurg, Santo Andre, SP, Brazil		Takahashi, AAR (corresponding author), Av Lauro Gomes 2000, Santo Andre, SP, Brazil.	andreakiratakahashi@gmail.com	Sousa, Luiz/ABC-3569-2021	Martinez, Anne/0000-0001-9433-1027; Pires de Aguiar, Paulo Henrique/0000-0002-9059-4978; Galafassi, Giovanna/0000-0001-6131-3498; Takahashi, Andre/0000-0003-4265-2499			Ahmad OB, 2001, AGE STANDARDIZATION; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; ConstOncio JF, 2018, REV BAIANA ENFERM, V32, P1; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hovda D., 2011, YOUMANS NEUROLOGICAL, P3305; Hovda D, 2011, EPIDEMIOL TRAUMAT BR, V4, P3270; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koizumi MS, 2001, CRIAN AS INTERNADAS; Lopes IMSS, 2020, CIENCIAS BIOL DIMENS; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Neto CDM., 2014, REV BRAS ED SAUDE RE, V4, P18; Oliveira E, 2012, ACTA MEDICA PORT, V25, P179; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Santos Maria Emilia, 2003, Acta Med Port, V16, P71; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Wehner DE, 2005, J EMERG NURS, V31, P383, DOI 10.1016/j.jen.2005.06.001; Youngers EH, 2017, NEUROSURGERY, V81, P416, DOI 10.1093/neuros/nyx053	22	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0103-5355	2359-5922		BRAZ NEUROSURG	Braz. Neurosurg.	DEC	2021	40	04					303	332		10.1055/s-0041-1733865		AUG 2021	30	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XF6RE	WOS:000683954900001		gold			2022-02-06	
J	Vehvilainen, J; Skrifvars, MB; Reinikainen, M; Bendel, S; Marinkovic, I; Ala-Kokko, T; Hoppu, S; Laitio, R; Siironen, J; Raj, R				Vehvilainen, Juho; Skrifvars, Markus B.; Reinikainen, Matti; Bendel, Stepani; Marinkovic, Ivan; Ala-Kokko, Tero; Hoppu, Sanna; Laitio, Ruut; Siironen, Jari; Raj, Rahul			Psychotropic medication use among patients with a traumatic brain injury treated in the intensive care unit: a multi-centre observational study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Psychiatric sequelae; Intensive care; Psychotropic medication	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; CRITICAL ILLNESS; MOOD DISORDERS; CLASSIFICATION; DEPRESSION; SURVIVORS; SYMPTOMS	Background Psychiatric sequelae after traumatic brain injury (TBI) are common and may impede recovery. We aimed to assess the occurrence and risk factors of post-injury psychotropic medication use in intensive care unit (ICU)-treated patients with TBI and its association with late mortality. Methods We conducted a retrospective multi-centre observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted in four university hospital ICUs during 2003-2013 that were alive at 1 year after injury. Patients were followed-up until end of 2016. We obtained data regarding psychotropic medication use through the national drug reimbursement database. We used multivariable logistic regression models to assess the association between TBI severity, treatment-related variables and the odds of psychotropic medication use and its association with late all-cause mortality (more than 1 year after TBI). Results Of 3061 patients, 2305 (75%) were alive at 1 year. Of these, 400 (17%) became new psychotropic medication users. The most common medication types were antidepressants (61%), antipsychotics (35%) and anxiolytics (26%). A higher Glasgow Coma Scale (GCS) score was associated with lower odds (OR 0.93, 95% CI 0.90-0.96) and a diffuse injury with midline shift was associated with higher odds (OR 3.4, 95% CI 1.3-9.0) of new psychotropic medication use. After adjusting for injury severity, new psychotropic medication use was associated with increased odds of late mortality (OR 1.19, 95% CI 1.19-2.17, median follow-up time 6.4 years). Conclusions Psychotropic medication use is common in TBI survivors. Higher TBI severity is associated with increased odds of psychotropic medication use. New use of psychotropic medications after TBI was associated with increased odds of late mortality. Our results highlight the need for early identification of potential psychiatric sequelae and psychiatric evaluation in TBI survivors.	[Vehvilainen, Juho; Marinkovic, Ivan; Siironen, Jari; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland; [Vehvilainen, Juho; Siironen, Jari; Raj, Rahul] Univ Helsinki, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland; [Skrifvars, Markus B.] Univ Helsinki, Dept Emergency Care & Serv, Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Helsinki, Finland; [Reinikainen, Matti; Bendel, Stepani] Kuopio Univ Hosp, Dept Intens Care, Kuopio, Finland; [Reinikainen, Matti; Bendel, Stepani] Univ Eastern Finland, Kuopio, Finland; [Marinkovic, Ivan] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Ala-Kokko, Tero] Oulu Univ Hosp, Dept Intens Care, Oulu, Finland; [Ala-Kokko, Tero] Univ Oulu, Oulu, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Intens Care & Emergency Med Serv, Tampere, Finland; [Hoppu, Sanna] Univ Tampere, Tampere, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Intens Care, Turku, Finland; [Laitio, Ruut] Univ Turku, Turku, Finland		Vehvilainen, J (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland.; Vehvilainen, J (corresponding author), Univ Helsinki, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland.	juho.vehvilainen@helsinki.fi	; Raj, Rahul/K-7693-2012	Marinkovic, Ivan/0000-0002-0950-8623; Raj, Rahul/0000-0003-4243-9591	Helsinki University Hospital (Finland) [VTR TYH2018227]; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv Halsa; Svenska Kulturfonden and Maire Taponen foundation	Independent funding support has been received from Helsinki University Hospital (State funding, Finland VTR TYH2018227); Finska Lakaresallskapet; Medicinska Understodsforeningen Liv & Halsa; Svenska Kulturfonden and Maire Taponen foundation. The funders had no role in study design, data collection, data analysis, data interpretation or writing of the manuscript. The first and last author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Access Economics , 2009, EC COST SPIN CORD IN; Albrecht JS, 2017, AM J GERIAT PSYCHIAT, V25, P415, DOI 10.1016/j.jagp.2016.11.018; [Anonymous], FIN STAT MED 2013; Bilgic Basar, 2004, Cogn Behav Neurol, V17, P118, DOI 10.1097/01.wnn.0000117862.44205.ea; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Deb S, 1999, AM J PSYCHIAT, V156, P374; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 1997, J PSYCHOSOM RES, V43, P335, DOI 10.1016/S0022-3999(97)00130-X; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kohnen RF, 2018, BRAIN INJURY, V32, P1591, DOI 10.1080/02699052.2018.1538537; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lewer D, 2015, BRIT J PSYCHIAT, V207, P221, DOI 10.1192/bjp.bp.114.156786; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nikayin S, 2016, GEN HOSP PSYCHIAT, V43, P23, DOI 10.1016/j.genhosppsych.2016.08.005; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Rabiee A, 2016, CRIT CARE MED, V44, P1744, DOI 10.1097/CCM.0000000000001811; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Richter JC, 2006, PSYCHOSOMATICS, V47, P223, DOI 10.1176/appi.psy.47.3.223; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wang S, 2017, J HOSP MED, V12, P831, DOI 10.12788/jhm.2827; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	40	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2021	163	10					2909	2917		10.1007/s00701-021-04956-3		AUG 2021	9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	UW6OM	WOS:000684046200001	34379205	Green Published, hybrid			2022-02-06	
J	Xiao, X; Hou, YY; Yu, W; Qi, SH				Xiao, Xi; Hou, Yuanyuan; Yu, Wei; Qi, Sihua			Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis	JOURNAL OF IMMUNOLOGY RESEARCH			English	Article							INDUCED UP-REGULATION; INFLAMMATORY RESPONSE; MICRORNAS; FAMILY	Background. Propofol is a widely used intravenous anesthetic drug with potential neuroprotective effect in diverse diseases of neuronal injuries such as traumatic brain injury and ischemic stroke. However, the underlying molecular mechanism remains largely unknown. Methods. Real-time qPCR, enzyme-linked immunosorbent assay, and Western blotting were used to identify the expression pattern of miR-221/222, inflammatory genes, cytokines, and IRF2. The biological roles and mechanisms of propofol in microglia activation were determined in BV2 cells and primary microglia. Bioinformatic analysis and luciferase reporter assay were used to confirm the regulatory role of miR-221/222 in Irf2 expression. Results. We found that miR-221 and miR-222 were downstream targets of propofol and were consistently upregulated in lipopolysaccharide- (LPS-) primed BV2 cells. Gain- and loss-of-function studies revealed that miR-221 and miR-222 were profoundly implicated in microglia activation. Then, interferon regulatory factor 2 (Irf2) was identified as a direct target gene of miR-221/222. IRF2 protein levels were reduced by miR-221/222 and increased by propofol treatment. Ectopic expression of IRF2 attenuated the proinflammatory roles induced by LPS in BV2 cells. More importantly, the suppressive effects of propofol on LPS-primed activation of BV2 cells or primary mouse microglia involved the inhibition of miR-221/222-IRF2 axis. Conclusions. Our study highlights the critical function of miR-221/222, which inhibited Irf2 translation, in the anti-inflammatory effects of propofol, and provides a new perspective for the molecular mechanism of propofol-mediated neuroprotective effect.	[Xiao, Xi; Hou, Yuanyuan; Yu, Wei; Qi, Sihua] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, Harbin 150001, Heilongjiang, Peoples R China; [Xiao, Xi; Hou, Yuanyuan] Dalian Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China		Qi, SH (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, Harbin 150001, Heilongjiang, Peoples R China.	qisihua2021@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271456]	This work was supported by a Grant from the Natural Science Foundation of China (No. 81271456).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Binas S, 2020, CELL MOL LIFE SCI, V77, P903, DOI 10.1007/s00018-019-03217-y; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Corsten M, 2015, EUR HEART J, V36, P2909, DOI 10.1093/eurheartj/ehv321; Cui HC, 2018, J IMMUNOL, V200, P3218, DOI 10.4049/jimmunol.1701571; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Guo YF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.663279; Habre C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5219; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Jalota L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1110; Ji FT, 2015, MOL MED REP, V12, P2049, DOI 10.3892/mmr.2015.3585; Lai TC, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.569150; Li SJ, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01278; Li Y, 2019, AUTOPHAGY, V15, P478, DOI 10.1080/15548627.2018.1522467; Liang YK, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0073-7; Liu S, 2017, FOLIA NEUROPATHOL, V55, P124, DOI 10.5114/fn.2017.68579; Lu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178098; Luo J, 2018, NEUROREPORT, V29, P839, DOI 10.1097/WNR.0000000000001041; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Ma Z, 2020, BIOL PHARM BULL, V43, P1481, DOI 10.1248/bpb.b20-00050; Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meng FF, 2020, FUND CLIN PHARMACOL, V34, P313, DOI 10.1111/fcp.12528; Pandey A, 2015, J NEUROCHEM, V133, P640, DOI 10.1111/jnc.13089; Peng M, 2014, INFLAMM RES, V63, P411, DOI 10.1007/s00011-014-0713-9; Peng XW, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8978704; Pereira JV, 2020, EUR J ANAESTH, V37, P121, DOI 10.1097/EJA.0000000000001131; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Qian C, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111614; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Subhramanyam CS, 2019, SEMIN CELL DEV BIOL, V94, P112, DOI 10.1016/j.semcdb.2019.05.004; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Swarbrick S, 2019, MOL NEUROBIOL, V56, P6156, DOI 10.1007/s12035-019-1500-y; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Wu QC, 2018, CAN J PHYSIOL PHARM, V96, DOI 10.1139/cjpp-2017-0243; Xu J, 2019, MOL THER, V27, P559, DOI 10.1016/j.ymthe.2019.01.012; Yan AJ, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00529; Zhang HB, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104375; Zheng XX, 2018, INFLAMMATION, V41, P11, DOI 10.1007/s10753-017-0658-6; Zhou JB, 2020, GENE, V735, DOI 10.1016/j.gene.2019.144277	43	0	0	3	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-8861	2314-7156		J IMMUNOL RES	J Immunol. Res.	AUG 11	2021	2021								3101146	10.1155/2021/3101146			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UD8JN	WOS:000687449300001	34423051	gold, Green Published			2022-02-06	
J	Zynda, AJ; Worrall, HM; Sabatino, MJ; Ellis, HB; Chung, JS; Cullum, CM; Miller, SM				Zynda, Aaron J.; Worrall, Hannah M.; Sabatino, Meagan J.; Ellis, Henry B.; Chung, Jane S.; Cullum, C. Munro; Miller, Shane M.			Continued play following adolescent sport-related concussion: Prospective data from the North Texas Concussion Registry (ConTex)	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Adolescent; athlete; concussion; sport-related concussion; continue to play; recovery	ASSOCIATION POSITION STATEMENT; 2ND IMPACT SYNDROME; HIGH-SCHOOL; UNITED-STATES; KNOWLEDGE; CHILDREN; DEPRESSION; VALIDITY; POPULATION; MANAGEMENT	Our study aims were to identify the frequency of continued play following sport-related concussion (SRC), defined as continuing athletic activity on the same day following a suspected SRC, characteristics associated with continued play, and whether continued play was associated with worse outcomes. A prospective study of participants ages 13-18 years diagnosed with SRC at a pediatric sports medicine clinic over a 4-year period was conducted. A comparison was performed between athletes who reported continued play following SRC (PLAY) and those who did not (NO PLAY). Of 441 participants, 231 (52.4%) were in the PLAY group. The PLAY group recalled less severe balance problems from the day of injury (p = 0.02), but reported greater symptoms of trouble falling asleep, concentrating, and remembering at their initial clinic visit (p < 0.05). There was no difference in recovery time between groups. Greater symptom severity score at the initial clinic visit and longer time to presentation were associated with prolonged recovery in both groups (p < 0.01). In conclusion, more than half of the athletes in this sample continued to play on the same day following SRC. Our results indicate the need for a heightened focus on education and additional efforts to reduce continued play following SRC in adolescents.	[Zynda, Aaron J.] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA; [Worrall, Hannah M.; Sabatino, Meagan J.; Ellis, Henry B.; Chung, Jane S.; Miller, Shane M.] Scottish Rite Children, Dept Sports Med, Frisco, TX USA; [Ellis, Henry B.; Chung, Jane S.; Miller, Shane M.] Univ Texas Southwestern, Dept Orthopaed Surg, Dallas, TX USA; [Chung, Jane S.; Miller, Shane M.] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [Cullum, C. Munro] Univ Texas Southwestern, Dept Psychiat, Dallas, TX USA; [Cullum, C. Munro] Univ Texas Southwestern, Dept Neurol, Dallas, TX USA; [Cullum, C. Munro] Univ Texas Southwestern, Dept Neurosurg, Dallas, TX USA; [Sabatino, Meagan J.] Univ Massachusetts, Grad Sch Biomed Sci, Sch Med, Worcester, MA USA		Zynda, AJ (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA.	zyndaaar@msu.edu	; Zynda, Aaron/P-5353-2018	Cullum, Munro/0000-0001-9706-5465; Miller, Shane/0000-0001-5002-5095; Zynda, Aaron/0000-0003-0663-7320	Texas Institute for Brain Injury and Repair (TIBIR), Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001105]	The North Texas Concussion Registry (ConTex) was supported by funds from the Texas Institute for Brain Injury and Repair (TIBIR), a state-funded initiative as part of the Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center. Support for the use of REDCap came from the National Center for Advancing Translational Sciences of the National Institutes of Health under award [number UL1TR001105].	Allgaier AK, 2012, DEPRESS ANXIETY, V29, P906, DOI 10.1002/da.21971; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cullum CM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032345; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Graham R., 2014, SPORTS RELATED CONCU, V1; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hinz A, 2017, SLEEP MED, V30, P57, DOI 10.1016/j.sleep.2016.03.008; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Olson A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00220; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Selph SS, 2019, AM FAM PHYSICIAN, V100, P609; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Wallace J, 2020, J SAFETY RES, V75, P166, DOI 10.1016/j.jsr.2020.09.007; Wallace J, 2021, J RACIAL ETHN HEALTH, V8, P1079, DOI 10.1007/s40615-020-00864-x; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Waltzman D, 2020, MMWR-MORBID MORTAL W, V69, P870, DOI 10.15585/mmwr.mm6927a4; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609; Zynda Aaron J, 2020, Int J Exerc Sci, V13, P87	57	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1957677		AUG 2021	12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UA3BN	WOS:000685037400001	34392774				2022-02-06	
J	Bailey, AM; Funk, JR; Crandall, JR; Myers, BS; Arbogast, KB				Bailey, Ann M.; Funk, James R.; Crandall, Jeff R.; Myers, Barry S.; Arbogast, Kristy B.			Laboratory Evaluation of Shell Add-On Products for American Football Helmets for Professional Linemen	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Concussion; American football; Head injury	IMPACT PERFORMANCE; INJURY RISK; CONCUSSION; REDUCE; EXPOSURE	The Guardian Cap NXT (GC NXT) and the ProTech Helmet Cap (ProTech) are commercially available aftermarket products designed to augment the energy attenuation characteristics of American football helmets. The ability of these helmet shell add-on products to mitigate the severity of impacts typically experienced by professional offensive and defensive linemen was evaluated for seven helmet models using two test series. In linear impactor tests, the GC NXT reduced head impact severity as measured by the head acceleration response metric (HARM) by 9% relative to the helmets only, while the ProTech reduced HARM by 5%. While both products significantly improved the performance of the football helmets tested overall, effects varied by impact condition and helmet model with the add-ons worsening helmet performance in some conditions. The GC NXT had a strong effect size (Cohen's d = 0.8) whereas the ProTech had a medium effect (Cohen's d = 0.5). A second study investigated add-on performance for helmet-to-helmet impacts with eccentric impact vectors and resulted in a mixture of increased and decreased HARM when either add-on was placed on one or both helmets. Estimated risk for serious neck injury with add-ons and without differed by less than 4% for these eccentric impacts.	[Bailey, Ann M.; Funk, James R.; Crandall, Jeff R.] Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Myers, Barry S.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Bailey, AM (corresponding author), Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA.	abailey@bicorellc.com			Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a Grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources.	Andrecovich C., 2011, 11101 WAYN STAT U BI; Association for the Advancement of Automotive Medicine, 2001, ABBREVIATED INJURY S; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Cohen J, 1988, STAT POWER ANAL BEHA; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cuccurullo N, 2014, THESIS STATE U NEW Y; de la Motte SJ, 2017, J STRENGTH COND RES, V31, P3218, DOI 10.1519/JSC.0000000000002174; Eppinger R, 1999, DEV IMPROVED INJURY, P1; Funk JR, 2020, ANN BIOMED ENG, V48, P2652, DOI 10.1007/s10439-020-02632-8; Funk JR, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039673; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; Jones Bruce H, 2017, J Sci Med Sport, V20 Suppl 4, pS17, DOI 10.1016/j.jsams.2017.09.015; Lessley DJ, 2020, ANN BIOMED ENG, V48, P2542, DOI 10.1007/s10439-020-02657-z; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Malone S, 2017, J SCI MED SPORT, V20, P250, DOI 10.1016/j.jsams.2016.08.005; Mertz H., 1996, SAE TECHNICAL PAPER; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; Oertengren R, 1985, P INT RES COUNC BIOM, V13, P29; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Sears J, 1981, J BIOMECH ENG, V10, P318; Society of Automotive Engineer (SAE), 2014, J2111201403 SAE INT; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1	29	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2747	2759		10.1007/s10439-021-02842-8		AUG 2021	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000683678000003	34378120				2022-02-06	
J	Feng, Y; Li, KG; Roth, E; Chao, DM; Mecca, CM; Hogan, QH; Pawela, C; Kwok, WM; Camara, AKS; Pan, B				Feng, Yin; Li, Keguo; Roth, Elizabeth; Chao, Dongman; Mecca, Christina M.; Hogan, Quinn H.; Pawela, Christopher; Kwok, Wai-Meng; Camara, Amadou K. S.; Pan, Bin			Repetitive Mild Traumatic Brain Injury in Rats Impairs Cognition, Enhances Prefrontal Cortex Neuronal Activity, and Reduces Pre-synaptic Mitochondrial Function	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						mild traumatic brain injury; rat model; cognitive impairment; neuronal activity; mitochondrial function	SYNAPTIC-TRANSMISSION; HEAD-INJURY; MODEL; MEMORY; CONCUSSIONS; ANESTHETICS; MODULATION; PLASTICITY; ORDER; FEAR	A major hurdle preventing effective interventions for patients with mild traumatic brain injury (mTBI) is the lack of known mechanisms for the long-term cognitive impairment that follows mTBI. The closed head impact model of repeated engineered rotational acceleration (rCHIMERA), a non-surgical animal model of repeated mTBI (rmTBI), mimics key features of rmTBI in humans. Using the rCHIMERA in rats, this study was designed to characterize rmTBI-induced behavioral disruption, underlying electrophysiological changes in the medial prefrontal cortex (mPFC), and associated mitochondrial dysfunction. Rats received 6 closed-head impacts over 2 days at 2 Joules of energy. Behavioral testing included automated analysis of behavior in open field and home-cage environments, rotarod test for motor skills, novel object recognition, and fear conditioning. Following rmTBI, rats spent less time grooming and less time in the center of the open field arena. Rats in their home cage had reduced inactivity time 1 week after mTBI and increased exploration time 1 month after injury. Impaired associative fear learning and memory in fear conditioning test, and reduced short-term memory in novel object recognition test were found 4 weeks after rmTBI. Single-unit in vivo recordings showed increased neuronal activity in the mPFC after rmTBI, partially attributable to neuronal disinhibition from reduced inhibitory synaptic transmission, possibly secondary to impaired mitochondrial function. These findings help validate this rat rmTBI model as replicating clinical features, and point to impaired mitochondrial functions after injury as causing imbalanced synaptic transmission and consequent impaired long-term cognitive dysfunction.	[Feng, Yin; Li, Keguo; Roth, Elizabeth; Chao, Dongman; Mecca, Christina M.; Hogan, Quinn H.; Pawela, Christopher; Kwok, Wai-Meng; Camara, Amadou K. S.; Pan, Bin] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Mecca, Christina M.; Hogan, Quinn H.; Pan, Bin] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Pawela, Christopher] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Pawela, Christopher] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Kwok, Wai-Meng] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Camara, Amadou K. S.] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA		Pan, B (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.; Pan, B (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	bpan@mcw.edu			Advancing Healthier Wisconsin Endowment Project [5520444]	This work was supported by Advancing Healthier Wisconsin Endowment Project #5520444 to the Department of Anesthesiology.	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brodkin J, 2014, J NEUROSCI METH, V224, P48, DOI 10.1016/j.jneumeth.2013.12.010; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cole W. R., 2016, TRANSLATIONAL RES TR; Collins JM, 2020, J NEUROTRAUM, V37, P782, DOI 10.1089/neu.2019.6906; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davenport Elizabeth M, 2016, Concussion, V1, pCNC19, DOI 10.2217/cnc-2016-0003; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Di Battista AP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232053; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Forstner P, 2020, FASEB J, V34, P3855, DOI 10.1096/fj.201902257RR; Gilmartin MR, 2014, TRENDS NEUROSCI, V37, P455, DOI 10.1016/j.tins.2014.05.004; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Ji GC, 2011, J NEUROPHYSIOL, V106, P2642, DOI 10.1152/jn.00461.2011; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Ljubkovic M, 2007, AM J PHYSIOL-CELL PH, V292, pC1583, DOI 10.1152/ajpcell.00221.2006; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Medler K, 2002, J NEUROPHYSIOL, V87, P1426, DOI 10.1152/jn.00627.2001; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Pan B, 2011, J NEUROSCI, V31, P11244, DOI 10.1523/JNEUROSCI.1040-11.2011; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Qubty D, 2018, HBK BEHAV NEUROSCI, V27, P331, DOI 10.1016/B978-0-12-812012-5.00022-7; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Sivakumaran MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30030-7; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yarnell Angela M, 1800, Curr Protoc Neurosci, V75, DOI 10.1002/cpns.10; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zucker RS, 2005, NEURON, V45, P482, DOI 10.1016/j.neuron.2005.02.003	69	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 10	2021	15								689334	10.3389/fncel.2021.689334			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UA1XI	WOS:000684958300002	34447298	gold, Green Published			2022-02-06	
J	Fraser, JJ; VanDehy, J; Bodell, DM; Gottshall, KR; Sessoms, PH				Fraser, John J.; VanDehy, Jacob; Bodell, Dawn M.; Gottshall, Kim R.; Sessoms, Pinata H.			Head and Body Dyskinesia During Gait in Tactical Athletes With Vestibular Deficit Following Concussion	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						movement; walking; dizziness; brain injuries; impairment	TRAUMATIC BRAIN-INJURY; STABILIZATION; DIZZINESS; STRENGTH; TASK	Background: Vestibular deficit is common following concussion and may affect gait. The purpose of this study was to investigate differences in head and pelvic center of mass (COM) movement during gait in military tactical athletes with and without concussion-related central vestibular impairment. Material and Methods: 24 patients with post-concussion vestibular impairment (20 males, 4 females; age: 31.7 +/- 7.9 years; BMI: 27.3 +/- 3.3) and 24 matched controls (20 males, 4 females; age: 31.8 +/- 6.4 years; BMI: 27.2 +/- 2.6) were included in the analyses. Three-dimensional head and pelvic displacement and velocities were collected at a 1.0 m/s standardized treadmill walking speed and assessed using Statistical Parametric Mapping t-tests. Maximum differences (d(max)) between groups were reported for all significant kinematic findings. Results: The Vestibular group demonstrated significantly diminished anteroposterior head excursions (d(max) = 2.3 cm, p = 0.02) and slower anteroposterior (d(max) = 0.37 m/s, p = 0.01), mediolateral (d(max) = 0.47 m/s, p = 0.02) and vertical (d(max) = 0.26 m/s, p < 0.001) velocities during terminal stance into pre-swing phases compared to the Control group. Vertical pelvic excursion was significantly increased in midstance (d(max) = 2.4 cm, p = 0.03) and mediolaterally during pre- to initial-swing phases (d(max) = 7.5 cm, p < 0.001) in the Vestibular group. In addition, pelvic velocities of the Vestibular group were higher mediolaterally during midstance (d(max) = 0.19 m/s, p = 0.02) and vertically during post-initial contact (d(max) = 0.14 m/s, p < 0.001) and pre-swing (d(max) = 0.16 m/s, p < 0.001) compared to the Control group. Significance: The Vestibular group demonstrated a more constrained head movement strategy during gait compared with Controls, a finding that is likely attributed to a neurological impairment of visual-vestibular-somatosensory integration.	[Fraser, John J.; VanDehy, Jacob; Bodell, Dawn M.; Sessoms, Pinata H.] Naval Hlth Res Ctr, Warfighter Performance Dept, Operat Readiness & Hlth Directorate, San Diego, CA 92152 USA; [VanDehy, Jacob; Bodell, Dawn M.; Gottshall, Kim R.] Leidos Inc, San Diego, CA USA; [Gottshall, Kim R.] Florida Ear & Balance Ctr, Kissimmee, FL USA		Fraser, JJ (corresponding author), Naval Hlth Res Ctr, Warfighter Performance Dept, Operat Readiness & Hlth Directorate, San Diego, CA 92152 USA.	john.j.fraser8.mil@mail.mil	Fraser, John J./H-6714-2016	Fraser, John J./0000-0001-9697-3795	U.S. Navy Bureau of Medicine and Surgery [N1703]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery under work unit no. N1703.	Bahat HS, 2014, MANUAL THER, V19, P252, DOI 10.1016/j.math.2013.10.006; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bisdorff AR, 1997, MOVEMENT DISORD, V12, P328, DOI 10.1002/mds.870120311; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Dougherty J.M., 2020, STATPEARLS; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Goldberg JM, 2011, EXP BRAIN RES, V210, P331, DOI 10.1007/s00221-011-2611-5; Han BI, 2011, J CLIN NEUROL, V7, P184, DOI 10.3988/jcn.2011.7.4.184; Karatas M, 2008, NEUROLOGIST, V14, P355, DOI 10.1097/NRL.0b013e31817533a3; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Krebs DE, 2002, PHYS THER, V82, P138, DOI 10.1093/ptj/82.2.138; Laurens J, 2011, EXP BRAIN RES, V210, P407, DOI 10.1007/s00221-011-2568-4; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mijovic T, 2014, OTOL NEUROTOL, V35, pE348, DOI 10.1097/MAO.0000000000000608; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Peng GCY, 1999, IEEE T BIO-MED ENG, V46, P1269, DOI 10.1109/10.797986; Pontzer H, 2009, J EXP BIOL, V212, P523, DOI 10.1242/jeb.024927; POZZO T, 1991, EXP BRAIN RES, V85, P208; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Scofield DE, 2015, STRENGTH COND J, V37, P2, DOI 10.1519/SSC.0000000000000149; Sessoms PH, 2015, MIL MED, V180, P135, DOI 10.7205/MILMED-D-14-00386; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	29	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	AUG 10	2021	3								703982	10.3389/fspor.2021.703982			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UE6SR	WOS:000688016100001	34447930	gold, Green Published, Green Submitted			2022-02-06	
J	Bogossian, EG; Diaferia, D; Djangang, NN; Menozzi, M; Vincent, JL; Talamonti, M; Dewitte, O; Peluso, L; Barrit, S; Al Barajraji, M; Andre, J; Schuind, S; Creteur, J; Taccone, FS				Gouvea Bogossian, Elisa; Diaferia, Daniela; Ndieugnou Djangang, Narcisse; Menozzi, Marco; Vincent, Jean-Louis; Talamonti, Marta; Dewitte, Olivier; Peluso, Lorenzo; Barrit, Sami; Al Barajraji, Mejdeddine; Andre, Joachim; Schuind, Sophie; Creteur, Jacques; Taccone, Fabio Silvio			Brain tissue oxygenation guided therapy and outcome in non-traumatic subarachnoid hemorrhage	SCIENTIFIC REPORTS			English	Article							INTRACRANIAL-PRESSURE; INJURY; MORTALITY; MECHANISMS; PREDICTION; MORBIDITY; VASOSPASM; ANEURYSM; HYPOXIA; DISEASE	Brain hypoxia can occur after non-traumatic subarachnoid hemorrhage (SAH), even when levels of intracranial pressure (ICP) remain normal. Brain tissue oxygenation (PbtO(2)) can be measured as a part of a neurological multimodal neuromonitoring. Low PbtO(2) has been associated with poor neurologic recovery. There is scarce data on the impact of PbtO(2) guided-therapy on patients' outcome. This single-center cohort study (June 2014-March 2020) included all patients admitted to the ICU after SAH who required multimodal monitoring. Patients with imminent brain death were excluded. Our primary goal was to assess the impact of PbtO(2)-guided therapy on neurological outcome. Secondary outcome included the association of brain hypoxia with outcome. Of the 163 patients that underwent ICP monitoring, 62 were monitored with PbtO(2) and 54 (87%) had at least one episode of brain hypoxia. In patients that required treatment based on neuromonitoring strategies, PbtO(2)-guided therapy (OR 0.33 [CI 95% 0.12-0.89]) compared to ICP-guided therapy had a protective effect on neurological outcome at 6 months. In this cohort of SAH patients, PbtO(2)-guided therapy might be associated with improved long-term neurological outcome, only when compared to ICP-guided therapy.	[Gouvea Bogossian, Elisa; Diaferia, Daniela; Ndieugnou Djangang, Narcisse; Menozzi, Marco; Vincent, Jean-Louis; Talamonti, Marta; Peluso, Lorenzo; Creteur, Jacques; Taccone, Fabio Silvio] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium; [Dewitte, Olivier; Barrit, Sami; Al Barajraji, Mejdeddine; Schuind, Sophie] Univ Libre Bruxelles, Erasme Hosp, Dept Neurosurg, Route Lennik 808, B-1070 Brussels, Belgium; [Andre, Joachim] Univ Libre Bruxelles, Erasme Hosp, Dept Radiol, Route Lennik 808, B-1070 Brussels, Belgium		Bogossian, EG (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	elisagobog@gmail.com	Peluso, Lorenzo/AAC-5224-2019; bogossian, elisa/AAY-9516-2021	Peluso, Lorenzo/0000-0001-6885-5353; Gouvea Bogossian, Elisa/0000-0002-2062-465X			Bardt TF, 1998, ACT NEUR S, V71, P153; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Carra G, 2021, NEUROCRIT CARE, V34, P722, DOI 10.1007/s12028-021-01221-4; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; DRAKE CG, 1988, J NEUROSURG, V68, P985; Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; GROTE E, 1988, NEUROSURGERY, V22, P654, DOI 10.1227/00006123-198804000-00006; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; Helbok R, 2011, NEUROCRIT CARE, V14, P162, DOI 10.1007/s12028-010-9472-9; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; JENNETT B, 1975, LANCET, V1, P480; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lee H, 2019, J NEUROSURG, V130, P1914, DOI 10.3171/2018.1.JNS172715; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Mozaffarian, 2015, CIRCULATION, V131, pE535, DOI 10.1161/CIR.0000000000000219; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; PROUST F, 1995, STROKE, V26, P1553, DOI 10.1161/01.STR.26.9.1553; Rass V, 2019, NEUROCRIT CARE, V31, P263, DOI 10.1007/s12028-019-00753-0; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; ROPPER AH, 1984, J NEUROSURG, V60, P909, DOI 10.3171/jns.1984.60.5.0909; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Sandsmark DK, 2012, STROKE, V43, P1440, DOI 10.1161/STROKEAHA.111.639906; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; TEASDALE G, 1974, LANCET, V2, P81; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vath A, 2002, ACT NEUR S, V81, P307; Veldeman M, 2021, NEUROCRIT CARE, V35, P172, DOI 10.1007/s12028-020-01169-x; Veldeman M, 2021, J NEUROSURG, V134, P1527, DOI 10.3171/2020.3.JNS20375; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Xie Q, 2017, WORLD NEUROSURG, V100, P118, DOI 10.1016/j.wneu.2016.12.097; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	51	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 10	2021	11	1							16235	10.1038/s41598-021-95602-6			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY6PJ	WOS:000683904100022	34376735	gold, Green Submitted, Green Published			2022-02-06	
J	Jobanputra, RD; Hayes, J; Royyuru, S; Masen, MA				Jobanputra, Rikeen D.; Hayes, Jack; Royyuru, Sravani; Masen, Marc A.			A numerical analysis of skin-PPE interaction to prevent facial tissue injury	SCIENTIFIC REPORTS			English	Article							CONTACT-DERMATITIS; HEAD MOVEMENT; FRICTION; DAMAGE; SHEAR; PRESSURES; HEADFORMS; ULCERS; FORCES; DEEP	The use of close-fitting PPE is essential to prevent exposure to dispersed airborne matter, including the COVID-19 virus. The current pandemic has increased pressure on healthcare systems around the world, leading to medical professionals using high-grade PPE for prolonged durations, resulting in device-induced skin injuries. This study focuses on computationally improving the interaction between skin and PPE to reduce the likelihood of discomfort and tissue damage. A finite element model is developed to simulate the movement of PPE against the face during day-to-day tasks. Due to limited available data on skin characteristics and how these vary interpersonally between sexes, races and ages, the main objective of this study was to establish the effects and trends that mask modifications have on the resulting subsurface strain energy density distribution in the skin. These modifications include the material, geometric and interfacial properties. Overall, the results show that skin injury can be reduced by using softer mask materials, whilst friction against the skin should be minimised, e.g. through use of micro-textures, humidity control and topical creams. Furthermore, the contact area between the mask and skin should be maximised, whilst the use of soft materials with incompressible behaviour (e.g. many elastomers) should be avoided.	[Jobanputra, Rikeen D.; Hayes, Jack; Royyuru, Sravani; Masen, Marc A.] Imperial Coll London, Dept Mech Engn, Tribol Grp, London, England		Jobanputra, RD (corresponding author), Imperial Coll London, Dept Mech Engn, Tribol Grp, London, England.	Rikeen.Jobanputra14@imperial.ac.uk			Imperial College COVID-19 Response Fund	The authors wish to thank the Imperial College COVID-19 Response Fund for their financial support of this project.	Adams MJ, 2007, TRIBOL LETT, V26, P239, DOI 10.1007/s11249-007-9206-0; Al Badri FM, 2017, CURR ALLERGY CLIN IM, V30, P183; ALY R, 1978, J INVEST DERMATOL, V71, P378, DOI 10.1111/1523-1747.ep12556778; Ascott A, 2021, BRIT J ANAESTH, V126, pE48, DOI 10.1016/j.bja.2020.10.016; Aumailley M, 1999, MATRIX BIOL, V18, P19, DOI 10.1016/S0945-053X(98)00004-3; Bader DL, 2019, CLIN BIOMECH, V67, P70, DOI 10.1016/j.clinbiomech.2019.04.018; Bishopp Abigail, 2019, Ulster Med J, V88, P17; Bouten CV, 2003, ARCH PHYS MED REHAB, V84, P616, DOI 10.1053/apmr.2003.50038; Brill AK, 2017, RESPIROLOGY, V22, P1343, DOI 10.1111/resp.13074; Chopra K, 2015, AESTHET SURG J, V35, P1007, DOI 10.1093/asj/sjv079; DHANDAPANI M, 2021, INDIAN J CRIT CARE M, DOI DOI 10.5005/JP-JOURNALS-10071-23713; Dong Y, 2012, FORENSIC SCI INT, V222, DOI 10.1016/j.forsciint.2012.06.004; Donovan J, 2007, DERMATITIS, V18, DOI [10.1097/01206501-200706000-00013, DOI 10.1097/01206501-200706000-00013]; Donovan J, 2007, DERMATITIS, V18, P40, DOI 10.2310/6620.2007.05003; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; Geerligs M, 2011, BIORHEOLOGY, V48, P229, DOI 10.3233/BIR-2011-0590; Gefen A, 2020, WOUND MANAGE PREV, V66, P6; Gefen Amit, 2020, J Wound Care, V29, pS1, DOI 10.12968/jowc.2020.29.Sup2a.S1; Gerhardt LC, 2008, J R SOC INTERFACE, V5, P1317, DOI 10.1098/rsif.2008.0034; Hatje LK, 2015, BRIT J DERMATOL, V172, P323, DOI 10.1111/bjd.13298; Hendriks CP, 2010, TRIBOL LETT, V37, P361, DOI 10.1007/s11249-009-9530-7; Hua W, 2020, CONTACT DERMATITIS, V83, P115, DOI 10.1111/cod.13601; Jagannathan NS, 2016, J BIOMECH, V49, P1311, DOI 10.1016/j.jbiomech.2015.12.022; Jiang QX, 2020, ADV WOUND CARE, V9, P357, DOI 10.1089/wound.2020.1212; Johnson KL, 1985, CONTACT MECH; Kantor J, 2020, J AM ACAD DERMATOL, V82, P1087, DOI 10.1016/j.jaad.2020.03.013; Klaassen M, 2019, J MECH BEHAV BIOMED, V92, P137, DOI 10.1016/j.jmbbm.2019.01.006; Klaassen M., 2016, BIOTRIBOLOGY, V6, P21, DOI [DOI 10.1016/J.BIOTRI.2016.03.003, 10.1016/j.biotri.2016.03.003]; Kleesz P, 2012, SKIN PHARMACOL PHYS, V25, P25, DOI 10.1159/000330721; Lan JJ, 2020, J AM ACAD DERMATOL, V82, P1215, DOI 10.1016/j.jaad.2020.03.014; Lei Z, 2010, COMPUT AIDED DES APP, V7, P847, DOI [10.3722/cadaps.2010.847-861, DOI 10.3722/CADAPS.2010.847-861]; Lei ZP, 2014, ANN OCCUP HYG, V58, P1186, DOI 10.1093/annhyg/meu064; Lei ZP, 2014, ANN OCCUP HYG, V58, P1175, DOI 10.1093/annhyg/meu051; Lei ZP, 2012, J OCCUP ENVIRON HYG, V9, P46, DOI 10.1080/15459624.2011.635130; Loerakker S, 2010, ANN BIOMED ENG, V38, P2577, DOI 10.1007/s10439-010-0002-x; Luboz V, 2014, ANN BIOMED ENG, V42, P2369, DOI 10.1007/s10439-014-1098-1; Maiti R, 2020, J MECH BEHAV BIOMED, V102, DOI 10.1016/j.jmbbm.2019.103501; Manorama A, 2013, CLIN BIOMECH, V28, P574, DOI 10.1016/j.clinbiomech.2013.04.001; Masen MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239363; Mimura M, 2009, WOUND REPAIR REGEN, V17, P789, DOI 10.1111/j.1524-475X.2009.00540.x; Moore ZEH, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009362.pub3; Oomens C. W. J., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P171, DOI 10.1080/1025584031000121034; Oomens CWJ, 2015, ANN BIOMED ENG, V43, P297, DOI 10.1007/s10439-014-1202-6; Payne A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1743; Polliack AA, 2006, WILD ENVIRON MED, V17, P109, DOI 10.1580/PR30-05.1; Rausch MK, 2017, BIOMECH MODEL MECHAN, V16, P249, DOI 10.1007/s10237-016-0814-1; REICHEL SM, 1958, JAMA-J AM MED ASSOC, V166, P762, DOI 10.1001/jama.1958.62990070004010a; Seo NJ, 2009, ERGONOMICS, V52, P121, DOI 10.1080/00140130802238622; Sernicola A, 2020, INT WOUND J, V17, P1520, DOI 10.1111/iwj.13397; Tang W, 2013, APPL SURF SCI, V273, P199, DOI 10.1016/j.apsusc.2013.02.013; Thorfinn J, 2009, SCAND J PLAST RECONS, V43, P82, DOI 10.1080/02844310902749455; van Kuilenburg J, 2013, TRIBOL INT, V65, P81, DOI 10.1016/j.triboint.2012.11.024; van Kuilenburg J, 2013, P I MECH ENG J-J ENG, V227, P349, DOI 10.1177/1350650112463307; Woo KY, 2017, ADV SKIN WOUND CARE, V30, P494, DOI 10.1097/01.ASW.0000525627.54569.da; Wu YB, 2016, J BIOMECH, V49, P1071, DOI 10.1016/j.jbiomech.2016.02.028; Xing M, 2007, SKIN RES TECHNOL, V13, P310, DOI 10.1111/j.1600-0846.2007.00230.x; Yan YC, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13310; Yang, 2015, 35 COMP INF ENG C A, V1A, DOI [10.1115/DETC2015-46465, DOI 10.1115/DETC2015-46465]; Yang J, 2015, 35 COMP INF ENG C A, V1A, DOI [10.1115/DETC2015-46363, DOI 10.1115/DETC2015-46363]; Yap KK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91119-0; Zahouani H, 2009, SKIN RES TECHNOL, V15, P68, DOI 10.1111/j.1600-0846.2008.00329.x; Zhang M, 1999, PROSTHET ORTHOT INT, V23, P135; Zhou Nuo-Ya, 2020, Int J Dermatol Venereol, DOI 10.1097/JD9.0000000000000085; Zulkowski K, 2017, ADV SKIN WOUND CARE, V30, P372, DOI 10.1097/01.ASW.0000521048.64537.6e	64	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 10	2021	11	1							16248	10.1038/s41598-021-95861-3			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY6PJ	WOS:000683904100051	34376802	Green Published, Green Submitted, gold			2022-02-06	
J	O'Brien, NF; Chetcuti, K; Fonseca, Y; Vidal, L; Raghavan, P; Postels, DG; Chimalizeni, Y; Ray, S; Seydel, KB; Taylor, TE				O'Brien, Nicole F.; Chetcuti, Karen; Fonseca, Yudy; Vidal, Lorenna; Raghavan, Prashant; Postels, Douglas G.; Chimalizeni, Yamikani; Ray, Stephen; Seydel, Karl B.; Taylor, Terrie E.			Cerebral Metabolic Crisis in Pediatric Cerebral Malaria	JOURNAL OF PEDIATRIC INTENSIVE CARE			English	Article; Early Access						cerebral malaria; cerebral blood flow; brain blood flow; brain disorders; metabolic; Doppler sonography; transcranial	TRAUMATIC BRAIN-INJURY; PLASMODIUM-FALCIPARUM MALARIA; CEREBROSPINAL-FLUID LACTATE; INTRACEREBRAL MICRODIALYSIS; PYRUVATE CONCENTRATIONS; THIAMINE-DEFICIENCY; OPENING PRESSURE; MRI FINDINGS; CHILDREN; DYSFUNCTION	Cerebral metabolic energy crisis ( CMEC), often defined as a cerebrospinal fluid (CSF) lactate: pyruvate ratio (LPR) >40, occurs in various diseases and is associated with poor neurologic outcomes. Cerebral malaria ( CM) causes significant mortality and neuro-disability in children worldwide. Multiple factors that could lead to CMEC are plausible in these patients, but its frequency has not been explored. Fifty-three children with CM were enrolled and underwent analysis of CSF lactate and pyruvate levels. All 53 patients met criteria for a CMEC(median CSF LPR of 72.9 [interquartile range [IQR]: 58.5-93.3]). Half of children met criteria for an ischemic CMEC (median LPR of 85 [IQR: 73-184]) and half met criteria for a nonischemic CMEC (median LPR of 60 [IQR: 54-79]. Children also underwent transcranial doppler ultrasound investigation. Cerebral blood flow velocities were more likely to meet diagnostic criteria for low flow (<2 standard deviation from normal) or vasospasm in children with an ischemic CMEC (73%) than in children with a nonischemic CMEC (20%, p = 0.04). Children with an ischemic CMEC had poorer outcomes (pediatric cerebral performance category of 3-6) than those with a nonischemic CMEC (46 vs. 22%, p = 0.03). CMEC was ubiquitous in this patient population and the processes underlying the two subtypes (ischemic and nonischemic) may represent targets for future adjunctive therapies.	[O'Brien, Nicole F.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Div Crit Care Med, 700 Childrens Dr, Columbus, OH 43210 USA; [Chetcuti, Karen] Chichiri, Dept Radiol, Coll Med, Blantyre, Malawi; [Fonseca, Yudy] Univ Maryland, Med Ctr, Dept Pediat, Div Crit Care Med, Baltimore, MD 21201 USA; [Vidal, Lorenna] Univ Penn, Clin Instructor Perelman, Div Neuroradiol, Childrens Hosp Philadelphia,Sch Med,Dept Radiol, Philadelphia, PA USA; [Raghavan, Prashant] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Postels, Douglas G.] George Washington Univ, Childrens Natl Med Ctr, Dept Neurol, Washington, DE USA; [Chimalizeni, Yamikani] Univ Malawi, Malawi Coll Med, Dept Pediat & Child Hlth, Blantyre, Malawi; [Ray, Stephen] Malawi Liverpool Wellcome Trust Clin Res Programm, Dept Paediat, Blantyre, Malawi; [Seydel, Karl B.; Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [Seydel, Karl B.] Blantyre Malaria Project, Blantyre, Malawi		O'Brien, NF (corresponding author), Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Div Crit Care Med, 700 Childrens Dr, Columbus, OH 43210 USA.	Nicole.obrien@nationwidechildrens.org		Vidal, Lorenna/0000-0003-3715-2510; Chetcuti, Karen/0000-0002-9768-9494; Postels, Douglas/0000-0001-5815-0691	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA016058]	The work for this project was carried out by MS and P laboratory at the Ohio State University, which is supported by NIH award number (grant no. P30 CA016058).	A quick guide to pediatric cardiopulmonary care, QUICK GUIDE PEDIAT C QUICK GUIDE PEDIAT C; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Alexandrov AV, 2007, J NEUROIMAGING, V17, P6, DOI 10.1111/j.1552-6569.2006.00083.x; APPLEGARTH DA, 1979, CLIN BIOCHEM, V12, P173, DOI 10.1016/S0009-9120(79)80084-3; Avery RA, 2014, J NEURO-OPHTHALMOL, V34, P284, DOI 10.1097/WNO.0000000000000154; Avery RA, 2010, NEW ENGL J MED, V363, P891, DOI 10.1056/NEJMc1004957; Barrow GI, 1993, COWAN STEELS MANUAL; Bartek Jiri Jr, 2016, PLoS One, V11, pe0152268, DOI 10.1371/journal.pone.0152268; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Benoist JF, 2003, CLIN CHEM, V49, P487, DOI 10.1373/49.3.487; Bitar R, 2006, RADIOGRAPHICS, V26, P513, DOI 10.1148/rg.262055063; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Carteron L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00325; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clavier N, 1999, CRIT CARE MED, V27, P628, DOI 10.1097/00003246-199903000-00047; CRUICKSHANK AM, 1988, INTENS CARE MED, V14, P384, DOI 10.1007/BF00262893; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; DRAYER B, 1987, AM J ROENTGENOL, V149, P357, DOI 10.2214/ajr.149.2.357; Engquist H, 2021, J NEUROSURG, V134, P555, DOI 10.3171/2019.11.JNS192759; Fahn S, 1976, Adv Neurol, V14, P59; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103; FUJISHIMA M, 1975, STROKE, V6, P707, DOI 10.1161/01.STR.6.6.707; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hiffler L, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00016; HO VB, 1993, RADIOGRAPHICS, V13, P269, DOI 10.1148/radiographics.13.2.8460220; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kampondeni SD, 2013, AM J TROP MED HYG, V88, P542, DOI 10.4269/ajtmh.12-0538; Kerscher SR, 2020, CHILD NERV SYST, V36, P107, DOI 10.1007/s00381-019-04336-4; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Kotlyar S, 2018, PEDIATR CRIT CARE ME, V19, P179, DOI 10.1097/PCC.0000000000001411; Krishna S, 1999, LANCET, V353, P546, DOI 10.1016/S0140-6736(98)06316-8; Langfitt JT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-1026; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Maitland K, 2003, QJM-INT J MED, V96, P427, DOI 10.1093/qjmed/hcg077; Mohanty S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00193-17, 10.1128/msphere.00193-17]; Mohanty S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-276; MORI K, 1993, ACTA NEUROCHIR, V125, P20, DOI 10.1007/BF01401823; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Newton CRJC, 1997, ARCH DIS CHILD, V76, P219, DOI 10.1136/adc.76.3.219; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; O'Brien NF, 2018, J PEDIATR-US, V203, P116, DOI 10.1016/j.jpeds.2018.07.075; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; OMANGA U, 1983, ANN PEDIATR-PARIS, V30, P294; PFALLER MA, 1982, EXP PARASITOL, V54, P391, DOI 10.1016/0014-4894(82)90048-0; Planche T, 2005, TRENDS PARASITOL, V21, P562, DOI 10.1016/j.pt.2005.09.010; Planche T, 2004, PLOS MED, V1, P56, DOI 10.1371/journal.pmed.0010018; Potchen MJ, 2012, AM J NEURORADIOL, V33, P1740, DOI 10.3174/ajnr.A3035; Quinn CT, 2015, BLOOD, V125, P1516, DOI 10.1182/blood-2015-01-619981; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Renfrow Jaclyn J, 2018, Surg Neurol Int, V9, P155, DOI 10.4103/sni.sni_105_18; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanchez-Guerrero A, 2017, J CEREBR BLOOD F MET, V37, P2742, DOI 10.1177/0271678X16674222; Sanni LA, 2001, AM J PATHOL, V159, P1105, DOI 10.1016/S0002-9440(10)61786-5; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Taylor Terrie E, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS6, DOI 10.1016/j.trstmh.2008.10.049; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tobieson L, 2019, NEUROSURGERY, V84, P1269, DOI 10.1093/neuros/nyy179; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wallin E, 2018, ACTA ANAESTH SCAND, V62, P1237, DOI 10.1111/aas.13162; WARRELL DA, 1988, LANCET, V2, P534; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; WYATT DT, 1991, AM J CLIN NUTR, V53, P530, DOI 10.1093/ajcn/53.2.530; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008	79	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2146-4618	2146-4626		J PEDIATR INTENSIVE	J. Pediatr. Intensive Care												10.1055/s-0041-1732444		AUG 2021	11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	TY1AV	WOS:000683517500001					2022-02-06	
J	Viet, QHN; Nguyen, VQ; Hoang, DML; Thi, THP; Tran, HP; Thi, CHC				Quang Hien Nguyen Viet; Viet Quang Nguyen; Duy Minh Le Hoang; Thuy Hoa Phan Thi; Huu Phuc Tran; Cam Ha Che Thi			Ability to regulate immunity of mesenchymal stem cells in the treatment of traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article; Early Access						Traumatic brain injury; Mesenchymal stem cell; Mononuclear cells; Transplantation; Neuroimmunity; Anti-inflammation	INFLAMMATION; CYTOKINES; THERAPY	Traumatic brain injury (TBI) is characterized by broad clinical symptoms in brain insult by external damages to the skull. TBI potentially leads to severe physical, cognitive, and emotional impairment. The complex biochemical reactions of inflammatory processes in TBI significantly influence brain function and clinical sequelae's overall severity. Mesenchymal stem cell therapy has become a promising therapeutic field of treatment for serious injuries due to its ability to regulate the inflammatory microenvironment. In this study, we aimed to investigate MSC's anti-inflammatory ability through regulating leukocyte, neutrophils, and inflammatory factors (IL-6, CRP, and TNF-a), thereby reducing the trauma in the TBI. Biological effects of autologous MNC and MSC cell transplantation have been studied in 40 patients with molded TBI, after being filtered according to appropriate criteria. All patients initially received MNCs and subsequently MSCs (both intravenously) followed by continuous monitoring during treatment (2 months) with clinical cognitive indicators. The results after transplantation MSC indicated that the majority of patients experienced improved health function in different degrees during the follow-up period. Lower serum levels of inflammatory factors, leukocytes, and neutrophils population were detected following the transplantation compared with the levels prior to treatment and with the control patients. No severe symptoms were observed in patients after transplantation, despite 3-4 death cases in each group. Overall, the present study suggests that transplantation of MSC possibly regulates inflammatory factors and appears to be safe in TBI treatment.	[Quang Hien Nguyen Viet; Viet Quang Nguyen] Hue Cent Hosp, Anesthesiol & Recovery Dept, 16 Le Loi St, Hue City, Vietnam; [Duy Minh Le Hoang; Huu Phuc Tran; Cam Ha Che Thi] Hue Univ, Biol Dept, 03 Le Loi St, Hue City, Vietnam; [Thuy Hoa Phan Thi] Hue Cent Hosp, Hematol Dept, Hue, Vietnam; [Cam Ha Che Thi] Hue Cent Hosp, Hue, Vietnam		Thi, CHC (corresponding author), Hue Univ, Biol Dept, 03 Le Loi St, Hue City, Vietnam.; Thi, CHC (corresponding author), Hue Cent Hosp, Hue, Vietnam.	chethicamha@husc.edu.vn			Vietnam Ministry of Science and Technology	The funding provided by the Vietnam Ministry of Science and Technology has been used in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bonsack B, 2020, CNS NEUROSCI THER, V26, P603, DOI 10.1111/cns.13378; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Huang P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42182-1; Kanof ME, 1996, ISOLATION WHOLE MONO, V19, DOI [10.1002/0471142735.im0701s19, DOI 10.1002/0471142735.IM0701S19]; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MAHONEY F I, 1965, Md State Med J, V14, P61; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; Ortiz G., 2014, SACCO R NATL I HLTH; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Ranneh Y, 2017, APPL BIOL CHEM, V60, P327, DOI 10.1007/s13765-017-0285-9; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Venetsanou K, 2007, EUR CYTOKINE NETW, V18, P206, DOI 10.1684/ecn.2007.0112	22	0	0	3	3	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.												10.1007/s10072-021-05529-z		AUG 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TY3MY	WOS:000683689500001	34374864				2022-02-06	
J	Schiffer, F; Khan, A; Bolger, E; Flynn, E; Seltzer, WPP; Teicher, MHH				Schiffer, Fredric; Khan, Alaptagin; Bolger, Elizabeth; Flynn, Edward; Seltzer, William P. P.; Teicher, Martin H. H.			An Effective and Safe Novel Treatment of Opioid Use Disorder: Unilateral Transcranial Photobiomodulation	FRONTIERS IN PSYCHIATRY			English	Article						opioid use disorder; opioid cravings; opioid use; hemispheric laterality; photobiomodulation	VISUAL-FIELD STIMULATION; TRAUMATIC BRAIN-INJURY; COGNITIVE PERFORMANCE; BUPRENORPHINE/NALOXONE; HEMISPHERE; PREDICTION; ADDICTION; RETENTION; ASYMMETRY; LIGHT	Background: The opioid epidemic is a global tragedy even with current treatments, and a novel, safe, and effective treatment would be welcomed. We report here our findings from our second randomized controlled trial to evaluate unilateral transcranial photobiomodulation as a treatment for opioid use disorder. Methods: We enrolled 39 participants with active opioid cravings at 2 sites, 19 received the active treatment which consisted of a 4-min twice weekly (every 3 or 4 days) application of a light-emitting diode at 810 nm with an irradiance of 250 mW/cm(2) and a fluence of 60 J/cm(2) to the forehead over either the left or right dorsolateral prefrontal cortex with a fluence to the brain of 2.1 J/cm(2). Twenty participants received a sham treatment with the same device with foil over the bulb. The side of the treatment was based on Dual-Brain Psychology, which posits that one hemisphere is more affected by past maltreatments and is more prone to anxiety and drug cravings that the other hemisphere. We treated the hemisphere with the more positive hemispheric emotional valence (HEV) by 2 tests for HEV. Results: Our primary outcome was changes in pre-treatment opioid craving scale (OCS) minus baseline, and we found using a mixed model that the active group had a highly significant treatment * time benefit over the sham group, p < 0.0001, effect size at the last follow-up of 1.5. The active treatment benefited those not on buprenorphine as well as those not on it. The TimeLine Follow Back measure of opioid use was significantly better in the actively treated group, p = 0.0001, with an effect size of 0.45. We observed no adverse effects. Conclusion: Active unilateral transcranial photobiomodulation to the brain hemisphere with the better HEV was better than sham in the reduction of opioid cravings and opioid use to a very significant degree in a RCT of 39 participants at 2 independent sites. In the active group those on buprenorphine and those not on it both had improvements in cravings over the study. No adverse responses were reported in either group. Identifier: NCT04340622.	[Schiffer, Fredric; Flynn, Edward; Seltzer, William P. P.] MindLight LLC, Newton Highlands, MA 02461 USA; [Schiffer, Fredric; Khan, Alaptagin; Bolger, Elizabeth; Teicher, Martin H. H.] McLean Hosp, Dev Biopsychiat Res Program, 115 Mill St, Belmont, MA 02178 USA; [Schiffer, Fredric; Khan, Alaptagin; Teicher, Martin H. H.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Schiffer, F (corresponding author), MindLight LLC, Newton Highlands, MA 02461 USA.; Schiffer, F (corresponding author), McLean Hosp, Dev Biopsychiat Res Program, 115 Mill St, Belmont, MA 02178 USA.; Schiffer, F (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.	fschiffer@mclean.harvard.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [1 R43 DA05035801]; HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44-Clinical Trial Optional)	This work was supported by the National Institutes of Health, and the National Institute on Drug Abuse Grant 1 R43 DA05035801 and HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44-Clinical Trial Optional).	[Anonymous], 1989, JMP VERS 15; Barolet D, 2016, J PHOTOCH PHOTOBIO B, V155, P78, DOI 10.1016/j.jphotobiol.2015.12.014; Caldieraro MA, 2019, J AFFECT DISORDERS, V243, P262, DOI 10.1016/j.jad.2018.09.048; Cassano P, 2019, PHOTOBIOMOD PHOTOMED, V37, P651, DOI 10.1089/photob.2019.4678; Cassano P, 2018, PHOTOMED LASER SURG, V36, P634, DOI 10.1089/pho.2018.4490; Cassano P, 2019, LASER SURG MED, V51, P127, DOI 10.1002/lsm.23011; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Committee for Medicinal Products for Human Use, 2015, GUID ADJ BAS COV CLI; de la Torre JC, 2020, NEUROPHARMACOLOGY, V171, DOI 10.1016/j.neuropharm.2019.107841; El Khoury H, 2019, NEUROSCIENCE, V422, P161, DOI 10.1016/j.neuroscience.2019.10.037; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Longo MGF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17337; Fudala PJ, 2003, NEW ENGL J MED, V349, P949, DOI 10.1056/NEJMoa022164; Gainotti G, 2019, J HIST NEUROSCI, V28, P23, DOI 10.1080/0964704X.2018.1524683; Gonzalez-Lima F, 2014, BIOCHEM PHARMACOL, V88, P584, DOI 10.1016/j.bcp.2013.11.010; Hamblin MR, 2019, PHOTONICS-BASEL, V6, DOI 10.3390/photonics6030077; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hedegaard Holly, 2017, NCHS Data Brief, P1; Heo YA, 2018, CNS DRUGS, V32, P875, DOI 10.1007/s40263-018-0560-2; Hser YI, 2014, ADDICTION, V109, P79, DOI 10.1111/add.12333; Hwang J, 2016, LASER MED SCI, V31, P1151, DOI 10.1007/s10103-016-1962-3; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Keshri GK, 2020, LASER SURG MED, V52, P424, DOI 10.1002/lsm.23156; Knudsen HK, 2011, J ADDICT MED, V5, P21, DOI 10.1097/ADM.0b013e3181d41ddb; Marcovitz DE, 2016, AM J ADDICTION, V25, P472, DOI 10.1111/ajad.12414; Mattick RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub4; McHugh RK, 2014, DRUG ALCOHOL DEPEN, V145, P121, DOI 10.1016/j.drugalcdep.2014.10.002; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; National Institute on Drug Abuse, 2018, FISC YEAR 2018 BUDG; Nielsen S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011117.pub2; Orman JS, 2009, CNS DRUGS, V23, P899, DOI 10.2165/11203740-000000000-00000; Pople CB, 2020, J ALZHEIMERS DIS, V78, P1299, DOI 10.3233/JAD-200913; R Core Team, 2020, R LANG ENV STAT COMP; Vitor LLR, 2020, J PHOTOCH PHOTOBIO B, V203, DOI 10.1016/j.jphotobiol.2019.111738; Salehpour F, 2019, PHOTOBIOMOD PHOTOMED, V37, P581, DOI 10.1089/photob.2019.4676; Salehpour F, 2019, PHOTOBIOMOD PHOTOMED, V37, P635, DOI 10.1089/photob.2019.4673; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; San Miguel M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100564; Schiffer F, 1998, NEUROPSY NEUROPSY BE, V11, P151; Schiffer F, 2004, PSYCHIAT RES-NEUROIM, V131, P1, DOI 10.1016/j.pscychresns.2004.01.002; Schiffer F, 1999, COMPR PSYCHIAT, V40, P221, DOI 10.1016/S0010-440X(99)90007-X; Schiffer F, 1996, HARVARD REV PSYCHIAT, V4, P126, DOI 10.3109/10673229609030535; Schiffer F, 1997, COMPR PSYCHIAT, V38, P289, DOI 10.1016/S0010-440X(97)90062-6; Schiffer F, 2002, NEUROPSY NEUROPSY BE, V15, P18; SCHIFFER F, 1995, J NEUROPSYCH CLIN N, V7, P169; Schiffer F., 2020, FRONT PSYCHIATRY, V11, P1; Schiffer F, 2000, J TRAUMA DISSOCIATIO, V1, P83, DOI DOI 10.1300/J229V01N02_06; Schiffer F., 2021, NEUROSCIENCE, V2, P224, DOI [10.3390/neurosci2020016, DOI 10.3390/NEUROSCI2020016]; Schiffer F., 1998, 2 MINDS REVOLUTIONAR; Schiffer F, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-13; Schiffer F, 2008, J NEUROPSYCH CLIN N, V20, P194, DOI 10.1176/appi.neuropsych.20.2.194; Schiffer F, 2021, J PSYCHIATR RES, V133, P134, DOI 10.1016/j.jpsychires.2020.12.004; Schiffer F, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00827; Schiffer F, 2019, MED HYPOTHESES, V125, P57, DOI 10.1016/j.mehy.2019.02.011; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Soeffing JM, 2009, J SUBST ABUSE TREAT, V37, P426, DOI 10.1016/j.jsat.2009.05.003; SPERRY RW, 1979, NEUROPSYCHOLOGIA, V17, P153, DOI 10.1016/0028-3932(79)90006-X; Stein MD, 2005, J GEN INTERN MED, V20, P1038, DOI 10.1111/j.1525-1497.2005.0228.x; Tomazoni SS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236689; Urquhart EL, 2020, BIOMED OPT EXPRESS, V11, P5783, DOI 10.1364/BOE.402047; Wang YG, 2017, BBA-GEN SUBJECTS, V1861, P441, DOI 10.1016/j.bbagen.2016.10.008; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WITTLING W, 1993, CORTEX, V29, P431, DOI 10.1016/S0010-9452(13)80252-3; WITTLING W, 1993, NEUROPSYCHOLOGIA, V31, P591, DOI 10.1016/0028-3932(93)90054-4; Zhang Z, 2020, AGING CELL, V19, DOI 10.1111/acel.13054; Zomorrodi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42693-x	71	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	AUG 10	2021	12								713686	10.3389/fpsyt.2021.713686			15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	UE2ET	WOS:000687708000001	34447323	gold, Green Published			2022-02-06	
J	Zhong, GB; Yang, YQ; Huang, XD; Chen, JL; Feng, DM; Wei, K; Chen, JW; Chen, HH				Zhong, Guibin; Yang, Yanqiu; Huang, Xiaodong; Chen, Junling; Feng, Daming; Wei, Ke; Chen, Jianwei; Chen, Haihong			The Serum SIRT1 Protein is Associated with the Severity of Injury and Neurological Recovery in Mice with Traumatic Spinal Cord Injury	NEUROSCIENCE			English	Article						traumatic spinal cord injury; Basso mouse scale; functional recovery; SIRT1	INTERNATIONAL STANDARDS; FUNCTIONAL OUTCOMES; BRAIN-INJURY; CLASSIFICATION; INFLAMMATION; PREVALENCE; SIRTUINS	present study aimed to investigate the association between the serum SIRT1 protein and the severity of spinal cord injury (SCI) as well as the neurological recovery in mice. In this study, the wild-type (WT), Mx1Cre+ SIRT1loxP/loxP (Mx1), and LCK-Cre+SIRT1loxP/loxP (LCK) mice were subjected to sham surgery, mild, moderate, or severe SCI, respectively. The serum was collected at intervals of 12 h, 1 day (d), 3 d, 5 d, 7 d, 10 d, 14 d, and 21 d after the injury. The locomotor function of all the animals was assessed using the Basso mouse scale (BMS) and the serum SIRT1 proteins were analyzed using enzyme-linked immunosorbent assay (ELISA). The results demonstrated that about 7-10 d after SCI, the levels of SIRT1 protein in the serum correlated significantly with the severity of the injury and at 28 d post-injury, there was a distant neurological recovery (BMS score). The serum SIRT1 concentration in both the Mx1 and LCK mice in the sham group was significantly reduced compared to that in the WT mice, and there was a delayed increase in the serum SIRT1 levels after injury. These findings indicate that the SIRT1 concentrations in the serum of the SCI mice closely correlated with the acute severity and neurological outcome. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of IBRO. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Zhong, Guibin; Yang, Yanqiu; Chen, Junling; Feng, Daming; Wei, Ke] Shanghai Jiao Tong Univ, Baoshan Branch, Med Dept, Ren Ji Hosp,Sch Med, Shanghai 200444, Peoples R China; [Huang, Xiaodong] Guangzhou Med Univ, Dept Orthoped, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Zhong, Guibin; Chen, Jianwei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Orthoped, Sch Med, Shanghai 200127, Peoples R China; [Chen, Haihong] Fudan Univ, Minhang Ctr Hosp, Orthoped Dept, Shanghai 201100, Peoples R China		Chen, JW (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Orthoped, Sch Med, Shanghai 200127, Peoples R China.; Chen, HH (corresponding author), Fudan Univ, Minhang Ctr Hosp, Orthoped Dept, Shanghai 201100, Peoples R China.	jwchenbone@126.com; 563287706@qq.com			Scientific Research Project of Shanghai Municipal Health Commission [202040370]; Shanghai Baoshan Science and Technology Innovation Fund Program [20E33]	Scientific Research Project of Shanghai Municipal Health Commission (No. 202040370) . Shanghai Baoshan Science and Technology Innovation Fund Program (No. 20E33) .	Ahrenhoerster LS, 2015, TOXICOL APPL PHARM, V283, P99, DOI 10.1016/j.taap.2014.12.017; Aimetti AA, 2019, SPINAL CORD, V57, P753, DOI 10.1038/s41393-019-0299-8; Becher B, 2018, IMMUNITY, V48, P835, DOI 10.1016/j.immuni.2018.05.002; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Cavanagh MM, 2012, CURR OPIN IMMUNOL, V24, P488, DOI 10.1016/j.coi.2012.04.003; Chen HH, 2017, J NEUROSCI, V37, P2916, DOI 10.1523/JNEUROSCI.3046-16.2017; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Duan WZ, 2013, CNS DRUGS, V27, P345, DOI 10.1007/s40263-013-0055-0; Eckert MJ, 2017, SURG CLIN N AM, V97, P1031, DOI 10.1016/j.suc.2017.06.008; Evaniew N, 2020, SPINAL CORD, V58, P247, DOI 10.1038/s41393-019-0359-0; Facchinello Y, 2017, J NEUROTRAUM; Fernandez AJ, 2019, P NATL ACAD SCI USA, V116, P20404, DOI 10.1073/pnas.1902211116; Frazier-Wood AC, 2013, NUTR METAB CARDIOVAS, V23, P1154, DOI 10.1016/j.numecd.2012.12.007; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kumar R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061560, 10.1371/journal.pone.0074743]; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Ma ZW, 2016, EXP NEUROL, V279, P261, DOI 10.1016/j.expneurol.2016.02.008; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Ng YS, 2007, ANN ACAD MED SINGAP, V36, P3; Nimmagadda VK, 2013, J IMMUNOL, V190, P4595, DOI 10.4049/jimmunol.1202584; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Priebe MM, 2007, ARCH PHYS MED REHAB, V88, pS84, DOI 10.1016/j.apmr.2006.12.005; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Santos DM, 2013, MOL NEUROBIOL, V47, P313, DOI 10.1007/s12035-012-8353-y; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Walden K, 2016, SPINAL CORD, V54, P197, DOI 10.1038/sc.2015.137; Wang YJ, 2015, RESPIROLOGY, V20, P1066, DOI 10.1111/resp.12558; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zheng MJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02525	38	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 10	2021	469						103	109		10.1016/j.neuroscience.2021.06.025			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TP6AF	WOS:000677679400009	34171408	hybrid			2022-02-06	
J	Garcia-Rudolph, A; Garcia-Molina, A; Opisso, E; Tormos, JM; Madai, VI; Frey, D; Bemabeu, M				Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Maria Tormos, Josep; Madai, Vince, I; Frey, Dietmar; Bemabeu, Montserrat			Neuropsychological Assessments of Patients With Acquired Brain Injury: A Cluster Analysis Approach to Address Heterogeneity in Web-Based Cognitive Rehabilitation	FRONTIERS IN NEUROLOGY			English	Article						acquired brain injury; cluster analysis; cognitive rehabilitation; web-based platform; neuropsychological assessment; mixed-type data; functional independence	STROKE; TRAIL; CLASSIFICATION; GUIDELINES; PROFILES; SCORES; ADULTS	We aimed to (1) apply cluster analysis techniques to mixed-type data (numerical and categorical) from baseline neuropsychological standard and widely used assessments of patients with acquired brain injury (ABI) (2) apply state-of-the-art cluster validity indexes (CVI) to assess their internal validity (3) study their external validity considering relevant aspects of ABI rehabilitation such as functional independence measure (FIM) in activities of daily life assessment (4) characterize the identified profiles by using demographic and clinically relevant variables and (5) extend the external validation of the obtained clusters to all cognitive rehabilitation tasks executed by the participants in a web-based cognitive rehabilitation platform (GNPT). We analyzed 1,107 patients with ABI, 58.1% traumatic brain injury (TBI), 21.8% stroke and 20.1% other ABIs (e.g., brain tumors, anoxia, infections) that have undergone inpatient GNPT cognitive rehabilitation from September 2008 to January 2021. We applied the k-prototypes algorithm from the clustMixType R package. We optimized seven CVIs and applied bootstrap resampling to assess clusters stability (fpc R package). Clusters' post hoc comparisons were performed using the Wilcoxon ranked test, paired t -test or Chi-square test when appropriate. We identified a three-clusters optimal solution, with strong stability (>0.85) and structure (e.g., Silhouette > 0.60, Gamma > 0.83), characterized by distinctive level of performance in all neuropsychological tests, demographics, FIM, response to GNPT tasks and tests normative data (e.g., the 3 min cut-off in Trail Making Test-B). Cluster 1 was characterized by severe cognitive impairment (N = 254, 22.9%) the mean age was 47 years, 68.5% patients with TBI and 22% with stroke. Cluster 2 was characterized by mild cognitive impairment (N = 376, 33.9%) mean age 54 years, 53.5% patients with stroke and 27% other ABI. Cluster 3, moderate cognitive impairment (N = 477, 43.2%) mean age 33 years, 83% patients with TBI and 14% other ABI. Post hoc analysis on cognitive FIM supported a significant higher performance of Cluster 2 vs. Cluster 3 (p < 0.001), Cluster 2 vs. Cluster 1 (p < 0.001) and Cluster 3 vs. Cluster 1 (p < 0.001). All patients executed 286,798 GNPT tasks, with performance significantly higher in Cluster 2 and 3 vs. Cluster 1 (p < 0.001).	[Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Maria Tormos, Josep; Bemabeu, Montserrat] Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain; [Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Maria Tormos, Josep; Bemabeu, Montserrat] Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain; [Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto; Opisso, Eloy; Maria Tormos, Josep; Bemabeu, Montserrat] Inst Guttmann Hosp Neurorehabil, Badalona, Spain; [Madai, Vince, I; Frey, Dietmar] Charite Univ Med Berlin, CLAIM Charite Lab AI Med, Berlin, Germany; [Madai, Vince, I] Berlin Inst Hlth BIH, QUEST Ctr Transforming Biomed Res, Berlin, Germany; [Madai, Vince, I] Birmingham City Univ, Fac Comp Engn & Built Environm, Sch Comp & Digital Technol, Birmingham, W Midlands, England		Garcia-Rudolph, A (corresponding author), Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain.; Garcia-Rudolph, A (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain.; Garcia-Rudolph, A (corresponding author), Inst Guttmann Hosp Neurorehabil, Badalona, Spain.	alejandropablogarcia@gmail.com	Madai, Vince/AAF-5525-2020	Madai, Vince/0000-0002-8552-6954	PRECISE4Q Personalised Medicine by Predictive Modelling in Stroke for better Quality	This research was partially funded by PRECISE4Q Personalised Medicine by Predictive Modelling in Stroke for better Quality	Ahmad A, 2019, IEEE ACCESS, V7, P31883, DOI 10.1109/ACCESS.2019.2903568; Akinina Y, 2021, APHASIOLOGY, V35, P1334, DOI 10.1080/02687038.2020.1812045; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Brock KA, 2007, ARCH PHYS MED REHAB, V88, P827, DOI 10.1016/j.apmr.2007.04.001; Cappa SF, 2005, EUR J NEUROL, V12, P665; Melendez-Moral JC, 2012, AN PSICOL-SPAIN, V28, P604, DOI 10.6018/analesps.28.2.148891; Cha YJ, 2013, NEUROREHABILITATION, V32, P359, DOI 10.3233/NRE-130856; D'Souza A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00353; Ferre P, 2012, FOLIA PHONIATR LOGO, V64, P199, DOI 10.1159/000340017; Garcia-Rudolph A, 2020, JMIR MED INF, V8, DOI 10.2196/16077; Gil-Pages M, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2577-8; Giles GM, 2019, BRAIN INJURY, V33, P129, DOI 10.1080/02699052.2018.1539762; Gocan Sophia, 2008, Can J Neurosci Nurs, V30, P31; Goldstein, 2013, CLUSTER ANAL NEUROPS, P37, DOI DOI 10.1007/978-1-4614-6744-1_3; Goldstein G.., 2013, CLUSTER ANAL NEUROPS, DOI [10.1007/978-1-4614-6744-1, DOI 10.1007/978-1-4614-6744-1]; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Harvey PD, 2018, BIOL PSYCHIAT-COGN N, V3, P907, DOI 10.1016/j.bpsc.2018.06.008; Heaton R., 1993, WISCONSIN CARD SORTI; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hiratsuka T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62176-8; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lemasson B, 2017, MONITORING GLIOMA HE; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; M Malathi, 2018, Asian Pac J Cancer Prev, V19, P3257; MacQueen J, 1967, P 5 BERKELEY S MATH; Maechler M., 2018, CLUSTER CLUSTER ANAL; Mattei TA, 2020, WORLD NEUROSURG, V134, P311, DOI 10.1016/j.wneu.2019.10.193; Modig S, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-55; Nousia A, 2021, APPL NEUROPSYCH-ADUL, V28, P717, DOI 10.1080/23279095.2019.1692842; Nyberg CK, 2018, TOP STROKE REHABIL, V25, P241, DOI 10.1080/10749357.2018.1443570; O'Neil-Pirozzi TM, 2016, BRAIN INJURY, V30, P1617, DOI 10.1080/02699052.2016.1199906; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Pena-Casanova J, 1991, REV LOGOPEDIA FONIAT, V11, P96; Perez LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166304; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Preiss M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00108; Quintana M, 2011, ARCH CLIN NEUROPSYCH, V26, P144, DOI 10.1093/arclin/acq098; Reitan R, 1985, HALSTEAD REITAN NEUR; Rocci, 2020, HDB CLUSTER ANAL; Roy M, 2013, CAN GERIATR J, V16, P120, DOI 10.5770/cgj.16.76; Ryan JJ, 2001, PERSP INDIV, P19; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Schmid M, 1996, REY AUDITORY VERBAL; Schroeder RW, 2019, AM FAM PHYSICIAN, V99, P101; Schultheis Maria T, 2014, Curr Phys Med Rehabil Rep, V2, P176; Scrutinio D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00084; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Sigmundsdottir L, 2016, NEUROPSYCHOL REHABIL, V26, P673, DOI 10.1080/09602011.2016.1140657; Sisik F, 2020, MED HYPOTHESES, V136, DOI 10.1016/j.mehy.2019.109507; Solana J, 2015, IEEE J BIOMED HEALTH, V19, P124, DOI 10.1109/JBHI.2014.2354537; Solana J, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-58; STROBE, STRENGTH REP OBS STU; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Svaerke K, 2019, TOP STROKE REHABIL, V26, P214, DOI 10.1080/10749357.2018.1556963; Szepannek G, 2020, ARCH DATA SCI, V6, DOI [10.5445/KSP/1000098011/02, DOI 10.5445/KSP/1000098011/02]; Szepannek G, 2018, R J, V10, P200; Thaler NS, 2013, ARCH CLIN NEUROPSYCH, V28, P798, DOI 10.1093/arclin/act080; van de Velden M, 2019, WIRES COMPUT STAT, V11, DOI 10.1002/wics.1456; van de Ven RM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00150; Wechsler D., 1997, WECHSLER ADULT INTEL, DOI [10.1037/t49755-000, DOI 10.1037/T49755-000]; Whitmer AJ, 2012, J ABNORM PSYCHOL, V121, P570, DOI 10.1037/a0027474; Yamanaka S., 2014, J STAGE, V29, P933, DOI [10.1589/rika.29.933, DOI 10.1589/RIKA.29.933]; Ye MM, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1831555; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613	73	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 9	2021	12								701946	10.3389/fneur.2021.701946			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UA2HQ	WOS:000684985700001	34434163	Green Published, gold			2022-02-06	
J	Liu, N; Han, JR; Li, YD; Jiang, YH; Shi, SX; Lok, J; Whalen, M; Dumont, AS; Wang, XY				Liu, Ning; Han, Jinrui; Li, Yadan; Jiang, Yinghua; Shi, Samuel X.; Lok, Josephine; Whalen, Michael; Dumont, Aaron S.; Wang, Xiaoying			Recombinant annexin A2 inhibits peripheral leukocyte activation and brain infiltration after traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Recombinant annexin A2; TLR4; Leukocyte infiltration; Neuroinflammation; Neurobehavioral	CONTROLLED CORTICAL IMPACT; DYSFUNCTION	Background Traumatic brain injury (TBI) is a significant cause of death and disability worldwide. The TLR4-NF kappa B signaling cascade is the critical pro-inflammatory activation pathway of leukocytes after TBI, and modulating this signaling cascade may be an effective therapeutic target for treating TBI. Previous studies indicate that recombinant annexin A2 (rA2) might be an interactive molecule modulating the TLR4-NF kappa B signaling; however, the role of rA2 in regulating this signaling pathway in leukocytes after TBI and its subsequent effects have not been investigated. Methods C57BL/6 mice were subjected to TBI and randomly divided into groups that received intraperitoneal rA2 or vehicle at 2 h after TBI. The peripheral leukocyte activation and infiltrating immune cells were examined by flow cytometry, RT-qPCR, and immunostaining. The neutrophilic TLR4 expression on the cell membrane was examined by flow cytometry and confocal microscope, and the interaction of annexin A2 with TLR4 was assessed by co-immunoprecipitation coupled with Western blotting. Neuroinflammation was measured via cytokine proteome profiler array and RT-qPCR. Neurodegeneration was determined by Western blotting and immunostaining. Neurobehavioral assessments were used to monitor motor and cognitive function. Brain tissue loss was assessed via MAP2 staining. Results rA2 administration given at 2 h after TBI significantly attenuates neutrophil activation and brain infiltration at 24 h of TBI. In vivo and in vitro data show that rA2 binds to and reduces TLR4 expression on the neutrophil surface and suppresses TLR4/NF kappa B signaling pathway in neutrophils at 12 h after TBI. Furthermore, rA2 administration also reduces pro-inflammation of brain tissues within 24 h and neurodegeneration at 48 h after TBI. Lastly, rA2 improves long-term sensorimotor ability and cognitive function, and reduces brain tissue loss at 28 days after TBI. Conclusions Systematic rA2 administration at 2 h after TBI significantly inhibits activation and brain infiltration of peripheral leukocytes, especially neutrophils at the acute phase. Consequently, rA2 reduces the detrimental brain pro-inflammation-associated neurodegeneration and ultimately ameliorates neurological deficits after TBI. The underlying molecular mechanism might be at least in part attributed to rA2 bindings to pro-inflammatory receptor TLR4 in peripheral leukocytes, thereby blocking NF kappa B signaling activation pathways following TBI.	[Liu, Ning; Han, Jinrui; Li, Yadan; Jiang, Yinghua; Shi, Samuel X.; Dumont, Aaron S.; Wang, Xiaoying] Tulane Univ, Clin Neurosci Res Ctr, Dept Neurosurg & Neurol, Sch Med, New Orleans, LA 70122 USA; [Lok, Josephine] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol & Neurol, Neuroprotect Res Lab, Boston, MA 02129 USA; [Lok, Josephine; Whalen, Michael] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Pediat Crit Care Med, Charlestown, MA 02129 USA		Liu, N; Wang, XY (corresponding author), Tulane Univ, Clin Neurosci Res Ctr, Dept Neurosurg & Neurol, Sch Med, New Orleans, LA 70122 USA.	nliu3@tulane.edu; xwang51@tulane.edu		Liu, Ning/0000-0002-5632-0359	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS092085]; Louisiana Clinical and Translational Science (LA CaTS) Center Pilot Project - National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; America Heart Association (AHA)American Heart Association [AHA833696]	This work was supported in part by the National Institutes of Health (NIH) grant RO1 NS092085 (Xiaoying Wang), and the Louisiana Clinical and Translational Science (LA CaTS) Center Pilot Project (Yinghua Jiang), which is funded by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, and the America Heart Association (AHA) grant AHA833696 Samuel X. Shi).	Ahmadabad RA, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01785-6; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Andersen BM, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0112-6; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dai HB, 2013, THROMB HAEMOSTASIS, V109, P1070, DOI 10.1160/TH12-12-0944; Dallacasagrande V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061499; Fan X, 2017, TRANSL STROKE RES, V8, P549, DOI 10.1007/s12975-017-0542-6; Fang MR, 2011, NEUROSIGNALS, V19, P16, DOI 10.1159/000324272; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Guo SZ, 2016, J NEUROTRAUM, V33, P1303, DOI 10.1089/neu.2015.4101; He QG, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7040024; He S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005743; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Lanati N, 2010, CURR VASC PHARMACOL, V8, P86, DOI 10.2174/157016110790226642; Lei YL, 2019, CLIN SCI, V133, P789, DOI 10.1042/CS20180687; Li WJ, 2019, J CLIN INVEST, V129, P2293, DOI 10.1172/JCI126428; Li WL, 2019, J CEREBR BLOOD F MET, V39, P2048, DOI 10.1177/0271678X18777916; Liu N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246125; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Lou YW, 2020, CELL MOL IMMUNOL, V17, P1053, DOI 10.1038/s41423-019-0278-1; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Nilsen J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0903-7; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Raddum AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060281; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sirbulescu RF, 2019, J NEUROTRAUM, V36, P2579, DOI 10.1089/neu.2018.6368; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Xie HX, 2013, MOL IMMUNOL, V53, P246, DOI 10.1016/j.molimm.2012.08.012; Zhang F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02392; Zhang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15859; Zhang ZB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1078-8	38	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	AUG 9	2021	18	1							173	10.1186/s12974-021-02219-7			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	UA3RU	WOS:000685079900002	34372870	Green Published, gold			2022-02-06	
J	Moraes, TM; Zaninotto, AL; Neville, IS; Hayashi, CY; Paiva, WS				Moraes, Thiago Mazzoli; Zaninotto, Ana Luiza; Neville, Iuri Santana; Hayashi, Cintya Yukie; Paiva, Wellingson Silva			Immersive virtual reality in patients with moderate and severe traumatic brain injury: a feasibility study	HEALTH AND TECHNOLOGY			English	Article						Traumatic brain injury; Cognitive rehabilitation; Virtual reality; Neuropsychology	EXECUTIVE FUNCTIONS; COGNITIVE REHABILITATION; VERBAL FLUENCY; NORMATIVE DATA; EDUCATION; AGE	Background Traumatic brain injury (TBI) remains a global health problem with cognitive impairments that can affect an individual's life. Although there is still no effective treatment for TBI sequelae, virtual reality (VR) technology shows promising results as a training tool to improve cognitive functions. Nonetheless, using a head-mounted display (HMD) device can induce cybersickness. Objective. To assess the feasibility of immersive VR cognitive training on EF and provide insights for a definitive trial. We aimed to assess the tolerability of TBI patients after prolonged use of a HMD. Also, as an exploratory analysis, we evaluated changes in cognition, including executive function, memory, and processing speed after the intervention. Methods. A prospective, single-arm, quasi-experimental study was performed to analyze the feasibility of twelve 20-min sessions of immersive VR over four weeks in patients with sustained TBI. Neuropsychological assessment was applied at baseline (T1), post-intervention (T2), and a three-months follow-up (T3). The Simulator Sickness Questionnaire (SSQ) was administered at the end of each session to evaluate the safety of the intervention. Results. Thirteen participants of mean age 34.86 (11.12), with moderate to severe TBI and average of 305.23 (51.23) days post-trauma were included. Patients showed improvements in EF between T1 and T3 (p = 0.02) and low scores in the SSQ (mean score = 4.33, SD = 4.06). Conclusions. The present VR intervention showed to be feasible and safe for patients with TBI to use a HMD. We also observed positive effects on EF and future studies should consider a home-based approach.	[Moraes, Thiago Mazzoli; Hayashi, Cintya Yukie] Univ Sao Paulo, Dept Neurol, Fac Med, Sao Paulo, Brazil; [Zaninotto, Ana Luiza] MGH Inst Hlth Profess, Speech & Feeding Disorders Lab, Boston, MA USA; [Neville, Iuri Santana] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Paiva, Wellingson Silva] Univ Sao Paulo, Dept Neurol, Fac Med, Inst Cent Hosp Clin, Sao Paulo, Brazil		Moraes, TM (corresponding author), Univ Sao Paulo, Dept Neurol, Fac Med, Sao Paulo, Brazil.	thiagompmoraes@gmail.com	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/11706-0]	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2016/11706-0.	Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Brucki SMD, 2004, BRAZ J MED BIOL RES, V37, P1771, DOI 10.1590/S0100-879X2004001200002; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carvalho Marcele Regine de, 2011, J. bras. psiquiatr., V60, P247, DOI 10.1590/S0047-20852011000400003; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; David S, 2014, PROCEEDINGS OF INTERNATIONAL CONFERENCE INFORMATION SYSTEMS AND DESIGN OF COMMUNICATION (ISDOC2014), P1, DOI 10.1145/2618168.2618169; de Carvalho MR, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7030043; Dodgson, STEREOSC DISPLAYS VI, P36; Freire Fabio Rios, 2011, Dement. neuropsychol., V5, P17, DOI 10.1590/S1980-57642011DN05010004; Goldberg Terry E, 2015, Alzheimers Dement (Amst), V1, P103, DOI 10.1016/j.dadm.2014.11.003; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kolasinski E. M., 1995, US ARMY RES I BEHAV, DOI [10.1121/1.404501, DOI 10.1121/1.404501]; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Larson EB, 2014, NEUROREHABILITATION, V34, P759, DOI 10.3233/NRE-141078; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lloyd J, 2009, NEUROPSYCHOL REHABIL, V19, P98, DOI 10.1080/09602010802117392; Malloy-Diniz LF, 2015, 5 DIGIT TEST TESTE 5; Maples-Keller JL, 2017, HARVARD REV PSYCHIAT, V25, P103, DOI 10.1097/HRP.0000000000000138; Middleton EL, 2012, NEUROPSYCHOL REHABIL, V22, P138, DOI 10.1080/09602011.2011.639619; Miotto EC, 2012, ARQ NEURO-PSIQUIAT, V70, P962, DOI 10.1590/S0004-282X2012001200014; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nascimento, 2005, WAIS 3 ESCALA INTELI; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Neville IS, 2019, NEUROLOGY, V93, pE190, DOI 10.1212/WNL.0000000000007748; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ravi DK, 2017, PHYSIOTHERAPY, V103, P245, DOI 10.1016/j.physio.2016.08.004; Reis, 2013, LIVRO ATAS 8 S NAC I; Saredakis D, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00096; Sharples S, 2008, DISPLAYS, V29, P58, DOI 10.1016/j.displa.2007.09.005; Shen JB, 2020, JMIR SERIOUS GAMES, V8, DOI 10.2196/16947; Steer RA, 1997, BECK ANXIETY INVENTO; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Weech S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00158; Werlang, 2011, MANUAL INVENTARIO DE; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574	42	0	0	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-7188	2190-7196		HEALTH TECHNOL-GER	Health Technol.	SEP	2021	11	5					1035	1044		10.1007/s12553-021-00582-2		AUG 2021	10	Medical Informatics	Emerging Sources Citation Index (ESCI)	Medical Informatics	UY8NK	WOS:000683227900001					2022-02-06	
J	Mondal, K; Takahashi, H; Cole, J; Del Mar, NA; Li, CY; Stephenson, DJ; Allegood, J; Cowart, LA; Chalfant, CE; Reiner, A; Mandal, N				Mondal, Koushik; Takahashi, Haruka; Cole, Jerome, II; Del Mar, Nobel A.; Li, Chunyan; Stephenson, Daniel J.; Allegood, Jeremy; Cowart, L. Ashley; Chalfant, Charles E.; Reiner, Anton; Mandal, Nawajes			Systemic Elevation of n-3 Polyunsaturated Fatty Acids (n-3-PUFA) Is Associated with Protection against Visual, Motor, and Emotional Deficits in Mice following Closed-Head Mild Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury (TBI); Visual deficits; Emotional deficits; Fearfulness; n-3 PUFA; Ceramide; Neuroinflammation	TRANSGENIC MICE; FAT-1 MICE; MODEL; SUPPLEMENTATION; NEUROPROTECTION; SPHINGOLIPIDS; INFLAMMATION; HOMEOSTASIS; INHIBITION; METABOLISM	Traumatic brain injury (TBI) causes neuroinflammation and neurodegeneration leading to various pathological complications such as motor and sensory (visual) deficits, cognitive impairment, and depression. N-3 polyunsaturated fatty acid (n-3 PUFA) containing lipids are known to be anti-inflammatory, whereas the sphingolipid, ceramide (Cer), is an inducer of neuroinflammation and degeneration. Using Fat1(+)-transgenic mice that contain elevated levels of systemic n-3 PUFA, we tested whether they are resistant to mild TBI-mediated sensory-motor and emotional deficits by subjecting Fat1-transgenic mice and their WT littermates to focal cranial air blast (50 psi) or sham blast (0 psi, control). We observed that visual function in WT mice was reduced significantly following TBI but not in Fat1(+)-blast animals. We also found Fat1(+)-blast mice were resistant to the decline in motor functions, depression, and fear-producing effects of blast, as well as the reduction in the area of oculomotor nucleus and increase in activated microglia in the optic tract in brain sections seen following blast in WT mice. Lipid and gene expression analyses confirmed an elevated level of the n-3 PUFA eicosapentaenoic acid (EPA) in the plasma and brain, blocking of TBI-mediated increase of Cer in the brain, and decrease in TBI-mediated induction of Cer biosynthetic and inflammatory gene expression in the brain of the Fat1(+) mice. Our results demonstrate that suppression of ceramide biosynthesis and inflammatory factors in Fat1(+)-transgenic mice is associated with significant protection against the visual, motor, and emotional deficits caused by mild TBI. This study suggests that n-3 PUFA (especially, EPA) has a promising therapeutic role in preventing neurodegeneration after TBI.	[Mondal, Koushik; Takahashi, Haruka; Cole, Jerome, II; Reiner, Anton; Mandal, Nawajes] Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Takahashi, Haruka] Iwate Univ, Dept Anim Sci, Morioka, Iwate, Japan; [Del Mar, Nobel A.; Li, Chunyan; Reiner, Anton; Mandal, Nawajes] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Stephenson, Daniel J.; Chalfant, Charles E.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Allegood, Jeremy; Cowart, L. Ashley] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23219 USA; [Cowart, L. Ashley] Hunter Holmes McGuire VA Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33620 USA; [Chalfant, Charles E.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Mandal, Nawajes] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Mandal, Nawajes] Memphis VA Med Ctr, Memphis, TN 38104 USA		Mandal, N (corresponding author), Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN 38163 USA.; Mandal, N (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN 38163 USA.; Mandal, N (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA.; Mandal, N (corresponding author), Memphis VA Med Ctr, Memphis, TN 38104 USA.	nmandal@uthsc.edu			US Department of Defense Office of the Congressionally Directed Medical Research Programs (CDMRP), Vision Research Program grant [W81XWH-20-1-0900]; Veterans' Administration (VA Merit Review Award) [I01BX004893]; Veterans' Administration (VA Merit Review)US Department of Veterans Affairs [I BX001792]; Senior Research Career Scientist Award [IK6BX004603]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY022071, R01 EY031316, EY005298]; National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI139072]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM137578, R01 GM137394]; DODUnited States Department of Defense [W81XWH-16-1-0076]; Methodist Hospitals Endowed Professorship in Neuroscience; VCU Massey Cancer Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA016059]; UTHSC Plough Center and Neuroscience Institute for Postdoctoral Award; Research to Prevent Blindness Inc., USAResearch to Prevent Blindness (RPB)	This work was supported by the US Department of Defense Office of the Congressionally Directed Medical Research Programs (CDMRP), Vision Research Program grant (W81XWH-20-1-0900) (N.M.); the Veterans' Administration (VA Merit Review Award I01BX004893) (N.M.); the Veterans' Administration (VA Merit Review, I BX001792 (C.E.C.) and a Senior Research Career Scientist Award, IK6BX004603 (C.E.C.)); National Eye Institute grants (EY022071, R01 EY031316) (N.M.); National Institute of Allergy and Infectious Diseases grant (R01 AI139072 (C.E.C.)), National Institute of General Medical Sciences grant (R01 GM137578 (C.E.C.) and R01 GM137394 (C.E.C.), grants from Research to Prevent Blindness Inc., USA (N.M.); National Eye Institute grant EY005298 (A.R.), DOD grant W81XWH-16-1-0076 (A.R.), and The Methodist Hospitals Endowed Professorship in Neuroscience (A.R.). The Lipidomic services (Virginia Commonwealth University (VCU) Lipidomics/Metabolomics Core) and products in support of the study were generated, in part, by the VCU Massey Cancer Center, with funding from National Institutes of Health Grant (P30 CA016059). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs, or the U.S. Government. UTHSC Plough Center and Neuroscience Institute for Postdoctoral Award (K.M.). Special thanks to Marion Joni from Anatomy and Neurobiology, UTHSC for technical assistance, and Dr. Robert E. Anderson from University of Oklahoma Health Sciences Center and Dr. Jing X. Kang from Harvard Medical School and Massachusetts General Hospital for providing Fat1 transgenic mice.	Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bazinet RP, 2020, BRAIN BEHAV IMMUN, V85, P21, DOI 10.1016/j.bbi.2019.07.001; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chaurasia B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.576347; Chen H, 2013, J LIPID RES, V54, P1616, DOI 10.1194/jlr.M035048; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Chen Y, 2013, CELL PHYSIOL BIOCHEM, V32, P523, DOI 10.1159/000354456; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Ji SN, 2009, J CELL BIOCHEM, V107, P809, DOI 10.1002/jcb.22179; Joffre C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01022; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Lim SY, 2005, J NEUROCHEM, V95, P848, DOI 10.1111/j.1471-4159.2005.03427.x; Liu Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0387-16.2017; MacKnight HP, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5918; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Miller G, 2011, SCIENCE, V333, P514, DOI 10.1126/science.333.6042.514; Mondal K, 2019, ADV EXP MED BIOL, V1161, P149, DOI 10.1007/978-3-030-21735-8_14; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Novgorodov SA, 2019, J LIPID RES, V60, P609, DOI 10.1194/jlr.M091132; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Opreanu M, 2010, INVEST OPHTH VIS SCI, V51, P3253, DOI 10.1167/iovs.09-4731; Paranjpe V, 2019, OCUL SURF, V17, P318, DOI 10.1016/j.jtos.2018.12.006; Peet M, 2002, ARCH GEN PSYCHIAT, V59, P913, DOI 10.1001/archpsyc.59.10.913; Peng ZL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051769; Petit CS, 2020, P NATL ACAD SCI USA, V117, P10565, DOI 10.1073/pnas.1913956117; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Shi Z, 2016, MOL NEUROBIOL, V53, P6482, DOI 10.1007/s12035-015-9554-y; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Stiles M, 2016, J LIPID RES, V57, P818, DOI 10.1194/jlr.M063719; Sugano E, 2019, J LIPID RES, V60, P30, DOI 10.1194/jlr.M082198; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Walchuk C, 2021, BRIT J NUTR, V125, P863, DOI 10.1017/S0007114520003177; Wang JY, 2014, NEUROBIOL DIS, V68, P91, DOI 10.1016/j.nbd.2014.04.014; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081	61	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2021	58	11					5564	5580		10.1007/s12035-021-02501-y		AUG 2021	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WZ5XS	WOS:000682652700002	34365584				2022-02-06	
J	Navarro-Main, B; Castano-Leon, A; Hilario, A; Gomez-Abascal, AL; Perianez, J; Rios-Lago, M				Navarro-Main, Blanca; Castano-Leon, Ana; Hilario, Amaya; Gomez-Abascal, Alfonso Lagares; Perianez, Jose; Rios-Lago, Marcos		INERTIA Grp Collaborators	Apathetic symptoms and white matter integrity after traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; white matter; DTI; Bayesian networks; apathy	VOXEL-BASED MORPHOMETRY; DIFFUSE AXONAL INJURY; HEAD-INJURY; NEGATIVE SYMPTOMS; DISEASE; DISORDERS; DTI; SCHIZOPHRENIA; ABNORMALITIES; CONNECTIVITY	Primary objective The aim of the study was twofold. First, to study the relationship among apathy in the long term, initial clinical measures, and standard outcome scores after traumatic brain injury (TBI). Second, to describe white matter integrity correlates of apathy symptoms. Research Design Correlational study. Methods and Procedures: Correlation and Bayesian networks analyses were performed in a sample of 40 patients with moderate to severe TBI in order to identify the relationship among clinical variables, functionality, and apathy. A diffusion tensor imaging study was developed in 25 participants to describe correlations between fractional anisotropy (FA) measures and apathetic symptoms. Main outcomes and results Correlation analysis revealed associations between pairs of variables as apathy in the long term and functional score at discharge from hospital. Bayesian network illustrated the relevant role of axonal injury mediating the relationship between apathy and initial clinical variables. FA in the superior longitudinal fasciculus, the inferior longitudinal fasciculus, and the internal capsule were negatively correlated with apathy measures. Widespread brain areas showed positive correlations between FA and apathy. Conclusions These results highlight the relevance of white matter integrity measures in initial assessment after TBI and its relationship with apathetic manifestations in the chronic phase.	[Navarro-Main, Blanca; Castano-Leon, Ana; Hilario, Amaya; Gomez-Abascal, Alfonso Lagares; Rios-Lago, Marcos] 12 Octubre Hosp, Madrid, Spain; [Navarro-Main, Blanca; Castano-Leon, Ana; Hilario, Amaya; Gomez-Abascal, Alfonso Lagares; Rios-Lago, Marcos; INERTIA Grp Collaborators] I 12 Invest Inst, INERTIA Res Grp, Madrid, Spain; [Perianez, Jose] UCM, Fac Psychol, Madrid, Spain; [Navarro-Main, Blanca; Rios-Lago, Marcos] UNED, Fac Psychol, Madrid, Spain		Navarro-Main, B (corresponding author), Hosp 12 Octubre, Serv Neurocirugia, 2a Planta, Madrid 28041, Spain.	bnavarromain@gmail.com	Lagares, Alfonso/B-2969-2011; Rios-Lago, Marcos/P-6930-2019; Perianez, Jose Antonio/ABE-7046-2021	Lagares, Alfonso/0000-0003-3996-0554; Rios-Lago, Marcos/0000-0003-0187-5047; Perianez, Jose A./0000-0003-4310-4021	Mapfre Fundation, Ignacio Larramendi Grant	The study is supported by Mapfre Fundation, Ignacio Larramendi Grant.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aguera-Ortiz L, 2017, INT J GERIATR PSYCH, V32, P922, DOI 10.1002/gps.4548; Alexander MP, 2000, SEMIN NEUROL, V20, P427, DOI 10.1055/s-2000-13175; Amodio A, 2018, CLIN EEG NEUROSCI, V49, P55, DOI 10.1177/1550059417745934; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bivona U, 2019, BRAIN INJURY, V33, P1245, DOI 10.1080/02699052.2019.1641225; Bortolon C, 2018, NEUROPSYCHOLOGIA, V118, P22, DOI 10.1016/j.neuropsychologia.2017.09.033; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Cacciari C, 2010, J ALZHEIMERS DIS, V20, P501, DOI 10.3233/JAD-2010-1384; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Baggio HC, 2015, MOVEMENT DISORD, V30, P671, DOI 10.1002/mds.26137; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Femiano C, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/2635202; Fernandez A, 2011, NEUROIMAGE, V57, P1300, DOI 10.1016/j.neuroimage.2011.05.079; Gracia-Garcia P, 2021, CURR OPIN PSYCHIATR, V34, P193, DOI 10.1097/YCO.0000000000000677; Hahn C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053493; Hanks R, 2019, BRAIN INJURY, V33, P355, DOI 10.1080/02699052.2018.1553073; Herbet G, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00077; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Joo SH, 2017, NEUROPSYCH DIS TREAT, V13, P61, DOI 10.2147/NDT.S123338; Kamat R, 2014, J CLIN EXP NEUROPSYC, V36, P854, DOI 10.1080/13803395.2014.950636; Kitamura S, 2018, J NEUROL NEUROSUR PS, V89, P1208, DOI 10.1136/jnnp-2018-317970; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Koller D., 2009, PROBABILISTIC GRAPHI; Kos C, 2016, NEUROSCI BIOBEHAV R, V69, P381, DOI 10.1016/j.neubiorev.2016.08.012; Kunimatsu A, 2007, J MAGN RESON IMAGING, V26, P1399, DOI 10.1002/jmri.20945; Le Heron C, 2018, NEUROPSYCHOLOGIA, V118, P54, DOI 10.1016/j.neuropsychologia.2017.07.003; Le Heron C, 2019, J NEUROL NEUROSUR PS, V90, P302, DOI 10.1136/jnnp-2018-318265; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McIntosh RC, 2015, NEUROSCI BIOBEHAV R, V55, P147, DOI 10.1016/j.neubiorev.2015.04.008; McPherson S, 2002, J INT NEUROPSYCH SOC, V8, P373, DOI 10.1017/S1355617702813182; Melero H, 2013, EXP BRAIN RES, V227, P343, DOI 10.1007/s00221-013-3514-4; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moretti R, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00289; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Njomboro P, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00073; Ohtani T, 2014, SCHIZOPHR RES, V157, P190, DOI 10.1016/j.schres.2014.05.016; Pearl J., 2014, PROBABILISTIC REASON; Robert GH, 2014, NEUROLOGY, V83, P1620, DOI 10.1212/WNL.0000000000000941; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rosso C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073164; Schiemanck SK, 2008, J REHABIL MED, V40, P96, DOI 10.2340/16501977-0130; Schroeter ML, 2011, PSYCHIAT RES-NEUROIM, V194, P235, DOI 10.1016/j.pscychresns.2011.06.009; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Setiadi TM, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2021.102567; Stanton BR, 2013, J NEUROL, V260, P2481, DOI 10.1007/s00415-013-6989-9; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Takayanagi Y, 2013, J NEUROPSYCH CLIN N, V25, P292, DOI 10.1176/appi.neuropsych.12040093; TATEMICHI TK, 1992, NEUROLOGY, V42, P1966, DOI 10.1212/WNL.42.10.1966; TEASDALE G, 1974, LANCET, V2, P81; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; Tsang A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00144; Tsujimoto M, 2011, J NEUROL SCI, V307, P34, DOI 10.1016/j.jns.2011.05.025; Tumati S, 2019, PROG NEUROBIOL, V175, P20, DOI 10.1016/j.pneurobio.2018.12.003; Tumati S, 2020, J AFFECT DISORDERS, V266, P473, DOI 10.1016/j.jad.2020.01.158; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Woolley SC, 2011, AMYOTROPH LATERAL SC, V12, P52, DOI 10.3109/17482968.2010.521842; Worthington A., 2009, REHABILITATION EXECU, P37; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; Yang SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116168; Zhang Y, 2018, INT J NEUROSCI, V128, P25, DOI 10.1080/00207454.2017.1347170	72	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1043	1053		10.1080/02699052.2021.1953145		AUG 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000682442600001	34357825				2022-02-06	
J	Rodriguez, AI; Chiao, J; Spencer, G				Rodriguez, Amanda, I; Chiao, Jonathan; Spencer, Gretchen			Vestibular-Evoked Myogenic Potential Outcomes Associated with Pediatric Sports-Related Concussion	LARYNGOSCOPE			English	Article						Concussion; VEMP; otoliths; pediatrics; dizziness	TRAUMATIC BRAIN-INJURY; MOTOR SCREENING VOMS; CHILDREN; EPIDEMIOLOGY; SENSITIVITY; BONE	Objectives/Hypothesis To 1) characterize vestibular-evoked myogenic potential responses in children and young adults with sports-related concussion (SRC) histories as compared with a normal healthy control group, and 2) correlate VEMP characteristics to SRC/sport history outcomes. Study Design Prospective cohort study. Methods Seventy-six children and young adults with and without a history of SRC received cervical and ocular VEMP testing using a 500 Hz tone burst air conduction stimuli. VEMP response parameters (response rates, peak latencies, and peak-to-peak amplitudes) were assessed. Other clinical vestibular measures were performed. In the SRC group, sport history outcomes including number of SRC sustained over a lifetime, years of playing contact sports, and length of time playing contact sports were collected via in-person questionnaire. Results Children and young adults with SRC had significantly reduced oVEMP responses and peak-to-peak amplitudes and greater amplitude response asymmetries between left and right ear. There was no effect of group on cVEMP findings. A greater frequency of SRCs sustained throughout a lifetime, a greater number of contact sports played, and a longer duration of playing a contact sport correlated with significantly poorer VEMP response characteristics. Conclusions Our results suggest that SRC and repeated subclinical head impact events have an effect on oVEMP outcomes. SRC may affect the utricle, superior vestibular nerve, and/or brainstem-mediated vestibular-ocular-reflex pathway. The prevalence of post-concussion-related dizziness is becoming increasingly common in a pediatric-otology clinic, thus performing VEMP testing in youth post-SRC provides an objective, noninvasive, and cost-effective method for monitoring the effects of sports-related impact on the vestibular system and related neural pathways. Level of Evidence 3 Laryngoscope, 2021	[Rodriguez, Amanda, I; Spencer, Gretchen] Univ Nebraska, Dept Special Educ & Commun Disorders, C68 East Stadium, Lincoln, NE 68588 USA; [Chiao, Jonathan] Univ Nebraska, Dept Otolaryngol Head & Neck Surg, Med Ctr, Omaha, NE USA; [Chiao, Jonathan] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX USA; [Chiao, Jonathan] Texas Childrens Hosp, Div Pediat Otolaryngol, Houston, TX USA		Rodriguez, AI (corresponding author), Univ Nebraska, Dept Special Educ & Commun Disorders, C68 East Stadium, Lincoln, NE 68588 USA.	amanda.rodriguez@unl.edu		Rodriguez, Amanda/0000-0002-8787-9534	University of Nebraska Lincoln Tobacco Settlement	Research reported in this publication was supported by the University of Nebraska Lincoln Tobacco Settlement.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Alkathiry AA, 2019, SPORTS HEALTH, V11, P479, DOI 10.1177/1941738119865262; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; American Speech-Language-Hearing Association, 1997, GUID AUD SCREEN; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Brodsky JR, 2018, OTOLARYNG HEAD NECK, V159, P365, DOI 10.1177/0194599818770618; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635, DOI 10.1212/WNL.42.8.1635; Curthoys IS, 2010, CLIN NEUROPHYSIOL, V121, P132, DOI 10.1016/j.clinph.2009.09.027; Curthoys IS, 2009, ANN NY ACAD SCI, V1164, P13, DOI 10.1111/j.1749-6632.2008.03729.x; Fuemmeler E, 2020, OTOL NEUROTOL, V41, pE1052, DOI 10.1097/MAO.0000000000002703; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Isaradisaikul Suwicha, 2012, Int J Otolaryngol, V2012, P913515, DOI 10.1155/2012/913515; Jafari Z, 2011, INT J PEDIATR OTORHI, V75, P919, DOI 10.1016/j.ijporl.2011.04.006; Janky KL, 2009, J AM ACAD AUDIOL, V20, P514, DOI 10.3766/jaaa.20.8.6; Kumar L, 2017, OTOL NEUROTOL, V38, pE378, DOI 10.1097/MAO.0000000000001525; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makowiec K, 2017, AM J AUDIOL, V26, P180, DOI 10.1044/2017_AJA-16-0108; Mantokoudis G, 2015, AUDIOL NEURO-OTOL, V20, P39, DOI 10.1159/000362780; McCaslin DL, 2011, J AM ACAD AUDIOL, V22, P542, DOI 10.3766/jaaa.22.8.6; Monaco MR, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041582; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; PAIGE GD, 1989, EXP BRAIN RES, V77, P585; Piker EG, 2013, EAR HEARING, V34, pE65, DOI 10.1097/AUD.0b013e31828fc9f2; Rodriguez AI, 2019, EAR HEARING, V40, P192, DOI 10.1097/AUD.0000000000000607; Sandhu JS, 2013, CLIN NEUROPHYSIOL, V124, P1232, DOI 10.1016/j.clinph.2012.11.019; Todd NPM, 2007, CLIN NEUROPHYSIOL, V118, P381, DOI 10.1016/j.clinph.2006.09.025; Wang A, 2021, LARYNGOSCOPE, V131, pE1308, DOI 10.1002/lary.29024; Xie YJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00173; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	34	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	FEB	2022	132	2					436	442		10.1002/lary.29803		AUG 2021	7	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	YD3LT	WOS:000682468000001	34363397				2022-02-06	
J	Al-Mansour, LS; AlRasheed, AA; AlEnezi, KR; AlAli, HM				Al-Mansour, Lama S.; AlRasheed, Abdulrahman A.; AlEnezi, Khaled R.; AlAli, Hamza M.			Elevated intracranial pressure requiring decompressive craniectomy in a child with progressive primary angiitis of the central nervous system: a case report	JOURNAL OF MEDICAL CASE REPORTS			English	Article						Intracranial pressure; Craniectomy; Primary angiitis; Central nervous system; Case report	TRAUMATIC BRAIN-INJURY; CASE SERIES; HEMICRANIECTOMY; VASCULITIS	Background: Elevated intracranial pressure is a potentially catastrophic complication of neurologic injury in children. Successful management of elevated intracranial pressure requires prompt recognition and therapy directed at both reducing intracranial pressure and reversing its underlying cause. A rare condition that causes elevated intracranial pressure is childhood primary angiitis of the central nervous system, which is a rare inflammatory central nervous system disease that poses diagnostic and therapeutic challenges. To our knowledge, this is the first reported case of angiography-positive progressive childhood primary angiitis of the central nervous system requiring decompressive hemicraniectomy for refractory elevated intracranial pressure in children. Case presentation: We report the case of a 5-year- old Saudi girl who presented to the pediatric emergency department with fever and new-onset status epilepticus. She had elevated inflammatory markers with radiological and histopathological evidence of angiography-positive progressive childhood primary angiitis of the central nervous system, complicated by elevated intracranial pressure. Despite medical management for both childhood primary angiitis of the central nervous system and elevated intracranial pressure, her neurological status continued to deteriorate and the elevated intracranial pressure became refractory. She developed right uncal, right subfalcine, and tonsillar herniation requiring decompressive hemicraniectomy with a favorable neurological outcome. Conclusion: Decompressive craniectomy might be considered in cases of angiography-positive progressive childhood primary angiitis of the central nervous system with elevated intracranial pressure refractory to medication. A multidisciplinary approach for the decision of decompressive craniectomy is advised to ensure patient safety and avoid possible morbidities and mortality.	[Al-Mansour, Lama S.; AlRasheed, Abdulrahman A.; AlAli, Hamza M.] Minist Natl Guards Hlth Affairs, Dept Pediat, Riyadh, Saudi Arabia; [AlEnezi, Khaled R.] Minist Natl Guards Hlth Affairs, Dept Med Imaging, Riyadh, Saudi Arabia; [Al-Mansour, Lama S.; AlRasheed, Abdulrahman A.; AlEnezi, Khaled R.; AlAli, Hamza M.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Al-Mansour, Lama S.; AlRasheed, Abdulrahman A.; AlEnezi, Khaled R.; AlAli, Hamza M.] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia		AlAli, HM (corresponding author), Minist Natl Guards Hlth Affairs, Dept Pediat, Riyadh, Saudi Arabia.; AlAli, HM (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; AlAli, HM (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.	drhamza80@hotmail.com		Alali, Hamza/0000-0002-3177-9147			Aghakhani N, 2009, J NEUROS-PEDIATR, V3, P66, DOI 10.3171/2008.10.PEDS08116; Alba MA, 2011, CURR NEUROPHARMACOL, V9, P437, DOI 10.2174/157015911796557920; Alotaibi NM, 2017, J NEUROSURG, V127, P1315, DOI 10.3171/2016.9.JNS161383; Beelen J, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000567; Benseler SM, 2006, ARTHRITIS RHEUM-US, V54, P1291, DOI 10.1002/art.21766; Benseler SM, 2005, ARTHRITIS RHEUM-US, V52, P2159, DOI 10.1002/art.21144; Benseler SM, 2016, CENTRAL NERVOUS SYST, DOI [10.1016/B978-0-444-63432-0.00016-5, DOI 10.1016/B978-0-444-63432-0.00016-5]; CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-00002; CALABRESE LH, 1992, CLEV CLIN J MED, V59, P293, DOI 10.3949/ccjm.59.3.293; Cellucci T, 2014, ARTHRITIS RHEUMATOL, V66, P750, DOI 10.1002/art.38274; Cellucci Tania, 2012, Arthritis Rheum, V64, P1665, DOI 10.1002/art.34527; Coutinho JM, 2009, STROKE, V40, P2233, DOI 10.1161/STROKEAHA.108.543421; Elbers J, 2010, ANN NEUROL, V68, P602, DOI 10.1002/ana.22075; Goedemans T, 2018, BRIT J NEUROSURG, V32, P149, DOI 10.1080/02688697.2017.1406453; Hajj-Ali RA, 2013, AUTOIMMUN REV, V12, P463, DOI 10.1016/j.autrev.2012.08.004; HIROHATA S, 1993, CLIN IMMUNOL IMMUNOP, V66, P225, DOI 10.1006/clin.1993.1029; Hofmann SR, 2017, CURR OSTEOPOROS REP, V15, P542, DOI 10.1007/s11914-017-0405-9; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Omay SB, 2013, NEUROSURG REV, V36, P21, DOI 10.1007/s10143-012-0411-4; Polin RS, 2003, CRIT CARE, V7, P409, DOI 10.1186/cc2370; Shah S, 2013, WORLD NEUROSURG, V80, P126, DOI 10.1016/j.wneu.2013.06.001; Smitka M, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00281; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Venkateswaran S, 2008, J CHILD NEUROL, V23, P253, DOI 10.1177/0883073807309254	24	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1752-1947		J MED CASE REP	J. Med. Case Rep.	AUG 6	2021	15	1							418	10.1186/s13256-021-03005-y			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TY5JT	WOS:000683821400001	34353355	Green Published, gold			2022-02-06	
J	De Luca, R; Pollicino, P; Rifici, C; de Cola, C; Billeri, L; Marino, S; Trifiro, S; Fiumara, E; Randazzo, M; Bramanti, P; Torrisi, M				De Luca, Rosaria; Pollicino, Patrizia; Rifici, Carmela; de Cola, Cristina; Billeri, Luana; Marino, Silvia; Trifiro, Simona; Fiumara, Elisabeth; Randazzo, Maria; Bramanti, Placido; Torrisi, Michele			Improving motor and cognitive recovery following severe traumatic brain injury using advanced emotional audio-video stimulation Lessons from a case report	MEDICINE			English	Article						minimally conscious state (MCS); Neurowave emotional stimulation (NES); standard sensorial stimulation; traumatic brain injury (TBI)	REHABILITATION; CONSCIOUSNESS; EPIDEMIOLOGY; DISORDERS; ATTENTION; SCALE; MILD	Rationale: It is estimated that about 6 million people suffer from severe traumatic brain injury (TBI) each year (73 cases per 100,000 people). TBI may affect emotional, sensory-motor, cognitive, and psychological functions with a consequent worsening of both patient and his/her caregiver's quality of life. In recent years, technological innovations allowed the development of new, advanced sensory stimulation systems, such as Neurowave, to further stimulate residual cognitive abilities and, at the same time, evaluate residual cognition. Patient concern: An 69-year-old Italian man entered our neurorehabilitation unit with a diagnosis of minimally conscious state following severe TBI. He breathed spontaneously via tracheostomy and was fed via percutaneous gastrostomy. At the neurological examination, the patient showed severe tetraparesis as he showed fluctuating alertness and responsiveness to external stimuli and opened the eyes without stimulation. Diagnosis: Patient was affected by subarachnoid hemorrhage and frontotemporal bilateral hematoma, which were surgically treated with decompressive craniotomy and subsequent cranioplasty about 6 months before. Interventions: The patient underwent a neuropsychological and clinical evaluation before (T0) and after a conventional rehabilitation cycle (T1), and after a Neurowave emotional stimulation-supported rehabilitative cycle (T2). Outcomes: Following conventional rehabilitation (T1), the patient achieved a partial improvement in behavioral responsiveness; there was also a mild improvement in the caregiver's distress. Conversely, Neurowave emotional stimulation session determined (at T2) a significant improvement of the patient's behavioral responsiveness, cognition, and in the caregiver's distress. The P300 recording in response to the NES showed a significant change of P300 magnitude and latency. Discussion: Our data suggest that emotional-integrated sensory stimulation using adequate visual stimuli represents a beneficial, complementary rehabilitative treatment for patients in minimally conscious state following a severe TBI. This may occur because stimuli with emotional salience can provide a reliable motivational resource to stimulate motor and cognitive recovery following severe TBI.	[De Luca, Rosaria; Pollicino, Patrizia; Rifici, Carmela; de Cola, Cristina; Billeri, Luana; Marino, Silvia; Trifiro, Simona; Fiumara, Elisabeth; Randazzo, Maria; Bramanti, Placido; Torrisi, Michele] IRCCS Centro, Neurolesi Bonino Pulejo, Via Palermo,SS113,C,Casazza, I-98124 Messina, Italy		Torrisi, M (corresponding author), IRCCS Centro, Neurolesi Bonino Pulejo, Via Palermo,SS113,C,Casazza, I-98124 Messina, Italy.	michele.torrisi@irccsme.it	Marino, Silvia/T-5118-2019	Marino, Silvia/0000-0002-1088-6808			Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Calabro RS, 2015, RESTOR NEUROL NEUROS, V33, P671, DOI 10.3233/RNN-140475; Canedo A, 2002, BRAIN INJURY, V16, P453, DOI 10.1080/02699050110119853; Chakraborty S, 2018, HDB NEUROEMERG CLIN, V5, P85; Corallo F, 2017, NEUROL SCI, V38, P1249, DOI 10.1007/s10072-017-2941-6; De Salvo S, 2020, INT J NEUROSCI, V130, P722, DOI 10.1080/00207454.2019.1705808; De Salvo S, 2015, FUNCT NEUROL, V30, P237; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Di H., 2012, COMA DISORDERS CONSC, P97; Di Stefano C, 2012, BRAIN INJURY, V26, P1250, DOI 10.3109/02699052.2012.667588; Frazzitta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158030; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; Holstege Gert, 2016, Sex Med Rev, V4, P303, DOI 10.1016/j.sxmr.2016.04.002; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lanz F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00799; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Manivannan S, 2019, J HEAD TRAUMA REHAB, V34, pE52, DOI 10.1097/HTR.0000000000000412; Mishra R, 2021, WORLD NEUROSURG, V146, P197, DOI 10.1016/j.wneu.2020.10.130; Palmese CA, 2000, BRAIN INJURY, V14, P535; Pape TLB, 2014, ARCH PHYS MED REHAB, V95, P1672, DOI 10.1016/j.apmr.2014.04.015; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Ulrich RS, 2008, HERD-HEALTH ENV RES, V1, P61, DOI 10.1177/193758670800100306; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wahrborg P, 2014, J REHABIL MED, V46, P271, DOI 10.2340/16501977-1259; Whyte J, 2011, ENCYCLINNEUROPSY; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	38	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG 6	2021	100	31							e26685	10.1097/MD.0000000000026685			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TT8VZ	WOS:000680622300059	34397801	Green Published, gold			2022-02-06	
J	Ercole, A; Dixit, A; Nelson, DW; Bhattacharyay, S; Zeiler, FA; Nieboer, D; Bouamra, O; Menon, DK; Maas, AIR; Dijkland, SA; Lingsma, HF; Wilson, L; Lecky, F; Steyerberg, EW				Ercole, Ari; Dixit, Abhishek; Nelson, David W.; Bhattacharyay, Shubhayu; Zeiler, Frederick A.; Nieboer, Daan; Bouamra, Omar; Menon, David K.; Maas, Andrew I. R.; Dijkland, Simone A.; Lingsma, Hester F.; Wilson, Lindsay; Lecky, Fiona; Steyerberg, Ewout W.		CENTER-TBI Investigators	Imputation strategies for missing baseline neurological assessment covariates after traumatic brain injury: A CENTER-TBI study	PLOS ONE			English	Article							GLASGOW COMA SCALE; PREDICTION; MODELS; REGRESSION; SCORE; CARE	Statistical models for outcome prediction are central to traumatic brain injury research and critical to baseline risk adjustment. Glasgow coma score (GCS) and pupil reactivity are crucial covariates in all such models but may be measured at multiple time points between the time of injury and hospital and are subject to a variable degree of unreliability and/or missingness. Imputation of missing data may be undertaken using full multiple imputation or by simple substitution of measurements from other time points. However, it is unknown which strategy is best or which time points are more predictive. We evaluated the pseudo-R-2 of logistic regression models (dichotomous survival) and proportional odds models (Glasgow Outcome Score-extended) using different imputation strategies on the The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study dataset. Substitution strategies were easy to implement, achieved low levels of missingness (<< 10%) and could outperform multiple imputation without the need for computationally costly calculations and pooling multiple final models. While model performance was sensitive to imputation strategy, this effect was small in absolute terms and clinical relevance. A strategy of using the emergency department discharge assessments and working back in time when these were missing generally performed well. Full multiple imputation had the advantage of preserving time-dependence in the models: the pre-hospital assessments were found to be relatively unreliable predictors of survival or outcome. The predictive performance of later assessments was model-dependent. In conclusion, simple substitution strategies for imputing baseline GCS and pupil response can perform well and may be a simple alternative to full multiple imputation in many cases.	[Ercole, Ari; Dixit, Abhishek; Bhattacharyay, Shubhayu; Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Ercole, Ari] Univ Cambridge, Ctr Artificial Intelligence Med, Cambridge, England; [Nelson, David W.] Karolinska Inst, Sect Anesthesiol Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Neurosurg, Dept Surg, Winnipeg, MB, Canada; [Nieboer, Daan; Dijkland, Simone A.; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Bouamra, Omar] Univ Manchester, Trauma Audit Res Network, Salford, Lancs, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Dijkland, Simone A.; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Rotterdam, Netherlands; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res ScHARR, Ctr Urgent & Emergency Care Res CURE, Sheffield, S Yorkshire, England; [Steyerberg, Ewout W.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands		Ercole, A (corresponding author), Univ Cambridge, Div Anaesthesia, Cambridge, England.; Ercole, A (corresponding author), Univ Cambridge, Ctr Artificial Intelligence Med, Cambridge, England.	ae105@cam.ac.uk	; Maas, Andrew I.R./C-5584-2013; Ercole, Ari/B-6288-2009	Bhattacharyay, Shubhayu/0000-0001-7428-5588; Nieboer, Daan/0000-0002-4403-6537; Zeiler, Frederick/0000-0003-1737-0510; Maas, Andrew I.R./0000-0003-1612-1264; Ercole, Ari/0000-0001-8350-8093; Nelson, David/0000-0003-2530-8207; Dixit, Abhishek/0000-0001-9543-5901	European UnionEuropean Commission [602150]; Hannelore Kohl Foundation (Germany); Integra Life Sciences; One Mind For Research; University of Manitoba VPRI Research Investment Fund (RIF); Winnipeg Health Sciences Centre (HSC) Foundation; University of Manitoba Rudy Falk Clinician-Scientist Professorship; Gates Cambridge fellowship	CENTER-TBI is supported by The European Union FP 7th Framework program (grant 602150) with additional funding provided by the Hannelore Kohl Foundation (Germany), Integra Life Sciences and by the non-profit organization One Mind For Research (directly to INCF). SB is currently funded by a Gates Cambridge fellowship. FAZ is supported by the University of Manitoba VPRI Research Investment Fund (RIF), Winnipeg Health Sciences Centre (HSC) Foundation, and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Lesko MM, 2013, J NEUROTRAUM, V30, P2021, DOI 10.1089/neu.2013.2988; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; van Buuren S, 2011, J STAT SOFTW, V45, P1; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x	15	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2021	16	8							e0253425	10.1371/journal.pone.0253425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6JM	WOS:000685266400016	34358231	Green Published, Green Accepted, gold, Green Submitted			2022-02-06	
J	Greenberg, JK; Ahluwalia, R; Hill, M; Johnson, G; Hale, AT; Belal, A; Baygani, S; Olsen, MA; Foraker, RE; Carpenter, CR; Yan, Y; Ackerman, L; Noje, C; Jackson, E; Burns, E; Sayama, CM; Selden, NR; Vachhrajani, S; Shannon, CN; Kuppermann, N; Limbrick, DD				Greenberg, Jacob K.; Ahluwalia, Ranbir; Hill, Madelyn; Johnson, Gabbie; Hale, Andrew T.; Belal, Ahmed; Baygani, Shawyon; Olsen, Margaret A.; Foraker, Randi E.; Carpenter, Christopher R.; Yan, Yan; Ackerman, Laurie; Noje, Corina; Jackson, Eric; Burns, Erin; Sayama, Christina M.; Selden, Nathan R.; Vachhrajani, Shobhan; Shannon, Chevis N.; Kuppermann, Nathan; Limbrick, David D., Jr.			Development and external validation of the KIIDS-TBI tool for managing children with mild traumatic brain injury and intracranial injuries	ACADEMIC EMERGENCY MEDICINE			English	Article							HEAD-INJURY; DECISION RULES; CARE; EPIDEMIOLOGY; ADMISSION; RISK	Background Clinical decision support (CDS) may improve the postneuroimaging management of children with mild traumatic brain injuries (mTBI) and intracranial injuries. While the CHIIDA score has been proposed for this purpose, a more sensitive risk model may have broader use. Consequently, this study's objectives were to: (1) develop a new risk model with improved sensitivity compared to the CHIIDA model and (2) externally validate the new model and CHIIDA model in a multicenter data set. Methods We analyzed children <= 18 years old with mTBI and intracranial injuries included in the PECARN head injury data set (2004-2006). We used binary recursive partitioning to predict the composite outcome of neurosurgical intervention, intubation for > 24 h due to TBI, or death due to TBI. The new model was externally validated in a separate data set that included children treated at any one of six centers from 2006 to 2019. Results Based on 839 patients from the PECARN data set, a new risk model, the KIIDS-TBI model, was developed that incorporated imaging (e.g., midline shift) and clinical (e.g., Glasgow Coma Scale score) findings. Based on the model-predicted probability of the composite outcome, three cutoffs were evaluated to classify patients as "high risk" for level of care decisions. In the external validation data set consisting of 1,630 patients, the most conservative cutoff (i.e., any predictor present) identified 119 of 119 children with the composite outcome (sensitivity = 100%), but had the lowest specificity (26.3%). The other two decision-making cutoffs had worse sensitivity (94.1%-96.6%) but improved specificity (67.4%-81.3%). The CHIIDA model lacked the most conservative cutoff and otherwise showed the same or slightly worse performance compared to the other two cutoffs. Conclusions The KIIDS-TBI model has high sensitivity and moderate specificity for risk stratifying children with mTBI and intracranial injuries. Use of this CDS tool may help improve the safe, resource-efficient management of this important patient population.	[Greenberg, Jacob K.; Johnson, Gabbie; Limbrick, David D., Jr.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Ahluwalia, Ranbir; Hale, Andrew T.; Shannon, Chevis N.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Hill, Madelyn; Vachhrajani, Shobhan] Dayton Childrens Hosp, Dept Neurol Surg, Dayton, OH USA; [Belal, Ahmed; Baygani, Shawyon; Ackerman, Laurie] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA; [Olsen, Margaret A.; Foraker, Randi E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Carpenter, Christopher R.] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Yan, Yan] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Noje, Corina] Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Jackson, Eric] Johns Hopkins Sch Med, Dept Neurol Surg, Baltimore, MD USA; [Burns, Erin] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Sayama, Christina M.; Selden, Nathan R.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Shannon, Chevis N.] Univ Calif Davis, Amer Soc Reprod Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Dept Emergency Med, Davis, CA 95616 USA		Greenberg, JK (corresponding author), Washington Univ, Sch Med, Dept Neurosurg, 660 S Euclid Ave,Box 8057, St Louis, MO 63110 USA.	jacobgreenberg@wustl.edu	; Carpenter, Christopher/E-3720-2013	Greenberg, Jacob/0000-0003-2675-5658; Hale, Andrew/0000-0003-3182-2966; Carpenter, Christopher/0000-0002-2603-7157; Johnson, Gabrielle/0000-0001-9463-4554	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1F32HS027075--01A1]; Thrasher Research Fund [15024]	This study was funded by grants from the Agency for Healthcare Research and Quality (1F32HS027075--01A1) and the Thrasher Research Fund (#15024). The sponsors had no role in the study design, data collection, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.	Ahmed AK, 2018, J NEUROSURG-PEDIATR, V21, P434, DOI 10.3171/2017.9.PEDS17436; Alvarez RV, 2018, J PEDIATR-US, V195, P206, DOI 10.1016/j.jpeds.2017.11.064; [Anonymous], 2015, ID CHILDR VER LOW RI; [Anonymous], 2020, R LANGUAGE ENV STAT; Ash Joan S, 2007, AMIA Annu Symp Proc, P26; Azim A, 2017, J TRAUMA ACUTE CARE, V83, P1200, DOI 10.1097/TA.0000000000001611; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Burns EC, 2019, PEDIATR EMERG CARE, V35, P161, DOI 10.1097/PEC.0000000000000950; Colville Gillian, 2009, Intensive Crit Care Nurs, V25, P72, DOI 10.1016/j.iccn.2008.10.002; Greenberg JK, 2019, J NEUROSURG-PEDIATR, V23, P227, DOI 10.3171/2018.7.PEDS18263; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Johnson K., 2013, APPL PREDICTIVE MODE; Kotwani, 2018, J NEUROANAESTH CRIT, V5, pA019; Kuppermann N, 2019, JAMA PEDIATR, V173, P342, DOI 10.1001/jamapediatrics.2018.5501; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Neumayer KE, 2020, J PEDIATR SURG, V55, P1255, DOI 10.1016/j.jpedsurg.2019.09.027; Noje C, 2019, PEDIATR CRIT CARE ME, V20, P1061, DOI 10.1097/PCC.0000000000002033; Shope C, 2021, J NEUROSURG-PEDIATR, V27, P475, DOI 10.3171/2020.8.PEDS20496; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tallapragada K, 2018, ANZ J SURG, V88, P202, DOI 10.1111/ans.14175; Therneau Terry., 2019, rpart: Recursive partitioning and regression trees R package version 4.1-15; Traube C, 2017, CRIT CARE MED, V45, P891, DOI 10.1097/CCM.0000000000002324; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Wang HE, 2012, ANN EMERG MED, V60, P632, DOI 10.1016/j.annemergmed.2012.02.020	35	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2021	28	12					1409	1420		10.1111/acem.14333		AUG 2021	12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	YA4IT	WOS:000681779600001	34245632				2022-02-06	
J	Kho, W; von Haefen, C; Paeschke, N; Nasser, F; Endesfelder, S; Sifringer, M; Gonzalez-Lopez, A; Lanzke, N; Spies, CD				Kho, Widuri; von Haefen, Clarissa; Paeschke, Nadine; Nasser, Fatme; Endesfelder, Stefanie; Sifringer, Marco; Gonzalez-Lopez, Adrian; Lanzke, Nadine; Spies, Claudia D.			Dexmedetomidine Restores Autophagic Flux, Modulates Associated microRNAs and the Cholinergic Anti-inflammatory Pathway upon LPS-Treatment in Rats	JOURNAL OF NEUROIMMUNE PHARMACOLOGY			English	Article; Early Access						Dexmedetomidine; Brain; Spleen; Autophagy; microRNA; Cholinergic anti-inflammatory pathway	TRAUMATIC BRAIN-INJURY; DOWN-REGULATION; NEUROINFLAMMATION; INFLAMMATION; ACTIVATION; EXPRESSION; APOPTOSIS; MIR-27A; DEATH	Infections and perioperative stress can lead to neuroinflammation, which in turn is linked to cognitive impairments such as postoperative delirium or postoperative cognitive dysfunctions. The alpha 2-adrenoceptor agonist dexmedetomidine (DEX) prevents cognitive impairments and has organo-protective and anti-inflammatory properties. Macroautophagy (autophagy) regulates many biological processes, but its role in DEX-mediated anti-inflammation and the underlying mechanism of DEX remains largely unclear. We were interested how a pretreatment with DEX protects against lipopolysaccharide (LPS)-induced inflammation in adult male Wistar rats. We used Western blot and activity assays to study how DEX modulated autophagy- and apoptosis-associated proteins as well as molecules of the cholinergic anti-inflammatory pathway, and qPCR to analyse the expression of autophagy and inflammation-associated microRNAs (miRNA) in the spleen, cortex and hippocampus at different time points (6 h, 24 h, 7 d). We showed that a DEX pretreatment prevents LPS-induced impairments in autophagic flux and attenuates the LPS-induced increase in the apoptosis-associated protein cleaved poly(ADP-ribose)-polymerase (PARP) in the spleen. Both, DEX and LPS altered miRNA expression and molecules of the cholinergic anti-inflammatory pathway in the spleen and brain. While only a certain set of miRNAs was up- and/or downregulated by LPS in each tissue, which was prevented or attenuated by a DEX pretreatment in the spleen and hippocampus, all miRNAs were up- and/or downregulated by DEX itself - independent of whether or not they were altered by LPS. Our results indicate that the organo-protective effect of DEX may be mediated by autophagy, possibly by acting on associated miRNAs, and the cholinergic anti-inflammatory pathway.	[Kho, Widuri; von Haefen, Clarissa; Paeschke, Nadine; Nasser, Fatme; Sifringer, Marco; Gonzalez-Lopez, Adrian; Lanzke, Nadine; Spies, Claudia D.] Charite Univ Med Berlin, Dept Anesthesiol & Operat Intens Care Med, Berlin, Germany; [Endesfelder, Stefanie] Charite Univ Med Berlin, Dept Neonatol, Berlin, Germany; [Gonzalez-Lopez, Adrian] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain		von Haefen, C (corresponding author), Charite Univ Med Berlin, Dept Anesthesiol & Operat Intens Care Med, Berlin, Germany.	clarissa.von-haefen@charite.de	Endesfelder, Stefanie/AAA-5534-2022	Endesfelder, Stefanie/0000-0002-4030-7969; Kho, Widuri/0000-0001-9587-885X	Elsa-Neumann-Scholarship, Berlin	Open Access funding enabled and organized by Projekt DEAL. This work was supported by grants from the Elsa-Neumann-Scholarship, Berlin.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Chua CEL, 2019, J MOL NEUROSCI, V67, P235, DOI 10.1007/s12031-018-1231-y; Dardalas I, 2019, EUR J PHARMACOL, V856, DOI 10.1016/j.ejphar.2019.05.030; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Ding MY, 2019, EXP THER MED, V18, P2323, DOI 10.3892/etm.2019.7790; Endesfelder S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171498; Feng YC, 2015, TRENDS CELL BIOL, V25, P354, DOI 10.1016/j.tcb.2015.02.002; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Gu YF, 2020, ANTI-CANCER DRUG, V31, P385, DOI 10.1097/CAD.0000000000000886; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Hoover DB, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106359; Hsieh CH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-69; Icaza EE, 2009, ANESTH ANALG, V109, P1500, DOI 10.1213/ANE.0b013e3181ba7815; Ishizawa Y, 2007, J ANESTH, V21, P187, DOI 10.1007/s00540-006-0482-x; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Jian YP, 2020, EUR REV MED PHARMACO, V24, P1420, DOI 10.26355/eurrev_202002_20199; Jones SA, 2013, IMMUNOL CELL BIOL, V91, P250, DOI 10.1038/icb.2012.82; Kalb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062679; Kamolz LP, 2002, BURNS, V28, P147, DOI 10.1016/S0305-4179(01)00091-2; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Liu ZG, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1598-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan YY, 2015, J INTERF CYTOK RES, V35, P17, DOI 10.1089/jir.2014.0069; Lykhmus O, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00019; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; Muller A, 2019, EUR J ANAESTH, V36, P114, DOI 10.1097/EJA.0000000000000888; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Na HST, 2019, J MOL NEUROSCI, V69, P106, DOI 10.1007/s12031-019-01338-4; Nguyen Viet, 2017, Anesthesiol Clin, V35, P233, DOI 10.1016/j.anclin.2017.01.009; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ntalouka MP, 2018, HIPPOKRATIA, V22, P147; Paeschke N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091830; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Plaza-Zabala A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030598; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; Qiao H, 2009, CRIT CARE, V13, DOI 10.1186/cc8012; Rong H, 2017, BRAIN BEHAV IMMUN, V64, P195, DOI 10.1016/j.bbi.2017.03.006; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Saxena S, 2018, PRESSE MED, V47, pE73, DOI 10.1016/j.lpm.2018.03.011; Seeman P, 2003, SYNAPSE, V50, P35, DOI 10.1002/syn.10221; Shalgunov V, 2019, MED RES REV, V39, P1014, DOI 10.1002/med.21552; Shao BZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00553; Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019; Silva AM, 2018, THERANOSTICS, V8, P3902, DOI 10.7150/thno.24444; Song J, 2015, EXP NEUROBIOL, V24, P117, DOI 10.5607/en.2015.24.2.117; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Stachurska A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00513; Su P, 2016, NEUROSCIENCE, V319, P155, DOI 10.1016/j.neuroscience.2016.01.035; Su ZY, 2015, ONCOTARGET, V6, P8474, DOI 10.18632/oncotarget.3523; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Taniguchi T, 2008, J ANESTH, V22, P221, DOI 10.1007/s00540-008-0611-9; Turunen H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0787-y; von Haefen C, 2018, J NEUROIMMUNE PHARM, V13, P383, DOI 10.1007/s11481-018-9790-9; Wang P, 2014, NEUROCHEM RES, V39, P1279, DOI 10.1007/s11064-014-1310-6; Xing N, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117359; Yan LH, 2019, ANN THORAC SURG, V107, P76, DOI 10.1016/j.athoracsur.2018.07.082; Zhao Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00128; Zhu YJ, 2016, BRAIN RES, V1644, P1, DOI 10.1016/j.brainres.2016.04.074	65	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1557-1890	1557-1904		J NEUROIMMUNE PHARM	J. Neuroimmune Pharm.												10.1007/s11481-021-10003-w		AUG 2021	16	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	TW5PZ	WOS:000682453000001	34357471	hybrid			2022-02-06	
J	Ramsay, S				Ramsay, Scott			In search of scientific objectivity: Is there such a property for paediatric concussion?	NURSING PHILOSOPHY			English	Article						Kuhn; objectivity; paediatric concussion; systems perspective	TRAUMATIC BRAIN-INJURY; DIAGNOSIS; RECOVERY	Concussions are a significant public health problem worldwide. This brain injury is problematic in the paediatric population for a variety of reasons; however, the enquiry into these problems has been mainly through the biomedical perspective. This approach has impacted nursing knowledge and practice of children and youth with a concussion, primarily since other perspectives are viewed as not being objective. In this manuscript, I draw on Thomas Kuhn's view of objectivity to evaluate the biomedical perspective of concussion. I utilize current research and clinical examples to illustrate the advantages and drawbacks of this perspective for nursing. From this discussion, I propose an alternative perspective to capture the complexity of paediatric concussions for nursing, a systems perspective. Although I argue for an alternative perspective to approach paediatric concussions for nursing, I maintain that the biomedical perspective can be incorporated as one part of nursing knowledge and practice for paediatric concussion.	[Ramsay, Scott] Univ British Columbia, Sch Nursing, T201-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada		Ramsay, S (corresponding author), Univ British Columbia, Sch Nursing, T201-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	S.Ramsay@alumni.ubc.ca		Ramsay, Scott/0000-0001-5427-219X	University of British Columbia [6721]; Canadian Nurses Foundation; Indspire	University of British Columbia, Grant/Award Number: 6721; Canadian Nurses Foundation; Indspire	Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beresford MJ, 2010, QJM-INT J MED, V103, P721, DOI 10.1093/qjmed/hcq057; Boschetti F, 2005, LECT NOTES ARTIF INT, V3684, P573; Broadbent A, 2009, STUD HIST PHI PART C, V40, P302, DOI 10.1016/j.shpsc.2009.09.006; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centre for Effective Practice, 2019, CONC TOOL; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Clark AM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8316; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Daston L., 2007, OBJECTIVITY; Department of Health and Social Care, 2010, MOD SCI CAR UK WAY F; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gagnon I, 2019, J ORTHOP SPORT PHYS, V49, P855, DOI 10.2519/jospt.2019.8918; Galavotti, 2006, CAMBRIDGE VIENNA VIE, V12; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hews-Girard J, 2020, NURS INQ, V27, DOI 10.1111/nin.12323; Kandel E.R., 2006, SEARCH MEMORY EMERGE; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Krieger N., 2011, EPIDEMIOLOGY CONTEXT, DOI [10.1093/acprof:oso/9780195383874.001.0001, DOI 10.1093/ACPROF:OSO/9780195383874.001.0001]; Kuhn Thomas S, 1973, MACHETE LECT, P320; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; Patil Tejas, 2010, Philos Ethics Humanit Med, V5, P3, DOI 10.1186/1747-5341-5-3; Pawson R., 1997, REALISTIC EVALUATION; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Prins E., 2011, REALIST EVALUATION O; Ramsay S, 2019, J NURS MEAS, V27, P361, DOI 10.1891/1061-3749.27.3.361; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; SCHUMACHER KL, 1992, ADV NURS SCI, V14, P1; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Snedden TR, 2013, J SPEC PEDIATR NURS, V18, P211, DOI 10.1111/jspn.12038; Suskauer SJ, 2019, J HEAD TRAUMA REHAB, V34, P215, DOI 10.1097/HTR.0000000000000455; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Wallace JS, 2021, J PEDIATR-US, V233, P249, DOI 10.1016/j.jpeds.2021.01.057; Williams L, 2017, NURS PHILOS, V18, DOI 10.1111/nup.12130; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zwibel H, 2018, J AM OSTEOPATH ASSOC, V118, P655, DOI 10.7556/jaoa.2018.144	44	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1466-7681	1466-769X		NURS PHILOS	Nurs. Philos.	OCT	2021	22	4							e12368	10.1111/nup.12368		AUG 2021	9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	WC7AJ	WOS:000681777800001	34358394				2022-02-06	
J	Wu, YH; Wang, YZ; Zhang, Y; Yuan, XF; Gao, XX				Wu, Yehuan; Wang, Yongzheng; Zhang, Yi; Yuan, Xiaofang; Gao, Xiaoxia			A preliminary study of the Saint Louis university mental status examination (SLUMS) for the assessment of cognition in moderate to severe traumatic brain injury patients	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Traumatic brain injury (TBI); cognition; Saint Louis University Mental Status (SLUMS) examination; Montreal Cognitive Assessment (MoCA); Mini-Mental State Examination (MMSE)	SCREENING TOOL; MOCA	Objectives: To compare the sensitivity and specificity of the Saint Louis University Mental Status (SLUMS) examination, the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE) in adults with moderate to severe traumatic brain injury (TBI). Methods: In this cross-sectional study, 98 patients with moderate to severe TBI and 30 matched controls were evaluated. All participants were assessed using the MMSE, the MoCA and the SLUMS examination. Results: The SLUMS, MoCA and MMSE scores of the TBI group were significantly lower than those of the control group, indicating that the cognitive function of patients with TBI was significantly impaired. The receiver operating characteristic (ROC) curve analysis indicated that the areas under the curve for the SLUMS examination, the MoCA and the MMSE were all greater than 0.8. There were no significant differences among the instruments, indicating that all three were equally effective for diagnosing cognitive impairment in patients with moderate to severe TBI. According to the ROC curve analysis, the optimal cutoff values for the SLUMS examination, the MoCA and the MMSE were 24.5, 21.5 and 28.5, respectively. At that cutoff value, the sensitivity and specificity of the SLUMS examination were well balanced, with both exceeding 80%. Conclusions: The SLUMS examination is better suited than the MMSE or the MoCA for assessing cognitive function in patients with moderate to severe TBI.Y	[Wu, Yehuan; Zhang, Yi; Yuan, Xiaofang; Gao, Xiaoxia] Soochow Univ, Peoples Hosp Changzhou 1, Affiliated Hosp 3, Dept Rehabil Med, Changzhou, Jiangsu, Peoples R China; [Wang, Yongzheng] Peoples Hosp Deyang City, Dept Rehabil Med, Deyang City, Sichuan, Peoples R China		Zhang, Y (corresponding author), First Peoples Hosp Changzhou, Dept Rehabil Med, 185,Juqian St,Tianning Area, Changzhou 213003, Jiangsu, Peoples R China.	yehuan0331@foxmail.com			Young Talent Development Plan of Changzhou Health Commission [2020-233]	This study was supported by Funding from Young Talent Development Plan of Changzhou Health Commission (number 2020-233).	Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Feliciano L, 2013, AM J GERIAT PSYCHIAT, V21, P623, DOI 10.1016/j.jagp.2013.01.024; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gagnon G, 2013, CAN J NEUROL SCI, V40, P678, DOI 10.1017/S0317167100014918; GORGORAPTIS N, 2019, J ALZHEIMERS DIS, V44, P321, DOI DOI 10.3233/NRE-182618; Kaya D, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.12.093; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ohta K, 2014, DEMENT GER COGN D EX, V4, P147, DOI 10.1159/000362124; Shiroky Jonah S, 2007, Am J Alzheimers Dis Other Demen, V22, P406, DOI 10.1177/1533317507304744; Shwartz SK, 2019, APPL NEUROPSYCH-ADUL, V26, P101, DOI 10.1080/23279095.2017.1362407; Sun DL, 2020, NEUROEPIDEMIOLOGY, V54, P106, DOI 10.1159/000501911; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Tay MRJ, 2019, AM J PHYS MED REHAB, V98, P971, DOI 10.1097/PHM.0000000000001227; Webster J, 2015, SAMJ S AFR MED J, V105, P195, DOI 10.7196/SAMJ.9014; Zhang S, 2021, APPL NEUROPSYCH-ADUL, V28, P633, DOI 10.1080/23279095.2019.1680986	15	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1952414		AUG 2021	5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TY1ZT	WOS:000683585500001	34372718				2022-02-06	
J	Yao, Y; Ji, YS; Ren, JH; Liu, HY; Khanna, R; Sun, L				Yao, Yuan; Ji, Yingshi; Ren, Jinghong; Liu, Huanyu; Khanna, Rajesh; Sun, Li			Inhibition of autophagy by CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKK beta/AMPK/mTOR pathway contributes to ischemic postconditioning-induced neuroprotection against cerebral ischemia-reperfusion injury	MOLECULAR BRAIN			English	Article						Cerebral ischemia injury; Glutamate; CRMP2; Apoptosis; Autophagy; CaMKK beta/AMPK/mTOR pathway	ARTERY OCCLUSION; NEUROPATHIC PAIN; NEURONAL INJURY; PROTECTS; CELLS; APOPTOSIS; BRAIN; SUPPRESSION; ACTIVATION; REVERSES	Cerebral ischemia, a common cerebrovascular disease, is characterized by functional deficits and apoptotic cell death. Autophagy, a type of programmed cell death, plays critical roles in controlling neuronal damage and metabolic homeostasis, and has been inextricably linked to cerebral ischemia. We previously identified a short peptide aptamer from collapsin response mediator protein 2 (CRMP2), designated the Ca2+ channel-binding domain 3 (CBD3) peptide, that conferred protection against excitotoxicity and traumatic brain injury. ST2-104, a nona-arginine (R9)-fused CBD3 peptide, exerted beneficial effects on neuropathic pain and was neuroprotective in a model of Alzheimer's disease; however, the effect of ST2-104 on cerebral ischemia and its mechanism of action have not been studied. In this study, we modeled cerebral ischemia-reperfusion injury in rats with the middle cerebral artery occlusion (MCAO) as well as challenged SH-SY5Y neuroblastoma cells with glutamate to induce toxicity to interrogate the effects of ST2-104 on autophagy following ischemic/excitotoxic insults. ST2-104 reduced the infarct volume and improved the neurological score of rats subjected to MCAO. ST2-104 protected SH-SY5Y cells from death following glutamate exposure via blunting apoptosis and autophagy as well as limiting excessive calcium entry. 3-Methyladenine (3-MA), an inhibitor of autophagy, promoted the effects of ST2-104 in inhibiting apoptosis triggered by glutamate while rapamycin, an activator of autophagy, failed to do so. ST2-104 peptide reversed glutamate-induced apoptosis via inhibiting Ca2+/CaM-dependent protein kinase kinase beta (CaMKK beta)-mediated autophagy, which was partly enhanced by STO-609 (an inhibitor of CaMKK beta). ST2-104 attenuated neuronal apoptosis by inhibiting autophagy through CaMKK beta/AMPK/mTOR pathway. Our results suggest that the neuroprotective effect of ST2-104 are due to actions on the crosstalk between apoptosis and autophagy via the CaMKK beta/AMPK/mTOR signaling pathway. The findings present novel insights into the potential neuroprotection of ST2-104 in cerebral ischemia.	[Yao, Yuan; Ji, Yingshi; Ren, Jinghong; Liu, Huanyu] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun 130021, Jilin, Peoples R China; [Khanna, Rajesh] Univ Arizona, Coll Med, Dept Pharmacol, 1501 North Campbell Dr,POB 245050, Tucson, AZ 85724 USA; [Sun, Li] First Hosp Jilin Univ, Dept Neurol, Changchun 130021, Jilin, Peoples R China; [Sun, Li] First Hosp Jilin Univ, Neurosci Ctr, Changchun 130021, Jilin, Peoples R China		Khanna, R (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, 1501 North Campbell Dr,POB 245050, Tucson, AZ 85724 USA.; Sun, L (corresponding author), First Hosp Jilin Univ, Dept Neurol, Changchun 130021, Jilin, Peoples R China.; Sun, L (corresponding author), First Hosp Jilin Univ, Neurosci Ctr, Changchun 130021, Jilin, Peoples R China.	rkhanna@arizona.edu; sunli99@jlu.edu.cn			Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2018YFC1312301]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071442, 81571231]; Technology Foundation of Jilin Province [20190701058GH]; Foundation of Health and Family Planning Commission of Jilin Province [2020J121]	This study was supported by grants from the Major Chronic Disease Program of the Ministry of Science and Technology of China (No. 2018YFC1312301), the General Program of the National Natural Science Foundation of China (No. 81571231), the General Program of the National Natural Science Foundation of China (No. 82071442), Technology Foundation of Jilin Province (20190701058GH), and the Foundation of Health and Family Planning Commission of Jilin Province (2020J121).	Betin VMS, 2009, AUTOPHAGY, V5, P1057, DOI 10.4161/auto.5.7.9684; Brittain JM, 2012, CHANNELS, V6, P52, DOI 10.4161/chan.18919; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chew Lindsey A, 2018, Neuronal Signal, V2, DOI 10.1042/NS20170220; Christophe BR, 2017, EXPERT OPIN PHARMACO, V18, P573, DOI 10.1080/14656566.2017.1309022; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fischer G, 2014, GENE THER, V21, P44, DOI 10.1038/gt.2013.56; Francois-Moutal L, 2015, PAIN, V156, P1247, DOI 10.1097/j.pain.0000000000000147; Fu L, 2016, BRAIN RES, V1650, P103, DOI 10.1016/j.brainres.2016.08.035; Gao Y, 2019, J BIOL REG HOMEOS AG, V33, P1507; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; He X, 2019, ONCOTARGETS THER, V12, P10811, DOI 10.2147/OTT.S220453; Huang LQ, 2019, OPEN LIFE SCI, V14, P179, DOI 10.1515/biol-2019-0020; Huang YG, 2019, NEURAL REGEN RES, V14, P954, DOI 10.4103/1673-5374.250569; Huang ZH, 2019, EUR J PHARMACOL, V857, DOI 10.1016/j.ejphar.2019.172424; Ji YS, 2019, CHEM-BIOL INTERACT, V305, P28, DOI 10.1016/j.cbi.2019.03.005; Jiang J, 2018, BIOMED PHARMACOTHER, V99, P583, DOI 10.1016/j.biopha.2018.01.067; Ju WN, 2013, J NEUROCHEM, V124, P869, DOI 10.1111/jnc.12070; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Khanna R, 2020, ACS CHEM NEUROSCI, V11, P2492, DOI 10.1021/acschemneuro.0c00307; Lalaoui N, 2015, SEMIN CELL DEV BIOL, V39, P63, DOI 10.1016/j.semcdb.2015.02.003; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Li L, 2019, NANOTOXICOLOGY, V13, P369, DOI 10.1080/17435390.2018.1550226; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14474; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Moutal A, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00471; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Oza R, 2017, AM FAM PHYSICIAN, V96, P436; Peng K, 2021, J CELL PHYSIOL, V236, P1309, DOI 10.1002/jcp.29938; Piekarz AD, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-54; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Sekerdag E, 2018, CURR NEUROPHARMACOL, V16, P1396, DOI 10.2174/1570159X16666180302115544; Singh V, 2019, INDIAN J CLIN BIOCHE, V34, P246, DOI 10.1007/s12291-019-00838-9; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Sun B, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0054-1; Sun YM, 2018, NEUROCHEM RES, V43, P1826, DOI 10.1007/s11064-018-2599-3; Tao SL, 2019, EXP THER MED, V18, P2153, DOI 10.3892/etm.2019.7782; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wang JF, 2018, NEURAL REGEN RES, V13, P989, DOI 10.4103/1673-5374.233441; Wang P, 2018, PROG NEUROBIOL, V163, P98, DOI 10.1016/j.pneurobio.2018.01.001; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wilson SM, 2011, CHANNELS, V5, P447, DOI 10.4161/chan.5.5.17363; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Zhang DM, 2019, FREE RADICAL BIO MED, V137, P13, DOI 10.1016/j.freeradbiomed.2019.04.002; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhao ZQ, 2010, CARDIOVASC DRUG THER, V24, P265, DOI 10.1007/s10557-010-6240-1; Zheng YQ, 2018, CELL PHYSIOL BIOCHEM, V47, P604, DOI 10.1159/000490016; Zheng Z, 2003, DRUG NEWS PERSPECT, V16, P497, DOI 10.1358/dnp.2003.16.8.829348	56	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	AUG 6	2021	14	1							123	10.1186/s13041-021-00836-0			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW6PO	WOS:000682519500001	34362425	gold, Green Published			2022-02-06	
J	Andruchow, JE; Grigat, D; McRae, AD; Innes, G; Vatanpour, S; Wang, DM; Taljaard, M; Lang, E				Andruchow, James E.; Grigat, Daniel; McRae, Andrew D.; Innes, Grant; Vatanpour, Shabnam; Wang, Dongmei; Taljaard, Monica; Lang, Eddy			Decision support for computed tomography in the emergency department: a multicenter cluster-randomized controlled trial	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Computerized decision support; Computed tomography; Mild traumatic brain injury; Pulmonary embolism; Emergency medicine; Evidence-based medicine	CT HEAD RULE; SUSPECTED PULMONARY-EMBOLISM; UNITED-STATES; DIAGNOSTIC YIELD; 10-COMMANDMENTS; GUIDELINES; MANAGEMENT; CRITERIA; INJURY	Objectives Clinical decision support may facilitate evidence-based imaging, but most studies to date examining the impact of decision support have used non-randomized designs which limit the conclusions that can be drawn from them. This randomized trial examines if decision support can reduce computed tomography (CT) utilization for patients with mild traumatic brain injuries and suspected pulmonary embolism in the emergency department. This study was funded by a competitive public research grant and registered on ClinicalTrials.gov (NCT02410941). Methods Emergency physicians at five urban sites were assigned to voluntary decision support for CT imaging of patients with either head injuries or suspected pulmonary embolism using a cluster-randomized design over a 1-year intervention period. The co-primary outcomes were CT head and CT pulmonary angiography utilization. CT pulmonary angiography diagnostic yield (proportion of studies diagnostic for acute pulmonary embolism) was a secondary outcome. Results A total of 225 physicians were randomized and studied over a 2-year baseline and 1-year intervention period. Physicians interacted with the decision support in 38.0% and 45.0% of eligible head injury and suspected pulmonary embolism cases, respectively. A mixed effects logistic regression model demonstrated no significant impact of decision support on head CT utilization (OR 0.93, 95% CI 0.79-1.10, p = 0.31), CT pulmonary angiography utilization (OR 0.98, 95% CI 0.88-1.11, p = 0.74) or diagnostic yield (OR 1.23, 95% CI 0.96-1.65, p = 0.10). However, overall CT pulmonary diagnostic yield (17.7%) was almost three times higher than that reported by a recent large US study, suggesting that selective imaging was already being employed. Conclusion Voluntary decision support addressing many commonly cited barriers to evidence-based imaging did not significantly reduce CT utilization or improve diagnostic yield but was limited by low rates of participation and high baseline rates of selective imaging. Demonstrating value to clinicians through interventions that improve workflow is likely necessary to meaningfully change imaging practices.	[Andruchow, James E.; McRae, Andrew D.; Innes, Grant; Vatanpour, Shabnam; Wang, Dongmei; Lang, Eddy] Univ Calgary, Cumming Sch Med, Foothills Med Ctr, Dept Emergency Med, Room C-231,1403-29st NW, Calgary, AB T2N 2T9, Canada; [Grigat, Daniel] Alberta Hlth Serv, Calgary, AB, Canada; [Andruchow, James E.; McRae, Andrew D.; Innes, Grant; Lang, Eddy] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Taljaard, Monica] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Taljaard, Monica] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada		Andruchow, JE (corresponding author), Univ Calgary, Cumming Sch Med, Foothills Med Ctr, Dept Emergency Med, Room C-231,1403-29st NW, Calgary, AB T2N 2T9, Canada.; Andruchow, JE (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	andruchow.james@gmail.com			Alberta Innovates Health Solutions (AIHS): Partnership for Research and Innovation in the Health System (PRIHS) [201300468]	This study was funded by a competitive unrestricted research Grant (201300468) from Alberta Innovates Health Solutions (AIHS): Partnership for Research and Innovation in the Health System (PRIHS).	American College of Emergency Physicians, IN ABIM FDN; Andruchow JE, 2012, ARCH INTERN MED, V172, P660, DOI 10.1001/archinternmed.2011.2243; Anjum O, 2019, EMERG RADIOL, V26, P29, DOI 10.1007/s10140-018-1641-8; Ballard DW, 2019, ANN EMERG MED, V73, P440, DOI 10.1016/j.annemergmed.2018.11.011; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; Bookman K, 2017, ACAD EMERG MED, V24, P839, DOI 10.1111/acem.13195; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bullard MJ, 2017, CAN J EMERG MED, V19, pS18, DOI 10.1017/cem.2017.365; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Cheng AHY, 2017, CAN J EMERG MED, V19, pS9, DOI 10.1017/cem.2017.1; Curran JA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-25; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Dunne RM, 2015, RADIOLOGY, V276, P167, DOI 10.1148/radiol.15141208; Goehler A, 2019, ACAD RADIOL, V26, P1077, DOI 10.1016/j.acra.2018.09.009; Grafstein E, 2008, CAN J EMERG MED, V10, P151; Gupta A, 2014, J AM MED INFORM ASSN, V21, P23, DOI 10.1136/amiajnl-2013-001617; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Hooper R, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1121; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Jimenez D, 2015, THORAX, V70, P909, DOI 10.1136/thoraxjnl-2014-206689; Khorasani R, 2014, AM J ROENTGENOL, V203, P945, DOI 10.2214/AJR.14.13134; Konstantinides SV, 2019, EUR HEART J, V40, P3453, DOI 10.1093/eurheartj/ehz726; Mettler FA, 2019, HEALTH PHYS, V116, P126, DOI 10.1097/HP.0000000000000996; Mills AM, 2018, AM J EMERG MED, V36, P540, DOI 10.1016/j.ajem.2017.09.004; Nybo M, 2017, SCAND J CLIN LAB INV, V77, P568, DOI 10.1080/00365513.2017.1390783; Patterson BW, 2019, ANN EMERG MED, V74, P285, DOI 10.1016/j.annemergmed.2018.10.034; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Singh B, 2013, EMERG MED J, V30, P701, DOI 10.1136/emermed-2012-201730; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Teerenstra S, 2012, STAT MED, V31, P2169, DOI 10.1002/sim.5352; van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1; Venkatesh AK, 2018, AM J ROENTGENOL, V210, P572, DOI 10.2214/AJR.17.18586; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368	40	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	SEP	2021	23	5					631	640		10.1007/s43678-021-00170-3		AUG 2021	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UN1IC	WOS:000681561700003	34351598	Bronze			2022-02-06	
J	Carrick, FRR; Pagnacco, G; Azzolino, SFF; Hunfalvay, M; Oggero, E; Frizzell, T; Smith, CJJ; Pawlowski, G; Campbell, NKJ; Fickling, SDD; Lakhani, B; D'Arcy, RCN				Carrick, Frederick R. R.; Pagnacco, Guido; Azzolino, Sergio F. F.; Hunfalvay, Melissa; Oggero, Elena; Frizzell, Tory; Smith, Christopher J. J.; Pawlowski, Gabriela; Campbell, Natasha K. J.; Fickling, Shaun D. D.; Lakhani, Bimal; D'Arcy, Ryan C. N.			Brain Vital Signs in Elite Ice Hockey: Towards Characterizing Objective and Specific Neurophysiological Reference Values for Concussion Management	FRONTIERS IN NEUROSCIENCE			English	Article						electroencephalography (EEG); event-related potentials; brain vital signs; ice hockey; normative data	EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL ASSESSMENT; ERP; SKILLS; N1	Background: Prior concussion studies have shown that objective neurophysiological measures are sensitive to detecting concussive and subconcussive impairments in youth ice-hockey. These studies monitored brain vital signs at rink-side using a within-subjects design to demonstrate significant changes from pre-season baseline scans. However, practical clinical implementation must overcome inherent challenges related to any dependence on a baseline. This requires establishing the start of normative reference data sets. Methods: The current study collected specific reference data for N = 58 elite, youth, male ice-hockey players and compared these with a general reference dataset from N = 135 of males and females across the lifespan. The elite hockey players were recruited to a select training camp through CAA Hockey, a management agency for players drafted to leagues such as the National Hockey League (NHL). The statistical analysis included a test-retest comparison to establish reliability, and a multivariate analysis of covariance to evaluate differences in brain vital signs between groups with age as a covariate. Findings: Test-retest assessments for brain vital signs evoked potentials showed moderate-to-good reliability (Cronbach's Alpha > 0.7, Intraclass correlation coefficient > 0.5) in five out of six measures. The multivariate analysis of covariance showed no overall effect for group (p = 0.105), and a significant effect of age as a covariate was observed (p < 0.001). Adjusting for the effect of age, a significant difference was observed in the measure of N100 latency (p = 0.022) between elite hockey players and the heterogeneous control group. Interpretation: The findings support the concept that normative physiological data can be used in brain vital signs evaluation in athletes, and should additionally be stratified for age, skill level, and experience. These can be combined with general norms and/or individual baseline assessments where appropriate and/or possible. The current results allow for brain vital sign evaluation independent of baseline assessment, therefore enabling objective neurophysiological evaluation of concussion management and cognitive performance optimization in ice-hockey.	[Carrick, Frederick R. R.] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Carrick, Frederick R. R.] MGH Inst Hlth Profess, Boston, MA 02129 USA; [Carrick, Frederick R. R.] Univ Cambridge, Ctr Mental Hlth Res, Cambridge, England; [Carrick, Frederick R. R.; Pagnacco, Guido; Azzolino, Sergio F. F.; Hunfalvay, Melissa; Oggero, Elena] Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge, England; [Pagnacco, Guido; Oggero, Elena] Univ Wyoming, Dept Elect & Comp Engn, Laramie, WY 82071 USA; [Frizzell, Tory; Pawlowski, Gabriela; Campbell, Natasha K. J.; Fickling, Shaun D. D.; D'Arcy, Ryan C. N.] BrainNET, Hlth & Technol Dist, Vancouver, BC, Canada; [Smith, Christopher J. J.; Pawlowski, Gabriela; Campbell, Natasha K. J.; Fickling, Shaun D. D.; Lakhani, Bimal; D'Arcy, Ryan C. N.] HealthTech Connex, Ctr Neurol Studies, Vancouver, BC, Canada; [D'Arcy, Ryan C. N.] Univ British Columbia, Dept Radiol, DM Ctr Brain Hlth, Vancouver, BC, Canada		Carrick, FRR (corresponding author), Univ Cent Florida, Coll Med, Orlando, FL 32816 USA.; Carrick, FRR (corresponding author), MGH Inst Hlth Profess, Boston, MA 02129 USA.; Carrick, FRR (corresponding author), Univ Cambridge, Ctr Mental Hlth Res, Cambridge, England.; Carrick, FRR (corresponding author), Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge, England.	drfrcarrick@post.harvard.edu		Oggero, Elena/0000-0002-7223-5613; Carrick, Frederick/0000-0002-2818-6551; Pagnacco, Guido/0000-0002-4844-1636	HealthTech Connex Inc.; Carrick Institute	HealthTech Connex Inc., and Carrick Institute provided the funding for this investigation.	Abel AD, 2018, LANG LEARN DEV, V14, P61, DOI 10.1080/15475441.2017.1362347; Bazarian JJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37349; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; Corbin-Berrigan LA, 2020, NEUROPSYCHOL REV, DOI 10.1007/s11065-020-09442-8; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; D'Arcy RCN, 2003, CLIN NEUROPHYSIOL, V114, P662, DOI 10.1016/S1388-2457(03)00007-5; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; Del Percio C, 2007, BRAIN RES BULL, V74, P104, DOI 10.1016/j.brainresbull.2007.05.011; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Eckner JT, 2016, BRAIN INJURY, V30, P1075, DOI 10.3109/02699052.2016.1160152; Fickling SD, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab019; Fickling SD, 2019, 2019 IEEE 10TH ANNUAL INFORMATION TECHNOLOGY, ELECTRONICS AND MOBILE COMMUNICATION CONFERENCE (IEMCON), P219, DOI 10.1109/IEMCON.2019.8936246; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Frehlick Z, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0538-4; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P53, DOI 10.1177/155005940503600203; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hajra SG, 2020, P 2020 IEEE INT IOT, P1; Hajra SG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00211; Hajra SG, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1527-2; He P, 2004, MED BIOL ENG COMPUT, V42, P407, DOI 10.1007/BF02344717; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Johnstone J., 2003, Journal of Neurotherapy, V7, P31, DOI 10.1300/J184v07n03_02; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pawlowski G.M., 2019, BRAIN VITAL SIGNS EX, DOI [10.3389/fnins.2018.00968/full, DOI 10.3389/FNINS.2018.00968/FULL]; Pender SC, 2020, CURR SPORT MED REP, V19, P380, DOI 10.1249/JSR.0000000000000752; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Ragan BG, 2007, ATHLET THER TODAY, V12, P2; Russo G, 2019, PSYCHOL SPORT EXERC, V44, P60, DOI 10.1016/j.psychsport.2019.05.004; Sato D, 2020, BEHAV BRAIN RES, V395, DOI 10.1016/j.bbr.2020.112835; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schulz E, 2008, NEUROIMAGE, V41, P153, DOI 10.1016/j.neuroimage.2008.02.012; Slavoaca D, 2020, NEUROL SCI, V41, P2033, DOI 10.1007/s10072-019-04238-y; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Smith C.J., 2020, BRAIN VITAL SIGNS DE; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; Taliep MS, 2014, PERCEPTION, V43, P316, DOI 10.1068/p7530; Taylor JR, 2007, CLIN EEG NEUROSCI, V38, P8, DOI 10.1177/155005940703800106; Tome D, 2015, J NEURAL TRANSM, V122, P375, DOI 10.1007/s00702-014-1258-3; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152; Yue JK, 2020, NEUROSURGERY, V87, P466, DOI 10.1093/neuros/nyaa022	55	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 5	2021	15								670563	10.3389/fnins.2021.670563			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UE2EF	WOS:000687706600001	34434084	gold, Green Published			2022-02-06	
J	Chaisrisawadisuk, S; Constantine, S; Lottering, N; Moore, MH; Anderson, PJ				Chaisrisawadisuk, Sarut; Constantine, Sarah; Lottering, Nicolene; Moore, Mark H.; Anderson, Peter J.			Incidence of persistent metopic suture in Australia: findings from 1034 three-dimensional computed tomography scans	CHILDS NERVOUS SYSTEM			English	Article						Craniofacial abnormalities; Metopism; Computed tomography	CRANIAL SUTURES; BIOLOGY; CLOSURE	Purpose To investigate the incidence of persistent, open metopic sutures in contemporary Australians aged 24 months and older. Methods Metopic suture evaluation was conducted on retrospective cranial/cervical computed tomography scans of patients aged 24 to 252 months who presented to the Women's and Children's Hospital in Adelaide, Australia, between 2010 and 2020. Suture ossification was graded according to Lottering scoring system based on 4 stages, on three-dimensional volume-rendered reconstructions (stage 1: fibrous tissue interface, stage 2: commenced fusion, stage 3: complete fusion and stage 4: obliterated suture). The complete persistent sutures were classified as stage 1. Partially closed sutures were classified into stages 2 and 3, while completely closed sutures were defined as stage 4. Results One thousand thirty-four patients (61.2% male and 38.8% female) were included, with a mean age at scan of 66 months. More than half of patients were subject to scanning due to closed-head injuries. The incidence of persistent (completely open) metopic suture was 4.8% (2.3% in males and 2.5% in females). In comparison, a partially closed metopic suture was found in 6.3% of the study cohort, with the remaining sutures located along the metopic suture line, at the glabella, mid-part of the suture, bregma and glabella-bregma areas. Conclusion The prevalence of persistent metopic sutures in our study of the Australian population is 4.8%, and it is equally distributed between the genders. The pattern of suture closure can commence from any location along the suture line, which is in contrast to the existing literature.	[Chaisrisawadisuk, Sarut; Moore, Mark H.; Anderson, Peter J.] Womens & Childrens Hosp, Cleft & Craniofacial South Australia, Adelaide, SA, Australia; [Constantine, Sarah] Womens & Childrens Hosp, Dept Med Imaging, Adelaide, SA, Australia; [Lottering, Nicolene] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia; [Anderson, Peter J.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Chaisrisawadisuk, Sarut] Mahidol Univ, Siriraj Hosp, Fac Med, Div Plast Surg,Dept Surg, Bangkok, Thailand		Chaisrisawadisuk, S (corresponding author), Womens & Childrens Hosp, Cleft & Craniofacial South Australia, Adelaide, SA, Australia.; Chaisrisawadisuk, S (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Div Plast Surg,Dept Surg, Bangkok, Thailand.	sarut.cha@mahidol.ac.th		Constantine, Sarah/0000-0001-8244-258X; ANDERSON, Peter/0000-0002-3730-4652; CHAISRISAWADISUK, SARUT/0000-0001-6040-0784			AJMANI ML, 1983, J ANAT, V137, P177; ALBIN RE, 1985, PLAST RECONSTR SURG, V76, P202, DOI 10.1097/00006534-198508000-00005; Anutschin D., 1883, ANAL REV ANTHR, P358; Ashley-Montagu MF, 1937, J R ANTHROPOL INST G, V67, P157, DOI 10.2307/2844176; Baaten PJJ, 2003, CLIN ANAT, V16, P148, DOI 10.1002/ca.10050; Bradley JP, 1996, CLEFT PALATE-CRAN J, V33, P150, DOI 10.1597/1545-1569(1996)033<0150:SICSBV>2.3.CO;2; Bradley JP, 1996, PLAST RECONSTR SURG, V98, P1039, DOI 10.1097/00006534-199611000-00018; Caliskan S, 2018, FOLIA MORPHOL, V77, P730, DOI 10.5603/FM.a2018.0030; COHEN MM, 1993, AM J MED GENET, V47, P581, DOI 10.1002/ajmg.1320470507; Coussens AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-458; da Silva Ivan do Nascimento, 2013, ISRN Anat, V2013, P158341, DOI 10.5402/2013/158341; Faro C, 2005, ULTRASOUND OBST GYN, V26, P618, DOI 10.1002/uog.1997; Fearon JA, 1996, PLAST RECONSTR SURG, V97, P503, DOI 10.1097/00006534-199603000-00001; Karabagli P, 2013, CHILD NERV SYST, V29, P2165, DOI 10.1007/s00381-013-2284-4; Levine JP, 1998, PLAST RECONSTR SURG, V101, P1441, DOI 10.1097/00006534-199805000-00002; Lottering N, 2016, J FORENSIC SCI, V61, pS39, DOI 10.1111/1556-4029.12956; MANZANARES MC, 1988, J ANAT, V161, P203; Opperman LA, 1996, IN VITRO CELL DEV-AN, V32, P627; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Panigrahi, 2017, NATL J BASIC MED SCI, V8, P77; Teager SJ, 2019, CHILD NERV SYST, V35, P329, DOI 10.1007/s00381-018-3957-9; Vinchon M, 2019, NEUROCHIRURGIE, V65, P239, DOI 10.1016/j.neuchi.2019.09.006; Vissers LELM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002278; Vu HL, 2001, J CRANIOFAC SURG, V12, P527, DOI 10.1097/00001665-200111000-00005; Woo JK, 1949, AM J PHYS ANTHROP-NE, V7, P215, DOI 10.1002/ajpa.1330070205; Zdilla MJ, 2018, J CRANIOFAC SURG, V29, P204, DOI 10.1097/SCS.0000000000004030	26	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2021	37	12					3871	3879		10.1007/s00381-021-05313-6		AUG 2021	9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XA4ZU	WOS:000681565000001	34351437				2022-02-06	
J	Corallo, F; Pria, D; Di Blasi, A; Bonanno, L; De Cola, MC; Di Cara, M; Rifici, C; De Salvo, S; Bramanti, P; Marino, S; Lo Buono, V				Corallo, Francesco; Pria, Deborah; Di Blasi, Agata; Bonanno, Lilla; De Cola, Maria Cristina; Di Cara, Marcella; Rifici, Carmela; De Salvo, Simona; Bramanti, Placido; Marino, Silvia; Lo Buono, Viviana			The effects of caregiver's burden on dynamic structure in disorder of consciousness families: An observational study	BRAIN AND BEHAVIOR			English	Article						caregivers; disorders of consciousness; minimally conscious state; psychological function	BRAIN-INJURY; VEGETATIVE STATE; PREDICTORS; HEALTH; NEEDS	Introduction Disorder of consciousness is a clinical condition due to severe brain damage. The impact of consciousness disorder on the family is characterized by a combination of biopsychosocial factors. The burden and suffering perceived by caregivers can cause psychological distress characterized by anxiety, depression, and physical illness. The aim of the study was to investigate the interaction between family dynamics and caregiver burden. Methods We enlisted 35 caregivers of subjects in a minimally conscious state. Two skilled psychologists administered the Olson's Adaptability and Family Cohesion Assessment Scale and the Novak's Burden Inventory Caregiver Scale to assess family function and family burden, respectively. Results We found that the caregiver burden correlates with the family adaptability and cohesion, as well as with enmeshment, rigidity, and disengagement. Conclusion Findings suggest that the traumatic event does not affect the family structure. Families are able to maintain a balanced functioning and control distress.	[Corallo, Francesco; Pria, Deborah; Di Blasi, Agata; Bonanno, Lilla; De Cola, Maria Cristina; Di Cara, Marcella; Rifici, Carmela; De Salvo, Simona; Bramanti, Placido; Marino, Silvia; Lo Buono, Viviana] IRCCS Ctr Neurolesi Bonino Pulejo, Via Palermo SS 113, I-98124 Messina, Italy		De Cola, MC (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Via Palermo SS 113, I-98124 Messina, Italy.	mariacristina.decola@irccsme.it	Marino, Silvia/T-5118-2019; corallo, francesco/K-5932-2016	Marino, Silvia/0000-0002-1088-6808; De Cola, Maria Cristina/0000-0002-7509-3833; corallo, francesco/0000-0003-4862-3832	 [GR-2013-02359341]	Italian Health Minister, Grant/Award Number: GR-2013-02359341	Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bramanti P, 2013, CHRONIC DISORDERS CO; Chiambretto P, 2001, ACTA NEUROL SCAND, V104, P364, DOI 10.1034/j.1600-0404.2001.00107.x; Corallo F, 2018, NEUROL SCI, V39, P1375, DOI 10.1007/s10072-018-3431-1; Corallo F, 2015, ACTA MEDICA MEDITERR, V31, P297; Corallo F, 2015, AM J HEALTH BEHAV, V39, P772, DOI 10.5993/AJHB.39.6.4; De Stefano N, 2012, NEUROIMAGING COGNITI; Guarnerio C, 2012, PSYCHIAT QUART, V83, P65, DOI 10.1007/s11126-011-9183-1; Ho SC, 2009, J GERONTOL A-BIOL, V64, P873, DOI 10.1093/gerona/glp034; Jacobs HE, 1986, J HEAD TRAUMA REHAB, V1, P55, DOI DOI 10.1136/BMJ.M1815; Kim H, 2012, J ADV NURS, V68, P846, DOI 10.1111/j.1365-2648.2011.05787.x; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Laureys S, 2018, COMA DISORDERS CONSC, P97; Leggett AN, 2011, GERONTOLOGIST, V51, P76, DOI 10.1093/geront/gnq055; Leibach GG, 2014, NEUROREHABILITATION, V34, P167, DOI 10.3233/NRE-131013; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Loriedo C, 2004, FACES 4 MODELLO CIRC; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Mariotti M, 2002, MEDICO FAMIGLIA COMU, V26; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Rasmussen MS, 2021, CLIN REHABIL, V35, P1428, DOI 10.1177/02692155211010369; Rolland JS, 2005, FAM PROCESS, V44, P283, DOI 10.1111/j.1545-5300.2005.00060.x; Sherwood PR, 2008, PSYCHO-ONCOLOGY, V17, P598, DOI 10.1002/pon.1287; Soeterik SM, 2018, NEUROPSYCHOL REHABIL, V28, P1392, DOI 10.1080/09602011.2018.1529603; TZIDKIAHU T, 1994, BRAIN INJURY, V8, P159, DOI 10.3109/02699059409150967	26	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	AUG	2021	11	8								10.1002/brb3.2305		AUG 2021	6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WK0YR	WOS:000681279800001	34350729	Green Published, gold			2022-02-06	
J	Francoeur, MJ; Tang, TZ; Fakhraei, L; Wu, XY; Hulyalkar, S; Cramer, J; Buscher, N; Ramanathan, DR				Francoeur, Miranda J.; Tang, Tianzhi; Fakhraei, Leila; Wu, Xuanyu; Hulyalkar, Sidharth; Cramer, Jessica; Buscher, Nathalie; Ramanathan, Dhakshin R.			Chronic, Multi-Site Recordings Supported by Two Low-Cost, Stationary Probe Designs Optimized to Capture Either Single Unit or Local Field Potential Activity in Behaving Rats	FRONTIERS IN PSYCHIATRY			English	Article						electrophysiology; single unit; field potentials; multi-site recordings; rodent models; fixed array	TRAUMATIC BRAIN-INJURY; MICROELECTRODE ARRAYS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; MICROWIRE ARRAY; SILICON PROBES; IMPULSIVITY; ELECTRODE; TISSUE	Rodent models of cognitive behavior have greatly contributed to our understanding of human neuropsychiatric disorders. However, to elucidate the neurobiological underpinnings of such disorders or impairments, animal models are more useful when paired with methods for measuring brain function in awake, behaving animals. Standard tools used for systems-neuroscience level investigations are not optimized for large-scale and high-throughput behavioral battery testing due to various factors including cost, time, poor longevity, and selective targeting limited to measuring only a few brain regions at a time. Here we describe two different "user-friendly" methods for building extracellular electrophysiological probes that can be used to measure either single units or local field potentials in rats performing cognitive tasks. Both probe designs leverage several readily available, yet affordable, commercial products to facilitate ease of production and offer maximum flexibility in terms of brain-target locations that can be scalable (32-64 channels) based on experimental needs. Our approach allows neural activity to be recorded simultaneously with behavior and compared between micro (single unit) and more macro (local field potentials) levels of brain activity in order to gain a better understanding of how local brain regions and their connected networks support cognitive functions in rats. We believe our novel probe designs make collecting electrophysiology data easier and will begin to fill the gap in knowledge between basic and clinical research.	[Francoeur, Miranda J.; Tang, Tianzhi; Fakhraei, Leila; Wu, Xuanyu; Hulyalkar, Sidharth; Cramer, Jessica; Buscher, Nathalie; Ramanathan, Dhakshin R.] VA San Diego Healthcare Syst, Mental Hlth Serv, San Diego, CA 92161 USA; [Francoeur, Miranda J.; Tang, Tianzhi; Fakhraei, Leila; Wu, Xuanyu; Hulyalkar, Sidharth; Cramer, Jessica; Buscher, Nathalie; Ramanathan, Dhakshin R.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA		Francoeur, MJ (corresponding author), VA San Diego Healthcare Syst, Mental Hlth Serv, San Diego, CA 92161 USA.; Francoeur, MJ (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	mfrancoeur@health.ucsd.edu	Francoeur, Miranda/ABD-6626-2021	Francoeur, Miranda/0000-0001-5694-8122	Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs [71K2BX003308]; UCSD Department of Psychiatry; Burroughs Wellcome FundBurroughs Wellcome Fund [1015644]; NARSAD Young Investigators AwardNARSAD; UCSD Institute for Neural Computation Award; National Cancer Institute Cancer Center Support Grant (CCSG Grant) [P30CA23100]	This work was supported by awards from the Department of Veterans Affairs, Veterans Health Administration (Career Development Award: 71K2BX003308 to DR); start-up funds from the UCSD Department of Psychiatry to DR; a Career Award for Medical Scientists from the Burroughs Wellcome Fund to DR (1015644); a NARSAD Young Investigators Award to DR; a UCSD Institute for Neural Computation Award to LF. Histopathology was performed in part by Tissue Technology Shared Resource supported by a National Cancer Institute Cancer Center Support Grant (CCSG Grant P30CA23100).	Adams WK, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0094-17.2017; Allen M, 2018, EFFICIENT SORTING SI, DOI [10.1101/303479, DOI 10.1101/303479]; Bae WJ, 2008, IEEE ENG MED BIO, P5794, DOI 10.1109/IEMBS.2008.4650531; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bhakta SG, 2017, J NEUROSCI METH, V292, P53, DOI 10.1016/j.jneumeth.2017.07.011; Bilkey DK, 1999, J NEUROSCI METH, V92, P87, DOI 10.1016/S0165-0270(99)00102-8; Billard MW, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0261-18.2018; Black BJ, 2018, J NEUROPHYSIOL, V120, P2083, DOI 10.1152/jn.00181.2018; Buscher N, 2020, J NEUROSCI METH, V342, DOI 10.1016/j.jneumeth.2020.108761; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cham JG, 2005, J NEUROPHYSIOL, V93, P570, DOI 10.1152/jn.00369.2004; Chaure FJ, 2018, J NEUROPHYSIOL, V120, P1859, DOI 10.1152/jn.00339.2018; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; Cohen MX, 2017, TRENDS NEUROSCI, V40, P208, DOI 10.1016/j.tins.2017.02.004; Copping NA, 2017, HUM MOL GENET, V26, P3995, DOI 10.1093/hmg/ddx289; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Der-Avakian A, 2016, CURR TOP BEHAV NEURO, V28, P231, DOI 10.1007/7854_2015_5004; Dumont JR, 2021, GENES BRAIN BEHAV, V20, DOI 10.1111/gbb.12650; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Polo-Castillo LE, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00128; Eubig PA, 2014, PHARMACOL BIOCHEM BE, V118, P1, DOI 10.1016/j.pbb.2013.12.021; Fakhraei L, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0406-20.2021; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Franca ASC, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04867; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Hardung S, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00027; Harris James P., 2013, Critical Reviews in Biomedical Engineering, V41, P435; Harris KD, 2016, NAT NEUROSCI, V19, P1165, DOI 10.1038/nn.4365; He F, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101387; He W, 2006, J NEURAL ENG, V3, P316, DOI 10.1088/1741-2560/3/4/009; Herreras O, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00101; Hillman KL, 2010, J NEUROSCI, V30, P7705, DOI 10.1523/JNEUROSCI.1273-10.2010; Hong GS, 2019, NAT REV NEUROSCI, V20, P330, DOI 10.1038/s41583-019-0140-6; Horner AE, 2021, GENES BRAIN BEHAV, V20, DOI 10.1111/gbb.12723; Huang WC, 2015, ADV MATER, V27, P4186, DOI 10.1002/adma.201500136; Hultman R, 2018, CELL, V173, P166, DOI 10.1016/j.cell.2018.02.012; Hvoslef-Eide M, 2015, PSYCHOPHARMACOLOGY, V232, P4005, DOI 10.1007/s00213-015-4038-3; Im C, 2016, BIOMED ENG LETT, V6, P104, DOI 10.1007/s13534-016-0235-1; Juavinett AL, 2019, ELIFE, V8, DOI 10.7554/eLife.47188; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kangas BD, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00969-1; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; Koffarnus MN, 2011, BEHAV PHARMACOL, V22, P300, DOI 10.1097/FBP.0b013e3283473bcb; Kook G, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7100179; Kozai TDY, 2015, BIOMATERIALS, V37, P25, DOI 10.1016/j.biomaterials.2014.10.040; Laubach M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0315-18.2018; Leblois A., 2017, NEUROBIOLOGY MOTOR C, P55, DOI [10.1002/9781118873397.ch3, DOI 10.1002/9781118873397.CH3]; Lefebvre Baptiste, 2016, J Physiol Paris, V110, P327, DOI 10.1016/j.jphysparis.2017.02.005; Lo RC, 2009, BIOMED ENG-APP BAS C, V21, P39, DOI 10.4015/S1016237209001076; Luan L, 2020, NEURON, V108, P302, DOI 10.1016/j.neuron.2020.10.011; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; Luo TZ, 2020, ELIFE, V9, DOI 10.7554/eLife.59716; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Masimore B, 2004, J NEUROSCI METH, V138, P97, DOI 10.1016/j.jneumeth.2004.03.014; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; McMahon DBT, 2014, J NEUROPHYSIOL, V112, P1748, DOI 10.1152/jn.00052.2014; Musallam S, 2007, J NEUROSCI METH, V160, P122, DOI 10.1016/j.jneumeth.2006.09.005; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Nolta NF, 2015, BIOMATERIALS, V53, P753, DOI 10.1016/j.biomaterials.2015.02.081; Norris RHC, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0292-2; Obaid A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay2789; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Ojeda A, 2021, NEURAL COMPUT, V33, P2408, DOI 10.1162/neco_a_01415; Onos KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149019; Patel PR, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046009; Paxinos G, 2013, RAT STEREOTAXIC COOR; Pesaran B, 2018, NAT NEUROSCI, V21, P903, DOI 10.1038/s41593-018-0171-8; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prasad Abhishek, 2014, Front Neuroeng, V7, P2, DOI 10.3389/fneng.2014.00002; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Prestigio C, 2019, MOL NEUROBIOL, V56, P6276, DOI 10.1007/s12035-019-1506-5; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Ramanathan DS, 2018, NAT MED, V24, P1257, DOI 10.1038/s41591-018-0058-y; Rennaker RL, 2005, J NEUROSCI METH, V142, P169, DOI 10.1016/j.jneumeth.2004.08.009; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; Riceberg JS, 2017, J NEUROSCI, V37, P2010, DOI 10.1523/JNEUROSCI.2951-16.2016; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Siegle JH, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa5eea; Stalnaker TA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4926; Sweis BM, 2018, SCIENCE, V361, P178, DOI 10.1126/science.aar8644; Swindale NV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00006; Tseng WT, 2012, J NEUROSCI, V32, P16051, DOI 10.1523/JNEUROSCI.1828-12.2012; Tseng WT, 2011, J NEUROSCI METH, V201, P368, DOI 10.1016/j.jneumeth.2011.08.028; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Vandecasteele M, 2012, JOVE-J VIS EXP, DOI 10.3791/3568; Vetter RJ, 2004, IEEE T BIO-MED ENG, V51, P896, DOI 10.1109/TBME.2004.826680; Voigts J, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab77f9; Voigts J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00008; von Heimendahl M, 2012, J NEUROSCI, V32, P2129, DOI 10.1523/JNEUROSCI.3812-11.2012; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Vonder Haar C, 2016, J NEUROTRAUM, V33, P1892, DOI 10.1089/neu.2015.4276; Welle EJ, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab8343; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2016, CURR TOP BEHAV NEURO, V28, P93, DOI 10.1007/7854_2015_5014; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Yang S, 2011, J NEUROSCI METH, V195, P117, DOI 10.1016/j.jneumeth.2010.09.006	107	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	AUG 5	2021	12								678103	10.3389/fpsyt.2021.678103			21	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	UD6OY	WOS:000687326200001	34421671	Green Published, gold			2022-02-06	
